Psyllid ID: psy14626

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------25
Protein Sequence
MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKLHILGCTHK
Secondary Structure (PSIPRED)
cccccccccEEEcEEEEEEEEEEEEEcccccEEEEEEEEcccccccccHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEcccccHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEEEccccEEEEcccccEEcccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHcccEEccccccc
Secondary Structure Prediction (SSPRO)
ccccccHHHEEEccccccEEEEEEEEcccccEEEEEEEccHHEccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEcccHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccccEEEEccccccEcccccEEEEEEccccccccEEEEccccHHHccHHHHHcccEccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccEccccccc
Coil and Loop (DISEMBL)
mlsvdpnkritIHEVINHKWlkmklhtsaeiepasfglpderlnhytteADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHendiihrdikphcvllankensapvklggFGVAiqlqdgqlycsggerldhyttkaghrigtphymapeviedqkygkpvdIWAAGVLLHVLLTgtlpfvgsrdrlfqsitkgklhilgcthk
Flexible Loop (DISEMBL)
mlsvdpnkritIHEVINHKWLKMKLHTSAEIEpasfglpderlNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFqsitkgklhilgcthk
Low Complexity Region (SEG)
MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWaagvllhvlltgtlPFVGSRDRLFQSITKGKLHILGCTHK
Disordered region (IsUnstruct)
********RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKLHILGC***
Disordered Region (DISOPRED)
*LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN******DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKLHIL*****
Disordered Region (DISEMBL)
MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKLHILGCTHK
Disordered Region (DISPRO)
*LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKLHILGCTH*
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKLHILGCTHK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	249	2.2.26 [Sep-21-2011]
O14936	926	Peripheral plasma membran	yes	N/A	0.710	0.191	0.715	4e-80
O70589	926	Peripheral plasma membran	yes	N/A	0.710	0.191	0.715	4e-80
Q62915	909	Peripheral plasma membran	yes	N/A	0.710	0.194	0.715	5e-80
Q24210	898	Peripheral plasma membran	yes	N/A	0.734	0.203	0.690	1e-74
P54936	961	Protein lin-2 OS=Caenorha	yes	N/A	0.726	0.188	0.426	5e-44
Q2HJF7	488	Calcium/calmodulin-depend	no	N/A	0.686	0.350	0.444	6e-38
O77708	533	Calcium/calmodulin-depend	no	N/A	0.686	0.320	0.444	6e-38
Q95266	499	Calcium/calmodulin-depend	no	N/A	0.686	0.342	0.444	6e-38
P15791	533	Calcium/calmodulin-depend	no	N/A	0.686	0.320	0.444	6e-38
Q6PHZ2	499	Calcium/calmodulin-depend	no	N/A	0.686	0.342	0.444	7e-38

>sp|O14936|CSKP_HUMAN Peripheral plasma membrane protein CASK OS=Homo sapiens GN=CASK PE=1 SV=3

 Score =  297 bits (761), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 136/190 (71%), Positives = 162/190 (85%), Gaps = 13/190 (6%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVYSEAV
Sbjct: 58  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 117

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  L   
Sbjct: 118 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-- 175

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                      AG R+GTPH+MAPEV++ + YGKPVD+W  GV+L +LL+G LPF G+++
Sbjct: 176 -----------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 224

Query: 231 RLFQSITKGK 240
           RLF+ I KGK
Sbjct: 225 RLFEGIIKGK 234

Multidomain scaffolding protein with a role in synaptic transmembrane protein anchoring and ion channel trafficking. Contributes to neural development and regulation of gene expression via interaction with the transcription factor TRB1. Binds to cell-surface proteins, including amyloid precursor protein, neurexins and syndecans. May mediate a link between the extracellular matrix and the actin cytoskeleton via its interaction with syndecan and with the actin/spectrin-binding protein 4.1.
Homo sapiens (taxid: 9606)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O70589|CSKP_MOUSE Peripheral plasma membrane protein CASK OS=Mus musculus GN=Cask PE=1 SV=2

 Score =  297 bits (761), Expect = 4e-80,   Method: Compositional matrix adjust.
 Identities = 136/190 (71%), Positives = 162/190 (85%), Gaps = 13/190 (6%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVYSEAV
Sbjct: 58  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 117

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  L   
Sbjct: 118 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-- 175

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                      AG R+GTPH+MAPEV++ + YGKPVD+W  GV+L +LL+G LPF G+++
Sbjct: 176 -----------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 224

Query: 231 RLFQSITKGK 240
           RLF+ I KGK
Sbjct: 225 RLFEGIIKGK 234

Multidomain scaffolding protein with a role in synaptic transmembrane protein anchoring and ion channel trafficking. Contributes to neural development and regulation of gene expression via interaction with the transcription factor TRB1. Binds to cell-surface proteins, including amyloid precursor protein, neurexins, and syndecans. May mediate a link between the extracellular matrix and the actin cytoskeleton via its interaction with syndecan and with the actin/spectrin-binding protein 4.1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q62915|CSKP_RAT Peripheral plasma membrane protein CASK OS=Rattus norvegicus GN=Cask PE=1 SV=1

 Score =  297 bits (761), Expect = 5e-80,   Method: Compositional matrix adjust.
 Identities = 136/190 (71%), Positives = 162/190 (85%), Gaps = 13/190 (6%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVYSEAV
Sbjct: 58  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 117

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  L   
Sbjct: 118 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-- 175

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                      AG R+GTPH+MAPEV++ + YGKPVD+W  GV+L +LL+G LPF G+++
Sbjct: 176 -----------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 224

Query: 231 RLFQSITKGK 240
           RLF+ I KGK
Sbjct: 225 RLFEGIIKGK 234

Multidomain scaffolding protein with a role in synaptic transmembrane protein anchoring and ion channel trafficking. Contributes to neural development and regulation of gene expression via interaction with the transcription factor TRB1. Binds to cell-surface proteins, including amyloid precursor protein, neurexins, and syndecans. May mediate a link between the extracellular matrix and the actin cytoskeleton via its interaction with syndecan and with the actin/spectrin-binding protein 4.1.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q24210|CSKP_DROME Peripheral plasma membrane protein CASK OS=Drosophila melanogaster GN=CASK PE=1 SV=4

 Score =  279 bits (713), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 134/194 (69%), Positives = 156/194 (80%), Gaps = 11/194 (5%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           + ADLKREATICHMLKHPH+VELLETYSSEGMLYMVFE+M+GSD+CFE+VRRA AGFVYS
Sbjct: 55  STADLKREATICHMLKHPHIVELLETYSSEGMLYMVFEFMEGSDLCFEVVRRAVAGFVYS 114

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EAVA HYMRQ+LEALRYCHENDI+HRD++P C LLA  +NSAPVKLGGFG AIQL     
Sbjct: 115 EAVACHYMRQILEALRYCHENDILHRDVRPACALLATVDNSAPVKLGGFGSAIQLP---- 170

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
               G R    T +   R+G PHYMAPEV+  + YGK  D+W AGV+LHVLL+G LPF+G
Sbjct: 171 ----GTR---ETIETHGRVGCPHYMAPEVVTRRLYGKGCDVWGAGVMLHVLLSGRLPFLG 223

Query: 228 SRDRLFQSITKGKL 241
           S  RL QS+ +G+L
Sbjct: 224 SGVRLQQSVARGRL 237

May regulate transmembrane proteins that bind calcium, calmodulin, or nucleotides. Functionally modulates eag potassium channels; increases eag current and whole-cell conductance. Also regulates autophosphorylation of CaMKII.

Drosophila melanogaster (taxid: 7227)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|P54936|LIN2_CAEEL Protein lin-2 OS=Caenorhabditis elegans GN=lin-2 PE=1 SV=1

 Score =  177 bits (450), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 84/197 (42%), Positives = 126/197 (63%), Gaps = 16/197 (8%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++  E  IC  L+HP++  L +T +S    +++FE M+G+DICFEIV+RA+ GFV+SE V
Sbjct: 63  EIDEEIRICQNLQHPYICRLEKTINSVHYRHIIFENMEGNDICFEIVQRASNGFVFSEYV 122

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD--GQLY 168
            SHY RQ+L+AL YCH   I+HRD++PH ++LA+K+ SAP+KL GFGVA  L +  G + 
Sbjct: 123 VSHYTRQLLDALDYCHTRKIVHRDVRPHNLVLASKDTSAPLKLCGFGVAKDLSEIGGSMA 182

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
           C               R+G P +MAPE++   +     DIW++GV+L +LL G LPF GS
Sbjct: 183 CG--------------RVGVPQFMAPEIVRKDRVSCSSDIWSSGVVLFLLLAGRLPFSGS 228

Query: 229 RDRLFQSITKGKLHILG 245
              +++ I +  + + G
Sbjct: 229 TSDIYERIMQTDVDVDG 245

May play a structural role in the induction of the vulva. May be required for the localization of signal transduction molecules (such as let-23 receptor) to either the basal membrane domain or the cell junctions.

Caenorhabditis elegans (taxid: 6239)

>sp|Q2HJF7|KCC2D_BOVIN Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Bos taurus GN=CAMK2D PE=2 SV=1

 Score =  157 bits (398), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 84/189 (44%), Positives = 118/189 (62%), Gaps = 18/189 (9%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 58  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 113

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ +CH N I+HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 114 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+WA GV+L++LL G  PF    + 
Sbjct: 174 F-------------AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 220

Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 221 RLYQQIKAG 229

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|O77708|KCC2D_RABIT Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Oryctolagus cuniculus GN=CAMK2D PE=2 SV=2

 Score =  157 bits (397), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 84/189 (44%), Positives = 118/189 (62%), Gaps = 18/189 (9%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 58  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 113

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ +CH N I+HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 114 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+WA GV+L++LL G  PF    + 
Sbjct: 174 -------------FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 220

Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 221 RLYQQIKAG 229

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q95266|KCC2D_PIG Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Sus scrofa GN=CAMK2D PE=2 SV=1

 Score =  157 bits (397), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 84/189 (44%), Positives = 118/189 (62%), Gaps = 18/189 (9%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 58  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 113

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ +CH N I+HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 114 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+WA GV+L++LL G  PF    + 
Sbjct: 174 -------------FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 220

Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 221 RLYQQIKAG 229

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|P15791|KCC2D_RAT Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Rattus norvegicus GN=Camk2d PE=1 SV=1

 Score =  157 bits (397), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 84/189 (44%), Positives = 118/189 (62%), Gaps = 18/189 (9%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 58  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 113

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ +CH N I+HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 114 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+WA GV+L++LL G  PF    + 
Sbjct: 174 -------------FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 220

Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 221 RLYQQIKAG 229

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

>sp|Q6PHZ2|KCC2D_MOUSE Calcium/calmodulin-dependent protein kinase type II subunit delta OS=Mus musculus GN=Camk2d PE=1 SV=1

 Score =  157 bits (397), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 84/189 (44%), Positives = 118/189 (62%), Gaps = 18/189 (9%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 58  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 113

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ +CH N I+HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 114 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 173

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+WA GV+L++LL G  PF    + 
Sbjct: 174 -------------FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 220

Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 221 RLYQQIKAG 229

Calcium/calmodulin-dependent protein kinase involved in the regulation of Ca(2+) homeostatis and excitation-contraction coupling (ECC) in heart by targeting ion channels, transporters and accessory proteins involved in Ca(2+) influx into the myocyte, Ca(2+) release from the sarcoplasmic reticulum (SR), SR Ca(2+) uptake and Na(+) and K(+) channel transport. Targets also transcription factors and signaling molecules to regulate heart function. In its activated form, is involved in the pathogenesis of dilated cardiomyopathy and heart failure. Contributes to cardiac decompensation and heart failure by regulating SR Ca(2+) release via direct phosphorylation of RYR2 Ca(2+) channel on 'Ser-2808'. In the nucleus, phosphorylates the MEF2 repressor HDAC4, promoting its nuclear export and binding to 14-3-3 protein, and expression of MEF2 and genes involved in the hypertrophic program. Is essential for left ventricular remodeling responses to myocardial infarction. In pathological myocardial remodeling acts downstream of the beta adrenergic receptor signaling cascade to regulate key proteins involved in ECC. Regulates Ca(2+) influx to myocytes by binding and phosphorylating the L-type Ca(2+) channel subunit beta-2 CACNB2. In addition to Ca(2+) channels, can target and regulate the cardiac sarcolemmal Na(+) channel Nav1.5/SCN5A and the K+ channel Kv4.3/KCND3, which contribute to arrhythmogenesis in heart failure. Phosphorylates phospholamban (PLN/PLB), an endogenous inhibitor of SERCA2A/ATP2A2, contributing to the enhancement of SR Ca(2+) uptake that may be important in frequency-dependent acceleration of relaxation (FDAR) and maintenance of contractile function during acidosis. May participate in the modulation of skeletal muscle function in response to exercise, by regulating SR Ca(2+) transport through phosphorylation of PLN/PLB and triadin, a ryanodine receptor-coupling factor.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

EC: 7

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	249
328706210	934	PREDICTED: peripheral plasma membrane pr	0.783	0.208	0.703	9e-82
328706212	924	PREDICTED: peripheral plasma membrane pr	0.783	0.211	0.703	9e-82
328706214	949	PREDICTED: peripheral plasma membrane pr	0.783	0.205	0.703	9e-82
345490094	905	PREDICTED: peripheral plasma membrane pr	0.734	0.202	0.744	3e-81
340718335	895	PREDICTED: peripheral plasma membrane pr	0.722	0.201	0.740	3e-81
307197569	492	Peripheral plasma membrane protein CASK	0.767	0.388	0.702	3e-81
328779053	918	PREDICTED: peripheral plasma membrane pr	0.767	0.208	0.721	3e-81
307171978	470	Peripheral plasma membrane protein CASK	0.787	0.417	0.710	4e-81
380030816	918	PREDICTED: peripheral plasma membrane pr	0.767	0.208	0.721	4e-81
345490096	919	PREDICTED: peripheral plasma membrane pr	0.787	0.213	0.714	8e-81

>gi|328706210|ref|XP_001951108.2| PREDICTED: peripheral plasma membrane protein CASK-like isoform 1 [Acyrthosiphon pisum]

 Score =  309 bits (791), Expect = 9e-82,   Method: Compositional matrix adjust.
 Identities = 147/209 (70%), Positives = 169/209 (80%), Gaps = 14/209 (6%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           + +DLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS
Sbjct: 55  STSDLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 114

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EAVASHYMRQ LEA+RYCHENDIIHRDIKPHCVLLA KENSAPVKLGGFGVAIQL DG  
Sbjct: 115 EAVASHYMRQTLEAIRYCHENDIIHRDIKPHCVLLATKENSAPVKLGGFGVAIQLHDGS- 173

Query: 168 YCSGGERLD-------------HYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
             +G +  D             +  +    RIGTPH+MAPEV+E Q+YGKP D+W+AGV+
Sbjct: 174 SINGAKSFDDLSRPNLSANGQVYLQSDRQGRIGTPHFMAPEVVERQQYGKPGDVWSAGVI 233

Query: 215 LHVLLTGTLPFVGSRDRLFQSITKGKLHI 243
           LH+LL+G  PF+G+ DRL+ +I   +L+ 
Sbjct: 234 LHILLSGLTPFLGTGDRLYHNICDARLNF 262

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328706212|ref|XP_003243024.1| PREDICTED: peripheral plasma membrane protein CASK-like isoform 2 [Acyrthosiphon pisum]

 Score =  309 bits (791), Expect = 9e-82,   Method: Compositional matrix adjust.
 Identities = 147/209 (70%), Positives = 169/209 (80%), Gaps = 14/209 (6%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           + +DLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS
Sbjct: 55  STSDLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 114

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EAVASHYMRQ LEA+RYCHENDIIHRDIKPHCVLLA KENSAPVKLGGFGVAIQL DG  
Sbjct: 115 EAVASHYMRQTLEAIRYCHENDIIHRDIKPHCVLLATKENSAPVKLGGFGVAIQLHDGS- 173

Query: 168 YCSGGERLD-------------HYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
             +G +  D             +  +    RIGTPH+MAPEV+E Q+YGKP D+W+AGV+
Sbjct: 174 SINGAKSFDDLSRPNLSANGQVYLQSDRQGRIGTPHFMAPEVVERQQYGKPGDVWSAGVI 233

Query: 215 LHVLLTGTLPFVGSRDRLFQSITKGKLHI 243
           LH+LL+G  PF+G+ DRL+ +I   +L+ 
Sbjct: 234 LHILLSGLTPFLGTGDRLYHNICDARLNF 262

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328706214|ref|XP_003243025.1| PREDICTED: peripheral plasma membrane protein CASK-like isoform 3 [Acyrthosiphon pisum]

 Score =  308 bits (790), Expect = 9e-82,   Method: Compositional matrix adjust.
 Identities = 147/209 (70%), Positives = 169/209 (80%), Gaps = 14/209 (6%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           + +DLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS
Sbjct: 55  STSDLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 114

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EAVASHYMRQ LEA+RYCHENDIIHRDIKPHCVLLA KENSAPVKLGGFGVAIQL DG  
Sbjct: 115 EAVASHYMRQTLEAIRYCHENDIIHRDIKPHCVLLATKENSAPVKLGGFGVAIQLHDGS- 173

Query: 168 YCSGGERLD-------------HYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
             +G +  D             +  +    RIGTPH+MAPEV+E Q+YGKP D+W+AGV+
Sbjct: 174 SINGAKSFDDLSRPNLSANGQVYLQSDRQGRIGTPHFMAPEVVERQQYGKPGDVWSAGVI 233

Query: 215 LHVLLTGTLPFVGSRDRLFQSITKGKLHI 243
           LH+LL+G  PF+G+ DRL+ +I   +L+ 
Sbjct: 234 LHILLSGLTPFLGTGDRLYHNICDARLNF 262

Source: Acyrthosiphon pisum

Species: Acyrthosiphon pisum

Genus: Acyrthosiphon

Family: Aphididae

Order: Hemiptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345490094|ref|XP_001602666.2| PREDICTED: peripheral plasma membrane protein CASK-like isoform 1 [Nasonia vitripennis]

 Score =  307 bits (786), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 146/196 (74%), Positives = 164/196 (83%), Gaps = 13/196 (6%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           + ADLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSD+CFE+VRRATAGFVYS
Sbjct: 55  STADLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDLCFEVVRRATAGFVYS 114

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EAVASHYMRQ+LEALRYCHENDIIHRD+KP C LLA KENSAPVKL GFGVA+QL   Q 
Sbjct: 115 EAVASHYMRQILEALRYCHENDIIHRDLKPQCALLAGKENSAPVKLRGFGVAVQLPSSQ- 173

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                       T    RIG PH+MAPEVI  ++YGKP D+W+AGVLLHVLLTGTLPFVG
Sbjct: 174 ------------TNGVGRIGCPHFMAPEVILRRQYGKPGDVWSAGVLLHVLLTGTLPFVG 221

Query: 228 SRDRLFQSITKGKLHI 243
           SR+RL +SI +G++ +
Sbjct: 222 SRERLRESICRGRVQM 237

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340718335|ref|XP_003397624.1| PREDICTED: peripheral plasma membrane protein CASK-like isoform 2 [Bombus terrestris] gi|350401680|ref|XP_003486226.1| PREDICTED: peripheral plasma membrane protein CASK-like isoform 1 [Bombus impatiens]

 Score =  307 bits (786), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 143/193 (74%), Positives = 163/193 (84%), Gaps = 13/193 (6%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSD+CFE+VRRATAGFVYSEAV
Sbjct: 58  DLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDLCFEVVRRATAGFVYSEAV 117

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCHENDIIHRD+KP C LLA KENSAPVKL GF VA+QLQ  Q    
Sbjct: 118 ASHYMRQILEALRYCHENDIIHRDLKPQCALLAGKENSAPVKLRGFSVAVQLQSSQANGV 177

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
           G             R+G PH+MAPEV++ ++YGKP D+W+AGVLLHVLLTGTLPFVGSRD
Sbjct: 178 G-------------RVGCPHFMAPEVVQRRQYGKPGDVWSAGVLLHVLLTGTLPFVGSRD 224

Query: 231 RLFQSITKGKLHI 243
           RL ++I +G++ +
Sbjct: 225 RLREAICRGRVQM 237

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307197569|gb|EFN78780.1| Peripheral plasma membrane protein CASK [Harpegnathos saltator]

 Score =  307 bits (786), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 149/212 (70%), Positives = 173/212 (81%), Gaps = 21/212 (9%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           + ADLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSD+CFE+VRRATAGFVYS
Sbjct: 78  STADLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDLCFEVVRRATAGFVYS 137

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EAVASHYMRQ+LEALRYCHENDIIHRD+KP C LLA KENSAPVKL GFGVA+QL   Q 
Sbjct: 138 EAVASHYMRQILEALRYCHENDIIHRDLKPQCALLAGKENSAPVKLRGFGVAVQLPTSQ- 196

Query: 168 YCSGGERLDHYTTK----------------AGHRIGTPHYMAPEVIEDQKYGKPVDIWAA 211
             S G  ++ YTT+                +  R+G PH+MAPEVI+ ++YGKP D+W+A
Sbjct: 197 --SNG--VECYTTEYRQCLSPKGQLYLKADSEGRVGCPHFMAPEVIQRRQYGKPGDVWSA 252

Query: 212 GVLLHVLLTGTLPFVGSRDRLFQSITKGKLHI 243
           GVLLHVLLTGTLPFVGSRDRL ++I +G++ +
Sbjct: 253 GVLLHVLLTGTLPFVGSRDRLREAICRGRVQM 284

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|328779053|ref|XP_394821.4| PREDICTED: peripheral plasma membrane protein CASK-like isoform 1 [Apis mellifera]

 Score =  307 bits (786), Expect = 3e-81,   Method: Compositional matrix adjust.
 Identities = 148/205 (72%), Positives = 170/205 (82%), Gaps = 14/205 (6%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSD+CFE+VRRATAGFVYSEAV
Sbjct: 58  DLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDLCFEVVRRATAGFVYSEAV 117

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCHENDIIHRD+KP C LLA KENSAPVKL GF VA+QLQ  Q   +
Sbjct: 118 ASHYMRQILEALRYCHENDIIHRDLKPQCALLAGKENSAPVKLRGFSVAVQLQTSQ--AN 175

Query: 171 GGERLDHYTT----------KAGH--RIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
           G E  + Y            KA +  R+G PH+MAPEVI+ ++YGKP D+W+AGVLLHVL
Sbjct: 176 GVEYYNEYRQCLSPKGQLYLKADNEGRVGCPHFMAPEVIQRRQYGKPGDVWSAGVLLHVL 235

Query: 219 LTGTLPFVGSRDRLFQSITKGKLHI 243
           LTGTLPFVGSRDRL ++I +G++ +
Sbjct: 236 LTGTLPFVGSRDRLREAICRGRVQM 260

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307171978|gb|EFN63587.1| Peripheral plasma membrane protein CASK [Camponotus floridanus]

 Score =  306 bits (785), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 147/207 (71%), Positives = 170/207 (82%), Gaps = 11/207 (5%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           + ADLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSD+CFE+VRRATAGFVYS
Sbjct: 51  STADLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDLCFEVVRRATAGFVYS 110

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL---QD 164
           EAVASHYMRQ+LEALRYCHENDIIHRD+KP C LLA KENSAPVKL GFGVA+QL   Q 
Sbjct: 111 EAVASHYMRQILEALRYCHENDIIHRDLKPQCALLAGKENSAPVKLRGFGVAVQLPTSQS 170

Query: 165 GQLYCSGGERLDHYTTK--------AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLH 216
             + C   E     + K        +  R+G PH+MAPEVI+ ++YGKP D+W+AGVLLH
Sbjct: 171 NGVACYTTEYRQCLSPKGQLYLKADSEGRVGCPHFMAPEVIQRRQYGKPGDVWSAGVLLH 230

Query: 217 VLLTGTLPFVGSRDRLFQSITKGKLHI 243
           VLLTGTLPFVGSRDRL ++I +G++ +
Sbjct: 231 VLLTGTLPFVGSRDRLREAICRGRVQM 257

Source: Camponotus floridanus

Species: Camponotus floridanus

Genus: Camponotus

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380030816|ref|XP_003699037.1| PREDICTED: peripheral plasma membrane protein CASK-like [Apis florea]

 Score =  306 bits (785), Expect = 4e-81,   Method: Compositional matrix adjust.
 Identities = 148/205 (72%), Positives = 169/205 (82%), Gaps = 14/205 (6%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSD+CFE+VRRATAGFVYSEAV
Sbjct: 58  DLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDLCFEVVRRATAGFVYSEAV 117

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCHENDIIHRD+KP C LLA KENSAPVKL GF VA+QLQ  Q   +
Sbjct: 118 ASHYMRQILEALRYCHENDIIHRDLKPQCALLAGKENSAPVKLRGFSVAVQLQSSQ--AN 175

Query: 171 GGERLDHYTT----------KAGH--RIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
           G E  + Y            KA +  R+G PH+MAPEVI+ ++YGKP D+W+AGVLLHVL
Sbjct: 176 GVEYYNEYRQCLSPKGQLYLKADNEGRVGCPHFMAPEVIQRRQYGKPGDVWSAGVLLHVL 235

Query: 219 LTGTLPFVGSRDRLFQSITKGKLHI 243
           LTGTLPFVGSRDRL  +I +G++ +
Sbjct: 236 LTGTLPFVGSRDRLRDAICRGRVQM 260

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345490096|ref|XP_003426296.1| PREDICTED: peripheral plasma membrane protein CASK-like [Nasonia vitripennis]

 Score =  305 bits (782), Expect = 8e-81,   Method: Compositional matrix adjust.
 Identities = 148/207 (71%), Positives = 169/207 (81%), Gaps = 11/207 (5%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           + ADLKREATICHMLKHPH+VELLETYSSEGMLYMVFEYMDGSD+CFE+VRRATAGFVYS
Sbjct: 55  STADLKREATICHMLKHPHIVELLETYSSEGMLYMVFEYMDGSDLCFEVVRRATAGFVYS 114

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ- 166
           EAVASHYMRQ+LEALRYCHENDIIHRD+KP C LLA KENSAPVKL GFGVA+QL   Q 
Sbjct: 115 EAVASHYMRQILEALRYCHENDIIHRDLKPQCALLAGKENSAPVKLRGFGVAVQLPSSQT 174

Query: 167 --LYCSGGERLDHYTTKAG--------HRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLH 216
             + C   E   + + K           RIG PH+MAPEVI  ++YGKP D+W+AGVLLH
Sbjct: 175 NGVECYTTEYRPYLSPKGQVYLKVDNEGRIGCPHFMAPEVILRRQYGKPGDVWSAGVLLH 234

Query: 217 VLLTGTLPFVGSRDRLFQSITKGKLHI 243
           VLLTGTLPFVGSR+RL +SI +G++ +
Sbjct: 235 VLLTGTLPFVGSRERLRESICRGRVQM 261

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	249
ZFIN|ZDB-GENE-020802-4	920	cask "calcium/calmodulin-depen	0.738	0.2	0.656	9.2e-68
UNIPROTKB|E1BWL4	920	CASK "Uncharacterized protein"	0.722	0.195	0.675	1.9e-67
UNIPROTKB|A5D7B9	908	CASK "CASK protein" [Bos tauru	0.722	0.198	0.675	1.9e-67
UNIPROTKB|E2RLG1	921	CASK "Uncharacterized protein"	0.722	0.195	0.675	1.9e-67
UNIPROTKB|J9NZ27	897	CASK "Uncharacterized protein"	0.722	0.200	0.675	1.9e-67
UNIPROTKB|F8W998	909	CASK "Peripheral plasma membra	0.722	0.198	0.675	1.9e-67
UNIPROTKB|H9KV37	921	CASK "Peripheral plasma membra	0.722	0.195	0.675	1.9e-67
UNIPROTKB|O14936	926	CASK "Peripheral plasma membra	0.722	0.194	0.675	1.9e-67
UNIPROTKB|Q5JS74	590	CASK "Peripheral plasma membra	0.722	0.305	0.675	1.9e-67
UNIPROTKB|K7GSB2	908	CASK "Uncharacterized protein"	0.722	0.198	0.675	1.9e-67

ZFIN|ZDB-GENE-020802-4 cask "calcium/calmodulin-dependent serine protein kinase" [Danio rerio (taxid:7955)]

 Score = 688 (247.2 bits), Expect = 9.2e-68, P = 9.2e-68
 Identities = 130/198 (65%), Positives = 158/198 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+I+HRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIVHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGKLHIL 244
             G+++RLF++I KGK  ++
Sbjct:   221 GTKERLFEAIIKGKYKVM 238

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|E1BWL4 CASK "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0001953 "negative regulation of cell-matrix adhesion" evidence=IEA

GO:0005604 "basement membrane" evidence=IEA

GO:0005652 "nuclear lamina" evidence=IEA

GO:0005730 "nucleolus" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0010839 "negative regulation of keratinocyte proliferation" evidence=IEA

GO:0016323 "basolateral plasma membrane" evidence=IEA

GO:0016363 "nuclear matrix" evidence=IEA

GO:0042043 "neurexin family protein binding" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0061045 "negative regulation of wound healing" evidence=IEA

GO:0070509 "calcium ion import" evidence=IEA

GO:0090280 "positive regulation of calcium ion import" evidence=IEA

GO:0090288 "negative regulation of cellular response to growth factor stimulus" evidence=IEA

UNIPROTKB|A5D7B9 CASK "CASK protein" [Bos taurus (taxid:9913)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0090288 "negative regulation of cellular response to growth factor stimulus" evidence=IEA

GO:0090280 "positive regulation of calcium ion import" evidence=IEA

GO:0070509 "calcium ion import" evidence=IEA

GO:0061045 "negative regulation of wound healing" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0045202 "synapse" evidence=IEA

GO:0042043 "neurexin family protein binding" evidence=IEA

GO:0016363 "nuclear matrix" evidence=IEA

GO:0016323 "basolateral plasma membrane" evidence=IEA

GO:0010839 "negative regulation of keratinocyte proliferation" evidence=IEA

GO:0005911 "cell-cell junction" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0005730 "nucleolus" evidence=IEA

GO:0005652 "nuclear lamina" evidence=IEA

GO:0005604 "basement membrane" evidence=IEA

GO:0001953 "negative regulation of cell-matrix adhesion" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|E2RLG1 CASK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|J9NZ27 CASK "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

UNIPROTKB|F8W998 CASK "Peripheral plasma membrane protein CASK" [Homo sapiens (taxid:9606)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|H9KV37 CASK "Peripheral plasma membrane protein CASK" [Homo sapiens (taxid:9606)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|O14936 CASK "Peripheral plasma membrane protein CASK" [Homo sapiens (taxid:9606)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005516 "calmodulin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005829 "cytosol" evidence=IEA

GO:0016323 "basolateral plasma membrane" evidence=IEA

GO:0042043 "neurexin family protein binding" evidence=IEA

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=IEA

GO:0070509 "calcium ion import" evidence=IEA

GO:0090280 "positive regulation of calcium ion import" evidence=IEA

GO:0005886 "plasma membrane" evidence=TAS

GO:0004385 "guanylate kinase activity" evidence=TAS

GO:0007155 "cell adhesion" evidence=TAS

GO:0015629 "actin cytoskeleton" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0042734 "presynaptic membrane" evidence=ISS

GO:0060170 "cilium membrane" evidence=ISS

GO:0005604 "basement membrane" evidence=IDA

GO:0016363 "nuclear matrix" evidence=IDA

GO:0005652 "nuclear lamina" evidence=IDA

GO:0010839 "negative regulation of keratinocyte proliferation" evidence=IMP

GO:0005730 "nucleolus" evidence=IDA

GO:0005911 "cell-cell junction" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0090288 "negative regulation of cellular response to growth factor stimulus" evidence=IMP

GO:0061045 "negative regulation of wound healing" evidence=IMP

GO:0001953 "negative regulation of cell-matrix adhesion" evidence=IMP

UNIPROTKB|Q5JS74 CASK "Peripheral plasma membrane protein CASK" [Homo sapiens (taxid:9606)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|K7GSB2 CASK "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 685 (246.2 bits), Expect = 1.9e-67, P = 1.9e-67
 Identities = 131/194 (67%), Positives = 155/194 (79%)

Query:    47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             +TE DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVY
Sbjct:    55 STE-DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY 113

Query:   107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
             SEAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  
Sbjct:   114 SEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG 173

Query:   167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
             L              AG R+GTPH+MAPEV++ + YGKPVD+W              PF 
Sbjct:   174 LV-------------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 220

Query:   227 GSRDRLFQSITKGK 240
             G+++RLF+ I KGK
Sbjct:   221 GTKERLFEGIIKGK 234

GO:0005524 "ATP binding" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O14936	CSKP_HUMAN	2, ., 7, ., 1, 1, ., 1	0.7157	0.7108	0.1911	yes	N/A
Q62915	CSKP_RAT	2, ., 7, ., 1, 1, ., 1	0.7157	0.7108	0.1947	yes	N/A
Q24210	CSKP_DROME	2, ., 7, ., 1, 1, ., 1, 7	0.6907	0.7349	0.2037	yes	N/A
O70589	CSKP_MOUSE	2, ., 7, ., 1, 1, ., 1	0.7157	0.7108	0.1911	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	249
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-59
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-47
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-44
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-40
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-36
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-36
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-35
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-33
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	9e-33
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-31
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-31
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	6e-31
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-31
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-30
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-30
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-29
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-28
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-27
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-26
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-26
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-26
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-26
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-26
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-25
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-25
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-25
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-25
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-25
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-24
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-24
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-24
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-24
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-24
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-23
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-23
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-23
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-23
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-23
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-23
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-23
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-22
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-22
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-22
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-22
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-22
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-22
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-22
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	6e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-21
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-21
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-21
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-21
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-21
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-21
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-21
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-21
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	7e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-21
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	9e-21
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-20
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-20
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-20
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-20
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-20
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-20
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	3e-20
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-20
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-20
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-20
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-20
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-20
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-19
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-19
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-19
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-18
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-18
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-18
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-18
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-18
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	7e-18
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-17
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-17
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-17
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-17
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-17
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-17
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-16
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	5e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-15
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-15
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-15
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-15
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	8e-15
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-15
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-14
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-14
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-14
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-14
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	6e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	8e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-13
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	8e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-13
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-12
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-12
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	6e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-12
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-11
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-11
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-11
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-11
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	8e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	3e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-10
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	8e-10
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-10
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	9e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-09
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-09
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-08
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-08
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-08
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-08
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	9e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-07
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-07
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-07
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-07
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-07
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-07
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-07
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-07
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-06
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	5e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	8e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-05
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-05
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	3e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	0.001
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	0.002
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	0.003
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  186 bits (476), Expect = 5e-59
 Identities = 77/195 (39%), Positives = 103/195 (52%), Gaps = 23/195 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
            + RE  I   LKHP++V L + +  E  LY+V EY +G D+   + +R       SE  
Sbjct: 43  RILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDE 98

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  Y+RQ+L AL Y H   I+HRD+KP  +LL    +   VKL  FG+A QL  G+   +
Sbjct: 99  ARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGH---VKLADFGLARQLDPGEKLTT 155

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                          +GTP YMAPEV+  + YGK VDIW+ GV+L+ LLTG  PF G   
Sbjct: 156 --------------FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQ 201

Query: 231 --RLFQSITKGKLHI 243
              LF+ I K K   
Sbjct: 202 LLELFKKIGKPKPPF 216

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  157 bits (400), Expect = 2e-47
 Identities = 69/195 (35%), Positives = 92/195 (47%), Gaps = 25/195 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  I   L HP++V L++ +  +  LY+V EY +G D+   + R    G   SE  A  
Sbjct: 47  REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKK 102

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+L  L Y H N IIHRD+KP  +LL        VK+  FG+A      +L  S   
Sbjct: 103 IALQILRGLEYLHSNGIIHRDLKPENILLDENGV---VKIADFGLA-----KKLLKSSS- 153

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDR- 231
                       +GTP YMAPEV+     YG  VD+W+ GV+L+ LLTG  PF G     
Sbjct: 154 -------SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILD 206

Query: 232 ---LFQSITKGKLHI 243
              L + I    L  
Sbjct: 207 QLQLIRRILGPPLEF 221

Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  149 bits (380), Expect = 1e-44
 Identities = 60/192 (31%), Positives = 94/192 (48%), Gaps = 17/192 (8%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
            D   E  I   L HP++++  E++  +G L +V EY DG D+  +I ++   G  + E 
Sbjct: 44  EDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE 103

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
               +  Q+  AL+Y H   I+HRDIKP  + L +      VKLG FG++  L       
Sbjct: 104 QILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSSTVDLA 160

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-S 228
                    T      +GTP+Y++PE+ +++ Y    DIW+ G +L+ L T   PF G +
Sbjct: 161 K--------TV-----VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207

Query: 229 RDRLFQSITKGK 240
              L   I KG+
Sbjct: 208 LLELALKILKGQ 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  138 bits (349), Expect = 2e-40
 Identities = 57/169 (33%), Positives = 84/169 (49%), Gaps = 19/169 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +L RE  I   L HP++V+L   +  E  LY+V EY +G  +  ++++        SE  
Sbjct: 37  ELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL-KDLLKENEGKL--SEDE 93

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
               + Q+LE L Y H N IIHRD+KP  +LL +      VKL  FG++  L   +    
Sbjct: 94  ILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGK--VKLADFGLSKLLTSDKSLLK 151

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVL 218
                          +GTP YMAPEV+  +  Y +  DIW+ GV+L+ L
Sbjct: 152 T-------------IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  129 bits (326), Expect = 2e-36
 Identities = 64/192 (33%), Positives = 104/192 (54%), Gaps = 15/192 (7%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +  E  I    + P+VV+L  ++  +  LY+V EY+ G D    ++    +     E VA
Sbjct: 40  VLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD-LASLLENVGS---LDEDVA 95

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQLYCS 170
             Y+ +++ AL Y H N IIHRD+KP  +L+   +++  +KL  FG++ + L   Q+  +
Sbjct: 96  RIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLN 152

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR 229
             E+ D         +GTP Y+APEVI  Q + K VD W+ G +L+  L G  PF G + 
Sbjct: 153 DDEKEDKRI------VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206

Query: 230 DRLFQSITKGKL 241
           + +FQ+I  GK+
Sbjct: 207 EEIFQNILNGKI 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  128 bits (324), Expect = 4e-36
 Identities = 63/201 (31%), Positives = 95/201 (47%), Gaps = 24/201 (11%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
              +  +  E  I     HP +V+L  T+  +  +YM+ EY  G ++ + I+R       
Sbjct: 34  TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL-WTILRDRGL--- 89

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
           + E  A  Y+  V+ A  Y H   II+RD+KP  +LL +      VKL  FG A +L+ G
Sbjct: 90  FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN---GYVKLVDFGFAKKLKSG 146

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           Q              K     GTP Y+APE+I ++ Y   VD W+ G+LL+ LLTG  PF
Sbjct: 147 Q--------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF 192

Query: 226 VGSRD---RLFQSITKGKLHI 243
               +    ++  I KG   +
Sbjct: 193 GEDDEDPMEIYNDILKGNGKL 213

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  128 bits (325), Expect = 4e-36
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 16/195 (8%)

Query: 53  KREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           K E  +   L  HP +++L  T+  E  LY V EY    ++  + +R+  +     E   
Sbjct: 49  KIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELL-QYIRKYGS---LDEKCT 104

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL---- 167
             Y  ++L AL Y H   IIHRD+KP  +LL    +   +K+  FG A  L         
Sbjct: 105 RFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH---IKITDFGTAKVLDPNSSPESN 161

Query: 168 ---YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                +   +++    +    +GT  Y++PE++ ++  GK  D+WA G +++ +LTG  P
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Query: 225 FVGSRDRL-FQSITK 238
           F GS + L FQ I K
Sbjct: 222 FRGSNEYLTFQKILK 236

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  126 bits (320), Expect = 2e-35
 Identities = 58/176 (32%), Positives = 86/176 (48%), Gaps = 20/176 (11%)

Query: 52  LKREATICHMLKHPHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           L+RE  I   L+HP++V    +   E    L +  EY+ G  +   ++++        E 
Sbjct: 46  LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLS-SLLKKFGK---LPEP 101

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
           V   Y RQ+LE L Y H N I+HRDIK   +L+ +      VKL  FG A +L D +   
Sbjct: 102 VIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGDIETGE 158

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                        G   GTP++MAPEVI  ++YG+  DIW+ G  +  + TG  P+
Sbjct: 159 GT-----------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  125 bits (316), Expect = 9e-35
 Identities = 64/195 (32%), Positives = 99/195 (50%), Gaps = 31/195 (15%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +  E  I    KHP++V+  ++Y     L++V EYMDG  +  +I+ +       +E   
Sbjct: 62  IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT-DIITQNFVRM--NEPQI 118

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           ++  R+VL+ L Y H  ++IHRDIK   +LL+   +   VKL  FG A QL         
Sbjct: 119 AYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQL--------- 166

Query: 172 GERLDHYTTKAGHR---IGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
                  T +   R   +GTP++MAPEVI+ + YG  VDIW+ G++   +  G  P++  
Sbjct: 167 -------TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL-- 217

Query: 229 RDR----LFQSITKG 239
           R+     LF   TKG
Sbjct: 218 REPPLRALFLITTKG 232

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  122 bits (308), Expect = 6e-34
 Identities = 52/175 (29%), Positives = 82/175 (46%), Gaps = 26/175 (14%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEIVRRATAGFVYSEAV 110
            E  I    KHP++V+   +Y  +  L++V E+  G    D+        +     +E+ 
Sbjct: 46  NEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLL------KSTNQTLTESQ 99

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            ++  +++L+ L Y H N IIHRDIK   +LL +      VKL  FG++ QL D +    
Sbjct: 100 IAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD---GEVKLIDFGLSAQLSDTK---- 152

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                          +GTP++MAPEVI  + Y    DIW+ G+    L  G  P+
Sbjct: 153 ----------ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY 197

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  123 bits (308), Expect = 4e-33
 Identities = 69/212 (32%), Positives = 98/212 (46%), Gaps = 14/212 (6%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHP-HVVELLETYSSEGMLYMVFEYMDGSDICFEI 96
           L  +  +         RE  I   L HP ++V+L + +  EG LY+V EY+DG  +  ++
Sbjct: 30  LAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSL-EDL 88

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
           +++       SE+ A   + Q+L AL Y H   IIHRDIKP  +LL    +   VKL  F
Sbjct: 89  LKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL--DRDGRVVKLIDF 146

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGV 213
           G+A  L D                     +GTP YMAPEV+            DIW+ G+
Sbjct: 147 GLAKLLPDPGST-------SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI 199

Query: 214 LLHVLLTGTLPFVGSRDRLFQSITKGKLHILG 245
            L+ LLTG  PF G ++    S T   +  L 
Sbjct: 200 TLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Length = 384

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 9e-33
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 21/190 (11%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
             E  I   + HP +V+L   + +E  LY+V EY  G ++   + +       +SE  A 
Sbjct: 41  LTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE----GRFSEERAR 96

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y  +++ AL Y H   II+RD+KP  +LL    +   +KL  FG+A +L       +  
Sbjct: 97  FYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH---IKLTDFGLAKELSSEGSRTNT- 152

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDR 231
                         GTP Y+APEV+  + YGK VD W+ GVLL+ +LTG  PF    R  
Sbjct: 153 ------------FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE 200

Query: 232 LFQSITKGKL 241
           +++ I K  L
Sbjct: 201 IYEKILKDPL 210

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  116 bits (292), Expect = 2e-31
 Identities = 53/176 (30%), Positives = 83/176 (47%), Gaps = 21/176 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
            E  I   L HP +V L  ++  E  +Y+V + + G D+ + + ++      +SE     
Sbjct: 49  NERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKF 104

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ +++ AL Y H   IIHRDIKP  +LL   +    V +  F +A ++    L      
Sbjct: 105 WICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLT----- 156

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR 229
                T+ +G    TP YMAPEV+  Q Y   VD W+ GV  +  L G  P+ G  
Sbjct: 157 -----TSTSG----TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  116 bits (293), Expect = 2e-31
 Identities = 62/184 (33%), Positives = 95/184 (51%), Gaps = 23/184 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   LKHP++V+LL+   +E  LY+VFEY D  D+  + + +       S  +   
Sbjct: 47  REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDL-KKYLDKRPGPL--SPNLIKS 102

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
            M Q+L  L YCH + I+HRD+KP  +L+ N++    +KL  FG+A            G 
Sbjct: 103 IMYQLLRGLAYCHSHRILHRDLKPQNILI-NRDGV--LKLADFGLARAF---------GI 150

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS--RD 230
            L  YT    H + T  Y APE++   + Y   VDIW+ G +   ++TG   F G    D
Sbjct: 151 PLRTYT----HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID 206

Query: 231 RLFQ 234
           +LF+
Sbjct: 207 QLFK 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 6e-31
 Identities = 60/179 (33%), Positives = 89/179 (49%), Gaps = 26/179 (14%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GS--DICFEIVRRATAGFVY 106
             + +E  +   LKHP++V+ + +  +   LY++ EY + GS   I      +    F  
Sbjct: 44  KSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQII-----KKFGPF-- 96

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
            E++ + Y+ QVL+ L Y HE  +IHRDIK   +L   K+    VKL  FGVA +L D  
Sbjct: 97  PESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT-TKDGV--VKLADFGVATKLND-- 151

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                    D  +      +GTP++MAPEVIE        DIW+ G  +  LLTG  P+
Sbjct: 152 ------VSKDDASV-----VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  115 bits (289), Expect = 8e-31
 Identities = 65/178 (36%), Positives = 96/178 (53%), Gaps = 20/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L+H ++V L E +  +G LY+VFEY++ +    E++  +  G    +AV S 
Sbjct: 49  REVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT--LLELLEASPGGLPP-DAVRS- 104

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+A+ YCH ++IIHRDIKP  +L+   E+   +KL  FG A  L+          
Sbjct: 105 YIWQLLQAIAYCHSHNIIHRDIKPENILV--SESGV-LKLCDFGFARALR-----ARPAS 156

Query: 174 RLDHYTTKAGHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
            L  Y       + T  Y APE+ + D  YGKPVD+WA G ++  LL G   F G  D
Sbjct: 157 PLTDY-------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  114 bits (288), Expect = 1e-30
 Identities = 62/190 (32%), Positives = 101/190 (53%), Gaps = 24/190 (12%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
             E  I   ++HP +V L  ++  +  LY+V EY+ G ++ F  +R++     + E VA 
Sbjct: 49  LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL-FSHLRKSGR---FPEPVAR 104

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y  QV+ AL Y H  DI++RD+KP  +LL +      +K+  FG A +++         
Sbjct: 105 FYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVKGRT------ 155

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDR 231
                YT       GTP Y+APE+I  + YGK VD WA G+L++ +L G  PF   +  +
Sbjct: 156 -----YTL-----CGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205

Query: 232 LFQSITKGKL 241
           +++ I +GK+
Sbjct: 206 IYEKILEGKV 215

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  112 bits (282), Expect = 7e-30
 Identities = 59/178 (33%), Positives = 90/178 (50%), Gaps = 20/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE       +HP+VV+LL+ +       +V EYM  SD+  E++R         EA    
Sbjct: 48  REIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDL-SEVLRDEERPL--PEAQVKS 103

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YMR +L+ + Y H N I+HRD+KP  +L++       +K+  FG+A      +L+     
Sbjct: 104 YMRMLLKGVAYMHANGIMHRDLKPANLLISADGV---LKIADFGLA------RLFSEEEP 154

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
           RL  Y+    H++ T  Y APE++   +KY   VD+WA G +   LL G+  F G  D
Sbjct: 155 RL--YS----HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  110 bits (277), Expect = 2e-29
 Identities = 53/180 (29%), Positives = 80/180 (44%), Gaps = 19/180 (10%)

Query: 62  LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           + HP+++   E +     L +V EY    D+   I +R     +  E        Q+L  
Sbjct: 56  VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
           L+  HE  I+HRD+K   +LL   +    VK+G  G++  L+                  
Sbjct: 116 LQALHEQKILHRDLKSANILLVANDL---VKIGDLGISKVLKKNMAKT------------ 160

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK 240
              +IGTPHYMAPEV + + Y    DIW+ G LL+ + T   PF   S   L   + +GK
Sbjct: 161 ---QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK 217

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 2e-28
 Identities = 57/178 (32%), Positives = 95/178 (53%), Gaps = 21/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP++++LL+ +  +G LY+VFE+MD +D+  ++++    G    E++   
Sbjct: 47  REIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLY-KLIKDRQRGL--PESLIKS 102

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + I+HRD+KP  +L+        +KL  FG+A            G 
Sbjct: 103 YLYQLLQGLAFCHSHGILHRDLKPENLLI--NTEGV-LKLADFGLARSF---------GS 150

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
            +  YT    H + T  Y APE++  D+ Y  PVDIW+ G +   LL+    F G  +
Sbjct: 151 PVRPYT----HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  107 bits (270), Expect = 3e-28
 Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 21/175 (12%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L RE       + P+VV+    +  EG + +V EYMDG  +    + +        E V 
Sbjct: 46  LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSL--ADLLKKVGKI--PEPVL 101

Query: 112 SHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ++  RQ+L+ L Y H +  IIHRDIKP  +L+ N +    VK+  FG++  L++    C+
Sbjct: 102 AYIARQILKGLDYLHTKRHIIHRDIKPSNLLI-NSKGE--VKIADFGISKVLENTLDQCN 158

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                          +GT  YM+PE I+ + Y    DIW+ G+ L     G  PF
Sbjct: 159 T-------------FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  106 bits (268), Expect = 5e-28
 Identities = 49/165 (29%), Positives = 74/165 (44%), Gaps = 23/165 (13%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC--FEIVRRATAGFVYSE 108
           ++ +E +I      P++V+   +Y     L++V EY     +    +I  +       +E
Sbjct: 44  EIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-----TLTE 98

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
              +  + Q L+ L Y H N  IHRDIK   +LL  +      KL  FGV+ QL D    
Sbjct: 99  EEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDTM-- 153

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGV 213
                       K    IGTP +MAPEVI++  Y    DIW+ G+
Sbjct: 154 -----------AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGI 187

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  106 bits (266), Expect = 3e-27
 Identities = 62/182 (34%), Positives = 93/182 (51%), Gaps = 21/182 (11%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           KHP + +L   + ++  L+ V EY++G D+ F I R       + E  A  Y  +++  L
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGL 109

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           ++ HE  II+RD+K   VLL   ++   +K+  FG+          C  G      T+  
Sbjct: 110 QFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGM----------CKEGILGGVTTSTF 156

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL 241
               GTP Y+APE++  Q YG  VD WA GVLL+ +L G  PF G   D LFQSI + ++
Sbjct: 157 ---CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213

Query: 242 HI 243
             
Sbjct: 214 RY 215

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 4e-27
 Identities = 62/182 (34%), Positives = 89/182 (48%), Gaps = 30/182 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSE--GMLYMVFEYMD----GSDICFEIVRRATAGFVYS 107
           RE  +   L+HP++V L E  +S+  G +YMVFEYMD    G      ++      F  +
Sbjct: 47  REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKF--T 98

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E+    YM+Q+LE L+Y H N I+HRDIK   +L+ N      +KL  FG+A        
Sbjct: 99  ESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYT---- 151

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                     YT    +R+ T  Y  PE++    +YG  VD+W+ G +L  L  G   F 
Sbjct: 152 ----KRNSADYT----NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203

Query: 227 GS 228
           GS
Sbjct: 204 GS 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  103 bits (259), Expect = 2e-26
 Identities = 62/178 (34%), Positives = 93/178 (52%), Gaps = 21/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L+H ++V L+E +  +  LY+VFE++D +    + + +   G    E+    
Sbjct: 49  REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT--VLDDLEKYPNGL--DESRVRK 104

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L  + +CH ++IIHRDIKP  +L++    S  VKL  FG A  L       + GE
Sbjct: 105 YLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLA------APGE 155

Query: 174 RLDHYTTKAGHRIGTPHYMAPE-VIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
               Y       + T  Y APE ++ D KYG+ VDIWA G L+  +LTG   F G  D
Sbjct: 156 VYTDY-------VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  104 bits (261), Expect = 2e-26
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 29/199 (14%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           A  K E  I   +KHP +V+L+  + + G LY++ EY+ G ++   + R      ++ E 
Sbjct: 45  AHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFMED 100

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDGQL- 167
            A  Y+ ++  AL + H+  II+RD+KP  +LL  + +   VKL  FG+  + + +G + 
Sbjct: 101 TACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH---VKLTDFGLCKESIHEGTVT 157

Query: 168 --YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
             +C                 GT  YMAPE++    +GK VD W+ G L++ +LTG  PF
Sbjct: 158 HTFC-----------------GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF 200

Query: 226 VG-SRDRLFQSITKGKLHI 243
              +R +    I KGKL++
Sbjct: 201 TAENRKKTIDKILKGKLNL 219

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  102 bits (257), Expect = 2e-26
 Identities = 58/177 (32%), Positives = 90/177 (50%), Gaps = 16/177 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +L++E        HP+VV+   ++     L++V  Y+ G     +I++ +       EA+
Sbjct: 45  ELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS-LLDIMKSSYPRGGLDEAI 103

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            +  +++VL+ L Y H N  IHRDIK   +LL   E+ + VK+  FGV+  L D      
Sbjct: 104 IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG--EDGS-VKIADFGVSASLAD------ 154

Query: 171 GGERLDHYTTKAGHR-IGTPHYMAPEVIE-DQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           GG+R    T K     +GTP +MAPEV+E    Y    DIW+ G+    L TG  P+
Sbjct: 155 GGDR----TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  102 bits (256), Expect = 3e-26
 Identities = 60/191 (31%), Positives = 97/191 (50%), Gaps = 18/191 (9%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           K+E  +   +KHP++V    ++   G L++V EY DG D+   I R+   G ++SE    
Sbjct: 47  KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQR--GVLFSEDQIL 104

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            +  Q+   L++ H+  I+HRDIK   + L+  +N    KLG FG+A QL D        
Sbjct: 105 SWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDS------- 155

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDR 231
                    A   +GTP+Y++PE+ +++ Y    DIW+ G +L+ L T   PF G +  +
Sbjct: 156 ------MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209

Query: 232 LFQSITKGKLH 242
           L   I +G   
Sbjct: 210 LVLKICQGYFA 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  103 bits (258), Expect = 4e-26
 Identities = 59/175 (33%), Positives = 92/175 (52%), Gaps = 21/175 (12%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP +  L  T+ ++  L+ V EY++G D+ F I         + EA A  Y  +++  L
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR----FDEARARFYAAEIICGL 109

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           ++ H+  II+RD+K   VLL   +    +K+  FG+  +  +G+              KA
Sbjct: 110 QFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGE-------------GKA 153

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI 236
               GTP Y+APE+++ QKY + VD W+ GVLL+ +L G  PF G   D LF SI
Sbjct: 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  103 bits (258), Expect = 4e-26
 Identities = 62/188 (32%), Positives = 99/188 (52%), Gaps = 24/188 (12%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E +I   L HP +V ++ ++  E  +Y + E++ G ++ F  +R+A     +   VA  Y
Sbjct: 68  EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL-FTHLRKAGR---FPNDVAKFY 123

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             +++ A  Y H  DII+RD+KP  +LL NK +   VK+  FG A ++ D          
Sbjct: 124 HAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH---VKVTDFGFAKKVPDRT-------- 172

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLF 233
              +T       GTP Y+APEVI+ + +GK VD W  GVLL+  + G  PF   +  R++
Sbjct: 173 ---FTL-----CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY 224

Query: 234 QSITKGKL 241
           + I  G+L
Sbjct: 225 EKILAGRL 232

Length = 329

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 7e-26
 Identities = 55/174 (31%), Positives = 88/174 (50%), Gaps = 17/174 (9%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+ E  +   L+H  +V+       +  L +  EYM G  +  ++      G + +E V 
Sbjct: 51  LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL---KAYGAL-TETVT 106

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             Y RQ+LE + Y H N I+HRDIK   +L   ++++  VKLG FG + +LQ   +  SG
Sbjct: 107 RKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQ--TICSSG 161

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                   T      GTP++M+PEVI  + YG+  D+W+ G  +  +LT   P+
Sbjct: 162 --------TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  100 bits (252), Expect = 1e-25
 Identities = 58/179 (32%), Positives = 92/179 (51%), Gaps = 23/179 (12%)

Query: 52  LKREATICHMLKHPHVVEL--LETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           +  E  +  +LKHP++V+   +E +  +  ++M  EY  G  +  E++     G +  E 
Sbjct: 46  IADEMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTL-EELLEH---GRILDEH 99

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
           V   Y  Q+LE L Y H + I+HRDIKP  + L    ++  +KLG FG A++L++     
Sbjct: 100 VIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTTM 156

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGVLLHVLLTGTLPF 225
             GE +           GTP YMAPEVI   K   +G+  DIW+ G ++  + TG  P+
Sbjct: 157 --GEEVQSLA-------GTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  101 bits (254), Expect = 2e-25
 Identities = 57/175 (32%), Positives = 89/175 (50%), Gaps = 21/175 (12%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           KHP +  L   + ++  L+ V EY++G D+ F+I R       + E  +  Y  +V  AL
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLAL 109

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            + H + +I+RD+K   +LL   +     KL  FG+          C  G      TT  
Sbjct: 110 MFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGM----------CKEGILNGVTTTTF 156

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF-VGSRDRLFQSI 236
               GTP Y+APE++++ +YG  VD WA GVL++ ++ G  PF   + D LF+SI
Sbjct: 157 ---CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  100 bits (251), Expect = 2e-25
 Identities = 57/189 (30%), Positives = 88/189 (46%), Gaps = 26/189 (13%)

Query: 62  LKHPHVVELL--ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY-SEAVASHYMRQV 118
           LKHP++V         S   LY+V EY +G D+  +++++      Y  E      + Q+
Sbjct: 56  LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCKKERKYIEEEFIWRILTQL 114

Query: 119 LEALRYCH-----ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           L AL  CH      N ++HRD+KP  + L    N   VKLG FG+A  L     +     
Sbjct: 115 LLALYECHNRSDPGNTVLHRDLKPANIFLDANNN---VKLGDFGLAKILGHDSSFAKT-- 169

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRL 232
                       +GTP+YM+PE +    Y +  DIW+ G L++ L   + PF   ++ +L
Sbjct: 170 -----------YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL 218

Query: 233 FQSITKGKL 241
              I +GK 
Sbjct: 219 ASKIKEGKF 227

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 2e-25
 Identities = 50/175 (28%), Positives = 79/175 (45%), Gaps = 21/175 (12%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
            D+++E       + P++ +   ++     L+++ EY  G   C ++++         E 
Sbjct: 44  EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS-CLDLLKPGK----LDET 98

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
             +  +R+VL  L Y HE   IHRDIK   +LL+       VKL  FGV+ QL       
Sbjct: 99  YIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE---EGDVKLADFGVSGQLTSTM--- 152

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                     +K    +GTP +MAPEVI+   Y +  DIW+ G+    L  G  P
Sbjct: 153 ----------SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 3e-25
 Identities = 60/194 (30%), Positives = 98/194 (50%), Gaps = 24/194 (12%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E  +  E  +   + HP ++ L  T   +  LYM+ EY+ G ++ F  +R +     +S 
Sbjct: 45  EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL-FSYLRNSGR---FSN 100

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           +    Y  +++ AL Y H  +I++RD+KP  +LL +KE    +KL  FG A +L+D    
Sbjct: 101 STGLFYASEIVCALEYLHSKEIVYRDLKPENILL-DKEGH--IKLTDFGFAKKLRD---- 153

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
                       +     GTP Y+APEVI+ + + K VD WA G+L++ +L G  PF   
Sbjct: 154 ------------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201

Query: 229 R-DRLFQSITKGKL 241
               +++ I  GKL
Sbjct: 202 NPFGIYEKILAGKL 215

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 99.1 bits (247), Expect = 5e-25
 Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 19/188 (10%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
            EA +   L   +++   E++  +G L +V EY +  D+   +  +   G    E     
Sbjct: 48  DEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLL--KMQRGRPLPEDQVWR 105

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  Q+L  L + H   I+HRDIK   + L   +N   VK+G  GVA  L D   +     
Sbjct: 106 FFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKLLSDNTNF----- 157

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF-VGSRDRL 232
                   A   +GTP+Y++PE+ ED+ Y +  D+WA GV+L+   TG  PF   ++  L
Sbjct: 158 --------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL 209

Query: 233 FQSITKGK 240
              I +G 
Sbjct: 210 ILKIIRGV 217

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 99.5 bits (248), Expect = 1e-24
 Identities = 60/176 (34%), Positives = 85/176 (48%), Gaps = 21/176 (11%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           K P + +L   + +   LY V EY++G D+ + I +       + E  A  Y  ++   L
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGL 114

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            + H   II+RD+K   V+L   +    +K+  FG+          C         TT+ 
Sbjct: 115 FFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGM----------CKEN-IFGGKTTRT 160

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT 237
               GTP Y+APE+I  Q YGK VD WA GVLL+ +L G  PF G   D LFQSI 
Sbjct: 161 --FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 98.0 bits (244), Expect = 1e-24
 Identities = 58/189 (30%), Positives = 97/189 (51%), Gaps = 21/189 (11%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           ++E  +   +KHP++V+  E++   G LY+V +Y +G D+  +I   A  G ++ E    
Sbjct: 47  RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI--NAQRGVLFPEDQIL 104

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            +  Q+  AL++ H+  I+HRDIK   + L        +KLG FG+A             
Sbjct: 105 DWFVQICLALKHVHDRKILHRDIKSQNIFLTK---DGTIKLGDFGIA------------- 148

Query: 173 ERLDHYTTK-AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF-VGSRD 230
            R+ + T + A   IGTP+Y++PE+ E++ Y    DIWA G +L+ + T    F  G+  
Sbjct: 149 -RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK 207

Query: 231 RLFQSITKG 239
            L   I +G
Sbjct: 208 NLVLKIIRG 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 2e-24
 Identities = 58/184 (31%), Positives = 86/184 (46%), Gaps = 36/184 (19%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEI 96
           +E L  +  E D+  E       KHP++V L E Y  E  L+++ E+ DG     I  E+
Sbjct: 43  EEELEDFMVEIDILSE------CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL 96

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R        +E    +  RQ+LEAL + H + +IHRD+K   +LL    +   VKL  F
Sbjct: 97  ER------GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD---VKLADF 147

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIWAA 211
           GV+ + +               T      IGTP++MAPEV+     +D  Y    DIW+ 
Sbjct: 148 GVSAKNKS--------TLQKRDTF-----IGTPYWMAPEVVACETFKDNPYDYKADIWSL 194

Query: 212 GVLL 215
           G+ L
Sbjct: 195 GITL 198

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 98.4 bits (246), Expect = 2e-24
 Identities = 56/173 (32%), Positives = 88/173 (50%), Gaps = 22/173 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   LKHP+++ LL+ +  +  + +VFE+M+ +D+  E V +  +  V + A    
Sbjct: 51  REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDL--EKVIKDKS-IVLTPADIKS 106

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM   L  L Y H N I+HRD+KP+ +L+A+      +KL  FG+A          S G 
Sbjct: 107 YMLMTLRGLEYLHSNWILHRDLKPNNLLIASD---GVLKLADFGLA---------RSFGS 154

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                T    H++ T  Y APE++   + YG  VD+W+ G +   LL    PF
Sbjct: 155 PNRKMT----HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 97.0 bits (241), Expect = 3e-24
 Identities = 58/190 (30%), Positives = 92/190 (48%), Gaps = 19/190 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D ++EA +   +KHP++V   E++ ++G LY+V EY DG D+  +I  +   G ++ E  
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKI--KLQRGKLFPEDT 101

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              +  Q+   +++ HE  ++HRDIK   + L        VKLG FG A           
Sbjct: 102 ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK---VKLGDFGSA----------- 147

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF-VGSR 229
               L      A   +GTP+Y+ PE+ E+  Y    DIW+ G +L+ L T   PF   S 
Sbjct: 148 --RLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW 205

Query: 230 DRLFQSITKG 239
             L   + +G
Sbjct: 206 KNLILKVCQG 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 96.4 bits (241), Expect = 8e-24
 Identities = 55/175 (31%), Positives = 91/175 (52%), Gaps = 23/175 (13%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP++V+L E +     LY VFEYM+G+   +++++    G  +SE+V    + Q+L+ L
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYMEGN--LYQLMKDRK-GKPFSESVIRSIIYQILQGL 112

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            + H++   HRD+KP  +L++  E    VK+  FG+A ++               YT   
Sbjct: 113 AHIHKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREI----------RSRPPYTD-- 157

Query: 183 GHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR--DRLFQ 234
              + T  Y APE++     Y  PVDIWA G ++  L T    F GS   D+L++
Sbjct: 158 --YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 95.6 bits (238), Expect = 1e-23
 Identities = 54/178 (30%), Positives = 88/178 (49%), Gaps = 18/178 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   E  I  +L+HP+++     +  +  L +  EY +G  +  +IVR+   G ++ E +
Sbjct: 45  DALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK--GQLFEEEM 102

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y+ Q++ A+ Y H+  I+HRDIK   + L  K     +KLG FG++  L        
Sbjct: 103 VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL-TKAGL--IKLGDFGISKILGSE----- 154

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
                    + A   +GTP+YM+PE+ +  KY    DIWA G +L+ LLT    F  +
Sbjct: 155 --------YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 96.7 bits (241), Expect = 1e-23
 Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 22/175 (12%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP +V L   + +E  +  V EY  G D+   I        V+SE  A  Y   V+  L
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGL 114

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           +Y HEN I++RD+K   +LL  +     VK+  FG+          C  G     +  + 
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTE---GFVKIADFGL----------CKEGM---GFGDRT 158

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI 236
               GTP ++APEV+ +  Y + VD W  GVL++ +L G  PF G   + +F SI
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI 213

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.8 bits (236), Expect = 2e-23
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 26/179 (14%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
             L++E  +   L+HP++V+ L T   E  LY+  E + G  +  +++++  +   + E 
Sbjct: 47  KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGS---FPEP 102

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL--QDGQL 167
           V   Y RQ+L  L Y H+ + +HRDIK   +L+   + +  VKL  FG+A Q+       
Sbjct: 103 VIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAK 159

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPF 225
                              G+P++MAPEVI  Q  YG   DIW+ G  +  + TG  P+
Sbjct: 160 SFK----------------GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW 202

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 94.5 bits (236), Expect = 3e-23
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 24/208 (11%)

Query: 42  RLNHYTTEADLK---REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIV 97
            L    +E + K   +EA +   L HP+VV LL   + E  LY+V EYM+G D+  +   
Sbjct: 30  TLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRK 89

Query: 98  RRATAGFVYSEAVAS----HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKL 153
            R          ++      +  Q+ + + Y      +HRD+     L+        VK+
Sbjct: 90  SRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV---VKI 146

Query: 154 GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGV 213
             FG++  + D   Y                      +MAPE ++D  +    D+W+ GV
Sbjct: 147 SDFGLSRDVYDDDYYRKKTGGKLPI-----------RWMAPESLKDGIFTSKSDVWSFGV 195

Query: 214 LLHVLLT-GTLPFVG-SRDRLFQSITKG 239
           LL  + T G  P+ G S + + + + KG
Sbjct: 196 LLWEIFTLGATPYPGLSNEEVLEYLRKG 223

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 94.5 bits (236), Expect = 3e-23
 Identities = 52/182 (28%), Positives = 78/182 (42%), Gaps = 20/182 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
              +  REA I   L HP++V+LL   + E  L +V EYM G D       R       S
Sbjct: 44  QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGD--LLDYLRKNRPKELS 101

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            +    +  Q+   + Y    + IHRD+     L+        VK+  FG++  L D   
Sbjct: 102 LSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDDDY 158

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
           Y   G +L             P  +MAPE +++ K+    D+W+ GVLL  + T G  P+
Sbjct: 159 YKVKGGKL-------------PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY 205

Query: 226 VG 227
            G
Sbjct: 206 PG 207

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 94.1 bits (235), Expect = 3e-23
 Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 24/190 (12%)

Query: 43  LNHYTTE---ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           L    +E    +  REA I   L HP+VV+LL   + E  LY+V EYM+G D     +R+
Sbjct: 36  LKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGD-LLSYLRK 94

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                  S+ +   +  Q+   + Y    + IHRD+     L+        VK+  FG++
Sbjct: 95  NRPKLSLSDLL--SFALQIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLS 149

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
             L D   Y   G +L             P  +MAPE +++ K+    D+W+ GVLL  +
Sbjct: 150 RDLYDDDYYRKRGGKL-------------PIRWMAPESLKEGKFTSKSDVWSFGVLLWEI 196

Query: 219 LT-GTLPFVG 227
            T G  P+ G
Sbjct: 197 FTLGEQPYPG 206

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 94.4 bits (235), Expect = 3e-23
 Identities = 57/192 (29%), Positives = 81/192 (42%), Gaps = 19/192 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  +E  +   L HP+V++ L ++     L +V E  D  D+   I        +  E  
Sbjct: 48  DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL + H   I+HRDIKP  V +        VKLG  G+            
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITAT---GVVKLGDLGL------------ 152

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
            G      TT A   +GTP+YM+PE I +  Y    DIW+ G LL+ +     PF G + 
Sbjct: 153 -GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Query: 231 ---RLFQSITKG 239
               L + I K 
Sbjct: 212 NLYSLCKKIEKC 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.5 bits (235), Expect = 3e-23
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 20/177 (11%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L RE  +   L+H ++V+ L +      L +  EY+ G  +   +         + E + 
Sbjct: 53  LAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA----FEETLV 108

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
            +++RQ+L+ L Y H   IIHRDIK   +L+ NK     +K+  FG++ +L+   L    
Sbjct: 109 RNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSL---- 161

Query: 172 GERLDHYTTKAGHRI---GTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                  T   G R    G+  +MAPEV++   Y +  DIW+ G L+  +LTG  PF
Sbjct: 162 ------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 94.1 bits (234), Expect = 4e-23
 Identities = 56/193 (29%), Positives = 92/193 (47%), Gaps = 26/193 (13%)

Query: 51  DLKREATICHMLKH-PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           ++K E  I  +    P+V +L  ++ S+  LY+V EY++G D C  +++  T G    E 
Sbjct: 42  NVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGD-CASLIK--TLG-GLPED 97

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
            A  Y+ +V+  +   H+  IIHRDIKP  +L+   + +  +KL  FG++          
Sbjct: 98  WAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLS---------- 144

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF-VGS 228
               R      K    +GTP Y+APE I      K  D W+ G ++   L G  PF   +
Sbjct: 145 ----RNGLENKKF---VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197

Query: 229 RDRLFQSITKGKL 241
            D +F +I   ++
Sbjct: 198 PDAVFDNILSRRI 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 95.1 bits (236), Expect = 4e-23
 Identities = 56/185 (30%), Positives = 92/185 (49%), Gaps = 25/185 (13%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A  Y
Sbjct: 45  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFY 100

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             +++ AL Y H  D+++RDIK   ++L   +    +K+  FG+          C  G  
Sbjct: 101 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGL----------CKEG-- 145

Query: 175 LDHYTTKAGHRI--GTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDR 231
               +  A  +   GTP Y+APEV+ED  YG+ VD W  GV+++ ++ G LPF     +R
Sbjct: 146 ---ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 202

Query: 232 LFQSI 236
           LF+ I
Sbjct: 203 LFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 94.4 bits (235), Expect = 4e-23
 Identities = 59/173 (34%), Positives = 91/173 (52%), Gaps = 29/173 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   LKHP++V L+E +  +  L++VFEY D + +  E+ +           V  H
Sbjct: 49  REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHT-VLNELEK-------NPRGVPEH 100

Query: 114 YMR----QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
            ++    Q L+A+ +CH+++ IHRD+KP  +L+  K+    +KL  FG A  L       
Sbjct: 101 LIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI-TKQGQ--IKLCDFGFARIL------- 150

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTG 221
           +G    D YT      + T  Y APE++  D +YG PVD+WA G +   LLTG
Sbjct: 151 TGPG--DDYT----DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 95.1 bits (236), Expect = 5e-23
 Identities = 69/214 (32%), Positives = 104/214 (48%), Gaps = 35/214 (16%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           DE ++   TE  +  +A+      HP +V L   + +E  L+ V EY++G D+ F + R+
Sbjct: 36  DEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 90

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E  A  Y  ++  AL Y HE  II+RD+K   VLL   ++   +KL  +G+ 
Sbjct: 91  RK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGM- 142

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL 219
                    C  G R    T+      GTP+Y+APE++  + YG  VD WA GVL+  ++
Sbjct: 143 ---------CKEGLRPGDTTSTF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190

Query: 220 TGTLPF--VGSRDR--------LFQSITKGKLHI 243
            G  PF  VGS D         LFQ I + ++ I
Sbjct: 191 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 224

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 2e-22
 Identities = 56/176 (31%), Positives = 77/176 (43%), Gaps = 24/176 (13%)

Query: 54  REATICHMLKHPHVVELLETYSSE--GMLYMVFEYMDGS--DICFEIVRRATAGFVYSEA 109
           RE  I    K P++V+    +  E    + +  EY +G   D  ++ V++        E 
Sbjct: 48  RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGG--RIGEK 105

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
           V       VL+ L Y H   IIHRDIKP  +LL  K     VKL  FGV+     G+L  
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVN 157

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           S           AG   GT  YMAPE I+ + Y    D+W+ G+ L  +     PF
Sbjct: 158 SL----------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 93.3 bits (232), Expect = 2e-22
 Identities = 61/190 (32%), Positives = 96/190 (50%), Gaps = 21/190 (11%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           K E  I   + HP +V+L   + +EG LY++ +++ G D+      R +   +++E    
Sbjct: 46  KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVK 101

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y+ ++  AL + H   II+RD+KP  +LL   +    +KL  FG++             
Sbjct: 102 FYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLS------------K 146

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDR 231
           E +DH   KA    GT  YMAPEV+  + + +  D W+ GVL+  +LTG+LPF G  R  
Sbjct: 147 ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE 205

Query: 232 LFQSITKGKL 241
               I K KL
Sbjct: 206 TMTMILKAKL 215

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 93.0 bits (231), Expect = 3e-22
 Identities = 62/189 (32%), Positives = 94/189 (49%), Gaps = 27/189 (14%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEI--VRRATAGFVYSEAV 110
           KR  ++     HP + +L   + +   L+ V E+++G D+ F I   RR      + EA 
Sbjct: 46  KRILSLAR--NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR------FDEAR 97

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  Y  ++  AL + H+  II+RD+K   VLL   ++    KL  FG+          C 
Sbjct: 98  ARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGM----------CK 144

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR 229
            G   +  TT      GTP Y+APE++++  YG  VD WA GVLL+ +L G  PF   + 
Sbjct: 145 EGIF-NGKTTST--FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201

Query: 230 DRLFQSITK 238
           D LF++I  
Sbjct: 202 DDLFEAILN 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 92.2 bits (229), Expect = 3e-22
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 19/195 (9%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  +R+     EA    E  I   +    VV L   Y ++  L +V   M+G D+ F I 
Sbjct: 33  LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 92

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
                GF   E  A  Y  ++   L   H   I++RD+KP  +LL   ++   +++   G
Sbjct: 93  NMGNPGF--DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLG 147

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A+++ +G+            T +   R+GT  YMAPEV+++++Y    D W  G L++ 
Sbjct: 148 LAVEIPEGE------------TIRG--RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYE 193

Query: 218 LLTGTLPFVGSRDRL 232
           ++ G  PF   ++++
Sbjct: 194 MIEGKSPFRQRKEKV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 3e-22
 Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 30/208 (14%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   L HP +  L  ++ +E  L +V +Y  G +     + +   G   SE VA  Y
Sbjct: 51  EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGE--LFRLLQRQPGKCLSEEVARFY 108

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLL----------------ANKENSAPVKLGGFG- 157
             +VL AL Y H   I++RD+KP  +LL                ++ E     K    G 
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168

Query: 158 ---VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
                  +           R + +       +GT  Y+APEVI    +G  VD W  G+L
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSF-------VGTEEYIAPEVISGDGHGSAVDWWTLGIL 221

Query: 215 LHVLLTGTLPFVGS-RDRLFQSITKGKL 241
           L+ +L GT PF GS RD  F +I K ++
Sbjct: 222 LYEMLYGTTPFKGSNRDETFSNILKKEV 249

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 91.8 bits (228), Expect = 3e-22
 Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 19/171 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +    +V L   + ++  L +V   M+G D+ + I      GF   EA A  Y
Sbjct: 43  EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGF--PEARAIFY 100

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++  L + H+  I++RD+KP  VLL +  N   V++   G+A++L+ G+        
Sbjct: 101 AAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN---VRISDLGLAVELKGGK-------- 149

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                 K   R GTP YMAPEV++ + Y   VD +A G  L+ ++ G  PF
Sbjct: 150 ----KIKG--RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 92.1 bits (229), Expect = 3e-22
 Identities = 53/171 (30%), Positives = 85/171 (49%), Gaps = 21/171 (12%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I    +HP++VE+  +Y     L++V E+++G  +  +IV   T   +  E +A+  
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIAT-V 120

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
              VL+AL + H   +IHRDIK   +LL +      VKL  FG   Q+            
Sbjct: 121 CLAVLKALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKE--------- 168

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                 +    +GTP++MAPEVI    YG  VDIW+ G+++  ++ G  P+
Sbjct: 169 ----VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 92.8 bits (230), Expect = 4e-22
 Identities = 60/175 (34%), Positives = 88/175 (50%), Gaps = 21/175 (12%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           K P + +L   + +   LY V EY++G D+ + I +       + E  A  Y  ++   L
Sbjct: 59  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGL 114

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            + H   II+RD+K   V+L   ++   +K+  FG+  +             +D  TT+ 
Sbjct: 115 FFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKE-----------HMVDGVTTRT 160

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRLFQSI 236
               GTP Y+APE+I  Q YGK VD WA GVLL+ +L G  PF G   D LFQSI
Sbjct: 161 --FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.5 bits (227), Expect = 5e-22
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 15/174 (8%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L++E  +   L HPH++ +L     +    +  E+M G  +   + +       + EAV 
Sbjct: 50  LRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA----FKEAVI 105

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
            +Y  Q+L  L Y HEN IIHRD+K   +L+        +++  FG A +L       + 
Sbjct: 106 INYTEQLLRGLSYLHENQIIHRDVKGANLLI--DSTGQRLRIADFGAAARLA------AK 157

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           G     +    G  +GT  +MAPEV+  ++YG+  D+W+ G ++  + T   P+
Sbjct: 158 GTGAGEFQ---GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 91.8 bits (228), Expect = 6e-22
 Identities = 62/181 (34%), Positives = 92/181 (50%), Gaps = 21/181 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I    ++P VV +  ++ ++  L MV EY++G D C  +++   A  V    +A  Y
Sbjct: 51  ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGD-CATLLKNIGALPV---DMARMY 106

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV--------AIQLQDGQ 166
             + + AL Y H   I+HRD+KP  +L+ +  +   +KL  FG+           L +G 
Sbjct: 107 FAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMSLTTNLYEGH 163

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
           +     E LD          GTP Y+APEVI  Q YGKPVD WA G++L+  L G +PF 
Sbjct: 164 IEKDTREFLDKQVC------GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217

Query: 227 G 227
           G
Sbjct: 218 G 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 91.6 bits (227), Expect = 6e-22
 Identities = 68/196 (34%), Positives = 102/196 (52%), Gaps = 22/196 (11%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           D   N    E  L RE  +   LK  ++VEL E +   G LY+VFEY++ +    E++  
Sbjct: 36  DSEENEEVKETTL-RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN--MLELLEE 92

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
              G V  E V S Y+ Q+++A+ +CH+NDI+HRDIKP  +L+++ +    +KL  FG A
Sbjct: 93  MPNG-VPPEKVRS-YIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFA 147

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL 219
             L +G           +YT      + T  Y +PE++    YGK VD+W+ G +L  L 
Sbjct: 148 RNLSEGS--------NANYT----EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELS 195

Query: 220 TGTLPFVGSR--DRLF 233
            G   F G    D+LF
Sbjct: 196 DGQPLFPGESEIDQLF 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 91.1 bits (226), Expect = 1e-21
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 41/232 (17%)

Query: 5   DPNKRITIHEVINHK-----WLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATIC 59
           DP K+ T  E I        +  + + T  E+      L  +           K+E  I 
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP----------KKELIIN 65

Query: 60  HML-----KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
            +L     KHP++V  L++Y     L++V EY+ G  +  ++V          E   +  
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCM----DEGQIAAV 120

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            R+ L+AL + H N +IHRDIK   +LL        VKL  FG   Q+   Q        
Sbjct: 121 CRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ-------- 169

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                +K    +GTP++MAPEV+  + YG  VDIW+ G++   ++ G  P++
Sbjct: 170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 91.4 bits (227), Expect = 1e-21
 Identities = 56/182 (30%), Positives = 95/182 (52%), Gaps = 25/182 (13%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP +  L  ++ +   L  V EY +G ++ F + R      V+SE  A  Y  +++ AL
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSAL 108

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDGQLYCSGGERLDHYTTK 181
            Y H  D+++RD+K   ++L   +    +K+  FG+  + + DG             T K
Sbjct: 109 GYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA------------TMK 153

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD--RLFQSITKG 239
                GTP Y+APEV+ED  YG+ VD W  GV+++ ++ G LPF  ++D  +LF+ I   
Sbjct: 154 T--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELILME 210

Query: 240 KL 241
           ++
Sbjct: 211 EI 212

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 91.6 bits (227), Expect = 1e-21
 Identities = 61/175 (34%), Positives = 88/175 (50%), Gaps = 21/175 (12%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           K P + +L   + +   LY V EY++G D+ ++I +       + E  A  Y  ++   L
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGL 114

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            + H   II+RD+K   V+L   ++   +K+  FG+  +              D  TTK 
Sbjct: 115 FFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE-----------NMWDGVTTKT 160

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRLFQSI 236
               GTP Y+APE+I  Q YGK VD WA GVLL+ +L G  PF G   D LFQSI
Sbjct: 161 --FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 1e-21
 Identities = 53/170 (31%), Positives = 78/170 (45%), Gaps = 28/170 (16%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEIVRRATAGFVY 106
             +++E ++    +HP++V    +Y     L++V EY  G    DI +++ R        
Sbjct: 45  EIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDI-YQVTRGP-----L 98

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           SE   ++  R+ L+ L Y HE   IHRDIK   +LL        VKL  FGV+ Q     
Sbjct: 99  SELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQ----- 150

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGV 213
                   L     K    IGTP++MAPEV   ++   Y    DIWA G+
Sbjct: 151 --------LTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 1e-21
 Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 25/182 (13%)

Query: 50  ADLKREATICHMLKH---PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           +D++RE  +   L+    P++ +   +Y     L+++ EY +G  +    + +A      
Sbjct: 44  SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGP---I 98

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           +E   S  +R+VL AL+Y H+  +IHRDIK   +L+ N  N   VKL  FGVA  L    
Sbjct: 99  AEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQN- 154

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                       ++K    +GTP++MAPEVI E + Y    DIW+ G+ ++ + TG  P+
Sbjct: 155 ------------SSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY 202

Query: 226 VG 227
             
Sbjct: 203 SD 204

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 90.6 bits (224), Expect = 2e-21
 Identities = 54/172 (31%), Positives = 86/172 (50%), Gaps = 21/172 (12%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +   LK+P++V  L+++     L++V EY+ G  +  ++V          EA  +  
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT-DVVTET----CMDEAQIAAV 120

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            R+ L+AL + H N +IHRDIK   VLL        VKL  FG   Q+   Q        
Sbjct: 121 CRECLQALEFLHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQ-------- 169

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                +K    +GTP++MAPEV+  + YG  VDIW+ G++   ++ G  P++
Sbjct: 170 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 58/205 (28%), Positives = 85/205 (41%), Gaps = 39/205 (19%)

Query: 45  HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD-----ICFEIVRR 99
           H   E D+  +A        P +V+L  ++  E  LY+V EYM G D     I  ++   
Sbjct: 47  HVRAERDILADA------DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE 100

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
            TA F  +E V          AL   H+   IHRDIKP  +L+    +   +KL  FG+ 
Sbjct: 101 ETARFYIAELVL---------ALDSVHKLGFIHRDIKPDNILIDADGH---IKLADFGLC 148

Query: 160 IQLQDG--QLYCSGGERLDHYTTKAGHR--------------IGTPHYMAPEVIEDQKYG 203
            ++     + Y         +      R              +GTP Y+APEV+    YG
Sbjct: 149 KKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG 208

Query: 204 KPVDIWAAGVLLHVLLTGTLPFVGS 228
              D W+ GV+L+ +L G  PF   
Sbjct: 209 LECDWWSLGVILYEMLYGFPPFYSD 233

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 90.5 bits (225), Expect = 2e-21
 Identities = 62/189 (32%), Positives = 86/189 (45%), Gaps = 30/189 (15%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           +E   H  TE D      I    K   +V+LL  +  +  LY+  EY+ G D  F  +  
Sbjct: 43  NEV-RHVLTERD------ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGD--FRTLLN 93

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                V SE  A  YM ++ EA+   HE   IHRD+KP   L+   + S  +KL  FG++
Sbjct: 94  NLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLS 148

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL 219
                      G        T A   +G+P YMAPEV+  + Y   VD W+ G +L+  L
Sbjct: 149 ----------KGI------VTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFL 192

Query: 220 TGTLPFVGS 228
            G  PF GS
Sbjct: 193 CGFPPFSGS 201

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 89.6 bits (222), Expect = 2e-21
 Identities = 60/181 (33%), Positives = 92/181 (50%), Gaps = 15/181 (8%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+ E  +   LKH ++V+ L T   +  + +  E++ G  I   I+ R        E V 
Sbjct: 49  LQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSIS-SILNRFGP---LPEPVF 104

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             Y +Q+L+ + Y H N ++HRDIK + V+L     +  +KL  FG A +L    L+ + 
Sbjct: 105 CKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARRLAWVGLHGTH 161

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDR 231
              L     K+ H  GTP++MAPEVI +  YG+  DIW+ G  +  + TG  P   S DR
Sbjct: 162 SNML-----KSMH--GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL-ASMDR 213

Query: 232 L 232
           L
Sbjct: 214 L 214

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 91.0 bits (226), Expect = 2e-21
 Identities = 52/166 (31%), Positives = 79/166 (47%), Gaps = 26/166 (15%)

Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
             +V+L   +  +  LYMV EYM G D+         + +   E  A  Y  +V+ AL  
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLV-----NLMSNYDIPEKWARFYTAEVVLALDA 157

Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGERLDHYTTKAG 183
            H    IHRD+KP  +LL   + S  +KL  FG  +++  +G + C              
Sbjct: 158 IHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTA----------- 203

Query: 184 HRIGTPHYMAPEVIEDQ----KYGKPVDIWAAGVLLHVLLTGTLPF 225
             +GTP Y++PEV++ Q     YG+  D W+ GV L+ +L G  PF
Sbjct: 204 --VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 89.1 bits (222), Expect = 3e-21
 Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 21/189 (11%)

Query: 43  LNHYTTE---ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           L    +E    +   EA+I   L HP++V LL   +    LY+V EYM G D+  + +R+
Sbjct: 36  LKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDL-LDFLRK 94

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   + +      Q+ + + Y    + +HRD+     L+        VK+  FG++
Sbjct: 95  HGEKLTLKDLL--QMALQIAKGMEYLESKNFVHRDLAARNCLVTENLV---VKISDFGLS 149

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL 219
             + +           D Y  K G       +MAPE ++D K+    D+W+ GVLL  + 
Sbjct: 150 RDIYE-----------DDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198

Query: 220 T-GTLPFVG 227
           T G  P+ G
Sbjct: 199 TLGEQPYPG 207

Length = 258

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 90.1 bits (223), Expect = 3e-21
 Identities = 65/230 (28%), Positives = 110/230 (47%), Gaps = 33/230 (14%)

Query: 8   KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHV 67
           K I + E  + K+  MK+     I      +  + + H  TE+ + +        +HP +
Sbjct: 10  KVILVREKASGKYYAMKILKKEVI------IAKDEVAHTLTESRVLKNT------RHPFL 57

Query: 68  VELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE 127
             L  ++ ++  L  V EY++G ++ F + R      V+SE     Y  +++ AL Y H 
Sbjct: 58  TSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHS 113

Query: 128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIG 187
             I++RD+K   ++L   +    +K+  FG+          C  G   D  T K     G
Sbjct: 114 GKIVYRDLKLENLML---DKDGHIKITDFGL----------CKEG-ITDAATMKT--FCG 157

Query: 188 TPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRLFQSI 236
           TP Y+APEV+ED  YG+ VD W  GV+++ ++ G LPF     ++LF+ I
Sbjct: 158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 89.6 bits (222), Expect = 4e-21
 Identities = 59/187 (31%), Positives = 93/187 (49%), Gaps = 23/187 (12%)

Query: 62  LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           LKHP +V L  ++ +   LY V +Y++G ++ F + R       + E  A  Y  +V  A
Sbjct: 53  LKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC----FLEPRARFYAAEVASA 108

Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
           + Y H  +II+RD+KP  +LL   ++   V L  FG+          C  G   +  T+ 
Sbjct: 109 IGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL----------CKEGVEPEETTST 155

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD--RLFQSITKG 239
                GTP Y+APEV+  + Y + VD W  G +L+ +L G  PF  SRD  +++ +I   
Sbjct: 156 F---CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDVSQMYDNILHK 211

Query: 240 KLHILGC 246
            L + G 
Sbjct: 212 PLQLPGG 218

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 88.9 bits (220), Expect = 5e-21
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 19/188 (10%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  +RL   + E     E  I   +  P +V L   + S+  L +V   M+G D+ + I 
Sbjct: 26  LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIY 85

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
                G      +  HY  Q+   + + H  DI++RD+KP  VLL ++ N    +L   G
Sbjct: 86  NVGERGLEMERVI--HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN---CRLSDLG 140

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A++L+DG+                  R GT  YMAPE+++++ Y  PVD +A G  ++ 
Sbjct: 141 LAVELKDGK--------------TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYE 186

Query: 218 LLTGTLPF 225
           ++ G  PF
Sbjct: 187 MVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 88.9 bits (220), Expect = 6e-21
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 19/195 (9%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  +R+     E+    E  I   +    VV L   Y ++  L +V   M+G D+ F I 
Sbjct: 33  LEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIY 92

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
                GF   E  A  Y  ++L  L   H  + ++RD+KP  +LL   ++   +++   G
Sbjct: 93  NMGNPGF--EEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLG 147

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A+++ +G+                  R+GT  YMAPEV+ +Q+Y    D W  G L++ 
Sbjct: 148 LAVKIPEGESIRG--------------RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYE 193

Query: 218 LLTGTLPFVGSRDRL 232
           ++ G  PF G ++++
Sbjct: 194 MIEGQSPFRGRKEKV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 88.1 bits (219), Expect = 7e-21
 Identities = 54/173 (31%), Positives = 79/173 (45%), Gaps = 22/173 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  I H    P++V     + + G + +  EYMDG     + + +   G    E +   
Sbjct: 48  RELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGG--SLDKILKEVQG-RIPERILGK 104

Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               VL+ L Y HE   IIHRD+KP  +L+ ++     +KL  FGV+ QL +        
Sbjct: 105 IAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLVN-------- 153

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                  + A   +GT  YMAPE I+   Y    DIW+ G+ L  L TG  P+
Sbjct: 154 -------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 87.6 bits (217), Expect = 9e-21
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 18/166 (10%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +  +L HP+++E  E +  +  L +V EY  G  +   I +R  +  +  E    H+
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS--LLDEDTILHF 106

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q+L AL + H   I+HRD+K   +LL   +    VK+G FG++  L            
Sbjct: 107 FVQILLALHHVHTKLILHRDLKTQNILLDKHKMV--VKIGDFGISKILSS---------- 154

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
                +KA   +GTP Y++PE+ E + Y +  DIWA G +L+ L +
Sbjct: 155 ----KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 90.7 bits (225), Expect = 9e-21
 Identities = 57/188 (30%), Positives = 86/188 (45%), Gaps = 22/188 (11%)

Query: 42  RLNHYTTE---ADLKREATICHMLKHPHVVELLETYSSE-GMLYMVFEYMDGSDICFEIV 97
           R +    E   A  +RE  +C  L HP++V LL++  +  G+L+ VFEY+ G  +     
Sbjct: 12  RTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLR---E 68

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
             A  G           M QVL+AL   H   I+HRD+KP  ++++        K+  FG
Sbjct: 69  VLAADG-ALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFG 127

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPV----DIWAAGV 213
           +      G L     +      T+    +GTP Y APE    Q  G+PV    D++A G+
Sbjct: 128 I------GTLLPGVRDADVATLTRTTEVLGTPTYCAPE----QLRGEPVTPNSDLYAWGL 177

Query: 214 LLHVLLTG 221
           +    LTG
Sbjct: 178 IFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 87.8 bits (218), Expect = 1e-20
 Identities = 52/160 (32%), Positives = 84/160 (52%), Gaps = 20/160 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V LL+   SE  LY+VFE++D  D+  +    ++        +   
Sbjct: 47  REISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDL--KKYMDSSPLTGLDPPLIKS 103

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ + YCH + ++HRD+KP   LL ++E +  +KL  FG+A            G 
Sbjct: 104 YLYQLLQGIAYCHSHRVLHRDLKPQN-LLIDREGA--LKLADFGLARAF---------GV 151

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAG 212
            +  YT    H + T  Y APE++   + Y  PVDIW+ G
Sbjct: 152 PVRTYT----HEVVTLWYRAPEILLGSRQYSTPVDIWSIG 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 87.6 bits (217), Expect = 1e-20
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 20/161 (12%)

Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEI--VRRATAGFVYSEAVASHYMRQVLEALRY 124
           +V L   + ++  L +V   M+G D+ + I  V     GF   E  A  Y  Q++  L +
Sbjct: 55  IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGF--PEPRACFYTAQIISGLEH 112

Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H+  II+RD+KP  VLL N  N   V++   G+A++L+DGQ             +K   
Sbjct: 113 LHQRRIIYRDLKPENVLLDNDGN---VRISDLGLAVELKDGQ-------------SKTKG 156

Query: 185 RIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
             GTP +MAPE+++ ++Y   VD +A GV L+ ++    PF
Sbjct: 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 88.4 bits (220), Expect = 1e-20
 Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 24/181 (13%)

Query: 54  REATICHMLKHPHVVELL-----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  +   L+H +++ LL      +      +Y+V E M+ +D+  ++++   +    ++
Sbjct: 48  REIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLH-KVIK---SPQPLTD 102

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               +++ Q+L  L+Y H  ++IHRD+KP  +L+ N      +K+  FG+A  +   +  
Sbjct: 103 DHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV-NSNCD--LKICDFGLARGVDPDE-- 157

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                 L  Y         T  Y APE++    +Y K +DIW+ G +   LLT    F G
Sbjct: 158 -DEKGFLTEYVV-------TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209

Query: 228 S 228
            
Sbjct: 210 R 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 87.9 bits (217), Expect = 2e-20
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 41/232 (17%)

Query: 5   DPNKRITIHEVINHK-----WLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATIC 59
           DP K+ T  E I        +  M + T  E+      L  +           K+E  I 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP----------KKELIIN 66

Query: 60  HML-----KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
            +L     K+P++V  L++Y     L++V EY+ G  +  ++V          E   +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCM----DEGQIAAV 121

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            R+ L+AL + H N +IHRDIK   +LL        VKL  FG   Q+   Q        
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ-------- 170

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                +K    +GTP++MAPEV+  + YG  VDIW+ G++   ++ G  P++
Sbjct: 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 88.5 bits (219), Expect = 2e-20
 Identities = 56/176 (31%), Positives = 83/176 (47%), Gaps = 26/176 (14%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I      P VV+L   +  +  LYMV EYM G D+         + +   E  A  Y
Sbjct: 93  ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFY 147

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGE 173
             +V+ AL   H    IHRD+KP  +LL   + S  +KL  FG  +++ ++G + C    
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTA- 203

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIWAAGVLLHVLLTGTLPF 225
                       +GTP Y++PEV++ Q     YG+  D W+ GV L+ +L G  PF
Sbjct: 204 ------------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 87.8 bits (217), Expect = 2e-20
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 33/212 (15%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           DE ++   TE  +  +A+      +P +V L   + +   L++V EY++G D+ F + R+
Sbjct: 36  DEDIDWVQTEKHVFEQAS-----SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ 90

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E  A  Y  ++  AL + HE  II+RD+K   VLL   +    +KL  +G+ 
Sbjct: 91  RK----LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGM- 142

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL 219
                    C  G      T+      GTP+Y+APE++  ++YG  VD WA GVL+  ++
Sbjct: 143 ---------CKEGLGPGDTTSTF---CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMM 190

Query: 220 TGTLPF--------VGSRDRLFQSITKGKLHI 243
            G  PF        + + D LFQ I +  + I
Sbjct: 191 AGRSPFDIITDNPDMNTEDYLFQVILEKPIRI 222

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 88.2 bits (218), Expect = 3e-20
 Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 26/176 (14%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I      P VV+L   +  +  LYMV EYM G D+         + +   E  A  Y
Sbjct: 93  ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFY 147

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGE 173
             +V+ AL   H   +IHRD+KP  +LL   +    +KL  FG  +++ + G + C    
Sbjct: 148 TAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTA- 203

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIWAAGVLLHVLLTGTLPF 225
                       +GTP Y++PEV++ Q     YG+  D W+ GV L  +L G  PF
Sbjct: 204 ------------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 86.6 bits (214), Expect = 3e-20
 Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 19/188 (10%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  +R+     E+    E  I   +    VV L   Y ++  L +V   M+G D+ F I 
Sbjct: 33  LEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY 92

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
               AGF   E  A  Y  ++   L   H+  I++RD+KP  +LL   ++   +++   G
Sbjct: 93  HMGEAGF--EEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLG 147

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A+ + +GQ            T K   R+GT  YMAPEV+++++Y    D WA G LL+ 
Sbjct: 148 LAVHVPEGQ------------TIKG--RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYE 193

Query: 218 LLTGTLPF 225
           ++ G  PF
Sbjct: 194 MIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 87.4 bits (216), Expect = 3e-20
 Identities = 56/176 (31%), Positives = 92/176 (52%), Gaps = 22/176 (12%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP +  L  ++ +   L  V EY +G ++ F + R      V+SE  A  Y  +++ AL
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSAL 108

Query: 123 RYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
            Y H E ++++RD+K   ++L   +    +K+  FG+          C  G + D  T K
Sbjct: 109 DYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGL----------CKEGIK-DGATMK 154

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRLFQSI 236
                GTP Y+APEV+ED  YG+ VD W  GV+++ ++ G LPF     ++LF+ I
Sbjct: 155 T--FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 87.2 bits (216), Expect = 3e-20
 Identities = 57/169 (33%), Positives = 89/169 (52%), Gaps = 21/169 (12%)

Query: 62  LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           +KHP +V L  ++ +   LY V +Y++G ++ F + R  +    + E  A  Y  ++  A
Sbjct: 53  VKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS----FPEPRARFYAAEIASA 108

Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
           L Y H  +II+RD+KP  +LL ++ +   V L  FG+          C   E ++H  T 
Sbjct: 109 LGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGL----------CK--EGIEHSKTT 153

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
           +    GTP Y+APEV+  Q Y + VD W  G +L+ +L G  PF  SRD
Sbjct: 154 STF-CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 86.8 bits (215), Expect = 4e-20
 Identities = 62/189 (32%), Positives = 95/189 (50%), Gaps = 32/189 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSE----------GMLYMVFEYMDGSDICFEIVRRATAG 103
           RE  I   L H ++V L E  + +          G  Y+VFEYMD      +++    +G
Sbjct: 55  REIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-----HDLMGLLESG 109

Query: 104 FV-YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
            V +SE     +M+Q+LE L YCH+ + +HRDIK   +LL NK     +KL  FG+A   
Sbjct: 110 LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK---GQIKLADFGLA--- 163

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPE-VIEDQKYGKPVDIWAAGVLLHVLLTG 221
              +LY S   R   YT K    + T  Y  PE ++ +++YG  +D+W+ G +L  L T 
Sbjct: 164 ---RLYNSEESRP--YTNK----VITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK 214

Query: 222 TLPFVGSRD 230
              F  +++
Sbjct: 215 KPIFQANQE 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 86.9 bits (215), Expect = 4e-20
 Identities = 55/175 (31%), Positives = 88/175 (50%), Gaps = 21/175 (12%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP +  L  T+ ++  L+ V EY++G D+ F I  ++   F    A  + Y  +++  L
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRA--TFYAAEIICGL 109

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           ++ H   I++RD+K   +LL   +    +K+  FG+  +   G               K 
Sbjct: 110 QFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGD-------------AKT 153

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI 236
               GTP Y+APE++  QKY   VD W+ GVLL+ +L G  PF G   + LFQSI
Sbjct: 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 86.5 bits (214), Expect = 6e-20
 Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           ++P +  L  T+ ++  L+ V E+++G D+ F I  +      +    A+ Y  +++  L
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR----FDLYRATFYAAEIVCGL 109

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           ++ H   II+RD+K   V+L   +    +K+  FG+  +   G               +A
Sbjct: 110 QFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGD-------------NRA 153

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL 241
               GTP Y+APE+++  KY   VD W+ GVLL+ +L G  PF G   D LF+SI     
Sbjct: 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213

Query: 242 H 242
           H
Sbjct: 214 H 214

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 86.2 bits (213), Expect = 9e-20
 Identities = 55/169 (32%), Positives = 83/169 (49%), Gaps = 21/169 (12%)

Query: 62  LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           +KHP +V L  ++ +   LY V ++++G ++ F + R  +    + E  A  Y  ++  A
Sbjct: 53  VKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS----FPEPRARFYAAEIASA 108

Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
           L Y H  +I++RD+KP  +LL   ++   V L  FG+          C  G      TT 
Sbjct: 109 LGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGL----------CKEGIAQSDTTTT 155

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                GTP Y+APEVI  Q Y   VD W  G +L+ +L G  PF   RD
Sbjct: 156 F---CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY-CRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 85.5 bits (211), Expect = 1e-19
 Identities = 55/179 (30%), Positives = 88/179 (49%), Gaps = 26/179 (14%)

Query: 53  KREATICHML-----KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           K+E  I  +L     K+P++V  L++Y     L++V EY+ G  +  ++V          
Sbjct: 59  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-DVVTETCM----D 113

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E   +   R+ L+AL + H N +IHRDIK   +LL        VKL  FG   Q+   Q 
Sbjct: 114 EGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ- 169

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                       +K    +GTP++MAPEV+  + YG  VDIW+ G++   ++ G  P++
Sbjct: 170 ------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 84.7 bits (209), Expect = 1e-19
 Identities = 55/176 (31%), Positives = 87/176 (49%), Gaps = 19/176 (10%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           L+ E  +   L+H  +V+            L +  EYM G  +  ++     A    +E+
Sbjct: 51  LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTES 106

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
           V   Y RQ+LE + Y H N I+HRDIK   +L   ++++  VKLG FG + +LQ     C
Sbjct: 107 VTRKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQT---IC 160

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
             G  +   T       GTP++M+PEVI  + YG+  D+W+ G  +  +LT   P+
Sbjct: 161 MSGTGIRSVT-------GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 84.7 bits (209), Expect = 1e-19
 Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 16/183 (8%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  +E  +   L HP+V++ L+++  +  L +V E  D  D+   I        +  E  
Sbjct: 48  DCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERT 107

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  A+ + H   ++HRDIKP  V +     +  VKLG  G+      G+ + S
Sbjct: 108 VWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGL------GRFFSS 158

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                   TT A   +GTP+YM+PE I +  Y    DIW+ G LL+ +     PF G + 
Sbjct: 159 K-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 211

Query: 231 RLF 233
            LF
Sbjct: 212 NLF 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.5 bits (209), Expect = 2e-19
 Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 22/184 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++       +    A+        +   
Sbjct: 48  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD---LKKFMDASPLSGIPLPLIKS 104

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 152

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGSR--D 230
            +  YT    H + T  Y APE++   K Y   VDIW+ G +   ++T    F G    D
Sbjct: 153 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208

Query: 231 RLFQ 234
           +LF+
Sbjct: 209 QLFR 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 84.4 bits (209), Expect = 2e-19
 Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 21/184 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L+HP++V L +    E  LY++FE++   D+   +       ++ +E V S 
Sbjct: 48  REISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKS- 105

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ + +CH   ++HRD+KP  +L+ NK     +KL  FG+A            G 
Sbjct: 106 YLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAF---------GI 153

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR--D 230
            +  YT    H + T  Y APEV+    +Y  PVDIW+ G +   + T    F G    D
Sbjct: 154 PVRVYT----HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID 209

Query: 231 RLFQ 234
           +LF+
Sbjct: 210 QLFR 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 85.3 bits (211), Expect = 2e-19
 Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 35/214 (16%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           DE ++   TE  +   A+      HP +V L   + +E  L+ V E++ G D+ F + R+
Sbjct: 36  DEDIDWVQTEKHVFETAS-----NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ 90

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E  A  Y  ++  AL + HE  II+RD+K   VLL   +    +KL  +G+ 
Sbjct: 91  RK----LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGM- 142

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL 219
                    C  G R    T+      GTP+Y+APE++  + YG  VD WA GVL+  ++
Sbjct: 143 ---------CKEGIRPGDTTSTF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 190

Query: 220 TGTLPF--VGS--------RDRLFQSITKGKLHI 243
            G  PF  VG          D LFQ I + ++ I
Sbjct: 191 AGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI 224

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 84.7 bits (210), Expect = 2e-19
 Identities = 60/192 (31%), Positives = 86/192 (44%), Gaps = 28/192 (14%)

Query: 54  REATICHMLKHPHVVELLE--------TYSSEGMLYMVFEYMDGSDIC--FEIVRRATAG 103
           RE  I   LKHP+VV L++        +    G +YMV  YMD  D+    E        
Sbjct: 56  REIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS----- 109

Query: 104 FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
              +E+    YM Q+LE + Y HEN I+HRDIK   +L+ N+     +K+  FG+A +  
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIADFGLA-RPY 165

Query: 164 DG---QLYCSGGERLDHYTTKAGHRIGTPHYMAPE-VIEDQKYGKPVDIWAAGVLLHVLL 219
           DG        GG     YT      + T  Y  PE ++ +++Y   VDIW  G +   + 
Sbjct: 166 DGPPPNPKGGGGGGTRKYTN----LVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221

Query: 220 TGTLPFVGSRDR 231
           T      G  D 
Sbjct: 222 TRRPILQGKSDI 233

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.1 bits (208), Expect = 2e-19
 Identities = 56/177 (31%), Positives = 82/177 (46%), Gaps = 18/177 (10%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  +   LKH ++V+ L + S  G   +  E + G  +   ++R        +E   
Sbjct: 52  LHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTI 110

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             Y +Q+LE L+Y H+N I+HRDIK   VL+     S  VK+  FG +            
Sbjct: 111 IFYTKQILEGLKYLHDNQIVHRDIKGDNVLV--NTYSGVVKISDFGTS------------ 156

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFV 226
            +RL           GT  YMAPEVI+   + YG P DIW+ G  +  + TG  PF+
Sbjct: 157 -KRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI 212

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 83.5 bits (206), Expect = 4e-19
 Identities = 55/184 (29%), Positives = 84/184 (45%), Gaps = 16/184 (8%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           AD  +E  +   L HP+V++   ++  +  L +V E  D  D+   I        +  E 
Sbjct: 47  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEK 106

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
               Y  Q+  AL + H   ++HRDIKP  V +     +  VKLG  G+      G+ + 
Sbjct: 107 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGL------GRFFS 157

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR 229
           S        TT A   +GTP+YM+PE I +  Y    DIW+ G LL+ +     PF G +
Sbjct: 158 SK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210

Query: 230 DRLF 233
             L+
Sbjct: 211 MNLY 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 83.6 bits (206), Expect = 4e-19
 Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 21/175 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+++E T+      P++     +Y     L+++ EY+ G     ++++         E  
Sbjct: 48  DIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGS-ALDLLKPGP----LEETY 102

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            +  +R++L+ L Y H    IHRDIK   VLL+ + +   VKL  FGVA QL D Q+   
Sbjct: 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQI--- 156

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                     K    +GTP +MAPEVI+   Y    DIW+ G+    L  G  P 
Sbjct: 157 ----------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 83.6 bits (206), Expect = 5e-19
 Identities = 54/174 (31%), Positives = 83/174 (47%), Gaps = 21/174 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+++E T+      P+V +   +Y     L+++ EY+ G     +++R       + E  
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGS-ALDLLRAGP----FDEFQ 102

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            +  ++++L+ L Y H    IHRDIK   VLL+ +     VKL  FGVA QL D Q+   
Sbjct: 103 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQ---GDVKLADFGVAGQLTDTQI--- 156

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                     K    +GTP +MAPEVI+   Y    DIW+ G+    L  G  P
Sbjct: 157 ----------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 83.4 bits (206), Expect = 6e-19
 Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 20/171 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E T+   +  P +V L  ++ S   LY+V  +++G ++   + R       +  + A  Y
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR----FDLSRARFY 98

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             ++L AL   H+ ++I+RD+KP  +LL  + + A   L  FG+       +L     ++
Sbjct: 99  TAELLCALENLHKFNVIYRDLKPENILLDYQGHIA---LCDFGLC------KLNMKDDDK 149

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
            + +        GTP Y+APE++    Y K VD W  GVLL+ +LTG  PF
Sbjct: 150 TNTFC-------GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF 193

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 82.3 bits (203), Expect = 9e-19
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 20/191 (10%)

Query: 53  KREATICHMLKHPHVVELLETYSSE-GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           ++EA +   LKHP++V   E++  E G+LY+V  + +G D+  ++  +   G +  E   
Sbjct: 47  EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQV 104

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             +  Q+  AL+Y HE  I+HRD+K   V L     +  +K+G  G+A            
Sbjct: 105 VEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR---TNIIKVGDLGIA------------ 149

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF-VGSRD 230
              L++    A   IGTP+YM+PE+  ++ Y    D+WA G  ++ + T    F     +
Sbjct: 150 -RVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN 208

Query: 231 RLFQSITKGKL 241
            L   I +GKL
Sbjct: 209 SLVYRIIEGKL 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 82.3 bits (203), Expect = 1e-18
 Identities = 56/195 (28%), Positives = 90/195 (46%), Gaps = 19/195 (9%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  +R+     EA    E  I   +    VV L   Y ++  L +V   M+G D+ F I 
Sbjct: 33  LEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY 92

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
                GF   E  A  Y  ++   L       I++RD+KP  +LL   ++   +++   G
Sbjct: 93  NMGNPGF--DEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLG 147

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A+Q+ +G+             T  G R+GT  YMAPEVI ++KY    D W  G L++ 
Sbjct: 148 LAVQIPEGE-------------TVRG-RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYE 193

Query: 218 LLTGTLPFVGSRDRL 232
           ++ G  PF   ++R+
Sbjct: 194 MIQGQSPFRKRKERV 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 82.0 bits (202), Expect = 2e-18
 Identities = 54/174 (31%), Positives = 81/174 (46%), Gaps = 21/174 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+++E T+      P+V +   +Y  +  L+++ EY+ G     +++          E  
Sbjct: 48  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP----LDETQ 102

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            +  +R++L+ L Y H    IHRDIK   VLL+       VKL  FGVA QL D Q+   
Sbjct: 103 IATILREILKGLDYLHSEKKIHRDIKAANVLLSEH---GEVKLADFGVAGQLTDTQI--- 156

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                     K    +GTP +MAPEVI+   Y    DIW+ G+    L  G  P
Sbjct: 157 ----------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 82.8 bits (204), Expect = 2e-18
 Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 20/164 (12%)

Query: 62  LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           +KHP +V L  ++ +   LY V +Y++G ++ + + R       + E  A  Y  ++  A
Sbjct: 53  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASA 108

Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
           L Y H  +I++RD+KP  +LL   ++   + L  FG+          C   E ++H  T 
Sbjct: 109 LGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGL----------CK--ENIEHNGTT 153

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           +    GTP Y+APEV+  Q Y + VD W  G +L+ +L G  PF
Sbjct: 154 STF-CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 83.1 bits (205), Expect = 2e-18
 Identities = 56/185 (30%), Positives = 87/185 (47%), Gaps = 15/185 (8%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
            H  +V+  + + S+  L ++ EY  G D+  +I +R      + E        Q++ AL
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
              H   ++HRD+K   + L     +  +KLG FG + Q  D          LD     A
Sbjct: 183 DEVHSRKMMHRDLKSANIFLMP---TGIIKLGDFGFSKQYSDSV-------SLD----VA 228

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDR-LFQSITKGKL 241
               GTP+Y+APE+ E ++Y K  D+W+ GV+L+ LLT   PF G   R + Q +  GK 
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288

Query: 242 HILGC 246
               C
Sbjct: 289 DPFPC 293

Length = 478

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 80.8 bits (199), Expect = 3e-18
 Identities = 51/149 (34%), Positives = 76/149 (51%), Gaps = 17/149 (11%)

Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  L +  E+M G  I  ++     +    +E V   Y RQ+LE + Y H N I+HRDIK
Sbjct: 78  ERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIK 133

Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              +L   +++   VKLG FG + +LQ     C  G  +   T       GTP++M+PEV
Sbjct: 134 GANIL---RDSVGNVKLGDFGASKRLQT---ICLSGTGMKSVT-------GTPYWMSPEV 180

Query: 197 IEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           I  + YG+  DIW+ G  +  +LT   P+
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 80.5 bits (198), Expect = 4e-18
 Identities = 54/176 (30%), Positives = 86/176 (48%), Gaps = 19/176 (10%)

Query: 52  LKREATICHMLKHPHVVELLETYS--SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           L+ E  +   L+H  +V+         E  L +  EYM G  I  ++     A    +E 
Sbjct: 51  LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTEN 106

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
           V   Y RQ+L+ + Y H N I+HRDIK   +L   ++++  VKLG FG + ++Q   +  
Sbjct: 107 VTRRYTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQ--TICM 161

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           SG        T      GTP++M+PEVI  + YG+  D+W+    +  +LT   P+
Sbjct: 162 SG--------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.5 bits (202), Expect = 5e-18
 Identities = 64/181 (35%), Positives = 93/181 (51%), Gaps = 25/181 (13%)

Query: 54  REATICHMLK-HPHVVELLETYSSEGM--LYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           RE      L  HP++V+LL    +E    +Y+VFEYM+ +D+    V RA    +  E V
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDL--HAVIRA--NIL--EDV 107

Query: 111 ASHY-MRQVLEALRYCHENDIIHRDIKPHCVLLANKENS-APVKLGGFGVAIQLQDGQLY 168
              Y M Q+L+AL+Y H  ++IHRD+KP  +LL    NS   VKL  FG+A  L + +  
Sbjct: 108 HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL----NSDCRVKLADFGLARSLSELEEN 163

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                 L  Y       + T  Y APE+ +   +Y K VD+W+ G +L  +L G   F G
Sbjct: 164 -PENPVLTDY-------VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215

Query: 228 S 228
           +
Sbjct: 216 T 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 80.6 bits (199), Expect = 6e-18
 Identities = 55/197 (27%), Positives = 85/197 (43%), Gaps = 28/197 (14%)

Query: 54  REATICHMLKH-PHVVELL-----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE ++  ML    ++V LL     E  + +  LY+VFEY+D     F        G    
Sbjct: 49  REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLP 108

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
                 +M Q+L+ + +CH++ ++HRD+KP  +L+  ++    +   G G A  +     
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP---- 164

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                  +  YT    H I T  Y APEV +    Y  PVDIW+ G +   +      F 
Sbjct: 165 -------VKSYT----HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213

Query: 227 GSRDRLFQSITKGKLHI 243
           G  D   Q +    LHI
Sbjct: 214 G--DSELQQL----LHI 224

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 81.8 bits (202), Expect = 7e-18
 Identities = 53/155 (34%), Positives = 76/155 (49%), Gaps = 26/155 (16%)

Query: 79  MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPH 138
           M+ +V +Y +  D+  EI  RA     + E  A     QVL A+ + H   +IHRDIK  
Sbjct: 113 MIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSA 172

Query: 139 CVLLANKENSAPVKLGGFGV----AIQLQD--GQLYCSGGERLDHYTTKAGHRIGTPHYM 192
            +LL    ++  VKLG FG     A  + D  G+ +C                 GTP+Y+
Sbjct: 173 NILLC---SNGLVKLGDFGFSKMYAATVSDDVGRTFC-----------------GTPYYV 212

Query: 193 APEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
           APE+   + Y K  D+++ GVLL+ LLT   PF G
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247

Length = 496

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 80.4 bits (198), Expect = 1e-17
 Identities = 54/183 (29%), Positives = 96/183 (52%), Gaps = 22/183 (12%)

Query: 61  MLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE 120
           + + P +V L  ++ ++  LY+V +YM G ++ + + +       +SE  A  Y+ +++ 
Sbjct: 52  LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR----FSEDRAKFYIAELVL 107

Query: 121 ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTT 180
           AL + H+ DI++RD+KP  +LL   + +  + L  FG+           S     D+ TT
Sbjct: 108 ALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGL-----------SKANLTDNKTT 153

Query: 181 KAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGSR-DRLFQSITK 238
                 GT  Y+APEV+ D+K Y K VD W+ GVL+  +  G  PF      +++++I  
Sbjct: 154 NT--FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211

Query: 239 GKL 241
           GK+
Sbjct: 212 GKV 214

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 80.6 bits (199), Expect = 1e-17
 Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 43/211 (20%)

Query: 45  HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           H   E D+  EA       +  VV+L  ++  +  LY V +Y+ G D+   ++R      
Sbjct: 47  HVKAERDILAEA------DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---- 96

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ- 163
           ++ E +A  Y+ ++  A+   H+   IHRDIKP  +L+   +    +KL  FG+    + 
Sbjct: 97  IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRW 153

Query: 164 --DGQLYCSGG------------------------ERL---DHYTTKAGHRIGTPHYMAP 194
             D + Y  G                         ER     H    A   +GTP+Y+AP
Sbjct: 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAP 213

Query: 195 EVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           EV+    Y +  D W+ GV+L+ +L G  PF
Sbjct: 214 EVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.9 bits (197), Expect = 1e-17
 Identities = 53/184 (28%), Positives = 92/184 (50%), Gaps = 21/184 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   ++H ++V L +   SE  LY+VFEY+D   +  +    ++  F  +  +   
Sbjct: 50  REISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKT 106

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L  + YCH + ++HRD+KP  +L+  + N+  +KL  FG+A            G 
Sbjct: 107 YLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNA--LKLADFGLARAF---------GI 155

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGSR--D 230
            +  +T    H + T  Y APE++   + Y  PVDIW+ G +   ++     F G    D
Sbjct: 156 PVRTFT----HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211

Query: 231 RLFQ 234
            LF+
Sbjct: 212 ELFK 215

Length = 294

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 79.2 bits (195), Expect = 1e-17
 Identities = 52/182 (28%), Positives = 83/182 (45%), Gaps = 19/182 (10%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           T +A+   EA +   L HP +V+   ++       ++ EY +G D+  ++      G   
Sbjct: 46  TVQANQ--EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTL 103

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           SE     +  Q+L  + Y H+  I+HRD+K   + L N      +K+G FGV+  L    
Sbjct: 104 SENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN----LLKIGDFGVSRLLMGS- 158

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
             C      D  TT      GTP+YM+PE ++ Q Y    DIW+ G +L+ +      F 
Sbjct: 159 --C------DLATTFT----GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206

Query: 227 GS 228
           G 
Sbjct: 207 GQ 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 79.3 bits (195), Expect = 2e-17
 Identities = 57/184 (30%), Positives = 86/184 (46%), Gaps = 36/184 (19%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEI 96
           +E L  Y  E D      I     HP++V+LL+ +  E  L+++ E+  G     +  E+
Sbjct: 43  EEELEDYMVEID------ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL 96

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R  T      E       +Q LEAL Y HEN IIHRD+K   +L     +   +KL  F
Sbjct: 97  ERPLT------EPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD---IKLADF 147

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIWAA 211
           GV+ +           +R D +       IGTP++MAPEV+     +D+ Y    D+W+ 
Sbjct: 148 GVSAK------NTRTIQRRDSF-------IGTPYWMAPEVVMCETSKDRPYDYKADVWSL 194

Query: 212 GVLL 215
           G+ L
Sbjct: 195 GITL 198

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 79.3 bits (195), Expect = 3e-17
 Identities = 52/189 (27%), Positives = 89/189 (47%), Gaps = 24/189 (12%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I + + HP  V L  ++  E  LY+V E++ G +  F  +RR      +   V   Y
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF-FTFLRRNKR---FPNDVGCFY 136

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y    +I++RD+KP  +LL   +    +K+  FG A ++ D + Y      
Sbjct: 137 AAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFA-KVVDTRTYT----- 187

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRL-F 233
                       GTP Y+APE++ +  +GK  D W  G+ ++ +L G  PF  +   L +
Sbjct: 188 ----------LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237

Query: 234 QSITKGKLH 242
           Q I +G ++
Sbjct: 238 QKILEGIIY 246

Length = 340

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 79.1 bits (195), Expect = 4e-17
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 29/181 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  I   + HP+VV+  + +   G + ++ E+MDG  +            +  E   + 
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL--------EGTHIADEQFLAD 172

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
             RQ+L  + Y H   I+HRDIKP  +L+ + +N   VK+  FGV+  L      C+   
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMDPCNSS- 228

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI----EDQKY-GKPVDIWAAGVLLHVLLTGTLPFVGS 228
                       +GT  YM+PE I        Y G   DIW+ GV +     G  PF   
Sbjct: 229 ------------VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVG 276

Query: 229 R 229
           R
Sbjct: 277 R 277

Length = 353

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 79.3 bits (195), Expect = 4e-17
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 41/213 (19%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           A +K E  I     +  VV L  ++  +  LY V +Y+ G D+   ++R      ++ E 
Sbjct: 46  AHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFPED 101

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ---DGQ 166
           +A  Y+ ++  A+   H+   IHRDIKP  +L+   +    +KL  FG+    +   D +
Sbjct: 102 LARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSK 158

Query: 167 LYCSG----------------------GERLDHYTTKAGHR---------IGTPHYMAPE 195
            Y SG                      G+RL     +A  +         +GTP+Y+APE
Sbjct: 159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPE 218

Query: 196 VIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
           V+    Y +  D W+ GV+L+ +L G  PF+  
Sbjct: 219 VLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 9e-17
 Identities = 47/140 (33%), Positives = 67/140 (47%), Gaps = 23/140 (16%)

Query: 80  LYMVFEYMDGSDICFEIVRRA-TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPH 138
           L++V E   G  +  ++V+     G    E   ++ +R+ L  L Y HEN +IHRDIK  
Sbjct: 84  LWLVMELCGGGSVT-DLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQ 142

Query: 139 CVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI- 197
            +LL     +A VKL  FGV+ Q             LD    +    IGTP++MAPEVI 
Sbjct: 143 NILLT---KNAEVKLVDFGVSAQ-------------LDSTLGRRNTFIGTPYWMAPEVIA 186

Query: 198 ----EDQKYGKPVDIWAAGV 213
                D  Y    D+W+ G+
Sbjct: 187 CDEQPDASYDARSDVWSLGI 206

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.8 bits (189), Expect = 1e-16
 Identities = 54/178 (30%), Positives = 91/178 (51%), Gaps = 19/178 (10%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   LKH ++V L +   +E  L +VFEYMD  D+   +      G +    V S 
Sbjct: 47  REISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKS- 104

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  Q+L+ + +CHEN ++HRD+KP   LL NK     +KL  FG+A            G 
Sbjct: 105 FTYQLLKGIAFCHENRVLHRDLKPQN-LLINKRGE--LKLADFGLARAF---------GI 152

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
            ++ ++ +    + T  Y AP+V+   + Y   +DIW+ G ++  ++TG   F G+ +
Sbjct: 153 PVNTFSNE----VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.9 bits (190), Expect = 1e-16
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 25/154 (16%)

Query: 64  HPHVVELLE-----TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQV 118
           HP++V LL+         E  L +VFE++D  D+   + +    G           MRQ+
Sbjct: 60  HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGL--PPETIKDLMRQL 116

Query: 119 LEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHY 178
           L  + + H + I+HRD+KP  +L+    +   VK+  FG+A      ++Y         +
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLA------RIYS--------F 159

Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAG 212
                  + T  Y APEV+    Y  PVD+W+ G
Sbjct: 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVG 193

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.0 bits (189), Expect = 1e-16
 Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 27/177 (15%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEIVRRATAGFVYSE 108
           L  E  I    +H +VVE+ ++Y     L+++ E++ G   +DI  +   R        E
Sbjct: 65  LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT--RLN-----EE 117

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
            +A+     VL+AL Y H   +IHRDIK   +LL        VKL  FG   Q+      
Sbjct: 118 QIAT-VCESVLQALCYLHSQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKD--- 170

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                       K    +GTP++MAPEVI    YG  VDIW+ G+++  ++ G  P+
Sbjct: 171 ----------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.2 bits (187), Expect = 2e-16
 Identities = 54/174 (31%), Positives = 87/174 (50%), Gaps = 21/174 (12%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I     H +VV++  +Y     L++V E+++G  +  +IV   T   +  E +A
Sbjct: 66  LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIA 121

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  +  VL AL Y H   +IHRDIK   +LL +      +KL  FG          +C+ 
Sbjct: 122 TVCL-SVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFG----------FCA- 166

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
             ++     K    +GTP++MAPEVI    YG  VDIW+ G+++  ++ G  P+
Sbjct: 167 --QVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 75.9 bits (187), Expect = 5e-16
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 46/215 (21%)

Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
           E++ H   E D+  EA       +P VV+L  ++  E  LY++ EY+ G D+   ++++ 
Sbjct: 43  EQVAHVRAERDILAEA------DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD 96

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
           T    ++E     Y+ + + A+   H+   IHRDIKP  +LL  K +   +KL  FG+  
Sbjct: 97  T----FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH---IKLSDFGLCT 149

Query: 161 QLQ---DGQLYCSGGERLDHY--------------------TTKAGHR------IGTPHY 191
            L+     + Y      L H                     T K   R      +GTP Y
Sbjct: 150 GLKKSHRTEFY----RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDY 205

Query: 192 MAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
           +APEV     Y K  D W+ GV+++ +L G  PF 
Sbjct: 206 IAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 75.5 bits (186), Expect = 6e-16
 Identities = 56/178 (31%), Positives = 85/178 (47%), Gaps = 23/178 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM--LYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           RE T+   L+HP++VEL E    + +  +++V EY +  D+   ++      F  SE+  
Sbjct: 55  REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLA-SLLDNMPTPF--SESQV 110

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
              M Q+L  L+Y HEN IIHRD+K   +LL +K     +K+  FG+A      + Y   
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDK---GCLKIADFGLA------RTY--- 158

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
           G      T K    + T  Y APE++     Y   +D+WA G +L  LL       G 
Sbjct: 159 GLPAKPMTPK----VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 74.1 bits (182), Expect = 1e-15
 Identities = 49/177 (27%), Positives = 86/177 (48%), Gaps = 19/177 (10%)

Query: 51  DLKREATIC-HMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           D+  E TI    L+HP++V   +T+     LY+V + ++G+ +             ++E 
Sbjct: 54  DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE 113

Query: 110 VASHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
              +   Q++ ALRY H E  I+HRD+ P+ ++L   +    V +  FG+A Q Q     
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITDFGLAKQKQP---- 166

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                  +   T     +GT  Y  PE+++++ YG+  D+WA G +L+ + T   PF
Sbjct: 167 -------ESKLTSV---VGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 74.4 bits (183), Expect = 1e-15
 Identities = 51/175 (29%), Positives = 77/175 (44%), Gaps = 29/175 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS--DICFEIVRRATAGFVYSEAVA 111
           RE  + H    P++V     + S+G + +  E+MDG   D   +   R     +   ++A
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA 107

Query: 112 SHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENS-APVKLGGFGVAIQLQDGQLYC 169
                 VL  L Y  E   I+HRD+KP  +L+    NS   +KL  FGV+ QL D     
Sbjct: 108 ------VLRGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDFGVSGQLID----- 152

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                     + A   +GT  YM+PE ++   Y    DIW+ G+ L  +  G  P
Sbjct: 153 ----------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 74.3 bits (182), Expect = 1e-15
 Identities = 59/184 (32%), Positives = 86/184 (46%), Gaps = 36/184 (19%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEI 96
           +E L  Y  E +      I     HP++V+LL  +  +G L+++ E+  G     I  E+
Sbjct: 50  EEELEDYMVEIE------ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL 103

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R  T      E       RQ+LEAL+Y H   IIHRD+K   VLL    +   +KL  F
Sbjct: 104 DRGLT------EPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD---IKLADF 154

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIWAA 211
           GV+ +           +R D +       IGTP++MAPEV+     +D  Y    DIW+ 
Sbjct: 155 GVSAK------NVKTLQRRDSF-------IGTPYWMAPEVVMCETMKDTPYDYKADIWSL 201

Query: 212 GVLL 215
           G+ L
Sbjct: 202 GITL 205

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 73.9 bits (181), Expect = 2e-15
 Identities = 51/191 (26%), Positives = 93/191 (48%), Gaps = 21/191 (10%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           TTE        + H+ + P +V L   + ++  L+++ +Y++G ++   + +R      +
Sbjct: 47  TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----F 102

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
            E     Y  +++ AL + H+  II+RDIK   +LL   +++  V L  FG++       
Sbjct: 103 KEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLS------- 152

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE--DQKYGKPVDIWAAGVLLHVLLTGTLP 224
                 E  +    +A    GT  YMAP+++   D  + K VD W+ GVL++ LLTG  P
Sbjct: 153 -----KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Query: 225 FVGSRDRLFQS 235
           F    ++  Q+
Sbjct: 208 FTVDGEKNSQA 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 51/191 (26%), Positives = 90/191 (47%), Gaps = 21/191 (10%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           T E        +  + + P +V L   + ++  L+++ +Y++G ++   + +R      +
Sbjct: 47  TAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH----F 102

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           +E+    Y+ +++ AL + H+  II+RDIK   +LL   ++   V L  FG++ +    +
Sbjct: 103 TESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEE 159

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE--DQKYGKPVDIWAAGVLLHVLLTGTLP 224
                         +A    GT  YMAPEVI      + K VD W+ GVL   LLTG  P
Sbjct: 160 EE------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Query: 225 FVGSRDRLFQS 235
           F    ++  QS
Sbjct: 208 FTVDGEQNSQS 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.8 bits (182), Expect = 2e-15
 Identities = 53/177 (29%), Positives = 84/177 (47%), Gaps = 23/177 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM--LYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           RE  I   L+HP++V + E      +  +YMV EY++  D+   ++      F+ SE   
Sbjct: 53  REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLK-SLMETMKQPFLQSEVKC 110

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
              M Q+L  + + H+N I+HRD+K   +LL N+     +K+  FG+A +          
Sbjct: 111 --LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNR---GILKICDFGLAREY--------- 156

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG 227
           G  L  YT      + T  Y APE++   K Y   +D+W+ G +   LLT    F G
Sbjct: 157 GSPLKPYT----QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 73.5 bits (180), Expect = 2e-15
 Identities = 56/177 (31%), Positives = 86/177 (48%), Gaps = 23/177 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   LKH ++V L +   +E  L +VFEY+D SD+   +      G + S      
Sbjct: 52  REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYL---DNCGNLMSMHNVKI 107

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +M Q+L  L YCH+  I+HRD+KP  +L+  K     +KL  FG+A              
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEK---GELKLADFGLA-------------- 150

Query: 174 RLDHYTTKA-GHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
           R     TK   + + T  Y  P+V +   +Y  P+D+W  G +L+ + TG   F GS
Sbjct: 151 RAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 74.2 bits (182), Expect = 2e-15
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 20/177 (11%)

Query: 60  HMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVL 119
           H+ + P +V L   + +E  L+++ +Y+ G ++   + +R      +SE     Y  +++
Sbjct: 60  HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEII 115

Query: 120 EALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYT 179
            AL + H+  I++RDIK   +LL   ++   V L  FG++             E L    
Sbjct: 116 LALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLS------------KEFLSEEK 160

Query: 180 TKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQS 235
            +     GT  YMAPE+I  +  +GK VD W+ G+L+  LLTG  PF    +R  QS
Sbjct: 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 73.1 bits (179), Expect = 3e-15
 Identities = 53/174 (30%), Positives = 88/174 (50%), Gaps = 21/174 (12%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I    +H +VVE+  +Y     L++V E+++G  +  +IV   T   +  E +A
Sbjct: 64  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIA 119

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  +  VL+AL   H   +IHRDIK   +LL +      VKL  FG          +C+ 
Sbjct: 120 AVCL-AVLKALSVLHAQGVIHRDIKSDSILLTH---DGRVKLSDFG----------FCA- 164

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
             ++     +    +GTP++MAPE+I    YG  VDIW+ G+++  ++ G  P+
Sbjct: 165 --QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 73.3 bits (180), Expect = 3e-15
 Identities = 51/167 (30%), Positives = 72/167 (43%), Gaps = 29/167 (17%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+ +E      L+HP+ +E    Y  E   ++V EY  GS      V +     V   A+
Sbjct: 61  DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAI 120

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                   L+ L Y H ++ IHRDIK   +LL        VKL  FG A  +     +  
Sbjct: 121 CH----GALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPANSF-- 171

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVI----EDQKYGKPVDIWAAGV 213
                          +GTP++MAPEVI    E Q  GK VD+W+ G+
Sbjct: 172 ---------------VGTPYWMAPEVILAMDEGQYDGK-VDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.9 bits (179), Expect = 3e-15
 Identities = 54/179 (30%), Positives = 79/179 (44%), Gaps = 25/179 (13%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  I H  + P++V     + +E  + M  E+MD    C  + R    G      +   
Sbjct: 52  RELQIMHECRSPYIVSFYGAFLNENNICMCMEFMD----CGSLDRIYKKGGPIPVEILGK 107

Query: 114 YMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSA-PVKLGGFGVAIQLQDGQLYCSG 171
               V+E L Y +  + I+HRDIKP  +L+    NS   +KL  FGV+     G+L  S 
Sbjct: 108 IAVAVVEGLTYLYNVHRIMHRDIKPSNILV----NSRGQIKLCDFGVS-----GELINS- 157

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                     A   +GT  YM+PE I+  KY    D+W+ G+ +  L  G  PF  S  
Sbjct: 158 ---------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 73.5 bits (180), Expect = 4e-15
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 41/212 (19%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           A +K E  I     +  VV+L  ++  +  LY V +Y+ G D+   ++R      V+ E 
Sbjct: 46  AHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME----VFPEV 101

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI--------- 160
           +A  Y+ ++  A+   H+   IHRDIKP  +L+   +    +KL  FG+           
Sbjct: 102 LARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSK 158

Query: 161 ----------------QLQDGQLYCSGGERL---------DHYTTKAGHRIGTPHYMAPE 195
                            L D    C  G+RL          H    A   +GTP+Y+APE
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218

Query: 196 VIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
           V+  + Y +  D W+ GV+L  +L G  PF+ 
Sbjct: 219 VLLRKGYTQLCDWWSVGVILFEMLVGQPPFLA 250

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 71.8 bits (176), Expect = 8e-15
 Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 24/211 (11%)

Query: 30  EIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG 89
           E+     G  D R         L+ E      L H ++V+ L   ++E  L +  EY+ G
Sbjct: 35  ELPATIAGRHDSRQK--DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPG 92

Query: 90  SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA 149
             I    +R       + E +   +  QVLE L Y H   I+HRD+K   +L+   +   
Sbjct: 93  GSIG-SCLRTYGR---FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADG 145

Query: 150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK--YGKPVD 207
             K+  FG++ +  D  +Y +     D   +      G+  +MAPEVI      Y   VD
Sbjct: 146 ICKISDFGISKKSDD--IYDN-----DQNMSMQ----GSVFWMAPEVIHSYSQGYSAKVD 194

Query: 208 IWAAGVLLHVLLTGTLPFVGSRDRLFQSITK 238
           IW+ G ++  +  G  P+  S +    ++ K
Sbjct: 195 IWSLGCVVLEMFAGRRPW--SDEEAIAAMFK 223

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 71.3 bits (175), Expect = 8e-15
 Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 17/178 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  +EA I H L H +++ L     +  ++ MV E      +  + +R+   G  +  + 
Sbjct: 42  DFLKEAAIMHSLDHENLIRLYGVVLTHPLM-MVTELAPLGSL-LDRLRKDALGH-FLIST 98

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+   +RY      IHRD+    +LLA+ +    VK+G FG+   L   +    
Sbjct: 99  LCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNE---- 151

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
                DHY  +   ++    + APE +  + +    D+W  GV L  + T G  P+ G
Sbjct: 152 -----DHYVMEEHLKVPFA-WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 72.4 bits (177), Expect = 9e-15
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 35/210 (16%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  E++ H   E D+  EA          VV++  ++  +  LY++ E++ G D+   ++
Sbjct: 40  LEKEQVAHIRAERDILVEA------DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM 93

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           ++ T     SE     Y+ + + A+   H+   IHRDIKP  +LL  K +   VKL  FG
Sbjct: 94  KKDT----LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFG 146

Query: 158 VAIQLQDGQL----------------YCSGGERLDHYTTKAGHR------IGTPHYMAPE 195
           +   L+                    + +   +    T K   R      +GTP Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206

Query: 196 VIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           V     Y K  D W+ GV+++ +L G  PF
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 71.1 bits (174), Expect = 1e-14
 Identities = 50/179 (27%), Positives = 78/179 (43%), Gaps = 19/179 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L    +    + +VFE+M+    C     RA  G    
Sbjct: 42  SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG--CLSDYLRAQRGKFSQ 99

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E +    +  V E + Y   +++IHRD+     L+   EN   VK+  FG+   + D   
Sbjct: 100 ETLLGMCL-DVCEGMAYLESSNVIHRDLAARNCLVG--ENQV-VKVSDFGMTRFVLD--- 152

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPF 225
                   D YT+  G +     + +PEV    KY    D+W+ GVL+  V   G  P+
Sbjct: 153 --------DQYTSSTGTKFPV-KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 72.0 bits (176), Expect = 1e-14
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 35/210 (16%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  E++ H   E D+  EA          VV++  ++  +  LY++ E++ G D+   ++
Sbjct: 40  LEKEQVGHIRAERDILVEA------DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM 93

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           ++ T     +E     Y+ + + A+   H+   IHRDIKP  +LL +K +   VKL  FG
Sbjct: 94  KKDT----LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH---VKLSDFG 146

Query: 158 VAIQLQDGQ----------------LYCSGGERLDHYTTKAGHR------IGTPHYMAPE 195
           +   L+                    + +   +    T K   R      +GTP Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206

Query: 196 VIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           V     Y K  D W+ GV+++ +L G  PF
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 18/180 (10%)

Query: 54  REATICHMLKHPHVVELLETY--SSEGMLYMVFEYMDGSDICFEIVR--RATAGFVYSEA 109
           RE  +   LKH +VV L+E +   ++  +Y++F+Y +  D+ ++I++  R         +
Sbjct: 51  REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDL-WQIIKFHRQAKRVSIPPS 108

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLL-ANKENSAPVKLGGFGVAIQLQDGQLY 168
           +    + Q+L  + Y H N ++HRD+KP  +L+         VK+G  G+A         
Sbjct: 109 MVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG 227
            +  + +          + T  Y APE++   + Y K +DIWA G +   LLT    F G
Sbjct: 169 LADLDPV----------VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 24/179 (13%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           + E  I  +   P + +L   +  +  LY+V EY  G D+   ++ R    F   E +A 
Sbjct: 49  EEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDL-LSLLNRYEDQF--DEDMAQ 105

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y+ +++ A+   H+   +HRDIKP  VL+   + +  +KL  FG A +L   +      
Sbjct: 106 FYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK------ 156

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIE----DQK--YGKPVDIWAAGVLLHVLLTGTLPF 225
                    +   +GTP Y+APEV+     D K  YG   D W+ GV+ + ++ G  PF
Sbjct: 157 ------MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 2e-14
 Identities = 54/177 (30%), Positives = 81/177 (45%), Gaps = 31/177 (17%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-----DICFEIVRRATAGFVYSE 108
           RE  +   LKH ++V L +   S+  L +VFEY D       D C         G +  E
Sbjct: 48  REICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--------NGDIDPE 99

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
            V S +M Q+L+ L +CH ++++HRD+KP   LL NK     +KL  FG+A         
Sbjct: 100 IVKS-FMFQLLKGLAFCHSHNVLHRDLKPQN-LLINKNGE--LKLADFGLARAF------ 149

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLP 224
              G  +  Y+      + T  Y  P+V+   K Y   +D+W+AG +   L     P
Sbjct: 150 ---GIPVRCYS----AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 70.8 bits (174), Expect = 2e-14
 Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 25/160 (15%)

Query: 64  HPHVVELLETY--SSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           HP+++ L+E       G L +VFE MD +   +E+++         E     YM Q+L++
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMN--LYELIKGRKRPL--PEKRVKSYMYQLLKS 112

Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
           L + H N I HRDIKP  +L+ +      +KL  FG    +     Y         Y   
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDDI----LKLADFGSCRGIYSKPPYTE-------Y--- 158

Query: 182 AGHRIGTPHYMAPE-VIEDQKYGKPVDIWAAGVLLHVLLT 220
               I T  Y APE ++ D  YG  +DIWA G +   +L+
Sbjct: 159 ----ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 71.3 bits (175), Expect = 2e-14
 Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 43/177 (24%)

Query: 54  REATICHMLKHPHVVELLETYSSE--------GMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  I  +LKH +VV L+E   ++        G  Y+VFE+ +  D+         AG +
Sbjct: 60  REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDL---------AGLL 109

Query: 106 ------YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                 ++ +     M+ +L  L Y H N I+HRD+K   +L+        +KL  FG+A
Sbjct: 110 SNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLA 166

Query: 160 ---IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV-IEDQKYGKPVDIWAAG 212
                 ++ +           YT     R+ T  Y  PE+ + ++ YG P+D+W AG
Sbjct: 167 RAFSLSKNSKPNR--------YTN----RVVTLWYRPPELLLGERDYGPPIDMWGAG 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 57/224 (25%)

Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
           ++L H   E D+  E+        P VV L  ++     LY++ E++ G D+   +++  
Sbjct: 43  DQLAHVKAERDVLAES------DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD 96

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
           T    +SE V   YM + + A+   H+   IHRDIKP  +L+   +    +KL  FG++ 
Sbjct: 97  T----FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLST 149

Query: 161 ------------QLQDGQLYCSGGE---------------------------RLDHYTTK 181
                       +L  G+   +  +                           RL  Y+T 
Sbjct: 150 GFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYST- 208

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
               +GTP Y+APE+   Q YG+  D W+ G ++   L G  PF
Sbjct: 209 ----VGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPF 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 72.1 bits (176), Expect = 2e-14
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 45/214 (21%)

Query: 37  GLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICF 94
           GL +   +    E ++ RE      LKH ++V  ++ + ++    LY++ E+ D  D+  
Sbjct: 50  GLKEREKSQLVIEVNVMRE------LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103

Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-------NDIIHRDIKPHCVLL----- 142
            I +         E       RQ+L AL YCH          ++HRD+KP  + L     
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163

Query: 143 --------ANKENSAPV-KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMA 193
                   AN  N  P+ K+G FG++  +        G E + H        +GTP+Y +
Sbjct: 164 HIGKITAQANNLNGRPIAKIGDFGLSKNI--------GIESMAHSC------VGTPYYWS 209

Query: 194 PEVI--EDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           PE++  E + Y    D+WA G +++ L +G  PF
Sbjct: 210 PELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 4e-14
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 21/180 (11%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP++V+L    + +  +++V EYM     C     R   G + +
Sbjct: 42  SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG--CLLNYLRERKGKLGT 99

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKP-HCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           E +       V EA+ Y   N  IHRD+   +C  L  ++N   VK+  FG+A  + D Q
Sbjct: 100 EWLLD-MCSDVCEAMEYLESNGFIHRDLAARNC--LVGEDNV--VKVSDFGLARYVLDDQ 154

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
              S G +   +  K         +  PEV +  ++    D+W+ GVL+  + + G +P+
Sbjct: 155 YTSSQGTK---FPVK---------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY 202

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 20/167 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA I   + HP +++L  T++      ++         C+   +R  A     + +A   
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIA---ICDILAIE- 188

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            R VL A++Y HEN IIHRDIK   + +    +   V LG FG A         C     
Sbjct: 189 -RSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAA---------CF---P 232

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           +D    K     GT    APE++    YG  VDIW+AG++L  + T 
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 68.5 bits (167), Expect = 1e-13
 Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 27/188 (14%)

Query: 49  EADLKREATICHML-KHPHVVELLETY-----SSEGMLYMVFEYMDGSDICFEIVRRATA 102
           + +++ E  I   L  HP+VV+    +        G L++V E  +G  +   +      
Sbjct: 62  DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
           G    EA+ S+ +   L  L++ H N IIHRD+K + +LL  +     VKL  FGV+ QL
Sbjct: 122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQL 178

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHV 217
              +L             +    +GTP +MAPEVI      D  Y    D+W+ G+    
Sbjct: 179 TSTRL-------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225

Query: 218 LLTGTLPF 225
           L  G  P 
Sbjct: 226 LGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 66.7 bits (163), Expect = 6e-13
 Identities = 56/195 (28%), Positives = 91/195 (46%), Gaps = 39/195 (20%)

Query: 54  REATICHMLKHPHVVELLETYSSEG--------------MLYMVFEYMDGSDICFEIVRR 99
           RE  I   L H ++V++ E     G               +Y+V EYM+ +D+       
Sbjct: 51  REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDL-----AN 104

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                  SE  A  +M Q+L  L+Y H  +++HRD+KP  V + N E+   +K+G FG+A
Sbjct: 105 VLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI-NTEDLV-LKIGDFGLA 162

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGH---RIGTPHYMAPE-VIEDQKYGKPVDIWAAGVLL 215
            ++ D            HY+ K G+    + T  Y +P  ++    Y K +D+WAAG + 
Sbjct: 163 -RIVD-----------PHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 209

Query: 216 HVLLTGTLPFVGSRD 230
             +LTG   F G+ +
Sbjct: 210 AEMLTGKPLFAGAHE 224

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 66.6 bits (162), Expect = 7e-13
 Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 27/174 (15%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS--DICFEIVRRATAGFVYSEAVA 111
           RE  + H    P++V     + S+G + +  E+MDG   D   +  +R     +   ++A
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA 111

Query: 112 SHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                 VL  L Y  E + I+HRD+KP  +L+ ++     +KL  FGV+ QL D      
Sbjct: 112 ------VLRGLAYLREKHQIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID------ 156

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                    + A   +GT  YM+PE ++   Y    DIW+ G+ L  L  G  P
Sbjct: 157 ---------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 66.6 bits (162), Expect = 8e-13
 Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 31/168 (18%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG--SDICFEIVRRATAGFVYSE 108
           D+ +E      L+HP+ ++    Y  E   ++V EY  G  SD+  E+ ++        E
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL-LEVHKKP-----LQE 114

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
              +      L+ L Y H +++IHRD+K   +LL+       VKLG FG A         
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA--------- 162

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVI---EDQKYGKPVDIWAAGV 213
                        A   +GTP++MAPEVI   ++ +Y   VD+W+ G+
Sbjct: 163 --------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 66.0 bits (161), Expect = 8e-13
 Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 20/179 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +  +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV
Sbjct: 48  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAV 104

Query: 111 ASHYM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
              YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++  +       
Sbjct: 105 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLSRLMTG----- 156

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
                 D YT  AG +     + APE +   K+    D+WA GVLL  + T G  P+ G
Sbjct: 157 ------DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 66.0 bits (161), Expect = 8e-13
 Identities = 54/182 (29%), Positives = 80/182 (43%), Gaps = 34/182 (18%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I H    P++V+    +  EG +YM  EYMD   +      +  AG V +E +    
Sbjct: 49  ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-----DKLYAGGVATEGIPEDV 103

Query: 115 MRQ----VLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
           +R+    V++ L++  E  +IIHRD+KP  VL+        VKL  FGV+     G L  
Sbjct: 104 LRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGN---GQVKLCDFGVS-----GNLVA 155

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ------KYGKPVDIWAAGVLLHVLLTGTL 223
           S           A   IG   YMAPE I+         Y    D+W+ G+ +  +  G  
Sbjct: 156 S----------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY 205

Query: 224 PF 225
           P+
Sbjct: 206 PY 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 66.4 bits (162), Expect = 8e-13
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 31/197 (15%)

Query: 43  LNHYTTEADLK---REATICHMLKHPHVVELLETY-SSEGMLYMVFEYMDGSDICFEIVR 98
           +  ++T    K   RE  +   L+H +++ L + + S    +Y V E + G+D+     R
Sbjct: 44  MKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLH----R 98

Query: 99  RATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV 158
             T+  +  + +  +++ Q+L  L+Y H   ++HRD+KP  +L+   EN   +K+  FG+
Sbjct: 99  LLTSRPLEKQFI-QYFLYQILRGLKYVHSAGVVHRDLKPSNILI--NEN-CDLKICDFGL 154

Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHV 217
           A ++QD Q+               G+ + T +Y APE++   QKY   VDIW+AG +   
Sbjct: 155 A-RIQDPQM--------------TGY-VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAE 198

Query: 218 LLTGTLPFVGSRDRLFQ 234
           +L G   F G +D + Q
Sbjct: 199 MLEGKPLFPG-KDHVNQ 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.8 bits (160), Expect = 9e-13
 Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 23/151 (15%)

Query: 80  LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC 139
           L++V E+     +  ++V+  T G    E   ++  R++L  L + H + +IHRDIK   
Sbjct: 94  LWLVMEFCGAGSVT-DLVKN-TKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQN 151

Query: 140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE- 198
           VLL   EN A VKL  FGV+ Q             LD    +    IGTP++MAPEVI  
Sbjct: 152 VLLT--EN-AEVKLVDFGVSAQ-------------LDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 199 ----DQKYGKPVDIWAAGVLLHVLLTGTLPF 225
               D  Y    DIW+ G+    +  G  P 
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 25/165 (15%)

Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           +  L   +  E  LY+V +Y  G D+   + +         E +A  Y+ +++ A+   H
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYIAEMVLAIHSIH 119

Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGERLDHYTTKAGHR 185
           +   +HRDIKP  VLL   + +  ++L  FG  +++ QDG             T ++   
Sbjct: 120 QLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG-------------TVQSSVA 163

Query: 186 IGTPHYMAPEVIEDQ-----KYGKPVDIWAAGVLLHVLLTGTLPF 225
           +GTP Y++PE+++       KYG   D W+ GV ++ +L G  PF
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 65.8 bits (160), Expect = 1e-12
 Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 27/166 (16%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+ +E      LKHP+ +E    Y  E   ++V EY  GS      V +     V   A+
Sbjct: 67  DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI 126

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                   L+ L Y H +++IHRDIK   +LL        VKL  FG A           
Sbjct: 127 T----HGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSA----------- 168

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVI---EDQKYGKPVDIWAAGV 213
                   ++ A   +GTP++MAPEVI   ++ +Y   VD+W+ G+
Sbjct: 169 ------SKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 65.7 bits (160), Expect = 1e-12
 Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 26/171 (15%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I +    P+++     +  E  + +  E+MDG  +  ++ R+     +   AVA   
Sbjct: 49  ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL--DVYRKIPEHVLGRIAVA--- 103

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
              V++ L Y     I+HRD+KP  +L+  +     VKL  FGV+ QL +          
Sbjct: 104 ---VVKGLTYLWSLKILHRDVKPSNMLVNTR---GQVKLCDFGVSTQLVN---------- 147

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                + A   +GT  YMAPE I  ++YG   D+W+ G+    L  G  P+
Sbjct: 148 -----SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 47/172 (27%), Positives = 81/172 (47%), Gaps = 23/172 (13%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 107

Query: 114 YMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E + I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 108 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 156

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                  + A   +GT  YM+PE ++   Y    DIW+ G+ L  +  G  P
Sbjct: 157 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 65.7 bits (160), Expect = 2e-12
 Identities = 50/200 (25%), Positives = 76/200 (38%), Gaps = 33/200 (16%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA +   + HP V+ + +T  S  +  MV  +   SD+   + +R+          A   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRP---LPIDQALII 162

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            +Q+LE LRY H   IIHRD+K   + +    +   V +G  G A               
Sbjct: 163 EKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAA--------QFPVVAP 211

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL------------TGT 222
                       GT    APEV+   KY    DIW+AG++L  +L            T  
Sbjct: 212 AFLGLA------GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265

Query: 223 LPFVGSRDRLFQSITKGKLH 242
                    L + I+  K+H
Sbjct: 266 EYVKSCHSHLLKIISTLKVH 285

Length = 357

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.0 bits (158), Expect = 2e-12
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 32/163 (19%)

Query: 64  HPHVVELLETYSSEGM-----LYMVFEYMDG---SDICFEIVRRATAGFVYSEAVASHYM 115
           HP+VV+    Y  + +     L++V E  +G   +D+    ++R   G    E + ++ +
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPIIAYIL 130

Query: 116 RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERL 175
            + L  L++ H N  IHRD+K + +LL  +     VKL  FGV+ QL   +L        
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTSTRL-------- 179

Query: 176 DHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGV 213
                +    +GTP +MAPEVI      D  Y    D+W+ G+
Sbjct: 180 -----RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 64.7 bits (157), Expect = 3e-12
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 23/165 (13%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +++E  +    KH ++V    +Y     L++  E+  G  +  + +   T     SE+  
Sbjct: 53  VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL--QDIYHVTGPL--SESQI 108

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           ++  R+ L+ L Y H    +HRDIK   +LL    ++  VKL  FGV+ Q+         
Sbjct: 109 AYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQIT-------- 157

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGV 213
                    K    IGTP++MAPEV   ++   Y +  DIWA G+
Sbjct: 158 -----ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 65.3 bits (159), Expect = 3e-12
 Identities = 48/186 (25%), Positives = 73/186 (39%), Gaps = 37/186 (19%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMV--------FEYMDGSD-ICFEIVRRAT 101
              RE  I   + H  ++ L+  Y  +  + MV        F Y+D S  +  E      
Sbjct: 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQA---- 187

Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
              +  +       R++LEAL Y H   IIHRD+K   + L   EN+    LG FG A +
Sbjct: 188 ---ITIQ-------RRLLEALAYLHGRGIIHRDVKTENIFLDEPENAV---LGDFGAACK 234

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           L                T +     GT    +PE++    Y    DIW+AG++L  +   
Sbjct: 235 LDAHP-----------DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK 283

Query: 222 TLPFVG 227
            +   G
Sbjct: 284 NVTLFG 289

Length = 392

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 64.3 bits (156), Expect = 4e-12
 Identities = 52/185 (28%), Positives = 84/185 (45%), Gaps = 28/185 (15%)

Query: 54  REATICHMLK---HPHVVELLETYS-----SEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  +   L+   HP+VV L +  +      E  L +VFE++D  D+   + +    G V
Sbjct: 50  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG-V 107

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            +E +    M Q+L  L + H + ++HRD+KP  +L+ +   S  +KL  FG+A      
Sbjct: 108 PTETIKD-MMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLA------ 157

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                   R+  +       + T  Y APEV+    Y  PVD+W+ G +   +      F
Sbjct: 158 --------RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 209

Query: 226 VGSRD 230
            GS D
Sbjct: 210 RGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.2 bits (156), Expect = 4e-12
 Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 28/170 (16%)

Query: 54  REATICHMLK---HPHVVELLETYSS-----EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  +   L+   HP++V L++  ++     E  + +VFE++D     +  + +     +
Sbjct: 48  REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTY--LDKVPPPGL 105

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            +E +    MRQ L  L + H N I+HRD+KP  +L+ +      VKL  FG+A      
Sbjct: 106 PAETIKD-LMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLA------ 155

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
                   R+          + T  Y APEV+    Y  PVD+W+ G + 
Sbjct: 156 --------RIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 64.3 bits (156), Expect = 4e-12
 Identities = 46/165 (27%), Positives = 81/165 (49%), Gaps = 25/165 (15%)

Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           +  L   +  E  LY+V +Y  G D+   + +         E +A  Y+ +++ A+   H
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYLAEMVIAIDSVH 119

Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGERLDHYTTKAGHR 185
           +   +HRDIKP  +L+   + +  ++L  FG  ++L +DG             T ++   
Sbjct: 120 QLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG-------------TVQSSVA 163

Query: 186 IGTPHYMAPEVI---EDQK--YGKPVDIWAAGVLLHVLLTGTLPF 225
           +GTP Y++PE++   ED K  YG   D W+ GV ++ +L G  PF
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 64.3 bits (156), Expect = 4e-12
 Identities = 48/182 (26%), Positives = 78/182 (42%), Gaps = 33/182 (18%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-----DICFEIVRRATAGFVYSE 108
           RE ++   LKH ++V L +   +E  L +VFEY+D       D C   +           
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL---- 108

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                ++ Q+L  L YCH   ++HRD+KP  +L+  +     +KL  FG+A         
Sbjct: 109 -----FLFQLLRGLNYCHRRKVLHRDLKPQNLLINER---GELKLADFGLA--------- 151

Query: 169 CSGGERLDHYTTKA-GHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                R     TK   + + T  Y  P++ +    Y   +D+W  G + + + TG   F 
Sbjct: 152 -----RAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP 206

Query: 227 GS 228
           GS
Sbjct: 207 GS 208

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.0 bits (155), Expect = 4e-12
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 23/151 (15%)

Query: 80  LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC 139
           L++V E+     +   I  + T G    E   ++  R++L  L + H++ +IHRDIK   
Sbjct: 84  LWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQN 141

Query: 140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE- 198
           VLL     +A VKL  FGV+ Q             LD    +    IGTP++MAPEVI  
Sbjct: 142 VLLT---ENAEVKLVDFGVSAQ-------------LDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 199 ----DQKYGKPVDIWAAGVLLHVLLTGTLPF 225
               D  Y    D+W+ G+    +  G  P 
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 64.3 bits (156), Expect = 5e-12
 Identities = 49/166 (29%), Positives = 73/166 (43%), Gaps = 27/166 (16%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+ +E      +KHP+ +E    Y  E   ++V EY  GS      V +     V   A+
Sbjct: 71  DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAI 130

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                   L+ L Y H +++IHRDIK   +LL        VKL  FG A           
Sbjct: 131 T----HGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSA----------- 172

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVI---EDQKYGKPVDIWAAGV 213
                    + A   +GTP++MAPEVI   ++ +Y   VD+W+ G+
Sbjct: 173 ------SIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.9 bits (155), Expect = 6e-12
 Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 33/182 (18%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-----DICFEIVRRATAGFVYSE 108
           RE ++   LKH ++V L +   ++  L +VFEY+D       D C         G + S 
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDC---------GNIMSM 103

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                ++ Q+L  L YCH   ++HRD+KP  +L+  +     +KL  FG+A         
Sbjct: 104 HNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER---GELKLADFGLA--------- 151

Query: 169 CSGGERLDHYTTKA-GHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                R     TK   + + T  Y  P+V +   +Y   +D+W  G +   + +G   F 
Sbjct: 152 -----RAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFP 206

Query: 227 GS 228
           GS
Sbjct: 207 GS 208

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.5 bits (154), Expect = 6e-12
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 23/165 (13%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +++E  +    KH ++V    +Y S   L++  EY  G  +  + +   T     SE   
Sbjct: 53  IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL--QDIYHVTGPL--SELQI 108

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           ++  R+ L+ L Y H    +HRDIK   +LL    ++  VKL  FGVA            
Sbjct: 109 AYVCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVA------------ 153

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGV 213
             ++     K    IGTP++MAPEV   +K   Y +  DIWA G+
Sbjct: 154 -AKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 63.0 bits (154), Expect = 8e-12
 Identities = 47/177 (26%), Positives = 78/177 (44%), Gaps = 37/177 (20%)

Query: 61  MLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE 120
           M  +P+ ++L  + ++     ++ +Y+   D+ F+++++       SEA     +RQ++E
Sbjct: 65  MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL-FDLLKKEGK---LSEAEVKKIIRQLVE 120

Query: 121 ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTT 180
           AL   H+++IIH DIK   VL    ++   + L  +G+                      
Sbjct: 121 ALNDLHKHNIIHNDIKLENVLYDRAKDR--IYLCDYGLC--------------------- 157

Query: 181 KAGHRIGTPH-------YMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                IGTP        Y +PE I+   Y    D WA GVL + LLTG  PF    D
Sbjct: 158 ---KIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211

Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 63.5 bits (155), Expect = 9e-12
 Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 22/167 (13%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML----YMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           RE  I    KH +++ + +     G      Y+V + M  SD+   I          +E 
Sbjct: 53  RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQP----LTEE 107

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
              +++ Q+L  L+Y H  ++IHRD+KP   LL N++    +++G FG+A      +   
Sbjct: 108 HIRYFLYQLLRGLKYIHSANVIHRDLKPSN-LLVNED--CELRIGDFGMA------RGLS 158

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLL 215
           S      ++ T+    + T  Y APE++    +Y   +D+W+ G + 
Sbjct: 159 SSPTEHKYFMTE---YVATRWYRAPELLLSLPEYTTAIDMWSVGCIF 202

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 63.2 bits (154), Expect = 9e-12
 Identities = 49/179 (27%), Positives = 86/179 (48%), Gaps = 23/179 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           REA++   LKH ++V L +   ++  L +VFEY+D +D+  + +     G          
Sbjct: 52  REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLK-QYMDDCGGGLSMHNVRL-- 107

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ Q+L  L YCH+  ++HRD+KP  +L++ +     +KL  FG+A              
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISER---GELKLADFGLA-------------- 150

Query: 174 RLDHYTTKA-GHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
           R     +K   + + T  Y  P+V+    +Y   +D+W  G + + + TG   F GS D
Sbjct: 151 RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 62.8 bits (153), Expect = 1e-11
 Identities = 48/192 (25%), Positives = 85/192 (44%), Gaps = 22/192 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D ++E      L+H H++ L    S    +Y++ E M+   +      R+  G V   A 
Sbjct: 48  DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVAS 105

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                 QV E + Y  E + IHRD+    +L+   E+    K+  FG+A  +++      
Sbjct: 106 LIDMACQVAEGMAYLEEQNSIHRDLAARNILVG--EDLV-CKVADFGLARLIKE------ 156

Query: 171 GGERLDHYTTKAGHRIGTPH-YMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG- 227
                D Y +    +I  P+ + APE      +    D+W+ G+LL+ + T G +P+ G 
Sbjct: 157 -----DVYLSSD-KKI--PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208

Query: 228 SRDRLFQSITKG 239
           +   ++  IT G
Sbjct: 209 NNHEVYDQITAG 220

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 62.8 bits (153), Expect = 1e-11
 Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 29/180 (16%)

Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P++V+    + ++  +++  E M     C + + +   G +  E +       +++AL Y
Sbjct: 74  PYIVKCYGYFITDSDVFICMELMS---TCLDKLLKRIQGPI-PEDILGKMTVAIVKALHY 129

Query: 125 CHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAG 183
             E   +IHRD+KP  +LL   + S  VKL  FG++ +L D               +KA 
Sbjct: 130 LKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVD---------------SKAK 171

Query: 184 HR-IGTPHYMAPEVIEDQ----KYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITK 238
            R  G   YMAPE I+      KY    D+W+ G+ L  L TG  P+       F+ +TK
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC-KTEFEVLTK 230

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 33/207 (15%)

Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 65  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 124

Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  QV   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 125 DIARVPDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 179

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W+ GVL
Sbjct: 180 DFGLARDVNN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVL 228

Query: 215 LHVLLT-GTLPFVG-SRDRLFQSITKG 239
           +  + T G  P+ G   + LF+ + +G
Sbjct: 229 MWEIFTLGGSPYPGIPVEELFKLLKEG 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 2e-11
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 29/160 (18%)

Query: 74  YSSEGMLYMVFEYMDGSDICFEIVRRATAGFV--YSEAVASHYMRQVLEALRYCHENDII 131
           +  E  LY+V +Y  G D+   + +     F     E +A  Y+ +++ A+   H+   +
Sbjct: 70  FQDENNLYLVMDYYVGGDLLTLLSK-----FEDRLPEDMARFYLAEMVLAIDSVHQLGYV 124

Query: 132 HRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGERLDHYTTKAGHRIGTPH 190
           HRDIKP  VLL   + +  ++L  FG  ++L  DG             T ++   +GTP 
Sbjct: 125 HRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG-------------TVQSNVAVGTPD 168

Query: 191 YMAPEVI---EDQK--YGKPVDIWAAGVLLHVLLTGTLPF 225
           Y++PE++   ED K  YG   D W+ GV ++ +L G  PF
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 39/221 (17%)

Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G D  F
Sbjct: 62  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF 121

Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +  +       + + V+  Y  QV   + Y      IHRD+    VL+        +K+ 
Sbjct: 122 DTCKLPEEQLTFKDLVSCAY--QVARGMEYLASQKCIHRDLAARNVLVTEDN---VMKIA 176

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W+ GVL
Sbjct: 177 DFGLARDVHN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVL 225

Query: 215 LHVLLT-GTLPFVG-SRDRLFQSITKGKLHIL----GCTHK 249
           L  + T G  P+ G   + LF+ + +G  H +     CTH+
Sbjct: 226 LWEIFTLGGSPYPGIPVEELFKLLKEG--HRMDKPANCTHE 264

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 61.4 bits (149), Expect = 3e-11
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 20/194 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L    + +  LY+V E+M+    C     R   G +  
Sbjct: 42  SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG--CLLNYLRQRQGKLSK 99

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + + S   + V E + Y   N  IHRD+     L++   ++  VK+  FG+   + D   
Sbjct: 100 DMLLS-MCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLD--- 152

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPFV 226
                   D YT+ +G +     +  PEV    KY    D+W+ GVL+  V   G +PF 
Sbjct: 153 --------DEYTSSSGAKFPV-KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203

Query: 227 GSRD-RLFQSITKG 239
              +  + + I++G
Sbjct: 204 KKSNYEVVEMISRG 217

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.2 bits (151), Expect = 3e-11
 Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 35/190 (18%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE T+   ++H +V+ LL+ ++S          Y+V  YM       +   +   G   S
Sbjct: 63  RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYM-------QTDLQKIMGHPLS 115

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E    + + Q+L  L+Y H   IIHRD+KP    LA  E+   +K+  FG+A        
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGN--LAVNED-CELKILDFGLA-------- 164

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                    H   +    + T  Y APEVI +   Y + VDIW+ G ++  +LTG   F 
Sbjct: 165 --------RHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216

Query: 227 GSR--DRLFQ 234
           G    D+L Q
Sbjct: 217 GKDYLDQLTQ 226

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 61.6 bits (150), Expect = 3e-11
 Identities = 51/155 (32%), Positives = 71/155 (45%), Gaps = 23/155 (14%)

Query: 76  SEGMLYMVFEYMDGS-DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHR 133
            EG  ++  E MD S D  ++ V       V  E +        ++AL Y  E   IIHR
Sbjct: 74  REGDCWICMELMDISLDKFYKYVYEVLKS-VIPEEILGKIAVATVKALNYLKEELKIIHR 132

Query: 134 DIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMA 193
           D+KP  +LL    N   +KL  FG++ QL D     S  +  D     AG R   P YMA
Sbjct: 133 DVKPSNILLDRNGN---IKLCDFGISGQLVD-----SIAKTRD-----AGCR---P-YMA 175

Query: 194 PEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           PE I+      Y    D+W+ G+ L+ + TG  P+
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 61.0 bits (148), Expect = 4e-11
 Identities = 51/186 (27%), Positives = 85/186 (45%), Gaps = 19/186 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           + +  +EA +     HP++V+LL         Y++ E M+G D+    +R A        
Sbjct: 43  KKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDL-LSYLRDARVERFGPP 101

Query: 109 AVA-SHYMRQVLEALRYCH---ENDIIHRDIKPHCVLLANKENSAP--VKLGGFGVAIQL 162
            +     +   L+  + C    +   IHRD+     L++ K   A   VK+G FG+A   
Sbjct: 102 LLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA--- 158

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-G 221
           +D  +Y S     D+Y  K G  +    +MAPE + D K+    D+W+ GVL+  +LT G
Sbjct: 159 RD--IYKS-----DYYR-KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG 210

Query: 222 TLPFVG 227
             P+  
Sbjct: 211 QQPYPA 216

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.8 bits (148), Expect = 6e-11
 Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 39/189 (20%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRA-TAGFVYSEA 109
           L++E      L+HP+++  + ++  +  LY+V   M  GS  C ++++     G    E 
Sbjct: 46  LQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS--CEDLLKTHFPEGL--PEL 101

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
             +  ++ VL AL Y H    IHR +K   +LL+                    DG++  
Sbjct: 102 AIAFILKDVLNALDYIHSKGFIHRSVKASHILLS-------------------GDGKVVL 142

Query: 170 SGGERLDHYTTKAGHRIGTPH-----------YMAPEVIED--QKYGKPVDIWAAGVLLH 216
           S G R      K G R    H           +++PEV++   Q Y +  DI++ G+   
Sbjct: 143 S-GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201

Query: 217 VLLTGTLPF 225
            L  G +PF
Sbjct: 202 ELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 6e-11
 Identities = 55/176 (31%), Positives = 83/176 (47%), Gaps = 33/176 (18%)

Query: 60  HMLKHPHVVELLETY----SSEGM--LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           HM  H +V+ LL+ +    S E    +Y+V   M G+D+   IV+        S+     
Sbjct: 70  HM-DHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQ----KLSDDHIQF 122

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
            + Q+L  L+Y H   IIHRD+KP    +A  E+   +K+  FG+A              
Sbjct: 123 LVYQILRGLKYIHSAGIIHRDLKPSN--IAVNEDCE-LKILDFGLARH------------ 167

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
             D   T  G+ + T  Y APE++ +   Y + VDIW+ G ++  LLTG   F GS
Sbjct: 168 -TDDEMT--GY-VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 6e-11
 Identities = 55/164 (33%), Positives = 76/164 (46%), Gaps = 24/164 (14%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVF-EYMDGSDICFEIVRRATA-GFVYSEAVAS 112
           EA +   L HP V+ LL+     G+  +V  +Y   SD+   +  R    G     AVA 
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR--SDLYTYLGARLRPLGLAQVTAVA- 266

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
              RQ+L A+ Y H   IIHRDIK   VL+   E+   + LG FG A   +        G
Sbjct: 267 ---RQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFAR--------G 312

Query: 173 ERLDHYTTKAGHRI-GTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
                 +T   + I GT    APEV+    Y   VDIW+AG+++
Sbjct: 313 SW----STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVI 352

Length = 461

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 60.7 bits (147), Expect = 7e-11
 Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 39/221 (17%)

Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           ADL  E  +  ++ KH +++ LL   + EG LY++ EY                G D  F
Sbjct: 62  ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTF 121

Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I +       + + V+  Y  QV   + Y      IHRD+    VL+  ++N   +K+ 
Sbjct: 122 DITKVPEEQLSFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVT-EDNV--MKIA 176

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
            FG+A  + D          +D+Y   +  R+    +MAPE + D+ Y    D+W+ G+L
Sbjct: 177 DFGLARGVHD----------IDYYKKTSNGRLPV-KWMAPEALFDRVYTHQSDVWSFGIL 225

Query: 215 LHVLLT-GTLPFVG-SRDRLFQSITKGKLHIL----GCTHK 249
           +  + T G  P+ G   + LF+ + +G  H +     CTH+
Sbjct: 226 MWEIFTLGGSPYPGIPVEELFKLLREG--HRMDKPSNCTHE 264

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 60.5 bits (147), Expect = 8e-11
 Identities = 48/189 (25%), Positives = 84/189 (44%), Gaps = 22/189 (11%)

Query: 45  HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           H+TT     RE  I + +KH +++ L++ Y     + +V + M       ++ +      
Sbjct: 64  HFTT----LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-----DLKKVVDRKI 114

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E+     + Q+L  L   H+   +HRD+ P  + + +K      K+  FG+A +   
Sbjct: 115 RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSK---GICKIADFGLARRYGY 171

Query: 165 GQLY--CSGGE---RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVL 218
                  S  E   R +  T+K    + T  Y APE++   +KY   VD+W+ G +   L
Sbjct: 172 PPYSDTLSKDETMQRREEMTSK----VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAEL 227

Query: 219 LTGTLPFVG 227
           LTG   F G
Sbjct: 228 LTGKPLFPG 236

Length = 335

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.5 bits (147), Expect = 9e-11
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 32/201 (15%)

Query: 54  REATICHMLK-HPHVVELLE----TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  +    + H ++  L +       +   LY+  E M+ +D+  +I+R   +G   ++
Sbjct: 50  RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLH-QIIR---SGQPLTD 104

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLL-ANKENSAPVKLGGFGVAIQLQDGQL 167
           A    ++ Q+L  L+Y H  +++HRD+KP  +L+ A+ E    +K+  FG+A    +   
Sbjct: 105 AHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE----LKICDFGLARGFSENP- 159

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
               GE     T      + T  Y APE+ +  Q Y K +D+W+ G +L  LL     F 
Sbjct: 160 ----GENAGFMT----EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211

Query: 227 GSR--DRLFQSITKGKLHILG 245
           G    D+L Q      L +LG
Sbjct: 212 GKDYVDQLNQI-----LQVLG 227

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 15/184 (8%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI---------CFEIVRRATAGF 104
           REA I   L HP +V +    S    +Y    Y++G  +           E + +  A  
Sbjct: 51  REAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQK-ESLSKELAEK 109

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-Q 163
               A  S + + +   + Y H   ++HRD+KP  +LL        +   G  +  +L +
Sbjct: 110 TSVGAFLSIFHK-ICATIEYVHSKGVLHRDLKPDNILLG-LFGEVVILDWGAAIFKKLEE 167

Query: 164 DGQLYCSGGER--LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           +  L     ER       T  G  +GTP YMAPE +      +  DI+A GV+L+ +LT 
Sbjct: 168 EDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227

Query: 222 TLPF 225
           + P+
Sbjct: 228 SFPY 231

Length = 932

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 59.7 bits (144), Expect = 1e-10
 Identities = 48/188 (25%), Positives = 87/188 (46%), Gaps = 21/188 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM  GS + F    ++  G          
Sbjct: 51  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF---LKSDEGGKVLLPKLID 107

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  Q+ E + Y    + IHRD++   VL++    S   K+  FG+A  ++D         
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSE---SLMCKIADFGLARVIED--------- 155

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDR 231
             + YT + G +     + APE I    +    D+W+ G+LL+ ++T G +P+ G S   
Sbjct: 156 --NEYTAREGAKFPI-KWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212

Query: 232 LFQSITKG 239
           +  ++ +G
Sbjct: 213 VMSALQRG 220

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 46/181 (25%), Positives = 86/181 (47%), Gaps = 30/181 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C  I           
Sbjct: 69  RELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI------HMELD 121

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A      + 
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA------RT 172

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
            C+      +  T+        +Y APEVI    Y + VDIW+ G ++  L+ G++ F G
Sbjct: 173 ACTNFMMTPYVVTR--------YYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224

Query: 228 S 228
           +
Sbjct: 225 T 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.6 bits (144), Expect = 2e-10
 Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 36/211 (17%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICF-EIVRRATAGFVYSE 108
           DL  E  +   + HPHV++L    S +G L ++ EY   GS   F    R+    ++ S+
Sbjct: 49  DLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD 108

Query: 109 AVASH------------------YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP 150
              +                   +  Q+   ++Y  E  ++HRD+    VL+A       
Sbjct: 109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK--- 165

Query: 151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWA 210
           +K+  FG++  + +           D Y  ++  RI    +MA E + D  Y    D+W+
Sbjct: 166 MKISDFGLSRDVYEE----------DSYVKRSKGRIPV-KWMAIESLFDHIYTTQSDVWS 214

Query: 211 AGVLLHVLLT-GTLPFVG-SRDRLFQSITKG 239
            GVLL  ++T G  P+ G + +RLF  +  G
Sbjct: 215 FGVLLWEIVTLGGNPYPGIAPERLFNLLKTG 245

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.3 bits (143), Expect = 2e-10
 Identities = 48/178 (26%), Positives = 90/178 (50%), Gaps = 21/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           REA++   LKH ++V L +   ++  L +VFEY+  +D+C  + +    G ++ E V   
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP--GGLHPENV-KL 107

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ Q+L  L Y H+  I+HRD+KP  +L++   ++  +KL  FG+A             +
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLA-----------RAK 153

Query: 174 RLDHYTTKAGHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
            +  +T    + + T  Y  P+V +   +Y   +D+W  G +   ++ G   F G +D
Sbjct: 154 SVPSHTYS--NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 59.0 bits (143), Expect = 3e-10
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 28/206 (13%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
             D +REA +    +H ++V+     +      MVFEYM+  D+  + +R       + +
Sbjct: 52  RKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN-KFLRSHGPDAAFLK 110

Query: 109 AVAS-----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           +  S               Q+   + Y      +HRD+     L+        VK+G FG
Sbjct: 111 SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD---LVVKIGDFG 167

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           ++   +D  +Y +     D+Y    GH +    +M PE I  +K+    D+W+ GV+L  
Sbjct: 168 MS---RD--VYTT-----DYYRVG-GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216

Query: 218 LLT-GTLPFVG-SRDRLFQSITKGKL 241
           + T G  P+ G S + + + IT+G+L
Sbjct: 217 IFTYGKQPWYGLSNEEVIECITQGRL 242

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.5 bits (144), Expect = 3e-10
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 9/98 (9%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY-SEAVASHYMRQVLEA 121
           K P +V L  +  S   +Y+V EY+ G D     V+     + Y  E +A  Y+ +V  A
Sbjct: 62  KSPFIVHLYYSLQSANNVYLVMEYLIGGD-----VKSLLHIYGYFDEEMAVKYISEVALA 116

Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
           L Y H + IIHRD+KP  +L++N+ +   +KL  FG++
Sbjct: 117 LDYLHRHGIIHRDLKPDNMLISNEGH---IKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 58.6 bits (142), Expect = 3e-10
 Identities = 51/189 (26%), Positives = 76/189 (40%), Gaps = 17/189 (8%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVY 106
            E+D   EA I     H ++V L+         +++ E M G D+  F    R       
Sbjct: 52  DESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS 111

Query: 107 SEAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
           S  +       R V +  +Y  EN  IHRDI     LL  K      K+  FG+A     
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA----- 166

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGT 222
             +Y     R  +Y  + G R   P  +M PE   D  +    D+W+ GVLL  +   G 
Sbjct: 167 RDIY-----RASYY--RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219

Query: 223 LPFVGSRDR 231
           +P+ G  ++
Sbjct: 220 MPYPGRTNQ 228

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 58.0 bits (140), Expect = 6e-10
 Identities = 57/188 (30%), Positives = 93/188 (49%), Gaps = 33/188 (17%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   +KH +V+ LL+ ++ +  L      Y+V  +M G+D+  ++++        S
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLG-KLMKHEK----LS 116

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E      + Q+L+ L+Y H   IIHRD+KP   L  N++    +K+  FG+A Q  D ++
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN-LAVNED--CELKILDFGLARQ-TDSEM 172

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                          G+ + T  Y APEVI +   Y + VDIW+ G ++  +LTG   F 
Sbjct: 173 --------------TGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217

Query: 227 GSRDRLFQ 234
           G  D L Q
Sbjct: 218 GH-DHLDQ 224

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.7 bits (139), Expect = 7e-10
 Identities = 54/207 (26%), Positives = 87/207 (42%), Gaps = 32/207 (15%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI----------CFEIV--- 97
           D +REA +   L+H H+V+          L MVFEYM   D+             +V   
Sbjct: 53  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112

Query: 98  -RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R+A      S+ +  H   Q+   + Y      +HRD+     L+     +  VK+G F
Sbjct: 113 PRQAKGELGLSQML--HIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIGDF 167

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLH 216
           G++  +     Y  GG           H +    +M PE I  +K+    D+W+ GV+L 
Sbjct: 168 GMSRDVYSTDYYRVGG-----------HTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216

Query: 217 VLLT-GTLP-FVGSRDRLFQSITKGKL 241
            + T G  P F  S   + + IT+G++
Sbjct: 217 EIFTYGKQPWFQLSNTEVIECITQGRV 243

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 57.5 bits (139), Expect = 8e-10
 Identities = 55/222 (24%), Positives = 92/222 (41%), Gaps = 42/222 (18%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +AD +REA +     HP++V+LL   +    + ++FEYM   D+  E +R  +     S
Sbjct: 51  MQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN-EFLRHRSPRAQCS 109

Query: 108 EAVASHYMR-------------------QVLEALRYCHENDIIHRDIKPHCVLLANKENS 148
            + ++   R                   QV   + Y  E   +HRD+     L+   EN 
Sbjct: 110 LSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVG--ENM 167

Query: 149 APVKLGGFGVA--IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPV 206
             VK+  FG++  I   D   Y    E  D    +         +M PE I   +Y    
Sbjct: 168 V-VKIADFGLSRNIYSAD---YYKASEN-DAIPIR---------WMPPESIFYNRYTTES 213

Query: 207 DIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGKLHILGC 246
           D+WA GV+L  + + G  P+ G + + +   +  G  ++L C
Sbjct: 214 DVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDG--NVLSC 253

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 57.7 bits (139), Expect = 8e-10
 Identities = 53/187 (28%), Positives = 83/187 (44%), Gaps = 42/187 (22%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 123

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 124 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED-CELKILDFGLA--- 167

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTG 221
                         H   +    + T  Y APE++ +   Y + VDIW+ G ++  LLTG
Sbjct: 168 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214

Query: 222 TLPFVGS 228
              F G+
Sbjct: 215 RTLFPGT 221

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.9 bits (140), Expect = 9e-10
 Identities = 55/199 (27%), Positives = 86/199 (43%), Gaps = 43/199 (21%)

Query: 45  HYTTEADLKREATICHMLKHPHVVELLETYSSEGML----------YMVFEYMDGSDICF 94
           H +    + RE  +  +L+HP +VE+        ML          Y+VFE M+ SD+  
Sbjct: 39  HVSDATRILREIKLLRLLRHPDIVEIKHI-----MLPPSRREFKDIYVVFELME-SDL-- 90

Query: 95  EIVRRATAGFVYSEAVASHY---MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV 151
             V +A       +    H+   + Q+L AL+Y H  ++ HRD+KP  + LAN +    +
Sbjct: 91  HQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNI-LANAD--CKL 142

Query: 152 KLGGFGVA-IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDI 208
           K+  FG+A +   D                     + T  Y APE+      KY   +DI
Sbjct: 143 KICDFGLARVAFNDTPT-----------AIFWTDYVATRWYRAPELCGSFFSKYTPAIDI 191

Query: 209 WAAGVLLHVLLTGTLPFVG 227
           W+ G +   +LTG   F G
Sbjct: 192 WSIGCIFAEVLTGKPLFPG 210

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 22/181 (12%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSE 108
               +EA I   L+H  +V+L    S E  +Y+V EYM  GS + F  ++      +   
Sbjct: 46  EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF--LKSGEGKKLRLP 103

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
            +      Q+ E + Y    + IHRD+    +L+   EN    K+  FG+A  ++D    
Sbjct: 104 QLVD-MAAQIAEGMAYLESRNYIHRDLAARNILVG--ENLV-CKIADFGLARLIED---- 155

Query: 169 CSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFV 226
                  D YT + G +   P  + APE     ++    D+W+ G+LL  ++T G +P+ 
Sbjct: 156 -------DEYTAREGAKF--PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYP 206

Query: 227 G 227
           G
Sbjct: 207 G 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 57.0 bits (137), Expect = 1e-09
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 25/202 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  REA +   L+H H+V+          L MVFEYM   D+   +        + +E  
Sbjct: 53  DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 112

Query: 111 AS---------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
                      H  +Q+   + Y      +HRD+     L+   EN   VK+G FG++  
Sbjct: 113 RPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG--ENLL-VKIGDFGMSRD 169

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT- 220
           +     Y  G           GH +    +M PE I  +K+    D+W+ GV+L  + T 
Sbjct: 170 VYSTDYYRVG-----------GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTY 218

Query: 221 GTLPFVG-SRDRLFQSITKGKL 241
           G  P+   S + + + IT+G++
Sbjct: 219 GKQPWYQLSNNEVIECITQGRV 240

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 54/183 (29%), Positives = 84/183 (45%), Gaps = 23/183 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           REA++   LKH ++V L +   ++  L  VFEYM  +D+   +++    G ++   V   
Sbjct: 52  REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP--GGLHPYNVRL- 107

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQLYCSGG 172
           +M Q+L  L Y H   I+HRD+KP  +L++       +KL  FG+A  +    Q Y S  
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAKSIPSQTYSS-- 162

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDR 231
                        + T  Y  P+V+     Y   +DIW AG +   +L G   F G  D 
Sbjct: 163 ------------EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210

Query: 232 LFQ 234
             Q
Sbjct: 211 FEQ 213

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 56.7 bits (137), Expect = 1e-09
 Identities = 37/113 (32%), Positives = 53/113 (46%), Gaps = 22/113 (19%)

Query: 118 VLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLD 176
           +++AL Y H    +IHRD+KP  V L N+     VKL  FG++     G L  S  + +D
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNV-LINRNGQ--VKLCDFGIS-----GYLVDSVAKTID 163

Query: 177 HYTTKAGHRIGTPHYMAPEVI----EDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                     G   YMAPE I      + Y    D+W+ G+ +  L TG  P+
Sbjct: 164 ---------AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.9 bits (137), Expect = 1e-09
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 22/177 (12%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFV 105
           T   D  +E  I   LK+P+++ LL    S+  L M+ EYM+  D+  F   R   + F 
Sbjct: 59  TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFT 118

Query: 106 YSEAVAS-------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV 158
           ++  + S       +   Q+   ++Y    + +HRD+     L+    N   +K+  FG+
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGM 175

Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
           +  L  G          D+Y  + G  +    +MA E I   K+    D+WA GV L
Sbjct: 176 SRNLYSG----------DYYRIQ-GRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 55.3 bits (133), Expect = 4e-09
 Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICF-EIVRRATAGFVY 106
           +E +   EA +   L H  +V+L    + +  +Y+V EYM  S+ C    +R     F  
Sbjct: 42  SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM--SNGCLLNYLREHGKRFQP 99

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           S+ +       V E + Y      IHRD+     L+   ++   VK+  FG++  + D  
Sbjct: 100 SQLLEMCK--DVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLD-- 152

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPF 225
                    D YT+  G +     +  PEV+   K+    D+WA GVL+  V   G +P+
Sbjct: 153 ---------DEYTSSVGSKFPV-RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.4 bits (133), Expect = 5e-09
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 33/207 (15%)

Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS- 107
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  Y  
Sbjct: 68  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY 127

Query: 108 -------------EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
                        + V+  Y  QV   + Y      IHRD+    VL+   E++  +K+ 
Sbjct: 128 NPTQVPEEQLSFKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIA 182

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
            FG+A  +            +D+Y      R+    +MAPE + D+ Y    D+W+ GVL
Sbjct: 183 DFGLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVWSFGVL 231

Query: 215 LHVLLT-GTLPFVG-SRDRLFQSITKG 239
           L  + T G  P+ G   + LF+ + +G
Sbjct: 232 LWEIFTLGGSPYPGVPVEELFKLLKEG 258

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 7e-09
 Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 31/198 (15%)

Query: 54  REATICHMLKHPHVVELL-----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  I    KH +++ +L      ++ S   +Y+V E M+ +D+      +       S 
Sbjct: 52  REIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLY-----KLIKTQHLSN 105

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               +++ Q+L  L+Y H  +++HRD+KP   LL N   +  +K+  FG+A ++ D +  
Sbjct: 106 DHIQYFLYQILRGLKYIHSANVLHRDLKP-SNLLLNT--NCDLKICDFGLA-RIADPEHD 161

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG 227
            +G   L  Y       + T  Y APE++ + K Y K +DIW+ G +L  +L+    F G
Sbjct: 162 HTGF--LTEY-------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212

Query: 228 SRDRLFQSITKGKLHILG 245
            +D L Q        ILG
Sbjct: 213 -KDYLHQL-----NLILG 224

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 54.3 bits (131), Expect = 8e-09
 Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 21/183 (11%)

Query: 43  LNHYTTEA---DLKREATICHMLKHPHVVELLETYSSEGM--LYMVFEYMDGSDICFEIV 97
           LNH   E    D +RE  I   L H ++V+        G   L ++ EY+          
Sbjct: 41  LNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYL--PSGSLRDY 98

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
            +     +  + +   +  Q+ + + Y      IHRD+    +L+   E+   VK+  FG
Sbjct: 99  LQRHRDQINLKRLLL-FSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFG 154

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A  L + +         D+Y  K         Y APE +   K+    D+W+ GV L+ 
Sbjct: 155 LAKVLPEDK---------DYYYVKEPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYE 204

Query: 218 LLT 220
           L T
Sbjct: 205 LFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 31/187 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQME-----LD 124

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                 R    +      + T +Y APEVI    Y + VDIW+ G ++  ++ G + F G
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227

Query: 228 SRDRLFQ 234
             D + Q
Sbjct: 228 -TDHIDQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.3 bits (130), Expect = 1e-08
 Identities = 52/190 (27%), Positives = 86/190 (45%), Gaps = 27/190 (14%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS--- 107
           + K EA +   L+HP++V LL   + E  L M+F Y   SD+   +V R+    V S   
Sbjct: 54  EFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 108 -EAVAS--------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV 158
            + V S        H + Q+   + +   + ++H+D+    VL+ +K N     LG F  
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF-- 171

Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HV 217
                  ++Y +     D+Y    G+ +    +M+PE I   K+    DIW+ GV+L  V
Sbjct: 172 ------REVYAA-----DYYKL-MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Query: 218 LLTGTLPFVG 227
              G  P+ G
Sbjct: 220 FSYGLQPYCG 229

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 54.0 bits (130), Expect = 1e-08
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 29/194 (14%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            + + ++EA +   L+HP++V LL   + E    M+FEY+   D+   +VR +    V +
Sbjct: 51  VQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGA 110

Query: 108 EA----VAS--------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
           E+    V S        H   Q+   + Y   +  +HRD+     L+        VK+  
Sbjct: 111 ESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT---VKISD 167

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVL 214
           FG++   +D   Y +     D+Y  +   +   P  +M PE I   K+    DIW+ GV+
Sbjct: 168 FGLS---RDI--YSA-----DYY--RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVV 215

Query: 215 L-HVLLTGTLPFVG 227
           L  +   G  P+ G
Sbjct: 216 LWEIFSYGLQPYYG 229

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 43/178 (24%), Positives = 80/178 (44%), Gaps = 23/178 (12%)

Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P +V +   + +   L  + + M+G D+ + + +      V+SEA    Y  +++  L +
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEH 112

Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H   +++RD+KP  +LL   +    V++   G+A         C   ++  H +     
Sbjct: 113 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLA---------CDFSKKKPHAS----- 155

Query: 185 RIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKL 241
            +GT  YMAPEV++    Y    D ++ G +L  LL G  PF   + +    I +  L
Sbjct: 156 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.9 bits (129), Expect = 1e-08
 Identities = 46/187 (24%), Positives = 88/187 (47%), Gaps = 31/187 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLC-QVIQME-----LD 117

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 166

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                 R    +      + T +Y APEVI    Y + VDIW+ G ++  ++   + F G
Sbjct: 167 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220

Query: 228 SRDRLFQ 234
            RD + Q
Sbjct: 221 -RDYIDQ 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.9 bits (130), Expect = 2e-08
 Identities = 49/188 (26%), Positives = 90/188 (47%), Gaps = 30/188 (15%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM-----LYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  +   L H +V+ + +            +Y+V+E MD +D+  +I+R +      S+
Sbjct: 53  REIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDL-HQIIRSSQT---LSD 107

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLL-ANKENSAPVKLGGFGVAIQLQDGQL 167
               +++ Q+L  L+Y H  +++HRD+KP  +LL AN +    +K+  FG+A      + 
Sbjct: 108 DHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLA------RT 157

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFV 226
               G+ +  Y         T  Y APE++ +  +Y   +D+W+ G +   LL     F 
Sbjct: 158 TSEKGDFMTEYVV-------TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210

Query: 227 GSRDRLFQ 234
           G +D + Q
Sbjct: 211 G-KDYVHQ 217

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 53.5 bits (128), Expect = 2e-08
 Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 29/208 (13%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           +   D +REA +  +L+H H+V      +    L MVFEYM   D+   +        + 
Sbjct: 49  SARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKIL 108

Query: 107 SEAVAS-----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
           +                    Q+   + Y      +HRD+     L+        VK+G 
Sbjct: 109 AGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGLVVKIGD 165

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVL 214
           FG++  +     Y  GG            R   P  +M PE I  +K+    DIW+ GV+
Sbjct: 166 FGMSRDIYSTDYYRVGG------------RTMLPIRWMPPESILYRKFTTESDIWSFGVV 213

Query: 215 LHVLLT-GTLPFVG-SRDRLFQSITKGK 240
           L  + T G  P+   S     + IT+G+
Sbjct: 214 LWEIFTYGKQPWYQLSNTEAIECITQGR 241

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.2 bits (127), Expect = 3e-08
 Identities = 50/216 (23%), Positives = 92/216 (42%), Gaps = 37/216 (17%)

Query: 43  LNHYTTEADLKREA----TICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVR 98
           +  Y ++ D +  A     +C +  HP+++ LL      G LY+  EY    ++  + +R
Sbjct: 30  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL-LDFLR 88

Query: 99  RATA-----GFVYSEAVASHY-MRQVLE-------ALRYCHENDIIHRDIKPHCVLLANK 145
           ++        F  + + AS    +Q+L         + Y  +   IHRD+    +L+   
Sbjct: 89  KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-- 146

Query: 146 ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP 205
           EN    K+  FG+           S G+ +  Y  K   R+    +MA E +    Y   
Sbjct: 147 ENYVA-KIADFGL-----------SRGQEV--YVKKTMGRLPV-RWMAIESLNYSVYTTN 191

Query: 206 VDIWAAGVLL-HVLLTGTLPFVG-SRDRLFQSITKG 239
            D+W+ GVLL  ++  G  P+ G +   L++ + +G
Sbjct: 192 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 52.8 bits (127), Expect = 3e-08
 Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 28/178 (15%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFE-YMDGSDICFEIVRRATAGFVYSEAVAS- 112
           EA I     HPH+V+L+   +   + ++V E    G    +  V +      YS  +AS 
Sbjct: 57  EAYIMRQFDHPHIVKLIGVITENPV-WIVMELAPLGELRSYLQVNK------YSLDLASL 109

Query: 113 -HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  L+D   Y + 
Sbjct: 110 ILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC---VKLGDFGLSRYLEDESYYKAS 166

Query: 172 GERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPFVG 227
             +L             P  +MAPE I  +++    D+W  GV +  +L+ G  PF G
Sbjct: 167 KGKL-------------PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 52.7 bits (126), Expect = 3e-08
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 23/162 (14%)

Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P +V +   + +   L  + + M+G D+ + + +      V+SE     Y  +++  L +
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG----VFSEKEMRFYATEIILGLEH 112

Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H   +++RD+KP  +LL   +    V++   G+A         C   ++  H +     
Sbjct: 113 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLA---------CDFSKKKPHAS----- 155

Query: 185 RIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPF 225
            +GT  YMAPEV++    Y    D ++ G +L  LL G  PF
Sbjct: 156 -VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 52.6 bits (126), Expect = 4e-08
 Identities = 50/188 (26%), Positives = 81/188 (43%), Gaps = 24/188 (12%)

Query: 53  KREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
           K+E  I   L H ++V+     S +G   L ++ EY+  GS      +R        + A
Sbjct: 54  KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS------LRDYLPKHKLNLA 107

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
               + +Q+ E + Y H    IHRD+    VLL   +N   VK+G FG+A  + +G  Y 
Sbjct: 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYY 164

Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
              E  D           +P  + A E +++ K+    D+W+ GV L+ LLT        
Sbjct: 165 RVREDGD-----------SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213

Query: 229 RDRLFQSI 236
             +  + I
Sbjct: 214 PKKFEEMI 221

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 52.3 bits (125), Expect = 4e-08
 Identities = 48/174 (27%), Positives = 83/174 (47%), Gaps = 25/174 (14%)

Query: 55  EATICHMLKHPHVVELLETYSSE-GMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVAS 112
           EA++   L+H ++V+LL     E G LY+V EYM  GS + +    R+    V       
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY---LRSRGRSVLGGDCLL 105

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            +   V EA+ Y   N+ +HRD+    VL++ ++N A  K+  FG+  +    Q      
Sbjct: 106 KFSLDVCEAMEYLEANNFVHRDLAARNVLVS-EDNVA--KVSDFGLTKEASSTQ------ 156

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
                 T K   +     + APE + ++K+    D+W+ G+LL  + + G +P+
Sbjct: 157 -----DTGKLPVK-----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 48/186 (25%), Positives = 83/186 (44%), Gaps = 40/186 (21%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   +KH +V+ LL+ ++    +      Y+V   M G+D+            V  
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADL---------NNIVKC 112

Query: 108 EAVASHYMR----QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
           + ++  +++    Q+L  L+Y H   IIHRD+KP  V +        +++  FG+A Q  
Sbjct: 113 QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQAD 169

Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGT 222
           D          +  Y       + T  Y APE++ +   Y + VDIW+ G ++  LL G 
Sbjct: 170 D---------EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Query: 223 LPFVGS 228
             F G+
Sbjct: 214 ALFPGN 219

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 52.0 bits (124), Expect = 5e-08
 Identities = 41/179 (22%), Positives = 80/179 (44%), Gaps = 19/179 (10%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   L+H  +V+L    S E  +Y+V EYM    +  + ++     ++    +   
Sbjct: 50  QEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSL-LDFLKGEMGKYLRLPQLVD- 106

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+   + Y    + +HRD++   +L+     +   K+  FG+A  ++D +       
Sbjct: 107 MAAQIASGMAYVERMNYVHRDLRAANILVGE---NLVCKVADFGLARLIEDNE------- 156

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGSRDR 231
               YT + G +     + APE     ++    D+W+ G+LL  L T G +P+ G  +R
Sbjct: 157 ----YTARQGAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 52.4 bits (126), Expect = 5e-08
 Identities = 47/188 (25%), Positives = 78/188 (41%), Gaps = 31/188 (16%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
           ++  EA +   + HPHVV LL    S  +  ++ + M  G     + VR           
Sbjct: 55  EILDEAYVMASVDHPHVVRLLGICLSSQVQ-LITQLMPLGC--LLDYVRNHKD------N 105

Query: 110 VASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
           + S Y+     Q+ + + Y  E  ++HRD+    VL+   ++   VK+  FG+A  L   
Sbjct: 106 IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLDVD 162

Query: 166 QLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
           +           Y  + G     P  +MA E I  + Y    D+W+ GV +  L+T G  
Sbjct: 163 E---------KEYHAEGGK---VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Query: 224 PFVGSRDR 231
           P+ G    
Sbjct: 211 PYEGIPAV 218

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 52.4 bits (126), Expect = 5e-08
 Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 55/199 (27%)

Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +  ++ H +++ LL  ++ +  L      Y+V E MD + +C ++++         
Sbjct: 64  RELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDAN-LC-QVIQMD-----LD 116

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPH-------CVLLANKENSAPVKLGGFGVAI 160
               S+ + Q+L  +++ H   IIHRD+KP        C L          K+  FG+A 
Sbjct: 117 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL----------KILDFGLA- 165

Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTP-----HYMAPEVIEDQKYGKPVDIWAAGVLL 215
                              T     + TP     +Y APEVI    Y + VDIW+ G ++
Sbjct: 166 ------------------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207

Query: 216 HVLLTGTLPFVGSRDRLFQ 234
             ++ GT+ F G  D + Q
Sbjct: 208 GEMIRGTVLFPG-TDHIDQ 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 41/167 (24%), Positives = 65/167 (38%), Gaps = 18/167 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           + +  REA++   L HP +V L+     E ++ +V E      +   + +R         
Sbjct: 40  KKEFLREASVMAQLDHPCIVRLIGVCKGEPLM-LVMELAPLGPLLKYLKKRRE----IPV 94

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           +       QV   + Y      +HRD+    VLL N+      K+  FG++  L  G   
Sbjct: 95  SDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ---AKISDFGMSRALGAGS-- 149

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
                  D+Y      R     Y APE I   K+    D+W+ GV L
Sbjct: 150 -------DYYRATTAGRWPLKWY-APECINYGKFSSKSDVWSYGVTL 188

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.9 bits (124), Expect = 5e-08
 Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 19/173 (10%)

Query: 44  NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-FEIVRRATA 102
           N  +   ++ REA I H L +P++V ++    +E ++ +V E   G  +  F   ++   
Sbjct: 34  NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALM-LVMEMASGGPLNKFLSGKKDE- 91

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +    V    M QV   ++Y    + +HRD+    VLL N+  +   K+  FG++  L
Sbjct: 92  --ITVSNVV-ELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA---KISDFGLSKAL 145

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
                    G    +Y  ++  +     Y APE I  +K+    D+W+ G+ +
Sbjct: 146 ---------GADDSYYKARSAGKWPLKWY-APECINFRKFSSRSDVWSYGITM 188

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 23/173 (13%)

Query: 44  NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATA 102
           +  T       EA++   L+HP++V+LL        LY+V EYM  GS + +    R+  
Sbjct: 39  DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDY---LRSRG 95

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             V + A    +   V E + Y  E + +HRD+    VL++  +  A  K+  FG+A   
Sbjct: 96  RAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE-DLVA--KVSDFGLA--- 149

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
           ++       G+    +T             APE + ++K+    D+W+ G+LL
Sbjct: 150 KEASQGQDSGKLPVKWT-------------APEALREKKFSTKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 52.1 bits (125), Expect = 6e-08
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 21/183 (11%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            EA +     + H+  H ++V LL   +  G + ++ EY    D+    +RR    F+  
Sbjct: 82  REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDL-LNFLRRKRESFLTL 140

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E +   +  QV + + +    + IHRD+    VLL + +    VK+  FG+A  + +   
Sbjct: 141 EDLL-SFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK---IVKICDFGLARDIMNDSN 196

Query: 168 YCS-GGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP 224
           Y   G  RL             P  +MAPE I +  Y    D+W+ G+LL  + + G+ P
Sbjct: 197 YVVKGNARL-------------PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243

Query: 225 FVG 227
           + G
Sbjct: 244 YPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.9 bits (124), Expect = 6e-08
 Identities = 46/185 (24%), Positives = 83/185 (44%), Gaps = 23/185 (12%)

Query: 39  PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICFEI 96
           P+   NH    ADLK+E  I   L H ++V+     + +G   + ++ E++    +  E 
Sbjct: 43  PESGGNHI---ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK-EY 98

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
           + R        + +   Y  Q+ + + Y      +HRD+    VL+   E+   VK+G F
Sbjct: 99  LPRNKNKINLKQQL--KYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDF 153

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL 215
           G+   ++  + Y +  + LD           +P  + APE +   K+    D+W+ GV L
Sbjct: 154 GLTKAIETDKEYYTVKDDLD-----------SPVFWYAPECLIQSKFYIASDVWSFGVTL 202

Query: 216 HVLLT 220
           + LLT
Sbjct: 203 YELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.5 bits (123), Expect = 6e-08
 Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 25/177 (14%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA I     HP++V+L+   +    +Y+V E + G D     +R+        E      
Sbjct: 42  EARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF-LSFLRKKK-----DELKTKQL 95

Query: 115 MRQVLEA---LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           ++  L+A   + Y    + IHRD+     L+   EN+  +K+  FG++ Q +D  +Y S 
Sbjct: 96  VKFALDAAAGMAYLESKNCIHRDLAARNCLVG--ENNV-LKISDFGMSRQ-EDDGIYSSS 151

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPFVG 227
           G  L     K         + APE +   +Y    D+W+ G+LL      G  P+ G
Sbjct: 152 G--LKQIPIK---------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 51.6 bits (124), Expect = 7e-08
 Identities = 45/196 (22%), Positives = 78/196 (39%), Gaps = 26/196 (13%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGF--VYSEAVA 111
           EA++       HVV LL   S+     +V E M   D+  +   RR  A           
Sbjct: 59  EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTL 118

Query: 112 SHYMR---QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA--IQLQDGQ 166
             +++   ++ + + Y      +HRD+     ++A       VK+G FG+   I   D  
Sbjct: 119 QKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT---VKIGDFGMTRDIYETD-- 173

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
                      Y  K G  +    +MAPE ++D  +    D+W+ GV+L  + T    P+
Sbjct: 174 -----------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY 222

Query: 226 VG-SRDRLFQSITKGK 240
            G S + + + +  G 
Sbjct: 223 QGLSNEEVLKFVIDGG 238

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.6 bits (123), Expect = 7e-08
 Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 23/199 (11%)

Query: 47  TTEADLK----REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATA 102
           T   DLK    +EA I     HP++V L+   + +  +Y+V E + G D     +R    
Sbjct: 31  TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF-LTFLRTEGP 89

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                E +    +      + Y      IHRD+     L+  K     +K+  FG++ + 
Sbjct: 90  RLKVKELI--QMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV---LKISDFGMSREE 144

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTG 221
           +DG    +GG  +     K         + APE +   +Y    D+W+ G+LL      G
Sbjct: 145 EDGVYASTGG--MKQIPVK---------WTAPEALNYGRYSSESDVWSFGILLWEAFSLG 193

Query: 222 TLPFVG-SRDRLFQSITKG 239
            +P+   S  +  ++I +G
Sbjct: 194 AVPYANLSNQQTREAIEQG 212

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 51.6 bits (123), Expect = 9e-08
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 18/175 (10%)

Query: 54  REATICHMLKHPHVVELLETY--SSEGMLYMVFEYMDGSDICFEIVRRATAG----FVYS 107
           RE  +   LKHP+V+ L + +   S+  ++++F+Y +          RA+          
Sbjct: 47  REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP 106

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL-LANKENSAPVKLGGFGVAIQLQDGQ 166
            ++    + Q+L+ + Y H N ++HRD+KP  +L +        VK+   G A      +
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------R 160

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLT 220
           L+ S  + L          + T  Y APE++   + Y K +DIWA G +   LLT
Sbjct: 161 LFNSPLKPL----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 48/175 (27%), Positives = 80/175 (45%), Gaps = 18/175 (10%)

Query: 54  REATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGS---DICFEIVRRATAGFV-YS 107
           RE  +   LKHP+V+ L + + S     ++++F+Y +      I F    +A    V   
Sbjct: 47  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 106

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL-LANKENSAPVKLGGFGVAIQLQDGQ 166
             +    + Q+L+ + Y H N ++HRD+KP  +L +        VK+   G A      +
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------R 160

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLT 220
           L+ S  + L          + T  Y APE++   + Y K +DIWA G +   LLT
Sbjct: 161 LFNSPLKPL----ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.2 bits (122), Expect = 1e-07
 Identities = 49/188 (26%), Positives = 84/188 (44%), Gaps = 22/188 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEAVASH 113
           EA I   L+H  +V+L    S E  +Y+V EYM  GS + F    +   G          
Sbjct: 51  EAQIMKKLRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDF---LKDGEGRALKLPNLVD 106

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              QV   + Y    + IHRD++   +L+ +       K+  FG+A  ++D +       
Sbjct: 107 MAAQVAAGMAYIERMNYIHRDLRSANILVGD---GLVCKIADFGLARLIEDNE------- 156

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGSRDR- 231
               YT + G +     + APE     ++    D+W+ G+LL  L+T G +P+ G  +R 
Sbjct: 157 ----YTARQGAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE 211

Query: 232 LFQSITKG 239
           + + + +G
Sbjct: 212 VLEQVERG 219

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 24/184 (13%)

Query: 50  ADLKR----EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
            DLKR    EA I     HP++V+L+     +  +Y+V E + G  +    +R+      
Sbjct: 33  PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL-LTFLRKKKNRLT 91

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKP-HCVLLANKENSAPVKLGGFGVAIQLQD 164
             + +           + Y    + IHRD+   +C  L  + N   +K+  FG++ + + 
Sbjct: 92  VKKLL--QMSLDAAAGMEYLESKNCIHRDLAARNC--LVGENNV--LKISDFGMSREEEG 145

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
           G            YT   G +     + APE +   +Y    D+W+ G+LL    + G  
Sbjct: 146 GI-----------YTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDT 194

Query: 224 PFVG 227
           P+ G
Sbjct: 195 PYPG 198

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 37/216 (17%)

Query: 43  LNHYTTEADLKREA----TICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVR 98
           L  + +E D +  A     +C +  HP+++ LL    + G LY+  EY    ++  + +R
Sbjct: 37  LKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL-LDFLR 95

Query: 99  RATA-----GFVYSEAVASHYM-RQVLE-------ALRYCHENDIIHRDIKPHCVLLANK 145
           ++        F      AS    +Q+L+        ++Y  E   IHRD+    VL+   
Sbjct: 96  KSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG-- 153

Query: 146 ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP 205
           EN A  K+  FG+           S GE +  Y  K   R+    +MA E +    Y   
Sbjct: 154 ENLAS-KIADFGL-----------SRGEEV--YVKKTMGRLPV-RWMAIESLNYSVYTTK 198

Query: 206 VDIWAAGVLL-HVLLTGTLPFVG-SRDRLFQSITKG 239
            D+W+ GVLL  ++  G  P+ G +   L++ + +G
Sbjct: 199 SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 50.3 bits (120), Expect = 2e-07
 Identities = 47/179 (26%), Positives = 83/179 (46%), Gaps = 23/179 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
           D   EA+I     HP+++ L    +    + +V EYM+ GS   F  +R+    F   + 
Sbjct: 51  DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAF--LRKHDGQFTVIQL 108

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLY 168
           V    +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D    
Sbjct: 109 VG--MLRGIASGMKYLSDMGYVHRDLAARNILV----NSNLVCKVSDFGLSRVLED---- 158

Query: 169 CSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPF 225
               +    YTT+ G     P  + APE I  +K+    D+W+ G+++  V+  G  P+
Sbjct: 159 ----DPEAAYTTRGGK---IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.1 bits (120), Expect = 2e-07
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 26/187 (13%)

Query: 41  ERLNHYTTEA--DLKREATICHMLKHPHVVELLETYSSEGM--LYMVFEYM-DGSDICFE 95
           ++L H T E   D +RE  I   L+H ++V+      S G   L +V EY+  GS   + 
Sbjct: 39  KKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL 98

Query: 96  IVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
              R      + + +   Y  Q+ + + Y      +HRD+    +L+   E+   VK+G 
Sbjct: 99  QKHRER--LDHRKLL--LYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGD 151

Query: 156 FGVAIQL-QDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGV 213
           FG+   L QD + Y            + G    +P  + APE + + K+    D+W+ GV
Sbjct: 152 FGLTKVLPQDKEYY---------KVREPGE---SPIFWYAPESLTESKFSVASDVWSFGV 199

Query: 214 LLHVLLT 220
           +L+ L T
Sbjct: 200 VLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 44/178 (24%), Positives = 82/178 (46%), Gaps = 21/178 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+HP +V L    + E  +Y++ EYM +GS + F    +   G   +      
Sbjct: 51  EANLMKQLQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPEGIKLTINKLID 106

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +    + IHRD++   +L++    +   K+  FG+A  ++D         
Sbjct: 107 MAAQIAEGMAFIERKNYIHRDLRAANILVSE---TLCCKIADFGLARLIED--------- 154

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGSRD 230
             + YT + G +     + APE I    +    D+W+ G+LL  ++T G +P+ G  +
Sbjct: 155 --NEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN 209

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 49.9 bits (119), Expect = 3e-07
 Identities = 46/185 (24%), Positives = 75/185 (40%), Gaps = 31/185 (16%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI---------------CFE 95
           D  +E  I   LK P+++ LL     E  L M+ EYM+  D+                 +
Sbjct: 65  DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124

Query: 96  IVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKP-HCVLLANKENSAPVKLG 154
            V  A      S +   H   Q+   ++Y    + +HRD+   +C++  N      +K+ 
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT----IKIA 180

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
            FG++  L  G          D+Y  + G  +    +MA E I   K+    D+WA GV 
Sbjct: 181 DFGMSRNLYAG----------DYYRIQ-GRAVLPIRWMAWECILMGKFTTASDVWAFGVT 229

Query: 215 LHVLL 219
           L  +L
Sbjct: 230 LWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 48/206 (23%), Positives = 95/206 (46%), Gaps = 29/206 (14%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-FEIVRRATA------- 102
           + ++EA++   L HP++V LL   + E  + M+FEY++  D+  F I+R   +       
Sbjct: 53  EFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSD 112

Query: 103 --GFVYSEAVASHYMR---QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
             G V S      ++    Q+   + Y   +  +H+D+    +L+  + +   VK+   G
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH---VKISDLG 169

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           ++      ++Y +     D+Y  +    +    +M PE I   K+    DIW+ GV+L  
Sbjct: 170 LS-----REIYSA-----DYYRVQPKSLLPI-RWMPPEAIMYGKFSSDSDIWSFGVVLWE 218

Query: 218 LLT-GTLPFVG-SRDRLFQSITKGKL 241
           + + G  P+ G S   + + + K +L
Sbjct: 219 IFSFGLQPYYGFSNQEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 50.0 bits (119), Expect = 3e-07
 Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 36/205 (17%)

Query: 41  ERLNHYTTEADLKREA----TICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEI 96
           +R+  Y ++ D +  A     +C +  HP+++ LL      G LY+  EY    ++  + 
Sbjct: 40  KRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL-LDF 98

Query: 97  VRRATA-----GFVYSEAVAS--------HYMRQVLEALRYCHENDIIHRDIKPHCVLLA 143
           +R++        F  + + AS        H+   V   + Y  +   IHRD+    +L+ 
Sbjct: 99  LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 158

Query: 144 NKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYG 203
             EN    K+  FG    L  GQ         + Y  K   R+    +MA E +    Y 
Sbjct: 159 --ENYV-AKIADFG----LSRGQ---------EVYVKKTMGRLPV-RWMAIESLNYSVYT 201

Query: 204 KPVDIWAAGVLL-HVLLTGTLPFVG 227
              D+W+ GVLL  ++  G  P+ G
Sbjct: 202 TNSDVWSYGVLLWEIVSLGGTPYCG 226

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 49.7 bits (119), Expect = 4e-07
 Identities = 37/124 (29%), Positives = 59/124 (47%), Gaps = 26/124 (20%)

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQLYCSGG 172
           ++ Q+L  L+Y H   I+HRDIKP   LL N  ++  +K+  FG+A ++  D   + +  
Sbjct: 108 FLYQILRGLKYLHSAGILHRDIKPGN-LLVN--SNCVLKICDFGLARVEEPDESKHMT-- 162

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDR 231
                        + T +Y APE++   + Y   VDIW+ G +   LL         R  
Sbjct: 163 -----------QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL--------GRRI 203

Query: 232 LFQS 235
           LFQ+
Sbjct: 204 LFQA 207

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 49.9 bits (119), Expect = 5e-07
 Identities = 26/70 (37%), Positives = 37/70 (52%), Gaps = 8/70 (11%)

Query: 171 GGERLDHYTTKAGHRI-GTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-S 228
           G   ++        RI GTP Y+APE++  + +G  VD WA GV L   LTG  PF   +
Sbjct: 531 GAAPVEG------ERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDET 584

Query: 229 RDRLFQSITK 238
             ++FQ+I  
Sbjct: 585 PQQVFQNILN 594

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 5e-07
 Identities = 45/168 (26%), Positives = 80/168 (47%), Gaps = 21/168 (12%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSE 108
            D   EA+I     HP+++ L    +    + ++ EYM+ GS   F  +R     F   +
Sbjct: 50  LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKF--LRENDGKFTVGQ 107

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQL 167
            V    +R +   ++Y  E + +HRD+    +L+    NS  V K+  FG++ +L+D + 
Sbjct: 108 LVG--MLRGIASGMKYLSEMNYVHRDLAARNILV----NSNLVCKVSDFGLSRRLEDSE- 160

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
                     YTTK G +I    + APE I  +K+    D+W+ G+++
Sbjct: 161 --------ATYTTKGG-KIPI-RWTAPEAIAYRKFTSASDVWSFGIVM 198

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 49.3 bits (118), Expect = 5e-07
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 26/184 (14%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYS 107
             D   EA I   L+HP +++L    + E  +Y+V E M  GS +  E ++      +  
Sbjct: 45  PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLL--EYLQGGAGRALKL 102

Query: 108 EA---VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
                +A+    QV   + Y    + IHRD+    VL+     +   K+  FG+A  +++
Sbjct: 103 PQLIDMAA----QVASGMAYLEAQNYIHRDLAARNVLVGE---NNICKVADFGLARVIKE 155

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
                      D Y  + G +     + APE     ++    D+W+ G+LL  ++T G +
Sbjct: 156 -----------DIYEAREGAKFPI-KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRM 203

Query: 224 PFVG 227
           P+ G
Sbjct: 204 PYPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 48.5 bits (115), Expect = 7e-07
 Identities = 44/188 (23%), Positives = 87/188 (46%), Gaps = 20/188 (10%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA I   L+H  +V L    S E  +Y+V E+M G     + ++     ++    +   
Sbjct: 50  QEAQIMKKLRHDKLVPLYAVVSEEP-IYIVTEFM-GKGSLLDFLKEGDGKYLKLPQLVD- 106

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ + + Y    + IHRD++   +L+ +   +   K+  FG+A  ++D +       
Sbjct: 107 MAAQIADGMAYIERMNYIHRDLRAANILVGD---NLVCKIADFGLARLIEDNE------- 156

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGSRDR- 231
               YT + G +     + APE     ++    D+W+ G+LL  L+T G +P+ G  +R 
Sbjct: 157 ----YTARQGAKFPI-KWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211

Query: 232 LFQSITKG 239
           + + + +G
Sbjct: 212 VLEQVERG 219

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 47.7 bits (114), Expect = 1e-06
 Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 23/182 (12%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-------FEIVRR 99
               D  +E  I   L  P++  LL   + +  L M+ EYM+  D+         E    
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
           A      S +   +   Q+   +RY    + +HRD+     L+     +  +K+  FG+ 
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG---KNYTIKIADFGM- 176

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
                  LY S     D+Y  +   R   P  +MA E +   K+    D+WA GV L  +
Sbjct: 177 ----SRNLYSS-----DYY--RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225

Query: 219 LT 220
           LT
Sbjct: 226 LT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 46.8 bits (111), Expect = 3e-06
 Identities = 45/178 (25%), Positives = 83/178 (46%), Gaps = 19/178 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
           D   EA+I     HP+++ L    +    + ++ E+M+ G+   F  +R+    F   + 
Sbjct: 51  DFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSF--LRQNDGQFTVIQL 108

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLY 168
           V    +R +   ++Y  E + +HRD+    +L+    NS  V K+  FG++  L+D    
Sbjct: 109 VG--MLRGIAAGMKYLSEMNYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSD 162

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAG-VLLHVLLTGTLPF 225
            +       YT+  G +I    + APE I  +K+    D+W+ G V+  V+  G  P+
Sbjct: 163 PT-------YTSSLGGKIPI-RWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 46.9 bits (111), Expect = 3e-06
 Identities = 45/188 (23%), Positives = 89/188 (47%), Gaps = 22/188 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V+L    + E  +Y++ E+M  GS + F    ++  G          
Sbjct: 51  EANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDF---LKSDEGSKQPLPKLID 106

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  Q+ E + +  + + IHRD++   +L++    S   K+  FG+A  ++D +       
Sbjct: 107 FSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE------- 156

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDR 231
               YT + G +     + APE I    +    D+W+ G+LL  ++T G +P+ G S   
Sbjct: 157 ----YTAREGAKFPI-KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211

Query: 232 LFQSITKG 239
           + +++ +G
Sbjct: 212 VIRALERG 219

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 46.3 bits (110), Expect = 4e-06
 Identities = 45/199 (22%), Positives = 83/199 (41%), Gaps = 24/199 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEA 109
           + +RE  +   L H +VV LL         YM+ EY D  D+  F    ++    +    
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 110 VAS----HYMRQVLEALRYCHENDIIHRDIKP-HCVLLANKENSAPVKLGGFGVAIQLQD 164
           +++        Q+   + +      +HRD+   +C++ + +E    VK+    ++     
Sbjct: 114 LSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE----VKVSLLSLS----- 164

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTL 223
             +Y S  E           R     ++APE +++  +    D+W+ GVL+  V   G L
Sbjct: 165 KDVYNS--EYYKLRNALIPLR-----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGEL 217

Query: 224 PFVG-SRDRLFQSITKGKL 241
           PF G S + +   +  GKL
Sbjct: 218 PFYGLSDEEVLNRLQAGKL 236

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 46.6 bits (110), Expect = 4e-06
 Identities = 39/126 (30%), Positives = 58/126 (46%), Gaps = 19/126 (15%)

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  Q+  AL Y H   I HRD+KP  +L+    N+  +KL  FG A  L         G+
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLI--DPNTHTLKLCDFGSAKNLL-------AGQ 225

Query: 174 RLDHYTTKAGHRIGTPHYMAPEV-IEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRD 230
           R   Y       I +  Y APE+ +    Y   +D+W+ G ++  ++ G   F G  S D
Sbjct: 226 RSVSY-------ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278

Query: 231 RLFQSI 236
           +L + I
Sbjct: 279 QLVRII 284

Length = 440

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 46.5 bits (110), Expect = 5e-06
 Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 35/187 (18%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+ E  +  +  HP++V    T+ ++  L++V  +M        I      G   SE   
Sbjct: 46  LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM--SELAI 103

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           ++ ++ VL+AL Y H    +HR +K   +L++                    DG++Y S 
Sbjct: 104 AYILQGVLKALDYIHHMGYVHRSVKASHILIS-------------------VDGKVYLS- 143

Query: 172 GERLDHYTTKAGHRIGTPH-----------YMAPEVIED--QKYGKPVDIWAAGVLLHVL 218
           G R +      G R+   H           +++PEV++   Q Y    DI++ G+    L
Sbjct: 144 GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203

Query: 219 LTGTLPF 225
             G +PF
Sbjct: 204 ANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.9 bits (109), Expect = 6e-06
 Identities = 48/175 (27%), Positives = 76/175 (43%), Gaps = 19/175 (10%)

Query: 54  REATICHMLKHPHVVELLE-TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           +E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +  
Sbjct: 45  KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDL-RNFIRSETHNPTVKDLIG- 102

Query: 113 HYMRQVLEALRYCHENDIIHRDIKP-HCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
            +  QV + + Y      +HRD+   +C+L    + S  VK+  FG+A  + D + Y   
Sbjct: 103 -FGLQVAKGMEYLASKKFVHRDLAARNCML----DESFTVKVADFGLARDIYDKEYYSVH 157

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
                    K         +MA E ++ QK+    D+W+ GVLL  L+T G  P+
Sbjct: 158 NHTGAKLPVK---------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 45.3 bits (107), Expect = 8e-06
 Identities = 46/193 (23%), Positives = 82/193 (42%), Gaps = 22/193 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEG-MLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           +L REA +   L +P++V ++    +E  ML M    +   +   +  +  T      E 
Sbjct: 42  ELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNKHVT------EK 95

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
             +  + QV   ++Y  E + +HRD+    VLL  +  +   K+  FG++  L   + Y 
Sbjct: 96  NITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYA---KISDFGLSKALGADENY- 151

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPFVGS 228
                   Y  K  H      + APE +   K+    D+W+ GVL+      G  P+ G 
Sbjct: 152 --------YKAK-THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202

Query: 229 R-DRLFQSITKGK 240
           + + + Q I  G+
Sbjct: 203 KGNEVTQMIESGE 215

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 45.8 bits (108), Expect = 9e-06
 Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 35/174 (20%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV- 110
           L+ E      L H +++++ E   SE   YM+ +  D     F++       F+Y EA  
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYD-----FDLY-----SFMYDEAFD 259

Query: 111 ---------ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
                        M+Q+L A+ Y H+  +IHRDIK   + L        + LG FG A+ 
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMP 316

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
            +  +     G             +GT    +PE++    Y +  DIW+ G++L
Sbjct: 317 FEKEREAFDYG------------WVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Length = 501

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 45.3 bits (107), Expect = 1e-05
 Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 23/178 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVR-RATAGFVYSEA 109
           D  +E  I   LK P+++ LL    +   L M+ EYM+  D+   + R         ++ 
Sbjct: 65  DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124

Query: 110 VASHY------MRQVLEALRYCHENDIIHRDIKP-HCVLLANKENSAPVKLGGFGVAIQL 162
           V   Y        Q+   ++Y    + +HRD+   +C  L  K  +  +K+  FG++  L
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC--LVGKNYT--IKIADFGMSRNL 180

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
             G          D+Y  + G  +    +M+ E I   K+    D+WA GV L  +LT
Sbjct: 181 YSG----------DYYRIQ-GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 28/81 (34%), Positives = 36/81 (44%), Gaps = 14/81 (17%)

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           MRQ+L AL   H   I+HRD+KP  ++ +  E S   K+   G A  L+ G  Y      
Sbjct: 261 MRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFL 318

Query: 175 LDHYTTKAGHRIGTPHYMAPE 195
           LD            P Y APE
Sbjct: 319 LD------------PRYAAPE 327

Length = 566

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.5 bits (105), Expect = 2e-05
 Identities = 35/117 (29%), Positives = 51/117 (43%), Gaps = 19/117 (16%)

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGG 172
           Y  QV   + +      IHRD+    +LL+       VK+  FG+A  + +D      G 
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGD 234

Query: 173 ERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
            RL             P  +MAPE I D+ Y    D+W+ GVLL  + + G  P+ G
Sbjct: 235 ARL-------------PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 3e-05
 Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 23/190 (12%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           +E L        L+ E  + H  +HP+++     +++   L+++  +M        +   
Sbjct: 40  EEHLKA------LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY 93

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
              G   SEA+  + +   L  L Y H+N  IHR+IK   +L++       V L G    
Sbjct: 94  FPEGM--SEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD---GLVSLSGL--- 145

Query: 160 IQLQDGQLYC--SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPV--DIWAAGVLL 215
                  LY     G++                +++PE++    YG  V  DI++ G+  
Sbjct: 146 -----SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA 200

Query: 216 HVLLTGTLPF 225
             L TG +PF
Sbjct: 201 CELATGRVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 43.6 bits (103), Expect = 4e-05
 Identities = 51/194 (26%), Positives = 81/194 (41%), Gaps = 32/194 (16%)

Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + EG LY+V EY                G     
Sbjct: 60  SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119

Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +  R         + V+  Y  QV   + +      IHRD+    VL+   E+   +K+ 
Sbjct: 120 DDPRPPEETLTQKDLVSFAY--QVARGMEFLASKKCIHRDLAARNVLVT--EDHV-MKIA 174

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
            FG+A  +            +D+Y      R+    +MAPE + D+ Y    D+W+ GVL
Sbjct: 175 DFGLARDIHH----------IDYYRKTTNGRLPV-KWMAPEALFDRVYTHQSDVWSFGVL 223

Query: 215 LHVLLT-GTLPFVG 227
           L  + T G  P+ G
Sbjct: 224 LWEIFTLGGSPYPG 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 43.7 bits (103), Expect = 4e-05
 Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 14/103 (13%)

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            +  QV + + +    + IHRD+    VLL +       K+  FG+A  + +        
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR---VAKICDFGLARDIMNDS------ 266

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
               +Y  K   R+    +MAPE I D  Y    D+W+ G+LL
Sbjct: 267 ----NYVVKGNARLPV-KWMAPESIFDCVYTVQSDVWSYGILL 304

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.5 bits (102), Expect = 4e-05
 Identities = 37/117 (31%), Positives = 53/117 (45%), Gaps = 19/117 (16%)

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGG 172
           Y  QV   + +      IHRD+    +LL+  EN+  VK+  FG+A  + +D      G 
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLS--ENNV-VKICDFGLARDIYKDPDYVRKGS 235

Query: 173 ERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPFVG 227
            RL             P  +MAPE I D+ Y    D+W+ GVLL  +   G  P+ G
Sbjct: 236 ARL-------------PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 43.1 bits (101), Expect = 5e-05
 Identities = 50/210 (23%), Positives = 88/210 (41%), Gaps = 31/210 (14%)

Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI--CFEIVR 98
           ER+  +  EA + +E   CH     HVV LL   S      ++ E M   D+      +R
Sbjct: 52  ERI-EFLNEASVMKEFN-CH-----HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 104

Query: 99  RATAGFVYSEAVASHYMRQ----VLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
                       +   M Q    + + + Y + N  +HRD+     ++A       VK+G
Sbjct: 105 PEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE---DFTVKIG 161

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGV 213
            FG+   + +   Y  GG+ L             P  +M+PE ++D  +    D+W+ GV
Sbjct: 162 DFGMTRDIYETDYYRKGGKGL------------LPVRWMSPESLKDGVFTTYSDVWSFGV 209

Query: 214 LLHVLLT-GTLPFVG-SRDRLFQSITKGKL 241
           +L  + T    P+ G S +++ + + +G L
Sbjct: 210 VLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 1e-04
 Identities = 41/134 (30%), Positives = 54/134 (40%), Gaps = 24/134 (17%)

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           MRQVL  LR  H   I+HRDIKP  +L+        VK+  FG A+ +  G  +      
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFNPLYGM 371

Query: 175 LDHYTTKAGHRIGTPHYMAP-EVIEDQKYGK-PVDIWAAGVLLHVLLTGTLPFVGSRDRL 232
           LD            P Y  P E++  Q   + P    AA       L     ++  R  L
Sbjct: 372 LD------------PRYSPPEELVMPQSCPRAPAPAMAA-------LLSPFAWLYGRPDL 412

Query: 233 FQSITKGKLHILGC 246
           F S T G L +  C
Sbjct: 413 FDSYTAGVLLMQMC 426

Length = 507

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 34/116 (29%), Positives = 50/116 (43%), Gaps = 17/116 (14%)

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  QV + + +      IHRD+    +LL+       VK+  FG+A  +     Y   G+
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENN---VVKICDFGLARDIYKDPDYVRKGD 240

Query: 174 -RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPFVG 227
            RL               +MAPE I D+ Y    D+W+ GVLL  +   G  P+ G
Sbjct: 241 ARL------------PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 41.8 bits (98), Expect = 1e-04
 Identities = 37/158 (23%), Positives = 70/158 (44%), Gaps = 23/158 (14%)

Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P++V L +   SE  +++V ++ +G  +   I +         E     +  +++ AL  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNI----PEECVKRWAAEMVVALDA 100

Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H   I+ RD+ P+ +LL   ++   ++L  F    +++D    C  GE +++       
Sbjct: 101 LHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDS---CD-GEAVENM------ 147

Query: 185 RIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGT 222
                 Y APEV    +  +  D W+ G +L  LLTG 
Sbjct: 148 ------YCAPEVGGISEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.9 bits (98), Expect = 1e-04
 Identities = 33/116 (28%), Positives = 49/116 (42%), Gaps = 17/116 (14%)

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV   + +    + +HRD+    VLLA  +    VK+  FG+A  +     Y S G 
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGK---IVKICDFGLARDIMHDSNYVSKGS 298

Query: 174 RLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPFVG 227
                          P  +MAPE I D  Y    D+W+ G+LL  +   G  P+ G
Sbjct: 299 TF------------LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 41.1 bits (96), Expect = 2e-04
 Identities = 39/177 (22%), Positives = 78/177 (44%), Gaps = 19/177 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     H +++ L    +      ++ EYM+   +  + +R     F   + V
Sbjct: 52  DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALD-KYLRDHDGEFSSYQLV 110

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
               +R +   ++Y  + + +HRD+    +L+    ++   K+  FG++  L+D      
Sbjct: 111 G--MLRGIAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLED------ 159

Query: 171 GGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPF 225
             +    YTT  G     P  + APE I  +K+    D+W+ G+++  V+  G  P+
Sbjct: 160 --DPEGTYTTSGGK---IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 25/187 (13%)

Query: 51  DLKREATICHMLKHPHVVEL----LETYSSEGML--YMVFEYMDGSDI-CFEIVRRA--T 101
           D   EA       HP+V+ L    L+T  SEG     ++  +M   D+  F +  R    
Sbjct: 46  DFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDC 105

Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
             ++ ++ +   +M  +   + Y      IHRD+     +L    N   V +  FG++ +
Sbjct: 106 PQYLPTQMLVK-FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVADFGLSKK 161

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT- 220
           + +G  Y  G  R+     K         ++A E + D+ Y    D+W+ GV +  + T 
Sbjct: 162 IYNGDYYRQG--RIAKMPVK---------WIAIESLADRVYTTKSDVWSFGVTMWEIATR 210

Query: 221 GTLPFVG 227
           G  P+ G
Sbjct: 211 GQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 40.8 bits (95), Expect = 3e-04
 Identities = 44/175 (25%), Positives = 78/175 (44%), Gaps = 21/175 (12%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA I   + HPH+V LL    S   + +V + M    +  + V            +  ++
Sbjct: 59  EALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCL-LDYVHEHKDNI--GSQLLLNW 114

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
             Q+ + + Y  E  ++HRD+    VL+ +  +   VK+  FG+A  L+ D + Y + G 
Sbjct: 115 CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGG 171

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
           ++               +MA E I  +K+    D+W+ GV +  L+T G  P+ G
Sbjct: 172 KM------------PIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 41/163 (25%), Positives = 67/163 (41%), Gaps = 25/163 (15%)

Query: 62  LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           L+HP++V+L+    SE   Y++ EY++G ++  E++R        S          + +A
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLS-EVLRN------LSWERRRKIAIGIAKA 792

Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
           LR+ H            C       N +P K     + I  +D          L    TK
Sbjct: 793 LRFLH----------CRCSPAVVVGNLSPEK-----IIIDGKDEPHLRLSLPGLLCTDTK 837

Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                 +  Y+APE  E +   +  DI+  G++L  LLTG  P
Sbjct: 838 ---CFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 39.5 bits (92), Expect = 7e-04
 Identities = 46/218 (21%), Positives = 85/218 (38%), Gaps = 41/218 (18%)

Query: 19  KWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLET---YS 75
           K LK  + +S++IE                  +  REA       HP+V++L+       
Sbjct: 33  KMLKADIFSSSDIE------------------EFLREAACMKEFDHPNVIKLIGVSLRSR 74

Query: 76  SEGML---YMVFEYMDGSDI-CFEIVRR-ATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
           ++G L    ++  +M   D+  F ++ R     F         +M  +   + Y    + 
Sbjct: 75  AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNF 134

Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
           IHRD+     +L        V +  FG++ ++  G          D+Y      ++    
Sbjct: 135 IHRDLAARNCMLNENMT---VCVADFGLSKKIYSG----------DYYRQGCASKLPV-K 180

Query: 191 YMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
           ++A E + D  Y    D+WA GV +  ++T G  P+ G
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 39.2 bits (91), Expect = 0.001
 Identities = 31/113 (27%), Positives = 54/113 (47%), Gaps = 17/113 (15%)

Query: 117 QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGERL 175
           Q+ + + Y  E  ++HRD+    VL+   ++   VK+  FG+A  L  D + Y + G ++
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGKV 173

Query: 176 DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
                          +MA E I  + Y    D+W+ GV +  L+T G+ P+ G
Sbjct: 174 ------------PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 38.4 bits (89), Expect = 0.002
 Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 26/181 (14%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFV 105
           T +A L+  A +  +  H ++V LL      G LY+V E M  G+ + F    R     +
Sbjct: 42  TAQAFLEETAVMTKL-HHKNLVRLLGVILHNG-LYIVMELMSKGNLVNF---LRTRGRAL 96

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            S      +   V E + Y     ++HRD+    +L++ ++  A  K+  FG+A      
Sbjct: 97  VSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS-EDGVA--KVSDFGLA------ 147

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLP 224
                    +    +K   +     + APE ++ +K+    D+W+ GVLL  V   G  P
Sbjct: 148 -----RVGSMGVDNSKLPVK-----WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Query: 225 F 225
           +
Sbjct: 198 Y 198

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 37.6 bits (87), Expect = 0.003
 Identities = 37/172 (21%), Positives = 72/172 (41%), Gaps = 19/172 (11%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA       H ++V L    +    + +V EYM  +      +R+     V  + +    
Sbjct: 56  EALTLGQFDHSNIVRLEGVITRGNTMMIVTEYM-SNGALDSFLRKHEGQLVAGQLMG--M 112

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           +  +   ++Y  E   +H+ +  H VL+    +    K+ GF    +LQ+ +      E 
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFR---RLQEDKS-----EA 161

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPF 225
           +  YTT +G       + APE I+   +    D+W+ G+++  V+  G  P+
Sbjct: 162 I--YTTMSGKSPVL--WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 37.3 bits (86), Expect = 0.004
 Identities = 30/119 (25%), Positives = 56/119 (47%), Gaps = 21/119 (17%)

Query: 117 QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA--IQLQDGQLYCSGGER 174
           Q+ + + Y  E  ++HRD+    VL+ +  +   VK+  FG+A  + + + + +  GG+ 
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHADGGK- 172

Query: 175 LDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGSRDR 231
                         P  +MA E I  +++    D+W+ GV +  L+T G  P+ G   R
Sbjct: 173 -------------VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR 218

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	249
KOG0595|consensus	429		100.0
KOG0591|consensus	375		100.0
KOG0575|consensus	592		100.0
KOG0598|consensus	357		100.0
KOG0615|consensus	475		100.0
KOG0592|consensus	604		100.0
KOG0581|consensus	364		100.0
KOG0616|consensus	355		100.0
KOG0033|consensus	355		100.0
KOG0192|consensus	362		100.0
KOG0197|consensus	468		100.0
KOG0605|consensus	550		100.0
KOG0578|consensus	550		100.0
KOG0611|consensus	668		100.0
KOG0583|consensus	370		100.0
KOG0610|consensus	459		100.0
KOG0600|consensus	560		100.0
KOG0593|consensus	396		100.0
KOG0597|consensus	808		100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG2345|consensus	302		100.0
KOG0694|consensus	694		100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0661|consensus	538		100.0
KOG0582|consensus	516		100.0
KOG0588|consensus	786		100.0
KOG0198|consensus	313		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG1026|consensus	774		100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0659|consensus	318		100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0589|consensus	426		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0585|consensus	576		100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0584|consensus	632		100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0032|consensus	382		100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0607|consensus	463		100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0663|consensus	419		100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0599|consensus	411		100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0667|consensus	586		100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0594|consensus	323		100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG1989|consensus	738		100.0
KOG0604|consensus	400		100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG1095|consensus	1025		100.0
KOG0580|consensus	281		100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG4236|consensus	888		100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0658|consensus	364		100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0986|consensus	591		100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG1187|consensus	361		100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0660|consensus	359		100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0690|consensus	516		100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0193|consensus	678		100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0194|consensus	474		100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0612|consensus	1317		100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG4721|consensus	904		100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG4257|consensus	974		100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG4717|consensus	864		100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0201|consensus	467		100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG0579|consensus	1187		100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0586|consensus	596		100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
KOG4250|consensus	732		100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4278|consensus	1157		100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0596|consensus	677		100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.98
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.98
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.98
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.98
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.98
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.98
PHA02882	294	putative serine/threonine kinase; Provisional	99.98
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.98
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.98
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.98
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.98
KOG0196|consensus	996		99.98
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.98
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.98
KOG0614|consensus	732		99.98
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.98
PHA03210	501	serine/threonine kinase US3; Provisional	99.98
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.98
KOG4279|consensus	1226		99.98
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.98
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.98
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.98
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.98
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.98
KOG0577|consensus	948		99.98
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.98
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.98
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.98
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.98
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.98
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.98
KOG0696|consensus	683		99.98
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.98
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.98
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.98
KOG0199|consensus	1039		99.98
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
KOG4645|consensus	1509		99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
KOG1094|consensus	807		99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.97
KOG0574|consensus	502		99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
KOG0608|consensus	1034		99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.97
KOG0671|consensus	415		99.97
KOG0666|consensus	438		99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
PLN00009	294	cyclin-dependent kinase A; Provisional	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.97
KOG0695|consensus	593		99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
KOG0603|consensus	612		99.97
KOG1025|consensus	1177		99.97
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0984|consensus	282		99.97
KOG1151|consensus	775		99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
KOG0662|consensus	292		99.96
KOG0200|consensus	609		99.96
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG1152|consensus	772		99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1035|consensus	1351		99.96
KOG0587|consensus	953		99.96
KOG0670|consensus	752		99.96
KOG0983|consensus	391		99.96
KOG0669|consensus	376		99.96
KOG1006|consensus	361		99.96
KOG1024|consensus	563		99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG0665|consensus	369		99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
KOG3653|consensus	534		99.95
KOG2052|consensus	513		99.95
KOG0664|consensus	449		99.94
KOG1027|consensus	903		99.94
KOG0668|consensus	338		99.94
KOG1345|consensus	378		99.93
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.92
KOG1167|consensus	418		99.92
KOG1164|consensus	322		99.92
KOG0576|consensus	829		99.91
KOG1163|consensus	341		99.91
PLN00181	793	protein SPA1-RELATED; Provisional	99.91
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.91
KOG1165|consensus	449		99.9
KOG1290|consensus	590		99.88
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
PRK09188	365	serine/threonine protein kinase; Provisional	99.83
KOG1240|consensus	1431		99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
KOG0603|consensus	612		99.79
PRK10345	210	hypothetical protein; Provisional	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
KOG0590|consensus	601		99.78
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.76
KOG1166|consensus	974		99.74
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.72
KOG4158|consensus	598		99.71
KOG0195|consensus	448		99.68
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.66
KOG1023|consensus	484		99.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
smart00090	237	RIO RIO-like kinase.	99.64
PRK14879	211	serine/threonine protein kinase; Provisional	99.6
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.58
KOG1033|consensus	516		99.55
KOG0606|consensus	1205		99.51
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.49
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.47
KOG1243|consensus	690		99.44
KOG1266|consensus	458		99.41
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.39
KOG0590|consensus	601		99.37
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.24
KOG0606|consensus	1205		99.21
KOG3087|consensus	229		99.19
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.18
KOG0601|consensus	524		99.13
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.08
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.04
KOG3741|consensus	655		98.97
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.96
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.95
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.91
COG4248	637	Uncharacterized protein with protein kinase and he	98.88
KOG0601|consensus	524		98.87
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.84
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.7
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.55
KOG2137|consensus	700		98.55
PRK09902	216	hypothetical protein; Provisional	98.54
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.42
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.14
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.04
KOG0576|consensus	829		97.97
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.92
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.91
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.89
PF01636	239	APH: Phosphotransferase enzyme family This family	97.76
PLN02876	822	acyl-CoA dehydrogenase	97.7
KOG1235|consensus	538		97.44
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.38
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.18
KOG1035|consensus	1351		97.18
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.18
KOG1826|consensus	2724		97.01
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.97
KOG2268|consensus	465		96.81
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	96.63
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.58
PRK09550	401	mtnK methylthioribose kinase; Reviewed	96.52
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.09
PLN02236	344	choline kinase	95.87
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.54
KOG1093|consensus	725		94.97
PHA03111	444	Ser/Thr kinase; Provisional	94.7
PLN02756	418	S-methyl-5-thioribose kinase	94.61
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	94.6
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.51
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.48
PTZ00384	383	choline kinase; Provisional	94.46
PRK05231	319	homoserine kinase; Provisional	94.29
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	93.57
PRK10593	297	hypothetical protein; Provisional	93.44
COG2334	331	Putative homoserine kinase type II (protein kinase	93.35
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	93.32
KOG2270|consensus	520		92.35
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	92.34
PRK10271	188	thiK thiamine kinase; Provisional	92.31
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.08
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	91.77
PRK12396	409	5-methylribose kinase; Reviewed	91.34
PRK11768	325	serine/threonine protein kinase; Provisional	91.08
PRK06149	972	hypothetical protein; Provisional	91.02
KOG4720|consensus	391		90.73
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	90.02
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	89.77

>KOG0595|consensus

Probab=100.00  E-value=3.3e-45  Score=297.56  Aligned_cols=223  Identities=32%  Similarity=0.514  Sum_probs=191.7

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .+....|.....|+.|-|+++|...........+++.....  ..+.++.+.+|+.+|+.++|||||.+++++.+++.+|
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~   85 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIY   85 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEE
Confidence            34456788888899999999997776655444444433333  4677889999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC---CCeEEcCcce
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS---APVKLGGFGV  158 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~---~~~~l~dfg~  158 (249)
                      +|||||.||+|.+++..++.    +++.+++.++.||+.|+++||+++||||||||.|||+......   ..+||+|||+
T Consensus        86 lVMEyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   86 LVMEYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEEEeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999999998875    9999999999999999999999999999999999999876333   5689999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      ++...+...              .....|++-|||||++....|+.++|+||+|+++|+|++|+.||.. +..++...+.
T Consensus       162 AR~L~~~~~--------------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~  227 (429)
T KOG0595|consen  162 ARFLQPGSM--------------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK  227 (429)
T ss_pred             hhhCCchhH--------------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence            988875332              2234599999999999999999999999999999999999999998 7888988999


Q ss_pred             cCccccc
Q psy14626        238 KGKLHIL  244 (249)
Q Consensus       238 ~g~~~~~  244 (249)
                      +|.-..|
T Consensus       228 k~~~~~~  234 (429)
T KOG0595|consen  228 KGNEIVP  234 (429)
T ss_pred             ccccccC
Confidence            9886555

>KOG0591|consensus

Probab=100.00  E-value=1.7e-45  Score=286.58  Aligned_cols=221  Identities=27%  Similarity=0.404  Sum_probs=193.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhh-eeecCCe-EEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLE-TYSSEGM-LYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~   84 (249)
                      .|++.+.|+.|-++.+|+.......+.++.++.....  ....+...+|+.+|++|+||||+++++ .|.++.. +++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            5999999999999999988877777766666555433  455677999999999999999999998 6665555 89999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH--CC--ceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE--ND--IIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~--~~--~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      |++.+|+|...+..-......+++.+++.++.|++.||.++|.  .+  +.||||||.||+++.++.   +||+|||+++
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv---vKLGDfGL~r  176 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV---VKLGDFGLGR  176 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc---eeeccchhHh
Confidence            9999999999999888888889999999999999999999998  45  999999999999987775   9999999997


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ......             +...+..|||+|||||.+.+.+++.++||||+||++|||+.-++||.+ +.-++.+.|.+|
T Consensus       177 ~l~s~~-------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg  243 (375)
T KOG0591|consen  177 FLSSKT-------------TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG  243 (375)
T ss_pred             Hhcchh-------------HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC
Confidence            776643             455566899999999999999999999999999999999999999999 677899999999


Q ss_pred             cccccccc
Q psy14626        240 KLHILGCT  247 (249)
Q Consensus       240 ~~~~~~~~  247 (249)
                        .+|++|
T Consensus       244 --d~~~~p  249 (375)
T KOG0591|consen  244 --DYPPLP  249 (375)
T ss_pred             --CCCCCc
Confidence              566666

>KOG0575|consensus

Probab=100.00  E-value=5.8e-45  Score=309.03  Aligned_cols=221  Identities=27%  Similarity=0.433  Sum_probs=199.8

Q ss_pred             CCCCCcchHHHhhcccceeeEeeecc---ccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSA---EIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .+. ++|..+.+++.|+++.+|...+   +..++++.+++..+....+.+.+.+|+++.++|+|||||+++++|++.+.+
T Consensus        15 ~~~-~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nV   93 (592)
T KOG0575|consen   15 PRS-KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNV   93 (592)
T ss_pred             CCc-ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCce
Confidence            344 8999999999999999997666   456777888899999999999999999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      |+|.|+|..++|..++.++..    +++.+++.+++||+.|+.|||+.+|+|||||..|++++.+.+   +||+|||+|.
T Consensus        94 YivLELC~~~sL~el~Krrk~----ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~---VKIgDFGLAt  166 (592)
T KOG0575|consen   94 YIVLELCHRGSLMELLKRRKP----LTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN---VKIGDFGLAT  166 (592)
T ss_pred             EEEEEecCCccHHHHHHhcCC----CCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc---EEecccceee
Confidence            999999999999998885544    999999999999999999999999999999999999998877   9999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .+.....             .....-||+.|.|||++.....+..+||||+||+||.|+.|++||.. +..+++..|..+
T Consensus       167 ~le~~~E-------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~  233 (592)
T KOG0575|consen  167 QLEYDGE-------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN  233 (592)
T ss_pred             eecCccc-------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc
Confidence            8775321             22334599999999999988899999999999999999999999998 589999999999


Q ss_pred             cccccc
Q psy14626        240 KLHILG  245 (249)
Q Consensus       240 ~~~~~~  245 (249)
                      ++.+|.
T Consensus       234 ~Y~~P~  239 (592)
T KOG0575|consen  234 EYSMPS  239 (592)
T ss_pred             Cccccc
Confidence            999985

>KOG0598|consensus

Probab=100.00  E-value=2.8e-44  Score=289.33  Aligned_cols=217  Identities=29%  Similarity=0.550  Sum_probs=189.5

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      -+.+..+++.|.++.++...+......|+.   .+..+......+....|.++|..++||+||+++.+|++.+.+|+|+|
T Consensus        26 dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld  105 (357)
T KOG0598|consen   26 DFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLD  105 (357)
T ss_pred             heeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEe
Confidence            466777889898888887766666666664   45555556678889999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.||.|...|.+++.    |++..++.++.+|+.||.|||++|||||||||+|||++.+++   ++|+|||+|......
T Consensus       106 ~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH---i~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  106 YLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH---IKLTDFGLCKEDLKD  178 (357)
T ss_pred             ccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc---EEEeccccchhcccC
Confidence            9999999999988776    999999999999999999999999999999999999998888   999999999755442


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc-ccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK-LHI  243 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~-~~~  243 (249)
                      .             +......||+.|+|||++.+..++..+|.||||+++|||++|.+||.+ +..++.+.|.+++ +.+
T Consensus       179 ~-------------~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~  245 (357)
T KOG0598|consen  179 G-------------DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLP  245 (357)
T ss_pred             C-------------CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCC
Confidence            2             233346799999999999999999999999999999999999999999 6788999999999 555


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       246 p~  247 (357)
T KOG0598|consen  246 PG  247 (357)
T ss_pred             Cc
Confidence            54

>KOG0615|consensus

Probab=100.00  E-value=9.9e-45  Score=294.92  Aligned_cols=225  Identities=27%  Similarity=0.432  Sum_probs=184.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc---ccc----chhHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LNH----YTTEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      .++.|.+...++.|.++.+-..........++++...   ...    ......+++|+++|++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3567888899999988887655555555555544222   111    123344689999999999999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      ..||||||+.||+|.+.+..+..    +.+..-+.++.||+.|++|||++||+||||||+|||+..+.....+||+|||+
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence            99999999999999999987765    78888899999999999999999999999999999999887777899999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCC---CCcchHHHHHHHHHHHHhCCCCCCC--ChHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY---GKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLF  233 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~  233 (249)
                      +...+..              +......||+.|.|||++.+...   ..++|+||+||+||-+++|.+||++  .+..+.
T Consensus       326 AK~~g~~--------------sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~  391 (475)
T KOG0615|consen  326 AKVSGEG--------------SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLK  391 (475)
T ss_pred             hhccccc--------------eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHH
Confidence            9777642              23344569999999999986553   3478999999999999999999998  344589


Q ss_pred             HHHHcCccccc-cccC
Q psy14626        234 QSITKGKLHIL-GCTH  248 (249)
Q Consensus       234 ~~i~~g~~~~~-~~~~  248 (249)
                      +.|.+|++.+- +.|.
T Consensus       392 eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  392 EQILKGRYAFGPLQWD  407 (475)
T ss_pred             HHHhcCcccccChhhh
Confidence            99999997764 6664

>KOG0592|consensus

Probab=100.00  E-value=2.2e-42  Score=289.60  Aligned_cols=232  Identities=26%  Similarity=0.444  Sum_probs=198.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      +-|.+++.+++|-|..++...+.-....|+   +.+.-+......+.+..|-.+|.+| .||.|++++..|++...+|+|
T Consensus        73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv  152 (604)
T KOG0592|consen   73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV  152 (604)
T ss_pred             hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence            368899999999999998777665555555   4455566677788999999999999 899999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +||+++|+|.+++.+.+.    |++...+.++.||+.||+|||++|||||||||+|||++.|++   ++|+|||.+..+.
T Consensus       153 Le~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh---ikITDFGsAK~l~  225 (604)
T KOG0592|consen  153 LEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH---IKITDFGSAKILS  225 (604)
T ss_pred             EEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc---EEEeeccccccCC
Confidence            999999999999988766    999999999999999999999999999999999999999988   9999999998887


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCChH-HHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD-RLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~~-~~~~~i~~g~~~  242 (249)
                      +......+...-........++.||-.|.+||++.....++++|+|+|||+||.|+.|++||.+..+ -+++.|+.-.+.
T Consensus       226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~  305 (604)
T KOG0592|consen  226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYE  305 (604)
T ss_pred             hhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhccc
Confidence            7554322211111122223567899999999999999999999999999999999999999999554 689999999999


Q ss_pred             cccc
Q psy14626        243 ILGC  246 (249)
Q Consensus       243 ~~~~  246 (249)
                      +|+.
T Consensus       306 fp~~  309 (604)
T KOG0592|consen  306 FPEG  309 (604)
T ss_pred             CCCC
Confidence            9853

>KOG0581|consensus

Probab=100.00  E-value=1.8e-42  Score=279.00  Aligned_cols=215  Identities=27%  Similarity=0.380  Sum_probs=186.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-eEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-MLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~   86 (249)
                      ......+++.|-.+.++.........+++++... ..+.+...++.+|+++++..+|||||++++.|...+ .+.++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3455667888888888888888888888887663 334667789999999999999999999999999888 49999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++|+|.+.+...+.    +++..+-.++.++++||.|||+ .+||||||||+|+|++.++.   +||+|||++..+.++
T Consensus       160 MDgGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe---VKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE---VKICDFGVSGILVNS  232 (364)
T ss_pred             cCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC---EEeccccccHHhhhh
Confidence            999999988876543    8999999999999999999995 89999999999999998887   999999999877764


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC------hHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS------RDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~------~~~~~~~i~~g  239 (249)
                                     ...+..||..|||||++.+..|+.++||||||+.++|+.+|+.||...      .-++++.|..+
T Consensus       233 ---------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~  297 (364)
T KOG0581|consen  233 ---------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE  297 (364)
T ss_pred             ---------------hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC
Confidence                           334557999999999999999999999999999999999999999872      34788888886


Q ss_pred             c-ccccc
Q psy14626        240 K-LHILG  245 (249)
Q Consensus       240 ~-~~~~~  245 (249)
                      + +++|.
T Consensus       298 ppP~lP~  304 (364)
T KOG0581|consen  298 PPPRLPE  304 (364)
T ss_pred             CCCCCCc
Confidence            5 56664

>KOG0616|consensus

Probab=100.00  E-value=3.3e-41  Score=264.15  Aligned_cols=213  Identities=28%  Similarity=0.484  Sum_probs=183.7

Q ss_pred             hHHHhhcccceeeEeeeccccCC---CcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         11 TIHEVINHKWLKMKLHTSAEIEP---ASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      .+...++-|-++.+-........   +.+.+.+..+-+-.+.+...+|-.+|+.++||+++++++.|.+.+.+++||||+
T Consensus        47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv  126 (355)
T KOG0616|consen   47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV  126 (355)
T ss_pred             hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence            33344555655555434433333   344455666666788889999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      +||.|..++.+.+.    |++..++.++.|++.||+|||++++++|||||+|||++.++.   ++|+|||++....... 
T Consensus       127 ~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~---iKitDFGFAK~v~~rT-  198 (355)
T KOG0616|consen  127 PGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH---IKITDFGFAKRVSGRT-  198 (355)
T ss_pred             CCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc---EEEEeccceEEecCcE-
Confidence            99999999987665    999999999999999999999999999999999999998887   9999999998887642 


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccccc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILGC  246 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~~  246 (249)
                                     -...||+.|+|||.+...++..++|.||||+++|||+.|.+||.+ +.-.+++.|.+|+..+|..
T Consensus       199 ---------------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~  263 (355)
T KOG0616|consen  199 ---------------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY  263 (355)
T ss_pred             ---------------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc
Confidence                           223589999999999999999999999999999999999999999 5678999999999999964

>KOG0033|consensus

Probab=100.00  E-value=9.1e-41  Score=255.81  Aligned_cols=223  Identities=38%  Similarity=0.679  Sum_probs=193.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+.|.+.++++.|-+.+++..-+......++++   ...+. ..+-+.+.+|+.+.+.|+||||+++++.+.+.+..|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~-~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc-cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            457899999999998888766665544444433   22233 23678899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +|+++|++|..-+..+.-    +++..+..++.||+.+|.|.|+++|||||+||+|+++..+.++..+||+|||++....
T Consensus        89 Fe~m~G~dl~~eIV~R~~----ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREF----YSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999999887777643    8999999999999999999999999999999999999988888889999999998887


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      +...+              ..+.||+.|+|||+++..+++..+|+|+.|++||-|+.|.+||.+ +..++++.|.+|.+.
T Consensus       165 ~g~~~--------------~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd  230 (355)
T KOG0033|consen  165 DGEAW--------------HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD  230 (355)
T ss_pred             Ccccc--------------ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC
Confidence            54332              334799999999999999999999999999999999999999999 889999999999999


Q ss_pred             ccc-ccC
Q psy14626        243 ILG-CTH  248 (249)
Q Consensus       243 ~~~-~~~  248 (249)
                      +|+ .|+
T Consensus       231 ~~~~~w~  237 (355)
T KOG0033|consen  231 YPSPEWD  237 (355)
T ss_pred             CCCcccC
Confidence            996 763

>KOG0192|consensus

Probab=100.00  E-value=5e-40  Score=274.89  Aligned_cols=219  Identities=23%  Similarity=0.371  Sum_probs=176.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCC--CcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-eEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEP--ASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-MLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e   85 (249)
                      ...+.+.++.|+++.++.....-..  +++.+......... .+.|.+|+.+|.+++|||||+++|++.+.. .+++|||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            3456667888999998866665433  44444433333333 789999999999999999999999999887 7999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC-ceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND-IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~-~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |+++|+|..++...  ....++...+..|+.||+.|+.|||+++ +||+||||+|+|++.+.  .++||+|||+++....
T Consensus       121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--KTLKIADFGLSREKVI  196 (362)
T ss_pred             eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC--CEEEECCCccceeecc
Confidence            99999999999875  2334999999999999999999999999 99999999999998775  2399999999977765


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH--cC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE--DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT--KG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~--~g  239 (249)
                      ...             ......||+.|||||++.  ...++.++||||||+++|||++|..||.+ ...++...+.  .-
T Consensus       197 ~~~-------------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~  263 (362)
T KOG0192|consen  197 SKT-------------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL  263 (362)
T ss_pred             ccc-------------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC
Confidence            320             111135899999999999  56899999999999999999999999999 4455555554  34


Q ss_pred             cccccc
Q psy14626        240 KLHILG  245 (249)
Q Consensus       240 ~~~~~~  245 (249)
                      ++.+|.
T Consensus       264 Rp~~p~  269 (362)
T KOG0192|consen  264 RPPIPK  269 (362)
T ss_pred             CCCCCc
Confidence            466665

>KOG0197|consensus

Probab=100.00  E-value=1.9e-40  Score=278.25  Aligned_cols=219  Identities=23%  Similarity=0.370  Sum_probs=182.1

Q ss_pred             cchHHHhhcccceeeEeeecccc--CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEI--EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++...-|+.|-|+.++.....-  +++++.++..    ..+.+.|.+|+++|++|+|++||+++++|..++.++|||||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~----~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG----SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEecc----ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            45667778889888888666542  3444444333    34468899999999999999999999999998899999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      ++.|+|.++|...  .+..+...+.+.++.||++|++||+++++|||||...|||++.+..   +||+|||+++.+.+..
T Consensus       283 m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~---vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  283 MPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV---VKISDFGLARLIGDDE  357 (468)
T ss_pred             cccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce---EEEcccccccccCCCc
Confidence            9999999999872  2334899999999999999999999999999999999999987765   9999999999666544


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc--cc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK--LH  242 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~--~~  242 (249)
                      .....            ...-++.|.|||++....++.+|||||||++||||+| |+.||.+ +..++.+.|.+|.  ++
T Consensus       358 Y~~~~------------~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~  425 (468)
T KOG0197|consen  358 YTASE------------GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR  425 (468)
T ss_pred             eeecC------------CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC
Confidence            22111            1225789999999999999999999999999999999 9999999 7888999999987  45


Q ss_pred             cccccC
Q psy14626        243 ILGCTH  248 (249)
Q Consensus       243 ~~~~~~  248 (249)
                      .+.||.
T Consensus       426 P~~CP~  431 (468)
T KOG0197|consen  426 PEGCPD  431 (468)
T ss_pred             CCCCCH
Confidence            557764

>KOG0605|consensus

Probab=100.00  E-value=3.2e-40  Score=276.48  Aligned_cols=230  Identities=25%  Similarity=0.438  Sum_probs=192.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      -|....+|+.|.|+.++...+......++++   +...-...+.+.++.|-.+|...++|+||+++.+|++...+|+|||
T Consensus       142 DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiME  221 (550)
T KOG0605|consen  142 DFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIME  221 (550)
T ss_pred             cchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEE
Confidence            4666778999999999988887777766644   5556667788889999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++||++..+|...+.    |++.+++.++.+++.||..+|+.|+|||||||+|+|++..|+   +||+|||+|......
T Consensus       222 ylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH---iKLSDFGLs~gl~~~  294 (550)
T KOG0605|consen  222 YLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH---IKLSDFGLSTGLDKK  294 (550)
T ss_pred             ecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC---Eeeccccccchhhhh
Confidence            9999999999988766    999999999999999999999999999999999999998887   999999998554331


Q ss_pred             Cccc------------c--CCcccc--------------------ccccccCCcccCCCCCCccccccCCCCCcchHHHH
Q psy14626        166 QLYC------------S--GGERLD--------------------HYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAA  211 (249)
Q Consensus       166 ~~~~------------~--~~~~~~--------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  211 (249)
                      ..-.            .  ...++.                    .......+..|||.|+|||++.+..++..+|.|||
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL  374 (550)
T KOG0605|consen  295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL  374 (550)
T ss_pred             hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence            1100            0  000010                    01123344569999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCC-ChHHHHHHHHcCc--ccccc
Q psy14626        212 GVLLHVLLTGTLPFVG-SRDRLFQSITKGK--LHILG  245 (249)
Q Consensus       212 G~~l~el~~g~~pf~~-~~~~~~~~i~~g~--~~~~~  245 (249)
                      ||+||||+.|.+||.+ +..+++..|.+.+  +++|.
T Consensus       375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~  411 (550)
T KOG0605|consen  375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE  411 (550)
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC
Confidence            9999999999999999 6788999999988  66664

>KOG0578|consensus

Probab=100.00  E-value=2.5e-40  Score=278.76  Aligned_cols=221  Identities=28%  Similarity=0.481  Sum_probs=192.1

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      .-||..+|+.-..+++|--+.+|..........++++.-.+......+.+.+|+.+|+..+|+|||++++.|..++.+++
T Consensus       268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            35899999999999999888887666666666677776777777788899999999999999999999999998899999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||++||+|.+.+....     +++.+|..++++++.||+|||.+||+|+|||.+|||++.++.   +||+|||+|..+
T Consensus       348 VMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~---vKltDFGFcaqi  419 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS---VKLTDFGFCAQI  419 (550)
T ss_pred             EEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc---EEEeeeeeeecc
Confidence            999999999988876543     899999999999999999999999999999999999998887   999999999877


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i~~g~  240 (249)
                      ....             +......||++|||||++....|++++||||||++++||+.|++||-.  ....++-.-.+|.
T Consensus       420 ~~~~-------------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~  486 (550)
T KOG0578|consen  420 SEEQ-------------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT  486 (550)
T ss_pred             cccc-------------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC
Confidence            6644             234456799999999999999999999999999999999999999996  3455555555677


Q ss_pred             cccc
Q psy14626        241 LHIL  244 (249)
Q Consensus       241 ~~~~  244 (249)
                      +++.
T Consensus       487 P~lk  490 (550)
T KOG0578|consen  487 PKLK  490 (550)
T ss_pred             CCcC
Confidence            6654

>KOG0611|consensus

Probab=100.00  E-value=5.8e-40  Score=267.24  Aligned_cols=221  Identities=29%  Similarity=0.553  Sum_probs=196.1

Q ss_pred             CCCcchHHHhhcccceeeEeeec---cccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTS---AEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      -..||.+.+.++.|.|+.+-...   ..-.++++.+.+..+.+..+.-.+++|+++|..|+||||+.++++|+..+.+.+
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            35699999999999887653322   234567778888889988999999999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||..+|.|.+|+..++.    +++.+.+.+++||.+|+.|+|.++++|+|||.+|||++.+++   ++|+|||++...
T Consensus       131 vMEYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N---iKIADFGLSNly  203 (668)
T KOG0611|consen  131 VMEYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN---IKIADFGLSNLY  203 (668)
T ss_pred             EEEecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC---eeeeccchhhhh
Confidence            9999999999999998877    999999999999999999999999999999999999999888   999999998665


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .+..              ....+.|++-|++||.+.|.+| ++.+|.||||++||.|..|.+||.+ +-..+...|.+|.
T Consensus       204 ~~~k--------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~Ga  269 (668)
T KOG0611|consen  204 ADKK--------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGA  269 (668)
T ss_pred             cccc--------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccc
Confidence            5432              2223458999999999999998 7999999999999999999999999 6677899999999


Q ss_pred             ccccccc
Q psy14626        241 LHILGCT  247 (249)
Q Consensus       241 ~~~~~~~  247 (249)
                      +.-|+.|
T Consensus       270 YrEP~~P  276 (668)
T KOG0611|consen  270 YREPETP  276 (668)
T ss_pred             ccCCCCC
Confidence            9988766

>KOG0583|consensus

Probab=100.00  E-value=1.7e-39  Score=273.68  Aligned_cols=220  Identities=31%  Similarity=0.570  Sum_probs=183.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccC---CCcccCChhccc-c-chhHHHHHHHHHHHHHcC-CCChhhhhheeecCCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDERLN-H-YTTEADLKREATICHMLK-HPHVVELLETYSSEGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~   79 (249)
                      ...+|.++..++.|.++.++.......   ++++.+.+.... . ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            356899999999999888876655443   333322222111 1 134567779999999998 9999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec-CCCCCeEEcCcce
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGV  158 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~-~~~~~~~l~dfg~  158 (249)
                      +++||||+.||+|.+++..++.    +.+.+++.++.|+++|+.|+|++|++||||||+|+|++.+ ++   +||+|||+
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~---~Kl~DFG~  167 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGN---LKLSDFGL  167 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCC---EEEecccc
Confidence            9999999999999999988544    8999999999999999999999999999999999999988 55   99999999


Q ss_pred             eEEcc-CCCccccCCccccccccccCCcccCCCCCCccccccCC-C-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHH
Q psy14626        159 AIQLQ-DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-Y-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQ  234 (249)
Q Consensus       159 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~  234 (249)
                      +.... ..              .......|++.|+|||++.+.. | ..++|+||+|++||.|++|+.||.. +...++.
T Consensus       168 s~~~~~~~--------------~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~  233 (370)
T KOG0583|consen  168 SAISPGED--------------GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR  233 (370)
T ss_pred             ccccCCCC--------------CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH
Confidence            97763 21              1223346999999999999977 7 5899999999999999999999998 6677888


Q ss_pred             HHHcCccccccc
Q psy14626        235 SITKGKLHILGC  246 (249)
Q Consensus       235 ~i~~g~~~~~~~  246 (249)
                      .|.+|++.+|..
T Consensus       234 ki~~~~~~~p~~  245 (370)
T KOG0583|consen  234 KIRKGEFKIPSY  245 (370)
T ss_pred             HHhcCCccCCCC
Confidence            899999999963

>KOG0610|consensus

Probab=100.00  E-value=1.4e-38  Score=259.35  Aligned_cols=234  Identities=24%  Similarity=0.368  Sum_probs=194.1

Q ss_pred             cchHHHhhcccceeeEeeeccccC---CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIE---PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .++.-..++.|-.+.+|.....-.   .+.+++.+..+.......+.+-|..+|+.++||.+++++..|+.+...|++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            456677788888888886655443   34455667777777778888899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ||+||+|...++++..  ..|++..++.++.+++.||+|||..|||+|||||+|||+..+++   +-|+||.++......
T Consensus       158 yCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH---IMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH---IMLSDFDLSLRCPVS  232 (459)
T ss_pred             cCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc---EEeeeccccccCCCC
Confidence            9999999887776654  45999999999999999999999999999999999999999888   999999987554321


Q ss_pred             Ccccc---------------------CCc-----c---------------c--cccccccCCcccCCCCCCccccccCCC
Q psy14626        166 QLYCS---------------------GGE-----R---------------L--DHYTTKAGHRIGTPHYMAPEVIEDQKY  202 (249)
Q Consensus       166 ~~~~~---------------------~~~-----~---------------~--~~~~~~~~~~~~~~~y~aPE~~~~~~~  202 (249)
                      +....                     ...     .               +  +.......+..||--|.|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence            11110                     000     0               0  223355667789999999999999999


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccccc
Q psy14626        203 GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILGCT  247 (249)
Q Consensus       203 ~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~~~  247 (249)
                      +.++|.|+||+++|||+.|..||.+ +.++.+-+|....+.+|+.+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~  358 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP  358 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC
Confidence            9999999999999999999999999 67788889999999999876

>KOG0600|consensus

Probab=100.00  E-value=3.2e-39  Score=268.67  Aligned_cols=207  Identities=28%  Similarity=0.451  Sum_probs=177.6

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecC--Ce
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSE--GM   79 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~   79 (249)
                      ......|..-+.|++|.|+.+|...+......+++++..++.  .....-..+|+.+|++|+||||+++.+...+.  +.
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            344556888899999999999999999999999999888776  55677789999999999999999999999766  78


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +|+|+|||+. +|.-++....-   .|++.+|+-++.||+.||.|+|++|++|||||.+|||++.++.   +||+|||++
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~v---kft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~---LKiaDFGLA  265 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGV---KFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV---LKIADFGLA  265 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCc---ccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC---EEeccccce
Confidence            9999999986 88777665332   3999999999999999999999999999999999999988777   999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCh
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGSR  229 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~~  229 (249)
                      +.......            ...-.+.-|..|.|||.+.|. .|+.++|+||.||||.||+.|++.|.+..
T Consensus       266 r~y~~~~~------------~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t  324 (560)
T KOG0600|consen  266 RFYTPSGS------------APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT  324 (560)
T ss_pred             eeccCCCC------------cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence            86655331            012234578999999999874 58999999999999999999999999943

>KOG0593|consensus

Probab=100.00  E-value=1.4e-38  Score=250.19  Aligned_cols=205  Identities=31%  Similarity=0.541  Sum_probs=170.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC--hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP--DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .+|..-.+++.|-|++++...+.....+.+++  .+..+++...+-..+|+.+|++++|||+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35777788899999999999888777776655  3444455666778999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC-
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD-  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~-  164 (249)
                      |++. ++.+.+.....+   ++...++.++.|++.|+.|+|+++++||||||+|||++.++-   +||+|||+|+.... 
T Consensus        82 ~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv---vKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV---VKLCDFGFARTLSAP  154 (396)
T ss_pred             ecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc---EEeccchhhHhhcCC
Confidence            9976 555556554443   899999999999999999999999999999999999977665   99999999988773 


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHH
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLF  233 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~  233 (249)
                      ...+       .++       .-|..|.|||.+.| .+|++.+||||+||++.||++|.+.|++  +.+.++
T Consensus       155 gd~Y-------TDY-------VATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy  212 (396)
T KOG0593|consen  155 GDNY-------TDY-------VATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY  212 (396)
T ss_pred             cchh-------hhh-------hhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence            2211       111       24778999999987 7889999999999999999999999998  344544

>KOG0597|consensus

Probab=100.00  E-value=1.5e-38  Score=267.92  Aligned_cols=216  Identities=29%  Similarity=0.473  Sum_probs=180.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|.+.+.+++|-++.+|+..+.-....+++   .+.... ......+++|+++++.++||||+.++++|++..++++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            4789999999999999997766544333333   232222 345677999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.| +|..++.....    ++++.++.++.++++||.|||+.+|+|+|+||.|||+.+.+.   +|++|||+++-...
T Consensus        81 e~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~---~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT---LKLCDFGLARAMST  152 (808)
T ss_pred             hhhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc---eeechhhhhhhccc
Confidence            99987 99999887655    999999999999999999999999999999999999988776   99999999976655


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ...             -...-.||+.|||||...+.+++..+|+||+||++||++.|++||-. +.-++.+.|..-....
T Consensus       153 ~t~-------------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~  219 (808)
T KOG0597|consen  153 NTS-------------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP  219 (808)
T ss_pred             Cce-------------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC
Confidence            321             11122489999999999999999999999999999999999999987 4556777777766666


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       220 p~  221 (808)
T KOG0597|consen  220 PS  221 (808)
T ss_pred             cc
Confidence            53

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=261.01  Aligned_cols=215  Identities=27%  Similarity=0.479  Sum_probs=179.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|++.+.++.|.++.+|...+......++++..   ........+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            3678888999999998887766544444444322   2233345677899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....    +++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~---~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH---IKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEEEecCcchhccC
Confidence            99999999998876543    899999999999999999999999999999999999987665   99999999865433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..                ....+++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+ +..++.+.+..+++.+
T Consensus       154 ~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  217 (291)
T cd05612         154 RT----------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEF  217 (291)
T ss_pred             Cc----------------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCC
Confidence            11                112478999999999988889999999999999999999999998 5667888999998887


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       218 ~~  219 (291)
T cd05612         218 PR  219 (291)
T ss_pred             Cc
Confidence            74

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG2345|consensus

Probab=100.00  E-value=2.9e-39  Score=247.56  Aligned_cols=232  Identities=22%  Similarity=0.269  Sum_probs=196.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-----eEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-----MLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   81 (249)
                      ++||++...++.|+++.++..+.--....|++++.......+.+..++|++..++++|||+++++++...+.     ..|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            689999999999999999888877778889999999998899999999999999999999999999985433     389


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      ++++|...|+|.+.+......+..+++.++++|+.++++||++||+..  +.|+||||.|||+.+++.   +.+.|||.+
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~---~vl~D~GS~  176 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL---PVLMDLGSA  176 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc---eEEEeccCc
Confidence            999999999999999988888878999999999999999999999998  999999999999987655   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCC---ChHHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLTGTLPFVG---SRDRLF  233 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~pf~~---~~~~~~  233 (249)
                      ....-.......+.+..++..    ..+|..|.|||.+.-   ...+.++|||||||+||+|+.|..||..   ..+.+.
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~----e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAE----ERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             cccceEeechHHHHHHHHHHH----HhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            776654443333333322222    247999999999863   4468899999999999999999999986   344577


Q ss_pred             HHHHcCcccccc
Q psy14626        234 QSITKGKLHILG  245 (249)
Q Consensus       234 ~~i~~g~~~~~~  245 (249)
                      -++.++++.+|.
T Consensus       253 LAv~n~q~s~P~  264 (302)
T KOG2345|consen  253 LAVQNAQISIPN  264 (302)
T ss_pred             EeeeccccccCC
Confidence            778888888884

>KOG0694|consensus

Probab=100.00  E-value=1.7e-38  Score=272.84  Aligned_cols=216  Identities=29%  Similarity=0.480  Sum_probs=185.2

Q ss_pred             cchHHHhhcccceeeEeeecccc---CCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEI---EPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+++..|++-|-++.++......   -.+++++++..+-.....+..+.|..++... +||.++.++..|++..++|+||
T Consensus       369 ~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm  448 (694)
T KOG0694|consen  369 DFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM  448 (694)
T ss_pred             ceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence            45666788888888877554333   4556777788888888999999999999999 5999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.||++..... .    ..|++..++.+++.++.||.|||++||||||||.+|||++.+|+   +||+|||++...-.
T Consensus       449 ey~~Ggdm~~~~~-~----~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh---~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  449 EYVAGGDLMHHIH-T----DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH---VKIADFGLCKEGMG  520 (694)
T ss_pred             EecCCCcEEEEEe-c----ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc---EEecccccccccCC
Confidence            9999998543222 1    23899999999999999999999999999999999999999888   99999999966543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      .             .......-||+.|+|||++.+..|+.++|.|||||+||||+.|+.||++ +.++++++|.+-++.+
T Consensus       521 ~-------------g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~y  587 (694)
T KOG0694|consen  521 Q-------------GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRY  587 (694)
T ss_pred             C-------------CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            2             2344556799999999999999999999999999999999999999998 5678999999999999


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       588 P~  589 (694)
T KOG0694|consen  588 PR  589 (694)
T ss_pred             CC
Confidence            84

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.7e-38  Score=263.68  Aligned_cols=215  Identities=27%  Similarity=0.506  Sum_probs=180.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ..|++.+.++.|.++.+|..........++++   +.........+.+.+|+.+++.++||||+++++.+..++.+++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            46778888999998888877665443333333   333333455677999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.+++|.+.+.....    +++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.....
T Consensus        98 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH---VKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC---EEEeeccCceEcCC
Confidence            99999999988876543    889999999999999999999999999999999999987766   99999999876543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..                ....+++.|+|||.+.+..++.++|+|||||++|+|++|..||.+ +..++.+.+.++++.+
T Consensus       171 ~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~  234 (329)
T PTZ00263        171 RT----------------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKF  234 (329)
T ss_pred             Cc----------------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCC
Confidence            21                112478999999999988889999999999999999999999988 5567888999998887


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       235 p~  236 (329)
T PTZ00263        235 PN  236 (329)
T ss_pred             CC
Confidence            74

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.1e-38  Score=264.46  Aligned_cols=215  Identities=23%  Similarity=0.408  Sum_probs=177.7

Q ss_pred             cchHHHhhcccceeeEeeeccccC----CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIE----PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .|++.+.++.|.++.+|.......    ++.+.+.+.........+.+.+|+.+++.++||||+++++++.+++.+++||
T Consensus        31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~  110 (340)
T PTZ00426         31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL  110 (340)
T ss_pred             hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence            677888899999988886653322    2223332333333455677899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.+++|.+++.....    +++..+..++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++.....
T Consensus       111 Ey~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~---ikL~DFG~a~~~~~  183 (340)
T PTZ00426        111 EFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF---IKMTDFGFAKVVDT  183 (340)
T ss_pred             eCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC---EEEecCCCCeecCC
Confidence            99999999998876543    899999999999999999999999999999999999987666   99999999876533


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..                ....+++.|+|||++.+..++.++|+||+||++|+|++|..||.+ +...+.+.+.++...+
T Consensus       184 ~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~  247 (340)
T PTZ00426        184 RT----------------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF  247 (340)
T ss_pred             Cc----------------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC
Confidence            11                122478999999999988889999999999999999999999998 5556788899988877


Q ss_pred             ccc
Q psy14626        244 LGC  246 (249)
Q Consensus       244 ~~~  246 (249)
                      |..
T Consensus       248 p~~  250 (340)
T PTZ00426        248 PKF  250 (340)
T ss_pred             CCC
Confidence            743

>KOG0661|consensus

Probab=100.00  E-value=8.4e-38  Score=258.55  Aligned_cols=208  Identities=26%  Similarity=0.465  Sum_probs=174.3

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHH-HHHHHHHHHHcC-CCChhhhhheeecCC-eEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEAD-LKREATICHMLK-HPHVVELLETYSSEG-MLY   81 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~   81 (249)
                      +.-+||++.+.+++|.++.++..+.......+++++-...-+...+. -.||+..|++++ ||||+++.+.+.+.. .++
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            34579999999999999999988887777777776555554443333 368999999998 999999999998887 899


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +|||||+. +|.+.+..+   ...|++.+|+.|+.||++||+|+|.+|+.|||+||+|||+.++.-   +||+|||+|+.
T Consensus        87 fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~---iKiaDFGLARe  159 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV---IKIADFGLARE  159 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce---eEecccccccc
Confidence            99999965 999888776   335999999999999999999999999999999999999986444   99999999999


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCC--hHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIWAAGVLLHVLLTGTLPFVGS--RDRLF  233 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~pf~~~--~~~~~  233 (249)
                      +....++.       .+       ..|..|.|||++. ...|+.+.|+|++||+++|+.+-++.|.|.  .++++
T Consensus       160 v~SkpPYT-------eY-------VSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~  220 (538)
T KOG0661|consen  160 VRSKPPYT-------EY-------VSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY  220 (538)
T ss_pred             cccCCCcc-------hh-------hhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence            88765431       11       3678899999965 566899999999999999999999999994  34443

>KOG0582|consensus

Probab=100.00  E-value=2.3e-37  Score=254.23  Aligned_cols=221  Identities=28%  Similarity=0.410  Sum_probs=178.8

Q ss_pred             CcchHHHhhcccceeeEeeecccc---CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI---EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +-|...++|+.|.-+.++......   -++++.+..+..+  ...+.+++|+..|+.++||||++++.+|..+..+++||
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence            467788888888766665443332   3334444444444  33789999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      .||.+||+.+.+....+++  +++..|..+++++++||.|||.+|.||||+|+.|||++.++.   |+|+|||++..+..
T Consensus       104 pfMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~---VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT---VKLADFGVSASLFD  178 (516)
T ss_pred             hhhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc---EEEcCceeeeeecc
Confidence            9999999999999888877  899999999999999999999999999999999999999888   99999999876665


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE--DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      ..      .+.   ........++++|+|||+++  ...|+.++||||||++..||.+|+.||.. ..-+++-.-.+|.+
T Consensus       179 ~G------~R~---~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~p  249 (516)
T KOG0582|consen  179 SG------DRQ---VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDP  249 (516)
T ss_pred             cC------cee---eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCC
Confidence            32      111   11224457999999999954  35689999999999999999999999999 55556656666666


Q ss_pred             ccc
Q psy14626        242 HIL  244 (249)
Q Consensus       242 ~~~  244 (249)
                      ..|
T Consensus       250 p~~  252 (516)
T KOG0582|consen  250 PTL  252 (516)
T ss_pred             CCc
Confidence            533

>KOG0588|consensus

Probab=100.00  E-value=1.3e-37  Score=266.36  Aligned_cols=215  Identities=31%  Similarity=0.598  Sum_probs=180.0

Q ss_pred             chHHHhhcccceeeEeeecccc---CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEI---EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      |..+.-++-|.-+.+...++..   ..+++.+++...........+.+|+.+|+.+.|||++++++.+++...+|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            4445555555444433333322   2334445555455567788899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      ++||.|.+++..++.    +++.+..++++||+.|+.|+|..+|+||||||+|+|++.+++   +||+|||.|.......
T Consensus        94 v~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n---IKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN---IKIADFGMASLEVPGK  166 (786)
T ss_pred             cCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC---EeeeccceeecccCCc
Confidence            999999999998877    899999999999999999999999999999999999998877   9999999997766533


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .              -..-.|++.|+|||+++|.+| +.++||||.|++||.|++|+.||.+ +...++..+.+|.+++|
T Consensus       167 l--------------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP  232 (786)
T KOG0588|consen  167 L--------------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP  232 (786)
T ss_pred             c--------------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC
Confidence            2              112248999999999999998 7899999999999999999999998 67889999999999999


Q ss_pred             c
Q psy14626        245 G  245 (249)
Q Consensus       245 ~  245 (249)
                      .
T Consensus       233 s  233 (786)
T KOG0588|consen  233 S  233 (786)
T ss_pred             C
Confidence            3

>KOG0198|consensus

Probab=100.00  E-value=1.4e-37  Score=253.48  Aligned_cols=204  Identities=29%  Similarity=0.448  Sum_probs=163.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC--eEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--MLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e   85 (249)
                      .++...+.++.|-++.++.........-.+++.....+....+.+.+|+.+|++++|||||+++|......  .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            46788899999998888866665433334444344433333778999999999999999999999854444  6999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeee-cCCCCCeEEcCcceeEEccC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN-KENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~-~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |+++|+|.+++...+.   .+++..++.+.+|++.||.|||++|++|+||||+|||++. ++.   ++|+|||.+.....
T Consensus        97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~---~KlaDFG~a~~~~~  170 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD---VKLADFGLAKKLES  170 (313)
T ss_pred             ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe---EEeccCcccccccc
Confidence            9999999999987653   3999999999999999999999999999999999999987 455   99999998866553


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...          .........||+.|+|||++.. ....+++||||+||++.||+||+.||..
T Consensus       171 ~~~----------~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  171 KGT----------KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccc----------cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence            110          0112233568999999999985 3445699999999999999999999987

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.7e-37  Score=258.51  Aligned_cols=211  Identities=25%  Similarity=0.490  Sum_probs=171.3

Q ss_pred             hhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCc
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD   91 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (249)
                      +++.|.++.+|...+......++++   +...........+.+|+.+++.++||||+++++.+..++.+++||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            4677778888766554443334333   3323334455678899999999999999999999999999999999999999


Q ss_pred             hhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccC
Q psy14626         92 ICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG  171 (249)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~  171 (249)
                      |.+++.....    +++.++..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.......     
T Consensus        82 L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DfG~a~~~~~~~-----  149 (323)
T cd05571          82 LFFHLSRERV----FSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH---IKITDFGLCKEGISDG-----  149 (323)
T ss_pred             HHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---EEEeeCCCCcccccCC-----
Confidence            9888865443    899999999999999999999999999999999999987766   9999999986432211     


Q ss_pred             CccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                              .......+++.|+|||++.+..++.++|+||+||++|||++|+.||.+ +.+.+.+.+..+.+.+|.
T Consensus       150 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~  216 (323)
T cd05571         150 --------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR  216 (323)
T ss_pred             --------CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence                    111223489999999999998899999999999999999999999987 566788888888887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-37  Score=255.56  Aligned_cols=211  Identities=25%  Similarity=0.442  Sum_probs=170.8

Q ss_pred             hcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         16 INHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      ++.|.++.+|...+......++++   +...........+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            355667777765554433333433   33333445567788999999999999999999999999999999999999999


Q ss_pred             hHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCC
Q psy14626         93 CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG  172 (249)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  172 (249)
                      .+++.....    +++..+..++.|++.||.|||+++++||||||+||+++.++.   ++|+|||++.......      
T Consensus        81 ~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~------  147 (312)
T cd05585          81 FHHLQREGR----FDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH---IALCDFGLCKLNMKDD------  147 (312)
T ss_pred             HHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc---EEEEECcccccCccCC------
Confidence            988876543    899999999999999999999999999999999999987766   9999999986532211      


Q ss_pred             ccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccccc
Q psy14626        173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILGC  246 (249)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~~  246 (249)
                             .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++.+.+.++.+.+|..
T Consensus       148 -------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  215 (312)
T cd05585         148 -------DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG  215 (312)
T ss_pred             -------CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCc
Confidence                   011223478999999999998899999999999999999999999988 5677888888888887753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.1e-37  Score=255.29  Aligned_cols=211  Identities=26%  Similarity=0.499  Sum_probs=169.3

Q ss_pred             hhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCc
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD   91 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (249)
                      +++.|.++.+|...+......++++   ............+.+|+.+++.++||||+++++.|...+.+++||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            4677778888766554443333333   2222233455677889999999999999999999999999999999999999


Q ss_pred             hhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccC
Q psy14626         92 ICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG  171 (249)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~  171 (249)
                      |..++.....    +++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.......     
T Consensus        82 L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg~~~~~~~~~-----  149 (323)
T cd05595          82 LFFHLSRERV----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDG-----  149 (323)
T ss_pred             HHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC---EEecccHHhccccCCC-----
Confidence            9887765443    899999999999999999999999999999999999987766   9999999876432211     


Q ss_pred             CccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                              .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.. +.+++.+.+..+...+|.
T Consensus       150 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~  216 (323)
T cd05595         150 --------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR  216 (323)
T ss_pred             --------CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence                    011123478999999999988899999999999999999999999987 566777788777777663

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1026|consensus

Probab=100.00  E-value=1.5e-37  Score=272.91  Aligned_cols=215  Identities=27%  Similarity=0.435  Sum_probs=178.1

Q ss_pred             hHHHhhcccceeeEeeec--------cccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626         11 TIHEVINHKWLKMKLHTS--------AEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ...+-++.|-|+.++...        ...-+++++++.  .++...+++|++|+.++..++|||||+++|.|.+++.+|+
T Consensus       489 ~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd--~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  489 VFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD--KAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             eehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc--cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            344556666666665332        222334444422  2333477899999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhc------C----CccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         83 VFEYMDGSDICFEIVRRATA------G----FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~------~----~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      |+|||..|+|.++|..+.+.      +    ..++..+.+.|+.||+.|+.||-++.+|||||...|+|++.+-.   ||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~---VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV---VK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE---EE
Confidence            99999999999999876543      1    22788999999999999999999999999999999999976555   99


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChH
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRD  230 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~  230 (249)
                      |+|||+++.+-.+..|....           ...-+++|||||.+...+++.++||||+||+|||+++ |..||.+ +.+
T Consensus       644 IsDfGLsRdiYssDYYk~~~-----------~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRG-----------NTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             ecccccchhhhhhhhhcccC-----------CceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            99999999988876654432           2246889999999999999999999999999999999 9999999 889


Q ss_pred             HHHHHHHcCcc
Q psy14626        231 RLFQSITKGKL  241 (249)
Q Consensus       231 ~~~~~i~~g~~  241 (249)
                      ++++.|++|+.
T Consensus       713 EVIe~i~~g~l  723 (774)
T KOG1026|consen  713 EVIECIRAGQL  723 (774)
T ss_pred             HHHHHHHcCCc
Confidence            99999999997

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=6.3e-37  Score=260.16  Aligned_cols=230  Identities=23%  Similarity=0.384  Sum_probs=176.7

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|++.+.++.|.++.+|...+......++++   +...........+.+|+.+++.++||||+++++.+.+...+++|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            5677788999999988876655443344433   2223334455678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++|++|.+++.....    +++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++......
T Consensus        82 ~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~---vkL~DFGla~~~~~~  154 (363)
T cd05628          82 FLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH---VKLSDFGLCTGLKKA  154 (363)
T ss_pred             CCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC---EEEeeccCccccccc
Confidence            9999999998876543    899999999999999999999999999999999999987765   999999998654321


Q ss_pred             Cccc---c---------CCc------ccc----ccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q psy14626        166 QLYC---S---------GGE------RLD----HYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       166 ~~~~---~---------~~~------~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  223 (249)
                      ....   .         ...      ...    ..........||+.|+|||++.+..++.++|+||+||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            1000   0         000      000    00000112358999999999998889999999999999999999999


Q ss_pred             CCCC-ChHHHHHHHHcCc--ccccc
Q psy14626        224 PFVG-SRDRLFQSITKGK--LHILG  245 (249)
Q Consensus       224 pf~~-~~~~~~~~i~~g~--~~~~~  245 (249)
                      ||.+ +..+....|.+++  +.+|+
T Consensus       235 Pf~~~~~~~~~~~i~~~~~~~~~p~  259 (363)
T cd05628         235 PFCSETPQETYKKVMNWKETLIFPP  259 (363)
T ss_pred             CCCCCCHHHHHHHHHcCcCcccCCC
Confidence            9988 5567777887643  44553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0659|consensus

Probab=100.00  E-value=1.5e-36  Score=234.78  Aligned_cols=206  Identities=28%  Similarity=0.472  Sum_probs=174.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccch--hHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYT--TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +||...++++.|.++.+|...+.......++++.......  ..-...+|+.+|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            6899999999999999998888777777777766655433  24567899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++ .+|...+..+..   .++..+++.|+.++++|++|+|.+.|+||||||.|+|++.++.   +||+|||+++.....
T Consensus        82 fm~-tdLe~vIkd~~i---~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~---lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKNI---ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ---LKIADFGLARFFGSP  154 (318)
T ss_pred             ecc-ccHHHHhccccc---ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc---EEeecccchhccCCC
Confidence            996 489888766543   4999999999999999999999999999999999999988777   999999999887753


Q ss_pred             CccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC--hHHHH
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGS--RDRLF  233 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~~--~~~~~  233 (249)
                      ..             ......-|..|.|||.+.| ..|+..+|+||.||++.||+.|.+-|.++  .+++.
T Consensus       155 ~~-------------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~  212 (318)
T KOG0659|consen  155 NR-------------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS  212 (318)
T ss_pred             Cc-------------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence            31             1111246888999999877 45899999999999999999999999983  34444

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-36  Score=267.34  Aligned_cols=221  Identities=26%  Similarity=0.393  Sum_probs=179.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccC-CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIE-PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ..|.+.+.++.|.++.+|...+... ....+++............+.+|+.+++.++||||+++++.|..++.+++||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3588888898888888776655544 233334333444445566788999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.........+++.++..++.|++.||.+||+++++||||||+||+++.++.   ++|+|||++.......
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~---~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI---IKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc---EEEEeCcCceecCCcc
Confidence            9999999888765544556899999999999999999999999999999999999987766   9999999987654422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      .           ........+|+.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++.+.+..|...
T Consensus       224 ~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~  289 (478)
T PTZ00267        224 S-----------LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD  289 (478)
T ss_pred             c-----------cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            1           0111223478999999999988899999999999999999999999998 556777777777654

>KOG0589|consensus

Probab=100.00  E-value=2.1e-37  Score=258.84  Aligned_cols=220  Identities=27%  Similarity=0.471  Sum_probs=190.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccch--hHHHHHHHHHHHHHcCCCChhhhhheeecCCe-EEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYT--TEADLKREATICHMLKHPHVVELLETYSSEGM-LYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   84 (249)
                      +.|...++++.|-|+..+......+...+++++......+  .+....+|+.++++++||||+.+.++|..++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5788889999999988887887777777777766655533  34468999999999999999999999998888 99999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      +|++||++.+.+.+..  +..|+++.+..|+.|++.|+.|||+++++|||||+.||+++.++.   |+|+|||++.....
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~---VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK---VKLGDFGLAKILNP  158 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc---eeecchhhhhhcCC
Confidence            9999999999998776  455999999999999999999999999999999999999998877   89999999988776


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc-cc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK-LH  242 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~-~~  242 (249)
                      ..             .......||+.|++||.+.+.+|..++|+|||||++|||++-+.+|.+ +...+...|.++. ..
T Consensus       159 ~~-------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P  225 (426)
T KOG0589|consen  159 ED-------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP  225 (426)
T ss_pred             ch-------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC
Confidence            33             133345799999999999999999999999999999999999999999 6677888888877 44


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|+
T Consensus       226 lp~  228 (426)
T KOG0589|consen  226 LPS  228 (426)
T ss_pred             CCc
Confidence            444

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-37  Score=261.18  Aligned_cols=225  Identities=25%  Similarity=0.426  Sum_probs=174.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|++.++|+.|.++.+|...+......++++..   ..........+.+|+.+++.++||||+++++.+.++..+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            577888999999999887666544444444322   22233455678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++..++.++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++......
T Consensus        82 ~~~~g~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~~~~~~~~  154 (364)
T cd05599          82 YLPGGDMMTLLMKKDT----FTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH---IKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCcHHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEeecccceecccc
Confidence            9999999998876443    899999999999999999999999999999999999988776   999999998765432


Q ss_pred             CccccCC---------------------ccccc----cccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh
Q psy14626        166 QLYCSGG---------------------ERLDH----YTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT  220 (249)
Q Consensus       166 ~~~~~~~---------------------~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~  220 (249)
                      .......                     .....    .........||+.|+|||++.+..++.++|+||+||++|+|++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100000                     00000    0001112358999999999998889999999999999999999


Q ss_pred             CCCCCCC-ChHHHHHHHHcCc
Q psy14626        221 GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       221 g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      |..||.+ +..+....+.+++
T Consensus       235 G~~Pf~~~~~~~~~~~i~~~~  255 (364)
T cd05599         235 GYPPFCSDNPQETYRKIINWK  255 (364)
T ss_pred             CCCCCCCCCHHHHHHHHHcCC
Confidence            9999998 4555666666654

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-37  Score=261.80  Aligned_cols=223  Identities=24%  Similarity=0.433  Sum_probs=170.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|++.+.++.|.++.+|...+......++++.   .........+.+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            57788889999999988665554444444432   222233456778999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++......
T Consensus        82 ~~~gg~L~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~---~kl~DfGla~~~~~~  154 (377)
T cd05629          82 FLPGGDLMTMLIKYDT----FSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH---IKLSDFGLSTGFHKQ  154 (377)
T ss_pred             CCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC---EEEeecccccccccc
Confidence            9999999988865433    899999999999999999999999999999999999987665   999999998533211


Q ss_pred             Cccc---c--CCcccc-----------------------------ccccccCCcccCCCCCCccccccCCCCCcchHHHH
Q psy14626        166 QLYC---S--GGERLD-----------------------------HYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAA  211 (249)
Q Consensus       166 ~~~~---~--~~~~~~-----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  211 (249)
                      ....   .  ......                             ..........||+.|+|||++.+..++.++|+||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            0000   0  000000                             00000012358999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        212 GVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       212 G~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ||++|||++|..||.+ +..+....+.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~  262 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKIIN  262 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHHHc
Confidence            9999999999999987 44455666655

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0585|consensus

Probab=100.00  E-value=8.4e-37  Score=252.63  Aligned_cols=224  Identities=30%  Similarity=0.512  Sum_probs=176.0

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccC---Chhcccc-----------chhHHHHHHHHHHHHHcCCCChhhhhhee
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNH-----------YTTEADLKREATICHMLKHPHVVELLETY   74 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   74 (249)
                      .|++..-++.|-++.+....+......+++   .+.....           -...+..++|+.+|+++.|||||+++++.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            688888899988887766666655554443   3322211           12356899999999999999999999999


Q ss_pred             ecC--CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         75 SSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        75 ~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      .+.  ..+|||+||+..|.+..    .......+.+.+++.++++++.||+|||.+|||||||||+|+|++.++.   +|
T Consensus       178 DDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~---VK  250 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT---VK  250 (576)
T ss_pred             cCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc---EE
Confidence            654  57999999999887643    3333333899999999999999999999999999999999999988876   99


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      |+|||++........        +..........||+.|+|||.+.+..    .+.+.||||+|++||.|+.|+.||.++
T Consensus       251 IsDFGVs~~~~~~~~--------~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSD--------EGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             eeccceeeecccCCc--------cccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            999999876533210        00111112246999999999987632    367899999999999999999999995


Q ss_pred             -hHHHHHHHHcCcccccccc
Q psy14626        229 -RDRLFQSITKGKLHILGCT  247 (249)
Q Consensus       229 -~~~~~~~i~~g~~~~~~~~  247 (249)
                       .-++++.|.+..+.+|+.+
T Consensus       323 ~~~~l~~KIvn~pL~fP~~p  342 (576)
T KOG0585|consen  323 FELELFDKIVNDPLEFPENP  342 (576)
T ss_pred             hHHHHHHHHhcCcccCCCcc
Confidence             4578999999999999876

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.8e-36  Score=254.08  Aligned_cols=211  Identities=25%  Similarity=0.492  Sum_probs=169.2

Q ss_pred             hhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCc
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD   91 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (249)
                      +++.|.++.+|...+......++   +.+...........+.+|+.+++.++||||+++++.+...+.+++||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            45677777777655443333333   333333334456678899999999999999999999999999999999999999


Q ss_pred             hhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccC
Q psy14626         92 ICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG  171 (249)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~  171 (249)
                      |...+.....    +++.+++.++.||+.||.|||+++++|+||||+|||++.++.   ++|+|||++.......     
T Consensus        82 L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~---~kL~DfG~~~~~~~~~-----  149 (328)
T cd05593          82 LFFHLSRERV----FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH---IKITDFGLCKEGITDA-----  149 (328)
T ss_pred             HHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc---EEEecCcCCccCCCcc-----
Confidence            9888765433    899999999999999999999999999999999999987766   9999999986432211     


Q ss_pred             CccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                              .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++.+.+..+.+.+|.
T Consensus       150 --------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~  216 (328)
T cd05593         150 --------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR  216 (328)
T ss_pred             --------cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC
Confidence                    011123478999999999988899999999999999999999999987 556777788878777763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0584|consensus

Probab=100.00  E-value=5.9e-37  Score=261.02  Aligned_cols=217  Identities=25%  Similarity=0.435  Sum_probs=184.4

Q ss_pred             CcCCCCCcc-hHHHhhcccceeeEeeeccc---cCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeec
Q psy14626          2 LSVDPNKRI-TIHEVINHKWLKMKLHTSAE---IEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSS   76 (249)
Q Consensus         2 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   76 (249)
                      ++.||..|| +..++++.|-++.+|..-++   +++++..+.... .+++...++|..|+.+|+.|+||||++++.+|.+
T Consensus        33 ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d  112 (632)
T KOG0584|consen   33 VEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVD  112 (632)
T ss_pred             cccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheec
Confidence            467888887 56778888889998866655   455555555443 4446677999999999999999999999999976


Q ss_pred             CC--eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeeecCCCCCeE
Q psy14626         77 EG--MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        77 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      ..  .+-+|+|+++.|+|..|+.+.+.    ...+.++.|++||++||.|||++.  |+|||||.+||+++++...  ||
T Consensus       113 ~~n~~in~iTEL~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~--VK  186 (632)
T KOG0584|consen  113 TDNKTINFITELFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGE--VK  186 (632)
T ss_pred             CCCceeeeeeecccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCc--ee
Confidence            54  48899999999999999988766    899999999999999999999885  9999999999999865443  99


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChH
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRD  230 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~  230 (249)
                      |+|+|+|.....+.               ..+..|||-|||||... ..|...+||||||+||.||.|+..||+.  +..
T Consensus       187 IGDLGLAtl~r~s~---------------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A  250 (632)
T KOG0584|consen  187 IGDLGLATLLRKSH---------------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA  250 (632)
T ss_pred             ecchhHHHHhhccc---------------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence            99999997776532               23357999999999988 6789999999999999999999999998  788


Q ss_pred             HHHHHHHcCc
Q psy14626        231 RLFQSITKGK  240 (249)
Q Consensus       231 ~~~~~i~~g~  240 (249)
                      +|+..+.+|.
T Consensus       251 QIYKKV~SGi  260 (632)
T KOG0584|consen  251 QIYKKVTSGI  260 (632)
T ss_pred             HHHHHHHcCC
Confidence            9999999986

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=256.16  Aligned_cols=210  Identities=27%  Similarity=0.426  Sum_probs=172.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.+|...+......++   +.+...........+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            367888899999999888776554333333   33333333445677899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....    +++..++.++.|++.||.+||+++++|+||||+||+++.++.   ++|+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH---IKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC---EEEEeCcCCccccc
Confidence            99999999998865443    899999999999999999999999999999999999987766   99999999865433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .                .....+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+ +..+....+....
T Consensus       154 ~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~  214 (333)
T cd05600         154 Y----------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK  214 (333)
T ss_pred             c----------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc
Confidence            1                1123478999999999988899999999999999999999999998 5556666665543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0032|consensus

Probab=100.00  E-value=4.6e-36  Score=253.03  Aligned_cols=224  Identities=32%  Similarity=0.599  Sum_probs=193.4

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccC---CCcccCChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYSSEGML   80 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (249)
                      +-..+|.+.+.++.|-++.++.......   .+.+.+++.......+.+.+.+|+.+|+++. ||||+.+++.|++...+
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            3455899999999999999987766553   4455566666665567789999999999998 99999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC-CCCeEEcCccee
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN-SAPVKLGGFGVA  159 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~-~~~~~l~dfg~~  159 (249)
                      ++|||++.||.|.+.+...     .+++..+..++.|++.+++|||+.|++|+||||+|+|+..... ...++++|||++
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            9999999999999999887     1899999999999999999999999999999999999987654 346999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      .......              ......||+.|+|||++....++..+|+||+|+++|.|+.|.+||.+ +.......|..
T Consensus       187 ~~~~~~~--------------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~  252 (382)
T KOG0032|consen  187 KFIKPGE--------------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR  252 (382)
T ss_pred             eEccCCc--------------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence            8776621              22234699999999999999999999999999999999999999999 56678889999


Q ss_pred             Ccccccccc
Q psy14626        239 GKLHILGCT  247 (249)
Q Consensus       239 g~~~~~~~~  247 (249)
                      |++.++..|
T Consensus       253 ~~~~f~~~~  261 (382)
T KOG0032|consen  253 GDFDFTSEP  261 (382)
T ss_pred             CCCCCCCCC
Confidence            999988443

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.6e-36  Score=251.67  Aligned_cols=212  Identities=30%  Similarity=0.500  Sum_probs=168.1

Q ss_pred             HhhcccceeeEeeecccc------CCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626         14 EVINHKWLKMKLHTSAEI------EPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +.++.|.++.+|...+..      .++.+.+.+... ........+.+|+.+++.++||||+++++.+..++.+++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            356777888877654321      122222222222 2223445678999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+.+.....    +.+..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          82 LSGGELFMHLEREGI----FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH---VKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEeeCcCCeecccCC
Confidence            999999888866543    788999999999999999999999999999999999987766   9999999986432211


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                                   .......+++.|+|||++.+..++.++|+||+|+++|+|++|+.||.+ +.....+.+.++...+|+
T Consensus       155 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~  221 (323)
T cd05584         155 -------------TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP  221 (323)
T ss_pred             -------------CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence                         111123478999999999988889999999999999999999999998 556678888888887774

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.3e-36  Score=258.74  Aligned_cols=218  Identities=28%  Similarity=0.479  Sum_probs=173.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .++|++.++++.|.++.+|..........++++   +.........+.+.+|+.+++.++||||+++++.+.+++.+++|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            357888899999999998876665444444433   22233334456688999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++...     .+++.++..++.|++.||.+||+++++||||||+|||++.++.   ++|+|||++....
T Consensus       122 ~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~---~kL~DFG~a~~~~  193 (370)
T cd05621         122 MEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH---LKLADFGTCMKMD  193 (370)
T ss_pred             EcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC---EEEEecccceecc
Confidence            9999999999888543     2789999999999999999999999999999999999987766   9999999987654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ....            .......+|+.|+|||++.+..    ++.++|+||+||++|+|++|+.||.+ +.......|..
T Consensus       194 ~~~~------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~  261 (370)
T cd05621         194 ETGM------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD  261 (370)
T ss_pred             cCCc------------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            3221            0112235899999999987543    67899999999999999999999998 45556667766


Q ss_pred             Cc--cccc
Q psy14626        239 GK--LHIL  244 (249)
Q Consensus       239 g~--~~~~  244 (249)
                      +.  +.+|
T Consensus       262 ~~~~~~~p  269 (370)
T cd05621         262 HKNSLNFP  269 (370)
T ss_pred             CCcccCCC
Confidence            43  4444

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=257.28  Aligned_cols=231  Identities=26%  Similarity=0.448  Sum_probs=180.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.+|...+......++++   +...........+.+|+.++..++||||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888899999999999877766444444433   333333455678899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++....    .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.   ++|+|||.+.....
T Consensus        81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~---~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH---IKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEeecCCCCccCcc
Confidence            9999999999887653    3899999999999999999999999999999999999988776   99999999876554


Q ss_pred             CCccccC----------------CccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q psy14626        165 GQLYCSG----------------GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-  227 (249)
Q Consensus       165 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-  227 (249)
                      .......                ...............+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.. 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            3200000                00000001122334589999999999999999999999999999999999999998 


Q ss_pred             ChHHHHHHHHc--Ccccccc
Q psy14626        228 SRDRLFQSITK--GKLHILG  245 (249)
Q Consensus       228 ~~~~~~~~i~~--g~~~~~~  245 (249)
                      +.......+.+  ....+|.
T Consensus       234 ~~~~~~~~i~~~~~~~~~p~  253 (350)
T cd05573         234 TLQETYNKIINWKESLRFPP  253 (350)
T ss_pred             CHHHHHHHHhccCCcccCCC
Confidence            55566777776  4455553

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.6e-36  Score=256.97  Aligned_cols=218  Identities=28%  Similarity=0.459  Sum_probs=174.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .++|++.+.++.|.++.+|..........++++.   .........+.+.+|+.+++.++||||+++++.+..++.+++|
T Consensus        42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (371)
T cd05622          42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  121 (371)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            3688999999999999888776665544444432   2223334456688999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++...     .+++..+..++.|++.||.+||+++++||||||+||+++.++.   ++|+|||++....
T Consensus       122 ~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~---ikL~DfG~a~~~~  193 (371)
T cd05622         122 MEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMN  193 (371)
T ss_pred             EcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC---EEEEeCCceeEcC
Confidence            9999999998887543     2789999999999999999999999999999999999987766   9999999987654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ....            .......+|+.|+|||++.+..    ++.++|+||+||++|+|++|..||.+ +.......|.+
T Consensus       194 ~~~~------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  261 (371)
T cd05622         194 KEGM------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN  261 (371)
T ss_pred             cCCc------------ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            3211            1112235899999999987543    67899999999999999999999998 45567777776


Q ss_pred             Cc--cccc
Q psy14626        239 GK--LHIL  244 (249)
Q Consensus       239 g~--~~~~  244 (249)
                      +.  +.+|
T Consensus       262 ~~~~~~~~  269 (371)
T cd05622         262 HKNSLTFP  269 (371)
T ss_pred             CCCcccCC
Confidence            54  4444

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.7e-36  Score=250.69  Aligned_cols=211  Identities=27%  Similarity=0.474  Sum_probs=170.3

Q ss_pred             hhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|..........+++   .+.........+.+.+|..++..+ +||||+++++++...+.+++||||++++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            466777778776665443333333   333233345566788899888877 6999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|.+++.....    +++..+..++.|++.||.|||+.+++||||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~i~~~~~----l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~---~kL~DfG~~~~~~~~~----  150 (320)
T cd05590          82 DLMFHIQKSRR----FDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGIFNG----  150 (320)
T ss_pred             hHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc---EEEeeCCCCeecCcCC----
Confidence            99888766543    899999999999999999999999999999999999987766   9999999976532211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++.+.+.++.+.+|.
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~  217 (320)
T cd05590         151 ---------KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT  217 (320)
T ss_pred             ---------CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence                     011123478999999999988889999999999999999999999998 566788899888887774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.5e-36  Score=249.83  Aligned_cols=211  Identities=30%  Similarity=0.536  Sum_probs=167.5

Q ss_pred             hhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|..........++   +.+.........+.+..|..++... +||||+++++++..++.+++||||++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            46778888887665543333333   3333333334455666777777655 8999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|..++.....    +++..+..++.|++.||.|||+.+++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~---~kL~Dfg~a~~~~~~~----  150 (316)
T cd05592          82 DLMFHIQSSGR----FDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH---IKIADFGMCKENMNGE----  150 (316)
T ss_pred             cHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC---EEEccCcCCeECCCCC----
Confidence            99888865433    899999999999999999999999999999999999987766   9999999986543211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++...+....+.+|.
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~  217 (316)
T cd05592         151 ---------GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR  217 (316)
T ss_pred             ---------CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence                     111223478999999999988899999999999999999999999998 566778888877777664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.3e-36  Score=250.98  Aligned_cols=211  Identities=27%  Similarity=0.452  Sum_probs=169.9

Q ss_pred             hhcccceeeEeeeccccCC---CcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEP---ASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|........   +.+.+.+.........+.+..|..++..+ +||||+++++++...+.+++||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            4677778888766554332   33333333333345556778899998877 7999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|..++.....    +++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++........   
T Consensus        82 ~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~---~kL~Dfg~~~~~~~~~~---  151 (321)
T cd05591          82 DLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH---CKLADFGMCKEGILNGV---  151 (321)
T ss_pred             cHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEeecccceecccCCc---
Confidence            99888865543    889999999999999999999999999999999999987766   99999999865432111   


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                                ......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +.+++.+.+.++...+|.
T Consensus       152 ----------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~  217 (321)
T cd05591         152 ----------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV  217 (321)
T ss_pred             ----------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence                      11123478999999999988899999999999999999999999998 566788889888877763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.2e-36  Score=253.16  Aligned_cols=211  Identities=25%  Similarity=0.491  Sum_probs=169.6

Q ss_pred             hhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCc
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD   91 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (249)
                      +++.|.++.+|...+......++   +.+...........+.+|+.+++.++||||+++++.+...+.+++||||+++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            46677778777655443333333   333333334455678899999999999999999999999999999999999999


Q ss_pred             hhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         92 ICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      |..++.....    +++..+..++.|++.||.|||+ .|++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~---~kL~Dfg~~~~~~~~~----  150 (325)
T cd05594          82 LFFHLSRERV----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKEGIKDG----  150 (325)
T ss_pred             HHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC---EEEecCCCCeecCCCC----
Confidence            9887765433    8999999999999999999997 79999999999999987766   9999999986533211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|..||.+ +.+++.+.+..+.+.+|.
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~  217 (325)
T cd05594         151 ---------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR  217 (325)
T ss_pred             ---------cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence                     011123478999999999988899999999999999999999999988 566788888888877774

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6e-36  Score=246.08  Aligned_cols=216  Identities=24%  Similarity=0.405  Sum_probs=169.6

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      |+..+.++.|.++.+|..........++++   +...........+.+|+.+++.++|++|+++++.+.+.+.+++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            556677888888888766654443444433   33333344456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+.+.....  ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.......
T Consensus        82 ~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~---~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          82 MNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH---IRISDLGLAVQIPEGE  156 (285)
T ss_pred             cCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---EEEeeCCCcEEcCCCC
Confidence            999999877754332  23889999999999999999999999999999999999987665   9999999987654321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh-----HHHHHHHHcCcc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR-----DRLFQSITKGKL  241 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~-----~~~~~~i~~g~~  241 (249)
                      .              .....++..|+|||++.+..++.++|+||+||++|+|++|+.||.+..     +.+...+..+..
T Consensus       157 ~--------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  222 (285)
T cd05631         157 T--------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE  222 (285)
T ss_pred             e--------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc
Confidence            1              112247899999999999899999999999999999999999998732     234444544444


Q ss_pred             ccc
Q psy14626        242 HIL  244 (249)
Q Consensus       242 ~~~  244 (249)
                      .+|
T Consensus       223 ~~~  225 (285)
T cd05631         223 EYS  225 (285)
T ss_pred             cCC
Confidence            444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0607|consensus

Probab=100.00  E-value=1.4e-35  Score=235.07  Aligned_cols=225  Identities=25%  Similarity=0.441  Sum_probs=181.1

Q ss_pred             HHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCCc
Q psy14626         13 HEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSD   91 (249)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (249)
                      +++++.|-++.+-...+-.....|+++....+-.-.+.++.+|++++.+. .|+||+.++++|+++..+|+|||-|.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            46677777777655555455555666555555556788999999999999 59999999999999999999999999999


Q ss_pred             hhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccC
Q psy14626         92 ICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG  171 (249)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~  171 (249)
                      |...+.++..    |++.++.++..+|+.||.+||++||.|||+||+|||-...+....+||+||.+...+.......  
T Consensus       163 lLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s--  236 (463)
T KOG0607|consen  163 LLSHIQKRKH----FNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS--  236 (463)
T ss_pred             HHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC--
Confidence            9999988776    9999999999999999999999999999999999999887777779999999875543322110  


Q ss_pred             CccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCCC----------------hH
Q psy14626        172 GERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVGS----------------RD  230 (249)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~~----------------~~  230 (249)
                          .......-...|+--|||||+..     ...|..++|.||||+++|=|+.|.+||.+.                .+
T Consensus       237 ----pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  237 ----PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN  312 (463)
T ss_pred             ----CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence                11112222345777899999864     344789999999999999999999999972                14


Q ss_pred             HHHHHHHcCcccccc-cc
Q psy14626        231 RLFQSITKGKLHILG-CT  247 (249)
Q Consensus       231 ~~~~~i~~g~~~~~~-~~  247 (249)
                      .++++|+.|+++||+ .|
T Consensus       313 ~LFesIQEGkYeFPdkdW  330 (463)
T KOG0607|consen  313 KLFESIQEGKYEFPDKDW  330 (463)
T ss_pred             HHHHHHhccCCcCChhhh
Confidence            789999999999994 44

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.6e-36  Score=250.64  Aligned_cols=216  Identities=27%  Similarity=0.453  Sum_probs=173.8

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCC-CChhhhhheeecCCeEEEEEe
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKH-PHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      |++.+.++.|.++.+|...+......++++   +.........+.+..|+.++..++| ++|+++++++...+.+++|||
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (324)
T cd05587           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME   81 (324)
T ss_pred             ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence            566778888988888876655443333333   2223334556778899999999975 568889999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++..+..++.|++.||.|||++|++|+||||+|||++.++.   ++|+|||++......
T Consensus        82 ~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---~kL~Dfg~~~~~~~~  154 (324)
T cd05587          82 YVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH---IKIADFGMCKENIFG  154 (324)
T ss_pred             CCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC---EEEeecCcceecCCC
Confidence            9999999888865443    889999999999999999999999999999999999987766   999999998643211


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .             .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++...+.++.+.+|
T Consensus       155 ~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~  221 (324)
T cd05587         155 G-------------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP  221 (324)
T ss_pred             C-------------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            1             011123478999999999998899999999999999999999999998 56678888888887776


Q ss_pred             c
Q psy14626        245 G  245 (249)
Q Consensus       245 ~  245 (249)
                      .
T Consensus       222 ~  222 (324)
T cd05587         222 K  222 (324)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.5e-36  Score=258.15  Aligned_cols=223  Identities=24%  Similarity=0.375  Sum_probs=170.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +|++..+++.|.++.+|...+......++++..   ..........+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            577778899999999887766554444444322   22234456778999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++..++.++.|++.||.+||+++++||||||+|||++.++.   ++|+|||++......
T Consensus        82 ~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~---~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRMGI----FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEEeECCCCcccccc
Confidence            9999999988865432    889999999999999999999999999999999999987766   999999987533211


Q ss_pred             Cccc---cC------Ccc-------------------------ccccccccCCcccCCCCCCccccccCCCCCcchHHHH
Q psy14626        166 QLYC---SG------GER-------------------------LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAA  211 (249)
Q Consensus       166 ~~~~---~~------~~~-------------------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  211 (249)
                      ....   ..      ...                         ............||+.|+|||++.+..++.++|+||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0000   00      000                         0000001122358899999999999889999999999


Q ss_pred             HHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        212 GVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       212 G~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ||++|||++|+.||.+ +..+....+.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i~~  262 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLETQMKVIN  262 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence            9999999999999998 44444445544

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.6e-36  Score=257.09  Aligned_cols=222  Identities=24%  Similarity=0.391  Sum_probs=169.5

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|.+.+.|+.|.++.+|...+......++++.   .........+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            46677788999999988776554444444433   233334556789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++..++.++.|++.||.+||+.|++||||||+|||++.++.   ++|+|||++......
T Consensus        82 ~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~---~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRMEV----FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH---IKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC---EEEeeCcCCcccccc
Confidence            9999999988876443    899999999999999999999999999999999999987665   999999987543211


Q ss_pred             Ccccc--C--------Cc------------------cc------cccccccCCcccCCCCCCccccccCCCCCcchHHHH
Q psy14626        166 QLYCS--G--------GE------------------RL------DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAA  211 (249)
Q Consensus       166 ~~~~~--~--------~~------------------~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  211 (249)
                      .....  .        ..                  ..      ...........||+.|+|||.+.+..++.++|+||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00000  0        00                  00      000001123458999999999998889999999999


Q ss_pred             HHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        212 GVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       212 G~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      ||++|||++|..||.. +..+....+.
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~~~i~  261 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQLKVI  261 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence            9999999999999988 4444444454

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5e-36  Score=250.82  Aligned_cols=216  Identities=27%  Similarity=0.452  Sum_probs=173.3

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEe
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      |++...++.|.++.+|...+......++++   +.........+.+..|..++..+ +|++|+++++++...+.+++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05616           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME   81 (323)
T ss_pred             ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence            566778888888888866555433333332   32233334455677888888887 58999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++.++..++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++......
T Consensus        82 ~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~kL~DfG~~~~~~~~  154 (323)
T cd05616          82 YVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENMWD  154 (323)
T ss_pred             CCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc---EEEccCCCceecCCC
Confidence            9999999888865543    899999999999999999999999999999999999988776   999999998654321


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .             .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +...+.+.+..+.+.+|
T Consensus       155 ~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p  221 (323)
T cd05616         155 G-------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP  221 (323)
T ss_pred             C-------------CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            1             011223478999999999998899999999999999999999999998 56678888888887766


Q ss_pred             c
Q psy14626        245 G  245 (249)
Q Consensus       245 ~  245 (249)
                      .
T Consensus       222 ~  222 (323)
T cd05616         222 K  222 (323)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=5.9e-36  Score=250.49  Aligned_cols=215  Identities=27%  Similarity=0.465  Sum_probs=169.7

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHHHH---HcCCCChhhhhheeecCCeEEEE
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATICH---MLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~---~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      |++.+.++.|.++.+|..........+++   .+.........+.+.+|+.++.   .++||||+++++++..++.+|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            45667788888888886655433333333   3322223344566777776664   55799999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+.+++|...+...     .+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++....
T Consensus        81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~---~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF---VKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc---EEeCcccCCccCC
Confidence            9999999998776432     3899999999999999999999999999999999999988776   9999999875432


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...             .......+++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+ +..++.+.+..+.+.
T Consensus       153 ~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~  219 (324)
T cd05589         153 GFG-------------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVR  219 (324)
T ss_pred             CCC-------------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            211             111223578999999999988899999999999999999999999998 566788888888877


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       220 ~p~  222 (324)
T cd05589         220 YPR  222 (324)
T ss_pred             CCC
Confidence            763

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=5.2e-36  Score=255.05  Aligned_cols=218  Identities=27%  Similarity=0.440  Sum_probs=173.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +.|++.+.++.|.++.+|..........++++.   .........+.+.+|+.+++.++||||+++++++.++..+++||
T Consensus        43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~  122 (370)
T cd05596          43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM  122 (370)
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence            467788889999998888666554444444432   22333345566889999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++...     .+++.++..++.|++.||.|||+.+++||||||+|||++.++.   ++|+|||.+.....
T Consensus       123 Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~---~kL~DfG~~~~~~~  194 (370)
T cd05596         123 EYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMDA  194 (370)
T ss_pred             cCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC---EEEEeccceeeccC
Confidence            999999999887543     2789999999999999999999999999999999999987766   99999999876543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccC----CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ----KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ...            .......+++.|+|||.+.+.    .++.++|+||+||++|+|++|..||.+ +....+..|.++
T Consensus       195 ~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  262 (370)
T cd05596         195 NGM------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH  262 (370)
T ss_pred             CCc------------ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence            211            011223589999999998653    368899999999999999999999998 455677777765


Q ss_pred             c--ccccc
Q psy14626        240 K--LHILG  245 (249)
Q Consensus       240 ~--~~~~~  245 (249)
                      +  +.+|.
T Consensus       263 ~~~~~~~~  270 (370)
T cd05596         263 KNSLTFPD  270 (370)
T ss_pred             CCcCCCCC
Confidence            4  44554

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.5e-36  Score=249.90  Aligned_cols=211  Identities=27%  Similarity=0.515  Sum_probs=166.4

Q ss_pred             hhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHH-HHHHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREAT-ICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|...+......++++   +...........+.+|.. +++.++||||+++++.+.+.+..++||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            4677778888766655444333333   222222333445556654 678889999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|...+.....    +++..+..++.|++.||.|||+.+++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~----  150 (321)
T cd05603          82 ELFFHLQRERC----FLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGLCKEGVEPE----  150 (321)
T ss_pred             CHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEccCCCCccCCCCC----
Confidence            99887765433    889999999999999999999999999999999999988776   9999999876432211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+ +...+.+.+..+...+|.
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  217 (321)
T cd05603         151 ---------ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG  217 (321)
T ss_pred             ---------CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence                     011223478999999999988899999999999999999999999998 556788888888877764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.3e-36  Score=257.90  Aligned_cols=225  Identities=24%  Similarity=0.381  Sum_probs=171.6

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|++...++.|.++.+|...+......++++.   .........+.+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            57788889999999988776654444444432   222233456678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++..++.++.||+.||.|||++|++||||||+||+++.++.   ++|+|||++......
T Consensus        82 ~~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~---ikL~DFG~a~~~~~~  154 (376)
T cd05598          82 YIPGGDMMSLLIRLGI----FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWT  154 (376)
T ss_pred             CCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC---EEEEeCCCCcccccc
Confidence            9999999999876443    889999999999999999999999999999999999987766   999999987432110


Q ss_pred             Cccc---------cC----Cccc-----------------cccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHH
Q psy14626        166 QLYC---------SG----GERL-----------------DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL  215 (249)
Q Consensus       166 ~~~~---------~~----~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l  215 (249)
                      ....         ..    ....                 ...........||+.|+|||++.+..++.++|+||+||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0000         00    0000                 0000011223589999999999998899999999999999


Q ss_pred             HHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        216 HVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       216 ~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      |+|++|+.||.+ +..+....+....
T Consensus       235 yell~G~~Pf~~~~~~~~~~~i~~~~  260 (376)
T cd05598         235 YEMLVGQPPFLADTPAETQLKVINWE  260 (376)
T ss_pred             eehhhCCCCCCCCCHHHHHHHHhccC
Confidence            999999999998 4445555555443

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.1e-35  Score=248.40  Aligned_cols=221  Identities=23%  Similarity=0.367  Sum_probs=168.7

Q ss_pred             CCCcchHHHhhcccceeeEeeecc-----ccCCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecC-
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSA-----EIEPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSE-   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-   77 (249)
                      |.+||++.+.++.|.++.+|....     ......++++.... ......+.+.+|+.+++.+ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            567999999999999999886542     11112233332221 1223456799999999999 899999999988654 


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhh--------------------------------------------------------
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRAT--------------------------------------------------------  101 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------------  101 (249)
                      +.+++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            468999999999999998875321                                                        


Q ss_pred             --cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccc
Q psy14626        102 --AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYT  179 (249)
Q Consensus       102 --~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  179 (249)
                        +...++..++..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.........           
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~---~kl~DfG~a~~~~~~~~~-----------  230 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDY-----------  230 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCc---EEEeecccccccccCcch-----------
Confidence              1234778899999999999999999999999999999999987665   999999998765432210           


Q ss_pred             cccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCC--hHHHHHHHHcCc
Q psy14626        180 TKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGS--RDRLFQSITKGK  240 (249)
Q Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~~--~~~~~~~i~~g~  240 (249)
                      .......++..|+|||++.+..++.++|+||+||++|||++ |..||.+.  .+.+.+.+..+.
T Consensus       231 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~  294 (338)
T cd05102         231 VRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT  294 (338)
T ss_pred             hcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence            11122235678999999998889999999999999999997 99999872  345566666554

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0663|consensus

Probab=100.00  E-value=6e-36  Score=238.14  Aligned_cols=203  Identities=24%  Similarity=0.339  Sum_probs=171.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccc--hhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHY--TTEADLKREATICHMLKHPHVVELLETYSSE--GMLY   81 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~   81 (249)
                      +-+.|.+...|+.|.|+++|..++.....++++++......  .-.-.-.+|+.+|.+.+|||||.+-++..-.  +.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            34568888999999999999999998888888776554432  2234568999999999999999999988533  4699


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++. +|...+....   ..|...+++-++.|++.|++|||+..|+|||||++|+|++..+.   +|++|||+|+.
T Consensus       154 ~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~---lKiaDFGLAR~  226 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI---LKIADFGLARE  226 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc---EEecccchhhh
Confidence            99999976 8988887765   34899999999999999999999999999999999999987776   99999999988


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .++...             ..-...-|..|.|||.+.+.+ |+.+.|+||+||++.||+++++.|.+.
T Consensus       227 ygsp~k-------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~  281 (419)
T KOG0663|consen  227 YGSPLK-------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK  281 (419)
T ss_pred             hcCCcc-------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence            877532             112235688999999998754 799999999999999999999999984

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.2e-35  Score=246.18  Aligned_cols=211  Identities=27%  Similarity=0.468  Sum_probs=167.2

Q ss_pred             hhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|...+......++++   +.........+.+..|..++... +||||+++++.+.+.+.+++||||+.++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g   81 (316)
T cd05620           2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence            4667777777766655443333333   22222234456677788888765 8999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|..++.....    +++.++..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~i~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~----  150 (316)
T cd05620          82 DLMFHIQDKGR----FDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH---IKIADFGMCKENVFGD----  150 (316)
T ss_pred             cHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEeCccCCCeecccCC----
Confidence            99888866433    899999999999999999999999999999999999987765   9999999876432111    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++.+.+..+.+.+|.
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~  217 (316)
T cd05620         151 ---------NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR  217 (316)
T ss_pred             ---------CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence                     011123478999999999998899999999999999999999999988 566788888888777664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0599|consensus

Probab=100.00  E-value=2.4e-36  Score=234.94  Aligned_cols=218  Identities=28%  Similarity=0.518  Sum_probs=175.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcc--------ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--------NHYTTEADLKREATICHML-KHPHVVELLETYSSEGM   79 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   79 (249)
                      .|...+++++|..+.+.....+.....++.+....        +-..-.++-.+|+.+|+++ .||+|+++.++++.+.-
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            45566777777666655444444444444332221        1123355667899999999 69999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +++|+|+|+.|.|.+++.....    ++++..+++++|++.|+.|||.++|||+||||+|||++++.+   ++|+|||++
T Consensus        98 ~FlVFdl~prGELFDyLts~Vt----lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~---i~isDFGFa  170 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTSKVT----LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN---IKISDFGFA  170 (411)
T ss_pred             hhhhhhhcccchHHHHhhhhee----ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc---eEEecccee
Confidence            9999999999999999988776    899999999999999999999999999999999999998887   999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCCChH-HH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE------DQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD-RL  232 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~pf~~~~~-~~  232 (249)
                      ..+.....              -....||++|.|||.+.      ...|+..+|+|++|++||.|+.|.+||--..+ -+
T Consensus       171 ~~l~~Gek--------------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM  236 (411)
T KOG0599|consen  171 CQLEPGEK--------------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM  236 (411)
T ss_pred             eccCCchh--------------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH
Confidence            87765331              12235999999999875      34578899999999999999999999976443 46


Q ss_pred             HHHHHcCccccc-ccc
Q psy14626        233 FQSITKGKLHIL-GCT  247 (249)
Q Consensus       233 ~~~i~~g~~~~~-~~~  247 (249)
                      .-.|++|++++- +.|
T Consensus       237 LR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  237 LRMIMEGKYQFRSPEW  252 (411)
T ss_pred             HHHHHhcccccCCcch
Confidence            778999999986 555

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-35  Score=247.39  Aligned_cols=216  Identities=27%  Similarity=0.450  Sum_probs=173.0

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEe
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      |.+..+++.|.++.+|...+......++++   +.........+.+..|+.++..+. |++|+++++++.+.+.+++|||
T Consensus         2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E   81 (323)
T cd05615           2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME   81 (323)
T ss_pred             ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence            455677888888888876655444444433   222333345567888999998885 6788899999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++.+++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||++......
T Consensus        82 y~~~g~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~---ikL~Dfg~~~~~~~~  154 (323)
T cd05615          82 YVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH---IKIADFGMCKEHMVD  154 (323)
T ss_pred             CCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEeccccccccCCC
Confidence            9999999888865443    899999999999999999999999999999999999987766   999999998643221


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .             .......+++.|+|||++.+..++.++|+||+||++|+|++|..||.+ +...+.+.+..+...+|
T Consensus       155 ~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p  221 (323)
T cd05615         155 G-------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP  221 (323)
T ss_pred             C-------------ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            1             011123478999999999988899999999999999999999999998 56678888888887776


Q ss_pred             c
Q psy14626        245 G  245 (249)
Q Consensus       245 ~  245 (249)
                      .
T Consensus       222 ~  222 (323)
T cd05615         222 K  222 (323)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.5e-35  Score=247.92  Aligned_cols=211  Identities=27%  Similarity=0.506  Sum_probs=165.7

Q ss_pred             hhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHH-HHHHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREAT-ICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|...+......++++   +...........+.+|.. +++.++||||+++++.+...+.+++||||+.++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            4667777777766655444434433   222222333445555554 567789999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|..++.....    +++..+..++.||+.||.|||++|++|+||||+|||++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~---~kl~Dfg~~~~~~~~~----  150 (323)
T cd05575          82 ELFFHLQRERS----FPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH---VVLTDFGLCKEGIEHS----  150 (323)
T ss_pred             CHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc---EEEeccCCCcccccCC----
Confidence            99888865443    899999999999999999999999999999999999987766   9999999875432211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||++.+..++.++|+|||||++|+|++|..||.+ +..++.+.+.++...+++
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  217 (323)
T cd05575         151 ---------KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP  217 (323)
T ss_pred             ---------CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence                     011123478999999999998899999999999999999999999998 567788888888766653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.3e-35  Score=245.12  Aligned_cols=211  Identities=27%  Similarity=0.463  Sum_probs=167.0

Q ss_pred             hhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      .++.|.++.+|...+......++++   +.........+.+..|..+++.. +||||+++++++.+.+.+++||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            4677778888766655443333333   22222233455677788888765 8999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|.+.+.....    +++.++..++.|++.||.|||+.+++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~---~kl~Dfg~~~~~~~~~----  150 (316)
T cd05619          82 DLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH---IKIADFGMCKENMLGD----  150 (316)
T ss_pred             cHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC---EEEccCCcceECCCCC----
Confidence            99888865433    889999999999999999999999999999999999987766   9999999986532211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|..||.+ +..++.+.+..+.+.+|.
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~  217 (316)
T cd05619         151 ---------AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR  217 (316)
T ss_pred             ---------CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence                     011123478999999999988899999999999999999999999988 566788888877776664

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5e-36  Score=254.37  Aligned_cols=224  Identities=24%  Similarity=0.401  Sum_probs=172.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|++...++.|.++.++..........++++   +...........+.+|+.++..++||+|+++++.+.+.+.+++|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            4666778888888888866555444344433   2223334556778899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++|++|.+++.....    +++..++.++.|++.||.+||++|++||||||+||+++.++.   ++|+|||++......
T Consensus        82 ~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~---vkL~DfG~~~~~~~~  154 (360)
T cd05627          82 FLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH---VKLSDFGLCTGLKKA  154 (360)
T ss_pred             CCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC---EEEeeccCCcccccc
Confidence            9999999998876543    899999999999999999999999999999999999987766   999999998654321


Q ss_pred             Ccccc-------C--------------Cccc-cccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q psy14626        166 QLYCS-------G--------------GERL-DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       166 ~~~~~-------~--------------~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  223 (249)
                      .....       .              .+.. ...........||+.|+|||++.+..++.++|+||+||++|+|++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10000       0              0000 000011123458999999999999889999999999999999999999


Q ss_pred             CCCC-ChHHHHHHHHcC
Q psy14626        224 PFVG-SRDRLFQSITKG  239 (249)
Q Consensus       224 pf~~-~~~~~~~~i~~g  239 (249)
                      ||.+ +..+....+.+.
T Consensus       235 Pf~~~~~~~~~~~i~~~  251 (360)
T cd05627         235 PFCSETPQETYRKVMNW  251 (360)
T ss_pred             CCCCCCHHHHHHHHHcC
Confidence            9988 556667777754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0667|consensus

Probab=100.00  E-value=4.9e-36  Score=256.94  Aligned_cols=200  Identities=26%  Similarity=0.392  Sum_probs=168.8

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-C-----CChhhhhheeecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-H-----PHVVELLETYSSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~~i~~~~~~~~~~~~~~l   82 (249)
                      ||.+.++|+.|.|+.++...+......++++... +...-..+...|+.+|..++ |     -|+|+++++|...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK-N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK-NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeec-cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            8999999999999998877766555555543332 22344556678999999996 3     489999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |+|++. -+|.+++..+...+  ++...++.++.||+.||.+||+.+|||+||||+|||+...+.+ .+|++|||.+...
T Consensus       266 VfELL~-~NLYellK~n~f~G--lsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~-~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLS-TNLYELLKNNKFRG--LSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRS-RIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhh-hhHHHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcC-ceeEEeccccccc
Confidence            999995 59999999887766  8999999999999999999999999999999999999876655 5999999999776


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR  229 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~  229 (249)
                      .....                .-.-+..|.|||++.|.+++.+.|+||||||++||++|.+.|.++.
T Consensus       342 ~q~vy----------------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  342 SQRVY----------------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             CCcce----------------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            65331                1124778999999999999999999999999999999999999954

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.4e-35  Score=245.31  Aligned_cols=211  Identities=30%  Similarity=0.504  Sum_probs=169.4

Q ss_pred             hhcccceeeEeeeccccCCC---cccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPA---SFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|.........   .+.+.+.........+.+.+|+.+++.+ +||||+++++++...+.+++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            46677777777665543333   3333333333445566788899999888 7999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|..++.....    +++.++..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~~----  150 (318)
T cd05570          82 DLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH---IKIADFGMCKEGILGG----  150 (318)
T ss_pred             CHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc---EEecccCCCeecCcCC----
Confidence            99888765433    899999999999999999999999999999999999987766   9999999886432211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +...+...+.++.+.+|.
T Consensus       151 ---------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~  217 (318)
T cd05570         151 ---------VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR  217 (318)
T ss_pred             ---------CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence                     011122478899999999998999999999999999999999999998 566778888888877763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.7e-35  Score=246.57  Aligned_cols=210  Identities=26%  Similarity=0.501  Sum_probs=163.5

Q ss_pred             hhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHH-HHHHHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREA-TICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~-~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|...+......++++.   ...........+.+|. .+++.++||||+++++.+...+.+++||||+.++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            46777788877666554433333332   2222222333444554 4567889999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|.+++.....    +.+..++.++.|++.||.|||+.|++||||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~~~~~~~----~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~---~kl~DfG~a~~~~~~~----  150 (325)
T cd05602          82 ELFYHLQRERC----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHN----  150 (325)
T ss_pred             cHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEEccCCCCcccccCC----
Confidence            99888866443    788999999999999999999999999999999999987766   9999999986432211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|..||.+ +..++++.+..+...++
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  216 (325)
T cd05602         151 ---------GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK  216 (325)
T ss_pred             ---------CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC
Confidence                     011223478999999999998899999999999999999999999998 55677788877766654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.8e-35  Score=247.66  Aligned_cols=211  Identities=26%  Similarity=0.487  Sum_probs=165.2

Q ss_pred             hhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHH-HHHHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREAT-ICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|...+......++++   +...........+.+|.. +++.++||||+++++.+...+.+++||||+.++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05604           2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG   81 (325)
T ss_pred             ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence            4677777787766554443333333   222223334455666655 567789999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|..++.....    +++..+..++.||+.||.|||+.|++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~---~kL~DfG~~~~~~~~~----  150 (325)
T cd05604          82 ELFFHLQRERS----FPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH---VVLTDFGLCKEGIAQS----  150 (325)
T ss_pred             CHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEEeecCCcccCCCCC----
Confidence            99887765433    899999999999999999999999999999999999988776   9999999986432211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.. +..++.+.+..+...+++
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~  217 (325)
T cd05604         151 ---------DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRP  217 (325)
T ss_pred             ---------CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCC
Confidence                     011123478999999999998899999999999999999999999998 566788888887766553

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0594|consensus

Probab=100.00  E-value=3.3e-35  Score=236.40  Aligned_cols=204  Identities=25%  Similarity=0.386  Sum_probs=172.7

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccch--hHHHHHHHHHHHHHcCCCC-hhhhhheeecCC------e
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYT--TEADLKREATICHMLKHPH-VVELLETYSSEG------M   79 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~------~   79 (249)
                      .|...+.++.|.|+.+|..........+++++..+....  ......+|+.+++.++|+| |+++++++.+..      .
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            477788899999999999888888878888877776542  5667799999999999999 999999998766      7


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +++|+||+. .+|..++.........++...++.++.||+.|+.|||+.+|+||||||.|||++.++.   +||+|||++
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~---lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV---LKLADFGLA  167 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc---EeeeccchH
Confidence            999999996 5999999877643244788999999999999999999999999999999999988766   999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCCh
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGSR  229 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~~  229 (249)
                      +...-..             ........|..|.|||++.+. .++...|+||+||+++||++++..|.++.
T Consensus       168 ra~~ip~-------------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s  225 (323)
T KOG0594|consen  168 RAFSIPM-------------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS  225 (323)
T ss_pred             HHhcCCc-------------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence            7443211             112234578899999999886 57999999999999999999999999954

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=7.1e-35  Score=239.15  Aligned_cols=213  Identities=26%  Similarity=0.399  Sum_probs=164.1

Q ss_pred             hcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         16 INHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      ++.|.++.+|...+......++++   +.........+.+..|+.+++.++||||+++.+.+.....+++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            355667777765544333333333   22233334456788999999999999999999999999999999999999999


Q ss_pred             hHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCC
Q psy14626         93 CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG  172 (249)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  172 (249)
                      .+.+.........+++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||.+........     
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~~~~~~~~-----  152 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN---VRISDLGLAVELKDGQS-----  152 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCccceecCCCCc-----
Confidence            8877554433445899999999999999999999999999999999999987665   99999999866543221     


Q ss_pred             ccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh-----HHHHHHHHcCccccc
Q psy14626        173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR-----DRLFQSITKGKLHIL  244 (249)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~-----~~~~~~i~~g~~~~~  244 (249)
                              ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||....     .++...+..+...+|
T Consensus       153 --------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  221 (280)
T cd05608         153 --------KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP  221 (280)
T ss_pred             --------cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc
Confidence                    1112247889999999999889999999999999999999999998632     234445555544444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.3e-35  Score=242.08  Aligned_cols=210  Identities=26%  Similarity=0.430  Sum_probs=165.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      -.+|++.+.++.|.++.+|...+......++++..... .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            35788899999999999887765544444444322221 22334567899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++ +|.+++.....   .++...++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        84 ~~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~DfG~~~~~~~~  156 (288)
T cd07871          84 YLDS-DLKQYLDNCGN---LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVP  156 (288)
T ss_pred             CCCc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEECcCcceeeccCC
Confidence            9975 88887765432   3789999999999999999999999999999999999987766   999999998654332


Q ss_pred             CccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ..             ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+ +..+....+
T Consensus       157 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~  216 (288)
T cd07871         157 TK-------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI  216 (288)
T ss_pred             Cc-------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            11             1112346889999999865 5578999999999999999999999998 434444333

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1989|consensus

Probab=100.00  E-value=3.8e-36  Score=264.83  Aligned_cols=228  Identities=25%  Similarity=0.321  Sum_probs=186.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheee-c----C--Ce
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYS-S----E--GM   79 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~----~--~~   79 (249)
                      .+++|..+|..|+|+.+|.....-....++++.....+......+++|+++|+.|. |+|||.++++.. .    .  -.
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            37899999999999999987777666888888888888999999999999999995 999999999432 1    1  24


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      +++.||||.|+.|.+++..+....  |++.++++|+.+++.|+.+||.+.  +||||||-+|||+..++.   +||||||
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~---~KLCDFG  191 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN---YKLCDFG  191 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC---EEeCccc
Confidence            789999999999999998776654  999999999999999999999887  999999999999998887   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCCChHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI---EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQ  234 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~~~~~~  234 (249)
                      .+.-.........+..-.    ...-....|+.|.|||.+   .+.+.+.++|||+|||+||-||....||.....   -
T Consensus       192 Satt~~~~~~~~~e~~~v----e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---l  264 (738)
T KOG1989|consen  192 SATTKILSPTSAQEVNYV----EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---L  264 (738)
T ss_pred             ccccccCCCccHHHHHHH----HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---e
Confidence            985544332111100000    011112368999999987   477789999999999999999999999988532   2


Q ss_pred             HHHcCcccccccc
Q psy14626        235 SITKGKLHILGCT  247 (249)
Q Consensus       235 ~i~~g~~~~~~~~  247 (249)
                      +|.+|++.||+.+
T Consensus       265 aIlng~Y~~P~~p  277 (738)
T KOG1989|consen  265 AILNGNYSFPPFP  277 (738)
T ss_pred             eEEeccccCCCCc
Confidence            7999999999865

>KOG0604|consensus

Probab=100.00  E-value=1.2e-35  Score=233.50  Aligned_cols=183  Identities=33%  Similarity=0.565  Sum_probs=158.6

Q ss_pred             HHHHHHHHHHHHc-CCCChhhhhheeec----CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHH
Q psy14626         50 ADLKREATICHML-KHPHVVELLETYSS----EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY  124 (249)
Q Consensus        50 ~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~  124 (249)
                      ...++|+++-.+. .|||||.++++++.    ...+.+|||.++||.|...+..++..  .|++.++..|+.||..|+.|
T Consensus        99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~--afTErea~eI~~qI~~Av~~  176 (400)
T KOG0604|consen   99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQ--AFTEREASEIMKQIGLAVRY  176 (400)
T ss_pred             HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccc--cchHHHHHHHHHHHHHHHHH
Confidence            5567899887777 69999999999853    35688999999999999999887654  59999999999999999999


Q ss_pred             HHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCC
Q psy14626        125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGK  204 (249)
Q Consensus       125 LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  204 (249)
                      ||+.+|.||||||+|+|+.....+..+||+|||++.......              .......|++|.|||++...+++.
T Consensus       177 lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~--------------~L~TPc~TPyYvaPevlg~eKydk  242 (400)
T KOG0604|consen  177 LHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG--------------DLMTPCFTPYYVAPEVLGPEKYDK  242 (400)
T ss_pred             HHhcchhhccCChhheeeecCCCCcceEecccccccccCCCc--------------cccCCcccccccCHHHhCchhcCC
Confidence            999999999999999999988888889999999997765422              112234689999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCC-----hHHHHHHHHcCccccc-cccC
Q psy14626        205 PVDIWAAGVLLHVLLTGTLPFVGS-----RDRLFQSITKGKLHIL-GCTH  248 (249)
Q Consensus       205 ~~DiwslG~~l~el~~g~~pf~~~-----~~~~~~~i~~g~~~~~-~~~~  248 (249)
                      ++|+||+|+++|-|+-|.+||-++     ...+.-+|+.|.+.|| +.|+
T Consensus       243 scdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs  292 (400)
T KOG0604|consen  243 SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS  292 (400)
T ss_pred             CCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh
Confidence            999999999999999999999873     3578889999999999 6664

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.7e-35  Score=245.52  Aligned_cols=211  Identities=29%  Similarity=0.481  Sum_probs=166.9

Q ss_pred             hhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|..........++   +.+.........+.+.+|..+++.+ +||||+++++++.+.+.+++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46777777777665544333333   3333333445566788999999999 7999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|.+++.....    +++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~~~~~~~~~----  150 (329)
T cd05588          82 DLMFHMQRQRK----LPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGIRPG----  150 (329)
T ss_pred             CHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC---EEECcCccccccccCC----
Confidence            99888765433    899999999999999999999999999999999999987766   9999999885422111    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----------ChHHHHHHHHcCc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----------SRDRLFQSITKGK  240 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----------~~~~~~~~i~~g~  240 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||..          ..+.+.+.+..+.
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  221 (329)
T cd05588         151 ---------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ  221 (329)
T ss_pred             ---------CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC
Confidence                     011123478999999999998899999999999999999999999963          1234667777887


Q ss_pred             ccccc
Q psy14626        241 LHILG  245 (249)
Q Consensus       241 ~~~~~  245 (249)
                      +.+|.
T Consensus       222 ~~~p~  226 (329)
T cd05588         222 IRIPR  226 (329)
T ss_pred             CCCCC
Confidence            77774

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG1095|consensus

Probab=100.00  E-value=8.5e-36  Score=270.19  Aligned_cols=228  Identities=24%  Similarity=0.407  Sum_probs=187.3

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCc-----ccCC-hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPAS-----FGLP-DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .+..+...+++.|.|+.+|.....-..+.     ++++ .....+......|.+|+.+|+.++||||++++|++-+.+..
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            55777888999999999886654322221     2222 23455567788999999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhc---CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         81 YMVFEYMDGSDICFEIVRRATA---GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ++++|||.||+|..+|......   ...++..+++.++.++++|..||+++++|||||...|+|++...   ++||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r---~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR---VVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC---cEEEcccc
Confidence            9999999999999999876222   33489999999999999999999999999999999999998764   49999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHH-
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQ-  234 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~-  234 (249)
                      +|+.+.+...++.+.+           ...+..|||||.+....++.++|||||||++||+++ |..||.+ +..+++. 
T Consensus       848 lArDiy~~~yyr~~~~-----------a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~  916 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGE-----------AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD  916 (1025)
T ss_pred             hhHhhhhchheeccCc-----------cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH
Confidence            9997766555443321           246789999999999999999999999999999999 9999999 5556655 


Q ss_pred             HHHcCccccc-cccC
Q psy14626        235 SITKGKLHIL-GCTH  248 (249)
Q Consensus       235 ~i~~g~~~~~-~~~~  248 (249)
                      -...|++..| .||+
T Consensus       917 ~~~ggRL~~P~~CP~  931 (1025)
T KOG1095|consen  917 VLEGGRLDPPSYCPE  931 (1025)
T ss_pred             HHhCCccCCCCCCCh
Confidence            7778888888 5663

>KOG0580|consensus

Probab=100.00  E-value=7.3e-36  Score=227.79  Aligned_cols=217  Identities=26%  Similarity=0.452  Sum_probs=185.1

Q ss_pred             cchHHHhhcccceeeEeeec---cccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTS---AEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .+.++..++.|=|+.+|...   ..--++.+++.++.+.......++.+|+++-..|+||||++++++|.+...+|+++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            45566667766666666433   333455667778888888888999999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |.+.|++...|......  .+++.....++.|++.|+.|+|.++++||||||+|+|++.++.   ++++|||.+.....+
T Consensus       103 ya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~---lkiAdfGwsV~~p~~  177 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPSN  177 (281)
T ss_pred             ecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC---eeccCCCceeecCCC
Confidence            99999998888744432  3888899999999999999999999999999999999987777   999999998776532


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .               .....||..|.+||...+...+..+|+|++|++.||++.|.+||.. +.++.+++|.+-++.+|
T Consensus       178 k---------------R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p  242 (281)
T KOG0580|consen  178 K---------------RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP  242 (281)
T ss_pred             C---------------ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC
Confidence            2               1233589999999999999999999999999999999999999998 67789999999999998


Q ss_pred             c
Q psy14626        245 G  245 (249)
Q Consensus       245 ~  245 (249)
                      +
T Consensus       243 ~  243 (281)
T KOG0580|consen  243 S  243 (281)
T ss_pred             c
Confidence            4

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-35  Score=248.95  Aligned_cols=215  Identities=24%  Similarity=0.454  Sum_probs=172.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|.+.+.++.|.++.+|...+......++++   +.........+.+.+|+.+++.++||||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46788889999999998866655444444433   333333445677899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....   .+++..+..++.|++.||.+||+.+++||||||+||+++.++.   ++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~---~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH---IKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC---EEeccCCCCeECCC
Confidence            99999999998876522   3899999999999999999999999999999999999987766   99999999876544


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE------DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      ....            ......+++.|+|||++.      ...++.++|+||+||++|+|++|+.||.. +..+....+.
T Consensus       155 ~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~  222 (330)
T cd05601         155 NKMV------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM  222 (330)
T ss_pred             CCce------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHH
Confidence            2210            111224788999999986      44567899999999999999999999987 4555666666


Q ss_pred             cCc
Q psy14626        238 KGK  240 (249)
Q Consensus       238 ~g~  240 (249)
                      +..
T Consensus       223 ~~~  225 (330)
T cd05601         223 NFQ  225 (330)
T ss_pred             cCC
Confidence            543

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-35  Score=245.77  Aligned_cols=214  Identities=23%  Similarity=0.410  Sum_probs=169.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.++..........++++   +.........+.+.+|+.+++.++|+||+++++.+.+++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            36788889999999888866655444444433   222333345567889999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....   .+++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||.+.....
T Consensus        81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH---IRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC---EEEEECCceeecCC
Confidence            99999999998865322   3899999999999999999999999999999999999987666   99999999866543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ...            .......+++.|+|||++.+     ..++.++|+||+||++|+|++|+.||.+ +..+....+..
T Consensus       155 ~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05597         155 DGT------------VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (331)
T ss_pred             CCC------------ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc
Confidence            221            01111247899999999863     3467899999999999999999999987 44555666654


Q ss_pred             C
Q psy14626        239 G  239 (249)
Q Consensus       239 g  239 (249)
                      .
T Consensus       223 ~  223 (331)
T cd05597         223 H  223 (331)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4236|consensus

Probab=100.00  E-value=3.9e-36  Score=251.73  Aligned_cols=219  Identities=27%  Similarity=0.456  Sum_probs=187.8

Q ss_pred             chHHHhhcccceeeEeeeccc---cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626         10 ITIHEVINHKWLKMKLHTSAE---IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +-.+++++.|-++.+|..+.+   -+++++.+.+..+.. .+.+++++|+.+|+++.||.||.+...|++.+.+++|||-
T Consensus       566 if~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK  644 (888)
T KOG4236|consen  566 IFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK  644 (888)
T ss_pred             hhhHhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence            345789999999999966644   456667777777664 4558899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.|.-|.-.+.....   ++++...+.++.||+.||+|||.++|+|+||||+|||+.....-.++||+|||+++.++...
T Consensus       645 l~GDMLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  645 LHGDMLEMILSSEKG---RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             hcchHHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            977555544444433   39999999999999999999999999999999999999887766789999999999998754


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCChHHHHHHHHcCccccccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKLHILGC  246 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~~~~~~~i~~g~~~~~~~  246 (249)
                      .              ..+..||+.|.|||+++.+.|.++-|+||+|+++|--++|..||.. ++++-+.|++..+-+|+-
T Consensus       722 F--------------RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE-dEdIndQIQNAaFMyPp~  786 (888)
T KOG4236|consen  722 F--------------RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE-DEDINDQIQNAAFMYPPN  786 (888)
T ss_pred             h--------------hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC-ccchhHHhhccccccCCC
Confidence            3              2234799999999999999999999999999999999999999987 456899999999999976


Q ss_pred             c
Q psy14626        247 T  247 (249)
Q Consensus       247 ~  247 (249)
                      |
T Consensus       787 P  787 (888)
T KOG4236|consen  787 P  787 (888)
T ss_pred             c
Confidence            5

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=239.81  Aligned_cols=217  Identities=23%  Similarity=0.405  Sum_probs=170.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +|++.++++.|.++.+|..........++++   ............+.+|+.+++.++||||+++++.+.+++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4667788888988888766654333333333   2233333445667899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+++|.+.+.....  ..+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH---IRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC---EEEeeCCCceecCCC
Confidence            9999999887765432  23899999999999999999999999999999999999987665   999999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh-----HHHHHHHHcCc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR-----DRLFQSITKGK  240 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~-----~~~~~~i~~g~  240 (249)
                      ..              .....++..|+|||++.+..++.++|+||+|+++|+|++|+.||.+..     +++...+..+.
T Consensus       156 ~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  221 (285)
T cd05605         156 ET--------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ  221 (285)
T ss_pred             Cc--------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc
Confidence            21              112247889999999998888999999999999999999999999732     23445555555


Q ss_pred             cccc
Q psy14626        241 LHIL  244 (249)
Q Consensus       241 ~~~~  244 (249)
                      ..+|
T Consensus       222 ~~~~  225 (285)
T cd05605         222 EEYS  225 (285)
T ss_pred             cccC
Confidence            5544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6e-35  Score=244.88  Aligned_cols=211  Identities=30%  Similarity=0.473  Sum_probs=166.4

Q ss_pred             hhcccceeeEeeeccccCCCc---ccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPAS---FGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|..........   +.+.+.........+.+.+|+.++.++ +||||+++++++...+.+++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            467777787776654433333   333333334445566788999998887 8999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|..++.....    +++..++.++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~~~~~~~----l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~---~kL~DfG~~~~~~~~~----  150 (329)
T cd05618          82 DLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPG----  150 (329)
T ss_pred             CHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC---EEEeeCCccccccCCC----
Confidence            99887765433    899999999999999999999999999999999999987776   9999999986432211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----------ChHHHHHHHHcCc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----------SRDRLFQSITKGK  240 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----------~~~~~~~~i~~g~  240 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||..          ..+.+.+.+..+.
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~  221 (329)
T cd05618         151 ---------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ  221 (329)
T ss_pred             ---------CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC
Confidence                     011123578999999999998899999999999999999999999952          1234566777777


Q ss_pred             ccccc
Q psy14626        241 LHILG  245 (249)
Q Consensus       241 ~~~~~  245 (249)
                      ..+|.
T Consensus       222 ~~~p~  226 (329)
T cd05618         222 IRIPR  226 (329)
T ss_pred             CCCCC
Confidence            77774

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.7e-35  Score=239.84  Aligned_cols=201  Identities=27%  Similarity=0.484  Sum_probs=160.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++...++.|.++.+|...+......++++...  .......+.+.+|+.+++.++||||+++++++...+.+++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36888888999988888876665444444433222  1223445678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++++.+..... ..   ..+++..++.++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~l~~~~~-~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEE-MP---NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV---LKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHh-cC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEEeeccCccccccc
Confidence            999876654432 21   23899999999999999999999999999999999999987765   999999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..            .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+
T Consensus       154 ~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~  203 (287)
T cd07848         154 SN------------ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG  203 (287)
T ss_pred             cc------------ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence            11            011122478899999999988889999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-34  Score=243.31  Aligned_cols=205  Identities=24%  Similarity=0.367  Sum_probs=167.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .++|.+.+.++.|.++.++...+......++++..... .....+.+.+|+.+++.++||||+++++++..++.+++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            46788888999999888887666544444444333222 23445679999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |+++++|.+++.....    +++..+..++.|++.||.|||++ +++|+||||+||+++.++.   ++|+|||++.....
T Consensus        84 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~  156 (331)
T cd06649          84 HMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID  156 (331)
T ss_pred             cCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc---EEEccCcccccccc
Confidence            9999999998876443    88999999999999999999986 5999999999999987766   99999999865433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-hHHHH
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRLF  233 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~-~~~~~  233 (249)
                      ..               .....++..|+|||++.+..++.++|+||+||++|+|++|+.||... ..++.
T Consensus       157 ~~---------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~  211 (331)
T cd06649         157 SM---------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE  211 (331)
T ss_pred             cc---------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            11               11224789999999999888999999999999999999999999873 33443

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.4e-35  Score=246.63  Aligned_cols=215  Identities=23%  Similarity=0.410  Sum_probs=170.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.++..........++++   +...........+.+|..++..++|++|+++++.+.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36788889999999888876655444444433   222223344556888999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++.....   .+++..+..++.|++.||.+||+++++|+||||+||+++.++.   ++|+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH---IRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC---EEEEeccceeeccC
Confidence            99999999998876332   3889999999999999999999999999999999999987666   99999999876543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ...            .......+++.|+|||++.+     ..++.++|+||+|+++|+|++|+.||.. +..+....+..
T Consensus       155 ~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~  222 (331)
T cd05624         155 DGT------------VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (331)
T ss_pred             CCc------------eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc
Confidence            221            01112348899999999875     4568899999999999999999999987 45556666665


Q ss_pred             Cc
Q psy14626        239 GK  240 (249)
Q Consensus       239 g~  240 (249)
                      ..
T Consensus       223 ~~  224 (331)
T cd05624         223 HE  224 (331)
T ss_pred             CC
Confidence            43

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-35  Score=247.76  Aligned_cols=210  Identities=30%  Similarity=0.468  Sum_probs=166.7

Q ss_pred             hhcccceeeEeeecccc------CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccC
Q psy14626         15 VINHKWLKMKLHTSAEI------EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD   88 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (249)
                      .++.|.++.+|...+..      .++.+.+.+... .......+.+|+.++++++||||+++++.+..++.+++||||++
T Consensus         3 ~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             eeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            46677777777544321      122222222221 12344567889999999999999999999999999999999999


Q ss_pred             CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626         89 GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                      +++|.+++.....    +++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++........ 
T Consensus        82 ~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          82 GGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc---EEEeeccCCcccCCCCC-
Confidence            9999888865433    899999999999999999999999999999999999987766   99999999865433210 


Q ss_pred             ccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                                  ......+++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+ +..+....+.++...+|.
T Consensus       154 ------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~  219 (318)
T cd05582         154 ------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ  219 (318)
T ss_pred             ------------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence                        11123478899999999988889999999999999999999999998 566778888888877774

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.9e-35  Score=256.27  Aligned_cols=223  Identities=26%  Similarity=0.368  Sum_probs=179.3

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEG----   78 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   78 (249)
                      ...++|++.++++.|.++.+|...+......++++.....  +......+.+|+.++..++|+|++++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            4568999999999999999887765544444554433222  2345567889999999999999999988875332    


Q ss_pred             ----eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         79 ----MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        79 ----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                          .+++||||+++++|.+++..+......+++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~---vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL---VKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC---EEEE
Confidence                368999999999999998776655556899999999999999999999999999999999999987766   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLF  233 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~  233 (249)
                      |||+++.......           ........+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++.
T Consensus       186 DFGls~~~~~~~~-----------~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~  254 (496)
T PTZ00283        186 DFGFSKMYAATVS-----------DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM  254 (496)
T ss_pred             ecccCeecccccc-----------ccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999876543211           0111223588999999999998899999999999999999999999998 556677


Q ss_pred             HHHHcCcc
Q psy14626        234 QSITKGKL  241 (249)
Q Consensus       234 ~~i~~g~~  241 (249)
                      +.+..+..
T Consensus       255 ~~~~~~~~  262 (496)
T PTZ00283        255 HKTLAGRY  262 (496)
T ss_pred             HHHhcCCC
Confidence            77776654

>KOG0658|consensus

Probab=100.00  E-value=3.1e-36  Score=242.50  Aligned_cols=200  Identities=28%  Similarity=0.384  Sum_probs=161.6

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC---C--eEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSE---G--MLYM   82 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~--~~~l   82 (249)
                      -.|...++++.|-++.+|...-.......++++.-.+.    ..-.+|+++|+.++|||||++.-+|...   +  .+.+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            36788899999999999877665554555554433332    2234799999999999999999888432   2  3568


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||++. +|...+..-...+..++.-.++-+.+||+.||.|||+.||+||||||.|+|++.+..  .+||+|||.|..+
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg--~LKicDFGSAK~L  176 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTG--VLKICDFGSAKVL  176 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCC--eEEeccCCcceee
Confidence            9999986 898888865555566899999999999999999999999999999999999987643  3899999999888


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ......              .+=..|..|.|||.+.| ..|+.+.||||.||++.||+.|++.|.|.
T Consensus       177 ~~~epn--------------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~  229 (364)
T KOG0658|consen  177 VKGEPN--------------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD  229 (364)
T ss_pred             ccCCCc--------------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence            764421              11247889999999877 56899999999999999999999999993

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.9e-34  Score=235.97  Aligned_cols=218  Identities=28%  Similarity=0.374  Sum_probs=174.8

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +.+|+++|++...++.|.++.+|..........++++..........+.+.+|+.+++.++|||++++++.+..++.+++
T Consensus         7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644           7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            36789999999999999999998776665555555555445555667789999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|..++.....   .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.   ++|+|||.+...
T Consensus        87 v~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~dfg~~~~~  160 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDR---GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD---IKLADFGVSAKN  160 (292)
T ss_pred             EEecCCCCcHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC---EEEccCccceec
Confidence            9999999999777654332   3899999999999999999999999999999999999987665   999999987654


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      .....             ......++..|+|||.+.     ...++.++|+||+||++|+|++|..||.. +..+....+
T Consensus       161 ~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  227 (292)
T cd06644         161 VKTLQ-------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI  227 (292)
T ss_pred             ccccc-------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence            33210             111234678899999984     34467889999999999999999999987 444444444


Q ss_pred             HcC
Q psy14626        237 TKG  239 (249)
Q Consensus       237 ~~g  239 (249)
                      .++
T Consensus       228 ~~~  230 (292)
T cd06644         228 AKS  230 (292)
T ss_pred             hcC
Confidence            444

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=236.21  Aligned_cols=218  Identities=28%  Similarity=0.391  Sum_probs=177.2

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+|.++|++.+.++.|.++.+|..........++++..........+.+.+|+.++++++|||++++++.+..+..+++|
T Consensus         1 ~~~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             CCchhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            37899999999999999998887766544445555544455556677899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++.....   .+++.++..++.|++.++.+||+++++|+||+|+||+++.++.   ++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~---~~l~d~g~~~~~~  154 (280)
T cd06611          81 IEFCDGGALDSIMLELER---GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD---VKLADFGVSAKNK  154 (280)
T ss_pred             eeccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC---EEEccCccchhhc
Confidence            999999999888765432   3899999999999999999999999999999999999987766   9999999875543


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      ....             ......++..|+|||.+.     +..++.++|+||+|+++|+|++|+.||.. +..+....+.
T Consensus       155 ~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~  221 (280)
T cd06611         155 STLQ-------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL  221 (280)
T ss_pred             cccc-------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh
Confidence            3211             111234788899999975     34467789999999999999999999987 4445555666


Q ss_pred             cCc
Q psy14626        238 KGK  240 (249)
Q Consensus       238 ~g~  240 (249)
                      ++.
T Consensus       222 ~~~  224 (280)
T cd06611         222 KSE  224 (280)
T ss_pred             cCC
Confidence            654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-34  Score=240.63  Aligned_cols=202  Identities=24%  Similarity=0.399  Sum_probs=162.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ...+|.+.+.++.|.++.+|...+......++++...... ......+.+|+.+++.++||||+++++++.++...++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            4578999999999999999877766554444544332221 223456788999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+. ++|.+++.....   .+++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||.+.....
T Consensus        83 e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~~  155 (303)
T cd07869          83 EYVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGLARAKSV  155 (303)
T ss_pred             ECCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECCCCcceeccC
Confidence            9996 477777655432   3789999999999999999999999999999999999987666   99999999865432


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...             ......+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+
T Consensus       156 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  206 (303)
T cd07869         156 PSH-------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             CCc-------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            110             1112346889999999865 4478899999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.3e-35  Score=245.54  Aligned_cols=215  Identities=23%  Similarity=0.419  Sum_probs=169.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +.|++.+.++.|.++.++..........++++   +...........+.+|+.++..++|++|+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            35778888999999888866655443334333   222223344556889999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....   .+++..++.++.|++.||.+||+.+++||||||+||+++.++.   ++|+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~---~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC---EEEeecchheeccc
Confidence            99999999999875432   3899999999999999999999999999999999999987666   99999999865432


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ...            .......+++.|+|||++.     ...++.++|+||+||++|||++|+.||.+ +..+....+.+
T Consensus       155 ~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~  222 (332)
T cd05623         155 DGT------------VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN  222 (332)
T ss_pred             CCc------------ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC
Confidence            211            0111235899999999986     24578899999999999999999999988 55566777766


Q ss_pred             Cc
Q psy14626        239 GK  240 (249)
Q Consensus       239 g~  240 (249)
                      ..
T Consensus       223 ~~  224 (332)
T cd05623         223 HK  224 (332)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0986|consensus

Probab=100.00  E-value=1.7e-35  Score=243.79  Aligned_cols=219  Identities=23%  Similarity=0.433  Sum_probs=188.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+.++...+++-|+++.++........+-|+   +.+..++.........+|-.+|.+++.+.||.+--.|++.+.+|+|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            3456777788889999888887776666655   4455666667777889999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +..|.||+|...|...+..+  |++..++.++.+|+.||++||..+||+|||||+|||+++.++   ++|+|+|++..+.
T Consensus       264 LtlMNGGDLkfHiyn~g~~g--F~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh---vRISDLGLAvei~  338 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGNPG--FDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH---VRISDLGLAVEIP  338 (591)
T ss_pred             EEeecCCceeEEeeccCCCC--CchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC---eEeeccceEEecC
Confidence            99999999998888776533  899999999999999999999999999999999999999888   9999999998887


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----hHHHHHHHHc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-----RDRLFQSITK  238 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~-----~~~~~~~i~~  238 (249)
                      ....              ...+.||.+|||||++.+..|+.+.|.|||||++|||+.|+.||...     .+++-.++.+
T Consensus       339 ~g~~--------------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~  404 (591)
T KOG0986|consen  339 EGKP--------------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLE  404 (591)
T ss_pred             CCCc--------------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhc
Confidence            6442              22236999999999999999999999999999999999999999972     3467777777


Q ss_pred             Cccccc
Q psy14626        239 GKLHIL  244 (249)
Q Consensus       239 g~~~~~  244 (249)
                      -..++|
T Consensus       405 ~~~ey~  410 (591)
T KOG0986|consen  405 DPEEYS  410 (591)
T ss_pred             chhhcc
Confidence            766666

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-34  Score=237.88  Aligned_cols=216  Identities=27%  Similarity=0.517  Sum_probs=177.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.+|..........++++   ..........+.+.+|+.++++++||||+++++++..++.+++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36788888999888888766554333333332   223333455677899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....    ++...+..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~~----l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~---~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKSGR----FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY---IKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC---EEEeeCCCccccCC
Confidence            99999999998876543    899999999999999999999999999999999999987766   99999999866543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..                ....+++.|+|||.+.+...+.++|+||||+++++|++|+.||.. +...+.+.+..+.+.+
T Consensus       154 ~~----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  217 (290)
T cd05580         154 RT----------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRF  217 (290)
T ss_pred             CC----------------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccC
Confidence            21                112468899999999888888999999999999999999999987 5556777888888877


Q ss_pred             ccc
Q psy14626        244 LGC  246 (249)
Q Consensus       244 ~~~  246 (249)
                      |..
T Consensus       218 ~~~  220 (290)
T cd05580         218 PSF  220 (290)
T ss_pred             Ccc
Confidence            743

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG1187|consensus

Probab=100.00  E-value=2.8e-35  Score=247.60  Aligned_cols=199  Identities=25%  Similarity=0.309  Sum_probs=158.9

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-eEEEEEecc
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-MLYMVFEYM   87 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~   87 (249)
                      .+....+++.|.++.+|...-.-. ...+++...........+|.+|+.++.+++|||+++++|+|.+.+ ..++|+||+
T Consensus        76 ~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym  154 (361)
T KOG1187|consen   76 NFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYM  154 (361)
T ss_pred             CCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEcc
Confidence            455567888888888885544432 233333222221110455999999999999999999999999888 599999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC---ceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND---IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ++|+|.+.+......  .++|..+++|+.+++.||.|||...   ++||||||+|||++.+..   +||+|||++.....
T Consensus       155 ~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~---aKlsDFGLa~~~~~  229 (361)
T KOG1187|consen  155 PNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN---AKLSDFGLAKLGPE  229 (361)
T ss_pred             CCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC---EEccCccCcccCCc
Confidence            999999999876543  5899999999999999999999754   999999999999987766   89999999955432


Q ss_pred             -CCccccCCccccccccccCCc-ccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 -GQLYCSGGERLDHYTTKAGHR-IGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 -~~~~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                       ..              ..... .||.+|++||+......+.++||||+|++|.|+++|+.|...
T Consensus       230 ~~~--------------~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~  280 (361)
T KOG1187|consen  230 GDT--------------SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ  280 (361)
T ss_pred             ccc--------------ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence             11              11111 589999999999988889999999999999999999988775

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-34  Score=242.36  Aligned_cols=211  Identities=28%  Similarity=0.452  Sum_probs=166.2

Q ss_pred             hhcccceeeEeeeccccCCCc---ccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPAS---FGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.++..........   +.+.+.........+.+.+|+.++.++ +||+|+++++.+...+.+++||||++++
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            466777777776554433333   333333333445567788999999988 6999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|..++.....    +++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.......    
T Consensus        82 ~L~~~~~~~~~----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg~~~~~~~~~----  150 (327)
T cd05617          82 DLMFHMQRQRK----LPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH---IKLTDYGMCKEGLGPG----  150 (327)
T ss_pred             cHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC---EEEeccccceeccCCC----
Confidence            99888765433    899999999999999999999999999999999999988776   9999999986432211    


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--------ChHHHHHHHHcCccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--------SRDRLFQSITKGKLH  242 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~--------~~~~~~~~i~~g~~~  242 (249)
                               .......+++.|+|||++.+..++.++|+||+||++|+|++|..||..        ..+.+.+.+..+...
T Consensus       151 ---------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  221 (327)
T cd05617         151 ---------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR  221 (327)
T ss_pred             ---------CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC
Confidence                     011123478999999999998899999999999999999999999963        123466667777666


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       222 ~p~  224 (327)
T cd05617         222 IPR  224 (327)
T ss_pred             CCC
Confidence            664

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7e-35  Score=244.74  Aligned_cols=217  Identities=24%  Similarity=0.386  Sum_probs=168.5

Q ss_pred             chHHHhhcccceeeEeeecccc---C---CCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEE
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEI---E---PASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLY   81 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (249)
                      |++.+.++.|.++.+|...+..   .   ++.+.+.+.. .......+.+.+|+.+++.+ +||+|+++++.+...+.++
T Consensus         2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (332)
T cd05614           2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH   81 (332)
T ss_pred             ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence            6677888999998888554321   1   2222222222 22234456788999999999 5999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+.+++|.+++..+..    +++.+++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++..
T Consensus        82 lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~---~kl~DfG~~~~  154 (332)
T cd05614          82 LILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH---VVLTDFGLSKE  154 (332)
T ss_pred             EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC---EEEeeCcCCcc
Confidence            99999999999988876543    899999999999999999999999999999999999987766   99999999865


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC-----ChHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG-----SRDRLFQS  235 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~-----~~~~~~~~  235 (249)
                      ......            .......+++.|+|||++.+.. ++.++|+||+||++|+|++|+.||..     ....+...
T Consensus       155 ~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  222 (332)
T cd05614         155 FLSEEK------------ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR  222 (332)
T ss_pred             ccccCC------------CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH
Confidence            432111            0111234789999999998654 68899999999999999999999974     23456667


Q ss_pred             HHcCcccccc
Q psy14626        236 ITKGKLHILG  245 (249)
Q Consensus       236 i~~g~~~~~~  245 (249)
                      +.+..+.+|.
T Consensus       223 ~~~~~~~~~~  232 (332)
T cd05614         223 ILKCDPPFPS  232 (332)
T ss_pred             HhcCCCCCCC
Confidence            7777766664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.1e-34  Score=233.63  Aligned_cols=224  Identities=21%  Similarity=0.353  Sum_probs=175.7

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-----CCCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ..+|.+.+.++.|.++.+|......     ....++++...... ....+.+.+|+++++.++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            4578999999999888887654321     11222222222111 22457899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhh----------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCC
Q psy14626         81 YMVFEYMDGSDICFEIVRRAT----------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP  150 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~  150 (249)
                      ++||||+++++|.+++.....          ....+++.++..++.|++.++.+||+++++|+||||+||+++.++.   
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~---  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV---  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe---
Confidence            999999999999999876532          2234788999999999999999999999999999999999987766   


Q ss_pred             eEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-C
Q psy14626        151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-S  228 (249)
Q Consensus       151 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~  228 (249)
                      ++|+|||.+.........           .......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+ +
T Consensus       161 ~kl~d~g~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~  229 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYY-----------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS  229 (280)
T ss_pred             EEECCcccceecccCcce-----------ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999998654332110           11112235678999999998889999999999999999998 9999987 6


Q ss_pred             hHHHHHHHHcCccccc
Q psy14626        229 RDRLFQSITKGKLHIL  244 (249)
Q Consensus       229 ~~~~~~~i~~g~~~~~  244 (249)
                      .+++.+.+.+|.+..+
T Consensus       230 ~~~~~~~~~~~~~~~~  245 (280)
T cd05049         230 NEEVIECITQGRLLQR  245 (280)
T ss_pred             HHHHHHHHHcCCcCCC
Confidence            6778888888876543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-34  Score=238.57  Aligned_cols=204  Identities=28%  Similarity=0.484  Sum_probs=170.2

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      -|+.++|++.+.++.|.++.+|...+......++++..........+.+.+|+.+++.++|||++++++.+..+...++|
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv   95 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence            47889999999999999988887765544445555544445455667899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++...     .++..++..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+....
T Consensus        96 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~---~kl~dfg~~~~~~  167 (296)
T cd06654          96 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQIT  167 (296)
T ss_pred             ecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC---EEECccccchhcc
Confidence            9999999999887542     2789999999999999999999999999999999999987665   9999999876543


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ....             ......+++.|+|||.+.+..++.++|+||+||++++|++|+.||...
T Consensus       168 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~  219 (296)
T cd06654         168 PEQS-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (296)
T ss_pred             cccc-------------ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence            2110             111224788999999998888899999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0660|consensus

Probab=100.00  E-value=1.2e-34  Score=232.93  Aligned_cols=204  Identities=25%  Similarity=0.438  Sum_probs=170.0

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeec-----CC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSS-----EG   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~   78 (249)
                      ...+|...+.++.|-++++-...+......+++++..  +.+....++..+|+.+|+.++|+||+.+.+++..     -.
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            3456666788899999988777777777778887777  7778888999999999999999999999999965     24


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+|+|+|+| +.+|...+..+..    ++...+..++.|++.||+|+|+.+++||||||+|++++.+..   +||+|||+
T Consensus       100 DvYiV~elM-etDL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~---lKI~DFGL  171 (359)
T KOG0660|consen  100 DVYLVFELM-ETDLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD---LKICDFGL  171 (359)
T ss_pred             eeEEehhHH-hhHHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC---EEeccccc
Confidence            589999999 5688888876554    899999999999999999999999999999999999987665   89999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ++.....    .....+..+       ..|..|.|||.+. ...++.+.||||+||+++||++|++.|.|.
T Consensus       172 AR~~~~~----~~~~~mTeY-------VaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~  231 (359)
T KOG0660|consen  172 ARYLDKF----FEDGFMTEY-------VATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGK  231 (359)
T ss_pred             eeecccc----Ccccchhcc-------eeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCC
Confidence            9888653    111111111       3578899999965 567899999999999999999999999983

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.7e-34  Score=234.20  Aligned_cols=221  Identities=22%  Similarity=0.392  Sum_probs=173.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccc-----cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      ++.|.+...++.|.++.+|.....     .....++++..........+.+.+|+.++++++||||+++++++..++.++
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356788889999888888765421     111222222222233345667999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhh---------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         82 MVFEYMDGSDICFEIVRRAT---------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      +||||+++++|.+++.....         ....+++.+++.++.|++.||.+||++|++|+||||+||+++.++.   ++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~---~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL---VK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc---EE
Confidence            99999999999998875432         2234899999999999999999999999999999999999987766   99


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChH
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRD  230 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~  230 (249)
                      |+|||.+.........           .......++..|+|||.+.+..++.++|+||||+++++|++ |..||.. ...
T Consensus       161 l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~  229 (288)
T cd05093         161 IGDFGMSRDVYSTDYY-----------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN  229 (288)
T ss_pred             eccCCccccccCCcee-----------ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999998655432210           01111224678999999998888999999999999999998 9999988 566


Q ss_pred             HHHHHHHcCcc
Q psy14626        231 RLFQSITKGKL  241 (249)
Q Consensus       231 ~~~~~i~~g~~  241 (249)
                      ++...+.++..
T Consensus       230 ~~~~~i~~~~~  240 (288)
T cd05093         230 EVIECITQGRV  240 (288)
T ss_pred             HHHHHHHcCCc
Confidence            67788888764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=5.6e-34  Score=231.55  Aligned_cols=212  Identities=21%  Similarity=0.341  Sum_probs=166.5

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      |++...+++|.++.++..........++++... .+....+.+.+|+.+++.++||||+++++++...+.++++|||+++
T Consensus         8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (263)
T cd05052           8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY   86 (263)
T ss_pred             eEEeeecCCcccceEEEEEEecCCceEEEEEec-CCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence            777778888877777655443222233332222 2234456789999999999999999999999999999999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++.....  ..++...++.++.|++.+|.+||+++++|+||||+||+++.++.   ++|+|||.+........  
T Consensus        87 ~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~df~~~~~~~~~~~--  159 (263)
T cd05052          87 GNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTY--  159 (263)
T ss_pred             CcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc---EEeCCCcccccccccee--
Confidence            999998865432  23789999999999999999999999999999999999987665   99999999866544221  


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                                +.......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.+ +.++..+.+.++
T Consensus       160 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  221 (263)
T cd05052         160 ----------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG  221 (263)
T ss_pred             ----------eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence                      01111123567999999998889999999999999999998 9999988 556677777664

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.2e-34  Score=232.65  Aligned_cols=207  Identities=25%  Similarity=0.342  Sum_probs=168.6

Q ss_pred             CCcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          1 MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ++..++.+.|++...++.|.++.+|..........++++..........+.+.+|+.++++++||||+++++++...+.+
T Consensus         2 ~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~   81 (267)
T cd06646           2 ILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL   81 (267)
T ss_pred             ccccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence            35678899999999999999888887665444444444433333334556788999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+++++|.+++.....    +++.++..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||.+.
T Consensus        82 ~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~---~~l~dfg~~~  154 (267)
T cd06646          82 WICMEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD---VKLADFGVAA  154 (267)
T ss_pred             EEEEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC---EEECcCccce
Confidence            999999999999888765432    799999999999999999999999999999999999987666   9999999987


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .......             ......++..|+|||.+.   ...++.++|+||+|+++++|++|+.||..
T Consensus       155 ~~~~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~  211 (267)
T cd06646         155 KITATIA-------------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             eeccccc-------------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence            6543210             111224678999999874   34467899999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.7e-34  Score=239.86  Aligned_cols=201  Identities=24%  Similarity=0.384  Sum_probs=165.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ..+|++.+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||++++++|.+++.+++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            46899999999999999887666544333333322221 23445679999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |+++++|.+++.....    +++..+..++.|++.||.|||+. +++|+||||+||+++.++.   ++|+|||++.....
T Consensus        84 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~~~~~~~  156 (333)
T cd06650          84 HMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID  156 (333)
T ss_pred             cCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC---EEEeeCCcchhhhh
Confidence            9999999998876443    78999999999999999999975 7999999999999987665   99999998754432


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR  229 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~  229 (249)
                      ..               .....++..|+|||++.+..++.++|+||+||++|+|++|+.||....
T Consensus       157 ~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~  206 (333)
T cd06650         157 SM---------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD  206 (333)
T ss_pred             hc---------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence            11               111247889999999998888999999999999999999999998743

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.8e-34  Score=232.68  Aligned_cols=217  Identities=25%  Similarity=0.368  Sum_probs=171.2

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .|.+-|++...++.|.++.+|..........++++..........+.+.+|+.+++.++|||++++++.+..++..++|+
T Consensus         2 ~~~~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~   81 (282)
T cd06643           2 NPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   81 (282)
T ss_pred             CHHHHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence            45566888899999988888876665444444444444444456678899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|...+....   ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++++|||.+.....
T Consensus        82 e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~---~kl~dfg~~~~~~~  155 (282)
T cd06643          82 EFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTR  155 (282)
T ss_pred             EecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC---EEEccccccccccc
Confidence            9999999987765422   23899999999999999999999999999999999999987766   99999999865433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ..             .......++..|+|||++.     +..++.++|+||+||++|+|++|+.||.. +..+....+.+
T Consensus       156 ~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~  222 (282)
T cd06643         156 TI-------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK  222 (282)
T ss_pred             cc-------------cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh
Confidence            21             1112234788999999974     34567899999999999999999999987 44444445544


Q ss_pred             Cc
Q psy14626        239 GK  240 (249)
Q Consensus       239 g~  240 (249)
                      +.
T Consensus       223 ~~  224 (282)
T cd06643         223 SE  224 (282)
T ss_pred             cC
Confidence            43

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.6e-34  Score=230.54  Aligned_cols=203  Identities=25%  Similarity=0.347  Sum_probs=167.1

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+..+|++.+.++.|.++.+|...+......++++............+.+|+.+++.++||||+++++.+...+.+++||
T Consensus         6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            45678999999999999988876655444455554444443445567889999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....    +++.+++.++.|++.|+.+||+.|++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        86 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---~~l~dfg~~~~~~~  158 (267)
T cd06645          86 EFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH---VKLADFGVSAQITA  158 (267)
T ss_pred             eccCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECcceeeeEccC
Confidence            99999999998865443    899999999999999999999999999999999999987666   99999999866543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...             ......++..|+|||.+.   ...++.++|+||+||++|+|++|..||..
T Consensus       159 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~  211 (267)
T cd06645         159 TIA-------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             ccc-------------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence            211             112234788999999974   44578899999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=4.3e-34  Score=237.09  Aligned_cols=216  Identities=22%  Similarity=0.332  Sum_probs=165.2

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccC----------------CCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChh
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIE----------------PASFGLPDERL-NHYTTEADLKREATICHMLKHPHVV   68 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~   68 (249)
                      |..+|++.+.++.|.++.+|.......                ...++++.... ........+.+|+.++.+++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            567899999999999999886543211                11122221111 1233456799999999999999999


Q ss_pred             hhhheeecCCeEEEEEeccCCCchhHHHHHhhhc---------------CCccCHHHHHHHHHHHHHHHHHHHHCCceee
Q psy14626         69 ELLETYSSEGMLYMVFEYMDGSDICFEIVRRATA---------------GFVYSEAVASHYMRQVLEALRYCHENDIIHR  133 (249)
Q Consensus        69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~  133 (249)
                      ++++++.+.+..++||||+.+++|.+++......               ...++..++..++.|++.||.+||+.|++|+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            9999999989999999999999999988654211               1236778899999999999999999999999


Q ss_pred             cCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHH
Q psy14626        134 DIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGV  213 (249)
Q Consensus       134 dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  213 (249)
                      ||||+||+++.++.   ++|+|||.+.........           .......++..|+|||++.+..++.++|+||||+
T Consensus       163 dlkp~Nill~~~~~---~kl~DfG~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~  228 (304)
T cd05096         163 DLATRNCLVGENLT---IKIADFGMSRNLYAGDYY-----------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV  228 (304)
T ss_pred             CcchhheEEcCCcc---EEECCCccceecccCcee-----------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence            99999999987665   999999998765432211           1111223567899999998888999999999999


Q ss_pred             HHHHHHh--CCCCCCC-ChHHHHHH
Q psy14626        214 LLHVLLT--GTLPFVG-SRDRLFQS  235 (249)
Q Consensus       214 ~l~el~~--g~~pf~~-~~~~~~~~  235 (249)
                      ++|+|++  +..||.. +.+++.+.
T Consensus       229 ~l~el~~~~~~~p~~~~~~~~~~~~  253 (304)
T cd05096         229 TLWEILMLCKEQPYGELTDEQVIEN  253 (304)
T ss_pred             HHHHHHHccCCCCCCcCCHHHHHHH
Confidence            9999987  6678887 44444433

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.3e-34  Score=233.41  Aligned_cols=216  Identities=16%  Similarity=0.274  Sum_probs=167.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC---CCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +++|++.++++.|.++.++.......   ...++++.... ........+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            35788999999999888876533211   11222221111 223445678999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|.+++.....   .+++.+++.++.|++.||.+||+++++|+||||+||+++.++.   ++++|||.+...
T Consensus        84 v~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~---~~l~dfg~~~~~  157 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEG---QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV---CKISGFRRLQED  157 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc---EEECCCcccccc
Confidence            9999999999988865432   3889999999999999999999999999999999999987665   899999976443


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....            .......++..|+|||.+.+..++.++|+||+||++||+++ |..||.. +..++.+.+.++.
T Consensus       158 ~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~  225 (266)
T cd05064         158 KSEAI------------YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF  225 (266)
T ss_pred             cccch------------hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC
Confidence            22110            00111224568999999998889999999999999999876 9999988 5556777777663

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-34  Score=243.55  Aligned_cols=210  Identities=25%  Similarity=0.453  Sum_probs=162.7

Q ss_pred             hcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHc---CCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         16 INHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHML---KHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      ++.|.++.+|...+......++++   +...........+.+|..++...   +||||+++++.+.....+++||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            355667777765554333333332   32222233344556677777665   699999999999999999999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+.+.....    +++..++.++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.......   
T Consensus        81 g~L~~~l~~~~~----~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~---~kl~Dfg~a~~~~~~~---  150 (330)
T cd05586          81 GELFWHLQKEGR----FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH---IALCDFGLSKANLTDN---  150 (330)
T ss_pred             ChHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC---EEEecCCcCcCCCCCC---
Confidence            999888765443    899999999999999999999999999999999999987766   9999999985432211   


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                                .......+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+ +..++...+..+...+|.
T Consensus       151 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  218 (330)
T cd05586         151 ----------KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK  218 (330)
T ss_pred             ----------CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence                      111223478999999998764 478999999999999999999999988 567788888888877763

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-34  Score=229.89  Aligned_cols=215  Identities=27%  Similarity=0.353  Sum_probs=172.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      |.++|.+.+.++.|.++.++..........++++..........+.+.+|+.++++++||||+++++.+..+..++++||
T Consensus         1 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           1 PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             CccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            67889999999999888888766554444444444444444567889999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....   .+++.++..++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~  154 (262)
T cd06613          81 YCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD---VKLADFGVSAQLTAT  154 (262)
T ss_pred             CCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC---EEECccccchhhhhh
Confidence            9999999888766422   2899999999999999999999999999999999999987766   999999998654432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ---KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ..             ......++..|+|||.+.+.   .++.++|+||+|+++++|++|..||.. +..+....+...
T Consensus       155 ~~-------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~  219 (262)
T cd06613         155 IA-------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKS  219 (262)
T ss_pred             hh-------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            10             11122467789999998776   778899999999999999999999987 333333344443

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-34  Score=241.39  Aligned_cols=201  Identities=26%  Similarity=0.439  Sum_probs=157.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC-----CeEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE-----GMLY   81 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~   81 (249)
                      ||++.++++.|.++.+|...+......++++...  .........+.+|+.+++.++||||+++++++...     ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            6888889999998888876655444444443222  22234456789999999999999999999988533     3589


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+. ++|.+.+.....    +++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||.+..
T Consensus        81 lv~e~~~-~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK---LKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhccc----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---EEEccCccccc
Confidence            9999995 588887765433    899999999999999999999999999999999999987766   99999999865


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ........          .......++..|+|||++.+  ..++.++|+||+||++|+|++|+.||.+
T Consensus       153 ~~~~~~~~----------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         153 AFNDTPTA----------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             cccccCcc----------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence            43211100          01112347899999999875  5678999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.4e-34  Score=234.92  Aligned_cols=202  Identities=30%  Similarity=0.505  Sum_probs=168.0

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +++++|++...++.|.++.+|...+......++++..........+.+.+|+.+++.++|||++++++.+..+..+++|+
T Consensus        16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            37889999999999998888866544444444444444444455678899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|..++...     .+++.++..++.|++.++.+||+.|++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~---~kl~dfg~~~~~~~  167 (296)
T cd06655          96 EYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS---VKLTDFGFCAQITP  167 (296)
T ss_pred             EecCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEccCccchhccc
Confidence            999999998877543     2799999999999999999999999999999999999987665   99999998765433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...             ......++..|+|||.+.+..++.++|+||+||++|+|++|..||..
T Consensus       168 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~  217 (296)
T cd06655         168 EQS-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (296)
T ss_pred             ccc-------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            210             11122467899999999988889999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.4e-33  Score=231.03  Aligned_cols=207  Identities=26%  Similarity=0.427  Sum_probs=159.3

Q ss_pred             cccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchh
Q psy14626         17 NHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC   93 (249)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (249)
                      +.|.++.+|..........++++   ............+..|+++++.++||||+++++.+..+..+++||||++|++|.
T Consensus         2 g~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~   81 (277)
T cd05607           2 GKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLK   81 (277)
T ss_pred             CCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHH
Confidence            45666677655544333333332   223333334456677999999999999999999999999999999999999998


Q ss_pred             HHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626         94 FEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                      +.+......  .++...+..++.|++.||.+||+.|++|+||||+||+++.++.   ++|+|||.+........      
T Consensus        82 ~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~---~~l~Dfg~~~~~~~~~~------  150 (277)
T cd05607          82 YHIYNVGER--GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN---CRLSDLGLAVELKDGKT------  150 (277)
T ss_pred             HHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC---EEEeeceeeeecCCCce------
Confidence            877654332  3788999999999999999999999999999999999987665   99999999876543221      


Q ss_pred             cccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----hHHHHHHHHcCccc
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-----RDRLFQSITKGKLH  242 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~-----~~~~~~~i~~g~~~  242 (249)
                              .....++..|+|||++.+..++.++|+||+||++|+|++|+.||...     ..++...+..+...
T Consensus       151 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  216 (277)
T cd05607         151 --------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK  216 (277)
T ss_pred             --------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc
Confidence                    01124788999999998888999999999999999999999999862     23344445444443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.7e-34  Score=243.32  Aligned_cols=207  Identities=22%  Similarity=0.357  Sum_probs=161.3

Q ss_pred             CCcchHHHhhcccceeeEeeecc-----ccCCCcccCChhccc-cchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSA-----EIEPASFGLPDERLN-HYTTEADLKREATICHML-KHPHVVELLETYSSEGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   79 (249)
                      .++|.+.++++.|.++.+|...+     ......++++..... .....+.+.+|+.+++.+ +|+||++++++|..++.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            45789999999999888875432     111112333322221 223456789999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhh----------------------------------------------------------
Q psy14626         80 LYMVFEYMDGSDICFEIVRRAT----------------------------------------------------------  101 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  101 (249)
                      +++||||+++++|.+++.....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999998865321                                                          


Q ss_pred             --------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626        102 --------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus       102 --------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                              ....++..+++.++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++.........     
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~---~kL~DfGla~~~~~~~~~-----  268 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRV---AKICDFGLARDIMNDSNY-----  268 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCe---EEEeeceeeeeccCCcce-----
Confidence                    0123788899999999999999999999999999999999987655   999999998665432110     


Q ss_pred             cccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG  227 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~  227 (249)
                            .......++..|+|||++.+..++.++|+||+||++|+|++ |+.||..
T Consensus       269 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~  317 (374)
T cd05106         269 ------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG  317 (374)
T ss_pred             ------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence                  11111224567999999988889999999999999999997 9999987

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=5.9e-34  Score=234.07  Aligned_cols=206  Identities=13%  Similarity=0.143  Sum_probs=157.2

Q ss_pred             hcccceeeEeeeccc-cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec----CCeEEEEEeccCCC
Q psy14626         16 INHKWLKMKLHTSAE-IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS----EGMLYMVFEYMDGS   90 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~   90 (249)
                      ++.|..+.++..... ..++.+.+...........+.+.+|+.+|++++||||+++++++.+    ...+++||||+++|
T Consensus        28 i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g  107 (283)
T PHA02988         28 IKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRG  107 (283)
T ss_pred             EeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCC
Confidence            344444444433332 2233333333222222335778899999999999999999999866    35689999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      +|.+++.....    +++.....++.+++.|+.+||+ .+++|+||||+||+++.++.   ++++|||++.......   
T Consensus       108 ~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~---~kl~dfg~~~~~~~~~---  177 (283)
T PHA02988        108 YLREVLDKEKD----LSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK---LKIICHGLEKILSSPP---  177 (283)
T ss_pred             cHHHHHhhCCC----CChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc---EEEcccchHhhhcccc---
Confidence            99999876533    7889999999999999999998 48999999999999988766   9999999986543311   


Q ss_pred             cCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC--ccccc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG--KLHIL  244 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g--~~~~~  244 (249)
                                   ....++..|+|||.+.+  ..++.++|+|||||++|||++|+.||.+ +..++...+.++  ++.+|
T Consensus       178 -------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  244 (283)
T PHA02988        178 -------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP  244 (283)
T ss_pred             -------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence                         11246889999999976  6789999999999999999999999998 556677777544  34444

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-34  Score=245.30  Aligned_cols=194  Identities=25%  Similarity=0.352  Sum_probs=159.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      .+|++.+.++.|.++.+|...+......++++..      ....+.+|+.+++.++||||++++++|......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAG------QRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEech------hhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            4788999999999999887776655555555432      2345789999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      . ++|..++.....    ++..+++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++........
T Consensus       166 ~-~~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~---vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        166 K-TDLYCYLAAKRN----IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAACFPVDINA  237 (391)
T ss_pred             C-CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC---EEEEeCCcccccccccc
Confidence            5 588777765433    889999999999999999999999999999999999987766   99999999854322110


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                  .......+|+.|+|||++.+..++.++|+||+||++|+|++|+.||-.
T Consensus       238 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        238 ------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence                        011123589999999999988899999999999999999999987653

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1e-33  Score=241.36  Aligned_cols=219  Identities=21%  Similarity=0.365  Sum_probs=167.6

Q ss_pred             CCcchHHHhhcccceeeEeeecc-----ccCCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSA-----EIEPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   79 (249)
                      ..+|++.+.++.|.++.+|....     ......++++... .......+.+.+|+.+++.+ +||||++++++|..++.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            34799999999999998876532     1111122222211 11234456789999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhh----------------------------------------------------------
Q psy14626         80 LYMVFEYMDGSDICFEIVRRAT----------------------------------------------------------  101 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~----------------------------------------------------------  101 (249)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999988865321                                                          


Q ss_pred             -------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626        102 -------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus       102 -------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                                   ....+++..+..++.|++.||.|||+++++|+||||+||+++.+..   ++|+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~---~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRI---TKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCc---EEEecCccceeccCcccc
Confidence                         1124778899999999999999999999999999999999987655   899999998765442210


Q ss_pred             ccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCC--hHHHHHHHHcC
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGS--RDRLFQSITKG  239 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~~--~~~~~~~i~~g  239 (249)
                                 .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...  ...+.+.+..+
T Consensus       271 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~  333 (375)
T cd05104         271 -----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG  333 (375)
T ss_pred             -----------cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC
Confidence                       01111224567999999998889999999999999999998 99999872  34455566655

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.5e-34  Score=247.55  Aligned_cols=203  Identities=24%  Similarity=0.367  Sum_probs=157.2

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      ..+.++|++.++++.|.++.+|..........++++....    ......+|+.+++.++||||+++++++...      
T Consensus        62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~----~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ----DPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEec----CcchHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3467789999999999999988766543333444432221    123345799999999999999998876321      


Q ss_pred             --CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         78 --GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                        ..+++||||+++ +|.+++.........+++..++.++.|++.||.|||+++++||||||+|||++.++.  .++|+|
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~--~vkL~D  214 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTH--TLKLCD  214 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCC--ceeeec
Confidence              246799999975 676666554444455899999999999999999999999999999999999975542  289999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ||++.......              ......+++.|+|||++.+. .++.++|+||+||++|+|++|.+||.+
T Consensus       215 FGla~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        215 FGSAKNLLAGQ--------------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             cccchhccCCC--------------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99986554321              11122468899999998764 579999999999999999999999998

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.5e-33  Score=229.93  Aligned_cols=220  Identities=21%  Similarity=0.356  Sum_probs=171.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCC-----CcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEP-----ASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      ..|++.+.++.|.++.+|........     ..++++... .........+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            36788899998888887755433221     122222221 122344567999999999999999999999999888999


Q ss_pred             EEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC
Q psy14626         82 MVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~  149 (249)
                      ++|||+++++|.+++......            ...++..+++.++.|++.||.+||+++++|+||||+||+++.++.  
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~--  162 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--  162 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--
Confidence            999999999999988764321            134788999999999999999999999999999999999987665  


Q ss_pred             CeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-
Q psy14626        150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-  227 (249)
Q Consensus       150 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-  227 (249)
                       ++|+|||++..........           ......+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+ 
T Consensus       163 -~~L~dfg~~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05048         163 -VKISDFGLSRDIYSADYYR-----------VQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF  230 (283)
T ss_pred             -EEECCCcceeecccccccc-----------ccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence             9999999987654322110           1112235788999999988888999999999999999998 9999988 


Q ss_pred             ChHHHHHHHHcCcc
Q psy14626        228 SRDRLFQSITKGKL  241 (249)
Q Consensus       228 ~~~~~~~~i~~g~~  241 (249)
                      +.+++.+.+.++..
T Consensus       231 ~~~~~~~~i~~~~~  244 (283)
T cd05048         231 SNQEVIEMIRSRQL  244 (283)
T ss_pred             CHHHHHHHHHcCCc
Confidence            56678888877653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0690|consensus

Probab=100.00  E-value=3.5e-34  Score=227.81  Aligned_cols=216  Identities=26%  Similarity=0.500  Sum_probs=184.6

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +-...+++.|.++.++.........-|++   +++.+-.......-.-|-.+|+..+||.+..+--+|++...+|+||||
T Consensus       170 FdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey  249 (516)
T KOG0690|consen  170 FDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY  249 (516)
T ss_pred             hhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence            44567889999888887776655555554   344444445555566788999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      ..||.|...+.+..-    |++...+.+..+|++||.|||+++||+||||.+|.+++++++   +||.|||+|...-.  
T Consensus       250 anGGeLf~HLsrer~----FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH---IKitDFGLCKE~I~--  320 (516)
T KOG0690|consen  250 ANGGELFFHLSRERV----FSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH---IKITDFGLCKEEIK--  320 (516)
T ss_pred             ccCceEeeehhhhhc----ccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc---eEeeecccchhccc--
Confidence            999999888876554    899999999999999999999999999999999999999988   99999999854432  


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                                 +........||+-|.|||++....+++++|.|.+|++||||+-|+.||.. +.+.+++.|.-+++++|-
T Consensus       321 -----------~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr  389 (516)
T KOG0690|consen  321 -----------YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPR  389 (516)
T ss_pred             -----------ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCc
Confidence                       22344556799999999999999999999999999999999999999998 778899999999999983

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.8e-33  Score=226.18  Aligned_cols=213  Identities=27%  Similarity=0.429  Sum_probs=168.5

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      |++.+.++.|.++.+|..........++++...  .......+.+.+|+.+++.++|||++++++++.+.+.+++||||+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd08529           2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA   81 (256)
T ss_pred             ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence            455566777777777766554333333333222  112445678999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++....  ...++...+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+........
T Consensus        82 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~---~~l~df~~~~~~~~~~~  156 (256)
T cd08529          82 ENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC---EEEcccccceeccCccc
Confidence            9999999887642  234889999999999999999999999999999999999987766   99999999876554221


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                                   ......+++.|+|||+..+..++.++|+||||+++++|++|+.||.. +...+...+.++.
T Consensus       157 -------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  217 (256)
T cd08529         157 -------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV  217 (256)
T ss_pred             -------------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence                         11112467889999999988889999999999999999999999988 4455666666654

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.6e-33  Score=232.26  Aligned_cols=221  Identities=23%  Similarity=0.386  Sum_probs=171.6

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-----CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .+.|.+...++.|.++.+|......     .....+++..........+.+.+|+.++++++||||+++++++..+...+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            3457777888888887777554221     11122232233333344567999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhh------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC
Q psy14626         82 MVFEYMDGSDICFEIVRRAT------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~  149 (249)
                      +||||+++++|.+++.....            ....+++..++.++.|++.||.+||+++++|+||||+||+++.++.  
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--
Confidence            99999999999999876432            1234789999999999999999999999999999999999987765  


Q ss_pred             CeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-
Q psy14626        150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-  227 (249)
Q Consensus       150 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-  227 (249)
                       ++|+|||.+.........           .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.. 
T Consensus       162 -~~l~dfg~a~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         162 -VKIGDFGMSRDVYSTDYY-----------RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             -EEECCCCcccccCCCcee-----------ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             999999998655432211           01112235678999999998888999999999999999998 9999987 


Q ss_pred             ChHHHHHHHHcCcc
Q psy14626        228 SRDRLFQSITKGKL  241 (249)
Q Consensus       228 ~~~~~~~~i~~g~~  241 (249)
                      +..++.+.+..+..
T Consensus       230 ~~~~~~~~~~~~~~  243 (291)
T cd05094         230 SNTEVIECITQGRV  243 (291)
T ss_pred             CHHHHHHHHhCCCC
Confidence            55667777777654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0193|consensus

Probab=100.00  E-value=6.3e-35  Score=247.69  Aligned_cols=212  Identities=22%  Similarity=0.350  Sum_probs=179.8

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccC
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD   88 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (249)
                      .+.+.+.|+.|-++.+++..+.-+++++.+.-..... .+.+.|++|+.++++=+|.||+-|.|+|...+. .||+.+|+
T Consensus       393 ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe  470 (678)
T KOG0193|consen  393 EVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE  470 (678)
T ss_pred             HhhccceeccccccceeecccccceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence            4566777888999999999988888888877666664 488999999999999999999999999998875 99999999


Q ss_pred             CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626         89 GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                      |.+|..++.-....   |+..+++.|+.|+++|+.|||.++|||+|||..||++..++.   |+|+|||++..-......
T Consensus       471 GsSLY~hlHv~etk---fdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k---VkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  471 GSSLYTHLHVQETK---FDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK---VKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             Cchhhhhccchhhh---hhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc---EEEecccceeeeeeeccc
Confidence            99999998876543   999999999999999999999999999999999999988766   999999998665543210


Q ss_pred             ccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                                 .......+...|+|||+++   ..+++..+||||||+++|||++|..||.. ..+.++-.+-+|
T Consensus       545 -----------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG  608 (678)
T KOG0193|consen  545 -----------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRG  608 (678)
T ss_pred             -----------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEeccc
Confidence                       1111223788999999986   45689999999999999999999999997 566677667666

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4e-33  Score=226.83  Aligned_cols=216  Identities=26%  Similarity=0.406  Sum_probs=172.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|++...++.|.++.+|..........++++..   ........+.+.+|+.+++.++||||+++++++..++.++++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            3688899999998888876665444444444322   2233445578899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.........+++.+++.++.|++.|+.+||++|++|+||+|+||+++.++.   ++++|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEECcchhhhcccc
Confidence            999999999888754444455899999999999999999999999999999999999987765   99999998765433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh---HHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR---DRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~---~~~~~~i~~g  239 (249)
                      ...             ......++..|+|||.+.+..++.++|+||+|+++++|++|..||.+..   .++.+.+..+
T Consensus       159 ~~~-------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  223 (267)
T cd08229         159 KTT-------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC  223 (267)
T ss_pred             CCc-------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC
Confidence            211             1112247789999999988888999999999999999999999998632   3445555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2e-33  Score=227.84  Aligned_cols=216  Identities=20%  Similarity=0.364  Sum_probs=173.5

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .|...|++.+.++.|.++.+|...... ....+++............+.+|+.+++.++||||+++++++......++||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            466789999999999988888655543 2333333333333445677999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....  ..++...+..++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~---~kl~d~g~~~~~~~  156 (261)
T cd05148          82 ELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV---CKVADFGLARLIKE  156 (261)
T ss_pred             eecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce---EEEccccchhhcCC
Confidence            99999999998876432  34789999999999999999999999999999999999987766   99999999865543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ...             ......++..|+|||.+.+..++.++|+||||+++++|++ |+.||.. +..++.+.+..+
T Consensus       157 ~~~-------------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05148         157 DVY-------------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG  220 (261)
T ss_pred             ccc-------------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC
Confidence            211             0111234668999999988888999999999999999998 8999988 455666666654

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-33  Score=231.78  Aligned_cols=210  Identities=24%  Similarity=0.354  Sum_probs=159.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccC-CCcccCChhc--cccchhHHHHHHHHHHHHHc---CCCChhhhhheee-----c
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIE-PASFGLPDER--LNHYTTEADLKREATICHML---KHPHVVELLETYS-----S   76 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~-----~   76 (249)
                      ++|++.+.++.|.++.+|...+... ...++++...  .........+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4788999999999999887654322 2222222211  11123345567788887776   5999999999885     3


Q ss_pred             CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         77 EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      ...+++|||++. ++|.+++......  .+++.++..++.|++.||.|||++|++|+||||+||+++.++.   ++|+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~---~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC---EEEccc
Confidence            456899999996 4888887654322  3789999999999999999999999999999999999987766   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      |.+.......              ......+++.|+|||.+.+..++.++|+||+||++|+|++|++||.+ +..+....
T Consensus       155 g~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~  220 (290)
T cd07862         155 GLARIYSFQM--------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK  220 (290)
T ss_pred             cceEeccCCc--------------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence            9987654321              11223478999999999888889999999999999999999999998 33344444


Q ss_pred             HH
Q psy14626        236 IT  237 (249)
Q Consensus       236 i~  237 (249)
                      |.
T Consensus       221 i~  222 (290)
T cd07862         221 IL  222 (290)
T ss_pred             HH
Confidence            43

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0194|consensus

Probab=100.00  E-value=1.3e-34  Score=246.18  Aligned_cols=211  Identities=20%  Similarity=0.290  Sum_probs=172.3

Q ss_pred             cchHHHhhcccceeeEeeeccccC-------CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIE-------PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .+.....++.|-|+.++...-...       ++++....+......+..++.+|+++|++++||||++++|+......++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            345557888888888876554433       2233333223345678889999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +|||+|.||+|.++|.+...   .++..+...++.+.+.||+|||+++++||||...|+|+..++.   +||+|||+++.
T Consensus       238 ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~---vKISDFGLs~~  311 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGV---VKISDFGLSRA  311 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCe---EEeCccccccC
Confidence            99999999999999988765   3899999999999999999999999999999999999977654   79999999755


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHc
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~  238 (249)
                      .....             .......-+..|+|||.+....++.++||||+|+++||+++ |..||.+ ...++...|..
T Consensus       312 ~~~~~-------------~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~  377 (474)
T KOG0194|consen  312 GSQYV-------------MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK  377 (474)
T ss_pred             Cccee-------------eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh
Confidence            43211             11111235789999999999999999999999999999999 9999999 66778888833

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=9e-34  Score=234.52  Aligned_cols=203  Identities=29%  Similarity=0.482  Sum_probs=170.5

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      -|+.++|++.+.++.|.++.+|...+......++++....+.....+.+.+|+.+++.++|+|++++++.+..++..++|
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            47789999999999998888887765444445555545555555667889999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++...     .++..++..++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+....
T Consensus        95 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~---~~l~Dfg~~~~~~  166 (297)
T cd06656          95 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQIT  166 (297)
T ss_pred             ecccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEECcCccceEcc
Confidence            9999999999887542     2789999999999999999999999999999999999987665   9999999986654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ....             ......+++.|+|||.+.+..++.++|+||+|+++|++++|..||..
T Consensus       167 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~  217 (297)
T cd06656         167 PEQS-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (297)
T ss_pred             CCcc-------------CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3211             11122467889999999988889999999999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0612|consensus

Probab=100.00  E-value=5.6e-34  Score=255.79  Aligned_cols=220  Identities=25%  Similarity=0.419  Sum_probs=183.8

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcc---ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL---NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      -|.|..+|+.|.|+.+-.....-...+|+.+...-   -......-|+.|-.+|..-+.+=|+.++-.|++..++|+|||
T Consensus        76 DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMd  155 (1317)
T KOG0612|consen   76 DFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMD  155 (1317)
T ss_pred             hhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEe
Confidence            57889999999999887777766667777543332   223445678889999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++||+|..++..-.    .++++.++.++.+|+.||.-||+.|+|||||||+|||++..|+   ++|+|||.|-.+...
T Consensus       156 Y~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH---ikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  156 YMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH---IKLADFGSCLKMDAD  228 (1317)
T ss_pred             cccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc---EeeccchhHHhcCCC
Confidence            999999998887654    3899999999999999999999999999999999999988887   999999998666532


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccc----c-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE----D-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ..            -......|||.|+|||++.    + +.|++.+|.||+|+++|||+.|..||-. +.-+.+-.|++-
T Consensus       229 G~------------V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h  296 (1317)
T KOG0612|consen  229 GT------------VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH  296 (1317)
T ss_pred             Cc------------EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch
Confidence            21            1233457999999999985    3 4589999999999999999999999998 566788888876


Q ss_pred             --cccccccc
Q psy14626        240 --KLHILGCT  247 (249)
Q Consensus       240 --~~~~~~~~  247 (249)
                        .+.||+.+
T Consensus       297 k~~l~FP~~~  306 (1317)
T KOG0612|consen  297 KESLSFPDET  306 (1317)
T ss_pred             hhhcCCCccc
Confidence              68888443

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.5e-33  Score=228.03  Aligned_cols=216  Identities=25%  Similarity=0.395  Sum_probs=173.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|++.++++.|.++.+|..........++++.   ...........+.+|+.+++.++||||+++++.+...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            468888999999888888666554444444432   22333455667899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.........+++.++..++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~---~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC---EEECccccceeccc
Confidence            999999998888765444455889999999999999999999999999999999999987666   99999999876543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS---RDRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~---~~~~~~~i~~g  239 (249)
                      ...             ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||..+   ...+.+.+..+
T Consensus       159 ~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~  223 (267)
T cd08228         159 KTT-------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQC  223 (267)
T ss_pred             hhH-------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcC
Confidence            221             111224678899999998888899999999999999999999999763   24556666553

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4721|consensus

Probab=100.00  E-value=1.1e-34  Score=244.98  Aligned_cols=174  Identities=24%  Similarity=0.482  Sum_probs=152.8

Q ss_pred             HHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy14626         53 KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIH  132 (249)
Q Consensus        53 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH  132 (249)
                      .-++.-|++|+||||+.|.|+|.+...+|||||||..|.|...|.....    ++...+..|..+|+.|+.|||...|||
T Consensus       160 ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~hKIIH  235 (904)
T KOG4721|consen  160 ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLHKIIH  235 (904)
T ss_pred             hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHhhHhh
Confidence            3467789999999999999999999999999999999999998876554    899999999999999999999999999


Q ss_pred             ecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHH
Q psy14626        133 RDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAG  212 (249)
Q Consensus       133 ~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  212 (249)
                      ||||..||||..++.   |||+|||-++...+-.              ..-++.||..|||||+++..+.+.++||||||
T Consensus       236 RDLKSPNiLIs~~d~---VKIsDFGTS~e~~~~S--------------TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfG  298 (904)
T KOG4721|consen  236 RDLKSPNILISYDDV---VKISDFGTSKELSDKS--------------TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFG  298 (904)
T ss_pred             hccCCCceEeeccce---EEeccccchHhhhhhh--------------hhhhhhhhHhhhCHHHhhcCCcccccceehhH
Confidence            999999999987766   9999999986665522              22345799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc---ccc
Q psy14626        213 VLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL---GCT  247 (249)
Q Consensus       213 ~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~---~~~  247 (249)
                      |+||||+||..||.+ +...|+.-+-++-+.+|   .||
T Consensus       299 VVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP  337 (904)
T KOG4721|consen  299 VVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCP  337 (904)
T ss_pred             HHHHHHHhcCCCccccchheeEEeccCCcccccCcccCc
Confidence            999999999999998 66667777777777776   555

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-33  Score=230.53  Aligned_cols=200  Identities=25%  Similarity=0.446  Sum_probs=161.4

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      |+...+++.|.++.+|..........++++.   ...........+.+|+.+++.++|+|++++.+.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            5566778888888887665544433344332   2233334456688999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+++|.+.+.....  ..+++..+..++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~---~kl~Dfg~~~~~~~~~  156 (285)
T cd05632          82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH---IRISDLGLAVKIPEGE  156 (285)
T ss_pred             ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC---EEEecCCcceecCCCC
Confidence            999999887765432  23899999999999999999999999999999999999987665   9999999886543321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .              .....++..|+|||.+.+..++.++|+||+|+++++|++|..||.+.
T Consensus       157 ~--------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~  204 (285)
T cd05632         157 S--------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR  204 (285)
T ss_pred             c--------------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            1              11224789999999999888999999999999999999999999873

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.7e-33  Score=225.06  Aligned_cols=216  Identities=27%  Similarity=0.427  Sum_probs=172.9

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ||++..+++.|.++.++..+.......++++.....  +......+.+|+.++++++|+||+++++++.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            577788888888776655554444444444332222  234556789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+.+....  ...++..++..++.|++.++.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~---~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL---IKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC---EEECcCcceEEccccc
Confidence            99999998887543  234899999999999999999999999999999999999987766   9999999987664422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      .             ......+++.|.|||.+.+..++.++|+||+|+++++|++|..||.. +..+....+..+.+.
T Consensus       156 ~-------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~  219 (256)
T cd08221         156 S-------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT  219 (256)
T ss_pred             c-------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence            1             11223478899999999888889999999999999999999999988 555667677766543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG4257|consensus

Probab=100.00  E-value=4.1e-34  Score=243.54  Aligned_cols=220  Identities=21%  Similarity=0.364  Sum_probs=182.4

Q ss_pred             cchHHHhhcccceeeEeeeccccC----CCcccCCh-hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIE----PASFGLPD-ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      +++.+..|++|.|+.+|.......    ....+++. +....+.+.+.|..|+.+|++++||||++++|+|.+.. .++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P-~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP-MWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc-eeEE
Confidence            567888999999888875543322    12233332 22355677899999999999999999999999998774 8999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||+++.|.|..++..+..+   ++..+...++.||+.||.|||+.++|||||...|||+.....   +||+|||+++.+.
T Consensus       469 mEL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C---VKLaDFGLSR~~e  542 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC---VKLADFGLSRYLE  542 (974)
T ss_pred             EecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce---eeecccchhhhcc
Confidence            9999999999999988765   899999999999999999999999999999999999988766   9999999999988


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc-
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK-  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~-  240 (249)
                      +...+...            ....++.|+|||.+....++.++|||-||+++||++. |..||.+ ....++-.|.+|+ 
T Consensus       543 d~~yYkaS------------~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeR  610 (974)
T KOG4257|consen  543 DDAYYKAS------------RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGER  610 (974)
T ss_pred             ccchhhcc------------ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCC
Confidence            86654322            2346789999999999999999999999999999998 9999999 5556777788876 


Q ss_pred             -ccccccc
Q psy14626        241 -LHILGCT  247 (249)
Q Consensus       241 -~~~~~~~  247 (249)
                       +..|-||
T Consensus       611 lP~P~nCP  618 (974)
T KOG4257|consen  611 LPCPPNCP  618 (974)
T ss_pred             CCCCCCCC
Confidence             4444565

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-33  Score=226.51  Aligned_cols=212  Identities=26%  Similarity=0.401  Sum_probs=172.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ++|++.+.++.|.++.+|..........++++..... .......+.+|+.+++.++|+|++++++++..+..+++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            4788999999988888886665544444444433322 234556789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++...     .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD---VKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEcccccceeecccc
Confidence            9999998888654     3899999999999999999999999999999999999988766   9999999987765432


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .             ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.. +.......+..+.
T Consensus       153 ~-------------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~  214 (274)
T cd06609         153 S-------------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN  214 (274)
T ss_pred             c-------------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC
Confidence            1             11123467889999999988899999999999999999999999987 4444555555543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.5e-33  Score=233.07  Aligned_cols=203  Identities=23%  Similarity=0.419  Sum_probs=161.2

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ..-.+|++.+.++.|.++.+|...+......++++..... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus         3 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   82 (309)
T cd07872           3 GKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV   82 (309)
T ss_pred             CCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence            4456899999999999998887665544444444332222 223345678899999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++ +|.+++.....   .++...+..++.|++.||.+||++|++||||||+||+++.++.   ++|+|||++....
T Consensus        83 ~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~  155 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGN---IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKS  155 (309)
T ss_pred             EeCCCC-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEECccccceecC
Confidence            999975 77777654432   3789999999999999999999999999999999999987766   9999999986543


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ....             ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.+
T Consensus       156 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  207 (309)
T cd07872         156 VPTK-------------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG  207 (309)
T ss_pred             CCcc-------------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            3211             1112246889999999865 4578999999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-33  Score=224.60  Aligned_cols=212  Identities=22%  Similarity=0.355  Sum_probs=167.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      +.+++.+.++.|.++.+|...... ...++++... ......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIR-EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEec-cCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            468899999999888887655432 2223332211 11223457889999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++..+..   .+++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||.++...+...
T Consensus        82 ~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          82 ANGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV---VKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc---EEECCcccceecccccc
Confidence            99999998875432   3899999999999999999999999999999999999987665   99999998876543211


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .            .......+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.. +..++...+..+
T Consensus       156 ~------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  217 (256)
T cd05059         156 T------------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG  217 (256)
T ss_pred             c------------ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcC
Confidence            0            0001123457999999998888999999999999999999 8999987 556666677665

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-33  Score=231.37  Aligned_cols=233  Identities=28%  Similarity=0.421  Sum_probs=176.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++...++.|.++.+|..........++++..   ........+.+.+|+.+++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4677788888888888887666544444444322   2232345677899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.+++|.+++....  +..+++..+..++.|++.||.+||+.|++|+||||+||+++.++.   ++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH---IMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC---EEEeecchhhcccc
Confidence            9999999998876432  234899999999999999999999999999999999999987766   99999998865543


Q ss_pred             CCccccCCcc----------------ccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q psy14626        165 GQLYCSGGER----------------LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-  227 (249)
Q Consensus       165 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-  227 (249)
                      ..........                ............++..|+|||.+.+..++.++|+||+|+++|+|++|+.||.+ 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            2110000000                00001112234578889999999988889999999999999999999999987 


Q ss_pred             ChHHHHHHHHcCcccccc
Q psy14626        228 SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       228 ~~~~~~~~i~~g~~~~~~  245 (249)
                      +.......+....+.+|.
T Consensus       236 ~~~~~~~~~~~~~~~~~~  253 (316)
T cd05574         236 NRDETFSNILKKEVTFPG  253 (316)
T ss_pred             chHHHHHHHhcCCccCCC
Confidence            445556666666655553

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.6e-33  Score=229.36  Aligned_cols=222  Identities=23%  Similarity=0.337  Sum_probs=169.9

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-----CCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ++.|++.+.++.|.++.+|......     ....++++... .........+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            4568888889999888877655443     11222222222 12233456789999999999999999999999888889


Q ss_pred             EEEEeccCCCchhHHHHHhhhc---CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         81 YMVFEYMDGSDICFEIVRRATA---GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ++||||+++++|.+++......   ...+++.+++.++.|++.||.+||+++++|+||||+||+++.++....++|+|||
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg  164 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG  164 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence            9999999999999988765421   2248899999999999999999999999999999999999876544558999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~  235 (249)
                      .+.........           ........+..|+|||++.+..++.++|+|||||++++|++ |+.||.+ +.+++.+.
T Consensus       165 ~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~  233 (277)
T cd05036         165 MARDIYRASYY-----------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF  233 (277)
T ss_pred             cccccCCccce-----------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            98765332110           01111123567999999988889999999999999999997 9999988 55666666


Q ss_pred             HHcC
Q psy14626        236 ITKG  239 (249)
Q Consensus       236 i~~g  239 (249)
                      +..+
T Consensus       234 ~~~~  237 (277)
T cd05036         234 VTGG  237 (277)
T ss_pred             HHcC
Confidence            5543

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG4717|consensus

Probab=100.00  E-value=1.7e-33  Score=235.47  Aligned_cols=217  Identities=27%  Similarity=0.491  Sum_probs=175.0

Q ss_pred             cchHHHhhcccceeeEeeeccc---cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAE---IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      -|-.++-++.|.|+++-....-   ..++++++.+..++. .....+.+|+..|+.++|||||+++++..+...+|+|+|
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4556667777777665322221   223344454555543 344678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      +-.+|+|.+|+-++...   +.+...+.++.||+.||.|.|...+|||||||+|+++-..-  +.+||.|||++....+.
T Consensus        98 LGD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl--GlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL--GLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec--CceEeeeccccccCCCc
Confidence            99999999999887664   89999999999999999999999999999999999876543  33899999998433321


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      .              ......|+..|-|||.+.|..| .+++||||||++||.|.-|++||.. ++.+.+-.|+..++++
T Consensus       173 ~--------------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv  238 (864)
T KOG4717|consen  173 K--------------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV  238 (864)
T ss_pred             c--------------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccC
Confidence            1              1222348899999999999888 6899999999999999999999998 7777888999999999


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       239 Ps  240 (864)
T KOG4717|consen  239 PS  240 (864)
T ss_pred             ch
Confidence            94

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.4e-33  Score=237.92  Aligned_cols=198  Identities=24%  Similarity=0.368  Sum_probs=158.8

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      .-++|++.+.++.|.++.++...+......++++...  .........+.+|+.+++.++||||+++++++...      
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999998877665444444443322  22334566788999999999999999999998644      


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..+++||||+.+ +|...+..      .++...+..++.|++.||.|||+.|++||||||+||+++.++.   ++|+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~---~kl~Dfg  168 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFG  168 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEecCC
Confidence            357999999976 56555432      2788999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++.......              ......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+
T Consensus       169 ~a~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~  224 (359)
T cd07876         169 LARTACTNF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             CccccccCc--------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            986543211              11112478899999999998899999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.8e-33  Score=237.13  Aligned_cols=198  Identities=24%  Similarity=0.381  Sum_probs=156.9

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-----eEEE
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-----MLYM   82 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~l   82 (249)
                      |.+.+.++.|.++.+|...+......++++...  ..+......+.+|+.+++.++||||+++++++....     ..++
T Consensus         2 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l   81 (372)
T cd07853           2 VEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYV   81 (372)
T ss_pred             CcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEE
Confidence            566778889988888876654444444444322  223345567899999999999999999999998766     7899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |+||+. ++|...+....    .++...++.++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++...
T Consensus        82 v~e~~~-~~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~---~kL~Dfg~a~~~  153 (372)
T cd07853          82 VTELMQ-SDLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV---LKICDFGLARVE  153 (372)
T ss_pred             Eeeccc-cCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC---EEeccccceeec
Confidence            999996 47777665433    3899999999999999999999999999999999999987765   999999998765


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....            .......++..|+|||.+.+.. ++.++|+||+||++++|++|+.||.+
T Consensus       154 ~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  207 (372)
T cd07853         154 EPDES------------KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA  207 (372)
T ss_pred             ccCcc------------ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence            43211            0111224688999999988744 68899999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.8e-33  Score=225.72  Aligned_cols=213  Identities=23%  Similarity=0.363  Sum_probs=167.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      +.|++.+.++.|.++.+|...... ...++++... ......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecc-cCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            346777788888888777554432 2223332222 22233567899999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++.....   .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++++|||.+........
T Consensus        82 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~kl~d~g~~~~~~~~~~  155 (256)
T cd05114          82 ENGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV---VKVSDFGMTRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe---EEECCCCCccccCCCce
Confidence            99999988765432   3789999999999999999999999999999999999987665   89999998865533211


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .            ......++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.. +..++.+.+.++.
T Consensus       156 ~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~  218 (256)
T cd05114         156 T------------SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF  218 (256)
T ss_pred             e------------ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence            0            0011124568999999988888999999999999999999 9999988 5566777887764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0201|consensus

Probab=100.00  E-value=3.4e-35  Score=241.03  Aligned_cols=218  Identities=28%  Similarity=0.414  Sum_probs=185.9

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccc-hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHY-TTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ...++...|+..+.++.|-++.+|...+......++++...+... ...+.+++|+.+|.+++++||.++++.+..+..+
T Consensus         7 ~~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen    7 LKIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             hcCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            356788899999999999999999888887777777665554433 4467899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      +++|||+.||++.+.+.....    +.+..+..++++++.|+.|||.++.+|+|||+.|||+..++.   ++++|||++-
T Consensus        87 wiiMey~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~---vkl~DfgVa~  159 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD---VKLADFGVAG  159 (467)
T ss_pred             HHHHHHhcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc---EEEEecceee
Confidence            999999999999988865443    588899999999999999999999999999999999988766   9999999997


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .......             ....+.||+.|||||++....|+.++||||||++.+||.+|.+|+.. ...++.-.|-+.
T Consensus       160 ql~~~~~-------------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~  226 (467)
T KOG0201|consen  160 QLTNTVK-------------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS  226 (467)
T ss_pred             eeechhh-------------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC
Confidence            7766442             23556799999999999988999999999999999999999999998 444444444433

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-33  Score=224.41  Aligned_cols=203  Identities=26%  Similarity=0.394  Sum_probs=161.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc---c--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---L--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +.|.+.+.++.|.++.+|..........++++...   .  ......+.+.+|+.++++++||||+++++++..+..+++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            45888999999988888766544333333332211   1  112234678999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |+|++++++|.+.+.....    ++...+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+...
T Consensus        82 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~---~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecccceec
Confidence            9999999999888865443    789999999999999999999999999999999999987666   999999998655


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ......          ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..
T Consensus       155 ~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  209 (263)
T cd06625         155 QTICSS----------GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             cccccc----------cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            432110          0000122467889999999988889999999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=6.6e-33  Score=227.40  Aligned_cols=220  Identities=22%  Similarity=0.356  Sum_probs=170.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccc-----cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      ++++...+.++.|.++.+|.....     .....++++..........+.+.+|+.+++.++|+||+++++++..+...+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            457888889999988888755321     112223333233333455678999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhc-----------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCC
Q psy14626         82 MVFEYMDGSDICFEIVRRATA-----------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP  150 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~  150 (249)
                      ++|||+++++|.+++......           ...+++.+++.++.|++.|+.|||+.+++|+||||+||+++.++.   
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~---  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV---  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC---
Confidence            999999999999988764321           123788999999999999999999999999999999999987665   


Q ss_pred             eEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-C
Q psy14626        151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-S  228 (249)
Q Consensus       151 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~  228 (249)
                      ++|+|||.+........+           .......+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.. .
T Consensus       161 ~kL~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  229 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYY-----------RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS  229 (280)
T ss_pred             EEECCCCceeEcCCCcee-----------ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC
Confidence            999999998655432210           01111234678999999998889999999999999999998 9999977 4


Q ss_pred             hHHHHHHHHcCc
Q psy14626        229 RDRLFQSITKGK  240 (249)
Q Consensus       229 ~~~~~~~i~~g~  240 (249)
                      ..+..+.+.++.
T Consensus       230 ~~~~~~~~~~~~  241 (280)
T cd05092         230 NTEAIECITQGR  241 (280)
T ss_pred             HHHHHHHHHcCc
Confidence            555666666654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG0579|consensus

Probab=100.00  E-value=1e-33  Score=241.79  Aligned_cols=223  Identities=26%  Similarity=0.368  Sum_probs=186.7

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ++||.+-+.|-.-+++|.|+.+|...+.....-.+.+..........+.+.-|+.+|...+||+|+++++.|...+.++|
T Consensus        27 dlnP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwi  106 (1187)
T KOG0579|consen   27 DLNPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWI  106 (1187)
T ss_pred             cCCHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEE
Confidence            46788888888889999999998777764433333444455556677889999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      +.|||.||.....+..-+.   ++++.+|..+++|++.||.|||+++|||||||..|||+.-+|.   ++|+|||++...
T Consensus       107 liEFC~GGAVDaimlEL~r---~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd---irLADFGVSAKn  180 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIMLELGR---VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD---IRLADFGVSAKN  180 (1187)
T ss_pred             EEeecCCchHhHHHHHhcc---ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc---Eeeecccccccc
Confidence            9999999988766665543   4999999999999999999999999999999999999999888   999999998655


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ....             ....++.||++|||||++.     ..+|..++||||||++|.||..+.+|-.. +.-+++-.|
T Consensus       181 ~~t~-------------qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi  247 (1187)
T KOG0579|consen  181 KSTR-------------QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI  247 (1187)
T ss_pred             hhHH-------------hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH
Confidence            4433             2334567999999999975     45689999999999999999999999998 777777788


Q ss_pred             HcCccccc
Q psy14626        237 TKGKLHIL  244 (249)
Q Consensus       237 ~~g~~~~~  244 (249)
                      .+.++.-.
T Consensus       248 aKSePPTL  255 (1187)
T KOG0579|consen  248 AKSEPPTL  255 (1187)
T ss_pred             hhcCCCcc
Confidence            87775544

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.9e-33  Score=225.49  Aligned_cols=215  Identities=29%  Similarity=0.506  Sum_probs=171.0

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      +|++.+.++.|.++.++...+......++++.... ......+.+.+|+.+++.++|||++++++.+.+++.++++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            36667788888887777666554444455443222 22345678889999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++....  +..+++..++.++.|++.||.+||+++++|+||+|+||+++.++.   ++++|||.+........
T Consensus        81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK---VKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc---EEEcccCcceeeccccc
Confidence            9999988776433  233789999999999999999999999999999999999987666   99999999866543211


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                                   ......++..|+|||++.+..++.++|+||+|+++++|++|..||.. +.......+.++..
T Consensus       156 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~  217 (255)
T cd08219         156 -------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY  217 (255)
T ss_pred             -------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCC
Confidence                         01112467889999999988889999999999999999999999988 44556666666654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.9e-33  Score=237.75  Aligned_cols=198  Identities=24%  Similarity=0.370  Sum_probs=159.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      ..++|++.+.++.|.++.++...+......++++...  .........+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999988876655444444433222  22334556788999999999999999999988543      


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..+++||||+.+ +|...+..      .++...+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG  171 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFG  171 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc---EEEEeCC
Confidence            357999999975 67666542      1788999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++.......              ......++..|+|||++.+..++.++|+|||||++|+|++|+.||.+
T Consensus       172 ~a~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  227 (364)
T cd07875         172 LARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             CccccCCCC--------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence            986543321              11122478899999999998899999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.9e-33  Score=237.61  Aligned_cols=220  Identities=22%  Similarity=0.360  Sum_probs=168.7

Q ss_pred             CCCcchHHHhhcccceeeEeeecccc-----CCCcccCChhc-cccchhHHHHHHHHHHHHHcC-CCChhhhhheeecCC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDER-LNHYTTEADLKREATICHMLK-HPHVVELLETYSSEG   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   78 (249)
                      |..+|++.++|+.|.++.+|......     ....++++... .......+.+.+|+.+++.+. ||||+++++++...+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            35688999999999999887654321     11112222222 122344567999999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhc--------------------------------------------------------
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATA--------------------------------------------------------  102 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------------  102 (249)
                      .+++||||+++|+|.+++......                                                        
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            999999999999999888654210                                                        


Q ss_pred             ------------------------------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626        103 ------------------------------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus       103 ------------------------------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                                                          ...++...+..++.|++.||.|||+.+++|+||||+||+++.++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~  274 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK  274 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence                                                12377888999999999999999999999999999999998766


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF  225 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf  225 (249)
                      .   ++|+|||++.........           .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||
T Consensus       275 ~---~kL~DfGla~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~  340 (400)
T cd05105         275 I---VKICDFGLARDIMHDSNY-----------VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY  340 (400)
T ss_pred             E---EEEEeCCcceeccccccc-----------cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            5   999999998765432210           11112235678999999988888999999999999999997 99999


Q ss_pred             CCC--hHHHHHHHHcC
Q psy14626        226 VGS--RDRLFQSITKG  239 (249)
Q Consensus       226 ~~~--~~~~~~~i~~g  239 (249)
                      ...  .+.+...+..+
T Consensus       341 ~~~~~~~~~~~~~~~~  356 (400)
T cd05105         341 PGMIVDSTFYNKIKSG  356 (400)
T ss_pred             cccchhHHHHHHHhcC
Confidence            872  34455555555

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.8e-33  Score=225.91  Aligned_cols=214  Identities=19%  Similarity=0.318  Sum_probs=167.6

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      +.|++.+.++.|.++.+|....... ..++++.... .....+.+.+|+.++++++||||+++++++.....++++|||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCC-CcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            4577778888888877775543321 1122222221 1223567999999999999999999999999888899999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      .+++|.+++.....   .+++.+++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+........
T Consensus        82 ~~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~---~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC---VKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC---EEECCCccceecCCCce
Confidence            99999988865432   3899999999999999999999999999999999999987665   99999999876543221


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCcc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                                  .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.. +.+++.+.+.++..
T Consensus       156 ------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~  219 (256)
T cd05113         156 ------------TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLR  219 (256)
T ss_pred             ------------eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCC
Confidence                        00111224678999999988888999999999999999998 9999987 55667777777653

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.1e-33  Score=230.02  Aligned_cols=199  Identities=26%  Similarity=0.438  Sum_probs=161.9

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      |++.++++.|.++.+|...+......++++..   ........+.+.+|+.++++++|++++++++.+.+.+.+++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            56667788888888876665544444444332   222233445678899999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+++|.+.+.....  ..+++.++..++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||++.......
T Consensus        82 ~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~---~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          82 MNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH---IRISDLGLAVHVPEGQ  156 (285)
T ss_pred             cCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---EEEeeccceeecCCCc
Confidence            999999888865433  23889999999999999999999999999999999999987665   9999999986654321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .              .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..
T Consensus       157 ~--------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         157 T--------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             c--------------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence            1              1122478999999999988899999999999999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.6e-33  Score=253.46  Aligned_cols=217  Identities=23%  Similarity=0.282  Sum_probs=167.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .||++.++++.|.++.+|...+......++++..   ........+++.+|+.+++.++||||+++++++.+++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5788999999999999987765543333333322   2223344667999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhc-------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         85 EYMDGSDICFEIVRRATA-------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ||++|++|.+++......       ...++...+..++.|++.||.+||++|++||||||+||+++.++.   ++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~---vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE---VVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC---EEEEecC
Confidence            999999999888653211       122556788999999999999999999999999999999987776   9999999


Q ss_pred             eeEEccCCCccccC-----CccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSG-----GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++............     ........+......||+.|+|||++.+..++.++|+||+||++++|++|..||..
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            99766221100000     00000011222334689999999999998899999999999999999999999987

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=6e-33  Score=229.07  Aligned_cols=211  Identities=26%  Similarity=0.437  Sum_probs=168.2

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +.+.|.....++.|.++.++..........++++..........+.+.+|+.+++.++|+|++++++.+..++..++|||
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e   99 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME   99 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence            34556666778888888887666555555555554444444566779999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++...     .+++.++..++.|++.|+.+||+++++|+||+|+||+++.++.   ++|+|||.+......
T Consensus       100 ~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~---~kL~dfg~~~~~~~~  171 (292)
T cd06658         100 FLEGGALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR---IKLSDFGFCAQVSKE  171 (292)
T ss_pred             CCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---EEEccCcchhhcccc
Confidence            99999998876432     2789999999999999999999999999999999999987765   999999988654321


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      .             .......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.. +.......+.
T Consensus       172 ~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~  231 (292)
T cd06658         172 V-------------PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIR  231 (292)
T ss_pred             c-------------ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            1             011123478899999999888889999999999999999999999987 3333344443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-33  Score=224.08  Aligned_cols=214  Identities=20%  Similarity=0.317  Sum_probs=168.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.++.|.++.+|....... ..++++.... .....+.+.+|+.++++++||||+++++++...+..+++||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCC-eEEEEEeeCC-CcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            45688889999888888775543322 2233332222 223456789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++....  +..++..++..++.|++.|+.+||+.+++|+||||+||+++.++.   ++|+|||.+.......
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~dfg~~~~~~~~~  157 (261)
T cd05068          83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI---CKVADFGLARVIKEDI  157 (261)
T ss_pred             ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC---EEECCcceEEEccCCc
Confidence            99999999886644  234899999999999999999999999999999999999988776   9999999997765322


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ..            .......+..|+|||.+.+..++.++|+||||+++++|++ |+.||.+ +..++...+.++
T Consensus       158 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05068         158 YE------------AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG  220 (261)
T ss_pred             cc------------ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            10            0001113457999999998888999999999999999999 9999988 555666666554

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.9e-33  Score=227.69  Aligned_cols=221  Identities=20%  Similarity=0.346  Sum_probs=168.5

Q ss_pred             CCCcchHHHhhcccceeeEeeeccc-----cCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      ..++|++...++.|.++.+|.....     .....++++... .........+.+|+.+++.++||||+++++++.++..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3567899999999988887754321     111123332221 1222345678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhc------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEE
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATA------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKL  153 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l  153 (249)
                      .++||||+++++|.+++......      ...++...+..++.|++.||.+||+.+++|+||||+||+++.++.   ++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~---~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC---EEE
Confidence            99999999999999988654321      123577889999999999999999999999999999999987665   999


Q ss_pred             cCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHH
Q psy14626        154 GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDR  231 (249)
Q Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~  231 (249)
                      +|||++..........           ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+ +.++
T Consensus       161 ~dfg~~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~  229 (277)
T cd05062         161 GDFGMTRDIYETDYYR-----------KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ  229 (277)
T ss_pred             CCCCCccccCCcceee-----------cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            9999986554322111           1111234678999999998888999999999999999999 7999988 5556


Q ss_pred             HHHHHHcCc
Q psy14626        232 LFQSITKGK  240 (249)
Q Consensus       232 ~~~~i~~g~  240 (249)
                      +.+.+..+.
T Consensus       230 ~~~~~~~~~  238 (277)
T cd05062         230 VLRFVMEGG  238 (277)
T ss_pred             HHHHHHcCC
Confidence            666666654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-32  Score=223.79  Aligned_cols=217  Identities=26%  Similarity=0.386  Sum_probs=173.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.+|..........++++   ..........+.+.+|+.++++++|++++++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57888899999888888766655333333333   222333445778999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|..++.........++..++..++.+++.||.+||+.|++|+||+|+||+++.++.   ++++|||.+.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~---~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV---VKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc---EEEeccceeeeccC
Confidence            999999999888764444445899999999999999999999999999999999999987766   99999999866543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHHcCc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS---RDRLFQSITKGK  240 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~---~~~~~~~i~~g~  240 (249)
                      ...             ......++..|.|||.+.+..++.++|+||+|+++++|++|+.||...   ..++.+.+..+.
T Consensus       159 ~~~-------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  224 (267)
T cd08224         159 KTT-------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD  224 (267)
T ss_pred             CCc-------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC
Confidence            211             111224678899999998888899999999999999999999999763   334555665554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.2e-33  Score=225.03  Aligned_cols=214  Identities=20%  Similarity=0.334  Sum_probs=168.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .+.|++.+.++.|.++.+|..... ....++++.... .....+.+.+|+.+++.++|+||+++++.+..++..+++|||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccC-CchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            457888888988888887765433 212222222221 223467899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++....  +..++...+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~dfg~~~~~~~~~  157 (261)
T cd05072          83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM---CKIADFGLARVIEDNE  157 (261)
T ss_pred             CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc---EEECCCccceecCCCc
Confidence            99999999886543  234788999999999999999999999999999999999987665   8999999997765422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .            +......++..|+|||++.+..++.++|+||||+++|+|++ |..||.. +.+.+...+.++
T Consensus       158 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05072         158 Y------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG  220 (261)
T ss_pred             e------------eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC
Confidence            1            01111234678999999988888999999999999999998 9999987 455666666655

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.8e-33  Score=225.46  Aligned_cols=205  Identities=25%  Similarity=0.439  Sum_probs=161.0

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhc---cc------cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LN------HYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      ||+++.+++.|.++.++...+......++++...   ..      .....+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5778888988888888766544333333332111   11      11234678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .+++|||+++++|.+++.....    ++...+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~---~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG---IKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC---EEecccCCC
Confidence            9999999999999988866433    789999999999999999999999999999999999987665   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...........       .........++..|+|||.+.+..++.++|+||+|+++++|++|+.||..
T Consensus       154 ~~~~~~~~~~~-------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         154 KKLEANSLSTK-------TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             cccccccccCC-------ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence            76653211000       00111123467889999999888889999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-32  Score=222.19  Aligned_cols=201  Identities=26%  Similarity=0.412  Sum_probs=166.0

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      |.++|++.+.++.|.++.++..........++++.....  ...+.+.+|+.+++.++||||+++++.+.....+++++|
T Consensus         1 ~~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           1 PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             CcccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH--HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            568899999999998888876665543333333322222  236789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++++++|.+++.....   .+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        79 ~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~---~~l~dfg~~~~~~~~  152 (256)
T cd06612          79 YCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ---AKLADFGVSGQLTDT  152 (256)
T ss_pred             cCCCCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc---EEEcccccchhcccC
Confidence            9999999988865332   3899999999999999999999999999999999999987766   999999998665442


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..             ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||..
T Consensus       153 ~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~  201 (256)
T cd06612         153 MA-------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD  201 (256)
T ss_pred             cc-------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21             11122367889999999888889999999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.8e-33  Score=228.26  Aligned_cols=216  Identities=20%  Similarity=0.347  Sum_probs=166.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCc--ccCC-hhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPAS--FGLP-DERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ++.|++.++++.|.++.++..........  .+++ ..........+.+.+|+.++.++ +||||+++++++...+.+++
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            36789999999999988876544322111  1111 11122334456789999999999 79999999999999889999


Q ss_pred             EEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCC
Q psy14626         83 VFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP  150 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~  150 (249)
                      ++||+++++|.+++......            ...++...++.++.|++.||.+||+.|++|+||||+||+++.++.   
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~---  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA---  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe---
Confidence            99999999999988654311            124788999999999999999999999999999999999987665   


Q ss_pred             eEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-C
Q psy14626        151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-S  228 (249)
Q Consensus       151 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~  228 (249)
                      ++|+|||++.......              .......+..|+|||++.+..++.++|+|||||++|+|++ |..||.+ +
T Consensus       158 ~kl~dfg~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~  223 (297)
T cd05089         158 SKIADFGLSRGEEVYV--------------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT  223 (297)
T ss_pred             EEECCcCCCcccccee--------------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            8999999874322110              0001123457999999988888999999999999999997 9999988 5


Q ss_pred             hHHHHHHHHcC
Q psy14626        229 RDRLFQSITKG  239 (249)
Q Consensus       229 ~~~~~~~i~~g  239 (249)
                      ...+.+.+.++
T Consensus       224 ~~~~~~~~~~~  234 (297)
T cd05089         224 CAELYEKLPQG  234 (297)
T ss_pred             HHHHHHHHhcC
Confidence            55666666655

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.9e-33  Score=223.00  Aligned_cols=208  Identities=20%  Similarity=0.377  Sum_probs=159.2

Q ss_pred             hhcccceeeEeeeccccCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchh
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC   93 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (249)
                      .++.|.++.+|..........++++... .........+.+|+.+++.++||||+++++++.....+++||||+++++|.
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (252)
T cd05084           2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL   81 (252)
T ss_pred             ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence            4666777777765544333334433222 122344567999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626         94 FEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                      +++.....   .+++.+++.++.|++.||.|||+++++|+||+|+||+++.++.   ++|+|||.+........      
T Consensus        82 ~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~~~~------  149 (252)
T cd05084          82 TFLRTEGP---RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV---LKISDFGMSREEEDGVY------  149 (252)
T ss_pred             HHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc---EEECccccCcccccccc------
Confidence            88865432   3789999999999999999999999999999999999987665   99999999865432110      


Q ss_pred             cccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                           .........+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.. +.+.....+.++
T Consensus       150 -----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~  212 (252)
T cd05084         150 -----ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG  212 (252)
T ss_pred             -----cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcC
Confidence                 011111123457999999988888999999999999999998 9999987 444555555443

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.5e-32  Score=231.02  Aligned_cols=221  Identities=23%  Similarity=0.358  Sum_probs=167.0

Q ss_pred             CCCcchHHHhhcccceeeEeeeccc-c----CCCcccCChhccc-cchhHHHHHHHHHHHHHc-CCCChhhhhheeec-C
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAE-I----EPASFGLPDERLN-HYTTEADLKREATICHML-KHPHVVELLETYSS-E   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~   77 (249)
                      |++||++.++++.|.++.+|..... .    ....++++..... .....+.+.+|+.+++++ +|+||+++++.|.. +
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            6789999999999999988755321 1    1122333322211 123346788999999999 89999999998854 4


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhc-------------------------------------------------------
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATA-------------------------------------------------------  102 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------  102 (249)
                      ..++++|||+++++|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5688999999999999888653211                                                       


Q ss_pred             --CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCcccccccc
Q psy14626        103 --GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTT  180 (249)
Q Consensus       103 --~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~  180 (249)
                        ...+++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.........           .
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~---vkL~DfG~a~~~~~~~~~-----------~  230 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDY-----------V  230 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCc---EEEeccccchhcccCcch-----------h
Confidence              124788999999999999999999999999999999999987665   999999998765332110           1


Q ss_pred             ccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC--ChHHHHHHHHcCc
Q psy14626        181 KAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG--SRDRLFQSITKGK  240 (249)
Q Consensus       181 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~--~~~~~~~~i~~g~  240 (249)
                      ......++..|+|||++.+..++.++|+||+||++++|++ |..||.+  ..+.+...+..+.
T Consensus       231 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~  293 (337)
T cd05054         231 RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT  293 (337)
T ss_pred             hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC
Confidence            1112235678999999999999999999999999999998 9999987  2344455555443

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.1e-33  Score=229.65  Aligned_cols=197  Identities=24%  Similarity=0.371  Sum_probs=160.1

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      .|++.+.++.|.++.++..........++++..... .......+.+|+.++++++||||+++++++..++.+++||||+
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~   81 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM   81 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence            577788888888888876654433333333322221 2334567889999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      ++++|.+++.....    +++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        82 ~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~~  154 (308)
T cd06615          82 DGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLIDSM  154 (308)
T ss_pred             CCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc---EEEccCCCcccccccc
Confidence            99999999876533    8999999999999999999997 58999999999999987766   9999999875443211


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                     .....++..|+|||.+.+..++.++|+||+|+++++|++|..||..
T Consensus       155 ---------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         155 ---------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             ---------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence                           1123478899999999888889999999999999999999999976

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.5e-33  Score=230.92  Aligned_cols=215  Identities=20%  Similarity=0.277  Sum_probs=165.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCC----cccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPA----SFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      ..+|+....++.|.++.+|.........    .++++... .......+.+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence            4568888999999988888654321111    12222221 22234567799999999999999999999999765 478


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      ++++|+++|+|.+++.....   .++...+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++..
T Consensus        85 ~v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~---~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc---EEEcccccccc
Confidence            99999999999998876432   3788999999999999999999999999999999999987666   99999999976


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .......           ........+..|+|||.+.+..++.++|+||||+++|||++ |..||.+ ...++.+.+..+
T Consensus       159 ~~~~~~~-----------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~  227 (316)
T cd05108         159 LGADEKE-----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG  227 (316)
T ss_pred             ccCCCcc-----------eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCC
Confidence            6542210           01111224568999999998889999999999999999998 9999988 444555444443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.9e-33  Score=253.85  Aligned_cols=218  Identities=23%  Similarity=0.417  Sum_probs=168.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeec--CCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSS--EGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   83 (249)
                      .+|.+...|+.|.++.+|...+......++++....  ........+.+|+.+++.++||||++++++|..  ...+|+|
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIV   92 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYIL   92 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEE
Confidence            489999999999999998777665444443332221  223446778999999999999999999998853  4579999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-------CceeecCCCCCeeeeecC----------
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-------DIIHRDIKPHCVLLANKE----------  146 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-------~~vH~dlkp~Nili~~~~----------  146 (249)
                      |||+++++|.+++.........+++..++.|+.||+.||.|||+.       +|+|+||||+|||++.+.          
T Consensus        93 MEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~  172 (1021)
T PTZ00266         93 MEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA  172 (1021)
T ss_pred             EeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence            999999999998876544444589999999999999999999984       499999999999996431          


Q ss_pred             ----CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHh
Q psy14626        147 ----NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLT  220 (249)
Q Consensus       147 ----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~  220 (249)
                          ....++|+|||++.......              ......+++.|+|||++.+  ..++.++|||||||+||+|++
T Consensus       173 ~n~ng~~iVKLsDFGlAr~l~~~s--------------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT  238 (1021)
T PTZ00266        173 NNLNGRPIAKIGDFGLSKNIGIES--------------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS  238 (1021)
T ss_pred             cccCCCCceEEccCCccccccccc--------------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence                12348999999986654321              1112357999999999864  347889999999999999999


Q ss_pred             CCCCCCC--ChHHHHHHHHcC
Q psy14626        221 GTLPFVG--SRDRLFQSITKG  239 (249)
Q Consensus       221 g~~pf~~--~~~~~~~~i~~g  239 (249)
                      |..||..  ....+...+..+
T Consensus       239 Gk~PF~~~~~~~qli~~lk~~  259 (1021)
T PTZ00266        239 GKTPFHKANNFSQLISELKRG  259 (1021)
T ss_pred             CCCCCCcCCcHHHHHHHHhcC
Confidence            9999986  334555555544

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.4e-33  Score=235.78  Aligned_cols=196  Identities=27%  Similarity=0.399  Sum_probs=155.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ..|...+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++|+||+++++++...+.+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            3577778899999999987765544444444332221 223456789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+++|....        ...+..+..++.||+.||.|||+++++|+||||+|||++.++.   ++|+|||++.......
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC---EEEcccccceeccccc
Confidence            9999885421        1567888899999999999999999999999999999987766   9999999987654321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .             ......++..|+|||.+..     ...+.++|||||||++|+|++|+.||..
T Consensus       223 ~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        223 D-------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             c-------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            0             1112357899999998743     2235689999999999999999999975

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.8e-32  Score=221.72  Aligned_cols=215  Identities=26%  Similarity=0.450  Sum_probs=169.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeec-CCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSS-EGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   85 (249)
                      +|++.+.++.|.++.++...+......++++.....  .....+.+.+|+.++++++|+|++++++.+.. ...++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            467777888888888876665544444444433222  22345678999999999999999999998864 456899999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++++++|.+.+.....  ..+++.++..++.+++.++.+||+.|++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~---~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI---IKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc---EEEecccceEEeccc
Confidence            9999999888865432  23899999999999999999999999999999999999987766   999999998766432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      ..             ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||.. +.......+.++.+
T Consensus       156 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~  219 (257)
T cd08223         156 CD-------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL  219 (257)
T ss_pred             CC-------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC
Confidence            11             11123468899999999988889999999999999999999999987 45556666766654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.2e-33  Score=226.36  Aligned_cols=214  Identities=29%  Similarity=0.419  Sum_probs=169.8

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      |+.+.|+..+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||+++++.+..+..+++|
T Consensus         1 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           1 DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             ChHHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            4677899999999998888887665443333333322211 223456799999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +||+++++|.+++...     .+++..+..++.|++.|+.+||+++++|+||+|+||+++.++.   ++++|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~---~~l~dfg~~~~~~  152 (277)
T cd06642          81 MEYLGGGSALDLLKPG-----PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLT  152 (277)
T ss_pred             EEccCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC---EEEcccccccccc
Confidence            9999999998877532     3789999999999999999999999999999999999987665   9999999986554


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ....             ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.. ........+..+
T Consensus       153 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  216 (277)
T cd06642         153 DTQI-------------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN  216 (277)
T ss_pred             Ccch-------------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC
Confidence            3211             11112467889999999988889999999999999999999999986 333444444433

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.4e-33  Score=235.92  Aligned_cols=198  Identities=23%  Similarity=0.359  Sum_probs=159.4

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      ..++|++.+.++.|.++.++...+......++++...  .........+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999877665444444443322  22334456788999999999999999999988543      


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ...++||||+.+ +|...+..      .++...+..++.|++.||.+||++|++||||||+||+++.++.   ++|+|||
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~---~kl~Dfg  164 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFG  164 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC---EEEeeCc
Confidence            357999999975 66555543      2788999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++.......              ......++..|+|||++.+..++.++|+||+||++|+|++|+.||.+
T Consensus       165 ~~~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  220 (355)
T cd07874         165 LARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             ccccCCCcc--------------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            986544321              11123478999999999988899999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-33  Score=226.47  Aligned_cols=224  Identities=21%  Similarity=0.346  Sum_probs=170.7

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-----CCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .++|++.+.++.|.++.+|......     ....++++..... .......+.+|+.+++.++||||+++++++..+...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4578888899988888877544321     1122222222211 224456788999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhc------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         81 YMVFEYMDGSDICFEIVRRATA------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                      ++||||+++++|.+++......      ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.   ++|+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~---~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT---VKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC---EEEC
Confidence            9999999999999988754321      123678899999999999999999999999999999999988766   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRL  232 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~  232 (249)
                      |||.+.........           .......++..|+|||.+.+..++.++|+||||+++|++++ |..||.+ +.+++
T Consensus       162 dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  230 (277)
T cd05032         162 DFGMTRDIYETDYY-----------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV  230 (277)
T ss_pred             CcccchhhccCccc-----------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH
Confidence            99998655432211           01112235678999999988888999999999999999998 9999987 55666


Q ss_pred             HHHHHcCc-cccc
Q psy14626        233 FQSITKGK-LHIL  244 (249)
Q Consensus       233 ~~~i~~g~-~~~~  244 (249)
                      .+.+..+. +.+|
T Consensus       231 ~~~~~~~~~~~~~  243 (277)
T cd05032         231 LKFVIDGGHLDLP  243 (277)
T ss_pred             HHHHhcCCCCCCC
Confidence            66666543 3444

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.2e-32  Score=223.83  Aligned_cols=214  Identities=19%  Similarity=0.324  Sum_probs=166.4

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +..+|++.+.++.|.++.+|....... ..++++.... .....+.+.+|+++++.++||||+++++.+.+ ...++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEeccc-CccCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            346799999999998888876544322 2233322221 22345678999999999999999999988754 45899999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++....  +..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~---~~L~dfg~~~~~~~~  155 (262)
T cd05071          81 YMSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDN  155 (262)
T ss_pred             cCCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc---EEeccCCceeecccc
Confidence            999999999887542  223788999999999999999999999999999999999987665   899999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ..            .......++..|+|||...+..++.++|+||+|+++|+|++ |+.||.+ ...++.+.+..+
T Consensus       156 ~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~  219 (262)
T cd05071         156 EY------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG  219 (262)
T ss_pred             cc------------ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC
Confidence            21            01111235678999999988888999999999999999999 9999988 455666666554

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.5e-32  Score=227.21  Aligned_cols=214  Identities=26%  Similarity=0.424  Sum_probs=167.8

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +|.+-|.....++.|.++.++..........++++..........+.+.+|+.+++.++|||++++++.+..++..++++
T Consensus        18 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~   97 (297)
T cd06659          18 DPRSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM   97 (297)
T ss_pred             cchhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence            44455666667788888887766554444444444433334445677899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|...+...     .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        98 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~---~kL~dfg~~~~~~~  169 (297)
T cd06659          98 EFLQGGALTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISK  169 (297)
T ss_pred             ecCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc---EEEeechhHhhccc
Confidence            999999998766432     2789999999999999999999999999999999999987766   99999998754432


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ..             .......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.. +..+....+...
T Consensus       170 ~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~  232 (297)
T cd06659         170 DV-------------PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS  232 (297)
T ss_pred             cc-------------ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc
Confidence            11             011123478899999999988889999999999999999999999987 333444444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-32  Score=221.83  Aligned_cols=214  Identities=20%  Similarity=0.328  Sum_probs=166.3

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +.++|++.+.++.|.++.+|....... ..++++.... .....+.+.+|+.++++++|++++++++.+.. ...+++||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~k~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCC-ceeEEEEecC-CCCCHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEE
Confidence            345799999999999888886654322 2222222221 22345679999999999999999999998854 45889999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++....  ...+++.+++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~---~~l~dfg~~~~~~~~  155 (260)
T cd05070          81 YMSKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV---CKIADFGLARLIEDN  155 (260)
T ss_pred             ecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce---EEeCCceeeeeccCc
Confidence            999999998886533  223789999999999999999999999999999999999987665   899999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ...            ......++..|+|||.+.+..++.++|+||||+++++|++ |..||.+ +..++.+.+..+
T Consensus       156 ~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05070         156 EYT------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG  219 (260)
T ss_pred             ccc------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            210            1111124567999999988888999999999999999999 9999988 455666666654

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-32  Score=226.29  Aligned_cols=219  Identities=20%  Similarity=0.373  Sum_probs=167.2

Q ss_pred             CcchHHHhhcccceeeEeeeccc---cC-CCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAE---IE-PASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +.|++.+.++.|.++.+|.....   .. ...++++... .........+.+|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            45777788888888887765421   11 1122222221 1223345678999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhh-------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC
Q psy14626         83 VFEYMDGSDICFEIVRRAT-------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~  149 (249)
                      +|||+++++|.+++..+..             ....+++.++..++.|++.||.|||+++++|+||||+||+++.++.  
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--  162 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--
Confidence            9999999999998864321             1223788999999999999999999999999999999999987665  


Q ss_pred             CeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-
Q psy14626        150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-  227 (249)
Q Consensus       150 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-  227 (249)
                       ++|+|||++.........           .......++..|+|||.+.+..++.++|+||||+++++|++ |..||.+ 
T Consensus       163 -~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         163 -VKISDLGLSREIYSADYY-----------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             -EEeccccccccccCCcce-----------ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence             999999998665432210           01112234667999999988888999999999999999998 9999987 


Q ss_pred             ChHHHHHHHHcCc
Q psy14626        228 SRDRLFQSITKGK  240 (249)
Q Consensus       228 ~~~~~~~~i~~g~  240 (249)
                      +..++.+.+..+.
T Consensus       231 ~~~~~~~~~~~~~  243 (283)
T cd05090         231 SNQEVIEMVRKRQ  243 (283)
T ss_pred             CHHHHHHHHHcCC
Confidence            5556677766654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-32  Score=231.46  Aligned_cols=197  Identities=24%  Similarity=0.396  Sum_probs=157.7

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      ..++|++.+.++.|.++.++...+......++++...  .........+.+|+.+++.++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999998876655444444443222  12223456688999999999999999999988543      


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ...+++++++ +++|...+...     .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.   ++|+|||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~---~kl~Dfg  163 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE---LRILDFG  163 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC---EEEcCCc
Confidence            3478999988 66887766432     3899999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++.......                ....++..|+|||++.+ ..++.++|+||+||++|+|++|+.||.+
T Consensus       164 ~~~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  218 (343)
T cd07878         164 LARQADDEM----------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             cceecCCCc----------------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            987654321                11247889999999876 4678999999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.9e-32  Score=225.24  Aligned_cols=217  Identities=25%  Similarity=0.428  Sum_probs=173.6

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ..|+.++|.....++.|.++.++..........++++..........+.+.+|+.+++.++|||++++++++..++..++
T Consensus        14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          14 PGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             CCcchHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            45666777877888888888887665544444445444444444556778999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ++||+++++|.+++.. .    .++...+..++.|++.++.+||+.|++|+||+|+||+++.++.   ++|+|||.+...
T Consensus        94 v~e~~~~~~L~~~~~~-~----~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~d~g~~~~~  165 (285)
T cd06648          94 VMEFLEGGALTDIVTH-T----RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR---VKLSDFGFCAQV  165 (285)
T ss_pred             EEeccCCCCHHHHHHh-C----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc---EEEcccccchhh
Confidence            9999999999988765 2    2789999999999999999999999999999999999987766   999999987544


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....             ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||.. +.......+..+.
T Consensus       166 ~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~  231 (285)
T cd06648         166 SKEVP-------------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL  231 (285)
T ss_pred             ccCCc-------------ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC
Confidence            33110             11123478899999999888889999999999999999999999987 4444555666553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-32  Score=222.43  Aligned_cols=217  Identities=16%  Similarity=0.340  Sum_probs=166.4

Q ss_pred             chHHHhhcccceeeEeeeccccCC---CcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe-----
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM-----   79 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----   79 (249)
                      |++.++++.|.++.++........   ..++++...  .......+.+.+|+.+++.++||||+++++.+.+...     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            467788888888888765543221   223332222  2223445689999999999999999999998865543     


Q ss_pred             -EEEEEeccCCCchhHHHHHhhh--cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         80 -LYMVFEYMDGSDICFEIVRRAT--AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        80 -~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                       .++++||+++++|..++.....  ....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.   ++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT---VCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe---EEECCc
Confidence             7999999999999888865432  2235899999999999999999999999999999999999987665   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~  234 (249)
                      |.+........+           ........+..|+|||.+.+..++.++|+||+||++|||++ |..||.+ ...++.+
T Consensus       158 g~~~~~~~~~~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~  226 (273)
T cd05035         158 GLSKKIYSGDYY-----------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYD  226 (273)
T ss_pred             cceeeccccccc-----------cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            998766443211           01111224568999999988888999999999999999999 9999988 5566777


Q ss_pred             HHHcCc
Q psy14626        235 SITKGK  240 (249)
Q Consensus       235 ~i~~g~  240 (249)
                      .+..+.
T Consensus       227 ~~~~~~  232 (273)
T cd05035         227 YLRHGN  232 (273)
T ss_pred             HHHcCC
Confidence            777654

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=8.8e-33  Score=228.17  Aligned_cols=202  Identities=29%  Similarity=0.500  Sum_probs=167.0

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++.++|.+.+.++.|.++.+|...+......++++..........+.+.+|+.+++.++|||++++++.+..++..++|+
T Consensus        16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            56789999999999998888876544333444444433444455678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++...     .++..++..++.|++.|+.+||++|++|+||+|+||+++.++.   ++|+|||++.....
T Consensus        96 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~---~kL~dfg~~~~~~~  167 (293)
T cd06647          96 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQITP  167 (293)
T ss_pred             ecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC---EEEccCcceecccc
Confidence            999999998887643     2788999999999999999999999999999999999987665   99999998765443


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...             ......+++.|++||.+.+..++.++|+||+|+++|++++|+.||..
T Consensus       168 ~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~  217 (293)
T cd06647         168 EQS-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN  217 (293)
T ss_pred             ccc-------------ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            221             11122467889999999888889999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0586|consensus

Probab=100.00  E-value=1.3e-33  Score=240.28  Aligned_cols=214  Identities=32%  Similarity=0.547  Sum_probs=178.8

Q ss_pred             cchHHHhhcccceeeEeeeccccCC---CcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      -|.+...|+.|-++.+......+..   +++.+.+...+ ......+.+|+++|+.++||||++++.+.+....+|+|||
T Consensus        57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e  135 (596)
T KOG0586|consen   57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME  135 (596)
T ss_pred             ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence            4556666666666665555554443   34434444444 3444559999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.++.+.+++...+.    ..+...+.+..|+.+|++|+|+++++|+|||.+|++++.+.+   ++|+|||++......
T Consensus       136 ya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn---ikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  136 YASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN---IKIADFGFSTFFDYG  208 (596)
T ss_pred             eccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc---eeeeccccceeeccc
Confidence            9999999999998776    667899999999999999999999999999999999998777   999999999776542


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      .              ......|++.|+|||++.+.++ ++.+|+||+|+++|.|+.|.+||.+ +..++.++...|++.+
T Consensus       209 ~--------------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rI  274 (596)
T KOG0586|consen  209 L--------------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRI  274 (596)
T ss_pred             c--------------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecc
Confidence            2              2233458999999999999887 7999999999999999999999999 7788899999999998


Q ss_pred             c
Q psy14626        244 L  244 (249)
Q Consensus       244 ~  244 (249)
                      |
T Consensus       275 p  275 (596)
T KOG0586|consen  275 P  275 (596)
T ss_pred             c
Confidence            8

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1e-32  Score=227.93  Aligned_cols=214  Identities=24%  Similarity=0.390  Sum_probs=164.4

Q ss_pred             CCCcchHHHhhcccceeeEeeecccc----------------CCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChh
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEI----------------EPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVV   68 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~   68 (249)
                      |.++|++.+.++.|.++.+|......                ....++++..... .....+.+.+|+.+++.++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            67889999999999999888653221                0111222222211 233456899999999999999999


Q ss_pred             hhhheeecCCeEEEEEeccCCCchhHHHHHhhhcC-------CccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCee
Q psy14626         69 ELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAG-------FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL  141 (249)
Q Consensus        69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nil  141 (249)
                      ++++++..++..++||||+++++|.+++.......       ..++..++..++.|++.||.+||+.+++|+||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999887643221       23677899999999999999999999999999999999


Q ss_pred             eeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-
Q psy14626        142 LANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-  220 (249)
Q Consensus       142 i~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-  220 (249)
                      ++.++.   ++|+|||.+.........           ........+..|++||...+..++.++|+||+||++|||++ 
T Consensus       163 i~~~~~---~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~  228 (296)
T cd05095         163 VGKNYT---IKIADFGMSRNLYSGDYY-----------RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTL  228 (296)
T ss_pred             EcCCCC---EEeccCcccccccCCcce-----------eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHh
Confidence            987665   999999998654332110           01111224578999999888888999999999999999998 


Q ss_pred             -CCCCCCC-ChHHHH
Q psy14626        221 -GTLPFVG-SRDRLF  233 (249)
Q Consensus       221 -g~~pf~~-~~~~~~  233 (249)
                       |..||.. +..++.
T Consensus       229 ~~~~p~~~~~~~~~~  243 (296)
T cd05095         229 CKEQPYSQLSDEQVI  243 (296)
T ss_pred             CCCCCccccChHHHH
Confidence             7789986 444433

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.4e-33  Score=226.36  Aligned_cols=194  Identities=25%  Similarity=0.405  Sum_probs=159.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +.|++.++++.|.++.+|...+......++++..... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577788899998888887765544444444433222 234456799999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|..+.        .+++..+..++.|++.|+.+||+.+++|+||||+||+++.++.   ++|+|||++.......
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~---~~l~dfg~~~~~~~~~  149 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLVNSI  149 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC---EEEeeCCcceeccccc
Confidence            9999885432        2688899999999999999999999999999999999988766   9999999986654321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                     .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||..
T Consensus       150 ---------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         150 ---------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             ---------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence                           1112478899999999988899999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.1e-32  Score=224.06  Aligned_cols=214  Identities=29%  Similarity=0.432  Sum_probs=170.1

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      |+...|+....++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||+++++.+.++..+++|
T Consensus         1 ~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           1 DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             ChHHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            4566788899999988888887665543333343322222 234567899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++...     .++..++..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++++|||.+....
T Consensus        81 ~e~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~---~~l~dfg~~~~~~  152 (277)
T cd06640          81 MEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLT  152 (277)
T ss_pred             EecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC---EEEcccccceecc
Confidence            9999999998887542     2789999999999999999999999999999999999987766   9999999986654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ....             ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.. +.......+..+
T Consensus       153 ~~~~-------------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~  216 (277)
T cd06640         153 DTQI-------------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN  216 (277)
T ss_pred             CCcc-------------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC
Confidence            3221             11112467789999999888889999999999999999999999987 444444444433

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.8e-32  Score=228.52  Aligned_cols=205  Identities=20%  Similarity=0.289  Sum_probs=153.3

Q ss_pred             HHHhhcccc--eeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         12 IHEVINHKW--LKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        12 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      +.++|+.|.  ++.++..........++++.....  .....+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            456777773  445554444434344444333222  2344567888999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++......  .+++..++.++.|++.||.|||+++++|+||||+||+++.++.   +++.||+..........
T Consensus        82 ~~~~l~~~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~---~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHFMD--GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc---EEEcccchhhccccccc
Confidence            999999988654332  3789999999999999999999999999999999999987765   89999976533322110


Q ss_pred             cccCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..      ...........++..|+|||++.+  ..++.++|+||+||++++|++|+.||..
T Consensus       157 ~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         157 RL------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             cc------cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            00      000001112235678999999876  3578999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.2e-33  Score=229.73  Aligned_cols=214  Identities=21%  Similarity=0.370  Sum_probs=164.6

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCc--ccCCh-hccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPAS--FGLPD-ERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .|++.++++.|.++.++..........  .+++. ...........+.+|+.++.++ +||||+++++++..++.+++||
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~   87 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI   87 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence            577788899998888887654322211  12211 1112234456789999999999 8999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhh------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         85 EYMDGSDICFEIVRRAT------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      ||+++++|.+++.....            ....++..+++.++.|++.||.+||++|++|+||||+||+++.++.   ++
T Consensus        88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~---~k  164 (303)
T cd05088          88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AK  164 (303)
T ss_pred             EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc---EE
Confidence            99999999998875532            1224789999999999999999999999999999999999987665   99


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChH
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRD  230 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~  230 (249)
                      |+|||++.......              .......+..|+|||.+.+..++.++|+||+|+++++|++ |..||.+ +..
T Consensus       165 l~dfg~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  230 (303)
T cd05088         165 IADFGLSRGQEVYV--------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA  230 (303)
T ss_pred             eCccccCcccchhh--------------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH
Confidence            99999874321100              0111123567999999988888999999999999999998 9999987 455


Q ss_pred             HHHHHHHcC
Q psy14626        231 RLFQSITKG  239 (249)
Q Consensus       231 ~~~~~i~~g  239 (249)
                      ++.+.+..+
T Consensus       231 ~~~~~~~~~  239 (303)
T cd05088         231 ELYEKLPQG  239 (303)
T ss_pred             HHHHHHhcC
Confidence            555555443

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG4250|consensus

Probab=100.00  E-value=9.2e-33  Score=238.33  Aligned_cols=205  Identities=26%  Similarity=0.387  Sum_probs=167.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC------eE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG------ML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~   80 (249)
                      --+...+.++.|.++.+|...+.......+++.- ........+.-.+|+++|++++|+|||+++++-++..      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3456678899999999987775544444443211 1224567788999999999999999999999976544      46


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC-CCCCeEEcCccee
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGGFGVA  159 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~-~~~~~~l~dfg~~  159 (249)
                      .+|||||.||||...+.+-. +...+++.+++.++..+..|+.|||++||+||||||.||++-... ...+.||+|||.|
T Consensus        93 vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            89999999999998886543 345599999999999999999999999999999999999986543 2344699999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      +...+..              ...+..||..|.+||.... ..++..+|.||+||++|++.||..||.-
T Consensus       172 rel~d~s--------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  172 RELDDNS--------------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             ccCCCCC--------------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            8887744              4455689999999999884 7789999999999999999999999985

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.7e-32  Score=222.43  Aligned_cols=215  Identities=24%  Similarity=0.364  Sum_probs=166.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC---CCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +++|++.++++.|.++.+|.......   ...++++...... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEE
Confidence            35688888999888888875543221   1223332222222 34567899999999999999999999998764 4789


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|.+++.....   .++..++..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||++...
T Consensus        84 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~---~~l~d~g~~~~~  157 (270)
T cd05056          84 VMELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDC---VKLGDFGLSRYL  157 (270)
T ss_pred             EEEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCC---eEEccCceeeec
Confidence            9999999999999865432   3799999999999999999999999999999999999987665   999999998766


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....+.            .....++..|+|||.+.+..++.++|+||||++++++++ |+.||.. +..+....+.++.
T Consensus       158 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~  225 (270)
T cd05056         158 EDESYYK------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE  225 (270)
T ss_pred             cccccee------------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence            5432110            001124567999999988888999999999999999986 9999988 4455556666654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.6e-33  Score=223.56  Aligned_cols=215  Identities=26%  Similarity=0.454  Sum_probs=171.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +|++.+.++.|.++.+|...+......++++   +.........+.+.+|+.++++++||||+++++.+..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            3667778888888888766655333333333   2233333556789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+++|..++....    .+++.++..++.|++.+|.+||+++++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH---VHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC---EEEeecccccccCCC
Confidence            999999998887653    2899999999999999999999999999999999999987766   999999998665442


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC----hHHHHHHHHcCcc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS----RDRLFQSITKGKL  241 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~----~~~~~~~i~~g~~  241 (249)
                      .              ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...    .+.+.+.......
T Consensus       154 ~--------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  219 (258)
T cd05578         154 T--------------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADV  219 (258)
T ss_pred             c--------------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccc
Confidence            1              111234678899999998888899999999999999999999999973    2444444443444


Q ss_pred             ccc
Q psy14626        242 HIL  244 (249)
Q Consensus       242 ~~~  244 (249)
                      .+|
T Consensus       220 ~~~  222 (258)
T cd05578         220 LYP  222 (258)
T ss_pred             cCc
Confidence            444

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.5e-32  Score=222.15  Aligned_cols=216  Identities=18%  Similarity=0.332  Sum_probs=169.6

Q ss_pred             CcchHHHhhcccceeeEeeeccccC---CCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+|++.+.++.|.++.+|.......   ...++++... .........+.+|+.+++.++||||+++++.+..++..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            4678889999998888876554332   1112222111 12234456789999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++.....   .++...+..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~---~~l~dfg~~~~~~  157 (266)
T cd05033          84 TEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRRLE  157 (266)
T ss_pred             EEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC---EEECccchhhccc
Confidence            999999999998866432   3899999999999999999999999999999999999987766   9999999987764


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....           .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||.. ...++.+.+.++.
T Consensus       158 ~~~~~-----------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~  225 (266)
T cd05033         158 DSEAT-----------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY  225 (266)
T ss_pred             ccccc-----------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCC
Confidence            21110           00111224678999999998889999999999999999998 9999987 5666777777653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-32  Score=228.27  Aligned_cols=201  Identities=23%  Similarity=0.402  Sum_probs=159.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      -++|++.+.++.|.++.+|...+......++++..... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            45789999999999988887665544333443322221 22334567899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+ +|.+++.....   .++...+..++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||.+......
T Consensus        85 ~~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~~~~  157 (301)
T cd07873          85 YLDK-DLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIP  157 (301)
T ss_pred             cccc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc---EEECcCcchhccCCC
Confidence            9974 88777765432   3789999999999999999999999999999999999987766   999999998654321


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..             ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|++||.+
T Consensus       158 ~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~  207 (301)
T cd07873         158 TK-------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG  207 (301)
T ss_pred             CC-------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence            10             11122467899999998654 468899999999999999999999988

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.6e-32  Score=226.57  Aligned_cols=229  Identities=26%  Similarity=0.415  Sum_probs=171.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|.+.+.++.|.++.+|..........++++   ..........+.+.+|+.+++.++||||+++++.+..++.+++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            4566677888888877765554433333333   2222223445678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++|++|.+++.....    +++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++++|||.+......
T Consensus        82 ~~~g~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~---~~l~dfg~~~~~~~~  154 (305)
T cd05609          82 YVEGGDCATLLKNIGA----LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKIGLMS  154 (305)
T ss_pred             cCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC---EEEeeCCCccccCcC
Confidence            9999999998866543    889999999999999999999999999999999999987665   999999987542211


Q ss_pred             CccccC--CccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        166 QLYCSG--GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       166 ~~~~~~--~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ......  ...............++..|+|||.+.+..++.++|+||+|+++++|++|..||.+ +.+++.+.+..+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~  234 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE  234 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence            100000  00000000000112367789999999888889999999999999999999999988 566777777777655


Q ss_pred             cc
Q psy14626        243 IL  244 (249)
Q Consensus       243 ~~  244 (249)
                      .|
T Consensus       235 ~~  236 (305)
T cd05609         235 WP  236 (305)
T ss_pred             CC
Confidence            54

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4278|consensus

Probab=100.00  E-value=6.1e-33  Score=236.59  Aligned_cols=218  Identities=22%  Similarity=0.352  Sum_probs=181.4

Q ss_pred             cchHHHhhcccceeeEeeeccc---cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAE---IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .+++...++||-|+.+|...+.   +.++++.++.    +....++|.+|+.+|+.++|||+|+++++|.....+|||+|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE----DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhh----cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            5778889999988888766554   3344443332    23557899999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ||.+|+|.+||.......  ++.-.++.++.||.+|++||..+++|||||...|+|+..+.-   +|++|||+++++...
T Consensus       344 fM~yGNLLdYLRecnr~e--v~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi---VKvADFGLsRlMtgD  418 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSE--VPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI---VKVADFGLSRLMTGD  418 (1157)
T ss_pred             cccCccHHHHHHHhchhh--cchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce---EEeeccchhhhhcCC
Confidence            999999999998765543  677788899999999999999999999999999999966554   999999999888764


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc-cc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK-LH  242 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~-~~  242 (249)
                      ..            |.......++.|.|||.+....++.++|||+||++|||+.| |-.||.+ +...+++.+.+|- ++
T Consensus       419 TY------------TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~  486 (1157)
T KOG4278|consen  419 TY------------TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMD  486 (1157)
T ss_pred             ce------------ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccccc
Confidence            32            22222235789999999999999999999999999999999 9999999 8888999888864 55


Q ss_pred             cc-ccc
Q psy14626        243 IL-GCT  247 (249)
Q Consensus       243 ~~-~~~  247 (249)
                      -| +||
T Consensus       487 ~PeGCP  492 (1157)
T KOG4278|consen  487 GPEGCP  492 (1157)
T ss_pred             CCCCCC
Confidence            55 555

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-32  Score=222.73  Aligned_cols=207  Identities=28%  Similarity=0.415  Sum_probs=165.1

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC----
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEG----   78 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~----   78 (249)
                      .+++.+|++.+.++.+.++.++..........++++..... ....+.+.+|+.+++++ +|+||+++++.+....    
T Consensus         2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            36889999999999998888877665544333443322222 23457799999999999 7999999999996543    


Q ss_pred             --eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         79 --MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        79 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                        .+++||||+++++|.+++......+..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+||
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~---~~l~d~  157 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE---VKLVDF  157 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe---EEECCC
Confidence              489999999999999888765533445899999999999999999999999999999999999987766   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      |.+........             ......++..|+|||.+..     ..++.++|+||+|+++++|++|+.||..
T Consensus       158 ~~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         158 GVSAQLDSTLG-------------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             ccceecccchh-------------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            99876543221             1122347888999998753     2357789999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.1e-32  Score=220.02  Aligned_cols=214  Identities=26%  Similarity=0.422  Sum_probs=168.0

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +|+..+.++.|.++.+|..........++++.....  .......+.+|+.++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            467777888888877775554433333333322211  234467899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.....  ..+++..+..++.+++.++.+||+++++|+||+|+||+++.++.  .++++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM--VVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEccCCCceecCCCc
Confidence            999999999876432  23789999999999999999999999999999999999975443  37999999987765422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                                    ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.. +.......+..+.
T Consensus       157 --------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  217 (256)
T cd08220         157 --------------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT  217 (256)
T ss_pred             --------------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC
Confidence                          11112467899999999988889999999999999999999999987 4455555555443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-32  Score=222.07  Aligned_cols=203  Identities=27%  Similarity=0.392  Sum_probs=159.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc-----cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-----LNHYTTEADLKREATICHMLKHPHVVELLETYSSE--GML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~   80 (249)
                      ..|++.++++.|.++.+|...+......++++...     .......+.+.+|+.++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            35777888988888888766554333333333221     11223456889999999999999999999998653  468


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      +++|||+++++|.+++.....    ++...+..++.|++.+|.+||+++++|+||+|+||+++.++.   ++|+|||.+.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC---EEECcCcccc
Confidence            899999999999988865433    788999999999999999999999999999999999987665   9999999886


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .........          .......++..|+|||++.+..++.++|+||+|+++|+|++|+.||..
T Consensus       155 ~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         155 RLQTICLSG----------TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             ccccccccc----------cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence            543211100          011122367899999999888889999999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.2e-32  Score=222.86  Aligned_cols=215  Identities=21%  Similarity=0.320  Sum_probs=155.4

Q ss_pred             hcccceeeEeeecc--ccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         16 INHKWLKMKLHTSA--EIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        16 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      ++.|.++.++....  ......++++..... .......+.+|+.+++.++||||+++++.+.+...+++||||+++++|
T Consensus         3 lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L   82 (269)
T cd05042           3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDL   82 (269)
T ss_pred             CCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcH
Confidence            56666666664422  122222333322222 223456788999999999999999999999999999999999999999


Q ss_pred             hHHHHHhhhc-CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccC
Q psy14626         93 CFEIVRRATA-GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG  171 (249)
Q Consensus        93 ~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~  171 (249)
                      .+++...... ...++...+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.........   
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~---~kl~dfg~~~~~~~~~~~---  156 (269)
T cd05042          83 KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS---VKIGDYGLALEQYPEDYY---  156 (269)
T ss_pred             HHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc---EEEeccccccccccchhe---
Confidence            9988765421 223567888999999999999999999999999999999987766   999999987543221100   


Q ss_pred             CccccccccccCCcccCCCCCCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHH-HHHHHHcCcc
Q psy14626        172 GERLDHYTTKAGHRIGTPHYMAPEVIED-------QKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDR-LFQSITKGKL  241 (249)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~-~~~~i~~g~~  241 (249)
                              .......+++.|+|||++..       ..++.++|+||+||++|+|++ |..||.. ...+ +.+.+..+..
T Consensus       157 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  228 (269)
T cd05042         157 --------ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI  228 (269)
T ss_pred             --------eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCc
Confidence                    00112235677999998743       345789999999999999999 8899987 3333 3444555554


Q ss_pred             ccc
Q psy14626        242 HIL  244 (249)
Q Consensus       242 ~~~  244 (249)
                      ++|
T Consensus       229 ~~~  231 (269)
T cd05042         229 KLP  231 (269)
T ss_pred             cCC
Confidence            444

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-32  Score=221.99  Aligned_cols=215  Identities=20%  Similarity=0.350  Sum_probs=169.9

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +..+|++.+.++.|.++.+|.....- ...++++... ......+.+.+|+.+++.++|+||+++++++......++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLK-PGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEec-CCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            45689999999999888887654332 2222322222 223345779999999999999999999999998888999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++++++|.+++....  +..++..++..++.|++.|+.+||+++++|+||+|+||+++.++.   ++++|||.+......
T Consensus        82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~---~~l~d~g~~~~~~~~  156 (261)
T cd05034          82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV---CKIADFGLARLIEDD  156 (261)
T ss_pred             ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC---EEECccccceeccch
Confidence            999999998886643  223899999999999999999999999999999999999988766   999999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ..            ........+..|+|||.+.+..++.++|+||+|++++++++ |+.||.+ +.....+.+..+
T Consensus       157 ~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~  220 (261)
T cd05034         157 EY------------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG  220 (261)
T ss_pred             hh------------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            11            00011124568999999998888999999999999999998 9999988 455666676654

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-32  Score=222.67  Aligned_cols=201  Identities=26%  Similarity=0.404  Sum_probs=160.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .+|++.++++.|.++.++..........++++..... .....+.+.+|+.++++++||||+++++.+...+.+++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            3688899999999998887766544444444322221 234457899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      +++++|..++.... ....+++..+..++.|++.||.+||+ .+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ---VKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC---EEEeecCCcccccCC
Confidence            99999988776532 12248999999999999999999997 59999999999999987665   999999988654331


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCC------CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK------YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .               .....++..|+|||.+.+..      ++.++|+||+||++|+|++|+.||..
T Consensus       157 ~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         157 L---------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             c---------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence            1               11123677899999986543      47899999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.2e-32  Score=223.40  Aligned_cols=222  Identities=19%  Similarity=0.321  Sum_probs=171.3

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-----CCCcccCChhccccch-hHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERLNHYT-TEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .++|++.+.++.|.++.+|......     ....++++........ ..+.+.+|+.++++++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            3678888889998888887665322     1122222222222222 456799999999999999999999999998899


Q ss_pred             EEEEeccCCCchhHHHHHhhhcC-----CccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAG-----FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                      ++||||+++++|.+++.......     ..+++..+..++.|++.+|.|||+++++|+||||+||+++.++.   ++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~---~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE---VKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc---EEEcc
Confidence            99999999999999887654221     14899999999999999999999999999999999999988766   89999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHH
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLF  233 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~  233 (249)
                      ||++........            .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||.. ....+.
T Consensus       161 ~~~~~~~~~~~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~  228 (275)
T cd05046         161 LSLSKDVYNSEY------------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL  228 (275)
T ss_pred             cccccccCcccc------------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH
Confidence            998754432211            11112235677999999988888899999999999999998 8899987 556667


Q ss_pred             HHHHcCcccc
Q psy14626        234 QSITKGKLHI  243 (249)
Q Consensus       234 ~~i~~g~~~~  243 (249)
                      ..+..+....
T Consensus       229 ~~~~~~~~~~  238 (275)
T cd05046         229 NRLQAGKLEL  238 (275)
T ss_pred             HHHHcCCcCC
Confidence            7777666443

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4e-32  Score=220.31  Aligned_cols=214  Identities=18%  Similarity=0.338  Sum_probs=167.5

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +.++|++...++.|.++.+|....... ..++++... ......+.+.+|+.+++.++|+||+++++.+.. ...+++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~iK~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCC-ccEEEEecC-CChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            467899999999999888886653321 122222111 222345778999999999999999999999887 67899999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++....  +..++...++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~  155 (260)
T cd05073          81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV---CKIADFGLARVIEDN  155 (260)
T ss_pred             eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc---EEECCCcceeeccCC
Confidence            999999999887643  233788899999999999999999999999999999999987665   999999998665432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ...            ......++..|+|||.+.+..++.++|+||+|++++++++ |+.||.+ +...+.+.+.++
T Consensus       156 ~~~------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05073         156 EYT------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG  219 (260)
T ss_pred             Ccc------------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC
Confidence            210            0011124567999999988888999999999999999998 9999998 455666666655

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-32  Score=237.74  Aligned_cols=212  Identities=27%  Similarity=0.347  Sum_probs=164.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +.+|.+...++.|.++.+|...+......++++.      .....+.+|+.++++++|+||+++++++..++..++||++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~------~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKA------GWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEec------ccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            4478888889888888888766654433333332      1223467899999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +. ++|..++.....   .+++.+++.++.|++.||.|||++|++|+||||+|||++.++.   ++|+|||++.......
T Consensus       242 ~~-~~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~---vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGARLR---PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC---EEEcccCCceeccccc
Confidence            95 588777765432   3899999999999999999999999999999999999987665   9999999987654321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC-CC--------hHHHHHHHH
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV-GS--------RDRLFQSIT  237 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~-~~--------~~~~~~~i~  237 (249)
                      ..           .......+|..|+|||++.+..++.++|+|||||++|||++|..|+- ..        ...+...|.
T Consensus       315 ~~-----------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~  383 (461)
T PHA03211        315 ST-----------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR  383 (461)
T ss_pred             cc-----------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence            10           01112358999999999999889999999999999999999765443 21        235666666


Q ss_pred             cCccc
Q psy14626        238 KGKLH  242 (249)
Q Consensus       238 ~g~~~  242 (249)
                      .+...
T Consensus       384 ~~~~~  388 (461)
T PHA03211        384 QAQVH  388 (461)
T ss_pred             hhccc
Confidence            65543

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-32  Score=235.30  Aligned_cols=196  Identities=24%  Similarity=0.329  Sum_probs=155.7

Q ss_pred             CcchHHHhhcccceeeEeeecccc-CC-CcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI-EP-ASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .+|.+...++.|.++.+|.....- .. ..++++..     .......+|+.+++.++||||+++++.+.....++++|+
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~-----~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-----TGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEec-----cccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            468899999999988888654321 11 11111111     112345689999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++. ++|.+++....    .+++.+++.++.|++.||.|||++|++|+||||+|||++.++.   ++|+|||++......
T Consensus       167 ~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~---~~l~DfG~a~~~~~~  238 (392)
T PHA03207        167 KYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN---AVLGDFGAACKLDAH  238 (392)
T ss_pred             hcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC---EEEccCccccccCcc
Confidence            996 57877774332    3899999999999999999999999999999999999987766   999999998655432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...           .......+++.|+|||++.+..++.++|+||+||++|+|++|+.||.+
T Consensus       239 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  289 (392)
T PHA03207        239 PDT-----------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG  289 (392)
T ss_pred             ccc-----------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            210           111123578999999999988899999999999999999999999976

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.9e-32  Score=227.21  Aligned_cols=221  Identities=24%  Similarity=0.399  Sum_probs=170.0

Q ss_pred             CCCcchHHHhhcccceeeEeeeccc-------cCCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeec
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAE-------IEPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSS   76 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~   76 (249)
                      |..+|.+.+.++.|.++.+|.....       .....++++.... ........+.+|+.+++++ +||||+++++++..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            4468999999999998888765421       1111222221111 1234456789999999999 69999999999998


Q ss_pred             CCeEEEEEeccCCCchhHHHHHhhh------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeee
Q psy14626         77 EGMLYMVFEYMDGSDICFEIVRRAT------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN  144 (249)
Q Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~  144 (249)
                      .+.++++|||+++++|.+++.....            ....++..++..++.|++.||.+||++|++|+||||+||+++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  169 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE  169 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcC
Confidence            8899999999999999999876432            1234888999999999999999999999999999999999987


Q ss_pred             cCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCC
Q psy14626        145 KENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL  223 (249)
Q Consensus       145 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~  223 (249)
                      ++.   ++|+|||.+.........           .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..
T Consensus       170 ~~~---~kL~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~  235 (314)
T cd05099         170 DNV---MKIADFGLARGVHDIDYY-----------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGS  235 (314)
T ss_pred             CCc---EEEccccccccccccccc-----------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCC
Confidence            665   999999998655432110           00011123467999999988888999999999999999999 999


Q ss_pred             CCCC-ChHHHHHHHHcCc
Q psy14626        224 PFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       224 pf~~-~~~~~~~~i~~g~  240 (249)
                      ||.+ +.+++.+.+..+.
T Consensus       236 p~~~~~~~~~~~~~~~~~  253 (314)
T cd05099         236 PYPGIPVEELFKLLREGH  253 (314)
T ss_pred             CCCCCCHHHHHHHHHcCC
Confidence            9988 5566777777664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.1e-32  Score=220.72  Aligned_cols=204  Identities=27%  Similarity=0.404  Sum_probs=159.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcc------ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL------NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +|++.+.++.|.++.+|....... ..++++....      ........+.+|+.+++.++|+||+++++++.+.+.+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~-~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQG-QLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCC-CeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            467788888888888776544322 2222221111      112334678999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ++||+++++|.+++.....    +++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+...
T Consensus        80 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~  152 (265)
T cd06631          80 FMEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI---IKLIDFGCARRL  152 (265)
T ss_pred             EEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe---EEeccchhhHhh
Confidence            9999999999998865433    789999999999999999999999999999999999987665   999999988654


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..........       .......++..|+|||.+.+..++.++|+||+|+++++|++|..||..
T Consensus       153 ~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         153 AWVGLHGTHS-------NMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             hhcccccccc-------ccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence            3211110000       001122478899999999988889999999999999999999999987

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-32  Score=224.47  Aligned_cols=216  Identities=25%  Similarity=0.353  Sum_probs=164.9

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccC--------------CCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhh
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIE--------------PASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVEL   70 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~   70 (249)
                      |+++|++.+.++.|.++.+|.....-.              ...++++.... ......+.+.+|++++++++|||++++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            567999999999999998886543211              00122221111 123445679999999999999999999


Q ss_pred             hheeecCCeEEEEEeccCCCchhHHHHHhhhc--------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeee
Q psy14626         71 LETYSSEGMLYMVFEYMDGSDICFEIVRRATA--------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLL  142 (249)
Q Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili  142 (249)
                      ++++...+..++||||+++++|.+++......        ...++..++..++.|++.||.+||+.+++|+||||+||++
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            99999999999999999999999988654211        1136788999999999999999999999999999999999


Q ss_pred             eecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh--
Q psy14626        143 ANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT--  220 (249)
Q Consensus       143 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--  220 (249)
                      +.++.   ++|+|||++.........           .......++..|+|||.+.+..++.++|+||||+++++|++  
T Consensus       163 ~~~~~---~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~  228 (295)
T cd05097         163 GNHYT---IKIADFGMSRNLYSGDYY-----------RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC  228 (295)
T ss_pred             cCCCc---EEecccccccccccCcce-----------eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence            87665   999999998654332110           11112234678999999988889999999999999999998  


Q ss_pred             CCCCCCC-ChHHHHHH
Q psy14626        221 GTLPFVG-SRDRLFQS  235 (249)
Q Consensus       221 g~~pf~~-~~~~~~~~  235 (249)
                      |..||.. +.+++.+.
T Consensus       229 ~~~p~~~~~~~~~~~~  244 (295)
T cd05097         229 KEQPYSLLSDEQVIEN  244 (295)
T ss_pred             CCCCCcccChHHHHHH
Confidence            6788887 44444433

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-32  Score=224.47  Aligned_cols=219  Identities=23%  Similarity=0.395  Sum_probs=169.3

Q ss_pred             CcchHHHhhcccceeeEeeeccc-------cCCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAE-------IEPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSEG   78 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   78 (249)
                      .+|++.+.++.|.++.+|.....       .....++++.... ........+.+|+.+++.+ +||||+++++.+....
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            47888899999988888755321       1111222222221 1234456789999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                      ..++||||+++++|.+++......            ...++..++..++.|++.||.|||+.|++|+||||+||+++.++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~  174 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN  174 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC
Confidence            999999999999999998765321            12477889999999999999999999999999999999998766


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF  225 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf  225 (249)
                      .   ++|+|||.+.........           .......++..|+|||++.+..++.++|+||||+++|+|++ |..||
T Consensus       175 ~---~kl~D~g~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~  240 (304)
T cd05101         175 V---MKIADFGLARDVNNIDYY-----------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  240 (304)
T ss_pred             c---EEECCCccceeccccccc-----------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence            5   999999998766432210           01111234578999999988888999999999999999998 89999


Q ss_pred             CC-ChHHHHHHHHcCc
Q psy14626        226 VG-SRDRLFQSITKGK  240 (249)
Q Consensus       226 ~~-~~~~~~~~i~~g~  240 (249)
                      .+ +.+++.+.+..+.
T Consensus       241 ~~~~~~~~~~~~~~~~  256 (304)
T cd05101         241 PGIPVEELFKLLKEGH  256 (304)
T ss_pred             ccCCHHHHHHHHHcCC
Confidence            88 5667777776654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=7e-32  Score=218.23  Aligned_cols=212  Identities=24%  Similarity=0.411  Sum_probs=165.0

Q ss_pred             hhcccceeeEeeeccccC---CCcccCChhccccc-hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIE---PASFGLPDERLNHY-TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.++.......   ...++++....... ...+.+.+|+.+++.++|+|++++++++.++..+++||||++++
T Consensus         2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (262)
T cd00192           2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG   81 (262)
T ss_pred             ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence            456666666665554432   23333322222211 24678999999999999999999999999999999999999999


Q ss_pred             chhHHHHHhhhc-----CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         91 DICFEIVRRATA-----GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        91 ~L~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      +|.+++......     ...+++.++..++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~---~~l~dfg~~~~~~~~  158 (262)
T cd00192          82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV---VKISDFGLSRDVYDD  158 (262)
T ss_pred             cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc---EEEcccccccccccc
Confidence            999998775211     234899999999999999999999999999999999999988766   999999998776543


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ...           .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||.. +..++.+.+.++.
T Consensus       159 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~  224 (262)
T cd00192         159 DYY-----------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY  224 (262)
T ss_pred             ccc-----------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence            210           01122246788999999988888999999999999999999 6999998 5566777776543

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.1e-32  Score=220.42  Aligned_cols=217  Identities=16%  Similarity=0.339  Sum_probs=164.7

Q ss_pred             chHHHhhcccceeeEeeeccccCCC--cccCC--hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------Ce
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPA--SFGLP--DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSE------GM   79 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~~   79 (249)
                      +.++++++.|.++.+|.........  .++++  +.........+.+.+|+.+++.++||||+++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567788888888887655432221  12222  11223345567889999999999999999999987432      24


Q ss_pred             EEEEEeccCCCchhHHHHHhhh--cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         80 LYMVFEYMDGSDICFEIVRRAT--AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      .+++|||+.+++|.+++.....  ....++...+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN---VCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC---EEECCCC
Confidence            6899999999999887754321  2234789999999999999999999999999999999999987665   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~  235 (249)
                      .+..........           .......++.|++||.+.+..++.++|+||+|+++|+|++ |+.||.+ ...++.+.
T Consensus       158 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  226 (272)
T cd05075         158 LSKKIYNGDYYR-----------QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY  226 (272)
T ss_pred             cccccCccccee-----------cCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            987654322110           1112235678999999998889999999999999999999 8999987 56677777


Q ss_pred             HHcCc
Q psy14626        236 ITKGK  240 (249)
Q Consensus       236 i~~g~  240 (249)
                      +.++.
T Consensus       227 ~~~~~  231 (272)
T cd05075         227 LRQGN  231 (272)
T ss_pred             HHcCC
Confidence            77765

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=6.2e-32  Score=219.01  Aligned_cols=177  Identities=23%  Similarity=0.426  Sum_probs=143.9

Q ss_pred             hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH  126 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH  126 (249)
                      ...+.+.+|+.++++++||||+++++.+.. ...++||||+++++|.+++.....   .+++.+++.++.|++.||.+||
T Consensus        37 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH  112 (257)
T cd05115          37 SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKD---EITVSNVVELMHQVSMGMKYLE  112 (257)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHH
Confidence            445679999999999999999999998864 468999999999999988865432   3899999999999999999999


Q ss_pred             HCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcc
Q psy14626        127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPV  206 (249)
Q Consensus       127 ~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  206 (249)
                      ++|++|+||||+||+++.++.   ++|+|||++..........          .......++..|+|||.+.+..++.++
T Consensus       113 ~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~  179 (257)
T cd05115         113 GKNFVHRDLAARNVLLVNQHY---AKISDFGLSKALGADDSYY----------KARSAGKWPLKWYAPECINFRKFSSRS  179 (257)
T ss_pred             hcCeeecccchheEEEcCCCc---EEeccCCccccccCCccce----------eccCCCCCCcccCCHHHHccCCCCchh
Confidence            999999999999999987665   9999999986543321100          000111235689999999888889999


Q ss_pred             hHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        207 DIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       207 DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      |+||||+++|++++ |+.||.+ ...++...+.+|.
T Consensus       180 Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  215 (257)
T cd05115         180 DVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK  215 (257)
T ss_pred             hHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC
Confidence            99999999999996 9999988 5556666676655

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.1e-32  Score=221.93  Aligned_cols=217  Identities=18%  Similarity=0.298  Sum_probs=165.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCC---cccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPA---SFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .|++.++++.|.++.+|.........   .++++.... ........+.+|+.+++.++||||+++++++.++...++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            47788889999888887655432221   122222211 12345678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....   .++..+++.++.|++.||.+||++|++|+||+|+||+++.++.   ++++|||.+.....
T Consensus        85 e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~---~kl~dfg~~~~~~~  158 (269)
T cd05065          85 EFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLED  158 (269)
T ss_pred             ecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCc---EEECCCcccccccc
Confidence            99999999888865432   3789999999999999999999999999999999999977655   99999998765543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .....      .  .........+..|+|||.+.+..++.++|+||+|++++|+++ |..||.. +..++.+.+..+
T Consensus       159 ~~~~~------~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~  227 (269)
T cd05065         159 DTSDP------T--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD  227 (269)
T ss_pred             Ccccc------c--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence            22100      0  000000112457999999998888999999999999999887 9999987 555666666543

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.8e-32  Score=225.99  Aligned_cols=219  Identities=24%  Similarity=0.399  Sum_probs=168.0

Q ss_pred             CcchHHHhhcccceeeEeeecccc-----CCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSEGML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (249)
                      .+|++.+.++.|.++.+|......     ....++++.... ........+.+|+.+++++ +|+||+++++++..++.+
T Consensus        12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   91 (293)
T cd05053          12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL   91 (293)
T ss_pred             hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCe
Confidence            477788888888877777554321     111222221111 1223446688999999999 799999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhh------------hcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC
Q psy14626         81 YMVFEYMDGSDICFEIVRRA------------TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS  148 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~  148 (249)
                      +++|||+++++|..++..+.            .....+++..++.++.|++.||.|||+.+++|+||||+||+++.++. 
T Consensus        92 ~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~-  170 (293)
T cd05053          92 YVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV-  170 (293)
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe-
Confidence            99999999999999887542            12345889999999999999999999999999999999999987665 


Q ss_pred             CCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy14626        149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG  227 (249)
Q Consensus       149 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~  227 (249)
                        ++|+|||.+..........           ......++..|+|||...+..++.++|+||+||++|+|++ |..||.+
T Consensus       171 --~kL~Dfg~~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         171 --MKIADFGLARDIHHIDYYR-----------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             --EEeCcccccccccccccee-----------ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence              9999999987654422110           0111124567999999988888999999999999999997 9999988


Q ss_pred             -ChHHHHHHHHcCc
Q psy14626        228 -SRDRLFQSITKGK  240 (249)
Q Consensus       228 -~~~~~~~~i~~g~  240 (249)
                       ..+++.+.+..+.
T Consensus       238 ~~~~~~~~~~~~~~  251 (293)
T cd05053         238 IPVEELFKLLKEGY  251 (293)
T ss_pred             CCHHHHHHHHHcCC
Confidence             5566777776654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=6.3e-32  Score=221.49  Aligned_cols=216  Identities=17%  Similarity=0.220  Sum_probs=164.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCC----cccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPA----SFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +.|++.+.++.|.++.+|.........    .++++..... .......+.+|+..+..++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            467778889999888887655422211    1222222111 12334577888889999999999999998754 45789


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ++||+++++|.+++.....   .+++..+..|+.|++.||.|||+++++|+||||+||+++.++.   ++|+|||.+...
T Consensus        86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~---~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI---VQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc---EEEcCCccceec
Confidence            9999999999998875432   3899999999999999999999999999999999999987665   999999998765


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ......           .......++..|+|||.+.+..++.++|+||||+++||+++ |..||.+ ...++.+.+.+|.
T Consensus       160 ~~~~~~-----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (279)
T cd05111         160 YPDDKK-----------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE  228 (279)
T ss_pred             cCCCcc-----------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC
Confidence            432110           00111235678999999988889999999999999999998 9999988 4556666776665


Q ss_pred             c
Q psy14626        241 L  241 (249)
Q Consensus       241 ~  241 (249)
                      .
T Consensus       229 ~  229 (279)
T cd05111         229 R  229 (279)
T ss_pred             c
Confidence            3

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.1e-32  Score=220.21  Aligned_cols=214  Identities=26%  Similarity=0.478  Sum_probs=169.6

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ||++...++.|.++..+..........++++.....  .....+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            577788888888877776555444444444432221  234456889999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+.+.....  ..+++.++..|+.|++.++.+||+++++|+||+|+||+++.++.   ++++|||.+.......
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~---~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---IKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEEeeccceeecCcch
Confidence            999999888865432  23789999999999999999999999999999999999987665   9999999987654422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .             ......+++.|+|||++.+..++.++|+||+|+++++|++|+.||.. +..++...+..+.
T Consensus       156 ~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~  217 (256)
T cd08218         156 E-------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS  217 (256)
T ss_pred             h-------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC
Confidence            1             01112367889999999888889999999999999999999999987 4555665655554

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.1e-32  Score=222.25  Aligned_cols=219  Identities=22%  Similarity=0.373  Sum_probs=168.6

Q ss_pred             cchHHHhhcccceeeEeeecccc-----CCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      .|.+.+.++.|.++.+|......     ....++++..... .....+.+.+|+.++..++||||+++++++.+.+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            47788889888888777554321     1122232222211 12335678999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhh------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCC
Q psy14626         83 VFEYMDGSDICFEIVRRAT------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP  150 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~  150 (249)
                      +++|+.+++|.+++..+..            ....++...+..++.|++.||.+||+.|++|+||||+||+++.++.   
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~---  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN---  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc---
Confidence            9999999999988864321            1123788899999999999999999999999999999999987665   


Q ss_pred             eEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-C
Q psy14626        151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-S  228 (249)
Q Consensus       151 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~  228 (249)
                      ++|+|||++.........           .......+++.|+|||.+.+..++.++|+||+||+++||++ |..||.+ .
T Consensus       163 ~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  231 (283)
T cd05091         163 VKISDLGLFREVYAADYY-----------KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  231 (283)
T ss_pred             eEecccccccccccchhe-----------eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999998655432210           11112235678999999988888999999999999999998 9999988 5


Q ss_pred             hHHHHHHHHcCcc
Q psy14626        229 RDRLFQSITKGKL  241 (249)
Q Consensus       229 ~~~~~~~i~~g~~  241 (249)
                      ..++.+.+.++..
T Consensus       232 ~~~~~~~i~~~~~  244 (283)
T cd05091         232 NQDVIEMIRNRQV  244 (283)
T ss_pred             HHHHHHHHHcCCc
Confidence            6678888877764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0596|consensus

Probab=100.00  E-value=2.5e-32  Score=229.80  Aligned_cols=220  Identities=23%  Similarity=0.377  Sum_probs=171.4

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCCh--hccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPD--ERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++.|++...|+.|+-..+|..... +..++++++  ....+....+.+.+|+.+|.+| .|.+|+.++++-..++.+|||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            467999999999987666644443 334444433  3344567788999999999999 599999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||+-+ -+|...|......   .+.-.++.++.||+.++.++|+.||||.||||.|+|+.. |.   +||+|||++.-+.
T Consensus       439 mE~Gd-~DL~kiL~k~~~~---~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~---LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  439 MECGD-IDLNKILKKKKSI---DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GR---LKLIDFGIANAIQ  510 (677)
T ss_pred             eeccc-ccHHHHHHhccCC---CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-ee---EEeeeechhcccC
Confidence            99874 4898888766543   344588999999999999999999999999999999976 33   8999999997776


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCC-----------CCCcchHHHHHHHHHHHHhCCCCCCC--ChH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-----------YGKPVDIWAAGVLLHVLLTGTLPFVG--SRD  230 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~el~~g~~pf~~--~~~  230 (249)
                      .......           ..+..||+.|||||.+....           .++++|||||||+||+|+.|+.||..  +.-
T Consensus       511 ~DTTsI~-----------kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~  579 (677)
T KOG0596|consen  511 PDTTSIV-----------KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI  579 (677)
T ss_pred             cccccee-----------eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH
Confidence            6443322           23346999999999985332           46789999999999999999999987  333


Q ss_pred             HHHHHHHcC--ccccccc
Q psy14626        231 RLFQSITKG--KLHILGC  246 (249)
Q Consensus       231 ~~~~~i~~g--~~~~~~~  246 (249)
                      .-+++|+.-  +++||.-
T Consensus       580 aKl~aI~~P~~~Iefp~~  597 (677)
T KOG0596|consen  580 AKLHAITDPNHEIEFPDI  597 (677)
T ss_pred             HHHHhhcCCCccccccCC
Confidence            446667663  4566643

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-32  Score=221.96  Aligned_cols=216  Identities=18%  Similarity=0.323  Sum_probs=166.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCC---CcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+|++.+.++.|.++.+|........   ..++++.... ......+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46778888988888777754432111   1222221111 1123456889999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++.....   .++..++..++.|++.|+.+||+++++|+||||+||+++.++.   ++++|||.+....
T Consensus        84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~---~~l~dfg~~~~~~  157 (267)
T cd05066          84 TEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV---CKVSDFGLSRVLE  157 (267)
T ss_pred             EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe---EEeCCCCcccccc
Confidence            999999999998875432   3789999999999999999999999999999999999987665   9999999987654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ......          ........+..|+|||.+.+..++.++|+||+|++++++++ |..||.. +..++.+.+.++
T Consensus       158 ~~~~~~----------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~  225 (267)
T cd05066         158 DDPEAA----------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG  225 (267)
T ss_pred             ccccee----------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC
Confidence            422100          00111123567999999998889999999999999999887 9999987 455677777765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.7e-32  Score=222.03  Aligned_cols=199  Identities=31%  Similarity=0.538  Sum_probs=164.4

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhccccchh--HHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTT--EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      |++.+.++.|.++.++...+......++++.........  .....+|+.+++.++||||+++++++......++|||++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567788999999999988877665555554444333222  223456999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++.....    ++..++..++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||.+....... 
T Consensus        81 ~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~---~~l~Dfg~~~~~~~~~-  152 (260)
T PF00069_consen   81 PGGSLQDYLQKNKP----LSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE---VKLIDFGSSVKLSENN-  152 (260)
T ss_dssp             TTEBHHHHHHHHSS----BBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE---EEESSGTTTEESTSTT-
T ss_pred             cccccccccccccc----cccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccc-
Confidence            99999999884433    899999999999999999999999999999999999987666   8999999987642111 


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                                  .......++..|+|||++. +...+.++|+||+|+++++|++|..||...
T Consensus       153 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  153 ------------ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             ------------SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             ------------cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence                        1222335788999999998 778899999999999999999999999984

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.5e-32  Score=216.93  Aligned_cols=206  Identities=19%  Similarity=0.392  Sum_probs=157.8

Q ss_pred             hhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchh
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC   93 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (249)
                      +++.|.++.+|..... ....++++..... .......+.+|+.+++.++||||+++++++...+..++||||+++++|.
T Consensus         2 ~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             ccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            5666777777655432 2222333222211 1233457899999999999999999999999999999999999999998


Q ss_pred             HHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626         94 FEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                      +++.....   .+++.++..++.|++.+|.++|+.|++|+||+|+||+++.++.   ++++|||.+........      
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~---~~l~d~g~~~~~~~~~~------  148 (250)
T cd05085          81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV---LKISDFGMSRQEDDGIY------  148 (250)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe---EEECCCccceecccccc------
Confidence            88765432   3789999999999999999999999999999999999987665   99999999865433211      


Q ss_pred             cccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                            ........+..|+|||++.+..++.++|+||+|++++++++ |..||.. ........+..+
T Consensus       149 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~  210 (250)
T cd05085         149 ------SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG  210 (250)
T ss_pred             ------ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence                  00111124567999999988888999999999999999998 9999987 445555666554

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.6e-32  Score=221.62  Aligned_cols=206  Identities=31%  Similarity=0.496  Sum_probs=169.7

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +-|+.+.|.+...++.|.++.+|..........++++....... ..+.+.+|+.+++.++|+|++++++.+......++
T Consensus        14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            34788899999999999888888766654444444433333322 56788999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ++||+++++|.+++....   ..++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.   ++|+|||.+...
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~---~~l~d~~~~~~~  166 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS---VKLADFGFAAQL  166 (286)
T ss_pred             EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC---EEECccchhhhh
Confidence            999999999999988764   23899999999999999999999999999999999999987666   999999987544


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .....             ......++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus       167 ~~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~  219 (286)
T cd06614         167 TKEKS-------------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE  219 (286)
T ss_pred             ccchh-------------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence            33210             011123678899999998888899999999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.7e-32  Score=224.39  Aligned_cols=200  Identities=26%  Similarity=0.373  Sum_probs=154.7

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHc---CCCChhhhhheeec-----CC
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHML---KHPHVVELLETYSS-----EG   78 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~   78 (249)
                      +|++.+.++.|.++.+|...+......++++....  ........+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            57788889999988888776554443343332221  1122234566788777766   69999999998854     34


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .++++||++.+ +|.+++.....  ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~---~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ---VKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECccCc
Confidence            58999999975 78777765432  23899999999999999999999999999999999999987766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      +........              .....++..|+|||++.+..++.++|+||+||++|+|++|++||.+.
T Consensus       155 ~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         155 ARIYSCQMA--------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             cccccCccc--------------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            865543210              11124688999999998888999999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=3.6e-32  Score=225.88  Aligned_cols=220  Identities=23%  Similarity=0.382  Sum_probs=168.3

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-------CCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-------EPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSE   77 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   77 (249)
                      ..+|.+.+.++.|.++.+|.....-       ....++++.... ........+.+|+.+++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3578899999999888887554211       111222222221 1233456788999999999 799999999999999


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK  145 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~  145 (249)
                      +..++||||+++++|.+++..+...            ...++..+++.++.|++.||.+||+.|++|+||||+||+++.+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~  176 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED  176 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence            9999999999999999999765321            1247889999999999999999999999999999999999877


Q ss_pred             CCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q psy14626        146 ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP  224 (249)
Q Consensus       146 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p  224 (249)
                      +.   ++|+|||.+.........           ........++.|+|||.+.+..++.++|+||+|+++|+|++ |..|
T Consensus       177 ~~---~kL~dfg~a~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p  242 (307)
T cd05098         177 NV---MKIADFGLARDIHHIDYY-----------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  242 (307)
T ss_pred             Cc---EEECCCcccccccccchh-----------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            65   999999998654331110           00011123468999999988888999999999999999998 9999


Q ss_pred             CCC-ChHHHHHHHHcCc
Q psy14626        225 FVG-SRDRLFQSITKGK  240 (249)
Q Consensus       225 f~~-~~~~~~~~i~~g~  240 (249)
                      |.+ +.+++.+.+..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~  259 (307)
T cd05098         243 YPGVPVEELFKLLKEGH  259 (307)
T ss_pred             CCcCCHHHHHHHHHcCC
Confidence            988 5566777776664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.1e-32  Score=223.23  Aligned_cols=219  Identities=18%  Similarity=0.274  Sum_probs=169.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC----CCcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeec-CCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE----PASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSS-EGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   80 (249)
                      +++|++.++++.|.++.++.......    ....+++.. ........+.+.+|+.+++.++||||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            56899999999999988886664431    111222111 12234556778999999999999999999998765 5678


Q ss_pred             EEEEeccCCCchhHHHHHhhhcC----CccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAG----FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      +++++++++++|.+++.......    ..++..++..++.|++.||.|||+.+++|+||+|+||+++.++.   ++++||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~---~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ---VKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc---EEECCC
Confidence            99999999999999887653321    45899999999999999999999999999999999999987665   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~  234 (249)
                      |+++..........           .....++..|+|||++.+..++.++|+||+|+++|++++ |+.||.. +..++..
T Consensus       162 g~~~~~~~~~~~~~-----------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~  230 (280)
T cd05043         162 ALSRDLFPMDYHCL-----------GDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA  230 (280)
T ss_pred             CCcccccCCceEEe-----------CCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence            99865543221100           011234677999999988888999999999999999999 9999987 4455666


Q ss_pred             HHHcC
Q psy14626        235 SITKG  239 (249)
Q Consensus       235 ~i~~g  239 (249)
                      .+..+
T Consensus       231 ~~~~~  235 (280)
T cd05043         231 YLKDG  235 (280)
T ss_pred             HHHcC
Confidence            55554

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.8e-32  Score=221.10  Aligned_cols=204  Identities=23%  Similarity=0.438  Sum_probs=161.1

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc------cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN------HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +|+.++.++.|.++.+|...+......++++.....      .....+.+.+|+.++++++|+||+++++++.+++.+++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467778888888888886654333333333322211      12245789999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |+||+++++|.+++....    .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.  .++|+|||.+...
T Consensus        81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~--~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ--RLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEEccccccccc
Confidence            999999999999886543    2789999999999999999999999999999999999976542  2899999998666


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .......         ........++..|+|||.+.+..++.++|+||+|+++++|++|..||..
T Consensus       155 ~~~~~~~---------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         155 AAKGTGA---------GEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             ccccccC---------CccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence            5431100         0011122467899999999888889999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.6e-32  Score=219.89  Aligned_cols=214  Identities=19%  Similarity=0.363  Sum_probs=167.2

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +.+.|++.++++.|.++.+|...... ...++++... ......+.+.+|+.++++++|+|++++++++. .+..+++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCC-CceEEEEEec-CCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            45678889999999988887655432 2223333222 22234568999999999999999999998874 456899999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++++++|.+++....  +..++..++..++.|++.||++||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC---CKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC---EEEccCcceeecCCC
Confidence            999999998876543  234889999999999999999999999999999999999987765   999999998765532


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ...            ......++..|+|||.+.+..++.++|+||+|++++++++ |+.||.+ +..++.+.+.++
T Consensus       156 ~~~------------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05067         156 EYT------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG  219 (260)
T ss_pred             Ccc------------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcC
Confidence            210            1111234678999999988888999999999999999998 9999987 555666666555

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=6.3e-32  Score=222.61  Aligned_cols=217  Identities=22%  Similarity=0.360  Sum_probs=164.9

Q ss_pred             cchHHHhhcccceeeEeeeccccC-----CCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIE-----PASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +|++...++.|.++.+|.....-.     ....+++.... ........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            367788888888888776543211     11122211111 112345678999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhh--------------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeee
Q psy14626         83 VFEYMDGSDICFEIVRRAT--------------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLL  142 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili  142 (249)
                      ++||+.+++|.+++.....                    ....++..++..++.|++.||.+||+.+++|+||||+||++
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill  160 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV  160 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence            9999999999988765321                    11247889999999999999999999999999999999999


Q ss_pred             eecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-C
Q psy14626        143 ANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-G  221 (249)
Q Consensus       143 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g  221 (249)
                      +.++.   ++|+|||.+..........           ......++..|+|||.+.+..++.++|+||||+++++|++ |
T Consensus       161 ~~~~~---~kl~dfg~~~~~~~~~~~~-----------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g  226 (290)
T cd05045         161 AEGRK---MKISDFGLSRDVYEEDSYV-----------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG  226 (290)
T ss_pred             cCCCc---EEeccccccccccCccchh-----------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcC
Confidence            87665   9999999986553322100           0111234668999999988888999999999999999998 9


Q ss_pred             CCCCCC-ChHHHHHHHHcC
Q psy14626        222 TLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       222 ~~pf~~-~~~~~~~~i~~g  239 (249)
                      ..||.+ ..+++.+.+..+
T Consensus       227 ~~p~~~~~~~~~~~~~~~~  245 (290)
T cd05045         227 GNPYPGIAPERLFNLLKTG  245 (290)
T ss_pred             CCCCCCCCHHHHHHHHhCC
Confidence            999988 556677666554

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.8e-32  Score=220.48  Aligned_cols=216  Identities=19%  Similarity=0.242  Sum_probs=166.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCC----cccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPA----SFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .++|++.++++.|.++.+|.........    .++++... .........+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            4578888899999999888665322211    12222221 12234466789999999999999999999998754 478


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      ++++++++++|.+++.....   .+++.++..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++..
T Consensus        85 l~~~~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~---~kL~dfG~~~~  158 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKD---RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARL  158 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc---EEECCCCceee
Confidence            99999999999988865432   3899999999999999999999999999999999999977665   99999999876


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .......           .......++..|+|||...+..++.++|+|||||++|||++ |..||.. ..+.+...+..+
T Consensus       159 ~~~~~~~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~  227 (279)
T cd05109         159 LDIDETE-----------YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG  227 (279)
T ss_pred             cccccce-----------eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC
Confidence            6432210           00111124678999999988888999999999999999998 9999987 455666667665


Q ss_pred             c
Q psy14626        240 K  240 (249)
Q Consensus       240 ~  240 (249)
                      .
T Consensus       228 ~  228 (279)
T cd05109         228 E  228 (279)
T ss_pred             C
Confidence            4

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.2e-32  Score=224.49  Aligned_cols=216  Identities=22%  Similarity=0.357  Sum_probs=164.0

Q ss_pred             CcchHHHhhcccceeeEeeecc-----ccCCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSA-----EIEPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (249)
                      .+|.+.+.++.|.++.++....     ......++++... .......+.+.+|+.+++++ +||||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            3677888888888877765432     1111122222111 11234456799999999999 799999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      +++|||+++++|.+++.....  ..+++.++..++.|++.||.|||+++++|+||||+||+++.++.   ++++|||.+.
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~~l~dfg~~~  189 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKI---VKICDFGLAR  189 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCe---EEECCCcccc
Confidence            999999999999998865332  22799999999999999999999999999999999999986655   8999999986


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-C-hHHHHHHHH
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-S-RDRLFQSIT  237 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~-~~~~~~~i~  237 (249)
                      ........           .......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+ . .+.....+.
T Consensus       190 ~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~  258 (302)
T cd05055         190 DIMNDSNY-----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIK  258 (302)
T ss_pred             cccCCCce-----------eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHH
Confidence            55432210           01111235678999999988888999999999999999998 9999987 3 334444554


Q ss_pred             cC
Q psy14626        238 KG  239 (249)
Q Consensus       238 ~g  239 (249)
                      .+
T Consensus       259 ~~  260 (302)
T cd05055         259 EG  260 (302)
T ss_pred             cC
Confidence            44

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.2e-32  Score=218.14  Aligned_cols=177  Identities=23%  Similarity=0.419  Sum_probs=145.8

Q ss_pred             chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH
Q psy14626         46 YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC  125 (249)
Q Consensus        46 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L  125 (249)
                      ....+.+.+|+.+++.++||||+++++++.. ...++||||+++++|.+++....    .+++..+..++.|++.|+.+|
T Consensus        37 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~l  111 (257)
T cd05116          37 PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYL  111 (257)
T ss_pred             HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHH
Confidence            3456789999999999999999999998754 45789999999999998886543    289999999999999999999


Q ss_pred             HHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCc
Q psy14626        126 HENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP  205 (249)
Q Consensus       126 H~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  205 (249)
                      |++|++|+||||+||+++.++.   ++|+|||.+..........          .......++..|+|||.+.+..++.+
T Consensus       112 H~~~i~H~dlkp~nill~~~~~---~kl~Dfg~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~  178 (257)
T cd05116         112 EETNFVHRDLAARNVLLVTQHY---AKISDFGLSKALGADENYY----------KAKTHGKWPVKWYAPECMNYYKFSSK  178 (257)
T ss_pred             HHCCEeecccchhhEEEcCCCe---EEECCCccccccCCCCCee----------eecCCCCCCccccCHhHhccCCcCch
Confidence            9999999999999999987665   9999999987654432110          00111124578999999988888999


Q ss_pred             chHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        206 VDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       206 ~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      +|+||||+++|||++ |+.||.+ +..++.+.+.++.
T Consensus       179 ~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~  215 (257)
T cd05116         179 SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE  215 (257)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence            999999999999998 9999987 5666777787764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=6.7e-32  Score=222.27  Aligned_cols=218  Identities=20%  Similarity=0.346  Sum_probs=166.6

Q ss_pred             CcchHHHhhcccceeeEeeeccc-----cCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .+|++.++++.|.++.+|.....     .....++++... .........+.+|+.+++.++||||+++++++..+...+
T Consensus         6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   85 (288)
T cd05061           6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL   85 (288)
T ss_pred             HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            58899999999998888864321     111122222111 112334456889999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhc------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         82 MVFEYMDGSDICFEIVRRATA------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                      +||||+++++|.+++......      ....+...+..++.|++.||.+||+++++|+||||+||+++.++.   ++|+|
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~---~~L~D  162 (288)
T cd05061          86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT---VKIGD  162 (288)
T ss_pred             EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc---EEECc
Confidence            999999999999998764321      123467788999999999999999999999999999999987665   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHH
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLF  233 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~  233 (249)
                      ||+++........           .......++..|+|||.+.+..++.++|+||+||+++||++ |..||.+ ..+++.
T Consensus       163 fg~~~~~~~~~~~-----------~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~  231 (288)
T cd05061         163 FGMTRDIYETDYY-----------RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL  231 (288)
T ss_pred             CCccccccccccc-----------cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9998654432210           01111234667999999988888999999999999999998 8999987 556666


Q ss_pred             HHHHcC
Q psy14626        234 QSITKG  239 (249)
Q Consensus       234 ~~i~~g  239 (249)
                      +.+..+
T Consensus       232 ~~~~~~  237 (288)
T cd05061         232 KFVMDG  237 (288)
T ss_pred             HHHHcC
Confidence            666554

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.1e-31  Score=217.23  Aligned_cols=208  Identities=23%  Similarity=0.357  Sum_probs=160.0

Q ss_pred             hhcccceeeEeeeccccCCC---cccCChhccccc-hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPA---SFGLPDERLNHY-TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|.........   .++++....... ...+.+.+|+.++++++||||+++++.+.. ..+++|||+++++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~   80 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLG   80 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCC
Confidence            45566666666544322111   123332232222 566789999999999999999999999988 8899999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|.+.+.....  ..+++..+..++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||.+.........  
T Consensus        81 ~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~---~kl~dfg~~~~~~~~~~~--  153 (257)
T cd05040          81 SLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK---VKIGDFGLMRALPQNEDH--  153 (257)
T ss_pred             cHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE---EEeccccccccccccccc--
Confidence            99998876542  34899999999999999999999999999999999999988765   999999998766442210  


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~  238 (249)
                             +. ......++..|+|||.+.+..++.++|+||+|+++++|++ |+.||.. +..++.+.+..
T Consensus       154 -------~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~  215 (257)
T cd05040         154 -------YV-MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK  215 (257)
T ss_pred             -------ee-cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence                   00 0112236778999999988889999999999999999998 9999976 55556555553

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1e-31  Score=219.10  Aligned_cols=204  Identities=25%  Similarity=0.392  Sum_probs=162.5

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecC------
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSE------   77 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~------   77 (249)
                      +|..+|++.+.++.|.++.+|..........++++.... .......+.+|+.+++++ +|||++++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~-~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEc-CCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            688899999999999988888665543333344333222 234456789999999999 799999999998642      


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..++++|||+++++|.+++....  ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.   ++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~---~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC---EEEccCC
Confidence            45899999999999998886532  234889999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++.......             .......++..|+|||++.     +..++.++|+||+||++|+|++|..||..
T Consensus       157 ~~~~~~~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         157 VSAQLDRTV-------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             Cceeccccc-------------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            987654321             1112234788999999986     33567899999999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.5e-32  Score=219.32  Aligned_cols=210  Identities=16%  Similarity=0.200  Sum_probs=155.8

Q ss_pred             hhcccceeeEeeeccccC-------CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         15 VINHKWLKMKLHTSAEIE-------PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      .++.|.++.+|...+...       ...++++..........+.+.+|+.+++.++|||++++++++..+...++||||+
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~   81 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV   81 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence            456666666665443221       1112222222333344567899999999999999999999999988899999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC-----CCeEEcCcceeEEc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS-----APVKLGGFGVAIQL  162 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~-----~~~~l~dfg~~~~~  162 (249)
                      ++++|.+++..+..   .+++..++.++.|++.||.|||+++++|+||||+||+++.++..     ..++++|||.+...
T Consensus        82 ~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          82 KFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             CCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            99999988876543   37899999999999999999999999999999999999876532     23689999987543


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhC-CCCCCCChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTG-TLPFVGSRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g-~~pf~~~~~~~~~~i~~g~  240 (249)
                      ....                 ...+++.|+|||++.+. .++.++|+||+|+++|+|++| ..||..........+....
T Consensus       159 ~~~~-----------------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~  221 (258)
T cd05078         159 LPKE-----------------ILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR  221 (258)
T ss_pred             CCch-----------------hccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHcc
Confidence            3211                 12367889999998864 468899999999999999998 5777763333333344445


Q ss_pred             cccc
Q psy14626        241 LHIL  244 (249)
Q Consensus       241 ~~~~  244 (249)
                      .++|
T Consensus       222 ~~~~  225 (258)
T cd05078         222 HQLP  225 (258)
T ss_pred             ccCC
Confidence            5555

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.3e-32  Score=221.79  Aligned_cols=200  Identities=27%  Similarity=0.416  Sum_probs=157.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++...++.|.++.+|..........++++....  ......+.+.+|+.++++++|||++++++++..+..+++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            467888888888888877665543333334332221  122334568899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|........    .+++.+++.++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNPR----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ---IKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc---EEECccccceecCCC
Confidence            999877766543322    3899999999999999999999999999999999999987765   999999998776542


Q ss_pred             CccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..             ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+
T Consensus       154 ~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~  203 (286)
T cd07847         154 GD-------------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG  203 (286)
T ss_pred             cc-------------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence            21             0111235778999999876 4568899999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=8.3e-32  Score=218.26  Aligned_cols=217  Identities=29%  Similarity=0.441  Sum_probs=171.9

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheee--cCCeEEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYS--SEGMLYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~   84 (249)
                      +|.+...++.|.++.+|...+......++++...  .......+.+.+|+++++.++||||+++++.+.  .+...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            3667778888888887765544443334433222  122345677899999999999999999999875  345689999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH-----HCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH-----ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH-----~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      ||+++++|.+++.........+++..++.++.|++.||.+||     +.+++|+||+|+||+++.++.   ++|+|||.+
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~---~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN---VKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC---EEEeccccc
Confidence            999999999998776544456899999999999999999999     889999999999999987666   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ........             ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||.. +.+++.+.+..
T Consensus       158 ~~~~~~~~-------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  224 (265)
T cd08217         158 KILGHDSS-------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKE  224 (265)
T ss_pred             ccccCCcc-------------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhc
Confidence            76654221             01122468899999999888889999999999999999999999998 56667777777


Q ss_pred             Ccc
Q psy14626        239 GKL  241 (249)
Q Consensus       239 g~~  241 (249)
                      +.+
T Consensus       225 ~~~  227 (265)
T cd08217         225 GKF  227 (265)
T ss_pred             CCC
Confidence            764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.7e-32  Score=218.87  Aligned_cols=207  Identities=22%  Similarity=0.391  Sum_probs=162.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhhee-ecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETY-SSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~   86 (249)
                      +.|++.+.++.|.++.+|.....  ...++++..  ......+.+.+|+.++++++|+|++++++++ ..++..++++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEe--CCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            36777888888887777755433  112222221  2233456789999999999999999999876 455678999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.....  ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.......
T Consensus        82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~---~kl~dfg~~~~~~~~~  156 (256)
T cd05082          82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc---EEecCCccceeccccC
Confidence            999999998865432  23789999999999999999999999999999999999987766   9999999986543311


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                                      .....+..|+|||++.+..++.++|+||+||++|+|++ |+.||.. +..++...+.++
T Consensus       157 ----------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~  215 (256)
T cd05082         157 ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG  215 (256)
T ss_pred             ----------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence                            11124567999999988888999999999999999997 9999987 555666666665

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.2e-32  Score=239.55  Aligned_cols=210  Identities=18%  Similarity=0.279  Sum_probs=158.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCC------CChhhhhheeecC-Ce
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKH------PHVVELLETYSSE-GM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~~i~~~~~~~~~~-~~   79 (249)
                      ..+|++.++|+.|.++.+|...+......++++.... .......+..|+.+++.++|      .++++++++|... +.
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRN-VPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEec-chhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            4689999999999999998776654444444433221 12233456678888877754      4588888888654 57


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCC----------
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENS----------  148 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~----------  148 (249)
                      +|+||+++ |++|.+++.....    +++..+..++.|++.||.|||+ .|++||||||+|||++.++..          
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHGP----FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            89999998 6688888765533    8999999999999999999998 599999999999999865421          


Q ss_pred             ---CCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy14626        149 ---APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF  225 (249)
Q Consensus       149 ---~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf  225 (249)
                         ..++|+|||.+......                .....+|+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       282 ~~~~~vkl~DfG~~~~~~~~----------------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDERHS----------------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             CCCceEEECCCCccccCccc----------------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence               24899999976432211                11235789999999999999999999999999999999999999


Q ss_pred             CC-ChHHHHHHHHc
Q psy14626        226 VG-SRDRLFQSITK  238 (249)
Q Consensus       226 ~~-~~~~~~~~i~~  238 (249)
                      .+ +..+....+.+
T Consensus       346 ~~~~~~~~~~~i~~  359 (467)
T PTZ00284        346 DTHDNLEHLHLMEK  359 (467)
T ss_pred             CCCChHHHHHHHHH
Confidence            88 33344444433

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6e-32  Score=219.28  Aligned_cols=212  Identities=19%  Similarity=0.322  Sum_probs=164.6

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      .+|.+.+.++.|.++.+|....... ...+++... ......+.+.+|+.+++.++|||++++++++.. +..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK-PGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcc-cCCccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence            5688889999998888876554322 122332222 122345678999999999999999999988754 4588999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      .+++|.+++....  +..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+........
T Consensus        83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~---~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV---CKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe---EEECCCccceEccCCcc
Confidence            9999998886543  233788999999999999999999999999999999999987766   99999999876543221


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                                  .......++..|+|||...+..++.++|+||+|+++|+|++ |..||.+ ...+..+.+.++
T Consensus       158 ------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~  219 (260)
T cd05069         158 ------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG  219 (260)
T ss_pred             ------------cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence                        01111224678999999988888999999999999999999 9999988 455566666554

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=8.7e-32  Score=217.31  Aligned_cols=214  Identities=28%  Similarity=0.422  Sum_probs=172.0

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +|++.+.+++|.++.+|...+......++++....  ........+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            46777888888888877665544444444332221  1234456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.........+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~---~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc---EEEeeccchhhhccCC
Confidence            9999999988775554556899999999999999999999999999999999999987665   9999999986654421


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                                     .....++..|+|||...+..++.++|+||+|+++++|++|+.||.. +.+++...+..+.
T Consensus       158 ---------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~  217 (256)
T cd08530         158 ---------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK  217 (256)
T ss_pred             ---------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence                           0112367889999999988889999999999999999999999998 5555666665554

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.7e-33  Score=224.03  Aligned_cols=214  Identities=25%  Similarity=0.414  Sum_probs=163.4

Q ss_pred             HHHhhcccceeeEeeecccc----CCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626         12 IHEVINHKWLKMKLHTSAEI----EPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +.+.|+.|.++.++......    .....+++... .......+.+.+|++.+++++||||+++++++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            34567888888877655541    11111121111 22234578999999999999999999999999988889999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++....  ...++..++..|+.|++.||.|||+++++|++|+++||+++.++.   +||+|||.+.......
T Consensus        83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~---~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ---VKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE---EEEESTTTGEETTTSS
T ss_pred             cccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccc
Confidence            99999999998871  123899999999999999999999999999999999999988765   9999999987773322


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCcc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      ..           ...........|+|||.+.+..++.++||||||+++||+++ |+.||.. +..++.+.+.++..
T Consensus       158 ~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~  223 (259)
T PF07714_consen  158 KY-----------KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR  223 (259)
T ss_dssp             SE-----------EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE
T ss_pred             cc-----------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            11           11122236778999999998889999999999999999999 7899998 66777777766654

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.5e-31  Score=217.83  Aligned_cols=182  Identities=26%  Similarity=0.464  Sum_probs=147.5

Q ss_pred             hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhc---CCccCHHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATA---GFVYSEAVASHYMRQVLEALR  123 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~  123 (249)
                      .....+.+|+.+++.++||||+++++++...+..++||||+++++|.+++......   ...+++.+++.++.|++.||.
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  120 (269)
T cd05044          41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV  120 (269)
T ss_pred             hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence            44667899999999999999999999999888999999999999999998764322   234788999999999999999


Q ss_pred             HHHHCCceeecCCCCCeeeeecC--CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC
Q psy14626        124 YCHENDIIHRDIKPHCVLLANKE--NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK  201 (249)
Q Consensus       124 ~LH~~~~vH~dlkp~Nili~~~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  201 (249)
                      |||+.+++|+||+|+||+++.++  ....++++|||.+.........           ........+..|+|||.+.+..
T Consensus       121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~  189 (269)
T cd05044         121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY-----------RKEGEGLLPVRWMAPESLLDGK  189 (269)
T ss_pred             HHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccccccccc-----------ccCcccCCCccccCHHHHccCC
Confidence            99999999999999999998765  1224899999998655432110           1111223567899999999888


Q ss_pred             CCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        202 YGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       202 ~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ++.++|+||||+++|+|++ |+.||.. +..++...+..+
T Consensus       190 ~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  229 (269)
T cd05044         190 FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG  229 (269)
T ss_pred             cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC
Confidence            9999999999999999998 9999987 444555555443

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.3e-32  Score=222.23  Aligned_cols=202  Identities=22%  Similarity=0.297  Sum_probs=154.9

Q ss_pred             Ccc-hHHHhhcccceeeEeeec----cccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecC--Ce
Q psy14626          8 KRI-TIHEVINHKWLKMKLHTS----AEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSE--GM   79 (249)
Q Consensus         8 ~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~   79 (249)
                      +|| ++.+.++.|.++.++...    .......++++..... .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            456 888889988888775422    1112222333222211 123467789999999999999999999988653  46


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      ++++|||+.+++|.+++...     .+++.+++.++.|++.||.+||+++++|+||||+||+++.++.   ++|+|||.+
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~~l~dfg~~  154 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL---VKIGDFGLA  154 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc---EEEeecccc
Confidence            89999999999998888643     2899999999999999999999999999999999999987665   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..........          .......++..|+|||.+.+..++.++|+||||+++++|++|..||..
T Consensus       155 ~~~~~~~~~~----------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         155 KAVPEGHEYY----------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             cccCCcchhh----------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence            7654322100          000111245679999999888889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-31  Score=217.29  Aligned_cols=209  Identities=23%  Similarity=0.392  Sum_probs=167.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .+.|++.+.++.|.++.++.....  ...++++..... ....+++.+|+.+++.++|+||+++++++......++|||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDD-STAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccc-hhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            457888889999888888765543  222333322222 22567899999999999999999999999988899999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++......  .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        82 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~---~~l~d~g~~~~~~~~~  156 (256)
T cd05039          82 MAKGSLVDYLRSRGRA--VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV---AKVSDFGLAKEASQGQ  156 (256)
T ss_pred             cCCCcHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC---EEEccccccccccccc
Confidence            9999999988765422  3899999999999999999999999999999999999987665   8999999986653211


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .                ....+..|+|||.+.+..++.++|+||+|++++++++ |..||.. +.+.+.+.+..+
T Consensus       157 ~----------------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  215 (256)
T cd05039         157 D----------------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG  215 (256)
T ss_pred             c----------------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC
Confidence            0                1124567999999988888999999999999999997 9999988 556666666554

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.1e-32  Score=225.86  Aligned_cols=201  Identities=22%  Similarity=0.367  Sum_probs=149.0

Q ss_pred             HhhcccceeeEeeeccc--cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec--CCeEEEEEeccCC
Q psy14626         14 EVINHKWLKMKLHTSAE--IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS--EGMLYMVFEYMDG   89 (249)
Q Consensus        14 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~   89 (249)
                      ..++.|.++.+|.....  .....++++...  .......+.+|+.+++.++||||+++++.+..  +..++++|||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             cccccCCCeEEEEEEEccCCCCceEEEEEEC--CCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            46788888888866532  222233333221  12233567899999999999999999999853  4568999999965


Q ss_pred             CchhHHHHHhhh-----cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC-CCCCeEEcCcceeEEcc
Q psy14626         90 SDICFEIVRRAT-----AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        90 ~~L~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~-~~~~~~l~dfg~~~~~~  163 (249)
                       +|.+++.....     ....++...++.++.|++.||.|||++|++|+||||+|||+..++ ....++|+|||++....
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence             78777653321     123488999999999999999999999999999999999995432 23459999999997654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....          ........+|+.|+|||++.+. .++.++|+||+||++++|++|++||.+
T Consensus       164 ~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         164 SPLKP----------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CCCcc----------ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            32110          0111223478899999998764 578999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-32  Score=220.25  Aligned_cols=217  Identities=21%  Similarity=0.278  Sum_probs=169.0

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCC----cccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPA----SFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ...+|++.+.++.|.++.+|.........    .++++..... .......+.+|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            34678888999999888887654322111    1222222211 13455788999999999999999999999987 679


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++|+||+++++|.+++.....   .+++..+..++.|++.|+.+||+++++|+||+|+||+++.++.   ++|+|||.+.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~---~kL~dfg~~~  157 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH---VKITDFGLAK  157 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe---EEECCCcccc
Confidence            999999999999998876433   2899999999999999999999999999999999999987665   9999999987


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHc
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~  238 (249)
                      .........           .......+..|+|||.+....++.++|+||+|++++|+++ |+.||.+ ..+++.+.+.+
T Consensus       158 ~~~~~~~~~-----------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  226 (279)
T cd05057         158 LLDVDEKEY-----------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK  226 (279)
T ss_pred             cccCcccce-----------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhC
Confidence            654322100           0011123567999999988888999999999999999998 9999998 56677777776


Q ss_pred             Cc
Q psy14626        239 GK  240 (249)
Q Consensus       239 g~  240 (249)
                      +.
T Consensus       227 ~~  228 (279)
T cd05057         227 GE  228 (279)
T ss_pred             CC
Confidence            64

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-31  Score=220.00  Aligned_cols=207  Identities=27%  Similarity=0.404  Sum_probs=163.1

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheee-----cCC
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYS-----SEG   78 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~   78 (249)
                      ++.++|++.+.++.|.++.+|...+......++++.... .......+.+|+.+++.+ +||||+++++++.     .++
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecc-ccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            577899999999999988887665544333333332221 123346788999999999 7999999999873     445


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+++||||+++++|.+++.........+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~---~kl~dfg~  170 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG---VKLVDFGV  170 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC---EEEccCCc
Confidence            789999999999999887654434445889999999999999999999999999999999999987766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----QKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      +........             ......++..|+|||.+..     ..++.++|+||+||++|+|++|+.||...
T Consensus       171 ~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         171 SAQLTSTRL-------------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             eeecccCCC-------------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            876543211             1112247889999998753     34688999999999999999999999873

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.98  E-value=1e-31  Score=221.82  Aligned_cols=218  Identities=20%  Similarity=0.309  Sum_probs=168.2

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCC----------------cccCChhccc-cchhHHHHHHHHHHHHHcCCCChh
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPA----------------SFGLPDERLN-HYTTEADLKREATICHMLKHPHVV   68 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~   68 (249)
                      +.++|++.+.++.|.++.++.........                .++++..... .....+.+.+|+.++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            35689999999999988887554332111                1122222111 124567899999999999999999


Q ss_pred             hhhheeecCCeEEEEEeccCCCchhHHHHHhhh-------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCee
Q psy14626         69 ELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT-------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL  141 (249)
Q Consensus        69 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nil  141 (249)
                      ++++++..++..+++||++.+++|.+++.....       ....+++..++.++.|++.||.+||+.+++|+||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            999999998999999999999999998876541       1124899999999999999999999999999999999999


Q ss_pred             eeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-
Q psy14626        142 LANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-  220 (249)
Q Consensus       142 i~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-  220 (249)
                      ++.++.   ++|+|||.+.........           .......++..|+|||.+.+..++.++|+||+|+++|+|++ 
T Consensus       163 i~~~~~---~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  228 (296)
T cd05051         163 VGKNYT---IKIADFGMSRNLYSSDYY-----------RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL  228 (296)
T ss_pred             ecCCCc---eEEccccceeecccCcce-----------eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhc
Confidence            987765   999999998665432210           11122235678999999988888999999999999999998 


Q ss_pred             -CCCCCCC-ChHHHHHHHH
Q psy14626        221 -GTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       221 -g~~pf~~-~~~~~~~~i~  237 (249)
                       |..||.. +...+...+.
T Consensus       229 ~~~~p~~~~~~~~~~~~~~  247 (296)
T cd05051         229 CREQPYEHLTDQQVIENAG  247 (296)
T ss_pred             CCCCCCCCcChHHHHHHHH
Confidence             7789987 4555555544

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.98  E-value=9e-32  Score=218.35  Aligned_cols=179  Identities=36%  Similarity=0.588  Sum_probs=150.5

Q ss_pred             cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHH
Q psy14626         45 HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY  124 (249)
Q Consensus        45 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~  124 (249)
                      .....+.+.+|+.+++.++||||+++++.+.++..+++++||+++++|.+++.....    ++...+..++.|++.||.+
T Consensus        33 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~~i~~~l~~  108 (262)
T cd05572          33 ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEY  108 (262)
T ss_pred             hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHH
Confidence            344567899999999999999999999999999999999999999999998876543    8999999999999999999


Q ss_pred             HHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCC
Q psy14626        125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGK  204 (249)
Q Consensus       125 LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  204 (249)
                      ||+++++|+||+|+||+++.++.   ++|+|||.+.......              ......++..|+|||.+.+..++.
T Consensus       109 lH~~~~~h~dl~~~nilv~~~~~---~~l~df~~~~~~~~~~--------------~~~~~~~~~~~~~PE~~~~~~~~~  171 (262)
T cd05572         109 LHNRGIIYRDLKPENLLLDSNGY---VKLVDFGFAKKLKSGQ--------------KTWTFCGTPEYVAPEIILNKGYDF  171 (262)
T ss_pred             HhhCCcccCCCCHHHEEEcCCCC---EEEeeCCcccccCccc--------------ccccccCCcCccChhHhcCCCCCC
Confidence            99999999999999999987766   9999999987665421              111124678899999998888899


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHHc--Cccccc
Q psy14626        205 PVDIWAAGVLLHVLLTGTLPFVGS---RDRLFQSITK--GKLHIL  244 (249)
Q Consensus       205 ~~DiwslG~~l~el~~g~~pf~~~---~~~~~~~i~~--g~~~~~  244 (249)
                      ++|+||+|+++|+|++|..||...   ..++...+..  ..+.+|
T Consensus       172 ~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  216 (262)
T cd05572         172 SVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP  216 (262)
T ss_pred             hhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC
Confidence            999999999999999999999873   3456666663  344444

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.98  E-value=7.2e-32  Score=219.60  Aligned_cols=215  Identities=18%  Similarity=0.315  Sum_probs=165.7

Q ss_pred             cchHHHhhcccceeeEeeeccccCC---CcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .|+....++.|.++.+|........   ..++++..... .....+.+.+|+.+++.++|||++++.+++...+..++||
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIIT   85 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEE
Confidence            5677788888888777755543221   12333322222 2344567899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....   .+++.++..++.|++.|+.+||+.+++|+||||+||+++.++.   ++++|||.+.....
T Consensus        86 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~---~kl~dfg~~~~~~~  159 (268)
T cd05063          86 EYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE---CKVSDFGLSRVLED  159 (268)
T ss_pred             EcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc---EEECCCccceeccc
Confidence            99999999888865432   3789999999999999999999999999999999999987665   99999999866543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .....         .+ ......+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.. +..++...+.++
T Consensus       160 ~~~~~---------~~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~  226 (268)
T cd05063         160 DPEGT---------YT-TSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG  226 (268)
T ss_pred             ccccc---------ee-ccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC
Confidence            22100         00 001113457999999988888999999999999999997 9999987 556677777654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.98  E-value=8.9e-32  Score=219.51  Aligned_cols=208  Identities=21%  Similarity=0.362  Sum_probs=156.6

Q ss_pred             hhcccceeeEeeeccccCCCc--ccCChh-ccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPAS--FGLPDE-RLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +++.|.++.+|..........  .+++.. ........+.+.+|+.+++++ +||||+++++++...+.++++|||++++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG   81 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence            456666766665543322211  111111 112234556789999999999 7999999999999999999999999999


Q ss_pred             chhHHHHHhhh------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         91 DICFEIVRRAT------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        91 ~L~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      +|.+++.....            ....++..+++.++.|++.||.+||+.+++|+||||+||+++.++.   ++++|||+
T Consensus        82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~---~kl~dfgl  158 (270)
T cd05047          82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIADFGL  158 (270)
T ss_pred             cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe---EEECCCCC
Confidence            99998876432            1123789999999999999999999999999999999999987665   99999998


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i  236 (249)
                      +.......              .......+..|+|||++.+..++.++|+||||+++++|++ |..||.+ +..++.+.+
T Consensus       159 ~~~~~~~~--------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~  224 (270)
T cd05047         159 SRGQEVYV--------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  224 (270)
T ss_pred             ccccchhh--------------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH
Confidence            74221100              0011123567999999988888999999999999999997 9999987 455566666


Q ss_pred             HcC
Q psy14626        237 TKG  239 (249)
Q Consensus       237 ~~g  239 (249)
                      ..+
T Consensus       225 ~~~  227 (270)
T cd05047         225 PQG  227 (270)
T ss_pred             hCC
Confidence            554

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.98  E-value=1.2e-31  Score=218.24  Aligned_cols=202  Identities=27%  Similarity=0.407  Sum_probs=159.1

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhc-----cccchhHHHHHHHHHHHHHcCCCChhhhhheeec--CCeEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-----LNHYTTEADLKREATICHMLKHPHVVELLETYSS--EGMLY   81 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~   81 (249)
                      .|++.++++.|.++.+|...+......++++...     .......+.+.+|+.+++.++||||+++++++.+  +..++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            4778889999988888766544333333333221     1122345678999999999999999999999865  35789


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +++||+++++|.+.+.....    ++...++.++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||++..
T Consensus        83 l~~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~---~~l~dfg~~~~  155 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKR  155 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEccCCCccc
Confidence            99999999999988865433    789999999999999999999999999999999999987665   99999999865


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ........          .......++..|+|||.+.+..++.++|+||+||++++|++|+.||..
T Consensus       156 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~  211 (266)
T cd06651         156 LQTICMSG----------TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE  211 (266)
T ss_pred             cccccccC----------CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence            53211100          011122367889999999988889999999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.6e-31  Score=216.35  Aligned_cols=208  Identities=21%  Similarity=0.340  Sum_probs=157.7

Q ss_pred             hhcccceeeEeeeccccCC---CcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEP---ASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      .++.|.++.++........   ..++++...... ....+.+.+|+.+++.++|||++++++++. +..+++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~   80 (257)
T cd05060           2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG   80 (257)
T ss_pred             ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence            4566666666544332221   122222222111 145678999999999999999999999876 44689999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|.+++....    .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......... 
T Consensus        81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~---~kl~df~~~~~~~~~~~~~-  152 (257)
T cd05060          81 PLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ---AKISDFGMSRALGAGSDYY-  152 (257)
T ss_pred             cHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc---EEeccccccceeecCCccc-
Confidence            9999987654    3899999999999999999999999999999999999987776   9999999987654322110 


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                               .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.. +..++...+.++.
T Consensus       153 ---------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~  215 (257)
T cd05060         153 ---------RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE  215 (257)
T ss_pred             ---------ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC
Confidence                     00111123567999999988889999999999999999998 9999987 5566777776664

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.98  E-value=6.3e-32  Score=223.22  Aligned_cols=229  Identities=17%  Similarity=0.178  Sum_probs=161.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccC---CCcccCChhccccchh-----------HHHHHHHHHHHHHcCCCChhhhh
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDERLNHYTT-----------EADLKREATICHMLKHPHVVELL   71 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~-----------~~~~~~E~~~l~~l~h~~i~~~~   71 (249)
                      .+++|++.++++.|.++.+|.......   ....+++.........           ......+...+..++|+++++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            357999999999999999987664433   2222222222111110           01122233445566899999999


Q ss_pred             heeecCC----eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC
Q psy14626         72 ETYSSEG----MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN  147 (249)
Q Consensus        72 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~  147 (249)
                      +.+....    ..+++++++.. ++.+.+.....    .++..+..++.|++.||.+||+++++||||||+|||++.++.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKC----KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             EeeeEecCCceEEEEEEehhcc-CHHHHHHhhcc----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc
Confidence            8765443    34778888743 66555543322    578889999999999999999999999999999999987665


Q ss_pred             CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        148 SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       148 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                         ++|+|||+++.........      ...........+|+.|+|||++.+..++.++|+||+||+++||++|+.||.+
T Consensus       165 ---~~l~DFGla~~~~~~~~~~------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        165 ---GYIIDYGIASHFIIHGKHI------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             ---EEEEEcCCceeeccCCccc------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence               8999999987664322110      0111112223589999999999999999999999999999999999999987


Q ss_pred             C-h-H--------HHHHHHHcCccccccccC
Q psy14626        228 S-R-D--------RLFQSITKGKLHILGCTH  248 (249)
Q Consensus       228 ~-~-~--------~~~~~i~~g~~~~~~~~~  248 (249)
                      . . .        +....+.+++..++.|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (294)
T PHA02882        236 FGHNGNLIHAAKCDFIKRLHEGKIKIKNANK  266 (294)
T ss_pred             cccchHHHHHhHHHHHHHhhhhhhccCCCCH
Confidence            3 1 1        345677778887877763

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.98  E-value=2.4e-31  Score=216.78  Aligned_cols=207  Identities=16%  Similarity=0.314  Sum_probs=151.7

Q ss_pred             hcccceeeEeeeccccC--CCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         16 INHKWLKMKLHTSAEIE--PASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      ++.|.++.+|.......  ...++++... .......+.+.+|+.+++.++||||+++++.+......++||||+++++|
T Consensus         3 lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L   82 (268)
T cd05086           3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDL   82 (268)
T ss_pred             CCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcH
Confidence            55666666665432211  1122222112 12234567899999999999999999999999999899999999999999


Q ss_pred             hHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCC
Q psy14626         93 CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG  172 (249)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  172 (249)
                      .+++.........++...+..++.|++.||.|||+.+++|+||||+||+++.++.   ++|+|||.+........     
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~---~~l~Dfg~~~~~~~~~~-----  154 (268)
T cd05086          83 KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT---VKVGDYGIGPSRYKEDY-----  154 (268)
T ss_pred             HHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc---EEecccccccccCcchh-----
Confidence            9998765443344677888999999999999999999999999999999987665   99999998643221110     


Q ss_pred             ccccccccccCCcccCCCCCCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHH
Q psy14626        173 ERLDHYTTKAGHRIGTPHYMAPEVIED-------QKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i  236 (249)
                            ........++..|+|||++..       ..++.++|+||+|+++|||++ |..||.. +..+....+
T Consensus       155 ------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~  221 (268)
T cd05086         155 ------IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV  221 (268)
T ss_pred             ------hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence                  011122346788999998743       235778999999999999997 6889987 444444443

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.98  E-value=1.6e-31  Score=216.55  Aligned_cols=217  Identities=28%  Similarity=0.445  Sum_probs=165.9

Q ss_pred             ccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhH
Q psy14626         18 HKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICF   94 (249)
Q Consensus        18 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (249)
                      .|.++.+|..........++++   ..........+.+.+|+.++++++||||+++++.+..+...++++|++++++|.+
T Consensus         3 ~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   82 (265)
T cd05579           3 KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLAS   82 (265)
T ss_pred             CCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHH
Confidence            3444555544443222233322   2233334566789999999999999999999999999999999999999999998


Q ss_pred             HHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCcc
Q psy14626         95 EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER  174 (249)
Q Consensus        95 ~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  174 (249)
                      ++....    .+++..+..++.|++.+|.+||+++++|+||+|+||+++.++.   ++|+|||++...........    
T Consensus        83 ~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~---~~l~dfg~~~~~~~~~~~~~----  151 (265)
T cd05579          83 LLENVG----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH---LKLTDFGLSKVGLVRRQINL----  151 (265)
T ss_pred             HHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC---EEEEecccchhcccCccccc----
Confidence            887644    3899999999999999999999999999999999999988776   99999998765433211000    


Q ss_pred             ccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccccc
Q psy14626        175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILGC  246 (249)
Q Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~~  246 (249)
                       ...........++..|+|||.......+.++|+||+|++++++++|..||.. ..+++.+.+..+.+..|..
T Consensus       152 -~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  223 (265)
T cd05579         152 -NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED  223 (265)
T ss_pred             -ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc
Confidence             0000011223467789999999888889999999999999999999999987 5667788888877776643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.98  E-value=1.3e-31  Score=216.61  Aligned_cols=212  Identities=22%  Similarity=0.361  Sum_probs=165.7

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccC
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD   88 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (249)
                      .|++.+.++.|.++.+|...... ...++++... ......+.+.+|++++++++||+++++++++......++|+||+.
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeC-CCeEEEEECC-CCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            67777888888888777554331 1222222111 122334678999999999999999999999999899999999999


Q ss_pred             CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626         89 GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                      +++|.+++.....   .+++..++.++.|++.++.+||+.+++|+||+|+||+++.++.   ++|+|||.+........ 
T Consensus        83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~---~~l~d~g~~~~~~~~~~-  155 (256)
T cd05112          83 HGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV---VKVSDFGMTRFVLDDQY-  155 (256)
T ss_pred             CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCe---EEECCCcceeecccCcc-
Confidence            9999888765432   3789999999999999999999999999999999999987665   99999999876543221 


Q ss_pred             ccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                                 ........+..|+|||.+.+..++.++|+||+|+++|+|++ |..||.. ...++.+.+..+.
T Consensus       156 -----------~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  218 (256)
T cd05112         156 -----------TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF  218 (256)
T ss_pred             -----------cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC
Confidence                       01111224578999999988888999999999999999998 9999987 5566777777653

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.98  E-value=2.5e-31  Score=219.47  Aligned_cols=212  Identities=25%  Similarity=0.408  Sum_probs=165.3

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +...+..-..++.|.++.++..........++++..........+.+.+|+.+++.++|+|++++++.+..++..+++||
T Consensus        18 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          18 PRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             hHHHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            33444555677777777777555544444444444334444556779999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++...     .+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~---~~l~dfg~~~~~~~~  169 (292)
T cd06657          98 FLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSKE  169 (292)
T ss_pred             cCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEcccccceecccc
Confidence            99999998876432     2789999999999999999999999999999999999987765   999999987655432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-hHHHHHHHHc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRLFQSITK  238 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~-~~~~~~~i~~  238 (249)
                      ..             ......++..|+|||.+.+..++.++|+||+|+++++|++|..||.+. ..+....+..
T Consensus       170 ~~-------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~  230 (292)
T cd06657         170 VP-------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD  230 (292)
T ss_pred             cc-------------cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            10             111224678899999998888899999999999999999999999873 3444444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.98  E-value=1.3e-31  Score=225.11  Aligned_cols=219  Identities=24%  Similarity=0.396  Sum_probs=168.7

Q ss_pred             CcchHHHhhcccceeeEeeecccc-------CCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI-------EPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSEG   78 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   78 (249)
                      .+|++...++.|.++.+|...+..       ....++++.... ......+.+.+|+.+++++ +||||+++++.+..++
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            478999999999988887553211       001122221111 1234457899999999999 7999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhh------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRAT------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                      .+++++||+++++|.+++.....            ....++..++..++.|++.||.+||++|++|+||||+||+++.++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~  171 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN  171 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC
Confidence            99999999999999999876432            122377889999999999999999999999999999999998776


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF  225 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf  225 (249)
                      .   ++|+|||.+..........           ......++..|+|||.+.+..++.++|+||+|+++|+|++ |..||
T Consensus       172 ~---~kL~Dfg~~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         172 V---MKIADFGLARDVHNIDYYK-----------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             c---EEECCcccceecccccccc-----------cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence            5   9999999987654422110           0011123467999999998889999999999999999998 89999


Q ss_pred             CC-ChHHHHHHHHcCc
Q psy14626        226 VG-SRDRLFQSITKGK  240 (249)
Q Consensus       226 ~~-~~~~~~~~i~~g~  240 (249)
                      .+ +.+++...+.++.
T Consensus       238 ~~~~~~~~~~~~~~~~  253 (334)
T cd05100         238 PGIPVEELFKLLKEGH  253 (334)
T ss_pred             CCCCHHHHHHHHHcCC
Confidence            88 5677777776653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0196|consensus

Probab=99.98  E-value=1.1e-33  Score=245.99  Aligned_cols=221  Identities=21%  Similarity=0.374  Sum_probs=180.7

Q ss_pred             cchHHHhhcccceeeEeeec------cccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTS------AEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      -++|++||+.|-++.+....      +++.++++.++...  ...++..|..|+.+|-+++||||+++.|.......+.|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            46788999999888776443      33444444443222  23667789999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |+|||++|+|..+|..+..+   |+..++..+++.|+.|++||.+.++|||||...|||++.+--   +|++|||+++.+
T Consensus       708 iTEyMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv---CKVsDFGLSRvl  781 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVL  781 (996)
T ss_pred             EhhhhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE---EEeccccceeec
Confidence            99999999999999877643   899999999999999999999999999999999999977654   899999999877


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .+...        ..+.+..+  .=+++|.|||.+...+++.++|+||+|++|||.++ |..||=. +.++++.+|.+|-
T Consensus       782 edd~~--------~~ytt~GG--KIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gy  851 (996)
T KOG0196|consen  782 EDDPE--------AAYTTLGG--KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGY  851 (996)
T ss_pred             ccCCC--------ccccccCC--ccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhcc
Confidence            65431        11222211  23579999999999999999999999999999888 9999998 7888999999886


Q ss_pred             -cc-ccccc
Q psy14626        241 -LH-ILGCT  247 (249)
Q Consensus       241 -~~-~~~~~  247 (249)
                       +. .+.||
T Consensus       852 RLPpPmDCP  860 (996)
T KOG0196|consen  852 RLPPPMDCP  860 (996)
T ss_pred             CCCCCCCCc
Confidence             22 22676

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.98  E-value=9.1e-32  Score=220.82  Aligned_cols=201  Identities=27%  Similarity=0.452  Sum_probs=156.9

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      |++.+.++.|.++.+|..........++++....  ......+.+.+|+.+++.++||||+++++++..++.+++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (285)
T cd07861           2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL   81 (285)
T ss_pred             ceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence            5566777888887777665543333344332222  22334567889999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      . ++|.+++..... ...+++.+++.++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||.+....... 
T Consensus        82 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          82 S-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV---IKLADFGLARAFGIPV-  155 (285)
T ss_pred             C-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc---EEECcccceeecCCCc-
Confidence            7 478777754332 234899999999999999999999999999999999999987776   9999999986543211 


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                                  .......+++.|+|||.+.+. .++.++|+||+|+++++|++|+.||.+.
T Consensus       156 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         156 ------------RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             ------------ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                        011122467889999998654 4688999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.98  E-value=1.6e-31  Score=216.06  Aligned_cols=198  Identities=29%  Similarity=0.454  Sum_probs=160.7

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc-----cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-----HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ||+..++++.|.++.+|..........++++.....     .....+.+.+|+.+++.++|+||+++++++..+..++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            577888898888888876554433333333322221     133557899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +||+++++|.+++....    .+++..+..++.|++.++.+||+.+++|+||+|+||+++.++.   ++|+|||.+....
T Consensus        81 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~---~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV---VKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEccCccceecc
Confidence            99999999998886543    2789999999999999999999999999999999999987665   9999999987654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...              ......++..|++||.+.... ++.++|+||+|+++++|++|+.||..
T Consensus       154 ~~~--------------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         154 EFS--------------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             ccc--------------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence            422              011224678899999987766 78999999999999999999999987

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0614|consensus

Probab=99.98  E-value=7.4e-33  Score=231.03  Aligned_cols=208  Identities=29%  Similarity=0.448  Sum_probs=176.7

Q ss_pred             hcccceeeEeeeccccC---CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         16 INHKWLKMKLHTSAEIE---PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      ++-|.++.+=..+..-.   .+-+.+++..+-+..+.+.+.+|-++|...+.|.||+++..|.+++.+|++||.|-||.|
T Consensus       428 LGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGEl  507 (732)
T KOG0614|consen  428 LGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGEL  507 (732)
T ss_pred             cccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchh
Confidence            44455554433333322   334445666677778889999999999999999999999999999999999999999999


Q ss_pred             hHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCC
Q psy14626         93 CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG  172 (249)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  172 (249)
                      ...+..++.    |+..+.+.++.-++.|+.|||.+|||+|||||+|.+++.++.   +||.|||++..+....      
T Consensus       508 WTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy---~KLVDFGFAKki~~g~------  574 (732)
T KOG0614|consen  508 WTILRDRGS----FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY---LKLVDFGFAKKIGSGR------  574 (732)
T ss_pred             hhhhhhcCC----cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc---eEEeehhhHHHhccCC------
Confidence            999988776    999999999999999999999999999999999999998887   9999999998887643      


Q ss_pred             ccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc--cccc
Q psy14626        173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK--LHIL  244 (249)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~--~~~~  244 (249)
                              ..-.+.||+-|.|||.+.+.....++|.||||+++|||++|.+||++ +.-.++..|.+|=  +.+|
T Consensus       575 --------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P  641 (732)
T KOG0614|consen  575 --------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP  641 (732)
T ss_pred             --------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc
Confidence                    33345699999999999999999999999999999999999999999 5667888888874  4444

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.98  E-value=1.5e-31  Score=221.02  Aligned_cols=199  Identities=27%  Similarity=0.441  Sum_probs=158.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc-----chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-----YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ||.+.+.++.|.++.+|..........++++......     ......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4677788888888888876654433333333222221     22345678899999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+ +++|.+++....   ..+++..++.++.|+++||.+||++|++|+||+|+||+++.++.   ++|+|||.+....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~---~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC---EEEccceeeeecc
Confidence            9999 889988886543   13899999999999999999999999999999999999987766   9999999987765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ....             ......+++.|+|||.+.+ ..++.++|+||+||++++|++|.+||.+
T Consensus       154 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~  205 (298)
T cd07841         154 SPNR-------------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG  205 (298)
T ss_pred             CCCc-------------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence            4221             1111235678999999865 4568899999999999999999888887

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=7e-32  Score=237.75  Aligned_cols=204  Identities=21%  Similarity=0.280  Sum_probs=153.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCc------------------ccCChhccccchhHHHHHHHHHHHHHcCCCChhh
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPAS------------------FGLPDERLNHYTTEADLKREATICHMLKHPHVVE   69 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   69 (249)
                      .+|++.+.|+.|.++.+|..........                  ..+.+...........+.+|+.+++.++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            5788889999999998885432211100                  0011111222234567899999999999999999


Q ss_pred             hhheeecCCeEEEEEeccCCCchhHHHHHhhhc-CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC
Q psy14626         70 LLETYSSEGMLYMVFEYMDGSDICFEIVRRATA-GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS  148 (249)
Q Consensus        70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~  148 (249)
                      +++++...+..++|++++.+ +|..++...... ........++.++.|++.||.|||++|++|+||||+|||++.++. 
T Consensus       228 l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~-  305 (501)
T PHA03210        228 IEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK-  305 (501)
T ss_pred             EeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC-
Confidence            99999999999999999964 666665443211 112346678889999999999999999999999999999987766 


Q ss_pred             CCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCC-CCCC
Q psy14626        149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL-PFVG  227 (249)
Q Consensus       149 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~-pf~~  227 (249)
                        ++|+|||++........            .......++..|+|||++.+..++.++|+|||||++|||++|.. ||..
T Consensus       306 --vkL~DFGla~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~  371 (501)
T PHA03210        306 --IVLGDFGTAMPFEKERE------------AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD  371 (501)
T ss_pred             --EEEEeCCCceecCcccc------------cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence              99999999876543221            11112358999999999999889999999999999999999764 5543

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.98  E-value=2e-31  Score=218.99  Aligned_cols=198  Identities=23%  Similarity=0.357  Sum_probs=162.6

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ..|++.+.++.|.++.++..........++++..... .....+.+.+|+.+++.++||||+++++.+...+.+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            5789999999999988887665543333443322222 234567899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      +++++|.+++....    .++...+..++.+++.+|.|||+ .+++|+||+|+||+++.++.   ++|+|||++......
T Consensus        85 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~---~~l~d~gl~~~~~~~  157 (284)
T cd06620          85 MDCGSLDRIYKKGG----PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc---EEEccCCcccchhhh
Confidence            99999988876543    38999999999999999999997 58999999999999987665   999999987544221


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .               .....++..|+|||++.+..++.++|+||+||+++++++|..||..
T Consensus       158 ~---------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~  204 (284)
T cd06620         158 I---------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF  204 (284)
T ss_pred             c---------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence            1               1123478899999999888889999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG4279|consensus

Probab=99.98  E-value=1.2e-32  Score=237.17  Aligned_cols=197  Identities=28%  Similarity=0.433  Sum_probs=161.1

Q ss_pred             hhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhH
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICF   94 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (249)
                      |++-|.|+++|...+.-.....+++.....+....+-+..|+.+-++++|.|||+++|++.+++.+-|.||-.+||+|++
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            45677899998777665555555555555555566778999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCcc
Q psy14626         95 EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER  174 (249)
Q Consensus        95 ~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  174 (249)
                      ++...=. +..-.+.++-.+.+||+.||+|||++.|||||||-+|+|++.-  ++.+||+|||-+.....-.+       
T Consensus       662 LLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy--SGvlKISDFGTsKRLAginP-------  731 (1226)
T KOG4279|consen  662 LLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY--SGVLKISDFGTSKRLAGINP-------  731 (1226)
T ss_pred             HHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec--cceEEecccccchhhccCCc-------
Confidence            8865422 2122778899999999999999999999999999999999753  45589999999876654321       


Q ss_pred             ccccccccCCcccCCCCCCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        175 LDHYTTKAGHRIGTPHYMAPEVIEDQ--KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                            -...+.||..|||||++..+  .|++++|||||||++.||.||++||..
T Consensus       732 ------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E  780 (1226)
T KOG4279|consen  732 ------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE  780 (1226)
T ss_pred             ------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence                  12234589999999999754  478999999999999999999999997

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.98  E-value=3e-31  Score=223.77  Aligned_cols=221  Identities=22%  Similarity=0.358  Sum_probs=165.4

Q ss_pred             CCCcchHHHhhcccceeeEeeecc-----ccCCCcccCChhccc-cchhHHHHHHHHHHHHHc-CCCChhhhhheeec-C
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSA-----EIEPASFGLPDERLN-HYTTEADLKREATICHML-KHPHVVELLETYSS-E   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~   77 (249)
                      |.+||++.+.|+.|.++.+|...+     ......++++..... .......+.+|+.++..+ +||||+++++++.. +
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            456899999999999999886542     112223333322221 123346788999999999 68999999998854 4


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhc-------------------------------------------------------
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATA-------------------------------------------------------  102 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------  102 (249)
                      ..++++|||+++++|.+++......                                                       
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            5689999999999999988653210                                                       


Q ss_pred             --------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCcc
Q psy14626        103 --------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER  174 (249)
Q Consensus       103 --------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  174 (249)
                              ...++...+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++.........      
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~---~kl~dfg~~~~~~~~~~~------  235 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV---VKICDFGLARDIYKDPDY------  235 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCc---EEEEecccccccccCcch------
Confidence                    123678888999999999999999999999999999999987665   999999998665332110      


Q ss_pred             ccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCC--hHHHHHHHHcCc
Q psy14626        175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGS--RDRLFQSITKGK  240 (249)
Q Consensus       175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~~--~~~~~~~i~~g~  240 (249)
                           .......++..|+|||.+.+..++.++|+||+|+++++|++ |..||...  .+.+.+.+..+.
T Consensus       236 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  299 (343)
T cd05103         236 -----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT  299 (343)
T ss_pred             -----hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccC
Confidence                 01111224567999999988888999999999999999997 99999872  334555555543

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.98  E-value=1.8e-31  Score=219.90  Aligned_cols=218  Identities=27%  Similarity=0.412  Sum_probs=166.6

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecC-----C
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSE-----G   78 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~-----~   78 (249)
                      ++..+|++...++.+.++.+|..........++++.... .....+.+.+|+.+++++ +|||++++++++...     +
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~-~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP-ISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecc-cccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            456789999999999888888666544433333332221 123356788999999999 899999999998643     3


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+++||||+++++|.+++.........+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~---~kl~dfg~  174 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG---VKLVDFGV  174 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC---EEEeeccc
Confidence            589999999999999888654444445899999999999999999999999999999999999987766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCC-hHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----KYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRL  232 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~pf~~~-~~~~  232 (249)
                      +........             ......++..|+|||.+...     .++.++|+||+||++|+|++|+.||... ..+.
T Consensus       175 ~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~  241 (291)
T cd06639         175 SAQLTSTRL-------------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT  241 (291)
T ss_pred             chhcccccc-------------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH
Confidence            865543221             11122467889999997643     2578999999999999999999999873 3333


Q ss_pred             HHHHHcC
Q psy14626        233 FQSITKG  239 (249)
Q Consensus       233 ~~~i~~g  239 (249)
                      ...+.++
T Consensus       242 ~~~~~~~  248 (291)
T cd06639         242 LFKIPRN  248 (291)
T ss_pred             HHHHhcC
Confidence            3344433

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.98  E-value=2.9e-31  Score=220.47  Aligned_cols=200  Identities=27%  Similarity=0.382  Sum_probs=162.8

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc---cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .+|.++|.+...++.|.++.+|..........++++...   .......+.+.+|+.+++.++|||++++++++..+...
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~   90 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA   90 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence            578899999999999998888877655444444443222   22234456789999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++|+||+.+ ++.+.+.....   .+++.++..++.|++.||.|||+.+++|+||+|+||+++.++.   ++|+|||.+.
T Consensus        91 ~lv~e~~~g-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~---~kL~dfg~~~  163 (307)
T cd06607          91 WLVMEYCLG-SASDILEVHKK---PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT---VKLADFGSAS  163 (307)
T ss_pred             EEEHHhhCC-CHHHHHHHccc---CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC---EEEeecCcce
Confidence            999999975 67666654322   3899999999999999999999999999999999999987766   9999999886


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ......                 ...++..|+|||.+.   ...++.++|+||+|+++|+|++|+.||.+
T Consensus       164 ~~~~~~-----------------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         164 LVSPAN-----------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             ecCCCC-----------------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence            543321                 123677899999874   34578899999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.98  E-value=2.7e-31  Score=215.45  Aligned_cols=203  Identities=28%  Similarity=0.454  Sum_probs=163.0

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ||++.+.++.|.++.++..........++++......  ....+.+.+|+.+++.++|+||+++++.+...+.+++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            6788888988888877766544333333333322222  34678899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.....    +++..+..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~---~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHGRI----LDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV---IKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhcCC----CChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEcccccccccCCCC
Confidence            999999988865432    788999999999999999999999999999999999987665   9999999987765433


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ....         .......++..|+|||.+.+..   .+.++|+||+|++++++++|+.||..
T Consensus       154 ~~~~---------~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~  208 (264)
T cd06626         154 TTMG---------EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE  208 (264)
T ss_pred             Cccc---------ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence            2111         0011234678999999998766   78999999999999999999999976

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.98  E-value=1.5e-31  Score=219.01  Aligned_cols=192  Identities=29%  Similarity=0.455  Sum_probs=152.4

Q ss_pred             cccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchh
Q psy14626         17 NHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC   93 (249)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (249)
                      +.|.++.+|...+......++   +.+...........+.+|+.+++.++|||++++++.+...+.+|+||||+++++|.
T Consensus         2 g~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   81 (277)
T cd05577           2 GKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK   81 (277)
T ss_pred             CCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHH
Confidence            445566666544433333333   32333333344566788999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626         94 FEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                      +++.....  ..+++.++..++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......       
T Consensus        82 ~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~---~~l~dfg~~~~~~~~~-------  149 (277)
T cd05577          82 YHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN---VRISDLGLAVELKGGK-------  149 (277)
T ss_pred             HHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC---EEEccCcchhhhccCC-------
Confidence            88876543  23899999999999999999999999999999999999987765   9999999876543211       


Q ss_pred             cccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                             ......++..|+|||.+.+..++.++|+||+|+++++|++|+.||..
T Consensus       150 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  196 (277)
T cd05577         150 -------KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ  196 (277)
T ss_pred             -------ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence                   11122467789999999888889999999999999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0577|consensus

Probab=99.98  E-value=9.1e-33  Score=234.22  Aligned_cols=218  Identities=24%  Similarity=0.346  Sum_probs=179.9

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      .-||.++|.-..-|++|-|+-+|+..+.....+++++   +...++......+.+|+..|+++.|||++.+-++|.....
T Consensus        21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T  100 (948)
T KOG0577|consen   21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT  100 (948)
T ss_pred             cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch
Confidence            3588899999999999999999877766555555544   4556666778899999999999999999999999998888


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .++|||||-| +-.+.+.-...   ++.+-+|..|+.+.+.||.|||+.+.||||||..|||+...+-   |||+|||.+
T Consensus       101 aWLVMEYClG-SAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~---VKLaDFGSA  173 (948)
T KOG0577|consen  101 AWLVMEYCLG-SASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL---VKLADFGSA  173 (948)
T ss_pred             HHHHHHHHhc-cHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe---eeeccccch
Confidence            9999999975 77777765543   3889999999999999999999999999999999999987666   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCCh-H-HHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR-D-RLFQ  234 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~~~-~-~~~~  234 (249)
                      ....+.                 +++.|||+|||||++.   .+.|+-++||||||++..||...++|+-+.. - .+++
T Consensus       174 si~~PA-----------------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYH  236 (948)
T KOG0577|consen  174 SIMAPA-----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  236 (948)
T ss_pred             hhcCch-----------------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHH
Confidence            776553                 3457999999999975   3568999999999999999999999988843 2 3444


Q ss_pred             HHHcCccccc
Q psy14626        235 SITKGKLHIL  244 (249)
Q Consensus       235 ~i~~g~~~~~  244 (249)
                      .-.+-.++++
T Consensus       237 IAQNesPtLq  246 (948)
T KOG0577|consen  237 IAQNESPTLQ  246 (948)
T ss_pred             HHhcCCCCCC
Confidence            4444445554

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.98  E-value=4e-31  Score=213.59  Aligned_cols=213  Identities=25%  Similarity=0.419  Sum_probs=167.5

Q ss_pred             hHHHhhcccceeeEeeeccccCC----CcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626         11 TIHEVINHKWLKMKLHTSAEIEP----ASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++.+.++.|.++.++........    ...+++...... ....+.+.+|+.+++.++|+||+++++.+.+.+..+++||
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e   81 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME   81 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence            45667788877777755554322    223332222222 1256789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++++++|.+.+.......  +++.++..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        82 ~~~~~~l~~~~~~~~~~~--~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~---~~l~dfg~~~~~~~~  156 (258)
T smart00219       82 YMEGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV---VKISDFGLSRDLYDD  156 (258)
T ss_pred             ccCCCCHHHHHHhhhhcc--CCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe---EEEcccCCceecccc
Confidence            999999998887644322  799999999999999999999999999999999999987765   999999998776653


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ....          ..  ...++..|+|||.+.+..++.++|+||+|+++++|++ |+.||.. +...+.+.+.++.
T Consensus       157 ~~~~----------~~--~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~  221 (258)
T smart00219      157 DYYK----------KK--GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY  221 (258)
T ss_pred             cccc----------cc--cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence            2110          00  1125788999999988888999999999999999998 8999987 5566777776655

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.98  E-value=1.9e-31  Score=219.03  Aligned_cols=200  Identities=28%  Similarity=0.448  Sum_probs=157.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|..........++++..  ........+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            3677888899988888876665433333333321  12222345678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|........    .+++.+++.++.|++.+|.|||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~---~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc---EEEEeeeeeeeccCC
Confidence            999888876544322    2899999999999999999999999999999999999987765   999999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..             ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||..
T Consensus       154 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~  203 (286)
T cd07846         154 GE-------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG  203 (286)
T ss_pred             cc-------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence            21             01112367889999998753 467889999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.98  E-value=1.9e-31  Score=218.91  Aligned_cols=201  Identities=28%  Similarity=0.448  Sum_probs=159.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +|++.+.++.|.++.++...+......++++......  ....+.+.+|+.++++++||||+++++++..+..+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5777888888888887766544333333333222221  34457899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      + +++|.+++....   ..+++.+++.++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~---~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV---LKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc---EEEeeeeecccccCCC
Confidence            9 899988876543   23899999999999999999999999999999999999987665   9999999986654422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .            .......++..|+|||.+.+.. ++.++|+||+|+++++|++|++||.+.
T Consensus       154 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         154 P------------RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             C------------CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence            1            0111234788999999986544 588999999999999999999999873

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.98  E-value=4.1e-31  Score=213.27  Aligned_cols=216  Identities=30%  Similarity=0.487  Sum_probs=173.0

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +|.+.+.++.|.++.++...+......++++......  ....+.+.+|+++++.++|||++++.+.+..+...++|+|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4666777888877777766665444445444333322  35667799999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++......+..++..++..++.+++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~---~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL---VKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc---EEECCccceeecccCc
Confidence            9999999988776433445899999999999999999999999999999999999987665   9999999987654422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .             ......+++.|+|||...+..++.++|+||+|+++++|++|+.||.. +..++.+.+.++.
T Consensus       158 ~-------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~  219 (258)
T cd08215         158 D-------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ  219 (258)
T ss_pred             c-------------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC
Confidence            0             11122467889999999888889999999999999999999999987 4555665555543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=5.3e-31  Score=213.60  Aligned_cols=215  Identities=24%  Similarity=0.394  Sum_probs=166.5

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCc---ccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPAS---FGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ||.+.+.++.|.++.+|..........   +..+.....  .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            688899999998888886554433221   222222211  223445677899999999999999999999998899999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +||+++++|.+.+.........+++.+++.++.|++.|+.+||+.|++|+||+|+||+++. +.   ++++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~---~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL---LKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC---EeecccCceeecC
Confidence            9999999998888764444456899999999999999999999999999999999999964 22   8999999986654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ....             ......++..|+|||.+.+..++.++|+||+|+++++|++|..||.. ........+..+.
T Consensus       157 ~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  221 (260)
T cd08222         157 GSCD-------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP  221 (260)
T ss_pred             CCcc-------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC
Confidence            3221             11122367889999999888888899999999999999999999986 3444444554443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.98  E-value=2.4e-31  Score=218.86  Aligned_cols=221  Identities=22%  Similarity=0.367  Sum_probs=168.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccc-----cCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .++|++...++.|.++.++.....     .....++++..... .......+.+|+.+++.++||||+++++++..+..+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            457888888888888877765432     12222333222211 223456799999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhh------------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeee
Q psy14626         81 YMVFEYMDGSDICFEIVRRAT------------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLL  142 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili  142 (249)
                      ++++||+++++|.+++.....                  ....++..+++.++.|++.||.+||+++++|+||+|+||++
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~  163 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV  163 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence            999999999999998875321                  11236788999999999999999999999999999999999


Q ss_pred             eecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-C
Q psy14626        143 ANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-G  221 (249)
Q Consensus       143 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g  221 (249)
                      +.++.   ++++|||.+.........           ........+..|+|||.+.+..++.++|+|||||++|+|++ |
T Consensus       164 ~~~~~---~~l~dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~  229 (288)
T cd05050         164 GENMV---VKIADFGLSRNIYSADYY-----------KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  229 (288)
T ss_pred             cCCCc---eEECccccceecccCccc-----------cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCC
Confidence            87766   999999998655332210           00111124567999999988889999999999999999997 8


Q ss_pred             CCCCCC-ChHHHHHHHHcCcc
Q psy14626        222 TLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       222 ~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      ..||.+ +.+++...+..+..
T Consensus       230 ~~p~~~~~~~~~~~~~~~~~~  250 (288)
T cd05050         230 MQPYYGMAHEEVIYYVRDGNV  250 (288)
T ss_pred             CCCCCCCCHHHHHHHHhcCCC
Confidence            889977 56667777776653

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.6e-31  Score=216.02  Aligned_cols=202  Identities=25%  Similarity=0.393  Sum_probs=158.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhc-----cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-----LNHYTTEADLKREATICHMLKHPHVVELLETYSSE--GMLY   81 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~   81 (249)
                      .|++.++++.|.++.+|...+.-....++++...     .........+.+|+.++++++|+||+++++.+.+.  +.++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (264)
T cd06653           3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLS   82 (264)
T ss_pred             ceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEE
Confidence            5778888888888887766544333333332211     12234456889999999999999999999998654  5689


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +++||+++++|.+++.....    ++...++.++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        83 ~v~e~~~~~~L~~~~~~~~~----l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~  155 (264)
T cd06653          83 IFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN---VKLGDFGASKR  155 (264)
T ss_pred             EEEEeCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEECccccccc
Confidence            99999999999888865433    789999999999999999999999999999999999987665   99999999876


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ........          .......++..|+|||.+.+..++.++|+||+|+++++|++|+.||..
T Consensus       156 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  211 (264)
T cd06653         156 IQTICMSG----------TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE  211 (264)
T ss_pred             cccccccC----------ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence            53211000          000112367889999999988889999999999999999999999987

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.98  E-value=2.6e-31  Score=214.78  Aligned_cols=206  Identities=22%  Similarity=0.389  Sum_probs=163.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ++|++.++++.|.++.++.....  ...++++....  ....+.+.+|+.+++.++|||++++++.+...+ .+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~--~~~~~iK~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEecccC--CCceEEEeecC--cchHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECC
Confidence            56888999999988887754422  22233322221  234467899999999999999999999986654 79999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++.....  ..++..++..++.|++.|+.+||+.|++|+||+|+||+++.++.   ++|+|||.+....... 
T Consensus        81 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~---~kl~Dfg~~~~~~~~~-  154 (254)
T cd05083          81 SKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV---AKVSDFGLARVGSMGV-  154 (254)
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc---EEECCCccceeccccC-
Confidence            99999998876432  23789999999999999999999999999999999999987665   9999999986543211 


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                                     .....+..|+|||.+.+..++.++|+||+|+++++|++ |+.||.. +..+..+.+.++
T Consensus       155 ---------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~  213 (254)
T cd05083         155 ---------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG  213 (254)
T ss_pred             ---------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCC
Confidence                           01123567999999988888999999999999999997 9999988 555666666665

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0696|consensus

Probab=99.98  E-value=2.4e-32  Score=223.40  Aligned_cols=215  Identities=29%  Similarity=0.448  Sum_probs=177.5

Q ss_pred             chHHHhhcccceeeEeeeccccC---CCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEe
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIE---PASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +.+.-|++-|-++.+....+.-.   .+++.+++..+-+..+.+--+.|-.+|... +-|.++.++..|++-+.+|+|||
T Consensus       351 FnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVME  430 (683)
T KOG0696|consen  351 FNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVME  430 (683)
T ss_pred             cceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEE
Confidence            33445677777777665554433   344445555565566666667777777777 57899999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.||+|.-.++.-+.    |.+..+..++.+|+-||-+||++||++||||.+||+++.+++   ++|.|||.+...--.
T Consensus       431 yvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH---iKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  431 YVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIFD  503 (683)
T ss_pred             EecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc---eEeeecccccccccC
Confidence            9999999988887665    889999999999999999999999999999999999998888   999999998554322


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .             .......||+.|+|||.+...+|+.++|.||+|++||||+.|++||.+ +.++++++|+.-...+|
T Consensus       504 ~-------------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP  570 (683)
T KOG0696|consen  504 G-------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP  570 (683)
T ss_pred             C-------------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc
Confidence            1             233445699999999999999999999999999999999999999999 56789999999887777

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.98  E-value=1.2e-31  Score=223.45  Aligned_cols=201  Identities=22%  Similarity=0.368  Sum_probs=148.9

Q ss_pred             HhhcccceeeEeeecccc--CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheee--cCCeEEEEEeccCC
Q psy14626         14 EVINHKWLKMKLHTSAEI--EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYS--SEGMLYMVFEYMDG   89 (249)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~   89 (249)
                      ..++.|.++.+|......  ....++++..  ........+.+|+.+++.++||||+++++++.  .+..+++|+||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEe--cCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            467888888888665332  2223333222  22223456889999999999999999999984  35678999999965


Q ss_pred             CchhHHHHHhhh-----cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC-CCCCeEEcCcceeEEcc
Q psy14626         90 SDICFEIVRRAT-----AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        90 ~~L~~~l~~~~~-----~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~-~~~~~~l~dfg~~~~~~  163 (249)
                       +|.+++.....     ....+++..++.++.|++.||.+||+++++|+||||+||++..++ ....++|+|||++....
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence             77666643221     123478899999999999999999999999999999999995432 23459999999997654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....          ........+++.|+|||.+.+. .++.++|+||+||++|+|++|++||..
T Consensus       164 ~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         164 SPLKP----------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CCccc----------ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            42210          0111223478899999998764 478999999999999999999999976

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.98  E-value=1.2e-31  Score=220.16  Aligned_cols=198  Identities=25%  Similarity=0.396  Sum_probs=152.9

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ||++.+.++.|.++.+|...+......++++....  ........+.+|+.++++++||||+++++++.+...+++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            56777788888887777655543333333322221  2223346688899999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+ +|.+++....   ..+++..++.++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~---~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLARAFGIPV  153 (284)
T ss_pred             CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc---EEECccchhhccCCCC
Confidence            975 7777665432   23899999999999999999999999999999999999987766   9999999986543211


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFV  226 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~  226 (249)
                      .             ......++..|+|||.+.+.. ++.++|+||+||++++|++|..||.
T Consensus       154 ~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~  201 (284)
T cd07839         154 R-------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF  201 (284)
T ss_pred             C-------------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence            0             111224678899999987644 6899999999999999999887754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.98  E-value=3.3e-31  Score=213.63  Aligned_cols=207  Identities=19%  Similarity=0.331  Sum_probs=158.6

Q ss_pred             hhcccceeeEeeeccccCCCcccCChhccccc-hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchh
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLPDERLNHY-TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC   93 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (249)
                      .++.|.++.+|...... ...++++....... ...+.+.+|++++++++|+||+++++++......++|||++.+++|.
T Consensus         2 ~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             ccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            35566666666554432 33333332222222 35678999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626         94 FEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                      +++.....   .++...+..++.+++.+|.+||+++++|+||+|+||+++.++.   ++|+|||.+.........     
T Consensus        81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~---~~l~d~g~~~~~~~~~~~-----  149 (251)
T cd05041          81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV---LKISDFGMSREEEGGIYT-----  149 (251)
T ss_pred             HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc---EEEeeccccccccCCcce-----
Confidence            88865432   3789999999999999999999999999999999999987766   999999998655421110     


Q ss_pred             cccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                            ........+..|+|||.+.+..++.++|+||||+++++|++ |..||.. ......+.+..+
T Consensus       150 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~  211 (251)
T cd05041         150 ------VSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESG  211 (251)
T ss_pred             ------eccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcC
Confidence                  00011123567999999988888999999999999999999 8999987 445556666554

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0199|consensus

Probab=99.98  E-value=2.9e-32  Score=234.74  Aligned_cols=219  Identities=23%  Similarity=0.374  Sum_probs=178.7

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCc---ccCChhccccc-hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPAS---FGLPDERLNHY-TTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      |.+.++..+++++|-|++++...+....+.   ++++....... ...+.|.+|+.+|.+|+|||+++++|+..+ ....
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            556788999999999999987776654332   22222222222 267889999999999999999999999988 5688


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +|||+++.|+|.++|......  .|....+-.++.||+.|+.||..+++|||||...|+++-....   |||+|||+++-
T Consensus       187 MV~ELaplGSLldrLrka~~~--~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt---VKI~DFGLmRa  261 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKA--ILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT---VKICDFGLMRA  261 (1039)
T ss_pred             HHhhhcccchHHHHHhhcccc--ceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce---eeeecccceec
Confidence            999999999999999873332  3778889999999999999999999999999999999966444   99999999988


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      +....-+.          .-...+.-.+.|+|||.++..+++.++|+|++||++|||++ |..||.+ ..-.|+++|..|
T Consensus       262 Lg~ned~Y----------vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~  331 (1039)
T KOG0199|consen  262 LGENEDMY----------VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG  331 (1039)
T ss_pred             cCCCCcce----------EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc
Confidence            87654221          12222345678999999999999999999999999999999 9999999 677899999877


Q ss_pred             c
Q psy14626        240 K  240 (249)
Q Consensus       240 ~  240 (249)
                      +
T Consensus       332 e  332 (1039)
T KOG0199|consen  332 E  332 (1039)
T ss_pred             c
Confidence            6

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=4.1e-31  Score=215.45  Aligned_cols=198  Identities=18%  Similarity=0.311  Sum_probs=148.0

Q ss_pred             hcccceeeEeeecccc--CCCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         16 INHKWLKMKLHTSAEI--EPASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      ++.|.++.+|......  ....++++...... ......+.+|+.++++++||||+++++.+.+....++||||+++++|
T Consensus         3 lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   82 (269)
T cd05087           3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDL   82 (269)
T ss_pred             ccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcH
Confidence            5666677766554321  12223332222221 23345789999999999999999999999988889999999999999


Q ss_pred             hHHHHHhhh-cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccC
Q psy14626         93 CFEIVRRAT-AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG  171 (249)
Q Consensus        93 ~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~  171 (249)
                      .+++..... .....+...+..++.|++.|+.|||+.+++|+||||+||+++.++.   ++|+|||.+.........   
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~---~kL~dfg~~~~~~~~~~~---  156 (269)
T cd05087          83 KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT---VKIGDYGLSHNKYKEDYY---  156 (269)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc---EEECCccccccccCccee---
Confidence            998875432 2223567788899999999999999999999999999999987655   999999988543322110   


Q ss_pred             CccccccccccCCcccCCCCCCccccccC-------CCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy14626        172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQ-------KYGKPVDIWAAGVLLHVLLT-GTLPFVG  227 (249)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~~l~el~~-g~~pf~~  227 (249)
                              .......++..|+|||++.+.       .++.++|+||+|+++++|++ |..||..
T Consensus       157 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~  212 (269)
T cd05087         157 --------VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH  212 (269)
T ss_pred             --------ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence                    011122356789999998642       35789999999999999996 9999987

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=2.6e-31  Score=214.79  Aligned_cols=214  Identities=29%  Similarity=0.501  Sum_probs=165.9

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +|++.+.++.|.++.+|..........++++.....  .....+.+.+|+.+++.++|+|++++++.+..+..+++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            467777888888777776555544333333322221  123456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.....  ..+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.  .++++|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM--VAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC--eEEecccccchhccCCc
Confidence            999999988865432  23789999999999999999999999999999999999986643  26999999886554321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .             ......+++.|+|||...+..++.++|+||+|+++++|++|+.||.. +..+....+..+
T Consensus       157 ~-------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  217 (257)
T cd08225         157 E-------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG  217 (257)
T ss_pred             c-------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence            1             11112478889999999888889999999999999999999999987 444444444443

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=8.9e-31  Score=210.79  Aligned_cols=209  Identities=31%  Similarity=0.507  Sum_probs=165.7

Q ss_pred             cccceeeEeeeccccCCCc---ccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchh
Q psy14626         17 NHKWLKMKLHTSAEIEPAS---FGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC   93 (249)
Q Consensus        17 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (249)
                      +.|.++.++..........   +.+.+.........+.+.+|+.++++++|||++++++.+..+..+++|||++.+++|.
T Consensus         2 g~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~   81 (250)
T cd05123           2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF   81 (250)
T ss_pred             CCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHH
Confidence            3455555554443322222   2233333444456778999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626         94 FEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                      +++.....    +++..+..++.|++.++.+||+.+++|+||+|+||+++.++.   ++|+|||.+........      
T Consensus        82 ~~l~~~~~----l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~---~~l~d~~~~~~~~~~~~------  148 (250)
T cd05123          82 SHLSKEGR----FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH---IKLTDFGLAKELSSEGS------  148 (250)
T ss_pred             HHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc---EEEeecCcceecccCCC------
Confidence            98876543    899999999999999999999999999999999999987765   99999999876644210      


Q ss_pred             cccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                             ......++..|+|||...+...+.++|+||+|++++++++|+.||.. +..++...+..+.+.+|.
T Consensus       149 -------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  214 (250)
T cd05123         149 -------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPE  214 (250)
T ss_pred             -------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence                   11122467889999999888889999999999999999999999987 456677777777777664

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=1.9e-31  Score=219.04  Aligned_cols=204  Identities=18%  Similarity=0.275  Sum_probs=157.2

Q ss_pred             CcchHHHhhcccceeeEeeecc----ccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec--CCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSA----EIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS--EGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~   81 (249)
                      ++|++.+.++.|.++.+|....    ......++++..........+.+.+|+.++++++||||+++++++..  ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4788889999998888876432    11222334433333344556789999999999999999999998743  34689


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +|+||+++++|.+++.....   .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+..
T Consensus        84 lv~e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~---~~l~dfg~~~~  157 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR---VKIGDFGLTKV  157 (284)
T ss_pred             EEEEecCCCCHHHHHHhcCc---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe---EEECCCccccc
Confidence            99999999999998865432   2789999999999999999999999999999999999987766   99999999876


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ........          .......++..|+|||++.+..++.++|+||+|++++||++|..|+..
T Consensus       158 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~  213 (284)
T cd05081         158 LPQDKEYY----------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS  213 (284)
T ss_pred             ccCCCcce----------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence            54322100          000011234568999999888889999999999999999998777654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.97  E-value=4.7e-31  Score=215.76  Aligned_cols=231  Identities=26%  Similarity=0.443  Sum_probs=177.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++|.+.+.++.|.++.+|..........++   ..+.........+.+.+|+.++++++ ||||+++++.+..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            367888889998888888666543333333   33333444455678899999999998 99999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||++.+++|.+++.....    +++.++..++.|++.||.+||+.+++|+||+|+||+++.++.   ++++|||.+....
T Consensus        81 ~e~~~~~~L~~~l~~~~~----l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~---~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKYGS----LDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH---IKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC---EEecCCccccccC
Confidence            999999999998876543    899999999999999999999999999999999999987766   9999999987655


Q ss_pred             CCCccccCCc-------cccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        164 DGQLYCSGGE-------RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       164 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      ..........       .............++..|+|||...+..++.++|+||+|++++++++|+.||.. +.....+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  233 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK  233 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            4321100000       000001122333467889999999888889999999999999999999999998 44455667


Q ss_pred             HHcCcccccc
Q psy14626        236 ITKGKLHILG  245 (249)
Q Consensus       236 i~~g~~~~~~  245 (249)
                      +..+...+|.
T Consensus       234 ~~~~~~~~~~  243 (280)
T cd05581         234 ILKLEYSFPP  243 (280)
T ss_pred             HHhcCCCCCC
Confidence            7777766664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=4e-31  Score=226.72  Aligned_cols=218  Identities=21%  Similarity=0.362  Sum_probs=164.9

Q ss_pred             CcchHHHhhcccceeeEeeecccc-----CCCcccCChhccc-cchhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERLN-HYTTEADLKREATICHMLK-HPHVVELLETYSSEGML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   80 (249)
                      ++|.+.+.++.|.++.+|...+.-     ....++++..... .....+.+.+|+.++.++. ||||+++++++...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            467888999999999988665321     1112222222211 1233457899999999997 99999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhh-----------------------------------------------------------
Q psy14626         81 YMVFEYMDGSDICFEIVRRAT-----------------------------------------------------------  101 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------------  101 (249)
                      ++||||+.+|+|.+++.....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999875421                                                           


Q ss_pred             -----------------------------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626        102 -----------------------------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus       102 -----------------------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                                                         ....++...+..++.|++.||.|||+.+++|+||||+||+++.++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC
Confidence                                               012356778889999999999999999999999999999998765


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF  225 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf  225 (249)
                      .   ++|+|||.+.........           .......++..|+|||.+.+..++.++|+||+|++++||++ |..||
T Consensus       277 ~---~kL~DfGla~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         277 L---VKICDFGLARDIMRDSNY-----------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             E---EEEEecCcceeccccccc-----------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            5   899999998764332110           01112235778999999988888999999999999999998 89999


Q ss_pred             CC-C-hHHHHHHHHcC
Q psy14626        226 VG-S-RDRLFQSITKG  239 (249)
Q Consensus       226 ~~-~-~~~~~~~i~~g  239 (249)
                      .. . .+...+.+..+
T Consensus       343 ~~~~~~~~~~~~~~~~  358 (401)
T cd05107         343 PELPMNEQFYNAIKRG  358 (401)
T ss_pred             CCCCchHHHHHHHHcC
Confidence            87 3 33344555555

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=4.8e-31  Score=221.69  Aligned_cols=219  Identities=20%  Similarity=0.312  Sum_probs=164.2

Q ss_pred             CcCCCCCcch-HHHhhcccceeeEeeeccccCCCcccCChhccccch--------------hHHHHHHHHHHHHHcCCCC
Q psy14626          2 LSVDPNKRIT-IHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYT--------------TEADLKREATICHMLKHPH   66 (249)
Q Consensus         2 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~~   66 (249)
                      |+++..+||. +...++.|.++.+|...+......++++........              ....+.+|+.+++.++|||
T Consensus         2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   81 (335)
T PTZ00024          2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN   81 (335)
T ss_pred             CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence            6788899997 467799999888887765544434443322221111              1235789999999999999


Q ss_pred             hhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626         67 VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus        67 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                      |+++++++..++..++|||++. ++|.+.+.....    ++...+..++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus        82 iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         82 IMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR----LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG  156 (335)
T ss_pred             eeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC
Confidence            9999999999999999999997 488887765433    89999999999999999999999999999999999998776


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCc-cccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGE-RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLP  224 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p  224 (249)
                      .   ++|+|||.+.............. .............++..|+|||.+.+.. ++.++|+||+|+++++|++|+.|
T Consensus       157 ~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p  233 (335)
T PTZ00024        157 I---CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL  233 (335)
T ss_pred             C---EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            5   99999999876652211100000 0000001111223578899999987643 58899999999999999999999


Q ss_pred             CCCC
Q psy14626        225 FVGS  228 (249)
Q Consensus       225 f~~~  228 (249)
                      |.+.
T Consensus       234 ~~~~  237 (335)
T PTZ00024        234 FPGE  237 (335)
T ss_pred             CCCC
Confidence            9983

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=2.6e-31  Score=217.59  Aligned_cols=214  Identities=29%  Similarity=0.433  Sum_probs=169.2

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      |+..-|++...++.|.++.+|...+......++++..... .....+.+.+|+.++++++||||+++++.+..+..+++|
T Consensus         1 ~~~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   80 (277)
T cd06641           1 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII   80 (277)
T ss_pred             CHHHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence            4555678888899998888887655444444444322222 223456789999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++...     .++...+..++.|++.++.+||+.+++|+||+|+||+++.++.   ++++|||.+....
T Consensus        81 ~e~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~---~~l~dfg~~~~~~  152 (277)
T cd06641          81 MEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLT  152 (277)
T ss_pred             EEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC---EEEeecccceecc
Confidence            9999999998887532     2789999999999999999999999999999999999987766   9999999886654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ....             ......++..|+|||.+.+..++.++|+||+||++++|++|..||.. +.......+..+
T Consensus       153 ~~~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~  216 (277)
T cd06641         153 DTQI-------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN  216 (277)
T ss_pred             cchh-------------hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC
Confidence            3221             01112467889999999888889999999999999999999999987 444445455444

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.3e-30  Score=217.04  Aligned_cols=204  Identities=19%  Similarity=0.291  Sum_probs=153.7

Q ss_pred             hHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccC
Q psy14626         11 TIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD   88 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (249)
                      .+++-++++.+..++....  ....++++....  ......+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP--TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhHhhcCCceEEEEEecC--CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            3455555544444433332  233333332222  234566789999999999999999999999999999999999999


Q ss_pred             CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626         89 GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                      +++|.+++......  .+++..+..++.|++.||.|||+.+++|+||||+||+++.++.   ++++||+.+.........
T Consensus        83 ~~~l~~~l~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~---~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          83 YGSCEDLLKTHFPE--GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK---VVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CCCHHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc---eEEecCccceeecccccc
Confidence            99999888765332  3889999999999999999999999999999999999987766   999999988655432211


Q ss_pred             ccCCccccccccccCCcccCCCCCCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ--KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..      ..........++..|+|||.+.+.  .++.++|+||+|+++++|++|+.||..
T Consensus       158 ~~------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~  212 (314)
T cd08216         158 QR------VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD  212 (314)
T ss_pred             cc------ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            00      000111223467789999998753  478899999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4645|consensus

Probab=99.97  E-value=3.4e-33  Score=253.67  Aligned_cols=221  Identities=26%  Similarity=0.426  Sum_probs=179.8

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      |++-+..+++|.++.+|...+.-.+...+.+...++.  .+....+.+|..++..++|||+|+++++-...+..+|.|||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence            5666777899999999877766555555555444433  34556788999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      |.+|+|.+.+...+.    .++.....+-.|++.|+.|||+.|||||||||.||+++.++-   +|++|||.+..+....
T Consensus      1316 C~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~---iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL---IKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             hccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc---EEeecccceeEecCch
Confidence            999999988875544    788889999999999999999999999999999999988775   9999999998887753


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCC-ChH-HHHHHHHcCc-
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGVLLHVLLTGTLPFVG-SRD-RLFQSITKGK-  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~pf~~-~~~-~~~~~i~~g~-  240 (249)
                      .         ......+...||+.|||||++.+.+   -..++|||||||++.||+||+.||.. +.+ .|+..+..|. 
T Consensus      1389 ~---------~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1389 Q---------TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK 1459 (1509)
T ss_pred             h---------cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC
Confidence            1         1123444567999999999987643   46789999999999999999999998 333 5666776665 


Q ss_pred             ccccc
Q psy14626        241 LHILG  245 (249)
Q Consensus       241 ~~~~~  245 (249)
                      |++|+
T Consensus      1460 Pq~P~ 1464 (1509)
T KOG4645|consen 1460 PQIPE 1464 (1509)
T ss_pred             CCCch
Confidence            66664

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=9.3e-32  Score=227.97  Aligned_cols=193  Identities=25%  Similarity=0.340  Sum_probs=154.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      .+|++...++.|.++.+|..........++++...      ......|+.++++++||||+++++++..++..++|||++
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  139 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ------KGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY  139 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCC------ccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc
Confidence            36888889999999888877665444444443211      123457999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      . ++|.+++....   ..+++..++.++.|++.||.|||+++++||||||+||+++.++.   ++|+|||.+....... 
T Consensus       140 ~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        140 S-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ---VCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             C-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEecCccccccccCc-
Confidence            6 47877775533   23899999999999999999999999999999999999987666   9999999986432211 


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG  227 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~  227 (249)
                                   ......++..|+|||++.+..++.++|+||+||++|||++ ++.+|..
T Consensus       212 -------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~  259 (357)
T PHA03209        212 -------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED  259 (357)
T ss_pred             -------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence                         1112347899999999998889999999999999999998 4555543

>KOG1094|consensus

Probab=99.97  E-value=2.2e-32  Score=231.36  Aligned_cols=212  Identities=24%  Similarity=0.347  Sum_probs=168.8

Q ss_pred             CCCcchHHHhhcccceeeEeeecccc--CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEI--EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      |.++..+.+.|++|-|+.+-....+.  .++.+.+  ...+.......|.+|+.+|.+++||||+++++.|..++.+++|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~L--r~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKIL--RPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeec--CcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence            55688999999999888763333332  1222222  2223334468899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +||+++|+|..++..+....  .......+++.||++|++||.+.++|||||.+.|+|++++.+   +||+|||.++-.-
T Consensus       614 ~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~---iKiadfgmsR~ly  688 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT---IKIADFGMSRNLY  688 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc---EEecCcccccccc
Confidence            99999999999998774321  344555679999999999999999999999999999987776   9999999987665


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCC-ChHHHHHH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT--GTLPFVG-SRDRLFQS  235 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~--g~~pf~~-~~~~~~~~  235 (249)
                      ....+..           ++....+++|+|+|.+..++++.++|+|++|+++||+++  ...||+. +++++.+.
T Consensus       689 sg~yy~v-----------qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven  752 (807)
T KOG1094|consen  689 SGDYYRV-----------QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN  752 (807)
T ss_pred             cCCceee-----------ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence            5443332           223357899999999999999999999999999999988  7789998 56555544

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=9.9e-31  Score=218.26  Aligned_cols=213  Identities=25%  Similarity=0.363  Sum_probs=166.2

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc---cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      ..||.+.|.....++.|.++.++..........++++...   .........+.+|+.+++.++|||++++++++..+..
T Consensus        20 ~~~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (317)
T cd06635          20 KEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT   99 (317)
T ss_pred             CCCchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence            3578888999999999998888766654333334333222   2233445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .++||||+.| +|.+.+.....   .+++.++..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||.+
T Consensus       100 ~~lv~e~~~g-~l~~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~---~kl~dfg~~  172 (317)
T cd06635         100 AWLVMEYCLG-SASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGSA  172 (317)
T ss_pred             EEEEEeCCCC-CHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC---EEEecCCCc
Confidence            9999999975 77666654322   3899999999999999999999999999999999999987665   999999987


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      .......                 ...++..|+|||.+.   ....+.++|+||+|+++++|++|+.||.. +.......
T Consensus       173 ~~~~~~~-----------------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~  235 (317)
T cd06635         173 SIASPAN-----------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  235 (317)
T ss_pred             cccCCcc-----------------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            5433211                 124678899999974   34578899999999999999999999987 33344444


Q ss_pred             HHcC
Q psy14626        236 ITKG  239 (249)
Q Consensus       236 i~~g  239 (249)
                      +..+
T Consensus       236 ~~~~  239 (317)
T cd06635         236 IAQN  239 (317)
T ss_pred             HHhc
Confidence            4443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=4.1e-31  Score=216.21  Aligned_cols=161  Identities=19%  Similarity=0.277  Sum_probs=133.7

Q ss_pred             hHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH
Q psy14626         48 TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE  127 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~  127 (249)
                      ....+.+|+.+++.++||||+++++++..+...++||||+++++|..++.....   .++..++..++.|++.||.|||+
T Consensus        59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~  135 (274)
T cd05076          59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---RVPVAWKITVAQQLASALSYLED  135 (274)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHc
Confidence            345788899999999999999999999999999999999999999888764322   37899999999999999999999


Q ss_pred             CCceeecCCCCCeeeeecCC----CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCC
Q psy14626        128 NDIIHRDIKPHCVLLANKEN----SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKY  202 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~  202 (249)
                      ++++|+||||+||+++..+.    ...++++|||.+.......                 ...++..|+|||.+.+ ..+
T Consensus       136 ~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-----------------~~~~~~~~~aPe~~~~~~~~  198 (274)
T cd05076         136 KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-----------------ERVERIPWIAPECVPGGNSL  198 (274)
T ss_pred             CCccCCCCCcccEEEeccCcccCccceeeecCCcccccccccc-----------------ccccCCcccCchhhcCCCCC
Confidence            99999999999999976432    2347999999874332211                 1236778999998865 557


Q ss_pred             CCcchHHHHHHHHHHHH-hCCCCCCCC
Q psy14626        203 GKPVDIWAAGVLLHVLL-TGTLPFVGS  228 (249)
Q Consensus       203 ~~~~DiwslG~~l~el~-~g~~pf~~~  228 (249)
                      +.++|+||||+++||++ +|+.||.+.
T Consensus       199 ~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         199 STAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            89999999999999995 599999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=5.9e-31  Score=213.90  Aligned_cols=162  Identities=21%  Similarity=0.348  Sum_probs=134.4

Q ss_pred             hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH  126 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH  126 (249)
                      .....+.+|+.+++.++||||+++++++......++||||+++++|..++.....   .+++.++..++.|++.|+.|||
T Consensus        46 ~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH  122 (262)
T cd05077          46 DISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD---VLTTPWKFKVAKQLASALSYLE  122 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHhh
Confidence            3455788899999999999999999999988889999999999999877754332   3899999999999999999999


Q ss_pred             HCCceeecCCCCCeeeeecCCC----CCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccc-cCC
Q psy14626        127 ENDIIHRDIKPHCVLLANKENS----APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-DQK  201 (249)
Q Consensus       127 ~~~~vH~dlkp~Nili~~~~~~----~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~  201 (249)
                      +++++|+||||+||+++.++..    ..++++|||.+.......                 ...++..|+|||.+. +..
T Consensus       123 ~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~-----------------~~~~~~~y~aPE~~~~~~~  185 (262)
T cd05077         123 DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ-----------------ECVERIPWIAPECVEDSKN  185 (262)
T ss_pred             hCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcc-----------------cccccccccChhhhcCCCC
Confidence            9999999999999999764421    237999999875443211                 123678899999986 466


Q ss_pred             CCCcchHHHHHHHHHHHH-hCCCCCCCC
Q psy14626        202 YGKPVDIWAAGVLLHVLL-TGTLPFVGS  228 (249)
Q Consensus       202 ~~~~~DiwslG~~l~el~-~g~~pf~~~  228 (249)
                      ++.++|+||+||++|+|+ +|..||...
T Consensus       186 ~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         186 LSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             CCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            789999999999999998 599999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=3.9e-31  Score=214.81  Aligned_cols=218  Identities=26%  Similarity=0.399  Sum_probs=167.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +.|++.+.++.|.++.+|..........++++..... .....+.+.+|+.+++.++|+|++++++.+..+...++++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4677888888888887776654333333333322211 123567899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++..... ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~---~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS---VKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC---EEEcccchHHHhccCc
Confidence            999999998876433 123899999999999999999999999999999999999987665   9999999886555432


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ...         ........++..|+|||.+... .++.++|+||+|+++++|++|+.||.. +..+....+.+
T Consensus       157 ~~~---------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~  221 (267)
T cd06610         157 DRT---------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ  221 (267)
T ss_pred             ccc---------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc
Confidence            110         0111223467899999998766 678999999999999999999999987 33333434333

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-31  Score=220.25  Aligned_cols=200  Identities=25%  Similarity=0.416  Sum_probs=158.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ++|++.+.++.|.++.+|...+......++++...... ......+.+|+.++++++||||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888889999988888877655444444444332221 22334577899999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+ +|.+++.....   .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        85 ~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~~~~~~  157 (291)
T cd07844          85 LDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPS  157 (291)
T ss_pred             CCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC---EEECccccccccCCCC
Confidence            975 88887765432   3789999999999999999999999999999999999987766   9999999985432211


Q ss_pred             ccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .             ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+
T Consensus       158 ~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         158 K-------------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             c-------------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            0             0011235778999999875 4578899999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=5.4e-31  Score=216.05  Aligned_cols=190  Identities=22%  Similarity=0.421  Sum_probs=145.5

Q ss_pred             hcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHc---CCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         16 INHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHML---KHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      ++.|.++.+|...+......++++   +...........+.+|..+++.+   +||+++.+++.+..++..++||||+++
T Consensus         2 lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (279)
T cd05633           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNG   81 (279)
T ss_pred             cccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCC
Confidence            566777777755544333333332   22222223334445555544444   699999999999998999999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++..+..    +++..+..++.|++.||.+||+++++|+||||+||+++.++.   ++++|||.+.......   
T Consensus        82 ~~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~---~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          82 GDLHYHLSQHGV----FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC---EEEccCCcceeccccC---
Confidence            999888865543    899999999999999999999999999999999999987665   9999999986543311   


Q ss_pred             cCCccccccccccCCcccCCCCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                  .....++..|+|||.+. +..++.++|+||+||++++|++|..||..
T Consensus       152 ------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  198 (279)
T cd05633         152 ------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ  198 (279)
T ss_pred             ------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence                        11124789999999986 45578999999999999999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=1.2e-30  Score=212.61  Aligned_cols=216  Identities=24%  Similarity=0.407  Sum_probs=168.8

Q ss_pred             cchHHHhhcccceeeEeeecccc-CCCcccCChhc----------cccchhHHHHHHHHHHHHH-cCCCChhhhhheeec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEI-EPASFGLPDER----------LNHYTTEADLKREATICHM-LKHPHVVELLETYSS   76 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----------~~~~~~~~~~~~E~~~l~~-l~h~~i~~~~~~~~~   76 (249)
                      .|++.+.++.|.++.+|...... ....++++...          .........+.+|+.++.+ ++||||+++++.+..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            37788889998888887666543 22333322111          1223345667889988875 699999999999999


Q ss_pred             CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         77 EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                      ++..+++|||+++++|.+++.........++...++.++.|++.+|.+||+ .+++|+||+|+||+++.++.   ++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~---~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK---VTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc---EEEec
Confidence            999999999999999988886644444558999999999999999999996 68999999999999987766   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHH
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQ  234 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~  234 (249)
                      ||.+.......              ......++..|++||.+.+..++.++|+||+|+++|+|++|+.||.. .......
T Consensus       158 fg~~~~~~~~~--------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~  223 (269)
T cd08528         158 FGLAKQKQPES--------------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT  223 (269)
T ss_pred             ccceeeccccc--------------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH
Confidence            99987654422              11122468889999999988889999999999999999999999987 4445566


Q ss_pred             HHHcCcc
Q psy14626        235 SITKGKL  241 (249)
Q Consensus       235 ~i~~g~~  241 (249)
                      .+.++..
T Consensus       224 ~~~~~~~  230 (269)
T cd08528         224 KIVEAVY  230 (269)
T ss_pred             HHhhccC
Confidence            6655543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7.3e-31  Score=211.56  Aligned_cols=199  Identities=29%  Similarity=0.461  Sum_probs=162.6

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +|++...++.|.++..+...+......++++......  ....+.+.+|++++++++|||++++++++..++..+++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5777888888888887765544333333333222222  24567899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++....    .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV---VKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC---EEEeccccceecCCCc
Confidence            99999998887653    3899999999999999999999999999999999999987655   9999999987765533


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..             .....++..|+|||...+..++.++|+||+|+++++|++|..||..
T Consensus       154 ~~-------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~  201 (254)
T cd06627         154 KD-------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD  201 (254)
T ss_pred             cc-------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence            10             1123467889999999887788999999999999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.1e-31  Score=212.22  Aligned_cols=206  Identities=26%  Similarity=0.419  Sum_probs=157.3

Q ss_pred             hhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHH-HHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATIC-HMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      .++.|.++.+|...+......++++   +...........+..|..++ ...+|+|++++++.+..++.+++|+||++++
T Consensus         3 ~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   82 (260)
T cd05611           3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG   82 (260)
T ss_pred             cCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence            3556666676665544333333332   22222222233445555544 4448999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS  170 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~  170 (249)
                      +|.+++.....    +++.++..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||++......     
T Consensus        83 ~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~~~~~~~-----  150 (260)
T cd05611          83 DCASLIKTLGG----LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH---LKLTDFGLSRNGLEN-----  150 (260)
T ss_pred             CHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc---EEEeecccceecccc-----
Confidence            99988865443    899999999999999999999999999999999999987665   999999987654321     


Q ss_pred             CCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                                  ....++..|+|||.+.+..++.++|+||+|+++++|++|..||.. +...+.+.+..+....|
T Consensus       151 ------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  213 (260)
T cd05611         151 ------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWP  213 (260)
T ss_pred             ------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                        112467889999999888789999999999999999999999988 56667777777665443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=7.9e-31  Score=212.18  Aligned_cols=158  Identities=22%  Similarity=0.305  Sum_probs=135.3

Q ss_pred             HHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC
Q psy14626         49 EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN  128 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~  128 (249)
                      ...+.+|+.+++.++||||+++++++.. ...++||||+++++|.+++.....   .++...+..++.|++.||.|||++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~  120 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK  120 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC
Confidence            6789999999999999999999999987 678999999999999998876543   388999999999999999999999


Q ss_pred             CceeecCCCCCeeeeecC----CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC--CC
Q psy14626        129 DIIHRDIKPHCVLLANKE----NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ--KY  202 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~----~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~  202 (249)
                      +++|+||||+||+++.++    ....++++|||.+.......                 ...++..|+|||++.+.  .+
T Consensus       121 ~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----------------~~~~~~~y~aPE~~~~~~~~~  183 (259)
T cd05037         121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE-----------------ERVERIPWIAPECIRNGQASL  183 (259)
T ss_pred             CeecccCccceEEEecCccccCCceeEEeCCCCccccccccc-----------------ccccCCCccChhhhcCCCCCc
Confidence            999999999999998765    11248999999986543311                 12356789999998876  67


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCCC
Q psy14626        203 GKPVDIWAAGVLLHVLLT-GTLPFVG  227 (249)
Q Consensus       203 ~~~~DiwslG~~l~el~~-g~~pf~~  227 (249)
                      +.++|+||+|+++++|++ |..||..
T Consensus       184 ~~~~Di~slG~~~~~l~~~~~~p~~~  209 (259)
T cd05037         184 TIAADKWSFGTTLLEICSNGEEPLST  209 (259)
T ss_pred             chhhHHHHHHHHHHHHHhCCCCCccc
Confidence            899999999999999999 6888876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=6.5e-31  Score=214.42  Aligned_cols=201  Identities=24%  Similarity=0.369  Sum_probs=158.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcc-----c-----cchhHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL-----N-----HYTTEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      +|...+.++.|.++.+|..........++++....     .     .....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            57788899999988888665443333333322111     0     1123457889999999999999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+++||||+++++|.+++....    .++...+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++++|||.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~---~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI---CKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe---EEEeeccc
Confidence            9999999999999998887653    3899999999999999999999999999999999999987665   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK--YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      +........           ........++..|+|||.+....  ++.++|+||+|++++++++|..||..
T Consensus       155 ~~~~~~~~~-----------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         155 SKKSDDIYD-----------NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             ccccccccc-----------ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            865432110           00111224678999999987654  78899999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=6.7e-31  Score=216.75  Aligned_cols=201  Identities=24%  Similarity=0.339  Sum_probs=160.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSE--GMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~l   82 (249)
                      .+.|++.+.++.|.++.+|...+......++++......  ......+.+|+.++++++||||+++++++...  ..+++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            357899999999998888877665444444443333222  23344678899999999999999999998766  78999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |+||+.+ +|.+.+.....   .+++.+++.++.|++.||.+||+++++|+||+|+||+++.++.   ++|+|||.+...
T Consensus        84 v~e~~~~-~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~---~~l~d~g~~~~~  156 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREY  156 (293)
T ss_pred             EehhcCc-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc---EEEeecCceeec
Confidence            9999975 88887765432   3899999999999999999999999999999999999987766   999999998766


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....             ......++..|+|||.+.+.. ++.++|+||+|+++++|++|..||..
T Consensus       157 ~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~  209 (293)
T cd07843         157 GSPLK-------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG  209 (293)
T ss_pred             cCCcc-------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence            54321             111223678899999987654 58899999999999999999999987

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=1e-30  Score=212.87  Aligned_cols=198  Identities=27%  Similarity=0.432  Sum_probs=154.1

Q ss_pred             HhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchh
Q psy14626         14 EVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC   93 (249)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   93 (249)
                      .+++.|.++.+|...+......++++..........+.+.+|+.+++.++|+||+++++++..++..++|+||+++++|.
T Consensus        14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~   93 (268)
T cd06624          14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS   93 (268)
T ss_pred             EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence            35777878887766544333333433333333445678999999999999999999999999999999999999999999


Q ss_pred             HHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626         94 FEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus        94 ~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                      +.+..... ....+...+..++.|++.||.+||+++++|+||+|+||+++.+..  .++|+|||.+........      
T Consensus        94 ~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~~~~------  164 (268)
T cd06624          94 ALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSG--VVKISDFGTSKRLAGINP------  164 (268)
T ss_pred             HHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--eEEEecchhheecccCCC------
Confidence            88875422 111278889999999999999999999999999999999975332  389999999866543211      


Q ss_pred             cccccccccCCcccCCCCCCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK--YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                             ......++..|+|||.+.+..  ++.++|+||+|+++++|++|..||..
T Consensus       165 -------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~  213 (268)
T cd06624         165 -------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE  213 (268)
T ss_pred             -------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence                   011123688999999986543  68899999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=4.2e-31  Score=217.40  Aligned_cols=202  Identities=27%  Similarity=0.382  Sum_probs=160.1

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeec--CCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSS--EGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e   85 (249)
                      +|.+.+.++.|.++.++..........++++..... .......+.+|++++++++||||++++++|..  .+.+++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e   81 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME   81 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence            455666777787777776665443333443322221 12456779999999999999999999999854  347899999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.........++...+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~---~~l~dfg~~~~~~~~  158 (287)
T cd06621          82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVSGELVNS  158 (287)
T ss_pred             ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe---EEEeecccccccccc
Confidence            99999998887765555556899999999999999999999999999999999999987665   999999997554331


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ..               ....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus       159 ~~---------------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         159 LA---------------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             cc---------------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence            11               1123577899999998888899999999999999999999999863

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0574|consensus

Probab=99.97  E-value=1e-32  Score=217.47  Aligned_cols=200  Identities=29%  Similarity=0.403  Sum_probs=171.4

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ..-+-+.+.++.|-|+.++..-.....-+.++++.-.  .++.+++.+|+.+|++.+.|++|++++++-....+++||||
T Consensus        32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            3346677888888888877666665555555544333  37788999999999999999999999999888889999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      |..|+.++.+..+..   .+++.+|..+++.-++||+|||...-+|||||..|||++.++.   .+|+|||++-...+.-
T Consensus       110 CGAGSiSDI~R~R~K---~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~---AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  110 CGAGSISDIMRARRK---PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI---AKLADFGVAGQLTDTM  183 (502)
T ss_pred             cCCCcHHHHHHHhcC---CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch---hhhhhccccchhhhhH
Confidence            999999998876544   4999999999999999999999999999999999999988877   8999999986665532


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                   ...+...||+.|+|||++..-.|...+||||||++..||..|++||..
T Consensus       184 -------------AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD  231 (502)
T KOG0574|consen  184 -------------AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD  231 (502)
T ss_pred             -------------HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence                         344556799999999999999999999999999999999999999987

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=5.4e-31  Score=216.07  Aligned_cols=205  Identities=25%  Similarity=0.375  Sum_probs=161.2

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeec------
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSS------   76 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------   76 (249)
                      .+|..+|++.++++.|.++.+|..........++++..... ......+..|+.+++++ +|+|++++++++..      
T Consensus        12 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   90 (282)
T cd06636          12 RDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH   90 (282)
T ss_pred             cChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence            36778999999999999988887665443333443322222 23456788999999999 79999999999853      


Q ss_pred             CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         77 EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      ...++++|||+++++|.+++.....  ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.   ++|+||
T Consensus        91 ~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~---~~l~df  165 (282)
T cd06636          91 DDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE---VKLVDF  165 (282)
T ss_pred             CCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeC
Confidence            4578999999999999888865432  23788899999999999999999999999999999999987666   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      |.+.......             .......+++.|+|||.+.     ...++.++|+||+|+++|+|++|..||..
T Consensus       166 g~~~~~~~~~-------------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~  228 (282)
T cd06636         166 GVSAQLDRTV-------------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD  228 (282)
T ss_pred             cchhhhhccc-------------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence            9876543211             0112234788999999975     34567889999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=9.4e-31  Score=214.02  Aligned_cols=198  Identities=29%  Similarity=0.457  Sum_probs=159.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcC---CCChhhhhheeecCCeEEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLK---HPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      -|++.+.++.|.++.++..........++++..... .....+.+.+|+.+++.++   |||++++++++..+..+++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788888888888876665444334443322222 2344567889999999996   999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++...     .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~---~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN---VKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC---EEEccCCceeecCC
Confidence            999999998887543     3889999999999999999999999999999999999987665   99999999876654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...             ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+
T Consensus       154 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  204 (277)
T cd06917         154 NSS-------------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD  204 (277)
T ss_pred             Ccc-------------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence            321             1112247788999999865 4468899999999999999999999987

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=6.9e-31  Score=222.33  Aligned_cols=199  Identities=24%  Similarity=0.396  Sum_probs=159.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      ..++|++.+.++.|.++.++...+......++++...  .......+.+.+|+.++++++||||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999998888876655444444443222  22334556788999999999999999999988543      


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ...++||||+.+ +|.+.+...      ++...+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~---~kL~Dfg  163 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFG  163 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEccCc
Confidence            357999999965 777766432      788999999999999999999999999999999999988766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .+........              .....++..|+|||.+.+..++.++|+||+||++++|++|+.||...
T Consensus       164 ~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         164 LARTAGTSFM--------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             cceeCCCCCC--------------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            9876543211              11124678899999999988999999999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=1.3e-30  Score=211.40  Aligned_cols=211  Identities=23%  Similarity=0.344  Sum_probs=154.2

Q ss_pred             hhcccceeeEeeecccc---CCCcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheee-cCCeEEEEEeccCC
Q psy14626         15 VINHKWLKMKLHTSAEI---EPASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYS-SEGMLYMVFEYMDG   89 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~   89 (249)
                      +++.|.++.+|......   ....++++.. ........+.+.+|+.+++.++|||++++++.+. .++..+++|||+.+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~   81 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH   81 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence            45666666666444221   1112233222 1223345678889999999999999999999775 45568999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++.....   ..+...+..++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||.+..........
T Consensus        82 ~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~---~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          82 GDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT---VKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc---EEECCccccccccCCccee
Confidence            999998865432   2577888999999999999999999999999999999987665   9999999986543321100


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                               ........++..|+|||.+.+..++.++|+||||++++||++ |.+||.. +..++...+.++.
T Consensus       156 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~  219 (262)
T cd05058         156 ---------VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR  219 (262)
T ss_pred             ---------ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence                     001111234668999999988888999999999999999999 6778876 4445555665554

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=9e-31  Score=215.65  Aligned_cols=216  Identities=24%  Similarity=0.383  Sum_probs=165.0

Q ss_pred             chHHHhhcccceeeEeeeccc------cCCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEE
Q psy14626         10 ITIHEVINHKWLKMKLHTSAE------IEPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLY   81 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (249)
                      |++.+.++.|.++.+|...+.      ..++.+.+.... .......+.+.+|+.+++++ +|++|+++++.+..+..++
T Consensus         2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (290)
T cd05613           2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH   81 (290)
T ss_pred             ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence            667778888888887765432      112222222221 12234457788999999999 6999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +|+||+++++|.+++.....    +++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~~  154 (290)
T cd05613          82 LILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKE  154 (290)
T ss_pred             EEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC---EEEeeCcccee
Confidence            99999999999998876543    789999999999999999999999999999999999987665   99999999866


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCC-----ChHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ--KYGKPVDIWAAGVLLHVLLTGTLPFVG-----SRDRLFQ  234 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~pf~~-----~~~~~~~  234 (249)
                      ......            .......++..|+|||.+.+.  .++.++|+||+|+++|+|++|..||..     ...++.+
T Consensus       155 ~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~  222 (290)
T cd05613         155 FHEDEV------------ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR  222 (290)
T ss_pred             cccccc------------cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH
Confidence            543211            011122467889999998753  357889999999999999999999974     2345666


Q ss_pred             HHHcCccccc
Q psy14626        235 SITKGKLHIL  244 (249)
Q Consensus       235 ~i~~g~~~~~  244 (249)
                      .+..+...+|
T Consensus       223 ~~~~~~~~~~  232 (290)
T cd05613         223 RILKSEPPYP  232 (290)
T ss_pred             HhhccCCCCC
Confidence            6666655544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=7.1e-31  Score=215.76  Aligned_cols=201  Identities=28%  Similarity=0.502  Sum_probs=159.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .+|.+.+.++.|.++.++..........++++...  .......+.+.+|+.++++++|+||+++++.+..++..+++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36778888888888777766554333334433222  2233455789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++++.+..+....    ..++..++..++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~---~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV---LKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEEeeecccccCCC
Confidence            99886665544332    22899999999999999999999999999999999999987666   999999998665543


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..            .......++..|+|||.+.+. .++.++|+||+|+++++|++|+.||.+
T Consensus       154 ~~------------~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  204 (288)
T cd07833         154 PA------------SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG  204 (288)
T ss_pred             cc------------ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            21            011112357789999999887 778999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=3.2e-31  Score=218.47  Aligned_cols=202  Identities=25%  Similarity=0.362  Sum_probs=157.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ..++|++.+.++.|.++.+|...+......++++...... ......+.+|+.+++.++|+||+++++++..+...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4578889999999988888866554444444443322221 223346789999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+. ++|.+.+....   ..++...+..++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||.+.....
T Consensus        83 e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc---EEEeccccccccCC
Confidence            9996 56766654432   23788889999999999999999999999999999999987766   99999998865432


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...             ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||.+
T Consensus       156 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         156 PSQ-------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             CCC-------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            110             11122367889999998764 468899999999999999999999987

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.97  E-value=1.4e-30  Score=218.40  Aligned_cols=216  Identities=19%  Similarity=0.292  Sum_probs=155.8

Q ss_pred             Hhhccc--ceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         14 EVINHK--WLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        14 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      ..++.|  .++.+|...+......++++.....  .....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            345555  4556666655444444444333221  223457899999999999999999999999999999999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++......  .+++..+..++.|++.||.|||+++++|+||||+||+++.++.   ++++||+.+..........
T Consensus        84 ~~l~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~---~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          84 GSANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL---VSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCHHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc---EEEechHHHhhhhccCccc
Confidence            9998888765432  3889999999999999999999999999999999999987665   8999997543222111000


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ--KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .    .  .........++..|+|||++.+.  .++.++|+||+||++++|++|+.||.. ...+....+..+.
T Consensus       159 ~----~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~  226 (328)
T cd08226         159 K----V--VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGP  226 (328)
T ss_pred             c----c--cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCC
Confidence            0    0  00001112245679999998763  468899999999999999999999987 3333333444443

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=1.1e-30  Score=216.56  Aligned_cols=215  Identities=21%  Similarity=0.293  Sum_probs=161.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCC----cccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPA----SFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ..|+...+++.|.++.+|.........    .++++.... ........+.+|+.+++.++||||+++++.+... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            456677788888888887654322211    112221111 1123345789999999999999999999998754 4679


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      +++|+++++|.+++.....   .++...+..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||.+...
T Consensus        86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~---~kL~Dfg~~~~~  159 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLL  159 (303)
T ss_pred             eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc---eEEccccccccc
Confidence            9999999999988865432   3789999999999999999999999999999999999977665   999999998765


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ......           .......++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+ ....+.+.+..+.
T Consensus       160 ~~~~~~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~  228 (303)
T cd05110         160 EGDEKE-----------YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE  228 (303)
T ss_pred             cCcccc-----------cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence            432210           01111234678999999988888999999999999999997 9999988 4455555555543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.97  E-value=8.8e-31  Score=217.70  Aligned_cols=213  Identities=26%  Similarity=0.367  Sum_probs=163.5

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSE--GML   80 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~   80 (249)
                      ++.++|++.+.++.|.++.+|...+......++++......  ......+.+|+.++++++|+|++++++++...  +.+
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence            46678999999999988888877665444444444333222  22234567899999999999999999998654  568


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+.+ +|.+.+....   ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+.
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~---~kL~dfg~~~  156 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLAR  156 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECccceee
Confidence            999999975 7877776532   23899999999999999999999999999999999999987665   9999999987


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      .......             .......+..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+ +..+....+.
T Consensus       157 ~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~  222 (309)
T cd07845         157 TYGLPAK-------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLII  222 (309)
T ss_pred             ecCCccC-------------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            6654211             0011124678999999875 4568999999999999999999999987 4444444443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1.3e-30  Score=213.62  Aligned_cols=207  Identities=22%  Similarity=0.363  Sum_probs=150.6

Q ss_pred             hcccceeeEeeeccccC---CCcccCChhccccchhHHHHHHHHHH---HHHcCCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         16 INHKWLKMKLHTSAEIE---PASFGLPDERLNHYTTEADLKREATI---CHMLKHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~E~~~---l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      ++.|.++.+|.......   ++.+.+.+...........+.+|..+   ++..+||+|+++.+.+...+.+++||||+.|
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g   81 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG   81 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence            45566666664443322   22232222222222333334455444   4445799999999999999999999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++....    .+++..++.++.|++.|+.+||+.+++|+||+|+||+++.++.   ++|+|||.+.......   
T Consensus        82 ~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~---~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          82 GDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK---  151 (278)
T ss_pred             CcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC---EEEccCcCccccCccC---
Confidence            99988776443    3899999999999999999999999999999999999987665   9999999886443211   


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC----hHHHHHHHHcCccccc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS----RDRLFQSITKGKLHIL  244 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~----~~~~~~~i~~g~~~~~  244 (249)
                                  .....++..|+|||.+.+. .++.++|+||+|+++++|++|+.||...    ...+...+....+.+|
T Consensus       152 ------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  219 (278)
T cd05606         152 ------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP  219 (278)
T ss_pred             ------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC
Confidence                        1122478899999998744 5789999999999999999999999863    2233444444445554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=5.7e-31  Score=213.83  Aligned_cols=199  Identities=27%  Similarity=0.418  Sum_probs=162.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +.|.+.+.++.|.++.++..........++++..... .....+.+.+|+.+++.++||||+++++.+..+..+++++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            3577888899888888876665543333343322222 124567789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      +++++|.+++....   ..+++..+..++.|++.++.+||+ .+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~---~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC---EEEeecccchhhHHH
Confidence            99999998887643   238999999999999999999999 99999999999999988665   999999987554321


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..               ....++..|+|||.+.+..++.++|+||+|+++++|++|..||..
T Consensus       155 ~~---------------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  201 (265)
T cd06605         155 LA---------------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP  201 (265)
T ss_pred             Hh---------------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence            10               013467889999999888889999999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.97  E-value=7e-31  Score=215.45  Aligned_cols=201  Identities=25%  Similarity=0.434  Sum_probs=157.5

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      +|++.+.++.|.++.+|...+......++++..... .....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            366677788888877776666544444444333222 2234567889999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      .+ +|.+++..... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.   ++++|||.+........
T Consensus        81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~---~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc---EEEeecchhhhhcCCcc
Confidence            85 88777765442 234899999999999999999999999999999999999987766   99999998854432110


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                   ......++..|++||.+.+. .++.++|+||+|+++++|++|+.||.+
T Consensus       156 -------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~  203 (284)
T cd07836         156 -------------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG  203 (284)
T ss_pred             -------------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                         11112357889999998664 468899999999999999999999987

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=6.4e-31  Score=220.92  Aligned_cols=207  Identities=22%  Similarity=0.356  Sum_probs=161.1

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeec----C
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSS----E   77 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~   77 (249)
                      |+...+|.+.+.++.|.++.++...+......++++....  ........+.+|+.+++.++||||+++++++..    .
T Consensus         1 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   80 (334)
T cd07855           1 FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADF   80 (334)
T ss_pred             CchhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCC
Confidence            4567899999999999888887665554444444433222  223455678899999999999999999998853    3


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..+++||||+. ++|.+.+.....    +++..+..++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||
T Consensus        81 ~~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~dfg  152 (334)
T cd07855          81 KDVYVVMDLME-SDLHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE---LRIGDFG  152 (334)
T ss_pred             ceEEEEEehhh-hhHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEecccc
Confidence            56899999996 588777654332    899999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .+..........         ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+
T Consensus       153 ~~~~~~~~~~~~---------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         153 MARGLSSSPTEH---------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             cceeecccCcCC---------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence            987654422110         011112246788999999765 4578999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=9.1e-31  Score=220.70  Aligned_cols=206  Identities=25%  Similarity=0.393  Sum_probs=162.8

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      +|...||++.+.++.|.++.+|...+......++++..........+.+.+|+.++++++||||+++++.+...      
T Consensus         1 ~~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CCcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            57889999999999999998887766655555665555555556677899999999999999999999887544      


Q ss_pred             --------CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC
Q psy14626         78 --------GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus        78 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~  149 (249)
                              ...++|+||++ ++|.+.+...     .+++..++.++.|++.||.+||+.|++|+||||+||+++.++.  
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~--  152 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL--  152 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc--
Confidence                    35799999997 4887766432     2889999999999999999999999999999999999975443  


Q ss_pred             CeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       150 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .++++|||.+..........          .......++..|+|||.+.+ ..++.++|+|||||++++|++|+.||.+
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~  221 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHK----------GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             eEEECCcccceecCCccccc----------cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            27999999987653321100          00111236788999998654 4568899999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=7.5e-31  Score=215.56  Aligned_cols=204  Identities=19%  Similarity=0.259  Sum_probs=156.3

Q ss_pred             CCcchHHHhhcccceeeEeeecc----ccCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC--Ce
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSA----EIEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSE--GM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~   79 (249)
                      ++-|++.+.++.|.++.+|....    ......++++... .......+.+.+|+.+++.++|||++++.+++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            35578888999998888875431    1122222222222 12234456799999999999999999999998764  56


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .++||||++|++|.+++.....   .+++.++..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~---~~l~dfg~~  156 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLT  156 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC---EEECCCccc
Confidence            8999999999999988865432   3789999999999999999999999999999999999987665   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV  226 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~  226 (249)
                      ..........          .......++..|+|||.+.+..++.++|+||||+++++|++++.|..
T Consensus       157 ~~~~~~~~~~----------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~  213 (284)
T cd05079         157 KAIETDKEYY----------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES  213 (284)
T ss_pred             cccccCccce----------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence            7654322100          00111235677999999988888999999999999999999776543

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0608|consensus

Probab=99.97  E-value=2.1e-31  Score=227.54  Aligned_cols=188  Identities=28%  Similarity=0.505  Sum_probs=153.0

Q ss_pred             cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHH
Q psy14626         43 LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL  122 (249)
Q Consensus        43 ~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (249)
                      .-...+...++.|-.+|...+++-||+++-+|.+.+.+|+||+|++||++..+|-+.+-    |++..++.++.++..|+
T Consensus       667 Vl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI----FeE~LARFYIAEltcAi  742 (1034)
T KOG0608|consen  667 VLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI----FEEDLARFYIAELTCAI  742 (1034)
T ss_pred             HHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHH
Confidence            33345667788899999999999999999999999999999999999999998887765    89999999999999999


Q ss_pred             HHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC--CccccCCc--------ccc----------------
Q psy14626        123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG--QLYCSGGE--------RLD----------------  176 (249)
Q Consensus       123 ~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~--------~~~----------------  176 (249)
                      +..|..|+|||||||+||||+.+++   +||.|||+|+-..+.  ..+.++.+        ...                
T Consensus       743 esVHkmGFIHRDiKPDNILIDrdGH---IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra  819 (1034)
T KOG0608|consen  743 ESVHKMGFIHRDIKPDNILIDRDGH---IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRA  819 (1034)
T ss_pred             HHHHhccceecccCccceEEccCCc---eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHH
Confidence            9999999999999999999999888   999999999665431  11111110        000                


Q ss_pred             ---ccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        177 ---HYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       177 ---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                         +..-......||..|+|||++....++..+|.||.|++|+||+.|+.||.. +..+....|.
T Consensus       820 ~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~  884 (1034)
T KOG0608|consen  820 MRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVI  884 (1034)
T ss_pred             HhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeee
Confidence               111233445699999999999999999999999999999999999999998 3333433443

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=7.9e-31  Score=212.64  Aligned_cols=200  Identities=28%  Similarity=0.441  Sum_probs=163.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccc-hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHY-TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      .|.+.+.++.+.++.++..........++++....... .....+.+|+..++.++|+|++++++++..++.+++|+||+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM   81 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence            35666778887777777665554444444433333222 45678999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      ++++|.+++....    .+++..+..++.|++.++.+||+ .+++|+||+|+||+++.++.   ++|+|||.+.......
T Consensus        82 ~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~---~~l~df~~~~~~~~~~  154 (264)
T cd06623          82 DGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE---VKIADFGISKVLENTL  154 (264)
T ss_pred             CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC---EEEccCccceecccCC
Confidence            9999999987653    38999999999999999999999 99999999999999988766   9999999987665422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ..             .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus       155 ~~-------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  203 (264)
T cd06623         155 DQ-------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP  203 (264)
T ss_pred             Cc-------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            11             01224678899999998888899999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.97  E-value=9.5e-31  Score=214.74  Aligned_cols=200  Identities=27%  Similarity=0.455  Sum_probs=154.3

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      |++.+.++.|.++.+|...+......++++....  ......+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (284)
T cd07860           2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL   81 (284)
T ss_pred             ceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence            4556667777777777655443333333332222  22334467899999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      . ++|..++.....  ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.   ++|+|||.+....... 
T Consensus        82 ~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~---~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          82 H-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPV-  154 (284)
T ss_pred             c-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC---EEEeeccchhhcccCc-
Confidence            6 578777765432  23889999999999999999999999999999999999988776   9999999876543211 


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                                  .......++..|+|||.+.+.. ++.++|+||+|+++++|++|+.||..+
T Consensus       155 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~  204 (284)
T cd07860         155 ------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD  204 (284)
T ss_pred             ------------cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                        0111123578899999887654 588899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=1.2e-30  Score=219.35  Aligned_cols=205  Identities=24%  Similarity=0.381  Sum_probs=159.5

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC-----
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSE-----   77 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----   77 (249)
                      ++.+++|++.+.++.|.++.+|...+......++++... .........+.+|+.+++.++||||+++++++...     
T Consensus         1 ~~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   80 (336)
T cd07849           1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF   80 (336)
T ss_pred             CccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence            467789999999999998888876554444444443222 22234456688999999999999999999987543     


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ...++++|++.+ +|...+...     .+++..++.++.|++.||.+||+.+++|+||||+||+++.++.   ++|+|||
T Consensus        81 ~~~~lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~---~kl~dfg  151 (336)
T cd07849          81 NDVYIVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFG  151 (336)
T ss_pred             ceEEEEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC---EEECccc
Confidence            358999999965 776665432     3899999999999999999999999999999999999987666   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++..........          .......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.+
T Consensus       152 ~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~  212 (336)
T cd07849         152 LARIADPEHDHT----------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             ceeecccccccc----------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            987654422110          01112346888999998754 4578999999999999999999999976

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.97  E-value=1.1e-30  Score=214.23  Aligned_cols=218  Identities=22%  Similarity=0.335  Sum_probs=161.0

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc-chhHHHHHHHHHH-HHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-YTTEADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .|++.+.++.|.++.+|...+......++++...... ......+..|+.. ++.++|||++++++++..++.++++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~   81 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV   81 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence            4677778888888888876665444444444322221 1233455566664 5666899999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++ ++|.+++.........+++.++..++.|++.||.+||++ +++|+||||+||+++.++.   ++|+|||.+......
T Consensus        82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~---~kl~dfg~~~~~~~~  157 (283)
T cd06617          82 MD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ---VKLCDFGISGYLVDS  157 (283)
T ss_pred             hc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC---EEEeecccccccccc
Confidence            97 588777765444445689999999999999999999997 9999999999999987766   999999998654331


Q ss_pred             CccccCCccccccccccCCcccCCCCCCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHHc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED----QKYGKPVDIWAAGVLLHVLLTGTLPFVGS---RDRLFQSITK  238 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~pf~~~---~~~~~~~i~~  238 (249)
                      .              ......++..|+|||.+.+    ..++.++|+||+||++++|++|+.||...   .+.+...+..
T Consensus       158 ~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (283)
T cd06617         158 V--------------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE  223 (283)
T ss_pred             c--------------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc
Confidence            1              0111246788999998865    34578999999999999999999999752   2344444433


Q ss_pred             Cccccc
Q psy14626        239 GKLHIL  244 (249)
Q Consensus       239 g~~~~~  244 (249)
                      ..+.+|
T Consensus       224 ~~~~~~  229 (283)
T cd06617         224 PSPQLP  229 (283)
T ss_pred             CCCCCC
Confidence            344443

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0671|consensus

Probab=99.97  E-value=1.3e-31  Score=216.61  Aligned_cols=212  Identities=21%  Similarity=0.325  Sum_probs=168.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-C-C----ChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-H-P----HVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----~i~~~~~~~~~~~~~   80 (249)
                      ..||.+.+.++.|.++.++...+... ......+...+-..-.++.+-|+++|+++. + |    -++.+.++|.-.++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRET-KEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCC-CceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            57999999999999998887776655 333332333333345567778999999993 2 2    367778889999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC--------------
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE--------------  146 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~--------------  146 (249)
                      |+|+|.+ |.|+.+++..+.-.  +|+...++.+++|++.++++||+.+++|.||||+|||+....              
T Consensus       167 Civfell-G~S~~dFlk~N~y~--~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYI--PFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCcc--ccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            9999999 67999998775544  489999999999999999999999999999999999986431              


Q ss_pred             ---CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q psy14626        147 ---NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       147 ---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  223 (249)
                         .+.-++++|||.++......                ..-..|..|.|||++.+.+++..+||||+||+|.|+++|..
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~h----------------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEHH----------------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             ccCCCcceEEEecCCcceeccCc----------------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence               12348999999987665422                22346889999999999999999999999999999999999


Q ss_pred             CCCC--ChH--HHHHHHHc
Q psy14626        224 PFVG--SRD--RLFQSITK  238 (249)
Q Consensus       224 pf~~--~~~--~~~~~i~~  238 (249)
                      .|..  +.+  .++++|..
T Consensus       308 LFqtHen~EHLaMMerIlG  326 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILG  326 (415)
T ss_pred             ecccCCcHHHHHHHHHhhC
Confidence            9998  334  25666654

>KOG0666|consensus

Probab=99.97  E-value=2.6e-31  Score=210.12  Aligned_cols=208  Identities=22%  Similarity=0.358  Sum_probs=158.5

Q ss_pred             chHHHhhcccceeeEeeeccccCCC----cccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeec-CCeEEE
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPA----SFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSS-EGMLYM   82 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l   82 (249)
                      |.....|+.|.|+.+|.........    .+++++-....  ........+|+.+++.++|||++.+..+|.. +..+++
T Consensus        26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l  105 (438)
T KOG0666|consen   26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL  105 (438)
T ss_pred             hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence            3444457788888888664332222    33443222211  1233567899999999999999999999976 778999


Q ss_pred             EEeccCCCchhHHHHHh-hhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC-CCeEEcCcceeE
Q psy14626         83 VFEYMDGSDICFEIVRR-ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS-APVKLGGFGVAI  160 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~-~~~~l~dfg~~~  160 (249)
                      ++||.+. +|...+.-+ ......++...++.+++||+.|+.|||++-++||||||.|||+..++.. +.|||+|+|+++
T Consensus       106 ~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR  184 (438)
T KOG0666|consen  106 LFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLAR  184 (438)
T ss_pred             Eehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence            9999976 776666532 2223458999999999999999999999999999999999999887432 459999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ...+......          ......-|+.|.|||.+.|.. |+++.|+|++||++.||++-++.|.+.
T Consensus       185 ~~~~plkpl~----------s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  185 LFNNPLKPLA----------SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             Hhhccccccc----------cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            8766443221          122235788999999998855 799999999999999999999988873

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=7.2e-31  Score=218.53  Aligned_cols=208  Identities=24%  Similarity=0.369  Sum_probs=157.4

Q ss_pred             cchHHHhhcccceeeEeeecccc--CCCcccCChhcc---ccchhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEI--EPASFGLPDERL---NHYTTEADLKREATICHMLKHPHVVELLETYSSE--GMLY   81 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~   81 (249)
                      ||++...++.|.++.+|......  ....++++....   ......+.+.+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            56777788888888887666544  333344332222   2234456788999999999999999999999877  7899


Q ss_pred             EEEeccCCCchhHHHHHhhhc-CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC-CCCeEEcCccee
Q psy14626         82 MVFEYMDGSDICFEIVRRATA-GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN-SAPVKLGGFGVA  159 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~-~~~~~l~dfg~~  159 (249)
                      +||||+++ +|.+.+...... ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++. ...++|+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999975 666665443322 235899999999999999999999999999999999999987221 234999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .........          ........++..|+|||.+.+. .++.++|+||+|+++++|++|+.||.+
T Consensus       160 ~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~  218 (316)
T cd07842         160 RLFNAPLKP----------LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG  218 (316)
T ss_pred             cccCCCccc----------ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence            765432210          0111223467889999988764 468899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.97  E-value=2.2e-30  Score=213.69  Aligned_cols=203  Identities=27%  Similarity=0.481  Sum_probs=155.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|...+......++++.....  .....+.+.+|+.++++++||||+++++++..+..+++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            3577778888887777776655433333444333222  12344678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++ +|.+.+.....  ..+++..+..++.|++.||.+||+++++|+||+|+||+++.++.  .++++|||.+......
T Consensus        82 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~--~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC--EEEEcccccccccCCC
Confidence            9964 77776654332  23678899999999999999999999999999999999975432  2899999998654332


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ..             ......+++.|+|||.+.+. .++.++|+||+|+++++|++|+.||...
T Consensus       157 ~~-------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        157 VR-------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             cc-------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            10             11112357889999998764 4688999999999999999999999873

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.8e-30  Score=217.66  Aligned_cols=210  Identities=22%  Similarity=0.373  Sum_probs=164.5

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-----eEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-----MLY   81 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~   81 (249)
                      ||++...++.|.++.++..........++++...  .......+.+.+|+.+++.++||||+++.+++....     .++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            6788889999988888877655434344433222  222455678999999999999999999999997765     789


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      ++|+|+++ +|.+.+....    .+++..+..++.|++.||.+||+.|++|+||||+||+++.++.   ++|+|||.+..
T Consensus        81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~---~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD---LKICDFGLARG  152 (330)
T ss_pred             EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEcccCceEe
Confidence            99999974 7877775433    3899999999999999999999999999999999999987765   99999999877


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      .......          ........++..|+|||.+.+. .++.++|+||+|+++++|++|+.||.+ +..+....+
T Consensus       153 ~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i  219 (330)
T cd07834         153 VDPDEDE----------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLI  219 (330)
T ss_pred             ecccccc----------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHH
Confidence            6553210          0111222467889999999887 789999999999999999999999988 333333333

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=3.2e-30  Score=212.74  Aligned_cols=202  Identities=26%  Similarity=0.401  Sum_probs=155.7

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCe-----E
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHML-KHPHVVELLETYSSEGM-----L   80 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-----~   80 (249)
                      +|++...++.|.++.+|...+......++++.....  .......+.+|+.+++.+ +||||+++++++.....     .
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            577788888888888877665544444444432222  122346788999999999 46999999999976655     8


Q ss_pred             EEEEeccCCCchhHHHHHhhhc-CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeee-cCCCCCeEEcCcce
Q psy14626         81 YMVFEYMDGSDICFEIVRRATA-GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN-KENSAPVKLGGFGV  158 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~-~~~~~~~~l~dfg~  158 (249)
                      ++||||+++ +|.+++...... ...+++..++.++.|++.||.|||+++++|+||+|+||+++. ++.   ++|+|||.
T Consensus        82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~---~kl~dfg~  157 (295)
T cd07837          82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL---LKIADLGL  157 (295)
T ss_pred             EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe---EEEeeccc
Confidence            999999986 788877655432 345899999999999999999999999999999999999987 444   89999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      +........             ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+
T Consensus       158 ~~~~~~~~~-------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         158 GRAFSIPVK-------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             ceecCCCcc-------------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence            865432110             1111235778999998865 4468999999999999999999999987

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.97  E-value=2.2e-30  Score=211.10  Aligned_cols=192  Identities=23%  Similarity=0.355  Sum_probs=147.5

Q ss_pred             cchHHHhh--cccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVI--NHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|.+...+  ++|.++.++..........++++.........     .|+.....+ +|||++++++.+...+.+++|||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e   89 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD   89 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence            34444444  77777777765554443444433222211111     122223323 79999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++....    .+++.++..++.|++.||.+||+.+++|+||+|+||+++.++.  .++++|||.+......
T Consensus        90 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         90 YIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKD--RIYLCDYGLCKIIGTP  163 (267)
T ss_pred             cCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCC--eEEEecCccceecCCC
Confidence            999999999887654    3899999999999999999999999999999999999987661  2999999998665432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .                 ...++..|+|||++.+..++.++|+||+|+++++|++|..||...
T Consensus       164 ~-----------------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  209 (267)
T PHA03390        164 S-----------------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED  209 (267)
T ss_pred             c-----------------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            1                 123688999999999888899999999999999999999999863

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=4.3e-30  Score=206.39  Aligned_cols=199  Identities=28%  Similarity=0.440  Sum_probs=160.8

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      |+..+.++.+.++.++..........++++..........+.+.+|+.+++.++|++++++++.+......++++||+++
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~   81 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG   81 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence            44556677776667666555433333444333333334678899999999999999999999999999999999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++....   ..+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+........  
T Consensus        82 ~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          82 GSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE---VKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe---EEEeecccccccccccc--
Confidence            99988876643   23899999999999999999999999999999999999987665   99999999866654220  


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                                  .....++..|+|||.+.+...+.++|+||+|+++++|++|+.||...
T Consensus       154 ------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         154 ------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             ------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence                        12234678899999998888899999999999999999999999873

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=8.4e-30  Score=211.85  Aligned_cols=200  Identities=26%  Similarity=0.390  Sum_probs=159.5

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc---cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      -+|.++|.....++.|.++.+|..........++++...   .........+.+|+.+++.++|+|++++.+++......
T Consensus        11 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   90 (308)
T cd06634          11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA   90 (308)
T ss_pred             CCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCee
Confidence            467788999999999988888866654443333333222   22334456788999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+.+ ++.+.+.....   .++..++..++.|++.++.+||+.+++|+||+|+||+++.++.   ++++|||.+.
T Consensus        91 ~lv~e~~~~-~l~~~~~~~~~---~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~---~kl~dfg~~~  163 (308)
T cd06634          91 WLVMEYCLG-SASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSAS  163 (308)
T ss_pred             EEEEEccCC-CHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc---EEECCcccce
Confidence            999999974 77666654322   3789999999999999999999999999999999999987665   9999999886


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ......                 ...++..|+|||.+.   ....+.++|+||+||++++|++|..||..
T Consensus       164 ~~~~~~-----------------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  216 (308)
T cd06634         164 IMAPAN-----------------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (308)
T ss_pred             eecCcc-----------------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence            543311                 123678899999974   34567899999999999999999999977

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.97  E-value=6.6e-30  Score=206.14  Aligned_cols=202  Identities=30%  Similarity=0.457  Sum_probs=163.1

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeEEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSE--GMLYMVF   84 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~   84 (249)
                      +|+..+.++.+.++.+|..........++++......  ....+.+.+|+.++++++||||+++++.+...  ..+++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            3566677888877777766554333333333222221  35678899999999999999999999999888  8899999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |++++++|.+++....    .+++.++..++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~---~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV---VKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC---EEEcccccEEeccc
Confidence            9999999999887654    3899999999999999999999999999999999999988665   99999999877765


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ....           .......++..|+|||...+...+.++|+||+|+++++|++|..||...
T Consensus       154 ~~~~-----------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (260)
T cd06606         154 IETG-----------EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL  206 (260)
T ss_pred             cccc-----------ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            4310           0112234778999999998888899999999999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=2.9e-30  Score=214.24  Aligned_cols=207  Identities=23%  Similarity=0.399  Sum_probs=158.4

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-----
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEG-----   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----   78 (249)
                      .-++|++...++.|.++.+|...+......++++.....  .......+.+|+.++++++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            345789999999999888887766554444554433222  1223345678999999999999999999986543     


Q ss_pred             ---eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         79 ---MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        79 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                         ..++||||+.+ +|.+.+....   ..+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~---~kl~d  162 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI---LKLAD  162 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc---EEECc
Confidence               46999999965 7777665432   23899999999999999999999999999999999999987665   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ||.+..........         ........++..|+|||.+.+.. ++.++|+||+|+++++|++|+.||.+.
T Consensus       163 fg~~~~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         163 FGLARAFSLSKNSK---------PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             CCCcccccCCcccC---------CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            99987654322100         01111234678899999987644 688999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=2e-30  Score=212.50  Aligned_cols=205  Identities=18%  Similarity=0.268  Sum_probs=159.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC----CCcccCChhccccc-hhHHHHHHHHHHHHHcCCCChhhhhheeec--CCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE----PASFGLPDERLNHY-TTEADLKREATICHMLKHPHVVELLETYSS--EGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~   79 (249)
                      .+.|++.+.++.|.++.+|.......    ...++++....... ...+.+.+|+.+++.++||||+++++++..  +..
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            35677888888888888876653211    22233322222211 356789999999999999999999999876  557


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .+++|||+++++|.+++.....   .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~---~~l~dfg~~  156 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL---VKISDFGLA  156 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC---EEEcccccc
Confidence            8999999999999999876543   3899999999999999999999999999999999999987765   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .........          .........+..|+|||...+..++.++|+||+|+++++|++|..|+..
T Consensus       157 ~~~~~~~~~----------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         157 KVLPEDKDY----------YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             cccccCCcc----------eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence            776532110          0001112345679999999888889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.97  E-value=6.1e-30  Score=209.85  Aligned_cols=200  Identities=27%  Similarity=0.470  Sum_probs=155.1

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      |++.+.++.|.++.+|...+......++++......  ....+.+.+|+.+++.++|||++++++++.+++..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            456667777777777765544344444443222221  233467889999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      + ++|.+++.....  ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+........
T Consensus        81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~---~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA---LKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCc---EEEeecccccccCCCcc
Confidence            5 588888765542  23899999999999999999999999999999999999988665   99999999854432110


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                                   ......++..|+|||++.+. .++.++|+||+|+++|+|++|+.||...
T Consensus       155 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         155 -------------TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             -------------ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         01112357889999988664 4688999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0695|consensus

Probab=99.97  E-value=1.2e-30  Score=208.75  Aligned_cols=215  Identities=29%  Similarity=0.455  Sum_probs=176.9

Q ss_pred             chHHHhhcccceeeEeeecccc---CCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEe
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEI---EPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +....||+.|-|+.++.....-   -.+.+.++++..++..+.+.++-|-.+..+. +||.+|.++..|++...+++|.|
T Consensus       252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie  331 (593)
T KOG0695|consen  252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE  331 (593)
T ss_pred             ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence            3444566666655544322222   2344556677788888888899998888888 79999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |.+||+|....+++..    ++++.++.+..+|+.||.|||++||+++|||.+|+|++..++   +||.|+|.+...-..
T Consensus       332 yv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh---ikltdygmcke~l~~  404 (593)
T KOG0695|consen  332 YVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH---IKLTDYGMCKEGLGP  404 (593)
T ss_pred             EecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc---eeecccchhhcCCCC
Confidence            9999999888777665    999999999999999999999999999999999999998887   999999998554321


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----C-----hHHHHHHH
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----S-----RDRLFQSI  236 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----~-----~~~~~~~i  236 (249)
                      .             .......||+.|.|||.+++..|..++|.|+||++|+||+.|+.||..    +     .+-+++-|
T Consensus       405 g-------------d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvi  471 (593)
T KOG0695|consen  405 G-------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVI  471 (593)
T ss_pred             C-------------cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHH
Confidence            1             233445699999999999999999999999999999999999999984    1     23478888


Q ss_pred             HcCccccc
Q psy14626        237 TKGKLHIL  244 (249)
Q Consensus       237 ~~g~~~~~  244 (249)
                      ...++.+|
T Consensus       472 lekqirip  479 (593)
T KOG0695|consen  472 LEKQIRIP  479 (593)
T ss_pred             hhhccccc
Confidence            88888887

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=6e-30  Score=208.76  Aligned_cols=217  Identities=18%  Similarity=0.362  Sum_probs=160.9

Q ss_pred             chHHHhhcccceeeEeeeccccC---CCcccCC--hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC------
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIE---PASFGLP--DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG------   78 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------   78 (249)
                      |++.++++.|.++.++.......   ...++++  ..........+.+.+|+.+++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            56778888888888775543221   1112222  222233445678999999999999999999999885432      


Q ss_pred             eEEEEEeccCCCchhHHHHHhhh--cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRAT--AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      ..+++++|+.+++|.+++.....  ....++...+..++.|++.||.|||+.+++|+||||+||+++.++.   ++++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~---~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT---VCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC---EEECcc
Confidence            24788999999999887754321  2234788999999999999999999999999999999999987665   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~  234 (249)
                      |.+..........           ......++..|++||...+..++.++|+||+|+++|+|++ |+.||.+ +..++..
T Consensus       158 g~~~~~~~~~~~~-----------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~  226 (273)
T cd05074         158 GLSKKIYSGDYYR-----------QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN  226 (273)
T ss_pred             cccccccCCccee-----------cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHH
Confidence            9987654322110           0011124567999999988888999999999999999999 9999987 4455666


Q ss_pred             HHHcCc
Q psy14626        235 SITKGK  240 (249)
Q Consensus       235 ~i~~g~  240 (249)
                      .+.++.
T Consensus       227 ~~~~~~  232 (273)
T cd05074         227 YLIKGN  232 (273)
T ss_pred             HHHcCC
Confidence            665543

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=8.4e-30  Score=212.31  Aligned_cols=201  Identities=26%  Similarity=0.380  Sum_probs=158.8

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      +.|+...|...+.++.|.++.+|...+......++++..   ..........+.+|+.+++.++|||++++++++.++..
T Consensus        16 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   95 (313)
T cd06633          16 KDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT   95 (313)
T ss_pred             cCCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            456667777777788888888887665444333443322   22233445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .++||||+.+ ++.+.+....   ..+++.++..++.|++.++.+||++|++|+||+|+||+++.++.   ++|+|||.+
T Consensus        96 ~~lv~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~---~kL~dfg~~  168 (313)
T cd06633          96 AWLVMEYCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ---VKLADFGSA  168 (313)
T ss_pred             EEEEEecCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC---EEEeecCCC
Confidence            9999999965 7766665433   23889999999999999999999999999999999999987665   999999987


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....                 .....++..|+|||++.   ...++.++|+||+|+++++|++|..||..
T Consensus       169 ~~~~~-----------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~  222 (313)
T cd06633         169 SKSSP-----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  222 (313)
T ss_pred             cccCC-----------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            43221                 11224678899999974   35578899999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=9.8e-30  Score=208.36  Aligned_cols=198  Identities=28%  Similarity=0.495  Sum_probs=154.9

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      |.+...++.|.++.+|..........++++...  .........+.+|+.+++.++|+||+++++++..+..+++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            344555666666666666554333333333222  222245678889999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++ +|.+.+....   ..+++.++..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+........
T Consensus        81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~---~~l~df~~~~~~~~~~~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVR  153 (283)
T ss_pred             CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc---EEEeeeeeeEecCCCcc
Confidence            75 7877766543   23899999999999999999999999999999999999987665   99999999876654320


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                   ......++..|+|||.+.+. .++.++|+||+|+++++|++|+.||.+
T Consensus       154 -------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         154 -------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             -------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence                         01112367789999998776 678999999999999999999999987

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=8.8e-30  Score=214.23  Aligned_cols=208  Identities=27%  Similarity=0.439  Sum_probs=159.5

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHc-CCCChhhhhheeec--C
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHML-KHPHVVELLETYSS--E   77 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~   77 (249)
                      +....++|++.+.++.|.++.+|...+......++++..  ..........+.+|+.+++++ +||||++++++|..  +
T Consensus         2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~   81 (337)
T cd07852           2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND   81 (337)
T ss_pred             CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence            345567999999999998888876655433333333222  122334456788999999999 99999999999854  3


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..+++||||+.+ +|..++...     .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||
T Consensus        82 ~~~~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~---~kl~d~g  152 (337)
T cd07852          82 KDIYLVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR---VKLADFG  152 (337)
T ss_pred             ceEEEEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc---EEEeecc
Confidence            468999999974 887777543     3788899999999999999999999999999999999988776   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .+...........        ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+
T Consensus       153 ~~~~~~~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~  215 (337)
T cd07852         153 LARSLSELEENPE--------NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG  215 (337)
T ss_pred             chhcccccccccc--------CcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence            9876544221100        001111246888999998765 4568899999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=8.3e-30  Score=208.79  Aligned_cols=196  Identities=28%  Similarity=0.399  Sum_probs=148.1

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcC-CCChhhhhheeecC--CeEEEEEe
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLK-HPHVVELLETYSSE--GMLYMVFE   85 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e   85 (249)
                      |++...++.|.++.+|..........++++..... .........+|+.++.++. |+|++++++++.++  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            45566677777777776655443333333322211 1122234457888999884 99999999999877  88999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+ +|.+.+....   ..+++.+++.++.|++.||.+||+.+++|+||+|+||+++. +.   ++|+|||.+......
T Consensus        81 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~---~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DI---LKLADFGSCRGIYSK  152 (282)
T ss_pred             cCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CC---eEEEecccccccccC
Confidence            9975 7777665432   23899999999999999999999999999999999999987 44   999999998665432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..              .....++..|+|||.+.. ..++.++|+||+||++++|++|..||.+
T Consensus       153 ~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         153 PP--------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             CC--------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence            21              011236788999998654 4568899999999999999999999987

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.3e-30  Score=216.72  Aligned_cols=198  Identities=26%  Similarity=0.386  Sum_probs=156.2

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-----
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-----   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----   78 (249)
                      ..+||++.+.++.|.++.++...+.-....++++..  ........+.+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            467899999999999888876654433333343322  1222334457889999999999999999999987553     


Q ss_pred             -eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         79 -MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        79 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                       .+++||+++ +++|.+++...     .+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.   ++++|||
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~---~kl~dfg  163 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE---LKILDFG  163 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecc
Confidence             368999999 66887766432     3899999999999999999999999999999999999987665   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .+.......                ....++..|+|||.+.+ ..++.++|+||+|++++++++|+.||.+.
T Consensus       164 ~~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         164 LARQTDSEM----------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             cccccccCc----------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            986543311                11236788999999876 45788999999999999999999999873

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=6.6e-30  Score=209.69  Aligned_cols=199  Identities=31%  Similarity=0.481  Sum_probs=155.4

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeEEEEEe
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSE--GMLYMVFE   85 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e   85 (249)
                      |++...++.|.++.+|..........++++.....  .......+.+|+.+++.++|||++++++++...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            34556677777777776655543333333333222  334456788999999999999999999999877  78999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++ +|.+.+....   ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~---~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV---LKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC---EEEccccceeeccCC
Confidence            9975 8877775542   24899999999999999999999999999999999999988766   999999998766543


Q ss_pred             CccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..            .......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||..
T Consensus       154 ~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         154 NS------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             Cc------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            21            01111235778999998765 4568999999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=5.8e-30  Score=210.63  Aligned_cols=216  Identities=25%  Similarity=0.377  Sum_probs=162.6

Q ss_pred             chHHHhhcccceeeEeeeccc------cCCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEE
Q psy14626         10 ITIHEVINHKWLKMKLHTSAE------IEPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLY   81 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (249)
                      |++.+.++.|.++.+|.....      ..++.+.+.+... ......+.+.+|+.+++++ +||+|+++++.+..+..++
T Consensus         2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~   81 (288)
T cd05583           2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH   81 (288)
T ss_pred             ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence            566777888888777754321      1222333322221 2234456788999999999 6999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+.+++|.+.+....    .+++..+..++.|++.+|.+||+.+++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        82 lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~---~~l~dfg~~~~  154 (288)
T cd05583          82 LILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH---VVLTDFGLSKE  154 (288)
T ss_pred             EEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC---EEEEECccccc
Confidence            9999999999988876543    2889999999999999999999999999999999999987665   99999998765


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCCC-----hHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK--YGKPVDIWAAGVLLHVLLTGTLPFVGS-----RDRLFQ  234 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~pf~~~-----~~~~~~  234 (249)
                      ......            .......++..|+|||.+.+..  .+.++|+||+|+++++|++|..||...     ..++.+
T Consensus       155 ~~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~  222 (288)
T cd05583         155 FLAEEE------------ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR  222 (288)
T ss_pred             cccccc------------cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH
Confidence            433211            0111223678999999987655  678999999999999999999999642     234445


Q ss_pred             HHHcCccccc
Q psy14626        235 SITKGKLHIL  244 (249)
Q Consensus       235 ~i~~g~~~~~  244 (249)
                      .+....+..|
T Consensus       223 ~~~~~~~~~~  232 (288)
T cd05583         223 RILKSKPPFP  232 (288)
T ss_pred             HHHccCCCCC
Confidence            5555544444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=6.1e-30  Score=215.25  Aligned_cols=202  Identities=21%  Similarity=0.379  Sum_probs=158.1

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC-----
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE-----   77 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----   77 (249)
                      ..+++|++...++.|.++.++...+......++++...  .........+.+|+.+++.++|+||+++++++...     
T Consensus         2 ~~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           2 EVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             ccccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence            35678999999999988888766654433333333222  12233456778899999999999999999988644     


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..+++|+||+. ++|.+++....    .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~---~kL~Dfg  153 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQ----TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFG  153 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC---EEECcCc
Confidence            34899999996 58877776443    3899999999999999999999999999999999999987665   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++........             ......++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.+
T Consensus       154 ~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  211 (337)
T cd07858         154 LARTTSEKGD-------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             cccccCCCcc-------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCC
Confidence            9866543210             0111236788999998764 4578999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.1e-29  Score=206.28  Aligned_cols=199  Identities=30%  Similarity=0.468  Sum_probs=156.2

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      |+..+.++.|.++.+|..........++++....  ......+.+.+|+.+++.++|+|++++++++...+.+++|+|++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            3455667777777776555544333343332222  23344567889999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      .+ +|.+++....   ..+++..+..++.|++.+|.+||+++++|+||+|+||+++.++.   ++|+|||.+........
T Consensus        81 ~~-~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~---~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 DM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV---LKLADFGLARAFGIPLR  153 (282)
T ss_pred             Cc-CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC---EEEecCCcccccCCCcc
Confidence            74 8988887653   23899999999999999999999999999999999999988666   99999999866543221


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                                   .......+..|+|||.+.+. .++.++|+||+|++++++++|+.||.+.
T Consensus       154 -------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  202 (282)
T cd07829         154 -------------TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD  202 (282)
T ss_pred             -------------ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence                         11112346789999998766 6789999999999999999999999873

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=7.8e-30  Score=215.29  Aligned_cols=196  Identities=24%  Similarity=0.404  Sum_probs=153.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------C
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------G   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~   78 (249)
                      .++|++.+.++.|.++.++...+......++++...  .......+.+.+|+.++++++||||+++++++...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            468999999999888887766544333344443322  12233456788999999999999999999988543      3


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      ..+++++++ +++|.+.+...     .+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||+
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~---~kl~dfg~  166 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGL  166 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC---EEEecccc
Confidence            478888887 67887766432     2889999999999999999999999999999999999988766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      +.......                ....++..|+|||.+.+ ..++.++|+||+||++++|++|+.||..
T Consensus       167 ~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~  220 (345)
T cd07877         167 ARHTDDEM----------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             cccccccc----------------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            86543211                11236788999999866 4578899999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0603|consensus

Probab=99.97  E-value=2.3e-30  Score=221.52  Aligned_cols=167  Identities=29%  Similarity=0.533  Sum_probs=138.6

Q ss_pred             HHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCc
Q psy14626         52 LKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDI  130 (249)
Q Consensus        52 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~  130 (249)
                      -.+|+.++... +||||+++++.+.++...++|||.+.|+-+.+.+.....    +. .++..|+.+|+.|+.+||++|+
T Consensus       362 ~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~----~~-~e~~~w~~~lv~Av~~LH~~gv  436 (612)
T KOG0603|consen  362 NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE----FC-SEASQWAAELVSAVDYLHEQGV  436 (612)
T ss_pred             cccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch----hH-HHHHHHHHHHHHHHHHHHhcCe
Confidence            44666555555 799999999999999999999999999877776665443    33 7778899999999999999999


Q ss_pred             eeecCCCCCeeee-ecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHH
Q psy14626        131 IHRDIKPHCVLLA-NKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW  209 (249)
Q Consensus       131 vH~dlkp~Nili~-~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  209 (249)
                      +||||||+|||+. ..++   ++|+|||.+....+.                .....-|..|.|||++....++.++|+|
T Consensus       437 vhRDLkp~NIL~~~~~g~---lrltyFG~a~~~~~~----------------~~tp~~t~~y~APEvl~~~~yt~acD~W  497 (612)
T KOG0603|consen  437 VHRDLKPGNILLDGSAGH---LRLTYFGFWSELERS----------------CDTPALTLQYVAPEVLAIQEYTEACDWW  497 (612)
T ss_pred             eecCCChhheeecCCCCc---EEEEEechhhhCchh----------------hcccchhhcccChhhhccCCCCcchhhH
Confidence            9999999999995 4444   999999998776653                1122357889999999988999999999


Q ss_pred             HHHHHHHHHHhCCCCCCC-C-hHHHHHHHHcCccc
Q psy14626        210 AAGVLLHVLLTGTLPFVG-S-RDRLFQSITKGKLH  242 (249)
Q Consensus       210 slG~~l~el~~g~~pf~~-~-~~~~~~~i~~g~~~  242 (249)
                      |||++||+|++|+.||.. + ..++..+|..|++.
T Consensus       498 SLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s  532 (612)
T KOG0603|consen  498 SLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS  532 (612)
T ss_pred             HHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc
Confidence            999999999999999998 3 34788888777543

>KOG1025|consensus

Probab=99.97  E-value=5.6e-31  Score=230.20  Aligned_cols=217  Identities=23%  Similarity=0.286  Sum_probs=176.0

Q ss_pred             hHHHhhcccceeeEeeeccc-------cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626         11 TIHEVINHKWLKMKLHTSAE-------IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      +-..+++.|-++.+|+..+-       +.++++++  ......+..+++.+|+..|.+++|||++++++++..+. +-+|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl--~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVL--IEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEe--eccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            33456677776666654433       33333333  33444566789999999999999999999999998776 8899


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ++|+++|+|.++++.+...   +-.+..+.|+.||++|+.|||+++++||||-..|+|+...+.   +++.|||++....
T Consensus       776 tq~mP~G~LlDyvr~hr~~---igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h---vkitdfgla~ll~  849 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDN---IGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH---VKITDFGLAKLLA  849 (1177)
T ss_pred             HHhcccchHHHHHHHhhcc---ccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe---EEEEecchhhccC
Confidence            9999999999999876654   888999999999999999999999999999999999987776   9999999998876


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc-
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK-  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~-  240 (249)
                      ....           ........-.+.|+|-|.+....+++++||||+||++||++| |..|+.+ +.++|-+.+..|+ 
T Consensus       850 ~d~~-----------ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR  918 (1177)
T KOG1025|consen  850 PDEK-----------EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER  918 (1177)
T ss_pred             cccc-----------cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc
Confidence            6432           112222345788999999999999999999999999999999 9999999 7888999999987 


Q ss_pred             -ccccccc
Q psy14626        241 -LHILGCT  247 (249)
Q Consensus       241 -~~~~~~~  247 (249)
                       .+.|.|+
T Consensus       919 LsqPpiCt  926 (1177)
T KOG1025|consen  919 LSQPPICT  926 (1177)
T ss_pred             CCCCCCcc
Confidence             4444554

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.97  E-value=2.1e-29  Score=207.21  Aligned_cols=202  Identities=24%  Similarity=0.315  Sum_probs=154.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .+...++++.|.++.+|...+......++++..... .......+.+|+.++.++. ||||+++++++..++..+++||+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            566778899988888876665544444444332221 1245667899999999995 99999999999888889999999


Q ss_pred             cCCCchhHHHHH-hhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         87 MDGSDICFEIVR-RATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        87 ~~~~~L~~~l~~-~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      +.. ++.+.... .......+++..+..++.|++.||+|||+. +++|+||||+||+++.++.   ++|+|||++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN---IKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc---EEEeecchhHHhcc
Confidence            864 55443221 111223489999999999999999999974 9999999999999987665   99999998855433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ---KYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ...              .....++..|+|||.+.+.   .++.++|+||+|+++++|++|+.||...
T Consensus       161 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  213 (288)
T cd06616         161 SIA--------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW  213 (288)
T ss_pred             CCc--------------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence            210              1112467889999998766   5789999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=2e-29  Score=211.37  Aligned_cols=198  Identities=23%  Similarity=0.414  Sum_probs=157.0

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeec-CCeEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSS-EGMLY   81 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   81 (249)
                      +.+++|++...++.|.++.++...+......++++...  .......+.+.+|+.+++.++||||+++.++|.. +...+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            45778999999999998888876655444444433221  2223445778899999999999999999999865 55789


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +++||+ +++|...+...     .++...+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        87 lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~---~~l~dfg~~~~  157 (328)
T cd07856          87 FVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD---LKICDFGLARI  157 (328)
T ss_pred             EEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC---EEeCccccccc
Confidence            999998 45887766432     2788889999999999999999999999999999999987665   99999998864


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....                ....++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||..
T Consensus       158 ~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~  208 (328)
T cd07856         158 QDPQM----------------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             cCCCc----------------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            32211                11235778999999765 5678999999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.7e-29  Score=202.37  Aligned_cols=153  Identities=24%  Similarity=0.332  Sum_probs=129.3

Q ss_pred             HHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCce
Q psy14626         52 LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDII  131 (249)
Q Consensus        52 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~v  131 (249)
                      +.+|...+....||||+++++++......++||||+++++|.+++.....    +++..+..++.|++.||.+||+++++
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~ql~~~l~~lH~~~i~  107 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN----IPEECVKRWAAEMVVALDALHREGIV  107 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34455555666799999999999999999999999999999988866543    89999999999999999999999999


Q ss_pred             eecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHH
Q psy14626        132 HRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAA  211 (249)
Q Consensus       132 H~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl  211 (249)
                      |+||||+||+++.++.   ++++|||.+.......                ....++..|+|||...+..++.++|+||+
T Consensus       108 H~dlkp~Nil~~~~~~---~~l~df~~~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl  168 (237)
T cd05576         108 CRDLNPNNILLDDRGH---IQLTYFSRWSEVEDSC----------------DGEAVENMYCAPEVGGISEETEACDWWSL  168 (237)
T ss_pred             ccCCCHHHEEEcCCCC---EEEecccchhcccccc----------------ccCCcCccccCCcccCCCCCCchhhHHHH
Confidence            9999999999987766   9999999765443311                11124567999999988888999999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q psy14626        212 GVLLHVLLTGTLPFVG  227 (249)
Q Consensus       212 G~~l~el~~g~~pf~~  227 (249)
                      |+++++|++|..|+..
T Consensus       169 G~il~el~~g~~~~~~  184 (237)
T cd05576         169 GAILFELLTGKTLVEC  184 (237)
T ss_pred             HHHHHHHHHCcchhhc
Confidence            9999999999988765

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0984|consensus

Probab=99.97  E-value=9.3e-30  Score=190.82  Aligned_cols=183  Identities=24%  Similarity=0.373  Sum_probs=150.3

Q ss_pred             hhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC  125 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L  125 (249)
                      ...+++.+|+++..+- .+|++|.|+|.....+.+++.||.|. .||..+-......+...++..+-+++..++.||.||
T Consensus        86 q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L  164 (282)
T KOG0984|consen   86 QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFL  164 (282)
T ss_pred             HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHH
Confidence            4456778888876665 79999999999988889999999995 488776666666777899999999999999999999


Q ss_pred             HHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc----C
Q psy14626        126 HEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED----Q  200 (249)
Q Consensus       126 H~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~  200 (249)
                      |++ .++|||+||+|||++.++.   +|++|||++-...++.....              ..|-..|+|||.+..    .
T Consensus       165 ~~kL~vIHRDvKPsNiLIn~~Gq---VKiCDFGIsG~L~dSiAkt~--------------daGCkpYmaPEri~~e~n~~  227 (282)
T KOG0984|consen  165 HSKLSVIHRDVKPSNILINYDGQ---VKICDFGISGYLVDSIAKTM--------------DAGCKPYMAPERINPELNQK  227 (282)
T ss_pred             HHHhhhhhccCCcceEEEccCCc---EEEcccccceeehhhhHHHH--------------hcCCCccCChhhcCcccCcc
Confidence            976 7999999999999988887   99999999988777543211              246788999999853    3


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCC--Ch-HHHHHHHHcCcccccccc
Q psy14626        201 KYGKPVDIWAAGVLLHVLLTGTLPFVG--SR-DRLFQSITKGKLHILGCT  247 (249)
Q Consensus       201 ~~~~~~DiwslG~~l~el~~g~~pf~~--~~-~~~~~~i~~g~~~~~~~~  247 (249)
                      .|+.++|+||||+++.||.+++.||..  +. +.+.+-+..-.+++|..+
T Consensus       228 gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~~~  277 (282)
T KOG0984|consen  228 GYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPADT  277 (282)
T ss_pred             cceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcccc
Confidence            578999999999999999999999997  33 455555666667777543

>KOG1151|consensus

Probab=99.96  E-value=3.1e-30  Score=212.76  Aligned_cols=232  Identities=25%  Similarity=0.403  Sum_probs=176.9

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-------chhHHHHHHHHHHHHHcCCCChhhhhheee-cC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-------YTTEADLKREATICHMLKHPHVVELLETYS-SE   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~   77 (249)
                      -++||....+++.|+|..+|..-+-.+..-.+.+...++.       ..-.+...+|-.+-+.|+||.||+++++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3579999999999988777644333222212222122111       112344678999999999999999999996 55


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC--CceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN--DIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~--~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                      ..+|-|+|||+|.+|..||..+..    +++++++.|+.||+.||.||-..  -|||-||||.|||+.....++.++|.|
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeee
Confidence            679999999999999999987765    89999999999999999999866  599999999999999888888899999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCCC--h
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED----QKYGKPVDIWAAGVLLHVLLTGTLPFVGS--R  229 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~~l~el~~g~~pf~~~--~  229 (249)
                      ||++....+.......+.++.      .-.+||..|++||++.-    .+.+.++||||+|+++|.++.|+-||..+  .
T Consensus       617 FGLSKIMdddSy~~vdGmeLT------SQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ  690 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELT------SQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ  690 (775)
T ss_pred             cchhhhccCCccCcccceeee------cccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence            999998887655433333321      22358999999999753    33588999999999999999999999873  4


Q ss_pred             HHHHHH---HHcCcccccccc
Q psy14626        230 DRLFQS---ITKGKLHILGCT  247 (249)
Q Consensus       230 ~~~~~~---i~~g~~~~~~~~  247 (249)
                      ..+++.   |..-+.+||+-|
T Consensus       691 QdILqeNTIlkAtEVqFP~KP  711 (775)
T KOG1151|consen  691 QDILQENTILKATEVQFPPKP  711 (775)
T ss_pred             HHHHhhhchhcceeccCCCCC
Confidence            455443   334556777544

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=2.4e-29  Score=211.19  Aligned_cols=202  Identities=21%  Similarity=0.335  Sum_probs=153.0

Q ss_pred             cchHHHhhcccceeeEeeeccccC--CCcccCChhc--cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecC----Ce
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIE--PASFGLPDER--LNHYTTEADLKREATICHML-KHPHVVELLETYSSE----GM   79 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~----~~   79 (249)
                      +|++...++.|.++.++.......  ...++++...  .......+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            466777888888888776665543  3333433222  22233456788999999999 599999999875422    45


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      ++++++++. ++|.+.+....    .+++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~---~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE---LKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC---EEeCcCCCc
Confidence            789999986 58877775433    3899999999999999999999999999999999999987765   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .........         .........++..|+|||.+.+ ..++.++|+||+|+++++|++|.+||..
T Consensus       153 ~~~~~~~~~---------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         153 RGFSENPGE---------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             eeccccccc---------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence            765532211         0011112347889999998765 4578999999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=2.9e-29  Score=205.97  Aligned_cols=207  Identities=25%  Similarity=0.370  Sum_probs=156.1

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHc---CCCChhhhhheeecCCe-----
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHML---KHPHVVELLETYSSEGM-----   79 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~-----   79 (249)
                      |++..+++.|.++.+|..........++++...  .........+.+|+.+++++   +|||++++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            345566777777777766655433334433222  12223345677888888777   59999999999987766     


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      ++++||++.+ +|.+++.....  ..+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||.+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~---~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ---VKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCC---EEEeccCcc
Confidence            9999999975 78877765432  23899999999999999999999999999999999999988765   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ........              .....++..|+|||.+.+..++.++|+||+|+++++|++|++||.+ +..+....+
T Consensus       155 ~~~~~~~~--------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~  218 (287)
T cd07838         155 RIYSFEMA--------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKI  218 (287)
T ss_pred             eeccCCcc--------------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHH
Confidence            76543211              1112357889999999988889999999999999999999999987 333333333

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.8e-29  Score=212.92  Aligned_cols=207  Identities=23%  Similarity=0.376  Sum_probs=160.9

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe----
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM----   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----   79 (249)
                      -.++|++...++.|.++.+|..........++++...  ..+....+.+.+|+.+++.++|||++++.+++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3568899999999988888866665444444433222  1223445678889999999999999999998866554    


Q ss_pred             --EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         80 --LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        80 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                        .++|+|++ +++|.+++...     .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~---~kL~dfg  163 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE---LKILDFG  163 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC---EEEcccc
Confidence              89999999 56898877542     3899999999999999999999999999999999999987666   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      .+.......                ....++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.+ +.......
T Consensus       164 ~~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~  227 (343)
T cd07851         164 LARHTDDEM----------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR  227 (343)
T ss_pred             ccccccccc----------------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            986553321                11235778999999865 3568899999999999999999999987 33333334


Q ss_pred             HH
Q psy14626        236 IT  237 (249)
Q Consensus       236 i~  237 (249)
                      +.
T Consensus       228 i~  229 (343)
T cd07851         228 IM  229 (343)
T ss_pred             HH
Confidence            33

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=2.8e-29  Score=207.76  Aligned_cols=201  Identities=29%  Similarity=0.465  Sum_probs=154.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-------
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEG-------   78 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------   78 (249)
                      .+|++.+.++.|.++.+|..........++++.....  .......+.+|+.+++.++|||++++++++.+..       
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~   86 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK   86 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence            4678888888888888776665543333333322221  2234467789999999999999999999986544       


Q ss_pred             ---eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         79 ---MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        79 ---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                         .+++|+||+++ ++...+....   ..+++.+++.++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|
T Consensus        87 ~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~---~kl~d  159 (302)
T cd07864          87 DKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ---IKLAD  159 (302)
T ss_pred             cCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc---EEeCc
Confidence               78999999986 6666655432   23899999999999999999999999999999999999987665   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ||.+........            .......++..|+|||.+.+. ..+.++|+||+||++++|++|+.||..
T Consensus       160 fg~~~~~~~~~~------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~  220 (302)
T cd07864         160 FGLARLYNSEES------------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA  220 (302)
T ss_pred             ccccccccCCcc------------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999866544221            001112356789999988653 468899999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.96  E-value=2.4e-29  Score=208.79  Aligned_cols=213  Identities=27%  Similarity=0.381  Sum_probs=156.9

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      ..++|++.+.++.|.++.+|...+......++++......  ......+.+|+.+++.++||||+++++.+.+.      
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            3568999999999998888877655444444443222211  22234678999999999999999999988443      


Q ss_pred             --CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         78 --GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                        ..+++|++|+.+ +|...+....   ..+++.+++.++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~---~~l~d  158 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI---LKIAD  158 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEECc
Confidence              347999999965 6655554322   24899999999999999999999999999999999999987766   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ||.+...............  ..........+++.|+|||.+.+. .++.++|+||+|+++++|++|++||.+
T Consensus       159 fg~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~  229 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGG--GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             CccchhccCCCcccccCCc--ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence            9998665432211110000  000111122457789999987654 468899999999999999999999987

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-28  Score=202.21  Aligned_cols=198  Identities=27%  Similarity=0.431  Sum_probs=154.2

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhcccc-chhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEecc
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-YTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      |++.+.++.|.++.+|..........++++...... ........+|+..+++++ |||++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            456677888888777766654333333333221111 123334567999999998 999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                       +++|.+.+....  +..+++.++..++.|++.+|.+||+++++|+||+|+||+++.++.   ++|+|||.+........
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~---~~l~d~~~~~~~~~~~~  154 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV---VKIADFGLAREIRSRPP  154 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC---EEEeecccceeccCCCC
Confidence             678888776554  224899999999999999999999999999999999999987666   99999999876544221


Q ss_pred             cccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                    .....++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||..
T Consensus       155 --------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~  201 (283)
T cd07830         155 --------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG  201 (283)
T ss_pred             --------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence                          111236778999998754 4578999999999999999999999987

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG0662|consensus

Probab=99.96  E-value=1.6e-29  Score=186.17  Aligned_cols=200  Identities=26%  Similarity=0.428  Sum_probs=166.9

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .|.-.+.|+.|.|+.++...+.....+.+++...++  +..-.....+|+-+++.++|.|||++++....++.+-+|+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            455678899999999998888777777776655443  344567789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      |.. +|..+......   .++.+.++.++.|++.||.+.|+.++.|+|+||.|.+++.+++   ++++|||+++-.+-..
T Consensus        83 cdq-dlkkyfdslng---~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge---lkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSLNG---DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE---LKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHhcCC---cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc---EEecccchhhhcCCce
Confidence            964 88777765433   3899999999999999999999999999999999999998887   9999999986554322


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLT-GTLPFVGS  228 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~-g~~pf~~~  228 (249)
                               .++.    ...-|..|.+|.++-|.+ ++.+.|+||.||++.|+.. |.+.|+++
T Consensus       156 ---------rcys----aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  156 ---------RCYS----AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             ---------Eeee----ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence                     1111    224688999999988765 6999999999999999998 99999983

>KOG0200|consensus

Probab=99.96  E-value=4.2e-29  Score=223.83  Aligned_cols=227  Identities=21%  Similarity=0.374  Sum_probs=177.9

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccc----------cCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhh
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAE----------IEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVEL   70 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~   70 (249)
                      |+++..+. .+...++.|.++.++...-.          ..++++.+ +.... ....+.+..|+.+|+.+ +|+||+.+
T Consensus       291 ~e~~~~~l-~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~-k~~~~-~~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  291 WEIPRENL-KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKML-KENAS-SSEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             eeechhhc-cccceeecccccceEeEEEeecccccccceEEEEEEec-ccccC-cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence            55666655 66678888888877644321          11122222 22222 36788999999999999 69999999


Q ss_pred             hheeecCCeEEEEEeccCCCchhHHHHHhh---hcC---------CccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCC
Q psy14626         71 LETYSSEGMLYMVFEYMDGSDICFEIVRRA---TAG---------FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPH  138 (249)
Q Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~---------~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~  138 (249)
                      ++.|..++.+++|+||+..|+|..++..+.   ...         ..++..++..++.||+.|++||++..++||||...
T Consensus       368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR  447 (609)
T KOG0200|consen  368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR  447 (609)
T ss_pred             eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence            999999999999999999999999998876   100         13888999999999999999999999999999999


Q ss_pred             CeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHH
Q psy14626        139 CVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL  218 (249)
Q Consensus       139 Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el  218 (249)
                      |||+..+..   +||+|||+++.......+...         ..... .+..|+|||.+....++.++||||+|++|||+
T Consensus       448 NVLi~~~~~---~kIaDFGlar~~~~~~~y~~~---------~~~~~-LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Ei  514 (609)
T KOG0200|consen  448 NVLITKNKV---IKIADFGLARDHYNKDYYRTK---------SSAGT-LPVKWMAPESLFDRVFTSKSDVWSFGILLWEI  514 (609)
T ss_pred             hEEecCCCE---EEEccccceeccCCCCceEec---------CCCCc-cceeecCHHHhccCcccccchhhHHHHHHHHH
Confidence            999987644   999999999876664433211         11111 35679999999999999999999999999999


Q ss_pred             Hh-CCCCCCC--ChHHHHHHHHcCcc-ccc
Q psy14626        219 LT-GTLPFVG--SRDRLFQSITKGKL-HIL  244 (249)
Q Consensus       219 ~~-g~~pf~~--~~~~~~~~i~~g~~-~~~  244 (249)
                      ++ |..||.+  ...++.+.+.+|.- ..|
T Consensus       515 fsLG~~PYp~~~~~~~l~~~l~~G~r~~~P  544 (609)
T KOG0200|consen  515 FTLGGTPYPGIPPTEELLEFLKEGNRMEQP  544 (609)
T ss_pred             hhCCCCCCCCCCcHHHHHHHHhcCCCCCCC
Confidence            99 9999998  36778888888863 444

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=8.5e-29  Score=224.66  Aligned_cols=146  Identities=24%  Similarity=0.394  Sum_probs=122.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.+|...+......++++   ............+.+|+.+++.++||||+++++.+.....+|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999988877665433333333   233333445578899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ||+.+++|.+++.....    +++..++.++.||+.||.|||.++++|+||||+|||++.++.   ++|+|||++.
T Consensus        84 Ey~~g~~L~~li~~~~~----l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~---vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH---IKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC---EEEEeCCCCc
Confidence            99999999988865432    789999999999999999999999999999999999987665   9999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1152|consensus

Probab=99.96  E-value=3.2e-30  Score=218.11  Aligned_cols=200  Identities=27%  Similarity=0.377  Sum_probs=164.0

Q ss_pred             CCCCc--chHHHhhcccceeeEeeeccccCC---CcccCChhccccc-----hhHHHHHHHHHHHHHcC---CCChhhhh
Q psy14626          5 DPNKR--ITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDERLNHY-----TTEADLKREATICHMLK---HPHVVELL   71 (249)
Q Consensus         5 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~-----~~~~~~~~E~~~l~~l~---h~~i~~~~   71 (249)
                      .+.+.  |+.-+.++.|-|+.++....+-..   .++-+.++.+--.     ...-.+-.|+++|..++   |+||++++
T Consensus       556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            34444  888888999888877654444333   3333444443222     22334678999999997   99999999


Q ss_pred             heeecCCeEEEEEecc-CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCC
Q psy14626         72 ETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP  150 (249)
Q Consensus        72 ~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~  150 (249)
                      ++|++++.+|++||.- +|-+|.+++..+..    +++.+.+.|..|++.|+++||++||||||||-+|+.++.++.   
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~---  708 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF---  708 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe---
Confidence            9999999999999986 46689999987765    999999999999999999999999999999999999999887   


Q ss_pred             eEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q psy14626        151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFV  226 (249)
Q Consensus       151 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~  226 (249)
                      ++|+|||.+....+.+               +..+.||..|+|||++.|.+| +...|||++|++||.+.....||-
T Consensus       709 ~klidfgsaa~~ksgp---------------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSGP---------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEeeccchhhhcCCC---------------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999987766533               234569999999999999988 788999999999999999998885

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=6.1e-29  Score=209.61  Aligned_cols=196  Identities=26%  Similarity=0.385  Sum_probs=150.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------C
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------G   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~   78 (249)
                      ..+|.+...++.|.++.++...+......++++...  .........+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468888889988888887765543333333333221  12223345688999999999999999999998654      3


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+++|++++.. +|.....      ..++...+..++.|++.||.+||+.+++|+||+|+||+++.++.   ++|+|||+
T Consensus        94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~---~kL~dfg~  163 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE---LKILDFGL  163 (342)
T ss_pred             eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEeeCCC
Confidence            46999999964 6655431      12889999999999999999999999999999999999987766   99999998


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      +.......                ....++..|+|||.+.+ ..++.++|+||+|+++++|++|+.||.+.
T Consensus       164 ~~~~~~~~----------------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         164 ARHADAEM----------------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             CcCCCCCC----------------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            75432211                11235778999999876 45788999999999999999999999873

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=4.1e-28  Score=200.47  Aligned_cols=200  Identities=22%  Similarity=0.344  Sum_probs=151.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+.|++.+.++.|.++.++..........++++..... .......+.+|+.++... .||||+++++++.++...+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            35678888888888888776665533333333322211 123445667777767666 5999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||+.+ +|...+.....   .+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.   ++|+|||.+....
T Consensus        94 e~~~~-~l~~l~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~---~kL~dfg~~~~~~  166 (296)
T cd06618          94 ELMST-CLDKLLKRIQG---PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN---VKLCDFGISGRLV  166 (296)
T ss_pred             eccCc-CHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC---EEECccccchhcc
Confidence            99854 67665544322   48999999999999999999997 59999999999999987665   9999999886543


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ....              .....++..|+|||.+.+..    ++.++|+||+|+++|+|++|+.||..
T Consensus       167 ~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         167 DSKA--------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             CCCc--------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence            3211              01123677899999987553    68899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=5.3e-28  Score=191.20  Aligned_cols=217  Identities=31%  Similarity=0.482  Sum_probs=169.5

Q ss_pred             hHHHhhcccceeeEeeeccccCCCcccCChhccccch-hHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         11 TIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYT-TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      ++.+.++.|.++.++..........++++........ ..+.+.+|+..++.++|+|++++++++......++++|++++
T Consensus         2 ~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~   81 (225)
T smart00221        2 ELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG   81 (225)
T ss_pred             ceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence            4455666777666665555432333333333333222 678899999999999999999999999988899999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++......   ++...+..++.+++.++.+||+.+++|+|++|+||+++.++.   ++|+|||.+........  
T Consensus        82 ~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~---~~l~d~g~~~~~~~~~~--  153 (225)
T smart00221       82 GDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL---VKLADFGLARFIHRDLA--  153 (225)
T ss_pred             CCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeeCceeeEecCccc--
Confidence            8998888764321   688999999999999999999999999999999999987655   99999999877654320  


Q ss_pred             cCCccccccccccCCcccCCCCCCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCCCC--C-hHHHHHHHHcCcccccc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--S-RDRLFQSITKGKLHILG  245 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~-~~~~~~~i~~g~~~~~~  245 (249)
                                .......++..|++||.+ ....++.++|+||+|+++++|++|+.||..  + ...+.+.|.+|.+.+++
T Consensus       154 ----------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (225)
T smart00221      154 ----------ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE  223 (225)
T ss_pred             ----------ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence                      011122467789999998 666678899999999999999999999976  3 34788999999866554

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1035|consensus

Probab=99.96  E-value=7.3e-29  Score=224.56  Aligned_cols=226  Identities=25%  Similarity=0.455  Sum_probs=175.4

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeec------------
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSS------------   76 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------------   76 (249)
                      +..-++++.|+|+.+++..+.++..-|++++..+. +......+.+|+.+|.+|+|||||+++..|.+            
T Consensus       481 FEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~  560 (1351)
T KOG1035|consen  481 FEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVA  560 (1351)
T ss_pred             hHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccc
Confidence            34567899999999999999999999998877766 34555678999999999999999999988632            


Q ss_pred             --------------------------------------------------------------------------------
Q psy14626         77 --------------------------------------------------------------------------------   76 (249)
Q Consensus        77 --------------------------------------------------------------------------------   76 (249)
                                                                                                      
T Consensus       561 ~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~  640 (1351)
T KOG1035|consen  561 SDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSV  640 (1351)
T ss_pred             cchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcc
Confidence                                                                                            


Q ss_pred             -------------------C--------CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC
Q psy14626         77 -------------------E--------GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND  129 (249)
Q Consensus        77 -------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~  129 (249)
                                         .        -.+||-||||+...|.+++..+....   .....+++.++|+.||.|+|++|
T Consensus       641 ~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  641 ILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             ccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHHHHhCc
Confidence                               0        13689999999878888887765421   57888999999999999999999


Q ss_pred             ceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC---C-CccccCC-ccccccccccCCcccCCCCCCccccccCC---
Q psy14626        130 IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD---G-QLYCSGG-ERLDHYTTKAGHRIGTPHYMAPEVIEDQK---  201 (249)
Q Consensus       130 ~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~---~-~~~~~~~-~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---  201 (249)
                      +|||||||.||+++.++.   |||+|||++.....   + ....... ..........-...||--|+|||++.+..   
T Consensus       718 iIHRDLKP~NIFLd~~~~---VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNS---VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             eeeccCCcceeEEcCCCC---eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence            999999999999997777   99999999977221   0 0000000 00001111223456999999999987654   


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHcCccccc
Q psy14626        202 YGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       202 ~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i~~g~~~~~  244 (249)
                      ++.++|+||||++++||+.   ||.-  ....++..+++|.++.|
T Consensus       795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~  836 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP  836 (1351)
T ss_pred             ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC
Confidence            8999999999999999995   5665  45578889998888777

>KOG0587|consensus

Probab=99.96  E-value=5.6e-29  Score=219.07  Aligned_cols=220  Identities=26%  Similarity=0.376  Sum_probs=178.1

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheee-----cC
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYS-----SE   77 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~-----~~   77 (249)
                      .||...+.+.++++.|.++.++..+.. ..+..+..+...-+....+++.-|.++++.. +|||++.++++|.     .+
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~-~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~   93 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHV-KTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG   93 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeee-ecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence            588899999999999988877755443 4444444444444455667888999999999 7999999999994     34


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      +.+++|||||.|||..+++....  +..+.+..|..|++.++.|+.+||...++|+|+|-.|||++.++.   |||.|||
T Consensus        94 DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~---VKLvDFG  168 (953)
T KOG0587|consen   94 DQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE---VKLVDFG  168 (953)
T ss_pred             CeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc---EEEeeee
Confidence            67999999999999999887655  667999999999999999999999999999999999999998887   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCCC--hH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----KYGKPVDIWAAGVLLHVLLTGTLPFVGS--RD  230 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~pf~~~--~~  230 (249)
                      ++.......             ...+...||++|||||++...     .++.++|+||||++-.||..|.+|+-..  -.
T Consensus       169 vSaQldsT~-------------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr  235 (953)
T KOG0587|consen  169 VSAQLDSTV-------------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR  235 (953)
T ss_pred             eeeeeeccc-------------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence            998877644             233455799999999998643     3678899999999999999999999883  33


Q ss_pred             HHHHHHHcCccc
Q psy14626        231 RLFQSITKGKLH  242 (249)
Q Consensus       231 ~~~~~i~~g~~~  242 (249)
                      .++...++=+++
T Consensus       236 aLF~IpRNPPPk  247 (953)
T KOG0587|consen  236 ALFLIPRNPPPK  247 (953)
T ss_pred             hhccCCCCCCcc
Confidence            455544443333

>KOG0670|consensus

Probab=99.96  E-value=1.2e-29  Score=212.39  Aligned_cols=216  Identities=21%  Similarity=0.345  Sum_probs=165.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC------CCChhhhhheeecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK------HPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~l   82 (249)
                      ||.+....+.|.|+.++...+......++++... ++..-.+.=++|+++|++|+      --|+++++..|...+++|+
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIR-nNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl  511 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIR-NNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL  511 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEee-cchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence            3444444444455555555554433333333222 22233345568999999995      3489999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |+|.+. .+|.+.|..-+. ...+....++.++.|+..||+.|-.+|++|+||||+|||++....  +++|||||.|..+
T Consensus       512 VFE~Ls-lNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~--iLKLCDfGSA~~~  587 (752)
T KOG0670|consen  512 VFEPLS-LNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN--ILKLCDFGSASFA  587 (752)
T ss_pred             Eehhhh-chHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc--eeeeccCcccccc
Confidence            999984 699988876554 445889999999999999999999999999999999999976433  4899999999888


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      ..+....        +       .-+..|.|||.+.|.+|....|+||+||+||||.||+..|++ +...|+...+.-+.
T Consensus       588 ~eneitP--------Y-------LVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KG  652 (752)
T KOG0670|consen  588 SENEITP--------Y-------LVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKG  652 (752)
T ss_pred             ccccccH--------H-------HHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcC
Confidence            7754311        0       134568999999999999999999999999999999999999 67778777776666


Q ss_pred             ccc
Q psy14626        242 HIL  244 (249)
Q Consensus       242 ~~~  244 (249)
                      +||
T Consensus       653 k~p  655 (752)
T KOG0670|consen  653 KFP  655 (752)
T ss_pred             CCc
Confidence            655

>KOG0983|consensus

Probab=99.96  E-value=5.2e-29  Score=194.09  Aligned_cols=208  Identities=21%  Similarity=0.352  Sum_probs=151.9

Q ss_pred             HHhhcccceeeEeeeccccCCCcccCChh-ccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         13 HEVINHKWLKMKLHTSAEIEPASFGLPDE-RLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      ...+++|.-+.++.....-...+.+++.- .-.+....+++...+.++..- ++|+||+.+|+|..+..+++.||.|. .
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~  175 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-T  175 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-H
Confidence            34455555444443333322222232211 122345566778888777666 59999999999999999999999983 3


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      .+..++ .+...  ++++..+-.+...+++||.||.++ +++|||+||+|||++..+.   +||+|||++-...++..+.
T Consensus       176 C~ekLl-krik~--piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn---iKlCDFGIsGrlvdSkAht  249 (391)
T KOG0983|consen  176 CAEKLL-KRIKG--PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN---IKLCDFGISGRLVDSKAHT  249 (391)
T ss_pred             HHHHHH-HHhcC--CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC---EEeecccccceeecccccc
Confidence            444433 33333  388988889999999999999854 8999999999999998887   9999999987766644321


Q ss_pred             cCCccccccccccCCcccCCCCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHcCcc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSITKGKL  241 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i~~g~~  241 (249)
                                    ..+|-+.|||||.+.-   .+|..++||||||++++||.||+.||.+  +.-+++-.|.+.++
T Consensus       250 --------------rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP  312 (391)
T KOG0983|consen  250 --------------RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP  312 (391)
T ss_pred             --------------cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC
Confidence                          2258899999999864   4578999999999999999999999999  44456666666554

>KOG0669|consensus

Probab=99.96  E-value=5.1e-29  Score=192.16  Aligned_cols=215  Identities=24%  Similarity=0.417  Sum_probs=161.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcccc--chhHHHHHHHHHHHHHcCCCChhhhhheeec--------C
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH--YTTEADLKREATICHMLKHPHVVELLETYSS--------E   77 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--------~   77 (249)
                      ..|.-...+++|.++.++...........++++.....  ..-.....+|+.+|..+.|+|++.+++.|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666777888888866655555444333443333321  1223556899999999999999999999943        2


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..+|+||++|+. +|.-.+....-   .++..+|..++.+++.||.|+|...|+|||+|+.|+||++++.   ++|+|||
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~v---r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi---lklADFG  169 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKV---RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI---LKLADFG  169 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccc---cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce---EEeeccc
Confidence            458999999975 77777655422   3899999999999999999999999999999999999988776   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCCh-HHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGSR-DRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~~~-~~~~~~  235 (249)
                      +++....+....-         ...-.+.-|..|.+||.+.| ..++++.|+|+.||++.||+++.+.+.++. ..-++.
T Consensus       170 lar~fs~~~n~~k---------prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~  240 (376)
T KOG0669|consen  170 LARAFSTSKNVVK---------PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL  240 (376)
T ss_pred             cccceecccccCC---------CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence            9865554332111         11122346899999999887 457999999999999999999999999954 334555


Q ss_pred             HHc
Q psy14626        236 ITK  238 (249)
Q Consensus       236 i~~  238 (249)
                      |+.
T Consensus       241 Is~  243 (376)
T KOG0669|consen  241 ISQ  243 (376)
T ss_pred             HHH
Confidence            543

>KOG1006|consensus

Probab=99.96  E-value=1.1e-29  Score=197.07  Aligned_cols=214  Identities=25%  Similarity=0.322  Sum_probs=159.5

Q ss_pred             HHhhcccceeeEeeeccccCCCcccCChhccccc-hhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         13 HEVINHKWLKMKLHTSAEIEPASFGLPDERLNHY-TTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      ...++.|.|+.+.+-.........+++....... ..++++..|.....+- ++||||+++|.+-.++--++.||+|.- 
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-  147 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-  147 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence            4456778888776555555555566655554443 6677888998766666 799999999999888889999999953 


Q ss_pred             chhHH---HHHhhhcCCccCHHHHHHHHHHHHHHHHHHH-HCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         91 DICFE---IVRRATAGFVYSEAVASHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        91 ~L~~~---l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH-~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      ||..+   .....  ...++++-+-.+..-.+.||.||. ...++|||+||+|||++..+.   +||+|||++-...++.
T Consensus       148 SlDklYk~vy~vq--~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~---vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  148 SLDKLYKRVYSVQ--KSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD---VKLCDFGICGQLVDSI  222 (361)
T ss_pred             hHHHHHHHHHHHH--hccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC---EeeecccchHhHHHHH
Confidence            55322   22222  223888888888888999999998 458999999999999998887   9999999986655533


Q ss_pred             ccccCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCC-Ch-HHHHHHHHcCccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR-DRLFQSITKGKLH  242 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~pf~~-~~-~~~~~~i~~g~~~  242 (249)
                      ..              ..-+|-..|+|||.+..  ..+..++|+||||++|+|+.||..||.+ +. -+=...+..|.++
T Consensus       223 Ak--------------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp  288 (361)
T KOG1006|consen  223 AK--------------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP  288 (361)
T ss_pred             Hh--------------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC
Confidence            21              11257889999999864  3478999999999999999999999998 33 2223345667776


Q ss_pred             cccc
Q psy14626        243 ILGC  246 (249)
Q Consensus       243 ~~~~  246 (249)
                      +.-.
T Consensus       289 ~l~~  292 (361)
T KOG1006|consen  289 ILLF  292 (361)
T ss_pred             eecC
Confidence            6543

>KOG1024|consensus

Probab=99.95  E-value=3.2e-28  Score=197.94  Aligned_cols=229  Identities=16%  Similarity=0.229  Sum_probs=183.8

Q ss_pred             CCcchHHHhhcccceeeEeeecccc------CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheee-cCCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI------EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYS-SEGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~   79 (249)
                      ..|++...++..|.++.+++.-...      ...++..--..-.+.-+...+..|.-++..+.|||+..+.+.+. +...
T Consensus       283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            3578888999999988888663221      11112111122333456778899999999999999999999985 4567


Q ss_pred             EEEEEeccCCCchhHHHHHhhh----cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         80 LYMVFEYMDGSDICFEIVRRAT----AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                      .++++.+..-|+|..++.....    ....++..++..++.|++.|+.|||..|+||.||...|++|++.-.   ++|+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq---VkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ---VKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee---EEecc
Confidence            8899999988999998874332    2334677889999999999999999999999999999999987655   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHH
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLF  233 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~  233 (249)
                      -.+++...+...+|.+..+           ..+..|||||.+....++.++|+||||++||||++ |+.||.. ++.++.
T Consensus       440 saLSRDLFP~DYhcLGDnE-----------nRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~  508 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNE-----------NRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME  508 (563)
T ss_pred             chhccccCcccccccCCCC-----------CCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH
Confidence            9999999887777666444           46889999999999999999999999999999999 9999998 888898


Q ss_pred             HHHHcCc-cccc-cccCC
Q psy14626        234 QSITKGK-LHIL-GCTHK  249 (249)
Q Consensus       234 ~~i~~g~-~~~~-~~~~~  249 (249)
                      .-+..|. +.-| -||+|
T Consensus       509 ~ylkdGyRlaQP~NCPDe  526 (563)
T KOG1024|consen  509 HYLKDGYRLAQPFNCPDE  526 (563)
T ss_pred             HHHhccceecCCCCCcHH
Confidence            8888876 4555 67764

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=6.3e-27  Score=186.72  Aligned_cols=175  Identities=45%  Similarity=0.734  Sum_probs=150.0

Q ss_pred             HHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC
Q psy14626         49 EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN  128 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~  128 (249)
                      .+.+.+|+..+++++|+|++++++.+......++++|++++++|.+++.....    ++...+..++.+++.++.+||+.
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lh~~  106 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR----LSEDEARFYARQILSALEYLHSN  106 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHc
Confidence            68899999999999999999999999998999999999999899988876443    78999999999999999999999


Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchH
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDI  208 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  208 (249)
                      +++|+||+|+||+++.++.   ++++|||.+.......              ......++..|+|||...+..++.++|+
T Consensus       107 ~i~h~~i~~~ni~~~~~~~---~~l~d~~~~~~~~~~~--------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di  169 (244)
T smart00220      107 GIIHRDLKPENILLDEDGH---VKLADFGLARQLDPGG--------------LLTTFVGTPEYMAPEVLLGKGYGKAVDV  169 (244)
T ss_pred             CeecCCcCHHHeEECCCCc---EEEccccceeeecccc--------------ccccccCCcCCCCHHHHccCCCCchhhH
Confidence            9999999999999987765   9999999987765532              1122346788999999988888899999


Q ss_pred             HHHHHHHHHHHhCCCCCCC--ChHHHHHHHHcCccccc
Q psy14626        209 WAAGVLLHVLLTGTLPFVG--SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       209 wslG~~l~el~~g~~pf~~--~~~~~~~~i~~g~~~~~  244 (249)
                      ||+|++++++++|..||..  +.+.+.+.+..+....+
T Consensus       170 ~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~  207 (244)
T smart00220      170 WSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP  207 (244)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc
Confidence            9999999999999999987  44556766766665543

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665|consensus

Probab=99.95  E-value=1.7e-28  Score=194.60  Aligned_cols=162  Identities=29%  Similarity=0.523  Sum_probs=136.8

Q ss_pred             cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC------eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHH
Q psy14626         43 LNHYTTEADLKREATICHMLKHPHVVELLETYSSEG------MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMR  116 (249)
Q Consensus        43 ~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~  116 (249)
                      ........+..+|..++..++|+||++++.+|.-..      ..|+|||++.. +|...+...      ++..++..+..
T Consensus        53 f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~~e------lDH~tis~i~y  125 (369)
T KOG0665|consen   53 FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVILME------LDHETISYILY  125 (369)
T ss_pred             cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHHHh------cchHHHHHHHH
Confidence            444566778899999999999999999999996443      47999999964 888877733      78999999999


Q ss_pred             HHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccc
Q psy14626        117 QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV  196 (249)
Q Consensus       117 ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  196 (249)
                      |++.|+++||+.||+||||||+||++..+..   +|+.|||.+......-       ....+       ..+..|.|||+
T Consensus       126 q~~~~ik~lhs~~IihRdLkPsnivv~~~~~---lKi~dfg~ar~e~~~~-------~mtpy-------VvtRyyrapev  188 (369)
T KOG0665|consen  126 QMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT---LKILDFGLARTEDTDF-------MMTPY-------VVTRYYRAPEV  188 (369)
T ss_pred             HHHHHHHHHHhcceeecccCcccceecchhh---eeeccchhhcccCccc-------ccCch-------hheeeccCchh
Confidence            9999999999999999999999999976655   9999999986654430       01111       35778999999


Q ss_pred             cccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        197 IEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       197 ~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      +.+..+...+||||+||++.||++|+..|.+.
T Consensus       189 il~~~~ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  189 ILGMGYKENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             eeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence            99988999999999999999999999999973

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=1.8e-27  Score=225.18  Aligned_cols=185  Identities=21%  Similarity=0.285  Sum_probs=142.6

Q ss_pred             hHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCC
Q psy14626         11 TIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      +...+++.|.++.+|..........++++......    ....+|+..+++++||||++++++|.+.+..++||||++++
T Consensus       693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g  768 (968)
T PLN00113        693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN----SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK  768 (968)
T ss_pred             CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc----cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence            34456788888888877654333334443222211    11235688999999999999999999999999999999999


Q ss_pred             chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH---HCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         91 DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH---ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        91 ~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH---~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      +|.+++..       +++..+..++.|++.|+.|||   +.+++||||||+||+++.+..   .++. ++.......   
T Consensus       769 ~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~---~~~~-~~~~~~~~~---  834 (968)
T PLN00113        769 NLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE---PHLR-LSLPGLLCT---  834 (968)
T ss_pred             cHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc---eEEE-ecccccccc---
Confidence            99998852       788999999999999999999   669999999999999987654   4443 333211111   


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                    .....++..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus       835 --------------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~  880 (968)
T PLN00113        835 --------------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA  880 (968)
T ss_pred             --------------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence                          0112468899999999998899999999999999999999999864

>KOG3653|consensus

Probab=99.95  E-value=8.9e-27  Score=193.25  Aligned_cols=214  Identities=22%  Similarity=0.359  Sum_probs=162.9

Q ss_pred             cchHHHhhcccceeeEeeeccc-cCCCcccCChhccccchhHHHHHHHHHHHH--HcCCCChhhhhheeecCC----eEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAE-IEPASFGLPDERLNHYTTEADLKREATICH--MLKHPHVVELLETYSSEG----MLY   81 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~--~l~h~~i~~~~~~~~~~~----~~~   81 (249)
                      ..+..++++.|-|+.+|+.+-. -.++++.++...      .+.+++|-++..  .++|+||++|++.-..+.    .++
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhccCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            4667788888888888866533 344444444333      345555555544  448999999999886555    799


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC---------CceeecCCCCCeeeeecCCCCCeE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN---------DIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---------~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      +|++|.+.|+|.++|..+.     .++....+++..|+.||.|||+.         .|+|||||+.|||+..|..   +-
T Consensus       285 LVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT---cc  356 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT---CC  356 (534)
T ss_pred             EEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc---EE
Confidence            9999999999999998765     79999999999999999999963         5999999999999998887   89


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC-C-----CCcchHHHHHHHHHHHHhCC----
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-Y-----GKPVDIWAAGVLLHVLLTGT----  222 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~-----~~~~DiwslG~~l~el~~g~----  222 (249)
                      |+|||++........           ........||.+|||||++.+.- +     -.+.||||+|.+||||++..    
T Consensus       357 IaDFGLAl~~~p~~~-----------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~  425 (534)
T KOG3653|consen  357 IADFGLALRLEPGKP-----------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD  425 (534)
T ss_pred             eeccceeEEecCCCC-----------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence            999999987764321           11222367999999999997632 2     25799999999999999864    


Q ss_pred             --------CCCCC------ChHHHHHHHH--cCcccccccc
Q psy14626        223 --------LPFVG------SRDRLFQSIT--KGKLHILGCT  247 (249)
Q Consensus       223 --------~pf~~------~~~~~~~~i~--~g~~~~~~~~  247 (249)
                              +||..      +.+++.+.+.  ++++.+|..|
T Consensus       426 ~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W  466 (534)
T KOG3653|consen  426 PGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAW  466 (534)
T ss_pred             CCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhh
Confidence                    35552      2356665554  3678999877

>KOG2052|consensus

Probab=99.95  E-value=2.6e-27  Score=195.10  Aligned_cols=225  Identities=20%  Similarity=0.309  Sum_probs=170.4

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc--CCCChhhhhheeecC--
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML--KHPHVVELLETYSSE--   77 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~--   77 (249)
                      ||....+.++..+.++.|=|+.++.....-+....++..     ..+.....+|.++.+.+  +|+||+.|+++-..+  
T Consensus       205 VQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~-----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g  279 (513)
T KOG2052|consen  205 VQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFS-----SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNG  279 (513)
T ss_pred             hHHhhhheeEEEEEecCccccceeeccccCCceEEEEec-----ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence            566677788888888888888888777664332222211     23446678888888876  999999999887433  


Q ss_pred             --CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCCeeeeecCC
Q psy14626         78 --GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN--------DIIHRDIKPHCVLLANKEN  147 (249)
Q Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~--------~~vH~dlkp~Nili~~~~~  147 (249)
                        ..+++|++|-+.|||.|+|.+..     ++.+..++++..++.||.+||..        .|.|||||+.|||+.+++.
T Consensus       280 s~TQLwLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~  354 (513)
T KOG2052|consen  280 SWTQLWLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  354 (513)
T ss_pred             ceEEEEEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence              25899999999999999998743     89999999999999999999964        4999999999999998887


Q ss_pred             CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC------CCCcchHHHHHHHHHHHHhC
Q psy14626        148 SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK------YGKPVDIWAAGVLLHVLLTG  221 (249)
Q Consensus       148 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g  221 (249)
                         +-|+|+|++..-....         ....-..+.+.||-+|||||++...-      .-..+||||||.++||++-.
T Consensus       355 ---C~IADLGLAv~h~~~t---------~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  355 ---CCIADLGLAVRHDSDT---------DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             ---EEEeeceeeEEecccC---------CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence               8999999986655432         12233455668999999999986432      22569999999999998743


Q ss_pred             ----------CCCCCC---C---hHHHHHH--HHcCccccccccC
Q psy14626        222 ----------TLPFVG---S---RDRLFQS--ITKGKLHILGCTH  248 (249)
Q Consensus       222 ----------~~pf~~---~---~~~~~~~--i~~g~~~~~~~~~  248 (249)
                                ++||-+   +   .+++.+-  +++-++.+|..|+
T Consensus       423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~  467 (513)
T KOG2052|consen  423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWK  467 (513)
T ss_pred             hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccc
Confidence                      478876   1   2333332  5667788888773

>KOG0664|consensus

Probab=99.94  E-value=2.2e-28  Score=190.79  Aligned_cols=194  Identities=25%  Similarity=0.400  Sum_probs=152.8

Q ss_pred             HhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-----eEEEEEec
Q psy14626         14 EVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-----MLYMVFEY   86 (249)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~   86 (249)
                      .-|+=|-++++|...+-.+....++++.  ...+-...+.+.+|+.+|..++|.|++..+++.....     .+|+++|+
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            3455677888887777666655554432  2444566788999999999999999999999986543     36788898


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +. ++|...+..    +..++.+.++.++.||+.||+|||+.+|.||||||.|.|++.+   ..+||+|||+++-.....
T Consensus       139 mQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSN---CvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  139 MQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSN---CILKICDFGLARTWDQRD  210 (449)
T ss_pred             HH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccC---ceEEecccccccccchhh
Confidence            85 577666654    3448999999999999999999999999999999999999654   348999999997654422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .            ...-...-|.+|.|||.++|.. |+.+.||||+||++.|++..+..|..
T Consensus       211 ~------------~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA  260 (449)
T KOG0664|consen  211 R------------LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA  260 (449)
T ss_pred             h------------hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence            1            1112234678999999998854 79999999999999999999999987

>KOG1027|consensus

Probab=99.94  E-value=6e-27  Score=205.43  Aligned_cols=185  Identities=23%  Similarity=0.358  Sum_probs=145.3

Q ss_pred             hhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC  125 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L  125 (249)
                      ...+-.++|+.+|+.- +||||+++++.-.+.+..||..|+|.. +|.+++............-..+..+.|+++|+.+|
T Consensus       544 e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHL  622 (903)
T KOG1027|consen  544 EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHL  622 (903)
T ss_pred             HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHH
Confidence            3445678999999999 699999999999999999999999965 99999987411111111134567899999999999


Q ss_pred             HHCCceeecCCCCCeeeeecCC--CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCC
Q psy14626        126 HENDIIHRDIKPHCVLLANKEN--SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYG  203 (249)
Q Consensus       126 H~~~~vH~dlkp~Nili~~~~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  203 (249)
                      |+.+||||||||.||||...+.  ...++|+|||+|........          ..+......||.+|.|||++.....+
T Consensus       623 Hsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s----------S~~r~s~~sGt~GW~APE~L~~~~~~  692 (903)
T KOG1027|consen  623 HSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS----------SFSRLSGGSGTSGWQAPEQLREDRKT  692 (903)
T ss_pred             HhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc----------hhhcccCCCCcccccCHHHHhccccC
Confidence            9999999999999999987422  23489999999988765331          11223445699999999999988888


Q ss_pred             CcchHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHcCcccc
Q psy14626        204 KPVDIWAAGVLLHVLLT-GTLPFVGSRDRLFQSITKGKLHI  243 (249)
Q Consensus       204 ~~~DiwslG~~l~el~~-g~~pf~~~~~~~~~~i~~g~~~~  243 (249)
                      .++||||+||++|+.++ |..||....++ ..+|.+|..++
T Consensus       693 ~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NIl~~~~~L  732 (903)
T KOG1027|consen  693 QAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANILTGNYTL  732 (903)
T ss_pred             cccchhhcCceEEEEecCCccCCCchHHh-hhhhhcCccce
Confidence            99999999999999998 69999886543 23566666554

>KOG0668|consensus

Probab=99.94  E-value=1.8e-26  Score=175.87  Aligned_cols=196  Identities=22%  Similarity=0.412  Sum_probs=150.5

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheeecC--CeEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYSSE--GMLYM   82 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~l   82 (249)
                      .++.|.+...++.|=++.++...+-.. ..+.+  ..+-.+...+.+.+|+.+|+.|. +|||++++++..+.  ....+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~-~eK~V--iKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITN-NEKCV--IKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCC-CceEE--EeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            456888888888876666553322211 11111  12233455678999999999996 99999999999754  45789


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |+|++.+.+.......       ++...|+.++.++++||.|+|+.||.|||+||.|++++-..  .+++|+|+|++...
T Consensus       113 iFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~--rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHEL--RKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhh--ceeeeeecchHhhc
Confidence            9999988776544332       78899999999999999999999999999999999997543  34999999999666


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ....              ..+.+..+.+|..||.+..- .+..+-|+||+||+++.|+..+-||--
T Consensus       184 Hp~~--------------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh  235 (338)
T KOG0668|consen  184 HPGK--------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  235 (338)
T ss_pred             CCCc--------------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence            5533              22334567788999998764 468999999999999999998877763

>KOG1345|consensus

Probab=99.93  E-value=1.3e-26  Score=180.48  Aligned_cols=200  Identities=24%  Similarity=0.394  Sum_probs=152.6

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhhe-eecCCeEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLET-YSSEGMLYM   82 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~-~~~~~~~~l   82 (249)
                      |-.+-|+|.+.++.||++........-..-..++ +....-......|.+|...--.| -|.||+.-++. |++.+.+++
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivl-Kavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVL-KAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEe-eccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            3445799999999999998876655533222222 22223345678899998765555 48888887654 688888999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ++||++.|+|.+-+...+     +-+...+.++.|+++||.|+|++++||||||.+|||+-..+.. ++||+|||.++..
T Consensus       100 ~qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~-rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFY-RVKLCDFGLTRKV  173 (378)
T ss_pred             eeccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCcc-EEEeeeccccccc
Confidence            999999999977654432     7788889999999999999999999999999999999765433 6999999998776


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCcccccc---CC--CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QK--YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~--~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      +....+                ......|.+||.+..   +.  ..+.+|+|.||++++.+++|+.||..
T Consensus       174 g~tV~~----------------~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk  227 (378)
T KOG1345|consen  174 GTTVKY----------------LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK  227 (378)
T ss_pred             Cceehh----------------hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence            653321                124667888887642   22  46889999999999999999999996

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.93  E-value=3.5e-25  Score=196.99  Aligned_cols=209  Identities=18%  Similarity=0.242  Sum_probs=135.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC----CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhhee------ec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE----PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETY------SS   76 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~------~~   76 (249)
                      .+.|.+.+.++.|.++.+|.......    ...++++..  ......+...+|  .++...+.++..+...+      ..
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~--~~~~~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA--TEYGAVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEe--cccchhHHHHHH--HHHhhchhhHHHHHHhhhccccccc
Confidence            34788889999999999987766544    333443322  111111222221  11222233444443332      34


Q ss_pred             CCeEEEEEeccCCCchhHHHHHhhhc----------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCe
Q psy14626         77 EGMLYMVFEYMDGSDICFEIVRRATA----------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCV  140 (249)
Q Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Ni  140 (249)
                      +..+++|+||+.+++|.+++......                ........+..++.|++.||.|||+++++||||||+||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI  286 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI  286 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence            56799999999999998887643210                00122345778999999999999999999999999999


Q ss_pred             eeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC-------------------
Q psy14626        141 LLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-------------------  201 (249)
Q Consensus       141 li~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------------------  201 (249)
                      |++.+..  .++|+|||++........            .......+++.|+|||.+....                   
T Consensus       287 Ll~~~~~--~~KL~DFGlA~~l~~~~~------------~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~  352 (566)
T PLN03225        287 IFSEGSG--SFKIIDLGAAADLRVGIN------------YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLW  352 (566)
T ss_pred             EEeCCCC--cEEEEeCCCccccccccc------------cCCcccccCCCccChHHhhccCCCCCCccccccccccchhc
Confidence            9985322  299999999865433211            1112235788999999653221                   


Q ss_pred             ---CCCcchHHHHHHHHHHHHhCCCCCCCChHHHH
Q psy14626        202 ---YGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLF  233 (249)
Q Consensus       202 ---~~~~~DiwslG~~l~el~~g~~pf~~~~~~~~  233 (249)
                         +..++||||+||++|||+++..|+......+.
T Consensus       353 ~~~~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~  387 (566)
T PLN03225        353 QLNLPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFN  387 (566)
T ss_pred             cccCCCCcccHHHHHHHHHHHhCcCCCchHHHHHH
Confidence               23456999999999999998777655433333

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1.4e-24  Score=189.20  Aligned_cols=206  Identities=22%  Similarity=0.294  Sum_probs=140.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccc----------------cCCCcccCChhccccchhH--------------HHHHHHH
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAE----------------IEPASFGLPDERLNHYTTE--------------ADLKREA   56 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~--------------~~~~~E~   56 (249)
                      .+.|.+.++|+.|.++.+|.....                .....++++..........              +....|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            457889999999999998865320                0111122222222211222              2234477


Q ss_pred             HHHHHcCCCC-----hhhhhheeec--------CCeEEEEEeccCCCchhHHHHHhhhc--------------------C
Q psy14626         57 TICHMLKHPH-----VVELLETYSS--------EGMLYMVFEYMDGSDICFEIVRRATA--------------------G  103 (249)
Q Consensus        57 ~~l~~l~h~~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~  103 (249)
                      .++.+++|.+     +++++++|..        .+..++|+||+++++|.+++......                    .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            7777776554     4677777743        34689999999999999888643210                    1


Q ss_pred             CccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccC
Q psy14626        104 FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAG  183 (249)
Q Consensus       104 ~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (249)
                      ..+++..++.++.|++.+|.+||+.+++|+||||+||+++.++.   ++|+|||++........            ....
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~---~kL~DFGla~~~~~~~~------------~~~~  368 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---VKIIDFGAAVDMCTGIN------------FNPL  368 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc---EEEEeCcCccccccCCc------------cCcc
Confidence            12456788999999999999999999999999999999987665   99999999865433111            0111


Q ss_pred             CcccCCCCCCccccccCCC----------------------CCcchHHHHHHHHHHHHhCCC-CCCC
Q psy14626        184 HRIGTPHYMAPEVIEDQKY----------------------GKPVDIWAAGVLLHVLLTGTL-PFVG  227 (249)
Q Consensus       184 ~~~~~~~y~aPE~~~~~~~----------------------~~~~DiwslG~~l~el~~g~~-pf~~  227 (249)
                      ....++.|+|||.+.....                      ..+.|+||+||++++|++|.. ||..
T Consensus       369 ~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~  435 (507)
T PLN03224        369 YGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN  435 (507)
T ss_pred             ccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence            1234789999998754321                      124699999999999999875 7753

>KOG1167|consensus

Probab=99.92  E-value=3.8e-25  Score=181.27  Aligned_cols=209  Identities=24%  Similarity=0.334  Sum_probs=158.9

Q ss_pred             CcchHHHhhcccceeeEeeecccc---CCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI---EPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      +-|...+.++.|.+..++......   ...-++++..  ...+....+.+|+++|..+ .+.||+++.+.+..++..++|
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i--~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~iv  113 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAI--YRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIV  113 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeec--ccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEE
Confidence            346677778888887777655544   2223333332  3335677899999999999 599999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +||++.....++...       ++..+++++++.++.||.++|.+||||||+||+|+|++....  +-.|+|||+++...
T Consensus       114 lp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~--rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  114 LPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQ--RGVLVDFGLAQRYD  184 (418)
T ss_pred             ecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccC--CceEEechhHHHHH
Confidence            999998877666543       789999999999999999999999999999999999986543  37999999997221


Q ss_pred             CCC-c-cccC---------------------------Ccc--ccccccccCCcccCCCCCCcccccc-CCCCCcchHHHH
Q psy14626        164 DGQ-L-YCSG---------------------------GER--LDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAA  211 (249)
Q Consensus       164 ~~~-~-~~~~---------------------------~~~--~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl  211 (249)
                      ... . .+..                           ..+  ...........+||++|.|||++.. ...++++|+||.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            110 0 0000                           000  1122334455679999999999865 446899999999


Q ss_pred             HHHHHHHHhCCCCCCC
Q psy14626        212 GVLLHVLLTGTLPFVG  227 (249)
Q Consensus       212 G~~l~el~~g~~pf~~  227 (249)
                      |+++..+++++.||-.
T Consensus       265 GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFK  280 (418)
T ss_pred             cceeehhhcccccccc
Confidence            9999999999999987

>KOG1164|consensus

Probab=99.92  E-value=1.2e-24  Score=181.90  Aligned_cols=211  Identities=23%  Similarity=0.236  Sum_probs=163.3

Q ss_pred             cchHHHhhcccceeeEeeeccccCC-CcccCChhccccchhHHHHHHHHHHHHHcCC----CChhhhhhee-ecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEP-ASFGLPDERLNHYTTEADLKREATICHMLKH----PHVVELLETY-SSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h----~~i~~~~~~~-~~~~~~~l   82 (249)
                      +|++...++.|.++.+|...+.... ..++++.+..........+..|..++..+..    +++..+++.. ..+...++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999877765443 2333333333322333378899999999963    6899999988 47778899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC--CCCeEEcCcceeE
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN--SAPVKLGGFGVAI  160 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~--~~~~~l~dfg~~~  160 (249)
                      ||+.+ |.+|.++.....  ...|+..++..++.|++.+|++||+.|++||||||.|+++.....  ...+.++|||+++
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            99998 789998775554  445999999999999999999999999999999999999986542  2459999999997


Q ss_pred             --EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 --QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                        .........     ............||..|+|+.++.+...+++.|+||++.++.++..|..||.+
T Consensus       176 ~~~~~~~~~~~-----~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~  239 (322)
T KOG1164|consen  176 RFKYVGDSGGN-----LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEA  239 (322)
T ss_pred             cccccCCCCcc-----cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence              322221100     00011111234599999999999999999999999999999999999999987

>KOG0576|consensus

Probab=99.91  E-value=8.6e-26  Score=194.10  Aligned_cols=221  Identities=24%  Similarity=0.342  Sum_probs=183.1

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .||+..|...+++++|.++.+|+..+.......+++...+.-..+..-+++|+-+++..+||||+.+++.+.....+++.
T Consensus        11 rnP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   11 RNPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             cCCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            58999999999999999999987776655554444444444446667788999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+.||+|++.-.-.+.    +++.++...+++.+++++|||++|-+|||||-.||++++.+.   +++.|||.+-.+.
T Consensus        91 MEycgggslQdiy~~Tgp----lselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD---vklaDfgvsaqit  163 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD---VKLADFGVSAQIT  163 (829)
T ss_pred             EEecCCCcccceeeeccc----chhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc---eeecccCchhhhh
Confidence            999999999886655444    899999999999999999999999999999999999998877   9999999987776


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ...             .+..++.||++|+|||+..   ...+...+|+|++|++-.|+-.-++|-.. ...+.....++.
T Consensus       164 ati-------------~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS  230 (829)
T KOG0576|consen  164 ATI-------------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS  230 (829)
T ss_pred             hhh-------------hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc
Confidence            644             2445567999999999853   45578999999999999999887777665 555555566666


Q ss_pred             ccccc
Q psy14626        240 KLHIL  244 (249)
Q Consensus       240 ~~~~~  244 (249)
                      -++-|
T Consensus       231 ~~qpp  235 (829)
T KOG0576|consen  231 GFQPP  235 (829)
T ss_pred             CCCCC
Confidence            65555

>KOG1163|consensus

Probab=99.91  E-value=7.2e-25  Score=168.25  Aligned_cols=225  Identities=16%  Similarity=0.215  Sum_probs=172.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .+|++...|+.|-++..|....-......+++.+..+  ....++..|..+.+.|+ ...|+.+..+..+...-.+||++
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            3566666667776666654443333333343333322  33456888999999996 46888888888888889999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      + |.+|.++..-....   |+.++++.++-|++..++|+|.++++||||||+|+|+.-+..+.++.++|||++....+..
T Consensus        93 L-GPsLEdLfnfC~R~---ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRR---FTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             c-CccHHHHHHHHhhh---hhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            9 78998887755443   8999999999999999999999999999999999999988888889999999997766543


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----ChHHHHHHHHcCccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----SRDRLFQSITKGKLH  242 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----~~~~~~~~i~~g~~~  242 (249)
                      ....-..+      +.....||-+|+|-..+.+...+.+.|+-|+|.+|.+.--|..||.+    +..+-++.|...+..
T Consensus       169 t~~HIpyr------e~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  169 TRQHIPYR------EDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             ccccCccc------cCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            32222111      12233589999999999988889999999999999999999999998    345678888887766


Q ss_pred             cc
Q psy14626        243 IL  244 (249)
Q Consensus       243 ~~  244 (249)
                      .|
T Consensus       243 ~~  244 (341)
T KOG1163|consen  243 TP  244 (341)
T ss_pred             CC
Confidence            66

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.91  E-value=9.3e-25  Score=202.38  Aligned_cols=163  Identities=17%  Similarity=0.184  Sum_probs=115.9

Q ss_pred             HcCC-CChhhhhheee-------cCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCcee
Q psy14626         61 MLKH-PHVVELLETYS-------SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIH  132 (249)
Q Consensus        61 ~l~h-~~i~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH  132 (249)
                      .++| +||.+++++|.       .+..++.++|++ +++|.+++....   ..++..+++.++.||+.||.|||++||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIVNAAHSQGIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            4456 68888999882       334577888987 559999886432   23899999999999999999999999999


Q ss_pred             ecCCCCCeeeeecCC----------------CCCeEEcCcceeEEccCCCcccc-C--CccccccccccCCcccCCCCCC
Q psy14626        133 RDIKPHCVLLANKEN----------------SAPVKLGGFGVAIQLQDGQLYCS-G--GERLDHYTTKAGHRIGTPHYMA  193 (249)
Q Consensus       133 ~dlkp~Nili~~~~~----------------~~~~~l~dfg~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~y~a  193 (249)
                      |||||+|||++..+.                ...++++|||+++.......... .  ...............+|+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999964322                22356667766644221100000 0  0000000111112357889999


Q ss_pred             ccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        194 PEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       194 PE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ||++.+..++.++||||+||+||||++|..|+..
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence            9999998899999999999999999999998865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.91  E-value=5.1e-23  Score=160.27  Aligned_cols=152  Identities=38%  Similarity=0.606  Sum_probs=130.4

Q ss_pred             hHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH
Q psy14626         48 TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE  127 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~  127 (249)
                      ..+.+.+|+..++.++|++++++++++......++++|++.+++|.+++....   ..++...+..++.+++.++.+||+
T Consensus        34 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~  110 (215)
T cd00180          34 LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLHS  110 (215)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45789999999999999999999999999899999999999899998887652   237899999999999999999999


Q ss_pred             CCceeecCCCCCeeeee-cCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCc
Q psy14626        128 NDIIHRDIKPHCVLLAN-KENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKP  205 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~-~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~  205 (249)
                      .+++|+||+|+||+++. ++.   ++|+||+.+........             ..........|++||..... ..+.+
T Consensus       111 ~~~~H~dl~~~ni~~~~~~~~---~~l~d~~~~~~~~~~~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~  174 (215)
T cd00180         111 NGIIHRDLKPENILLDSDNGK---VKLADFGLSKLLTSDKS-------------LLKTIVGTPAYMAPEVLLGKGYYSEK  174 (215)
T ss_pred             CCeeccCCCHhhEEEeCCCCc---EEEecCCceEEccCCcc-------------hhhcccCCCCccChhHhcccCCCCch
Confidence            99999999999999987 554   99999999876654321             11122467889999998876 77899


Q ss_pred             chHHHHHHHHHHH
Q psy14626        206 VDIWAAGVLLHVL  218 (249)
Q Consensus       206 ~DiwslG~~l~el  218 (249)
                      .|+|++|++++++
T Consensus       175 ~D~~~lg~~~~~l  187 (215)
T cd00180         175 SDIWSLGVILYEL  187 (215)
T ss_pred             hhhHHHHHHHHHH
Confidence            9999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1165|consensus

Probab=99.90  E-value=2.4e-23  Score=166.56  Aligned_cols=221  Identities=18%  Similarity=0.247  Sum_probs=177.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      -.|+++..|+.|-|++.+..++-+.....+++.+-..  +..-+++.|-...+.| ..++|+..+-+-.++.+..+|+|+
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            3688888899988888776666666555666555444  3445688999999999 589999998777888888999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC--CCeEEcCcceeEEccC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS--APVKLGGFGVAIQLQD  164 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~--~~~~l~dfg~~~~~~~  164 (249)
                      + |.||.|+....+..   |+.+++..++.||+.-++++|++.+|+|||||+|+||...+..  ..+.++|||.+....+
T Consensus       106 L-GPSLEDLFD~CgR~---FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRR---FSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCc---ccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9 78999999887765   9999999999999999999999999999999999999864432  4589999999988776


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----ChHHHHHHHHcCc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----SRDRLFQSITKGK  240 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----~~~~~~~~i~~g~  240 (249)
                      .......+.+      +..+..||-+|||-.-+.|...+++.|+-|||-++.+.+-|.+||.+    +..+-++.|-..+
T Consensus       182 p~TkqHIPYr------E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  182 PKTKQHIPYR------EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             ccccccCccc------cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            5443322222      23344589999999999999999999999999999999999999998    3445666664443

>KOG1290|consensus

Probab=99.88  E-value=1.6e-22  Score=168.73  Aligned_cols=133  Identities=23%  Similarity=0.309  Sum_probs=101.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-----C---CChhhhhheeec---
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-----H---PHVVELLETYSS---   76 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~~i~~~~~~~~~---   76 (249)
                      .||.+...++=|-|.++|...+.....-.+++... ....=.+....|+.+|++++     +   .+||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            47777777776778888877766543333322111 11122356789999999993     2   479999999963   


Q ss_pred             -CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH-HCCceeecCCCCCeeeee
Q psy14626         77 -EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLAN  144 (249)
Q Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH-~~~~vH~dlkp~Nili~~  144 (249)
                       +.++|||+|++ |.+|..+|....-++  ++...++.|+.|++.||.||| .+||||.||||+|||+..
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~YrG--lpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~  223 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNYRG--LPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS  223 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCCCC--CcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence             45799999999 668888888776655  899999999999999999999 569999999999999854

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.87  E-value=7.9e-22  Score=150.70  Aligned_cols=106  Identities=29%  Similarity=0.311  Sum_probs=90.7

Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      |+|.+++..+..   .+++.+++.++.|++.||.|||+++      ||+||+++.++.   +++  ||.+.......   
T Consensus         1 GsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~---~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVRGR---PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL---LKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc---eee--ccceEeecccc---
Confidence            578888875432   3899999999999999999999998      999999987665   777  99887654421   


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                     ..+++.|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus        64 ---------------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~  106 (176)
T smart00750       64 ---------------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE  106 (176)
T ss_pred             ---------------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence                           1378999999999999999999999999999999999999986

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=8e-20  Score=151.19  Aligned_cols=221  Identities=32%  Similarity=0.419  Sum_probs=161.8

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCC-ChhhhhheeecCCeEEEEEeccC
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHP-HVVELLETYSSEGMLYMVFEYMD   88 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~   88 (249)
                      |.+.+.++.|.++.++........+...+.............+.+|+.++..+.|+ +++++.+.+......+++++++.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            33444555555566665555522333333333333334678899999999999887 79999999987777899999999


Q ss_pred             CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626         89 GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                      ++++.+.+...... ..++......++.|++.++.++|..+++|+|+||+||+++..+.  .++++|||.+.........
T Consensus        82 ~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~--~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR--VVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--eEEEeccCcceecCCCCcc
Confidence            99998555544311 23889999999999999999999999999999999999987652  2899999998754432210


Q ss_pred             ccCCccccccccccCCcccCCCCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCCCh-----HHHHHHHHcCc
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLTGTLPFVGSR-----DRLFQSITKGK  240 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~pf~~~~-----~~~~~~i~~g~  240 (249)
                      ....       .......++..|++||.+.+   .......|+||+|++++++++|..||....     ....+.+....
T Consensus       159 ~~~~-------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         159 SSIP-------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cccc-------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            0000       12234468999999999987   567899999999999999999999988743     35555554443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.7e-20  Score=157.48  Aligned_cols=169  Identities=18%  Similarity=0.199  Sum_probs=116.4

Q ss_pred             CcchHHHhhcccceeeEeeecccc-CCCcccCChhccc-----cchhHHHHHHHHHHHHHcCCCChhh-hhheeecCCeE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI-EPASFGLPDERLN-----HYTTEADLKREATICHMLKHPHVVE-LLETYSSEGML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~   80 (249)
                      .+|.+.++++.|.++.+|...... ....++++.....     .....+.+.+|+.+|+.++|+|+++ +++    .+..
T Consensus        18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~   93 (365)
T PRK09188         18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKD   93 (365)
T ss_pred             CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCc
Confidence            479999999999999998765432 2222233221111     2234667999999999999999885 433    2458


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecC-CCCCeeeeecCCCCCeEEcCccee
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDI-KPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dl-kp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      ++||||++|++|.. .  . .    ..   ...++.+++.+|.+||+.|++|||| ||+|||++.++.   ++|+|||++
T Consensus        94 ~LVmE~~~G~~L~~-~--~-~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~---ikLiDFGlA  159 (365)
T PRK09188         94 GLVRGWTEGVPLHL-A--R-P----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGE---AAVIDFQLA  159 (365)
T ss_pred             EEEEEccCCCCHHH-h--C-c----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCC---EEEEECccc
Confidence            99999999998852 1  1 0    11   1467889999999999999999999 999999976655   999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCcccccc
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED  199 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  199 (249)
                      +........    ........ -....+++.|+|||.+..
T Consensus       160 ~~~~~~~~~----~~~~~~~d-~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        160 SVFRRRGAL----YRIAAYED-LRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eecccCcch----hhhhhhhh-hhhhhccCccCCcccCCh
Confidence            876542200    00000000 012346778899998853

>KOG1240|consensus

Probab=99.81  E-value=7.8e-21  Score=171.68  Aligned_cols=158  Identities=20%  Similarity=0.276  Sum_probs=124.9

Q ss_pred             HHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceee
Q psy14626         54 REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHR  133 (249)
Q Consensus        54 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~  133 (249)
                      .|++ ...+++||.+++.-........|+|-+|... +|.|++..+..    +..-+.++|+-|++.||...|..|++||
T Consensus        71 ~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~gVcHG  144 (1431)
T KOG1240|consen   71 EEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKLGVCHG  144 (1431)
T ss_pred             HHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence            3444 4445899999999998888888999999965 99999988876    8889999999999999999999999999


Q ss_pred             cCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc----------CC-C
Q psy14626        134 DIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED----------QK-Y  202 (249)
Q Consensus       134 dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----------~~-~  202 (249)
                      |||.+|||+..-+.   +.|+||....+.--.   ..+..++..   .+.......+|.|||.+..          .+ .
T Consensus       145 DIKsENILiTSWNW---~~LtDFAsFKPtYLP---eDNPadf~f---FFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L  215 (1431)
T KOG1240|consen  145 DIKSENILITSWNW---LYLTDFASFKPTYLP---EDNPADFTF---FFDTSRRRTCYIAPERFVSALGKTSVGQDAPLL  215 (1431)
T ss_pred             ccccceEEEeeech---hhhhcccccCCccCC---CCCcccceE---EEecCCceeeecChHhhhccccccccCCccccc
Confidence            99999999998887   899999876433211   111122222   2222235679999998753          12 5


Q ss_pred             CCcchHHHHHHHHHHHHh-CCCCCC
Q psy14626        203 GKPVDIWAAGVLLHVLLT-GTLPFV  226 (249)
Q Consensus       203 ~~~~DiwslG~~l~el~~-g~~pf~  226 (249)
                      +++.||||+||+++||++ |++||.
T Consensus       216 ~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  216 TPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             ChhhhhhhhhHHHHHHHhcCCCccc
Confidence            789999999999999999 999996

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=6.5e-20  Score=143.95  Aligned_cols=170  Identities=11%  Similarity=0.079  Sum_probs=118.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc---cccchhHHH------HHHHHHHHHHcCCCChhhhhheeecC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LNHYTTEAD------LKREATICHMLKHPHVVELLETYSSE   77 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~------~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (249)
                      +.||++..+++++.++.++.....  ...++++...   .......+.      +.+|+..+.+++|++|+.+..++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            458889999999888888765443  2223332221   122222222      68999999999999999998886532


Q ss_pred             --------CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC
Q psy14626         78 --------GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus        78 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~  149 (249)
                              +..+++|||++|.+|.+...        +++.    .+.+++.++..+|..|++|+|++|+||+++.++   
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---
Confidence                    35789999999999876521        3332    456899999999999999999999999997644   


Q ss_pred             CeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHH
Q psy14626        150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL  219 (249)
Q Consensus       150 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  219 (249)
                       ++++|||..........                   .      ...+....+..++|+||||+++.-..
T Consensus       173 -i~liDfg~~~~~~e~~a-------------------~------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKA-------------------K------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhh-------------------H------HHHHHHhHhcccccccceeEeehHHH
Confidence             89999998744322110                   0      01223334557899999999987543

>KOG0603|consensus

Probab=99.79  E-value=1.5e-20  Score=161.67  Aligned_cols=166  Identities=31%  Similarity=0.519  Sum_probs=143.3

Q ss_pred             HHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC
Q psy14626         51 DLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND  129 (249)
Q Consensus        51 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~  129 (249)
                      .-..|-.++..++ ||.+++++..|+.++..++++++..|+.|...+.....    +++.....+...++.++.++|+.+
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l~  117 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKLG  117 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchhH
Confidence            4445667777775 99999999999999999999999999998877766655    888899999999999999999999


Q ss_pred             ceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHH
Q psy14626        130 IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW  209 (249)
Q Consensus       130 ~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw  209 (249)
                      ++|+|+|++||+++.+|.   +++.|||.++........                 .|+.-|+|||.+.  ....++|.|
T Consensus       118 iiyrd~k~enilld~~Gh---i~~tdfglske~v~~~~~-----------------cgt~eymApEI~~--gh~~a~D~w  175 (612)
T KOG0603|consen  118 IAYRDYKLENVLLLLEGH---IKLTDFGLSKEAVKEKIA-----------------CGTYEYRAPEIIN--GHLSAADWW  175 (612)
T ss_pred             HHHhcccccceeecccCc---cccCCchhhhHhHhhhhc-----------------ccchhhhhhHhhh--ccCCcccch
Confidence            999999999999998887   999999998776553321                 3799999999998  446889999


Q ss_pred             HHHHHHHHHHhCCCCCCCChHHHHHHHHcCcccccc
Q psy14626        210 AAGVLLHVLLTGTLPFVGSRDRLFQSITKGKLHILG  245 (249)
Q Consensus       210 slG~~l~el~~g~~pf~~~~~~~~~~i~~g~~~~~~  245 (249)
                      |+|+++++|++|..||..   ++..+|.+.++.+|.
T Consensus       176 s~gvl~felltg~~pf~~---~~~~~Il~~~~~~p~  208 (612)
T KOG0603|consen  176 SFGVLAFELLTGTLPFGG---DTMKRILKAELEMPR  208 (612)
T ss_pred             hhhhhHHHHhhCCCCCch---HHHHHHhhhccCCch
Confidence            999999999999999987   677788887777774

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=9.6e-19  Score=136.65  Aligned_cols=140  Identities=15%  Similarity=0.177  Sum_probs=102.9

Q ss_pred             HHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-----CCCChhhhhheeecCC---eEE-E
Q psy14626         12 IHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-----KHPHVVELLETYSSEG---MLY-M   82 (249)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-l   82 (249)
                      -.++|+.|.++.+|.   ....+.+.++..........+.+.+|+.+++.+     +||||++++++++++.   .++ +
T Consensus         6 ~~~~LG~G~~~~Vy~---hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          6 EQSPLGTGRHRKCYA---HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CcceecCCCceEEEE---CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            346788888888884   222333444433433344567899999999999     5799999999998763   434 7


Q ss_pred             EEec--cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHH-HHHHHCCceeecCCCCCeeeeecC-CCCCeEEcC-cc
Q psy14626         83 VFEY--MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL-RYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGG-FG  157 (249)
Q Consensus        83 v~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l-~~LH~~~~vH~dlkp~Nili~~~~-~~~~~~l~d-fg  157 (249)
                      |+||  +.+++|.+++... .    +++.  ..++.+++.++ +|||+++|+|+||||+|||++..+ ....++|+| ||
T Consensus        83 I~e~~G~~~~tL~~~l~~~-~----~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-R----YEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-c----ccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  5578999999542 1    5555  35678888887 899999999999999999998644 234699999 55


Q ss_pred             eeEE
Q psy14626        158 VAIQ  161 (249)
Q Consensus       158 ~~~~  161 (249)
                      ....
T Consensus       156 ~~~~  159 (210)
T PRK10345        156 ESTF  159 (210)
T ss_pred             Ccce
Confidence            5433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=4e-19  Score=136.94  Aligned_cols=197  Identities=16%  Similarity=0.112  Sum_probs=125.5

Q ss_pred             HHHhhcccceeeEeeeccccCCCc-ccCChhccc-cchhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccC
Q psy14626         12 IHEVINHKWLKMKLHTSAEIEPAS-FGLPDERLN-HYTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMD   88 (249)
Q Consensus        12 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~   88 (249)
                      +..++..+.|+.++.....-.... ..+...... .......+.+|+++|++++ ++++++++++    +..+++|+|+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            456677777777763333111111 011111110 1112336899999999995 5889999875    34799999999


Q ss_pred             CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecC-CCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         89 GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDI-KPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dl-kp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      |.+|......          . ...++.|++.+|+++|++|++|+|| ||+|||++.++.   ++|+|||.+........
T Consensus        82 G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~---i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         82 GAAMYQRPPR----------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS---PAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             CccHHhhhhh----------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC---EEEEECCCceecCCcch
Confidence            9888543211          1 1346789999999999999999999 799999987665   99999999975543221


Q ss_pred             ccc--CCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        168 YCS--GGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       168 ~~~--~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ...  ..++.+...+..  ...++.+++|+...-  .+.-.+.+.++.|+-+|.++|+..|.-++
T Consensus       148 ~~r~L~~rDl~~llk~~--~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        148 WMRLLAREDLRHLLKHK--RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHHH--HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            000  000111111111  124667777765432  22236789999999999999988776553

>KOG0590|consensus

Probab=99.78  E-value=1.3e-19  Score=161.34  Aligned_cols=159  Identities=23%  Similarity=0.476  Sum_probs=130.3

Q ss_pred             HHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCce
Q psy14626         52 LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDII  131 (249)
Q Consensus        52 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~v  131 (249)
                      +..|..+-..+.|||++.....+.+.....-.|||+++ +|...+.....    ++..++..++.|++.|++|+|+.|+.
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~----~~~~e~~c~fKqL~~Gv~y~h~~Gia  442 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK----LTPLEADCFFKQLLRGVKYLHSMGLA  442 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc----cchhhhhHHHHHHHHHHHHHHhcCce
Confidence            66777777888999999998888777666656999999 99888776533    88899999999999999999999999


Q ss_pred             eecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCC-CcchHHH
Q psy14626        132 HRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYG-KPVDIWA  210 (249)
Q Consensus       132 H~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Diws  210 (249)
                      |+|+|++|+++..++.   ++|+|||.+....-.-         +..........|+..|+|||.+.+..+. ...||||
T Consensus       443 hrdlK~enll~~~~g~---lki~Dfg~~~vf~~~~---------e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS  510 (601)
T KOG0590|consen  443 HRDLKLENLLVTENGI---LKIIDFGAASVFRYPW---------EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWS  510 (601)
T ss_pred             eccCccccEEEecCCc---eEEeecCcceeeccCc---------chhhhhhcCcccCCcCcCcccccccccCcchhhhhh
Confidence            9999999999988765   9999999874432211         1111222334588999999999999885 5699999


Q ss_pred             HHHHHHHHHhCCCCCCC
Q psy14626        211 AGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       211 lG~~l~el~~g~~pf~~  227 (249)
                      .|+++..|.+|+.||..
T Consensus       511 ~~ii~~~m~~~~~~Wk~  527 (601)
T KOG0590|consen  511 CGIIYICMILGRFPWKV  527 (601)
T ss_pred             ccceEEEEecCCCcccc
Confidence            99999999999999996

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.76  E-value=2.2e-18  Score=133.17  Aligned_cols=101  Identities=14%  Similarity=0.169  Sum_probs=78.4

Q ss_pred             HHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH-HHCCc
Q psy14626         52 LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC-HENDI  130 (249)
Q Consensus        52 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L-H~~~~  130 (249)
                      ..+|+.++..+.++++...... .... .++||||++|+++........    .++..++..++.|++.+|.++ |+.|+
T Consensus        66 ~~~E~~~l~~l~~~~v~~p~~~-~~~~-~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~gi  139 (190)
T cd05147          66 AEKEMRNLKRLVTAGIPCPEPI-LLKS-HVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDCRL  139 (190)
T ss_pred             HHHHHHHHHHHHHCCCCCCcEE-EecC-CEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3459999999988776443322 2222 389999999877654433222    388999999999999999999 79999


Q ss_pred             eeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       131 vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      +|+||||+||+++. +.   ++|+|||++...
T Consensus       140 iHrDlkP~NIli~~-~~---v~LiDFG~a~~~  167 (190)
T cd05147         140 VHADLSEYNLLYHD-GK---LYIIDVSQSVEH  167 (190)
T ss_pred             ccCCCCHHHEEEEC-Cc---EEEEEccccccC
Confidence            99999999999973 33   999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1166|consensus

Probab=99.74  E-value=6.1e-18  Score=154.54  Aligned_cols=197  Identities=19%  Similarity=0.181  Sum_probs=151.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc---cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN---HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      +..|.|...++.|.++.+|...... ...++++.....   ..-.-.+++..+.  .+ --+.|+.+.......+.-++|
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk--~~-~~~~~~~~~~a~~~~~~S~lv  772 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK--PQ-MLPSIMHISSAHVFQNASVLV  772 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc--hh-hhcchHHHHHHHccCCcceee
Confidence            4578888899999999888776665 445555544422   2233333443333  11 135778888777777888999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec----CCCCCeEEcCccee
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK----ENSAPVKLGGFGVA  159 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~----~~~~~~~l~dfg~~  159 (249)
                      ++|.+.|+|.+++..    ...+++..+..+..||+..+++||..+||||||||+|+++...    ....-++|+|||.+
T Consensus       773 ~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s  848 (974)
T KOG1166|consen  773 SEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS  848 (974)
T ss_pred             eeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence            999999999999873    3348999999999999999999999999999999999999643    12334899999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGT  222 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~  222 (249)
                      ..+.....           .+.+.....|..+-++|...|.+|+...|.|+++.+++-|+.|+
T Consensus       849 iDm~lfp~-----------~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  849 IDMKLFPD-----------GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             eeeeEcCC-----------CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            66654331           23445556788999999999999999999999999999999986

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.72  E-value=3.9e-17  Score=126.47  Aligned_cols=104  Identities=15%  Similarity=0.136  Sum_probs=81.2

Q ss_pred             HHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CC
Q psy14626         51 DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-ND  129 (249)
Q Consensus        51 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~  129 (249)
                      .+.+|...+.++.++++.....+....  .++||||++|+++........    .++...+..++.|++.++.++|. .|
T Consensus        65 ~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~g  138 (190)
T cd05145          65 WAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEAG  138 (190)
T ss_pred             HHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            456899999999998875544433322  489999998875543322222    27788999999999999999999 99


Q ss_pred             ceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626        130 IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus       130 ~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ++|+||||+||+++ ++.   ++|+|||++.....
T Consensus       139 ivHrDlkP~NIll~-~~~---~~liDFG~a~~~~~  169 (190)
T cd05145         139 LVHGDLSEYNILYH-DGK---PYIIDVSQAVELDH  169 (190)
T ss_pred             EecCCCChhhEEEE-CCC---EEEEEcccceecCC
Confidence            99999999999997 444   99999999866544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158|consensus

Probab=99.71  E-value=5.7e-17  Score=133.19  Aligned_cols=152  Identities=24%  Similarity=0.392  Sum_probs=114.6

Q ss_pred             CCCChhhhhheeec---------------------------CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHH
Q psy14626         63 KHPHVVELLETYSS---------------------------EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYM  115 (249)
Q Consensus        63 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~  115 (249)
                      .||||+++.+.|.+                           +..+|+||...+. +|..++-.+.     .+......++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence            49999999998843                           2458999999875 8988887665     4667778899


Q ss_pred             HHHHHHHHHHHHCCceeecCCCCCeeeeec-CCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCc
Q psy14626        116 RQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAP  194 (249)
Q Consensus       116 ~ql~~~l~~LH~~~~vH~dlkp~Nili~~~-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  194 (249)
                      .|+++|..|||.+|+.|||+|++|||+.-+ +...++.++|||++--..... .     ++ .+.+..-..-|+-..+||
T Consensus       348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hG-l-----ql-py~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHG-L-----QL-PYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccc-c-----cc-ccccccccCCCcceecch
Confidence            999999999999999999999999999744 445668999999984333210 0     01 111112223367788999


Q ss_pred             cccccCC-----C-CCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        195 EVIEDQK-----Y-GKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       195 E~~~~~~-----~-~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      |+....+     . -.++|.|+.|.+-||+++...||-+
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            9975332     1 2479999999999999999999987

>KOG0195|consensus

Probab=99.68  E-value=1.6e-16  Score=124.70  Aligned_cols=179  Identities=18%  Similarity=0.303  Sum_probs=135.6

Q ss_pred             chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH
Q psy14626         46 YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC  125 (249)
Q Consensus        46 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L  125 (249)
                      ......|..|.-.|+-+.||||..+++.|.....+.++..||+.|+|...+....  +...+..+..+++.+++.|+.||
T Consensus       228 ~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t--~vvvd~sqav~faldiargmafl  305 (448)
T KOG0195|consen  228 ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQT--SVVVDHSQAVRFALDIARGMAFL  305 (448)
T ss_pred             hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCc--cEEEecchHHHHHHHHHhhHHHH
Confidence            3344567888888888899999999999999999999999999999998886543  45678889999999999999999


Q ss_pred             HHCC--ceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCC-
Q psy14626        126 HEND--IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-  202 (249)
Q Consensus       126 H~~~--~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-  202 (249)
                      |+..  +.---|++..++++.+-. .++-.+|--++....                    .+.-++.|+|||.+...+- 
T Consensus       306 hslep~ipr~~lns~hvmidedlt-arismad~kfsfqe~--------------------gr~y~pawmspealqrkped  364 (448)
T KOG0195|consen  306 HSLEPMIPRFYLNSKHVMIDEDLT-ARISMADTKFSFQEV--------------------GRAYSPAWMSPEALQRKPED  364 (448)
T ss_pred             hhcchhhhhhhcccceEEecchhh-hheecccceeeeecc--------------------ccccCcccCCHHHHhcCchh
Confidence            9874  334467888899987654 224444544432211                    1235789999999986553 


Q ss_pred             --CCcchHHHHHHHHHHHHhCCCCCCC-ChHH--HHHHHHcCcccccccc
Q psy14626        203 --GKPVDIWAAGVLLHVLLTGTLPFVG-SRDR--LFQSITKGKLHILGCT  247 (249)
Q Consensus       203 --~~~~DiwslG~~l~el~~g~~pf~~-~~~~--~~~~i~~g~~~~~~~~  247 (249)
                        -.++|+|||++++||+.|...||.. +.-+  +.-++..=+.++|+..
T Consensus       365 ~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgi  414 (448)
T KOG0195|consen  365 LNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGI  414 (448)
T ss_pred             cchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCc
Confidence              3579999999999999999999998 4333  2333444567777654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.66  E-value=9.9e-17  Score=129.73  Aligned_cols=200  Identities=18%  Similarity=0.201  Sum_probs=124.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCC----------CChhhhhheee
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKH----------PHVVELLETYS   75 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h----------~~i~~~~~~~~   75 (249)
                      .+..++.|+.+..+.++...+.-....++++   ..........+.+++|......+.+          -.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4556677777777777766666544433332   2223334567788888766655422          23333333332


Q ss_pred             c---------C---C-----eEEEEEeccCCCchhHHHHH---hhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecC
Q psy14626         76 S---------E---G-----MLYMVFEYMDGSDICFEIVR---RATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDI  135 (249)
Q Consensus        76 ~---------~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dl  135 (249)
                      .         .   .     ..+++|+-+. ++|.+.+..   .......+.......+..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            1         1   1     2367888885 488766543   2222222445555667799999999999999999999


Q ss_pred             CCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc--------CCCCCcch
Q psy14626        136 KPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--------QKYGKPVD  207 (249)
Q Consensus       136 kp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~D  207 (249)
                      +|+|++++.++.   +.|+||+.....+.....                ...+..|.+||....        ..++.+.|
T Consensus       172 ~~~nfll~~~G~---v~Lg~F~~~~r~g~~~~~----------------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D  232 (288)
T PF14531_consen  172 KPENFLLDQDGG---VFLGDFSSLVRAGTRYRC----------------SEFPVAFTPPELESCAGQFGQNNAPYTFATD  232 (288)
T ss_dssp             SGGGEEE-TTS----EEE--GGGEEETTEEEEG----------------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred             ceeeEEEcCCCC---EEEcChHHHeecCceeec----------------cCCCcccCChhhhhhhcccCcccceeeeccC
Confidence            999999998877   999999987666542210                124577899997643        24688999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCC
Q psy14626        208 IWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       208 iwslG~~l~el~~g~~pf~~~  228 (249)
                      .|+||+++|.|..+..||...
T Consensus       233 aW~LG~~ly~lWC~~lPf~~~  253 (288)
T PF14531_consen  233 AWQLGITLYSLWCGRLPFGLS  253 (288)
T ss_dssp             HHHHHHHHHHHHHSS-STCCC
T ss_pred             HHHHHHHHHHHHHccCCCCCC
Confidence            999999999999999999973

>KOG1023|consensus

Probab=99.65  E-value=4.9e-16  Score=133.38  Aligned_cols=163  Identities=17%  Similarity=0.280  Sum_probs=130.2

Q ss_pred             HHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCc-eeecCCC
Q psy14626         59 CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDI-IHRDIKP  137 (249)
Q Consensus        59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~-vH~dlkp  137 (249)
                      |+.+.|.|+.++++.+..++..+.|.+|+..|+|.+.+....   ..++..-...++++++.|+.|||...+ .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecc
Confidence            456789999999999999999999999999999999988743   338888889999999999999997654 9999999


Q ss_pred             CCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC-------CCCcchHHH
Q psy14626        138 HCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-------YGKPVDIWA  210 (249)
Q Consensus       138 ~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~Diws  210 (249)
                      .|++++..   +.+|++|||+.........      .     ..........-|.|||.+++..       .+++.|+||
T Consensus        78 ~nClvd~~---w~lklt~~Gl~~~~~~~~~------~-----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs  143 (484)
T KOG1023|consen   78 SNCLVDSR---WVLKLTDFGLNSLLEETAE------P-----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYS  143 (484)
T ss_pred             ccceeeee---EEEEechhhhccccccccc------c-----cccchhHHHHhccCHHHhcccccccccccccccCCeeh
Confidence            99999654   4499999999866643110      0     0111112456789999987642       367799999


Q ss_pred             HHHHHHHHHhCCCCCCC-----ChHHHHHHHHc
Q psy14626        211 AGVLLHVLLTGTLPFVG-----SRDRLFQSITK  238 (249)
Q Consensus       211 lG~~l~el~~g~~pf~~-----~~~~~~~~i~~  238 (249)
                      +|++++|+++.+.||..     +.+++...+.+
T Consensus       144 ~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~  176 (484)
T KOG1023|consen  144 FGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK  176 (484)
T ss_pred             HHHHHHHHHhccCccccccccCChHHHHHHHHh
Confidence            99999999999999996     23467777777

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=3.5e-15  Score=132.90  Aligned_cols=138  Identities=16%  Similarity=0.133  Sum_probs=102.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCC-Cccc-CChh----ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEP-ASFG-LPDE----RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~----~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +|...+.++.|.++.+|........ ..+. ..+.    ........+.+.+|+.+++.++|++++....++......++
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            4456778888888888863322111 1111 1111    11122334678999999999999999888777777667899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||++|++|.+++.            ....++.+++.+|.+||+.+++|+||||+||+++ ++.   ++|+|||.+...
T Consensus       414 v~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~~---~~liDFGla~~~  477 (535)
T PRK09605        414 VMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DDR---LYLIDFGLGKYS  477 (535)
T ss_pred             EEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CCc---EEEEeCcccccC
Confidence            999999999987764            2356889999999999999999999999999993 344   899999998554

>smart00090 RIO RIO-like kinase

Probab=99.64  E-value=6.1e-16  Score=123.53  Aligned_cols=142  Identities=13%  Similarity=0.088  Sum_probs=98.5

Q ss_pred             cchHHHhhcccceeeEeeec-cccCCCcccCChhcccc----------------------c--hhHHHHHHHHHHHHHcC
Q psy14626          9 RITIHEVINHKWLKMKLHTS-AEIEPASFGLPDERLNH----------------------Y--TTEADLKREATICHMLK   63 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~----------------------~--~~~~~~~~E~~~l~~l~   63 (249)
                      -|.+.+.++.|.++.+|... +......++++......                      +  .....+.+|+.+++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47888999999999888775 22222233332211110                      0  01234678999999997


Q ss_pred             CC--ChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC-ceeecCCCCCe
Q psy14626         64 HP--HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND-IIHRDIKPHCV  140 (249)
Q Consensus        64 h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~-~vH~dlkp~Ni  140 (249)
                      +.  .++++++   .. ..++||||++|.+|........    .+...++..++.|++.++.+||+.| ++|+||||+||
T Consensus       109 ~~~i~~p~~~~---~~-~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIA---WR-RNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeE---ec-CceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence            53  3334443   22 3589999999887765432222    2566677899999999999999999 99999999999


Q ss_pred             eeeecCCCCCeEEcCcceeEEc
Q psy14626        141 LLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       141 li~~~~~~~~~~l~dfg~~~~~  162 (249)
                      +++ ++.   ++|+|||.+...
T Consensus       181 li~-~~~---i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGK---VVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCC---EEEEEChhhhcc
Confidence            998 444   999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.60  E-value=7.1e-15  Score=115.53  Aligned_cols=101  Identities=21%  Similarity=0.248  Sum_probs=86.3

Q ss_pred             HHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC
Q psy14626         49 EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN  128 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~  128 (249)
                      ...+.+|+.++..+.|++++....++......+++|||++|++|.+.+...       .. ....++.+++.++.++|+.
T Consensus        43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~  114 (211)
T PRK14879         43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA  114 (211)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC
Confidence            456889999999999999888777776777789999999999998887542       22 7788999999999999999


Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +++|+|++|.||+++ ++.   ++++|||.+..
T Consensus       115 ~i~H~Dl~p~Nil~~-~~~---~~liDf~~a~~  143 (211)
T PRK14879        115 GIIHGDLTTSNMILS-GGK---IYLIDFGLAEF  143 (211)
T ss_pred             CcccCCCCcccEEEE-CCC---EEEEECCcccC
Confidence            999999999999998 343   89999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.58  E-value=1.2e-14  Score=113.32  Aligned_cols=98  Identities=16%  Similarity=0.246  Sum_probs=80.4

Q ss_pred             HHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC
Q psy14626         49 EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN  128 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~  128 (249)
                      .+.+.+|+.++..++++++....-++......++|||+++|++|.+.+.....           .++.+++.+|.+||+.
T Consensus        41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-----------~~~~~i~~~l~~lH~~  109 (199)
T TIGR03724        41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-----------ELLREIGRLVGKLHKA  109 (199)
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-----------HHHHHHHHHHHHHHHC
Confidence            46788999999999888766555555556667899999999999877643211           6889999999999999


Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      |++|+|++|.||+++ ++.   ++++|||.+..
T Consensus       110 gi~H~Dl~~~Nil~~-~~~---~~liDfg~a~~  138 (199)
T TIGR03724       110 GIVHGDLTTSNIIVR-DDK---LYLIDFGLGKY  138 (199)
T ss_pred             CeecCCCCcceEEEE-CCc---EEEEECCCCcC
Confidence            999999999999998 444   89999998754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033|consensus

Probab=99.55  E-value=1.1e-15  Score=129.54  Aligned_cols=128  Identities=28%  Similarity=0.508  Sum_probs=104.0

Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      ++++.|+++...+|.+.+..+.... .-+......|..|+..+++|   ++.+|+|+||.||+...+..   ++|+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e-~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q---~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGE-ERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ---LKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCccc-ccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh---hhhhhhhh
Confidence            5789999999999999997554433 25677888999999999999   99999999999999987765   89999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT  220 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~  220 (249)
                      .........   .    .+..+..-...+|..|++||++.+..++.++||||||++|+|++.
T Consensus       403 ~ts~~~~~~---~----~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDET---V----APAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCc---c----cchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            877665330   0    011122223358999999999999999999999999999999997

>KOG0606|consensus

Probab=99.51  E-value=1.2e-14  Score=131.95  Aligned_cols=124  Identities=34%  Similarity=0.600  Sum_probs=96.2

Q ss_pred             HHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc---ccCCccc-cccccccCCcccCCCCCC
Q psy14626        118 VLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY---CSGGERL-DHYTTKAGHRIGTPHYMA  193 (249)
Q Consensus       118 l~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~~~y~a  193 (249)
                      ++.+++|||+.|++|+|+||+|.+|..-++   +++.|||+++...-....   ....+.. ..+..  ....+|+.|.|
T Consensus       152 mvla~Eylh~ygivhrdlkpdnllIT~mGh---iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~d--KqvcgTPeyia  226 (1205)
T KOG0606|consen  152 MVLAVEYLHSYGIVHRDLKPDNLLITSMGH---IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQD--KQVCGTPEYIA  226 (1205)
T ss_pred             hhHHhHhhccCCeecCCCCCCcceeeeccc---ccccchhhhhhhhhhccchhhhcchHHHHHHhhh--ccccCCccccC
Confidence            377899999999999999999999988777   999999988655432111   0000000 01111  11248999999


Q ss_pred             ccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccccc
Q psy14626        194 PEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILGC  246 (249)
Q Consensus       194 PE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~~  246 (249)
                      ||++....|+..+|.|++|+++||.+-|+.||.+ +.++++..+..-....|+.
T Consensus       227 PeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~  280 (1205)
T KOG0606|consen  227 PEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE  280 (1205)
T ss_pred             hhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence            9999989999999999999999999999999999 6788888888888777754

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.49  E-value=9.1e-14  Score=111.22  Aligned_cols=103  Identities=16%  Similarity=0.183  Sum_probs=79.3

Q ss_pred             hhHHHHHHHHHHHHHcCCCCh--hhhhheeecC-C---eEEEEEeccCC-CchhHHHHHhhhcCCccCHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLKHPHV--VELLETYSSE-G---MLYMVFEYMDG-SDICFEIVRRATAGFVYSEAVASHYMRQVL  119 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~h~~i--~~~~~~~~~~-~---~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~  119 (249)
                      .....+.+|+.++..++|+++  ++.++..... +   ..++|||+++| .+|.+++...     .++...    +.+++
T Consensus        82 ~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~~----~~~i~  152 (239)
T PRK01723         82 LERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA-----PLSEEQ----WQAIG  152 (239)
T ss_pred             hhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHHH----HHHHH
Confidence            345678999999999988775  6666664332 2   23599999997 6887776432     245443    56899


Q ss_pred             HHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        120 EALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       120 ~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      .++.+||+.|++|+||||.|||++.++.   ++|+|||.+..
T Consensus       153 ~~l~~lH~~GI~HrDlkp~NILv~~~~~---v~LIDfg~~~~  191 (239)
T PRK01723        153 QLIARFHDAGVYHADLNAHNILLDPDGK---FWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHHCCCCCCCCCchhEEEcCCCC---EEEEECCCccc
Confidence            9999999999999999999999987664   99999998733

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.47  E-value=1.6e-13  Score=106.84  Aligned_cols=135  Identities=16%  Similarity=0.193  Sum_probs=93.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhcccc----------------------chhHHHHHHHHHHHHHcCCCC
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH----------------------YTTEADLKREATICHMLKHPH   66 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~~   66 (249)
                      .|.+.+.++.|.++.+|..... ....++++......                      ........+|..++..+.+++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            4778888989888888765543 22222222110000                      012234678899999997764


Q ss_pred             --hhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeee
Q psy14626         67 --VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN  144 (249)
Q Consensus        67 --i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~  144 (249)
                        ++..++    ....++|||+++|++|.....          ......++.+++.++.++|+.|++|+||+|+||+++.
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~  160 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD  160 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence              343332    234689999999988865422          1334578899999999999999999999999999987


Q ss_pred             cCCCCCeEEcCcceeEE
Q psy14626        145 KENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       145 ~~~~~~~~l~dfg~~~~  161 (249)
                      ++.   ++|+|||.+..
T Consensus       161 ~~~---~~liDfg~~~~  174 (198)
T cd05144         161 DEK---IYIIDWPQMVS  174 (198)
T ss_pred             CCc---EEEEECCcccc
Confidence            655   99999998843

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1243|consensus

Probab=99.44  E-value=1.8e-12  Score=113.29  Aligned_cols=149  Identities=22%  Similarity=0.364  Sum_probs=115.8

Q ss_pred             hhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH  126 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH  126 (249)
                      ...+...+-+.-|+.++||||+++++.++..+++|+|+|-+.  .|..++...       ....+...+.||+.||.+||
T Consensus        51 ~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~~v~~Gl~qIl~AL~FL~  121 (690)
T KOG1243|consen   51 EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKEEVCLGLFQILAALSFLN  121 (690)
T ss_pred             hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHHHHHHHHHHHHHHHHHHh
Confidence            445667888899999999999999999999999999999985  666677653       46667788999999999998


Q ss_pred             -HCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCc
Q psy14626        127 -ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP  205 (249)
Q Consensus       127 -~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  205 (249)
                       +++++|+|+.-+.|+++..+.   ++|++|..+........             ..........|..|+.+....  -.
T Consensus       122 ~d~~lvHgNv~~~SVfVn~~Ge---WkLggle~v~~~~~~~~-------------~~~~~~~~~s~~~P~~~~~s~--~s  183 (690)
T KOG1243|consen  122 DDCNLVHGNVCKDSVFVNESGE---WKLGGLELVSKASGFNA-------------PAKSLYLIESFDDPEEIDPSE--WS  183 (690)
T ss_pred             ccCCeeeccEeeeeEEEcCCCc---EEEeeeEEEeccccCCc-------------ccccchhhhcccChhhcCccc--cc
Confidence             678999999999999988877   99999988755444221             001111233456666554333  34


Q ss_pred             chHHHHHHHHHHHHhCC
Q psy14626        206 VDIWAAGVLLHVLLTGT  222 (249)
Q Consensus       206 ~DiwslG~~l~el~~g~  222 (249)
                      .|.|.|||++++++.|.
T Consensus       184 ~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  184 IDSWGLGCLIEELFNGS  200 (690)
T ss_pred             hhhhhHHHHHHHHhCcc
Confidence            69999999999999993

>KOG1266|consensus

Probab=99.41  E-value=1.2e-12  Score=105.60  Aligned_cols=155  Identities=17%  Similarity=0.233  Sum_probs=115.6

Q ss_pred             HHHHcCCCChhhhhheeecCC-----eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--c
Q psy14626         58 ICHMLKHPHVVELLETYSSEG-----MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--I  130 (249)
Q Consensus        58 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~  130 (249)
                      -|-++.|.||++++.++.+.+     ...+++||+..+++..+|++.......+....+++|+.||++||.|||+..  +
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            344556999999999996543     478999999999999999988888888999999999999999999999885  9


Q ss_pred             eeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHH
Q psy14626        131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWA  210 (249)
Q Consensus       131 vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  210 (249)
                      +|+++..+.|++..++-   +++..-.... ..........        .+.....+.++|.+||.-.....+..+|||+
T Consensus       200 ihgnlTc~tifiq~ngL---Ikig~~ap~s-~h~s~~~~~~--------~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~  267 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGL---IKIGSVAPDS-THPSVNSTRE--------AEKSVNTSLPGFSAPESGTTTNTTGASDIYK  267 (458)
T ss_pred             ccCCcchhheeecCCce---EEecccCccc-cchhhhhhhH--------hhhhccccCCccccCCcCcccccccchhhhh
Confidence            99999999999974432   5544322111 1111110110        1111123567899999877777788999999


Q ss_pred             HHHHHHHHHhCCCC
Q psy14626        211 AGVLLHVLLTGTLP  224 (249)
Q Consensus       211 lG~~l~el~~g~~p  224 (249)
                      +|++..+|..+..-
T Consensus       268 fgmcAlemailEiq  281 (458)
T KOG1266|consen  268 FGMCALEMAILEIQ  281 (458)
T ss_pred             hhHHHHHHHHheec
Confidence            99999999987653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.39  E-value=6.8e-13  Score=98.03  Aligned_cols=98  Identities=24%  Similarity=0.342  Sum_probs=82.3

Q ss_pred             HHHHHHHHHHHHHcCC--CChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH
Q psy14626         49 EADLKREATICHMLKH--PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH  126 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH  126 (249)
                      ...+.+|+.+++.+++  .++++++..+..++..+++||++.+.++..+           +......++.+++.++..+|
T Consensus        35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh  103 (155)
T cd05120          35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLH  103 (155)
T ss_pred             hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHh
Confidence            5678999999999976  5899998888887889999999988766432           34556678899999999999


Q ss_pred             HC---CceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626        127 EN---DIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus       127 ~~---~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ..   +++|+|++|.||+++..+.   ++++||+.+.
T Consensus       104 ~~~~~~i~H~Dl~~~Nil~~~~~~---~~l~Df~~~~  137 (155)
T cd05120         104 QLPLLVLCHGDLHPGNILVDDGKI---LGIIDWEYAG  137 (155)
T ss_pred             CCCceEEEecCCCcceEEEECCcE---EEEEeccccc
Confidence            74   6999999999999987544   9999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590|consensus

Probab=99.37  E-value=6.8e-14  Score=125.05  Aligned_cols=168  Identities=31%  Similarity=0.516  Sum_probs=134.2

Q ss_pred             chhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHH
Q psy14626         46 YTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY  124 (249)
Q Consensus        46 ~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~  124 (249)
                      ....+.+..|..+=+.+. |+|++.+++........++++++..|+++.+-+..  ......+......+..|+..++.|
T Consensus        61 ~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~  138 (601)
T KOG0590|consen   61 EDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSY  138 (601)
T ss_pred             cchhhhcCccccccccccccccccccCCccCCCcccccccCccccccccccccc--CCccCCCCcchhhhhhhhccCccc
Confidence            445566667877777776 99999999999999999999999999988776631  111135667778899999999999


Q ss_pred             HH-HCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCccc-CCCCCCccccccCC-
Q psy14626        125 CH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIG-TPHYMAPEVIEDQK-  201 (249)
Q Consensus       125 LH-~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~y~aPE~~~~~~-  201 (249)
                      +| ..++.|+|++|+|.+++..+.  ..++.|||++........          .........+ ++.|.|||...+.. 
T Consensus       139 ~H~~~~~~h~~ikP~n~~l~~s~~--~l~~~df~~At~~~~~~g----------~~~~~~~~~g~s~~y~a~E~~~~~~~  206 (601)
T KOG0590|consen  139 LHPENGVTHRDIKPSNSLLDESGS--ALKIADFGLATAYRNKNG----------AERSLKDRCGSSPPYGAPEHLSGKAY  206 (601)
T ss_pred             cCcccccccCCCCCccchhccCCC--cccCCCchhhccccccCC----------cceeeecccCCCCCCCCcccccchhh
Confidence            99 999999999999999987762  289999999977665210          1122223346 89999999998854 


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        202 YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       202 ~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..+..|+||.|+++..+++|..||..
T Consensus       207 ~~~~~d~~S~g~~l~~~~~g~~p~~~  232 (601)
T KOG0590|consen  207 RGPSVDVWSLGIVLSAMLTGELPWDF  232 (601)
T ss_pred             cCCCcccccccccccccccCCCCccc
Confidence            47889999999999999999999986

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.24  E-value=2.9e-11  Score=93.15  Aligned_cols=97  Identities=16%  Similarity=0.224  Sum_probs=67.2

Q ss_pred             HHHHHHHHHcCCCC--hhhhhheeecCCeEEEEEeccCCCchhH-HHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-C
Q psy14626         53 KREATICHMLKHPH--VVELLETYSSEGMLYMVFEYMDGSDICF-EIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-N  128 (249)
Q Consensus        53 ~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~  128 (249)
                      ..|...+..+.+..  +++.++.    ...++||||++++.+.. .+... .    . ...+..++.+++.++.++|. .
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~----~-~~~~~~~~~~~~~~l~~lh~~~  134 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-R----L-LEDPEELYDQILELMRKLYREA  134 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-h----h-cccHHHHHHHHHHHHHHHhhcc
Confidence            35555666664332  3333332    23689999999854321 11111 1    1 15678899999999999999 9


Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +++|+||+|+||+++ ++.   ++++|||.+....
T Consensus       135 ~ivH~Dl~p~Nili~-~~~---~~liDfg~a~~~~  165 (187)
T cd05119         135 GLVHGDLSEYNILVD-DGK---VYIIDVPQAVEID  165 (187)
T ss_pred             CcCcCCCChhhEEEE-CCc---EEEEECccccccc
Confidence            999999999999998 444   8999999985543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606|consensus

Probab=99.21  E-value=6.5e-12  Score=114.47  Aligned_cols=179  Identities=25%  Similarity=0.411  Sum_probs=134.5

Q ss_pred             cCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCee
Q psy14626         62 LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL  141 (249)
Q Consensus        62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nil  141 (249)
                      ..+|.+++..-.+......+++++|..+++|...+...+.    .+.+-.+.....+..++++||...+.|+|++|+|++
T Consensus       861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l  936 (1205)
T KOG0606|consen  861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLL  936 (1205)
T ss_pred             CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccchhhcccccccchh
Confidence            3456667666666667789999999999999887776553    455566777888889999999998999999999999


Q ss_pred             eeecCCCCCeEEcCcceeEEccCCCc--------cccCCccc------cccc----cccCCcccCCCCCCccccccCCCC
Q psy14626        142 LANKENSAPVKLGGFGVAIQLQDGQL--------YCSGGERL------DHYT----TKAGHRIGTPHYMAPEVIEDQKYG  203 (249)
Q Consensus       142 i~~~~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~------~~~~----~~~~~~~~~~~y~aPE~~~~~~~~  203 (249)
                      ...++.   ..+.||+.....+....        ......++      ....    .......+|+.|.+||...+....
T Consensus       937 ~~~~gh---~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen  937 IAYDGH---RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred             hcccCC---cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence            987776   78888873332221100        00000000      0001    123344589999999999999999


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccccc
Q psy14626        204 KPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILGCT  247 (249)
Q Consensus       204 ~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~~~  247 (249)
                      ..+|.|+.|++++|.++|.+||.. ..+++.+.|.++....|..+
T Consensus      1014 s~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~ 1058 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGP 1058 (1205)
T ss_pred             CcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCc
Confidence            999999999999999999999999 67889999999998888665

>KOG3087|consensus

Probab=99.19  E-value=1.5e-10  Score=86.71  Aligned_cols=117  Identities=21%  Similarity=0.229  Sum_probs=88.6

Q ss_pred             cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCC-CchhHHHHHhhhcCCccCHHHHHHHHHHHHHH
Q psy14626         43 LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG-SDICFEIVRRATAGFVYSEAVASHYMRQVLEA  121 (249)
Q Consensus        43 ~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~  121 (249)
                      ++..-...+-.+|+.+|.++.--.|.-..=+|.+...-++.||+++| .++.+++.......  ........++..+=..
T Consensus        48 LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~  125 (229)
T KOG3087|consen   48 LDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGEL  125 (229)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHH
Confidence            33344566788899999988644444444456666667899999987 47788877665443  2333336788889899


Q ss_pred             HHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       122 l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +.-||..+++||||..+||++..++....+.++|||++..
T Consensus       126 igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  126 IGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999999999999999999999988877779999999744

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.18  E-value=1.4e-10  Score=89.44  Aligned_cols=99  Identities=12%  Similarity=0.176  Sum_probs=73.3

Q ss_pred             HHHHHHHHHcCC--CChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH-HHCC
Q psy14626         53 KREATICHMLKH--PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC-HEND  129 (249)
Q Consensus        53 ~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L-H~~~  129 (249)
                      .+|+..|+++..  -++++.+..    ...++||||+.+..+........    .++..++..+..+++.++..| |..|
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g  145 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN  145 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            489999999953  456666654    44789999997654422111111    155666778889999999988 8999


Q ss_pred             ceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626        130 IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       130 ~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ++||||++.||++.. +.   +.|+|||.+....
T Consensus       146 lVHGDLs~~NIL~~~-~~---v~iIDF~qav~~~  175 (197)
T cd05146         146 LVHADLSEYNMLWHD-GK---VWFIDVSQSVEPT  175 (197)
T ss_pred             eecCCCCHHHEEEEC-Cc---EEEEECCCceeCC
Confidence            999999999999964 33   8999999875554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601|consensus

Probab=99.13  E-value=3.8e-11  Score=103.80  Aligned_cols=165  Identities=21%  Similarity=0.249  Sum_probs=128.6

Q ss_pred             hHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHH----HH
Q psy14626         48 TEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE----AL  122 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~----~l  122 (249)
                      ....=.+|+..-+++ .|++.++.+..+..++..++-+|++. .+|..+....   ...++...++....+...    |+
T Consensus       160 ~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al  235 (524)
T KOG0601|consen  160 DSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTAL  235 (524)
T ss_pred             ccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccc
Confidence            334445677777777 49999999999999999999999995 5776655443   233788889999999999    99


Q ss_pred             HHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCC
Q psy14626        123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY  202 (249)
Q Consensus       123 ~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  202 (249)
                      .++|..+++|.|++|.||++..+...  ++++||+....+.+..........        ....+...|++||...+. +
T Consensus       236 ~~~hs~~~~~~~~kp~~i~~~~~~~s--~~~~df~~v~~i~~~~~~~~~~~~--------~r~~~~~~Y~~ke~~~~l-~  304 (524)
T KOG0601|consen  236 SHLHSNNIVHDDLKPANIFTTSDWTS--CKLTDFGLVSKISDGNFSSVFKVS--------KRPEGDCIYAAKELLNGL-A  304 (524)
T ss_pred             cccCCCcccccccchhheecccccce--eecCCcceeEEccCCccccceeee--------ecCCCCceEeChhhhccc-c
Confidence            99999999999999999999887322  899999999988876543222111        111467789999998865 5


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        203 GKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       203 ~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      +..+|++|+|.+..+...+..+...
T Consensus       305 ~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  305 TFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             chHhhhcchhhhhHhhHhhcccccC
Confidence            8899999999999998887655544

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=2.6e-10  Score=85.58  Aligned_cols=104  Identities=18%  Similarity=0.243  Sum_probs=79.7

Q ss_pred             cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHH
Q psy14626         43 LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL  122 (249)
Q Consensus        43 ~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (249)
                      ++..-..++-.+|+.++.++.--.|....=+..+.....++|||++|..|.+.+...       .    ..++..+=.-+
T Consensus        37 LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~----~~~~r~vG~~v  105 (204)
T COG3642          37 LDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------R----PDLLREVGRLV  105 (204)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------c----hHHHHHHHHHH
Confidence            443445667788999999996555555554566667788999999998888887654       1    23555666667


Q ss_pred             HHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       123 ~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      .-||..|++||||+++||++.+++    +.++|||++..
T Consensus       106 g~lH~~givHGDLTtsNiIl~~~~----i~~IDfGLg~~  140 (204)
T COG3642         106 GKLHKAGIVHGDLTTSNIILSGGR----IYFIDFGLGEF  140 (204)
T ss_pred             HHHHhcCeecCCCccceEEEeCCc----EEEEECCcccc
Confidence            789999999999999999998654    89999999843

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.08  E-value=1.1e-09  Score=88.95  Aligned_cols=109  Identities=17%  Similarity=0.101  Sum_probs=80.7

Q ss_pred             HHHHHHHHHHHcCCCChhhh--hheeec-----CCeEEEEEeccCCC-chhHHHHHhhhcCCccCHHHHHHHHHHHHHHH
Q psy14626         51 DLKREATICHMLKHPHVVEL--LETYSS-----EGMLYMVFEYMDGS-DICFEIVRRATAGFVYSEAVASHYMRQVLEAL  122 (249)
Q Consensus        51 ~~~~E~~~l~~l~h~~i~~~--~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (249)
                      .+.+|...+..+..-+|...  +++.+.     ...-++|||++++. +|.+++......  ..+......++.+++..+
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~--~~~~~~~~~ll~~la~~i  151 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN--PPDPRLKRMLIKRVATMV  151 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc--CCCHHHHHHHHHHHHHHH
Confidence            57789998888854444333  445532     22468999999876 788887543221  245677788999999999


Q ss_pred             HHHHHCCceeecCCCCCeeeeec----CCCCCeEEcCcceeEE
Q psy14626        123 RYCHENDIIHRDIKPHCVLLANK----ENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       123 ~~LH~~~~vH~dlkp~Nili~~~----~~~~~~~l~dfg~~~~  161 (249)
                      ..||+.|++|+|++++|||++.+    +....+.++||+.++.
T Consensus       152 ~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        152 RDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99999999999999999999852    2234589999998753

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.04  E-value=3.7e-10  Score=85.47  Aligned_cols=92  Identities=18%  Similarity=0.269  Sum_probs=67.5

Q ss_pred             HHHHHHHHHHHHcCCCC-hhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC
Q psy14626         50 ADLKREATICHMLKHPH-VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN  128 (249)
Q Consensus        50 ~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~  128 (249)
                      ..+.+|+.+++.+.+.+ +++++.....  ..++|||+++|.++...     .    ..   ...++.+++.++..||..
T Consensus        37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~~l~~~-----~----~~---~~~~~~~l~~~l~~LH~~  102 (170)
T cd05151          37 INRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGSELLTE-----D----FS---DPENLEKIAKLLKKLHSS  102 (170)
T ss_pred             cCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCCccccc-----c----cc---CHHHHHHHHHHHHHHhCC
Confidence            35678999999985444 4455544332  34799999999877532     0    11   123567899999999998


Q ss_pred             Cc-----eeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626        129 DI-----IHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus       129 ~~-----vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      ++     +|+|++|.||+++ ++.   ++++||+.+
T Consensus       103 ~~~~~~~~HgD~~~~Nil~~-~~~---~~liDf~~a  134 (170)
T cd05151         103 PLPDLVPCHNDLLPGNFLLD-DGR---LWLIDWEYA  134 (170)
T ss_pred             CCCCceeecCCCCcCcEEEE-CCe---EEEEecccc
Confidence            85     9999999999998 333   899999986

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3741|consensus

Probab=98.97  E-value=8e-09  Score=88.52  Aligned_cols=167  Identities=19%  Similarity=0.283  Sum_probs=118.5

Q ss_pred             EeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec----CCeEEEEEeccCC-CchhHHHHH
Q psy14626         24 KLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS----EGMLYMVFEYMDG-SDICFEIVR   98 (249)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l~~   98 (249)
                      .|+....++...|.++..-..+.........-++.++++.|+|+|++.++|.+    ...+++|++|.++ ++|.++-..
T Consensus       292 tyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~  371 (655)
T KOG3741|consen  292 TYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFA  371 (655)
T ss_pred             eEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHcc
Confidence            34444455555555554422222222233456788999999999999999963    3468999999985 356555443


Q ss_pred             hhh-----------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         99 RAT-----------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        99 ~~~-----------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ...           .+...++..++.++.|+..||..+|+.|+..+-|.|.+|+++++..   ++|+..|+...+.... 
T Consensus       372 ~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~R---IriS~C~i~Dvl~~d~-  447 (655)
T KOG3741|consen  372 NPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMR---IRISGCGIMDVLQEDP-  447 (655)
T ss_pred             CCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcce---EEEecccceeeecCCC-
Confidence            222           1334778999999999999999999999999999999999987765   8888888775554421 


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  223 (249)
                                              .+|  +   .-..+-|.-.||.++..|.+|.-
T Consensus       448 ------------------------~~~--l---e~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  448 ------------------------TEP--L---ESQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             ------------------------Ccc--h---hHHhhhhHHHHHHHHHHHhhccc
Confidence                                    001  0   12367899999999999999854

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.96  E-value=2.7e-09  Score=92.70  Aligned_cols=105  Identities=18%  Similarity=0.274  Sum_probs=70.7

Q ss_pred             HHHHHHHHHHHcC----CCChhhhhhee-ecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHH-HHHH
Q psy14626         51 DLKREATICHMLK----HPHVVELLETY-SSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE-ALRY  124 (249)
Q Consensus        51 ~~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~-~l~~  124 (249)
                      .+.+|+..+.++.    +.+-+.+-..+ ...+..++||||++|.+|.+........   .+   ...++..++. .+..
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~~---~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---LD---RKALAENLARSFLNQ  272 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---CC---HHHHHHHHHHHHHHH
Confidence            3566776666662    22222222222 2234468999999999998766432211   22   2345555555 4678


Q ss_pred             HHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626        125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus       125 LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      +|..|++|+|++|.||+++.++.   ++++|||.+.....
T Consensus       273 l~~~g~~H~D~hPgNilv~~~g~---i~liDfG~~~~l~~  309 (437)
T TIGR01982       273 VLRDGFFHADLHPGNIFVLKDGK---IIALDFGIVGRLSE  309 (437)
T ss_pred             HHhCCceeCCCCcccEEECCCCc---EEEEeCCCeeECCH
Confidence            89999999999999999987665   99999999977754

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.95  E-value=6e-09  Score=81.61  Aligned_cols=112  Identities=15%  Similarity=0.164  Sum_probs=85.0

Q ss_pred             hhHHHHHHHHHHHHHcCCC--ChhhhhheeecCC----eEEEEEeccCCC-chhHHHHHhhhcCCccCHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLKHP--HVVELLETYSSEG----MLYMVFEYMDGS-DICFEIVRRATAGFVYSEAVASHYMRQVL  119 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~ql~  119 (249)
                      -......+|...+..+..-  ..++.+++.+...    ..++|+|.+++. +|.+++.....    .+......++.+++
T Consensus        53 ~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   53 LRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALA  128 (206)
T ss_pred             ccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHH
Confidence            3445678888888888533  3455555554422    358999999874 78877765333    45667788999999


Q ss_pred             HHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        120 EALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       120 ~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ..+.-||+.|++|+|+++.|||++.++....+.++||+.+...
T Consensus       129 ~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  129 RLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999999999999998874455999999987543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=4.1e-09  Score=80.88  Aligned_cols=104  Identities=20%  Similarity=0.240  Sum_probs=68.0

Q ss_pred             chhHHHHHHHHHHHHHcCCC--ChhhhhheeecCCeEEEEEeccC--CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHH
Q psy14626         46 YTTEADLKREATICHMLKHP--HVVELLETYSSEGMLYMVFEYMD--GSDICFEIVRRATAGFVYSEAVASHYMRQVLEA  121 (249)
Q Consensus        46 ~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~  121 (249)
                      .......++|...|+++..-  ++++.+.+-    ..++||||++  |..+.... ...     ++......++.+++..
T Consensus        49 ~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~-~~~-----~~~~~~~~~~~~il~~  118 (188)
T PF01163_consen   49 YLIREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLK-DVD-----LSPEEPKELLEEILEE  118 (188)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHH-HCG-----GGGSTHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHH-hcc-----ccchhHHHHHHHHHHH
Confidence            44567789999999999755  566666442    2479999998  65554332 221     1233445677778775


Q ss_pred             HHH-HHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626        122 LRY-CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       122 l~~-LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +.. +|..|++||||.+.||+++.+ .   +.++|||.+....
T Consensus       119 ~~~~~~~~givHGDLs~~NIlv~~~-~---~~iIDf~qav~~~  157 (188)
T PF01163_consen  119 IIKMLHKAGIVHGDLSEYNILVDDG-K---VYIIDFGQAVDSS  157 (188)
T ss_dssp             HHHHHHCTTEEESS-STTSEEEETT-C---EEE--GTTEEETT
T ss_pred             HHHHHHhcCceecCCChhhEEeecc-e---EEEEecCcceecC
Confidence            544 579999999999999999875 3   9999999875544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.88  E-value=1.7e-08  Score=84.81  Aligned_cols=147  Identities=18%  Similarity=0.240  Sum_probs=104.5

Q ss_pred             EEEEEeccCCCc-hhHHHH--HhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         80 LYMVFEYMDGSD-ICFEIV--RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        80 ~~lv~e~~~~~~-L~~~l~--~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      +.++|+.+.|.. ...+..  .+....-.+.+...++.++.++.+...||..|.+-||.+++|+|+++++.   +.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~---V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK---VVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce---EEEEcc
Confidence            778898887642 111111  11111223677889999999999999999999999999999999988777   888887


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHh-CCCCCCCC--
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLT-GTLPFVGS--  228 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~-g~~pf~~~--  228 (249)
                      +..+...+...              ..-..+...|.+||.-.     +..-+...|.|.||+++++++. |+.||++-  
T Consensus       162 Dsfqi~~ng~~--------------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~  227 (637)
T COG4248         162 DSFQINANGTL--------------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL  227 (637)
T ss_pred             cceeeccCCce--------------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc
Confidence            66555433221              11224778899999865     3345678999999999999998 59999971  


Q ss_pred             ----hHHHHHHHHcCcccc
Q psy14626        229 ----RDRLFQSITKGKLHI  243 (249)
Q Consensus       229 ----~~~~~~~i~~g~~~~  243 (249)
                          .......|..|.+.+
T Consensus       228 ~~~ap~p~E~~Ia~g~f~y  246 (637)
T COG4248         228 ISDAPNPLETDIAHGRFAY  246 (637)
T ss_pred             cCCCCCcchhhhhcceeee
Confidence                123344677776543

>KOG0601|consensus

Probab=98.87  E-value=1.1e-09  Score=94.91  Aligned_cols=186  Identities=20%  Similarity=0.234  Sum_probs=130.1

Q ss_pred             hcccceeeEeeeccc-cCCCcccCChhc--cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCCc
Q psy14626         16 INHKWLKMKLHTSAE-IEPASFGLPDER--LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSD   91 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (249)
                      ++.+-++.++..... .+...|+.+...  +....+...-..|+.+...+ .|.+.++....|.+-...++--||+.+++
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s  352 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGS  352 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcc
Confidence            344444444433333 444555554333  22233334446688888888 59999999999988877889999999888


Q ss_pred             hhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccC
Q psy14626         92 ICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG  171 (249)
Q Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~  171 (249)
                      +...+.....    +.+..++++..|++.++.++|+..++|.|++|+||++..++  ...++.||+......-...    
T Consensus       353 ~~l~~~~~~~----~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~--~~~~~~~~~~~t~~~~~~~----  422 (524)
T KOG0601|consen  353 SSLRSVTSQM----LDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG--FFSKLGDFGCWTRLAFSSG----  422 (524)
T ss_pred             hhhhhHHHHh----cCcchhhhhHHHHHhccccccchhhhcccccccceeeccch--hhhhccccccccccceecc----
Confidence            7665544433    78899999999999999999999999999999999998764  2268899988754222111    


Q ss_pred             CccccccccccCCcccCCCCC--CccccccCCCCCcchHHHHHHHHHHHHhCCC
Q psy14626        172 GERLDHYTTKAGHRIGTPHYM--APEVIEDQKYGKPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  223 (249)
                                  ......++.  ++.......+..+.|++|||..+.+..++..
T Consensus       423 ------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  423 ------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             ------------cccccccccccchhhccccccccccccccccccccccccCcc
Confidence                        011233333  5555566677899999999999999888753

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.84  E-value=4.3e-09  Score=92.91  Aligned_cols=79  Identities=19%  Similarity=0.236  Sum_probs=53.0

Q ss_pred             eEEEEEeccCCCchhHHHH--HhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC-CCCCeEEcC
Q psy14626         79 MLYMVFEYMDGSDICFEIV--RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGG  155 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~-~~~~~~l~d  155 (249)
                      ..++||||+.|+++.+...  ..+.+...+....+..++.|+       ...|++|+|+||.||+++.++ ....+.++|
T Consensus       235 ~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~GffHaDpHPGNIlv~~~g~~~~~i~llD  307 (537)
T PRK04750        235 ETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDGFFHADMHPGNIFVSYDPPENPRYIALD  307 (537)
T ss_pred             CceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCCeeeCCCChHHeEEecCCCCCCeEEEEe
Confidence            3569999999999976422  221111113333444444444       458999999999999998765 122499999


Q ss_pred             cceeEEccC
Q psy14626        156 FGVAIQLQD  164 (249)
Q Consensus       156 fg~~~~~~~  164 (249)
                      ||.+.....
T Consensus       308 FGivg~l~~  316 (537)
T PRK04750        308 FGIVGSLNK  316 (537)
T ss_pred             cceEEECCH
Confidence            999877754

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.70  E-value=4.4e-08  Score=77.23  Aligned_cols=106  Identities=22%  Similarity=0.285  Sum_probs=73.1

Q ss_pred             hHHHHHHHHHHHHHcCC--CChhhhhheeecC---CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHH
Q psy14626         48 TEADLKREATICHMLKH--PHVVELLETYSSE---GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL  122 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (249)
                      ....+.+|+.+++.+.+  ..+++++.+....   +..++|||+++|.++.+.+.. .    .++......++.+++..|
T Consensus        38 ~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~----~~~~~~~~~i~~~i~~~l  112 (223)
T cd05154          38 SAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-P----ELSPEERRALARALADTL  112 (223)
T ss_pred             ccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-C----CCCHHHHHHHHHHHHHHH
Confidence            35678999999999965  3467777776553   357899999998877554321 0    145555555566666666


Q ss_pred             HHHHH--------------------------------------------------------CCceeecCCCCCeeeeecC
Q psy14626        123 RYCHE--------------------------------------------------------NDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus       123 ~~LH~--------------------------------------------------------~~~vH~dlkp~Nili~~~~  146 (249)
                      ..||+                                                        ..++|+|++|+||+++.++
T Consensus       113 ~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~  192 (223)
T cd05154         113 AALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDE  192 (223)
T ss_pred             HHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCC
Confidence            66652                                                        2469999999999998631


Q ss_pred             CCCCeEEcCccee
Q psy14626        147 NSAPVKLGGFGVA  159 (249)
Q Consensus       147 ~~~~~~l~dfg~~  159 (249)
                       ...+.|+||+.+
T Consensus       193 -~~~~~iID~e~~  204 (223)
T cd05154         193 -PRVVAVLDWELA  204 (223)
T ss_pred             -CcEEEEEecccc
Confidence             123789999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.55  E-value=3.1e-07  Score=71.61  Aligned_cols=67  Identities=18%  Similarity=0.310  Sum_probs=51.8

Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ...+++|||++|..|.+...        +++    .++..+.+++..||+.|++|||.+|+|+++.+++    ++++|++
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~----i~iID~~  179 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG----IRIIDTQ  179 (229)
T ss_pred             eEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc----EEEEECc
Confidence            34679999999987765432        232    2445677789999999999999999999998544    8999997


Q ss_pred             eeE
Q psy14626        158 VAI  160 (249)
Q Consensus       158 ~~~  160 (249)
                      ...
T Consensus       180 ~k~  182 (229)
T PF06176_consen  180 GKR  182 (229)
T ss_pred             ccc
Confidence            653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG2137|consensus

Probab=98.55  E-value=1.6e-08  Score=89.26  Aligned_cols=124  Identities=17%  Similarity=0.298  Sum_probs=88.1

Q ss_pred             HHHHHHHHHHHHHHHHHH-HCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCcccc-ccccccCCcc
Q psy14626        109 AVASHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLD-HYTTKAGHRI  186 (249)
Q Consensus       109 ~~~~~~~~ql~~~l~~LH-~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  186 (249)
                      +....=+.+.+.|+.++| +.++||++|.|++|.++..+.   +|++.|+++.-......+     ++. +.........
T Consensus        99 e~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~---wkl~Gf~f~v~~~~~~~~-----p~~~yd~~lp~~~~  170 (700)
T KOG2137|consen   99 EDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD---WKLAGFSFCVNANGPTEY-----PFSEYDPPLPLLLQ  170 (700)
T ss_pred             cHhhhhhhcccchhhhhccCcceeecccchhheeeccCcc---eeeccchhhhccCCCCcc-----ccccCCCCCChhhc
Confidence            333444556669999999 458999999999999988776   999999988665553321     222 2222333334


Q ss_pred             cCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCChHHHHHHHHcCc
Q psy14626        187 GTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGSRDRLFQSITKGK  240 (249)
Q Consensus       187 ~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~~~~~~~~~i~~g~  240 (249)
                      ....|.+||.+.+..-+.++|+||+|+++|.+.. |+.-+......+......+.
T Consensus       171 ~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~  225 (700)
T KOG2137|consen  171 PHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL  225 (700)
T ss_pred             cCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc
Confidence            5678999999998777899999999999999994 77666655444444444433

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=5.2e-07  Score=70.01  Aligned_cols=112  Identities=18%  Similarity=0.172  Sum_probs=82.1

Q ss_pred             chhHHHHHHHHHHHHHcCCC--Chhhhhheeec---CC--eEEEEEeccCC-CchhHHHHHhhhcCCccCHHHHHHHHHH
Q psy14626         46 YTTEADLKREATICHMLKHP--HVVELLETYSS---EG--MLYMVFEYMDG-SDICFEIVRRATAGFVYSEAVASHYMRQ  117 (249)
Q Consensus        46 ~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~---~~--~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~q  117 (249)
                      +.....|.+|...++++..-  .+++.. ++..   +.  .-++|+|-++| .+|.+.+......  ..+......++.+
T Consensus        60 P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~--~~~~~~k~~il~~  136 (216)
T PRK09902         60 PFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVS--PYSDEVRQAMLKA  136 (216)
T ss_pred             CCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcC--CcchHHHHHHHHH
Confidence            45678899999999999532  355555 3321   11  25799997753 4787776543221  2567777889999


Q ss_pred             HHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        118 VLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       118 l~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      ++..+..||+.|+.|+|+.+.||+++.++ ...+.++||..++.
T Consensus       137 va~~ia~LH~~Gv~Hgdly~khIll~~~g-~~~v~lIDlEk~r~  179 (216)
T PRK09902        137 VALAFKKMHSVNRQHGCCYVRHIYVKTEG-KAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHHHHHHCCCcCCCCCHhheeecCCC-CeeEEEEEhhccch
Confidence            99999999999999999999999998654 33489999987643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.42  E-value=7.4e-07  Score=71.17  Aligned_cols=98  Identities=17%  Similarity=0.268  Sum_probs=73.9

Q ss_pred             chhHHHHHHHHHHHHHcCCC--ChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHH
Q psy14626         46 YTTEADLKREATICHMLKHP--HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALR  123 (249)
Q Consensus        46 ~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~  123 (249)
                      +.+....++|..+|++|...  .+++.++.    +...+|||++.|-.|...-         ++......++..|+.-+.
T Consensus       150 ~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~  216 (304)
T COG0478         150 YVSRLAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVR  216 (304)
T ss_pred             hhHHHHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHH
Confidence            45677789999999999755  77776655    4578999999987664321         223444455666666666


Q ss_pred             HHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626        124 YCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus       124 ~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .+-..|+||||+.+-||+++.++.   +.++||--+
T Consensus       217 ~~~~~GiVHGDlSefNIlV~~dg~---~~vIDwPQ~  249 (304)
T COG0478         217 KAYRRGIVHGDLSEFNILVTEDGD---IVVIDWPQA  249 (304)
T ss_pred             HHHHcCccccCCchheEEEecCCC---EEEEeCccc
Confidence            666899999999999999999877   899999554

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.14  E-value=3.7e-05  Score=59.61  Aligned_cols=103  Identities=17%  Similarity=0.237  Sum_probs=74.0

Q ss_pred             hHHHHHHHHHHHHHcC------CCChhhhhheeecCCeEEEEEeccCCC------chhHHHHHhhhcCCccCHHHHHHHH
Q psy14626         48 TEADLKREATICHMLK------HPHVVELLETYSSEGMLYMVFEYMDGS------DICFEIVRRATAGFVYSEAVASHYM  115 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~------~L~~~l~~~~~~~~~~~~~~~~~~~  115 (249)
                      ...+..+|+.-...+.      +.+|.+++|..+++..+.+|+|.+...      +|.+++....     ++. .+... 
T Consensus        54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-----~~~-~~~~~-  126 (199)
T PF10707_consen   54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-----LTE-ELRQA-  126 (199)
T ss_pred             hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-----ccH-HHHHH-
Confidence            4566777777666665      889999999999999999999998532      5677764322     454 33333 


Q ss_pred             HHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC-CeEEcC-ccee
Q psy14626        116 RQVLEALRYCHENDIIHRDIKPHCVLLANKENSA-PVKLGG-FGVA  159 (249)
Q Consensus       116 ~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~-~~~l~d-fg~~  159 (249)
                        +-.-..+|-+.+|+.+|++|+||++...+... .+.++| ||..
T Consensus       127 --L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  127 --LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             --HHHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence              33445667788899999999999998776554 567776 5544

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.04  E-value=1.6e-05  Score=61.17  Aligned_cols=103  Identities=16%  Similarity=0.139  Sum_probs=77.3

Q ss_pred             HHHHHHHHHcCC-CChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH---C
Q psy14626         53 KREATICHMLKH-PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE---N  128 (249)
Q Consensus        53 ~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~  128 (249)
                      .+|..+++.+++ +++++++|+|.    -++|.|+.+.+++...- .....-...++..+.+++.+++..+.+|+.   .
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            468888999965 79999999995    36789999765543110 000001125899999999999999999986   3


Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      .+.-+|++|+|+.++.++.   ++++|.+-+....
T Consensus        82 ~~~lcDv~~~nfgv~~~~~---lk~iDld~v~~~~  113 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGR---LKLIDLDDVFVED  113 (188)
T ss_pred             cEEEeecchHHeEEeCCCc---EEEEechhcchhH
Confidence            4888999999999987766   9999998764443

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0576|consensus

Probab=97.97  E-value=5.2e-06  Score=73.40  Aligned_cols=153  Identities=24%  Similarity=0.302  Sum_probs=107.6

Q ss_pred             HHHHHHHHHHHHcCCCC-hhhhhheeecCCeEEEEEeccCCC-chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH
Q psy14626         50 ADLKREATICHMLKHPH-VVELLETYSSEGMLYMVFEYMDGS-DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE  127 (249)
Q Consensus        50 ~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~  127 (249)
                      ....-++++|.+++||| .+..++.++.+....++++++.++ +........   .-.+..-++..+++.-+.++.++|+
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s---e~~~~~~~~~~~~r~et~~l~~l~~  354 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVS---EIALEQYQFAYPLRKETRPLAELHS  354 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChh---hHhhhhhhhhhhhhhhccccccccc
Confidence            55667889999999999 777777777778889999999766 211111000   1114455666677778888999998


Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcch
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD  207 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D  207 (249)
                      .--+|+|    ||+....    ..+..+|+.........              ......+++.++|||+.....+....|
T Consensus       355 ~~~~~~d----~~l~s~~----~~~~~~~~v~~~L~~~~--------------~~~t~~~~~~~~~pev~~~~~~~~~p~  412 (829)
T KOG0576|consen  355 SYKVHRD----NILGSEE----EVKLLDFAVPPQLTRTM--------------KPRTAIGTPEPLAPEVIQENTIDGCPD  412 (829)
T ss_pred             ccccCcc----ccccccc----ccccccccCCcccCccc--------------ccccCCCCCCCCCchhhcccccccCCC
Confidence            7667887    7766442    26889998876555421              223345789999999998888889999


Q ss_pred             HHHHHHHHHHHHhCCCCCCC
Q psy14626        208 IWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       208 iwslG~~l~el~~g~~pf~~  227 (249)
                      .||++.--.++.-|-+|-..
T Consensus       413 ~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  413 SGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ccCCCcchhhcCCCCCCCCC
Confidence            99999765666666655443

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.92  E-value=2e-05  Score=69.62  Aligned_cols=106  Identities=19%  Similarity=0.290  Sum_probs=68.0

Q ss_pred             HHHHHHHHHHHcC-----CCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH
Q psy14626         51 DLKREATICHMLK-----HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC  125 (249)
Q Consensus        51 ~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L  125 (249)
                      .+.+|+.-+.++.     .+++.-..=+++-.+.-.++|||+.|-.+.+........   ++.+.+...+.++.  +..+
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~k~ia~~~~~~f--~~q~  281 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDRKELAELLVRAF--LRQL  281 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCHHHHHHHHHHHH--HHHH
Confidence            3566776666662     233222222233345578999999998887774333321   45444333333322  3444


Q ss_pred             HHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626        126 HENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus       126 H~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      -..|+.|+|.+|.||+++.++.   +.+.|||.......
T Consensus       282 ~~dgffHaDpHpGNi~v~~~g~---i~~lDfGi~g~l~~  317 (517)
T COG0661         282 LRDGFFHADPHPGNILVRSDGR---IVLLDFGIVGRLDP  317 (517)
T ss_pred             HhcCccccCCCccceEEecCCc---EEEEcCcceecCCH
Confidence            4589999999999999998876   99999999866654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.91  E-value=8e-05  Score=59.16  Aligned_cols=43  Identities=16%  Similarity=0.241  Sum_probs=33.9

Q ss_pred             hHHHHHHHHHHHHHcCCC--ChhhhhheeecCCeEEEEEeccCCC
Q psy14626         48 TEADLKREATICHMLKHP--HVVELLETYSSEGMLYMVFEYMDGS   90 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~   90 (249)
                      ....+.+|.++++.+..-  .+++.+.+...++...+||++++|.
T Consensus        35 ~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172        35 DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            345678999999999533  3577788887888888999999885

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.89  E-value=5.2e-05  Score=60.84  Aligned_cols=45  Identities=22%  Similarity=0.270  Sum_probs=34.5

Q ss_pred             HHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCchhH
Q psy14626         50 ADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICF   94 (249)
Q Consensus        50 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (249)
                      ..+.+|+.+++.+. +--+++++.+...++..++||++++|.++..
T Consensus        36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150          36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            45778999998883 4556777877776667899999999877643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.76  E-value=0.00017  Score=56.99  Aligned_cols=75  Identities=19%  Similarity=0.253  Sum_probs=44.6

Q ss_pred             hcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCC--Chhhhhhee---ecCCeEEEEEeccCCC
Q psy14626         16 INHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHP--HVVELLETY---SSEGMLYMVFEYMDGS   90 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--~i~~~~~~~---~~~~~~~lv~e~~~~~   90 (249)
                      +++|+...+|.......  .+.++.....  .....+.+|..+++.+...  .+++++...   ......+++|++++|.
T Consensus         5 l~~G~~n~~~~v~~~~~--~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~   80 (239)
T PF01636_consen    5 LSGGFSNRVYRVTTDDG--RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR   80 (239)
T ss_dssp             EEESSSSEEEEEEETTS--EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred             CCCCCeeeEEEEEECCc--EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence            45666655554444432  3333222111  4567888999999999532  356666643   2334579999999988


Q ss_pred             chhH
Q psy14626         91 DICF   94 (249)
Q Consensus        91 ~L~~   94 (249)
                      .+..
T Consensus        81 ~~~~   84 (239)
T PF01636_consen   81 PLDD   84 (239)
T ss_dssp             EHHH
T ss_pred             cccc
Confidence            7766

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PLN02876 acyl-CoA dehydrogenase

Probab=97.70  E-value=0.00015  Score=68.41  Aligned_cols=43  Identities=21%  Similarity=0.424  Sum_probs=33.3

Q ss_pred             HHHHHHHHHHHHHcC-CCCh--hhhhheeecC---CeEEEEEeccCCCc
Q psy14626         49 EADLKREATICHMLK-HPHV--VELLETYSSE---GMLYMVFEYMDGSD   91 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~   91 (249)
                      ...+.+|+.+++.+. |.++  ++++.++.+.   +..|+|||+++|..
T Consensus        82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            457889999999995 6655  7777777654   46789999998764

>KOG1235|consensus

Probab=97.44  E-value=0.001  Score=58.98  Aligned_cols=91  Identities=16%  Similarity=0.159  Sum_probs=58.3

Q ss_pred             hhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626         67 VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus        67 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                      |++++-.+.  ..-.++|||++|..+.+...-....   ++...+..-+.+..  +..+-..|++|+|=+|.||+++.+.
T Consensus       266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~  338 (538)
T KOG1235|consen  266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNP  338 (538)
T ss_pred             CCeehhhcC--cceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCC
Confidence            444443333  3478999999998775543322222   55555444333333  2333457899999999999999542


Q ss_pred             -CCCCeEEcCcceeEEccC
Q psy14626        147 -NSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus       147 -~~~~~~l~dfg~~~~~~~  164 (249)
                       ....+.+.|||+...+..
T Consensus       339 ~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  339 EGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCCccEEEEcccccccccH
Confidence             334589999999866654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.38  E-value=0.00062  Score=54.36  Aligned_cols=44  Identities=16%  Similarity=0.231  Sum_probs=29.6

Q ss_pred             HHHHHHHHHHHHHcCCC---ChhhhhheeecC---CeEEEEEeccCCCch
Q psy14626         49 EADLKREATICHMLKHP---HVVELLETYSSE---GMLYMVFEYMDGSDI   92 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~h~---~i~~~~~~~~~~---~~~~lv~e~~~~~~L   92 (249)
                      ...+.+|+.++..+...   -++++++.....   +..+++|++++|.++
T Consensus        32 ~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l   81 (235)
T cd05155          32 AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETA   81 (235)
T ss_pred             HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCC
Confidence            45799999999988532   345555444332   235889999998665

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.18  E-value=0.0014  Score=52.14  Aligned_cols=100  Identities=13%  Similarity=0.130  Sum_probs=61.7

Q ss_pred             HHHHHHHHHHcC--CCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-C
Q psy14626         52 LKREATICHMLK--HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-N  128 (249)
Q Consensus        52 ~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~  128 (249)
                      ..+|..-|+++.  +=.+++.+..    ....+||||+.....    .........++..+...+..+++..+.-|-. .
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~----pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGL----PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCC----CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc
Confidence            345555555553  2223333322    235799999954311    0000111123444677777888888888765 8


Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ++||+||..=|||+. ++.   +.++|++-+....
T Consensus       187 ~LVHgDLSEyNiL~~-~~~---p~iID~~QaV~~~  217 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGE---PYIIDVSQAVTID  217 (268)
T ss_pred             CcccccchhhheEEE-CCe---EEEEECccccccC
Confidence            999999999999998 344   8999999775443

>KOG1035|consensus

Probab=97.18  E-value=0.0022  Score=60.99  Aligned_cols=156  Identities=15%  Similarity=0.138  Sum_probs=103.3

Q ss_pred             HHHHHHHHHHHHcCCCChhhhhheeecCCe----EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH
Q psy14626         50 ADLKREATICHMLKHPHVVELLETYSSEGM----LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC  125 (249)
Q Consensus        50 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L  125 (249)
                      .....|+..+..+.|+|++.++.+-.+...    ..+..+++...++...+.....    .+..+.+.+..++..|+.++
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~----i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS----IPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc----cCHHHHHHHHHHHhhhHHHH
Confidence            344567788888899999999888754432    2345567777777777766554    78999999999999999999


Q ss_pred             HHCCceeecCCCCCeeeeecCCCCCeEEc--CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCC
Q psy14626        126 HENDIIHRDIKPHCVLLANKENSAPVKLG--GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYG  203 (249)
Q Consensus       126 H~~~~vH~dlkp~Nili~~~~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  203 (249)
                      |+....|.-+..+...-........+.++  ||+.+....+...              ......+..+.++|........
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--------------~~~~~~~~~~~~~e~~~~~~~~  368 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--------------SFSDLLAEIRNADEDLKENTAK  368 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCccc--------------chhhcCccccccccccccccch
Confidence            99866666655552221111111224444  7777655554321              1112345567778877665544


Q ss_pred             --CcchHHHHHHHHHHHHhCCC
Q psy14626        204 --KPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       204 --~~~DiwslG~~l~el~~g~~  223 (249)
                        ...|+|.+|.....+..|..
T Consensus       369 ~~r~~dL~~lgll~~~~~~~~~  390 (1351)
T KOG1035|consen  369 KSRLTDLWCLGLLLLQLSQGED  390 (1351)
T ss_pred             hhhhhHHHHHHHHHhhhhhcCc
Confidence              44799999999999887653

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.18  E-value=0.0014  Score=54.41  Aligned_cols=116  Identities=14%  Similarity=0.184  Sum_probs=68.6

Q ss_pred             chhHHHHHHHHHHHHHcC--CCChhhhhheeecCC--eEEEEEeccCCCchhH----------HHH--------Hhhh--
Q psy14626         46 YTTEADLKREATICHMLK--HPHVVELLETYSSEG--MLYMVFEYMDGSDICF----------EIV--------RRAT--  101 (249)
Q Consensus        46 ~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~----------~l~--------~~~~--  101 (249)
                      ........+|..+++.+.  .--+.+.+++|.++.  ..+.||++..|..+.+          +..        .-..  
T Consensus        62 ~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~id  141 (321)
T COG3173          62 VESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSID  141 (321)
T ss_pred             chhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCC
Confidence            355667788888888884  345666677776665  7799999998842211          111        0000  


Q ss_pred             ------cC--CccCHHHHHHHHHHH--------------HHHHHHHHHC--------CceeecCCCCCeeeeecCCCCCe
Q psy14626        102 ------AG--FVYSEAVASHYMRQV--------------LEALRYCHEN--------DIIHRDIKPHCVLLANKENSAPV  151 (249)
Q Consensus       102 ------~~--~~~~~~~~~~~~~ql--------------~~~l~~LH~~--------~~vH~dlkp~Nili~~~~~~~~~  151 (249)
                            .+  ..+...++..+..+.              .....+++..        .++|||+++.|++++++..   +
T Consensus       142 a~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~---~  218 (321)
T COG3173         142 AAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRP---T  218 (321)
T ss_pred             CcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCe---e
Confidence                  00  001112222222222              1113333322        4899999999999988766   8


Q ss_pred             EEcCcceeEEccC
Q psy14626        152 KLGGFGVAIQLQD  164 (249)
Q Consensus       152 ~l~dfg~~~~~~~  164 (249)
                      -++||+.+..-.+
T Consensus       219 gVlDwe~~~lGDP  231 (321)
T COG3173         219 GVLDWELATLGDP  231 (321)
T ss_pred             EEEeccccccCCc
Confidence            9999998755443

>KOG1826|consensus

Probab=97.01  E-value=4.4e-05  Score=73.83  Aligned_cols=159  Identities=14%  Similarity=0.070  Sum_probs=112.1

Q ss_pred             HHHHHHHHHcCCCChhhhhheeec--CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC--
Q psy14626         53 KREATICHMLKHPHVVELLETYSS--EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN--  128 (249)
Q Consensus        53 ~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~--  128 (249)
                      ..|...++...|+++.+...-...  +...+..++++.+|.+.+.+-+...........-+.....+.+....-.|.+  
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence            334445556678888877666643  3446889999999999888876544433333333333333335555555543  


Q ss_pred             ---CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCc
Q psy14626        129 ---DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP  205 (249)
Q Consensus       129 ---~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  205 (249)
                         --+|.++++-|.++..+.+   +++.++|+.+....             .....+...+++.|++|+.....+++.+
T Consensus      1357 lg~T~v~~~Lkf~lpmIVtny~---v~~gk~gLdKIknp-------------~~sf~Gl~l~sp~~v~qli~N~ik~t~r 1420 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYN---VKLGKGGLDKIKNP-------------VLSFFGLELCSPIYVLQLIKNEIKFTKR 1420 (2724)
T ss_pred             CCccchhhhhhhhccceecCCc---ccccccccccccCc-------------hHhhhhhhhCCHHHHHHHHHHHHhhhhH
Confidence               2689999999999988776   89999999872222             1234555678888999999888888888


Q ss_pred             chHHHHHHHHHHHHhCCCCCCC
Q psy14626        206 VDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       206 ~DiwslG~~l~el~~g~~pf~~  227 (249)
                      +|+|+.++-+++...|..+|..
T Consensus      1421 sdilr~s~~ly~rs~~n~~fi~ 1442 (2724)
T KOG1826|consen 1421 SDILRRSLSLYLRSDGNAYFIF 1442 (2724)
T ss_pred             HHHHHHHHHHHHHhcccHHHHH
Confidence            9999999999998888777754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.97  E-value=0.0017  Score=52.58  Aligned_cols=30  Identities=17%  Similarity=0.203  Sum_probs=24.6

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      .++|+|+.|.||+++.++    +.++||..+...
T Consensus       147 ~l~H~Dl~~~Nil~~~~~----~~lIDwE~a~~g  176 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG----LKLIDWEYASDG  176 (256)
T ss_pred             eeecCCCCcCcEEEeCCC----CEEEeccccCcC
Confidence            489999999999998654    689999876443

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268|consensus

Probab=96.81  E-value=0.0022  Score=53.12  Aligned_cols=96  Identities=11%  Similarity=0.159  Sum_probs=66.6

Q ss_pred             hhHHHHHHHHHHHHHcCC-C-ChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLKH-P-HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY  124 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~h-~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~  124 (249)
                      -++-+..+|...|+.|.. . -+++.++.    ...++||+++.|..|.....-       ....+   +...+..-|..
T Consensus       152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~  217 (465)
T KOG2268|consen  152 LSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVR  217 (465)
T ss_pred             hHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHH
Confidence            345556789999999853 2 34444443    457899999998877543211       22333   34445555677


Q ss_pred             HHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626        125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus       125 LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      |-..|+||||.+--||++..++.   +.++||--+
T Consensus       218 la~~GlIHgDFNEFNimv~dd~~---i~vIDFPQm  249 (465)
T KOG2268|consen  218 LANHGLIHGDFNEFNIMVKDDDK---IVVIDFPQM  249 (465)
T ss_pred             HHHcCceecccchheeEEecCCC---EEEeechHh
Confidence            78899999999999999987666   999999644

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=96.63  E-value=0.008  Score=45.48  Aligned_cols=131  Identities=18%  Similarity=0.172  Sum_probs=82.6

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChh-hhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVV-ELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~   86 (249)
                      ...++...++-||.+.+|........  .++  ......+....+..|+++|..++-.++. +++.+-.    -++.|||
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~--~a~--Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~   93 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWRGGE--VAL--KVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEY   93 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeeccCce--EEE--EEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhh
Confidence            35677888899998888876655331  111  1222345667899999999999755443 3333322    3455999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCC-CC-CeeeeecCCCCCeEEcCcceeEE
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK-PH-CVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlk-p~-Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +.|.+|.+.-..       .+.+.    +..++....-|-..||-|+.|. |. ||++++ ..   +.|+||..++.
T Consensus        94 i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~~---~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-RD---VYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhc-------ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecC-Cc---EEEEEccchhh
Confidence            999887654321       12333    3345555556777889999885 33 455543 33   89999998753

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.58  E-value=0.028  Score=46.36  Aligned_cols=30  Identities=27%  Similarity=0.280  Sum_probs=24.6

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      .+++|+|+.|.|++++.++.   +.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~---~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDEL---SGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCce---EEEeehhhhc
Confidence            36999999999999986542   5899998763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=96.52  E-value=0.03  Score=48.30  Aligned_cols=74  Identities=16%  Similarity=0.070  Sum_probs=43.7

Q ss_pred             hhcccceeeEeeeccccCCCcccCCh----hcc--cc-chhHHHHHHHHHHHHHcC---CCChhhhhheeecCCeEEEEE
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLPD----ERL--NH-YTTEADLKREATICHMLK---HPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~-~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      -+++|....+|.....-+...+.++.    ...  .. +...++...|...|+.+.   ..++++++.+-  .+..++||
T Consensus        33 elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~lVM  110 (401)
T PRK09550         33 EIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVTVM  110 (401)
T ss_pred             EcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEEEE
Confidence            46778777777665542211222221    111  11 235677888999888873   24677777663  35578999


Q ss_pred             eccCCC
Q psy14626         85 EYMDGS   90 (249)
Q Consensus        85 e~~~~~   90 (249)
                      |++++.
T Consensus       111 E~L~~~  116 (401)
T PRK09550        111 EDLSDH  116 (401)
T ss_pred             ecCCCc
Confidence            999763

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.09  E-value=0.037  Score=46.82  Aligned_cols=74  Identities=18%  Similarity=0.240  Sum_probs=54.8

Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      ...|++|++- |+++...-    .    -..+++..++++.+..+.-+..+ .+-|+|+..+||+++ +|+   +.|+||
T Consensus       299 ~y~yl~~kdh-gt~is~ik----~----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~Gn---vtLIDf  365 (488)
T COG5072         299 LYLYLHFKDH-GTPISIIK----A----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGN---VTLIDF  365 (488)
T ss_pred             eEEEEEEecC-Cceeeeee----c----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCc---eEEEEe
Confidence            4567888876 55553211    1    35677888888888877777644 689999999999999 566   999999


Q ss_pred             ceeEEccC
Q psy14626        157 GVAIQLQD  164 (249)
Q Consensus       157 g~~~~~~~  164 (249)
                      .+++....
T Consensus       366 klsRl~~~  373 (488)
T COG5072         366 KLSRLSYS  373 (488)
T ss_pred             eeeecccC
Confidence            99985443

>PLN02236 choline kinase

Probab=95.87  E-value=0.027  Score=47.77  Aligned_cols=33  Identities=9%  Similarity=0.200  Sum_probs=25.9

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      .++|+|+++.||+++.++  ..+.++||..+....
T Consensus       201 ~~cH~Dl~~~Nil~~~~~--~~~~lID~Eya~~~~  233 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEET--RAITIIDYEYASYNP  233 (344)
T ss_pred             eEEeCCCCcCcEEEeCCC--CcEEEEeehhccccc
Confidence            589999999999997532  238999998875443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.54  E-value=0.042  Score=46.26  Aligned_cols=30  Identities=13%  Similarity=0.181  Sum_probs=24.4

Q ss_pred             ceeecCCCCCeeeeec-CCCCCeEEcCcceeEEc
Q psy14626        130 IIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       130 ~vH~dlkp~Nili~~~-~~~~~~~l~dfg~~~~~  162 (249)
                      ++|+|+.+.||+++.+ +.   +.++||..+-..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~---l~lID~EYag~n  214 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGK---LYFIDFEYGSYS  214 (330)
T ss_pred             EEECCCCcccEEEeCCCCc---EEEEcccccCCC
Confidence            7999999999999754 33   999999877443

>KOG1093|consensus

Probab=94.97  E-value=0.084  Score=46.70  Aligned_cols=50  Identities=10%  Similarity=0.074  Sum_probs=39.3

Q ss_pred             HHHHHHHHHHHHHcCCCChhhhhheeec-CCeEEEEEeccCCCchhHHHHHh
Q psy14626         49 EADLKREATICHMLKHPHVVELLETYSS-EGMLYMVFEYMDGSDICFEIVRR   99 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~   99 (249)
                      ..++.-..++++.++|+|+..++..-.. .....+|+|++ +.||.+.+..+
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhc
Confidence            4667888899999999999988877643 34578999998 56888877654

>PHA03111 Ser/Thr kinase; Provisional

Probab=94.70  E-value=0.12  Score=43.20  Aligned_cols=68  Identities=16%  Similarity=0.172  Sum_probs=40.1

Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH-H---HCCceeecCCCCCeeeeecCC
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC-H---ENDIIHRDIKPHCVLLANKEN  147 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L-H---~~~~vH~dlkp~Nili~~~~~  147 (249)
                      -.+|++++...+=.--.......++.--.+-++.+..|++.-.-.+ .   -..++|-||||+|||+-+...
T Consensus       250 nIIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~  321 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDE  321 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCC
Confidence            5688888765321101111122233234567778888887654233 2   125999999999999976543

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.61  E-value=0.23  Score=43.01  Aligned_cols=40  Identities=20%  Similarity=0.138  Sum_probs=28.1

Q ss_pred             hHHHHHHHHHHHHHcC---CCChhhhhheeecCCeEEEEEeccCC
Q psy14626         48 TEADLKREATICHMLK---HPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      ..++-..|+..|+.+.   ..++++++.++.+.  .+++||++++
T Consensus        77 ~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~--~vlvME~L~~  119 (418)
T PLN02756         77 TKERAYFEATALREHGRLCPDHVPEVYHFDRTM--ALIGMRYLEP  119 (418)
T ss_pred             CccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC--CEEEEeecCC
Confidence            4455566677777764   24788888887743  6788999976

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=94.60  E-value=0.031  Score=44.36  Aligned_cols=28  Identities=21%  Similarity=0.325  Sum_probs=23.9

Q ss_pred             CceeecCCCCCeeeee-cCCCCCeEEcCccee
Q psy14626        129 DIIHRDIKPHCVLLAN-KENSAPVKLGGFGVA  159 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~-~~~~~~~~l~dfg~~  159 (249)
                      +++|+|+.+.||+++. ++.   +.++||..+
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~---~~lIDwe~a  199 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNS---VKFIDYEYA  199 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCC---EEEEEcccC
Confidence            5899999999999986 343   899999876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.51  E-value=0.056  Score=44.95  Aligned_cols=30  Identities=27%  Similarity=0.338  Sum_probs=25.2

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      .+++|+|++++|++++.++.   +.++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~---~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSV---KGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCce---EEEeeccccc
Confidence            57999999999999987542   5899998873

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.48  E-value=0.077  Score=44.04  Aligned_cols=28  Identities=25%  Similarity=0.387  Sum_probs=23.7

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .+++|||++++|++++. +.   +.++||+.+
T Consensus       187 ~~liHgD~~~~Nil~~~-~~---i~lIDfd~~  214 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NE---VYVIDFDYC  214 (313)
T ss_pred             CceEcCCCCcccEEEeC-Cc---EEEEECccc
Confidence            47899999999999976 33   789999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PTZ00384 choline kinase; Provisional

Probab=94.46  E-value=0.11  Score=44.73  Aligned_cols=36  Identities=11%  Similarity=0.399  Sum_probs=26.5

Q ss_pred             HHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         53 KREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        53 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      .+|..+++.+. +..-+++++.+..    +++.||++|..|
T Consensus       100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l  136 (383)
T PTZ00384        100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTM  136 (383)
T ss_pred             HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccC
Confidence            56888999994 5566666766653    489999988765

>PRK05231 homoserine kinase; Provisional

Probab=94.29  E-value=0.026  Score=47.14  Aligned_cols=30  Identities=23%  Similarity=0.251  Sum_probs=24.2

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      .+++|+|++|+||+++++.-   ..++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~---~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRL---SGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCce---EEEEeccccc
Confidence            37999999999999975432   4799998763

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=93.57  E-value=0.09  Score=43.51  Aligned_cols=30  Identities=27%  Similarity=0.306  Sum_probs=24.8

Q ss_pred             CceeecCCCCCeeeeec----CCCCCeEEcCcceeEE
Q psy14626        129 DIIHRDIKPHCVLLANK----ENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~----~~~~~~~l~dfg~~~~  161 (249)
                      .++|+|+.+.||+++.+    +.   +.++||..+..
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~---i~lIDwEya~~  213 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKK---LVLIDFEYASY  213 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCc---EEEEeeCCCCC
Confidence            58999999999999864    43   89999987743

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10593 hypothetical protein; Provisional

Probab=93.44  E-value=0.29  Score=40.62  Aligned_cols=102  Identities=14%  Similarity=0.052  Sum_probs=59.0

Q ss_pred             HHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-C--CChhhhhheeec---CCeEEEEEec
Q psy14626         13 HEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-H--PHVVELLETYSS---EGMLYMVFEY   86 (249)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~~i~~~~~~~~~---~~~~~lv~e~   86 (249)
                      .+-+++|-.+..|.....-..  +.++ . .........+..|+..|+.+. +  -.++++++.+..   .+..++|||+
T Consensus        19 ~~~i~~G~~~~vy~~~~~~~~--~~~k-~-~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         19 VECISEQPYAALWALYDSQGN--PMPL-M-ARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeecCCccceeEEEEEcCCCC--EEEE-E-ecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            344566666666654432221  1111 1 111123468999999999994 3  368888887754   3568999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE  127 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~  127 (249)
                      ++|.++.+.     .    .+......++.+++.+|..||.
T Consensus        95 i~G~~~~~~-----~----~~~~~~~~l~~~l~~~La~LH~  126 (297)
T PRK10593         95 LRGVSVEAP-----A----RTPERWEQLKDQIVEGLLAWHR  126 (297)
T ss_pred             cCCEecCCC-----C----CCHHHHHHHHHHHHHHHHHHhC
Confidence            998766430     0    1223333444555566666664

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.35  E-value=0.097  Score=44.01  Aligned_cols=28  Identities=32%  Similarity=0.495  Sum_probs=24.1

Q ss_pred             ceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626        130 IIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus       130 ~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +||+|+.|+||+++.++.  .+.++||+-+
T Consensus       199 iIH~D~~~~NVl~d~~~~--~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTD--VSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCC--eeeEEEcccc
Confidence            899999999999987653  3689999876

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=93.32  E-value=0.18  Score=42.47  Aligned_cols=66  Identities=17%  Similarity=0.208  Sum_probs=38.0

Q ss_pred             EEEEEeccCCCc--hhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH---H-HCCceeecCCCCCeeeeecCC
Q psy14626         80 LYMVFEYMDGSD--ICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC---H-ENDIIHRDIKPHCVLLANKEN  147 (249)
Q Consensus        80 ~~lv~e~~~~~~--L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L---H-~~~~vH~dlkp~Nili~~~~~  147 (249)
                      -.+|++++...+  +....  ...-|+..-.+-++.+..|++.-.--+   - -..++|-||||+|||+-+..+
T Consensus       246 nIIIfPLA~~Sadkv~~~~--~~e~GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~  317 (434)
T PF05445_consen  246 NIIIFPLARCSADKVTESN--AAELGFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKE  317 (434)
T ss_pred             cEEEEehhhcchhhcCHHH--HHhcCchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCC
Confidence            458888886542  11111  111122233456677777876532112   2 225899999999999966543

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>KOG2270|consensus

Probab=92.35  E-value=0.48  Score=40.49  Aligned_cols=101  Identities=11%  Similarity=0.122  Sum_probs=61.5

Q ss_pred             HHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH-HHCCc
Q psy14626         52 LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC-HENDI  130 (249)
Q Consensus        52 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L-H~~~~  130 (249)
                      ..+|+.-|++++...|+-.--+..  ....+||+++.....-.    ..-....++...+..+-.+++.-+..| +.+++
T Consensus       213 AEKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~L  286 (520)
T KOG2270|consen  213 AEKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKCRL  286 (520)
T ss_pred             HHHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHhce
Confidence            456777777776555442221111  12579999995332110    001122256556666666666666665 57789


Q ss_pred             eeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       131 vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||.||.-=|+|+... .   +.++|.+-+...
T Consensus       287 VHADLSEfN~LyhdG-~---lyiIDVSQSVE~  314 (520)
T KOG2270|consen  287 VHADLSEFNLLYHDG-K---LYIIDVSQSVEH  314 (520)
T ss_pred             eccchhhhhheEECC-E---EEEEEccccccC
Confidence            999999999999653 2   899998766433

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=92.34  E-value=0.16  Score=41.47  Aligned_cols=50  Identities=20%  Similarity=0.239  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHHHHHHHHHHC--CceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        109 AVASHYMRQVLEALRYCHEN--DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       109 ~~~~~~~~ql~~~l~~LH~~--~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      ..+...+..+-..+.-.+..  -.+|+|+.|.|++.++++.   +.|+||..|..
T Consensus       132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~---l~LIDWEyAg~  183 (269)
T COG0510         132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGG---LFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCc---EEEEecccCCC
Confidence            34444555555555555533  5899999999999988565   99999987643

>PRK10271 thiK thiamine kinase; Provisional

Probab=92.31  E-value=0.095  Score=40.22  Aligned_cols=29  Identities=14%  Similarity=0.187  Sum_probs=23.9

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      ..+|+|+.|.|+++.+++    ++++||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~----~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG----LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC----EEEEeCCcccC
Confidence            469999999999987544    78999998743

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.08  E-value=0.19  Score=41.83  Aligned_cols=30  Identities=13%  Similarity=0.093  Sum_probs=25.4

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +++|+|+.++|+++++++.   +.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~---~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRG---GYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCC---EEEEEhhhccc
Confidence            6999999999999987665   88999987633

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=91.77  E-value=0.094  Score=41.01  Aligned_cols=31  Identities=29%  Similarity=0.340  Sum_probs=19.5

Q ss_pred             CceeecCCCCCeee-eecCCCCCeEEcCcceeEEc
Q psy14626        129 DIIHRDIKPHCVLL-ANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       129 ~~vH~dlkp~Nili-~~~~~~~~~~l~dfg~~~~~  162 (249)
                      .+.|+|+.|.||++ ..++.   ++++||..|...
T Consensus       144 v~cHnDl~~~Nil~~~~~~~---~~lIDfEya~~n  175 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGE---VKLIDFEYAGYN  175 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSC---EEE--GTT-EEE
T ss_pred             eEeeccCccccEEeccCCCe---EEEecHHHHhhc
Confidence            58999999999999 44444   999999887443

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=91.34  E-value=0.21  Score=43.04  Aligned_cols=28  Identities=25%  Similarity=0.345  Sum_probs=24.0

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +.++|||++|.||+++.+.    ++++|..++
T Consensus       227 ~aLlHGDlHtGSI~v~~~~----~kvIDpEFA  254 (409)
T PRK12396        227 QALIHGDLHTGSVFVKNDS----TKVIDPEFA  254 (409)
T ss_pred             hhhccCcCCCCCEEecCCc----eEEEccccc
Confidence            4699999999999998754    799998776

>PRK11768 serine/threonine protein kinase; Provisional

Probab=91.08  E-value=0.26  Score=41.40  Aligned_cols=27  Identities=19%  Similarity=0.161  Sum_probs=22.6

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .+++|+|+.++||+++ + .   +.++||+-+
T Consensus       196 ~~liHgD~h~~NvL~~-d-~---~~iIDFDd~  222 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-G---PHFVDLDDA  222 (325)
T ss_pred             ccceecCCCchhcccc-C-C---cEEEeCCCC
Confidence            3689999999999994 3 3   689999876

>PRK06149 hypothetical protein; Provisional

Probab=91.02  E-value=0.23  Score=48.07  Aligned_cols=32  Identities=22%  Similarity=0.217  Sum_probs=25.0

Q ss_pred             CCceeecCCCCCeeeeecC--CCCCeEEcCccee
Q psy14626        128 NDIIHRDIKPHCVLLANKE--NSAPVKLGGFGVA  159 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~--~~~~~~l~dfg~~  159 (249)
                      .++||+|++++||+++.++  ......|+|||-+
T Consensus       208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~  241 (972)
T PRK06149        208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDL  241 (972)
T ss_pred             ccccCCCCCcccEEEcCCCCCCcceeEEEEcccc
Confidence            5799999999999998653  2123489999876

>KOG4720|consensus

Probab=90.73  E-value=0.79  Score=37.84  Aligned_cols=36  Identities=19%  Similarity=0.467  Sum_probs=28.8

Q ss_pred             HHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         53 KREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        53 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      .+|+...+.| .|..-.++++.|..+    +|++|++|.+|
T Consensus       126 e~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL  162 (391)
T KOG4720|consen  126 ENEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTL  162 (391)
T ss_pred             HHHHHHHHHHHHcCcChhhhheecCc----eEEeeecCccc
Confidence            4567777777 488889999988766    79999998776

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=90.02  E-value=0.21  Score=40.98  Aligned_cols=31  Identities=19%  Similarity=0.307  Sum_probs=24.1

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      .++|+|++|.||+++.++.  ...|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~--~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDAR--VTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCC--EEEEECcHhccc
Confidence            4899999999999985332  257999998743

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=89.77  E-value=0.28  Score=38.87  Aligned_cols=85  Identities=13%  Similarity=0.093  Sum_probs=52.1

Q ss_pred             HHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH--
Q psy14626         50 ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE--  127 (249)
Q Consensus        50 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~--  127 (249)
                      ..+.++..++.++.  .|+++..  ..+-.+.++.|.|-....             ...+.    +.-=+++|..+|+  
T Consensus       103 ~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i-------------~~~N~----i~agi~~L~~fH~~~  161 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI-------------NFSNF----ITAGIKDLMDFHSEN  161 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc-------------chhHH----HHHhHHHHHHhhccC
Confidence            34555555544442  3444431  133357799999843321             12111    1112456777883  


Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+.+|||..|+||+-++.+.   +||.|-+.
T Consensus       162 ~~~lHGD~np~NiM~D~~G~---lKlVDP~~  189 (308)
T PF07387_consen  162 QHCLHGDCNPDNIMCDKFGY---LKLVDPVC  189 (308)
T ss_pred             CCeecCCCChhheeecCCCC---EEecChhh
Confidence            47999999999999998887   89998764

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	249
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-74
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-74
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-71
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-33
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-33
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-31
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-31
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		6e-31
3soa_A	444	Full-Length Human Camkii Length = 444		2e-30
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-30
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-30
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-30
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-30
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-21
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-21
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-21
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-21
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-21
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		8e-21
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		8e-21
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		9e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-20
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-20
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-20
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-19
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-19
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-19
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-19
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-19
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		7e-19
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		8e-19
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-18
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-18
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-18
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-18
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-18
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-17
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-17
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-16
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-16
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-16
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-16
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-15
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-15
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-15
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-15
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-15
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-15
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		8e-15
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-15
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-14
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-14
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-14
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-14
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-14
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-14
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-14
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-14
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-14
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-14
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-14
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-14
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-14
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-14
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-14
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-14
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-14
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-14
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-14
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-14
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-14
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-14
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-14
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-14
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-14
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		3e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		3e-14
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-14
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-14
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-14
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-14
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-14
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		7e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-14
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-14
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-14
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-14
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-14
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		8e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-14
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-14
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		9e-14
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-14
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-14
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		9e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-14
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-14
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-14
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-14
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-14
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-14
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-14
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		9e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		9e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-14
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-13
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-13
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		4e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-13
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-13
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-13
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		8e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		9e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		8e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		8e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		8e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		9e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-11
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-11
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-11
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		7e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		8e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		9e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-10
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-10
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-10
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-10
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-10
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-10
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-10
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-10
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-10
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-10
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-10
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-10
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-10
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-10
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-10
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-10
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-10
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		7e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		7e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		8e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		8e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		8e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		9e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-09
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-09
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		1e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-08
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-08
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		4e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		5e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-08
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-08
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		8e-08
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		8e-08
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		8e-08
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-08
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		8e-08
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		9e-08
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		9e-08
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		9e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		9e-08
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		9e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-08
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-07
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-07
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-07
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		2e-07
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		2e-07
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		2e-07
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		2e-07
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		2e-07
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		2e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		2e-07
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		2e-07
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		2e-07
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-07
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		2e-07
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		3e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		4e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		4e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-07
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		4e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		5e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		5e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		5e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		6e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		6e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		6e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		6e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		9e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		9e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		9e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-07
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-06
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-06
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-06
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-06
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-06
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-06
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-06
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-06
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-06
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-06
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-06
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-06
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-06
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-06
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-06
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-06
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-06
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-06
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-06
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-06
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-06
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-06
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-06
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-06
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-06
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-06
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-06
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-06
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-06
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-06
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-06
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-06
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-06
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-06
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-06
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-06
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-06
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-06
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-06
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-06
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-06
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-06
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-06
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-06
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-06
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-06
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-06
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-06
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		7e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-06
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		7e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		7e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-06
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		9e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		9e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		9e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-05
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-05
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-05
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-05
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-05
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-05
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-05
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-05
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-05
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-05
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-05
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-05
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-05
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-05
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-05
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-05
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-05
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		4e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-05
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-05
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-05
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-05
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-05
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-05
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-05
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		4e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-05
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-05
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-05
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		7e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		7e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-05
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-05
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-05
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		8e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		9e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-05
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-05
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-04
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-04
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-04
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-04
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-04
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-04
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-04
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-04
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-04
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-04
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		2e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-04
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-04
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-04
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-04
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-04
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		5e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		6e-04
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-04
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-04
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		6e-04
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		6e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		6e-04
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-04
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-04
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		8e-04

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  275 bits (702), Expect = 3e-74,   Method: Compositional matrix adjust.
 Identities = 129/190 (67%), Positives = 152/190 (80%), Gaps = 13/190 (6%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVYSEAV
Sbjct: 74  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 133
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  L   
Sbjct: 134 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-- 191
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD 230
                      AG R+GTPH+MAPEV++ + YGKPVD+W              PF G+++
Sbjct: 192 -----------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 240
Query: 231 RLFQSITKGK 240
           RLF+ I KGK
Sbjct: 241 RLFEGIIKGK 250

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  274 bits (700), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 129/190 (67%), Positives = 152/190 (80%), Gaps = 13/190 (6%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVYSEAV
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  L   
Sbjct: 132 ASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV-- 189
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD 230
                      AG R+GTPH+MAPEV++ + YGKPVD+W              PF G+++
Sbjct: 190 -----------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238
Query: 231 RLFQSITKGK 240
           RLF+ I KGK
Sbjct: 239 RLFEGIIKGK 248

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  265 bits (676), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 126/190 (66%), Positives = 149/190 (78%), Gaps = 13/190 (6%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVYSEAV
Sbjct: 72  DLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASHYMRQ+LEALRYCH+N+IIHRD+KP  VLLA+KENSAPVKLG FGVAIQL +  L   
Sbjct: 132 ASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLV-- 189
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD 230
                      AG R+GTPH+MAPEV++ + YGKPVD+W              PF G+++
Sbjct: 190 -----------AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238
Query: 231 RLFQSITKGK 240
           RLF+ I KGK
Sbjct: 239 RLFEGIIKGK 248

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  137 bits (345), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 77/189 (40%), Positives = 108/189 (57%), Gaps = 18/189 (9%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 50  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 105
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ +CH N I+HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 106 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+W              PF    + 
Sbjct: 166 F-------------AGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 212
Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 213 RLYQQIKAG 221

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  136 bits (343), Expect = 9e-33,   Method: Compositional matrix adjust.
 Identities = 77/189 (40%), Positives = 108/189 (57%), Gaps = 18/189 (9%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 50  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 105
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ +CH N I+HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 106 SHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+W              PF    + 
Sbjct: 166 FA-------------GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQH 212
Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 213 RLYQQIKAG 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  132 bits (331), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/189 (40%), Positives = 108/189 (57%), Gaps = 18/189 (9%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 77  LEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 132
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH + Q+LE++ + H++DI+HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 133 SHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV+    YGKPVDIW              PF    + 
Sbjct: 193 FA-------------GTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQH 239
Query: 231 RLFQSITKG 239
           +L+Q I  G
Sbjct: 240 KLYQQIKAG 248

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  131 bits (329), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 75/189 (39%), Positives = 108/189 (57%), Gaps = 18/189 (9%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKH ++V L ++ S EG  Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 50  LEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVARE----YYSEADA 105
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LEA+ +CH+  ++HRD+KP  +LLA+K   A VKL  FG+AI++Q  Q    G
Sbjct: 106 SHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG 165
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV+  + YGKPVDIW              PF    + 
Sbjct: 166 FA-------------GTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQH 212
Query: 231 RLFQSITKG 239
           +L+Q I  G
Sbjct: 213 KLYQQIKAG 221

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  130 bits (328), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 74/189 (39%), Positives = 108/189 (57%), Gaps = 18/189 (9%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y++F+ + G ++  +IV R      YSEA A
Sbjct: 68  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADA 123
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LEA+ +CH+  ++HRD+KP  +LLA+K   A VKL  FG+AI+++  Q    G
Sbjct: 124 SHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 183
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+W              PF    + 
Sbjct: 184 -------------FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 230
Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 231 RLYQQIKAG 239

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  129 bits (324), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 73/189 (38%), Positives = 108/189 (57%), Gaps = 18/189 (9%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC +LKHP++V L ++ S EG  Y++F+ + G ++  +IV R      YSEA A
Sbjct: 57  LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE----YYSEADA 112
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LEA+ +CH+  ++HR++KP  +LLA+K   A VKL  FG+AI+++  Q    G
Sbjct: 113 SHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV+    YGKPVD+W              PF    + 
Sbjct: 173 FA-------------GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH 219
Query: 231 RLFQSITKG 239
           RL+Q I  G
Sbjct: 220 RLYQQIKAG 228

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  128 bits (322), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 65/158 (41%), Positives = 96/158 (60%), Gaps = 18/158 (11%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC  L+HP++V L ++   E   Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 75  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADA 130
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ YCH N I+HR++KP  +LLA+K   A VKL  FG+AI++ D + +   
Sbjct: 131 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 190
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                          GTP Y++PEV++   Y KPVDIW
Sbjct: 191 A--------------GTPGYLSPEVLKKDPYSKPVDIW 214

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  128 bits (322), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 71/189 (37%), Positives = 104/189 (55%), Gaps = 19/189 (10%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC  L+HP++V L ++   E   Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADA 107
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ YCH N I+HR++KP  +LLA+K   A VKL  FG+AI++ D + +   
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV++   Y KPVDIW              PF    + 
Sbjct: 168 A--------------GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213
Query: 231 RLFQSITKG 239
           RL+  I  G
Sbjct: 214 RLYAQIKAG 222

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  128 bits (321), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 71/189 (37%), Positives = 104/189 (55%), Gaps = 19/189 (10%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC  L+HP++V L ++   E   Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 52  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADA 107
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ YCH N I+HR++KP  +LLA+K   A VKL  FG+AI++ D + +   
Sbjct: 108 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 167
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV++   Y KPVDIW              PF    + 
Sbjct: 168 A--------------GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 213
Query: 231 RLFQSITKG 239
           RL+  I  G
Sbjct: 214 RLYAQIKAG 222

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  128 bits (321), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 71/189 (37%), Positives = 104/189 (55%), Gaps = 19/189 (10%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L+REA IC  L+HP++V L ++   E   Y+VF+ + G ++  +IV R      YSEA A
Sbjct: 51  LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE----FYSEADA 106
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           SH ++Q+LE++ YCH N I+HR++KP  +LLA+K   A VKL  FG+AI++ D + +   
Sbjct: 107 SHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGF 166
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRD 230
                          GTP Y++PEV++   Y KPVDIW              PF    + 
Sbjct: 167 A--------------GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH 212
Query: 231 RLFQSITKG 239
           RL+  I  G
Sbjct: 213 RLYAQIKAG 221

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 97.4 bits (241), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           ++   T +  L RE  +   L HP++++L E +  +G  Y+V E   G ++  EI+ R  
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               +SE  A+  +RQVL  + Y H+N I+HRD+KP  +LL +K   A +++  FG++  
Sbjct: 123 ----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXX 221
            +               + K   +IGT +Y+APEV+    Y +  D+W            
Sbjct: 179 FE--------------ASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223
Query: 222 XXPFVGSRD-RLFQSITKGK 240
             PF G+ +  + + + KGK
Sbjct: 224 CPPFNGANEYDILKKVEKGK 243

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           ++   T +  L RE  +   L HP++++L E +  +G  Y+V E   G ++  EI+ R  
Sbjct: 86  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 145
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               +SE  A+  +RQVL  + Y H+N I+HRD+KP  +LL +K   A +++  FG++  
Sbjct: 146 ----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 201
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXX 221
            +               + K   +IGT +Y+APEV+    Y +  D+W            
Sbjct: 202 FE--------------ASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 246
Query: 222 XXPFVGSRD-RLFQSITKGK 240
             PF G+ +  + + + KGK
Sbjct: 247 CPPFNGANEYDILKKVEKGK 266

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 97.4 bits (241), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           ++   T +  L RE  +   L HP++++L E +  +G  Y+V E   G ++  EI+ R  
Sbjct: 87  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 146
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               +SE  A+  +RQVL  + Y H+N I+HRD+KP  +LL +K   A +++  FG++  
Sbjct: 147 ----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 202
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXX 221
            +               + K   +IGT +Y+APEV+    Y +  D+W            
Sbjct: 203 FE--------------ASKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 247
Query: 222 XXPFVGSRD-RLFQSITKGK 240
             PF G+ +  + + + KGK
Sbjct: 248 CPPFNGANEYDILKKVEKGK 267

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E  ++ E  + H +KHP++V L + Y S G LY++ + + G ++   IV +   GF Y+E
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GF-YTE 115
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             AS  + QVL+A++Y H+  I+HRD+KP  +L  + +  + + +  FG++     G + 
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS 228
            +                GTP Y+APEV+  + Y K VD W              PF   
Sbjct: 176 STA--------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 221
Query: 229 RD-RLFQSITKGK 240
            D +LF+ I K +
Sbjct: 222 NDAKLFEQILKAE 234

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E  ++ E  + H +KHP++V L + Y S G LY++ + + G ++   IV +   GF Y+E
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GF-YTE 115
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             AS  + QVL+A++Y H+  I+HRD+KP  +L  + +  + + +  FG++     G + 
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS 228
            +                GTP Y+APEV+  + Y K VD W              PF   
Sbjct: 176 STA--------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 221
Query: 229 RD-RLFQSITKGK 240
            D +LF+ I K +
Sbjct: 222 NDAKLFEQILKAE 234

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           +   ++   T +  L RE  +   L HP++++L E +  +G  Y+V E   G ++  EI+
Sbjct: 65  ISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEII 124
Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
            R      +SE  A+  +RQVL  + Y H+N I+HRD+KP  +LL +K   A +++  FG
Sbjct: 125 SRKR----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFG 180
Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXX 217
           ++   +               + K   +IGT +Y+APEV+    Y +  D+W        
Sbjct: 181 LSTHFEA--------------SKKMKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYI 225
Query: 218 XXXXXXPFVGSRD-RLFQSITKGK 240
                 PF G+ +  + + + KGK
Sbjct: 226 LLSGCPPFNGANEYDILKKVEKGK 249

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E  ++ E  + H +KHP++V L + Y S G LY++ + + G ++   IV +   GF Y+E
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GF-YTE 115
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             AS  + QVL+A++Y H+  I+HRD+KP  +L  + +  + + +  FG++     G + 
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS 228
            +                GTP Y+APEV+  + Y K VD W              PF   
Sbjct: 176 STA--------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 221
Query: 229 RD-RLFQSITKGK 240
            D +LF+ I K +
Sbjct: 222 NDAKLFEQILKAE 234

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 97.1 bits (240), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 96/193 (49%), Gaps = 19/193 (9%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E  ++ E  + H +KHP++V L + Y S G LY++ + + G ++   IV +   GF Y+E
Sbjct: 60  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK---GF-YTE 115
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             AS  + QVL+A++Y H+  I+HRD+KP  +L  + +  + + +  FG++     G + 
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 175
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS 228
            +                GTP Y+APEV+  + Y K VD W              PF   
Sbjct: 176 STA--------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 221
Query: 229 RD-RLFQSITKGK 240
            D +LF+ I K +
Sbjct: 222 NDAKLFEQILKAE 234

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 96.7 bits (239), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           ++   T +  L RE  +   L HP++ +L E +  +G  Y+V E   G ++  EI+ R  
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               +SE  A+  +RQVL  + Y H+N I+HRD+KP  +LL +K   A +++  FG++  
Sbjct: 123 ----FSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXX 221
            +               + K   +IGT +Y+APEV+    Y +  D+W            
Sbjct: 179 FE--------------ASKKXKDKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSG 223
Query: 222 XXPFVGSRD-RLFQSITKGK 240
             PF G+ +  + + + KGK
Sbjct: 224 CPPFNGANEYDILKKVEKGK 243

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 95/192 (49%), Gaps = 20/192 (10%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           ++ L+ E  +   +KH ++V L + Y S    Y+V + + G ++   I+ R     VY+E
Sbjct: 50  DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTE 105
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             AS  ++QVL A++Y HEN I+HRD+KP  +L    E ++ + +  FG++   Q+G + 
Sbjct: 106 KDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS 165
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV-G 227
            +                GTP Y+APEV+  + Y K VD W              PF   
Sbjct: 166 TA---------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210
Query: 228 SRDRLFQSITKG 239
           +  +LF+ I +G
Sbjct: 211 TESKLFEKIKEG 222

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 101/195 (51%), Gaps = 20/195 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           ++ + L  E  +  +L HP++++L + +  +   Y+V E   G ++  EI+ R      +
Sbjct: 78  SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK----F 133
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           +E  A+  ++QVL  + Y H+++I+HRD+KP  +LL +KE  A +K+  FG++   ++ +
Sbjct: 134 NEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK 193
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
                         K   R+GT +Y+APEV+  +KY +  D+W              PF 
Sbjct: 194 --------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFG 238
Query: 227 GSRDR-LFQSITKGK 240
           G  D+ + + + KGK
Sbjct: 239 GQTDQEILRKVEKGK 253

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 94.0 bits (232), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 97/190 (51%), Gaps = 20/190 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E ++   L HP++++L + +  +   Y+V E+ +G ++  +I+ R      + E  A++ 
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANI 151
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           M+Q+L  + Y H+++I+HRDIKP  +LL NK +   +K+  FG++               
Sbjct: 152 MKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---------- 201
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDR-LF 233
                 K   R+GT +Y+APEV++ +KY +  D+W              PF G  D+ + 
Sbjct: 202 ----DYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDII 256
Query: 234 QSITKGKLHI 243
           + + KGK + 
Sbjct: 257 KKVEKGKYYF 266

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 5   DPNKRITIHEVINH-KW--LKMKLHTSAEIEPASFGLPDERLNHYTTEAD-LKREATICH 60
           D N+  T+   I    W  +K+ +     I  A+  +P     ++  + D  K+E  I  
Sbjct: 23  DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP----KYFVEDVDRFKQEIEIMK 78
Query: 61  MLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE 120
            L HP+++ L ET+     +Y+V E   G     E+  R     V+ E+ A+  M+ VL 
Sbjct: 79  SLDHPNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLS 134
Query: 121 ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTT 180
           A+ YCH+ ++ HRD+KP   L       +P+KL  FG+A + + G++  +          
Sbjct: 135 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---------- 184
Query: 181 KAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD 230
               ++GTP+Y++P+V+E   YG   D W              PF    D
Sbjct: 185 ----KVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 229

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 5   DPNKRITIHEVINH-KW--LKMKLHTSAEIEPASFGLPDERLNHYTTEAD-LKREATICH 60
           D N+  T+   I    W  +K+ +     I  A+  +P     ++  + D  K+E  I  
Sbjct: 6   DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIP----KYFVEDVDRFKQEIEIMK 61
Query: 61  MLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE 120
            L HP+++ L ET+     +Y+V E   G     E+  R     V+ E+ A+  M+ VL 
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLS 117
Query: 121 ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTT 180
           A+ YCH+ ++ HRD+KP   L       +P+KL  FG+A + + G++  +          
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---------- 167
Query: 181 KAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD 230
               ++GTP+Y++P+V+E   YG   D W              PF    D
Sbjct: 168 ----KVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 212

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 20/188 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +   L HP++++L E +  +   Y+V E   G ++  EI+ R      +SE  A+  
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK----FSEVDAAVI 109
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           M+QVL    Y H+++I+HRD+KP  +LL +K   A +K+  FG++   + G         
Sbjct: 110 MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--------- 160
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDR-LF 233
                 K   R+GT +Y+APEV+  +KY +  D+W              PF G  D+ + 
Sbjct: 161 -----GKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEIL 214
Query: 234 QSITKGKL 241
           + + KGK 
Sbjct: 215 KRVEKGKF 222

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 20/188 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +   L HP++++L E +  +   Y+V E   G ++  EI+ R      +SE  A+  
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK----FSEVDAAVI 126
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           M+QVL    Y H+++I+HRD+KP  +LL +K   A +K+  FG++   + G         
Sbjct: 127 MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--------- 177
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDR-LF 233
                 K   R+GT +Y+APEV+  +KY +  D+W              PF G  D+ + 
Sbjct: 178 -----GKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEIL 231
Query: 234 QSITKGKL 241
           + + KGK 
Sbjct: 232 KRVEKGKF 239

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 94/193 (48%), Gaps = 19/193 (9%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E+ ++ E  +   +KH ++V L + Y S   LY+V + + G ++   IV +   GF Y+E
Sbjct: 64  ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEK---GF-YTE 119
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             AS  +RQVL+A+ Y H   I+HRD+KP  +L  +++  + + +  FG++     G + 
Sbjct: 120 KDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM 179
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS 228
            +                GTP Y+APEV+  + Y K VD W              PF   
Sbjct: 180 STA--------------CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 225
Query: 229 RD-RLFQSITKGK 240
            D +LF+ I K +
Sbjct: 226 NDSKLFEQILKAE 238

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 21  LKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML 80
           +K+  HT+   + A   +  + L     +  ++RE +   +L+HPH+++L +   S+  +
Sbjct: 29  VKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88
Query: 81  YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCV 140
            MV EY  G+++   IV+R       SE  A  + +Q++ A+ YCH + I+HRD+KP  +
Sbjct: 89  IMVIEYA-GNELFDYIVQRDKM----SEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL 143
Query: 141 LLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ 200
           LL    N   VK+  FG++  + DG    +                G+P+Y APEVI  +
Sbjct: 144 LLDEHLN---VKIADFGLSNIMTDGNFLKTS--------------CGSPNYAAPEVISGK 186
Query: 201 KYGKP-VDIWXXXXXXXXXXXXXXPFVG-SRDRLFQSITKG 239
            Y  P VD+W              PF   S   LF++I+ G
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 227

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 21  LKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML 80
           +K+  HT+   + A   +  + L     +  ++RE +   +L+HPH+++L +   S+  +
Sbjct: 20  VKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 79
Query: 81  YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCV 140
            MV EY  G+++   IV+R       SE  A  + +Q++ A+ YCH + I+HRD+KP  +
Sbjct: 80  IMVIEYA-GNELFDYIVQRDKM----SEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL 134
Query: 141 LLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ 200
           LL    N   VK+  FG++  + DG    +                G+P+Y APEVI  +
Sbjct: 135 LLDEHLN---VKIADFGLSNIMTDGNFLKTS--------------CGSPNYAAPEVISGK 177
Query: 201 KYGKP-VDIWXXXXXXXXXXXXXXPFVG-SRDRLFQSITKG 239
            Y  P VD+W              PF   S   LF++I+ G
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 218

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 21  LKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML 80
           +K+  HT+   + A   +  + L     +  ++RE +   +L+HPH+++L +   S+  +
Sbjct: 30  VKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 89
Query: 81  YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCV 140
            MV EY  G+++   IV+R       SE  A  + +Q++ A+ YCH + I+HRD+KP  +
Sbjct: 90  IMVIEYA-GNELFDYIVQRDKM----SEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL 144
Query: 141 LLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ 200
           LL    N   VK+  FG++  + DG    +                G+P+Y APEVI  +
Sbjct: 145 LLDEHLN---VKIADFGLSNIMTDGNFLKTS--------------CGSPNYAAPEVISGK 187
Query: 201 KYGKP-VDIWXXXXXXXXXXXXXXPFVG-SRDRLFQSITKG 239
            Y  P VD+W              PF   S   LF++I+ G
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 228

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 91.3 bits (225), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 20/188 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP++++L E        Y+V E   G ++  EI++R      +SE  A+ 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAAR 125
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
            ++QV   + Y H+++I+HRD+KP  +LL +KE    +K+  FG++   Q          
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------- 177
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RL 232
                 TK   RIGT +Y+APEV+    Y +  D+W              PF G  +  +
Sbjct: 178 ------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
Query: 233 FQSITKGK 240
            + +  GK
Sbjct: 231 LKRVETGK 238

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 21  LKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML 80
           +K+  HT+   + A   +  + L     +  ++RE +   +L+HPH+++L +   S+  +
Sbjct: 24  VKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 83
Query: 81  YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCV 140
            MV EY  G+++   IV+R       SE  A  + +Q++ A+ YCH + I+HRD+KP  +
Sbjct: 84  IMVIEYA-GNELFDYIVQRDKM----SEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL 138
Query: 141 LLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ 200
           LL    N   VK+  FG++  + DG    +                G+P+Y APEVI  +
Sbjct: 139 LLDEHLN---VKIADFGLSNIMTDGNFLKTS--------------CGSPNYAAPEVISGK 181
Query: 201 KYGKP-VDIWXXXXXXXXXXXXXXPFVG-SRDRLFQSITKG 239
            Y  P VD+W              PF   S   LF++I+ G
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 222

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 20/188 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP++++L E        Y+V E   G ++  EI++R      +SE  A+ 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAAR 125
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
            ++QV   + Y H+++I+HRD+KP  +LL +KE    +K+  FG++   Q          
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------- 177
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RL 232
                 TK   RIGT +Y+APEV+    Y +  D+W              PF G  +  +
Sbjct: 178 ------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
Query: 233 FQSITKGK 240
            + +  GK
Sbjct: 231 LKRVETGK 238

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 89/188 (47%), Gaps = 20/188 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP++++L E        Y+V E   G ++  EI++R      +SE  A+ 
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR----FSEHDAAR 125
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
            ++QV   + Y H+++I+HRD+KP  +LL +KE    +K+  FG++   Q          
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------- 177
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RL 232
                 TK   RIGT +Y+APEV+    Y +  D+W              PF G  +  +
Sbjct: 178 ------TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230
Query: 233 FQSITKGK 240
            + +  GK
Sbjct: 231 LKRVETGK 238

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 90.9 bits (224), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           T+   L RE  I  +L HP++V+L E   +E  LY+V EY  G ++   +V         
Sbjct: 56  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRM---- 111
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
            E  A    RQ++ A++YCH+  I+HRD+K   +LL    N   +K+  FG + +     
Sbjct: 112 KEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMN---IKIADFGFSNEF---- 164
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIWXXXXXXXXXXXXXXPF 225
              + G +LD +        G+P Y APE+ + +KY  P VD+W              PF
Sbjct: 165 ---TVGNKLDTFC-------GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
Query: 226 VGSR-DRLFQSITKGKLHI 243
            G     L + + +GK  I
Sbjct: 215 DGQNLKELRERVLRGKYRI 233

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 90.5 bits (223), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 24/229 (10%)
Query: 17  NHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS 76
           N   +K+  H     E A   +   +LN  + +  L RE  I  +L HP++V+L E   +
Sbjct: 26  NFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEVIET 84
Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  LY+V EY  G ++   +V          E  A    RQ++ A++YCH+  I+HRD+K
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              +LL    N   +K+  FG + +        + G +LD +        G+P Y APE+
Sbjct: 141 AENLLLDADMN---IKIADFGFSNEF-------TFGNKLDEFC-------GSPPYAAPEL 183
Query: 197 IEDQKYGKP-VDIWXXXXXXXXXXXXXXPFVGSR-DRLFQSITKGKLHI 243
            + +KY  P VD+W              PF G     L + + +GK  I
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 94/199 (47%), Gaps = 23/199 (11%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           T+   L RE  I  +L HP++V+L E   +E  LY++ EY  G ++   +V         
Sbjct: 53  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRM---- 108
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
            E  A    RQ++ A++YCH+  I+HRD+K   +LL    N   +K+  FG + +     
Sbjct: 109 KEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNE----- 160
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIWXXXXXXXXXXXXXXPF 225
            +  GG +LD +        G+P Y APE+ + +KY  P VD+W              PF
Sbjct: 161 -FTVGG-KLDTFC-------GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 211
Query: 226 VGSR-DRLFQSITKGKLHI 243
            G     L + + +GK  I
Sbjct: 212 DGQNLKELRERVLRGKYRI 230

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 24/229 (10%)
Query: 17  NHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS 76
           N   +K+  H     E A   +   +LN  + +  L RE  I  +L HP++V+L E   +
Sbjct: 26  NFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEVIET 84
Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  LY+V EY  G ++   +V          E  A    RQ++ A++YCH+  I+HRD+K
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              +LL    N   +K+  FG + +        + G +LD +        G+P Y APE+
Sbjct: 141 AENLLLDADMN---IKIADFGFSNEF-------TFGNKLDTFC-------GSPPYAAPEL 183
Query: 197 IEDQKYGKP-VDIWXXXXXXXXXXXXXXPFVGSR-DRLFQSITKGKLHI 243
            + +KY  P VD+W              PF G     L + + +GK  I
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 24/229 (10%)
Query: 17  NHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS 76
           N   +K+  H     E A   +   +LN  + +  L RE  I  +L HP++V+L E   +
Sbjct: 26  NFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEVIET 84
Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  LY+V EY  G ++   +V          E  A    RQ++ A++YCH+  I+HRD+K
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              +LL    N   +K+  FG + +        + G +LD +        G+P Y APE+
Sbjct: 141 AENLLLDADMN---IKIADFGFSNEF-------TFGNKLDTFC-------GSPPYAAPEL 183
Query: 197 IEDQKYGKP-VDIWXXXXXXXXXXXXXXPFVGSR-DRLFQSITKGKLHI 243
            + +KY  P VD+W              PF G     L + + +GK  I
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 24/229 (10%)
Query: 17  NHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS 76
           N   +K+  H     E A   +   +LN  + +  L RE  I  +L HP++V+L E   +
Sbjct: 26  NFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEVIET 84
Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  LY+V EY  G ++   +V          E  A    RQ++ A++YCH+  I+HRD+K
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              +LL    N   +K+  FG + +        + G +LD +        G+P Y APE+
Sbjct: 141 AENLLLDADMN---IKIADFGFSNEF-------TFGNKLDTFC-------GSPPYAAPEL 183
Query: 197 IEDQKYGKP-VDIWXXXXXXXXXXXXXXPFVGSR-DRLFQSITKGKLHI 243
            + +KY  P VD+W              PF G     L + + +GK  I
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           T+   L RE  I  +L HP++V+L E   +E  LY++ EY  G ++   +V         
Sbjct: 56  TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRM---- 111
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
            E  A    RQ++ A++YCH+  I+HRD+K   +LL    N   +K+  FG + +     
Sbjct: 112 KEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNE----- 163
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIWXXXXXXXXXXXXXXPF 225
            +  GG +LD +        G P Y APE+ + +KY  P VD+W              PF
Sbjct: 164 -FTVGG-KLDAFC-------GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214
Query: 226 VGSR-DRLFQSITKGKLHI 243
            G     L + + +GK  I
Sbjct: 215 DGQNLKELRERVLRGKYRI 233

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 17  NHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS 76
           N   +K+  H     E A   +   +LN  + +  L RE  I  +L HP++V+L E   +
Sbjct: 26  NFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEVIET 84
Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  LY+V EY  G ++   +V          E  A    RQ++ A++YCH+  I+HRD+K
Sbjct: 85  EKTLYLVMEYASGGEVFDYLVAHGRM----KEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              +LL    N   +K+  FG + +        + G +LD +        G P Y APE+
Sbjct: 141 AENLLLDADMN---IKIADFGFSNEF-------TFGNKLDAFC-------GAPPYAAPEL 183
Query: 197 IEDQKYGKP-VDIWXXXXXXXXXXXXXXPFVGSR-DRLFQSITKGKLHI 243
            + +KY  P VD+W              PF G     L + + +GK  I
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 107/229 (46%), Gaps = 24/229 (10%)
Query: 17  NHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS 76
           N   +K+  H     E A   +   +LN  + +  L RE  I  +L HP++V+L E   +
Sbjct: 19  NFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIMKVLNHPNIVKLFEVIET 77
Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  LY+V EY  G ++   +V     G++  E  A    RQ++ A++YCH+  I+HRD+K
Sbjct: 78  EKTLYLVMEYASGGEVFDYLV---AHGWM-KEKEARAKFRQIVSAVQYCHQKFIVHRDLK 133
Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              +LL    N   +K+  FG + +        + G +LD +        G+P Y APE+
Sbjct: 134 AENLLLDADMN---IKIADFGFSNEF-------TFGNKLDTFC-------GSPPYAAPEL 176
Query: 197 IEDQKYGKP-VDIWXXXXXXXXXXXXXXPFVGSR-DRLFQSITKGKLHI 243
            + +KY  P VD+W              PF G     L + + +GK  I
Sbjct: 177 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 225

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 103/229 (44%), Gaps = 24/229 (10%)
Query: 17  NHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS 76
           N   +K+  H     E A   +   +LN  + +  L RE  I  +L HP++V+L E   +
Sbjct: 26  NFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQK-LFREVRIXKVLNHPNIVKLFEVIET 84
Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  LY+V EY  G ++   +V          E  A    RQ++ A++YCH+  I+HRD+K
Sbjct: 85  EKTLYLVXEYASGGEVFDYLVAHGRX----KEKEARAKFRQIVSAVQYCHQKFIVHRDLK 140
Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              +LL    N   +K+  FG + +        + G +LD +        G P Y APE+
Sbjct: 141 AENLLLDADXN---IKIADFGFSNEF-------TFGNKLDAFC-------GAPPYAAPEL 183
Query: 197 IEDQKYGKP-VDIWXXXXXXXXXXXXXXPFVGSR-DRLFQSITKGKLHI 243
            + +KY  P VD+W              PF G     L + + +GK  I
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 232

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           +RE  +   +KHP++V+  E++   G LY+V +Y +G D+   I   A  G ++ E    
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQIL 128
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            +  Q+  AL++ H+  I+HRDIK   + L        V+LG FG+A             
Sbjct: 129 DWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIA------------- 172
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             L+     A   IGTP+Y++PE+ E++ Y    DIW
Sbjct: 173 RVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIW 209

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 85/182 (46%), Gaps = 18/182 (9%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           ++ E  +   L HP++++L E + +   + +V E + G ++   IV +      YSE  A
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG----YYSERDA 150
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  ++Q+LEA+ Y HEN I+HRD+KP  +L A     AP+K+  FG++            
Sbjct: 151 ADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS------------ 198
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDR 231
             ++  +        GTP Y APE++    YG  VD+W              PF   R  
Sbjct: 199 --KIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD 256
Query: 232 LF 233
            F
Sbjct: 257 QF 258

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  +++        +KRE     + +HPH+++L +  S+    +MV EY+ G ++   I 
Sbjct: 44  LNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC 103
Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           +         E  A    +Q+L A+ YCH + ++HRD+KP  VLL    N+   K+  FG
Sbjct: 104 KHGRV----EEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA---KIADFG 156
Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIWXXXXXXX 216
           ++  + DG+   +                G+P+Y APEVI  + Y  P VDIW       
Sbjct: 157 LSNMMSDGEFLRTS--------------CGSPNYAAPEVISGRLYAGPEVDIWSCGVILY 202
Query: 217 XXXXXXXPFVGSR-DRLFQSITKGKLHI 243
                  PF       LF+ I  G  +I
Sbjct: 203 ALLCGTLPFDDEHVPTLFKKIRGGVFYI 230

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  +++        +KRE     + +HPH+++L +  S+    +MV EY+ G ++   I 
Sbjct: 44  LNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYIC 103
Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           +         E  A    +Q+L A+ YCH + ++HRD+KP  VLL    N+   K+  FG
Sbjct: 104 KHGRV----EEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA---KIADFG 156
Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIWXXXXXXX 216
           ++  + DG+                    G+P+Y APEVI  + Y  P VDIW       
Sbjct: 157 LSNMMSDGEFLRDS--------------CGSPNYAAPEVISGRLYAGPEVDIWSCGVILY 202
Query: 217 XXXXXXXPFVGSR-DRLFQSITKGKLHI 243
                  PF       LF+ I  G  +I
Sbjct: 203 ALLCGTLPFDDEHVPTLFKKIRGGVFYI 230

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 87/168 (51%), Gaps = 33/168 (19%)
Query: 54  REATI--CHMLK----HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           REAT    H+L+    HPH++ L+++Y S   +++VF+ M       E+    T     S
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALS 198
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E      MR +LEA+ + H N+I+HRD+KP  +LL   +++  ++L  FG +  L+ G+ 
Sbjct: 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGE- 254
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQK---YGKPVDIW 209
                        K     GTP Y+APE+++   D+    YGK VD+W
Sbjct: 255 -------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 29/199 (14%)
Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           A  K E  I   +KHP +V+L+  + + G LY++ EY+ G ++  ++ R      ++ E 
Sbjct: 66  AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFMED 121
Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDGQL- 167
            A  Y+ ++  AL + H+  II+RD+KP  ++L ++ +   VKL  FG+  + + DG + 
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVT 178
Query: 168 --YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
             +C                 GT  YMAPE++    + + VD W              PF
Sbjct: 179 HXFC-----------------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221
Query: 226 VG-SRDRLFQSITKGKLHI 243
            G +R +    I K KL++
Sbjct: 222 TGENRKKTIDKILKCKLNL 240

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 29/199 (14%)
Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           A  K E  I   +KHP +V+L+  + + G LY++ EY+ G ++  ++ R      ++ E 
Sbjct: 66  AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFMED 121
Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDGQL- 167
            A  Y+ ++  AL + H+  II+RD+KP  ++L ++ +   VKL  FG+  + + DG + 
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVT 178
Query: 168 --YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
             +C                 GT  YMAPE++    + + VD W              PF
Sbjct: 179 HTFC-----------------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221
Query: 226 VG-SRDRLFQSITKGKLHI 243
            G +R +    I K KL++
Sbjct: 222 TGENRKKTIDKILKCKLNL 240

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 22/159 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           ++RE     + +HPH+++L +  S+   ++MV EY+ G ++   I +         E  +
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKES 118
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
               +Q+L  + YCH + ++HRD+KP  VLL    N+   K+  FG++  + DG+     
Sbjct: 119 RRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNA---KIADFGLSNMMSDGEFLRXS 175
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIW 209
                          G+P+Y APEVI  + Y  P VDIW
Sbjct: 176 --------------CGSPNYAAPEVISGRLYAGPEVDIW 200

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 15/177 (8%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           ++ E  +   L HP+++++ E +     +Y+V E  +G ++   IV     G   SE   
Sbjct: 67  IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYV 126
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  M+Q++ AL Y H   ++H+D+KP  +L  +    +P+K+  FG+A      +L+ S 
Sbjct: 127 AELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA------ELFKS- 179
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS 228
               D ++T A    GT  YMAPEV +     K  DIW              PF G+
Sbjct: 180 ----DEHSTNAA---GTALYMAPEVFKRDVTFK-CDIWSAGVVMYFLLTGCLPFTGT 228

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 48  TEAD---LKREATICHMLKHPHVVELLETY--SSEGMLYMVFEYMDGSDICFEIVRRATA 102
           TEA+   L  E  +   LKHP++V   +     +   LY+V EY +G D+   I +    
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 103 GFVYSEAVASHYMRQVLEALRYCHEND-----IIHRDIKPHCVLLANKENSAPVKLGGFG 157
                E      M Q+  AL+ CH        ++HRD+KP  V L  K+N   VKLG FG
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFG 161
Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXX 217
           +A               L+H T+ A   +GTP+YM+PE +    Y +  DIW        
Sbjct: 162 LA-------------RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 218 XXXXXXPFVG-SRDRLFQSITKGKLH 242
                 PF   S+  L   I +GK  
Sbjct: 209 LCALMPPFTAFSQKELAGKIREGKFR 234

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 48  TEAD---LKREATICHMLKHPHVVELLETY--SSEGMLYMVFEYMDGSDICFEIVRRATA 102
           TEA+   L  E  +   LKHP++V   +     +   LY+V EY +G D+   I +    
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 103 GFVYSEAVASHYMRQVLEALRYCHEND-----IIHRDIKPHCVLLANKENSAPVKLGGFG 157
                E      M Q+  AL+ CH        ++HRD+KP  V L  K+N   VKLG FG
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFG 161
Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXX 217
           +A               L+H T+ A   +GTP+YM+PE +    Y +  DIW        
Sbjct: 162 LA-------------RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 218 XXXXXXPFVG-SRDRLFQSITKGKLH 242
                 PF   S+  L   I +GK  
Sbjct: 209 LCALMPPFTAFSQKELAGKIREGKFR 234

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 23/159 (14%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           ++RE +   +L+HPH+++L +  ++   + MV EY  G    + + ++       +E   
Sbjct: 56  VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKKRM-----TEDEG 110
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             + +Q++ A+ YCH + I+HRD+KP  +LL +  N   VK+  FG++  + DG    + 
Sbjct: 111 RRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN---VKIADFGLSNIMTDGNFLKTS 167
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIW 209
                          G+P+Y APEVI  + Y  P VD+W
Sbjct: 168 --------------CGSPNYAAPEVINGKLYAGPEVDVW 192

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 27/183 (14%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           EA LK    +  +  HP++++L +TY +    ++VF+ M   ++   +  + T     SE
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTL----SE 110
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 MR +LE +   H+ +I+HRD+KP  +LL +  N   +KL  FG + QL  G+  
Sbjct: 111 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGE-- 165
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK------YGKPVDIWXXXXXXXXXXXXX 222
                       K     GTP Y+APE+IE         YGK VD+W             
Sbjct: 166 ------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 213
Query: 223 XPF 225
            PF
Sbjct: 214 PPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 27/183 (14%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           EA LK    +  +  HP++++L +TY +    ++VF+ M   ++   +  + T     SE
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSE 123
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 MR +LE +   H+ +I+HRD+KP  +LL +  N   +KL  FG + QL  G+  
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGE-- 178
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIE------DQKYGKPVDIWXXXXXXXXXXXXX 222
                       K     GTP Y+APE+IE         YGK VD+W             
Sbjct: 179 ------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226
Query: 223 XPF 225
            PF
Sbjct: 227 PPF 229

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 27/183 (14%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           EA LK    +  +  HP++++L +TY +    ++VF+ M   ++   +  + T     SE
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSE 123
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 MR +LE +   H+ +I+HRD+KP  +LL +  N   +KL  FG + QL  G+  
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGE-- 178
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK------YGKPVDIWXXXXXXXXXXXXX 222
                       K     GTP Y+APE+IE         YGK VD+W             
Sbjct: 179 ------------KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226
Query: 223 XPF 225
            PF
Sbjct: 227 PPF 229

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 89/178 (50%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++RE +I   + HP+++ L + Y +   + ++ E + G ++ F+ + +  +    SE  
Sbjct: 61  EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL-FDFLAQKES---LSEEE 116
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++DG    
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---- 172
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                      +  +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 173 ----------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EYM G D+ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +K+  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EYM G D+ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +K+  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 5   DPNKRITIHEVINHK-----WLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATIC 59
           DP K+ T  E I        +  M + T  E+           +     +   K+E  I 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVA----------IRQMNLQQQPKKELIIN 66
Query: 60  HML-----KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
            +L     K+P++V  L++Y     L++V EY+ G  +   +           E   +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAV 121
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            R+ L+AL + H N +IHRDIK   +LL        VKL  FG   Q+   Q        
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ-------- 170
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                +K    +GTP++MAPEV+  + YG  VDIW
Sbjct: 171 -----SKRSEMVGTPYWMAPEVVTRKAYGPKVDIW 200

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 87/206 (42%), Gaps = 27/206 (13%)
Query: 48  TEAD---LKREATICHMLKHPHVVELLETY--SSEGMLYMVFEYMDGSDICFEIVRRATA 102
           TEA+   L  E  +   LKHP++V   +     +   LY+V EY +G D+   I +    
Sbjct: 45  TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE 104
Query: 103 GFVYSEAVASHYMRQVLEALRYCHEND-----IIHRDIKPHCVLLANKENSAPVKLGGFG 157
                E      M Q+  AL+ CH        ++HRD+KP  V L  K+N   VKLG FG
Sbjct: 105 RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFG 161
Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXX 217
           +A               L+H    A   +GTP+YM+PE +    Y +  DIW        
Sbjct: 162 LA-------------RILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYE 208
Query: 218 XXXXXXPFVG-SRDRLFQSITKGKLH 242
                 PF   S+  L   I +GK  
Sbjct: 209 LCALMPPFTAFSQKELAGKIREGKFR 234

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 5   DPNKRITIHEVINHK-----WLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATIC 59
           DP K+ T  E I        +  M + T  E+           +     +   K+E  I 
Sbjct: 18  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVA----------IRQMNLQQQPKKELIIN 67
Query: 60  HML-----KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
            +L     K+P++V  L++Y     L++V EY+ G  +   +           E   +  
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAV 122
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            R+ L+AL + H N +IHRDIK   +LL        VKL  FG   Q+   Q        
Sbjct: 123 CRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ-------- 171
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                +K    +GTP++MAPEV+  + YG  VDIW
Sbjct: 172 -----SKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 201

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 5   DPNKRITIHEVINHK-----WLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATIC 59
           DP K+ T  E I        +  M + T  E+           +     +   K+E  I 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVA----------IRQMNLQQQPKKELIIN 66
Query: 60  HML-----KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
            +L     K+P++V  L++Y     L++V EY+ G  +   +           E   +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAV 121
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            R+ L+AL + H N +IHRDIK   +LL        VKL  FG   Q+   Q        
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ-------- 170
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                +K    +GTP++MAPEV+  + YG  VDIW
Sbjct: 171 -----SKRSXMVGTPYWMAPEVVTRKAYGPKVDIW 200

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 91/215 (42%), Gaps = 41/215 (19%)
Query: 5   DPNKRITIHEVINHK-----WLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATIC 59
           DP K+ T  E I        +  M + T  E+           +     +   K+E  I 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVA----------IRQMNLQQQPKKELIIN 66
Query: 60  HML-----KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
            +L     K+P++V  L++Y     L++V EY+ G  +   +           E   +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAV 121
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            R+ L+AL + H N +IHRDIK   +LL        VKL  FG   Q+   Q        
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQ-------- 170
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                +K    +GTP++MAPEV+  + YG  VDIW
Sbjct: 171 -----SKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 200

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 29/187 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A  Y
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFY 110
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYCS 170
             +++ AL Y H  D+++RDIK   ++L   +    +K+  FG+  + + DG   + +C 
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFC- 166
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR- 229
                           GTP Y+APEV+ED  YG+ VD W              PF     
Sbjct: 167 ----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 230 DRLFQSI 236
           +RLF+ I
Sbjct: 211 ERLFELI 217

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 29/187 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A  Y
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFY 110
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYCS 170
             +++ AL Y H  D+++RDIK   ++L   +    +K+  FG+  + + DG   + +C 
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC- 166
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR- 229
                           GTP Y+APEV+ED  YG+ VD W              PF     
Sbjct: 167 ----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 230 DRLFQSI 236
           +RLF+ I
Sbjct: 211 ERLFELI 217

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 29/187 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A  Y
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFY 110
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYCS 170
             +++ AL Y H  D+++RDIK   ++L   +    +K+  FG+  + + DG   + +C 
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFC- 166
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR- 229
                           GTP Y+APEV+ED  YG+ VD W              PF     
Sbjct: 167 ----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 230 DRLFQSI 236
           +RLF+ I
Sbjct: 211 ERLFELI 217

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 29/187 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A  Y
Sbjct: 58  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFY 113
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYCS 170
             +++ AL Y H  D+++RDIK   ++L   +    +K+  FG+  + + DG   + +C 
Sbjct: 114 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC- 169
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR- 229
                           GTP Y+APEV+ED  YG+ VD W              PF     
Sbjct: 170 ----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 213
Query: 230 DRLFQSI 236
           +RLF+ I
Sbjct: 214 ERLFELI 220

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 29/187 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A  Y
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFY 110
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYCS 170
             +++ AL Y H  D+++RDIK   ++L   +    +K+  FG+  + + DG   + +C 
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFC- 166
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR- 229
                           GTP Y+APEV+ED  YG+ VD W              PF     
Sbjct: 167 ----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 230 DRLFQSI 236
           +RLF+ I
Sbjct: 211 ERLFELI 217

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 29/187 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A  Y
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFY 110
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYCS 170
             +++ AL Y H  D+++RDIK   ++L   +    +K+  FG+  + + DG   + +C 
Sbjct: 111 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFC- 166
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR- 229
                           GTP Y+APEV+ED  YG+ VD W              PF     
Sbjct: 167 ----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 230 DRLFQSI 236
           +RLF+ I
Sbjct: 211 ERLFELI 217

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           DE ++   TE  +  +A+      HP +V L   + +E  L+ V EY++G D+ F + R+
Sbjct: 61  DEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 115
Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E  A  Y  ++  AL Y HE  II+RD+K   VLL   ++   +KL  +G+ 
Sbjct: 116 RK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGM- 167
Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXX 219
                    C  G R    T+      GTP+Y+APE++  + YG  VD W          
Sbjct: 168 ---------CKEGLRPGDTTSXF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 215
Query: 220 XXXXPF--VGSRDR--------LFQSITKGKLHI 243
               PF  VGS D         LFQ I + ++ I
Sbjct: 216 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 249

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 85/187 (45%), Gaps = 29/187 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A  Y
Sbjct: 60  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFY 115
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYCS 170
             +++ AL Y H  D+++RDIK   ++L   +    +K+  FG+  + + DG   + +C 
Sbjct: 116 GAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKXFC- 171
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR- 229
                           GTP Y+APEV+ED  YG+ VD W              PF     
Sbjct: 172 ----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 215
Query: 230 DRLFQSI 236
           +RLF+ I
Sbjct: 216 ERLFELI 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           DE ++   TE  +  +A+      HP +V L   + +E  L+ V EY++G D+ F + R+
Sbjct: 93  DEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 147
Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E  A  Y  ++  AL Y HE  II+RD+K   VLL   ++   +KL  +G+ 
Sbjct: 148 RK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGM- 199
Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXX 219
                    C  G R    T+      GTP+Y+APE++  + YG  VD W          
Sbjct: 200 ---------CKEGLRPGDTTSTF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 247
Query: 220 XXXXPF--VGSRDR--------LFQSITKGKLHI 243
               PF  VGS D         LFQ I + ++ I
Sbjct: 248 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           DE ++   TE  +  +A+      HP +V L   + +E  L+ V EY++G D+ F + R+
Sbjct: 46  DEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 100
Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E  A  Y  ++  AL Y HE  II+RD+K   VLL   ++   +KL  +G+ 
Sbjct: 101 RK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGM- 152
Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXX 219
                    C  G R    T+      GTP+Y+APE++  + YG  VD W          
Sbjct: 153 ---------CKEGLRPGDTTSXF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 200
Query: 220 XXXXPF--VGSRDR--------LFQSITKGKLHI 243
               PF  VGS D         LFQ I + ++ I
Sbjct: 201 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 234

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           DE ++   TE  +  +A+      HP +V L   + +E  L+ V EY++G D+ F + R+
Sbjct: 50  DEDIDWVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 104
Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E  A  Y  ++  AL Y HE  II+RD+K   VLL   ++   +KL  +G+ 
Sbjct: 105 RK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGM- 156
Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXX 219
                    C  G R    T+      GTP+Y+APE++  + YG  VD W          
Sbjct: 157 ---------CKEGLRPGDTTSXF---CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM 204
Query: 220 XXXXPF--VGSRDR--------LFQSITKGKLHI 243
               PF  VGS D         LFQ I + ++ I
Sbjct: 205 AGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 238

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 88/180 (48%), Gaps = 18/180 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K E ++ + L H ++++L + + S+  + +V EY+DG ++   I+  +   +  +E  
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES---YNLTELD 188
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              +M+Q+ E +R+ H+  I+H D+KP  +L  N++ +  +K+  FG+A + +  +    
Sbjct: 189 TILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD-AKQIKIIDFGLARRYKPRE---- 243
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD 230
                     K     GTP ++APEV+       P D+W              PF+G  D
Sbjct: 244 ----------KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 26/191 (13%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +  ++ HP ++ +  T+     ++M+ +Y++G ++ F ++R++     +   VA  Y
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQR---FPNPVAKFY 111
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             +V  AL Y H  DII+RD+KP  +LL   + +  +K+  FG A               
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFA--------------- 153
Query: 175 LDHYTTKAGHRI-GTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RL 232
              Y     + + GTP Y+APEV+  + Y K +D W              PF  S   + 
Sbjct: 154 --KYVPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
Query: 233 FQSITKGKLHI 243
           ++ I   +L  
Sbjct: 212 YEKILNAELRF 222

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 77.8 bits (190), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 22/188 (11%)
Query: 43  LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATA 102
           L+ YT    +K E +I + L HP ++ L + +  +  + ++ E++ G ++     R A  
Sbjct: 90  LDKYT----VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---FDRIAAE 142
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
            +  SEA   +YMRQ  E L++ HE+ I+H DIKP  ++   K+ S+ VK+  FG+A +L
Sbjct: 143 DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATKL 201
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXX 222
              ++           TT       T  + APE+++ +  G   D+W             
Sbjct: 202 NPDEIV--------KVTT------ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 247
Query: 223 XPFVGSRD 230
            PF G  D
Sbjct: 248 SPFAGEDD 255

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L+H ++V LLE    +   Y+VFE++D +    + +     G  Y   V   
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT--ILDDLELFPNGLDYQ--VVQK 128
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q++  + +CH ++IIHRDIKP  +L++    S  VKL  FG A  L       + GE
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTL------AAPGE 179
Query: 174 RLDHYTTKAGHRIGTPHYMAPE-VIEDQKYGKPVDIW 209
             D         + T  Y APE ++ D KYGK VD+W
Sbjct: 180 VYD-------DEVATRWYRAPELLVGDVKYGKAVDVW 209

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 53/191 (27%), Positives = 79/191 (41%), Gaps = 16/191 (8%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
             AD  +E  +   L HP+V++   ++  +  L +V E  D  D+   I        +  
Sbjct: 75  ARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP 134
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E     Y  Q+  AL + H   ++HRDIKP  V +     +  VKLG  G+      G+ 
Sbjct: 135 ERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDLGL------GRF 185
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
           + S        TT A   +GTP+YM+PE I +  Y    DIW              PF G
Sbjct: 186 FSSK-------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 238
Query: 228 SRDRLFQSITK 238
            +  L+    K
Sbjct: 239 DKMNLYSLCKK 249

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++ E  I   L HP ++++   + +E   Y+V E M+G     E+  +        EA 
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVGNKRLKEAT 254
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  FG +  L        
Sbjct: 255 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-------- 306
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEV---IEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
            GE     T+      GTP Y+APEV   +    Y + VD W              PF  
Sbjct: 307 -GE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 360
Query: 228 SRDR--LFQSITKGKLHIL 244
            R +  L   IT GK + +
Sbjct: 361 HRTQVSLKDQITSGKYNFI 379

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 76/162 (46%), Gaps = 26/162 (16%)
Query: 53  KREATICHML-----KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           K+E  I  +L     K+P++V  L++Y     L++V EY+ G  +   +           
Sbjct: 61  KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-----MD 115
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E   +   R+ L+AL + H N +IHR+IK   +LL        VKL  FG   Q+   Q 
Sbjct: 116 EGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGM---DGSVKLTDFGFCAQITPEQ- 171
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                       +K    +GTP++MAPEV+  + YG  VDIW
Sbjct: 172 ------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIW 201

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 77.0 bits (188), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++ E  I   L HP ++++   + +E   Y+V E M+G     E+  +        EA 
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVGNKRLKEAT 240
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  FG +  L        
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-------- 292
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEV---IEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
            GE     T+      GTP Y+APEV   +    Y + VD W              PF  
Sbjct: 293 -GE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346
Query: 228 SRDR--LFQSITKGKLHIL 244
            R +  L   IT GK + +
Sbjct: 347 HRTQVSLKDQITSGKYNFI 365

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           ++E T+      P++     +Y     L+++ EY+ G     ++++         E   +
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGS-ALDLLKPGP----LEETYIA 119
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             +R++L+ L Y H    IHRDIK   VLL+ + +   VKL  FGVA QL D Q+     
Sbjct: 120 TILREILKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQI----- 171
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   K    +GTP +MAPEVI+   Y    DIW
Sbjct: 172 --------KRNXFVGTPFWMAPEVIKQSAYDFKADIW 200

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           ++E T+       +V +   +Y     L+++ EY+ G     +++R       + E   +
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGS-ALDLLRAGP----FDEFQIA 123
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             ++++L+ L Y H    IHRDIK   VLL+ + +   VKL  FGVA QL D Q+     
Sbjct: 124 TMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQI----- 175
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   K    +GTP +MAPEVI+   Y    DIW
Sbjct: 176 --------KRNTFVGTPFWMAPEVIQQSAYDSKADIW 204

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 24/199 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++ E  I   L HP ++++   + +E   Y+V E M+G     E+  +        EA 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVGNKRLKEAT 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  FG +  L +  L  +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEV---IEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                           GTP Y+APEV   +    Y + VD W              PF  
Sbjct: 176 --------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 228 SRDR--LFQSITKGKLHIL 244
            R +  L   IT GK + +
Sbjct: 222 HRTQVSLKDQITSGKYNFI 240

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 24/199 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++ E  I   L HP ++++   + +E   Y+V E M+G     E+  +        EA 
Sbjct: 60  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVGNKRLKEAT 114
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  FG +  L +  L  +
Sbjct: 115 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 174
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEV---IEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                           GTP Y+APEV   +    Y + VD W              PF  
Sbjct: 175 --------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220
Query: 228 SRDR--LFQSITKGKLHIL 244
            R +  L   IT GK + +
Sbjct: 221 HRTQVSLKDQITSGKYNFI 239

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 24/199 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++ E  I   L HP ++++   + +E   Y+V E M+G     E+  +        EA 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVGNKRLKEAT 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  FG +  L +  L  +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEV---IEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                           GTP Y+APEV   +    Y + VD W              PF  
Sbjct: 176 --------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 228 SRDR--LFQSITKGKLHIL 244
            R +  L   IT GK + +
Sbjct: 222 HRTQVSLKDQITSGKYNFI 240

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 24/199 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++ E  I   L HP ++++   + +E   Y+V E M+G     E+  +        EA 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVGNKRLKEAT 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  FG +  L +  L  +
Sbjct: 116 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 175
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEV---IEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                           GTP Y+APEV   +    Y + VD W              PF  
Sbjct: 176 --------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221
Query: 228 SRDR--LFQSITKGKLHIL 244
            R +  L   IT GK + +
Sbjct: 222 HRTQVSLKDQITSGKYNFI 240

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 24/199 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++ E  I   L HP ++++   + +E   Y+V E M+G     E+  +        EA 
Sbjct: 67  NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGG----ELFDKVVGNKRLKEAT 121
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  FG +  L +  L  +
Sbjct: 122 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT 181
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEV---IEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                           GTP Y+APEV   +    Y + VD W              PF  
Sbjct: 182 --------------LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227
Query: 228 SRDR--LFQSITKGKLHIL 244
            R +  L   IT GK + +
Sbjct: 228 HRTQVSLKDQITSGKYNFI 246

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/182 (21%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  +++RE  I   ++HP+++ L + + ++  + ++ E + G ++   +  + +     
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES----L 112
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           +E  A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++ G
Sbjct: 113 TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 172
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
             +               +  GTP ++APE++  +  G   D+W              PF
Sbjct: 173 NEF--------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 226 VG 227
           +G
Sbjct: 219 LG 220

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 21/157 (13%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           ++E T+      P+V +   +Y  +  L+++ EY+ G     +++          E   +
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP----LDETQIA 127
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             +R++L+ L Y H    IHRDIK   VLL+       VKL  FGVA QL D Q+     
Sbjct: 128 TILREILKGLDYLHSEKKIHRDIKAANVLLSE---HGEVKLADFGVAGQLTDTQI----- 179
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   K    +GTP +MAPEVI+   Y    DIW
Sbjct: 180 --------KRNTFVGTPFWMAPEVIKQSAYDSKADIW 208

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 29/161 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   LKHP++V LLE +  +  L++VFEY D + +  E+ R       Y   V  H
Sbjct: 51  REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDR-------YQRGVPEH 102
Query: 114 YMR----QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
            ++    Q L+A+ +CH+++ IHRD+KP  +L+      + +KL  FG A  L       
Sbjct: 103 LVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPS--- 156
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPE-VIEDQKYGKPVDIW 209
                 D+Y  +    + T  Y +PE ++ D +YG PVD+W
Sbjct: 157 ------DYYDDE----VATRWYRSPELLVGDTQYGPPVDVW 187

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 21/157 (13%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           ++E T+      P+V +   +Y  +  L+++ EY+ G     +++          E   +
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP----LDETQIA 122
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             +R++L+ L Y H    IHRDIK   VLL+       VKL  FGVA QL D Q+     
Sbjct: 123 TILREILKGLDYLHSEKKIHRDIKAANVLLSE---HGEVKLADFGVAGQLTDTQI----- 174
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   K    +GTP +MAPEVI+   Y    DIW
Sbjct: 175 --------KRNXFVGTPFWMAPEVIKQSAYDSKADIW 203

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/182 (21%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  +++RE  I   ++HP+++ L + + ++  + ++ E + G ++   +  + +     
Sbjct: 71  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES----L 126
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           +E  A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++ G
Sbjct: 127 TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 186
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
             +               +  GTP ++APE++  +  G   D+W              PF
Sbjct: 187 NEF--------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232
Query: 226 VG 227
           +G
Sbjct: 233 LG 234

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 21/157 (13%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           ++E T+      P+V +   +Y  +  L+++ EY+ G     +++          E   +
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP----LDETQIA 107
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             +R++L+ L Y H    IHRDIK   VLL+       VKL  FGVA QL D Q+     
Sbjct: 108 TILREILKGLDYLHSEKKIHRDIKAANVLLSE---HGEVKLADFGVAGQLTDTQI----- 159
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   K    +GTP +MAPEVI+   Y    DIW
Sbjct: 160 --------KRNXFVGTPFWMAPEVIKQSAYDSKADIW 188

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 73/157 (46%), Gaps = 21/157 (13%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           ++E T+      P+V +   +Y  +  L+++ EY+ G     +++          E   +
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPGP----LDETQIA 107
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             +R++L+ L Y H    IHRDIK   VLL+       VKL  FGVA QL D Q+     
Sbjct: 108 TILREILKGLDYLHSEKKIHRDIKAANVLLSE---HGEVKLADFGVAGQLTDTQI----- 159
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   K    +GTP +MAPEVI+   Y    DIW
Sbjct: 160 --------KRNTFVGTPFWMAPEVIKQSAYDSKADIW 188

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 40/182 (21%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  +++RE  I   ++HP+++ L + + ++  + ++ E + G ++   +  + +     
Sbjct: 50  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES----L 105
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           +E  A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++ G
Sbjct: 106 TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 165
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
             +               +  GTP ++APE++  +  G   D+W              PF
Sbjct: 166 NEF--------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211
Query: 226 VG 227
           +G
Sbjct: 212 LG 213

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  +++RE +I   + H +V+ L + Y +   + ++ E + G ++ F+ + +  +    
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-FDFLAQKES---L 112
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           SE  A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++DG
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
                          +  +  GTP ++APE++  +  G   D+W              PF
Sbjct: 173 --------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 226 VG 227
           +G
Sbjct: 219 LG 220

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  +++RE +I   + H +V+ L + Y +   + ++ E + G ++ F+ + +  +    
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-FDFLAQKES---L 112
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           SE  A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++DG
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
                          +  +  GTP ++APE++  +  G   D+W              PF
Sbjct: 173 --------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 226 VG 227
           +G
Sbjct: 219 LG 220

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 104 EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 159 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 211
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 212 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 247

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  +++RE +I   + H +V+ L + Y +   + ++ E + G ++   + ++ +     
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES----L 112
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           SE  A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++DG
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
                          +  +  GTP ++APE++  +  G   D+W              PF
Sbjct: 173 --------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 226 VG 227
           +G
Sbjct: 219 LG 220

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  +++RE +I   + H +V+ L + Y +   + ++ E + G ++ F+ + +  +    
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-FDFLAQKES---L 112
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           SE  A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++DG
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
                          +  +  GTP ++APE++  +  G   D+W              PF
Sbjct: 173 --------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 226 VG 227
           +G
Sbjct: 219 LG 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  +++RE +I   + H +V+ L + Y +   + ++ E + G ++ F+ + +  +    
Sbjct: 57  VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-FDFLAQKES---L 112
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           SE  A+ +++Q+L+ + Y H   I H D+KP  ++L +K    P +KL  FG+A +++DG
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
                          +  +  GTP ++APE++  +  G   D+W              PF
Sbjct: 173 --------------VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 226 VG 227
           +G
Sbjct: 219 LG 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 45  HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           H + +  +++E     +L+HP +V L + +  +  + M++E+M G ++ FE V  A    
Sbjct: 88  HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL-FEKV--ADEHN 144
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             SE  A  YMRQV + L + HEN+ +H D+KP  ++   K  S  +KL  FG+   L  
Sbjct: 145 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDP 203
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXP 224
            Q            + K     GT  + APEV E +  G   D+W              P
Sbjct: 204 KQ------------SVKV--TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 249
Query: 225 FVGSRD 230
           F G  D
Sbjct: 250 FGGEND 255

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 110 EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 164
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 165 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 217
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 218 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 253

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 60  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 115 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 167
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 168 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 203

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 60  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 115 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 167
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 168 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 203

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 66  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 120
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 121 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 173
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 174 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 209

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 64  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 118
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 119 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 171
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 172 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 207

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 65  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 119
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 120 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 172
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 173 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 208

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 18/186 (9%)
Query: 45  HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           H + +  +++E     +L+HP +V L + +  +  + M++E+M G ++ FE V  A    
Sbjct: 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL-FEKV--ADEHN 250
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             SE  A  YMRQV + L + HEN+ +H D+KP  ++   K  S  +KL  FG+   L  
Sbjct: 251 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDP 309
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXP 224
            Q            TT      GT  + APEV E +  G   D+W              P
Sbjct: 310 KQSV--------KVTT------GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
Query: 225 FVGSRD 230
           F G  D
Sbjct: 356 FGGEND 361

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 59  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 113
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 114 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 166
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 167 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 202

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 58  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 112
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 113 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 165
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 166 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 201

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 74  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 128
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 129 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 181
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D+W
Sbjct: 182 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDMW 217

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +K+  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 87/182 (47%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----L 111
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           +E  A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G
Sbjct: 112 TEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
             +               +  GTP ++APE++  +  G   D+W              PF
Sbjct: 172 NEF--------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 226 VG 227
           +G
Sbjct: 218 LG 219

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 58  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 112
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 113 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 165
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H          TP+Y+APEV+  +KY K  D+W
Sbjct: 166 -------KETTSH--NSLTEPCYTPYYVAPEVLGPEKYDKSCDMW 201

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 21/149 (14%)
Query: 65  PHVVELLETYSS----EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE 120
           PH+V +L+ Y +    +  L ++ E M+G ++   I  R    F  +E  A+  MR +  
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF--TEREAAEIMRDIGT 120
Query: 121 ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTT 180
           A+++ H ++I HRD+KP  +L  +KE  A +KL  FG A +     L             
Sbjct: 121 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP---------- 170
Query: 181 KAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  TP+Y+APEV+  +KY K  D+W
Sbjct: 171 -----CYTPYYVAPEVLGPEKYDKSCDMW 194

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 175 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 175 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 175 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 87/182 (47%), Gaps = 19/182 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
            +  D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----L 111
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDG 165
           +E  A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G
Sbjct: 112 TEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF 225
             +               +  GTP ++APE++  +  G   D+W              PF
Sbjct: 172 NEF--------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217
Query: 226 VG 227
           +G
Sbjct: 218 LG 219

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 175 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 114
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 174 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 175 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 59  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 114
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 115 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 173
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 174 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 175 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEE 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 175 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 88/181 (48%), Gaps = 19/181 (10%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +  D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++ F+ +    +    +
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL-FDFLAEKES---LT 112
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQ 166
           E  A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G 
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
            +               +  GTP ++APE++  +  G   D+W              PF+
Sbjct: 173 EF--------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 227 G 227
           G
Sbjct: 219 G 219

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 21/149 (14%)
Query: 65  PHVVELLETYSS----EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE 120
           PH+V +L+ Y +    +  L ++ E M+G ++   I  R    F  +E  A+  MR +  
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF--TEREAAEIMRDIGT 139
Query: 121 ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTT 180
           A+++ H ++I HRD+KP  +L  +KE  A +KL  FG A +     L             
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP---------- 189
Query: 181 KAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  TP+Y+APEV+  +KY K  D+W
Sbjct: 190 -----CYTPYYVAPEVLGPEKYDKSCDMW 213

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY  G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +K+  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIKVADFGFAKRVK----------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/181 (23%), Positives = 88/181 (48%), Gaps = 19/181 (10%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +  D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++ F+ +    +    +
Sbjct: 57  SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL-FDFLAEKES---LT 112
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQ 166
           E  A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G 
Sbjct: 113 EEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
            +               +  GTP ++APE++  +  G   D+W              PF+
Sbjct: 173 EF--------------KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218
Query: 227 G 227
           G
Sbjct: 219 G 219

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           K E  I   + HP +V+L   + +EG LY++ +++ G D    +  R +   +++E    
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVK 129
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y+ ++  AL + H   II+RD+KP  +LL   +    +KL  FG++             
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLS------------K 174
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS-RDR 231
           E +DH   KA    GT  YMAPEV+  + + +  D W              PF G  R  
Sbjct: 175 ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 232 LFQSITKGKL 241
               I K KL
Sbjct: 234 TMTMILKAKL 243

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I      P VV+L   +  +  LYMV EYM G D+         + +   E  A  Y
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFY 173
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGE 173
             +V+ AL   H    IHRD+KP  +LL   + S  +KL  FG  +++ ++G + C    
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTA- 229
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIW 209
                       +GTP Y++PEV++ Q     YG+  D W
Sbjct: 230 ------------VGTPDYISPEVLKSQGGDGYYGRECDWW 257

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 20/171 (11%)
Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
           ER + Y+    L  E  +   LKH ++V+ L ++S  G + +  E + G  +   ++R  
Sbjct: 57  ERDSRYSQP--LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS-ALLRSK 113
Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                 +E     Y +Q+LE L+Y H+N I+HRDIK   VL+     S  +K+  FG + 
Sbjct: 114 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT--YSGVLKISDFGTSK 171
Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIW 209
           +L  G   C+     + +T       GT  YMAPE+I+   + YGK  DIW
Sbjct: 172 RLA-GINPCT-----ETFT-------GTLQYMAPEIIDKGPRGYGKAADIW 209

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 18/185 (9%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           T +  +K+E +I ++ +H +++ L E++ S   L M+FE++ G DI FE  R  T+ F  
Sbjct: 43  TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI-FE--RINTSAFEL 99
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           +E     Y+ QV EAL++ H ++I H DI+P  ++   +  S+ +K+  FG A QL+ G 
Sbjct: 100 NEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGD 158
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFV 226
            +     RL             P Y APEV +        D+W              PF+
Sbjct: 159 NF-----RL---------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204
Query: 227 GSRDR 231
              ++
Sbjct: 205 AETNQ 209

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           K E  I   + HP +V+L   + +EG LY++ +++ G D    +  R +   +++E    
Sbjct: 75  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVK 130
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y+ ++  AL + H   II+RD+KP  +LL   +    +KL  FG++             
Sbjct: 131 FYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLS------------K 175
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS-RDR 231
           E +DH   KA    GT  YMAPEV+  + + +  D W              PF G  R  
Sbjct: 176 ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 234
Query: 232 LFQSITKGKL 241
               I K KL
Sbjct: 235 TMTMILKAKL 244

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 93/207 (44%), Gaps = 35/207 (16%)
Query: 57  TICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMR 116
           T+     + +++EL+E +  +   Y+VFE + G  I   I ++      ++E  AS  +R
Sbjct: 63  TLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKH----FNEREASRVVR 118
Query: 117 QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF--GVAIQLQDGQLYCSGGER 174
            V  AL + H   I HRD+KP  +L  + E  +PVK+  F  G  ++L +    C+    
Sbjct: 119 DVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNS---CT---- 171
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIE---DQK--YGKPVDIWXXXXXXXXXXXXXXPFVG-- 227
               T +     G+  YMAPEV+E   DQ   Y K  D+W              PFVG  
Sbjct: 172 -PITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHC 230
Query: 228 --------------SRDRLFQSITKGK 240
                          +++LF+SI +GK
Sbjct: 231 GADCGWDRGEVCRVCQNKLFESIQEGK 257

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 74.3 bits (181), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I      P VV+L   +  +  LYMV EYM G D+         + +   E  A  Y
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFY 178
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGE 173
             +V+ AL   H    IHRD+KP  +LL   + S  +KL  FG  +++ ++G + C    
Sbjct: 179 TAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTA- 234
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIW 209
                       +GTP Y++PEV++ Q     YG+  D W
Sbjct: 235 ------------VGTPDYISPEVLKSQGGDGYYGRECDWW 262

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++ G+ +      
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWXLA--- 199
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                       GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 200 ------------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I      P VV+L   +  +  LYMV EYM G D+         + +   E  A  Y
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-----NLMSNYDVPEKWARFY 178
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL-QDGQLYCSGGE 173
             +V+ AL   H    IHRD+KP  +LL   + S  +KL  FG  +++ ++G + C    
Sbjct: 179 TAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTA- 234
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIW 209
                       +GTP Y++PEV++ Q     YG+  D W
Sbjct: 235 ------------VGTPDYISPEVLKSQGGDGYYGRECDWW 262

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 85/171 (49%), Gaps = 20/171 (11%)
Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
           ER + Y+    L  E  +   LKH ++V+ L ++S  G + +  E + G  +   ++R  
Sbjct: 43  ERDSRYSQP--LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS-ALLRSK 99
Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                 +E     Y +Q+LE L+Y H+N I+HRDIK   VL+     S  +K+  FG + 
Sbjct: 100 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTY--SGVLKISDFGTSK 157
Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIW 209
           +L  G   C+     + +T       GT  YMAPE+I+   + YGK  DIW
Sbjct: 158 RLA-GINPCT-----ETFT-------GTLQYMAPEIIDKGPRGYGKAADIW 195

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 85/190 (44%), Gaps = 21/190 (11%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           K E  I   + HP +V+L   + +EG LY++ +++ G D    +  R +   +++E    
Sbjct: 74  KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVK 129
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y+ ++  AL + H   II+RD+KP  +LL   +    +KL  FG++             
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLS------------K 174
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS-RDR 231
           E +DH   KA    GT  YMAPEV+  + + +  D W              PF G  R  
Sbjct: 175 ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE 233
Query: 232 LFQSITKGKL 241
               I K KL
Sbjct: 234 TMTMILKAKL 243

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 21/175 (12%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
            HP + +L   + +   L+ V E+++G D+ F I +       + EA A  Y  +++ AL
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISAL 137
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            + H+  II+RD+K   VLL   ++    KL  FG+    ++G   C+G           
Sbjct: 138 MFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMC---KEG--ICNG--------VTT 181
Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRDRLFQSI 236
               GTP Y+APE++++  YG  VD W              PF   + D LF++I
Sbjct: 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY  G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +K+  FG+A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGLAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 139
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 140 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 185
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 186 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 240
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 241 EKIVSGKVRF 250

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 21/190 (11%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           K E  I   + HP VV+L   + +EG LY++ +++ G D    +  R +   +++E    
Sbjct: 78  KMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVK 133
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y+ ++   L + H   II+RD+KP  +LL   +    +KL  FG++             
Sbjct: 134 FYLAELALGLDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLS------------K 178
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRDR 231
           E +DH   KA    GT  YMAPEV+  Q +    D W              PF G  R  
Sbjct: 179 EAIDH-EKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKE 237
Query: 232 LFQSITKGKL 241
               I K KL
Sbjct: 238 TMTLILKAKL 247

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 42/178 (23%), Positives = 86/178 (48%), Gaps = 19/178 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E  
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKES----LTEEE 115
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  + 
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF- 174
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                         +  GTP ++APE++  +  G   D+W              PF+G
Sbjct: 175 -------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 167
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG---------- 214
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 215 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 268
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 269 EKIVSGKVRF 278

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 77  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 132
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++ G+ +      
Sbjct: 133 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT----- 183
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                       GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 184 ----------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 233
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 234 EKIVSGKVRF 243

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 86/190 (45%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++ G+ +      
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK-GRTWT----- 198
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                       GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 199 ----------LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 167
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGATWTLC---- 220
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                       GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 221 ------------GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 268
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 269 EKIVSGKVRF 278

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 90/220 (40%), Gaps = 54/220 (24%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFE-------------YMDGS------DI 92
           +K E  +   L HP++  L E Y  E  + +V E             ++D S      D+
Sbjct: 75  IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 93  -------CFEIVRRATAG----------FVYSEAVASHYMRQVLEALRYCHENDIIHRDI 135
                  C E    A  G          FV  E + S+ MRQ+  AL Y H   I HRDI
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 136 KPHCVLLANKENSAPVKLGGFGVA---IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYM 192
           KP   L +  + S  +KL  FG++    +L +G+ Y          TTKA    GTP+++
Sbjct: 195 KPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGEYY--------GMTTKA----GTPYFV 241
Query: 193 APEVIE--DQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD 230
           APEV+   ++ YG   D W              PF G  D
Sbjct: 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVND 281

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 78  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 133
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 134 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DEQGYIQVTDFGFAKRVK----------- 179
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 180 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 234
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 235 EKIVSGKVRF 244

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A          + G 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLA---------RAFGV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYT----HEVVTLWYRAPEILLGXKYYSTAVDIW 188

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY  G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +K+  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG---------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY  G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +K+  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG---------- 194
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 195 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 86/192 (44%), Gaps = 21/192 (10%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            E  +  +  +  + K P + +L   + +   LY V EY++G D+ + I +       + 
Sbjct: 63  VECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK----FK 118
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E  A  Y  ++   L + H+  II+RD+K   V+L   ++   +K+  FG+  +      
Sbjct: 119 EPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVML---DSEGHIKIADFGMCKE------ 169
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                  +D  TT+     GTP Y+APE+I  Q YGK VD W              PF G
Sbjct: 170 -----HMMDGVTTR--EFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 222
Query: 228 -SRDRLFQSITK 238
              D LFQSI +
Sbjct: 223 EDEDELFQSIME 234

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 58  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 114
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A          + G 
Sbjct: 115 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLA---------RAFGV 162
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 163 PVRTYT----HEVVTLWYRAPEILLGXKYYSTAVDIW 195

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF      +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADEPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 20/148 (13%)
Query: 62  LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           +KHP +V L  ++ +   LY V +Y++G ++ + + R       + E  A  Y  ++  A
Sbjct: 96  VKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASA 151
Query: 122 LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK 181
           L Y H  +I++RD+KP  +LL   ++   + L  FG+          C   E ++H +T 
Sbjct: 152 LGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGL----------CK--ENIEHNSTT 196
Query: 182 AGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           +    GTP Y+APEV+  Q Y + VD W
Sbjct: 197 STF-CGTPEYLAPEVLHKQPYDRTVDWW 223

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 29/160 (18%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +    +HP +  L  ++ +   L  V EY +G ++ F + R      V+SE  A  Y
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFY 253
Query: 115 MRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYC 169
             +++ AL Y H E ++++RD+K   ++L   +    +K+  FG+  + ++DG   + +C
Sbjct: 254 GAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFC 310
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            GTP Y+APEV+ED  YG+ VD W
Sbjct: 311 -----------------GTPEYLAPEVLEDNDYGRAVDWW 333

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 30/188 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +    +HP +  L  ++ +   L  V EY +G ++ F + R      V+SE  A  Y
Sbjct: 201 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFY 256
Query: 115 MRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYC 169
             +++ AL Y H E ++++RD+K   ++L   +    +K+  FG+  + ++DG   + +C
Sbjct: 257 GAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFC 313
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR 229
                            GTP Y+APEV+ED  YG+ VD W              PF    
Sbjct: 314 -----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 356
Query: 230 -DRLFQSI 236
            ++LF+ I
Sbjct: 357 HEKLFELI 364

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      ++E  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FAEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY  G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +++  FG+A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIQVTDFGLAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 108 YLFQLLQGLSFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 84/190 (44%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLII---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 50  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 106
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 154
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 155 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 187

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 30/188 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +    +HP +  L  ++ +   L  V EY +G ++ F + R      V+SE  A  Y
Sbjct: 59  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFY 114
Query: 115 MRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYC 169
             +++ AL Y H E ++++RD+K   ++L   +    +K+  FG+  + ++DG   + +C
Sbjct: 115 GAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFC 171
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS- 228
                            GTP Y+APEV+ED  YG+ VD W              PF    
Sbjct: 172 -----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 214
Query: 229 RDRLFQSI 236
            ++LF+ I
Sbjct: 215 HEKLFELI 222

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 30/188 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +    +HP +  L  ++ +   L  V EY +G ++ F + R      V+SE  A  Y
Sbjct: 58  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFY 113
Query: 115 MRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYC 169
             +++ AL Y H E ++++RD+K   ++L   +    +K+  FG+  + ++DG   + +C
Sbjct: 114 GAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFC 170
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS- 228
                            GTP Y+APEV+ED  YG+ VD W              PF    
Sbjct: 171 -----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 213
Query: 229 RDRLFQSI 236
            ++LF+ I
Sbjct: 214 HEKLFELI 221

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 108
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 156
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 157 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 189

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 50  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 106
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 154
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 155 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 187

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY  G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIQVTDFGFAKRVKG---------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 50  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 106
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 154
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 155 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 187

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 58  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 114
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 115 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 162
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 163 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 195

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/188 (27%), Positives = 87/188 (46%), Gaps = 30/188 (15%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +    +HP +  L  ++ +   L  V EY +G ++ F + R      V+SE  A  Y
Sbjct: 60  ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFY 115
Query: 115 MRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ-LQDG---QLYC 169
             +++ AL Y H E ++++RD+K   ++L   +    +K+  FG+  + ++DG   + +C
Sbjct: 116 GAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKXFC 172
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSR 229
                            GTP Y+APEV+ED  YG+ VD W              PF    
Sbjct: 173 -----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 215
Query: 230 -DRLFQSI 236
            ++LF+ I
Sbjct: 216 HEKLFELI 223

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 24/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEY--MDGSDICFEIVRRATAGFVYSEAVA 111
           RE ++   L HP++V+LL+   +E  LY+VFE+  MD  D        A+A       + 
Sbjct: 53  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM-----DASALTGIPLPLI 107
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            
Sbjct: 108 KSYLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF--------- 155
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           G  +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 156 GVPVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 190

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 25/165 (15%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 104 EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAF 158
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E  AS   + + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A     
Sbjct: 159 --TEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----- 211
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   E   H +        TP+Y+APEV+  +KY K  D W
Sbjct: 212 -------KETTSHNSLTTP--CYTPYYVAPEVLGPEKYDKSCDXW 247

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P + +L  ++     LYMV EY  G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +K+  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG---------- 194
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 195 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 24/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEY--MDGSDICFEIVRRATAGFVYSEAVA 111
           RE ++   L HP++V+LL+   +E  LY+VFE+  MD  D        A+A       + 
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFM-----DASALTGIPLPLI 108
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            
Sbjct: 109 KSYLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF--------- 156
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           G  +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 157 GVPVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 191

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P + +L  ++     LYMV EY  G ++ F  +RR      +SE  A  Y
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FSEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +K+  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG---------- 194
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 195 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FXEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG---------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 86  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FXEPHARFY 141
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 142 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 187
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 188 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 242
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 243 EKIVSGKVRF 252

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FXEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FXEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG---------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FXEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FXEPHARFY 167
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 168 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG---------- 214
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 215 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 268
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 269 EKIVSGKVRF 278

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 84  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FXEPHARFY 139
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 140 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 185
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 186 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 240
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 241 EKIVSGKVRF 250

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FXEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      + E  A  Y
Sbjct: 92  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM-FSHLRRIGR---FXEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKG---------- 194
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 195 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 55  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLP--LIKS 111
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 159
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 160 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 192

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY    ++  E+ + + 
Sbjct: 50  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK 109
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 110 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 162
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 163 AP---------------SSRRXXLXGTLDYLPPEMIEGRMHDEKVDLW 195

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 82/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY  G ++ F  +RR      + E  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FXEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +K+  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG---------- 193
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 194 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            E  L+RE  I   L+HP+++ +   +     +Y++ E+    ++  E+ +       + 
Sbjct: 58  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FD 113
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E  ++ +M ++ +AL YCHE  +IHRDIKP  +L+  K     +K+  FG ++       
Sbjct: 114 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAP---- 166
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                      + +     GT  Y+ PE+IE + + + VD+W
Sbjct: 167 -----------SLRRRXMCGTLDYLPPEMIEGKTHDEKVDLW 197

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I      P VV+L   +  +  LYMV EYM G D+         + +   E  A  Y
Sbjct: 125 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLV-----NLMSNYDVPEKWAKFY 179
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD-GQLYCSGGE 173
             +V+ AL   H   +IHRD+KP  +LL   +    +KL  FG  +++ + G ++C    
Sbjct: 180 TAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVHCDTA- 235
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIW 209
                       +GTP Y++PEV++ Q     YG+  D W
Sbjct: 236 ------------VGTPDYISPEVLKSQGGDGYYGRECDWW 263

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++D  D+   +   A  G      +   
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLP--LIKS 110
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 158
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 159 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 191

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+AP +I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            E  L+RE  I   L+HP+++ +   +     +Y++ E+    ++  E+ +       + 
Sbjct: 57  VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FD 112
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E  ++ +M ++ +AL YCHE  +IHRDIKP  +L+  K     +K+  FG ++       
Sbjct: 113 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYK---GELKIADFGWSVHAP---- 165
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                      + +     GT  Y+ PE+IE + + + VD+W
Sbjct: 166 -----------SLRRRXMCGTLDYLPPEMIEGKTHDEKVDLW 196

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++      F     A+A       +   
Sbjct: 50  REISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTF---MDASALTGIPLPLIKS 106
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 154
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  YT    H + T  Y APE++   K Y   VDIW
Sbjct: 155 PVRTYT----HEVVTLWYRAPEILLGCKYYSTAVDIW 187

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 93/189 (49%), Gaps = 29/189 (15%)
Query: 49  EADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           EA+ ++E T   + + HP++V+L E +  +   ++V E ++G ++ FE +++      +S
Sbjct: 49  EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL-FERIKKKKH---FS 104
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQ 166
           E  AS+ MR+++ A+ + H+  ++HRD+KP  +L  ++ ++  +K+  FG A ++  D Q
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 167 LYCSGGERLDHYTTKAGHRIGTP----HYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXX 222
                              + TP    HY APE++    Y +  D+W             
Sbjct: 165 ------------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206
Query: 223 XPFVGSRDR 231
            PF  S DR
Sbjct: 207 VPF-QSHDR 214

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 80/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY    ++  E+ + + 
Sbjct: 50  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSK 109
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 110 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 162
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 163 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 195

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/170 (33%), Positives = 77/170 (45%), Gaps = 22/170 (12%)
Query: 43  LNHYTTEADLK---REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           +     E+DL+   +E +I      PHVV+   +Y     L++V EY  G+    +I+R 
Sbjct: 59  IKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC-GAGSVSDIIRL 117
Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E   +  ++  L+ L Y H    IHRDIK   +LL N E  A  KL  FGVA
Sbjct: 118 RNKTLTEDEI--ATILQSTLKGLEYLHFMRKIHRDIKAGNILL-NTEGHA--KLADFGVA 172
Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            QL D                K    IGTP +MAPEVI++  Y    DIW
Sbjct: 173 GQLTD-------------XMAKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 45  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK 104
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 105 ----FDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLG---SAGELKIADFGWSVH 157
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 158 AP---------------SSRRAALCGTLDYLPPEMIEGRMHDEKVDLW 190

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           ++ E  I   LKHP ++EL   +     +Y+V E     ++   +  R      +SE  A
Sbjct: 58  VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEA 114
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
            H+M Q++  + Y H + I+HRD+    +LL    N   +K+  FG+A QL+        
Sbjct: 115 RHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLK-------- 163
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                HYT       GTP+Y++PE+     +G   D+W
Sbjct: 164 MPHEKHYTL-----CGTPNYISPEIATRSAHGLESDVW 196

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP+++ L + Y     +Y+V E M G ++  +I+R+      +SE  AS  +  + + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----FFSEREASAVLFTITKTV 129
Query: 123 RYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGGFGVAIQL--QDGQLYCSGGERLDHYT 179
            Y H   ++HRD+KP  +L  ++  N   +++  FG A QL  ++G L            
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP--------- 180
Query: 180 TKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD----RLFQS 235
                   T +++APEV+E Q Y    DIW              PF    D     +   
Sbjct: 181 ------CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234
Query: 236 ITKGKLHILG 245
           I  GK  + G
Sbjct: 235 IGSGKFSLSG 244

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 50  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 109
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 110 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV- 161
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 +     R D          GT  Y+ PE+IE + + + VD+W
Sbjct: 162 ------HAPSSRRTD--------LCGTLDYLPPEMIEGRMHDEKVDLW 195

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 78/157 (49%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++      F     A+A       +   
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTF---MDASALTGIPLPLIKS 110
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 158
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 159 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 191

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 46  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 105
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 106 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV- 157
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 +     R D          GT  Y+ PE+IE + + + VD+W
Sbjct: 158 ------HAPSSRRTD--------LCGTLDYLPPEMIEGRMHDEKVDLW 191

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 45  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 104
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 105 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV- 156
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 +     R D          GT  Y+ PE+IE + + + VD+W
Sbjct: 157 ------HAPSSRRTD--------LCGTLDYLPPEMIEGRMHDEKVDLW 190

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 36/178 (20%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEI 96
           +E L  Y  E D      I     HP++V+LL+ +  E  L+++ E+  G     +  E+
Sbjct: 75  EEELEDYMVEID------ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL 128
Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R  T      E+      +Q L+AL Y H+N IIHRD+K   +L         +KL  F
Sbjct: 129 ERPLT------ESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADF 179
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIW 209
           GV+ +           +R D +       IGTP++MAPEV+     +D+ Y    D+W
Sbjct: 180 GVSAK------NTRTIQRRDSF-------IGTPYWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++    +  +    A+A       +   
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKS 108
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPEN-LLINTEGA--IKLADFGLARAF---------GV 156
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 157 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 189

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 45  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 104
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 105 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV- 156
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 +     R D          GT  Y+ PE+IE + + + VD+W
Sbjct: 157 ------HAPSSRRTD--------LCGTLDYLPPEMIEGRMHDEKVDLW 190

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 17/183 (9%)
Query: 50  ADLKREATICHMLKH-PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           A++  E  +  + K  P V+ L E Y +   + ++ EY  G +I F +     A  V SE
Sbjct: 73  AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI-FSLCLPELAEMV-SE 130
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 ++Q+LE + Y H+N+I+H D+KP  +LL++      +K+  FG++         
Sbjct: 131 NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS--------- 181
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS 228
                R   +  +    +GTP Y+APE++         D+W              PFVG 
Sbjct: 182 -----RKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGE 236
Query: 229 RDR 231
            ++
Sbjct: 237 DNQ 239

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 36/178 (20%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEI 96
           +E L  Y  E D      I     HP++V+LL+ +  E  L+++ E+  G     +  E+
Sbjct: 75  EEELEDYMVEID------ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL 128
Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R  T      E+      +Q L+AL Y H+N IIHRD+K   +L         +KL  F
Sbjct: 129 ERPLT------ESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADF 179
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIW 209
           GV+ +           +R D +       IGTP++MAPEV+     +D+ Y    D+W
Sbjct: 180 GVSAK------NTRXIQRRDSF-------IGTPYWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 48  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 108 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 160
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 161 AP---------------SSRRAALCGTLDYLPPEMIEGRMHDEKVDLW 193

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++    +  +    A+A       +   
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKS 110
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPEN-LLINTEGA--IKLADFGLARAF---------GV 158
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 159 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 191

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 45  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 104
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 105 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 157
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 158 AP---------------SSRRAALCGTLDYLPPEMIEGRMHDEKVDLW 190

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 36/178 (20%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEI 96
           +E L  Y  E D      I     HP++V+LL+ +  E  L+++ E+  G     +  E+
Sbjct: 75  EEELEDYMVEID------ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL 128
Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R  T      E+      +Q L+AL Y H+N IIHRD+K   +L         +KL  F
Sbjct: 129 ERPLT------ESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADF 179
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIW 209
           GV+ +           +R D +       IGTP++MAPEV+     +D+ Y    D+W
Sbjct: 180 GVSAK------NTRXIQRRDXF-------IGTPYWMAPEVVMCETSKDRPYDYKADVW 224

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 45  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 104
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 105 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 157
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 158 AP---------------SSRRTELCGTLDYLPPEMIEGRMHDEKVDLW 190

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 47  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 106
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 107 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIANFGWSVH 159
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 160 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 192

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           K P + +L   + +   LY V EY++G D+ + I +       + E  A  Y  ++   L
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGL 134
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            +     II+RD+K   V+L   ++   +K+  FG+  +              D  TTK 
Sbjct: 135 FFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE-----------NIWDGVTTKX 180
Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRDRLFQSI 236
               GTP Y+APE+I  Q YGK VD W              PF G   D LFQSI
Sbjct: 181 --FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGR---FSEPHARFY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +L+   +    +++  FG A +++           
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK----------- 192
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP  +APE+I  + Y K VD W              PF   +  +++
Sbjct: 193 -----GRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 248 EKIVSGKVRF 257

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 71  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 130
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 131 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 183
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 184 AP---------------SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLW 216

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 48  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 108 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIANFGWSVH 160
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 161 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 193

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 48  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 108 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 160
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 161 AP---------------SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLW 193

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 45  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 104
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 105 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 157
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 158 AP---------------SSRRTXLCGTLDYLPPEMIEGRMHDEKVDLW 190

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 55  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 111
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 159
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 160 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 192

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 79/159 (49%), Gaps = 24/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYM--DGSDICFEIVRRATAGFVYSEAVA 111
           RE ++   L HP++V+LL+   +E  LY+VFE++  D  D        A+A       + 
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFM-----DASALTGIPLPLI 105
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            
Sbjct: 106 KSYLFQLLQGLAFCHSHRVLHRDLKPEN-LLINTEGA--IKLADFGLARAF--------- 153
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           G  +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 154 GVPVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 81/190 (42%), Gaps = 24/190 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P + +L  ++     LYMV EY  G ++ F  +RR      + E  A  Y
Sbjct: 92  EKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM-FSHLRRIGR---FXEPHARFY 147
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++    Y H  D+I+RD+KP  +++   +    +K+  FG A +++           
Sbjct: 148 AAQIVLTFEYLHSLDLIYRDLKPENLMI---DQQGYIKVTDFGFAKRVKG---------- 194
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD-RLF 233
                 +     GTP Y+APE+I  + Y K VD W              PF   +  +++
Sbjct: 195 ------RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 248
Query: 234 QSITKGKLHI 243
           + I  GK+  
Sbjct: 249 EKIVSGKVRF 258

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 108
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 156
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 157 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 189

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 77/175 (44%), Gaps = 21/175 (12%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           K P + +L   + +   LY V EY++G D+ + I +       + E  A  Y  ++   L
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGL 455
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            +     II+RD+K   V+L   ++   +K+  FG+  +              D  TTK 
Sbjct: 456 FFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKE-----------NIWDGVTTKX 501
Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRDRLFQSI 236
               GTP Y+APE+I  Q YGK VD W              PF G   D LFQSI
Sbjct: 502 --FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 554

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 47  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 106
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 107 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 159
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 160 AP---------------SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLW 192

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 53  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 109
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 110 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 157
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 158 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 190

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 51  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 107
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 108 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 155
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 156 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 188

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 45  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 104
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 105 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 157
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 158 AP---------------SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLW 190

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           EA    E  I   +    VV L   Y ++  L +V   M+G D+ F I     AGF   E
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF--PE 285
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           A A  Y  ++   L   H   I++RD+KP  +LL   ++   +++   G+A+ + +GQ  
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ-- 340
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                     T K   R+GT  YMAPEV+++++Y    D W
Sbjct: 341 ----------TIKG--RVGTVGYMAPEVVKNERYTFSPDWW 369

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 110
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 158
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 159 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 191

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 53  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 109
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 110 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 157
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 158 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 190

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 50  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 106
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 154
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 155 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 187

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 50  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 106
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 107 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 154
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 155 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 187

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 54  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 110
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 111 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 158
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 159 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 191

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 48  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 108 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 160
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 161 AP---------------SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLW 193

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 46  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 105
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 106 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 158
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 159 AP---------------SSRRDTLCGTLDYLPPEMIEGRMHDEKVDLW 191

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 19/161 (11%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           EA    E  I   +    VV L   Y ++  L +V   M+G D+ F I     AGF   E
Sbjct: 228 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF--PE 285
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           A A  Y  ++   L   H   I++RD+KP  +LL   ++   +++   G+A+ + +GQ  
Sbjct: 286 ARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ-- 340
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                     T K   R+GT  YMAPEV+++++Y    D W
Sbjct: 341 ----------TIKG--RVGTVGYMAPEVVKNERYTFSPDWW 369

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 108
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPQN-LLINTEGA--IKLADFGLARAF---------GV 156
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 157 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 189

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 48  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 108 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 160
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 161 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 193

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 50  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 109
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 110 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 162
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 163 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 195

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 62  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 121
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 122 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 174
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 175 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 49  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR 108
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 109 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SNGELKIADFGWSVH 161
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 162 AP---------------SSRRDTLCGTLDYLPPEMIEGRMHDEKVDLW 194

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 44  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 103
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 104 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 156
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 157 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 189

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 48  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 107
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 108 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 160
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 161 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 193

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 49  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 108
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 109 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 161
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 162 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 194

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 45  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 104
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 105 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 157
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 158 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 190

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 78/168 (46%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 50  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 109
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 110 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 162
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE IE + + + VD+W
Sbjct: 163 AP---------------SSRRTTLCGTLDYLPPEXIEGRXHDEKVDLW 195

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 71  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 130
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 131 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 183
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 184 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 216

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 52  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLP--LIKS 108
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 109 YLFQLLQGLAFCHSHRVLHRDLKPEN-LLINTEGA--IKLADFGLARAF---------GV 156
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 157 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 189

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 49  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSR 108
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 109 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SNGELKIADFGWSVH 161
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 162 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 194

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 79/157 (50%), Gaps = 20/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V+LL+   +E  LY+VFE++   D+   +   A  G      +   
Sbjct: 53  REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGI--PLPLIKS 109
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L+ L +CH + ++HRD+KP   LL N E +  +KL  FG+A            G 
Sbjct: 110 YLFQLLQGLAFCHSHRVLHRDLKPEN-LLINTEGA--IKLADFGLARAF---------GV 157
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y     H + T  Y APE++   K Y   VDIW
Sbjct: 158 PVRTYX----HEVVTLWYRAPEILLGCKYYSTAVDIW 190

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 42  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 101
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG ++ 
Sbjct: 102 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSVH 154
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                            +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 155 AP---------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLW 187

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 20/159 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV--YSEAVA 111
           RE ++   LKH ++V L +   +E  L +VFE+MD +D+   +  R            + 
Sbjct: 52  REISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLV 110
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
            ++  Q+L+ L +CHEN I+HRD+KP  +L+  +     +KLG FG+A            
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKR---GQLKLGDFGLARAF--------- 158
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           G  ++ ++++    + T  Y AP+V+   + Y   +DIW
Sbjct: 159 GIPVNTFSSE----VVTLWYRAPDVLMGSRTYSTSIDIW 193

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 79/181 (43%), Gaps = 26/181 (14%)
Query: 54  REATICHMLKHPHVVELLETYS--SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +E  I   L HP+VV+L+E     +E  LYMVFE ++        V         SE  A
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP-----VMEVPTLKPLSEDQA 139
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
             Y + +++ + Y H   IIHRDIKP  +L+        +K+  FGV+ + +      S 
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKGSDALLS- 195
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXXXXXXPFVGS 228
                       + +GTP +MAPE + + +    GK +D+W              PF+  
Sbjct: 196 ------------NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 229 R 229
           R
Sbjct: 244 R 244

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATA---- 102
           T+  +L +E        HP++V    ++  +  L++V + + G  +  +I++   A    
Sbjct: 55  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEH 113
Query: 103 -GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
              V  E+  +  +R+VLE L Y H+N  IHRD+K   +LL        V++  FGV+  
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAF 170
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           L       +GG+   +   K    +GTP +MAPEV+E  + Y    DIW
Sbjct: 171 L------ATGGDITRNKVRKT--FVGTPCWMAPEVMEQVRGYDFKADIW 211

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATA---- 102
           T+  +L +E        HP++V    ++  +  L++V + + G  +  +I++   A    
Sbjct: 50  TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEH 108
Query: 103 -GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
              V  E+  +  +R+VLE L Y H+N  IHRD+K   +LL        V++  FGV+  
Sbjct: 109 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAF 165
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           L       +GG+   +   K    +GTP +MAPEV+E  + Y    DIW
Sbjct: 166 L------ATGGDITRNKVRKT--FVGTPCWMAPEVMEQVRGYDFKADIW 206

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 77/158 (48%), Gaps = 21/158 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I     H +VV++  +Y     L++V E+++G  +  +IV   T   +  E +A
Sbjct: 89  LFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIA 144
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  +  VL AL Y H   +IHRDIK   +LL +      +KL  FG          +C+ 
Sbjct: 145 TVCL-SVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFG----------FCA- 189
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             ++     K    +GTP++MAPEVI    YG  VDIW
Sbjct: 190 --QVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 22/159 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +  E  I   L +PHVV     +  +  +Y+V E      +  E+ +R  A    +E  A
Sbjct: 73  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKA---VTEPEA 128
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCS 170
            ++MRQ ++ ++Y H N +IHRD+K   + L +  +   VK+G FG+A +++ DG+    
Sbjct: 129 RYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD---VKIGDFGLATKIEFDGE---- 181
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                     +     GTP+Y+APEV+  + +   VDIW
Sbjct: 182 ----------RKKDLCGTPNYIAPEVLCKKGHSFEVDIW 210

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 22/159 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +  E  I   L +PHVV     +  +  +Y+V E      +  E+ +R  A    +E  A
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKA---VTEPEA 144
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCS 170
            ++MRQ ++ ++Y H N +IHRD+K   + L +  +   VK+G FG+A +++ DG+    
Sbjct: 145 RYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD---VKIGDFGLATKIEFDGE---- 197
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                     +     GTP+Y+APEV+  + +   VDIW
Sbjct: 198 ----------RKKDLCGTPNYIAPEVLCKKGHSFEVDIW 226

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 22/159 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +  E  I   L +PHVV     +  +  +Y+V E      +  E+ +R  A    +E  A
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKA---VTEPEA 144
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCS 170
            ++MRQ ++ ++Y H N +IHRD+K   + L +  +   VK+G FG+A +++ DG+    
Sbjct: 145 RYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD---VKIGDFGLATKIEFDGE---- 197
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                     +     GTP+Y+APEV+  + +   VDIW
Sbjct: 198 ----------RKKXLCGTPNYIAPEVLCKKGHSFEVDIW 226

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 22/159 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           +  E  I   L +PHVV     +  +  +Y+V E      +  E+ +R  A    +E  A
Sbjct: 89  MSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSL-LELHKRRKA---VTEPEA 144
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCS 170
            ++MRQ ++ ++Y H N +IHRD+K   + L +  +   VK+G FG+A +++ DG+    
Sbjct: 145 RYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMD---VKIGDFGLATKIEFDGE---- 197
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                     +     GTP+Y+APEV+  + +   VDIW
Sbjct: 198 ----------RKKTLCGTPNYIAPEVLCKKGHSFEVDIW 226

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 83/190 (43%), Gaps = 26/190 (13%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP+++ L + Y     +Y+V E   G ++  +I+R+      +SE  AS  +  + + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQK----FFSEREASAVLFTITKTV 129
Query: 123 RYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGGFGVAIQL--QDGQLYCSGGERLDHYT 179
            Y H   ++HRD+KP  +L  ++  N   +++  FG A QL  ++G L            
Sbjct: 130 EYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP--------- 180
Query: 180 TKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGSRD----RLFQS 235
                   T +++APEV+E Q Y    DIW              PF    D     +   
Sbjct: 181 ------CYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILAR 234
Query: 236 ITKGKLHILG 245
           I  GK  + G
Sbjct: 235 IGSGKFSLSG 244

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 22/168 (13%)
Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + + 
Sbjct: 46  QLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK 105
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
               + E   + Y+ ++  AL YCH   +IHRDIKP  +LL    ++  +K+  FG +  
Sbjct: 106 ----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWS-- 156
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  C         +++     GT  Y+ PE+IE + + + VD+W
Sbjct: 157 -------CHAP------SSRRTTLSGTLDYLPPEMIEGRMHDEKVDLW 191

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 21/175 (12%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP +  +  T+ ++  L+ V EY++G D+ + I     +   +  + A+ Y  +++  L
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGL 132
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           ++ H   I++RD+K   +LL   +    +K+  FG+  +   G               K 
Sbjct: 133 QFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD-------------AKT 176
Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS-RDRLFQSI 236
               GTP Y+APE++  QKY   VD W              PF G   + LF SI
Sbjct: 177 NEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 231

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 31/162 (19%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-----DICFEIVRRATAGFVYSE 108
           RE +I   LKH ++V+L +   ++  L +VFE++D       D+C   +   TA      
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTA------ 102
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                ++ Q+L  + YCH+  ++HRD+KP   LL N+E    +K+  FG+A         
Sbjct: 103 ---KSFLLQLLNGIAYCHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAF------ 150
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIW 209
              G  +  YT    H I T  Y AP+V+   +KY   +DIW
Sbjct: 151 ---GIPVRKYT----HEIVTLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +    +V L   + ++  L +V   M+G DI + I         + E  A  Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++  L + H+ +II+RD+KP  VLL +  N   V++   G+A++L+ GQ        
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQ-------- 343
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
                TK     GTP +MAPE++  ++Y   VD
Sbjct: 344 -----TKTKGYAGTPGFMAPELLLGEEYDFSVD 371

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +    +V L   + ++  L +V   M+G DI + I         + E  A  Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++  L + H+ +II+RD+KP  VLL +  N   V++   G+A++L+ GQ        
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQ-------- 343
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
                TK     GTP +MAPE++  ++Y   VD
Sbjct: 344 -----TKTKGYAGTPGFMAPELLLGEEYDFSVD 371

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 21/175 (12%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP +  +  T+ ++  L+ V EY++G D+ + I     +   +  + A+ Y  +++  L
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI----QSCHKFDLSRATFYAAEIILGL 131
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           ++ H   I++RD+K   +LL   +    +K+  FG+  +   G               K 
Sbjct: 132 QFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD-------------AKT 175
Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG-SRDRLFQSI 236
               GTP Y+APE++  QKY   VD W              PF G   + LF SI
Sbjct: 176 NXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +    +V L   + ++  L +V   M+G DI + I         + E  A  Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++  L + H+ +II+RD+KP  VLL +  N   V++   G+A++L+ GQ        
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQ-------- 343
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
                TK     GTP +MAPE++  ++Y   VD
Sbjct: 344 -----TKTKGYAGTPGFMAPELLLGEEYDFSVD 371

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +    +V L   + ++  L +V   M+G DI + I         + E  A  Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++  L + H+ +II+RD+KP  VLL +  N   V++   G+A++L+ GQ        
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQ-------- 343
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
                TK     GTP +MAPE++  ++Y   VD
Sbjct: 344 -----TKTKGYAGTPGFMAPELLLGEEYDFSVD 371

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V L++   SE  L +VFE+M+      +++     G    ++    
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGL--QDSQIKI 123
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L  + +CH++ I+HRD+KP  +L+    +   +KL  FG+A            G 
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAF---------GI 171
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIW 209
            +  YT    H + T  Y AP+V+   +KY   VDIW
Sbjct: 172 PVRSYT----HEVVTLWYRAPDVLMGSKKYSTSVDIW 204

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V L++   SE  L +VFE+M+      +++     G    ++    
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD--LKKVLDENKTGL--QDSQIKI 123
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L  + +CH++ I+HRD+KP  +L+    +   +KL  FG+A            G 
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAF---------GI 171
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIW 209
            +  YT    H + T  Y AP+V+   +KY   VDIW
Sbjct: 172 PVRSYT----HEVVTLWYRAPDVLMGSKKYSTSVDIW 204

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I    +H +VVE+  +Y     L++V E+++G  +  +IV   T   +  E +A
Sbjct: 73  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIA 128
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  +  VL+AL   H   +IHRDIK   +LL +      VKL  FG          +C+ 
Sbjct: 129 AVCL-AVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFG----------FCA- 173
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             ++     +    +GTP++MAPE+I    YG  VDIW
Sbjct: 174 --QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I    +H +VVE+  +Y     L++V E+++G  +  +IV   T   +  E +A
Sbjct: 75  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIA 130
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  +  VL+AL   H   +IHRDIK   +LL +      VKL  FG          +C+ 
Sbjct: 131 AVCL-AVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFG----------FCA- 175
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             ++     +    +GTP++MAPE+I    YG  VDIW
Sbjct: 176 --QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 211

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 31/162 (19%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-----DICFEIVRRATAGFVYSE 108
           RE +I   LKH ++V+L +   ++  L +VFE++D       D+C   +   TA      
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTA------ 102
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                ++ Q+L  + YCH+  ++HRD+KP   LL N+E    +K+  FG+A         
Sbjct: 103 ---KSFLLQLLNGIAYCHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAF------ 150
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIW 209
              G  +  YT    H + T  Y AP+V+   +KY   +DIW
Sbjct: 151 ---GIPVRKYT----HEVVTLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 79/162 (48%), Gaps = 31/162 (19%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-----DICFEIVRRATAGFVYSE 108
           RE +I   LKH ++V+L +   ++  L +VFE++D       D+C   +   TA      
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTA------ 102
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                ++ Q+L  + YCH+  ++HRD+KP   LL N+E    +K+  FG+A         
Sbjct: 103 ---KSFLLQLLNGIAYCHDRRVLHRDLKPQN-LLINREGE--LKIADFGLARAF------ 150
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIW 209
              G  +  YT    H + T  Y AP+V+   +KY   +DIW
Sbjct: 151 ---GIPVRKYT----HEVVTLWYRAPDVLMGSKKYSTTIDIW 185

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 77/155 (49%), Gaps = 21/155 (13%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I    +H +VVE+  +Y     L++V E+++G  +  +IV   T   +  E +A+  
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIAAVC 253
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           +  VL+AL   H   +IHRDIK   +LL +      VKL  FG          +C+   +
Sbjct: 254 L-AVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFG----------FCA---Q 296
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           +     +    +GTP++MAPE+I    YG  VDIW
Sbjct: 297 VSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 331

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I    +H +VVE+  +Y     L++V E+++G  +  +IV   T   +  E +A
Sbjct: 64  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIA 119
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  +  VL+AL   H   +IHRDIK   +LL +      VKL  FG          +C+ 
Sbjct: 120 AVCL-AVLQALSVLHAQGVIHRDIKSDSILLTH---DGRVKLSDFG----------FCA- 164
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             ++     +    +GTP++MAPE+I    YG  VDIW
Sbjct: 165 --QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 200

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I    +H +VVE+  +Y     L++V E+++G  +  +IV   T   +  E +A
Sbjct: 68  LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIA 123
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  +  VL+AL   H   +IHRDIK   +LL +      VKL  FG          +C+ 
Sbjct: 124 AVCL-AVLQALSVLHAQGVIHRDIKSDSILLTH---DGRVKLSDFG----------FCA- 168
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             ++     +    +GTP++MAPE+I    YG  VDIW
Sbjct: 169 --QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 204

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 74/158 (46%), Gaps = 21/158 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I    +H +VVE+ ++Y     L+++ E++ G  +  +IV +       +E   
Sbjct: 89  LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-DIVSQVR----LNEEQI 143
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +     VL+AL Y H   +IHRDIK   +LL        VKL  FG          +C+ 
Sbjct: 144 ATVCEAVLQALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSDFG----------FCA- 189
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             ++     K    +GTP++MAPEVI    Y   VDIW
Sbjct: 190 --QISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIW 225

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 21/158 (13%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L  E  I    +H +VVE+  +Y     L++V E+++G  +  +IV   T   +  E +A
Sbjct: 118 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT-DIV---THTRMNEEQIA 173
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           +  +  VL+AL   H   +IHRDIK   +LL +      VKL  FG          +C+ 
Sbjct: 174 AVCL-AVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFG----------FCA- 218
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             ++     +    +GTP++MAPE+I    YG  VDIW
Sbjct: 219 --QVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIW 254

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 82/178 (46%), Gaps = 36/178 (20%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEI 96
           +E L  Y  E +      I     HP++V+LL  Y  +G L+++ E+  G     I  E+
Sbjct: 49  EEELEDYIVEIE------ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL 102
Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R  T      E       RQ+LEAL + H   IIHRD+K   VL+  + +   ++L  F
Sbjct: 103 DRGLT------EPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADF 153
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIW 209
           GV+ +           ++ D +       IGTP++MAPEV+     +D  Y    DIW
Sbjct: 154 GVSAK------NLKTLQKRDSF-------IGTPYWMAPEVVMCETMKDTPYDYKADIW 198

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/179 (31%), Positives = 81/179 (45%), Gaps = 38/179 (21%)
Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG---SDICFEI 96
           +E L  Y  E +      I     HP++V+LL  Y  +G L+++ E+  G     I  E+
Sbjct: 57  EEELEDYIVEIE------ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL 110
Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            R  T      E       RQ+LEAL + H   IIHRD+K   VL+  + +   ++L  F
Sbjct: 111 DRGLT------EPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADF 161
Query: 157 GV-AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIW 209
           GV A  L+  Q              K    IGTP++MAPEV+     +D  Y    DIW
Sbjct: 162 GVSAKNLKTLQ--------------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIW 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 137
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 185
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 186 --ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 243
Query: 233 FQSITK 238
           FQ I K
Sbjct: 244 FQKIIK 249

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 81/163 (49%), Gaps = 7/163 (4%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           T+    +E  +   L+HP+V++ +     +  L  + EY+ G  +   I++   + + +S
Sbjct: 50  TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL-RGIIKSMDSQYPWS 108
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + V+  + + +   + Y H  +IIHRD+  H  L+   +N   V +  FG+A  + D + 
Sbjct: 109 QRVS--FAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDEKT 163
Query: 168 YCSGGERLDHYTTKAGHRI-GTPHYMAPEVIEDQKYGKPVDIW 209
              G   L     K  + + G P++MAPE+I  + Y + VD++
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 133
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 134 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 181
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 182 --ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 239
Query: 233 FQSITK 238
           FQ I K
Sbjct: 240 FQKIIK 245

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 137
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 138 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 185
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 186 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 243
Query: 233 FQSITK 238
           FQ I K
Sbjct: 244 FQKIIK 249

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 139
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 140 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 187
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 188 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 245
Query: 233 FQSITK 238
           FQ I K
Sbjct: 246 FQKIIK 251

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 136
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 184
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 185 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 242
Query: 233 FQSITK 238
           FQ I K
Sbjct: 243 FQKIIK 248

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 134
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 182
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 183 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240
Query: 233 FQSITK 238
           FQ I K
Sbjct: 241 FQKIIK 246

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 133
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 134 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 181
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 182 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 239
Query: 233 FQSITK 238
           FQ I K
Sbjct: 240 FQKIIK 245

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 134
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 182
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 183 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240
Query: 233 FQSITK 238
           FQ I K
Sbjct: 241 FQKIIK 246

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 136
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 184
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 185 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 242
Query: 233 FQSITK 238
           FQ I K
Sbjct: 243 FQKIIK 248

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 134
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 182
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 183 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240
Query: 233 FQSITK 238
           FQ I K
Sbjct: 241 FQKIIK 246

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 136
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 184
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 185 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 242
Query: 233 FQSITK 238
           FQ I K
Sbjct: 243 FQKIIK 248

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 63  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 118
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 119 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 166
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 167 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 224
Query: 233 FQSITK 238
           FQ I K
Sbjct: 225 FQKIIK 230

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 111
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 112 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 159
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 160 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 217
Query: 233 FQSITK 238
           FQ I K
Sbjct: 218 FQKIIK 223

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 112
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 160
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 161 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218
Query: 233 FQSITK 238
           FQ I K
Sbjct: 219 FQKIIK 224

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 134
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 135 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 182
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 183 --ESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240
Query: 233 FQSITK 238
           FQ I K
Sbjct: 241 FQKIIK 246

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 114
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 115 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 162
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 163 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 220
Query: 233 FQSITK 238
           FQ I K
Sbjct: 221 FQKIIK 226

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 79/186 (42%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 113
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 114 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 161
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 162 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 219
Query: 233 FQSITK 238
           FQ I K
Sbjct: 220 FQKIIK 225

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           A++KRE      L+HP++V   E   +   L +V EY  G ++ FE  R   AG  +SE 
Sbjct: 60  ANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-FE--RICNAG-RFSED 115
Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLY 168
            A  + +Q++  + YCH   + HRD+K    LL    + AP +K+  FG +         
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS--------- 164
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
                 + H   K+   +GTP Y+APEV+  ++Y GK  D+W
Sbjct: 165 ---KSSVLHSQPKS--TVGTPAYIAPEVLLKKEYDGKVADVW 201

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 74/186 (39%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y      C     R    F   E     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG--CLLKYIRKIGSF--DETCTRF 136
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 184
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 185 --ESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 242
Query: 233 FQSITK 238
           FQ I K
Sbjct: 243 FQKIIK 248

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 26/190 (13%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP+++ L + Y     +Y+V E M G ++  +I+R+      +SE  AS  +  + + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTV 134
Query: 123 RYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGGFGVAIQL--QDGQLYCSGGERLDHYT 179
            Y H   ++HRD+KP  +L  ++  N   +++  FG A QL  ++G L            
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--------- 185
Query: 180 TKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG----SRDRLFQS 235
                   T +++APEV++ Q Y +  DIW              PF      + + +   
Sbjct: 186 ------CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTR 239
Query: 236 ITKGKLHILG 245
           I  GK  + G
Sbjct: 240 IGSGKFTLSG 249

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 26/190 (13%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP+++ L + Y     +Y+V E M G ++  +I+R+      +SE  AS  +  + + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK----FFSEREASFVLHTIGKTV 134
Query: 123 RYCHENDIIHRDIKPHCVLLANKE-NSAPVKLGGFGVAIQL--QDGQLYCSGGERLDHYT 179
            Y H   ++HRD+KP  +L  ++  N   +++  FG A QL  ++G L            
Sbjct: 135 EYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTP--------- 185
Query: 180 TKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG----SRDRLFQS 235
                   T +++APEV++ Q Y +  DIW              PF      + + +   
Sbjct: 186 ------CYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTR 239
Query: 236 ITKGKLHILG 245
           I  GK  + G
Sbjct: 240 IGSGKFTLSG 249

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           + +++RE      L+HP++V   E   +   L ++ EY  G     E+  R      +SE
Sbjct: 60  DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG----ELYERICNAGRFSE 115
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQL 167
             A  + +Q+L  + YCH   I HRD+K    LL    + AP +K+  FG +        
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG--SPAPRLKICDFGYS-------- 165
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
                  + H   K+   +GTP Y+APEV+  Q+Y GK  D+W
Sbjct: 166 ----KSSVLHSQPKST--VGTPAYIAPEVLLRQEYDGKIADVW 202

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 136
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 184
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 185 --ESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242
Query: 233 FQSITK 238
           F  I K
Sbjct: 243 FAKIIK 248

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 22/163 (13%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           + ++KRE      L+HP++V   E   +   L +V EY  G ++ FE  R   AG  +SE
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-FE--RICNAG-RFSE 114
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQL 167
             A  + +Q++  + YCH   + HRD+K    LL    + AP +K+  FG +        
Sbjct: 115 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG--SPAPRLKICAFGYS-------- 164
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
                  + H   K+   +GTP Y+APEV+  ++Y GK  D+W
Sbjct: 165 ----KSSVLHSQPKS--TVGTPAYIAPEVLLKKEYDGKVADVW 201

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 55  EATICHMLKHPHVVEL------LETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E  I   L HP+VV        L+  +   +  +  EY +G D+     R+    F    
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL-----RKYLNQFENCC 117
Query: 109 AVASHYMRQVLE----ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
            +    +R +L     ALRY HEN IIHRD+KP  ++L         K+   G A +L  
Sbjct: 118 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+L C+               +GT  Y+APE++E +KY   VD W
Sbjct: 178 GEL-CT-------------EFVGTLQYLAPELLEQKKYTVTVDYW 208

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 136
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 137 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 184
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 185 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI 242
Query: 233 FQSITK 238
           F  I K
Sbjct: 243 FAKIIK 248

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 73/165 (44%), Gaps = 29/165 (17%)
Query: 55  EATICHMLKHPHVVEL------LETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E  I   L HP+VV        L+  +   +  +  EY +G D+     R+    F    
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL-----RKYLNQFENCC 116
Query: 109 AVASHYMRQVLE----ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
            +    +R +L     ALRY HEN IIHRD+KP  ++L         K+   G A +L  
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+L C+               +GT  Y+APE++E +KY   VD W
Sbjct: 177 GEL-CT-------------EFVGTLQYLAPELLEQKKYTVTVDYW 207

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 22/163 (13%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           + ++KRE      L+HP++V   E   +   L +V EY  G     E+  R      +SE
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFSE 114
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQL 167
             A  + +Q++  + YCH   + HRD+K    LL    + AP +K+  FG +   +   L
Sbjct: 115 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG--SPAPRLKICAFGYS---KSSVL 169
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
           +           ++    +GTP Y+APEV+  ++Y GK  D+W
Sbjct: 170 H-----------SQPKDTVGTPAYIAPEVLLKKEYDGKVADVW 201

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 64.7 bits (156), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP+++ LL+ +  +  + +VF++M+      E++ +  +  V + +    
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD---LEVIIKDNS-LVLTPSHIKA 116
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM   L+ L Y H++ I+HRD+KP+ +LL   + +  +KL  FG+A          S G 
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLA---------KSFGS 164
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
               Y     H++ T  Y APE++   + YG  VD+W
Sbjct: 165 PNRAYX----HQVVTRWYRAPELLFGARMYGVGVDMW 197

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 22/163 (13%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           + ++KRE      L+HP++V   E   +   L +V EY  G ++ FE  R   AG  +SE
Sbjct: 58  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-FE--RICNAG-RFSE 113
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQL 167
             A  + +Q++  + YCH   + HRD+K    LL    + AP +K+  FG +        
Sbjct: 114 DEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDG--SPAPRLKICDFGYS-------- 163
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
                  + H   K+   +GTP Y+APEV+  ++Y GK  D+W
Sbjct: 164 ----KSSVLHSQPKS--TVGTPAYIAPEVLLKKEYDGKVADVW 200

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 19/186 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP  V+L   +  +  LY    Y    ++  + +R+  +   + E     
Sbjct: 86  RERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGEL-LKYIRKIGS---FDETCTRF 141
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L           
Sbjct: 142 YTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP--------- 189
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPF-VGSRDRL 232
             +    +A   +GT  Y++PE++ ++   K  D+W              PF  G+   +
Sbjct: 190 --ESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 247
Query: 233 FQSITK 238
           FQ I K
Sbjct: 248 FQKIIK 253

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMXGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 51  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 106
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 158
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 159 NRERL------LNKMXGTLPYVAPELLKRREFHAEPVDVW 192

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 22/156 (14%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E +I   L H HVV     +     +++V E      +  E+ +R  A    +E  A +Y
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKA---LTEPEARYY 122
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           +RQ++   +Y H N +IHRD+K   + L        VK+G FG+A +++ DG+       
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE------- 172
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  +     GTP+Y+APEV+  + +   VD+W
Sbjct: 173 -------RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 201

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMXGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 22/156 (14%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E +I   L H HVV     +     +++V E      +  E+ +R  A    +E  A +Y
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKA---LTEPEARYY 122
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           +RQ++   +Y H N +IHRD+K   + L        VK+G FG+A +++ DG+       
Sbjct: 123 LRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE------- 172
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  +     GTP+Y+APEV+  + +   VD+W
Sbjct: 173 -------RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 201

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 22/156 (14%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E +I   L H HVV     +     +++V E      +  E+ +R  A    +E  A +Y
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKA---LTEPEARYY 126
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           +RQ++   +Y H N +IHRD+K   + L        VK+G FG+A +++ DG+       
Sbjct: 127 LRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE------- 176
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  +     GTP+Y+APEV+  + +   VD+W
Sbjct: 177 -------RKKTLCGTPNYIAPEVLSKKGHSFEVDVW 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 28/205 (13%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSE--GMLYMVFEYMDGSDIC-FEIVRRATAGFV 105
           EA++K+E  +   L+H +V++L++   +E    +YMV EY     +C  + +  +     
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC----VCGMQEMLDSVPEKR 105
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
           +    A  Y  Q+++ L Y H   I+H+DIKP  +LL        +K+   GVA      
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVA------ 156
Query: 166 QLYCSGGERLDHYTTKAGHRI--GTPHYMAPEVIE--DQKYGKPVDIWXXXXXXXXXXXX 221
                  E L  +      R   G+P +  PE+    D   G  VDIW            
Sbjct: 157 -------EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
Query: 222 XXPFVGSRD-RLFQSITKGKLHILG 245
             PF G    +LF++I KG   I G
Sbjct: 210 LYPFEGDNIYKLFENIGKGSYAIPG 234

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMXGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 106
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A           
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVF-------- 155
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
              R ++         GT  Y+APE+++ +++  +PVD+W
Sbjct: 156 ---RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 192

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMXGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 22/163 (13%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           + ++KRE      L+HP++V   E   +   L +V EY  G ++ FE  R   AG  +SE
Sbjct: 59  DENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-FE--RICNAG-RFSE 114
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQL 167
             A  + +Q++  + Y H   + HRD+K    LL    + AP +K+  FG          
Sbjct: 115 DEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDG--SPAPRLKIADFG---------- 162
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
           Y      + H   K+   +GTP Y+APEV+  ++Y GK  D+W
Sbjct: 163 YSKAS--VLHSQPKSA--VGTPAYIAPEVLLKKEYDGKVADVW 201

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A           
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVF-------- 154
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
              R ++         GT  Y+APE+++ +++  +PVD+W
Sbjct: 155 ---RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 49  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 104
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 156
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 157 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 190

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 106
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 158
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 159 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 192

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 106
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 158
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 159 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 192

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 50  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 105
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 157
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 158 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 191

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/176 (23%), Positives = 78/176 (44%), Gaps = 19/176 (10%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
            +RE      L H ++V +++    +   Y+V EY++G  +   I          S   A
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTA 113
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
            ++  Q+L+ +++ H+  I+HRDIKP  +L+   +++  +K+  FG+A  L +  L    
Sbjct: 114 INFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSL---- 166
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                   T+  H +GT  Y +PE  + +   +  DI+              PF G
Sbjct: 167 --------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 22/156 (14%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E +I   L H HVV     +     +++V E      +  E+ +R  A    +E  A +Y
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKA---LTEPEARYY 120
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           +RQ++   +Y H N +IHRD+K   + L        VK+G FG+A +++ DG+       
Sbjct: 121 LRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE------- 170
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  +     GTP+Y+APEV+  + +   VD+W
Sbjct: 171 -------RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 199

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 106
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 158
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 159 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 192

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 106
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 158
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 159 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 192

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 51  NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 106
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 158
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 159 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 192

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 22/156 (14%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E +I   L H HVV     +     +++V E      +  E+ +R  A    +E  A +Y
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKA---LTEPEARYY 144
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           +RQ++   +Y H N +IHRD+K   + L        VK+G FG+A +++ DG+       
Sbjct: 145 LRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE------- 194
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  +     GTP+Y+APEV+  + +   VD+W
Sbjct: 195 -------RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 223

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 22/156 (14%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E +I   L H HVV     +     +++V E      +  E+ +R  A    +E  A +Y
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSL-LELHKRRKA---LTEPEARYY 146
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           +RQ++   +Y H N +IHRD+K   + L        VK+G FG+A +++ DG+       
Sbjct: 147 LRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGE------- 196
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  +     GTP+Y+APEV+  + +   VD+W
Sbjct: 197 -------RKKVLCGTPNYIAPEVLSKKGHSFEVDVW 225

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++K+E  I  ML H +VV+         + Y+  EY  G     E+  R        E  
Sbjct: 51  NIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGG----ELFDRIEPDIGMPEPD 106
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +      +
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFR-----YN 158
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIW 209
             ERL           GT  Y+APE+++ +++  +PVD+W
Sbjct: 159 NRERL------LNKMCGTLPYVAPELLKRREFHAEPVDVW 192

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 76/182 (41%), Gaps = 31/182 (17%)
Query: 80  LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC 139
            Y+VFE M G  I   I +R      ++E  AS  ++ V  AL + H   I HRD+KP  
Sbjct: 86  FYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNKGIAHRDLKPEN 141
Query: 140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-- 197
           +L  +    +PVK+  FG+   ++        G+     T +     G+  YMAPEV+  
Sbjct: 142 ILCEHPNQVSPVKICDFGLGSGIK------LNGDCSPISTPELLTPCGSAEYMAPEVVEA 195
Query: 198 ---EDQKYGKPVDIWXXXXXXXXXXXXXXPFVG----------------SRDRLFQSITK 238
              E   Y K  D+W              PFVG                 ++ LF+SI +
Sbjct: 196 FSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE 255
Query: 239 GK 240
           GK
Sbjct: 256 GK 257

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 27/162 (16%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+ +E      L+HP+ ++    Y  E   ++V EY  GS      V +     V   AV
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                   L+ L Y H +++IHRD+K   +LL+       VKLG FG A           
Sbjct: 121 T----HGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA----------- 162
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVI---EDQKYGKPVDIW 209
                      A   +GTP++MAPEVI   ++ +Y   VD+W
Sbjct: 163 ------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 198

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 64/138 (46%), Gaps = 23/138 (16%)
Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           +  L++V E+     +   I  + T G    E   ++  R++L  L + H++ +IHRDIK
Sbjct: 99  DDQLWLVMEFCGAGSVTDLI--KNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIK 156
Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
              VLL     +A VKL  FGV+ Q             LD    +    IGTP++MAPEV
Sbjct: 157 GQNVLLT---ENAEVKLVDFGVSAQ-------------LDRTVGRRNTFIGTPYWMAPEV 200
Query: 197 IE-----DQKYGKPVDIW 209
           I      D  Y    D+W
Sbjct: 201 IACDENPDATYDFKSDLW 218

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 27/162 (16%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+ +E      L+HP+ ++    Y  E   ++V EY  GS      V +     V   AV
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 159
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                   L+ L Y H +++IHRD+K   +LL+       VKLG FG A           
Sbjct: 160 T----HGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA----------- 201
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVI---EDQKYGKPVDIW 209
                      A   +GTP++MAPEVI   ++ +Y   VD+W
Sbjct: 202 ------SIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVW 237

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 11/115 (9%)
Query: 49  EADLKREATICHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           E +L   A+ C     PH+V +++ Y    +    L +V E +DG ++   I  R    F
Sbjct: 60  EVELHWRASQC-----PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
             +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A
Sbjct: 115 --TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 84/197 (42%), Gaps = 30/197 (15%)
Query: 39  PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVR 98
           PDE ++   T  ++++EA +  MLKHP+++ L      E  L +V E+  G  +      
Sbjct: 42  PDEDISQ--TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL-----N 94
Query: 99  RATAGFVYSEAVASHYMRQVLEALRYCHEN---DIIHRDIKPHCVLLANK-EN----SAP 150
           R  +G      +  ++  Q+   + Y H+     IIHRD+K   +L+  K EN    +  
Sbjct: 95  RVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI 154
Query: 151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWX 210
           +K+  FG+A              R  H TTK     G   +MAPEVI    + K  D+W 
Sbjct: 155 LKITDFGLA--------------REWHRTTKMSAA-GAYAWMAPEVIRASMFSKGSDVWS 199
Query: 211 XXXXXXXXXXXXXPFVG 227
                        PF G
Sbjct: 200 YGVLLWELLTGEVPFRG 216

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 28/164 (17%)
Query: 54  REATICHMLK---HPHVVELLETYSS-----EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  +   L+   HP+VV L++  ++     E  + +VFE++D     +  + +A    +
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY--LDKAPPPGL 109
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            +E +    MRQ L  L + H N I+HRD+KP  +L+    +   VKL  FG+A      
Sbjct: 110 PAETI-KDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLA------ 159
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   R+  Y       + T  Y APEV+    Y  PVD+W
Sbjct: 160 --------RIYSYQMALAPVVVTLWYRAPEVLLQSTYATPVDMW 195

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  ++++ A       E +   
Sbjct: 63  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKEAKR---IPEEILGK 118
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               VL  L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 167
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YMAPE ++   Y    DIW
Sbjct: 168 -------SMANSFVGTRSYMAPERLQGTHYSVQSDIW 197

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 72  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 127
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 128 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 176
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YM+PE ++   Y    DIW
Sbjct: 177 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIW 206

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 76/184 (41%), Gaps = 35/184 (19%)
Query: 80  LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC 139
            Y+VFE M G  I   I +R      ++E  AS  ++ V  AL + H   I HRD+KP  
Sbjct: 86  FYLVFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNKGIAHRDLKPEN 141
Query: 140 VLLANKENSAPVKLGGF--GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI 197
           +L  +    +PVK+  F  G  I+L         G+     T +     G+  YMAPEV+
Sbjct: 142 ILCEHPNQVSPVKICDFDLGSGIKLN--------GDCSPISTPELLTPCGSAEYMAPEVV 193
Query: 198 -----EDQKYGKPVDIWXXXXXXXXXXXXXXPFVG----------------SRDRLFQSI 236
                E   Y K  D+W              PFVG                 ++ LF+SI
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESI 253
Query: 237 TKGK 240
            +GK
Sbjct: 254 QEGK 257

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEG----MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +REA     L HP +V + +T  +E     + Y+V EY+DG  +    +          
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPK 116
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            A+    +    +AL + H+N IIHRD+KP  ++++       VK+  FG+A  + D   
Sbjct: 117 RAI--EVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIAD--- 168
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
             SG     +  T+    IGT  Y++PE    Q  G  VD
Sbjct: 169 --SG-----NSVTQTAAVIGTAQYLSPE----QARGDSVD 197

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEG----MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +REA     L HP +V + +T  +E     + Y+V EY+DG  +    +          
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPK 116
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            A+    +    +AL + H+N IIHRD+KP  ++++       VK+  FG+A  + D   
Sbjct: 117 RAI--EVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIAD--- 168
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
             SG     +  T+    IGT  Y++PE    Q  G  VD
Sbjct: 169 --SG-----NSVTQTAAVIGTAQYLSPE----QARGDSVD 197

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 28/164 (17%)
Query: 54  REATICHMLK---HPHVVELLETYSS-----EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  +   L+   HP+VV L++  ++     E  + +VFE++D     +  + +A    +
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY--LDKAPPPGL 109
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            +E +    MRQ L  L + H N I+HRD+KP  +L+    +   VKL  FG+A      
Sbjct: 110 PAETI-KDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLA------ 159
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   R+  Y       + T  Y APEV+    Y  PVD+W
Sbjct: 160 --------RIYSYQMALDPVVVTLWYRAPEVLLQSTYATPVDMW 195

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 25/165 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSE--------GMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  I  +LKH +VV L+E   ++        G +Y+VF++ +  D+   ++      F 
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLA-GLLSNVLVKFT 123
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            SE      M+ +L  L Y H N I+HRD+K   VL+        +KL  FG+A      
Sbjct: 124 LSEI--KRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLA 178
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           +         +    +  +R+ T  Y  PE++  ++ YG P+D+W
Sbjct: 179 K---------NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLW 214

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEG----MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +REA     L HP +V + +T  +E     + Y+V EY+DG  +    +          
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPK 116
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            A+    +    +AL + H+N IIHRD+KP  ++++       VK+  FG+A  + D   
Sbjct: 117 RAI--EVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIAD--- 168
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
             SG     +  T+    IGT  Y++PE    Q  G  VD
Sbjct: 169 --SG-----NSVTQTAAVIGTAQYLSPE----QARGDSVD 197

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 27/186 (14%)
Query: 52  LKREATICHM--LKHPHVVELLETYS-----SEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           ++  A + H+   +HP+VV L +  +      E  L +VFE++D  D+   + +    G 
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG- 116
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
           V +E +    M Q+L  L + H + ++HRD+KP  +L+    +S  +KL  FG+A     
Sbjct: 117 VPTETIKD-MMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA----- 167
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXP 224
                    R+  +       + T  Y APEV+    Y  PVD+W               
Sbjct: 168 ---------RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 225 FVGSRD 230
           F GS D
Sbjct: 219 FRGSSD 224

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 28/164 (17%)
Query: 54  REATICHMLK---HPHVVELLETYSS-----EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  +   L+   HP+VV L++  ++     E  + +VFE++D     +  + +A    +
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY--LDKAPPPGL 117
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            +E +    MRQ L  L + H N I+HRD+KP  +L+    +   VKL  FG+A      
Sbjct: 118 PAETI-KDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLA------ 167
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   R+  Y       + T  Y APEV+    Y  PVD+W
Sbjct: 168 --------RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMW 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 80  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 135
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 184
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YM+PE ++   Y    DIW
Sbjct: 185 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIW 214

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 25/165 (15%)
Query: 54  REATICHMLKHPHVVELLE---TYSS-----EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  I  +LKH +VV L+E   T +S     +G +Y+VF++ +  D+   ++      F 
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLA-GLLSNVLVKFT 123
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            SE      M+ +L  L Y H N I+HRD+K   VL+        +KL  FG+A      
Sbjct: 124 LSEI--KRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLA 178
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           +         +    +  +R+ T  Y  PE++  ++ YG P+D+W
Sbjct: 179 K---------NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLW 214

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 25/165 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSE--------GMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  I  +LKH +VV L+E   ++        G +Y+VF++ +  D+   ++      F 
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLA-GLLSNVLVKFT 122
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            SE      M+ +L  L Y H N I+HRD+K   VL+        +KL  FG+A      
Sbjct: 123 LSEI--KRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLA 177
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           +         +    +  +R+ T  Y  PE++  ++ YG P+D+W
Sbjct: 178 K---------NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLW 213

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 21/172 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   ++H +++++L+ + ++G   +V E        F  + R        E +AS+ 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYI 135
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
            RQ++ A+ Y    DIIHRDIK   +++A       +KL  FG A  L+ G+L+      
Sbjct: 136 FRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGSAAYLERGKLF------ 186
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIWXXXXXXXXXXXXXXPF 225
              YT       GT  Y APEV+    Y  P +++W              PF
Sbjct: 187 ---YTF-----CGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 108
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 157
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YM+PE ++   Y    DIW
Sbjct: 158 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIW 187

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 108
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 157
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YM+PE ++   Y    DIW
Sbjct: 158 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIW 187

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 27/188 (14%)
Query: 50  ADLKREATICHM--LKHPHVVELLETYS-----SEGMLYMVFEYMDGSDICFEIVRRATA 102
           + ++  A + H+   +HP+VV L +  +      E  L +VFE++D  D+   + +    
Sbjct: 57  STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEP 115
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
           G V +E +    M Q+L  L + H + ++HRD+KP  +L+    +S  +KL  FG+A   
Sbjct: 116 G-VPTETI-KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA--- 167
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXX 222
                      R+  +       + T  Y APEV+    Y  PVD+W             
Sbjct: 168 -----------RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
Query: 223 XPFVGSRD 230
             F GS D
Sbjct: 217 PLFRGSSD 224

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 27/186 (14%)
Query: 52  LKREATICHM--LKHPHVVELLETYS-----SEGMLYMVFEYMDGSDICFEIVRRATAGF 104
           ++  A + H+   +HP+VV L +  +      E  L +VFE++D  D+   + +    G 
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG- 116
Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
           V +E +    M Q+L  L + H + ++HRD+KP  +L+    +S  +KL  FG+A     
Sbjct: 117 VPTETI-KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA----- 167
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXP 224
                    R+  +       + T  Y APEV+    Y  PVD+W               
Sbjct: 168 ---------RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 218
Query: 225 FVGSRD 230
           F GS D
Sbjct: 219 FRGSSD 224

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 108
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 157
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YM+PE ++   Y    DIW
Sbjct: 158 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIW 187

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEG----MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +REA     L HP +V + +T  +E     + Y+V EY+DG  +    +          
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPK 133
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            A+    +    +AL + H+N IIHRD+KP  ++++       VK+  FG+A  + D   
Sbjct: 134 RAI--EVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIAD--- 185
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
             SG     +  T+    IGT  Y++PE           D++              PF G
Sbjct: 186 --SG-----NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 108
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 157
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YM+PE ++   Y    DIW
Sbjct: 158 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIW 187

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 28/164 (17%)
Query: 54  REATICHMLK---HPHVVELLETYSS-----EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  +   L+   HP+VV L++  ++     E  + +VFE++D     +  + +A    +
Sbjct: 52  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTY--LDKAPPPGL 109
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            +E +    MRQ L  L + H N I+HRD+KP  +L+    +   VKL  FG+A      
Sbjct: 110 PAETI-KDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLA------ 159
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   R+  Y       + T  Y APEV+    Y  PVD+W
Sbjct: 160 --------RIYSYQMALFPVVVTLWYRAPEVLLQSTYATPVDMW 195

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 115 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 170
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 171 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 219
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YM+PE ++   Y    DIW
Sbjct: 220 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIW 249

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 53  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 108
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 157
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  + A   +GT  YM+PE ++   Y    DIW
Sbjct: 158 -------SMANSFVGTRSYMSPERLQGTHYSVQSDIW 187

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            E  L+RE  I   L HP+++ L   +     +Y++ EY    ++  E+ +  T    + 
Sbjct: 66  VEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT----FD 121
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E   +  M ++ +AL YCH   +IHRDIKP  +LL  K       +  FG ++       
Sbjct: 122 EQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELK---IADFGWSVHAP---- 174
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                      + +     GT  Y+ PE+IE + + + VD+W
Sbjct: 175 -----------SLRRKTMCGTLDYLPPEMIEGRMHNEKVDLW 205

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEG----MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +REA     L HP +V +  T  +E     + Y+V EY+DG  +    +          
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPK 116
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            A+    +    +AL + H+N IIHRD+KP  ++++       VK+  FG+A  + D   
Sbjct: 117 RAI--EVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIAD--- 168
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
             SG     +  T+    IGT  Y++PE    Q  G  VD
Sbjct: 169 --SG-----NSVTQTAAVIGTAQYLSPE----QARGDSVD 197

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 72/157 (45%), Gaps = 23/157 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  + H    P++V     + S+G + +  E+MDG  +  +++++A       E +   
Sbjct: 56  RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD-QVLKKAGR---IPEQILGK 111
Query: 114 YMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
               V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D        
Sbjct: 112 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR---GEIKLCDFGVSGQLID-------- 160
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                    A   +GT  YM+PE ++   Y    DIW
Sbjct: 161 -------EMANEFVGTRSYMSPERLQGTHYSVQSDIW 190

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 25/160 (15%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEG----MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +REA     L HP +V + +T  +E     + Y+V EY+DG  +    +          
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDG--VTLRDIVHTEGPMTPK 116
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            A+    +    +AL + H+N IIHRD+KP  +L++       VK+  FG+A  + D   
Sbjct: 117 RAI--EVIADACQALNFSHQNGIIHRDVKPANILISATNA---VKVVDFGIARAIAD--- 168
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
             SG     +   +    IGT  Y++PE    Q  G  VD
Sbjct: 169 --SG-----NSVXQTAAVIGTAQYLSPE----QARGDSVD 197

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 62/130 (47%), Gaps = 19/130 (14%)
Query: 80  LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC 139
           L++  E+ D   +   I +R   G    + +A     Q+ + + Y H   +IHRD+KP  
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSN 166
Query: 140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED 199
           + L +   +  VK+G FG+   L++           D   T++    GT  YM+PE I  
Sbjct: 167 IFLVD---TKQVKIGDFGLVTSLKN-----------DGKRTRSK---GTLRYMSPEQISS 209
Query: 200 QKYGKPVDIW 209
           Q YGK VD++
Sbjct: 210 QDYGKEVDLY 219

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 25/165 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGM--------LYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  I  +LKH +VV L+E   ++          +Y+VF++ +  D+   ++      F 
Sbjct: 66  REIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCE-HDLA-GLLSNVLVKFT 123
Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            SE      M+ +L  L Y H N I+HRD+K   VL+        +KL  FG+A      
Sbjct: 124 LSEI--KRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLA 178
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           +         +    +  +R+ T  Y  PE++  ++ YG P+D+W
Sbjct: 179 K---------NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLW 214

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 33/163 (20%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-----DICFEIVRRATAGFVYSE 108
           RE ++   LKH ++V L +   +E  L +VFEY+D       D C  I+           
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL---- 104
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                ++ Q+L  L YCH   ++HRD+KP  +L+  +     +KL  FG+A         
Sbjct: 105 -----FLFQLLRGLAYCHRQKVLHRDLKPQNLLINER---GELKLADFGLA--------- 147
Query: 169 CSGGERLDHYTTKA-GHRIGTPHYMAPEV-IEDQKYGKPVDIW 209
                R     TK   + + T  Y  P++ +    Y   +D+W
Sbjct: 148 -----RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMW 185

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 74/164 (45%), Gaps = 31/164 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-----DICFEIVRRATAGFVYSE 108
           RE ++   L+H +++EL         L+++FEY +       D   ++  R    F+Y  
Sbjct: 82  REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY-- 139
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS-APV-KLGGFGVAIQLQDGQ 166
                   Q++  + +CH    +HRD+KP  +LL+  + S  PV K+G FG+A       
Sbjct: 140 --------QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF---- 187
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
                G  +  +T    H I T  Y  PE++   + Y   VDIW
Sbjct: 188 -----GIPIRQFT----HEIITLWYRPPEILLGSRHYSTSVDIW 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 24/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +E  I   L+HP +V L  ++  E  ++MV + + G D+ + + +       + E     
Sbjct: 64  KELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH----FKEETVKL 119
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ +++ AL Y     IIHRD+KP  +LL   +    V +  F +A  L           
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML----------P 166
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIW 209
           R    TT A    GT  YMAPE+   +K   Y   VD W
Sbjct: 167 RETQITTMA----GTKPYMAPEMFSSRKGAGYSFAVDWW 201

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 30/168 (17%)
Query: 82  MVFEYMDGSDI--CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC 139
           +VFEY++ +D    ++I+      F         YM ++L+AL YCH   I+HRD+KPH 
Sbjct: 112 LVFEYINNTDFKQLYQILTDFDIRF---------YMYELLKALDYCHSKGIMHRDVKPHN 162
Query: 140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED 199
           V++ +++    ++L  +G+A      Q Y                R+ + ++  PE++ D
Sbjct: 163 VMIDHQQKK--LRLIDWGLAEFYHPAQEYNV--------------RVASRYFKGPELLVD 206
Query: 200 -QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKLHILGC 246
            Q Y   +D+W              PF   +D   Q +   K  +LG 
Sbjct: 207 YQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAK--VLGT 252

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 30/168 (17%)
Query: 82  MVFEYMDGSDI--CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC 139
           +VFEY++ +D    ++I+      F         YM ++L+AL YCH   I+HRD+KPH 
Sbjct: 117 LVFEYINNTDFKQLYQILTDFDIRF---------YMYELLKALDYCHSKGIMHRDVKPHN 167
Query: 140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED 199
           V++ +++    ++L  +G+A      Q Y                R+ + ++  PE++ D
Sbjct: 168 VMIDHQQKK--LRLIDWGLAEFYHPAQEYNV--------------RVASRYFKGPELLVD 211
Query: 200 -QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKLHILGC 246
            Q Y   +D+W              PF   +D   Q +   K  +LG 
Sbjct: 212 YQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAK--VLGT 257

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 64/146 (43%), Gaps = 21/146 (14%)
Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P       + S    L++  E+ D   +   I +R   G    + +A     Q+ + + Y
Sbjct: 80  PETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDY 137
Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGERLDHYTTKAG 183
            H   +I+RD+KP  + L +   +  VK+G FG+   L+ DG+   S G           
Sbjct: 138 IHSKKLINRDLKPSNIFLVD---TKQVKIGDFGLVTSLKNDGKRXRSKG----------- 183
Query: 184 HRIGTPHYMAPEVIEDQKYGKPVDIW 209
               T  YM+PE I  Q YGK VD++
Sbjct: 184 ----TLRYMSPEQISSQDYGKEVDLY 205

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 21/182 (11%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           TTE        + H+ + P +V L   + +E  L+++ +Y++G ++   + +R      +
Sbjct: 101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----F 156
Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           +E     Y+ +++ AL + H+  II+RDIK   +LL   +++  V L  FG++       
Sbjct: 157 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLS------- 206
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE--DQKYGKPVDIWXXXXXXXXXXXXXXP 224
                 E +   T +A    GT  YMAP+++   D  + K VD W              P
Sbjct: 207 -----KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
Query: 225 FV 226
           F 
Sbjct: 262 FT 263

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 73/168 (43%), Gaps = 34/168 (20%)
Query: 54  REATICHMLKHPHVVELLETYSSEG------MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  I  ++KHP+VV+L   + S G       L +V EY+       E V RA+  +   
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP------ETVYRASRHYAKL 134
Query: 108 EAVASH-----YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
           +          YM Q+L +L Y H   I HRDIKP  +LL     S  +KL  FG A  L
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKIL 192
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIW 209
             G+   S               I + +Y APE+I     Y   +DIW
Sbjct: 193 IAGEPNVS--------------XICSRYYRAPELIFGATNYTTNIDIW 226

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L      +  + +VFE+M+    C     R   G   +
Sbjct: 45  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG--CLSDYLRTQRGLFAA 102
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E +    +  V E + Y  E  +IHRD+     L+   EN   +K+  FG+   + D   
Sbjct: 103 ETLLGMCL-DVCEGMAYLEEASVIHRDLAARNCLVG--ENQV-IKVSDFGMTRFVLD--- 155
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     + +PEV    +Y    D+W
Sbjct: 156 --------DQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVW 188

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 22/145 (15%)
Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT-AGFVYSEAVASHYMRQVLEALRY 124
           +V+ +LE ++    + M FE +  S   +E++++    GF  S  +   +   +L+ L  
Sbjct: 160 NVIHMLENFTFRNHICMTFELL--SMNLYELIKKNKFQGF--SLPLVRKFAHSILQCLDA 215
Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H+N IIH D+KP  +LL  +  S  +K+  FG +         C   +R+  YT     
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSS---------CYEHQRV--YTX---- 259
Query: 185 RIGTPHYMAPEVIEDQKYGKPVDIW 209
            I +  Y APEVI   +YG P+D+W
Sbjct: 260 -IQSRFYRAPEVILGARYGMPIDMW 283

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/145 (29%), Positives = 72/145 (49%), Gaps = 22/145 (15%)
Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT-AGFVYSEAVASHYMRQVLEALRY 124
           +V+ +LE ++    + M FE +  S   +E++++    GF  S  +   +   +L+ L  
Sbjct: 160 NVIHMLENFTFRNHICMTFELL--SMNLYELIKKNKFQGF--SLPLVRKFAHSILQCLDA 215
Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H+N IIH D+KP  +LL  +  S  +K+  FG +         C   +R+  YT     
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSS---------CYEHQRV--YTX---- 259
Query: 185 RIGTPHYMAPEVIEDQKYGKPVDIW 209
            I +  Y APEVI   +YG P+D+W
Sbjct: 260 -IQSRFYRAPEVILGARYGMPIDMW 283

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 26/166 (15%)
Query: 82  MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL 141
           +VFE+++ +D  F+ +R+    +         YM ++L+AL YCH   I+HRD+KPH V+
Sbjct: 111 LVFEHVNNTD--FKQLRQTLTDYD-----IRFYMYEILKALDYCHSMGIMHRDVKPHNVM 163
Query: 142 LANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-Q 200
           + ++     ++L  +G+A     GQ Y                R+ + ++  PE++ D Q
Sbjct: 164 IDHEHRK--LRLIDWGLAEFYHPGQEYNV--------------RVASRYFKGPELLVDYQ 207
Query: 201 KYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKLHILGC 246
            Y   +D+W              PF    D   Q +   K  +LG 
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK--VLGT 251

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 43  LNHYTTEAD---LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           L   T +AD   + REA I H L +P++V L+    +E ++ +V E   G  +   +V +
Sbjct: 45  LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK 103
Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                V + A   H   QV   ++Y  E + +HRD+    VLL N+  +   K+  FG++
Sbjct: 104 REEIPVSNVAELLH---QVSMGMKYLEEKNFVHRDLAARNVLLVNRHYA---KISDFGLS 157
Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             L         G    +YT ++  +     Y APE I  +K+    D+W
Sbjct: 158 KAL---------GADDSYYTARSAGKWPLKWY-APECINFRKFSSRSDVW 197

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L      +  + +VFE+M+    C     R   G   +
Sbjct: 48  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG--CLSDYLRTQRGLFAA 105
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E +    +  V E + Y  E  +IHRD+     L+   EN   +K+  FG+   + D   
Sbjct: 106 ETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLVG--ENQV-IKVSDFGMTRFVLD--- 158
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     + +PEV    +Y    D+W
Sbjct: 159 --------DQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVW 191

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 28/150 (18%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR--ATAGFVYSEAVASHYMRQVLE 120
           +HP  V L + +   G+LY+       +++C   +++     G    EA    Y+R  L 
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQ------TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLL 168
Query: 121 ALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTT 180
           AL + H   ++H D+KP  + L  +      KLG FG+ ++L                T 
Sbjct: 169 ALAHLHSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELG---------------TA 210
Query: 181 KAGH-RIGTPHYMAPEVIEDQKYGKPVDIW 209
            AG  + G P YMAPE+++   YG   D++
Sbjct: 211 GAGEVQEGDPRYMAPELLQG-SYGTAADVF 239

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 54.7 bits (130), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L      +  + +VFE+M+    C     R   G   +
Sbjct: 45  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG--CLSDYLRTQRGLFAA 102
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E +    +  V E + Y  E  +IHRD+     L+   EN   +K+  FG+   + D   
Sbjct: 103 ETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLVG--ENQV-IKVSDFGMTRFVLD--- 155
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     + +PEV    +Y    D+W
Sbjct: 156 --------DQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVW 188

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L      +  + +VFE+M+    C     R   G   +
Sbjct: 65  SEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG--CLSDYLRTQRGLFAA 122
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E +    +  V E + Y  E  +IHRD+     L+   EN   +K+  FG+   + D   
Sbjct: 123 ETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLVG--ENQV-IKVSDFGMTRFVLD--- 175
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     + +PEV    +Y    D+W
Sbjct: 176 --------DQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVW 208

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L      +  + +VFE+M+    C     R   G   +
Sbjct: 43  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHG--CLSDYLRTQRGLFAA 100
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E +    +  V E + Y  E  +IHRD+     L+   EN   +K+  FG+   + D   
Sbjct: 101 ETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLVG--ENQV-IKVSDFGMTRFVLD--- 153
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     + +PEV    +Y    D+W
Sbjct: 154 --------DQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVW 186

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   LKH ++V L +   S+  L +VFE+ D      +    +  G +  E V S 
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD---LKKYFDSCNGDLDPEIVKS- 105
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ Q+L+ L +CH  +++HRD+KP  +L+     +  +KL  FG+A            G 
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAF---------GI 153
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y+ +    + T  Y  P+V+   K Y   +D+W
Sbjct: 154 PVRCYSAE----VVTLWYRPPDVLFGAKLYSTSIDMW 186

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 31/171 (18%)
Query: 52  LKREATICHMLKHPHVVE--------LLETYSSEGMLYMVFEYMDGSDICFEIVRRATAG 103
           LKR  T C   +   +V         L   +  E  LY+V +Y  G D+   + +     
Sbjct: 129 LKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDK- 187
Query: 104 FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
               E +A  Y+ +++ A+   H+   +HRDIKP  VLL   + +  ++L  FG  +++ 
Sbjct: 188 --LPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL---DVNGHIRLADFGSCLKMN 242
Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----KYGKPVDIW 209
           D              T ++   +GTP Y++PE+++       KYG   D W
Sbjct: 243 DDG------------TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 281

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 66/142 (46%), Gaps = 23/142 (16%)
Query: 73  TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIH 132
            +  E  LY+V +Y  G D+   + +         E +A  Y+ +++ A+   H+   +H
Sbjct: 142 AFQDENHLYLVMDYYVGGDLLTLLSKFEDK---LPEDMARFYIGEMVLAIDSIHQLHYVH 198
Query: 133 RDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYM 192
           RDIKP  VLL   + +  ++L  FG  +++ D              T ++   +GTP Y+
Sbjct: 199 RDIKPDNVLL---DVNGHIRLADFGSCLKMNDDG------------TVQSSVAVGTPDYI 243
Query: 193 APEVIEDQ-----KYGKPVDIW 209
           +PE+++       KYG   D W
Sbjct: 244 SPEILQAMEDGMGKYGPECDWW 265

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/187 (23%), Positives = 88/187 (47%), Gaps = 26/187 (13%)
Query: 58  ICHMLKHPHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYM 115
           + +++  P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+
Sbjct: 79  LQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYI 131
Query: 116 RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERL 175
            ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E  
Sbjct: 132 YELLKALDYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE-- 181
Query: 176 DHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQ 234
             Y      R+ + ++  PE++ D Q Y   +D+W              PF    D   Q
Sbjct: 182 --YNV----RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQ 235
Query: 235 SITKGKL 241
            +   K+
Sbjct: 236 LVKIAKV 242

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   LKH ++V L +   S+  L +VFE+ D      +    +  G +  E V S 
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD---LKKYFDSCNGDLDPEIVKS- 105
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ Q+L+ L +CH  +++HRD+KP  +L+     +  +KL  FG+A            G 
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLADFGLARAF---------GI 153
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            +  Y+ +    + T  Y  P+V+   K Y   +D+W
Sbjct: 154 PVRCYSAE----VVTLWYRPPDVLFGAKLYSTSIDMW 186

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 64/144 (44%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E M+     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 131
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 132 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 178
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 179 YSP----PEWIRYHRYHGRSAAVW 198

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 138
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 184
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 185 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 138
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 184
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 185 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 139
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 140 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 185
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 186 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 243

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 138
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 184
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 185 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 138
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 184
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 185 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 139
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 140 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 185
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 186 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 243

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH VL+ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 138
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 139 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 184
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 185 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 242

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 39/204 (19%)
Query: 31  IEPASFGLPDE--------RLNHYTTEADLKRE-----ATICHMLKHPHVVELLETYSSE 77
           +E  +FGL  E        ++   T  AD K         + H+ +H ++V LL   +  
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122
Query: 78  GMLYMVFEYMDGSDICFEIVRRATAGFVYS--------EAVAS----HYMRQVLEALRYC 125
           G + ++ EY    D+   + R+   G  YS        E ++S    H+  QV + + + 
Sbjct: 123 GPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL 182
Query: 126 HENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHR 185
              + IHRD+    VLL N   +   K+G FG+A  + +            +Y  K   R
Sbjct: 183 ASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMND----------SNYIVKGNAR 229
Query: 186 IGTPHYMAPEVIEDQKYGKPVDIW 209
           +    +MAPE I D  Y    D+W
Sbjct: 230 LPV-KWMAPESIFDCVYTVQSDVW 252

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 140
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 141 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 186
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 187 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 244

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDYYKNTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 191 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 245
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 246 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 289

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 22/145 (15%)
Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT-AGFVYSEAVASHYMRQVLEALRY 124
           +V+ +LE ++    + M FE +  S   +E++++    GF  S  +   +   +L+ L  
Sbjct: 160 NVIHMLENFTFRNHICMTFELL--SMNLYELIKKNKFQGF--SLPLVRKFAHSILQCLDA 215
Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H+N IIH D+KP  +LL  +  S  +K+  FG +         C   +R+  Y      
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSG-IKVIDFGSS---------CYEHQRV--YXX---- 259
Query: 185 RIGTPHYMAPEVIEDQKYGKPVDIW 209
            I +  Y APEVI   +YG P+D+W
Sbjct: 260 -IQSRFYRAPEVILGARYGMPIDMW 283

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/180 (24%), Positives = 84/180 (46%), Gaps = 26/180 (14%)
Query: 65  PHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           P++V+LL+    +      ++FEY++ +D  F+++      +        +Y+ ++L+AL
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNNTD--FKVLYPTLTDYD-----IRYYIYELLKAL 159
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            YCH   I+HRD+KPH V++ ++     ++L  +G+A      + Y  G E    Y    
Sbjct: 160 DYCHSQGIMHRDVKPHNVMIDHELRK--LRLIDWGLA------EFYHPGKE----YNV-- 205
Query: 183 GHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
             R+ + ++  PE++ D Q Y   +D+W              PF    D   Q +   K+
Sbjct: 206 --RVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKV 263

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 29/199 (14%)
Query: 52  LKREATICHMLKH-PHVVELLETYSS--EGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           +KRE  I   L+  P+++ L +           +VFE+++ +D  F+ + +    +    
Sbjct: 78  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD--FKQLYQTLTDYD--- 132
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y
Sbjct: 133 --IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEY 188
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVG 227
                           R+ + ++  PE++ D Q Y   +D+W              PF  
Sbjct: 189 NV--------------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 234
Query: 228 SRDRLFQSITKGKLHILGC 246
             D   Q +   K  +LG 
Sbjct: 235 GHDNYDQLVRIAK--VLGT 251

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 72  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 131
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 132 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLTARNVLVT--ENNV-MKIA 186
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 187 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 230

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 77  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 136
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 137 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 191
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 192 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 235

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 74  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 133
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 134 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 188
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 189 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 232

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL-LDYLRECNRQEV--NAVVLL 119
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 168
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 169 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 201

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL-LDYLRECNRQEV-SAVVLLY 115
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G        
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 163
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D YT  AG +     + APE +   K+    D+W
Sbjct: 164 --DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 196

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL-LDYLRECNRQEV-SAVVLLY 115
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G        
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 163
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D YT  AG +     + APE +   K+    D+W
Sbjct: 164 --DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 196

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 27/167 (16%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-----FEIVRRATAGFV 105
           D K E  I   +K+ + +      ++   +Y+++EYM+   I      F ++ +    F+
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 106 YSEAVASHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             + +    ++ VL +  Y H E +I HRD+KP  +L+   + +  VKL  FG +  + D
Sbjct: 149 PIQVIKC-IIKSVLNSFSYIHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVD 204
Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY--GKPVDIW 209
            ++               G R GT  +M PE   ++    G  VDIW
Sbjct: 205 KKI--------------KGSR-GTYEFMPPEFFSNESSYNGAKVDIW 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 39/203 (19%)
Query: 31  IEPASFGLPDE--------RLNHYTTEADLKRE-----ATICHMLKHPHVVELLETYSSE 77
           +E  +FGL  E        ++   T  AD K         + H+ +H ++V LL   +  
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122
Query: 78  GMLYMVFEYMDGSDICFEIVRRAT------AGFVYSEAVAS-----HYMRQVLEALRYCH 126
           G + ++ EY    D+    +RR +        F  + + AS     H+  QV + + +  
Sbjct: 123 GPVLVITEYCCYGDL-LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA 181
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
             + IHRD+    VLL N   +   K+G FG+A  + +            +Y  K   R+
Sbjct: 182 SKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMND----------SNYIVKGNARL 228
Query: 187 GTPHYMAPEVIEDQKYGKPVDIW 209
               +MAPE I D  Y    D+W
Sbjct: 229 PV-KWMAPESIFDCVYTVQSDVW 250

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 135 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 189
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 190 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 239 DQLVRIAK--VLGT 250

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG-QLYCSGGE 173
            RQ+LEAL Y H   IIHRD+KP  + +    N   VK+G FG+A  +     +     +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---VKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            L   +      IGT  Y+A EV++    Y + +D++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 135 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 189
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 190 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 238
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 239 DQLVRIAK--VLGT 250

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 134 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 188
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 189 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 238 DQLVRIAK--VLGT 249

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 5/97 (5%)
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG-QLYCSGGE 173
            RQ+LEAL Y H   IIHRD+KP  + +    N   VK+G FG+A  +     +     +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---VKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
            L   +      IGT  Y+A EV++    Y + +D++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 43  LNHYTTEAD---LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR 99
           L   T +AD   + REA I H L +P++V L+    +E ++ +V E   G  +   +V +
Sbjct: 371 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGK 429
Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                V + A   H   QV   ++Y  E + +HR++    VLL N+  +   K+  FG++
Sbjct: 430 REEIPVSNVAELLH---QVSMGMKYLEEKNFVHRNLAARNVLLVNRHYA---KISDFGLS 483
Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             L         G    +YT ++  +     Y APE I  +K+    D+W
Sbjct: 484 KAL---------GADDSYYTARSAGKWPLKWY-APECINFRKFSSRSDVW 523

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 115
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 164
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 165 ---DTYTAPAGAKFPI-KWTAPESLAYNKFSIKSDVW 197

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 141 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 195
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 196 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 244
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 245 DQLVRIAK--VLGT 256

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 19/134 (14%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     GQ Y     
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNV--- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWXXXXXXXXXXXXXXPFVGSRDRL 232
                      R+ + ++  PE++ D Q Y   +D+W              PF    D  
Sbjct: 191 -----------RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 239
Query: 233 FQSITKGKLHILGC 246
            Q +   K  +LG 
Sbjct: 240 DQLVRIAK--VLGT 251

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 116
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 165
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 166 ---DTYTAPAGAKFPI-KWTAPESLAYNKFSIKSDVW 198

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV-SAVVLLY 115
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G        
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 163
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D YT  AG +     + APE +   K+    D+W
Sbjct: 164 --DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 196

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV-SAVVLLY 120
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G        
Sbjct: 121 MATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 168
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D YT  AG +     + APE +   K+    D+W
Sbjct: 169 --DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 201

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +++ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MRIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 119
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 168
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 169 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 201

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV-SAVVLLY 115
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G        
Sbjct: 116 MATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 163
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D YT  AG +     + APE +   K+    D+W
Sbjct: 164 --DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 196

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E   C  L  P +V L         + +  E ++G  +  +++++        E  A +Y
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMG---CLPEDRALYY 155
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           + Q LE L Y H   I+H D+K   VLL++  + A   L  FG A+ LQ DG        
Sbjct: 156 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA--ALCDFGHALCLQPDG-------- 205
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            L        +  GT  +MAPEV+  +     VDIW
Sbjct: 206 -LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 240

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E   C  L  P +V L         + +  E ++G  +  +++++        E  A +Y
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMG---CLPEDRALYY 169
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           + Q LE L Y H   I+H D+K   VLL++  + A   L  FG A+ LQ DG        
Sbjct: 170 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA--ALCDFGHALCLQPDG-------- 219
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            L        +  GT  +MAPEV+  +     VDIW
Sbjct: 220 -LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 254

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 114
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 163
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 164 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 196

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 118
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 119 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 167
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 168 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 200

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 58  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 114
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 163
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 164 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 196

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 71  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 127
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 176
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 177 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 209

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 119
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 168
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 169 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 201

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 28/182 (15%)
Query: 64  HPHVVELLETY-SSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           HP V+ LL+ + + EG + ++   +   D+   I  +   G    E  +  +  QV+ A+
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLG----EGPSRCFFGQVVAAI 152
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           ++CH   ++HRDIK   +L+  +   A  KL  FG    L D           + YT   
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSGALLHD-----------EPYTDFD 199
Query: 183 GHRIGTPHYMAPEVIEDQKY-GKPVDIWXXXXXXXXXXXXXXPFVGSRDRLFQSITKGKL 241
           G R+    Y  PE I   +Y   P  +W              PF   RD   Q I + +L
Sbjct: 200 GTRV----YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF--ERD---QEILEAEL 250
Query: 242 HI 243
           H 
Sbjct: 251 HF 252

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 116
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 165
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 166 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 198

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/172 (24%), Positives = 77/172 (44%), Gaps = 33/172 (19%)
Query: 52  LKREATICHMLKHPHVVE--------LLETYSSEGMLYMVFEYMDGSDICFEIVRRATAG 103
           LKR  T C   +   +V         L   +  +  LY+V +Y  G D+   + +     
Sbjct: 113 LKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR- 171
Query: 104 FVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL- 162
               E +A  Y+ +++ A+   H+   +HRDIKP  +L+   + +  ++L  FG  ++L 
Sbjct: 172 --LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----KYGKPVDIW 209
           +DG             T ++   +GTP Y++PE+++       +YG   D W
Sbjct: 227 EDG-------------TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWW 265

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 68/156 (43%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E   C  L  P +V L         + +  E ++G  +  +++++        E  A +Y
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGC---LPEDRALYY 171
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           + Q LE L Y H   I+H D+K   VLL++  + A   L  FG A+ LQ DG        
Sbjct: 172 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRA--ALCDFGHALCLQPDG-------- 221
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            L        +  GT  +MAPEV+  +     VDIW
Sbjct: 222 -LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIW 256

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 60  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 116
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 165
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 166 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 198

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 128 NXGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 174
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 175 YSP----PEWIRYHRYHGRSAAVW 194

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 46  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 97
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 98  DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 151
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 152 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 195
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 196 YRAPELIFGATDYTSSIDVW 215

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 57  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 108
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 109 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 162
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 163 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 206
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 207 YRAPELIFGATDYTSSIDVW 226

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 38  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 90  DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 143
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 144 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 187
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 188 YRAPELIFGATDYTSSIDVW 207

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 38  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 90  DVVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 143
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 144 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 187
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 188 YRAPELIFGATDYTSSIDVW 207

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 38  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 90  DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 143
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 144 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 187
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 188 YRAPELIFGATDYTSSIDVW 207

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 50  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 101
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 102 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 155
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 156 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 199
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 200 YRAPELIFGATDYTSSIDVW 219

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 50  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 101
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 102 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 155
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 156 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 199
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 200 YRAPELIFGATDYTSSIDVW 219

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 42  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 93
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 94  DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 147
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 148 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 191
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 192 YRAPELIFGATDYTSSIDVW 211

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 39  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 90
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 91  DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 144
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 145 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 188
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 189 YRAPELIFGATDYTSSIDVW 208

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 174
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 175 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 221
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 222 YSP----PEWIRYHRYHGRSAAVW 241

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 72  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 123
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 124 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 177
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 178 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------XICSRY 221
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 222 YRAPELIFGATDYTSSIDVW 241

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L      +  + +V E+M+    C     R   G   +
Sbjct: 46  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG--CLSDYLRTQRGLFAA 103
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E +    +  V E + Y  E  +IHRD+     L+   EN   +K+  FG+   + D   
Sbjct: 104 ETLLGMCL-DVCEGMAYLEEACVIHRDLAARNCLVG--ENQV-IKVSDFGMTRFVLD--- 156
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     + +PEV    +Y    D+W
Sbjct: 157 --------DQYTSSTGTKFPV-KWASPEVFSFSRYSSKSDVW 189

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 64/133 (48%), Gaps = 20/133 (15%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           + +L   +  E  LY+V EY  G D+   +   +  G      +A  Y+ +++ A+   H
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGERLDHYTTKAGHR 185
               +HRDIKP  +LL   +    ++L  FG  ++L+ DG             T ++   
Sbjct: 180 RLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADG-------------TVRSLVA 223
Query: 186 IGTPHYMAPEVIE 198
           +GTP Y++PE+++
Sbjct: 224 VGTPDYLSPEILQ 236

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+      YS  +AS
Sbjct: 88  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK------YSLDLAS 140
Query: 113 H--YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   Y +
Sbjct: 141 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKA 197
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              +L               +MAPE I  +++    D+W
Sbjct: 198 SKGKLPI------------KWMAPESINFRRFTSASDVW 224

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 159
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 160 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 206
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 207 YSP----PEWIRYHRYHGRSAAVW 226

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 77/185 (41%), Gaps = 30/185 (16%)
Query: 54  REATICHMLKHPHVVELL----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           RE  +   L H ++V+L     ET +   +L M F    GS   + ++   +  +   E+
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF-CPCGS--LYTVLEEPSNAYGLPES 112
Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLY 168
                +R V+  + +  EN I+HR+IKP  ++    E+   V KL  FG A +L+D + +
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIE--------DQKYGKPVDIWXXXXXXXXXXX 220
            S                GT  Y+ P++ E         +KYG  VD+W           
Sbjct: 173 VS--------------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 221 XXXPF 225
              PF
Sbjct: 219 GSLPF 223

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 21/132 (15%)
Query: 92  ICFEIVRRATAGFV-------YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN 144
           I FE++ + T  F+       Y      H   Q+  ALR+ HEN + H D+KP  +L  N
Sbjct: 131 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 190
Query: 145 -------KENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI 197
                   E+ +  +      +I++ D   + S     +H+TT     + T HY  PEVI
Sbjct: 191 SEFETLYNEHKSCEEKSVKNTSIRVAD---FGSATFDHEHHTTI----VATRHYRPPEVI 243
Query: 198 EDQKYGKPVDIW 209
            +  + +P D+W
Sbjct: 244 LELGWAQPCDVW 255

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 174
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 175 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 221
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 222 YSP----PEWIRYHRYHGRSAAVW 241

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 21/132 (15%)
Query: 92  ICFEIVRRATAGFV-------YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN 144
           I FE++ + T  F+       Y      H   Q+  ALR+ HEN + H D+KP  +L  N
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158
Query: 145 -------KENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI 197
                   E+ +  +      +I++ D   + S     +H+TT     + T HY  PEVI
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVAD---FGSATFDHEHHTTI----VATRHYRPPEVI 211
Query: 198 EDQKYGKPVDIW 209
            +  + +P D+W
Sbjct: 212 LELGWAQPCDVW 223

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 43  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 94
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 95  DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 148
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 149 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------YICSRY 192
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 193 YRAPELIFGATDYTSSIDVW 212

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 51  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 102
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 103 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 156
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 157 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------YICSRY 200
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 201 YRAPELIFGATDYTSSIDVW 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 34/169 (20%)
Query: 53  KREATICHMLKHPHVVELLETYSSEG------MLYMVFEYMDGSDICFEIVR-----RAT 101
            RE  I   L H ++V L   + S G       L +V +Y+  +   + + R     + T
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPAT--VYRVARHYSRAKQT 118
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
              +Y +     YM Q+  +L Y H   I HRDIKP  +LL    ++A +KL  FG A Q
Sbjct: 119 LPVIYVKL----YMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQ 172
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIW 209
           L  G+   S               I + +Y APE+I     Y   +D+W
Sbjct: 173 LVRGEPNVS--------------XICSRYYRAPELIFGATDYTSSIDVW 207

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 38  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 89
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 90  DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 143
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 144 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------YICSRY 187
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 188 YRAPELIFGATDYTSSIDVW 207

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 174
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 175 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 221
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 222 YSP----PEWIRYHRYHGRSAAVW 241

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 160
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 161 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 207
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 208 YSP----PEWIRYHRYHGRSAAVW 227

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 160
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 161 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 207
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 208 YSP----PEWIRYHRYHGRSAAVW 227

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 159
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 160 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 206
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 207 YSP----PEWIRYHRYHGRSAAVW 226

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 160
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 161 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 207
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 208 YSP----PEWIRYHRYHGRSAAVW 227

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+      YS  +AS
Sbjct: 65  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK------YSLDLAS 117
Query: 113 H--YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   Y +
Sbjct: 118 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKA 174
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              +L               +MAPE I  +++    D+W
Sbjct: 175 SKGKLPI------------KWMAPESINFRRFTSASDVW 201

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 60/132 (45%), Gaps = 21/132 (15%)
Query: 92  ICFEIVRRATAGFV-------YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN 144
           I FE++ + T  F+       Y      H   Q+  ALR+ HEN + H D+KP  +L  N
Sbjct: 108 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 167
Query: 145 -------KENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI 197
                   E+ +  +      +I++ D   + S     +H+TT     + T HY  PEVI
Sbjct: 168 SEFETLYNEHKSCEEKSVKNTSIRVAD---FGSATFDHEHHTTI----VATRHYRPPEVI 220
Query: 198 EDQKYGKPVDIW 209
            +  + +P D+W
Sbjct: 221 LELGWAQPCDVW 232

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 159
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 160 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 206
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 207 YSP----PEWIRYHRYHGRSAAVW 226

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 179
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 180 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 226
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 227 YSP----PEWIRYHRYHGRSAAVW 246

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 159
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 160 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 206
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 207 YSP----PEWIRYHRYHGRSAAVW 226

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 160
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 161 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 207
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 208 YSP----PEWIRYHRYHGRSAAVW 227

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 128 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 174
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 175 YSP----PEWIRYHRYHGRSAAVW 194

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 74  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 130
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 131 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 177
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 178 YSP----PEWIRYHRYHGRSAAVW 197

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 72  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 123
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 124 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 177
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 178 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------YICSRY 221
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 222 YRAPELIFGATDYTSSIDVW 241

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 66  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 117
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 118 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 171
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 172 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------YICSRY 215
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 216 YRAPELIFGATDYTSSIDVW 235

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+      YS  +AS
Sbjct: 60  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK------YSLDLAS 112
Query: 113 H--YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   Y +
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKA 169
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              +L               +MAPE I  +++    D+W
Sbjct: 170 SKGKLPI------------KWMAPESINFRRFTSASDVW 196

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+      YS  +AS
Sbjct: 60  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK------YSLDLAS 112
Query: 113 H--YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   Y +
Sbjct: 113 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKA 169
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              +L               +MAPE I  +++    D+W
Sbjct: 170 SKGKLPI------------KWMAPESINFRRFTSASDVW 196

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 146
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 147 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 193
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 194 YSP----PEWIRYHRYHGRSAAVW 213

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 76  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 127
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 128 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 181
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 182 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------YICSRY 225
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 226 YRAPELIFGATDYTSSIDVW 245

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+    F    A   
Sbjct: 440 QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLI 494
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   Y +  
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKASK 551
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            +L               +MAPE I  +++    D+W
Sbjct: 552 GKL------------PIKWMAPESINFRRFTSASDVW 576

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 90  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 146
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 147 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 193
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 194 YSP----PEWIRYHRYHGRSAAVW 213

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 132
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 133 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 179
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 180 YSP----PEWIRYHRYHGRSAAVW 199

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 147
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 148 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 194
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 195 YSP----PEWIRYHRYHGRSAAVW 214

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 128 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 174
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 175 YSP----PEWIRYHRYHGRSAAVW 194

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 132
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 133 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 179
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 180 YSP----PEWIRYHRYHGRSAAVW 199

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 76  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 132
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 133 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 179
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 180 YSP----PEWIRYHRYHGRSAAVW 199

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 166
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 167 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 213
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 214 YSP----PEWIRYHRYHGRSAAVW 233

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+      YS  +AS
Sbjct: 62  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK------YSLDLAS 114
Query: 113 H--YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   Y +
Sbjct: 115 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKA 171
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              +L               +MAPE I  +++    D+W
Sbjct: 172 SKGKLPI------------KWMAPESINFRRFTSASDVW 198

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 75  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 131
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 132 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 178
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 179 YSP----PEWIRYHRYHGRSAAVW 198

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E   C  L  P +V L         + +  E ++G  +  ++V+         E  A +Y
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQG---CLPEDRALYY 190
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           + Q LE L Y H   I+H D+K   VLL++  + A   L  FG A+ LQ DG        
Sbjct: 191 LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHA--ALCDFGHAVCLQPDG-------- 240
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            L        +  GT  +MAPEV+  +     VD+W
Sbjct: 241 -LGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVW 275

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+      YS  +AS
Sbjct: 63  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK------YSLDLAS 115
Query: 113 H--YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   Y +
Sbjct: 116 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKA 172
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              +L               +MAPE I  +++    D+W
Sbjct: 173 SKGKLPI------------KWMAPESINFRRFTSASDVW 199

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 33/198 (16%)
Query: 31  IEPASFGLPDE--------RLNHYTTEADLKRE-----ATICHMLKHPHVVELLETYSSE 77
           +E  +FGL  E        ++   T  AD K         + H+ +H ++V LL   +  
Sbjct: 55  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 114
Query: 78  GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS------HYMRQVLEALRYCHENDII 131
           G + ++ EY    D+   + R+A A     +          H+  QV + + +    + I
Sbjct: 115 GPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI 174
Query: 132 HRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHY 191
           HRD+    VLL N   +   K+G FG+A  + +            +Y  K   R+    +
Sbjct: 175 HRDVAARNVLLTNGHVA---KIGDFGLARDIMND----------SNYIVKGNARLPV-KW 220
Query: 192 MAPEVIEDQKYGKPVDIW 209
           MAPE I D  Y    D+W
Sbjct: 221 MAPESIFDCVYTVQSDVW 238

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 74  QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 125
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 126 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 179
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 180 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------YICSRY 223
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 224 YRAPELIFGATDYTSSIDVW 243

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 98  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 154
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 155 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 201
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 202 YSP----PEWIRYHRYHGRSAAVW 221

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 147
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 148 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 194
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 195 YSP----PEWIRYHRYHGRSAAVW 214

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 63/144 (43%), Gaps = 21/144 (14%)
Query: 67  VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH 126
           V+ LL+ +       ++ E  +     F+ +    A     E +A  +  QVLEA+R+CH
Sbjct: 91  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 147
Query: 127 ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRI 186
              ++HRDIK   +L+    N   +KL  FG    L+D             YT   G R+
Sbjct: 148 NCGVLHRDIKDENILI--DLNRGELKLIDFGSGALLKDTV-----------YTDFDGTRV 194
Query: 187 GTPHYMAPEVIEDQKY-GKPVDIW 209
            +P    PE I   +Y G+   +W
Sbjct: 195 YSP----PEWIRYHRYHGRSAAVW 214

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 56  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV-SAVVLLY 113
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G        
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 161
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D +T  AG +     + APE +   K+    D+W
Sbjct: 162 --DTFTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 194

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 75/175 (42%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++  Y                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 84/200 (42%), Gaps = 42/200 (21%)
Query: 22  KMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--- 78
           + KL  S E+      L D+R  +        RE  I   L H ++V L   + S G   
Sbjct: 117 QAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIVRLRYFFYSSGEKK 168
Query: 79  ---MLYMVFEYMDGSDICFEIVR-----RATAGFVYSEAVASHYMRQVLEALRYCHENDI 130
               L +V +Y+   +  + + R     + T   +Y +     YM Q+  +L Y H   I
Sbjct: 169 DEVYLNLVLDYV--PETVYRVARHYSRAKQTLPVIYVKL----YMYQLFRSLAYIHSFGI 222
Query: 131 IHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPH 190
            HRDIKP  +LL    ++A +KL  FG A QL  G+   S               I + +
Sbjct: 223 CHRDIKPQNLLL--DPDTAVLKLCDFGSAKQLVRGEPNVS--------------YICSRY 266
Query: 191 YMAPEVI-EDQKYGKPVDIW 209
           Y APE+I     Y   +D+W
Sbjct: 267 YRAPELIFGATDYTSSIDVW 286

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 73/159 (45%), Gaps = 25/159 (15%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+      YS  +AS
Sbjct: 57  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK------YSLDLAS 109
Query: 113 H--YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   Y +
Sbjct: 110 LILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTYYKA 166
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              +L               +MAPE I  +++    D+W
Sbjct: 167 SKGKLPI------------KWMAPESINFRRFTSASDVW 193

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 81/198 (40%), Gaps = 33/198 (16%)
Query: 31  IEPASFGLPDE--------RLNHYTTEADLKRE-----ATICHMLKHPHVVELLETYSSE 77
           +E  +FGL  E        ++   T  AD K         + H+ +H ++V LL   +  
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122
Query: 78  GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS------HYMRQVLEALRYCHENDII 131
           G + ++ EY    D+   + R+A A     +          H+  QV + + +    + I
Sbjct: 123 GPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCI 182
Query: 132 HRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHY 191
           HRD+    VLL N   +   K+G FG+A  + +            +Y  K   R+    +
Sbjct: 183 HRDVAARNVLLTNGHVA---KIGDFGLARDIMND----------SNYIVKGNARLPV-KW 228
Query: 192 MAPEVIEDQKYGKPVDIW 209
           MAPE I D  Y    D+W
Sbjct: 229 MAPESIFDCVYTVQSDVW 246

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 29/191 (15%)
Query: 25  LHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS----EGML 80
           L T   +E A   L D +L   +     K EA     L+HP++V   +++ S    +  +
Sbjct: 46  LDTETTVEVAWCELQDRKLTK-SERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCI 104
Query: 81  YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPH 138
            +V E      +   + R      V    V   + RQ+L+ L++ H     IIHRD+K  
Sbjct: 105 VLVTELXTSGTLKTYLKRFK----VXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD 160
Query: 139 CVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE 198
            + +     S  VK+G  G+A  L+                  A   IGTP + APE  E
Sbjct: 161 NIFITGPTGS--VKIGDLGLAT-LKRASF--------------AKAVIGTPEFXAPEXYE 203
Query: 199 DQKYGKPVDIW 209
            +KY + VD++
Sbjct: 204 -EKYDESVDVY 213

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y+V EYM   ++  + +R      V   AV   
Sbjct: 77  KEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNL-LDYLRECNREEV--TAVVLL 133
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHV-VKVADFGLS-RLMTG------- 182
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +    +    D+W
Sbjct: 183 ---DTYTAHAGAKFPI-KWTAPESLAYNTFSIKSDVW 215

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 4/101 (3%)
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
            V  H   Q+ EA+ + H   ++HRD+KP  +     +    VK+G FG+   +   +  
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEE 220
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            +    +  Y T  G ++GT  YM+PE I    Y   VDI+
Sbjct: 221 QTVLTPMPAYATHXG-QVGTKLYMSPEQIHGNNYSHKVDIF 260

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 265 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV-SAVVLLY 322
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHR++     L+   EN   VK+  FG++ +L  G        
Sbjct: 323 MATQISSAMEYLEKKNFIHRNLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 370
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D YT  AG +     + APE +   K+    D+W
Sbjct: 371 --DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 403

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/202 (24%), Positives = 83/202 (41%), Gaps = 37/202 (18%)
Query: 31  IEPASFGLPDE--------RLNHYTTEADLKRE-----ATICHMLKHPHVVELLETYSSE 77
           +E  +FGL  E        ++   T  AD K         + H+ +H ++V LL   +  
Sbjct: 63  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122
Query: 78  GMLYMVFEYMDGSDICFEIVRRATA-----GFVYSEAVAS-----HYMRQVLEALRYCHE 127
           G + ++ EY    D+   + R++        F  + +  S     H+  QV + + +   
Sbjct: 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLAS 182
Query: 128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIG 187
            + IHRD+    VLL N   +   K+G FG+A  + +            +Y  K   R+ 
Sbjct: 183 KNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMND----------SNYIVKGNARLP 229
Query: 188 TPHYMAPEVIEDQKYGKPVDIW 209
              +MAPE I D  Y    D+W
Sbjct: 230 V-KWMAPESIFDCVYTVQSDVW 250

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 34/168 (20%)
Query: 54  REATICHMLKHPHVVELLETYSSEG------MLYMVFEYMDGSDICFEIVR-----RATA 102
           RE  I   L H ++V L   + S G       L +V +Y+   +  + + R     + T 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQTL 119
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y +     YM Q+  +L Y H   I HRDIKP  +LL    ++A +KL  FG A QL
Sbjct: 120 PVIYVKL----YMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQL 173
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIW 209
             G+   S               I + +Y APE+I     Y   +D+W
Sbjct: 174 VRGEPNVS--------------YICSRYYRAPELIFGATDYTSSIDVW 207

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 73/169 (43%), Gaps = 34/169 (20%)
Query: 53  KREATICHMLKHPHVVELLETYSSEG------MLYMVFEYMDGSDICFEIVR-----RAT 101
            RE  I   L H ++V L   + S G       L +V +Y+   +  + + R     + T
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV--PETVYRVARHYSRAKQT 118
Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
              +Y +     YM Q+  +L Y H   I HRDIKP  +LL    ++A +KL  FG A Q
Sbjct: 119 LPVIYVKL----YMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQ 172
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIW 209
           L  G+   S               I + +Y APE+I     Y   +D+W
Sbjct: 173 LVRGEPNVS--------------YICSRYYRAPELIFGATDYTSSIDVW 207

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 75/175 (42%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++  Y                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDYYKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 43/85 (50%), Gaps = 4/85 (4%)
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG-QLYCSGGE 173
            RQ+LEAL Y H   IIHR++KP  + +    N   VK+G FG+A  +     +     +
Sbjct: 122 FRQILEALSYIHSQGIIHRNLKPXNIFIDESRN---VKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIE 198
            L   +      IGT  Y+A EV++
Sbjct: 179 NLPGSSDNLTSAIGTAXYVATEVLD 203

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA I   L HPH+V+L+     E   +++ E     ++   + R   +  V +  +   Y
Sbjct: 75  EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVL---Y 130
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q+ +A+ Y    + +HRDI    +L+A+ E    VKLG FG++  ++D   Y +   R
Sbjct: 131 SLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLSRYIEDEDYYKASVTR 187
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           L               +M+PE I  +++    D+W
Sbjct: 188 L------------PIKWMSPESINFRRFTTASDVW 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 304 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 360
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHR++     L+   EN   VK+  FG++ +L  G       
Sbjct: 361 YMATQISSAMEYLEKKNFIHRNLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 409
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D YT  AG +     + APE +   K+    D+W
Sbjct: 410 ---DTYTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 442

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 90/195 (46%), Gaps = 23/195 (11%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
            K E  +    +H +++ L   YS++  L +V ++ +GS + +  +  +   F   + + 
Sbjct: 67  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL-YHHLHASETKFEMKKLI- 123
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
               RQ    + Y H   IIHRD+K + + L +++N+  VK+G FG+A +    +   SG
Sbjct: 124 -DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNT--VKIGDFGLATE----KSRWSG 175
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXXXXXXPF--V 226
             + +  +       G+  +MAPEVI  Q    Y    D++              P+  +
Sbjct: 176 SHQFEQLS-------GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
Query: 227 GSRDRLFQSITKGKL 241
            +RD++ + + +G L
Sbjct: 229 NNRDQIIEMVGRGSL 243

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA I   L HPH+V+L+     E   +++ E     ++   + R   +  V +  +   Y
Sbjct: 59  EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVL---Y 114
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q+ +A+ Y    + +HRDI    +L+A+ E    VKLG FG++  ++D   Y +   R
Sbjct: 115 SLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLSRYIEDEDYYKASVTR 171
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           L               +M+PE I  +++    D+W
Sbjct: 172 L------------PIKWMSPESINFRRFTTASDVW 194

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 67/156 (42%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E   C  L  P +V L         + +  E ++G  +  ++V+         E  A +Y
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQG---CLPEDRALYY 171
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQLYCSGGE 173
           + Q LE L Y H   I+H D+K   VLL++  + A   L  FG A+ LQ DG        
Sbjct: 172 LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHA--ALCDFGHAVCLQPDG-------- 221
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            L        +  GT  +MAPEV+  +     VD+W
Sbjct: 222 -LGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVW 256

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 56  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL-LDYLRECNRQEV-SAVVLLY 113
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G        
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 161
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D  T  AG +     + APE +   K+    D+W
Sbjct: 162 --DTXTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 194

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA I   L HPH+V+L+     E   +++ E     ++   + R   +  V +  +   Y
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVL---Y 118
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q+ +A+ Y    + +HRDI    +L+A+ E    VKLG FG++  ++D   Y +   R
Sbjct: 119 SLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLSRYIEDEDYYKASVTR 175
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           L               +M+PE I  +++    D+W
Sbjct: 176 L------------PIKWMSPESINFRRFTTASDVW 198

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+    F    A   
Sbjct: 440 QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLI 494
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y  Q+  AL Y      +HRDI    VL++  +    VKLG FG++  ++D   Y +  
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSATDC---VKLGDFGLSRYMEDSTYYKASK 551
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            +L               +MAPE I  +++    D+W
Sbjct: 552 GKL------------PIKWMAPESINFRRFTSASDVW 576

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+    F    A   
Sbjct: 60  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLI 114
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y  Q+  AL Y      +HRDI    VL++  +    VKLG FG++  ++D   Y +  
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSATDC---VKLGDFGLSRYMEDSTYYKASK 171
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            +L               +MAPE I  +++    D+W
Sbjct: 172 GKLPI------------KWMAPESINFRRFTSASDVW 196

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 21/168 (12%)
Query: 54  REATICHMLK-HPHVVELLETYSSEGM--LYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           RE  I   L  H ++V LL    ++    +Y+VF+YM+       ++R      V+ + V
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYV 114
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG-----VAIQLQDG 165
               + Q+++ ++Y H   ++HRD+KP  +LL N E    VK+  FG     V I+    
Sbjct: 115 ----VYQLIKVIKYLHSGGLLHRDMKPSNILL-NAE--CHVKVADFGLSRSFVNIRRVTN 167
Query: 166 QLYCSGGERLDHYTTKA---GHRIGTPHYMAPEV-IEDQKYGKPVDIW 209
            +  S  E  +++          + T  Y APE+ +   KY K +D+W
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMW 215

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 59  KEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNL-LDYLRECNRQEV--NAVVLL 115
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 164
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D  T  AG +     + APE +   K+    D+W
Sbjct: 165 ---DTXTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 197

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
            K E  +    +H +++ L   YS+   L +V ++ +GS + +  +  +   F   + + 
Sbjct: 67  FKNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSL-YHHLHASETKFEMKKLI- 123
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
               RQ    + Y H   IIHRD+K + + L +++N+  VK+G FG+A +    +   SG
Sbjct: 124 -DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNT--VKIGDFGLATE----KSRWSG 175
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXXXXXXPF--V 226
             + +  +       G+  +MAPEVI  Q    Y    D++              P+  +
Sbjct: 176 SHQFEQLS-------GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
Query: 227 GSRDRLFQSITKGKL 241
            +RD++ + + +G L
Sbjct: 229 NNRDQIIEMVGRGSL 243

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS- 107
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  YS 
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 178
Query: 108 -------EAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 235
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 236 GLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 277

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS- 107
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  YS 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSY 137
Query: 108 -------EAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 194
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 195 GLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 236

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 76/185 (41%), Gaps = 30/185 (16%)
Query: 54  REATICHMLKHPHVVELL----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           RE  +   L H ++V+L     ET +   +L M F    GS   + ++   +  +   E+
Sbjct: 56  REFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC-GS--LYTVLEEPSNAYGLPES 112
Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLY 168
                +R V+  + +  EN I+HR+IKP  ++    E+   V KL  FG A +L+D + +
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIE--------DQKYGKPVDIWXXXXXXXXXXX 220
                             GT  Y+ P++ E         +KYG  VD+W           
Sbjct: 173 VX--------------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
Query: 221 XXXPF 225
              PF
Sbjct: 219 GSLPF 223

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +  ++ H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++ A +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS- 107
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  YS 
Sbjct: 67  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 126
Query: 108 -------EAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 127 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 183
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 184 GLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 225

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D        R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDXXKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS- 107
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  YS 
Sbjct: 70  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 129
Query: 108 -------EAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 130 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 186
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 187 GLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 228

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS- 107
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  YS 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 137
Query: 108 -------EAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 194
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 195 GLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS- 107
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  YS 
Sbjct: 71  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 130
Query: 108 -------EAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 131 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 187
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 188 GLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 229

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG+A  L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLARVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +  ++ H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++ A +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +  ++ H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++ A +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 47/101 (46%), Gaps = 4/101 (3%)
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           +V  H   Q+ EA+ + H   ++HRD+KP  +     +    VK+G FG+   +   +  
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEE 174
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            +    +  Y    G  +GT  YM+PE I    Y   VDI+
Sbjct: 175 QTVLTPMPAYARHTGQ-VGTKLYMSPEQIHGNSYSHKVDIF 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+ GFG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILGFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 74/175 (42%), Gaps = 31/175 (17%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMD--------------GSDICF 94
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY                G +  +
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           +I R       + + V+  Y  Q+   + Y      IHRD+    VL+   EN+  +K+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTY--QLARGMEYLASQKCIHRDLAARNVLVT--ENNV-MKIA 199
Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            FG+A  + +          +D        R+    +MAPE + D+ Y    D+W
Sbjct: 200 DFGLARDINN----------IDXXKKTTNGRLPV-KWMAPEALFDRVYTHQSDVW 243

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V S  V  +
Sbjct: 56  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV-SAVVLLY 113
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G        
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG-------- 161
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D  T  AG +     + APE +   K+    D+W
Sbjct: 162 --DTXTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 194

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 54  REATICHMLKHPHVVELL-----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  I    KH +++ +      +++ +   +Y++ E M         + R  +  + S+
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRVISTQMLSD 111
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               +++ Q L A++  H +++IHRD+KP  +L+    ++  +K+  FG+A  + +    
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDE---- 164
Query: 169 CSGGERLDHYTTKAG--HRIGTPHYMAPEV-IEDQKYGKPVDIW 209
            S  +  +    ++G    + T  Y APEV +   KY + +D+W
Sbjct: 165 -SAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVW 207

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 32/163 (19%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   ++H +V+ LL+ ++ +  L      Y+V  +M G+D+  ++++    G    
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLG-KLMKHEKLG---- 126
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E      + Q+L+ LRY H   IIHRD+KP    LA  E+   +K+  FG+A Q      
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN--LAVNEDCE-LKILDFGLARQAD---- 179
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                       ++    + T  Y APEVI +  +Y + VDIW
Sbjct: 180 ------------SEMXGXVVTRWYRAPEVILNWMRYTQTVDIW 210

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 78/167 (46%), Gaps = 40/167 (23%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   LKH +V+ LL+ ++    +      Y+V   M G+D+            V S
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLN---------NIVKS 125
Query: 108 EAVASHYMR----QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
           +A++  +++    Q+L  L+Y H   IIHRD+KP  V  A  E+S  +++  FG+A Q  
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV--AVNEDSE-LRILDFGLARQ-- 180
Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                    E +  Y       + T  Y APE++ +   Y + VDIW
Sbjct: 181 -------ADEEMTGY-------VATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 19/157 (12%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +EA +   +KHP++V+LL   + E   Y++ E+M   ++  + +R      V   AV   
Sbjct: 63  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL-LDYLRECNRQEV--NAVVLL 119
Query: 114 YM-RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           YM  Q+  A+ Y  + + IHRD+     L+   EN   VK+  FG++ +L  G       
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVG--ENHL-VKVADFGLS-RLMTG------- 168
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              D  T  AG +     + APE +   K+    D+W
Sbjct: 169 ---DTXTAHAGAKFPI-KWTAPESLAYNKFSIKSDVW 201

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 19/157 (12%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           +REA     L+ PHVV + +    +G LY+    ++G D+   + R+         AVA 
Sbjct: 82  QREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGP--LAPPRAVA- 138
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             +RQ+  AL   H     HRD+KP  +L++  + +    L  FG+A    D +L     
Sbjct: 139 -IVRQIGSALDAAHAAGATHRDVKPENILVSADDFA---YLVDFGIASATTDEKL----- 189
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  T+ G+ +GT +Y APE   +       DI+
Sbjct: 190 -------TQLGNTVGTLYYXAPERFSESHATYRADIY 219

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGFVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 134
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+S  +K+  FG+A   
Sbjct: 135 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDSE-LKILDFGLA--- 178
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 179 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 75/171 (43%), Gaps = 25/171 (14%)
Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
           ER+N +       RE  I   L+HP++V  +   +    L +V EY+    + + ++ ++
Sbjct: 76  ERVNEFL------REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKS 128
Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGV 158
            A     E         V + + Y H  +  I+HRD+K   +L+  K     VK+  FG+
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYT---VKVCDFGL 185
Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           + +L+      S                GTP +MAPEV+ D+   +  D++
Sbjct: 186 S-RLKASXFLXSKXA------------AGTPEWMAPEVLRDEPSNEKSDVY 223

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 130
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+S  +K+  FG+A   
Sbjct: 131 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDSE-LKILDFGLA--- 174
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 175 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 89/195 (45%), Gaps = 23/195 (11%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
            K E  +    +H +++ L   YS++  L +V ++ +GS + +  +  +   F   + + 
Sbjct: 55  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSL-YHHLHASETKFEMKKLI- 111
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
               RQ    + Y H   IIHRD+K + + L +++N+  VK+G FG+A      +   SG
Sbjct: 112 -DIARQTARGMDYLHAKSIIHRDLKSNNIFL-HEDNT--VKIGDFGLATV----KSRWSG 163
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXXXXXXPF--V 226
             + +  +       G+  +MAPEVI  Q    Y    D++              P+  +
Sbjct: 164 SHQFEQLS-------GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 216
Query: 227 GSRDRLFQSITKGKL 241
            +RD++ + + +G L
Sbjct: 217 NNRDQIIEMVGRGSL 231

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 33/163 (20%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   ++H +V+ LL+ ++    L      Y+V  +M  +D+      +   G  +S
Sbjct: 72  RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDL------QKIMGLKFS 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E    + + Q+L+ L+Y H   ++HRD+KP    LA  E+   +K+  FG+A        
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN--LAVNEDCE-LKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                    H   +    + T  Y APEVI     Y + VDIW
Sbjct: 174 --------RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 208

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 21/144 (14%)
Query: 80  LYMVFEYMDGSDICFEIVRRATAGFV-------YSEAVASHYMRQVLEALRYCHENDIIH 132
           ++  F+Y     I FE++  +T  F+       Y      H   Q+ +A+++ H+N + H
Sbjct: 101 MFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTH 160
Query: 133 RDIKPHCVLLANKENSAPVKL-------GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHR 185
            D+KP  +L  N +      L            A+++ D   + S     +H++T     
Sbjct: 161 TDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVD---FGSATFDHEHHSTI---- 213
Query: 186 IGTPHYMAPEVIEDQKYGKPVDIW 209
           + T HY APEVI +  + +P D+W
Sbjct: 214 VSTRHYRAPEVILELGWSQPCDVW 237

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C  I           
Sbjct: 72  RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI------HMELD 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A      + 
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA------RT 175
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            C+      +  T+        +Y APEVI    Y   VDIW
Sbjct: 176 ACTNFMMTPYVVTR--------YYRAPEVILGMGYAANVDIW 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 44  NHYTTEADLKREATICHMLKHPHVVELLETYSSE-GMLYMVFEYMDGSDICFEIVRRATA 102
           N  T +A L  EA++   L+H ++V+LL     E G LY+V EYM    +   +  R  +
Sbjct: 39  NDATAQAFLA-EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 97
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             V        +   V EA+ Y   N+ +HRD+    VL++ ++N A  K+  FG+  + 
Sbjct: 98  --VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVA--KVSDFGLTKEA 152
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              Q     G+    +T             APE + ++K+    D+W
Sbjct: 153 SSTQ---DTGKLPVKWT-------------APEALREKKFSTKSDVW 183

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 54  REATICHMLKHPHVVELLETYSS--EGMLYMVFEYMDGS---DICFEIVRRATAGFV-YS 107
           RE  +   LKHP+V+ L + + S  +  ++++F+Y +      I F    +A    V   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL-LANKENSAPVKLGGFGVAIQLQDGQ 166
             +    + Q+L+ + Y H N ++HRD+KP  +L +        VK+   G A      +
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------R 180
Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           L+ S  + L          + T  Y APE++   + Y K +DIW
Sbjct: 181 LFNSPLKPL----ADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 39/174 (22%)
Query: 54  REATICHMLKHPHVVELLETYSSEGM--------------LYMVFEYMDGSDICFEIVRR 99
           RE  I   L H ++V++ E     G               +Y+V EYM+      ++   
Sbjct: 57  REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-----DLANV 111
Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
              G +  E  A  +M Q+L  L+Y H  +++HRD+KP   L  N E+   +K+G FG+A
Sbjct: 112 LEQGPLLEEH-ARLFMYQLLRGLKYIHSANVLHRDLKP-ANLFINTEDLV-LKIGDFGLA 168
Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHR---IGTPHYMAPE-VIEDQKYGKPVDIW 209
            ++ D            HY+ K GH    + T  Y +P  ++    Y K +D+W
Sbjct: 169 -RIMD-----------PHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 209

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 54  REATICHMLKHPHVVELL-----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  I    KH +++ +      +++ +   +Y++ E M         + R  +  + S+
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRVISTQMLSD 111
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               +++ Q L A++  H +++IHRD+KP  +L+    ++  +K+  FG+A  + +    
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDE---- 164
Query: 169 CSGGERLDHYTTKAG--HRIGTPHYMAPEV-IEDQKYGKPVDIW 209
            S  +  +    ++G    + T  Y APEV +   KY + +D+W
Sbjct: 165 -SAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVW 207

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 44  NHYTTEADLKREATICHMLKHPHVVELLETYSSE-GMLYMVFEYMDGSDICFEIVRRATA 102
           N  T +A L  EA++   L+H ++V+LL     E G LY+V EYM    +   +  R  +
Sbjct: 54  NDATAQAFLA-EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 112
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             V        +   V EA+ Y   N+ +HRD+    VL++ ++N A  K+  FG+  + 
Sbjct: 113 --VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVA--KVSDFGLTKEA 167
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              Q     G+    +T             APE + ++K+    D+W
Sbjct: 168 SSTQ---DTGKLPVKWT-------------APEALREKKFSTKSDVW 198

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 21/157 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYSEAVAS 112
           +EA       HPH+V+L+   + E  ++++ E     ++  F  VR+    F    A   
Sbjct: 60  QEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK----FSLDLASLI 114
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D        
Sbjct: 115 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDST------ 165
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   KA        +MAPE I  +++    D+W
Sbjct: 166 ------XXKASKGKLPIKWMAPESINFRRFTSASDVW 196

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/164 (22%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 54  REATICHMLKHPHVVELL-----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  I    KH +++ +      +++ +   +Y++ E M         + R  +  + S+
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRVISTQMLSD 111
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               +++ Q L A++  H +++IHRD+KP  +L+    ++  +K+  FG+A  + +    
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDE---- 164
Query: 169 CSGGERLDHYTTKAG--HRIGTPHYMAPEV-IEDQKYGKPVDIW 209
            S  +  +    ++G    + T  Y APEV +   KY + +D+W
Sbjct: 165 -SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 48.5 bits (114), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 71/174 (40%), Gaps = 32/174 (18%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI----------CFEIV--- 97
           D +REA +   L+H H+V+          L MVFEYM   D+             +V   
Sbjct: 63  DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 98  -RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKP-HCVLLANKENSAPVKLGG 155
            R+A      S+ +  H   Q+   + Y      +HRD+   +C++ AN      VK+G 
Sbjct: 123 PRQAKGELGLSQML--HIASQIASGMVYLASQHFVHRDLATRNCLVGAN----LLVKIGD 176
Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           FG++  +     Y  G           GH +    +M PE I  +K+    D+W
Sbjct: 177 FGMSRDVYSTDYYRVG-----------GHTMLPIRWMPPESIMYRKFTTESDVW 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMEL-----D 117
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 118 HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLA-------- 166
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 167 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 73  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 125
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 174
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 175 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 74/162 (45%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +  ++ H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++ A +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 75/167 (44%), Gaps = 23/167 (13%)
Query: 44  NHYTTEADLKREATICHMLKHPHVVELLETYSSE-GMLYMVFEYMDGSDICFEIVRRATA 102
           N  T +A L  EA++   L+H ++V+LL     E G LY+V EYM    +   +  R  +
Sbjct: 226 NDATAQAFLA-EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 284
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             V        +   V EA+ Y   N+ +HRD+    VL++ ++N A  K+  FG+  + 
Sbjct: 285 --VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVA--KVSDFGLTKEA 339
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              Q     G+    +T             APE + ++K+    D+W
Sbjct: 340 SSTQ---DTGKLPVKWT-------------APEALREKKFSTKSDVW 370

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 66  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 118
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 167
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 168 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 203

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 73  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 125
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 174
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 175 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 33/163 (20%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   ++H +V+ LL+ ++    L      Y+V  +M  +D+      +   G  +S
Sbjct: 90  RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDL------QKIMGMEFS 142
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E    + + Q+L+ L+Y H   ++HRD+KP    LA  E+   +K+  FG+A        
Sbjct: 143 EEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN--LAVNEDCE-LKILDFGLA-------- 191
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                    H   +    + T  Y APEVI     Y + VDIW
Sbjct: 192 --------RHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIW 226

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 117
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 166
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 167 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 162
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 211
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 212 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 247

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 66  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 118
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 167
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 168 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 203

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 71  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 123
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 124 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 172
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 173 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 208

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 162
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 211
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 212 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 247

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 25/171 (14%)
Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
           ER+N +       RE  I   L+HP++V  +   +    L +V EY+    + + ++ ++
Sbjct: 76  ERVNEFL------REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKS 128
Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGV 158
            A     E         V + + Y H  +  I+HR++K   +L+  K     VK+  FG+
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGL 185
Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           + +L+      S                GTP +MAPEV+ D+   +  D++
Sbjct: 186 S-RLKASTFLSSKSA------------AGTPEWMAPEVLRDEPSNEKSDVY 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLC-QVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 73/160 (45%), Gaps = 16/160 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+V+ L    +    + ++ E+M+   +    +R+    F   + V
Sbjct: 80  DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQFTVIQLV 138
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  + + +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 139 G--MLRGIAAGMKYLADMNYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDP 192
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           +       YT+  G +I    + APE I+ +K+    D+W
Sbjct: 193 T-------YTSALGGKIPI-RWTAPEAIQYRKFTSASDVW 224

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 80  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 138
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 139 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 187
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 188 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 222

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 54/99 (54%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     ++ +K+  FG+A ++ D        
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTSDLKICDFGLA-RVADP------- 178
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 179 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 82/211 (38%), Gaps = 46/211 (21%)
Query: 31  IEPASFGLPDE--------RLNHYTTEADLKRE-----ATICHMLKHPHVVELLETYSSE 77
           +E  +FGL  E        ++   T  AD K         + H+ +H ++V LL   +  
Sbjct: 48  VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 107
Query: 78  GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS-------------------HYMRQV 118
           G + ++ EY    D+   + R+A A    S A                      H+  QV
Sbjct: 108 GPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQV 167
Query: 119 LEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHY 178
            + + +    + IHRD+    VLL N   +   K+G FG+A  + +            +Y
Sbjct: 168 AQGMAFLASKNCIHRDVAARNVLLTNGHVA---KIGDFGLARDIMND----------SNY 214
Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             K   R+    +MAPE I D  Y    D+W
Sbjct: 215 IVKGNARLPV-KWMAPESIFDCVYTVQSDVW 244

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 121
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 122 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 170
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 171 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 205

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDXTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 90  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 148
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 149 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 197
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 198 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 232

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 63/150 (42%), Gaps = 22/150 (14%)
Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P++V+       EG  ++  E M  S   F     +    V  E +        ++AL +
Sbjct: 81  PYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 125 CHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAG 183
             EN  IIHRDIKP  +LL   + S  +KL  FG++ QL D              T  AG
Sbjct: 141 LKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSI----------AKTRDAG 187
Query: 184 HRIGTPHYMAPEVIED----QKYGKPVDIW 209
            R     YMAPE I+     Q Y    D+W
Sbjct: 188 CR----PYMAPERIDPSASRQGYDVRSDVW 213

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG+   L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLGRVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKIXDFGLA-RVADP------- 176
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 177 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 212

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY-- 106
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  Y  
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 122
Query: 107 ------SEAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 179
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 180 GLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 221

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 29/152 (19%)
Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P++V+   T+ +   +++  E M     C E +++   G +  E +       +++AL Y
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMG---TCAEKLKKRMQGPI-PERILGKMTVAIVKALYY 139
Query: 125 CHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAG 183
             E   +IHRD+KP  +LL   +    +KL  FG++ +L D                KA 
Sbjct: 140 LKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVD---------------DKAK 181
Query: 184 HR-IGTPHYMAPEVIEDQKYGKP-----VDIW 209
            R  G   YMAPE I+     KP      D+W
Sbjct: 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVW 213

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/173 (24%), Positives = 75/173 (43%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY-- 106
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  Y  
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 137
Query: 107 ------SEAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 194
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D+Y      R+    +MAPE + D+ Y    D+W
Sbjct: 195 GLARDIH----------HIDYYKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 236

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 180
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 181 ---DHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIW 216

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 133 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 181
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 182 ---DHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIW 217

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 40/167 (23%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+            V S
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL---------NNIVKS 119
Query: 108 EAVASHYMR----QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
           + +   +++    Q+L  L+Y H  DIIHRD+KP    LA  E+S  +K+  FG+     
Sbjct: 120 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN--LAVNEDSE-LKILDFGL----- 171
Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                C       H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 172 -----CR------HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 176
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 177 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 212

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQME-----LD 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 178
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 179 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 214

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 67/179 (37%), Gaps = 35/179 (19%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-------------- 92
           +   D +REA +  ML+H H+V      +    L MVFEYM   D+              
Sbjct: 62  SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 121
Query: 93  -CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV 151
              E V     G     AVAS    QV   + Y      +HRD+     L+        V
Sbjct: 122 AGGEDVAPGPLGLGQLLAVAS----QVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVV 174
Query: 152 KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
           K+G FG++  +     Y  GG            R   P  +M PE I  +K+    D+W
Sbjct: 175 KIGDFGMSRDIYSTDYYRVGG------------RTMLPIRWMPPESILYRKFTTESDVW 221

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 130 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 178
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 179 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 214

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 180
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 181 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 126 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 174
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 175 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 210

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 67/179 (37%), Gaps = 35/179 (19%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-------------- 92
           +   D +REA +  ML+H H+V      +    L MVFEYM   D+              
Sbjct: 56  SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 115
Query: 93  -CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV 151
              E V     G     AVAS    QV   + Y      +HRD+     L+        V
Sbjct: 116 AGGEDVAPGPLGLGQLLAVAS----QVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVV 168
Query: 152 KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
           K+G FG++  +     Y  GG            R   P  +M PE I  +K+    D+W
Sbjct: 169 KIGDFGMSRDIYSTDYYRVGG------------RTMLPIRWMPPESILYRKFTTESDVW 215

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 67/179 (37%), Gaps = 35/179 (19%)
Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-------------- 92
           +   D +REA +  ML+H H+V      +    L MVFEYM   D+              
Sbjct: 85  SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 93  -CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV 151
              E V     G     AVAS    QV   + Y      +HRD+     L+        V
Sbjct: 145 AGGEDVAPGPLGLGQLLAVAS----QVAAGMVYLAGLHFVHRDLATRNCLVG---QGLVV 197
Query: 152 KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
           K+G FG++  +     Y  GG            R   P  +M PE I  +K+    D+W
Sbjct: 198 KIGDFGMSRDIYSTDYYRVGG------------RTMLPIRWMPPESILYRKFTTESDVW 244

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 133 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 181
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 182 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 217

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C  I           
Sbjct: 70  RELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVI------HMELD 122
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 123 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 171
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R           + T +Y APEVI    Y + VDIW
Sbjct: 172 ------RTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIW 207

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 134 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 182
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 183 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 218

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 125 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 173
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 174 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 209

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 180
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 181 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 136 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 184
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 185 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 220

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 176
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 177 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 212

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 180
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 181 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLA-RVADP------- 176
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 177 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 212

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 128 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLA-RVADP------- 176
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 177 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 212

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLA-RVADP------- 180
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 181 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLA-RVADP------- 180
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 181 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 216

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 126 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 174
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 175 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 210

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 47.4 bits (111), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 83/162 (51%), Gaps = 25/162 (15%)
Query: 54  REATICHMLKHPHVV---ELLETYSSEGM--LYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  I    +H +V+   ++L   + E M  +Y+V + M+ +D+ +++++        S 
Sbjct: 90  REIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLME-TDL-YKLLKSQQ----LSN 143
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               +++ Q+L  L+Y H  +++HRD+KP  +L+     +  +K+  FG+A ++ D +  
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLI---NTTCDLKICDFGLA-RIADPE-- 197
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
                  DH T      + T  Y APE++ + K Y K +DIW
Sbjct: 198 ------HDH-TGFLTEXVATRWYRAPEIMLNSKGYTKSIDIW 232

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLA-RVADP------- 196
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 197 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 232

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 16/99 (16%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H  +++HRD+KP  +LL     +  +K+  FG+A ++ D        
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTXDLKICDFGLA-RVADP------- 196
Query: 173 ERLDH-YTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
              DH +T      + T  Y APE++ + K Y K +DIW
Sbjct: 197 ---DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIW 232

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 65/168 (38%), Gaps = 23/168 (13%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  REA +   L+H H+V+          L MVFEYM   D+   +        + +E  
Sbjct: 61  DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN 120
Query: 111 AS---------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
                      H  +Q+   + Y      +HRD+     L+   EN   VK+G FG++  
Sbjct: 121 PPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG--ENLL-VKIGDFGMSRD 177
Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           +     Y  G           GH +    +M PE I  +K+    D+W
Sbjct: 178 VYSTDYYRVG-----------GHTMLPIRWMPPESIMYRKFTTESDVW 214

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 73/162 (45%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++ A +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDATLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 133
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 134 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDXE-LKILDFGLA--- 177
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 178 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 135
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 136 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 179
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 180 -------------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 133
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 134 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDXE-LKILDFGLA--- 177
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 178 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 32/163 (19%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+   IV+ A      +
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN-NIVKCAK----LT 119
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           +      + Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A        
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA-------- 168
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                    H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 169 --------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 139
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 140 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDXE-LKILDFGLA--- 183
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 184 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 124
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 125 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 168
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 169 -------------RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+   IV+        +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN-NIVKXQK----LT 123
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           +      + Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A        
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSN--LAVNEDXE-LKILDFGLA-------- 172
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                    H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 --------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 13/98 (13%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H   +IHRD+KP  +L+   EN   +K+G FG+A  L      C+  
Sbjct: 162 YFLYQLLRGLKYMHSAQVIHRDLKPSNLLV--NENCE-LKIGDFGMARGL------CTSP 212
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
               ++ T+    + T  Y APE++    +Y + +D+W
Sbjct: 213 AEHQYFMTE---YVATRWYRAPELMLSLHEYTQAIDLW 247

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 135
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 136 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 179
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 180 -------------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 135
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 136 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 179
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 180 -------------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 73  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQMEL-----D 125
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 174
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 175 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 210

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 148
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 149 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 192
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 193 -------------RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 134
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 135 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED-CELKILDFGLA--- 178
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 179 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 67/155 (43%), Gaps = 17/155 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA +   L+H  +V L    + E  +Y++ EYM    +  + ++    G V    +   +
Sbjct: 58  EANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSL-LDFLKSDEGGKVLLPKLID-F 115
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q+ E + Y    + IHRD++   VL++    S   K+  FG+A  ++D          
Sbjct: 116 SAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIED---------- 162
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            + YT + G +     + APE I    +    D+W
Sbjct: 163 -NEYTAREGAKFPI-KWTAPEAINFGCFTIKSDVW 195

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 133
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 134 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 177
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 178 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 40/167 (23%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   LKH +V+ LL+ ++    +      Y+V   M G+D+            V  
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADLN---------NIVKC 125
Query: 108 EAVASHYMR----QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
           +A++  +++    Q+L  L+Y H   IIHRD+KP  V  A  E+S  +++  FG+A Q  
Sbjct: 126 QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNV--AVNEDSE-LRILDFGLARQ-- 180
Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                    E +  Y       + T  Y APE++ +   Y + VDIW
Sbjct: 181 -------ADEEMTGY-------VATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIW 207

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 26/171 (15%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS--- 107
           + + EA +   L+HP+VV LL   + +  L M+F Y    D+   +V R+    V S   
Sbjct: 58  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117
Query: 108 -EAVAS--------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV 158
              V S        H + Q+   + Y   + ++H+D+    VL+ +K N     LG F  
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF-- 175
Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  ++Y +     D+Y    G+ +    +MAPE I   K+    DIW
Sbjct: 176 ------REVYAA-----DYYKL-LGNSLLPIRWMAPEAIMYGKFSIDSDIW 214

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 133
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 134 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 177
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 178 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 212

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 69  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 127
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 128 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 171
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 172 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 206

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 125
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 126 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 169
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 170 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 139
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 140 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 183
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 184 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 218

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 68  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 126
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 127 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 170
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 171 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 205

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 135
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 136 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 179
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 180 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 214

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 130
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 131 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED-CELKILDFGLA--- 174
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 175 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 140
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 141 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED-CELKILDFGLA--- 184
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 185 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 26/171 (15%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS--- 107
           + + EA +   L+HP+VV LL   + +  L M+F Y    D+   +V R+    V S   
Sbjct: 75  EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 134
Query: 108 -EAVAS--------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV 158
              V S        H + Q+   + Y   + ++H+D+    VL+ +K N     LG F  
Sbjct: 135 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF-- 192
Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  ++Y +     D+Y    G+ +    +MAPE I   K+    DIW
Sbjct: 193 ------REVYAA-----DYYKL-LGNSLLPIRWMAPEAIMYGKFSIDSDIW 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 140
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 141 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED-CELKILDFGLA--- 184
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 185 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 125
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 126 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 169
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 170 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 204

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 148
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 149 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 192
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 193 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 124
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 125 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 168
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 169 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 99  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 155
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 208
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 209 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 239

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 13/98 (13%)
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           +++ Q+L  L+Y H   +IHRD+KP  +L+   EN   +K+G FG+A  L      C+  
Sbjct: 163 YFLYQLLRGLKYMHSAQVIHRDLKPSNLLV--NENCE-LKIGDFGMARGL------CTSP 213
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
               ++ T+    + T  Y APE++    +Y + +D+W
Sbjct: 214 AEHQYFMTE---YVATRWYRAPELMLSLHEYTQAIDLW 248

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 147
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 148 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 191
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 192 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 134
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 135 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 178
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 179 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 140
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 141 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED-CELKILDFGLA--- 184
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 185 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 219

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 151
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 152 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 195
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 196 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 230

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 130
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 131 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 174
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 175 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 130
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 131 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED-CELKILDFGLA--- 174
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 175 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 209

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+   IV+        +
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLN-NIVKXQK----LT 123
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           +      + Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A        
Sbjct: 124 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA-------- 172
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                    H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 --------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 134
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 135 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 178
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 179 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 213

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 124
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 125 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 168
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 169 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 203

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 151
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 152 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED-CELKILDFGLA--- 195
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 196 -------------RHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIW 230

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 80  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 138
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 139 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 182
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 183 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 217

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 53  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 108
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 109 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 156
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             + YT + G +     + APE I    +    D+W
Sbjct: 157 --NEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 189

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 148
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 149 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 192
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 193 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 227

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 79  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIG-- 135
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 188
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 189 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 219

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 81  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 137
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 191 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 221

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 113
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 161
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             + YT + G +     + APE I    +    D+W
Sbjct: 162 --NEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 194

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 64  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 119
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 167
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             + YT + G +     + APE I    +    D+W
Sbjct: 168 --NEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 200

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 78  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 134
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 187
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 188 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 218

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 51  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 109
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A + 
Sbjct: 110 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATE- 153
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 154 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYL 227

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 71  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 129
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A + 
Sbjct: 130 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATE- 173
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 174 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 223
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 224 TGQLPYSNINNRDQIIFMVGRGYL 247

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 80  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 136
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 189
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 190 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 220

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 63  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 118
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 119 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 166
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             + YT + G +     + APE I    +    D+W
Sbjct: 167 --NEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 199

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 100 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 156
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 209
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 210 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 147
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 148 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLA--- 191
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 192 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 226

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 49  EADLKREATICHM-----LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAG 103
           E++ +R+A I  +     + HP++V+L     +   + +V EY +G  + + ++  A   
Sbjct: 40  ESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSL-YNVLHGAEPL 96
Query: 104 FVYSEAVASHYMRQVLEALRYCHE---NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
             Y+ A A  +  Q  + + Y H      +IHRD+KP  +LL        +K+  FG A 
Sbjct: 97  PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTAC 154
Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDI 208
            +Q                T   +  G+  +MAPEV E   Y +  D+
Sbjct: 155 DIQ----------------THMTNNKGSAAWMAPEVFEGSNYSEKCDV 186

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 73  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 129
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 182
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 183 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 68  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 123
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 124 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 171
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             + YT + G +     + APE I    +    D+W
Sbjct: 172 --NEYTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 204

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 81  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 137
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 190
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 191 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 221

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 76  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 132
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + Y     
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEYYS---- 185
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 186 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 216

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 84/204 (41%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 79  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 137
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A + 
Sbjct: 138 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATE- 181
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 182 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 232 TGQLPYSNINNRDQIIFMVGRGYL 255

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +   +  +V EYM+   +    +R     F   + V
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD-TFLRTHDGQFTIMQLV 154
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
               +R V   +RY  +   +HRD+    VL+   +++   K+  FG++  L+D      
Sbjct: 155 G--MLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDP---- 205
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                D   T  G +I    + APE I  + +    D+W
Sbjct: 206 -----DAAXTTTGGKIPI-RWTAPEAIAFRTFSSASDVW 238

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 74/168 (44%), Gaps = 29/168 (17%)
Query: 49  EADLKREATICHM-----LKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAG 103
           E++ +R+A I  +     + HP++V+L     +   + +V EY +G  + + ++  A   
Sbjct: 41  ESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSL-YNVLHGAEPL 97
Query: 104 FVYSEAVASHYMRQVLEALRYCHE---NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
             Y+ A A  +  Q  + + Y H      +IHRD+KP  +LL        +K+  FG A 
Sbjct: 98  PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTAC 155
Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDI 208
            +Q                T   +  G+  +MAPEV E   Y +  D+
Sbjct: 156 DIQ----------------THMTNNKGSAAWMAPEVFEGSNYSEKCDV 187

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 86  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIG-- 142
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + +++      +HRD+     +L  K     VK+  FG+A  + D        +
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD--------K 191
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D    K G ++    +MA E ++ QK+    D+W
Sbjct: 192 EFDSVHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 226

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 82  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIG-- 138
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + +++      +HRD+     +L  K     VK+  FG+A  + D        +
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD--------K 187
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D    K G ++    +MA E ++ QK+    D+W
Sbjct: 188 EFDSVHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 222

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 19/173 (10%)
Query: 41  ERLNHYTTEADLKR---EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEI 96
           + LN  T   ++ +   E  I     HP+V+ LL     SEG   +V  YM   D+    
Sbjct: 123 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNF 181
Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
           +R  T      + +   +  QV + +++      +HRD+     +L  K     VK+  F
Sbjct: 182 IRNETHNPTVKDLIG--FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADF 236
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  + D        +  D    K G ++    +MA E ++ QK+    D+W
Sbjct: 237 GLARDMYD--------KEFDSVHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 280

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 81  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIG-- 137
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + +++      +HRD+     +L  K     VK+  FG+A  + D        +
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD--------K 186
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D    K G ++    +MA E ++ QK+    D+W
Sbjct: 187 EFDSVHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 221

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 23/171 (13%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML-----YMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE TI + LK  +++ L +    + +L     Y+V E  D      ++ +        +E
Sbjct: 74  REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-----DLKKLFKTPIFLTE 128
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL------ 162
                 +  +L    + HE+ IIHRD+KP   LL        VK+  FG+A  +      
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDT 185
Query: 163 ---QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
               D +     G    +   +    + T  Y APE+I  Q+ Y K +DIW
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 44  NHYTTEADLKREATICHMLKHPHVVELLETYSSE-GMLYMVFEYMDGSDICFEIVRRATA 102
           N  T +A L  EA++   L+H ++V+LL     E G LY+V EYM    +   +  R  +
Sbjct: 45  NDATAQAFLA-EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS 103
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             V        +   V EA+ Y   N+ +HRD+    VL++ ++N A  K+  FG+  + 
Sbjct: 104 --VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS-EDNVA--KVSDFGLTKEA 158
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
              Q     G+    +T             APE + +  +    D+W
Sbjct: 159 SSTQ---DTGKLPVKWT-------------APEALREAAFSTKSDVW 189

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 74  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQMEL-----D 126
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 127 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 175
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 176 ------RTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIW 211

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 82  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIG-- 138
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + +++      +HRD+     +L  K     VK+  FG+A  + D        +
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMLD--------K 187
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D    K G ++    +MA E ++ QK+    D+W
Sbjct: 188 EFDSVHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 222

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 63/161 (39%), Gaps = 17/161 (10%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           +A   +EA I     HP++V L+   + +  +Y+V E + G D     +R  T G     
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF-LTFLR--TEGARLRV 212
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 +      + Y      IHRD+     L+  K     +K+  FG++ +  DG   
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADGVXA 269
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            SGG  L     K         + APE +   +Y    D+W
Sbjct: 270 ASGG--LRQVPVK---------WTAPEALNYGRYSSESDVW 299

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 81  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIG-- 137
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + +++      +HRD+     +L  K     VK+  FG+A  + D        +
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD--------K 186
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D    K G ++    +MA E ++ QK+    D+W
Sbjct: 187 EFDSVHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 221

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 65/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 79  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIG-- 135
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + +++      +HRD+     +L  K     VK+  FG+A  + D        +
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYD--------K 184
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             D    K G ++    +MA E ++ QK+    D+W
Sbjct: 185 EFDSVHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 219

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VD+W
Sbjct: 174 ------RTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLW 209

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 63/161 (39%), Gaps = 17/161 (10%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           +A   +EA I     HP++V L+   + +  +Y+V E + G D     +R  T G     
Sbjct: 156 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF-LTFLR--TEGARLRV 212
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 +      + Y      IHRD+     L+  K     +K+  FG++ +  DG   
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADGVYA 269
Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            SGG  L     K         + APE +   +Y    D+W
Sbjct: 270 ASGG--LRQVPVK---------WTAPEALNYGRYSSESDVW 299

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 77  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQMEL-----D 129
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 130 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 178
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VD+W
Sbjct: 179 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLW 214

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 63/134 (47%), Gaps = 22/134 (16%)
Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P +V +   + +   L  + + M+G D+ + + +      V+SEA    Y  +++  L +
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEH 307
Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H   +++RD+KP  +LL   +    V++   G+A         C   ++  H +     
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLA---------CDFSKKKPHAS----- 350
Query: 185 RIGTPHYMAPEVIE 198
            +GT  YMAPEV++
Sbjct: 351 -VGTHGYMAPEVLQ 363

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 63/134 (47%), Gaps = 22/134 (16%)
Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P +V +   + +   L  + + M+G D+ + + +      V+SEA    Y  +++  L +
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEH 307
Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H   +++RD+KP  +LL   +    V++   G+A         C   ++  H +     
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLA---------CDFSKKKPHAS----- 350
Query: 185 RIGTPHYMAPEVIE 198
            +GT  YMAPEV++
Sbjct: 351 -VGTHGYMAPEVLQ 363

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 63/134 (47%), Gaps = 22/134 (16%)
Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P +V +   + +   L  + + M+G D+ + + +      V+SEA    Y  +++  L +
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEH 307
Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H   +++RD+KP  +LL   +    V++   G+A         C   ++  H +     
Sbjct: 308 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLA---------CDFSKKKPHAS----- 350
Query: 185 RIGTPHYMAPEVIE 198
            +GT  YMAPEV++
Sbjct: 351 -VGTHGYMAPEVLQ 363

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/134 (23%), Positives = 63/134 (47%), Gaps = 22/134 (16%)
Query: 65  PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY 124
           P +V +   + +   L  + + M+G D+ + + +      V+SEA    Y  +++  L +
Sbjct: 251 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEH 306
Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H   +++RD+KP  +LL   +    V++   G+A         C   ++  H +     
Sbjct: 307 MHNRFVVYRDLKPANILL---DEHGHVRISDLGLA---------CDFSKKKPHAS----- 349
Query: 185 RIGTPHYMAPEVIE 198
            +GT  YMAPEV++
Sbjct: 350 -VGTHGYMAPEVLQ 362

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +++C ++++         
Sbjct: 66  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQMEL-----D 118
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 167
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VD+W
Sbjct: 168 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLW 203

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 15/86 (17%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q          
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP--------- 206
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED 199
             D  +     ++GT +YM PE I+D
Sbjct: 207 --DTTSVVKDSQVGTVNYMPPEAIKD 230

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V E M+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGAVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 15/86 (17%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q          
Sbjct: 113 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP--------- 159
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED 199
             D  +     ++GT +YM PE I+D
Sbjct: 160 --DTTSVVKDSQVGTVNYMPPEAIKD 183

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +   +  +V EYM+   +    +R     F   + V
Sbjct: 96  DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLD-TFLRTHDGQFTIMQLV 154
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
               +R V   +RY  +   +HRD+    VL+   +++   K+  FG++  L+D      
Sbjct: 155 G--MLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDP---- 205
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                D   T  G +I    + APE I  + +    D+W
Sbjct: 206 -----DAAYTTTGGKIPI-RWTAPEAIAFRTFSSASDVW 238

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 15/86 (17%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q          
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP--------- 178
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED 199
             D  +     ++GT +YM PE I+D
Sbjct: 179 --DTTSVVKDSQVGTVNYMPPEAIKD 202

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 72/162 (44%), Gaps = 30/162 (18%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +  L      Y+V E MD +    ++++         
Sbjct: 72  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQMEL-----D 124
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP  +++   ++   +K+  FG+A        
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA-------- 173
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                 R    +      + T +Y APEVI    Y + VDIW
Sbjct: 174 ------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 209

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 15/86 (17%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q          
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP--------- 206
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED 199
             D  +     ++GT +YM PE I+D
Sbjct: 207 --DTTSVVKDSQVGTVNYMPPEAIKD 230

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 72/174 (41%), Gaps = 26/174 (14%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML-----YMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE TI + LK  +++ L +    E +L     Y+V E  D      ++ +        +E
Sbjct: 76  REITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADS-----DLKKLFKTPIFLTE 130
Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ-DGQL 167
                 +  +L   ++ HE+ IIHRD+KP   LL        VK+  FG+A  +  D  +
Sbjct: 131 QHVKTILYNLLLGEKFIHESGIIHRDLKPANCLL---NQDCSVKICDFGLARTINSDKDI 187
Query: 168 YCSG-----------GERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIW 209
           +              G    +   +    + T  Y APE+I  Q+ Y   +DIW
Sbjct: 188 HIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIW 241

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 99  RELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 157
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  FG+A   
Sbjct: 158 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFGLARHT 204
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
            D                  G+ + T  Y APE++ +   Y   VDIW
Sbjct: 205 DDEM---------------TGY-VATRWYRAPEIMLNWMHYNMTVDIW 236

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+            +++
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNED----------CELKI 166
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
            DG L     + +  Y       + T  Y APE++ +   Y + VDIW
Sbjct: 167 LDGGLARHTDDEMTGY-------VATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 15/86 (17%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q          
Sbjct: 116 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP--------- 162
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED 199
             D  +     ++GT +YM PE I+D
Sbjct: 163 --DTTSVVKDSQVGTVNYMPPEAIKD 186

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 40/167 (23%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   LKH +V+ LL+ ++    +      Y+V   M G+D+            V  
Sbjct: 68  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM-GADL---------NNIVKC 117
Query: 108 EAVASHYMR----QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
           +A++  +++    Q+L  L+Y H   IIHRD+KP  V +        +++  FG+A Q  
Sbjct: 118 QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQ-- 172
Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                    E +  Y       + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------ADEEMTGY-------VATRWYRAPEIMLNWMHYNQTVDIW 205

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 44/86 (51%), Gaps = 15/86 (17%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q          
Sbjct: 112 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP--------- 158
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED 199
             D  +     ++GT +YM PE I+D
Sbjct: 159 --DTTSVVKDSQVGTVNYMPPEAIKD 182

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V E M+   +    +R+  A F   + V
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD-SFLRKHDAQFTVIQLV 121
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 122 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 170
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 171 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 205

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEA 109
           D   EA+I     HP+++ L    +    + ++ EYM +GS   F  +R+    F   + 
Sbjct: 76  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF--LRKNDGRFTVIQL 133
Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLY 168
           V    +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D    
Sbjct: 134 VG--MLRGIGSGMKYLSDMSAVHRDLAARNILV----NSNLVCKVSDFGMSRVLED---- 183
Query: 169 CSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
               +    YTT+ G     P  + APE I  +K+    D+W
Sbjct: 184 ----DPEAAYTTRGGK---IPIRWTAPEAIAYRKFTSASDVW 218

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V E M+   +    +R+  A F   + V
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLD-SFLRKHDAQFTVIQLV 150
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 151 G--MLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 199
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + +PE I  +K+    D+W
Sbjct: 200 ---DPEAAYTTRGGK---IPIRWTSPEAIAYRKFTSASDVW 234

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 72/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  +G+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDYGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+V+ L    +    + ++ E+M+   +    +R+    F   + V
Sbjct: 54  DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQFTVIQLV 112
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  + + +HR +    +L+    NS  V K+  FG++  L+D     
Sbjct: 113 G--MLRGIAAGMKYLADMNYVHRALAARNILV----NSNLVCKVSDFGLSRFLEDDTSDP 166
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           +       YT+  G +I    + APE I+ +K+    D+W
Sbjct: 167 T-------YTSALGGKIPI-RWTAPEAIQYRKFTSASDVW 198

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/86 (31%), Positives = 43/86 (50%), Gaps = 15/86 (17%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q          
Sbjct: 132 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP--------- 178
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED 199
             D        ++GT +YM PE I+D
Sbjct: 179 --DXXXVVKDSQVGTVNYMPPEAIKD 202

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 56  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 114
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A   
Sbjct: 115 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV- 158
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 159 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 209 TGQLPYSNINNRDQIIFMVGRGYL 232

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+++ L    +    + +V EYM+   +    +++    F   + V
Sbjct: 69  DFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD-TFLKKNDGQFTVIQLV 127
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D     
Sbjct: 128 G--MLRGISAGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLSRVLED----- 176
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
              +    YTT+ G     P  + APE I  +K+    D+W
Sbjct: 177 ---DPEAAYTTRGGK---IPIRWTAPEAIAFRKFTSASDVW 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 56  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 114
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A   
Sbjct: 115 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV- 158
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 159 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 209 TGQLPYSNINNRDQIIFMVGRGYL 232

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 51  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 109
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A   
Sbjct: 110 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV- 153
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 154 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYL 227

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEA 109
           D   EA+I     HP+++ L    +    + ++ EYM +GS   F  +R+    F   + 
Sbjct: 61  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF--LRKNDGRFTVIQL 118
Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLY 168
           V    +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D    
Sbjct: 119 VG--MLRGIGSGMKYLSDMSYVHRDLAARNILV----NSNLVCKVSDFGMSRVLED---- 168
Query: 169 CSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
               +    YTT+ G     P  + APE I  +K+    D+W
Sbjct: 169 ----DPEAAYTTRGGK---IPIRWTAPEAIAYRKFTSASDVW 203

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 53  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 111
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A   
Sbjct: 112 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV- 155
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 156 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 205
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 206 TGQLPYSNINNRDQIIFMVGRGYL 229

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 22/162 (13%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEA 109
           D   EA+I     HP+++ L    +    + ++ EYM +GS   F  +R+    F   + 
Sbjct: 55  DFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF--LRKNDGRFTVIQL 112
Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLY 168
           V    +R +   ++Y  +   +HRD+    +L+    NS  V K+  FG++  L+D    
Sbjct: 113 VG--MLRGIGSGMKYLSDMSYVHRDLAARNILV----NSNLVCKVSDFGMSRVLED---- 162
Query: 169 CSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
               +    YTT+ G     P  + APE I  +K+    D+W
Sbjct: 163 ----DPEAAYTTRGGK---IPIRWTAPEAIAYRKFTSASDVW 197

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/178 (30%), Positives = 83/178 (46%), Gaps = 32/178 (17%)
Query: 54  REATICHMLKHPHVVELLETYSSEGM-----LYMVFEYMDGSDICFEIVRRATAGFVY-S 107
           RE  I + L H HVV++L+    + +     LY+V E  D     F+ + R     VY +
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD---FKKLFRTP---VYLT 154
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKP-HCVLLANKENSAPVKLGGFGVAIQL---Q 163
           E      +  +L  ++Y H   I+HRD+KP +C  L N++ S  VK+  FG+A  +   +
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANC--LVNQDCS--VKVCDFGLARTVDYPE 210
Query: 164 DGQLYCSGGERLDHYT------TKAGHRIGTPH-----YMAPEVIEDQK-YGKPVDIW 209
           +G        R D         TK   R  T H     Y APE+I  Q+ Y + +D+W
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 79  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 137
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A   
Sbjct: 138 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV- 181
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 182 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 232 TGQLPYSNINNRDQIIFMVGRGYL 255

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 83/204 (40%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS++  L +V ++ +GS +          FE+++    
Sbjct: 78  FKNEVGVLRKTRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 136
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A   
Sbjct: 137 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV- 180
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 181 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 230
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 231 TGQLPYSNINNRDQIIFMVGRGYL 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 74/173 (42%), Gaps = 27/173 (15%)
Query: 50  ADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS- 107
           +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  +S 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSF 137
Query: 108 -------EAVASHYM----RQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                  E ++S  +     QV   + Y      IHRD+    VL+   E++  +K+  F
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNV-MKIADF 194
Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           G+A  +            +D        R+    +MAPE + D+ Y    D+W
Sbjct: 195 GLARDIH----------HIDXXKKTTNGRLPV-KWMAPEALFDRIYTHQSDVW 236

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 41/204 (20%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC---------FEIVRRATA 102
            K E  +    +H +++ L   YS+   L +V ++ +GS +          FE+++    
Sbjct: 51  FKNEVGVLRKTRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDI 109
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                        RQ  + + Y H   IIHRD+K + + L        VK+G FG+A   
Sbjct: 110 A------------RQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATV- 153
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWXXXXXXXXXX 219
              +   SG  + +  +       G+  +MAPEVI  Q    Y    D++          
Sbjct: 154 ---KSRWSGSHQFEQLS-------GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 220 XXXXPF--VGSRDRLFQSITKGKL 241
               P+  + +RD++   + +G L
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYL 227

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +  +EA     L HP +V+     S E  +Y+V EY+    +    +R    G   S
Sbjct: 46  SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL-LNYLRSHGKGLEPS 104
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +   Y   V E + +   +  IHRD+     L+   +    VK+  FG+   + D   
Sbjct: 105 QLLEMCY--DVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLD--- 156
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D Y +  G +     + APEV    KY    D+W
Sbjct: 157 --------DQYVSSVGTKFPV-KWSAPEVFHYFKYSSKSDVW 189

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 17/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  RE    H L H +++ L     +  M  MV E      +  + +R+    F+     
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSL-LDRLRKHQGHFLL--GT 122
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            S Y  QV E + Y      IHRD+    +LLA ++    VK+G FG+   L        
Sbjct: 123 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQND---- 175
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                DHY  +  HR     + APE ++ + +    D W
Sbjct: 176 -----DHYVMQE-HRKVPFAWCAPESLKTRTFSHASDTW 208

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 17/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  RE    H L H +++ L     +  M  MV E      +  + +R+    F+     
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSL-LDRLRKHQGHFLL--GT 116
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            S Y  QV E + Y      IHRD+    +LLA ++    VK+G FG+   L        
Sbjct: 117 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQND---- 169
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                DHY  +  HR     + APE ++ + +    D W
Sbjct: 170 -----DHYVMQE-HRKVPFAWCAPESLKTRTFSHASDTW 202

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 17/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  RE    H L H +++ L     +  M  MV E      +  + +R+    F+     
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSL-LDRLRKHQGHFLL--GT 112
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            S Y  QV E + Y      IHRD+    +LLA ++    VK+G FG+   L        
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQND---- 165
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                DHY  +  HR     + APE ++ + +    D W
Sbjct: 166 -----DHYVMQE-HRKVPFAWCAPESLKTRTFSHASDTW 198

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +   EA +   L H  +V+L    + +  ++++ EYM  +      +R     F   
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM-ANGCLLNYLREMRHRFQTQ 120
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +     + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D   
Sbjct: 121 QLL--EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLD--- 172
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     +  PEV+   K+    DIW
Sbjct: 173 --------DEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIW 205

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 17/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  RE    H L H +++ L     +  M  MV E      +  + +R+    F+     
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSL-LDRLRKHQGHFLL--GT 112
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            S Y  QV E + Y      IHRD+    +LLA ++    VK+G FG+   L        
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQND---- 165
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                DHY  +  HR     + APE ++ + +    D W
Sbjct: 166 -----DHYVMQE-HRKVPFAWCAPESLKTRTFSHASDTW 198

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 31/154 (20%)
Query: 66  HVVELLETYSSEGM----LYMVFEYMDGSDICFEIVRRATAG--FVYSEAVASHYMRQVL 119
           H+++LL+ ++ +G     + MVFE + G ++   I +    G   +Y + ++    +Q+L
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS----KQLL 141
Query: 120 EALRYCHEN-DIIHRDIKPHCVLLA---NKENSAPVKLGGFGVAIQLQDGQLYCSGGERL 175
             L Y H    IIH DIKP  VL+    + EN   +K+   G A         C   E  
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------CWYDE-- 190
Query: 176 DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            HYT      I T  Y +PEV+    +G   DIW
Sbjct: 191 -HYTNS----IQTREYRSPEVLLGAPWGCGADIW 219

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 71/154 (46%), Gaps = 31/154 (20%)
Query: 66  HVVELLETYSSEGM----LYMVFEYMDGSDICFEIVRRATAG--FVYSEAVASHYMRQVL 119
           H+++LL+ ++ +G     + MVFE + G ++   I +    G   +Y + ++    +Q+L
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQIS----KQLL 141
Query: 120 EALRYCHEN-DIIHRDIKPHCVLLA---NKENSAPVKLGGFGVAIQLQDGQLYCSGGERL 175
             L Y H    IIH DIKP  VL+    + EN   +K+   G A         C   E  
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------CWYDE-- 190
Query: 176 DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            HYT      I T  Y +PEV+    +G   DIW
Sbjct: 191 -HYTNS----IQTREYRSPEVLLGAPWGCGADIW 219

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 73/182 (40%), Gaps = 36/182 (19%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           +AD +REA +     +P++V+LL   +    + ++FEYM   D+  E +R  +   V S 
Sbjct: 94  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSL 152
Query: 109 A---------VASH------------YMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN 147
           +         V+S               RQV   + Y  E   +HRD+     L+   EN
Sbjct: 153 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG--EN 210
Query: 148 SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVD 207
              VK+  FG++  +             D+Y       I    +M PE I   +Y    D
Sbjct: 211 MV-VKIADFGLSRNIYSA----------DYYKADGNDAIPI-RWMPPESIFYNRYTTESD 258
Query: 208 IW 209
           +W
Sbjct: 259 VW 260

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 35/155 (22%), Positives = 67/155 (43%), Gaps = 17/155 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA +   L+H  +V L    + E  +Y++ E+M    +  + ++    G V    +   +
Sbjct: 57  EANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSL-LDFLKSDEGGKVLLPKLID-F 114
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q+ E + Y    + IHRD++   VL++    S   K+  FG+A  ++D          
Sbjct: 115 SAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIED---------- 161
Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            + YT + G +     + APE I    +    ++W
Sbjct: 162 -NEYTAREGAKFPI-KWTAPEAINFGCFTIKSNVW 194

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +   EA +   L H  +V+L    + +  ++++ EYM  +      +R     F   
Sbjct: 46  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM-ANGCLLNYLREMRHRFQTQ 104
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +     + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D   
Sbjct: 105 QLL--EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLD--- 156
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     +  PEV+   K+    DIW
Sbjct: 157 --------DEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIW 189

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 64/159 (40%), Gaps = 17/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  RE    H L H +++ L     +  M  MV E      +  + +R+    F+     
Sbjct: 61  DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSL-LDRLRKHQGHFLL--GT 116
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            S Y  QV E + Y      IHRD+    +LLA ++    VK+G FG+   L        
Sbjct: 117 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQND---- 169
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                DHY  +  HR     + APE ++ + +    D W
Sbjct: 170 -----DHYVMQE-HRKVPFAWCAPESLKTRTFSHASDTW 202

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 64/156 (41%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      + +   
Sbjct: 80  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVKDLIG-- 136
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D +       
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEXXS---- 189
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                  K G ++    +MA E ++ QK+    D+W
Sbjct: 190 ----VHNKTGAKLPV-KWMALESLQTQKFTTKSDVW 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +   EA +   L H  +V+L    + +  ++++ EYM  +      +R     F   
Sbjct: 42  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM-ANGCLLNYLREMRHRFQTQ 100
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +     + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D   
Sbjct: 101 QLL--EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLD--- 152
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     +  PEV+   K+    DIW
Sbjct: 153 --------DEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIW 185

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 18/149 (12%)
Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
            + E  +    +H +++ L   Y ++  L +V ++ +GS +   +  + T   ++     
Sbjct: 79  FRNEVAVLRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQ---L 134
Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
               RQ  + + Y H  +IIHRD+K + + L        VK+G FG+A      +   SG
Sbjct: 135 IDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATV----KSRWSG 187
Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVIEDQ 200
            ++++  T       G+  +MAPEVI  Q
Sbjct: 188 SQQVEQPT-------GSVLWMAPEVIRMQ 209

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +   EA +   L H  +V+L    + +  ++++ EYM  +      +R     F   
Sbjct: 47  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM-ANGCLLNYLREMRHRFQTQ 105
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +     + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D   
Sbjct: 106 QLL--EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLD--- 157
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     +  PEV+   K+    DIW
Sbjct: 158 --------DEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIW 190

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 43.9 bits (102), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +   EA +   L H  +V+L    + +  ++++ EYM  +      +R     F   
Sbjct: 53  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM-ANGCLLNYLREMRHRFQTQ 111
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +     + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D   
Sbjct: 112 QLL--EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLD--- 163
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     +  PEV+   K+    DIW
Sbjct: 164 --------DEYTSSVGSKFPV-RWSPPEVLMYSKFSSKSDIW 196

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 20/159 (12%)
Query: 53  KREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           K+E  I   L H H+++       +G   L +V EY+    +  + + R + G     A 
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL-RDYLPRHSIGL----AQ 118
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              + +Q+ E + Y H    IHR++    VLL   +N   VK+G FG+A  + +G  Y  
Sbjct: 119 LLLFAQQICEGMAYLHSQHYIHRNLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             E  D              + APE +++ K+    D+W
Sbjct: 176 VREDGD----------SPVFWYAPECLKEYKFYYASDVW 204

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 15/86 (17%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q          
Sbjct: 160 YWKNMLEAVHTIHQHGIVHSDLKPANFLIVD----GMLKLIDFGIANQMQP--------- 206
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIED 199
             D  +     ++G  +YM PE I+D
Sbjct: 207 --DTTSVVKDSQVGAVNYMPPEAIKD 230

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 16/156 (10%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           EA+I    +HP+++ L    ++   + ++ E+M+   +    +R     F   + V    
Sbjct: 65  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALD-SFLRLNDGQFTVIQLVG--M 121
Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYCSGGE 173
           +R +   +RY  E   +HRD+    +L+    NS  V K+  FG++  L++     +   
Sbjct: 122 LRGIASGMRYLAEMSYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEENSSDPT--- 174
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
               YT+  G +I    + APE I  +K+    D W
Sbjct: 175 ----YTSSLGGKIPI-RWTAPEAIAFRKFTSASDAW 205

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 70/161 (43%), Gaps = 20/161 (12%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   EA+I     HP+VV L    +    + +V E+M+   +    +R+    F   + V
Sbjct: 90  DFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALD-AFLRKHDGQFTVIQLV 148
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV-KLGGFGVAIQLQDGQLYC 169
               +R +   +RY  +   +HRD+    +L+    NS  V K+  FG++  ++D     
Sbjct: 149 G--MLRGIAAGMRYLADMGYVHRDLAARNILV----NSNLVCKVSDFGLSRVIEDDPEAV 202
Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
                   YTT  G     P  + APE I+ +K+    D+W
Sbjct: 203 --------YTTTGGK---IPVRWTAPEAIQYRKFTSASDVW 232

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 113
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 161
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             +  T + G +     + APE I    +    D+W
Sbjct: 162 --NEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 194

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 59  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 114
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 115 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 162
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             +  T + G +     + APE I    +    D+W
Sbjct: 163 --NEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 195

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 60  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 115
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 116 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 163
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             +  T + G +     + APE I    +    D+W
Sbjct: 164 --NEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 196

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/162 (22%), Positives = 67/162 (41%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +   EA +   L H  +V+L    + +  ++++ EYM  +      +R     F   
Sbjct: 47  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM-ANGCLLNYLREMRHRFQTQ 105
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +     + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D   
Sbjct: 106 QLL--EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLD--- 157
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D YT+  G +     +  PEV+   K+    DIW
Sbjct: 158 --------DEYTSSRGSKFPV-RWSPPEVLMYSKFSSKSDIW 190

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 20/159 (12%)
Query: 53  KREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           K+E  I   L H H+++       +G   L +V EY+    +  + + R + G     A 
Sbjct: 64  KQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL-RDYLPRHSIGL----AQ 118
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              + +Q+ E + Y H    IHR++    VLL   +N   VK+G FG+A  + +G  Y  
Sbjct: 119 LLLFAQQICEGMAYLHAQHYIHRNLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             E  D              + APE +++ K+    D+W
Sbjct: 176 VREDGD----------SPVFWYAPECLKEYKFYYASDVW 204

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 58/164 (35%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I   L H ++V  +         +++ E M G D+  F    R       S
Sbjct: 78  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 198 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 67  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 122
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 123 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 170
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             +  T + G +     + APE I    +    D+W
Sbjct: 171 --NEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 203

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/179 (22%), Positives = 73/179 (40%), Gaps = 34/179 (18%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICF-EIVRRATAGFVYSE 108
           DL  E  +   + HPHV++L    S +G L ++ EY   GS   F    R+   G++ S 
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131
Query: 109 AVAS------------------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP 150
              +                   +  Q+ + ++Y  E  ++HRD+    +L+A       
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--- 188
Query: 151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           +K+  FG++  + +           D Y  ++  RI    +MA E + D  Y    D+W
Sbjct: 189 MKISDFGLSRDVYEE----------DSYVKRSQGRIPV-KWMAIESLFDHIYTTQSDVW 236

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 64  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 119
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 120 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 167
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             +  T + G +     + APE I    +    D+W
Sbjct: 168 --NEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 200

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/156 (22%), Positives = 67/156 (42%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 113
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D +     G 
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDAEXTAREGA 170
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
           +                + APE I    +    D+W
Sbjct: 171 KFPI------------KWTAPEAINYGTFTIKSDVW 194

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 66  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 121
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 122 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 169
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             +  T + G +     + APE I    +    D+W
Sbjct: 170 --NEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 202

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+   G+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDAGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 43.1 bits (100), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V L    + E  +Y++ EYM +GS + F    +  +G   +      
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDF---LKTPSGIKLTINKLLD 113
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q+ E + +  E + IHRD++   +L++   ++   K+  FG+A  ++D         
Sbjct: 114 MAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIED--------- 161
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             +  T + G +     + APE I    +    D+W
Sbjct: 162 --NEXTAREGAKFPI-KWTAPEAINYGTFTIKSDVW 194

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+  F +A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDFYLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 58/164 (35%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I   L H ++V  +         +++ E M G D+  F    R       S
Sbjct: 92  ELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 212 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 71/168 (42%), Gaps = 42/168 (25%)
Query: 54  REATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDI-----CFEIVRRATA 102
           RE  +   +KH +V+ LL+ ++    L      Y+V   M G+D+     C ++      
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQ 128
Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
             +Y          Q+L  L+Y H  DIIHRD+KP    LA  E+   +K+   G+A   
Sbjct: 129 FLIY----------QILRGLKYIHSADIIHRDLKPSN--LAVNEDCE-LKILDRGLA--- 172
Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIW 209
                         H   +    + T  Y APE++ +   Y + VDIW
Sbjct: 173 -------------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIW 207

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/139 (23%), Positives = 62/139 (44%), Gaps = 32/139 (23%)
Query: 64  HPHVVELLETYS-----SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQV 118
           HP +V++           + + Y+V EY+ G  +     R        +EA+A  Y+ ++
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIA--YLLEI 191
Query: 119 LEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHY 178
           L AL Y H   +++ D+KP  ++L  ++    +KL   G                R++ +
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTEEQ----LKLIDLGAV-------------SRINSF 234
Query: 179 TTKAGHRIGTPHYMAPEVI 197
               G+  GTP + APE++
Sbjct: 235 ----GYLYGTPGFQAPEIV 249

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 60/164 (36%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 95  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 154
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A      
Sbjct: 155 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-----R 209
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            +Y +G      Y  K G  +    +M PE   +  +    D W
Sbjct: 210 DIYRAG------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 247

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 60/164 (36%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 177
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A      
Sbjct: 178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA-----R 232
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            +Y +G      Y  K G  +    +M PE   +  +    D W
Sbjct: 233 DIYRAG------YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 270

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 63/146 (43%), Gaps = 11/146 (7%)
Query: 68  VELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE 127
           V++LE +   G + +VFE +  S   F I       F         Y  Q+ +++ + H 
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDF-IKENGFLPFRLDHIRKMAY--QICKSVNFLHS 136
Query: 128 NDIIHRDIKPHCVLLANKENSAPV--KLGGFGVAIQLQDGQLYCSGGERLD--HYTTKAG 183
           N + H D+KP  +L    + +     K+      +   D ++   G    D  H++T   
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHST--- 193
Query: 184 HRIGTPHYMAPEVIEDQKYGKPVDIW 209
             + T HY APEVI    + +P D+W
Sbjct: 194 -LVSTRHYRAPEVILALGWSQPCDVW 218

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 22/160 (13%)
Query: 53  KREATICHMLKHPHVVELLETYSSEGM--LYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           K+E  I   L H H+++        G   L +V EY+    +  + + R + G     A 
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL-RDYLPRHSIGL----AQ 135
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              + +Q+ E + Y H    IHRD+    VLL   +N   VK+G FG+A  + +G     
Sbjct: 136 LLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEG----- 187
Query: 171 GGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIW 209
                 H   +      +P  + APE +++ K+    D+W
Sbjct: 188 ------HEXYRVREDGDSPVFWYAPECLKEYKFYYASDVW 221

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 83/205 (40%), Gaps = 42/205 (20%)
Query: 61  MLKHPHVVELLETYSSEG-------MLYMVFEYMDGS--DICFEIVRRATAGFVYSEAVA 111
           +L HP++V+L   + + G        L +V EY+  +    C    RR  A       + 
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAP---PPILI 131
Query: 112 SHYMRQVLEALRYCH--ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
             ++ Q++ ++   H    ++ HRDIKPH VL+   E    +KL  FG A +L   +   
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV--NEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWXXXXXXXXXXXXXXPFVGS 228
           +               I + +Y APE+I  +Q Y   VDIW               F G 
Sbjct: 190 A--------------YICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD 235
Query: 229 RDRLFQSITKGKLH----ILGCTHK 249
                   + G+LH    +LGC  +
Sbjct: 236 N-------SAGQLHEIVRVLGCPSR 253

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 35/186 (18%)
Query: 41  ERLNHYTTEADLKREA----TICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEI 96
           +R+  Y ++ D +  A     +C +  HP+++ LL      G LY+  EY    ++  + 
Sbjct: 58  KRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL-LDF 116
Query: 97  VRRATA-----GFVYSEAVAS--------HYMRQVLEALRYCHENDIIHRDIKPHCVLLA 143
           +R++        F  + + AS        H+   V   + Y  +   IHRD+    +L+ 
Sbjct: 117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 176
Query: 144 NKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYG 203
             EN    K+  FG    L  GQ         + Y  K   R+    +MA E +    Y 
Sbjct: 177 --ENYV-AKIADFG----LSRGQ---------EVYVKKTMGRLPV-RWMAIESLNYSVYT 219
Query: 204 KPVDIW 209
              D+W
Sbjct: 220 TNSDVW 225

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 69  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 128
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 129 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 188
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 189 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 221

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 197
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 198 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 78  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 137
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 138 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRA 197
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 198 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 230

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 35/186 (18%)
Query: 41  ERLNHYTTEADLKREA----TICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEI 96
           +R+  Y ++ D +  A     +C +  HP+++ LL      G LY+  EY    ++  + 
Sbjct: 48  KRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL-LDF 106
Query: 97  VRRATA-----GFVYSEAVAS--------HYMRQVLEALRYCHENDIIHRDIKPHCVLLA 143
           +R++        F  + + AS        H+   V   + Y  +   IHRD+    +L+ 
Sbjct: 107 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 166
Query: 144 NKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYG 203
             EN    K+  FG    L  GQ         + Y  K   R+    +MA E +    Y 
Sbjct: 167 --ENYV-AKIADFG----LSRGQ---------EVYVKKTMGRLPV-RWMAIESLNYSVYT 209
Query: 204 KPVDIW 209
              D+W
Sbjct: 210 TNSDVW 215

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 84  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 143
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 144 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 203
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 204 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 236

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 136
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 197 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 94  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 153
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 154 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 213
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 214 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 246

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 151
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 212 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 62/159 (38%), Gaps = 17/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  RE    H L H +++ L     +  M  MV E      +  + +R+    F+     
Sbjct: 57  DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSL-LDRLRKHQGHFLL--GT 112
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            S Y  QV E + Y      IHRD+    +LLA ++    VK+G FG+   L        
Sbjct: 113 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQN----- 164
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                D +     HR     + APE ++ + +    D W
Sbjct: 165 -----DDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTW 198

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 104 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS 163
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 164 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 223
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 224 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 256

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 197 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/164 (24%), Positives = 57/164 (34%), Gaps = 14/164 (8%)
Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 92  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 151
Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 152 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 211
Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             Y            K G  +    +M PE   +  +    D W
Sbjct: 212 SYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTW 244

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 62/159 (38%), Gaps = 17/159 (10%)
Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  RE    H L H +++ L     +  M  MV E      +  + +R+    F+     
Sbjct: 67  DFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSL-LDRLRKHQGHFLL--GT 122
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            S Y  QV E + Y      IHRD+    +LLA ++    VK+G FG+   L        
Sbjct: 123 LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRALPQN----- 174
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                D +     HR     + APE ++ + +    D W
Sbjct: 175 -----DDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTW 208

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/157 (22%), Positives = 65/157 (41%), Gaps = 16/157 (10%)
Query: 54  REATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           RE  +   L HP+V+ L+      EG+ +++  YM   D+  + +R         + ++ 
Sbjct: 71  REGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL-LQFIRSPQRNPTVKDLIS- 128
Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            +  QV   + Y  E   +HRD+     +L   + S  VK+  FG+A  + D + Y    
Sbjct: 129 -FGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQ 184
Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
            R      K         + A E ++  ++    D+W
Sbjct: 185 HRHARLPVK---------WTALESLQTYRFTTKSDVW 212

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 41.2 bits (95), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 62/146 (42%), Gaps = 11/146 (7%)
Query: 68  VELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE 127
           V++LE +   G + +VFE +  S   F I       F         Y  Q+ +++ + H 
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDF-IKENGFLPFRLDHIRKMAY--QICKSVNFLHS 136
Query: 128 NDIIHRDIKPHCVLLANKENSAPV--KLGGFGVAIQLQDGQLYCSGGERLD--HYTTKAG 183
           N + H D+KP  +L    + +     K+      +   D ++   G    D  H++T   
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVX 196
Query: 184 HRIGTPHYMAPEVIEDQKYGKPVDIW 209
            R    HY APEVI    + +P D+W
Sbjct: 197 XR----HYRAPEVILALGWSQPCDVW 218

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 5/140 (3%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +H HVV     ++ +  + +  EY +G  +   I         + EA     + QV   L
Sbjct: 65  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 124
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           RY H   ++H DIKP  + ++    S P      G        ++    G+ L H T  +
Sbjct: 125 RYIHSMSLVHMDIKPSNIFISR--TSIPNAASEEGDEDDWASNKVMFKIGD-LGHVTRIS 181
Query: 183 GHRI--GTPHYMAPEVIEDQ 200
             ++  G   ++A EV+++ 
Sbjct: 182 SPQVEEGDSRFLANEVLQEN 201

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V+L    + E  +Y++ E+M  GS + F    ++  G          
Sbjct: 60  EANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDF---LKSDEGSKQPLPKLID 115
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  Q+ E + +  + + IHRD++   +L++    S   K+  FG+A  ++D         
Sbjct: 116 FSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIED--------- 163
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             + YT + G +     + APE I    +    D+W
Sbjct: 164 --NEYTAREGAKFPI-KWTAPEAINFGSFTIKSDVW 196

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 20/159 (12%)
Query: 53  KREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +RE  I   L H H+V+       +G   + +V EY+    +  + + R   G     A 
Sbjct: 59  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL-RDYLPRHCVGL----AQ 113
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              + +Q+ E + Y H    IHR +    VLL   +N   VK+G FG+A  + +G  Y  
Sbjct: 114 LLLFAQQICEGMAYLHAQHYIHRALAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYR 170
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             E  D              + APE +++ K+    D+W
Sbjct: 171 VREDGD----------SPVFWYAPECLKECKFYYASDVW 199

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 14/85 (16%)
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ + +  L+  H+  I HRDIK   VLL N   +    +  FG+A++ + G+   S G+
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC---IADFGLALKFEAGK---SAGD 189
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIE 198
                      ++GT  YMAPEV+E
Sbjct: 190 --------THGQVGTRRYMAPEVLE 206

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 22/146 (15%)
Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC 125
           ++V L   +     L +VFE +  S   ++++R      V S  +   + +Q+  AL + 
Sbjct: 98  YIVHLKRHFMFRNHLCLVFEML--SYNLYDLLRNTNFRGV-SLNLTRKFAQQMCTALLFL 154
Query: 126 H--ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAG 183
              E  IIH D+KP  +LL N + SA +K+  FG + QL         G+R+        
Sbjct: 155 ATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL---------GQRI-------Y 197
Query: 184 HRIGTPHYMAPEVIEDQKYGKPVDIW 209
             I +  Y +PEV+    Y   +D+W
Sbjct: 198 QXIQSRFYRSPEVLLGMPYDLAIDMW 223

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 5/140 (3%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +H HVV     ++ +  + +  EY +G  +   I         + EA     + QV   L
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           RY H   ++H DIKP  + ++    S P      G        ++    G+ L H T  +
Sbjct: 127 RYIHSMSLVHMDIKPSNIFISR--TSIPNAASEEGDEDDWASNKVMFKIGD-LGHVTRIS 183
Query: 183 GHRI--GTPHYMAPEVIEDQ 200
             ++  G   ++A EV+++ 
Sbjct: 184 SPQVEEGDSRFLANEVLQEN 203

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 67/159 (42%), Gaps = 20/159 (12%)
Query: 53  KREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +RE  I   L H H+V+       +G   + +V EY+    +  + + R   G     A 
Sbjct: 58  QREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSL-RDYLPRHCVGL----AQ 112
Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              + +Q+ E + Y H    IHR +    VLL   +N   VK+G FG+A  + +G  Y  
Sbjct: 113 LLLFAQQICEGMAYLHAQHYIHRALAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYR 169
Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             E  D              + APE +++ K+    D+W
Sbjct: 170 VREDGD----------SPVFWYAPECLKECKFYYASDVW 198

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 5/140 (3%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +H HVV     ++ +  + +  EY +G  +   I         + EA     + QV   L
Sbjct: 69  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           RY H   ++H DIKP  + ++    S P      G        ++    G+ L H T  +
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISR--TSIPNAASEEGDEDDWASNKVMFKIGD-LGHVTRIS 185
Query: 183 GHRI--GTPHYMAPEVIEDQ 200
             ++  G   ++A EV+++ 
Sbjct: 186 SPQVEEGDSRFLANEVLQEN 205

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 40.8 bits (94), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 5/140 (3%)
Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +H HVV     ++ +  + +  EY +G  +   I         + EA     + QV   L
Sbjct: 67  QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 126
Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
           RY H   ++H DIKP  + ++    S P      G        ++    G+ L H T  +
Sbjct: 127 RYIHSMSLVHMDIKPSNIFISR--TSIPNAASEEGDEDDWASNKVMFKIGD-LGHVTRIS 183
Query: 183 GHRI--GTPHYMAPEVIEDQ 200
             ++  G   ++A EV+++ 
Sbjct: 184 SPQVEEGDSRFLANEVLQEN 203

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 22/146 (15%)
Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC 125
           ++V L   +     L +VFE +  S   ++++R      V S  +   + +Q+  AL + 
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML--SYNLYDLLRNTNFRGV-SLNLTRKFAQQMCTALLFL 173
Query: 126 H--ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAG 183
              E  IIH D+KP  +LL N + SA +K+  FG + QL         G+R+        
Sbjct: 174 ATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSSCQL---------GQRI-------Y 216
Query: 184 HRIGTPHYMAPEVIEDQKYGKPVDIW 209
             I +  Y +PEV+    Y   +D+W
Sbjct: 217 QXIQSRFYRSPEVLLGMPYDLAIDMW 242

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 40.8 bits (94), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 69/156 (44%), Gaps = 20/156 (12%)
Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYM-DGSDICFEIVRRATAGFVYSEAVASH 113
           EA +   L+H  +V+L    + E  +Y++ E+M  GS + F    ++  G          
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDF---LKSDEGSKQPLPKLID 288
Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           +  Q+ E + +  + + IHRD++   +L++    S   K+  FG+A  ++D         
Sbjct: 289 FSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIED--------- 336
Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             + YT + G +     + APE I    +    D+W
Sbjct: 337 --NEYTAREGAKFPI-KWTAPEAINFGSFTIKSDVW 369

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 40.4 bits (93), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 35/162 (21%), Positives = 66/162 (40%), Gaps = 18/162 (11%)
Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +   EA +   L H  +V+L    + +  ++++ EYM  +      +R     F   
Sbjct: 62  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM-ANGCLLNYLREMRHRFQTQ 120
Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +     + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D   
Sbjct: 121 QLL--EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ---GVVKVSDFGLSRYVLD--- 172
Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
                   D  T+  G +     +  PEV+   K+    DIW
Sbjct: 173 --------DEETSSVGSKFPV-RWSPPEVLMYSKFSSKSDIW 205

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	249
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-90
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-05
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-77
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-05
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-75
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-05
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-70
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-05
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-61
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-05
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-61
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-04
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	9e-61
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-05
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-60
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-05
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-59
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-05
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-59
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-04
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-58
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-05
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-58
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-04
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-58
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	7e-06
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-58
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-05
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-58
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-07
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-58
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-05
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-58
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-05
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-57
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-06
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-57
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-06
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-57
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-04
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-57
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-05
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-57
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-04
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-57
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-05
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-56
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-04
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-56
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	9e-05
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-56
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-05
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-55
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-04
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-55
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-05
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-55
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-05
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-54
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-05
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-53
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-05
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-52
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-05
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-49
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-04
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-49
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	7e-49
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-48
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-48
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-48
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-48
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-04
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-48
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-04
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-47
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-47
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-47
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-05
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-47
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-47
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-04
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-47
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-46
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-04
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-46
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-05
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-45
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	7e-05
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-45
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-04
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-45
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-05
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	9e-45
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-05
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-45
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-04
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	5e-44
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-44
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-05
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-43
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-04
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-43
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-05
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-43
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-04
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-43
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-43
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-05
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-42
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-42
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-05
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-42
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-05
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-41
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-41
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-41
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-06
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	9e-41
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-05
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-40
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-40
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-39
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-38
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-37
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-36
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-36
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-35
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-35
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-34
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-34
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-34
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-34
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	7e-34
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-33
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-33
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-33
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-33
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-33
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-33
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-33
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-32
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-32
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-32
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-32
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-32
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	8e-32
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-31
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-31
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-31
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-31
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-31
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	4e-31
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-31
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-31
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-31
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-30
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-30
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-30
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-30
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-30
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	8e-30
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-29
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-29
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-29
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-29
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-28
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	7e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-27
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-27
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	5e-27
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-27
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-26
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-25
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-25
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	9e-25
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-24
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	9e-24
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	4e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-19
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-18
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-18
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	7e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-18
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-17
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-17
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-17
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-16
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-16
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-16
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-16
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-16
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-16
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-16
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	9e-16
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-15
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-15
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-15
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-15
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-15
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-15
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-15
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-15
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-15
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-14
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-14
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-14
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-14
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-14
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-14
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-14
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-14
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	4e-14
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-14
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-14
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-14
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-13
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-13
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-13
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	6e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-12
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-11
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-11
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-11
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-11
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-11
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-11
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-11
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-10
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-10
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-10
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-09
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-07
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	8e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-06
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-05

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  268 bits (688), Expect = 6e-90
 Identities = 135/194 (69%), Positives = 162/194 (83%), Gaps = 13/194 (6%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +  DLKREA+ICHMLKHPH+VELLETYSS+GMLYMVFE+MDG+D+CFEIV+RA AGFVYS
Sbjct: 69  STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYS 128

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EAVASHYMRQ+LEALRYCH+N+IIHRD+KPHCVLLA+KENSAPVKLGGFGVAIQL +  L
Sbjct: 129 EAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
              G             R+GTPH+MAPEV++ + YGKPVD+W  GV+L +LL+G LPF G
Sbjct: 189 VAGG-------------RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG 235

Query: 228 SRDRLFQSITKGKL 241
           +++RLF+ I KGK 
Sbjct: 236 TKERLFEGIIKGKY 249

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 43.4 bits (103), Expect = 3e-05
 Identities = 13/22 (59%), Positives = 18/22 (81%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML +DP +RIT++E +NH WLK
Sbjct: 270 MLMLDPAERITVYEALNHPWLK 291

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  235 bits (602), Expect = 8e-77
 Identities = 79/192 (41%), Positives = 115/192 (59%), Gaps = 19/192 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
            L+REA IC  L+HP++V L ++   E   Y+VF+ + G ++  +IV R      YSEA 
Sbjct: 74  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEAD 129

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASH ++Q+LE++ YCH N I+HR++KP  +LLA+K   A VKL  FG+AI++ D +    
Sbjct: 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--- 186

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR 229
                  +   A    GTP Y++PEV++   Y KPVDIWA GV+L++LL G  PF    +
Sbjct: 187 -------WHGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 235

Query: 230 DRLFQSITKGKL 241
            RL+  I  G  
Sbjct: 236 HRLYAQIKAGAY 247

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 43.5 bits (103), Expect = 3e-05
 Identities = 9/22 (40%), Positives = 14/22 (63%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML+V+P KRIT  + +   W+ 
Sbjct: 268 MLTVNPKKRITADQALKVPWIC 289

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  233 bits (596), Expect = 5e-75
 Identities = 80/192 (41%), Positives = 119/192 (61%), Gaps = 18/192 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
            L+REA IC +LKHP++V L ++ S EG  Y++F+ + G ++  +IV R      YSEA 
Sbjct: 56  KLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEAD 111

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASH ++Q+LEA+ +CH+  ++HR++KP  +LLA+K   A VKL  FG+AI+++  Q    
Sbjct: 112 ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ---- 167

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR 229
                  +   A    GTP Y++PEV+    YGKPVD+WA GV+L++LL G  PF    +
Sbjct: 168 -----QAWFGFA----GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218

Query: 230 DRLFQSITKGKL 241
            RL+Q I  G  
Sbjct: 219 HRLYQQIKAGAY 230

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 44.6 bits (106), Expect = 1e-05
 Identities = 15/72 (20%), Positives = 28/72 (38%), Gaps = 3/72 (4%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICH 60
           ML+++P+KRIT  E + H W+  +   ++ +         + L  +     LK       
Sbjct: 251 MLTINPSKRITAAEALKHPWISHRSTVASCMHRQETV---DCLKKFNARRKLKGAILTVM 307

Query: 61  MLKHPHVVELLE 72
           +      V   E
Sbjct: 308 LATRNFSVRKQE 319

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  216 bits (552), Expect = 3e-70
 Identities = 79/192 (41%), Positives = 115/192 (59%), Gaps = 19/192 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
            L+REA IC  L+HP++V L ++   E   Y+VF+ + G ++  +IV R      YSEA 
Sbjct: 51  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF----YSEAD 106

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           ASH ++Q+LE++ YCH N I+HR++KP  +LLA+K   A VKL  FG+AI++ D +    
Sbjct: 107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--- 163

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR 229
                  +   A    GTP Y++PEV++   Y KPVDIWA GV+L++LL G  PF    +
Sbjct: 164 -------WHGFA----GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212

Query: 230 DRLFQSITKGKL 241
            RL+  I  G  
Sbjct: 213 HRLYAQIKAGAY 224

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 42.9 bits (102), Expect = 4e-05
 Identities = 10/31 (32%), Positives = 18/31 (58%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEI 31
           ML+V+P KRIT  + +   W+  +   ++ I
Sbjct: 245 MLTVNPKKRITADQALKVPWICNRERVASAI 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  194 bits (496), Expect = 2e-61
 Identities = 64/196 (32%), Positives = 107/196 (54%), Gaps = 22/196 (11%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVY 106
            ++ L+ E  +   +KH ++V L + Y S    Y+V + + G ++ F+ I+ R   G  Y
Sbjct: 49  RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL-FDRILER---GV-Y 103

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           +E  AS  ++QVL A++Y HEN I+HRD+KP  +L    E ++ + +  FG++   Q+G 
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
           +           +T      GTP Y+APEV+  + Y K VD W+ GV+ ++LL G  PF 
Sbjct: 164 M-----------STAC----GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208

Query: 227 G-SRDRLFQSITKGKL 241
             +  +LF+ I +G  
Sbjct: 209 EETESKLFEKIKEGYY 224

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 42.6 bits (101), Expect = 5e-05
 Identities = 10/34 (29%), Positives = 18/34 (52%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPA 34
           +L  DPN+R T  + ++H W+        +I P+
Sbjct: 245 LLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  194 bits (496), Expect = 4e-61
 Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 20/195 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           +  ++ E  +   L HP++++L E + +   + +V E + G ++   IV +      YSE
Sbjct: 92  KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY----YSE 147

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             A+  ++Q+LEA+ Y HEN I+HRD+KP  +L A     AP+K+  FG++  ++   L 
Sbjct: 148 RDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
                      T      GTP Y APE++    YG  VD+W+ G++ ++LL G  PF   
Sbjct: 207 ---------MKTVC----GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253

Query: 229 RD--RLFQSITKGKL 241
           R    +F+ I   + 
Sbjct: 254 RGDQFMFRRILNCEY 268

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 41.2 bits (97), Expect = 2e-04
 Identities = 7/22 (31%), Positives = 14/22 (63%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ++ +DP KR+T  + + H W+ 
Sbjct: 289 LIVLDPKKRLTTFQALQHPWVT 310

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  193 bits (492), Expect = 9e-61
 Identities = 50/193 (25%), Positives = 97/193 (50%), Gaps = 20/193 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +++RE +I   + H +V+ L + Y +   + ++ E + G ++ F+           SE  
Sbjct: 61  EIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL-FD---FLAQKESLSEEE 116

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQLQDGQLYC 169
           A+ +++Q+L+ + Y H   I H D+KP  ++L +K      +KL  FG+A +++DG  + 
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK 176

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR 229
           +                GTP ++APE++  +  G   D+W+ GV+ ++LL+G  PF+G  
Sbjct: 177 N--------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 222

Query: 230 D-RLFQSITKGKL 241
                 +IT    
Sbjct: 223 KQETLANITSVSY 235

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 14/64 (21%), Positives = 24/64 (37%), Gaps = 1/64 (1%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICH 60
           +L  +  KR+TI E + H W+    +  A +   S  +  E           K   +I  
Sbjct: 256 LLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESV-VNLENFRKQYVRRRWKLSFSIVS 314

Query: 61  MLKH 64
           +  H
Sbjct: 315 LCNH 318

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  189 bits (483), Expect = 8e-60
 Identities = 56/195 (28%), Positives = 96/195 (49%), Gaps = 18/195 (9%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYS 107
              ++ E  +   L HP+++++ E +     +Y+V E  +G ++  E IV     G   S
Sbjct: 64  MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL-LERIVSAQARGKALS 122

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E   +  M+Q++ AL Y H   ++H+D+KP  +L  +    +P+K+  FG+A   +  + 
Sbjct: 123 EGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
             +                GT  YMAPEV + +      DIW+AGV+++ LLTG LPF G
Sbjct: 183 STN--------------AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227

Query: 228 -SRDRLFQSITKGKL 241
            S + + Q  T  + 
Sbjct: 228 TSLEEVQQKATYKEP 242

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 9/22 (40%), Positives = 16/22 (72%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML+ DP +R +  +V++H+W K
Sbjct: 262 MLTKDPERRPSAAQVLHHEWFK 283

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  188 bits (479), Expect = 2e-59
 Identities = 63/195 (32%), Positives = 101/195 (51%), Gaps = 22/195 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYS 107
               K+E  I   L HP+++ L ET+     +Y+V E   G ++ FE +V +      + 
Sbjct: 50  VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL-FERVVHKRV----FR 104

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E+ A+  M+ VL A+ YCH+ ++ HRD+KP   L       +P+KL  FG+A + + G++
Sbjct: 105 ESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                       TK     GTP+Y++P+V+E   YG   D W+AGV+++VLL G  PF  
Sbjct: 165 ----------MRTKV----GTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSA 209

Query: 228 SRD-RLFQSITKGKL 241
             D  +   I +G  
Sbjct: 210 PTDSEVMLKIREGTF 224

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 42.6 bits (101), Expect = 4e-05
 Identities = 9/28 (32%), Positives = 18/28 (64%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTS 28
           +L+  P +RIT  + + H+W + +L +S
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQLSSS 272

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  188 bits (479), Expect = 3e-59
 Identities = 58/195 (29%), Positives = 102/195 (52%), Gaps = 22/195 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYS 107
            + + RE  +   L HP++++L E        Y+V E   G ++ F+ I++R      +S
Sbjct: 65  TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-FDEIIKRKR----FS 119

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E  A+  ++QV   + Y H+++I+HRD+KP  +LL +KE    +K+  FG++   Q    
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                        +     GT +Y+APEV+    Y +  D+W+AGV+L++LL+GT PF G
Sbjct: 180 ----------MKDRI----GTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYG 224

Query: 228 -SRDRLFQSITKGKL 241
            +   + + +  GK 
Sbjct: 225 KNEYDILKRVETGKY 239

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 41.4 bits (98), Expect = 1e-04
 Identities = 8/22 (36%), Positives = 14/22 (63%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML+  P+ RIT  + + H W++
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQ 281

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  187 bits (478), Expect = 1e-58
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 26/211 (12%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-I 96
                        +++ E  I   L HP ++++   + +E   Y+V E M+G ++ F+ +
Sbjct: 48  FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL-FDKV 105

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
           V          EA    Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  F
Sbjct: 106 VGNKR----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 161

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGV 213
           G +  L +  L            T      GTP Y+APEV+       Y + VD W+ GV
Sbjct: 162 GHSKILGETSL----------MRTLC----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207

Query: 214 LLHVLLTGTLPFVGSRD--RLFQSITKGKLH 242
           +L + L+G  PF   R    L   IT GK +
Sbjct: 208 ILFICLSGYPPFSEHRTQVSLKDQITSGKYN 238

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 44.2 bits (105), Expect = 2e-05
 Identities = 10/22 (45%), Positives = 13/22 (59%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L VDP  R T  E + H WL+
Sbjct: 258 LLVVDPKARFTTEEALRHPWLQ 279

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  187 bits (478), Expect = 1e-58
 Identities = 56/195 (28%), Positives = 99/195 (50%), Gaps = 21/195 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYS 107
           +  +K+E +I ++ +H +++ L E++ S   L M+FE++ G DI FE I       F  +
Sbjct: 45  QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI-FERINTS---AFELN 100

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E     Y+ QV EAL++ H ++I H DI+P  ++   + +S  +K+  FG A QL+ G  
Sbjct: 101 EREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDN 159

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
           +                    P Y APEV +        D+W+ G L++VLL+G  PF+ 
Sbjct: 160 FRL--------------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205

Query: 228 SRDR-LFQSITKGKL 241
             ++ + ++I   + 
Sbjct: 206 ETNQQIIENIMNAEY 220

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 39.9 bits (94), Expect = 4e-04
 Identities = 9/24 (37%), Positives = 13/24 (54%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMK 24
           +L  +   R+T  E + H WLK K
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQK 264

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  190 bits (485), Expect = 5e-58
 Identities = 60/193 (31%), Positives = 102/193 (52%), Gaps = 22/193 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSEA 109
            + RE  +   L HP++++L E        Y+V E   G ++ F+ I++R      +SE 
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-FDEIIKRKR----FSEH 121

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
            A+  ++QV   + Y H+++I+HRD+KP  +LL +KE    +K+  FG++   Q      
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-S 228
                          RIGT +Y+APEV+    Y +  D+W+AGV+L++LL+GT PF G +
Sbjct: 182 D--------------RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKN 226

Query: 229 RDRLFQSITKGKL 241
              + + +  GK 
Sbjct: 227 EYDILKRVETGKY 239

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 45.4 bits (108), Expect = 7e-06
 Identities = 12/57 (21%), Positives = 22/57 (38%), Gaps = 1/57 (1%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPD-ERLNHYTTEADLKREA 56
           ML+  P+ RIT  + + H W++     +  I            +  +  E  L + A
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAA 316

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  186 bits (475), Expect = 5e-58
 Identities = 63/232 (27%), Positives = 95/232 (40%), Gaps = 49/232 (21%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR--------- 99
              +K E  +   L HP++  L E Y  E  + +V E   G  +  ++            
Sbjct: 72  VERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131

Query: 100 ---------------------------ATAGFVYSEAVASHYMRQVLEALRYCHENDIIH 132
                                       +  FV  E + S+ MRQ+  AL Y H   I H
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICH 191

Query: 133 RDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYM 192
           RDIKP   L +  ++   +KL  FG++ +          GE     T     + GTP+++
Sbjct: 192 RDIKPENFLFSTNKSF-EIKLVDFGLSKEFYKLN----NGEYYGMTT-----KAGTPYFV 241

Query: 193 APEVIE--DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL 241
           APEV+   ++ YG   D W+AGVLLH+LL G +PF G +       +   KL
Sbjct: 242 APEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL 293

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 42.5 bits (100), Expect = 6e-05
 Identities = 4/22 (18%), Positives = 11/22 (50%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L+ + ++R      + H W+ 
Sbjct: 314 LLNRNVDERFDAMRALQHPWIS 335

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  190 bits (484), Expect = 6e-58
 Identities = 62/202 (30%), Positives = 108/202 (53%), Gaps = 22/202 (10%)

Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRA 100
           ++   T +  L RE  +   L HP++++L E +  +G  Y+V E   G ++ F+ I+ R 
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL-FDEIISRK 121

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                +SE  A+  +RQVL  + Y H+N I+HRD+KP  +LL +K   A +++  FG++ 
Sbjct: 122 R----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177

Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
             +  +                  +IGT +Y+APEV+    Y +  D+W+ GV+L++LL+
Sbjct: 178 HFEASKKMKD--------------KIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLS 222

Query: 221 GTLPFVG-SRDRLFQSITKGKL 241
           G  PF G +   + + + KGK 
Sbjct: 223 GCPPFNGANEYDILKKVEKGKY 244

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 48.9 bits (117), Expect = 5e-07
 Identities = 10/56 (17%), Positives = 24/56 (42%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREA 56
           ML+  P+ RI+  + ++H+W++        ++  S       +  +     L + A
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQFQGTQKLAQAA 320

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  185 bits (472), Expect = 9e-58
 Identities = 52/202 (25%), Positives = 100/202 (49%), Gaps = 26/202 (12%)

Query: 49  EADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           EA+ ++E T   + + HP++V+L E +  +   ++V E ++G ++   I ++      +S
Sbjct: 49  EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH----FS 104

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E  AS+ MR+++ A+ + H+  ++HRD+KP  +L  ++ ++  +K+  FG A        
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN- 163

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                       T       T HY APE++    Y +  D+W+ GV+L+ +L+G +PF  
Sbjct: 164 --------QPLKTPC----FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211

Query: 228 --------SRDRLFQSITKGKL 241
                   S   + + I KG  
Sbjct: 212 HDRSLTCTSAVEIMKKIKKGDF 233

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 43.4 bits (103), Expect = 3e-05
 Identities = 9/22 (40%), Positives = 17/22 (77%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L+VDPNKR+ +  +  ++WL+
Sbjct: 254 LLTVDPNKRLKMSGLRYNEWLQ 275

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  186 bits (475), Expect = 9e-58
 Identities = 50/201 (24%), Positives = 101/201 (50%), Gaps = 22/201 (10%)

Query: 44  NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATA 102
                  +++RE +I   + HP+++ L + Y +   + ++ E + G ++ F+ + ++   
Sbjct: 54  RRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL-FDFLAQK--- 109

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQ 161
               SE  A+ +++Q+L+ + Y H   I H D+KP  ++L +K      +KL  FG+A +
Sbjct: 110 -ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           ++DG  + +                GTP ++APE++  +  G   D+W+ GV+ ++LL+G
Sbjct: 169 IEDGVEFKN--------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

Query: 222 TLPFVGSRD-RLFQSITKGKL 241
             PF+G        +IT    
Sbjct: 215 ASPFLGDTKQETLANITAVSY 235

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 42.7 bits (101), Expect = 5e-05
 Identities = 14/64 (21%), Positives = 23/64 (35%), Gaps = 1/64 (1%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICH 60
           +L  +  KR+TI E + H W+       A +   S  +  E           K   +I  
Sbjct: 256 LLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESV-VNLENFKKQYVRRRWKLSFSIVS 314

Query: 61  MLKH 64
           +  H
Sbjct: 315 LCNH 318

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  190 bits (484), Expect = 1e-57
 Identities = 57/195 (29%), Positives = 107/195 (54%), Gaps = 22/195 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYS 107
             ++  E ++   L HP++++L + +  +   Y+V E+ +G ++ FE I+ R      + 
Sbjct: 90  HEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-FEQIINRHK----FD 144

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E  A++ M+Q+L  + Y H+++I+HRDIKP  +LL NK +   +K+  FG++        
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                            R+GT +Y+APEV++ +KY +  D+W+ GV++++LL G  PF G
Sbjct: 205 LRD--------------RLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249

Query: 228 -SRDRLFQSITKGKL 241
            +   + + + KGK 
Sbjct: 250 QNDQDIIKKVEKGKY 264

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 13/56 (23%), Positives = 24/56 (42%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREA 56
           ML+ D NKR T  E +N +W+K   +   + +  +       +  +     L + A
Sbjct: 285 MLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQAA 340

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  189 bits (483), Expect = 1e-57
 Identities = 59/194 (30%), Positives = 107/194 (55%), Gaps = 20/194 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
            + L  E  +  +L HP++++L + +  +   Y+V E   G ++  EI+ R      ++E
Sbjct: 80  NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK----FNE 135

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             A+  ++QVL  + Y H+++I+HRD+KP  +LL +KE  A +K+  FG++   ++ +  
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
                           R+GT +Y+APEV+  +KY +  D+W+ GV+L +LL G  PF G 
Sbjct: 196 KE--------------RLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ 240

Query: 229 RDR-LFQSITKGKL 241
            D+ + + + KGK 
Sbjct: 241 TDQEILRKVEKGKY 254

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 45.5 bits (108), Expect = 8e-06
 Identities = 12/59 (20%), Positives = 21/59 (35%), Gaps = 5/59 (8%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREA 56
           ML  D  +RI+  + + H W+K     S +             E +  +     L + A
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKE--MCSKKESGIELPSLANAIENMRKFQNSQKLAQAA 331

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  186 bits (474), Expect = 2e-57
 Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 21/194 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYS 107
           +  +K E +I + L HP ++ L + +  +  + ++ E++ G ++ F+ I       +  S
Sbjct: 92  KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL-FDRIAAE---DYKMS 147

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EA   +YMRQ  E L++ HE+ I+H DIKP  ++   K+ S  VK+  FG+A +L   ++
Sbjct: 148 EAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEI 206

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                               T  + APE+++ +  G   D+WA GVL +VLL+G  PF G
Sbjct: 207 VKV--------------TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252

Query: 228 SRDR-LFQSITKGK 240
             D    Q++ +  
Sbjct: 253 EDDLETLQNVKRCD 266

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 10/24 (41%), Positives = 16/24 (66%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMK 24
           +L  +P KR+T+H+ + H WLK  
Sbjct: 288 LLQKEPRKRLTVHDALEHPWLKGD 311

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  186 bits (475), Expect = 4e-57
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 26/211 (12%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-I 96
                        +++ E  I   L HP ++++   + +E   Y+V E M+G ++ F+ +
Sbjct: 173 FAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL-FDKV 230

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
           V          EA    Y  Q+L A++Y HEN IIHRD+KP  VLL+++E    +K+  F
Sbjct: 231 VGNKR----LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF 286

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGV 213
           G +  L +  L            T      GTP Y+APEV+       Y + VD W+ GV
Sbjct: 287 GHSKILGETSL----------MRTLC----GTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332

Query: 214 LLHVLLTGTLPFVGSRD--RLFQSITKGKLH 242
           +L + L+G  PF   R    L   IT GK +
Sbjct: 333 ILFICLSGYPPFSEHRTQVSLKDQITSGKYN 363

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 43.9 bits (104), Expect = 3e-05
 Identities = 10/22 (45%), Positives = 13/22 (59%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L VDP  R T  E + H WL+
Sbjct: 383 LLVVDPKARFTTEEALRHPWLQ 404

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  181 bits (463), Expect = 7e-57
 Identities = 46/194 (23%), Positives = 102/194 (52%), Gaps = 22/194 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSEA 109
           +++RE  I   ++HP+++ L + + ++  + ++ E + G ++ F+ +  + +     +E 
Sbjct: 54  EIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGEL-FDFLAEKES----LTED 108

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQLQDGQLY 168
            A+ +++Q+L+ + Y H   I H D+KP  ++L +K   +  +KL  FG+A +++ G  +
Sbjct: 109 EATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
            +                GTP ++APE++  +  G   D+W+ GV+ ++LL+G  PF+G 
Sbjct: 169 KN--------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGE 214

Query: 229 RD-RLFQSITKGKL 241
                  +I+    
Sbjct: 215 TKQETLTNISAVNY 228

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 40.6 bits (96), Expect = 2e-04
 Identities = 9/22 (40%), Positives = 15/22 (68%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L  DP +R+TI + + H W+K
Sbjct: 249 LLVKDPKRRMTIAQSLEHSWIK 270

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  183 bits (467), Expect = 8e-57
 Identities = 57/198 (28%), Positives = 92/198 (46%), Gaps = 25/198 (12%)

Query: 51  DLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSE 108
           D   E  I     +HP+++ L + Y     +Y+V E M G ++  + I+R+      +SE
Sbjct: 61  DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL-LDKILRQKF----FSE 115

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQLQDGQL 167
             AS  +  + + + Y H   ++HRD+KP  +L  ++  N   +++  FG A QL+    
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN- 174

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                       T       T +++APEV+E Q Y    DIW+ GVLL+ +LTG  PF  
Sbjct: 175 --------GLLMTPCY----TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222

Query: 228 SRD----RLFQSITKGKL 241
             D     +   I  GK 
Sbjct: 223 GPDDTPEEILARIGSGKF 240

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 10/22 (45%), Positives = 15/22 (68%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML VDP++R+T   V+ H W+ 
Sbjct: 261 MLHVDPHQRLTAALVLRHPWIV 282

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  182 bits (465), Expect = 1e-56
 Identities = 47/194 (24%), Positives = 101/194 (52%), Gaps = 22/194 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSEA 109
           D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++ F+ +  + +     +E 
Sbjct: 60  DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL-FDFLAEKES----LTEE 114

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQLQDGQLY 168
            A+ +++Q+L  + Y H   I H D+KP  ++L ++      +K+  FG+A ++  G  +
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 174

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
            +                GTP ++APE++  +  G   D+W+ GV+ ++LL+G  PF+G 
Sbjct: 175 KN--------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220

Query: 229 RDR-LFQSITKGKL 241
             +    +++    
Sbjct: 221 TKQETLANVSAVNY 234

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 41.1 bits (97), Expect = 1e-04
 Identities = 14/36 (38%), Positives = 19/36 (52%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASF 36
           +L  DP KR+TI + + H W+K K    A    AS 
Sbjct: 255 LLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASA 290

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  182 bits (464), Expect = 2e-56
 Identities = 50/196 (25%), Positives = 94/196 (47%), Gaps = 20/196 (10%)

Query: 49  EADLKREATICHMLKH-PHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVY 106
            A++  E  +  + K  P V+ L E Y +   + ++ EY  G +I F   +       + 
Sbjct: 72  RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI-FSLCLPELAE--MV 128

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           SE      ++Q+LE + Y H+N+I+H D+KP  +LL++      +K+  FG++ ++    
Sbjct: 129 SENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                              +GTP Y+APE++         D+W  G++ ++LLT T PFV
Sbjct: 189 ELRE--------------IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234

Query: 227 GSRD-RLFQSITKGKL 241
           G  +   + +I++  +
Sbjct: 235 GEDNQETYLNISQVNV 250

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 41.9 bits (99), Expect = 9e-05
 Identities = 8/56 (14%), Positives = 20/56 (35%), Gaps = 2/56 (3%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREA 56
           +L  +P KR T    ++H WL+        +          +   ++  +   + +
Sbjct: 271 LLVKNPEKRPTAEICLSHSWLQQ--WDFENLFHPEETSSSSQTQDHSVRSSEDKTS 324

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  183 bits (466), Expect = 5e-56
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 26/202 (12%)

Query: 50  ADLKREATI-CHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
              +RE  +     + PH+V +++ Y    +    L +V E +DG ++   I  R     
Sbjct: 99  PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA- 157

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
            ++E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A +   
Sbjct: 158 -FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                         TT       TP+Y+APEV+  +KY K  D+W+ GV++++LL G  P
Sbjct: 217 HNS----------LTTPC----YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

Query: 225 FVGSR-----DRLFQSITKGKL 241
           F  +        +   I  G+ 
Sbjct: 263 FYSNHGLAISPGMKTRIRMGQY 284

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 43.2 bits (102), Expect = 3e-05
 Identities = 9/22 (40%), Positives = 15/22 (68%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L  +P +R+TI E +NH W+ 
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIM 326

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  181 bits (460), Expect = 2e-55
 Identities = 50/193 (25%), Positives = 100/193 (51%), Gaps = 21/193 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSEA 109
           ++K E ++ + L H ++++L + + S+  + +V EY+DG ++ F+ I+      +  +E 
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL-FDRIIDE---SYNLTEL 187

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
               +M+Q+ E +R+ H+  I+H D+KP  +L  N++    +K+  FG+A + +  +   
Sbjct: 188 DTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLK 246

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR 229
                            GTP ++APEV+       P D+W+ GV+ ++LL+G  PF+G  
Sbjct: 247 V--------------NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN 292

Query: 230 DR-LFQSITKGKL 241
           D     +I   + 
Sbjct: 293 DAETLNNILACRW 305

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 40.5 bits (95), Expect = 3e-04
 Identities = 7/24 (29%), Positives = 12/24 (50%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMK 24
           +L  + + RI+  E + H WL   
Sbjct: 326 LLIKEKSWRISASEALKHPWLSDH 349

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  179 bits (457), Expect = 2e-55
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 27/202 (13%)

Query: 50  ADLKREATI-CHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGF 104
              ++E          PH+V +L+ Y      +  L ++ E M+G ++   I  R     
Sbjct: 66  PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA- 124

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
            ++E  A+  MR +  A+++ H ++I HRD+KP  +L  +KE  A +KL  FG A +   
Sbjct: 125 -FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
             L            T       TP+Y+APEV+  +KY K  D+W+ GV++++LL G  P
Sbjct: 184 NAL-----------QTPC----YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

Query: 225 FVGSRDR-----LFQSITKGKL 241
           F  +  +     + + I  G+ 
Sbjct: 229 FYSNTGQAISPGMKRRIRLGQY 250

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 42.3 bits (100), Expect = 7e-05
 Identities = 9/22 (40%), Positives = 15/22 (68%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L  DP +R+TI + +NH W+ 
Sbjct: 271 LLKTDPTERLTITQFMNHPWIN 292

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  177 bits (452), Expect = 6e-55
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 32/216 (14%)

Query: 48  TEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
             + + RE  + +  + H +V+EL+E +  E   Y+VFE M G  I   I +R      +
Sbjct: 53  IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH----F 108

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           +E  AS  ++ V  AL + H   I HRD+KP  +L  +    +PVK+  F +   ++   
Sbjct: 109 NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG 168

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----KYGKPVDIWAAGVLLHVLLTG 221
                       T +     G+  YMAPEV+E        Y K  D+W+ GV+L++LL+G
Sbjct: 169 DCS------PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

Query: 222 TLPFVG----------------SRDRLFQSITKGKL 241
             PFVG                 ++ LF+SI +GK 
Sbjct: 223 YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 42.3 bits (100), Expect = 7e-05
 Identities = 6/22 (27%), Positives = 14/22 (63%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L  D  +R++  +V+ H W++
Sbjct: 279 LLVRDAKQRLSAAQVLQHPWVQ 300

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  181 bits (462), Expect = 5e-54
 Identities = 57/192 (29%), Positives = 92/192 (47%), Gaps = 19/192 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
            +++E     +L+HP +V L + +  +  + M++E+M G ++ FE  + A      SE  
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL-FE--KVADEHNKMSEDE 256

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  YMRQV + L + HEN+ +H D+KP  ++   K  S  +KL  FG+   L   Q    
Sbjct: 257 AVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQSV-- 313

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
                           GT  + APEV E +  G   D+W+ GVL ++LL+G  PF G  D
Sbjct: 314 ------------KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361

Query: 231 R-LFQSITKGKL 241
               +++     
Sbjct: 362 DETLRNVKSCDW 373

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 43.3 bits (102), Expect = 5e-05
 Identities = 15/58 (25%), Positives = 23/58 (39%), Gaps = 5/58 (8%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATI 58
           +L  DPN R+TIH+ + H WL        + +     +P  R          K +A  
Sbjct: 394 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ-----IPSSRYTKIRDSIKTKYDAWP 446

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  174 bits (443), Expect = 6e-53
 Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 31/202 (15%)

Query: 49  EADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVY 106
               +RE  I   +  HPH++ L+++Y S   +++VF+ M   ++ F+ +  +       
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-FDYLTEKVA----L 197

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           SE      MR +LEA+ + H N+I+HRD+KP  +LL +      ++L  FG +  L+ G+
Sbjct: 198 SEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDN---MQIRLSDFGFSCHLEPGE 254

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE------DQKYGKPVDIWAAGVLLHVLLT 220
                               GTP Y+APE+++         YGK VD+WA GV+L  LL 
Sbjct: 255 K----------LRELC----GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

Query: 221 GTLPFVGSRD-RLFQSITKGKL 241
           G+ PF   R   + + I +G+ 
Sbjct: 301 GSPPFWHRRQILMLRMIMEGQY 322

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 42.8 bits (101), Expect = 5e-05
 Identities = 7/22 (31%), Positives = 13/22 (59%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L VDP  R+T  + + H + +
Sbjct: 343 LLQVDPEARLTAEQALQHPFFE 364

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  171 bits (436), Expect = 1e-52
 Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 31/202 (15%)

Query: 49  EADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVY 106
                +E  I   +  HP++++L +TY +    ++VF+ M   ++ F+ +  + T     
Sbjct: 67  REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-FDYLTEKVT----L 121

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           SE      MR +LE +   H+ +I+HRD+KP  +LL +      +KL  FG + QL  G+
Sbjct: 122 SEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD---MNIKLTDFGFSCQLDPGE 178

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE------DQKYGKPVDIWAAGVLLHVLLT 220
                               GTP Y+APE+IE         YGK VD+W+ GV+++ LL 
Sbjct: 179 K----------LREVC----GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 224

Query: 221 GTLPFVGSRD-RLFQSITKGKL 241
           G+ PF   +   + + I  G  
Sbjct: 225 GSPPFWHRKQMLMLRMIMSGNY 246

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 9/33 (27%), Positives = 14/33 (42%), Gaps = 2/33 (6%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEP 33
            L V P KR T  E + H + +   +   E+  
Sbjct: 267 FLVVQPQKRYTAEEALAHPFFQQ--YVVEEVRH 297

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  164 bits (418), Expect = 2e-49
 Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 31/216 (14%)

Query: 39  PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVR 98
            +++++  +   D K E  I   +K+ + +      ++   +Y+++EYM+   I      
Sbjct: 77  NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY 136

Query: 99  R----ATAGFVYSEAVASHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKL 153
                          V    ++ VL +  Y H E +I HRD+KP  +L+        VKL
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR---VKL 193

Query: 154 GGFGVAIQLQDGQLY--CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK--YGKPVDIW 209
             FG +  + D ++                     GT  +M PE   ++    G  VDIW
Sbjct: 194 SDFGESEYMVDKKIKGSR-----------------GTYEFMPPEFFSNESSYNGAKVDIW 236

Query: 210 AAGVLLHVLLTGTLPFVGSRD--RLFQSITKGKLHI 243
           + G+ L+V+    +PF        LF +I    +  
Sbjct: 237 SLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEY 272

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 8/22 (36%), Positives = 13/22 (59%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
            L  +P +RIT  + + H+WL 
Sbjct: 306 FLRKNPAERITSEDALKHEWLA 327

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  161 bits (410), Expect = 6e-49
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 27/206 (13%)

Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
            +L     E  L+RE  I   L+HP+++ +   +     +Y++ E+    ++  E+ +  
Sbjct: 50  SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG 109

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                + E  ++ +M ++ +AL YCHE  +IHRDIKP  +L+  K     +K+  FG ++
Sbjct: 110 R----FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSV 162

Query: 161 QLQDGQLY--CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
                +    C                 GT  Y+ PE+IE + + + VD+W AGVL +  
Sbjct: 163 HAPSLRRRTMC-----------------GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEF 205

Query: 219 LTGTLPFVG-SRDRLFQSITKGKLHI 243
           L G  PF   S     + I    L  
Sbjct: 206 LVGMPPFDSPSHTETHRRIVNVDLKF 231

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  162 bits (412), Expect = 7e-49
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 31/205 (15%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
             RE  +   L H ++V+L             ++ E+     + + ++   +  +   E+
Sbjct: 54  QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL-YTVLEEPSNAYGLPES 112

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLA-NKENSAPVKLGGFGVAIQLQDGQLY 168
                +R V+  + +  EN I+HR+IKP  ++    ++  +  KL  FG A +L+D + +
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIE--------DQKYGKPVDIWAAGVLLHVLLT 220
            S                GT  Y+ P++ E         +KYG  VD+W+ GV  +   T
Sbjct: 173 VS--------------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 221 GTLPFVGSRD-----RLFQSITKGK 240
           G+LPF           +   I  GK
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGK 243

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  160 bits (406), Expect = 2e-48
 Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 27/206 (13%)

Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
            +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ + +
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                + E   + Y+ ++  AL YCH   +IHRDIKP  +LL +      +K+  FG ++
Sbjct: 105 K----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSV 157

Query: 161 QLQDGQLY--CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
                +    C                 GT  Y+ PE+IE + + + VD+W+ GVL +  
Sbjct: 158 HAPSSRRTDLC-----------------GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200

Query: 219 LTGTLPFVG-SRDRLFQSITKGKLHI 243
           L G  PF   +    ++ I++ +   
Sbjct: 201 LVGKPPFEANTYQETYKRISRVEFTF 226

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  167 bits (425), Expect = 3e-48
 Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 22/199 (11%)

Query: 52  LKREATICHMLKHPHVVELLETYSSE------GMLYMVFEYMDGSDICFEIVRRATAGFV 105
              E  I   L HP+VV   E            +  +  EY +G D+  + + +      
Sbjct: 59  WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL-RKYLNQFENCCG 117

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
             E      +  +  ALRY HEN IIHRD+KP  ++L         K+   G A +L  G
Sbjct: 118 LKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 177

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           +L                  +GT  Y+APE++E +KY   VD W+ G L    +TG  PF
Sbjct: 178 ELCTE--------------FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

Query: 226 VG-SRDRLFQSITKGKLHI 243
           +   +   +    + K + 
Sbjct: 224 LPNWQPVQWHGKVREKSNE 242

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  162 bits (412), Expect = 4e-48
 Identities = 47/205 (22%), Positives = 85/205 (41%), Gaps = 31/205 (15%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEG--MLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
             RE  +   L H ++V+L             ++ E+     + + ++   +  +   E+
Sbjct: 54  QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL-YTVLEEPSNAYGLPES 112

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLL-ANKENSAPVKLGGFGVAIQLQDGQLY 168
                +R V+  + +  EN I+HR+IKP  ++    ++  +  KL  FG A +L+D + +
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIE--------DQKYGKPVDIWAAGVLLHVLLT 220
            S                GT  Y+ P++ E         +KYG  VD+W+ GV  +   T
Sbjct: 173 VS--------------LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

Query: 221 GTLPFVGSRD-----RLFQSITKGK 240
           G+LPF           +   I  GK
Sbjct: 219 GSLPFRPFEGPRRNKEVMYKIITGK 243

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  159 bits (404), Expect = 6e-48
 Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 27/231 (11%)

Query: 19  KWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLE--TYSS 76
           K ++            +   P   +        + +E  I   L HP+VV+L+E     +
Sbjct: 50  KLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPN 109

Query: 77  EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIK 136
           E  LYMVFE ++   +  E+          SE  A  Y + +++ + Y H   IIHRDIK
Sbjct: 110 EDHLYMVFELVNQGPV-MEVPTLKP----LSEDQARFYFQDLIKGIEYLHYQKIIHRDIK 164

Query: 137 PHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEV 196
           P  +L+    +   +K+  FGV+ + +            D   +      GTP +MAPE 
Sbjct: 165 PSNLLVGEDGH---IKIADFGVSNEFKGS----------DALLSNTV---GTPAFMAPES 208

Query: 197 IEDQK--Y-GKPVDIWAAGVLLHVLLTGTLPFVGSR-DRLFQSITKGKLHI 243
           + + +  + GK +D+WA GV L+  + G  PF+  R   L   I    L  
Sbjct: 209 LSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 8/22 (36%), Positives = 12/22 (54%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML  +P  RI + E+  H W+ 
Sbjct: 276 MLDKNPESRIVVPEIKLHPWVT 297

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  162 bits (412), Expect = 8e-48
 Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 21/188 (11%)

Query: 51  DLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
              RE  +     +HP+V+    T       Y+  E    +    E V +    F +   
Sbjct: 63  FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT--LQEYVEQK--DFAHLGL 118

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP--VKLGGFGVAIQLQDGQL 167
                ++Q    L + H  +I+HRD+KPH +L++           +  FG+  +L  G+ 
Sbjct: 119 EPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR- 177

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLT-GTL 223
                    H  ++     GT  ++APE++ +   +     VDI++AG + + +++ G+ 
Sbjct: 178 ---------HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

Query: 224 PFVGSRDR 231
           PF  S  R
Sbjct: 229 PFGKSLQR 236

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 40.1 bits (94), Expect = 4e-04
 Identities = 7/22 (31%), Positives = 13/22 (59%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           M+++DP KR +   V+ H +  
Sbjct: 267 MIAMDPQKRPSAKHVLKHPFFW 288

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  158 bits (401), Expect = 1e-47
 Identities = 64/198 (32%), Positives = 92/198 (46%), Gaps = 24/198 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETY--SSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
            L  E  +   LKHP++V   +     +   LY+V EY +G D+   I +         E
Sbjct: 51  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110

Query: 109 AVASHYMRQVLEALRYCHE-----NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
                 M Q+  AL+ CH      + ++HRD+KP  V L  K+N   VKLG FG+A  L 
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARIL- 166

Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL 223
                       +H T+ A   +GTP+YM+PE +    Y +  DIW+ G LL+ L     
Sbjct: 167 ------------NHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214

Query: 224 PFVG-SRDRLFQSITKGK 240
           PF   S+  L   I +GK
Sbjct: 215 PFTAFSQKELAGKIREGK 232

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  159 bits (404), Expect = 2e-47
 Identities = 58/191 (30%), Positives = 89/191 (46%), Gaps = 19/191 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           + +RE  +   +KHP++V+  E++   G LY+V +Y +G D+   I  +    F   E  
Sbjct: 69  ESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF--QEDQ 126

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              +  Q+  AL++ H+  I+HRDIK   + L        V+LG FG+A  L        
Sbjct: 127 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNST----- 178

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR 229
                      A   IGTP+Y++PE+ E++ Y    DIWA G +L+ L T    F   S 
Sbjct: 179 --------VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230

Query: 230 DRLFQSITKGK 240
             L   I  G 
Sbjct: 231 KNLVLKIISGS 241

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  158 bits (401), Expect = 4e-47
 Identities = 64/197 (32%), Positives = 102/197 (51%), Gaps = 29/197 (14%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
           L RE  I  +L HP++V+L E   +E  LY++ EY  G ++   +V     G +  E  A
Sbjct: 61  LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH---GRM-KEKEA 116

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL---Y 168
               RQ++ A++YCH+  I+HRD+K   +LL    N   +K+  FG + +   G     +
Sbjct: 117 RSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVGGKLDAF 173

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG 227
           C                 G P Y APE+ + +KY G  VD+W+ GV+L+ L++G+LPF G
Sbjct: 174 C-----------------GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216

Query: 228 SRDR-LFQSITKGKLHI 243
              + L + + +GK  I
Sbjct: 217 QNLKELRERVLRGKYRI 233

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 42.7 bits (101), Expect = 4e-05
 Identities = 6/25 (24%), Positives = 14/25 (56%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKL 25
            L ++P KR T+ +++  +W+    
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGH 272

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  157 bits (400), Expect = 4e-47
 Identities = 53/193 (27%), Positives = 80/193 (41%), Gaps = 19/193 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D  +E  +   L HP+V++   ++  +  L +V E  D  D+   I        +  E  
Sbjct: 78  DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 137

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y  Q+  AL + H   ++HRDIKP  V +        VKLG  G+            
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGRFFS------- 187

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--- 227
                   TT A   +GTP+YM+PE I +  Y    DIW+ G LL+ +     PF G   
Sbjct: 188 ------SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM 241

Query: 228 SRDRLFQSITKGK 240
           +   L + I +  
Sbjct: 242 NLYSLCKKIEQCD 254

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  157 bits (398), Expect = 5e-47
 Identities = 43/208 (20%), Positives = 78/208 (37%), Gaps = 24/208 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETY-------------SSEGMLYMVFEYMDGSDICFE 95
            + +  E  +   L H +VV     +               +  L++  EY +   +   
Sbjct: 46  LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL 105

Query: 96  IVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
           I                   RQ+LEAL Y H   IIHRD+KP  + +    N   VK+G 
Sbjct: 106 IHSE---NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---VKIGD 159

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGH-RIGTPHYMAPEVIEDQK-YGKPVDIWAAGV 213
           FG+A  +           +    ++      IGT  Y+A EV++    Y + +D+++ G+
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219

Query: 214 LLHVLLTGTLPFVGS-RDRLFQSITKGK 240
           +   ++       G  R  + + +    
Sbjct: 220 IFFEMIYP--FSTGMERVNILKKLRSVS 245

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 41.5 bits (98), Expect = 1e-04
 Identities = 9/28 (32%), Positives = 14/28 (50%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTS 28
           ++  DPNKR     ++N  WL +K    
Sbjct: 267 LIDHDPNKRPGARTLLNSGWLPVKHQDE 294

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  156 bits (396), Expect = 6e-47
 Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 20/207 (9%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           +  + +        ++ E  I   LKHP ++EL   +     +Y+V E     ++   + 
Sbjct: 44  IDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK 103

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
            R      +SE  A H+M Q++  + Y H + I+HRD+    +LL    N   +K+  FG
Sbjct: 104 NR---VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFG 157

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A QL+         E+   YT       GTP+Y++PE+     +G   D+W+ G + + 
Sbjct: 158 LATQLK------MPHEKH--YTL-----CGTPNYISPEIATRSAHGLESDVWSLGCMFYT 204

Query: 218 LLTGTLPFVG-SRDRLFQSITKGKLHI 243
           LL G  PF   +       +      +
Sbjct: 205 LLIGRPPFDTDTVKNTLNKVVLADYEM 231

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  156 bits (396), Expect = 3e-46
 Identities = 44/209 (21%), Positives = 84/209 (40%), Gaps = 39/209 (18%)

Query: 52  LKREATICHMLKHP--HVVELLETYSSEGMLYMVFEYMDGS--DICFEIVRRATAGFVYS 107
            + E    + L+     ++ L +   ++  +YMV E  +         + ++ +      
Sbjct: 54  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSW---LKKKKS----ID 106

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
                 Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q    
Sbjct: 107 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQP--- 159

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----------KYGKPVDIWAAGVLLH 216
                   D  +     ++GT +YM PE I+D            K     D+W+ G +L+
Sbjct: 160 --------DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211

Query: 217 VLLTGTLPFVGSRDRL--FQSITKGKLHI 243
            +  G  PF    +++    +I      I
Sbjct: 212 YMTYGKTPFQQIINQISKLHAIIDPNHEI 240

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 9/35 (25%), Positives = 21/35 (60%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPAS 35
            L  DP +RI+I E++ H +++++ H   ++   +
Sbjct: 257 CLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 291

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  155 bits (393), Expect = 5e-46
 Identities = 43/207 (20%), Positives = 83/207 (40%), Gaps = 35/207 (16%)

Query: 52  LKREATICHMLKHP--HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
            + E    + L+     ++ L +   ++  +YMV E  +        +++  +       
Sbjct: 73  YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNID--LNSWLKKKKS---IDPW 127

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
               Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q      
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTT-- 181

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----------KYGKPVDIWAAGVLLHVL 218
                    +     ++GT +YM PE I+D            K     D+W+ G +L+ +
Sbjct: 182 ---------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232

Query: 219 LTGTLPFVGSRDRL--FQSITKGKLHI 243
             G  PF    +++    +I      I
Sbjct: 233 TYGKTPFQQIINQISKLHAIIDPNHEI 259

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 9/35 (25%), Positives = 21/35 (60%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPAS 35
            L  DP +RI+I E++ H +++++ H   ++   +
Sbjct: 276 CLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 310

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  154 bits (392), Expect = 1e-45
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           +P   L        +  E +I   L H HVV     +     +++V E      +     
Sbjct: 74  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 133

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           RR       +E  A +Y+RQ++   +Y H N +IHRD+K   + L        VK+G FG
Sbjct: 134 RRKA----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFG 186

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A +++        GER            GTP+Y+APEV+  + +   VD+W+ G +++ 
Sbjct: 187 LATKVE------YDGERK--KVL-----CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 233

Query: 218 LLTGTLPFVGSR-DRLFQSITKGKLHI 243
           LL G  PF  S     +  I K +  I
Sbjct: 234 LLVGKPPFETSCLKETYLRIKKNEYSI 260

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 42.3 bits (100), Expect = 7e-05
 Identities = 13/50 (26%), Positives = 22/50 (44%), Gaps = 5/50 (10%)

Query: 1   MLSVDPNKRITIHEVINHKWLKM-----KLHTSAEIEPASFGLPDERLNH 45
           ML  DP  R TI+E++N ++        +L  +    P  F +    L+ 
Sbjct: 275 MLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDP 324

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  151 bits (385), Expect = 5e-45
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 21/207 (10%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           +P   L        +  E +I   L H HVV     +     +++V E      +     
Sbjct: 48  VPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHK 107

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           RR       +E  A +Y+RQ++   +Y H N +IHRD+K   + L        VK+G FG
Sbjct: 108 RRKA----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFG 160

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +A +++        GER            GTP+Y+APEV+  + +   VD+W+ G +++ 
Sbjct: 161 LATKVE------YDGERK--KVL-----CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYT 207

Query: 218 LLTGTLPFVGSR-DRLFQSITKGKLHI 243
           LL G  PF  S     +  I K +  I
Sbjct: 208 LLVGKPPFETSCLKETYLRIKKNEYSI 234

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 39.9 bits (94), Expect = 3e-04
 Identities = 12/45 (26%), Positives = 20/45 (44%), Gaps = 5/45 (11%)

Query: 1   MLSVDPNKRITIHEVINHKWLKM-----KLHTSAEIEPASFGLPD 40
           ML  DP  R TI+E++N ++        +L  +    P  F +  
Sbjct: 249 MLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAP 293

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  152 bits (385), Expect = 6e-45
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 36/199 (18%)

Query: 52  LKREATICHMLKH--PHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSE 108
           +  E  +   +      V+ LL+ +       ++ E  +     F+ I  R   G +  E
Sbjct: 93  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER---GAL-QE 148

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLL-ANKENSAPVKLGGFGVAIQLQDGQL 167
            +A  +  QVLEA+R+CH   ++HRDIK   +L+  N+     +KL  FG    L+D   
Sbjct: 149 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLIDFGSGALLKDTVY 205

Query: 168 --YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLP 224
             +                  GT  Y  PE I   +Y G+   +W+ G+LL+ ++ G +P
Sbjct: 206 TDFD-----------------GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

Query: 225 FVGSRDRLFQSITKGKLHI 243
           F    +     I +G++  
Sbjct: 249 FEHDEE-----IIRGQVFF 262

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 11/41 (26%), Positives = 17/41 (41%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE 41
            L++ P+ R T  E+ NH W++  L      E     L   
Sbjct: 277 CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPG 317

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  150 bits (382), Expect = 9e-45
 Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 31/212 (14%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-I 96
           L  +++        +KRE     + +HPH+++L +  S+    +MV EY+ G ++ F+ I
Sbjct: 44  LNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGEL-FDYI 102

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
            +    G V  E  A    +Q+L A+ YCH + ++HRD+KP  VLL    N    K+  F
Sbjct: 103 CKH---GRV-EEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADF 155

Query: 157 GVAIQLQDGQL---YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAG 212
           G++  + DG+     C                 G+P+Y APEVI  + Y G  VDIW+ G
Sbjct: 156 GLSNMMSDGEFLRTSC-----------------GSPNYAAPEVISGRLYAGPEVDIWSCG 198

Query: 213 VLLHVLLTGTLPFVGSR-DRLFQSITKGKLHI 243
           V+L+ LL GTLPF       LF+ I  G  +I
Sbjct: 199 VILYALLCGTLPFDDEHVPTLFKKIRGGVFYI 230

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 43.0 bits (102), Expect = 3e-05
 Identities = 13/25 (52%), Positives = 16/25 (64%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKL 25
           ML VDP KR TI ++  H+W K  L
Sbjct: 245 MLQVDPLKRATIKDIREHEWFKQDL 269

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  153 bits (389), Expect = 9e-45
 Identities = 42/209 (20%), Positives = 82/209 (39%), Gaps = 39/209 (18%)

Query: 52  LKREATICHMLKHP--HVVELLETYSSEGMLYMVFEYMDGS--DICFEIVRRATAGFVYS 107
            + E    + L+     ++ L +   ++  +YMV E  +         + ++ +      
Sbjct: 101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSW---LKKKKS----ID 153

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
                 Y + +LEA+   H++ I+H D+KP   L+ +      +KL  FG+A Q+Q    
Sbjct: 154 PWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTT 209

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----------KYGKPVDIWAAGVLLH 216
                      +     ++G  +YM PE I+D            K     D+W+ G +L+
Sbjct: 210 -----------SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258

Query: 217 VLLTGTLPFVGSRDRL--FQSITKGKLHI 243
            +  G  PF    +++    +I      I
Sbjct: 259 YMTYGKTPFQQIINQISKLHAIIDPNHEI 287

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 42.1 bits (99), Expect = 1e-04
 Identities = 9/35 (25%), Positives = 21/35 (60%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPAS 35
            L  DP +RI+I E++ H +++++ H   ++   +
Sbjct: 304 CLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGT 338

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  149 bits (379), Expect = 5e-44
 Identities = 48/201 (23%), Positives = 85/201 (42%), Gaps = 38/201 (18%)

Query: 52  LKREATICHML----KHPHVVELLETYSSEGMLYMVFEY-MDGSDICFE-IVRRATAGFV 105
              E  +   +     HP V+ LL+ + ++    +V E  +   D+ F+ I  +   G +
Sbjct: 81  CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL-FDYITEK---GPL 136

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
             E  +  +  QV+ A+++CH   ++HRDIK   +L+  +      KL  FG    L D 
Sbjct: 137 -GEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC--AKLIDFGSGALLHDE 193

Query: 166 QL--YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGT 222
               +                  GT  Y  PE I   +Y   P  +W+ G+LL+ ++ G 
Sbjct: 194 PYTDFD-----------------GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

Query: 223 LPFVGSRDRLFQSITKGKLHI 243
           +PF   ++     I + +LH 
Sbjct: 237 IPFERDQE-----ILEAELHF 252

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 43.1 bits (102), Expect = 3e-05
 Identities = 5/23 (21%), Positives = 13/23 (56%)

Query: 1   MLSVDPNKRITIHEVINHKWLKM 23
            L+  P+ R ++ E++   W++ 
Sbjct: 267 CLAPKPSSRPSLEEILLDPWMQT 289

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  148 bits (377), Expect = 7e-44
 Identities = 51/202 (25%), Positives = 85/202 (42%), Gaps = 49/202 (24%)

Query: 51  DLKREATI-CHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFE-IVRRATAGF 104
             +RE  +     + PH+V +++ Y    +    L +V E +DG ++ F  I  R     
Sbjct: 56  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL-FSRIQDRGDQA- 113

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
            ++E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG       
Sbjct: 114 -FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG------- 165

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                                       A E    +KY K  D+W+ GV++++LL G  P
Sbjct: 166 ---------------------------FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPP 197

Query: 225 FVGSR-----DRLFQSITKGKL 241
           F  +        +   I  G+ 
Sbjct: 198 FYSNHGLAISPGMKTRIRMGQY 219

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 42.7 bits (101), Expect = 4e-05
 Identities = 9/22 (40%), Positives = 15/22 (68%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L  +P +R+TI E +NH W+ 
Sbjct: 240 LLKTEPTQRMTITEFMNHPWIM 261

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  151 bits (382), Expect = 2e-43
 Identities = 42/214 (19%), Positives = 85/214 (39%), Gaps = 31/214 (14%)

Query: 51  DLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGS--DICFEIVRRATAGFVYS 107
               E  +      HP+V+    + +++  LY+  E  + +  D+            +  
Sbjct: 54  IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQK 113

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE----------NSAPVKLGGFG 157
           E      +RQ+   + + H   IIHRD+KP  +L++              +  + +  FG
Sbjct: 114 EYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-------QKYGKPVDIWA 210
           +  +L  GQ           + T   +  GT  + APE++E+       ++  + +DI++
Sbjct: 174 LCKKLDSGQ---------SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224

Query: 211 AGVLLHVLLT-GTLPFVGSRDRLFQSITKGKLHI 243
            G + + +L+ G  PF     R    I +G   +
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSRESN-IIRGIFSL 257

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 40.9 bits (96), Expect = 2e-04
 Identities = 8/22 (36%), Positives = 11/22 (50%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           M+  DP KR T  +V+ H    
Sbjct: 279 MIDHDPLKRPTAMKVLRHPLFW 300

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  147 bits (374), Expect = 5e-43
 Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 36/198 (18%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFE-YMDGSDICFE-IVRRATAGFVYSEA 109
           +  E  I   ++H +++++L+ + ++G   +V E +  G D+ F  I R         E 
Sbjct: 76  VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDL-FAFIDRHPR----LDEP 130

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL-- 167
           +AS+  RQ++ A+ Y    DIIHRDIK   +++A       +KL  FG A  L+ G+L  
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFGSAAYLERGKLFY 187

Query: 168 -YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPF 225
            +C                 GT  Y APEV+    Y G  +++W+ GV L+ L+    PF
Sbjct: 188 TFC-----------------GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF 230

Query: 226 VGSRDRLFQSITKGKLHI 243
                   +   +  +H 
Sbjct: 231 CE-----LEETVEAAIHP 243

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 41.6 bits (98), Expect = 1e-04
 Identities = 5/23 (21%), Positives = 12/23 (52%)

Query: 1   MLSVDPNKRITIHEVINHKWLKM 23
           +L   P +R T+ +++   W+  
Sbjct: 258 LLQPVPERRTTLEKLVTDPWVTQ 280

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  145 bits (369), Expect = 6e-43
 Identities = 48/207 (23%), Positives = 80/207 (38%), Gaps = 36/207 (17%)

Query: 51  DLKREATICHMLKHPHVVELLETY----------------SSEGMLYMVFEYMDGSDICF 94
             +RE      L H ++V     +                S    L++  E+ D   +  
Sbjct: 50  KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ 109

Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
            I +R        + +A     Q+ + + Y H   +I+RD+KP  + L + +    VK+G
Sbjct: 110 WIEKRRGEKL--DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---VKIG 164

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL 214
            FG+   L++                K     GT  YM+PE I  Q YGK VD++A G++
Sbjct: 165 DFGLVTSLKN--------------DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210

Query: 215 LHVLLTGTLPFVGSRDRLFQSITKGKL 241
           L  LL           + F  +  G +
Sbjct: 211 LAELLHVCDTAF-ETSKFFTDLRDGII 236

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  150 bits (380), Expect = 7e-43
 Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 31/209 (14%)

Query: 41  ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRR 99
           +++        ++RE     + +HPH+++L +  S+   ++MV EY+ G ++ F+ I + 
Sbjct: 52  QKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGEL-FDYICKN 110

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
              G +  E  +    +Q+L  + YCH + ++HRD+KP  VLL    N    K+  FG++
Sbjct: 111 ---GRL-DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLS 163

Query: 160 IQLQDGQL---YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLL 215
             + DG+     C                 G+P+Y APEVI  + Y G  VDIW++GV+L
Sbjct: 164 NMMSDGEFLRTSC-----------------GSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

Query: 216 HVLLTGTLPFVGSRDR-LFQSITKGKLHI 243
           + LL GTLPF       LF+ I  G  + 
Sbjct: 207 YALLCGTLPFDDDHVPTLFKKICDGIFYT 235

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 43.6 bits (103), Expect = 3e-05
 Identities = 13/25 (52%), Positives = 16/25 (64%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKL 25
           ML VDP KR TI ++  H+W K  L
Sbjct: 250 MLQVDPMKRATIKDIREHEWFKQDL 274

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  145 bits (369), Expect = 2e-42
 Identities = 40/204 (19%), Positives = 75/204 (36%), Gaps = 16/204 (7%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEG----MLYMVFEYMDGSDICFEIVRRATAGF 104
             + +REA +  +  HP+++ L+     E       +++  +     +  EI R    G 
Sbjct: 70  REEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN 129

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +E      +  +   L   H     HRD+KP  +LL ++       L   G   Q   
Sbjct: 130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQACI 186

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY---GKPVDIWAAGVLLHVLLTG 221
                     L  +  +      T  Y APE+   Q +    +  D+W+ G +L+ ++ G
Sbjct: 187 HVEGSRQALTLQDWAAQ----RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

Query: 222 TLPF--VGSRDRLFQSITKGKLHI 243
             P+  V  +        + +L I
Sbjct: 243 EGPYDMVFQKGDSVALAVQNQLSI 266

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  146 bits (370), Expect = 2e-42
 Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 32/212 (15%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-I 96
           +  + L        ++RE +   +L+HPH+++L +  ++   + MV EY  G    F+ I
Sbjct: 42  ISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGE--LFDYI 99

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
           V +     + +E     + +Q++ A+ YCH + I+HRD+KP  +LL +  N   VK+  F
Sbjct: 100 VEK---KRM-TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN---VKIADF 152

Query: 157 GVAIQLQDGQL---YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAG 212
           G++  + DG      C                 G+P+Y APEVI  + Y G  VD+W+ G
Sbjct: 153 GLSNIMTDGNFLKTSC-----------------GSPNYAAPEVINGKLYAGPEVDVWSCG 195

Query: 213 VLLHVLLTGTLPFVGSRDR-LFQSITKGKLHI 243
           ++L+V+L G LPF       LF+ +      +
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVM 227

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 44.2 bits (105), Expect = 1e-05
 Identities = 11/68 (16%), Positives = 22/68 (32%), Gaps = 2/68 (2%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKL--HTSAEIEPASFGLPDERLNHYTTEADLKREATI 58
           M+  DP +RITI E+    W  + L  +     E          ++          +  +
Sbjct: 242 MIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIV 301

Query: 59  CHMLKHPH 66
             +    +
Sbjct: 302 EALRSDEN 309

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  143 bits (363), Expect = 5e-42
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 23/196 (11%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSEAV 110
           +K+E  I  ML H +VV+         + Y+  EY  G ++ F+ I           E  
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPDI----GMPEPD 106

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +       
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN----- 158

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVGSR 229
             ERL +         GT  Y+APE+++ +++  +PVD+W+ G++L  +L G LP+    
Sbjct: 159 NRERLLN-KM-----CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

Query: 230 D--RLFQSITKGKLHI 243
           D  + +    + K ++
Sbjct: 213 DSCQEYSDWKEKKTYL 228

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 42.6 bits (101), Expect = 4e-05
 Identities = 8/25 (32%), Positives = 14/25 (56%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKL 25
           +L  +P+ RITI ++   +W    L
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPL 269

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  143 bits (362), Expect = 1e-41
 Identities = 47/196 (23%), Positives = 76/196 (38%), Gaps = 25/196 (12%)

Query: 49  EADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            A    E      + +HP  V L + +   G+LY+  E    S    +      A     
Sbjct: 100 RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPS--LQQHCEAWGASL--P 155

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           EA    Y+R  L AL + H   ++H D+KP  + L  +      KLG FG+ ++L     
Sbjct: 156 EAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGTAGA 212

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG-TLPFV 226
                            + G P YMAPE+++   YG   D+++ G+ +  +     LP  
Sbjct: 213 GEV--------------QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG 257

Query: 227 G-SRDRLFQSITKGKL 241
           G    +L Q     + 
Sbjct: 258 GEGWQQLRQGYLPPEF 273

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  141 bits (358), Expect = 9e-41
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 23/196 (11%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSEAV 110
           +K+E  I  ML H +VV+         + Y+  EY  G ++ F+ I        +  E  
Sbjct: 52  IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL-FDRIEPD---IGM-PEPD 106

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
           A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +       
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN----- 158

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVGSR 229
             ERL +         GT  Y+APE+++ +++  +PVD+W+ G++L  +L G LP+    
Sbjct: 159 NRERLLN-KM-----CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

Query: 230 D--RLFQSITKGKLHI 243
           D  + +    + K ++
Sbjct: 213 DSCQEYSDWKEKKTYL 228

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 43.1 bits (102), Expect = 4e-05
 Identities = 8/25 (32%), Positives = 14/25 (56%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKL 25
           +L  +P+ RITI ++   +W    L
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPL 269

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  142 bits (360), Expect = 9e-41
 Identities = 61/201 (30%), Positives = 93/201 (46%), Gaps = 31/201 (15%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE-IVRRATAGFVYSEAV 110
           ++RE      L+HP++V   E   +   L ++ EY  G ++ +E I         +SE  
Sbjct: 63  VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL-YERICNAGR----FSEDE 117

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGV-AIQLQDGQLY 168
           A  + +Q+L  + YCH   I HRD+K    LL    + AP +K+  FG     +   Q  
Sbjct: 118 ARFFFQQLLSGVSYCHSMQICHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP- 174

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG 227
                     +T     +GTP Y+APEV+  Q+Y GK  D+W+ GV L+V+L G  PF  
Sbjct: 175 ---------KST-----VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220

Query: 228 SRD-----RLFQSITKGKLHI 243
             +     +  Q I   K  I
Sbjct: 221 PEEPRDYRKTIQRILSVKYSI 241

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 46.2 bits (110), Expect = 4e-06
 Identities = 16/61 (26%), Positives = 25/61 (40%), Gaps = 3/61 (4%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLH---TSAEIEPASFGLPDERLNHYTTEADLKREAT 57
           +   DP  RI+I E+  H W    L     +     + F  P++ +    T   +  EAT
Sbjct: 258 IFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEAT 317

Query: 58  I 58
           I
Sbjct: 318 I 318

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  140 bits (356), Expect = 9e-41
 Identities = 59/200 (29%), Positives = 93/200 (46%), Gaps = 22/200 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           EA++K+E  +   L+H +V++L++   +E    +YMV EY        E++         
Sbjct: 50  EANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQ--EMLDSVPEKRF- 106

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
               A  Y  Q+++ L Y H   I+H+DIKP  +LL        +K+   GVA  L    
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAEALHPF- 162

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY--GKPVDIWAAGVLLHVLLTGTLP 224
              +  +     T+      G+P +  PE+        G  VDIW+AGV L+ + TG  P
Sbjct: 163 ---AADDTCR--TS-----QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

Query: 225 FVGSR-DRLFQSITKGKLHI 243
           F G    +LF++I KG   I
Sbjct: 213 FEGDNIYKLFENIGKGSYAI 232

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 43.0 bits (102), Expect = 4e-05
 Identities = 9/25 (36%), Positives = 14/25 (56%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKL 25
           ML  +P KR +I ++  H W + K 
Sbjct: 247 MLEYEPAKRFSIRQIRQHSWFRKKH 271

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  139 bits (353), Expect = 2e-40
 Identities = 47/205 (22%), Positives = 80/205 (39%), Gaps = 22/205 (10%)

Query: 51  DLKREATICHMLKHPHVVELLE------------TYSSEGMLYMVFEYMDGSDICFEIVR 98
            + RE      L+HP +V                  S +  LY+  +     ++  + + 
Sbjct: 49  KVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMN 107

Query: 99  RATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV 158
                     +V  H   Q+ EA+ + H   ++HRD+KP  +     +    VK+G FG+
Sbjct: 108 GRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGL 164

Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
              +   +   +    +  Y    G ++GT  YM+PE I    Y   VDI++ G++L  L
Sbjct: 165 VTAMDQDEEEQTVLTPMPAYARHTG-QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

Query: 219 LTGTLPFVGS--RDRLFQSITKGKL 241
           L    PF     R R    +   K 
Sbjct: 224 LY---PFSTQMERVRTLTDVRNLKF 245

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (352), Expect = 8e-40
 Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 16/178 (8%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYS 107
           E     E   C  L  P +V L         + +  E ++ GS    +++++        
Sbjct: 94  EVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS--LGQLIKQMGC---LP 148

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E  A +Y+ Q LE L Y H   I+H D+K   VLL++  + +   L  FG A+ LQ   L
Sbjct: 149 EDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS--DGSRAALCDFGHALCLQPDGL 206

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
             S                GT  +MAPEV+  +     VDIW++  ++  +L G  P+
Sbjct: 207 GKSLLTGDYI--------PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPW 256

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  138 bits (348), Expect = 4e-39
 Identities = 27/199 (13%), Positives = 64/199 (32%), Gaps = 22/199 (11%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV--RRATAGFVYSEA 109
             +             ++    +  +    +V E      +    +   + T   V  + 
Sbjct: 114 GTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL-LNAINLYKNTPEKVMPQG 172

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP--------VKLGGFGVAIQ 161
           +   +  ++L  +   H+ +IIH DIKP   +L N              + L   G +I 
Sbjct: 173 LVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSID 232

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           +           +L    T    +  T  +   E++ ++ +   +D +     ++ +L G
Sbjct: 233 M-----------KLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281

Query: 222 TLPFVGSRDRLFQSITKGK 240
           T   V +     +     +
Sbjct: 282 TYMKVKNEGGECKPEGLFR 300

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  133 bits (336), Expect = 7e-38
 Identities = 37/198 (18%), Positives = 68/198 (34%), Gaps = 36/198 (18%)

Query: 61  MLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE 120
           + +H HVV     ++ +  + +  EY +G  +   I         + EA     + QV  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 121 ALRYCHENDIIHRDIKPHCVLLANK----------------ENSAPVKLGGFGVAIQLQD 164
            LRY H   ++H DIKP  + ++                   N    K+G  G   ++  
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTL 223
            Q+                   G   ++A EV+ E+  +    DI+A  + +        
Sbjct: 187 PQVE-----------------EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP 229

Query: 224 PFVGSRDRLFQSITKGKL 241
                    +  I +G+L
Sbjct: 230 LP--RNGDQWHEIRQGRL 245

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  133 bits (337), Expect = 7e-38
 Identities = 50/192 (26%), Positives = 86/192 (44%), Gaps = 19/192 (9%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
            RE  +   L HP  V+L  T+  +  LY    Y    ++  + +R+      + E    
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL-LKYIRKIG---SFDETCTR 133

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG A  L          
Sbjct: 134 FYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSP-------- 182

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDR 231
              +    +A   +GT  Y++PE++ ++   K  D+WA G +++ L+ G  PF   +   
Sbjct: 183 ---ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239

Query: 232 LFQSITKGKLHI 243
           +FQ I K +   
Sbjct: 240 IFQKIIKLEYDF 251

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  130 bits (329), Expect = 9e-37
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 20/178 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
            L  E  +   LKH ++V+ L ++S  G + +  E +  GS     ++R        +E 
Sbjct: 65  PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGS--LSALLRSKWGPLKDNEQ 122

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
               Y +Q+LE L+Y H+N I+HRDIK   VL+        +K+  FG + +L       
Sbjct: 123 TIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV--LKISDFGTSKRLAGIN--- 177

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK--YGKPVDIWAAGVLLHVLLTGTLPF 225
                            GT  YMAPE+I+     YGK  DIW+ G  +  + TG  PF
Sbjct: 178 ----------PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  130 bits (329), Expect = 1e-36
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 19/175 (10%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           +REA     L+ PHVV + +    +G LY+    ++G D+   + R+         AV  
Sbjct: 82  QREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAV-- 137

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             +RQ+  AL   H     HRD+KP  +L++  +      L  FG+A    D +L     
Sbjct: 138 AIVRQIGSALDAAHAAGATHRDVKPENILVSADDF---AYLVDFGIASATTDEKL----- 189

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                  T+ G+ +GT +YMAPE   +       DI+A   +L+  LTG+ P+ G
Sbjct: 190 -------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  132 bits (335), Expect = 6e-36
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 24/194 (12%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +    VV L   Y ++  L +V   M+G D+ F I     AGF   EA A  Y
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGF--PEARAVFY 291

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             ++   L   H   I++RD+KP  +LL +  +   +++   G+A+ + +GQ        
Sbjct: 292 AAEICCGLEDLHRERIVYRDLKPENILLDDHGH---IRISDLGLAVHVPEGQ-------- 340

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-----SR 229
               T K   R+GT  YMAPEV+++++Y    D WA G LL+ ++ G  PF        R
Sbjct: 341 ----TIKG--RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394

Query: 230 DRLFQSITKGKLHI 243
           + + + + +     
Sbjct: 395 EEVERLVKEVPEEY 408

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  126 bits (318), Expect = 6e-35
 Identities = 45/193 (23%), Positives = 78/193 (40%), Gaps = 10/193 (5%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
               +          + V  L+  S +  LY+  +     ++   + RR +        V
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED-REHGV 165

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
             H   Q+ EA+ + H   ++HRD+KP  +     +    VK+G FG+   +   +   +
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQT 222

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-- 228
               +  Y T  G ++GT  YM+PE I    Y   VDI++ G++L  LL     F     
Sbjct: 223 VLTPMPAYATHTG-QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQME 278

Query: 229 RDRLFQSITKGKL 241
           R R+   +   K 
Sbjct: 279 RVRIITDVRNLKF 291

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  126 bits (318), Expect = 9e-35
 Identities = 55/190 (28%), Positives = 90/190 (47%), Gaps = 26/190 (13%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +  P +V+L  ++     LYMV EY+ G ++ F  +RR      +SE  A  Y
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIG---RFSEPHARFY 146

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG-QLYCSGGE 173
             Q++    Y H  D+I+RD+KP  +L+  +     +++  FG A +++      C    
Sbjct: 147 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKGRTWTLC---- 199

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRL 232
                        GTP  +APE+I  + Y K VD WA GVL++ +  G  PF      ++
Sbjct: 200 -------------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246

Query: 233 FQSITKGKLH 242
           ++ I  GK+ 
Sbjct: 247 YEKIVSGKVR 256

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  128 bits (324), Expect = 2e-34
 Identities = 53/194 (27%), Positives = 88/194 (45%), Gaps = 21/194 (10%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I   +    +V L   + ++  L +V   M+G DI + I         + E  A  Y
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             Q++  L + H+ +II+RD+KP  VLL +  N   V++   G+A++L+ GQ        
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKAGQ-------- 343

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-----SR 229
                TK     GTP +MAPE++  ++Y   VD +A GV L+ ++    PF         
Sbjct: 344 -----TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398

Query: 230 DRLFQSITKGKLHI 243
             L Q + +  +  
Sbjct: 399 KELKQRVLEQAVTY 412

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  126 bits (317), Expect = 2e-34
 Identities = 39/178 (21%), Positives = 78/178 (43%), Gaps = 15/178 (8%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
            L+ E  +  +  HP++V    T+ ++  L++V  +M  GS    +++         +E 
Sbjct: 72  FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS--AKDLICTHFMD-GMNEL 128

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
             ++ ++ VL+AL Y H    +HR +K   +L++       V L G    + +       
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMIS----- 180

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIE--DQKYGKPVDIWAAGVLLHVLLTGTLPF 225
             G+R         + +    +++PEV++   Q Y    DI++ G+    L  G +PF
Sbjct: 181 -HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  124 bits (314), Expect = 3e-34
 Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 29/197 (14%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
              E+ +    +HP +  L   + +   L  V EY +G ++ F + R      V++E  A
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERA 107

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL--- 167
             Y  +++ AL Y H  D+++RDIK   ++L    +   +K+  FG+    + DG     
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISDGATMKT 164

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
           +C                 GTP Y+APEV+ED  YG+ VD W  GV+++ ++ G LPF  
Sbjct: 165 FC-----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

Query: 228 -SRDRLFQSITKGKLHI 243
              +RLF+ I   ++  
Sbjct: 208 QDHERLFELILMEEIRF 224

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  123 bits (312), Expect = 3e-34
 Identities = 45/175 (25%), Positives = 87/175 (49%), Gaps = 19/175 (10%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           +RE      L H ++V +++    +   Y+V EY++G  +  E +           A+  
Sbjct: 59  EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLS-EYIESHGP-LSVDTAI-- 114

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
           ++  Q+L+ +++ H+  I+HRDIKP  +L+ + +    +K+  FG+A  L +  L     
Sbjct: 115 NFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFGIAKALSETSL----- 166

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                  T+  H +GT  Y +PE  + +   +  DI++ G++L+ +L G  PF G
Sbjct: 167 -------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  125 bits (315), Expect = 3e-34
 Identities = 24/202 (11%), Positives = 57/202 (28%), Gaps = 36/202 (17%)

Query: 58  ICHMLKHPHVVELLETYSSEGMLYMVFEYM----DGSDICFEIVRRATAGFVYSEAVASH 113
           +    +   ++ +        +L   F Y     +       ++  ++            
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              QV+  L   H   ++H  ++P  ++L  +     V L GF   ++     +      
Sbjct: 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG---VFLTGFEHLVRDGARVVSS---- 263

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-----------EDQKYGKPVDIWAAGVLLHVLLTGT 222
                         +  +  PE+                     D WA G++++ +    
Sbjct: 264 -------------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 223 LPFVGSRDR-LFQSITKGKLHI 243
           LP          + I +   +I
Sbjct: 311 LPITKDAALGGSEWIFRSCKNI 332

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  123 bits (311), Expect = 7e-34
 Identities = 50/209 (23%), Positives = 80/209 (38%), Gaps = 23/209 (11%)

Query: 49  EADLKREATICHMLK-HPHVVELL--------ETYSSEGMLYMVFEYMDGSDICFEIVRR 99
              + +E      L  HP++V+          E+ + +    ++ E   G  + F     
Sbjct: 69  NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME 128

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFG 157
           +      S         Q   A+++ H     IIHRD+K   +LL+N+     +KL  FG
Sbjct: 129 SRGPL--SCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDFG 183

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVL 214
            A  +     Y    +R      +   R  TP Y  PE+I+   +   G+  DIWA G +
Sbjct: 184 SATTISHYPDYSWSAQRRALVEEEIT-RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242

Query: 215 LHVLLTGTLPFVGSRDRLFQSITKGKLHI 243
           L++L     PF          I  GK  I
Sbjct: 243 LYLLCFRQHPFEDG---AKLRIVNGKYSI 268

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  123 bits (310), Expect = 1e-33
 Identities = 59/196 (30%), Positives = 102/196 (52%), Gaps = 29/196 (14%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           K E  I   +KHP +V+L+  + + G LY++ EY+ G ++  ++ R      ++ E  A 
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG----IFMEDTAC 124

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL---Y 168
            Y+ ++  AL + H+  II+RD+KP  ++L ++ +   VKL  FG+    + DG +   +
Sbjct: 125 FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLCKESIHDGTVTHTF 181

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG- 227
           C                 GT  YMAPE++    + + VD W+ G L++ +LTG  PF G 
Sbjct: 182 C-----------------GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224

Query: 228 SRDRLFQSITKGKLHI 243
           +R +    I K KL++
Sbjct: 225 NRKKTIDKILKCKLNL 240

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  121 bits (306), Expect = 3e-33
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 29/200 (14%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
               K E  I   + HP +V+L   + +EG LY++ +++ G D+   + +       ++E
Sbjct: 70  RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM----FTE 125

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL 167
                Y+ ++  AL + H   II+RD+KP  +LL  + +   +KL  FG++   +   + 
Sbjct: 126 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKESIDHEKK 182

Query: 168 ---YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
              +C                 GT  YMAPEV+  + + +  D W+ GVL+  +LTGTLP
Sbjct: 183 AYSFC-----------------GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

Query: 225 FVG-SRDRLFQSITKGKLHI 243
           F G  R      I K KL +
Sbjct: 226 FQGKDRKETMTMILKAKLGM 245

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  122 bits (309), Expect = 4e-33
 Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 28/198 (14%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
            +E  I   L+HP +V L  ++  E  ++MV + + G D+ + + +       + E    
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV----HFKEETVK 118

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            ++ +++ AL Y     IIHRD+KP  +LL    +   V +  F +A  L          
Sbjct: 119 LFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH---VHITDFNIAAMLPRETQ----- 170

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGVLLHVLLTGTLPFVG-- 227
                 TT A    GT  YMAPE+   +K   Y   VD W+ GV  + LL G  P+    
Sbjct: 171 -----ITTMA----GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221

Query: 228 --SRDRLFQSITKGKLHI 243
             S   +  +     +  
Sbjct: 222 STSSKEIVHTFETTVVTY 239

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  121 bits (306), Expect = 4e-33
 Identities = 57/178 (32%), Positives = 84/178 (47%), Gaps = 21/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L+H ++V LLE    +   Y+VFE++D   I  + +     G      V   
Sbjct: 73  REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD-HTIL-DDLELFPNGL--DYQVVQK 128

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q++  + +CH ++IIHRDIKP  +L++       VKL  FG A  L           
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFARTL---------AA 176

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
             + Y       + T  Y APE++  D KYGK VD+WA G L+  +  G   F G  D
Sbjct: 177 PGEVYD----DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  121 bits (305), Expect = 5e-33
 Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 26/190 (13%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  +  ++ HP ++ +  T+     ++M+ +Y++G ++ F ++R++     +   VA  Y
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQ---RFPNPVAKFY 111

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG-QLYCSGGE 173
             +V  AL Y H  DII+RD+KP  +LL    +   +K+  FG A  + D     C    
Sbjct: 112 AAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPDVTYTLC---- 164

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRL 232
                        GTP Y+APEV+  + Y K +D W+ G+L++ +L G  PF   +  + 
Sbjct: 165 -------------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211

Query: 233 FQSITKGKLH 242
           ++ I   +L 
Sbjct: 212 YEKILNAELR 221

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  121 bits (306), Expect = 7e-33
 Identities = 56/186 (30%), Positives = 93/186 (50%), Gaps = 29/186 (15%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
            HP + +L   + +   L+ V E+++G D+ F I +       + EA A  Y  +++ AL
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISAL 137

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL---YCSGGERLDHY 178
            + H+  II+RD+K   VLL ++ +    KL  FG+    + +G     +C         
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGICNGVTTATFC--------- 185

Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT 237
                   GTP Y+APE++++  YG  VD WA GVLL+ +L G  PF   + D LF++I 
Sbjct: 186 --------GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237

Query: 238 KGKLHI 243
             ++  
Sbjct: 238 NDEVVY 243

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  121 bits (305), Expect = 9e-33
 Identities = 59/186 (31%), Positives = 89/186 (47%), Gaps = 29/186 (15%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           K P + +L   + +   LY V EY++G D+ + I +       + E  A  Y  ++   L
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGL 134

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL---YCSGGERLDHY 178
            +     II+RD+K   V+L ++ +   +K+  FG+    + DG     +C         
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFC--------- 182

Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT 237
                   GTP Y+APE+I  Q YGK VD WA GVLL+ +L G  PF G   D LFQSI 
Sbjct: 183 --------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234

Query: 238 KGKLHI 243
           +  +  
Sbjct: 235 EHNVAY 240

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  122 bits (308), Expect = 1e-32
 Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 30/198 (15%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
              E  +    +HP +  L  ++ +   L  V EY +G ++ F + R      V+SE  A
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRA 250

Query: 112 SHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL-- 167
             Y  +++ AL Y H E ++++RD+K   ++L    +   +K+  FG+    ++DG    
Sbjct: 251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKEGIKDGATMK 307

Query: 168 -YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
            +C                 GTP Y+APEV+ED  YG+ VD W  GV+++ ++ G LPF 
Sbjct: 308 TFC-----------------GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350

Query: 227 G-SRDRLFQSITKGKLHI 243
               ++LF+ I   ++  
Sbjct: 351 NQDHEKLFELILMEEIRF 368

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  119 bits (301), Expect = 2e-32
 Identities = 57/178 (32%), Positives = 87/178 (48%), Gaps = 21/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   LKHP++V LLE +  +  L++VFEY D   +    + R   G    E +   
Sbjct: 51  REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD-HTV-LHELDRYQRGV--PEHLVKS 106

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q L+A+ +CH+++ IHRD+KP  +L+        +KL  FG A  L           
Sbjct: 107 ITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLL---------TG 154

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
             D+Y       + T  Y +PE++  D +YG PVD+WA G +   LL+G   + G  D
Sbjct: 155 PSDYYD----DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD 208

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (300), Expect = 2e-32
 Identities = 53/164 (32%), Positives = 74/164 (45%), Gaps = 21/164 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
           ++ +E +I      PHVV+   +Y     L++V EY   GS    +I+R        +E 
Sbjct: 70  EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS--VSDIIRLRNKTL--TED 125

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
             +  ++  L+ L Y H    IHRDIK   +LL         KL  FGVA QL D     
Sbjct: 126 EIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNT---EGHAKLADFGVAGQLTDTM--- 179

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGV 213
                      K    IGTP +MAPEVI++  Y    DIW+ G+
Sbjct: 180 ----------AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGI 213

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  120 bits (302), Expect = 2e-32
 Identities = 50/186 (26%), Positives = 86/186 (46%), Gaps = 29/186 (15%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           +HP +  +  T+ ++  L+ V EY++G D+ + I         +  + A+ Y  +++  L
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGL 131

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL---YCSGGERLDHY 178
           ++ H   I++RD+K   +LL    +   +K+  FG+    +        +C         
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENMLGDAKTNTFC--------- 179

Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT 237
                   GTP Y+APE++  QKY   VD W+ GVLL+ +L G  PF G   + LF SI 
Sbjct: 180 --------GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231

Query: 238 KGKLHI 243
                 
Sbjct: 232 MDNPFY 237

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  119 bits (300), Expect = 4e-32
 Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 38/195 (19%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
            HP +V L   + +E  L+ V EY++G D+ F + R+        E  A  Y  ++  AL
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLAL 123

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL---YCSGGERLDHY 178
            Y HE  II+RD+K   VLL ++ +   +KL  +G+    L+ G     +C         
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFC--------- 171

Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----------S 228
                   GTP+Y+APE++  + YG  VD WA GVL+  ++ G  PF            +
Sbjct: 172 --------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223

Query: 229 RDRLFQSITKGKLHI 243
            D LFQ I + ++ I
Sbjct: 224 EDYLFQVILEKQIRI 238

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  118 bits (297), Expect = 4e-32
 Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 20/182 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRA-----TAGF 104
           +L +E        HP++V    ++  +  L++V + +  GS    +I++           
Sbjct: 59  ELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS--VLDIIKHIVAKGEHKSG 116

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
           V  E+  +  +R+VLE L Y H+N  IHRD+K   +LL        V++  FGV+  L  
Sbjct: 117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLAT 173

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTL 223
           G        R     T     +GTP +MAPEV+E  + Y    DIW+ G+    L TG  
Sbjct: 174 GGDITRNKVR----KTF----VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225

Query: 224 PF 225
           P+
Sbjct: 226 PY 227

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  120 bits (302), Expect = 4e-32
 Identities = 21/196 (10%), Positives = 54/196 (27%), Gaps = 25/196 (12%)

Query: 58  ICHMLKHPHVVELLETYSSEGM----LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           +    +   ++ +        +            +       ++  ++            
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 215

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              QV+  L   H   ++H  ++P  ++L  +     V L GF   ++     +      
Sbjct: 216 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG---VFLTGFEHLVRDGASAV------ 266

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG- 227
                 +  G     P   A  ++              D W  G+ ++ +    LP    
Sbjct: 267 ------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320

Query: 228 SRDRLFQSITKGKLHI 243
           +     + I +   +I
Sbjct: 321 AALGGSEWIFRSCKNI 336

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (298), Expect = 8e-32
 Identities = 48/177 (27%), Positives = 81/177 (45%), Gaps = 25/177 (14%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
            + RE  + H    P++V     + S+G + +  E+MD GS    +++++A       E 
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS--LDQVLKKAG---RIPEQ 131

Query: 110 VASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           +       V++ L Y  E   I+HRD+KP  +L+ ++     +KL  FGV+ QL D    
Sbjct: 132 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID---- 184

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                      + A   +GT  YM+PE ++   Y    DIW+ G+ L  +  G  P 
Sbjct: 185 -----------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  118 bits (298), Expect = 1e-31
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 29/186 (15%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           KHP +V L  ++ +   LY V +Y++G ++ + + R       + E  A  Y  ++  AL
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASAL 152

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL---YCSGGERLDHY 178
            Y H  +I++RD+KP  +LL ++ +   + L  FG+    ++       +C         
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENIEHNSTTSTFC--------- 200

Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT 237
                   GTP Y+APEV+  Q Y + VD W  G +L+ +L G  PF   +   ++ +I 
Sbjct: 201 --------GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252

Query: 238 KGKLHI 243
              L +
Sbjct: 253 NKPLQL 258

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  119 bits (299), Expect = 1e-31
 Identities = 57/194 (29%), Positives = 85/194 (43%), Gaps = 25/194 (12%)

Query: 55  EATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHY 114
           E  I      P VV+L   +  +  LYMV EYM G D+   ++      +   E  A  Y
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL-VNLMSN----YDVPEKWARFY 173

Query: 115 MRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
             +V+ AL   H    IHRD+KP  +LL   + S  +KL  FG  +++            
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEG-------- 222

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQ----KYGKPVDIWAAGVLLHVLLTGTLPFVG-SR 229
                 +    +GTP Y++PEV++ Q     YG+  D W+ GV L+ +L G  PF   S 
Sbjct: 223 ----MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 278

Query: 230 DRLFQSITKGKLHI 243
              +  I   K  +
Sbjct: 279 VGTYSKIMNHKNSL 292

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  117 bits (295), Expect = 1e-31
 Identities = 51/171 (29%), Positives = 74/171 (43%), Gaps = 21/171 (12%)

Query: 43  LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATA 102
           L        L  E  I    +H +VVE+ ++Y     L+++ E++ G     +IV +   
Sbjct: 80  LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA-LTDIVSQVR- 137

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
               +E   +     VL+AL Y H   +IHRDIK   +LL        VKL  FG   Q+
Sbjct: 138 ---LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLD---GRVKLSDFGFCAQI 191

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGV 213
                             K    +GTP++MAPEVI    Y   VDIW+ G+
Sbjct: 192 SKDV-------------PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGI 229

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  116 bits (293), Expect = 2e-31
 Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 23/164 (14%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
           D+++E T+      P+V +   +Y  +  L+++ EY+  GS    +++          E 
Sbjct: 66  DIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS--ALDLLEPGP----LDET 119

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
             +  +R++L+ L Y H    IHRDIK   VLL+       VKL  FGVA QL D Q   
Sbjct: 120 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSE---HGEVKLADFGVAGQLTDTQ--- 173

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGV 213
                      K    +GTP +MAPEVI+   Y    DIW+ G+
Sbjct: 174 ----------IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGI 207

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  118 bits (298), Expect = 2e-31
 Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 26/189 (13%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
               + +L   +  E  LY+V EY  G D+   + +    G      +A  Y+ +++ A+
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAI 175

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
              H    +HRDIKP  +LL   +    ++L  FG  ++L+               T ++
Sbjct: 176 DSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADG------------TVRS 220

Query: 183 GHRIGTPHYMAPEVIEDQ-------KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQ 234
              +GTP Y++PE+++          YG   D WA GV  + +  G  PF   S    + 
Sbjct: 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG 280

Query: 235 SITKGKLHI 243
            I   K H+
Sbjct: 281 KIVHYKEHL 289

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  116 bits (293), Expect = 2e-31
 Identities = 49/179 (27%), Positives = 81/179 (45%), Gaps = 21/179 (11%)

Query: 53  KREATICHMLKHPHVVELL----ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           +REA     L HP +V +         +  + Y+V EY+DG  +  +IV         + 
Sbjct: 60  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR-DIVHTEGP---MTP 115

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             A   +    +AL + H+N IIHRD+KP  ++++       VK+  FG+A  + D    
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIARAIADSG-- 170

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                   +  T+    IGT  Y++PE           D+++ G +L+ +LTG  PF G
Sbjct: 171 --------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  116 bits (292), Expect = 2e-31
 Identities = 51/171 (29%), Positives = 79/171 (46%), Gaps = 21/171 (12%)

Query: 43  LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATA 102
           L     +  +  E  +    K+P++V  L++Y     L++V EY+ G     ++V     
Sbjct: 55  LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS-LTDVVTETC- 112

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                E   +   R+ L+AL + H N +IHRDIK   +LL        VKL  FG   Q+
Sbjct: 113 ---MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD---GSVKLTDFGFCAQI 166

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGV 213
              Q             +K    +GTP++MAPEV+  + YG  VDIW+ G+
Sbjct: 167 TPEQ-------------SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGI 204

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (303), Expect = 2e-31
 Identities = 42/209 (20%), Positives = 78/209 (37%), Gaps = 52/209 (24%)

Query: 40  DERLN---------HYTTEADL----KREATICHMLKHPHVVELL-----ETYSSEGMLY 81
           D  +N          ++ +A+       E      + HP +V++           + + Y
Sbjct: 101 DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160

Query: 82  MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL 141
           +V EY+ G  +     ++        EA+A  Y+ ++L AL Y H   +++ D+KP  ++
Sbjct: 161 IVMEYVGGQSLKRSKGQKLPVA----EAIA--YLLEILPALSYLHSIGLVYNDLKPENIM 214

Query: 142 LANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK 201
           L  ++    +KL   G   ++                    G+  GTP + APE++    
Sbjct: 215 LTEEQ----LKLIDLGAVSRI-----------------NSFGYLYGTPGFQAPEIVR--- 250

Query: 202 YGKPV---DIWAAGVLLHVLLTGTLPFVG 227
              P    DI+  G  L  L        G
Sbjct: 251 -TGPTVATDIYTVGRTLAALTLDLPTRNG 278

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  118 bits (297), Expect = 2e-31
 Identities = 60/195 (30%), Positives = 93/195 (47%), Gaps = 38/195 (19%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
            HP +V L   + +E  L+ V EY++G D+ F + R+        E  A  Y  ++  AL
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEISLAL 166

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL---YCSGGERLDHY 178
            Y HE  II+RD+K   VLL ++ +   +KL  +G+    L+ G     +C         
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGLRPGDTTSTFC--------- 214

Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----------S 228
                   GTP+Y+APE++  + YG  VD WA GVL+  ++ G  PF            +
Sbjct: 215 --------GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266

Query: 229 RDRLFQSITKGKLHI 243
            D LFQ I + ++ I
Sbjct: 267 EDYLFQVILEKQIRI 281

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (294), Expect = 3e-31
 Identities = 19/194 (9%), Positives = 47/194 (24%), Gaps = 25/194 (12%)

Query: 58  ICHMLKHPHVVELLETYSSEGM--LYMVFEYMDGS--DICFEIVRRATAGFVYSEAVASH 113
              +   P   +L        +    ++          +   +                 
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
              Q++          ++H    P  + +        + LG      ++         G 
Sbjct: 199 LTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR---LMLGDVSALWKV---------GT 246

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK--YGKPVDIWAAGVLLHVLLTGTLPFVGSRDR 231
           R    +           Y   E +      +   ++ W  G+ ++ +    LPF      
Sbjct: 247 RGPASS-------VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299

Query: 232 LFQSITKGKLHILG 245
           +  S  +  L + G
Sbjct: 300 IKGSWKRPSLRVPG 313

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  116 bits (293), Expect = 4e-31
 Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 27/166 (16%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+ +E      L+HP+ ++    Y  E   ++V EY  GS    +++          E  
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPL--QEVE 155

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            +      L+ L Y H +++IHRD+K   +LL+       VKLG FG A  +        
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIM-------- 204

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGV 213
                      A   +GTP++MAPEVI       Y   VD+W+ G+
Sbjct: 205 ---------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  119 bits (300), Expect = 5e-31
 Identities = 40/189 (21%), Positives = 77/189 (40%), Gaps = 27/189 (14%)

Query: 60  HMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVL 119
                P +V +   + +   L  + + M+G D+ + + +      V+SEA    Y  +++
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEII 302

Query: 120 EALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYT 179
             L + H   +++RD+KP  +LL    +   V++   G+A      +             
Sbjct: 303 LGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKK------------- 346

Query: 180 TKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGS----RDRLFQ 234
             A   +GT  YMAPEV++    Y    D ++ G +L  LL G  PF       +  + +
Sbjct: 347 PHA--SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 404

Query: 235 SITKGKLHI 243
                 + +
Sbjct: 405 MTLTMAVEL 413

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  115 bits (289), Expect = 6e-31
 Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 26/169 (15%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
           D   E  I     HP++V+LL  Y  +G L+++ E+   G+     I+     G   +E 
Sbjct: 62  DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA--VDAIMLELDRGL--TEP 117

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
                 RQ+LEAL + H   IIHRD+K   VL+        ++L  FGV+ +        
Sbjct: 118 QIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFGVSAKNLKTL--- 171

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIWAAGV 213
                      K    IGTP++MAPEV+     +D  Y    DIW+ G+
Sbjct: 172 ----------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGI 210

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  118 bits (298), Expect = 8e-31
 Identities = 59/186 (31%), Positives = 89/186 (47%), Gaps = 29/186 (15%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           K P + +L   + +   LY V EY++G D+ + I +       + E  A  Y  ++   L
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGL 455

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-IQLQDGQL---YCSGGERLDHY 178
            +     II+RD+K   V+L ++ +   +K+  FG+    + DG     +C         
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFC--------- 503

Query: 179 TTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT 237
                   GTP Y+APE+I  Q YGK VD WA GVLL+ +L G  PF G   D LFQSI 
Sbjct: 504 --------GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555

Query: 238 KGKLHI 243
           +  +  
Sbjct: 556 EHNVAY 561

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  114 bits (288), Expect = 1e-30
 Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 20/180 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI--CFEIVRRATAGFVYSEAVA 111
           RE ++   LKH ++V L +   +E  L +VFE+MD +D+    +              + 
Sbjct: 52  REISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLV 110

Query: 112 SHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
            ++  Q+L+ L +CHEN I+HRD+KP  +L+  +     +KLG FG+A          + 
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLA---------RAF 158

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
           G  ++ ++      + T  Y AP+V+   + Y   +DIW+ G +L  ++TG   F G+ D
Sbjct: 159 GIPVNTFS----SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  113 bits (286), Expect = 3e-30
 Identities = 54/178 (30%), Positives = 92/178 (51%), Gaps = 21/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L HP++V L++   SE  L +VFE+M+  D+  +++     G    ++    
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLK-KVLDENKTGL--QDSQIKI 123

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y+ Q+L  + +CH++ I+HRD+KP  +L+ +      +KL  FG+A          + G 
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLA---------RAFGI 171

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
            +  YT    H + T  Y AP+V+   +KY   VDIW+ G +   ++TG   F G  D
Sbjct: 172 PVRSYT----HEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD 225

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  113 bits (284), Expect = 3e-30
 Identities = 49/182 (26%), Positives = 81/182 (44%), Gaps = 30/182 (16%)

Query: 51  DLKREATICHMLKHPHVVELL----ETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFV 105
             K EA +   L+HP++V        T   +  + +V E M  G+      ++R      
Sbjct: 71  RFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGT--LKTYLKRFKV--- 125

Query: 106 YSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
               V   + RQ+L+ L++ H     IIHRD+K   + +     S  VK+G  G+A   +
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR 183

Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL 223
                           + A   IGTP +MAPE+ E +KY + VD++A G+ +  + T   
Sbjct: 184 A---------------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEY 227

Query: 224 PF 225
           P+
Sbjct: 228 PY 229

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  112 bits (284), Expect = 3e-30
 Identities = 51/178 (28%), Positives = 90/178 (50%), Gaps = 21/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE +I   LKH ++V+L +   ++  L +VFE++D  D+  +++     G       A  
Sbjct: 49  REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLK-KLLDVCEGGL--ESVTAKS 104

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ Q+L  + YCH+  ++HRD+KP  +L+  +     +K+  FG+A          + G 
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLA---------RAFGI 152

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
            +  YT    H I T  Y AP+V+   +KY   +DIW+ G +   ++ GT  F G  +
Sbjct: 153 PVRKYT----HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  115 bits (290), Expect = 3e-30
 Identities = 42/187 (22%), Positives = 83/187 (44%), Gaps = 24/187 (12%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
               +  L   +  +  LY+V +Y  G D+   ++ +        E +A  Y+ +++ A+
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRL--PEEMARFYLAEMVIAI 188

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
              H+   +HRDIKP  +L+   + +  ++L  FG  +            + ++  T ++
Sbjct: 189 DSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCL------------KLMEDGTVQS 233

Query: 183 GHRIGTPHYMAPEVIEDQ-----KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI 236
              +GTP Y++PE+++       +YG   D W+ GV ++ +L G  PF   S    +  I
Sbjct: 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 293

Query: 237 TKGKLHI 243
              K   
Sbjct: 294 MNHKERF 300

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  112 bits (283), Expect = 8e-30
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 21/178 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   LKH ++V L +   +E  L +VFEY+D  D+  + +         +      
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLK-QYLDDCGNII--NMHNVKL 104

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ Q+L  L YCH   ++HRD+KP  +L+  +     +KL  FG+A              
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAK---------SI 152

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
               Y     + + T  Y  P+++     Y   +D+W  G + + + TG   F GS  
Sbjct: 153 PTKTYD----NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV 206

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  111 bits (281), Expect = 1e-29
 Identities = 43/173 (24%), Positives = 77/173 (44%), Gaps = 21/173 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   LKH ++V L +   S+  L +VFE+ D  D+  +              +   
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLK-KYFDSCNGDL--DPEIVKS 105

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           ++ Q+L+ L +CH  +++HRD+KP  +L+        +KL  FG+A          + G 
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLA---------RAFGI 153

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
            +  Y+      + T  Y  P+V+   + Y   +D+W+AG +   L     P 
Sbjct: 154 PVRCYS----AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  113 bits (285), Expect = 1e-29
 Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 20/184 (10%)

Query: 54  REATICHMLKHPHVVELLE--TYSSEGMLYMVFEYMDGSDI-----CFEIVRRATAGFVY 106
           RE  +   LKHP+V+ L +     ++  ++++F+Y +  D+          +        
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQL 125

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA-PVKLGGFGVAIQLQDG 165
              +    + Q+L+ + Y H N ++HRD+KP  +L+  +      VK+   G A      
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLP 224
           +L+ S  + L          + T  Y APE++   + Y K +DIWA G +   LLT    
Sbjct: 180 RLFNSPLKPLADLDP----VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235

Query: 225 FVGS 228
           F   
Sbjct: 236 FHCR 239

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  112 bits (283), Expect = 1e-29
 Identities = 51/188 (27%), Positives = 91/188 (48%), Gaps = 26/188 (13%)

Query: 63  KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL 122
           + P +V L   + +E  L+++ +Y++G ++   + +R      ++E     Y+ +++ AL
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLAL 172

Query: 123 RYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
            + H+  II+RDIK   +LL +  +   V L  FG++             E +   T +A
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLS------------KEFVADETERA 217

Query: 183 GHRIGTPHYMAPEVIEDQKYG--KPVDIWAAGVLLHVLLTGTLPFVG-----SRDRLFQS 235
               GT  YMAP+++     G  K VD W+ GVL++ LLTG  PF       S+  + + 
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277

Query: 236 ITKGKLHI 243
           I K +   
Sbjct: 278 ILKSEPPY 285

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  112 bits (282), Expect = 2e-29
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 21/170 (12%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE  +   L HP+++ LL+ +  +  + +VF++M+ +D+   I++  +     + +    
Sbjct: 61  REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLE-VIIKDNSLVL--TPSHIKA 116

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           YM   L+ L Y H++ I+HRD+KP+ +LL        +KL  FG+A            G 
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSF---------GS 164

Query: 174 RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGT 222
               YT    H++ T  Y APE++   + YG  VD+WA G +L  LL   
Sbjct: 165 PNRAYT----HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  110 bits (278), Expect = 3e-29
 Identities = 45/183 (24%), Positives = 80/183 (43%), Gaps = 21/183 (11%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
              +  RE  I   L+HP++V  +   +    L +V EY+    + + ++ ++ A     
Sbjct: 77  RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSL-YRLLHKSGAREQLD 135

Query: 108 EAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
           E         V + + Y H  +  I+HR++K   +L+  K     VK+  FG++      
Sbjct: 136 ERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLS------ 186

Query: 166 QLYCSGGERLDHYTTKAGH-RIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                   RL   T  +     GTP +MAPEV+ D+   +  D+++ GV+L  L T   P
Sbjct: 187 --------RLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP 238

Query: 225 FVG 227
           +  
Sbjct: 239 WGN 241

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  110 bits (276), Expect = 8e-29
 Identities = 52/182 (28%), Positives = 77/182 (42%), Gaps = 25/182 (13%)

Query: 51  DLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-DICFEIVRRATAGFVYSE 108
            L  +  +       P++V+       EG  ++  E M  S D  ++ V       +  E
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVI-PE 124

Query: 109 AVASHYMRQVLEALRYCHEND-IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            +        ++AL +  EN  IIHRDIKP  +LL    N   +KL  FG++ QL D   
Sbjct: 125 EILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVD--- 178

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIE----DQKYGKPVDIWAAGVLLHVLLTGTL 223
             S  +  D          G   YMAPE I+     Q Y    D+W+ G+ L+ L TG  
Sbjct: 179 --SIAKTRD---------AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227

Query: 224 PF 225
           P+
Sbjct: 228 PY 229

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  108 bits (273), Expect = 2e-28
 Identities = 45/180 (25%), Positives = 83/180 (46%), Gaps = 21/180 (11%)

Query: 54  REATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASH 113
           RE ++   L+H +++EL         L+++FEY + +D+  +           S  V   
Sbjct: 82  REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDL--KKYMDKNPDV--SMRVIKS 136

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLL--ANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
           ++ Q++  + +CH    +HRD+KP  +LL  ++   +  +K+G FG+A          + 
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---------RAF 187

Query: 172 GERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
           G  +  +T    H I T  Y  PE++   + Y   VDIW+   +   +L  T  F G  +
Sbjct: 188 GIPIRQFT----HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  107 bits (270), Expect = 3e-28
 Identities = 44/182 (24%), Positives = 67/182 (36%), Gaps = 26/182 (14%)

Query: 51  DLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGS-DICFEIVRRATAGFVYSE 108
            L  +  I    +  P  V        EG +++  E MD S D  ++ V          E
Sbjct: 51  RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTI--PE 108

Query: 109 AVASHYMRQVLEALRYCHEND-IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            +       +++AL + H    +IHRD+KP  VL+        VK+  FG++  L D   
Sbjct: 109 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLVD--- 162

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIE----DQKYGKPVDIWAAGVLLHVLLTGTL 223
                              G   YMAPE I      + Y    DIW+ G+ +  L     
Sbjct: 163 -----------DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211

Query: 224 PF 225
           P+
Sbjct: 212 PY 213

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  108 bits (273), Expect = 3e-28
 Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 25/177 (14%)

Query: 54  REATICHMLKHPHVVELLE--------TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  I  +LKH +VV L+E            +G +Y+VF++ +  D+   +   +     
Sbjct: 65  REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLL---SNVLVK 120

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
           ++ +     M+ +L  L Y H N I+HRD+K   VL+        +KL  FG+A      
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLARAFSLA 177

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTG 221
           +       + + YT    +R+ T  Y  PE++  ++ YG P+D+W AG ++  + T 
Sbjct: 178 K-----NSQPNRYT----NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  107 bits (269), Expect = 7e-28
 Identities = 43/183 (23%), Positives = 76/183 (41%), Gaps = 30/183 (16%)

Query: 51  DLKREATICH-MLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
            +  +  +       P++V+   T+ +   +++  E M       ++ +R        E 
Sbjct: 69  RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC--AEKLKKRMQGPI--PER 124

Query: 110 VASHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           +       +++AL Y   ++ +IHRD+KP  +LL  +     +KL  FG++ +L D    
Sbjct: 125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVD---- 177

Query: 169 CSGGERLDHYTTKAGHR-IGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGT 222
                       KA  R  G   YMAPE I+        Y    D+W+ G+ L  L TG 
Sbjct: 178 -----------DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

Query: 223 LPF 225
            P+
Sbjct: 227 FPY 229

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  105 bits (265), Expect = 2e-27
 Identities = 42/187 (22%), Positives = 76/187 (40%), Gaps = 24/187 (12%)

Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
           ++   +       E      + HP++V+L     +   + +V EY +G  + + ++  A 
Sbjct: 38  QIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSL-YNVLHGAE 94

Query: 102 AGFVYSEAVASHYMRQVLEALRYCHE---NDIIHRDIKPHCVLLANKENSAPVKLGGFGV 158
               Y+ A A  +  Q  + + Y H      +IHRD+KP  +LL        +K+  FG 
Sbjct: 95  PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGT 152

Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
           A                           G+  +MAPEV E   Y +  D+++ G++L  +
Sbjct: 153 A--------------CDIQTHMTNN--KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEV 196

Query: 219 LTGTLPF 225
           +T   PF
Sbjct: 197 ITRRKPF 203

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  103 bits (260), Expect = 5e-27
 Identities = 57/189 (30%), Positives = 87/189 (46%), Gaps = 30/189 (15%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVY 106
           T  ++++EA +  MLKHP+++ L      E  L +V E+   G       + R  +G   
Sbjct: 49  TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGP------LNRVLSGKRI 102

Query: 107 SEAVASHYMRQVLEALRYCHEN---DIIHRDIKPHCVLLANKENSAP-----VKLGGFGV 158
              +  ++  Q+   + Y H+     IIHRD+K   +L+  K  +       +K+  FG+
Sbjct: 103 PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162

Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
           A              R  H TTK     G   +MAPEVI    + K  D+W+ GVLL  L
Sbjct: 163 A--------------REWHRTTKMS-AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWEL 207

Query: 219 LTGTLPFVG 227
           LTG +PF G
Sbjct: 208 LTGEVPFRG 216

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  104 bits (262), Expect = 6e-27
 Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 36/187 (19%)

Query: 54  REATICHMLK---HPHVVELLE-----TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  +   L+   HP+VV L++         E  + +VFE++D  D+   + +    G  
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGL- 117

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
                    MRQ L  L + H N I+HRD+KP  +L+ +      VKL  FG+A      
Sbjct: 118 -PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKLADFGLA------ 167

Query: 166 QLYCSGGERL----DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
                   R+       T      + T  Y APEV+    Y  PVD+W+ G +   +   
Sbjct: 168 --------RIYSYQMALT----PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

Query: 222 TLPFVGS 228
              F G+
Sbjct: 216 KPLFCGN 222

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  103 bits (259), Expect = 1e-26
 Identities = 41/198 (20%), Positives = 81/198 (40%), Gaps = 35/198 (17%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM----LYMVFEYMDGSDICFE 95
           +          + +RE  I   L HP++V+L       G+      MV E++   D+ + 
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLY------GLMHNPPRMVMEFVPCGDL-YH 110

Query: 96  IVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAP--V 151
            +           +V    M  +   + Y    +  I+HRD++   + L + + +AP   
Sbjct: 111 RLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168

Query: 152 KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI--EDQKYGKPVDIW 209
           K+  FG++              +   ++      +G   +MAPE I  E++ Y +  D +
Sbjct: 169 KVADFGLS--------------QQSVHSVSGL--LGNFQWMAPETIGAEEESYTEKADTY 212

Query: 210 AAGVLLHVLLTGTLPFVG 227
           +  ++L+ +LTG  PF  
Sbjct: 213 SFAMILYTILTGEGPFDE 230

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  103 bits (258), Expect = 3e-26
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 32/178 (17%)

Query: 49  EADLKREATICHML-KHPHVVELLETY------SSEGMLYMVFEYMD-GSDICFEIVRRA 100
           E ++K+E  +      H ++      +        +  L++V E+   GS    ++++  
Sbjct: 64  EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGS--VTDLIKNT 121

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                  E   ++  R++L  L + H++ +IHRDIK   VLL     +A VKL  FGV+ 
Sbjct: 122 KGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSA 177

Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIWAAGV 213
           QL                  +    IGTP++MAPEVI      D  Y    D+W+ G+
Sbjct: 178 QLDRTV-------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  103 bits (258), Expect = 3e-26
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 28/185 (15%)

Query: 54  REATICHMLK---HPHVVELLE-----TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           RE  +   L+   HP+VV L +         E  L +VFE++D  D+    + +     V
Sbjct: 60  REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLT-TYLDKVPEPGV 117

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            +E +    M Q+L  L + H + ++HRD+KP  +L+ +      +KL  FG+A      
Sbjct: 118 PTETIKD-MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLADFGLA------ 167

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                   R+  +       + T  Y APEV+    Y  PVD+W+ G +   +      F
Sbjct: 168 --------RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 219

Query: 226 VGSRD 230
            GS D
Sbjct: 220 RGSSD 224

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  102 bits (257), Expect = 4e-26
 Identities = 42/179 (23%), Positives = 87/179 (48%), Gaps = 7/179 (3%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           T+    +E  +   L+HP+V++ +     +  L  + EY+ G  +   I++   + + +S
Sbjct: 50  TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL-RGIIKSMDSQYPWS 108

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + V   + + +   + Y H  +IIHRD+  H  L+  +  +  V +  FG+A  + D + 
Sbjct: 109 QRV--SFAKDIASGMAYLHSMNIIHRDLNSHNCLV-RENKN--VVVADFGLARLMVDEKT 163

Query: 168 YCSGGERLDHYTTKAGH-RIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
              G   L     K  +  +G P++MAPE+I  + Y + VD+++ G++L  ++      
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD 222

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 99.6 bits (249), Expect = 6e-25
 Identities = 44/177 (24%), Positives = 85/177 (48%), Gaps = 27/177 (15%)

Query: 53  KREATI-CHMLKHPHVVELLET--YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
           KRE  I  ++   P+++ L +           +VFE+++ +D   ++ +  T   +    
Sbjct: 78  KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQTLTDYDIRF-- 134

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
               YM ++L+AL YCH   I+HRD+KPH V++ + E+   ++L  +G+A          
Sbjct: 135 ----YMYEILKALDYCHSMGIMHRDVKPHNVMI-DHEHRK-LRLIDWGLA---------- 178

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPF 225
                  H   +   R+ + ++  PE++ D Q Y   +D+W+ G +L  ++    PF
Sbjct: 179 ----EFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  100 bits (251), Expect = 9e-25
 Identities = 62/201 (30%), Positives = 86/201 (42%), Gaps = 31/201 (15%)

Query: 54  REATICHMLKHPHVVELLETYSSEG------MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  I   L H ++V L   + S G       L +V +Y+    +       + A     
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLP 154

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
                 YM Q+  +L Y H   I HRDIKP  +LL    ++A +KL  FG A QL     
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQL----- 207

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
               GE    Y       I + +Y APE+I     Y   +D+W+AG +L  LL G   F 
Sbjct: 208 --VRGEPNVSY-------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258

Query: 227 G--SRDRLFQSITKGKLHILG 245
           G    D+L + I K    +LG
Sbjct: 259 GDSGVDQLVE-IIK----VLG 274

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 99.0 bits (247), Expect = 9e-25
 Identities = 38/189 (20%), Positives = 71/189 (37%), Gaps = 24/189 (12%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
                KRE       +H +VV  +    S   L ++     G  + + +VR A      +
Sbjct: 72  QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL-YSVVRDAKIVLDVN 130

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           +       +++++ + Y H   I+H+D+K   V   N +    V +  FG+         
Sbjct: 131 KTR--QIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGK----VVITDFGLF-------- 176

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVI---------EDQKYGKPVDIWAAGVLLHVL 218
             SG  +      K   + G   ++APE+I         +   + K  D++A G + + L
Sbjct: 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

Query: 219 LTGTLPFVG 227
                PF  
Sbjct: 237 HAREWPFKT 245

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.9 bits (247), Expect = 2e-24
 Identities = 62/201 (30%), Positives = 87/201 (43%), Gaps = 31/201 (15%)

Query: 54  REATICHMLKHPHVVELLETYSS------EGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  I  ++KHP+VV+L   + S      E  L +V EY+    +       A       
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMP 139

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
             +   YM Q+L +L Y H   I HRDIKP  +LL     S  +KL  FG A  L  G+ 
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL--DPPSGVLKLIDFGSAKILIAGEP 197

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                     Y       I + +Y APE+I     Y   +DIW+ G ++  L+ G   F 
Sbjct: 198 NV-------SY-------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 227 G--SRDRLFQSITKGKLHILG 245
           G    D+L + I K    +LG
Sbjct: 244 GESGIDQLVE-IIK----VLG 259

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 97.4 bits (243), Expect = 3e-24
 Identities = 45/186 (24%), Positives = 79/186 (42%), Gaps = 27/186 (14%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
                K E  +    +H +++  +  YS+   L +V ++ +GS + +  +  +   F   
Sbjct: 63  QLQAFKNEVGVLRKTRHVNILLFM-GYSTAPQLAIVTQWCEGSSL-YHHLHASETKFEMK 120

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +     RQ    + Y H   IIHRD+K + + L        VK+G FG+A        
Sbjct: 121 KLI--DIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT---VKIGDFGLA-------- 167

Query: 168 YCSGGERLDHYTTKAGH---RIGTPHYMAPEVIEDQ---KYGKPVDIWAAGVLLHVLLTG 221
                       + +       G+  +MAPEVI  Q    Y    D++A G++L+ L+TG
Sbjct: 168 ------TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221

Query: 222 TLPFVG 227
            LP+  
Sbjct: 222 QLPYSN 227

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 94.6 bits (236), Expect = 2e-23
 Identities = 31/187 (16%), Positives = 64/187 (34%), Gaps = 30/187 (16%)

Query: 48  TEADLKREATICHMLKHPHVVELL--ETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
              D   E     +  HP+V+ +L            ++  +M    + + ++   T  FV
Sbjct: 50  KSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL-YNVLHEGT-NFV 107

Query: 106 YSEAVASHYMRQVLEALRYCH--ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
             ++ A  +   +   + + H  E  I    +    V++         ++    V    Q
Sbjct: 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQ 164

Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYG---KPVDIWAAGVLLHVLLT 220
                                R+  P ++APE ++ +      +  D+W+  VLL  L+T
Sbjct: 165 SPG------------------RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206

Query: 221 GTLPFVG 227
             +PF  
Sbjct: 207 REVPFAD 213

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.0 bits (221), Expect = 3e-21
 Identities = 25/179 (13%), Positives = 45/179 (25%), Gaps = 49/179 (27%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
            +          +  P V  +L+   +     +V E++ G  +  E+   +      S  
Sbjct: 76  QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSP-----SPV 129

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
            A   M+ +  A    H   +      P  V ++                    DG +  
Sbjct: 130 GAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSI-------------------DGDV-- 168

Query: 170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
                           +  P  M              DI   G  L+ LL    P   +
Sbjct: 169 ---------------VLAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEA 205

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 84.7 bits (210), Expect = 3e-19
 Identities = 43/181 (23%), Positives = 86/181 (47%), Gaps = 30/181 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM------LYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +        +Y+V E MD +++C ++++         
Sbjct: 73  RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLC-QVIQME-----LD 125

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP   ++   + +  +K+  FG+A       +
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKP-SNIVVKSDCT--LKILDFGLARTAGTSFM 182

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                  +  Y       + T +Y APEVI    Y + VDIW+ G ++  ++ G + F G
Sbjct: 183 -------MTPY-------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228

Query: 228 S 228
           +
Sbjct: 229 T 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 83.9 bits (208), Expect = 4e-19
 Identities = 54/208 (25%), Positives = 88/208 (42%), Gaps = 37/208 (17%)

Query: 53  KREATICHMLK---HPHVVELLETYSSEGM-------LYMVFEYMDGSDICFEIVRRATA 102
            RE  I   L    HP++V+L   + + G        L +V EY+    +          
Sbjct: 64  NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRR 122

Query: 103 GFVYSEAVASHYMRQVLEALRYCHEN--DIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                  +   ++ Q++ ++   H    ++ HRDIKPH  +L N+ +   +KL  FG A 
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEADGT-LKLCDFGSAK 180

Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLL 219
           +L       S  E    Y       I + +Y APE+I  +Q Y   VDIW+ G +   ++
Sbjct: 181 KL-------SPSEPNVAY-------ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

Query: 220 TGTLPFVG--SRDRLFQSITKGKLHILG 245
            G   F G  S  +L + I +    +LG
Sbjct: 227 LGEPIFRGDNSAGQLHE-IVR----VLG 249

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 84.5 bits (209), Expect = 5e-19
 Identities = 46/187 (24%), Positives = 86/187 (45%), Gaps = 31/187 (16%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM------LYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   + H +++ LL  ++ +        +Y+V E MD +++C  I        +  
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERM-- 166

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
               S+ + Q+L  +++ H   IIHRD+KP   ++   + +  +K+  FG+A       +
Sbjct: 167 ----SYLLYQMLCGIKHLHSAGIIHRDLKP-SNIVVKSDCT--LKILDFGLARTAGTSFM 219

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                  +  Y       + T +Y APEVI    Y + VDIW+ G ++  ++   + F G
Sbjct: 220 -------MTPY-------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265

Query: 228 SRDRLFQ 234
            RD + Q
Sbjct: 266 -RDYIDQ 271

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 83.7 bits (207), Expect = 9e-19
 Identities = 49/179 (27%), Positives = 80/179 (44%), Gaps = 28/179 (15%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM-----LYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  I + L H HVV++L+    + +     LY+V E  D SD   ++ R        +E
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFK-KLFR---TPVYLTE 155

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA-----IQLQ 163
                 +  +L  ++Y H   I+HRD+KP   L+ N++ S  VK+  FG+A      +  
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV-NQDCS--VKVCDFGLARTVDYPENG 212

Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPH---------YMAPEVI-EDQKYGKPVDIWAAG 212
           + QL  S  E   +  T    +              Y APE+I   + Y + +D+W+ G
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 83.3 bits (206), Expect = 1e-18
 Identities = 49/199 (24%), Positives = 85/199 (42%), Gaps = 26/199 (13%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM-----LYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE TI + LK  +++ L +    + +     LY+V E  D SD+  ++ +        +E
Sbjct: 74  REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLK-KLFK---TPIFLTE 128

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 +  +L    + HE+ IIHRD+KP    L N++ S  VK+  FG+A  +   +  
Sbjct: 129 EHIKTILYNLLLGENFIHESGIIHRDLKP-ANCLLNQDCS--VKVCDFGLARTINSEKDT 185

Query: 169 CSGGERLDHYTTKAGHRIGTPH---------YMAPEVI-EDQKYGKPVDIWAAGVLLHVL 218
               +  ++      ++              Y APE+I   + Y K +DIW+ G +   L
Sbjct: 186 NIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

Query: 219 LTG---TLPFVGSRDRLFQ 234
           L      +    +R  LF 
Sbjct: 246 LNMLQSHINDPTNRFPLFP 264

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 43/181 (23%), Positives = 77/181 (42%), Gaps = 18/181 (9%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM-----LYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  I    KH +++ +      +       +Y++ E M  +D+   ++         S+
Sbjct: 58  REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLH-RVISTQML----SD 111

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               +++ Q L A++  H +++IHRD+KP   LL N      +K+  FG+A  + +    
Sbjct: 112 DHIQYFIYQTLRAVKVLHGSNVIHRDLKP-SNLLINSNCD--LKVCDFGLARIIDESAAD 168

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
            S               + T  Y APEV+    KY + +D+W+ G +L  L      F G
Sbjct: 169 NSEPTGQQSGMV---EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

Query: 228 S 228
            
Sbjct: 226 R 226

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 81.7 bits (202), Expect = 4e-18
 Identities = 47/187 (25%), Positives = 88/187 (47%), Gaps = 21/187 (11%)

Query: 54  REATI-CHMLKHPHVVELLETYSSEGM--LYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           RE  I   +  H ++V LL    ++    +Y+VF+YM+ +D+   ++R      +     
Sbjct: 57  REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLH-AVIR----ANILEPVH 110

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
             + + Q+++ ++Y H   ++HRD+KP   +L N E    VK+  FG++    + +   +
Sbjct: 111 KQYVVYQLIKVIKYLHSGGLLHRDMKP-SNILLNAECH--VKVADFGLSRSFVNIRRVTN 167

Query: 171 GGERLDHYTTKAGHR--------IGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTG 221
                 +  T+            + T  Y APE++    KY K +D+W+ G +L  +L G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

Query: 222 TLPFVGS 228
              F GS
Sbjct: 228 KPIFPGS 234

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 81.3 bits (201), Expect = 5e-18
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 22/164 (13%)

Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV-YSEAVASHYMRQVLEALRY 124
           +V+ +LE ++    + M FE +  +   +E++++    F  +S  +   +   +L+ L  
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMN--LYELIKKN--KFQGFSLPLVRKFAHSILQCLDA 215

Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGH 184
            H+N IIH D+KP  +LL   +  + +K+  FG +         C   +R+  Y      
Sbjct: 216 LHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSS---------CYEHQRVYTY------ 259

Query: 185 RIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
            I +  Y APEVI   +YG P+D+W+ G +L  LLTG     G 
Sbjct: 260 -IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.8 bits (200), Expect = 5e-18
 Identities = 41/181 (22%), Positives = 75/181 (41%), Gaps = 27/181 (14%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM-----LYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  + +   HP+++ L + +          LY+V E M  +D+  +++         S 
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLA-QVIHDQRIVI--SP 133

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               ++M  +L  L   HE  ++HRD+ P   +L    N   + +  F +A         
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHP-GNILLADNND--ITICDFNLA--------- 181

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                R D       H +    Y APE++ + + + K VD+W+AG ++  +      F G
Sbjct: 182 -----REDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236

Query: 228 S 228
           S
Sbjct: 237 S 237

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.6 bits (197), Expect = 6e-18
 Identities = 46/197 (23%), Positives = 83/197 (42%), Gaps = 22/197 (11%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
             +E D   EA +   L HP +V+L      +  + +V E+M+   +  + +R     F 
Sbjct: 44  AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCL-SDYLRTQRGLFA 102

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
               +       V E + Y  E  +IHRD+     L+   +    +K+  FG+   + D 
Sbjct: 103 AETLL--GMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLD- 156

Query: 166 QLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
                     D YT+  G +   P  + +PEV    +Y    D+W+ GVL+  + + G +
Sbjct: 157 ----------DQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

Query: 224 PFVG-SRDRLFQSITKG 239
           P+   S   + + I+ G
Sbjct: 205 PYENRSNSEVVEDISTG 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 80.5 bits (199), Expect = 8e-18
 Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 32/182 (17%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM------LYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   +KH +V+ LL+ ++          +Y+V   M  +D+   IV+        +
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLN-NIVKCQK----LT 130

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           +      + Q+L  L+Y H  DIIHRD+KP   L  N++    +K+  FG+A    D   
Sbjct: 131 DDHVQFLIYQILRGLKYIHSADIIHRDLKP-SNLAVNEDCE--LKILDFGLARHTAD--- 184

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                  +  Y       + T  Y APE++     Y + VDIW+ G ++  LLTG   F 
Sbjct: 185 ------EMTGY-------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 231

Query: 227 GS 228
           G+
Sbjct: 232 GT 233

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.5 bits (199), Expect = 8e-18
 Identities = 41/193 (21%), Positives = 73/193 (37%), Gaps = 18/193 (9%)

Query: 36  FGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFE 95
           F    +         D   +    +   + H   ++   S    L ++ EY+    +   
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKV 127

Query: 96  IVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
           +     +G      + S Y+ Q+  A+ + H   I HRDIKP  +L+        +KL  
Sbjct: 128 LKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV--NSKDNTLKLCD 185

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVL 214
           FG A +L   +   +       Y       I +  Y APE++    +Y   +D+W+ G +
Sbjct: 186 FGSAKKLIPSEPSVA-------Y-------ICSRFYRAPELMLGATEYTPSIDLWSIGCV 231

Query: 215 LHVLLTGTLPFVG 227
              L+ G   F G
Sbjct: 232 FGELILGKPLFSG 244

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 79.3 bits (196), Expect = 1e-17
 Identities = 38/197 (19%), Positives = 75/197 (38%), Gaps = 37/197 (18%)

Query: 49  EADLKREATICHM--LKHPHVVELL----ETYSSEGMLYMVFEYMDGSDICFEIVRRATA 102
           E    RE  + +   L+H +++  +     +  S   L+++  Y +   + ++ ++  T 
Sbjct: 44  EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSL-YDYLQLTT- 101

Query: 103 GFVYSEAVASHYMRQVLEALRYCHE--------NDIIHRDIKPHCVLLANKENSAPVKLG 154
                       +  +   L + H           I HRD+K   +L+          + 
Sbjct: 102 ---LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ---CCIA 155

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ------KYGKPVDI 208
             G+A+      ++     +LD        R+GT  YMAPEV+++          K VDI
Sbjct: 156 DLGLAV------MHSQSTNQLDVGNN---PRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206

Query: 209 WAAGVLLHVLLTGTLPF 225
           WA G++L  +    +  
Sbjct: 207 WAFGLVLWEVARRMVSN 223

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 79.8 bits (197), Expect = 1e-17
 Identities = 40/197 (20%), Positives = 71/197 (36%), Gaps = 37/197 (18%)

Query: 49  EADLKREATICHM--LKHPHVVELL----ETYSSEGMLYMVFEYMDGSDICFEIVRRATA 102
           E    REA I     L+H +++  +    +   +   L++V +Y +   + F+ + R T 
Sbjct: 78  ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYT- 135

Query: 103 GFVYSEAVASHYMRQVLEALRYCHEN--------DIIHRDIKPHCVLLANKENSAPVKLG 154
               +              L + H           I HRD+K   +L+          + 
Sbjct: 136 ---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIA 189

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED------QKYGKPVDI 208
             G+A++              D       HR+GT  YMAPEV++D       +  K  DI
Sbjct: 190 DLGLAVRHDSA---------TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240

Query: 209 WAAGVLLHVLLTGTLPF 225
           +A G++   +       
Sbjct: 241 YAMGLVFWEIARRCSIG 257

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 79.8 bits (197), Expect = 1e-17
 Identities = 32/197 (16%), Positives = 69/197 (35%), Gaps = 37/197 (18%)

Query: 49  EADLKREATICHM--LKHPHVVELL----ETYSSEGMLYMVFEYMDGSDICFEIVRRATA 102
           EA   RE  I     ++H +++  +    +   S   LY++ +Y +   + ++ ++  T 
Sbjct: 73  EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL-YDYLKSTT- 130

Query: 103 GFVYSEAVASHYMRQVLEALRYCHEND--------IIHRDIKPHCVLLANKENSAPVKLG 154
                           +  L + H           I HRD+K   +L+          + 
Sbjct: 131 ---LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT---CCIA 184

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE------DQKYGKPVDI 208
             G+A++              +        R+GT  YM PEV++        +     D+
Sbjct: 185 DLGLAVKFISDT---------NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235

Query: 209 WAAGVLLHVLLTGTLPF 225
           ++ G++L  +    +  
Sbjct: 236 YSFGLILWEVARRCVSG 252

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.2 bits (196), Expect = 1e-17
 Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 33/190 (17%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM--------------LYMVFEYMDGSDICFEIVRR 99
           RE  I   L H ++V++ E     G               +Y+V EYM+ +D+   ++ +
Sbjct: 57  REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLA-NVLEQ 114

Query: 100 ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA 159
                   E  A  +M Q+L  L+Y H  +++HRD+KP   L  N E+   +K+G FG+A
Sbjct: 115 GPL----LEEHARLFMYQLLRGLKYIHSANVLHRDLKP-ANLFINTEDLV-LKIGDFGLA 168

Query: 160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVL 218
             +       S    L          + T  Y +P ++     Y K +D+WAAG +   +
Sbjct: 169 RIMDPHY---SHKGHLSEG-------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 218

Query: 219 LTGTLPFVGS 228
           LTG   F G+
Sbjct: 219 LTGKTLFAGA 228

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 79.7 bits (197), Expect = 2e-17
 Identities = 50/182 (27%), Positives = 85/182 (46%), Gaps = 32/182 (17%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM------LYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   ++H +V+ LL+ ++ +         Y+V  +M  +D+  ++++         
Sbjct: 73  RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLG-KLMKHEK----LG 126

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E      + Q+L+ LRY H   IIHRD+KP   L  N++    +K+  FG+A Q      
Sbjct: 127 EDRIQFLVYQMLKGLRYIHAAGIIHRDLKP-GNLAVNEDCE--LKILDFGLARQADS--- 180

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                  +  Y       + T  Y APEVI    +Y + VDIW+ G ++  ++TG   F 
Sbjct: 181 ------EMTGY-------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 227

Query: 227 GS 228
           GS
Sbjct: 228 GS 229

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 79.3 bits (196), Expect = 2e-17
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 33/182 (18%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM------LYMVFEYMDGSDICFEIVRRATAGFVYS 107
           RE  +   ++H +V+ LL+ ++           Y+V  +M  +D+  +I+        +S
Sbjct: 72  RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ-KIMGLK-----FS 124

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           E    + + Q+L+ L+Y H   ++HRD+KP   L  N++    +K+  FG+A        
Sbjct: 125 EEKIQYLVYQMLKGLKYIHSAGVVHRDLKP-GNLAVNEDCE--LKILDFGLARHADA--- 178

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
                  +  Y       + T  Y APEVI     Y + VDIW+ G ++  +LTG   F 
Sbjct: 179 ------EMTGY-------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225

Query: 227 GS 228
           G 
Sbjct: 226 GK 227

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 78.4 bits (194), Expect = 2e-17
 Identities = 45/197 (22%), Positives = 84/197 (42%), Gaps = 22/197 (11%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
             +E +   EA +   L H  +V+L    + +  ++++ EYM    +    +R     F 
Sbjct: 60  SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL-LNYLREMRHRFQ 118

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
             + +     + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D 
Sbjct: 119 TQQLL--EMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLD- 172

Query: 166 QLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
                     D YT+  G +   P  +  PEV+   K+    DIWA GVL+  + + G +
Sbjct: 173 ----------DEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220

Query: 224 PFVG-SRDRLFQSITKG 239
           P+   +     + I +G
Sbjct: 221 PYERFTNSETAEHIAQG 237

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 77.7 bits (192), Expect = 4e-17
 Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 23/198 (11%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
                +  +EA +   +KHP++V+LL   + E   Y++ E+M  G+ + +    R     
Sbjct: 50  TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY---LRECNRQ 106

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             S  V  +   Q+  A+ Y  + + IHRD+     L+        VK+  FG++  +  
Sbjct: 107 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTG 163

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
                      D YT  AG +   P  + APE +   K+    D+WA GVLL  + T G 
Sbjct: 164 -----------DTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM 210

Query: 223 LPFVG-SRDRLFQSITKG 239
            P+ G    ++++ + K 
Sbjct: 211 SPYPGIDLSQVYELLEKD 228

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 78.7 bits (194), Expect = 5e-17
 Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 21/197 (10%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
                +  +EA +   +KHP++V+LL   + E   Y++ E+M  G+ + +    R     
Sbjct: 257 TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY---LRECNRQ 313

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             S  V  +   Q+  A+ Y  + + IHR++     L+        VK+  FG++  +  
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL---VKVADFGLSRLMTG 370

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
                      D YT  AG +     + APE +   K+    D+WA GVLL  + T G  
Sbjct: 371 -----------DTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418

Query: 224 PFVGSRDR-LFQSITKG 239
           P+ G     +++ + K 
Sbjct: 419 PYPGIDLSQVYELLEKD 435

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 76.8 bits (190), Expect = 7e-17
 Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 22/197 (11%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
             +E +  +EA     L HP +V+     S E  +Y+V EY+    +    +R    G  
Sbjct: 44  SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL-LNYLRSHGKGLE 102

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            S+ +       V E + +   +  IHRD+     L+        VK+  FG+   + D 
Sbjct: 103 PSQLL--EMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRYVLD- 156

Query: 166 QLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
                     D Y +  G +   P  + APEV    KY    D+WA G+L+  + + G +
Sbjct: 157 ----------DQYVSSVGTKF--PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204

Query: 224 PFVG-SRDRLFQSITKG 239
           P+   +   +   +++G
Sbjct: 205 PYDLYTNSEVVLKVSQG 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.7 bits (192), Expect = 9e-17
 Identities = 45/187 (24%), Positives = 85/187 (45%), Gaps = 26/187 (13%)

Query: 54  REATICHMLKHPHVVELLETYSSEGM-----LYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           RE  I    +H +++ + +   +  +     +Y+V + M+ +D+  ++++        S 
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLY-KLLKTQH----LSN 127

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               +++ Q+L  L+Y H  +++HRD+KP   LL N      +K+  FG+A         
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKP-SNLLLNTTCD--LKICDFGLARVADPDH-- 182

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                 L  Y       + T  Y APE++   + Y K +DIW+ G +L  +L+    F G
Sbjct: 183 -DHTGFLTEY-------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234

Query: 228 SRDRLFQ 234
            +  L Q
Sbjct: 235 -KHYLDQ 240

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 77.1 bits (190), Expect = 2e-16
 Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 24/166 (14%)

Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV-YSEAVASHYMRQVLEALRY 124
           ++V L   +     L +VFE +  +   ++++R     F   S  +   + +Q+  AL +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNT--NFRGVSLNLTRKFAQQMCTALLF 172

Query: 125 CHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKA 182
               +  IIH D+KP  +LL N + SA +K+  FG +         C  G+R+  Y    
Sbjct: 173 LATPELSIIHCDLKPENILLCNPKRSA-IKIVDFGSS---------CQLGQRIYQY---- 218

Query: 183 GHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
              I +  Y +PEV+    Y   +D+W+ G +L  + TG   F G+
Sbjct: 219 ---IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 24/198 (12%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
             +     +EA +   L+H  +V+L    S E + Y+V EYM  GS + F    +   G 
Sbjct: 303 TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDF---LKGETGK 358

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
                       Q+   + Y    + +HRD++   +L+         K+  FG+A  ++D
Sbjct: 359 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIED 415

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
                      + YT + G +   P  + APE     ++    D+W+ G+LL  L T G 
Sbjct: 416 -----------NEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

Query: 223 LPFVGSRDR-LFQSITKG 239
           +P+ G  +R +   + +G
Sbjct: 463 VPYPGMVNREVLDQVERG 480

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 76.7 bits (189), Expect = 2e-16
 Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 24/198 (12%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
             +     +EA +   L+H  +V+L    S E + Y+V EYM  GS + F    +   G 
Sbjct: 220 TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDF---LKGETGK 275

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
                       Q+   + Y    + +HRD++   +L+         K+  FG+A  ++D
Sbjct: 276 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIED 332

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
                      + YT + G +   P  + APE     ++    D+W+ G+LL  L T G 
Sbjct: 333 -----------NEYTARQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

Query: 223 LPFVGSRDR-LFQSITKG 239
           +P+ G  +R +   + +G
Sbjct: 380 VPYPGMVNREVLDQVERG 397

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 75.9 bits (187), Expect = 3e-16
 Identities = 44/170 (25%), Positives = 70/170 (41%), Gaps = 27/170 (15%)

Query: 66  HVVELLETYSSEGM----LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEA 121
           H+++LL+ ++ +G     + MVFE +  +     ++++                +Q+L  
Sbjct: 87  HILKLLDHFNHKGPNGVHVVMVFEVLGEN--LLALIKK-YEHRGIPLIYVKQISKQLLLG 143

Query: 122 LRYCH-ENDIIHRDIKPHCVLLANK---ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDH 177
           L Y H    IIH DIKP  VL+      EN   +K+   G A         C   E   +
Sbjct: 144 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------CWYDEHYTN 194

Query: 178 YTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                   I T  Y +PEV+    +G   DIW+   L+  L+TG   F  
Sbjct: 195 S-------IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 75.4 bits (186), Expect = 3e-16
 Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 22/175 (12%)

Query: 50  ADLKREATICHMLKHPHVVELLE--TYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVY 106
           ADLK+E  I   L H ++V+     T      + ++ E++  GS   +  + +       
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEY--LPKNKNKINL 125

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
            + +   Y  Q+ + + Y      +HRD+    VL+ ++     VK+G FG+   ++  +
Sbjct: 126 KQQL--KYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLTKAIETDK 180

Query: 167 LYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
                    ++YT K       P  + APE +   K+    D+W+ GV LH LLT
Sbjct: 181 ---------EYYTVKDDRDS--PVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 74.6 bits (184), Expect = 5e-16
 Identities = 40/175 (22%), Positives = 76/175 (43%), Gaps = 22/175 (12%)

Query: 50  ADLKREATICHMLKHPHVVELLE--TYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVY 106
            D +RE  I   L+H ++V+       +    L ++ EY+  GS   +  +++      +
Sbjct: 56  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY--LQKHKERIDH 113

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
            + +   Y  Q+ + + Y      IHRD+    +L+ N+     VK+G FG+   L   +
Sbjct: 114 IKLL--QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDK 168

Query: 167 LYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
                    + +  K       P  + APE + + K+    D+W+ GV+L+ L T
Sbjct: 169 ---------EFFKVKEPGES--PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 74.7 bits (184), Expect = 8e-16
 Identities = 44/190 (23%), Positives = 78/190 (41%), Gaps = 23/190 (12%)

Query: 48  TEADLKREATICHMLKHPHVVELLE--TYSSEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
            + D +RE  I   L    +V+            L +V EY+  G    F  ++R  A  
Sbjct: 67  QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF--LQRHRARL 124

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             S  +   Y  Q+ + + Y      +HRD+    +L+ ++ +   VK+  FG+A  L  
Sbjct: 125 DASRLL--LYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAKLLPL 179

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
            +         D+Y  +   +   P  + APE + D  + +  D+W+ GV+L+ L T   
Sbjct: 180 DK---------DYYVVREPGQS--PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228

Query: 223 LPFVGSRDRL 232
                S + L
Sbjct: 229 KSCSPSAEFL 238

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 74.5 bits (183), Expect = 9e-16
 Identities = 41/191 (21%), Positives = 69/191 (36%), Gaps = 38/191 (19%)

Query: 49  EADLKREATICHM--LKHPHVVELL-----ETYSSEGMLYMVFEYMD-GSDICFEIVRRA 100
             +   E  I  +  ++H ++   +      T        +V EY   GS      + + 
Sbjct: 49  RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGS------LXKY 102

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHEND---------IIHRDIKPHCVLLANKENSAPV 151
            +        +      V   L Y H            I HRD+    VL+ N       
Sbjct: 103 LSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT---C 159

Query: 152 KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-------QKYGK 204
            +  FG++++L   +L   G E  D+        +GT  YMAPEV+E        +   K
Sbjct: 160 VISDFGLSMRLTGNRLVRPGEE--DNAAI---SEVGTIRYMAPEVLEGAVNLRDXESALK 214

Query: 205 PVDIWAAGVLL 215
            VD++A G++ 
Sbjct: 215 QVDMYALGLIY 225

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 74.3 bits (183), Expect = 9e-16
 Identities = 41/175 (23%), Positives = 77/175 (44%), Gaps = 22/175 (12%)

Query: 50  ADLKREATICHMLKHPHVVELLE--TYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVY 106
            D +RE  I   L+H ++V+       +    L ++ EY+  GS   +  +++      +
Sbjct: 87  RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDY--LQKHKERIDH 144

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
            + +   Y  Q+ + + Y      IHRD+    +L+ N+     VK+G FG+   L   +
Sbjct: 145 IKLL--QYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTKVLPQDK 199

Query: 167 LYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
                    ++Y  K       P  + APE + + K+    D+W+ GV+L+ L T
Sbjct: 200 ---------EYYKVKEPGES--PIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 73.0 bits (180), Expect = 2e-15
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 24/198 (12%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
             +      EA +   L+H  +V L    + E + Y++ EYM+ GS + F    +  +G 
Sbjct: 49  SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDF---LKTPSGI 104

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
             +         Q+ E + +  E + IHRD++   +L+++  +    K+  FG+A  ++D
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIED 161

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
                      + YT + G +   P  + APE I    +    D+W+ G+LL  ++T G 
Sbjct: 162 -----------NEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

Query: 223 LPFVG-SRDRLFQSITKG 239
           +P+ G +   + Q++ +G
Sbjct: 209 IPYPGMTNPEVIQNLERG 226

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 45/198 (22%), Positives = 90/198 (45%), Gaps = 24/198 (12%)

Query: 46  YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
             +      EA +   L+H  +V+L    + E + Y++ E+M  GS + F    ++  G 
Sbjct: 224 SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDF---LKSDEGS 279

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
                    +  Q+ E + +  + + IHRD++   +L++        K+  FG+A  ++D
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV---CKIADFGLARVIED 336

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
                      + YT + G +   P  + APE I    +    D+W+ G+LL  ++T G 
Sbjct: 337 -----------NEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

Query: 223 LPFVG-SRDRLFQSITKG 239
           +P+ G S   + +++ +G
Sbjct: 384 IPYPGMSNPEVIRALERG 401

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 73.7 bits (181), Expect = 3e-15
 Identities = 45/195 (23%), Positives = 81/195 (41%), Gaps = 23/195 (11%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
                 +EA       HPH+V+L+   +   + +++ E     ++    ++        +
Sbjct: 434 VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGEL-RSFLQVRKFSLDLA 491

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
             +   Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   
Sbjct: 492 SLI--LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDSTY 546

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
           Y +   +L             P  +MAPE I  +++    D+W  GV +  +L  G  PF
Sbjct: 547 YKASKGKL-------------PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593

Query: 226 VG-SRDRLFQSITKG 239
            G   + +   I  G
Sbjct: 594 QGVKNNDVIGRIENG 608

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 72.4 bits (178), Expect = 3e-15
 Identities = 43/206 (20%), Positives = 81/206 (39%), Gaps = 46/206 (22%)

Query: 49  EADLKREATICHM--LKHPHVVELL----ETYSSEGMLYMVFEYMD-GS----------- 90
           +   + E  +  +  +KH ++++ +       S +  L+++  + + GS           
Sbjct: 60  KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS 119

Query: 91  -DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA 149
            +    I      G          Y+ + +  L+  H+  I HRDIK   VLL N     
Sbjct: 120 WNELCHIAETMARGL--------AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT-- 169

Query: 150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----QKYGK 204
              +  FG+A++ + G+             T    ++GT  YMAPEV+E      +    
Sbjct: 170 -ACIADFGLALKFEAGK---------SAGDTH--GQVGTRRYMAPEVLEGAINFQRDAFL 217

Query: 205 PVDIWAAGVLLHVLLTGTLPFVGSRD 230
            +D++A G++L  L +      G  D
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVD 243

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 72.8 bits (179), Expect = 5e-15
 Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 28/198 (14%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYS-SEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
            T      EA++   L+H ++V+LL      +G LY+V EYM  GS + +    R+    
Sbjct: 228 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY---LRSRGRS 284

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
           V        +   V EA+ Y   N+ +HRD+    VL++  E++   K+  FG+      
Sbjct: 285 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS--EDNV-AKVSDFGLT----- 336

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
                    + +  +T+   ++  P  + APE + ++K+    D+W+ G+LL  + + G 
Sbjct: 337 ---------K-EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

Query: 223 LPFVG-SRDRLFQSITKG 239
           +P+       +   + KG
Sbjct: 385 VPYPRIPLKDVVPRVEKG 402

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 72.0 bits (177), Expect = 6e-15
 Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 24/177 (13%)

Query: 48  TEADLKREATICHMLKHPHVVELLE--TYSSEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
             +  K+E  I   L H H+++       +    L +V EY+  GS   +  + R + G 
Sbjct: 76  HRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY--LPRHSIGL 133

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
               A    + +Q+ E + Y H    IHRD+    VLL N      VK+G FG+A  + +
Sbjct: 134 ----AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDFGLAKAVPE 186

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
           G          ++Y  +       P  + APE +++ K+    D+W+ GV L+ LLT
Sbjct: 187 GH---------EYYRVREDGDS--PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 72.4 bits (178), Expect = 6e-15
 Identities = 43/180 (23%), Positives = 81/180 (45%), Gaps = 21/180 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEA 109
           D   EA+I     HP+++ L    +    + +V EYM+ GS   F  +R+  A F   + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF--LRKHDAQFTVIQL 149

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC 169
           V    +R +   ++Y  +   +HRD+    +L+ +       K+  FG+   L+D     
Sbjct: 150 V--GMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLGRVLEDDP--- 201

Query: 170 SGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
                 +   T  G +I  P  + +PE I  +K+    D+W+ G++L  +++ G  P+  
Sbjct: 202 ------EAAYTTRGGKI--PIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 71.1 bits (175), Expect = 7e-15
 Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 28/198 (14%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYS-SEGMLYMVFEYMD-GSDICFEIVRRATAGF 104
            T      EA++   L+H ++V+LL      +G LY+V EYM  GS + +    R+    
Sbjct: 56  ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY---LRSRGRS 112

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
           V        +   V EA+ Y   N+ +HRD+    VL++        K+  FG+      
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLT----- 164

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
                    + +  +T+   ++  P  + APE + ++K+    D+W+ G+LL  + + G 
Sbjct: 165 ---------K-EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212

Query: 223 LPFVG-SRDRLFQSITKG 239
           +P+       +   + KG
Sbjct: 213 VPYPRIPLKDVVPRVEKG 230

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 71.1 bits (175), Expect = 8e-15
 Identities = 51/193 (26%), Positives = 79/193 (40%), Gaps = 22/193 (11%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEI 96
           L  + L+      D  RE    H L H +++ L     +  M  MV E    GS +    
Sbjct: 54  LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDR-- 110

Query: 97  VRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
           +R+    F+        Y  QV E + Y      IHRD+    +LLA ++    VK+G F
Sbjct: 111 LRKHQGHFLLGTLS--RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDF 165

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL 215
           G+   L             DHY  +   ++  P  + APE ++ + +    D W  GV L
Sbjct: 166 GLMRALPQND---------DHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTL 214

Query: 216 HVLLT-GTLPFVG 227
             + T G  P++G
Sbjct: 215 WEMFTYGQEPWIG 227

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 71.5 bits (176), Expect = 1e-14
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 20/182 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +A   +EA I     HP++V L+   + +  +Y+V E + G D     +R   A     
Sbjct: 155 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF-LTFLRTEGARLRVK 213

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
             +    +      + Y      IHRD+     L+  K     +K+  FG++ +  DG  
Sbjct: 214 TLL--QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADGVY 268

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
             SGG R              P  + APE +   +Y    D+W+ G+LL    + G  P+
Sbjct: 269 AASGGLRQ------------VPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316

Query: 226 VG 227
             
Sbjct: 317 PN 318

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 71.2 bits (175), Expect = 1e-14
 Identities = 44/200 (22%), Positives = 81/200 (40%), Gaps = 24/200 (12%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
             +   EA++       HVV LL   S      ++ E M   D+  +    R        
Sbjct: 72  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131

Query: 108 EAVAS-----HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
            A  S         ++ + + Y + N  +HRD+     ++A       VK+G FG+   +
Sbjct: 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDI 188

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT- 220
            +   Y  GG+ L             P  +M+PE ++D  +    D+W+ GV+L  + T 
Sbjct: 189 YETDYYRKGGKGL------------LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236

Query: 221 GTLPFVG-SRDRLFQSITKG 239
              P+ G S +++ + + +G
Sbjct: 237 AEQPYQGLSNEQVLRFVMEG 256

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 70.7 bits (174), Expect = 1e-14
 Identities = 41/196 (20%), Positives = 80/196 (40%), Gaps = 22/196 (11%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
               ++  EA +   + +PHV  LL        + ++ + M    +  + VR        
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCL-LDYVREHKDNIGS 116

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
              +  ++  Q+ + + Y  +  ++HRD+    VL+   ++   VK+  FG+A  L    
Sbjct: 117 QYLL--NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAE- 170

Query: 167 LYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP 224
                    +      G ++  P  +MA E I  + Y    D+W+ GV +  L+T G+ P
Sbjct: 171 ---------EKEYHAEGGKV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

Query: 225 FVG-SRDRLFQSITKG 239
           + G     +   + KG
Sbjct: 220 YDGIPASEISSILEKG 235

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 70.4 bits (173), Expect = 1e-14
 Identities = 44/182 (24%), Positives = 78/182 (42%), Gaps = 20/182 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
              ++ REA I H L +P++V L+    +E +  +V E   G  +  + +         S
Sbjct: 53  DTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPL-HKFLVGKREEIPVS 110

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
                  + QV   ++Y  E + +HRD+    VLL N+      K+  FG++  L     
Sbjct: 111 NVA--ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGADD- 164

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
                    +YT ++  +   P  + APE I  +K+    D+W+ GV +   L+ G  P+
Sbjct: 165 --------SYYTARSAGKW--PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214

Query: 226 VG 227
             
Sbjct: 215 KK 216

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 70.4 bits (173), Expect = 2e-14
 Identities = 50/197 (25%), Positives = 75/197 (38%), Gaps = 18/197 (9%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVYS 107
           E D   EA I     H ++V  +         +++ E M G D+  F    R       S
Sbjct: 77  ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS 136

Query: 108 EAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +   
Sbjct: 137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

Query: 166 QLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
             Y  GG  +             P  +M PE   +  +    D W+ GVLL  + + G +
Sbjct: 197 SYYRKGGCAM------------LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYM 244

Query: 224 PFVG-SRDRLFQSITKG 239
           P+   S   + + +T G
Sbjct: 245 PYPSKSNQEVLEFVTSG 261

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 70.5 bits (173), Expect = 2e-14
 Identities = 50/198 (25%), Positives = 75/198 (37%), Gaps = 18/198 (9%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI-CFEIVRRATAGFVY 106
            E D   EA I     H ++V  +         +++ E M G D+  F    R       
Sbjct: 117 DELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS 176

Query: 107 SEAVAS--HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
           S A+    H  R +    +Y  EN  IHRDI     LL         K+G FG+A  +  
Sbjct: 177 SLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT 222
              Y  GG  +             P  +M PE   +  +    D W+ GVLL  + + G 
Sbjct: 237 AGYYRKGGCAM------------LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284

Query: 223 LPFVG-SRDRLFQSITKG 239
           +P+   S   + + +T G
Sbjct: 285 MPYPSKSNQEVLEFVTSG 302

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 70.0 bits (172), Expect = 2e-14
 Identities = 42/182 (23%), Positives = 77/182 (42%), Gaps = 22/182 (12%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
                 +EA       HPH+V+L+   +   + +++ E     ++    ++        +
Sbjct: 59  VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGEL-RSFLQVRKYSLDLA 116

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
             +   Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D   
Sbjct: 117 SLI--LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMED--- 168

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
                     Y   +  ++  P  +MAPE I  +++    D+W  GV +  +L  G  PF
Sbjct: 169 --------STYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218

Query: 226 VG 227
            G
Sbjct: 219 QG 220

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 22/183 (12%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVY 106
              ++ REA I H L +P++V L+    +E +  +V E    G    F  +         
Sbjct: 379 DTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKF--LVGKREEIPV 435

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           S       + QV   ++Y  E + +HR++    VLL N+      K+  FG++  L    
Sbjct: 436 SNVA--ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADD 490

Query: 167 LYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP 224
                     +YT ++  +   P  + APE I  +K+    D+W+ GV +   L+ G  P
Sbjct: 491 ---------SYYTARSAGKW--PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

Query: 225 FVG 227
           +  
Sbjct: 540 YKK 542

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 70.0 bits (172), Expect = 3e-14
 Identities = 46/196 (23%), Positives = 79/196 (40%), Gaps = 24/196 (12%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVY 106
           +   +         L H H+V LL       +  +V +Y+  GS +    VR+       
Sbjct: 58  SFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDH--VRQHRGALGP 114

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
              +  ++  Q+ + + Y  E+ ++HR++    VLL +      V++  FGVA  L    
Sbjct: 115 QLLL--NWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVADLLPPD- 168

Query: 167 LYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP 224
                    D     +  +   P  +MA E I   KY    D+W+ GV +  L+T G  P
Sbjct: 169 ---------DKQLLYSEAKT--PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

Query: 225 FVGSRDR-LFQSITKG 239
           + G R   +   + KG
Sbjct: 218 YAGLRLAEVPDLLEKG 233

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 69.6 bits (171), Expect = 3e-14
 Identities = 51/206 (24%), Positives = 79/206 (38%), Gaps = 30/206 (14%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-FEIVRRATAGFVYS 107
             D +REA +   L+H H+V+          L MVFEYM   D+  F       A  +  
Sbjct: 61  RKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVD 120

Query: 108 EAVAS-----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
                           H   Q+   + Y      +HRD+     L+        VK+G F
Sbjct: 121 GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL---VKIGDF 177

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL 215
           G++  +     Y  GG  +             P  +M PE I  +K+    D+W+ GV+L
Sbjct: 178 GMSRDVYSTDYYRVGGHTM------------LPIRWMPPESIMYRKFTTESDVWSFGVIL 225

Query: 216 HVLLT-GTLPFVG-SRDRLFQSITKG 239
             + T G  P+   S   + + IT+G
Sbjct: 226 WEIFTYGKQPWFQLSNTEVIECITQG 251

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 70.0 bits (172), Expect = 3e-14
 Identities = 40/171 (23%), Positives = 66/171 (38%), Gaps = 19/171 (11%)

Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV-YSEAVASHYMRQVLEALRY 124
             V + + ++  G + + FE +  +   FE ++     F  Y      H   Q+  ALR+
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGKN--TFEFLKEN--NFQPYPLPHVRHMAYQLCHALRF 138

Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY-------CSGGERLDH 177
            HEN + H D+KP  +L  N E               +++  +            E   H
Sbjct: 139 LHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--H 196

Query: 178 YTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
            T      + T HY  PEVI +  + +P D+W+ G +L     G   F   
Sbjct: 197 TTI-----VATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 69.6 bits (171), Expect = 4e-14
 Identities = 44/182 (24%), Positives = 76/182 (41%), Gaps = 19/182 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
              D   EA+I     HP+++ L    +   +  +V EYM+   +    +R     F   
Sbjct: 93  QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFLRTHDGQFTIM 151

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + V    +R V   +RY  +   +HRD+    VL+ +       K+  FG++  L+D   
Sbjct: 152 QLV--GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV---CKVSDFGLSRVLEDDP- 205

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
                   D   T  G +I  P  + APE I  + +    D+W+ GV++  +L  G  P+
Sbjct: 206 --------DAAYTTTGGKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

Query: 226 VG 227
             
Sbjct: 256 WN 257

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 69.6 bits (171), Expect = 4e-14
 Identities = 37/171 (21%), Positives = 67/171 (39%), Gaps = 19/171 (11%)

Query: 66  HVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV-YSEAVASHYMRQVLEALRY 124
             V++LE +   G + +VFE +  S   ++ ++    GF+ +          Q+ +++ +
Sbjct: 78  RCVQMLEWFEHHGHICIVFELLGLS--TYDFIKEN--GFLPFRLDHIRKMAYQICKSVNF 133

Query: 125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY-------CSGGERLDH 177
            H N + H D+KP  +L    + +             L +  +            E   H
Sbjct: 134 LHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--H 191

Query: 178 YTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
            T      + T HY APEVI    + +P D+W+ G +L     G   F   
Sbjct: 192 STL-----VSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTH 237

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 68.8 bits (169), Expect = 6e-14
 Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 22/182 (12%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +     EA I   L HPH+V+L+     E   +++ E     ++    + R        
Sbjct: 56  NKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGEL-GHYLERNKNSLKVL 113

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
             V   Y  Q+ +A+ Y    + +HRDI    +L+A+ E    VKLG FG++  ++D   
Sbjct: 114 TLV--LYSLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLSRYIED--- 165

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
                   + Y   +  R+  P  +M+PE I  +++    D+W   V +  +L+ G  PF
Sbjct: 166 --------EDYYKASVTRL--PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF 215

Query: 226 VG 227
             
Sbjct: 216 FW 217

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 69.2 bits (170), Expect = 6e-14
 Identities = 51/205 (24%), Positives = 78/205 (38%), Gaps = 29/205 (14%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-FEIVRRATAGFVYS 107
             D +REA +  ML+H H+V      +    L MVFEYM   D+  F       A  +  
Sbjct: 87  RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG 146

Query: 108 EAVAS----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
               +              QV   + Y      +HRD+     L+        VK+G FG
Sbjct: 147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV---VKIGDFG 203

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLH 216
           ++  +             D+Y       +  P  +M PE I  +K+    D+W+ GV+L 
Sbjct: 204 MSRDIYST----------DYYRVGGRTML--PIRWMPPESILYRKFTTESDVWSFGVVLW 251

Query: 217 VLLT-GTLPFVG-SRDRLFQSITKG 239
            + T G  P+   S       IT+G
Sbjct: 252 EIFTYGKQPWYQLSNTEAIDCITQG 276

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 69.2 bits (169), Expect = 8e-14
 Identities = 50/224 (22%), Positives = 76/224 (33%), Gaps = 48/224 (21%)

Query: 45  HYTTEADLKREATICHMLK-----HP---HVVELLETYSSEGM----LYMVFEYMDGSDI 92
           HYT  A    E  +   ++      P    VV+LL+ +   G+    + MVFE + G  +
Sbjct: 75  HYTETA--LDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHL 131

Query: 93  CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH-ENDIIHRDIKPHCVLLANKENSA-- 149
              I++    G           ++QVL+ L Y H +  IIH DIKP  +LL+  E     
Sbjct: 132 LKWIIKSNYQGL--PLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189

Query: 150 ---------------PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAG----------- 183
                          P             +  +     +  +    K             
Sbjct: 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH 249

Query: 184 --HRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
               I T  Y + EV+    Y  P DIW+   +   L TG   F
Sbjct: 250 FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 68.9 bits (169), Expect = 8e-14
 Identities = 43/193 (22%), Positives = 76/193 (39%), Gaps = 26/193 (13%)

Query: 53  KREATICHMLKH-----PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV-Y 106
           K EA I   +++      ++V+    +     + ++FE +  S   +EI+ R    +  +
Sbjct: 79  KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPS--LYEIITRN--NYNGF 134

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
                  Y  ++L+AL Y  +  + H D+KP  +LL +      +         +     
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194

Query: 167 LYCSGGERL-----------DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
              S G +L            H +      I T  Y APEVI +  +    D+W+ G +L
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSI-----INTRQYRAPEVILNLGWDVSSDMWSFGCVL 249

Query: 216 HVLLTGTLPFVGS 228
             L TG+L F   
Sbjct: 250 AELYTGSLLFRTH 262

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 41/196 (20%), Positives = 80/196 (40%), Gaps = 22/196 (11%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
               ++  EA +   + +PHV  LL        + ++ + M    +  + VR        
Sbjct: 59  KANKEILDEAYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCL-LDYVREHKDNIGS 116

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
              +  ++  Q+ + + Y  +  ++HRD+    VL+   ++   VK+  FG+A  L    
Sbjct: 117 QYLL--NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGAE- 170

Query: 167 LYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP 224
                    +      G ++  P  +MA E I  + Y    D+W+ GV +  L+T G+ P
Sbjct: 171 ---------EKEYHAEGGKV--PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

Query: 225 FVG-SRDRLFQSITKG 239
           + G     +   + KG
Sbjct: 220 YDGIPASEISSILEKG 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 68.1 bits (167), Expect = 1e-13
 Identities = 39/182 (21%), Positives = 78/182 (42%), Gaps = 19/182 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
              D   EA I     H +++ L    S    + ++ EYM+   +  + +R     F   
Sbjct: 89  QRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKFLREKDGEFSVL 147

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + V    +R +   ++Y    + +HRD+    +L+ +       K+  FG++  L+D   
Sbjct: 148 QLV--GMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDP- 201

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
                   +   T +G +I  P  + APE I  +K+    D+W+ G+++  ++T G  P+
Sbjct: 202 --------EATYTTSGGKI--PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251

Query: 226 VG 227
             
Sbjct: 252 WE 253

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 39/184 (21%), Positives = 77/184 (41%), Gaps = 23/184 (12%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFV 105
             + +L  EA +   L +P++V ++    +E    +V E  + G    +    +      
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKY---LQQNRHVK 115

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
               +    + QV   ++Y  E++ +HRD+    VLL  +      K+  FG++  L+  
Sbjct: 116 DKNII--ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRAD 170

Query: 166 QLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
           +         ++Y  +   +   P  + APE I   K+    D+W+ GVL+    + G  
Sbjct: 171 E---------NYYKAQTHGKW--PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

Query: 224 PFVG 227
           P+ G
Sbjct: 220 PYRG 223

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 66.5 bits (163), Expect = 4e-13
 Identities = 43/180 (23%), Positives = 78/180 (43%), Gaps = 28/180 (15%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-FEIVRRATAGFVYS 107
             + + EA +   L+HP+VV LL   + +  L M+F Y    D+  F ++R   +    +
Sbjct: 56  REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 115

Query: 108 EAVAS-----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF 156
           +   +           H + Q+   + Y   + ++H+D+    VL+ +K N   VK+   
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN---VKISDL 172

Query: 157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL 215
           G+  ++             D+Y       +  P  +MAPE I   K+    DIW+ GV+L
Sbjct: 173 GLFREVYAA----------DYYKLLGNSLL--PIRWMAPEAIMYGKFSIDSDIWSYGVVL 220

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 66.1 bits (162), Expect = 5e-13
 Identities = 44/194 (22%), Positives = 79/194 (40%), Gaps = 20/194 (10%)

Query: 50  ADLKREATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
               RE  +   L HP+V+ L+      EG+ +++  YM   D+  + +R         +
Sbjct: 67  EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL-LQFIRSPQRNPTVKD 125

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
            +   +  QV   + Y  E   +HRD+     +L        VK+  FG+A  + D    
Sbjct: 126 LI--SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT---VKVADFGLARDILDR--- 177

Query: 169 CSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFV 226
                  ++Y+ +       P  + A E ++  ++    D+W+ GVLL  LLT G  P+ 
Sbjct: 178 -------EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230

Query: 227 G-SRDRLFQSITKG 239
                 L   + +G
Sbjct: 231 HIDPFDLTHFLAQG 244

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 66.2 bits (162), Expect = 6e-13
 Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 26/201 (12%)

Query: 50  ADLKREATICHMLKHPHVVELL------ETYSSEGMLYMVFEYMDGSDI-CFEIVRRA-T 101
            +  REA       HPHV +L+             +  ++  +M   D+  F +  R   
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE 129

Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
             F         +M  +   + Y    + IHRD+     +LA       V +  FG++ +
Sbjct: 130 NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT---VCVADFGLSRK 186

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
           +  G  Y  G                 P  ++A E + D  Y    D+WA GV +  ++T
Sbjct: 187 IYSGDYYRQGCASK------------LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

Query: 221 -GTLPFVG-SRDRLFQSITKG 239
            G  P+ G     ++  +  G
Sbjct: 235 RGQTPYAGIENAEIYNYLIGG 255

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 65.7 bits (161), Expect = 6e-13
 Identities = 50/195 (25%), Positives = 83/195 (42%), Gaps = 20/195 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +    E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      
Sbjct: 70  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVK 128

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +   +  QV + ++Y      +HRD+     +L  K     VK+  FG+A  + D + 
Sbjct: 129 DLI--GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEY 183

Query: 168 YCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF 225
           Y            K G ++  P  +MA E ++ QK+    D+W+ GVLL  L+T G  P+
Sbjct: 184 YSVHN--------KTGAKL--PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233

Query: 226 VG-SRDRLFQSITKG 239
              +   +   + +G
Sbjct: 234 PDVNTFDITVYLLQG 248

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 63.8 bits (156), Expect = 3e-12
 Identities = 33/187 (17%), Positives = 65/187 (34%), Gaps = 27/187 (14%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
                   A++   L H H+V             +V E++    +    +++        
Sbjct: 55  YSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSL-DTYLKKNKNCINIL 113

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-----VKLGGFGVAIQL 162
             +     +Q+  A+ +  EN +IH ++    +LL  +E+        +KL   G++I +
Sbjct: 114 WKL--EVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLT- 220
                             +   RI    ++ PE IE+ K      D W+ G  L  + + 
Sbjct: 172 LP-----------KDILQE---RI---PWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

Query: 221 GTLPFVG 227
           G  P   
Sbjct: 215 GDKPLSA 221

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 64.0 bits (156), Expect = 4e-12
 Identities = 48/197 (24%), Positives = 84/197 (42%), Gaps = 24/197 (12%)

Query: 49  EADLKREATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +    E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      
Sbjct: 134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVK 192

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA--IQLQDG 165
           + +   +  QV + +++      +HRD+     +L  K     VK+  FG+A  +  ++ 
Sbjct: 193 DLI--GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKE- 246

Query: 166 QLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL 223
             +       D    K G ++  P  +MA E ++ QK+    D+W+ GVLL  L+T G  
Sbjct: 247 --F-------DSVHNKTGAKL--PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295

Query: 224 PFVG-SRDRLFQSITKG 239
           P+   +   +   + +G
Sbjct: 296 PYPDVNTFDITVYLLQG 312

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 63.5 bits (155), Expect = 5e-12
 Identities = 38/200 (19%), Positives = 75/200 (37%), Gaps = 25/200 (12%)

Query: 50  ADLKREATICHMLKHPHVVELL-----ETYSSEGMLYMVFEYMDGSDI-CFEIVRRA-TA 102
            +   EA       HP+V+ LL      +        ++  +M   D+  + +  R  T 
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                      +M  +   + Y    + +HRD+     +L +      V +  FG++ ++
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT---VCVADFGLSKKI 197

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT- 220
             G          D+Y      ++  P  ++A E + D+ Y    D+WA GV +  + T 
Sbjct: 198 YSG----------DYYRQGRIAKM--PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245

Query: 221 GTLPFVG-SRDRLFQSITKG 239
           G  P+ G     ++  +  G
Sbjct: 246 GMTPYPGVQNHEMYDYLLHG 265

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 61.9 bits (151), Expect = 2e-11
 Identities = 45/188 (23%), Positives = 71/188 (37%), Gaps = 36/188 (19%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-FEIVRRATAGFVYS 107
           +AD +REA +     +P++V+LL   +    + ++FEYM   D+  F            S
Sbjct: 94  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 153

Query: 108 EAVAS-------------------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS 148
            +  S                      RQV   + Y  E   +HRD+     L+      
Sbjct: 154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV- 212

Query: 149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVD 207
             VK+  FG++  +             D+Y       I  P  +M PE I   +Y    D
Sbjct: 213 --VKIADFGLSRNIYSA----------DYYKADGNDAI--PIRWMPPESIFYNRYTTESD 258

Query: 208 IWAAGVLL 215
           +WA GV+L
Sbjct: 259 VWAYGVVL 266

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 36/210 (17%)

Query: 50  ADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
             L  E  +  ++  H ++V LL   +  G   ++ EY    D+    +RR    F+ S+
Sbjct: 71  EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL-NFLRRKRDSFICSK 129

Query: 109 AVAS---------------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKL 153
              +                +  QV + + +    + IHRD+    +LL +       K+
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI---TKI 186

Query: 154 GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAG 212
             FG+A  +++            +Y  K   R+  P  +MAPE I +  Y    D+W+ G
Sbjct: 187 CDFGLARDIKND----------SNYVVKGNARL--PVKWMAPESIFNCVYTFESDVWSYG 234

Query: 213 VLLHVLLT-GTLPFVG--SRDRLFQSITKG 239
           + L  L + G+ P+ G     + ++ I +G
Sbjct: 235 IFLWELFSLGSSPYPGMPVDSKFYKMIKEG 264

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 61.5 bits (150), Expect = 3e-11
 Identities = 47/179 (26%), Positives = 77/179 (43%), Gaps = 27/179 (15%)

Query: 49  EADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-FEIVRRATAGFVY 106
           +  L  E  I  H+ +H ++V LL   +  G + ++ EY    D+  F   +        
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152

Query: 107 SEAVAS---------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           + A+A+         H+  QV + + +    + IHRD+    VLL N       K+G FG
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV---AKIGDFG 209

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLL 215
           +A  + +            +Y  K   R+  P  +MAPE I D  Y    D+W+ G+LL
Sbjct: 210 LARDIMND----------SNYIVKGNARL--PVKWMAPESIFDCVYTVQSDVWSYGILL 256

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 61.2 bits (149), Expect = 3e-11
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 31/207 (14%)

Query: 49  EADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD-ICFEIVRRATAGFVY 106
            +DL  E  +   + KH +++ LL   + +G LY++ EY    +   +   RR       
Sbjct: 84  LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143

Query: 107 SEAVAS-----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
            +                   Q+   + Y      IHRD+    VL+        +K+  
Sbjct: 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIAD 200

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVL 214
           FG+A  + +           D+Y      R+  P  +MAPE + D+ Y    D+W+ GVL
Sbjct: 201 FGLARDINNI----------DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVL 248

Query: 215 LHVLLT-GTLPFVG-SRDRLFQSITKG 239
           +  + T G  P+ G   + LF+ + +G
Sbjct: 249 MWEIFTLGGSPYPGIPVEELFKLLKEG 275

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 60.8 bits (148), Expect = 4e-11
 Identities = 42/191 (21%), Positives = 68/191 (35%), Gaps = 37/191 (19%)

Query: 43  LNHYTTE---ADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDIC-FEIV 97
           +  Y ++    D   E  + C +  HP+++ LL      G LY+  EY    ++  F   
Sbjct: 60  MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 119

Query: 98  RRATAGFVYSEAVAS-----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE 146
            R            S           H+   V   + Y  +   IHRD+    +L+    
Sbjct: 120 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179

Query: 147 NSAPVKLGGFGVAIQLQDGQLYCSGGER-LDHYTTKAGHRIGTP-HYMAPEVIEDQKYGK 204
                K+  FG++              R  + Y  K   R+  P  +MA E +    Y  
Sbjct: 180 V---AKIADFGLS--------------RGQEVYVKKTMGRL--PVRWMAIESLNYSVYTT 220

Query: 205 PVDIWAAGVLL 215
             D+W+ GVLL
Sbjct: 221 NSDVWSYGVLL 231

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 60.8 bits (148), Expect = 5e-11
 Identities = 48/207 (23%), Positives = 84/207 (40%), Gaps = 31/207 (14%)

Query: 49  EADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD-ICFEIVRRATAGFVY 106
            +DL  E  +   + KH +++ LL   + +G LY++ EY    +   +   RR       
Sbjct: 130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189

Query: 107 SEAVAS-----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
            +                   Q+   + Y      IHRD+    VL+        +K+  
Sbjct: 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV---MKIAD 246

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVL 214
           FG+A  + +           D+Y      R+  P  +MAPE + D+ Y    D+W+ GVL
Sbjct: 247 FGLARDINNI----------DYYKKTTNGRL--PVKWMAPEALFDRVYTHQSDVWSFGVL 294

Query: 215 LHVLLT-GTLPFVG-SRDRLFQSITKG 239
           +  + T G  P+ G   + LF+ + +G
Sbjct: 295 MWEIFTLGGSPYPGIPVEELFKLLKEG 321

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 60.5 bits (147), Expect = 6e-11
 Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 31/207 (14%)

Query: 49  EADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVY 106
            +DL  E  +   + KH +++ LL   + +G LY++ EY   G+   +   RR       
Sbjct: 118 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 177

Query: 107 SEAVAS-----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
                +               QV   + Y      IHRD+    VL+        +K+  
Sbjct: 178 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIAD 234

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVL 214
           FG+A  +             D+Y      R+  P  +MAPE + D+ Y    D+W+ GVL
Sbjct: 235 FGLARDIHHI----------DYYKKTTNGRL--PVKWMAPEALFDRIYTHQSDVWSFGVL 282

Query: 215 LHVLLT-GTLPFVG-SRDRLFQSITKG 239
           L  + T G  P+ G   + LF+ + +G
Sbjct: 283 LWEIFTLGGSPYPGVPVEELFKLLKEG 309

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 59.2 bits (144), Expect = 1e-10
 Identities = 41/188 (21%), Positives = 73/188 (38%), Gaps = 36/188 (19%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD----------ICFEIVR 98
             DL  E  +   + HPHV++L    S +G L ++ EY               +    + 
Sbjct: 70  LRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129

Query: 99  RATAGFVYSEAVAS----------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS 148
              +    S                +  Q+ + ++Y  E  ++HRD+    +L+A     
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK- 188

Query: 149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVD 207
             +K+  FG++  + +           D Y  ++  RI  P  +MA E + D  Y    D
Sbjct: 189 --MKISDFGLSRDVYEE----------DSYVKRSQGRI--PVKWMAIESLFDHIYTTQSD 234

Query: 208 IWAAGVLL 215
           +W+ GVLL
Sbjct: 235 VWSFGVLL 242

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 58.0 bits (141), Expect = 4e-10
 Identities = 44/182 (24%), Positives = 69/182 (37%), Gaps = 30/182 (16%)

Query: 49  EADLKREATI-CHMLKHPHVVELLETYSSEGM-LYMVFEYMD------------GSDICF 94
              L  E  I  H+  H +VV LL   +  G  L ++ E+                 + +
Sbjct: 74  HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 133

Query: 95  EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG 154
           ++          +      Y  QV + + +      IHRD+    +LL+ K     VK+ 
Sbjct: 134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKIC 190

Query: 155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGV 213
            FG+A  +               Y  K   R+  P  +MAPE I D+ Y    D+W+ GV
Sbjct: 191 DFGLARDIYKD----------PDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGV 238

Query: 214 LL 215
           LL
Sbjct: 239 LL 240

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 57.3 bits (139), Expect = 6e-10
 Identities = 40/187 (21%), Positives = 70/187 (37%), Gaps = 36/187 (19%)

Query: 50  ADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSD------------ICFEI 96
             L  E  +   +  H ++V LL   +  G +Y++FEY    D               EI
Sbjct: 93  EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152

Query: 97  VRRATAGFVYSEAVAS-------HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA 149
                      E +          +  QV + + +      +HRD+    VL+ + +   
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-- 210

Query: 150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDI 208
            VK+  FG+A  +              +Y  +   R+  P  +MAPE + +  Y    D+
Sbjct: 211 -VKICDFGLARDIMSD----------SNYVVRGNARL--PVKWMAPESLFEGIYTIKSDV 257

Query: 209 WAAGVLL 215
           W+ G+LL
Sbjct: 258 WSYGILL 264

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 53.7 bits (130), Expect = 9e-09
 Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 36/171 (21%)

Query: 61  MLKHPHVVELLETYSSEG---MLYMVFEYM-DGS--DICFEIVRRATAGFVYSEAVASHY 114
             +H ++VELL  +SS+G    L  V+ YM +GS  D    +       +          
Sbjct: 86  KCQHENLVELL-GFSSDGDDLCL--VYVYMPNGSLLDRLSCLDGTPPLSW-------HMR 135

Query: 115 MRQVLEA---LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSG 171
            +    A   + + HEN  IHRDIK   +LL     +   K+  FG+A      +     
Sbjct: 136 CKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTA---KISDFGLA------RASEKF 186

Query: 172 GERLDHYTTKAGHRI-GTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
            +     T+    RI GT  YMAPE +  +   K  DI++ GV+L  ++TG
Sbjct: 187 AQT--VMTS----RIVGTTAYMAPEALRGEITPK-SDIYSFGVVLLEIITG 230

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 49.5 bits (119), Expect = 3e-07
 Identities = 46/182 (25%), Positives = 72/182 (39%), Gaps = 38/182 (20%)

Query: 61  MLKHPHVVELLETYSSEG---MLYMVFEYMD-GSDICFEIVRRATAGFVYSEAVASHYMR 116
           M  H +++ L   +       +L  V+ YM  GS      V         S+       R
Sbjct: 83  MAVHRNLLRLR-GFCMTPTERLL--VYPYMANGS------VASCLRERPESQPPLDWPKR 133

Query: 117 Q-----VLEALRYCHEN---DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           Q         L Y H++    IIHRD+K   +LL  +  +    +G FG+A  +      
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA---VVGDFGLAKLMDYKD-- 188

Query: 169 CSGGERLDHYTTKAGHRI-GTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                   H TT     + GT  ++APE +   K  +  D++  GV+L  L+TG   F  
Sbjct: 189 -------THVTT----AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL 237

Query: 228 SR 229
           +R
Sbjct: 238 AR 239

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 49.2 bits (117), Expect = 4e-07
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 17/116 (14%)

Query: 114 YMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGE 173
           Y  QV + + +      IHRD+    +LL+ K     VK+  FG+A  +           
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKD-------- 246

Query: 174 RLDHYTTKAGHRIGTP-HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
               Y  K   R+  P  +MAPE I D+ Y    D+W+ GVLL  + + G  P+ G
Sbjct: 247 --PDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 48.0 bits (115), Expect = 8e-07
 Identities = 44/185 (23%), Positives = 76/185 (41%), Gaps = 34/185 (18%)

Query: 62  LKHPHVVELLETYSSEG---MLYMVFEYMD-GSDICFEIVRRATAGFVYSEAVASHYMRQ 117
            +HPH+V L+  +  E    +L  +++YM+ G+      ++R   G        S   R 
Sbjct: 92  CRHPHLVSLI-GFCDERNEMIL--IYKYMENGN------LKRHLYGSDLPTMSMSWEQRL 142

Query: 118 --VLEA---LRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
              + A   L Y H   IIHRD+K   +LL         K+  FG++      +      
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP---KITDFGIS------KKGTELD 193

Query: 173 ERLDHYTTKAGHRI-GTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDR 231
           +   H +T     + GT  Y+ PE     +  +  D+++ GV+L  +L      V S  R
Sbjct: 194 Q--THLST----VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR 247

Query: 232 LFQSI 236
              ++
Sbjct: 248 EMVNL 252

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 48.2 bits (115), Expect = 8e-07
 Identities = 23/77 (29%), Positives = 35/77 (45%), Gaps = 9/77 (11%)

Query: 117 QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLD 176
           ++L+ L Y HE++ +H DIK   +LL N +N   V L  +G+A +      YC  G    
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLL-NYKNPDQVYLVDYGLAYR------YCPEGVH-K 211

Query: 177 HYTTKAGHR-IGTPHYM 192
            Y         GT  + 
Sbjct: 212 AYAADPKRCHDGTIEFT 228

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 47.7 bits (113), Expect = 1e-06
 Identities = 31/138 (22%), Positives = 57/138 (41%), Gaps = 24/138 (17%)

Query: 117 QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLD 176
           Q++  + + H    +HRDIKP   L+     +  V +  FG+A + +D     +   +  
Sbjct: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD-----TSTHQHI 165

Query: 177 HYTTKAGHRIGTPHYM---APEVIE----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-- 227
            Y        GT  Y        IE    D       D+ + G +L   L G+LP+ G  
Sbjct: 166 PYRENKN-LTGTARYASVNTHLGIEQSRRD-------DLESLGYVLMYFLRGSLPWQGLK 217

Query: 228 --SRDRLFQSITKGKLHI 243
             ++ + ++ I++ K+  
Sbjct: 218 AGTKKQKYEKISEKKVAT 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 23/77 (29%), Positives = 36/77 (46%), Gaps = 9/77 (11%)

Query: 117 QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLD 176
           ++L+ L Y HEN+ +H DIK   +LL   +N   V L  +G++ +      YC  G    
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLSYR------YCPNGNHKQ 211

Query: 177 -HYTTKAGHRIGTPHYM 192
                + GH  GT  + 
Sbjct: 212 YQENPRKGH-NGTIEFT 227

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 22/112 (19%), Positives = 48/112 (42%), Gaps = 10/112 (8%)

Query: 81  YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCV 140
           ++V   + G  +  +     +   V SE        ++L+AL + HEN+ +H ++    +
Sbjct: 134 FLVLPSL-GRSL--QSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENI 190

Query: 141 LLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYM 192
            + + E+ + V L G+G A +      YC  G+ + +         G   ++
Sbjct: 191 FV-DPEDQSQVTLAGYGFAFR------YCPSGKHVAYVEGSRSPHEGDLEFI 235

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 46.2 bits (110), Expect = 3e-06
 Identities = 31/133 (23%), Positives = 59/133 (44%), Gaps = 12/133 (9%)

Query: 117 QVLEALRYCHENDIIHRDIKPHCVLL--ANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           Q+L  ++  HE  +++RDIKP   L+   N +N+  + +  FG+    +D        + 
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV----TKQH 169

Query: 175 LDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----SRD 230
           +  Y  K     GT  YM+      ++  +  D+ A G +    L G+LP+ G    +  
Sbjct: 170 IP-YREKKN-LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK 227

Query: 231 RLFQSITKGKLHI 243
           + ++ I + K   
Sbjct: 228 QKYERIGEKKQST 240

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 45.4 bits (108), Expect = 6e-06
 Identities = 31/139 (22%), Positives = 58/139 (41%), Gaps = 26/139 (18%)

Query: 117 QVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLD 176
           Q++  + Y H  + IHRD+KP   L+   +    V +  FG+A + +D +      +   
Sbjct: 113 QMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR----THQ--- 165

Query: 177 HYTTKAGHR-IGTPHYM---APEVIE----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG- 227
           H   +      GT  Y        IE    D       D+ + G +L     G+LP+ G 
Sbjct: 166 HIPYRENKNLTGTARYASINTHLGIEQSRRD-------DLESLGYVLMYFNLGSLPWQGL 218

Query: 228 ---SRDRLFQSITKGKLHI 243
              ++ + ++ I++ K+  
Sbjct: 219 KAATKRQKYERISEKKMST 237

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 44.5 bits (104), Expect = 1e-05
 Identities = 18/100 (18%), Positives = 36/100 (36%), Gaps = 14/100 (14%)

Query: 74  YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIH 132
           +  +  L++V E+  G     ++  + +     S A A   + Q+  +L     +    H
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLS-----SLATAKSILHQLTASLAVAEASLRFEH 185

Query: 133 RDIKPHCVL--------LANKENSAPVKLGGFGVAIQLQD 164
           RD+    VL        L    N     +   G+ + + D
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 42.4 bits (100), Expect = 6e-05
 Identities = 30/141 (21%), Positives = 52/141 (36%), Gaps = 28/141 (19%)

Query: 117 QVLEALRYCHENDIIHRDIKPHCVLL--ANKENSAPVKLGGFGVAIQLQDGQLYCSGGER 174
           Q++  + Y H  ++I+RD+KP   L+     +    + +  F +A +  D +        
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK------ 166

Query: 175 LDHYTTKAGHR-IGTPHYMAPEV---IE----DQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
             H   +      GT  YM+       E    D       D+ A G +    L G+LP+ 
Sbjct: 167 -KHIPYREHKSLTGTARYMSINTHLGKEQSRRD-------DLEALGHMFMYFLRGSLPWQ 218

Query: 227 G----SRDRLFQSITKGKLHI 243
           G    +    +Q I   K   
Sbjct: 219 GLKADTLKERYQKIGDTKRAT 239

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	249
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.98
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.98
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.98
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.98
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.98
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.97
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.83
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.64
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.42
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.19
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.89
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.8
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.77
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.47
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.37
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.27
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.82
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.53
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.46
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.98
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.9
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.69
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.45
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.3
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.05
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.46
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.13
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	92.2
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	91.64
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	91.33
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	91.09
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.95
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	89.7
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	86.94
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.43
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	85.01
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	80.14

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.4e-50  Score=331.48  Aligned_cols=220  Identities=22%  Similarity=0.432  Sum_probs=190.6

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|.+.++|+.|.++.++...+......++++   +....+....+.+.+|+.+|++++||||++++++|++.+.+|+|||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4899999999999999987766554444443   4444555667889999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++||+|.+++...+.    +++.+++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|......
T Consensus       113 y~~gG~L~~~i~~~~~----l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~---vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          113 YAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECCTT
T ss_pred             cCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC---EEEEEcCCceecCCC
Confidence            9999999999987654    999999999999999999999999999999999999987776   999999999876542


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      ..           ........||+.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++.+.|.++++.+|
T Consensus       186 ~~-----------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p  254 (311)
T 4aw0_A          186 SK-----------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP  254 (311)
T ss_dssp             TT-----------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             CC-----------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            21           1223345699999999999999999999999999999999999999998 67789999999999988


Q ss_pred             cc
Q psy14626        245 GC  246 (249)
Q Consensus       245 ~~  246 (249)
                      ..
T Consensus       255 ~~  256 (311)
T 4aw0_A          255 EK  256 (311)
T ss_dssp             TT
T ss_pred             cc
Confidence            53

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=8.7e-50  Score=332.69  Aligned_cols=216  Identities=25%  Similarity=0.405  Sum_probs=187.3

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ||.++|.+.+.|+.|.++.+|...+......++++.....+....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus        71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm  150 (346)
T 4fih_A           71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  150 (346)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            67788999999999999999988777666666666555555556677999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++||+|.+++...     .+++.+++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|.....
T Consensus       151 Ey~~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~  222 (346)
T 4fih_A          151 EFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSK  222 (346)
T ss_dssp             CCCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC---EEEecCcCceecCC
Confidence            999999999988642     2899999999999999999999999999999999999988776   99999999987654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      ..             .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+ +..+++..|.++.+
T Consensus       223 ~~-------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~  287 (346)
T 4fih_A          223 EV-------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP  287 (346)
T ss_dssp             SS-------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred             CC-------------CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence            32             122234699999999999999999999999999999999999999998 56677888887653

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=335.14  Aligned_cols=216  Identities=25%  Similarity=0.405  Sum_probs=188.0

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ||.++|++.+.|+.|.++.+|...+......++++..........+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus       148 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            67889999999999999999988877666666666555555566678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |||+||+|.+++...     .+++.++..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|.....
T Consensus       228 Ey~~gG~L~~~i~~~-----~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~---vKl~DFGla~~~~~  299 (423)
T 4fie_A          228 EFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---VKLSDFGFCAQVSK  299 (423)
T ss_dssp             ECCTTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC---EEECCCTTCEECCS
T ss_pred             eCCCCCcHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---EEEecCccceECCC
Confidence            999999999988543     2899999999999999999999999999999999999988776   99999999987654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      ..             .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+ +..+++..|.++..
T Consensus       300 ~~-------------~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~  364 (423)
T 4fie_A          300 EV-------------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP  364 (423)
T ss_dssp             SC-------------CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred             CC-------------ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence            32             122334699999999999999999999999999999999999999998 56677888887653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-48  Score=317.00  Aligned_cols=216  Identities=31%  Similarity=0.570  Sum_probs=171.6

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +|++.+.|+.|.++.++...+......++++   +.........+.+.+|+.+|++++||||+++++++.+.+.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            7999999999999999887765544444443   3444445567789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+ +|+|.+++..+..    +++.+++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||+|+.....
T Consensus        94 y~-~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~---vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN---VKIADFGLSNIMTDG  165 (275)
T ss_dssp             CC-CEEHHHHHHHSCS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC---EEECCSSCC------
T ss_pred             CC-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC---EEEeecCCCeecCCC
Confidence            99 6799998876543    999999999999999999999999999999999999987776   999999999765442


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      .              ......||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+ +..++.+.|.++.+++
T Consensus       166 ~--------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~  231 (275)
T 3hyh_A          166 N--------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTL  231 (275)
T ss_dssp             -----------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             C--------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            2              1123469999999999998876 6899999999999999999999998 6678899999999988


Q ss_pred             ccc
Q psy14626        244 LGC  246 (249)
Q Consensus       244 ~~~  246 (249)
                      |..
T Consensus       232 p~~  234 (275)
T 3hyh_A          232 PKF  234 (275)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            853

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.1e-49  Score=328.55  Aligned_cols=216  Identities=27%  Similarity=0.476  Sum_probs=176.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +||++.+.|+.|.++.+|...+......++++....  ......+.+.+|+.+|++++|||||+++++|.+++.+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            589999999999999999877665544455443221  223456789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++||+|.+++..+..  ..+++.+++.|+.||+.||.|||++||+||||||+|||++.++.   +||+|||+++.....
T Consensus       104 y~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT---VQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC---EEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC---EEEcccccceeecCC
Confidence            9999999999976543  33799999999999999999999999999999999999988776   999999999665431


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      .             .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+ +..++...|.++.+
T Consensus       179 ~-------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~  242 (350)
T 4b9d_A          179 V-------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF  242 (350)
T ss_dssp             H-------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC
T ss_pred             c-------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence            1             111223589999999999999999999999999999999999999998 66778888888875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.7e-49  Score=324.91  Aligned_cols=217  Identities=29%  Similarity=0.466  Sum_probs=176.4

Q ss_pred             CcchHHHhhcccceeeEeeecccc---C---CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI---E---PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .+|++.+.|+.|.++.+|...+..   .   ++.+.+.+.... ......+.+|+.+|++++||||+++++++.+++.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            469999999999999998654321   1   233333333322 233457889999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++||+|.+++.....    +++.+++.++.|++.||.|||++|++||||||+|||++.++.   +||+|||+|+.
T Consensus       103 ivmEy~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---vKl~DFGla~~  175 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH---IKLTDFGLSKE  175 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC---EEEESSEEEEC
T ss_pred             EEEEcCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC---EEeccccccee
Confidence            99999999999999987654    899999999999999999999999999999999999988776   99999999976


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....             +......||+.|+|||++.+..++.++|+||+||++|||++|+.||.+ +..++...|.++.
T Consensus       176 ~~~~~-------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~  242 (304)
T 3ubd_A          176 SIDHE-------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK  242 (304)
T ss_dssp             ------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred             ccCCC-------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC
Confidence            54322             122334699999999999999999999999999999999999999998 6778899999999


Q ss_pred             ccccc
Q psy14626        241 LHILG  245 (249)
Q Consensus       241 ~~~~~  245 (249)
                      +.+|.
T Consensus       243 ~~~p~  247 (304)
T 3ubd_A          243 LGMPQ  247 (304)
T ss_dssp             CCCCT
T ss_pred             CCCCC
Confidence            98885

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=6.7e-48  Score=316.90  Aligned_cols=223  Identities=22%  Similarity=0.372  Sum_probs=180.3

Q ss_pred             CcchHHHhhcccceeeEeeecccc-----CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +.|.+.+.|+.|.++.+|......     ....++++.....+....+.|.+|+.+|++++|||||+++++|.+++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            468888899999999998765321     112233333333445567889999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhh---------hcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEE
Q psy14626         83 VFEYMDGSDICFEIVRRA---------TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKL  153 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l  153 (249)
                      ||||+++|+|.+++....         .....+++.+++.++.|++.||.|||+++++||||||+|||++.++.   +||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~---~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL---VKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc---EEE
Confidence            999999999999997653         22345899999999999999999999999999999999999988776   999


Q ss_pred             cCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHH
Q psy14626        154 GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDR  231 (249)
Q Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~  231 (249)
                      +|||+++.......           ........+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+ +..+
T Consensus       170 ~DFGla~~~~~~~~-----------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~  238 (299)
T 4asz_A          170 GDFGMSRDVYSTDY-----------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE  238 (299)
T ss_dssp             CCCSCHHHHTGGGC-----------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             CCcccceecCCCCc-----------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999965543221           111223358999999999999999999999999999999998 9999998 6778


Q ss_pred             HHHHHHcCc-cccc
Q psy14626        232 LFQSITKGK-LHIL  244 (249)
Q Consensus       232 ~~~~i~~g~-~~~~  244 (249)
                      +...|.+|. +..|
T Consensus       239 ~~~~i~~~~~~~~p  252 (299)
T 4asz_A          239 VIECITQGRVLQRP  252 (299)
T ss_dssp             HHHHHHHTCCCCCC
T ss_pred             HHHHHHcCCCCCCC
Confidence            899998886 3444

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-47  Score=310.02  Aligned_cols=213  Identities=24%  Similarity=0.410  Sum_probs=171.7

Q ss_pred             CCCcc-hHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeec----CC
Q psy14626          6 PNKRI-TIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSS----EG   78 (249)
Q Consensus         6 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~   78 (249)
                      +..|| ++...|+.|.++.+|...+......++++...  .......+.|.+|+.+|++++|||||+++++|.+    ++
T Consensus        23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            44455 67788999999999977665444444433222  2223456789999999999999999999999864    35


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeee-cCCCCCeEEcC
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLAN-KENSAPVKLGG  155 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~-~~~~~~~~l~d  155 (249)
                      .+++||||++||+|.+++.....    +++..++.|+.||+.||.|||+++  |+||||||+|||++. ++.   +||+|
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~---vKl~D  175 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIGD  175 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSC---EEECC
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCC---EEEEe
Confidence            68999999999999999976543    899999999999999999999998  999999999999974 344   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHH
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLF  233 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~  233 (249)
                      ||+|......               ......||+.|+|||++.+ +++.++||||+||++|||++|+.||.+  +...+.
T Consensus       176 FGla~~~~~~---------------~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~  239 (290)
T 3fpq_A          176 LGLATLKRAS---------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY  239 (290)
T ss_dssp             TTGGGGCCTT---------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH
T ss_pred             CcCCEeCCCC---------------ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHH
Confidence            9998543221               1223469999999999875 589999999999999999999999986  456678


Q ss_pred             HHHHcCcc
Q psy14626        234 QSITKGKL  241 (249)
Q Consensus       234 ~~i~~g~~  241 (249)
                      ..+.++..
T Consensus       240 ~~i~~~~~  247 (290)
T 3fpq_A          240 RRVTSGVK  247 (290)
T ss_dssp             HHHTTTCC
T ss_pred             HHHHcCCC
Confidence            88877753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.3e-47  Score=318.63  Aligned_cols=217  Identities=24%  Similarity=0.308  Sum_probs=175.1

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccC
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD   88 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (249)
                      .|++.+.|+.|.++.+|...+......++++......     ...+|+.+++.++|||||+++++|.+++.+|+||||++
T Consensus        59 ~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~  133 (336)
T 4g3f_A           59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE  133 (336)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             heEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccC
Confidence            4667778999999999987766554455554433221     12479999999999999999999999999999999999


Q ss_pred             CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626         89 GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                      ||+|.+++.....    +++.+++.++.|++.||.|||+++|+||||||+|||++.++.  .+||+|||++.........
T Consensus       134 gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          134 GGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS--RAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             TCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC--CEEECCCTTCEEC------
T ss_pred             CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC--EEEEeeCCCCeEccCCCcc
Confidence            9999999977654    999999999999999999999999999999999999987652  2999999999876543210


Q ss_pred             ccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                              ..........||+.|+|||++.+..++.++||||+||++|||++|+.||.+ +..++...|.++.+.++
T Consensus       208 --------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~  276 (336)
T 4g3f_A          208 --------KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR  276 (336)
T ss_dssp             --------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG
T ss_pred             --------cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch
Confidence                    011122234589999999999999999999999999999999999999998 55667888888876544

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=311.69  Aligned_cols=219  Identities=21%  Similarity=0.328  Sum_probs=172.9

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      |++++ +.+++.+.|+.|.++.+|.......++++.++... .+....+.|.+|+.+|++++|||||++++++.++ .++
T Consensus        31 Wei~~-~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~~~  107 (307)
T 3omv_A           31 WEIEA-SEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD-NLA  107 (307)
T ss_dssp             CBCCT-TSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SCE
T ss_pred             cEEcH-HHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECC-eEE
Confidence            44444 46788899999999999988776666665554332 3345678899999999999999999999988654 589


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++||+|.+++.....   .+++.++..++.|++.||.|||+++|+||||||+|||++.++.   +||+|||+|+.
T Consensus       108 iVmEy~~gGsL~~~l~~~~~---~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~---~Ki~DFGla~~  181 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQET---KFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT---VKIGDFGLATV  181 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE---EEECCCSSCBC
T ss_pred             EEEEcCCCCCHHHHHhhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc---EEEeeccCcee
Confidence            99999999999999865432   3899999999999999999999999999999999999987765   99999999966


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCC-C-hHHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLTGTLPFVG-S-RDRLFQSI  236 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~pf~~-~-~~~~~~~i  236 (249)
                      ......           ........||+.|+|||++.+   .+++.++|||||||++|||++|+.||.+ + ...+...+
T Consensus       182 ~~~~~~-----------~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~  250 (307)
T 3omv_A          182 KSRWSG-----------SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV  250 (307)
T ss_dssp             -----------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred             cccCCc-----------ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            543211           111223468999999999864   3578999999999999999999999987 3 34556666


Q ss_pred             HcCc
Q psy14626        237 TKGK  240 (249)
Q Consensus       237 ~~g~  240 (249)
                      .++.
T Consensus       251 ~~~~  254 (307)
T 3omv_A          251 GRGY  254 (307)
T ss_dssp             HTTC
T ss_pred             hcCC
Confidence            6653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=313.33  Aligned_cols=222  Identities=23%  Similarity=0.348  Sum_probs=173.8

Q ss_pred             cchHHHhhcccceeeEeeeccc-----cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+.+.+.|+.|.++.+|.....     .....++++.....+....+.|.+|+.+|++++|||||+++++|.+++.+++|
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV  121 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMV  121 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            4666778999999999876532     11222333333334455678899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhc-----------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         84 FEYMDGSDICFEIVRRATA-----------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~-----------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      |||+++|+|.+++......           ...+++.+++.|+.|++.||.|||+++++||||||+|||++.++.   +|
T Consensus       122 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~---~K  198 (329)
T 4aoj_A          122 FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV---VK  198 (329)
T ss_dssp             EECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE---EE
T ss_pred             EEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc---EE
Confidence            9999999999998764321           235899999999999999999999999999999999999987766   99


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChH
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRD  230 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~  230 (249)
                      |+|||+++........           .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+ +..
T Consensus       199 i~DFGla~~~~~~~~~-----------~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYY-----------RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             ECCCC---------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             EcccccceeccCCCcc-----------eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999766442211           11223358999999999999999999999999999999999 9999998 677


Q ss_pred             HHHHHHHcCc-cccc
Q psy14626        231 RLFQSITKGK-LHIL  244 (249)
Q Consensus       231 ~~~~~i~~g~-~~~~  244 (249)
                      ++.+.|.+|. +.+|
T Consensus       268 ~~~~~i~~g~~~~~p  282 (329)
T 4aoj_A          268 EAIDCITQGRELERP  282 (329)
T ss_dssp             HHHHHHHHTCCCCCC
T ss_pred             HHHHHHHcCCCCCCc
Confidence            7888888875 5555

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-46  Score=309.91  Aligned_cols=216  Identities=23%  Similarity=0.361  Sum_probs=176.7

Q ss_pred             cchHHHhhcccceeeEeeeccc--------cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAE--------IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .+++.+.|+.|.|+.+|.....        ..++++.+...  .+....+.|.+|+.++++++|||||+++++|.+++.+
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~  104 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL  104 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC---CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc--cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence            5667778999999999876521        22334443322  2334567899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC
Q psy14626         81 YMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS  148 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~  148 (249)
                      ++||||+++|+|.+++..+...            ...+++.++..++.|++.||.|||++++|||||||+|||++.++. 
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~-  183 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN-  183 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC-
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC-
Confidence            9999999999999999764321            234899999999999999999999999999999999999988776 


Q ss_pred             CCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy14626        149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG  227 (249)
Q Consensus       149 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~  227 (249)
                        +||+|||+++.......           ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus       184 --~Ki~DFGlar~~~~~~~-----------~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~  250 (308)
T 4gt4_A          184 --VKISDLGLFREVYAADY-----------YKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG  250 (308)
T ss_dssp             --EEECCSCCBCGGGGGGC-----------BCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             --EEECCcccceeccCCCc-----------eeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence              99999999876543221           112233458999999999999999999999999999999998 9999998


Q ss_pred             -ChHHHHHHHHcCc
Q psy14626        228 -SRDRLFQSITKGK  240 (249)
Q Consensus       228 -~~~~~~~~i~~g~  240 (249)
                       +..++.+.|.+|.
T Consensus       251 ~~~~~~~~~i~~~~  264 (308)
T 4gt4_A          251 YSNQDVVEMIRNRQ  264 (308)
T ss_dssp             CCHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHcCC
Confidence             6778888998876

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.2e-44  Score=302.11  Aligned_cols=225  Identities=20%  Similarity=0.307  Sum_probs=177.3

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC-----CCcccCChhc-cccchhHHHHHHHHHHHHHcCC-CChhhhhheeec-CC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE-----PASFGLPDER-LNHYTTEADLKREATICHMLKH-PHVVELLETYSS-EG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~-~~   78 (249)
                      .++|++.+.|+.|.|+.+|.......     ...++++... .......+.|.+|+.+|++++| ||||+++++|.+ ++
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~  142 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG  142 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence            35899999999999999987653311     1122222221 1223456789999999999965 899999999965 45


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                      .+++|||||++|+|.+++......            ...+++.++..++.|++.||.|||++++|||||||+|||++.++
T Consensus       143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~  222 (353)
T 4ase_A          143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  222 (353)
T ss_dssp             CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence            789999999999999999865432            23489999999999999999999999999999999999998877


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF  225 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf  225 (249)
                      .   +||+|||+|+.......           ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus       223 ~---vKi~DFGlar~~~~~~~-----------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          223 V---VKICDFGLARDIYKDPD-----------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             C---EEECCCGGGSCTTTCTT-----------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             C---EEECcchhhhhcccCCC-----------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            6   99999999976544221           112223458899999999999999999999999999999998 99999


Q ss_pred             CC--ChHHHHHHHHcCc-ccccc
Q psy14626        226 VG--SRDRLFQSITKGK-LHILG  245 (249)
Q Consensus       226 ~~--~~~~~~~~i~~g~-~~~~~  245 (249)
                      .+  ..+.+...+.+|. +.+|.
T Consensus       289 ~~~~~~~~~~~~i~~g~~~~~p~  311 (353)
T 4ase_A          289 PGVKIDEEFCRRLKEGTRMRAPD  311 (353)
T ss_dssp             TTCCCSHHHHHHHHHTCCCCCCT
T ss_pred             CCCCHHHHHHHHHHcCCCCCCCc
Confidence            98  3566777777764 55553

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=303.37  Aligned_cols=220  Identities=22%  Similarity=0.341  Sum_probs=175.0

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeec-----
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSS-----   76 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----   76 (249)
                      ++.+.+|.+.+.|+.|.++.+|...+......++++...  .......+.+.+|+.+|+.++||||+++++++..     
T Consensus        50 ~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           50 FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTT
T ss_pred             CCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccc
Confidence            456679999999999999999988766555555554322  2334556788999999999999999999998753     


Q ss_pred             -CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         77 -EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        77 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                       .+.+|+||||+. |+|.+++....    .+++.+++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~~~----~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~---~Ki~D  201 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHSSQ----PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE---LKIGD  201 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTSSS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---EEECC
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC---EEEee
Confidence             367999999996 57988886543    3999999999999999999999999999999999999987776   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHH
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLF  233 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~  233 (249)
                      ||++.........         .........||+.|+|||++.+. .++.++||||+||++|||++|++||.+ +..+.+
T Consensus       202 FGla~~~~~~~~~---------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l  272 (398)
T 4b99_A          202 FGMARGLCTSPAE---------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL  272 (398)
T ss_dssp             CTTCBCC----------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH
T ss_pred             cceeeecccCccc---------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999765432210         01122334699999999998875 469999999999999999999999998 555666


Q ss_pred             HHHHcCc
Q psy14626        234 QSITKGK  240 (249)
Q Consensus       234 ~~i~~g~  240 (249)
                      +.|.+..
T Consensus       273 ~~I~~~~  279 (398)
T 4b99_A          273 QLIMMVL  279 (398)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHhc
Confidence            6776543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.4e-44  Score=293.51  Aligned_cols=223  Identities=21%  Similarity=0.372  Sum_probs=161.1

Q ss_pred             chHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----------
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEG----------   78 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----------   78 (249)
                      |.+.+.|+.|.++.+|...+......++++..... .....+.+.+|+.+|++++||||++++++|.+.+          
T Consensus         7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~   86 (299)
T 4g31_A            7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP   86 (299)
T ss_dssp             EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred             CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence            66778899999999998877666666666544333 2345678999999999999999999999996543          


Q ss_pred             --eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         79 --MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        79 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                        .+|+||||++|++|.+++..+... ...+...++.++.|++.||.|||++|++||||||+|||++.++.   +||+||
T Consensus        87 ~~~l~ivmE~~~gg~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~---vKl~DF  162 (299)
T 4g31_A           87 KVYLYIQMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDF  162 (299)
T ss_dssp             CEEEEEEEECCCSCCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCC
T ss_pred             CcEEEEEEecCCCCcHHHHHHhcCCC-ChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc---EEEccC
Confidence              379999999999999998764331 22466778999999999999999999999999999999987776   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCChH--HHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD--RLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~~--~~~~  234 (249)
                      |+|+.............. ...........||+.|+|||++.+..++.++||||+||++|||++   ||.+..+  ....
T Consensus       163 Gla~~~~~~~~~~~~~~~-~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          163 GLVTAMDQDEEEQTVLTP-MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCC---------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             ccceecCCCccccccccc-cccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            999776543221110000 000112223459999999999999999999999999999999996   8877333  3444


Q ss_pred             HHHcCc
Q psy14626        235 SITKGK  240 (249)
Q Consensus       235 ~i~~g~  240 (249)
                      .+.+++
T Consensus       239 ~~~~~~  244 (299)
T 4g31_A          239 DVRNLK  244 (299)
T ss_dssp             HHHTTC
T ss_pred             HHhcCC
Confidence            555544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.1e-43  Score=315.62  Aligned_cols=219  Identities=27%  Similarity=0.471  Sum_probs=188.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ++|.+.+.|+.|.++.++...+......++++..........+.+.+|+.+|+.++||||++++++|.+.+.+++||||+
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            47899999999999999988777666666666555555566788999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      .||+|.+++..+..   .+++.+++.++.||+.||.|||+++++||||||+|||++.+. ...+||+|||++........
T Consensus       237 ~gg~L~~~i~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~-~~~vKl~DFG~a~~~~~~~~  312 (573)
T 3uto_A          237 SGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQS  312 (573)
T ss_dssp             CCCBHHHHHTCTTS---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCSSCEECCTTSE
T ss_pred             CCCcHHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCC-CCCEEEeeccceeEccCCCc
Confidence            99999998865432   389999999999999999999999999999999999997642 22399999999988755321


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                                    .....||+.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..+++..|.++.+.+|
T Consensus       313 --------------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~  376 (573)
T 3uto_A          313 --------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD  376 (573)
T ss_dssp             --------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             --------------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCC
Confidence                          1123589999999999999999999999999999999999999998 66788999999988776

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.5e-43  Score=312.15  Aligned_cols=217  Identities=20%  Similarity=0.379  Sum_probs=179.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHH---HHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKRE---ATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E---~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      +.|.+..+|+.|.++.++...+......++++   +...........+.+|   +.+++.++||||++++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            46888899999999999987766555555544   3334334444445555   55666778999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++||+|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||+|..
T Consensus       269 lVmEy~~GGdL~~~l~~~~~----l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~---vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC---EEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC---EEecccceeee
Confidence            99999999999999987654    999999999999999999999999999999999999988776   99999999987


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCC----ChHHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIWAAGVLLHVLLTGTLPFVG----SRDRLFQSI  236 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~~l~el~~g~~pf~~----~~~~~~~~i  236 (249)
                      .....               .....||+.|+|||++. +..++.++|+||+||++|||++|++||.+    +..++...+
T Consensus       342 ~~~~~---------------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i  406 (689)
T 3v5w_A          342 FSKKK---------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT  406 (689)
T ss_dssp             CSSCC---------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH
T ss_pred             cCCCC---------------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh
Confidence            65422               22346999999999996 45789999999999999999999999986    234677888


Q ss_pred             HcCccccccc
Q psy14626        237 TKGKLHILGC  246 (249)
Q Consensus       237 ~~g~~~~~~~  246 (249)
                      ..+.+.+|..
T Consensus       407 ~~~~~~~p~~  416 (689)
T 3v5w_A          407 LTMAVELPDS  416 (689)
T ss_dssp             HHCCCCCCTT
T ss_pred             cCCCCCCCcc
Confidence            8898888853

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.1e-42  Score=288.30  Aligned_cols=211  Identities=20%  Similarity=0.307  Sum_probs=163.5

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccC---CCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (249)
                      ..++|++.+.|+.|.++.+|...+...   ...++++..  ........+.+|+.+|+.+ +||||++++++|.+.+.+|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i--~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL--IPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEE--CTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEE--ccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            356899999999999999997765432   122333322  2234456789999999999 6999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++|++|.+++.       .+++.+++.++.||+.||.|||++||+||||||+|||++.+.  ..++|+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~--~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL--KKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT--TEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC--CeEEECcCCCCcc
Confidence            9999999999998873       289999999999999999999999999999999999997652  2399999999987


Q ss_pred             ccCCCccccCCccc---------------cccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCC
Q psy14626        162 LQDGQLYCSGGERL---------------DHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPF  225 (249)
Q Consensus       162 ~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf  225 (249)
                      ..+...........               ...........||+.|+|||++.+. .++.++|+||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            65543211100000               0001112234699999999999875 4799999999999999999999999


Q ss_pred             CC
Q psy14626        226 VG  227 (249)
Q Consensus       226 ~~  227 (249)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            75

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.9e-42  Score=281.94  Aligned_cols=200  Identities=19%  Similarity=0.236  Sum_probs=151.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----eEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG----MLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~l   82 (249)
                      .++|.+.+.|+.|.++.+|.....  ...++++..... ......+..|+..+.+++||||+++++++.+++    .+++
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~-~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc-chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            467889999999999999876543  222333322211 122223345666667889999999999997653    5899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN--------DIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~--------~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                      ||||+++|+|.+++....     +++..+..++.|++.||.|||++        +++||||||+|||++.++.   +||+
T Consensus        79 V~Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~---~Ki~  150 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIA  150 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC---EEEC
T ss_pred             EecCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC---EEEE
Confidence            999999999999996532     89999999999999999999987        8999999999999987776   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC------CCCCcchHHHHHHHHHHHHhCCCCCC
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ------KYGKPVDIWAAGVLLHVLLTGTLPFV  226 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g~~pf~  226 (249)
                      |||+++........         ..+......||+.|+|||++.+.      .++.++|||||||++|||++|..||.
T Consensus       151 DFGla~~~~~~~~~---------~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~  219 (303)
T 3hmm_A          151 DLGLAVRHDSATDT---------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             CCTTCEEEETTTTE---------ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             eCCCCccccCCCCc---------eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence            99999776543211         11122334689999999998764      35678999999999999999976553

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.8e-40  Score=278.28  Aligned_cols=225  Identities=62%  Similarity=1.066  Sum_probs=189.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-----cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-----HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .++|++.+.++.|.++.+|...+......++++.....     .....+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            45899999999999999987766544444444422211     1224678999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++|++|.+.+......+..+++..+..++.|++.||.|||+++++|+||||+||+++.++....++|+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            99999999999988887766666689999999999999999999999999999999999998776666699999999977


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCChHHHHHHHHcCcc
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSITKGKL  241 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~~~~~~~i~~g~~  241 (249)
                      ......             ......+|+.|+|||++.+..++.++|+||+||++|+|++|+.||.+..+++.+.+.++.+
T Consensus       183 ~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~  249 (351)
T 3c0i_A          183 LGESGL-------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKY  249 (351)
T ss_dssp             CCTTSC-------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCC
T ss_pred             ecCCCe-------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCC
Confidence            654321             1122358999999999998889999999999999999999999999988888888988887


Q ss_pred             ccc
Q psy14626        242 HIL  244 (249)
Q Consensus       242 ~~~  244 (249)
                      .++
T Consensus       250 ~~~  252 (351)
T 3c0i_A          250 KMN  252 (351)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            665

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.1e-40  Score=271.20  Aligned_cols=204  Identities=28%  Similarity=0.484  Sum_probs=176.9

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      -++.++|++.+.++.|.++.+|...+......++++..........+.+.+|+.+++.++||||+++++++..++.+++|
T Consensus        16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence            36788999999999999999998876655555666555555556678899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+.+++|.+++...     .+++.++..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++....
T Consensus        96 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQIT  167 (297)
T ss_dssp             EECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC---EEEeeCCCceecC
Confidence            9999999999988654     2899999999999999999999999999999999999987776   9999999987765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ....             ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.
T Consensus       168 ~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  219 (297)
T 3fxz_A          168 PEQS-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (297)
T ss_dssp             STTC-------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             Cccc-------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            4321             122335899999999999999999999999999999999999999883

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.1e-40  Score=275.14  Aligned_cols=218  Identities=25%  Similarity=0.483  Sum_probs=183.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|.+.++++.|.++.++...+......++++   +.........+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            47888899999999998876655444444433   333334456778999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++.....    +++..++.++.||+.||.|||++|++||||||+||+++.++.   ++|+|||++.....
T Consensus        85 E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           85 EYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCC
T ss_pred             eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC---EEEeeccchhhccc
Confidence            99999999988876543    899999999999999999999999999999999999987776   99999999865332


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..             .......+|+.|+|||++.+..++.++|+|||||++|||++|+.||.+ +..++.+.|..+.+.+
T Consensus       158 ~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  224 (337)
T 1o6l_A          158 DG-------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF  224 (337)
T ss_dssp             TT-------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             CC-------------CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            11             112234589999999999998899999999999999999999999998 6677888999998888


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       225 p~  226 (337)
T 1o6l_A          225 PR  226 (337)
T ss_dssp             CT
T ss_pred             CC
Confidence            74

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.6e-40  Score=275.15  Aligned_cols=217  Identities=30%  Similarity=0.524  Sum_probs=182.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .+|++.+.++.|.++.++...+......++++...  ..+....+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e   94 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIME   94 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEE
Confidence            47999999999999999877665444444444322  2234556789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.....    +++..+..++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++......
T Consensus        95 ~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           95 YASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN---IKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSTTCCGGGSSS
T ss_pred             CCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC---EEEeeccCceecCCC
Confidence            9999999999877644    899999999999999999999999999999999999987766   999999998554332


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      .              ......+|+.|+|||.+.+..+ +.++|+||+||++|+|++|+.||.+ +..++.+.+..+.+.+
T Consensus       168 ~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  233 (328)
T 3fe3_A          168 G--------------KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI  233 (328)
T ss_dssp             C--------------GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             C--------------ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            1              1122358999999999988776 4789999999999999999999998 6678899999999888


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       234 p~  235 (328)
T 3fe3_A          234 PF  235 (328)
T ss_dssp             CT
T ss_pred             CC
Confidence            74

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=279.07  Aligned_cols=219  Identities=26%  Similarity=0.469  Sum_probs=182.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++|++.++++.|.++.++...+......++++   +.........+.+.+|..+++.+ +||||+++++++.+.+.+++|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            47889999999999999877655444444433   33334455677889999999998 799999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....    +++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus       103 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~---ikL~DFG~a~~~~  175 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGI  175 (353)
T ss_dssp             EECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC---EEEccccceeecc
Confidence            999999999998876644    899999999999999999999999999999999999987776   9999999986432


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...             .......+|+.|+|||++.+..++.++|+||+||++|||++|+.||.+ +..++.+.|.++++.
T Consensus       176 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~  242 (353)
T 3txo_A          176 CNG-------------VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV  242 (353)
T ss_dssp             C----------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             cCC-------------ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            211             112233589999999999988899999999999999999999999998 667899999999998


Q ss_pred             cccc
Q psy14626        243 ILGC  246 (249)
Q Consensus       243 ~~~~  246 (249)
                      +|..
T Consensus       243 ~p~~  246 (353)
T 3txo_A          243 YPTW  246 (353)
T ss_dssp             CCTT
T ss_pred             CCCC
Confidence            8853

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.6e-40  Score=276.15  Aligned_cols=223  Identities=23%  Similarity=0.453  Sum_probs=184.8

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc------chhHHHHHHHHHHHHHcCCCChhhhhheeecC
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH------YTTEADLKREATICHMLKHPHVVELLETYSSE   77 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (249)
                      .+..++|.+.+.++.|.++.++...+......++++......      ....+.+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~   87 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR   87 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence            456678999999999999999877665444444433222111      12467899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC-CCCeEEcCc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN-SAPVKLGGF  156 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~-~~~~~l~df  156 (249)
                      +.+++||||++|++|.+++....    .+++..+..++.|++.||.|||++|++|+||||+||+++.++. ...++|+||
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           88 TDVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             SEEEEEEECCCSCBHHHHHTTCS----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            99999999999999999886543    3899999999999999999999999999999999999976652 124999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      |++.......              ......+|+.|+|||++.+..++.++|+||+||++|+|++|..||.+ +..++...
T Consensus       164 G~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~  229 (361)
T 2yab_A          164 GLAHEIEDGV--------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN  229 (361)
T ss_dssp             SSCEECCTTC--------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH
T ss_pred             CCceEcCCCC--------------ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9997765422              11223589999999999998899999999999999999999999998 66778889


Q ss_pred             HHcCccccc
Q psy14626        236 ITKGKLHIL  244 (249)
Q Consensus       236 i~~g~~~~~  244 (249)
                      |.++.+.+|
T Consensus       230 i~~~~~~~~  238 (361)
T 2yab_A          230 ITAVSYDFD  238 (361)
T ss_dssp             HHTTCCCCC
T ss_pred             HHhcCCCCC
Confidence            999887776

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-39  Score=271.08  Aligned_cols=215  Identities=24%  Similarity=0.475  Sum_probs=182.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.++..........++++   +.........+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57888999999999998876655444333333   333334456778899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++.....    +++..++.++.|++.||.+||++|++||||||+||+++.++.   ++|+|||++.....
T Consensus        86 e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPD  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC---EEECCCSSCEECSS
T ss_pred             eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC---EEEeecCcceecCC
Confidence            99999999999876543    899999999999999999999999999999999999987766   99999999976543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..                ....+|+.|+|||++.+..++.++|+|||||++|+|++|+.||.+ +..++.+.|.++.+.+
T Consensus       159 ~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  222 (318)
T 1fot_A          159 VT----------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF  222 (318)
T ss_dssp             CB----------------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC
T ss_pred             cc----------------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            21                123589999999999998899999999999999999999999988 5667888999998888


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       223 p~  224 (318)
T 1fot_A          223 PP  224 (318)
T ss_dssp             CT
T ss_pred             CC
Confidence            75

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=282.19  Aligned_cols=221  Identities=36%  Similarity=0.624  Sum_probs=182.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .++|++.+.++.|.++.+|...+......++++....  ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            4588999999999999998776554444444332221  12345677999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.|++|.+.+..+..    +++..+..++.|++.||.|||++|++|+||||+||+++.+.....++|+|||++.....
T Consensus        90 E~~~gg~L~~~i~~~~~----~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~  165 (444)
T 3soa_A           90 DLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG  165 (444)
T ss_dssp             CCCBCCBHHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred             EeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence            99999999998876543    89999999999999999999999999999999999998654445599999999866544


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ...             ......+|+.|+|||++.+..++.++||||+||++|+|++|..||.+ +..++.+.+..+.+.+
T Consensus       166 ~~~-------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  232 (444)
T 3soa_A          166 EQQ-------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDF  232 (444)
T ss_dssp             TCC-------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC
T ss_pred             CCc-------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCC
Confidence            221             11223589999999999998899999999999999999999999998 6678899999998877


Q ss_pred             c
Q psy14626        244 L  244 (249)
Q Consensus       244 ~  244 (249)
                      |
T Consensus       233 ~  233 (444)
T 3soa_A          233 P  233 (444)
T ss_dssp             C
T ss_pred             C
Confidence            6

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.6e-39  Score=274.73  Aligned_cols=219  Identities=37%  Similarity=0.642  Sum_probs=183.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|...+......++++....  ......+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e  108 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD  108 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            478899999999999998776654444444432221  123456789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.|++|.+.+....    .+++..+..++.|++.||.|||++|++|+||||+||+++.++....++|+|||++......
T Consensus       109 ~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          109 LVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             cCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            999999988886543    3899999999999999999999999999999999999987665556999999998665432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .              ......+|+.|+|||++.+..++.++|+||+||++|+|++|..||.+ +..++...+..+.+.+|
T Consensus       185 ~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  250 (362)
T 2bdw_A          185 E--------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYP  250 (362)
T ss_dssp             C--------------SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             c--------------ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            2              11123589999999999998899999999999999999999999998 56778889999988776

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.9e-40  Score=275.06  Aligned_cols=216  Identities=24%  Similarity=0.441  Sum_probs=184.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|++.+.++.|.++.+|...+......++++   +.........+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999998877665444444433   333334456778999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++.....    +++..++.++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++.....
T Consensus       121 e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC---EEEcccccceeccC
Confidence            99999999999876543    899999999999999999999999999999999999987766   99999999977644


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..                ....+|+.|+|||++.+..++.++|+|||||++|+|++|..||.+ +..++.+.|.++++.+
T Consensus       194 ~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~  257 (350)
T 1rdq_E          194 RT----------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF  257 (350)
T ss_dssp             CB----------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             Cc----------------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            21                123589999999999998899999999999999999999999998 5677899999999888


Q ss_pred             ccc
Q psy14626        244 LGC  246 (249)
Q Consensus       244 ~~~  246 (249)
                      |..
T Consensus       258 p~~  260 (350)
T 1rdq_E          258 PSH  260 (350)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-39  Score=272.79  Aligned_cols=218  Identities=25%  Similarity=0.471  Sum_probs=182.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++|.+.++++.|.++.+|..........++++   +.........+.+.+|..+++.+ +||||+++++++.+.+.+++|
T Consensus        17 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv   96 (345)
T 1xjd_A           17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   96 (345)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEE
Confidence            57889999999999999877665444334433   33333345567788999999987 899999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....    +++..++.++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++....
T Consensus        97 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---vkL~DFG~a~~~~  169 (345)
T 1xjd_A           97 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENM  169 (345)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC---EEEeEChhhhhcc
Confidence            999999999999876543    899999999999999999999999999999999999987776   9999999986533


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...             .......+|+.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++.+.|..+.+.
T Consensus       170 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  236 (345)
T 1xjd_A          170 LGD-------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF  236 (345)
T ss_dssp             CTT-------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             cCC-------------CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCC
Confidence            211             112234589999999999998899999999999999999999999998 667889999999888


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       237 ~p~  239 (345)
T 1xjd_A          237 YPR  239 (345)
T ss_dssp             CCT
T ss_pred             CCc
Confidence            774

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.3e-39  Score=272.74  Aligned_cols=218  Identities=27%  Similarity=0.421  Sum_probs=182.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCC---cccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPA---SFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+|.+..+++.|.++.+|...+.....   .+.+.+.........+.+.+|..++..+ +||+|+++++++.+.+.+|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            478888999999999988776654333   3333333333445677889999999988 799999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....    +++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus       100 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---vkL~DFG~a~~~~  172 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENI  172 (353)
T ss_dssp             EECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCC
T ss_pred             EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc---EEEEeCCcccccc
Confidence            999999999999876543    899999999999999999999999999999999999987776   9999999986532


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...             .......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+ +..++.+.|.++.+.
T Consensus       173 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~  239 (353)
T 2i0e_A          173 WDG-------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA  239 (353)
T ss_dssp             CTT-------------CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             cCC-------------cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC
Confidence            211             112234589999999999998899999999999999999999999998 667889999999988


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       240 ~p~  242 (353)
T 2i0e_A          240 YPK  242 (353)
T ss_dssp             CCT
T ss_pred             CCC
Confidence            874

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=269.62  Aligned_cols=221  Identities=26%  Similarity=0.433  Sum_probs=183.8

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +-.++|++.+.++.|.++.+|...+......++++.... .....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec-CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            456899999999999999999777665544444433322 2345677899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++....   ..+++.++..++.|++.||.|||++|++|+||||+||+++.+. ...++|+|||.+.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~-~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           81 EFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECCT
T ss_pred             EeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCC-CCCEEEEECCCCeECCC
Confidence            9999999998886432   2389999999999999999999999999999999999998632 23399999999977654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ...              .....+++.|+|||++.+..++.++|+||+|+++|+|++|..||.+ +..++.+.+.++.+.+
T Consensus       157 ~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  222 (321)
T 1tki_A          157 GDN--------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF  222 (321)
T ss_dssp             TCE--------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC
T ss_pred             CCc--------------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCC
Confidence            321              1123478999999999988889999999999999999999999998 5677888999888776


Q ss_pred             c
Q psy14626        244 L  244 (249)
Q Consensus       244 ~  244 (249)
                      |
T Consensus       223 ~  223 (321)
T 1tki_A          223 D  223 (321)
T ss_dssp             C
T ss_pred             C
Confidence            6

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.3e-39  Score=275.33  Aligned_cols=219  Identities=29%  Similarity=0.480  Sum_probs=179.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++|.+.++|+.|.++.++..........++   +.+.........+.+.+|..++.++ +||||++++++|.+.+.+++|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            478888999999999998776554433333   3344444445556788999999888 899999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....    +++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus       132 ~E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~---ikL~DFGla~~~~  204 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEGL  204 (396)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCC
T ss_pred             EEcCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC---EEEeecceeeecc
Confidence            999999999988876544    899999999999999999999999999999999999988776   9999999986432


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----------ChHHHH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----------SRDRLF  233 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----------~~~~~~  233 (249)
                      ...             .......+|+.|+|||++.+..++.++|+|||||++|||++|+.||..          ..+.+.
T Consensus       205 ~~~-------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~  271 (396)
T 4dc2_A          205 RPG-------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF  271 (396)
T ss_dssp             CTT-------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH
T ss_pred             cCC-------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH
Confidence            211             122234589999999999999999999999999999999999999963          234578


Q ss_pred             HHHHcCccccccc
Q psy14626        234 QSITKGKLHILGC  246 (249)
Q Consensus       234 ~~i~~g~~~~~~~  246 (249)
                      +.+..+.+.+|..
T Consensus       272 ~~i~~~~~~~p~~  284 (396)
T 4dc2_A          272 QVILEKQIRIPRS  284 (396)
T ss_dssp             HHHHHCCCCCCTT
T ss_pred             HHHhccccCCCCc
Confidence            8899999888853

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4e-39  Score=264.88  Aligned_cols=209  Identities=25%  Similarity=0.443  Sum_probs=170.8

Q ss_pred             CCcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC
Q psy14626          1 MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSE   77 (249)
Q Consensus         1 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (249)
                      |+..-.++||++.+.++.|.++.+|...+......++++.   .........+.+.+|+.++++++||||+++++++.++
T Consensus         4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~   83 (294)
T 4eqm_A            4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED   83 (294)
T ss_dssp             CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred             chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence            4555667899999999999999998776554444444332   2233445567899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      +.+++||||++|++|.+++.....    +++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||
T Consensus        84 ~~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg  156 (294)
T 4eqm_A           84 DCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT---LKIFDFG  156 (294)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCS
T ss_pred             CeEEEEEeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC---EEEEeCC
Confidence            999999999999999999876643    899999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ++........            .......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.+.
T Consensus       157 ~~~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~  215 (294)
T 4eqm_A          157 IAKALSETSL------------TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE  215 (294)
T ss_dssp             SSTTC-------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             Cccccccccc------------cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            9855433211            1122235899999999999998999999999999999999999999983

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=7.9e-39  Score=260.56  Aligned_cols=222  Identities=28%  Similarity=0.508  Sum_probs=184.5

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +..++|++.+.++.|.++.+|...+......++++..........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            34568999999999999999877666554444544444444456788999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....    +++..+..++.|++.||.+||++|++|+||||+||++..++....++|+|||.+.....
T Consensus        86 e~~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             ECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             eccCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            99999999988876544    89999999999999999999999999999999999995444444599999999877654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..              ......+++.|+|||.+.+. ++.++|+||+|+++++|++|+.||.. +..++...+.++...+
T Consensus       162 ~~--------------~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (277)
T 3f3z_A          162 GK--------------MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF  226 (277)
T ss_dssp             TS--------------CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cc--------------chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            22              11223588999999998765 78999999999999999999999998 5667888888888777


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       227 ~~  228 (277)
T 3f3z_A          227 PE  228 (277)
T ss_dssp             CH
T ss_pred             Cc
Confidence            63

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=272.56  Aligned_cols=218  Identities=22%  Similarity=0.398  Sum_probs=181.6

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++..+++.|.++.+|...+......++++   +.........+.+.+|+.+++.++||||++++++|.+.+.+++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            47899999999999999877665554444443   333344556778999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.|++|.+++.....    +++..++.++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++.....
T Consensus        95 e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH---VHITDFNIAAMLPR  167 (384)
T ss_dssp             CCCTTEEHHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCT
T ss_pred             ecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC---EEEeccceeeeccC
Confidence            99999999988875433    899999999999999999999999999999999999987776   99999999977654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCC----ChHHHHHHHH
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLTGTLPFVG----SRDRLFQSIT  237 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~pf~~----~~~~~~~~i~  237 (249)
                      ..              ......+|+.|+|||++.+   ..++.++|+|||||++|+|++|+.||..    ...++...+.
T Consensus       168 ~~--------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~  233 (384)
T 4fr4_A          168 ET--------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE  233 (384)
T ss_dssp             TC--------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH
T ss_pred             CC--------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh
Confidence            22              1223458999999999864   4578999999999999999999999975    3456777788


Q ss_pred             cCccccccc
Q psy14626        238 KGKLHILGC  246 (249)
Q Consensus       238 ~g~~~~~~~  246 (249)
                      .....+|..
T Consensus       234 ~~~~~~p~~  242 (384)
T 4fr4_A          234 TTVVTYPSA  242 (384)
T ss_dssp             HCCCCCCTT
T ss_pred             hcccCCCCc
Confidence            888777754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1e-38  Score=268.12  Aligned_cols=219  Identities=29%  Similarity=0.475  Sum_probs=181.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l   82 (249)
                      -.+|++.++++.|.++.++..........++   +.+.........+.+.+|..+++++ +||||+++++++.+.+.+++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            3578899999999999998776554433333   3334444455677899999999998 89999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||++|++|.+++.....    +++..++.++.|++.||.|||++|++||||||+||+++.++.   ++|+|||++...
T Consensus        88 v~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~---~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH---IKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC---EEEEeccccccc
Confidence            9999999999998876543    899999999999999999999999999999999999987776   999999998653


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----------ChHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----------SRDRL  232 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----------~~~~~  232 (249)
                      ....             .......+|+.|+|||++.+..++.++|+||+||++|||++|+.||..          ....+
T Consensus       161 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  227 (345)
T 3a8x_A          161 LRPG-------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL  227 (345)
T ss_dssp             CCTT-------------CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHH
T ss_pred             cCCC-------------CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHH
Confidence            2211             112233589999999999998899999999999999999999999974          23457


Q ss_pred             HHHHHcCcccccc
Q psy14626        233 FQSITKGKLHILG  245 (249)
Q Consensus       233 ~~~i~~g~~~~~~  245 (249)
                      .+.+..+.+.+|.
T Consensus       228 ~~~i~~~~~~~p~  240 (345)
T 3a8x_A          228 FQVILEKQIRIPR  240 (345)
T ss_dssp             HHHHHHCCCCCCT
T ss_pred             HHHHHcCCCCCCC
Confidence            7888888888774

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-39  Score=266.44  Aligned_cols=222  Identities=21%  Similarity=0.446  Sum_probs=181.5

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc------chhHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH------YTTEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      +..++|.+.+.++.|.++.+|...+......++++......      ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   87 (326)
T 2y0a_A            8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   87 (326)
T ss_dssp             CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            44568999999999999999877665444444433222111      124678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC-CCCeEEcCcc
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN-SAPVKLGGFG  157 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~-~~~~~l~dfg  157 (249)
                      .+++||||+++++|.+++....    .+++..+..++.|++.||.|||++|++|+||||+||+++.++. ...++|+|||
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           88 DVILILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            9999999999999999886543    3899999999999999999999999999999999999987651 2349999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ++.......              ......+|+.|+|||++.+..++.++|+||+||++|+|++|..||.+ +..+....+
T Consensus       164 ~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  229 (326)
T 2y0a_A          164 LAHKIDFGN--------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV  229 (326)
T ss_dssp             TCEECCTTS--------------CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred             CCeECCCCC--------------ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence            997765422              11223589999999999988899999999999999999999999988 556677778


Q ss_pred             HcCccccc
Q psy14626        237 TKGKLHIL  244 (249)
Q Consensus       237 ~~g~~~~~  244 (249)
                      ..+.+.+|
T Consensus       230 ~~~~~~~~  237 (326)
T 2y0a_A          230 SAVNYEFE  237 (326)
T ss_dssp             HHTCCCCC
T ss_pred             HhcCCCcC
Confidence            77776655

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.2e-39  Score=266.57  Aligned_cols=219  Identities=27%  Similarity=0.485  Sum_probs=169.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccc---cCCCcccCC---hhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAE---IEPASFGLP---DERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      .++|++.++++.|.++.+|...+.   .....++++   +... ........+.+|+.+++.++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            357999999999999998865542   122223322   2211 123445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +++||||+++++|.+++.....    +++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~~  168 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGI----FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH---VKLTDFGLC  168 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC---EEECCCSCC
T ss_pred             EEEEEeCCCCCcHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc---EEEEeCCcc
Confidence            9999999999999998876543    899999999999999999999999999999999999987766   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      .......             .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+ +..++.+.+.+
T Consensus       169 ~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  235 (327)
T 3a62_A          169 KESIHDG-------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK  235 (327)
T ss_dssp             -----------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cccccCC-------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence            6543211             111223589999999999988899999999999999999999999998 56678888988


Q ss_pred             Ccccccc
Q psy14626        239 GKLHILG  245 (249)
Q Consensus       239 g~~~~~~  245 (249)
                      +.+.+|+
T Consensus       236 ~~~~~p~  242 (327)
T 3a62_A          236 CKLNLPP  242 (327)
T ss_dssp             TCCCCCT
T ss_pred             CCCCCCC
Confidence            8888774

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.8e-39  Score=278.15  Aligned_cols=219  Identities=27%  Similarity=0.464  Sum_probs=179.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .++|.+.++++.|.++.+|..........++++   +.........+.+.+|+.+++.++||||++++++|.+.+.+++|
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV  147 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV  147 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            357888899999999999977766544444443   22233334445688999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++...     .+++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus       148 ~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~---ikL~DFG~a~~~~  219 (410)
T 3v8s_A          148 MEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH---LKLADFGTCMKMN  219 (410)
T ss_dssp             ECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC
T ss_pred             EeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC---EEEeccceeEeec
Confidence            9999999999888643     2899999999999999999999999999999999999987776   9999999997765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK----YGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ....            .......||+.|+|||++.+..    ++.++|+|||||++|||++|+.||.+ +..++...|.+
T Consensus       220 ~~~~------------~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~  287 (410)
T 3v8s_A          220 KEGM------------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMN  287 (410)
T ss_dssp             TTSE------------EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             cCCc------------ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHh
Confidence            4321            1122345899999999998655    67899999999999999999999998 56678888887


Q ss_pred             Cc--ccccc
Q psy14626        239 GK--LHILG  245 (249)
Q Consensus       239 g~--~~~~~  245 (249)
                      +.  +.+|.
T Consensus       288 ~~~~~~~p~  296 (410)
T 3v8s_A          288 HKNSLTFPD  296 (410)
T ss_dssp             HHHHCCCCT
T ss_pred             ccccccCCC
Confidence            64  44453

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.3e-39  Score=277.32  Aligned_cols=222  Identities=22%  Similarity=0.393  Sum_probs=179.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .++|.+.++|+.|.++.++..........++++.   .........+.+.+|+.++..++||||++++++|.+++.+++|
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  152 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLV  152 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEE
Confidence            3578888999999999998777665444444432   2222233344589999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....   .+++..++.++.|++.||.|||+++++||||||+|||++.++.   ++|+|||++....
T Consensus       153 ~Ey~~gg~L~~~l~~~~~---~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~---vkL~DFGla~~~~  226 (437)
T 4aw2_A          153 MDYYVGGDLLTLLSKFED---RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH---IRLADFGSCLKLM  226 (437)
T ss_dssp             ECCCTTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHHccC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC---EEEcchhhhhhcc
Confidence            999999999999876322   3899999999999999999999999999999999999987776   9999999997665


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      ....            .......||+.|+|||++.     ...++.++|+||+||++|||++|+.||.+ +..++...|.
T Consensus       227 ~~~~------------~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~  294 (437)
T 4aw2_A          227 EDGT------------VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM  294 (437)
T ss_dssp             TTSC------------EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred             cCCC------------cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh
Confidence            4321            1112235899999999987     45679999999999999999999999998 5667777877


Q ss_pred             cCc--cccccc
Q psy14626        238 KGK--LHILGC  246 (249)
Q Consensus       238 ~g~--~~~~~~  246 (249)
                      ++.  +.+|..
T Consensus       295 ~~~~~~~~p~~  305 (437)
T 4aw2_A          295 NHKERFQFPTQ  305 (437)
T ss_dssp             THHHHCCCCSS
T ss_pred             hccccccCCcc
Confidence            643  555543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.7e-39  Score=272.16  Aligned_cols=218  Identities=25%  Similarity=0.493  Sum_probs=172.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHH-HHHcCCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATI-CHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+|++.++++.|.++.+|...+......+++   .+...........+.+|..+ ++.++||||++++++|.+.+.+|+|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            4788899999999999987766544443443   33334344555667778776 5678999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....    +++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus       118 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~---ikL~DFG~a~~~~  190 (373)
T 2r5t_A          118 LDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH---IVLTDFGLCKENI  190 (373)
T ss_dssp             EECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCBCGGGB
T ss_pred             EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC---EEEeeCccccccc
Confidence            999999999998876543    899999999999999999999999999999999999987776   9999999986432


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...             .......+|+.|+|||++.+..++.++|+|||||++|||++|..||.+ +..++.+.|.++.+.
T Consensus       191 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~  257 (373)
T 2r5t_A          191 EHN-------------STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQ  257 (373)
T ss_dssp             CCC-------------CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCC
T ss_pred             cCC-------------CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccC
Confidence            211             122234589999999999999999999999999999999999999998 567889999999888


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       258 ~~~  260 (373)
T 2r5t_A          258 LKP  260 (373)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            774

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.4e-38  Score=255.58  Aligned_cols=222  Identities=36%  Similarity=0.625  Sum_probs=186.3

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +..++|++.+.++.|.++.+|...+......++++....  ......+.+.+|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            457899999999999999998776554444444433222  223455778999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+.+++|.+.+.....    +++..+..++.|++.||.+||++|++|+||||+||+++.++....++|+|||.+...
T Consensus        83 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999999888876643    899999999999999999999999999999999999987766666999999999766


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      .....              .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||.+ +..++...+..+..
T Consensus       159 ~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  224 (284)
T 3kk8_A          159 NDSEA--------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAY  224 (284)
T ss_dssp             CSSCB--------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ccCcc--------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccc
Confidence            54321              1123578999999999998899999999999999999999999998 56678888888887


Q ss_pred             ccc
Q psy14626        242 HIL  244 (249)
Q Consensus       242 ~~~  244 (249)
                      .+|
T Consensus       225 ~~~  227 (284)
T 3kk8_A          225 DYP  227 (284)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            766

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-38  Score=270.39  Aligned_cols=219  Identities=26%  Similarity=0.416  Sum_probs=181.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ++|++.+.++.|.++.+|...+......++++............+.+|+.+++.++||||+++++++.+.+.+++||||+
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~  130 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  130 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence            47899999999999999877666555555554444333445668999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      .+++|.+++....   ..+++.++..++.|++.||.|||++|++|+||||+||+++.++ ...++|+|||++........
T Consensus       131 ~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~~~vkL~DFG~a~~~~~~~~  206 (387)
T 1kob_A          131 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPDEI  206 (387)
T ss_dssp             CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CCCEEECCCTTCEECCTTSC
T ss_pred             CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCC-CCceEEEecccceecCCCcc
Confidence            9999988876543   2389999999999999999999999999999999999997432 23399999999987654221


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                                    .....+|+.|+|||++.+..++.++|+|||||++|+|++|..||.+ +..+....+..+.+.++
T Consensus       207 --------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~  270 (387)
T 1kob_A          207 --------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD  270 (387)
T ss_dssp             --------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             --------------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                          1112478999999999988899999999999999999999999998 55667788888776655

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.2e-38  Score=278.35  Aligned_cols=222  Identities=25%  Similarity=0.372  Sum_probs=184.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|.+..+|+.|.++.+|..........+++   .+.........+.+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            4677888899999999887765444333443   3333444455678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++.........+++..++.++.||+.||.|||++|++||||||+||+++.++.   ++|+|||++.....
T Consensus       265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~---vkL~DFGla~~~~~  341 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN---VRISDLGLAVELKA  341 (543)
T ss_dssp             CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTCEECCT
T ss_pred             EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC---EEEeecceeeeccC
Confidence            999999999988765544445999999999999999999999999999999999999987776   99999999977654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----hHHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-----RDRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~-----~~~~~~~i~~g  239 (249)
                      ...             ......||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.     ..++.+.+..+
T Consensus       342 ~~~-------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~  408 (543)
T 3c4z_A          342 GQT-------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ  408 (543)
T ss_dssp             TCC-------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC
T ss_pred             CCc-------------ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc
Confidence            221             112235899999999999988999999999999999999999999873     36788888888


Q ss_pred             cccccc
Q psy14626        240 KLHILG  245 (249)
Q Consensus       240 ~~~~~~  245 (249)
                      ...+|.
T Consensus       409 ~~~~p~  414 (543)
T 3c4z_A          409 AVTYPD  414 (543)
T ss_dssp             CCCCCT
T ss_pred             ccCCCc
Confidence            887774

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.5e-38  Score=263.31  Aligned_cols=214  Identities=22%  Similarity=0.314  Sum_probs=164.8

Q ss_pred             CCCcchHHHhhcccceeeEeeecccc-CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEI-EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +..+|++.+.++.|.++.+|.....- .++.+.+.. ........+.+.+|+.++++++||||+++++++...+.+++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~-~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILME-QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECC-CCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecC-CCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            34689999999999999998765432 222222222 2223455678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||+++++|.+++...... ..+++..++.++.|++.||.+||++|  ++|+||||+||+++.++.   ++|+|||++...
T Consensus       114 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~---~kL~Dfg~a~~~  189 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT---VKVCDFGLSRLK  189 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHH-HHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC---EEECCCC-----
T ss_pred             ecCCCCcHHHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc---EEECCCCCCccc
Confidence            999999999988754321 13899999999999999999999999  999999999999987765   999999998654


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      ....             .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+ +..++...+.
T Consensus       190 ~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~  252 (309)
T 3p86_A          190 ASTF-------------LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG  252 (309)
T ss_dssp             -------------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH
T ss_pred             cccc-------------cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            4321             111223589999999999999899999999999999999999999998 5555555553

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-38  Score=272.36  Aligned_cols=216  Identities=22%  Similarity=0.395  Sum_probs=176.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChh---ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .++|.+.++++.|.++.++..........++++..   ........+.+.+|..++..++||||++++++|.+.+.+|+|
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV  139 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLV  139 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEE
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            35788889999999998887766544444444432   222333445688999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....   .+++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus       140 mE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~---vkL~DFGla~~~~  213 (412)
T 2vd5_A          140 MEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH---IRLADFGSCLKLR  213 (412)
T ss_dssp             ECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC
T ss_pred             EcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC---EEEeechhheecc
Confidence            999999999999876532   3899999999999999999999999999999999999987776   9999999997765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccc-------cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-------DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      ....            .......||+.|+|||++.       +..++.++|+|||||++|||++|+.||.+ +..++...
T Consensus       214 ~~~~------------~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~  281 (412)
T 2vd5_A          214 ADGT------------VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK  281 (412)
T ss_dssp             TTSC------------EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             CCCc------------cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            4221            1112235899999999987       35678999999999999999999999998 56677778


Q ss_pred             HHcCc
Q psy14626        236 ITKGK  240 (249)
Q Consensus       236 i~~g~  240 (249)
                      |.+++
T Consensus       282 i~~~~  286 (412)
T 2vd5_A          282 IVHYK  286 (412)
T ss_dssp             HHTHH
T ss_pred             HHhcc
Confidence            77644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9e-38  Score=261.34  Aligned_cols=222  Identities=25%  Similarity=0.388  Sum_probs=185.6

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ....++|++.+.++.|.++.+|...+......++++   ..........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus        37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence            456779999999999999999877665444444433   23333445678899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+.+++|.+++.....    +++.+++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg~~~  189 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLAT  189 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCE
T ss_pred             EEEEecCCCCCHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC---EEEeeccCce
Confidence            999999999999988876543    899999999999999999999999999999999999987766   9999999997


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .......             ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.. ...+....+.++
T Consensus       190 ~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  256 (335)
T 2owb_A          190 KVEYDGE-------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN  256 (335)
T ss_dssp             ECCSTTC-------------CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred             ecccCcc-------------cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC
Confidence            7643221             11223578999999999988889999999999999999999999998 556677788888


Q ss_pred             cccccc
Q psy14626        240 KLHILG  245 (249)
Q Consensus       240 ~~~~~~  245 (249)
                      .+.+|.
T Consensus       257 ~~~~~~  262 (335)
T 2owb_A          257 EYSIPK  262 (335)
T ss_dssp             CCCCCT
T ss_pred             CCCCCc
Confidence            877764

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.5e-38  Score=284.33  Aligned_cols=218  Identities=27%  Similarity=0.436  Sum_probs=184.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+|.+..+|+.|.++.+|...+......+++   .+.........+.+..|..++..+ +||+|+++++++.+.+.+|+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            3678888999999999987766544433443   333344455667889999999988 799999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....    +++..++.++.||+.||.|||++||+||||||+|||++.++.   ++|+|||++....
T Consensus       421 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~---ikL~DFGla~~~~  493 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENI  493 (674)
T ss_dssp             EECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC---EEECCCTTCEECC
T ss_pred             EeCcCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc---EEEeecceeeccc
Confidence            999999999999887654    899999999999999999999999999999999999988776   9999999997643


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...             .......||+.|+|||++.+..++.++|+||||+++|||++|+.||.+ +..++.+.|.++.+.
T Consensus       494 ~~~-------------~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~  560 (674)
T 3pfq_A          494 WDG-------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA  560 (674)
T ss_dssp             CTT-------------CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCC
T ss_pred             cCC-------------cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCC
Confidence            321             112234589999999999999999999999999999999999999998 677899999999998


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       561 ~p~  563 (674)
T 3pfq_A          561 YPK  563 (674)
T ss_dssp             CCT
T ss_pred             CCc
Confidence            885

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.3e-37  Score=255.59  Aligned_cols=223  Identities=25%  Similarity=0.387  Sum_probs=185.6

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      +....++|++.+.++.|.++.+|...+......++++   ..........+.+.+|+.+++.++||||+++++++.+++.
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   89 (294)
T 2rku_A           10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF   89 (294)
T ss_dssp             ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE
Confidence            3456779999999999999999877765444433333   2333344567889999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .++|||++++++|.+++.....    +++.++..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~  162 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLA  162 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTC
T ss_pred             EEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC---EEEEeccCc
Confidence            9999999999999988776543    899999999999999999999999999999999999987766   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ........             ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||.. ...+....+..
T Consensus       163 ~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  229 (294)
T 2rku_A          163 TKVEYDGE-------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK  229 (294)
T ss_dssp             EECCSTTC-------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred             eecccCcc-------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh
Confidence            77643221             11223578999999999988889999999999999999999999998 55667778888


Q ss_pred             Ccccccc
Q psy14626        239 GKLHILG  245 (249)
Q Consensus       239 g~~~~~~  245 (249)
                      +.+.+|.
T Consensus       230 ~~~~~~~  236 (294)
T 2rku_A          230 NEYSIPK  236 (294)
T ss_dssp             TCCCCCT
T ss_pred             ccCCCcc
Confidence            8877764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.4e-38  Score=265.53  Aligned_cols=214  Identities=23%  Similarity=0.446  Sum_probs=171.2

Q ss_pred             HHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         13 HEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      .++|+.|.++.+|..........++++..........+.+.+|+.++++++||||+++++++.+.+.+++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56789999999887665544444554444444445677899999999999999999999999999999999999999999


Q ss_pred             hHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCC
Q psy14626         93 CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG  172 (249)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  172 (249)
                      .+++.....   .+++..++.++.|++.||.|||+++++|+||||+|||+..+. ...++|+|||++........     
T Consensus       174 ~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~~~kl~DFG~a~~~~~~~~-----  244 (373)
T 2x4f_A          174 FDRIIDESY---NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRD-AKQIKIIDFGLARRYKPREK-----  244 (373)
T ss_dssp             HHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETT-TTEEEECCCSSCEECCTTCB-----
T ss_pred             HHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCC-CCcEEEEeCCCceecCCccc-----
Confidence            888875443   389999999999999999999999999999999999995432 23399999999987654321     


Q ss_pred             ccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                               .....+|+.|+|||++.+..++.++|+|||||++|+|++|..||.+ +..+....+.++.+.++
T Consensus       245 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~  308 (373)
T 2x4f_A          245 ---------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE  308 (373)
T ss_dssp             ---------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSC
T ss_pred             ---------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCC
Confidence                     1123489999999999988899999999999999999999999998 55667778887776554

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.3e-37  Score=273.73  Aligned_cols=220  Identities=26%  Similarity=0.520  Sum_probs=180.0

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhcccc----------chhHHHHHHHHHHHHHcCCCChhhhhh
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNH----------YTTEADLKREATICHMLKHPHVVELLE   72 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----------~~~~~~~~~E~~~l~~l~h~~i~~~~~   72 (249)
                      ..++|++.+.++.|.++.+|...+......++++   +.....          ....+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4568999999999999999977655443333332   222111          134678999999999999999999999


Q ss_pred             eeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         73 TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      ++.+++.+++||||+++++|.+++.....    +++..+..++.|++.||.|||++|++|+||||+||+++.++....++
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999998876544    89999999999999999999999999999999999998876555699


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHH
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDR  231 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~  231 (249)
                      |+|||++.......              ......+|+.|+|||++.+ .++.++|+||+||++|+|++|..||.+ +..+
T Consensus       190 l~Dfg~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  254 (504)
T 3q5i_A          190 IVDFGLSSFFSKDY--------------KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD  254 (504)
T ss_dssp             ECCCTTCEECCTTS--------------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEECCCCEEcCCCC--------------ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999997765432              1122358999999999874 578999999999999999999999998 6678


Q ss_pred             HHHHHHcCccccc
Q psy14626        232 LFQSITKGKLHIL  244 (249)
Q Consensus       232 ~~~~i~~g~~~~~  244 (249)
                      +...+.++.+.++
T Consensus       255 ~~~~i~~~~~~~~  267 (504)
T 3q5i_A          255 IIKKVEKGKYYFD  267 (504)
T ss_dssp             HHHHHHHCCCCCC
T ss_pred             HHHHHHcCCCCCC
Confidence            8999999987665

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.1e-38  Score=259.81  Aligned_cols=222  Identities=30%  Similarity=0.524  Sum_probs=179.7

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+..++|++.+.++.|.++.+|...+......++++..........+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            45567899999999999999987776555555555444433334556789999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++.....    +++..+..++.|++.||.+||++|++|+||||+||++..++....++|+|||.+....
T Consensus        85 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           85 MQLVSGGELFDRILERGV----YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             EEcCCCccHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999998876543    8999999999999999999999999999999999999543334449999999875433


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...               .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||.. +..++.+.+.++.+.
T Consensus       161 ~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  225 (304)
T 2jam_A          161 NGI---------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYE  225 (304)
T ss_dssp             CBT---------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCC
T ss_pred             CCc---------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence            211               1112478999999999998899999999999999999999999998 566788888888766


Q ss_pred             cc
Q psy14626        243 IL  244 (249)
Q Consensus       243 ~~  244 (249)
                      ++
T Consensus       226 ~~  227 (304)
T 2jam_A          226 FE  227 (304)
T ss_dssp             CC
T ss_pred             CC
Confidence            54

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.4e-38  Score=258.94  Aligned_cols=215  Identities=20%  Similarity=0.339  Sum_probs=172.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ..+|++.++++.|.++.+|...+......++++.....+....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46899999999999999998777655555555544444566778899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.....   .+++.++..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||.+.......
T Consensus        89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN---VVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC---EEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC---EEEeecccceeccccc
Confidence            999999999876432   3899999999999999999999999999999999999987766   9999999998765533


Q ss_pred             ccccCCcccc-ccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        167 LYCSGGERLD-HYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       167 ~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .......... ..........+|+.|+|||++.+..++.++||||+|+++|+|++|..||..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence            2111100000 000111134589999999999999999999999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.5e-38  Score=274.35  Aligned_cols=218  Identities=28%  Similarity=0.535  Sum_probs=178.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|...+......++++....  ........+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            379999999999999999776654444344332221  123345778999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+++|.+.+.....    +++..+..++.|++.||.|||++|++||||||+||+++.++....++|+|||++......
T Consensus       117 ~~~~g~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          117 CYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             CCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             cCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            9999999988876644    899999999999999999999999999999999999987665566999999998776542


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .              ......+|+.|+|||++.+ .++.++|+||+||++|+|++|..||.+ +..++...+.++.+.++
T Consensus       193 ~--------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~  257 (494)
T 3lij_A          193 K--------------KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD  257 (494)
T ss_dssp             B--------------CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             c--------------cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            2              1122358999999999874 589999999999999999999999998 66788999999987765

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.3e-38  Score=276.16  Aligned_cols=218  Identities=24%  Similarity=0.474  Sum_probs=171.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|++.++++.|.++.+|...+......++++   +...........+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            46888899999999999876655443334433   333334455677889999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||+++++|.+++.....    +++..++.++.|++.||.|||+ +|++||||||+|||++.++.   ++|+|||++....
T Consensus       228 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~---~kl~DFG~a~~~~  300 (446)
T 4ejn_A          228 EYANGGELFFHLSRERV----FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH---IKITDFGLCKEGI  300 (446)
T ss_dssp             CCCSSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC---EEECCCCCCCTTC
T ss_pred             eeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC---EEEccCCCceecc
Confidence            99999999988876543    8999999999999999999998 99999999999999987776   9999999985432


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...             .......+|+.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +...+.+.+..+.+.
T Consensus       301 ~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~  367 (446)
T 4ejn_A          301 KDG-------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR  367 (446)
T ss_dssp             C------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             CCC-------------cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            211             112234589999999999999999999999999999999999999998 667788889888888


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       368 ~p~  370 (446)
T 4ejn_A          368 FPR  370 (446)
T ss_dssp             CCT
T ss_pred             CCc
Confidence            774

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.1e-38  Score=260.03  Aligned_cols=222  Identities=23%  Similarity=0.452  Sum_probs=181.0

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc------chhHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH------YTTEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      +..++|++.+.++.|.++.+|...+......++++......      ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   88 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT   88 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34458999999999999998877655443334433222111      124678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC-CCeEEcCcc
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS-APVKLGGFG  157 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~-~~~~l~dfg  157 (249)
                      .+++||||+++++|.+++....    .+++..+..++.|++.||.+||++|++|+||||+||+++.++.. ..++|+|||
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           89 DVVLILELVSGGELFDFLAQKE----SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEEEECCCCSCBHHHHHHTCS----CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            9999999999999999886543    38999999999999999999999999999999999999876521 249999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      .+.......              ......+++.|+|||.+.+..++.++|+||||+++++|++|..||.+ +..+....+
T Consensus       165 ~~~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i  230 (321)
T 2a2a_A          165 LAHEIEDGV--------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI  230 (321)
T ss_dssp             TCEECCTTC--------------CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH
T ss_pred             cceecCccc--------------cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            997765422              11223478999999999988899999999999999999999999998 566778888


Q ss_pred             HcCccccc
Q psy14626        237 TKGKLHIL  244 (249)
Q Consensus       237 ~~g~~~~~  244 (249)
                      .++...+|
T Consensus       231 ~~~~~~~~  238 (321)
T 2a2a_A          231 TSVSYDFD  238 (321)
T ss_dssp             HTTCCCCC
T ss_pred             HhcccccC
Confidence            88776655

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-37  Score=254.18  Aligned_cols=216  Identities=25%  Similarity=0.480  Sum_probs=179.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.+|...+......++++   ............+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   88 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEE
Confidence            57899999999999999877665544334433   333333445678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+.+.....    +++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.....
T Consensus        89 e~~~~~~l~~~l~~~~~----~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~---~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           89 EYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPS  161 (279)
T ss_dssp             CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC---EEECSCCEESCC--
T ss_pred             ecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC---EEEEeccccccCCc
Confidence            99999999998876543    899999999999999999999999999999999999987766   99999998744332


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..               .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||.. +..+..+.+..+...+
T Consensus       162 ~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  226 (279)
T 3fdn_A          162 SR---------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF  226 (279)
T ss_dssp             ---------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC
T ss_pred             cc---------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCC
Confidence            11               1123478999999999998889999999999999999999999998 5667888888888877


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       227 ~~  228 (279)
T 3fdn_A          227 PD  228 (279)
T ss_dssp             CT
T ss_pred             CC
Confidence            74

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.6e-38  Score=267.82  Aligned_cols=224  Identities=22%  Similarity=0.333  Sum_probs=178.4

Q ss_pred             CCCcchHHHhhcccceeeEeeeccc-----cCCCcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      +.++|++.+.++.|.++.+|.....     .....++++.. ..........+.+|+.+++.++||||+++++++.+.+.
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3568899999999999988866522     11122232222 12234556678999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhc---CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATA---GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      .++||||+.+++|.+++......   ...+++.+++.++.|++.||.|||++|++||||||+|||++.++....++|+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF  228 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  228 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence            99999999999999999876532   234899999999999999999999999999999999999987666666999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~  234 (249)
                      |++........           ........+|+.|+|||++.+..++.++|+|||||++|||++ |..||.+ +..++.+
T Consensus       229 G~a~~~~~~~~-----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~  297 (367)
T 3l9p_A          229 GMARDIYRAGY-----------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE  297 (367)
T ss_dssp             HHHHHHHHHSS-----------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             ccccccccccc-----------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            99864432111           111222346889999999998889999999999999999998 9999998 5667777


Q ss_pred             HHHcCc
Q psy14626        235 SITKGK  240 (249)
Q Consensus       235 ~i~~g~  240 (249)
                      .+..+.
T Consensus       298 ~i~~~~  303 (367)
T 3l9p_A          298 FVTSGG  303 (367)
T ss_dssp             HHHTTC
T ss_pred             HHHcCC
Confidence            877765

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-37  Score=258.12  Aligned_cols=230  Identities=29%  Similarity=0.443  Sum_probs=179.3

Q ss_pred             CCCCcchH-HHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEE
Q psy14626          5 DPNKRITI-HEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         5 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ...++|++ +++++.|.++.+|...+......++++..........+.+.+|+.+++++ +||||+++++++.+++.+++
T Consensus         9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l   88 (316)
T 2ac3_A            9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL   88 (316)
T ss_dssp             CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence            34568888 47899999999988776655555555544444445677899999999995 79999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|.+++.....    +++..+..++.|++.||.+||+++++|+||||+||+++.++....++|+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EEEcCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            9999999999999877543    899999999999999999999999999999999999987766566999999998655


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCCC---------
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----QKYGKPVDIWAAGVLLHVLLTGTLPFVGS---------  228 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~~l~el~~g~~pf~~~---------  228 (249)
                      ........      ..........+++.|+|||++.+     ..++.++|+||+||++|+|++|+.||.+.         
T Consensus       165 ~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  238 (316)
T 2ac3_A          165 KLNGDCSP------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR  238 (316)
T ss_dssp             -----------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred             ccCCcccc------ccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence            32211000      00011122348899999999875     45789999999999999999999999873         


Q ss_pred             -------hHHHHHHHHcCccccc
Q psy14626        229 -------RDRLFQSITKGKLHIL  244 (249)
Q Consensus       229 -------~~~~~~~i~~g~~~~~  244 (249)
                             ...+.+.+.++.+.+|
T Consensus       239 ~~~~~~~~~~~~~~i~~~~~~~~  261 (316)
T 2ac3_A          239 GEACPACQNMLFESIQEGKYEFP  261 (316)
T ss_dssp             --CCHHHHHHHHHHHHHCCCCCC
T ss_pred             cccchhHHHHHHHHHhccCcccC
Confidence                   2457788888887776

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.1e-38  Score=266.98  Aligned_cols=218  Identities=28%  Similarity=0.531  Sum_probs=175.7

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ...+|++.+.++.|.++.++...+......++++   +...........+.+|+.+++.++||||+++++++.+.+.+++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            3468999999999999999877765444444433   2333333445689999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+ +++|.+++.....    +++.+++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++...
T Consensus        87 v~E~~-~g~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~DFG~s~~~  158 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN---VKIADFGLSNIM  158 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC---EEECCSSCTBTT
T ss_pred             EEECC-CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC---EEEEEeccceec
Confidence            99999 6789888876544    899999999999999999999999999999999999987766   999999998654


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ....              ......+|+.|+|||.+.+..+ ++++|+||+|+++|+|++|+.||.+ ....+.+.+..+.
T Consensus       159 ~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~  224 (336)
T 3h4j_B          159 TDGN--------------FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCV  224 (336)
T ss_dssp             TTSB--------------TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSC
T ss_pred             cCCc--------------ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC
Confidence            4321              1122358999999999988776 7899999999999999999999987 3344444555555


Q ss_pred             ccccc
Q psy14626        241 LHILG  245 (249)
Q Consensus       241 ~~~~~  245 (249)
                      +.+|.
T Consensus       225 ~~~p~  229 (336)
T 3h4j_B          225 YVMPD  229 (336)
T ss_dssp             CCCCT
T ss_pred             CCCcc
Confidence            55553

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=7.9e-38  Score=274.04  Aligned_cols=219  Identities=30%  Similarity=0.557  Sum_probs=180.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .++|++.+.++.|.++.+|...+......++++...  .........+.+|+.++++++||||+++++++.+.+.+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            458999999999999999977765444444443221  222345678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.+++|.+.+.....    +++..+..++.|++.||.|||++|++|+||||+||+++.++....++|+|||++.....
T Consensus       101 e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            99999999988876643    89999999999999999999999999999999999997655555699999999854433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..              ......+|+.|+|||++.+ .++.++|+||+||++|+|++|..||.+ +..++...+..+.+.+
T Consensus       177 ~~--------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  241 (486)
T 3mwu_A          177 NT--------------KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF  241 (486)
T ss_dssp             C------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS
T ss_pred             CC--------------ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            21              1122358999999999986 488999999999999999999999998 5667888999988765


Q ss_pred             c
Q psy14626        244 L  244 (249)
Q Consensus       244 ~  244 (249)
                      +
T Consensus       242 ~  242 (486)
T 3mwu_A          242 D  242 (486)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.3e-38  Score=255.82  Aligned_cols=224  Identities=25%  Similarity=0.431  Sum_probs=177.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ..++|++.+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            346899999999999999987665544433443322222 2345688999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+.+.........+++..+..++.|++.||.+||++|++|+||||+||+++.++....++|+|||.+.....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            99999999999877655556699999999999999999999999999999999999997655445599999999865443


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..              ......+++.|+|||.+.+ .++.++|+||+|+++++|++|+.||.+ +.+++...+..+.+.+
T Consensus       180 ~~--------------~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~  244 (285)
T 3is5_A          180 DE--------------HSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY  244 (285)
T ss_dssp             ---------------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cc--------------cCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc
Confidence            21              1122347899999999864 578999999999999999999999998 5566666666665544


Q ss_pred             c
Q psy14626        244 L  244 (249)
Q Consensus       244 ~  244 (249)
                      +
T Consensus       245 ~  245 (285)
T 3is5_A          245 A  245 (285)
T ss_dssp             C
T ss_pred             c
Confidence            4

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.5e-38  Score=263.29  Aligned_cols=218  Identities=26%  Similarity=0.482  Sum_probs=164.3

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|.+.+.++.|.++.+|...+......++++...  .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  129 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL  129 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE--C----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEec--cchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence            357899999999999999877765444444443222  223456788999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++....    .+++.++..++.|++.||.|||++|++|+||||+||+++..+....++|+|||++.......
T Consensus       130 ~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  205 (349)
T 2w4o_A          130 VTGGELFDRIVEKG----YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV  205 (349)
T ss_dssp             CCSCBHHHHHTTCS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             CCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence            99999998886543    38999999999999999999999999999999999999863334459999999987654321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHcCccccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i~~g~~~~~  244 (249)
                                    ......+++.|+|||++.+..++.++|+|||||++|+|++|..||..  ..+.+...+.++...++
T Consensus       206 --------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~  271 (349)
T 2w4o_A          206 --------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFI  271 (349)
T ss_dssp             ---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCC
T ss_pred             --------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccC
Confidence                          11123478999999999998899999999999999999999999987  33457778888776654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-37  Score=259.46  Aligned_cols=211  Identities=24%  Similarity=0.454  Sum_probs=156.9

Q ss_pred             HhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         14 EVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      ..++.|.++.+|...+......++++...   ......+.+|+.+++.+. ||||+++++++.+++..++||||+++++|
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~---~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L   93 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL   93 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEE---GGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEC---hhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence            67889999998877665544444443322   234567889999999996 99999999999999999999999999999


Q ss_pred             hHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCC
Q psy14626         93 CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG  172 (249)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  172 (249)
                      .+++.....    +++.++..++.|++.||.|||++|++|+||||+||+++.++....++|+|||++........     
T Consensus        94 ~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-----  164 (325)
T 3kn6_A           94 FERIKKKKH----FSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-----  164 (325)
T ss_dssp             HHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred             HHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-----
Confidence            999876543    89999999999999999999999999999999999998766444599999999976544221     


Q ss_pred             ccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC--------hHHHHHHHHcCccccc
Q psy14626        173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS--------RDRLFQSITKGKLHIL  244 (249)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~--------~~~~~~~i~~g~~~~~  244 (249)
                              ......+|+.|+|||++.+..++.++|+||+|+++|+|++|+.||.+.        ..++.+.+.++.+.++
T Consensus       165 --------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          165 --------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             ---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred             --------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence                    112234789999999999999999999999999999999999999862        2467888888887765

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.4e-37  Score=265.16  Aligned_cols=222  Identities=18%  Similarity=0.241  Sum_probs=173.4

Q ss_pred             CCCcchHHHhhccc--ceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          6 PNKRITIHEVINHK--WLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         6 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      ...+|++.+.++.|  .++.+|...+......++++....  ......+.+.+|+.+++.++||||+++++++.+++.++
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45689999999999  888888777664444444443222  22355678899999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++++|.+++......  .+++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||.+..
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~---~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK---VYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhhccc--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEccccccee
Confidence            999999999999998765322  3899999999999999999999999999999999999987766   99999998765


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      .........      ..........+++.|+|||++.+  ..++.++|+||+||++|+|++|+.||.+ +.......+..
T Consensus       178 ~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  251 (389)
T 3gni_B          178 MISHGQRQR------VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN  251 (389)
T ss_dssp             CEETTEECS------CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--
T ss_pred             ecccccccc------ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence            543221110      01111222357889999999987  5689999999999999999999999987 33333333333

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-37  Score=263.53  Aligned_cols=218  Identities=23%  Similarity=0.409  Sum_probs=175.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccc----------cCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheee
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAE----------IEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYS   75 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~   75 (249)
                      .++|++.+.++.|.++.+|.....          ..++.+.+...  ......+.+.+|+.+++.+ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            358889999999999998866432          11222222211  2334567899999999999 8999999999999


Q ss_pred             cCCeEEEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeee
Q psy14626         76 SEGMLYMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLA  143 (249)
Q Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~  143 (249)
                      +.+.+++||||+++++|.+++......            ...+++.+++.++.|++.||.|||++|++|+||||+||+++
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEEC
Confidence            999999999999999999999865421            23478999999999999999999999999999999999998


Q ss_pred             ecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CC
Q psy14626        144 NKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GT  222 (249)
Q Consensus       144 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~  222 (249)
                      .++.   ++|+|||++.........           .......+++.|+|||++.+..++.++|+|||||++|||++ |.
T Consensus       238 ~~~~---~kl~DFG~a~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~  303 (370)
T 2psq_A          238 ENNV---MKIADFGLARDINNIDYY-----------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG  303 (370)
T ss_dssp             TTCC---EEECCCSSCEETTCCCTT-----------CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCCC---EEEccccCCcccCcccce-----------ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence            7766   999999999876543211           11112236788999999999889999999999999999999 99


Q ss_pred             CCCCC-ChHHHHHHHHcCc
Q psy14626        223 LPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       223 ~pf~~-~~~~~~~~i~~g~  240 (249)
                      .||.+ +.+++...+..+.
T Consensus       304 ~p~~~~~~~~~~~~~~~~~  322 (370)
T 2psq_A          304 SPYPGIPVEELFKLLKEGH  322 (370)
T ss_dssp             CSSTTCCGGGHHHHHHTTC
T ss_pred             CCCCCCCHHHHHHHHhcCC
Confidence            99998 5667777777764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-37  Score=259.55  Aligned_cols=213  Identities=25%  Similarity=0.384  Sum_probs=175.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ...|...+.++.|.++.+|..........++++..........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus        44 ~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence            33466667888899998887765544444555444444455678899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++...     .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.   ++|+|||++.......
T Consensus       124 ~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~~~~~~~~~  195 (321)
T 2c30_A          124 LQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR---VKLSDFGFCAQISKDV  195 (321)
T ss_dssp             CCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSSS
T ss_pred             CCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc---EEEeeeeeeeecccCc
Confidence            9999999887532     3899999999999999999999999999999999999987766   9999999987765422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .             ......+|+.|+|||++.+..++.++|+||+|+++++|++|+.||.+ +..+....+..+.
T Consensus       196 ~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  257 (321)
T 2c30_A          196 P-------------KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP  257 (321)
T ss_dssp             C-------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSS
T ss_pred             c-------------ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC
Confidence            1             11223589999999999988899999999999999999999999988 4555666666654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.6e-38  Score=260.81  Aligned_cols=217  Identities=19%  Similarity=0.304  Sum_probs=172.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCc---ccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPAS---FGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ..+|++.+.++.|.++.+|..........   ++++.... ......+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            45899999999999999887665432221   33332222 133456789999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|.+++.....   .+++.++..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||++...
T Consensus       128 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~  201 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHDG---QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV---CKVSDFGLSRVL  201 (325)
T ss_dssp             EEECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCSSCEEC
T ss_pred             EeeCCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC---EEECCCCccccc
Confidence            9999999999998865432   3899999999999999999999999999999999999987665   999999999876


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ......          ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.+ +..++...+..+
T Consensus       202 ~~~~~~----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  270 (325)
T 3kul_A          202 EDDPDA----------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG  270 (325)
T ss_dssp             C----C----------CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT
T ss_pred             ccCccc----------eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence            543210          001111235678999999998889999999999999999999 9999998 566677777766

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.9e-38  Score=271.95  Aligned_cols=217  Identities=29%  Similarity=0.559  Sum_probs=181.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|.+.+.++.|.++.++...+......++++   ..........+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            47899999999999998877655444334433   333333445678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++....    .+++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.....
T Consensus        96 E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~---vkL~DFG~a~~~~~  168 (476)
T 2y94_A           96 EYVSGGELFDYICKNG----RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSD  168 (476)
T ss_dssp             ECCSSEEHHHHTTSSS----SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC---EEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC---eEEEeccchhhccc
Confidence            9999999999886543    3899999999999999999999999999999999999987766   99999999977654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...              .....+++.|+|||++.+..+ +.++|+||+||++|+|++|+.||.+ +...+...|.++.+.
T Consensus       169 ~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~  234 (476)
T 2y94_A          169 GEF--------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFY  234 (476)
T ss_dssp             TCC--------------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCC
T ss_pred             ccc--------------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcC
Confidence            221              112358999999999988765 6899999999999999999999998 567788899998887


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      .|.
T Consensus       235 ~p~  237 (476)
T 2y94_A          235 TPQ  237 (476)
T ss_dssp             CCT
T ss_pred             CCc
Confidence            774

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.7e-37  Score=248.89  Aligned_cols=216  Identities=19%  Similarity=0.290  Sum_probs=175.4

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.++.|.++.+|...... ...++++... ......+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEEC-BTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEec-cCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            4689999999999999988765442 2223332222 2223457799999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.....   .+++.++..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.......
T Consensus        85 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           85 ISNGCLLNYLRSHGK---GLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC---VKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             CTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC---EEECCTTCEEECCTTC
T ss_pred             cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC---EEEccCccceecchhh
Confidence            999999999876543   3899999999999999999999999999999999999987766   9999999998765533


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ..            ......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.. +.......+..+...
T Consensus       159 ~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~  224 (268)
T 3sxs_A          159 YV------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRL  224 (268)
T ss_dssp             EE------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             hh------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCC
Confidence            21            1112235678999999998889999999999999999999 9999998 556666667666533

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9e-37  Score=253.42  Aligned_cols=215  Identities=26%  Similarity=0.437  Sum_probs=158.5

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ...+|++.+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||+++++++..++.+++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            356899999999999999987766544444444433222 2234567889999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhc--CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         85 EYMDGSDICFEIVRRATA--GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||+.+ +|.+++......  ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||.+...
T Consensus        83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLARAF  158 (317)
T ss_dssp             ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCSSCEET
T ss_pred             EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC---EEECcCccceec
Confidence            99985 898888765422  234899999999999999999999999999999999999987766   999999999776


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      .....             ......+|+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+ +..+....+.
T Consensus       159 ~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  222 (317)
T 2pmi_A          159 GIPVN-------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF  222 (317)
T ss_dssp             TSCCC-------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCcc-------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            43221             11223578999999998764 579999999999999999999999998 4444454543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-37  Score=275.55  Aligned_cols=220  Identities=25%  Similarity=0.407  Sum_probs=182.3

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .++|++..+|+.|.++.+|..........++++   +.........+.+.+|+.+|+.++||||+++++++.+.+.+++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            357888899999999999877665444444433   33334445667889999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....  ..+++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus       263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~---vKL~DFGla~~~~  337 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH---IRISDLGLAVHVP  337 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC---eEEEecccceecc
Confidence            999999999988875432  23899999999999999999999999999999999999987776   9999999997765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----hHHHHHHHHc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS-----RDRLFQSITK  238 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~-----~~~~~~~i~~  238 (249)
                      ....              .....||+.|+|||++.+..++.++|+||+||++|+|++|+.||.+.     ..++...+..
T Consensus       338 ~~~~--------------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~  403 (576)
T 2acx_A          338 EGQT--------------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE  403 (576)
T ss_dssp             TTCC--------------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH
T ss_pred             cCcc--------------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc
Confidence            4221              11235899999999999888999999999999999999999999873     3567778888


Q ss_pred             Ccccccc
Q psy14626        239 GKLHILG  245 (249)
Q Consensus       239 g~~~~~~  245 (249)
                      ....+|.
T Consensus       404 ~~~~~p~  410 (576)
T 2acx_A          404 VPEEYSE  410 (576)
T ss_dssp             CCCCCCT
T ss_pred             ccccCCc
Confidence            7777764

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.8e-37  Score=251.57  Aligned_cols=216  Identities=25%  Similarity=0.483  Sum_probs=180.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.+|...+......++++   ..........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57888999999999998877665443333333   222333344678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |++++++|.+++.....    +++..+..++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        94 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGWSVHAPS  166 (284)
T ss_dssp             CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC---EEECCCTTCEECSS
T ss_pred             EeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC---EEEecccccccCcc
Confidence            99999999998876543    899999999999999999999999999999999999987766   99999999866543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..               .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||.. +..+....+.++.+.+
T Consensus       167 ~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  231 (284)
T 2vgo_A          167 LR---------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF  231 (284)
T ss_dssp             SC---------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC
T ss_pred             cc---------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCC
Confidence            21               1123478999999999988889999999999999999999999998 5566777888888777


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       232 ~~  233 (284)
T 2vgo_A          232 PP  233 (284)
T ss_dssp             CT
T ss_pred             CC
Confidence            64

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.9e-38  Score=260.86  Aligned_cols=218  Identities=24%  Similarity=0.384  Sum_probs=167.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG----   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   78 (249)
                      ..++|++.+.++.|.++.+|...+......++++   .....+......+.+|+.+++.++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            3578999999999999999877654443333333   333334455678999999999999999999999986543    


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      ..++||||++|++|.+++.....    +++.+++.++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||.
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~  162 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGI  162 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC---EEECCCSC
T ss_pred             ccEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC---EEEeeccC
Confidence            35999999999999999876543    899999999999999999999999999999999999988776   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      +.........          ........+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+ +...+...+.
T Consensus       163 a~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~  232 (311)
T 3ork_A          163 ARAIADSGNS----------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV  232 (311)
T ss_dssp             C----------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cccccccccc----------cccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence            8765442210          1122223579999999999998899999999999999999999999998 4444444444


Q ss_pred             cCc
Q psy14626        238 KGK  240 (249)
Q Consensus       238 ~g~  240 (249)
                      .+.
T Consensus       233 ~~~  235 (311)
T 3ork_A          233 RED  235 (311)
T ss_dssp             HCC
T ss_pred             cCC
Confidence            443

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.5e-37  Score=259.67  Aligned_cols=220  Identities=25%  Similarity=0.427  Sum_probs=171.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ..+||++.+.++.|.++.++...+......++++..... ....+.+.+|+.+++.++||||+++++++.+.+.+++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG-AAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESS-TTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecC-ccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            357999999999999999887776655555555433322 2334678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+++|.+++.....    +++..++.++.|++.||.|||++|++||||||+||+++.++. ..++|+|||++......
T Consensus        97 ~~~~~~L~~~l~~~~~----~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~-~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           97 YASGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSS-CCEEECCCCCC------
T ss_pred             eCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC-ceEEEeecCcccccccc
Confidence            9999999998876543    899999999999999999999999999999999999975442 34899999998643221


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCc-chHHHHHHHHHHHHhCCCCCCCC-----hHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP-VDIWAAGVLLHVLLTGTLPFVGS-----RDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~pf~~~-----~~~~~~~i~~g  239 (249)
                      .              ......+|+.|+|||++.+..+..+ +|+||+||++|+|++|+.||.+.     ...+.+.+...
T Consensus       172 ~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~  237 (361)
T 3uc3_A          172 S--------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV  237 (361)
T ss_dssp             -----------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT
T ss_pred             C--------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC
Confidence            1              1122358999999999988777544 89999999999999999999872     24566777777


Q ss_pred             cccccc
Q psy14626        240 KLHILG  245 (249)
Q Consensus       240 ~~~~~~  245 (249)
                      ...+|.
T Consensus       238 ~~~~~~  243 (361)
T 3uc3_A          238 KYSIPD  243 (361)
T ss_dssp             CCCCCT
T ss_pred             CCCCCC
Confidence            777664

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=255.84  Aligned_cols=217  Identities=27%  Similarity=0.452  Sum_probs=169.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc--------------------------cchhHHHHHHHHHHHHH
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--------------------------HYTTEADLKREATICHM   61 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~E~~~l~~   61 (249)
                      ++|++.+.++.|.++.+|...+......++++.....                          .....+.+.+|+.+++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            5899999999999999987765443333333222111                          11234678999999999


Q ss_pred             cCCCChhhhhheeec--CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCC
Q psy14626         62 LKHPHVVELLETYSS--EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC  139 (249)
Q Consensus        62 l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~N  139 (249)
                      ++||||+++++++.+  .+.+++||||+++++|.+++.     ...+++.+++.++.|++.||.|||++|++|+||||+|
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N  167 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN  167 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence            999999999999976  568999999999999876432     2248999999999999999999999999999999999


Q ss_pred             eeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC---CCCcchHHHHHHHHH
Q psy14626        140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGVLLH  216 (249)
Q Consensus       140 ili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~  216 (249)
                      |+++.++.   ++|+|||++........             ......+|+.|+|||.+.+..   .+.++|+||||+++|
T Consensus       168 il~~~~~~---~kl~Dfg~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~  231 (298)
T 2zv2_A          168 LLVGEDGH---IKIADFGVSNEFKGSDA-------------LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY  231 (298)
T ss_dssp             EEECTTSC---EEECCCTTCEECSSSSC-------------EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred             EEECCCCC---EEEecCCCccccccccc-------------cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence            99987766   99999999977654321             111235899999999998755   367899999999999


Q ss_pred             HHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        217 VLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       217 el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                      +|++|+.||.+ ....+...+..+.+.+|.
T Consensus       232 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  261 (298)
T 2zv2_A          232 CFVFGQCPFMDERIMCLHSKIKSQALEFPD  261 (298)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred             HHHHCCCCCCCccHHHHHHHHhcccCCCCC
Confidence            99999999998 455677778777776664

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=8.1e-38  Score=273.82  Aligned_cols=219  Identities=30%  Similarity=0.573  Sum_probs=181.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .++|++.++++.|.++.+|...+......++++   +.........+.+.+|+.++++++||||+++++++.+.+.+++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            358999999999999999877665444444433   33344456678899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+.+++|.+.+.....    +++..+..++.|++.||.|||++|++|+||||+||+++.++....++|+|||++....
T Consensus       105 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSC----CBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            999999999988875543    8999999999999999999999999999999999999654444559999999986554


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ....              .....+|+.|+|||++.+ .++.++|+||+||++|+|++|..||.+ +..++...+.++.+.
T Consensus       181 ~~~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  245 (484)
T 3nyv_A          181 ASKK--------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT  245 (484)
T ss_dssp             CCCS--------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             cccc--------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC
Confidence            3221              112247999999999876 589999999999999999999999998 566788899998876


Q ss_pred             cc
Q psy14626        243 IL  244 (249)
Q Consensus       243 ~~  244 (249)
                      ++
T Consensus       246 ~~  247 (484)
T 3nyv_A          246 FE  247 (484)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.5e-38  Score=262.06  Aligned_cols=228  Identities=28%  Similarity=0.444  Sum_probs=174.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChh---cc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE---RL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .++|++.+.++.|.++.+|...+......++++..   ..  ......+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            45899999999999999987766555444444322   11  13456788999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhh------------------------------------cCCccCHHHHHHHHHHHHHHHHHH
Q psy14626         82 MVFEYMDGSDICFEIVRRAT------------------------------------AGFVYSEAVASHYMRQVLEALRYC  125 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~------------------------------------~~~~~~~~~~~~~~~ql~~~l~~L  125 (249)
                      +||||+++++|.+++.....                                    ....+++..++.++.|++.||.+|
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999888742110                                    012246788999999999999999


Q ss_pred             HHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc--CCCC
Q psy14626        126 HENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYG  203 (249)
Q Consensus       126 H~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~  203 (249)
                      |+++++|+||||+||+++.++ ...++|+|||.+..........         ........+++.|+|||.+.+  ..++
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~-~~~~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~  254 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNK-SFEIKLVDFGLSKEFYKLNNGE---------YYGMTTKAGTPYFVAPEVLNTTNESYG  254 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSS-SCCEEECCCTTCEEGGGTTCC-----------------CCCGGGCCHHHHTCSSSCCC
T ss_pred             HHCCccccCCChhhEEEecCC-CceEEEeeccccccccccCccc---------cccccccCCCccccCchhhccCCCCCC
Confidence            999999999999999997654 2249999999997764322100         011223358899999999875  5678


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        204 KPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       204 ~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .++|+||||+++|+|++|+.||.+ +..+....+.++...++
T Consensus       255 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  296 (345)
T 3hko_A          255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFE  296 (345)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTT
T ss_pred             cHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccC
Confidence            999999999999999999999998 55666777777765544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=9.4e-38  Score=260.04  Aligned_cols=207  Identities=24%  Similarity=0.448  Sum_probs=167.7

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .....++|++.+.++.|.++.+|...+......++++...... ....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus         2 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   81 (323)
T 3tki_A            2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY   81 (323)
T ss_dssp             CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            4455689999999999999999877666554445544332221 233467899999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++++|.+++.....    +++.+++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kl~Dfg~a~~  154 (323)
T 3tki_A           82 LFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATV  154 (323)
T ss_dssp             EEEECCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC---EEEEEeeccce
Confidence            99999999999888764433    899999999999999999999999999999999999987766   99999999976


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ......           ........+++.|+|||++.+..+ +.++|+||+||++|+|++|+.||..
T Consensus       155 ~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  210 (323)
T 3tki_A          155 FRYNNR-----------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (323)
T ss_dssp             CEETTE-----------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             eccCCc-----------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence            543221           011123358999999999987765 7789999999999999999999987

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1e-37  Score=265.01  Aligned_cols=216  Identities=20%  Similarity=0.351  Sum_probs=174.6

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ++|++.+.++.|.++.+|..........++++.... ......+.+.+|+.++++++||||+++++++..++.+++||||
T Consensus       114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~  193 (377)
T 3cbl_A          114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL  193 (377)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence            578889999999999998776653333344332221 1234456789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.....   .++..++..++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++.......
T Consensus       194 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~---~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          194 VQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV---LKISDFGMSREEADGV  267 (377)
T ss_dssp             CTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCGGGCEECTTSE
T ss_pred             CCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc---EEECcCCCceecCCCc
Confidence            999999999876543   2899999999999999999999999999999999999987765   9999999987654422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .           ........+++.|+|||.+.+..++.++|+||||+++|||++ |..||.+ +..++.+.+.++.
T Consensus       268 ~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  332 (377)
T 3cbl_A          268 Y-----------AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG  332 (377)
T ss_dssp             E-----------ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC
T ss_pred             e-----------eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            1           111122235678999999998888999999999999999998 9999998 5666777776653

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=7.5e-37  Score=249.48  Aligned_cols=219  Identities=21%  Similarity=0.478  Sum_probs=176.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc---cc---cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LN---HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      ++|++.+.++.|.++.+|...+......++++...   ..   .....+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57889999999999998877655433333332221   11   1224688999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC-CCCeEEcCcceeE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN-SAPVKLGGFGVAI  160 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~-~~~~~l~dfg~~~  160 (249)
                      +|||++++++|.+++.....    +++.++..++.|++.||.+||++|++|+||||+||+++.++. ...++|+|||.+.
T Consensus        85 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            99999999999999876543    899999999999999999999999999999999999987652 2249999999987


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .......              .....+++.|+|||.+.+..++.++|+||+|+++++|++|..||.+ +..+....+..+
T Consensus       161 ~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  226 (283)
T 3bhy_A          161 KIEAGNE--------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV  226 (283)
T ss_dssp             ECC----------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred             eccCCCc--------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc
Confidence            7654221              1123478899999999988899999999999999999999999998 556677777777


Q ss_pred             ccccc
Q psy14626        240 KLHIL  244 (249)
Q Consensus       240 ~~~~~  244 (249)
                      ...++
T Consensus       227 ~~~~~  231 (283)
T 3bhy_A          227 NYDFD  231 (283)
T ss_dssp             CCCCC
T ss_pred             ccCCc
Confidence            65544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1e-36  Score=257.05  Aligned_cols=215  Identities=23%  Similarity=0.304  Sum_probs=173.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-----CCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-----HPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~   81 (249)
                      +++|++.+.++.|.++.+|...+......++++... ........+.+|+.+++.++     ||||+++++++...+..+
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~  112 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC  112 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC-SCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEec-cchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence            468999999999999999977765444444443322 22345567888999999996     999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC---------------
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE---------------  146 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~---------------  146 (249)
                      +|||++ +++|.+++......  .++..+++.++.||+.||.|||++|++|+||||+|||++.+.               
T Consensus       113 lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~  189 (360)
T 3llt_A          113 LIFEPL-GPSLYEIITRNNYN--GFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK  189 (360)
T ss_dssp             EEECCC-CCBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred             EEEcCC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence            999999 88999998765433  389999999999999999999999999999999999997411               


Q ss_pred             -------CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHH
Q psy14626        147 -------NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL  219 (249)
Q Consensus       147 -------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  219 (249)
                             ....++|+|||++.......                ....+|+.|+|||++.+..++.++|+||+||++|+|+
T Consensus       190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          190 KIQIYRTKSTGIKLIDFGCATFKSDYH----------------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             EEEEEEESCCCEEECCCTTCEETTSCC----------------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             cccccccCCCCEEEEeccCceecCCCC----------------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                   12349999999997654321                1235789999999999999999999999999999999


Q ss_pred             hCCCCCCC-ChHHHHHHHHcCcc
Q psy14626        220 TGTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       220 ~g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      +|+.||.. +..+....+.....
T Consensus       254 ~g~~pf~~~~~~~~~~~~~~~~~  276 (360)
T 3llt_A          254 TGSLLFRTHEHMEHLAMMESIIQ  276 (360)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHTC
T ss_pred             HCCCCCCCCcHHHHHHHHHHhcC
Confidence            99999998 44455555554433

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.6e-37  Score=253.61  Aligned_cols=201  Identities=26%  Similarity=0.430  Sum_probs=162.9

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ..++|++.+.++.|.++.+|...+.. ...++++...  .......+.+.+|+.+++.++||||+++++++.+++.+++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            35799999999999999998776642 3333333222  22234457789999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++ +|.+.+.....   .+++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||.+....
T Consensus        98 ~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a~~~~  170 (311)
T 3niz_A           98 FEFMEK-DLKKVLDENKT---GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---LKLADFGLARAFG  170 (311)
T ss_dssp             EECCSE-EHHHHHHTCTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEETT
T ss_pred             EcCCCC-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC---EEEccCcCceecC
Confidence            999975 78777765432   3899999999999999999999999999999999999987776   9999999997765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ....             ......+++.|+|||++.+ ..++.++|+||+||++++|++|+.||.+
T Consensus       171 ~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  222 (311)
T 3niz_A          171 IPVR-------------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG  222 (311)
T ss_dssp             SCCC----------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCcc-------------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence            3221             1122347899999999876 5579999999999999999999999998

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3e-37  Score=250.24  Aligned_cols=213  Identities=21%  Similarity=0.355  Sum_probs=173.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ++|++.+.++.|.++.+|...... ...++++... ......+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEEC-TTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecC-CCeEEEEEec-ccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            579999999999999988766542 2223332222 22334577999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++.....   .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+........
T Consensus        88 ~~~~L~~~l~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~~~  161 (269)
T 4hcu_A           88 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQY  161 (269)
T ss_dssp             TTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC---EEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHHhcCc---ccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC---EEecccccccccccccc
Confidence            99999998865433   3899999999999999999999999999999999999987766   99999999865433211


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                                  .......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.. +..++.+.+..+.
T Consensus       162 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~  224 (269)
T 4hcu_A          162 ------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF  224 (269)
T ss_dssp             ------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred             ------------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc
Confidence                        11122235778999999998889999999999999999999 9999998 5667777777763

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.8e-37  Score=254.88  Aligned_cols=221  Identities=19%  Similarity=0.358  Sum_probs=162.4

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCC---cccCCh--hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPA---SFGLPD--ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      +.++|++.+.++.|.++.+|.........   .++++.  .........+.+.+|+.++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            56789999999999999998776554322   222221  1222345678899999999999999999999999776554


Q ss_pred             ------EEEEeccCCCchhHHHHHhhhc--CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         81 ------YMVFEYMDGSDICFEIVRRATA--GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        81 ------~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                            ++||||+.+++|.+++......  ...+++.++..++.|++.||.|||++|++|+||||+||+++.++.   ++
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~---~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT---VC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC---EE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC---EE
Confidence                  9999999999999998765422  224899999999999999999999999999999999999987765   99


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChH
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRD  230 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~  230 (249)
                      |+|||.+.........           .......+++.|+|||.+.+..++.++|+|||||++|+|++ |+.||.+ +..
T Consensus       178 l~Dfg~a~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  246 (323)
T 3qup_A          178 VADFGLSRKIYSGDYY-----------RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA  246 (323)
T ss_dssp             ECCCCC----------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             Eeeccccccccccccc-----------cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence            9999998765443211           11112235778999999999989999999999999999999 9999998 555


Q ss_pred             HHHHHHHcCc
Q psy14626        231 RLFQSITKGK  240 (249)
Q Consensus       231 ~~~~~i~~g~  240 (249)
                      ++...+..+.
T Consensus       247 ~~~~~~~~~~  256 (323)
T 3qup_A          247 EIYNYLIGGN  256 (323)
T ss_dssp             GHHHHHHTTC
T ss_pred             HHHHHHhcCC
Confidence            6666666554

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.4e-37  Score=254.73  Aligned_cols=219  Identities=27%  Similarity=0.379  Sum_probs=174.7

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      .+|++++|++.+.++.|.++.+|...+......++++..........+.+.+|+.+++.++||||+++++++...+.+++
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            46899999999999999999998777665555555544444445667889999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|.+++.....   .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||++...
T Consensus        94 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~  167 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD---IRLADFGVSAKN  167 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC---EEECCCHHHHHH
T ss_pred             EEEeCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC---EEEEECCCCccc
Confidence            9999999999888766433   3899999999999999999999999999999999999987766   999999986432


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ....             .......+++.|+|||.+.     +..++.++|+||||+++++|++|..||.. +.......+
T Consensus       168 ~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  234 (302)
T 2j7t_A          168 LKTL-------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI  234 (302)
T ss_dssp             HHHH-------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             cccc-------------cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence            2110             0111234789999999983     56678999999999999999999999998 455555566


Q ss_pred             HcCc
Q psy14626        237 TKGK  240 (249)
Q Consensus       237 ~~g~  240 (249)
                      .++.
T Consensus       235 ~~~~  238 (302)
T 2j7t_A          235 AKSD  238 (302)
T ss_dssp             HHSC
T ss_pred             hccC
Confidence            5554

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.2e-37  Score=256.66  Aligned_cols=227  Identities=17%  Similarity=0.172  Sum_probs=176.5

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+++|++.+.++.|.++.+|...+......++++.....  ...+.+.+|+.+++.+ +||||+++++++..++..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMK--SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETT--CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccc--cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            467899999999999999887765444444444332222  2334688999999999 8999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC--CCeEEcCcceeEEc
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS--APVKLGGFGVAIQL  162 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~--~~~~l~dfg~~~~~  162 (249)
                      ||+ +++|.+++.....   .+++.+++.++.|++.||.|||++|++|+||||+||+++.++..  ..++|+|||++...
T Consensus        85 e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDR---TFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 8899999876422   38999999999999999999999999999999999999866532  33899999999876


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-C---hHHHHHHHHc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-S---RDRLFQSITK  238 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~---~~~~~~~i~~  238 (249)
                      .........      .........+|+.|+|||++.+..++.++|+||||+++|+|++|+.||.+ +   ..+..+.+..
T Consensus       161 ~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~  234 (330)
T 2izr_A          161 IDPETKKHI------PYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD  234 (330)
T ss_dssp             BCTTTCCBC------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred             ecCCCCccc------cccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence            543211100      00112334689999999999999899999999999999999999999997 2   2345556655


Q ss_pred             Cccccc
Q psy14626        239 GKLHIL  244 (249)
Q Consensus       239 g~~~~~  244 (249)
                      ++...|
T Consensus       235 ~~~~~~  240 (330)
T 2izr_A          235 TKRATP  240 (330)
T ss_dssp             HHHHSC
T ss_pred             hhccCC
Confidence            544433

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-37  Score=254.90  Aligned_cols=222  Identities=22%  Similarity=0.338  Sum_probs=174.2

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC--eEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEG--MLY   81 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~   81 (249)
                      -.+++|++.++++.|.++.+|...+......++++.... ......+.+.+|+.+++.++||||+++++++....  ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            356799999999999999999777665444444433221 22344677889999999999999999999987654  789


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec-CCCCCeEEcCcceeE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAI  160 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~-~~~~~~~l~dfg~~~  160 (249)
                      +||||+++++|.+++..... ...+++.+++.++.|++.||.|||++|++|+||||+||++..+ +....++|+|||.+.
T Consensus        86 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            99999999999999876543 2338999999999999999999999999999999999998322 223348999999997


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccc--------cCCCCCcchHHHHHHHHHHHHhCCCCCCC-----
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE--------DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-----  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~~l~el~~g~~pf~~-----  227 (249)
                      .......              .....+++.|+|||++.        +..++.++|+||+||++|+|++|+.||..     
T Consensus       165 ~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  230 (319)
T 4euu_A          165 ELEDDEQ--------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR  230 (319)
T ss_dssp             ECCTTCC--------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG
T ss_pred             ecCCCCc--------------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence            7654321              11234789999999986        46678999999999999999999999974     


Q ss_pred             ChHHHHHHHHcCcc
Q psy14626        228 SRDRLFQSITKGKL  241 (249)
Q Consensus       228 ~~~~~~~~i~~g~~  241 (249)
                      ...++...+..+.+
T Consensus       231 ~~~~~~~~~~~~~p  244 (319)
T 4euu_A          231 RNKEVMYKIITGKP  244 (319)
T ss_dssp             GCHHHHHHHHHHCC
T ss_pred             hhHHHHHHHhcCCC
Confidence            23456666666554

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-37  Score=258.51  Aligned_cols=222  Identities=22%  Similarity=0.345  Sum_probs=175.8

Q ss_pred             CCCcchHHHhhcccceeeEeeecccc-----CCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      +.++|++.+.++.|.++.+|......     ....++++.... ......+.+.+|+.+++.++||||+++++++.+++.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            34688899999999999888766542     111222222111 223456789999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhc--------------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCC
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATA--------------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC  139 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~N  139 (249)
                      .++||||+++++|.+++......                    ...+++.+++.++.|++.||.+||++|++|+||||+|
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N  204 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  204 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence            99999999999999998764321                    1358999999999999999999999999999999999


Q ss_pred             eeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHH
Q psy14626        140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL  219 (249)
Q Consensus       140 ili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  219 (249)
                      |+++.++.   ++|+|||.+........           ........+++.|+|||.+.+..++.++|+||||+++|+|+
T Consensus       205 Il~~~~~~---~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  270 (343)
T 1luf_A          205 CLVGENMV---VKIADFGLSRNIYSADY-----------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  270 (343)
T ss_dssp             EEECGGGC---EEECCCSCHHHHTGGGC-----------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             EEECCCCe---EEEeecCCCcccccCcc-----------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence            99987776   99999999865533211           01112234688899999999888999999999999999999


Q ss_pred             h-CCCCCCC-ChHHHHHHHHcCcc
Q psy14626        220 T-GTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       220 ~-g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      + |..||.+ +..++...+.++..
T Consensus       271 t~g~~p~~~~~~~~~~~~~~~~~~  294 (343)
T 1luf_A          271 SYGLQPYYGMAHEEVIYYVRDGNI  294 (343)
T ss_dssp             TTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             hcCCCcCCCCChHHHHHHHhCCCc
Confidence            9 9999998 56677888887764

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.4e-37  Score=260.92  Aligned_cols=218  Identities=27%  Similarity=0.459  Sum_probs=176.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .++|++.+.++.|.++.++...+......++++......    ....+|+.++.++ +||||+++++++.+++.+++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            457888899999999998877665444444443322221    1245788888888 79999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec-CCCCCeEEcCcceeEEccC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~-~~~~~~~l~dfg~~~~~~~  164 (249)
                      |+.|++|.+++.....    +++..+..++.|++.||.|||++|++|+||||+||++..+ +....++|+|||++.....
T Consensus        97 ~~~gg~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           97 LMKGGELLDKILRQKF----FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCSCBHHHHHHTCTT----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             CCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            9999999998876543    8999999999999999999999999999999999998544 3334599999999977654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----ChHHHHHHHHcCc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----SRDRLFQSITKGK  240 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----~~~~~~~~i~~g~  240 (249)
                      ...             ......+|+.|+|||++.+..++.++|+|||||++|+|++|..||.+    +.+++.+.|..+.
T Consensus       173 ~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  239 (342)
T 2qr7_A          173 ENG-------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK  239 (342)
T ss_dssp             TTC-------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC
T ss_pred             CCC-------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC
Confidence            221             11223578999999999888788999999999999999999999985    3567889999998


Q ss_pred             ccccc
Q psy14626        241 LHILG  245 (249)
Q Consensus       241 ~~~~~  245 (249)
                      +.++.
T Consensus       240 ~~~~~  244 (342)
T 2qr7_A          240 FSLSG  244 (342)
T ss_dssp             CCCCS
T ss_pred             cccCc
Confidence            88763

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=3.3e-37  Score=256.28  Aligned_cols=207  Identities=18%  Similarity=0.265  Sum_probs=171.8

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ..++|++.+.++.|.++.+|..... ....++++..........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  115 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK  115 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence            3468999999999999999877654 233444444444445667889999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++.........+++.++..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+......
T Consensus       116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV---PKITDFGISKKGTEL  192 (321)
T ss_dssp             CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC---EEECCCTTCEECSSS
T ss_pred             cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC---EEEeecccccccccc
Confidence            99999999888655444445899999999999999999999999999999999999987665   999999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...           .......+++.|+|||++.+..++.++|+||||+++|+|++|+.||.+
T Consensus       193 ~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~  243 (321)
T 2qkw_B          193 DQT-----------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ  243 (321)
T ss_dssp             SCC-----------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred             ccc-----------ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence            210           111223478999999999888899999999999999999999999986

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-37  Score=260.24  Aligned_cols=217  Identities=18%  Similarity=0.335  Sum_probs=163.2

Q ss_pred             CcchHHHhhcccceeeEeeecccc---CCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI---EPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .+|++.++++.|.++.+|......   ....++++.... ......+.+.+|+.++++++||||+++++++.+++.+++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            478999999999999998765442   111223322221 1334567899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++.....   .+++.++..++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||++....
T Consensus       125 ~e~~~~~sL~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Dfg~a~~~~  198 (373)
T 2qol_A          125 TEYMENGSLDSFLRKHDA---QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV---CKVSDFGLGRVLE  198 (373)
T ss_dssp             EECCTTCBHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC-------
T ss_pred             EeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC---EEECcCccccccc
Confidence            999999999999875432   3899999999999999999999999999999999999987665   9999999987665


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ......          .......+++.|+|||++.+..++.++|+||||+++|||++ |+.||.. +..++.+.+..+.
T Consensus       199 ~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~  267 (373)
T 2qol_A          199 DDPEAA----------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY  267 (373)
T ss_dssp             -------------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE
T ss_pred             cCCccc----------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            422100          01111224678999999999899999999999999999998 9999988 5667777777663

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.8e-37  Score=254.68  Aligned_cols=220  Identities=21%  Similarity=0.361  Sum_probs=175.7

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-----CCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .++|++.+.++.|.++.+|...+..     ....++++... .......+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            5689999999999998888765421     11222222221 12345567899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhh--------------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCe
Q psy14626         81 YMVFEYMDGSDICFEIVRRAT--------------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCV  140 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Ni  140 (249)
                      ++||||+++++|.+++.....                    ....+++.+++.++.|++.||.+||++|++|+||||+||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI  181 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI  181 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence            999999999999999987543                    123489999999999999999999999999999999999


Q ss_pred             eeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh
Q psy14626        141 LLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT  220 (249)
Q Consensus       141 li~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~  220 (249)
                      +++.++.   ++|+|||++.........           .......+++.|+|||.+.+..++.++|+||+|+++++|++
T Consensus       182 li~~~~~---~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          182 LVAEGRK---MKISDFGLSRDVYEEDSY-----------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             EEETTTE---EEECCCTTCEECTTTSCE-----------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred             EEcCCCC---EEEccccccccccccccc-----------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence            9987665   999999999876543211           11122236778999999998888999999999999999999


Q ss_pred             -CCCCCCC-ChHHHHHHHHcCc
Q psy14626        221 -GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       221 -g~~pf~~-~~~~~~~~i~~g~  240 (249)
                       |..||.+ +.+++.+.+..+.
T Consensus       248 ~g~~p~~~~~~~~~~~~~~~~~  269 (314)
T 2ivs_A          248 LGGNPYPGIPPERLFNLLKTGH  269 (314)
T ss_dssp             TSCCSSTTCCGGGHHHHHHTTC
T ss_pred             CCCCCCCCCCHHHHHHHhhcCC
Confidence             9999998 5566777777664

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-36  Score=259.01  Aligned_cols=220  Identities=23%  Similarity=0.382  Sum_probs=176.3

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-------CCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-------EPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSE   77 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   77 (249)
                      .++|.+.+.++.|.++.+|...+..       ....++++... .......+.+.+|+.+++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4689999999999999998665321       11112222211 12234567899999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK  145 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~  145 (249)
                      +..++||||+.+++|.+++......            ...+++.+++.++.|++.||.+||+++++|+||||+||+++.+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  227 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED  227 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence            9999999999999999999876521            1348999999999999999999999999999999999999877


Q ss_pred             CCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q psy14626        146 ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP  224 (249)
Q Consensus       146 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p  224 (249)
                      +.   ++|+|||++.........           .......+++.|+|||++.+..++.++|||||||++++|++ |..|
T Consensus       228 ~~---~kL~DFG~a~~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p  293 (382)
T 3tt0_A          228 NV---MKIADFGLARDIHHIDYY-----------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  293 (382)
T ss_dssp             CC---EEECSCSCCCCSSCCCTT-----------CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             Cc---EEEcccCccccccccccc-----------ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence            65   999999998765442210           11122346788999999999989999999999999999999 9999


Q ss_pred             CCC-ChHHHHHHHHcCc
Q psy14626        225 FVG-SRDRLFQSITKGK  240 (249)
Q Consensus       225 f~~-~~~~~~~~i~~g~  240 (249)
                      |.+ +.+++.+.+.++.
T Consensus       294 ~~~~~~~~~~~~~~~~~  310 (382)
T 3tt0_A          294 YPGVPVEELFKLLKEGH  310 (382)
T ss_dssp             STTCCHHHHHHHHHTTC
T ss_pred             CCCCCHHHHHHHHHcCC
Confidence            998 5667777777764

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5.1e-37  Score=259.59  Aligned_cols=207  Identities=16%  Similarity=0.193  Sum_probs=165.5

Q ss_pred             CCcchHHHhhcccceeeEeeec-----cccCCCcccCChhccccchhHHHHHHHHHHHHHcC---CCChhhhhheeecCC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTS-----AEIEPASFGLPDERLNHYTTEADLKREATICHMLK---HPHVVELLETYSSEG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~   78 (249)
                      .++|++.+.++.|.++.+|...     +......++++...   ......+.+|+.+++.++   |+||+++++.+..++
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~---~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~  140 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK---PANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN  140 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEES---SCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeC---CCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence            4679999999999999999773     33333344443322   234567889999999997   899999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhh-cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeee--------cCCCC
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRAT-AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN--------KENSA  149 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~--------~~~~~  149 (249)
                      ..++||||+++++|.+++..... ....+++.+++.++.|++.||.|||++|++||||||+|||++.        +....
T Consensus       141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~  220 (365)
T 3e7e_A          141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA  220 (365)
T ss_dssp             CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred             CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence            99999999999999999976443 2345999999999999999999999999999999999999987        11123


Q ss_pred             CeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       150 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .++|+|||++........           ........+|+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus       221 ~~kl~DFG~a~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          221 GLALIDLGQSIDMKLFPK-----------GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             TEEECCCTTCEEGGGSCT-----------TEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             CEEEeeCchhhhhhccCC-----------CceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence            499999999976543211           1122233589999999999999899999999999999999999998864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.4e-37  Score=249.98  Aligned_cols=214  Identities=19%  Similarity=0.312  Sum_probs=170.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.++.|.++.+|...... ...++++... ......+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETT-TEEEEEEEEC-TTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcC-CCeEEEEEec-CCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            4589999999999999988765542 2222332222 2223457799999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+++|.+++.....   .+++.++..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.......
T Consensus       101 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          101 MANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CTTCBHHHHHHCGGG---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC---EEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC---EEEccccccccccccc
Confidence            999999999876433   2899999999999999999999999999999999999987665   9999999986543321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .            .......+++.|+|||.+.+..++.++|+||+|+++|+|++ |+.||.. +..+..+.+.++.
T Consensus       175 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~  238 (283)
T 3gen_A          175 Y------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL  238 (283)
T ss_dssp             H------------HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC
T ss_pred             c------------ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhccc
Confidence            1            11122235778999999998889999999999999999998 9999998 6667777777764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9.2e-37  Score=250.32  Aligned_cols=211  Identities=24%  Similarity=0.390  Sum_probs=167.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|...+......++++...  .......+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999877765544444444332  2233455788999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+ ++.+.+.....   .+++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        82 ~~~~-~l~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC---EEEeecccceecCCc
Confidence            9976 66555544322   3899999999999999999999999999999999999987766   999999999776432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCC-CCC-ChHHHHHHHHc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLP-FVG-SRDRLFQSITK  238 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~p-f~~-~~~~~~~~i~~  238 (249)
                      .             .......+|+.|+|||++.+.. ++.++|+||+||++++|++|..| |.+ +.......+.+
T Consensus       155 ~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~  217 (292)
T 3o0g_A          155 V-------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_dssp             C-------------SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred             c-------------ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence            2             1112235789999999998765 79999999999999999987766 555 44445555543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.2e-36  Score=250.13  Aligned_cols=207  Identities=25%  Similarity=0.375  Sum_probs=161.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      -++|++.+.++.|.++.+|...+......++++   ..........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            358999999999999988877654433333333   23333344567899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||++++++|.+++.....    +++..+..++.|++.||.+||+++++|+||||+||+++.++.   ++|+|||.+....
T Consensus       113 ~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~---~kl~Dfg~~~~~~  185 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF---AYLVDFGIASATT  185 (309)
T ss_dssp             EECCCCEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSCCC-----
T ss_pred             EEecCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC---EEEecCccCcccc
Confidence            999999999999876543    899999999999999999999999999999999999987765   9999999986654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCChHHH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRDRL  232 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~~~~  232 (249)
                      ....            .......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.....
T Consensus       186 ~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  242 (309)
T 2h34_A          186 DEKL------------TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV  242 (309)
T ss_dssp             -----------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH
T ss_pred             cccc------------ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH
Confidence            4221            11122347899999999998888999999999999999999999999855443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-36  Score=247.30  Aligned_cols=217  Identities=30%  Similarity=0.556  Sum_probs=173.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+|++.+.++.|.++.+|...+......++++   ..........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            58999999999999998877655443334433   222333445678999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |++++++|.+++.....    +++..+..++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus        91 e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN---AKIADFGLSNMMSD  163 (276)
T ss_dssp             ECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC---EEECCCCGGGCCCC
T ss_pred             eccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC---EEEeecccccccCC
Confidence            99999999999876543    899999999999999999999999999999999999987766   99999999865443


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ..              ......+++.|+|||.+.+..+ +.++|+||+|+++++|++|+.||.. +...+.+.+..+.+.
T Consensus       164 ~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  229 (276)
T 2h6d_A          164 GE--------------FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFY  229 (276)
T ss_dssp             ---------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             Cc--------------ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccc
Confidence            21              1112347889999999987765 6899999999999999999999998 566788888888777


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       230 ~~~  232 (276)
T 2h6d_A          230 IPE  232 (276)
T ss_dssp             CCT
T ss_pred             Cch
Confidence            664

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.2e-37  Score=251.05  Aligned_cols=218  Identities=24%  Similarity=0.375  Sum_probs=165.2

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++.+|++.+.++.|.++.+|.......++.+.+... .......+.+.+|+.+++.++||||+++++++ ..+..++|||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVT-APTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCS-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcCceEEEEEecc-CCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            356899999999999999998776654444433322 23345667899999999999999999999965 4456899999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+++|.+++.....   .+++.++..++.|++.||.+||+++++|+||||+||+++.++.   ++|+|||.+......
T Consensus       100 ~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~  173 (289)
T 3og7_A          100 WCEGSSLYHHLHASET---KFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT---VKIGDFGLATEKSRW  173 (289)
T ss_dssp             CCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE---EEECCCC--------
T ss_pred             ecCCCcHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC---EEEccceeccccccc
Confidence            9999999888854432   3899999999999999999999999999999999999988766   999999998655432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHcCc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSITKGK  240 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i~~g~  240 (249)
                      ..           ........+++.|+|||.+.   +..++.++|+||||+++++|++|+.||.+  ..+.+.+.+..+.
T Consensus       174 ~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~  242 (289)
T 3og7_A          174 SG-----------SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGS  242 (289)
T ss_dssp             ---------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTS
T ss_pred             cc-----------cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccc
Confidence            11           01112234799999999986   56678899999999999999999999987  4456677776665


Q ss_pred             cc
Q psy14626        241 LH  242 (249)
Q Consensus       241 ~~  242 (249)
                      ..
T Consensus       243 ~~  244 (289)
T 3og7_A          243 LS  244 (289)
T ss_dssp             CC
T ss_pred             cC
Confidence            43

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=7e-37  Score=249.68  Aligned_cols=215  Identities=23%  Similarity=0.383  Sum_probs=162.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC---CCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      .++|++.+.++.|.++.+|.......   ...++++... .......+.+.+|+.++++++||||+++++++.+ +..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-CccEE
Confidence            56899999999999999886654321   1122322221 2234556789999999999999999999999854 56899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|.+++.....   .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+...
T Consensus        93 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~  166 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYM  166 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECC-------
T ss_pred             EEecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC---EEECcccccccc
Confidence            9999999999999876532   3899999999999999999999999999999999999998776   999999998766


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ......            ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+ +..++...+.++.
T Consensus       167 ~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~  234 (281)
T 1mp8_A          167 EDSTYY------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE  234 (281)
T ss_dssp             ------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             Cccccc------------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC
Confidence            543211            1112235678999999998889999999999999999997 9999998 5566777777664

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.7e-37  Score=252.31  Aligned_cols=208  Identities=18%  Similarity=0.271  Sum_probs=165.5

Q ss_pred             CCCcchHHHhhcccceeeEeeec----cccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec--CCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTS----AEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS--EGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~   79 (249)
                      ..++|++.+.++.|.++.+|...    +......++++..........+.+.+|+.+++.++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            35799999999999999998765    333334445544444455666789999999999999999999999854  356


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +++||||+++++|.+++.....   .+++..+..++.|++.||.+||+++++|+||||+||+++.++.   ++|+|||.+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~kl~Dfg~~  161 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLT  161 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCCSC
T ss_pred             eEEEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe---EEEccCccc
Confidence            8999999999999999876543   2899999999999999999999999999999999999998776   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR  229 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~  229 (249)
                      .........          ........++..|+|||.+.+..++.++|+||+|+++++|++|..||....
T Consensus       162 ~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~  221 (295)
T 3ugc_A          162 KVLPQDKEF----------FKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP  221 (295)
T ss_dssp             C-----------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred             ccccCCcce----------eeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence            765442210          011112235677999999999999999999999999999999999987643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-36  Score=260.60  Aligned_cols=215  Identities=28%  Similarity=0.466  Sum_probs=165.6

Q ss_pred             cchHH-HhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeec----CCeEEE
Q psy14626          9 RITIH-EVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSS----EGMLYM   82 (249)
Q Consensus         9 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~l   82 (249)
                      .|.+. ++++.|.++.+|...+......++++...     ....+.+|+.++.++ +||||+++++++..    .+.+++
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~-----~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l  136 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI  136 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeC-----cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence            44444 67888999998877665554445544332     224677899887555 89999999999865    567899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+.|++|.+++.....  ..+++.+++.++.|++.||.|||++|++|+||||+|||++.++....++|+|||++...
T Consensus       137 v~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~  214 (400)
T 1nxk_A          137 VMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET  214 (400)
T ss_dssp             EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccccc
Confidence            9999999999999876432  23899999999999999999999999999999999999987443455999999999765


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh-----HHHHHHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR-----DRLFQSIT  237 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~-----~~~~~~i~  237 (249)
                      ....              ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+..     ..+...+.
T Consensus       215 ~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~  280 (400)
T 1nxk_A          215 TSHN--------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR  280 (400)
T ss_dssp             C-------------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred             CCCC--------------ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence            4321              1112347899999999999899999999999999999999999998732     23667788


Q ss_pred             cCccccc
Q psy14626        238 KGKLHIL  244 (249)
Q Consensus       238 ~g~~~~~  244 (249)
                      .+.+.+|
T Consensus       281 ~~~~~~~  287 (400)
T 1nxk_A          281 MGQYEFP  287 (400)
T ss_dssp             HTCCCCC
T ss_pred             cCcccCC
Confidence            8887776

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.2e-37  Score=249.47  Aligned_cols=219  Identities=22%  Similarity=0.410  Sum_probs=153.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      -++|++.+.++.|.++.+|...+......++++   ..........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            357899999999999998877654333333333   22223334457899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++....   ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+....
T Consensus        90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC---EEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEEEeecceeecc
Confidence            99999999998887542   23899999999999999999999999999999999999987766   9999999987764


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ....             ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||.. +.......+....+.
T Consensus       164 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  230 (278)
T 3cok_A          164 MPHE-------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE  230 (278)
T ss_dssp             -----------------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCC
T ss_pred             CCCC-------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccC
Confidence            3221             11123478999999999988889999999999999999999999987 333444445444444


Q ss_pred             cc
Q psy14626        243 IL  244 (249)
Q Consensus       243 ~~  244 (249)
                      +|
T Consensus       231 ~~  232 (278)
T 3cok_A          231 MP  232 (278)
T ss_dssp             CC
T ss_pred             Cc
Confidence            44

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-36  Score=248.95  Aligned_cols=217  Identities=29%  Similarity=0.428  Sum_probs=178.1

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      ..++.++|++.+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||+++++++...+.++
T Consensus        17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   96 (303)
T 3a7i_A           17 KADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLW   96 (303)
T ss_dssp             EECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            457888999999999999999887765444444444322221 2345678999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++++|.+++...     .++...+..++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        97 lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~Dfg~~~~  168 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQ  168 (303)
T ss_dssp             EEEECCTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC---EEEeeccccee
Confidence            999999999999887532     3899999999999999999999999999999999999987665   99999999977


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCc
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ......             ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||.. ...++...+.++.
T Consensus       169 ~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  235 (303)
T 3a7i_A          169 LTDTQI-------------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN  235 (303)
T ss_dssp             CBTTBC-------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred             cCcccc-------------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC
Confidence            654321             11223578899999999988889999999999999999999999998 4555555665544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=250.80  Aligned_cols=209  Identities=26%  Similarity=0.387  Sum_probs=164.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|...+......++++..  ........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            6899999999999999987776544444444322  22223446778899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++....    .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        83 ~~~~~~l~~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           83 YCDHTVLHELDRYQR----GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGFARLLTGP  155 (311)
T ss_dssp             CCSEEHHHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECC--
T ss_pred             eCCCchHHHHHhhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC---EEEeeCCCchhccCc
Confidence            999988887765443    2899999999999999999999999999999999999987665   999999999776532


Q ss_pred             CccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ..             ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+ +..+....+
T Consensus       156 ~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  215 (311)
T 4agu_A          156 SD-------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI  215 (311)
T ss_dssp             -----------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cc-------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            21             1122347889999999876 5679999999999999999999999998 333333333

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-36  Score=264.18  Aligned_cols=206  Identities=22%  Similarity=0.349  Sum_probs=161.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------C
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------G   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------~   78 (249)
                      .+||++.+.++.|.++.++...+......++++...  .......+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            468999999999999999877655544444444332  23445667899999999999999999999999644      4


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+++||||+.+ +|.+.+..      .+++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||+
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~---~kl~DFG~  210 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL  210 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC---EEEEEEEe
Confidence            67999999976 56555532      2899999999999999999999999999999999999987766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      +.......              ......+|+.|+|||++.+..++.++|+||+||++++|++|+.||.+ +.......|
T Consensus       211 a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i  275 (464)
T 3ttj_A          211 ARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV  275 (464)
T ss_dssp             C-----CC--------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             eeecCCCc--------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            97654421              11223579999999999999999999999999999999999999998 333334343

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.7e-36  Score=248.02  Aligned_cols=222  Identities=25%  Similarity=0.376  Sum_probs=169.5

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .....+|++.+.++.|.++.+|..........++++   ..........+.+.+|+.+++.++||||+++++++...+..
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            344568999999999999998876654433334433   22333455677899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++|||++.+++|.+++.........+++..+..++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+.
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~---~kl~Dfg~~~  184 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV---VKLGDLGLGR  184 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCC----
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC---EEEEecccee
Confidence            9999999999999998876555566899999999999999999999999999999999999987665   9999999986


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC---hHHHHHHHH
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS---RDRLFQSIT  237 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~---~~~~~~~i~  237 (249)
                      .......             ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||.+.   ...+...+.
T Consensus       185 ~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  251 (310)
T 2wqm_A          185 FFSSKTT-------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE  251 (310)
T ss_dssp             ---------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHH
T ss_pred             eecCCCc-------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhh
Confidence            6543221             112234789999999999888999999999999999999999999862   345666666


Q ss_pred             cCcc
Q psy14626        238 KGKL  241 (249)
Q Consensus       238 ~g~~  241 (249)
                      .+..
T Consensus       252 ~~~~  255 (310)
T 2wqm_A          252 QCDY  255 (310)
T ss_dssp             TTCS
T ss_pred             cccC
Confidence            6543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.7e-37  Score=254.26  Aligned_cols=217  Identities=18%  Similarity=0.265  Sum_probs=169.3

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcc----cCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASF----GLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ...+|++.++++.|.++.+|...+.......    +++.. ........+.+.+|+.++++++||||+++++++.++. .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            4568999999999999999876643222211    22111 1223355678999999999999999999999998765 7


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++|++++.+++|.+++.....   .+++..++.++.|++.||.|||+++++||||||+||+++.++.   ++|+|||++.
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~  165 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAK  165 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCTTHHH
T ss_pred             EEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC---EEEccCccee
Confidence            899999999999998876443   3899999999999999999999999999999999999988776   9999999987


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHc
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~  238 (249)
                      ........           .......+++.|+|||++.+..++.++|+||||+++|+|++ |+.||.+ +..++.+.+..
T Consensus       166 ~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  234 (327)
T 3poz_A          166 LLGAEEKE-----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK  234 (327)
T ss_dssp             HHTTTCC------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             EccCCccc-----------ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc
Confidence            65442210           11112235778999999999999999999999999999999 9999998 55566667766


Q ss_pred             Cc
Q psy14626        239 GK  240 (249)
Q Consensus       239 g~  240 (249)
                      +.
T Consensus       235 ~~  236 (327)
T 3poz_A          235 GE  236 (327)
T ss_dssp             TC
T ss_pred             CC
Confidence            54

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.1e-37  Score=249.71  Aligned_cols=220  Identities=15%  Similarity=0.191  Sum_probs=172.0

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCC-------CcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEP-------ASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSE   77 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (249)
                      =..++|++.+.++.|.++.+|...+....       ..++++..........+.+.+|+.++++++||||+++++++.++
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG   84 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence            35679999999999999998876554322       12333333334445678899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC-----CCeE
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS-----APVK  152 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~-----~~~~  152 (249)
                      +..++||||+++++|.+++.....   .+++.++..++.|++.||.+||+++++|+||||+||+++.++..     ..++
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGG---GCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            999999999999999999976543   28999999999999999999999999999999999999876542     2289


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHh-CCCCCCCChH
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLT-GTLPFVGSRD  230 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~-g~~pf~~~~~  230 (249)
                      |+|||.+......                 ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++ |.+||.....
T Consensus       162 l~Dfg~~~~~~~~-----------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~  224 (289)
T 4fvq_A          162 LSDPGISITVLPK-----------------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS  224 (289)
T ss_dssp             ECCCCSCTTTSCH-----------------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             eccCcccccccCc-----------------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence            9999987433221                 11236888999999987 668999999999999999999 5667766443


Q ss_pred             HHHHHHHcCccccc
Q psy14626        231 RLFQSITKGKLHIL  244 (249)
Q Consensus       231 ~~~~~i~~g~~~~~  244 (249)
                      .....+......+|
T Consensus       225 ~~~~~~~~~~~~~~  238 (289)
T 4fvq_A          225 QRKLQFYEDRHQLP  238 (289)
T ss_dssp             HHHHHHHHTTCCCC
T ss_pred             HHHHHHhhccCCCC
Confidence            33334444444444

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=7.8e-37  Score=257.54  Aligned_cols=221  Identities=21%  Similarity=0.355  Sum_probs=172.3

Q ss_pred             CCCcchHHHhhcccceeeEeeec-----cccCCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTS-----AEIEPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSEG   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   78 (249)
                      +.++|++.+.++.|.++.+|...     .......++++.... ......+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~   99 (359)
T 3vhe_A           20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   99 (359)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence            45789999999999999998765     222222333332222 2234457799999999999 7999999999997754


Q ss_pred             -eEEEEEeccCCCchhHHHHHhhhc-------------------------------------------------------
Q psy14626         79 -MLYMVFEYMDGSDICFEIVRRATA-------------------------------------------------------  102 (249)
Q Consensus        79 -~~~lv~e~~~~~~L~~~l~~~~~~-------------------------------------------------------  102 (249)
                       .+++||||+++++|.+++......                                                       
T Consensus       100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (359)
T 3vhe_A          100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  179 (359)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred             CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence             489999999999999998765431                                                       


Q ss_pred             -------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccc
Q psy14626        103 -------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERL  175 (249)
Q Consensus       103 -------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  175 (249)
                             ...+++..++.++.|++.||.|||+++++|+||||+||+++.++.   ++|+|||.+.........       
T Consensus       180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kl~Dfg~a~~~~~~~~~-------  249 (359)
T 3vhe_A          180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV---VKICDFGLARDIYKDPDY-------  249 (359)
T ss_dssp             ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCGGGSCTTSCTTC-------
T ss_pred             ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCc---EEEEeccceeeecccccc-------
Confidence                   122889999999999999999999999999999999999987766   999999998655432210       


Q ss_pred             cccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCCC--hHHHHHHHHcCc
Q psy14626        176 DHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVGS--RDRLFQSITKGK  240 (249)
Q Consensus       176 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~~--~~~~~~~i~~g~  240 (249)
                          .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.  .+.+...+..+.
T Consensus       250 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  313 (359)
T 3vhe_A          250 ----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT  313 (359)
T ss_dssp             ----EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTC
T ss_pred             ----hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCC
Confidence                11222347888999999999889999999999999999998 99999982  445555555543

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.7e-36  Score=254.97  Aligned_cols=213  Identities=24%  Similarity=0.363  Sum_probs=170.3

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc---cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      -++.++|+..+.++.|.++.+|...+......++++...   .......+.+.+|+.+++.++||||+++++++..++..
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeE
Confidence            456678899999999999999877654444344443322   23344557899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+. ++|.+.+.....   .+++.++..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||++.
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~a~  202 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSAS  202 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE---EEECCCTTCB
T ss_pred             EEEEecCC-CCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC---EEEeeccCce
Confidence            99999997 578777754432   3899999999999999999999999999999999999987765   9999999985


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      .....                 ....+++.|+|||++.   +..++.++|+|||||++++|++|+.||.+ +.......+
T Consensus       203 ~~~~~-----------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  265 (348)
T 1u5q_A          203 IMAPA-----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI  265 (348)
T ss_dssp             SSSSB-----------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             ecCCC-----------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            54321                 1235789999999984   45678999999999999999999999988 444444445


Q ss_pred             HcCc
Q psy14626        237 TKGK  240 (249)
Q Consensus       237 ~~g~  240 (249)
                      ..+.
T Consensus       266 ~~~~  269 (348)
T 1u5q_A          266 AQNE  269 (348)
T ss_dssp             HHSC
T ss_pred             HhcC
Confidence            4443

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9e-37  Score=249.99  Aligned_cols=208  Identities=27%  Similarity=0.441  Sum_probs=162.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|...+. ....++++....  ......+.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC-CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            57899999999999999877653 223333332221  222334678899999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++.+ +|.+++.....   .+++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        81 ~~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIP  153 (288)
T ss_dssp             CCSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCTTHHHHHCC-
T ss_pred             ecCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC---EEEeECccccccCcc
Confidence            9976 88887765432   3899999999999999999999999999999999999987766   999999998654321


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      .             .......+|+.|+|||++.+. .++.++|+||+||++|+|++|+.||.+ +..+....+
T Consensus       154 ~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  213 (288)
T 1ob3_A          154 V-------------RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI  213 (288)
T ss_dssp             ---------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             c-------------cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            1             011123478999999998764 579999999999999999999999998 444444444

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.5e-37  Score=248.98  Aligned_cols=219  Identities=29%  Similarity=0.439  Sum_probs=176.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhhee--ecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETY--SSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~l   82 (249)
                      .++|++.+.++.|.++.+|...+......++++....  ......+.+.+|+.++++++||||+++++++  ..++.+++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            4689999999999999888776654444444333222  2234567899999999999999999999987  44678999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC-----ceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND-----IIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~-----~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ||||+++++|.+++.........+++..++.++.|++.||.+||+++     ++|+||||+||+++.++.   ++|+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~---~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC---EEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC---EEEecCc
Confidence            99999999999999877665666899999999999999999999999     999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      .+........             ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.. +..++.+.+
T Consensus       162 ~~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i  228 (279)
T 2w5a_A          162 LARILNHDTS-------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI  228 (279)
T ss_dssp             HHHHC---CH-------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hheeeccccc-------------cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH
Confidence            9865443211             01112478999999999988899999999999999999999999998 566778888


Q ss_pred             HcCcc
Q psy14626        237 TKGKL  241 (249)
Q Consensus       237 ~~g~~  241 (249)
                      .++..
T Consensus       229 ~~~~~  233 (279)
T 2w5a_A          229 REGKF  233 (279)
T ss_dssp             HHTCC
T ss_pred             hhccc
Confidence            88765

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-36  Score=255.76  Aligned_cols=208  Identities=24%  Similarity=0.374  Sum_probs=162.5

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG----   78 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   78 (249)
                      +..++|++.+.++.|.++.++...+......++++..  ........+.+.+|+.+++.++||||+++++++...+    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            4567999999999999999987765544444444332  2233445678899999999999999999999997653    


Q ss_pred             --eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         79 --MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        79 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                        .+++|||++ +++|.+++...     .+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+||
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~Df  172 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---LKILDF  172 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCC
T ss_pred             CceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC---EEEEee
Confidence              469999999 77998887652     2899999999999999999999999999999999999987766   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~  234 (249)
                      |++.......                ....+|+.|+|||++.+ ..++.++|+||+||++++|++|+.||.+ +......
T Consensus       173 g~a~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~  236 (367)
T 1cm8_A          173 GLARQADSEM----------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK  236 (367)
T ss_dssp             TTCEECCSSC----------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eccccccccc----------------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9997754321                12247889999999887 6789999999999999999999999998 3333444


Q ss_pred             HHH
Q psy14626        235 SIT  237 (249)
Q Consensus       235 ~i~  237 (249)
                      .|.
T Consensus       237 ~i~  239 (367)
T 1cm8_A          237 EIM  239 (367)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.5e-36  Score=247.19  Aligned_cols=219  Identities=30%  Similarity=0.556  Sum_probs=178.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .++|++.+.++.|.++.+|...+......++++..  ........+.+.+|+.++++++||||+++++++...+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            45899999999999998887766544444443322  1222345778999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |++++++|.+++.....    +++..++.++.|++.||.+||++|++|+||+|+||+++.++....++|+|||.+.....
T Consensus       101 e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             CCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EccCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            99999999888876543    89999999999999999999999999999999999998765555699999998755433


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..              ......+++.|+|||.+.+. ++.++|+||||+++++|++|..||.+ +..++.+.+.++...+
T Consensus       177 ~~--------------~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  241 (287)
T 2wei_A          177 NT--------------KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAF  241 (287)
T ss_dssp             CS--------------SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             CC--------------ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            21              11223478899999998765 78999999999999999999999998 5667788888887654


Q ss_pred             c
Q psy14626        244 L  244 (249)
Q Consensus       244 ~  244 (249)
                      +
T Consensus       242 ~  242 (287)
T 2wei_A          242 D  242 (287)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.8e-36  Score=255.63  Aligned_cols=223  Identities=22%  Similarity=0.381  Sum_probs=161.8

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcC-CCChhhhhheeecC--CeE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLK-HPHVVELLETYSSE--GML   80 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~   80 (249)
                      ..++|++.+.++.|.++.++...+......++++..  ..........+.+|+.+++.+. ||||+++++++...  ..+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            346899999999999999987766555444554432  2334556678889999999996 99999999999654  369


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      |+||||+. ++|..++...     .++...+..++.|++.||.|||+.|++||||||+|||++.++.   ++|+|||+++
T Consensus        87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~  157 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH---VKVADFGLSR  157 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCE
T ss_pred             EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC---EEecCCcccc
Confidence            99999997 5888887653     2899999999999999999999999999999999999987766   9999999998


Q ss_pred             EccCCCccccCC--------ccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChH
Q psy14626        161 QLQDGQLYCSGG--------ERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRD  230 (249)
Q Consensus       161 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~  230 (249)
                      ............        ..............+|+.|+|||++.+ ..++.++|+||+||+++||++|+.||.+ +..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            764421110000        000001111223358999999999886 5689999999999999999999999998 444


Q ss_pred             HHHHHHH
Q psy14626        231 RLFQSIT  237 (249)
Q Consensus       231 ~~~~~i~  237 (249)
                      ...+.|.
T Consensus       238 ~~~~~i~  244 (388)
T 3oz6_A          238 NQLERII  244 (388)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            4444443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-36  Score=266.76  Aligned_cols=214  Identities=21%  Similarity=0.320  Sum_probs=173.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ..|++.+.|+.|.++.+|..........++++.... .....+.+.+|+.+|++++||||+++++++...+.+++||||+
T Consensus       220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~  298 (495)
T 1opk_A          220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM  298 (495)
T ss_dssp             GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCS-SSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecC-cccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEcc
Confidence            468888899999998888665543222233322222 2334678999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++.....  ..++...++.++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++........
T Consensus       299 ~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          299 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL---VKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC---EEECCTTCEECCTTCCE
T ss_pred             CCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc---EEEeecccceeccCCce
Confidence            99999999876432  23899999999999999999999999999999999999987766   99999999977654221


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                                  +......+++.|+|||++.+..++.++||||||+++|||++ |..||.+ +..++.+.+.++
T Consensus       374 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~  435 (495)
T 1opk_A          374 ------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD  435 (495)
T ss_dssp             ------------ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             ------------eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence                        11112235678999999998889999999999999999999 9999998 556677777665

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9e-36  Score=244.83  Aligned_cols=217  Identities=28%  Similarity=0.499  Sum_probs=177.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc---------cchhHHHHHHHHHHHHHcC-CCChhhhhheeec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN---------HYTTEADLKREATICHMLK-HPHVVELLETYSS   76 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   76 (249)
                      .++|++.+.++.|.++.+|...+......++++.....         .....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            46899999999999999887766544433443322211         1234567889999999995 9999999999999


Q ss_pred             CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         77 EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      .+..++|||++++++|.+++.....    +++..+..++.|++.||.+||++|++|+||+|+||+++.++.   ++|+||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~df  168 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDF  168 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCC
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc---EEEecc
Confidence            9999999999999999999876543    899999999999999999999999999999999999987766   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCC-Ch
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE------DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR  229 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~  229 (249)
                      |.+.......              ......+++.|+|||.+.      ...++.++|+||||+++++|++|..||.. +.
T Consensus       169 g~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~  234 (298)
T 1phk_A          169 GFSCQLDPGE--------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  234 (298)
T ss_dssp             TTCEECCTTC--------------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cchhhcCCCc--------------ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence            9987765422              112234788999999985      44578899999999999999999999988 55


Q ss_pred             HHHHHHHHcCccccc
Q psy14626        230 DRLFQSITKGKLHIL  244 (249)
Q Consensus       230 ~~~~~~i~~g~~~~~  244 (249)
                      ..+...+.++.+.++
T Consensus       235 ~~~~~~~~~~~~~~~  249 (298)
T 1phk_A          235 MLMLRMIMSGNYQFG  249 (298)
T ss_dssp             HHHHHHHHHTCCCCC
T ss_pred             HHHHHHHhcCCcccC
Confidence            667778888776654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.3e-37  Score=254.23  Aligned_cols=205  Identities=19%  Similarity=0.245  Sum_probs=167.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ..++|++.+.++.|.++.+|...... ...++++..... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus        28 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  106 (326)
T 3uim_A           28 ASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVY  106 (326)
T ss_dssp             TTTSSCSTTEEECCSSSEEEEECCSS-SCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEE
T ss_pred             HhhccccceeEecCCCcEEEEEEecC-CCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEE
Confidence            35689999999999999998765432 222332222111 1122336899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC---CceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN---DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      ||+.+++|.+++.........+++..+..++.|++.||.+||++   |++|+||||+||+++.++.   ++|+|||.+..
T Consensus       107 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~~~~  183 (326)
T 3uim_A          107 PYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE---AVVGDFGLAKL  183 (326)
T ss_dssp             ECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC---EEECCCSSCEE
T ss_pred             EeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC---EEeccCccccc
Confidence            99999999999987666566699999999999999999999999   9999999999999987765   99999999987


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV  226 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~  226 (249)
                      ......            .......+|+.|+|||.+.+..++.++|+||+|+++|+|++|+.||.
T Consensus       184 ~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          184 MDYKDT------------HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CCSSSS------------CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             cCcccc------------cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence            654321            11122347999999999988889999999999999999999999995

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.6e-36  Score=252.73  Aligned_cols=224  Identities=23%  Similarity=0.347  Sum_probs=174.4

Q ss_pred             CCCcchHHHhhcccceeeEeeeccc-----cCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      +.++|++.+.++.|.++.+|.....     .....++++... .........+.+|+.++++++||||+++++++...+.
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            4679999999999999888876522     222223332221 2234556689999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhc---CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATA---GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      .++||||+++++|.+++......   ...++...++.++.|++.||.+||++|++|+||||+||+++.++....++|+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence            99999999999999999876432   134889999999999999999999999999999999999986655566999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~  234 (249)
                      |.+.........           .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.. +..++.+
T Consensus       188 g~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  256 (327)
T 2yfx_A          188 GMARDIYRASYY-----------RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE  256 (327)
T ss_dssp             HHHHHHHC-----------------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cccccccccccc-----------ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH
Confidence            998654332211           11122346889999999998889999999999999999998 9999998 5666777


Q ss_pred             HHHcCc
Q psy14626        235 SITKGK  240 (249)
Q Consensus       235 ~i~~g~  240 (249)
                      .+..+.
T Consensus       257 ~~~~~~  262 (327)
T 2yfx_A          257 FVTSGG  262 (327)
T ss_dssp             HHHTTC
T ss_pred             HHhcCC
Confidence            777664

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.9e-36  Score=252.77  Aligned_cols=216  Identities=29%  Similarity=0.558  Sum_probs=174.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc--------cchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--------HYTTEADLKREATICHML-KHPHVVELLETYSSEG   78 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   78 (249)
                      .+|.+.+.++.|.++.+|..........++++.....        .....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            3677778899999998887665433333333322111        112356788999999999 7999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      ..++||||++|++|.+++.....    +++..+..++.|++.||.+||+.|++|+||||+||+++.++.   ++|+|||.
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~---ikl~DfG~  246 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ---IRLSDFGF  246 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC---EEEEecCc
Confidence            99999999999999998876543    899999999999999999999999999999999999987766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED------QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDR  231 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~  231 (249)
                      +.......              ......+|+.|+|||++.+      ..++.++|+|||||++|+|++|..||.. +...
T Consensus       247 ~~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  312 (365)
T 2y7j_A          247 SCHLEPGE--------------KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL  312 (365)
T ss_dssp             CEECCTTC--------------CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ccccCCCc--------------ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence            87765422              1122358999999999863      3478899999999999999999999988 5566


Q ss_pred             HHHHHHcCccccc
Q psy14626        232 LFQSITKGKLHIL  244 (249)
Q Consensus       232 ~~~~i~~g~~~~~  244 (249)
                      +...+..+.+.++
T Consensus       313 ~~~~i~~~~~~~~  325 (365)
T 2y7j_A          313 MLRMIMEGQYQFS  325 (365)
T ss_dssp             HHHHHHHTCCCCC
T ss_pred             HHHHHHhCCCCCC
Confidence            7778888876654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-36  Score=250.30  Aligned_cols=217  Identities=18%  Similarity=0.265  Sum_probs=168.7

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcc----cCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASF----GLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ...+|++.++++.|.++.+|...+......+    +++.. ........+.+.+|+.+++.++||||+++++++..+. .
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~   91 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence            4678999999999999999877654332222    11111 1223456788999999999999999999999998765 8


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++|++++.+++|.+++.....   .+++..++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kL~DfG~a~  165 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAK  165 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCTTC--
T ss_pred             eEEEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC---EEEccCccee
Confidence            899999999999998876543   3899999999999999999999999999999999999988776   9999999997


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHc
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~  238 (249)
                      ........           .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+ +..++.+.+..
T Consensus       166 ~~~~~~~~-----------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~  234 (327)
T 3lzb_A          166 LLGAEEKE-----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK  234 (327)
T ss_dssp             -------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred             EccCcccc-----------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence            66442211           11112235778999999999999999999999999999999 9999998 55666666666


Q ss_pred             Cc
Q psy14626        239 GK  240 (249)
Q Consensus       239 g~  240 (249)
                      +.
T Consensus       235 ~~  236 (327)
T 3lzb_A          235 GE  236 (327)
T ss_dssp             TC
T ss_pred             CC
Confidence            54

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.2e-36  Score=248.85  Aligned_cols=215  Identities=21%  Similarity=0.329  Sum_probs=175.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.++.|.++.+|...+......++++... .+....+.+.+|+.+++.++||||+++++++.+.+..++|||+
T Consensus        12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   90 (288)
T 3kfa_A           12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   90 (288)
T ss_dssp             GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEEC-SCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecC-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence            458999999999999998877665443334433222 3345668899999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+++|.+++.....  ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.......
T Consensus        91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC---EEECCCCGGGTSCSSS
T ss_pred             CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC---EEEccCccceeccCCc
Confidence            999999999876433  33899999999999999999999999999999999999987766   9999999986544322


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .            .......+++.|+|||.+.+..++.++|+||+|+++++|++ |..||.+ +...+.+.+.++
T Consensus       166 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~  228 (288)
T 3kfa_A          166 Y------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD  228 (288)
T ss_dssp             S------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred             c------------ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc
Confidence            1            11122346778999999998889999999999999999999 9999998 555666666555

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.4e-36  Score=261.23  Aligned_cols=212  Identities=22%  Similarity=0.363  Sum_probs=169.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-eEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-MLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~   86 (249)
                      ++|++.+.++.|.++.+|.....-  ..++++..  ......+.+.+|+.++++++||||+++++++.+.+ .+++||||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~~--~~vavK~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYRG--NKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETT--EEEEEEEE--SSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             HHeEEEeeecCcCCeeEEEEEecC--CeEEEEEe--CCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            578888899999999888665431  12222222  12235678999999999999999999999986654 79999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++.....  ..++...++.++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++.......
T Consensus       269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC---EEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC---EEEeeCCCcccccccc
Confidence            999999999986543  23789999999999999999999999999999999999987665   9999999987543311


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc-ccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK-LHI  243 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~-~~~  243 (249)
                                      ....+++.|+|||.+.+..++.++|+||||+++|||++ |+.||.+ +..++...+.+|. +..
T Consensus       344 ----------------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~  407 (450)
T 1k9a_A          344 ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA  407 (450)
T ss_dssp             -------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC
T ss_pred             ----------------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence                            11236788999999999999999999999999999998 9999998 5566777777763 444


Q ss_pred             c
Q psy14626        244 L  244 (249)
Q Consensus       244 ~  244 (249)
                      |
T Consensus       408 p  408 (450)
T 1k9a_A          408 P  408 (450)
T ss_dssp             C
T ss_pred             C
Confidence            4

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.4e-36  Score=251.23  Aligned_cols=205  Identities=26%  Similarity=0.407  Sum_probs=163.5

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      +..-++|++.+.++.|.++.+|...+......++++...  .......+.+.+|+.+++.++||||+++++++...+..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            345568999999999999999877765544444444222  222344567889999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++++|.+++....    .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+..
T Consensus       101 lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~---~kl~Dfg~~~~  173 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPN----GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGFART  173 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCTTC--
T ss_pred             EEEecCCcchHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc---EEEEeCCCcee
Confidence            9999999988877654433    2899999999999999999999999999999999999987765   99999999866


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ......             ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.
T Consensus       174 ~~~~~~-------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  228 (331)
T 4aaa_A          174 LAAPGE-------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD  228 (331)
T ss_dssp             -----------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ecCCcc-------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            543211             11223478999999998875 6799999999999999999999999983

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-36  Score=250.60  Aligned_cols=217  Identities=18%  Similarity=0.296  Sum_probs=166.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCC----cccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPA----SFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .++|++.++++.|.++.+|.........    .++++.... ........+.+|+.+++.++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            4578888999999998888665432211    122222111 12345667999999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++++|.+++.....   .+++.+++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+..
T Consensus       123 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~~~~  196 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRV  196 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC---
T ss_pred             EEEeCCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc---EEECCCCcchh
Confidence            99999999999999876432   3899999999999999999999999999999999999987665   99999999876


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ........          .......+++.|+|||.+.+..++.++|+||||+++++|++ |..||.+ +..++.+.+.++
T Consensus       197 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  266 (333)
T 1mqb_A          197 LEDDPEAT----------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG  266 (333)
T ss_dssp             ------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT
T ss_pred             hccccccc----------cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC
Confidence            65422100          01111235678999999998889999999999999999999 9999988 566777777776

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=246.01  Aligned_cols=214  Identities=27%  Similarity=0.397  Sum_probs=167.9

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+.++|.+.+.++.|.++.+|...+......++++....  ....+.+.+|+.+++.++||||+++++++...+.+++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEET--TSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCc--hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            466789999999999999888776554444444432222  234577899999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++++|.+++.....   .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.   ++|+|||.+.....
T Consensus       104 e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~  177 (314)
T 3com_A          104 EYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH---AKLADFGVAGQLTD  177 (314)
T ss_dssp             ECCTTEEHHHHHHHHTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECBT
T ss_pred             ecCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC---EEEeecccchhhhh
Confidence            99999999998864432   3899999999999999999999999999999999999987766   99999999977654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ...             ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||.. ........+..+
T Consensus       178 ~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~  240 (314)
T 3com_A          178 TMA-------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTN  240 (314)
T ss_dssp             TBS-------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred             hcc-------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC
Confidence            321             11223578899999999988899999999999999999999999988 333334344433

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-36  Score=244.57  Aligned_cols=213  Identities=21%  Similarity=0.335  Sum_probs=172.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ++|++.+.++.|.++.+|...... ...++++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECT-TTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecC-CCeEEEEEccc-cCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            579999999999999888765532 22233322222 2234578999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++++|.+++.....   .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+........
T Consensus        86 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~---~kl~dfg~~~~~~~~~~  159 (267)
T 3t9t_A           86 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQY  159 (267)
T ss_dssp             TTCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC---EEECCTTGGGGBCCHHH
T ss_pred             CCCcHHHHHhhCcc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC---EEEcccccccccccccc
Confidence            99999999876532   3899999999999999999999999999999999999987766   99999999865433111


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                                  .......++..|+|||.+.+..++.++|+||+|+++++|++ |+.||.. +..++.+.+.++.
T Consensus       160 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~  222 (267)
T 3t9t_A          160 ------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF  222 (267)
T ss_dssp             ------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred             ------------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC
Confidence                        11112236778999999998889999999999999999999 9999998 5667777777764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.4e-37  Score=263.58  Aligned_cols=219  Identities=27%  Similarity=0.477  Sum_probs=165.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccc-----cchhHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLN-----HYTTEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      .++|.+.+.++.|.++.+|...+......++++   +....     .......+.+|+.++++++||||+++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            357889999999999999876655443333333   22211     12223358899999999999999999999864 4


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      ..++||||+++++|.+++....    .+++.+++.++.|++.||.|||+++++|+||||+|||++.++....++|+|||+
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             ceEEEEEcCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            5899999999999988775443    389999999999999999999999999999999999998766556699999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLF  233 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~  233 (249)
                      +.......              ......+|+.|+|||++.+   ..++.++|+||+||++|+|++|+.||..  ....+.
T Consensus       289 a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  354 (419)
T 3i6u_A          289 SKILGETS--------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK  354 (419)
T ss_dssp             TTSCC-------------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH
T ss_pred             ceecCCCc--------------cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH
Confidence            86544321              1122358999999999853   5567899999999999999999999987  334567


Q ss_pred             HHHHcCccccc
Q psy14626        234 QSITKGKLHIL  244 (249)
Q Consensus       234 ~~i~~g~~~~~  244 (249)
                      +.+..+...++
T Consensus       355 ~~i~~~~~~~~  365 (419)
T 3i6u_A          355 DQITSGKYNFI  365 (419)
T ss_dssp             HHHHTTCCCCC
T ss_pred             HHHhcCCCCCC
Confidence            77787776554

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=7.2e-36  Score=245.28  Aligned_cols=223  Identities=16%  Similarity=0.200  Sum_probs=176.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .+++|++.+.++.|.++.+|...+......++++..  ......+.+.+|+.+++.+ +|++++++++++..+...++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~--~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEE--ECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEe--ccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            457899999999999999987765444444444322  2223445688999999999 7999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC--CCCeEEcCcceeEEc
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN--SAPVKLGGFGVAIQL  162 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~--~~~~~l~dfg~~~~~  162 (249)
                      ||+ +++|.+++.....   .+++.++..++.|++.||.+||++|++|+||||+||+++.++.  ...++|+|||.+...
T Consensus        86 e~~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999 8899999876532   3899999999999999999999999999999999999976542  345999999999877


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC----ChHHHHHHHHc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG----SRDRLFQSITK  238 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~----~~~~~~~~i~~  238 (249)
                      .........      .........+|+.|+|||.+.+..++.++|+||||+++|+|++|+.||.+    ...+....+..
T Consensus       162 ~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          162 RDPVTKQHI------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             BCTTTCCBC------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccc------cccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            653321100      00122334589999999999998899999999999999999999999987    23445555554


Q ss_pred             Cc
Q psy14626        239 GK  240 (249)
Q Consensus       239 g~  240 (249)
                      +.
T Consensus       236 ~~  237 (298)
T 1csn_A          236 KK  237 (298)
T ss_dssp             HH
T ss_pred             hc
Confidence            43

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-36  Score=253.71  Aligned_cols=217  Identities=20%  Similarity=0.261  Sum_probs=170.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcc----cCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASF----GLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      ..++|++.++++.|.++.+|...+......+    +++.. ..........+.+|+.+++.++||||+++++++.. +..
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~   89 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSL   89 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSE
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-Ccc
Confidence            4578999999999999999876644332221    11111 11112334567889999999999999999999864 558


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+.+++|.+++.....   .+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++.
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~---~kl~Dfg~a~  163 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ---VQVADFGVAD  163 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSGG---GSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC---EEECSCSGGG
T ss_pred             EEEEEeCCCCCHHHHHHHccc---cCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe---EEECCCCccc
Confidence            999999999999998876432   3889999999999999999999999999999999999987766   9999999986


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHc
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~  238 (249)
                      ........           .......++..|+|||++.+..++.++|+||+|+++|+|++ |..||.+ ...++.+.+..
T Consensus       164 ~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~  232 (325)
T 3kex_A          164 LLPPDDKQ-----------LLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK  232 (325)
T ss_dssp             GSCCCTTC-----------CC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT
T ss_pred             ccCccccc-----------ccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc
Confidence            65432210           11122346779999999998889999999999999999999 9999998 56677777777


Q ss_pred             Cc
Q psy14626        239 GK  240 (249)
Q Consensus       239 g~  240 (249)
                      +.
T Consensus       233 ~~  234 (325)
T 3kex_A          233 GE  234 (325)
T ss_dssp             TC
T ss_pred             CC
Confidence            64

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.3e-35  Score=243.18  Aligned_cols=212  Identities=24%  Similarity=0.409  Sum_probs=168.9

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeec----CCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSS----EGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~~   79 (249)
                      .+++|++...++.|.++.+|...+......++++...  .......+.+.+|+.+++.++||||+++++++..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            3557889999999999999877665444444333222  2234556789999999999999999999998864    456


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeee-ecCCCCCeEEcCc
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLA-NKENSAPVKLGGF  156 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~-~~~~~~~~~l~df  156 (249)
                      +++||||+++++|.+++.....    ++...++.++.|++.||.+||+++  ++|+||||+||+++ .++.   ++|+||
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~---~kl~Df  176 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIGDL  176 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC---EEECCT
T ss_pred             EEEEEEecCCCCHHHHHHHccC----CCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCC---EEEeeC
Confidence            8999999999999999876543    899999999999999999999999  99999999999997 4444   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~  234 (249)
                      |.+.......               .....+++.|+|||.+.+ .++.++|+||+|+++++|++|+.||..  +...+..
T Consensus       177 g~~~~~~~~~---------------~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~  240 (290)
T 1t4h_A          177 GLATLKRASF---------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR  240 (290)
T ss_dssp             TGGGGCCTTS---------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred             CCcccccccc---------------cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHH
Confidence            9985433221               112347899999998875 489999999999999999999999987  3455666


Q ss_pred             HHHcCc
Q psy14626        235 SITKGK  240 (249)
Q Consensus       235 ~i~~g~  240 (249)
                      .+..+.
T Consensus       241 ~~~~~~  246 (290)
T 1t4h_A          241 RVTSGV  246 (290)
T ss_dssp             HHTTTC
T ss_pred             HHhccC
Confidence            666654

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-36  Score=251.28  Aligned_cols=220  Identities=22%  Similarity=0.398  Sum_probs=172.3

Q ss_pred             cchHH-HhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEE
Q psy14626          9 RITIH-EVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         9 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +|.+. +.++.|.++.+|...+......++++...  .........+.+|+.+++.+ +||||+++++++...+.+++||
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~  108 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILIL  108 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEE
Confidence            56665 67888888888876655444444443222  22234567899999999999 5799999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.+++|.+++....  ...+++.+++.++.|++.||.+||++|++|+||||+||+++.......++|+|||.+.....
T Consensus       109 e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          109 EYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             ECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            9999999988775432  23489999999999999999999999999999999999998733333499999999977654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ...              .....+++.|+|||++.+..++.++|+||||+++++|++|+.||.+ +..+....+......+
T Consensus       187 ~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  252 (327)
T 3lm5_A          187 ACE--------------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY  252 (327)
T ss_dssp             ---------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             ccc--------------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccccc
Confidence            221              1123589999999999999999999999999999999999999998 5566677777766555


Q ss_pred             c
Q psy14626        244 L  244 (249)
Q Consensus       244 ~  244 (249)
                      +
T Consensus       253 ~  253 (327)
T 3lm5_A          253 S  253 (327)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-36  Score=253.87  Aligned_cols=211  Identities=23%  Similarity=0.416  Sum_probs=163.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      ++|++.+.++.|.++.+|...+......++++...... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            47899999999999999987766554444444332221 11122456899999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+ +|.+++.....   .+++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.......
T Consensus        82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LDK-DLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPT  154 (324)
T ss_dssp             CSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC---EEECSSSEEECC----
T ss_pred             ccc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC---EEEccCcccccccCCc
Confidence            975 88888776533   3899999999999999999999999999999999999987766   9999999987554321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                                   .......+++.|+|||++.+ ..++.++|+||+||++++|++|+.||.+ +..+....+.+
T Consensus       155 -------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~  215 (324)
T 3mtl_A          155 -------------KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR  215 (324)
T ss_dssp             ---------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             -------------cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence                         11122347899999999876 5679999999999999999999999998 44444444443

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4e-36  Score=248.32  Aligned_cols=212  Identities=25%  Similarity=0.362  Sum_probs=166.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-----chhHHHHHHHHHHHHHcC---CCChhhhhheeecCC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-----YTTEADLKREATICHMLK---HPHVVELLETYSSEG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~   78 (249)
                      ..||++.+.++.|.++.+|...+......++++......     ......+.+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            568999999999999999987765555445544333221     122356778888877774   999999999997654


Q ss_pred             -----eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEE
Q psy14626         79 -----MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKL  153 (249)
Q Consensus        79 -----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l  153 (249)
                           .+++|||++.+ +|.+++......  .+++.+++.++.|++.||.|||+++++|+||||+||+++.++.   ++|
T Consensus        88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~---~kl  161 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPP--GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT---VKL  161 (308)
T ss_dssp             SSSEEEEEEEEECCCC-BHHHHHHTCCTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC---EEE
T ss_pred             CCCceeEEEEehhhhc-CHHHHHhhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC---EEE
Confidence                 58999999974 998888765432  3899999999999999999999999999999999999987766   999


Q ss_pred             cCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHH
Q psy14626        154 GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRL  232 (249)
Q Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~  232 (249)
                      +|||.+.......              ......+|+.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +....
T Consensus       162 ~Dfg~a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~  227 (308)
T 3g33_A          162 ADFGLARIYSYQM--------------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ  227 (308)
T ss_dssp             CSCSCTTTSTTCC--------------CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH
T ss_pred             eeCccccccCCCc--------------ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999985443211              11223579999999999998899999999999999999999999998 44444


Q ss_pred             HHHHHc
Q psy14626        233 FQSITK  238 (249)
Q Consensus       233 ~~~i~~  238 (249)
                      ...+.+
T Consensus       228 ~~~i~~  233 (308)
T 3g33_A          228 LGKIFD  233 (308)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            545443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.4e-37  Score=261.78  Aligned_cols=202  Identities=14%  Similarity=0.172  Sum_probs=155.6

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCCh---hccccchhHHHHHHHHH---HHHHcCCCChhhhh-------
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPD---ERLNHYTTEADLKREAT---ICHMLKHPHVVELL-------   71 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~E~~---~l~~l~h~~i~~~~-------   71 (249)
                      ++.++|++.+.++.|.++.+|...+......++++.   .........+.+.+|+.   +++.++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            346789999999999999998776544333444333   22444566788999995   45555799999999       


Q ss_pred             heeecCC-----------------eEEEEEeccCCCchhHHHHHhhhcC---CccCHHHHHHHHHHHHHHHHHHHHCCce
Q psy14626         72 ETYSSEG-----------------MLYMVFEYMDGSDICFEIVRRATAG---FVYSEAVASHYMRQVLEALRYCHENDII  131 (249)
Q Consensus        72 ~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~~v  131 (249)
                      +++...+                 ..++||||+ +|+|.+++.......   ..+++..+..++.|++.||.|||++|++
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4444332                 389999999 579999998764411   1133488889999999999999999999


Q ss_pred             eecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-----------
Q psy14626        132 HRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----------  200 (249)
Q Consensus       132 H~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------  200 (249)
                      |+||||+|||++.++.   ++|+|||++.......                ....+ +.|+|||++.+.           
T Consensus       229 HrDikp~NIll~~~~~---~kL~DFG~a~~~~~~~----------------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~  288 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGG---VFLTGFEHLVRDGARV----------------VSSVS-RGFEPPELEARRATISYHRDRRT  288 (377)
T ss_dssp             CSCCCGGGEEECTTCC---EEECCGGGCEETTCEE----------------ECCCC-TTCCCHHHHHHHTSTHHHHCCEE
T ss_pred             cCCCCHHHEEEcCCCC---EEEEechhheecCCcc----------------cCCCC-cCccChhhhcccccccccccccc
Confidence            9999999999987765   9999999997643311                12246 899999999887           


Q ss_pred             CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        201 KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       201 ~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .++.++|+|||||++|+|++|+.||.+
T Consensus       289 ~~~~~~DvwSlG~il~elltg~~Pf~~  315 (377)
T 3byv_A          289 LMTFSFDAWALGLVIYWIWCADLPITK  315 (377)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cCChhhhHHHHHHHHHHHHHCCCCCcc
Confidence            789999999999999999999999986

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.3e-36  Score=262.44  Aligned_cols=214  Identities=18%  Similarity=0.307  Sum_probs=167.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.++.|.++.+|....... ..++++..... ....+.+.+|+.+|++++||||+++++++.+ +.+++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            45788899999999999887665422 12232222221 2345789999999999999999999999876 568999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++......  .++..++..++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++.......
T Consensus       260 ~~~gsL~~~l~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNE  334 (452)
T ss_dssp             CTTCBHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCTTC------
T ss_pred             hcCCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC---EEECCCccceecCCCc
Confidence            9999999999764332  3899999999999999999999999999999999999987766   9999999986654321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .            +......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+ ...++.+.+.+|.
T Consensus       335 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~  398 (452)
T 1fmk_A          335 Y------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY  398 (452)
T ss_dssp             --------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             e------------ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            1            11112235778999999998889999999999999999999 9999998 5667777777763

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.1e-36  Score=248.37  Aligned_cols=220  Identities=21%  Similarity=0.370  Sum_probs=172.1

Q ss_pred             CCCcchHHHhhcccceeeEeeecc-----ccCCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSA-----EIEPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSEG   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   78 (249)
                      +..+|++.+.++.|.++.+|....     ......++++... .......+.+.+|+.+++++ +||||+++++++..++
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            346899999999999998886652     1111222222221 12234567899999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhc--------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeee
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATA--------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN  144 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~  144 (249)
                      ..++||||+++++|.+++......              ...+++..++.++.|++.||.+||++|++|+||||+||+++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence            999999999999999998765431              224899999999999999999999999999999999999987


Q ss_pred             cCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCC
Q psy14626        145 KENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTL  223 (249)
Q Consensus       145 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~  223 (249)
                      ++.   ++|+|||.+.........           .......+++.|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus       181 ~~~---~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  246 (313)
T 1t46_A          181 GRI---TKICDFGLARDIKNDSNY-----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS  246 (313)
T ss_dssp             TTE---EEECCCGGGSCTTSCTTS-----------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCC---EEEccccccccccccccc-----------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            665   999999998665543211           11122346788999999998889999999999999999999 999


Q ss_pred             CCCCC--hHHHHHHHHcC
Q psy14626        224 PFVGS--RDRLFQSITKG  239 (249)
Q Consensus       224 pf~~~--~~~~~~~i~~g  239 (249)
                      ||.+.  ...+...+..+
T Consensus       247 p~~~~~~~~~~~~~~~~~  264 (313)
T 1t46_A          247 PYPGMPVDSKFYKMIKEG  264 (313)
T ss_dssp             SSTTCCSSHHHHHHHHHT
T ss_pred             CCCcccchhHHHHHhccC
Confidence            99983  34445445444

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.4e-36  Score=245.48  Aligned_cols=222  Identities=26%  Similarity=0.420  Sum_probs=173.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccc-cchhHHHHHHHHHHHHHcCCCChhhhhhee--ecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLN-HYTTEADLKREATICHMLKHPHVVELLETY--SSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~   80 (249)
                      ..+|++.+.++.|.++.+|...+......++++   ..... .....+.+.+|+.+++.++||||+++++++  ......
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999998877665443333332   22221 235567899999999999999999999998  455679


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+.++ |.+.+.....  ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~---~kl~dfg~~~  157 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT---LKISALGVAE  157 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCE
T ss_pred             EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc---EEeecccccc
Confidence            9999999875 7666655432  34899999999999999999999999999999999999987766   9999999997


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCC--CCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY--GKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      .......           ........+++.|+|||++.+...  +.++|+||+|+++++|++|+.||.+ +..++.+.+.
T Consensus       158 ~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~  226 (305)
T 2wtk_C          158 ALHPFAA-----------DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG  226 (305)
T ss_dssp             ECCTTCS-----------SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccCcccc-----------ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh
Confidence            7653221           011122347899999999876543  6789999999999999999999998 5667888888


Q ss_pred             cCcccccc
Q psy14626        238 KGKLHILG  245 (249)
Q Consensus       238 ~g~~~~~~  245 (249)
                      ++.+.+|.
T Consensus       227 ~~~~~~~~  234 (305)
T 2wtk_C          227 KGSYAIPG  234 (305)
T ss_dssp             HCCCCCCS
T ss_pred             cCCCCCCC
Confidence            88887764

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.7e-36  Score=263.47  Aligned_cols=213  Identities=17%  Similarity=0.328  Sum_probs=170.4

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.++.|.++.+|....... ..++++.... .....+.+.+|+.++++++||||+++++++. .+.+++||||
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~  263 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF  263 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTT-EEEEEEEECT-TSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCc-cEEEEEEecC-CCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence            35788889999999999987665321 1223222222 2245788999999999999999999999987 5568999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+++|.+++......  .++...+..++.|++.||.|||+++++||||||+|||++.++.   ++|+|||++.......
T Consensus       264 ~~~g~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          264 MAKGSLLDFLKSDEGS--KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV---CKIADFGLARVIEDNE  338 (454)
T ss_dssp             CTTCBHHHHHHSHHHH--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC---EEECSTTGGGGBCCHH
T ss_pred             cCCCcHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc---EEEeeCCCceEcCCCc
Confidence            9999999999754322  2789999999999999999999999999999999999987665   9999999986554321


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .            +......+++.|+|||++.+..++.++||||||+++|||++ |+.||.+ +..++.+.+.++
T Consensus       339 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~  401 (454)
T 1qcf_A          339 Y------------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG  401 (454)
T ss_dssp             H------------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred             e------------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            1            11112235778999999998889999999999999999999 9999998 566777777766

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.1e-36  Score=250.47  Aligned_cols=220  Identities=22%  Similarity=0.381  Sum_probs=174.4

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-------CCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-------EPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSE   77 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~   77 (249)
                      .++|++.+.++.|.++.+|...+..       ....++++... .......+.+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            4689999999999999888665321       11112222111 11234567899999999999 899999999999999


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK  145 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~  145 (249)
                      +.+++||||+++++|.+++......            ...+++.+++.++.|++.||.+||++|++|+||||+||+++.+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~  193 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN  193 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence            9999999999999999998765421            1238899999999999999999999999999999999999876


Q ss_pred             CCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q psy14626        146 ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP  224 (249)
Q Consensus       146 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p  224 (249)
                      +.   ++|+|||.+..........           ......+++.|+|||++.+..++.++|+||||+++|+|++ |..|
T Consensus       194 ~~---~kL~Dfg~~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  259 (334)
T 2pvf_A          194 NV---MKIADFGLARDINNIDYYK-----------KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP  259 (334)
T ss_dssp             CC---EEECCCTTCEECTTTSSEE-----------CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CC---EEEcccccccccccccccc-----------ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence            65   9999999998765432111           1112235778999999988888999999999999999999 9999


Q ss_pred             CCC-ChHHHHHHHHcCc
Q psy14626        225 FVG-SRDRLFQSITKGK  240 (249)
Q Consensus       225 f~~-~~~~~~~~i~~g~  240 (249)
                      |.+ +.+++...+.++.
T Consensus       260 ~~~~~~~~~~~~~~~~~  276 (334)
T 2pvf_A          260 YPGIPVEELFKLLKEGH  276 (334)
T ss_dssp             STTCCHHHHHHHHHHTC
T ss_pred             cCcCCHHHHHHHHhcCC
Confidence            998 5667777777664

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.3e-36  Score=245.80  Aligned_cols=222  Identities=23%  Similarity=0.333  Sum_probs=169.5

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccC------CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIE------PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      ..++|++.+.++.|.++.+|.......      ++.+.+...........+.+.+|+.+++.++||||+++++++..+. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            356899999999999888886653221      2333333333344566788999999999999999999999998765 


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .++|||++++++|.+++.....   .+++.++..++.|++.||.+||+++++|+||||+||+++.++.   ++|+|||.+
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~  168 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLM  168 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTC
T ss_pred             ceeeEecccCCCHHHHHHhccC---CcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC---EEEcccccc
Confidence            8899999999999999876543   2899999999999999999999999999999999999988776   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~  237 (249)
                      ..........          .......++..|+|||.+.+..++.++|+||||+++++|++ |+.||.+ +..++...+.
T Consensus       169 ~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~  238 (291)
T 1u46_A          169 RALPQNDDHY----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID  238 (291)
T ss_dssp             EECCC-CCEE----------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH
T ss_pred             ccccccccch----------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHH
Confidence            7765432110          11122346778999999988888999999999999999999 9999998 5667777777


Q ss_pred             cCccccc
Q psy14626        238 KGKLHIL  244 (249)
Q Consensus       238 ~g~~~~~  244 (249)
                      ......|
T Consensus       239 ~~~~~~~  245 (291)
T 1u46_A          239 KEGERLP  245 (291)
T ss_dssp             TSCCCCC
T ss_pred             ccCCCCC
Confidence            6654443

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.9e-36  Score=244.27  Aligned_cols=215  Identities=20%  Similarity=0.355  Sum_probs=172.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +.++|++.+.++.|.++.+|...... ...++++... ......+.+.+|+.+++.++||||+++++++..+ ..++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEEC-TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEec-CCcccHHHHHHHHHHHHhCCCcCcceEEEEEcCC-CcEEEEe
Confidence            45789999999999999988765432 2223332222 2223467899999999999999999999998754 5899999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++++++|.+++......  .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        88 ~~~~~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDN  162 (279)
T ss_dssp             CCTTCBHHHHTTSHHHH--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECSSS
T ss_pred             cCCCCCHHHHHhcCCCC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC---EEECCCcccccccCc
Confidence            99999999988754321  2899999999999999999999999999999999999987665   999999999876543


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ..            .......++..|+|||.+.+..++.++|+||||+++++|++ |+.||.+ +..++.+.+.++.
T Consensus       163 ~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  227 (279)
T 1qpc_A          163 EY------------TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY  227 (279)
T ss_dssp             CE------------ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             cc------------ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc
Confidence            21            11112235778999999988888999999999999999999 9999998 5667777777663

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.1e-36  Score=250.52  Aligned_cols=218  Identities=23%  Similarity=0.387  Sum_probs=168.5

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeec------
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSS------   76 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   76 (249)
                      +.-.+|++.+.++.|.++.+|...+......++++...  .........+.+|+.+++.++||||+++++++..      
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   93 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence            34568999999999999988877665444444433221  1223335678899999999999999999999976      


Q ss_pred             --CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         77 --EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        77 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                        .+.+++||||+.+ +|.+.+.....   .+++.+++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+
T Consensus        94 ~~~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~---~kl~  166 (351)
T 3mi9_A           94 RCKGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLA  166 (351)
T ss_dssp             ---CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEEC
T ss_pred             cCCceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC---EEEc
Confidence              4568999999975 77666654432   3899999999999999999999999999999999999987766   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRL  232 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~  232 (249)
                      |||.+.........         .........+|+.|+|||++.+ ..++.++|+||+||++++|++|+.||.+ +....
T Consensus       167 Dfg~a~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  237 (351)
T 3mi9_A          167 DFGLARAFSLAKNS---------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ  237 (351)
T ss_dssp             CCTTCEECCCCSSS---------SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cchhcccccccccc---------cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            99999876532211         0112223357899999999876 4579999999999999999999999998 44455


Q ss_pred             HHHHHc
Q psy14626        233 FQSITK  238 (249)
Q Consensus       233 ~~~i~~  238 (249)
                      ...+.+
T Consensus       238 ~~~i~~  243 (351)
T 3mi9_A          238 LALISQ  243 (351)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            555544

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.2e-36  Score=243.55  Aligned_cols=220  Identities=27%  Similarity=0.399  Sum_probs=163.5

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeecccc-CCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEI-EPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      ++.+ ..+|++.+.++.|.++.+|...+.- .++.+.+...... .....+.+.+|+.+++.++||||+++++++.+++.
T Consensus         2 ~~~~-~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            2 LEID-FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             CBCC-TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             Cccc-hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            3444 4689999999999999998766441 1222222221111 12345789999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC---ceeecCCCCCeeeeecCC-----CCCe
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND---IIHRDIKPHCVLLANKEN-----SAPV  151 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---~vH~dlkp~Nili~~~~~-----~~~~  151 (249)
                      .++||||+++++|.+++...     .+++..+..++.|++.||.+||+++   ++|+||||+||+++.+..     ...+
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             eEEEEEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            99999999999998887422     3899999999999999999999999   899999999999976321     3449


Q ss_pred             EEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChH
Q psy14626        152 KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRD  230 (249)
Q Consensus       152 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~  230 (249)
                      +|+|||.+........               ....+++.|+|||.+.+..++.++|+||+|+++++|++|+.||.+ +..
T Consensus       156 kl~Dfg~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~  220 (271)
T 3dtc_A          156 KITDFGLAREWHRTTK---------------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL  220 (271)
T ss_dssp             EECCCCC----------------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH
T ss_pred             EEccCCcccccccccc---------------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999865543221               123478999999999998899999999999999999999999998 455


Q ss_pred             HHHHHHHcCccc
Q psy14626        231 RLFQSITKGKLH  242 (249)
Q Consensus       231 ~~~~~i~~g~~~  242 (249)
                      .....+..+...
T Consensus       221 ~~~~~~~~~~~~  232 (271)
T 3dtc_A          221 AVAYGVAMNKLA  232 (271)
T ss_dssp             HHHHHHHTSCCC
T ss_pred             HHHHhhhcCCCC
Confidence            555555555433

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-36  Score=244.36  Aligned_cols=216  Identities=22%  Similarity=0.356  Sum_probs=169.0

Q ss_pred             CcchHHH-hhcccceeeEeeecccc--CCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHE-VINHKWLKMKLHTSAEI--EPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++|.+.+ .++.|.++.+|......  ....++++.... ......+.+.+|+.+++.++||||+++++++. .+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEE
Confidence            4555555 89999988888664321  111122222211 23456778999999999999999999999994 4569999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||++++++|.+++....   ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+....
T Consensus        88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~Dfg~~~~~~  161 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALG  161 (287)
T ss_dssp             EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE---EEECCCTTCEECT
T ss_pred             EEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC---EEECcccceeeec
Confidence            99999999999886432   23899999999999999999999999999999999999998776   9999999998775


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....          ........+++.|+|||.+.+..++.++|+||+|+++++|++ |+.||.. +..++...+.++.
T Consensus       162 ~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~  230 (287)
T 1u59_A          162 ADDSY----------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK  230 (287)
T ss_dssp             TCSCE----------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC
T ss_pred             cCcce----------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC
Confidence            43211          011122235788999999988888999999999999999998 9999998 5667777777765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=258.85  Aligned_cols=221  Identities=22%  Similarity=0.343  Sum_probs=173.4

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC--eEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEG--MLYM   82 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~l   82 (249)
                      .+++|++.++++.|.++.+|...+......++++.... ......+.+.+|+.+++.++||||+++++++...+  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            46799999999999999999777654444444433221 22344677889999999999999999999997654  7899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec-CCCCCeEEcCcceeEE
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~-~~~~~~~l~dfg~~~~  161 (249)
                      ||||+++++|.+++..... ...+++..++.++.|++.||.|||++|++|+||||+||++..+ +....++|+|||.+..
T Consensus        87 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999998876543 2338999999999999999999999999999999999998322 2223489999999977


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCcccccc--------CCCCCcchHHHHHHHHHHHHhCCCCCCC-----C
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--------QKYGKPVDIWAAGVLLHVLLTGTLPFVG-----S  228 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~pf~~-----~  228 (249)
                      .....              ......+++.|+|||++.+        ..++.++|+||+||++|+|++|+.||..     .
T Consensus       166 ~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~  231 (396)
T 4eut_A          166 LEDDE--------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR  231 (396)
T ss_dssp             CCCGG--------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT
T ss_pred             ccCCC--------------ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc
Confidence            65422              1122358999999999865        4567899999999999999999999974     2


Q ss_pred             hHHHHHHHHcCcc
Q psy14626        229 RDRLFQSITKGKL  241 (249)
Q Consensus       229 ~~~~~~~i~~g~~  241 (249)
                      ..++...+..+.+
T Consensus       232 ~~~~~~~~~~~~p  244 (396)
T 4eut_A          232 NKEVMYKIITGKP  244 (396)
T ss_dssp             CHHHHHHHHHSCC
T ss_pred             hHHHHHHHhcCCC
Confidence            3456666766654

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.6e-36  Score=254.69  Aligned_cols=201  Identities=24%  Similarity=0.386  Sum_probs=168.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .++|++.+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||+++++++..++.+++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            56899999999999999987776644444444333222 34456789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |+++++|.+++.....    +++..+..++.|++.||.+||++ |++|+||||+||+++.++.   ++|+|||.+.....
T Consensus       112 ~~~~~~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~~  184 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID  184 (360)
T ss_dssp             CCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC---EEECCCCCCHHHHH
T ss_pred             CCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC---EEEEECCCCccccc
Confidence            9999999999876543    89999999999999999999986 9999999999999987766   99999998754322


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR  229 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~  229 (249)
                      .               ......+++.|+|||++.+..++.++|+||+|+++++|++|+.||....
T Consensus       185 ~---------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          185 S---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             H---------------C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             c---------------cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            1               1112357899999999999989999999999999999999999999843

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-36  Score=251.99  Aligned_cols=213  Identities=23%  Similarity=0.376  Sum_probs=160.9

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      .-.+|++.+.++.|.++.+|...+......++++....  ......+.+.+|+.+++.++||||+++++++..++.+++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            34589999999999999998776554444444433222  2233456788999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC--CCCCeEEcCcceeEE
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE--NSAPVKLGGFGVAIQ  161 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~--~~~~~~l~dfg~~~~  161 (249)
                      |||+.+ +|.+++.....    +++..++.++.|++.||.|||+++++|+||||+||+++.++  ....++|+|||.+..
T Consensus       112 ~e~~~~-~L~~~~~~~~~----~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~  186 (329)
T 3gbz_A          112 FEYAEN-DLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA  186 (329)
T ss_dssp             EECCSE-EHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred             EecCCC-CHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence            999975 99888876544    89999999999999999999999999999999999996443  223489999999865


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      .....             .......+++.|+|||++.+.. ++.++|+||+||++++|++|+.||.+ +..+....+
T Consensus       187 ~~~~~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  250 (329)
T 3gbz_A          187 FGIPI-------------RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI  250 (329)
T ss_dssp             HC------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             cCCcc-------------cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH
Confidence            54321             1112234689999999998744 79999999999999999999999998 333333343

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.8e-36  Score=250.50  Aligned_cols=215  Identities=20%  Similarity=0.373  Sum_probs=169.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcc--cCChh-ccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASF--GLPDE-RLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++|++.+.++.|.++.+|..........+  +++.. ........+.+.+|+.+++++ +||||+++++++.+.+.+++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            58899999999999888876654332211  22211 122334556799999999999 899999999999999999999


Q ss_pred             EeccCCCchhHHHHHhh------------hcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCe
Q psy14626         84 FEYMDGSDICFEIVRRA------------TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV  151 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~  151 (249)
                      |||+++++|.+++....            .....+++.+++.++.|++.||.+||++|++|+||||+||+++.++.   +
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~---~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---A  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC---E
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe---E
Confidence            99999999999987653            12234899999999999999999999999999999999999987766   9


Q ss_pred             EEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-Ch
Q psy14626        152 KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SR  229 (249)
Q Consensus       152 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~  229 (249)
                      +|+|||++.......              ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+ +.
T Consensus       182 kL~Dfg~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~  247 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  247 (327)
T ss_dssp             EECCTTCEESSCEEC--------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEcccCcCccccccc--------------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH
Confidence            999999986332211              1112235788999999998888999999999999999998 9999998 56


Q ss_pred             HHHHHHHHcC
Q psy14626        230 DRLFQSITKG  239 (249)
Q Consensus       230 ~~~~~~i~~g  239 (249)
                      .++.+.+..+
T Consensus       248 ~~~~~~~~~~  257 (327)
T 1fvr_A          248 AELYEKLPQG  257 (327)
T ss_dssp             HHHHHHGGGT
T ss_pred             HHHHHHhhcC
Confidence            6677777766

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-35  Score=251.84  Aligned_cols=208  Identities=23%  Similarity=0.361  Sum_probs=160.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC------
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEG------   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------   78 (249)
                      .++|++.+.++.|.++.++...+......++++...  .......+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            468999999999999999877655444444443322  223455677899999999999999999999997654      


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+++||||+.+ +|.+.+..      .+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||+
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~---~kl~Dfg~  173 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL  173 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---EEEEEeec
Confidence            78999999975 77777642      2899999999999999999999999999999999999987766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      +.......              ......+|+.|+|||++.+..++.++|+||+||++++|++|+.||.+ +.......+.
T Consensus       174 a~~~~~~~--------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  239 (371)
T 2xrw_A          174 ARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI  239 (371)
T ss_dssp             ------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             cccccccc--------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            87654321              11123578999999999998899999999999999999999999998 4444444444


Q ss_pred             c
Q psy14626        238 K  238 (249)
Q Consensus       238 ~  238 (249)
                      +
T Consensus       240 ~  240 (371)
T 2xrw_A          240 E  240 (371)
T ss_dssp             C
T ss_pred             H
Confidence            3

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-36  Score=253.41  Aligned_cols=220  Identities=20%  Similarity=0.343  Sum_probs=168.5

Q ss_pred             CCCcchHHHhhcccceeeEeeeccc----c-CCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAE----I-EPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSEG   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   78 (249)
                      +.++|++.+.++.|.++.+|.....    . ....++++... .......+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            3468899999999999988866541    1 11112222111 11234457899999999999 8999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhc-------------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCC
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATA-------------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC  139 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~N  139 (249)
                      ..++||||+++++|.+++......                   ...+++..++.++.|++.||.+||++|++|+||||+|
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  202 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  202 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            999999999999999998765421                   1237899999999999999999999999999999999


Q ss_pred             eeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHH
Q psy14626        140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL  219 (249)
Q Consensus       140 ili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  219 (249)
                      |+++.++.   ++|+|||++........           ........+++.|+|||.+.+..++.++|+||||+++++|+
T Consensus       203 Ill~~~~~---~kL~Dfg~~~~~~~~~~-----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~  268 (344)
T 1rjb_A          203 VLVTHGKV---VKICDFGLARDIMSDSN-----------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF  268 (344)
T ss_dssp             EEEETTTE---EEECCCGGGSCGGGCTT-----------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHT
T ss_pred             EEEcCCCc---EEeCCCccCcccccCcc-----------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHH
Confidence            99987765   99999999865543221           01122234678899999999888999999999999999999


Q ss_pred             h-CCCCCCC-C-hHHHHHHHHcC
Q psy14626        220 T-GTLPFVG-S-RDRLFQSITKG  239 (249)
Q Consensus       220 ~-g~~pf~~-~-~~~~~~~i~~g  239 (249)
                      + |..||.+ + .+.+...+..+
T Consensus       269 t~g~~p~~~~~~~~~~~~~~~~~  291 (344)
T 1rjb_A          269 SLGVNPYPGIPVDANFYKLIQNG  291 (344)
T ss_dssp             TTSCCSSTTCCCSHHHHHHHHTT
T ss_pred             cCCCCCcccCCcHHHHHHHHhcC
Confidence            8 9999998 3 34455555544

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6e-36  Score=249.11  Aligned_cols=215  Identities=20%  Similarity=0.357  Sum_probs=163.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC--------
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEG--------   78 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--------   78 (249)
                      ++|++.+.++.|.++.+|...+......++++.... ......+.+.+|+.++++++||||++++++|.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            468888999999999998777665555555543332 23446688999999999999999999999985433        


Q ss_pred             -------------------------------------------------eEEEEEeccCCCchhHHHHHhhhcCCccCHH
Q psy14626         79 -------------------------------------------------MLYMVFEYMDGSDICFEIVRRATAGFVYSEA  109 (249)
Q Consensus        79 -------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  109 (249)
                                                                       .+++||||+++++|.+++...... ...+..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~  164 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL-EDREHG  164 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG-GGSCHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc-cchhhH
Confidence                                                             389999999999999998765432 235677


Q ss_pred             HHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCC
Q psy14626        110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTP  189 (249)
Q Consensus       110 ~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (249)
                      .++.++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||.+.................. ........+|+
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~DfG~a~~~~~~~~~~~~~~~~~~-~~~~~~~~gt~  240 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV---VKVGDFGLVTAMDQDEEEQTVLTPMPA-YATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCTTCEECSCC---------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCC---EEEeecCcccccccchhhccccccccc-cccccccCCCc
Confidence            88999999999999999999999999999999987765   999999999877654321110000000 01222345899


Q ss_pred             CCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        190 HYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       190 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .|+|||.+.+..++.++|+||+|+++++|++|..|+..
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~  278 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME  278 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH
Confidence            99999999998999999999999999999998777643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.4e-36  Score=245.60  Aligned_cols=216  Identities=19%  Similarity=0.323  Sum_probs=169.7

Q ss_pred             CCcchHHH-hhcccceeeEeeecc--ccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHE-VINHKWLKMKLHTSA--EIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .++|++.+ .++.|.++.+|....  ......++++..  ........+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45788888 899999998887632  211122222211  122334567899999999999999999999999 556789


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +|||++++++|.+++.....    +++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+..
T Consensus        94 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~~~  166 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKA  166 (291)
T ss_dssp             EEEECCTTEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhCcC----CCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc---EEEccCCccee
Confidence            99999999999999876543    899999999999999999999999999999999999998776   99999999977


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ........          .......+++.|+|||.+.+..++.++|+||||+++++|++ |+.||.+ +..++.+.+..+
T Consensus       167 ~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~  236 (291)
T 1xbb_A          167 LRADENYY----------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG  236 (291)
T ss_dssp             CCTTCSEE----------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             eccCCCcc----------cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            65432110          11111235678999999988888999999999999999999 9999998 566777777776


Q ss_pred             c
Q psy14626        240 K  240 (249)
Q Consensus       240 ~  240 (249)
                      .
T Consensus       237 ~  237 (291)
T 1xbb_A          237 E  237 (291)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-36  Score=252.53  Aligned_cols=219  Identities=24%  Similarity=0.379  Sum_probs=172.2

Q ss_pred             CcchHHHhhcccceeeEeeecccc---C---CCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI---E---PASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSEGM   79 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   79 (249)
                      .+|++.+.|+.|.++.+|...+..   .   ++.+.+.+... ......+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            589999999999999988655421   2   22222222221 2234456788899999999 79999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +++||||+++++|.+++.....    +++..+..++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~a  206 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLS  206 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEESCSSEE
T ss_pred             EEEEeecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc---EEEeeCCCC
Confidence            9999999999999999876543    899999999999999999999999999999999999987766   999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCC-----ChHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFVG-----SRDRL  232 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~pf~~-----~~~~~  232 (249)
                      ........            .......+|+.|+|||++.+  ..++.++|+|||||++|+|++|+.||..     ....+
T Consensus       207 ~~~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  274 (355)
T 1vzo_A          207 KEFVADET------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  274 (355)
T ss_dssp             EECCGGGG------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             eecccCCC------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH
Confidence            76543221            11122358999999999986  3468899999999999999999999975     23456


Q ss_pred             HHHHHcCcccccc
Q psy14626        233 FQSITKGKLHILG  245 (249)
Q Consensus       233 ~~~i~~g~~~~~~  245 (249)
                      ...+..+.+.+|.
T Consensus       275 ~~~~~~~~~~~~~  287 (355)
T 1vzo_A          275 SRRILKSEPPYPQ  287 (355)
T ss_dssp             HHHHHHCCCCCCT
T ss_pred             HHHHhccCCCCCc
Confidence            6677777666653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6e-36  Score=245.97  Aligned_cols=222  Identities=23%  Similarity=0.335  Sum_probs=169.8

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCC---CcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhhee-ecCCeE
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETY-SSEGML   80 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   80 (249)
                      ...+|++.++++.|.++.+|........   ..++++.. ........+.+.+|+.++++++||||+++++++ ..++..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            3458899999999999999866532211   11222221 233345567899999999999999999999986 455678


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+++++|.+++.....   .++...+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~a~  176 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFT---VKVADFGLAR  176 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECSCGGGC
T ss_pred             EEEEeCCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCC---EEECcccccc
Confidence            999999999999999865332   3799999999999999999999999999999999999987665   9999999987


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHc
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~  238 (249)
                      .........         ........+++.|+|||.+.+..++.++|+||+|+++++|++ |.+||.+ +..++...+.+
T Consensus       177 ~~~~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~  247 (298)
T 3f66_A          177 DMYDKEYYS---------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ  247 (298)
T ss_dssp             CCSCGGGCB---------C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT
T ss_pred             cccccchhc---------cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc
Confidence            654422110         011122346788999999999889999999999999999999 7778887 44455666666


Q ss_pred             Cccc
Q psy14626        239 GKLH  242 (249)
Q Consensus       239 g~~~  242 (249)
                      +...
T Consensus       248 ~~~~  251 (298)
T 3f66_A          248 GRRL  251 (298)
T ss_dssp             TCCC
T ss_pred             CCCC
Confidence            6543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4e-36  Score=250.81  Aligned_cols=219  Identities=23%  Similarity=0.365  Sum_probs=170.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCC-----cccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPA-----SFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~   79 (249)
                      .++|++.+.++.|.++.+|.........     .++++... .......+.+.+|+.+++.+ +||||+++++++..++.
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  124 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP  124 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence            3578889999999999988765432211     22222111 12234567899999999999 89999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhc----------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATA----------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~  149 (249)
                      +++||||+++++|.+++......          ...++...+..++.|++.||.+||++|++|+||||+||+++.++.  
T Consensus       125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--  202 (333)
T 2i1m_A          125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--  202 (333)
T ss_dssp             CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--
T ss_pred             eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--
Confidence            99999999999999998865431          234799999999999999999999999999999999999987766  


Q ss_pred             CeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-
Q psy14626        150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-  227 (249)
Q Consensus       150 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-  227 (249)
                       ++|+|||++.........           .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+ 
T Consensus       203 -~kl~Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  270 (333)
T 2i1m_A          203 -AKIGDFGLARDIMNDSNY-----------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI  270 (333)
T ss_dssp             -EEBCCCGGGCCGGGCTTS-----------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             -EEECccccccccccccce-----------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence             999999998655432210           11122346788999999998889999999999999999998 9999998 


Q ss_pred             C-hHHHHHHHHcC
Q psy14626        228 S-RDRLFQSITKG  239 (249)
Q Consensus       228 ~-~~~~~~~i~~g  239 (249)
                      . ...+...+..+
T Consensus       271 ~~~~~~~~~~~~~  283 (333)
T 2i1m_A          271 LVNSKFYKLVKDG  283 (333)
T ss_dssp             CSSHHHHHHHHHT
T ss_pred             chhHHHHHHHhcC
Confidence            3 33444444443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-35  Score=242.41  Aligned_cols=215  Identities=21%  Similarity=0.365  Sum_probs=167.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCC---cccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPA---SFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      .++|++.+.++.|.++.+|.........   .++++.... ......+.+.+|+.+++.++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4689999999999999888665332211   122221111 1334567899999999999999999999998765 4689


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |||++++++|.+++.....   .++...+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+...
T Consensus        90 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~  163 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPEC---VKLGDFGLSRYI  163 (281)
T ss_dssp             EEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE---EEECCCCGGGCC
T ss_pred             EEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCc---EEeCccCCCccc
Confidence            9999999999999876543   3899999999999999999999999999999999999998776   999999998655


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....            .......+++.|+|||.+.+..++.++|+||||+++++|++ |+.||.. ....+.+.+..+.
T Consensus       164 ~~~~~------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~  231 (281)
T 3cc6_A          164 EDEDY------------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD  231 (281)
T ss_dssp             ---------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTC
T ss_pred             ccccc------------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCC
Confidence            43221            01112235778999999998889999999999999999998 9999987 4555666666553

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.8e-36  Score=248.62  Aligned_cols=205  Identities=18%  Similarity=0.250  Sum_probs=169.1

Q ss_pred             CCcchHHHhhcccceeeEeeec----cccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheee--cCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTS----AEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYS--SEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~   80 (249)
                      .++|++.+.++.|.++.+|...    +......++++..........+.+.+|+.++++++||||+++++++.  ....+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            4689999999999999998765    33333444544444445566678999999999999999999999885  45679


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+++++|.+++.....   .+++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg~~~  175 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH---VKIADFGLAK  175 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCGGGCE
T ss_pred             EEEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC---EEEcccccce
Confidence            999999999999999876543   2899999999999999999999999999999999999988776   9999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ........          ........++..|+|||.+.+..++.++|+||||+++++|++|..||..
T Consensus       176 ~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~  232 (327)
T 3lxl_A          176 LLPLDKDY----------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS  232 (327)
T ss_dssp             ECCTTCSE----------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ecccCCcc----------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            76543211          0112223467889999999988889999999999999999999999976

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8e-36  Score=247.79  Aligned_cols=220  Identities=20%  Similarity=0.335  Sum_probs=173.1

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-----CCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      .++|++.+.++.|.++.+|......     ....++++... .........+.+|+.+++.++||||+++++++.+++..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  103 (322)
T 1p4o_A           24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT  103 (322)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence            3589999999999988888654331     11112222111 12234556799999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhc------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         81 YMVFEYMDGSDICFEIVRRATA------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                      ++||||+++++|.+++......      ...++...+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+
T Consensus       104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~---~kl~  180 (322)
T 1p4o_A          104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIG  180 (322)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC---EEEC
T ss_pred             EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe---EEEC
Confidence            9999999999999998765421      123689999999999999999999999999999999999987765   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRL  232 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~  232 (249)
                      |||.+........           ........+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||.+ +..++
T Consensus       181 Dfg~~~~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  249 (322)
T 1p4o_A          181 DFGMTRDIYETDY-----------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV  249 (322)
T ss_dssp             CTTCCCGGGGGGC-----------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred             cCccccccccccc-----------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence            9999865433211           011122346788999999998889999999999999999999 8999998 56667


Q ss_pred             HHHHHcCc
Q psy14626        233 FQSITKGK  240 (249)
Q Consensus       233 ~~~i~~g~  240 (249)
                      ...+.++.
T Consensus       250 ~~~~~~~~  257 (322)
T 1p4o_A          250 LRFVMEGG  257 (322)
T ss_dssp             HHHHHTTC
T ss_pred             HHHHHcCC
Confidence            77777665

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.6e-35  Score=249.02  Aligned_cols=214  Identities=23%  Similarity=0.358  Sum_probs=169.2

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC-----
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSE-----   77 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----   77 (249)
                      ++.+.||++.+.++.|.++.+|...+......++++... .......+.+.+|+.++++++||||+++++++...     
T Consensus        23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence            566789999999999999999877665544444444332 22334557899999999999999999999999654     


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ...++|||++.+ +|.+++...     .+++.++..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||
T Consensus       103 ~~~~iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~---~kl~Dfg  173 (364)
T 3qyz_A          103 KDVYIVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFG  173 (364)
T ss_dssp             CCEEEEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCT
T ss_pred             ceEEEEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC---EEEEeCc
Confidence            468999999974 898887543     2899999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      .+.........          ........+|+.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+ +..+....
T Consensus       174 ~a~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  243 (364)
T 3qyz_A          174 LARVADPDHDH----------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH  243 (364)
T ss_dssp             TCEECCGGGCB----------CCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH
T ss_pred             ceEecCCCCCc----------cccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH
Confidence            99776542210          011122358999999998654 4579999999999999999999999998 33333434


Q ss_pred             H
Q psy14626        236 I  236 (249)
Q Consensus       236 i  236 (249)
                      +
T Consensus       244 i  244 (364)
T 3qyz_A          244 I  244 (364)
T ss_dssp             H
T ss_pred             H
Confidence            3

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-35  Score=241.69  Aligned_cols=215  Identities=20%  Similarity=0.312  Sum_probs=170.8

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ..+|++.+.++.|.++.+|...+......++++...  .........+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            457888899999999998877665444444444322  22344567889999999999 899999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC----------------C
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE----------------N  147 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~----------------~  147 (249)
                      |||+++++|.+++.........+++.+++.++.|++.||.+||++|++|+||||+||+++.++                .
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            999999999999987765445589999999999999999999999999999999999998554                3


Q ss_pred             CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q psy14626        148 SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFV  226 (249)
Q Consensus       148 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~  226 (249)
                      ...++|+|||.+.......                 ...+++.|+|||.+.+. .++.++|+||||+++++|++|..|+.
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~-----------------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSPQ-----------------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             CCCEEECCCTTCEETTCSC-----------------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             ceEEEEcccccccccCCcc-----------------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            3458999999987765422                 12378999999999865 45689999999999999999998775


Q ss_pred             CChHHHHHHHHcCc
Q psy14626        227 GSRDRLFQSITKGK  240 (249)
Q Consensus       227 ~~~~~~~~~i~~g~  240 (249)
                      ...  ....+.++.
T Consensus       233 ~~~--~~~~~~~~~  244 (289)
T 1x8b_A          233 NGD--QWHEIRQGR  244 (289)
T ss_dssp             SSH--HHHHHHTTC
T ss_pred             chh--HHHHHHcCC
Confidence            532  344455544

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-35  Score=251.34  Aligned_cols=209  Identities=22%  Similarity=0.366  Sum_probs=164.2

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec---------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS---------   76 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---------   76 (249)
                      ..++|++.+.++.|.++.+|...+......++++.....    .....+|+.+++.++||||++++++|..         
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~----~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~   80 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD----PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP   80 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence            457899999999999999998766555555555433222    1223479999999999999999999843         


Q ss_pred             -----------------------------CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH
Q psy14626         77 -----------------------------EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE  127 (249)
Q Consensus        77 -----------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~  127 (249)
                                                   ...+++||||+++ +|.+.+.........+++..++.++.|++.||.|||+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  159 (383)
T 3eb0_A           81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS  159 (383)
T ss_dssp             -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence                                         3348899999984 8888877655555669999999999999999999999


Q ss_pred             CCceeecCCCCCeeeee-cCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCc
Q psy14626        128 NDIIHRDIKPHCVLLAN-KENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKP  205 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~-~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~  205 (249)
                      +|++|+||||+||+++. ++.   ++|+|||.+........              .....+++.|+|||.+.+. .++.+
T Consensus       160 ~gi~H~Dikp~Nil~~~~~~~---~kl~Dfg~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~  222 (383)
T 3eb0_A          160 LGICHRDIKPQNLLVNSKDNT---LKLCDFGSAKKLIPSEP--------------SVAYICSRFYRAPELMLGATEYTPS  222 (383)
T ss_dssp             TTEECSCCCGGGEEEETTTTE---EEECCCTTCEECCTTSC--------------CCCCCCCSSCCCHHHHTTCSSCCTH
T ss_pred             CcCccCccCHHHEEEcCCCCc---EEEEECCCCcccCCCCC--------------CcCcccCCCccCHHHhcCCCCCCcc
Confidence            99999999999999974 443   99999999987654321              1123478899999998775 48999


Q ss_pred             chHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        206 VDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       206 ~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      +|+||+||++|+|++|+.||.+ +..+....+
T Consensus       223 ~DiwslG~il~ell~g~~pf~~~~~~~~~~~i  254 (383)
T 3eb0_A          223 IDLWSIGCVFGELILGKPLFSGETSIDQLVRI  254 (383)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            9999999999999999999998 343444443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.6e-36  Score=251.95  Aligned_cols=210  Identities=16%  Similarity=0.172  Sum_probs=159.1

Q ss_pred             CCCcchHHHhhcccceeeEeeecccc---CCCcccCChhccccc-----------hhHHHHHHHHHHHHHcCCCChhhhh
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEI---EPASFGLPDERLNHY-----------TTEADLKREATICHMLKHPHVVELL   71 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~~   71 (249)
                      .+++|++.+.++.|.++.+|...+..   ....++++.......           .....+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            35689999999999999998776654   333344333222211           1223467788899999999999999


Q ss_pred             heeec----CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC
Q psy14626         72 ETYSS----EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN  147 (249)
Q Consensus        72 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~  147 (249)
                      +++..    ....++||||+ +++|.+++....    .+++.+++.++.|++.||.|||+++++|+||||+||+++.++.
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSST
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCC
Confidence            99977    67899999999 889999887655    3899999999999999999999999999999999999987651


Q ss_pred             CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        148 SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       148 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                       ..++|+|||++..........      ...........+++.|+|||++.+..++.++|+|||||++|+|++|+.||.+
T Consensus       190 -~~~kL~Dfg~a~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          190 -DQVYLADYGLSYRYCPNGNHK------QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             -TSEEECCCTTCEESSGGGCCC------CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             -CcEEEEeCCCceecccccccc------cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence             239999999998765422100      0001111233589999999999998899999999999999999999999965

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4e-36  Score=249.83  Aligned_cols=218  Identities=28%  Similarity=0.478  Sum_probs=169.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc---c-----ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---L-----NHYTTEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      .++|++.+.++.|.++.+|...+......++++...   .     ........+.+|+.+++.++||||+++++++..+.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            358899999999999999877655443333333221   1     11233456889999999999999999999997665


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                       .++||||+++++|.+++....    .+++..++.++.|++.||.+||++|++|+||||+||+++.++....++|+|||.
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  163 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  163 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred             -eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence             899999999999988886543    389999999999999999999999999999999999998766556699999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCCC--hHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVGS--RDRLF  233 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~g~~pf~~~--~~~~~  233 (249)
                      +........              .....+++.|+|||++.   +..++.++|+||||+++|+|++|..||...  ...+.
T Consensus       164 ~~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (322)
T 2ycf_A          164 SKILGETSL--------------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK  229 (322)
T ss_dssp             CEECCCCHH--------------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHH
T ss_pred             ceecccccc--------------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHH
Confidence            977654221              11124789999999974   456789999999999999999999999872  33566


Q ss_pred             HHHHcCcccc
Q psy14626        234 QSITKGKLHI  243 (249)
Q Consensus       234 ~~i~~g~~~~  243 (249)
                      ..+.++...+
T Consensus       230 ~~~~~~~~~~  239 (322)
T 2ycf_A          230 DQITSGKYNF  239 (322)
T ss_dssp             HHHHHTCCCC
T ss_pred             HHHHhCcccc
Confidence            6777776554

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.2e-35  Score=241.32  Aligned_cols=203  Identities=24%  Similarity=0.447  Sum_probs=165.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .++|++.+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            35788889999999998887765544444444332222 23456789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++++++|.+++....    .+++..+..++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+......
T Consensus        86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYN  158 (276)
T ss_dssp             CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCCTTCEECEET
T ss_pred             ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC---EEEeeCCCccccCCC
Confidence            999999988775433    3899999999999999999999999999999999999987666   999999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...           .......+++.|+|||.+.+..+ +.++|+||+|+++++|++|+.||..
T Consensus       159 ~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  210 (276)
T 2yex_A          159 NRE-----------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ  210 (276)
T ss_dssp             TEE-----------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred             cch-----------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence            110           11122347899999999987665 7789999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-35  Score=257.38  Aligned_cols=215  Identities=24%  Similarity=0.335  Sum_probs=154.1

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeec-----C
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSS-----E   77 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~   77 (249)
                      ...++|++.++|+.|.++.++...+......++++..  ...+....+.+.+|+.+|+.++||||+++++++..     .
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~  129 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF  129 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence            3457899999999999999987766555444554432  23344566789999999999999999999999943     3


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..+|+|||++. ++|.+++....    .+++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||
T Consensus       130 ~~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~---~kl~DFG  201 (458)
T 3rp9_A          130 DELYVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS---VKVCDFG  201 (458)
T ss_dssp             CCEEEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC---EEECCCT
T ss_pred             ceEEEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC---Eeecccc
Confidence            56999999985 68888876443    3899999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCc--------------cccccccccCCcccCCCCCCcccc-ccCCCCCcchHHHHHHHHHHHHh--
Q psy14626        158 VAIQLQDGQLYCSGGE--------------RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLT--  220 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~--  220 (249)
                      ++..............              .............+|+.|+|||++ .+..++.++||||+||++|||++  
T Consensus       202 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~  281 (458)
T 3rp9_A          202 LARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMI  281 (458)
T ss_dssp             TCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred             cchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhc
Confidence            9977653221100000              000000112233579999999986 55668999999999999999998  


Q ss_pred             ---------CCCCCCC
Q psy14626        221 ---------GTLPFVG  227 (249)
Q Consensus       221 ---------g~~pf~~  227 (249)
                               |+++|.+
T Consensus       282 ~~~~~~~~~~~p~f~g  297 (458)
T 3rp9_A          282 KENVAYHADRGPLFPG  297 (458)
T ss_dssp             TTTCSSGGGCCCSCC-
T ss_pred             cccccccccccccCCC
Confidence                     7777766

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.3e-35  Score=254.77  Aligned_cols=216  Identities=23%  Similarity=0.323  Sum_probs=162.3

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC---
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE---   77 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   77 (249)
                      +++..++|++.++++.|.++.++...+......++++...  .......+.+.+|+.+|+.++||||+++++++...   
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  100 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLL  100 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCC
Confidence            4566789999999999999999987765544444444322  33445667899999999999999999999999765   


Q ss_pred             --CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcC
Q psy14626         78 --GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG  155 (249)
Q Consensus        78 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~d  155 (249)
                        ..+|+|||++. ++|.+++....    .+++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|
T Consensus       101 ~~~~~~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~---~kL~D  172 (432)
T 3n9x_A          101 KFDELYIVLEIAD-SDLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS---VKVCD  172 (432)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECC
T ss_pred             cCCeEEEEEecCC-cCHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC---EEEcc
Confidence              57999999996 59988886543    3899999999999999999999999999999999999987766   99999


Q ss_pred             cceeEEccCCCccccCCc---------cccccccccCCcccCCCCCCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy14626        156 FGVAIQLQDGQLYCSGGE---------RLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLPF  225 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~~l~el~~g~~pf  225 (249)
                      ||++..............         .............+|+.|+|||++ .+..++.++|+||+||++|||++|..||
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            999987654321100000         000000112334589999999986 5566899999999999999999854444


Q ss_pred             C
Q psy14626        226 V  226 (249)
Q Consensus       226 ~  226 (249)
                      .
T Consensus       253 ~  253 (432)
T 3n9x_A          253 I  253 (432)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-35  Score=251.73  Aligned_cols=206  Identities=24%  Similarity=0.381  Sum_probs=150.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSE------   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~------   77 (249)
                      ..+||++.+.++.|.++.+|...+......++++...  .......+.+.+|+.+++.++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            4579999999999999999877654443334433222  23345667889999999999999999999998653      


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      ..+++|++++ +++|.+++...     .+++..+..++.||+.||.|||++|++|+||||+||+++.++.   ++|+|||
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~---~kL~DFG  177 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFG  177 (367)
T ss_dssp             CCCEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECC--
T ss_pred             CeEEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC---EEEeecc
Confidence            5689999999 67998877542     3899999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      ++.......                ....+|+.|+|||++.+ ..++.++|+||+||++++|++|+.||.+ +.......
T Consensus       178 ~a~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  241 (367)
T 2fst_X          178 LARHTADEM----------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  241 (367)
T ss_dssp             -----------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccC----------------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            986654311                12247899999999887 6789999999999999999999999998 33333333


Q ss_pred             H
Q psy14626        236 I  236 (249)
Q Consensus       236 i  236 (249)
                      |
T Consensus       242 i  242 (367)
T 2fst_X          242 I  242 (367)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-36  Score=243.74  Aligned_cols=209  Identities=17%  Similarity=0.252  Sum_probs=164.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC-CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC--CeEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE-PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSE--GMLYMV   83 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv   83 (249)
                      .++|++.+.++.|.++.+|.....-. ++.+.+. .........+.+.+|+.++++++||||+++++++.+.  +..++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~-~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLK-VRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEEC-CTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEec-ccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35899999999999999887765421 2222222 1222345567899999999999999999999999876  778999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      |||+++++|.+++.....  ..+++.++..++.|++.||.|||+++  ++|+||||+||+++.++.   ++++||+++..
T Consensus        88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~---~~l~~~~~~~~  162 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFS  162 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC---EEEEGGGSCCT
T ss_pred             ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc---eeEEeccceee
Confidence            999999999999875432  24899999999999999999999999  999999999999987665   88888887532


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCC---cchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGK---PVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      ...                  ....+|+.|+|||.+.+...+.   ++|+||+|+++|+|++|+.||.+ +.......+.
T Consensus       163 ~~~------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~  224 (271)
T 3kmu_A          163 FQS------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA  224 (271)
T ss_dssp             TSC------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHH
T ss_pred             ecc------------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHH
Confidence            211                  1234789999999998765444   79999999999999999999998 4555545554


Q ss_pred             cC
Q psy14626        238 KG  239 (249)
Q Consensus       238 ~g  239 (249)
                      ..
T Consensus       225 ~~  226 (271)
T 3kmu_A          225 LE  226 (271)
T ss_dssp             HS
T ss_pred             hc
Confidence            43

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.3e-35  Score=245.17  Aligned_cols=211  Identities=19%  Similarity=0.309  Sum_probs=166.9

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-CCCcccCChhccccchhHHHHHHHHHHHHHcCCC------ChhhhhheeecCCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-EPASFGLPDERLNHYTTEADLKREATICHMLKHP------HVVELLETYSSEGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------~i~~~~~~~~~~~~   79 (249)
                      .++|++.+.++.|.++.+|...+.. ....++++.. .......+.+.+|+.+++.++|+      +++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~-~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEE-CSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEE-ecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            4699999999999999998765422 2222333222 22234567889999999999765      49999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC------------
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN------------  147 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~------------  147 (249)
                      +++||||+ +++|.+++.....  ..+++.++..++.|++.||.|||++|++|+||||+||+++.++.            
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~  168 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE  168 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence            99999999 7899988876543  23889999999999999999999999999999999999976321            


Q ss_pred             ----CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q psy14626        148 ----SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       148 ----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  223 (249)
                          ...++|+|||.+.......                ....+|+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       169 ~~~~~~~~kl~Dfg~~~~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  232 (339)
T 1z57_A          169 RTLINPDIKVVDFGSATYDDEHH----------------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT  232 (339)
T ss_dssp             EEESCCCEEECCCSSCEETTSCC----------------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             ccccCCCceEeeCcccccCcccc----------------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                2348999999987654321                12357899999999999889999999999999999999999


Q ss_pred             CCCC-ChHHHHHHHH
Q psy14626        224 PFVG-SRDRLFQSIT  237 (249)
Q Consensus       224 pf~~-~~~~~~~~i~  237 (249)
                      ||.. +..+....+.
T Consensus       233 pf~~~~~~~~~~~~~  247 (339)
T 1z57_A          233 VFPTHDSKEHLAMME  247 (339)
T ss_dssp             SCCCSCHHHHHHHHH
T ss_pred             CCCCCChHHHHHHHH
Confidence            9998 4444444433

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-36  Score=250.64  Aligned_cols=212  Identities=26%  Similarity=0.427  Sum_probs=162.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-----chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-----YTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      .++|++.+.++.|.++.+|...+......++++......     ......+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            468999999999999999877765444444443222211     112346889999999999999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+.+ +|.+.+....   ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++..
T Consensus        89 lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~---~kl~Dfg~a~~  161 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKS  161 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCCGGGST
T ss_pred             EEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC---EEEEeccccee
Confidence            99999976 8877775432   34889999999999999999999999999999999999987766   99999999865


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      .....             .......+|+.|+|||.+.+. .++.++|+||+||++|+|++|.+||.+ +..+....+.+
T Consensus       162 ~~~~~-------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~  227 (346)
T 1ua2_A          162 FGSPN-------------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE  227 (346)
T ss_dssp             TTSCC-------------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccCCc-------------ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            43321             111223578999999998764 478999999999999999999999998 44444445443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.3e-35  Score=244.27  Aligned_cols=205  Identities=19%  Similarity=0.282  Sum_probs=163.3

Q ss_pred             CCcchHHHhhcccceeeEeeec----cccCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC--Ce
Q psy14626          7 NKRITIHEVINHKWLKMKLHTS----AEIEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSE--GM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~   79 (249)
                      .++|++.+.++.|.++.+|...    +......++++... .......+.+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            4578999999999999988665    22233333333222 12234567899999999999999999999999766  66


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +++||||+++++|.+++.....   .+++.+++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~---~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ---VKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC---EEECccccc
Confidence            8999999999999999866543   2899999999999999999999999999999999999988776   999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .........          ........++..|+|||.+.+..++.++|+||+|+++++|++|..|+..
T Consensus       174 ~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  231 (302)
T 4e5w_A          174 KAIETDKEY----------YTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSS  231 (302)
T ss_dssp             EECCTTCCE----------EECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccCCCcc----------eeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcc
Confidence            776553211          1112223477789999999988889999999999999999999987643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.6e-35  Score=244.15  Aligned_cols=214  Identities=18%  Similarity=0.235  Sum_probs=167.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheee----cCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYS----SEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----~~~~~~l   82 (249)
                      +++|++.+.++.|.++.+|...+......++++..........+.+.+|+.+++.++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            468999999999999999877765555555555444455567788999999999999999999999986    3347899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+.+++|.+++.........+++.+++.++.|++.||.+||+++++|+||||+||+++.++.   ++|+|||.+...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ---PVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC---EEEEecCcchhc
Confidence            99999999999999876555556999999999999999999999999999999999999987666   999999988665


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .........    ...........+++.|+|||.+.+..   ++.++|+||||+++|+|++|+.||..
T Consensus       185 ~~~~~~~~~----~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          185 CIHVEGSRQ----ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             CEEEESHHH----HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             ccccccccc----cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence            321100000    00000001123688999999987554   68899999999999999999999964

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.9e-35  Score=244.04  Aligned_cols=216  Identities=24%  Similarity=0.367  Sum_probs=165.9

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeec------C
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSS------E   77 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~------~   77 (249)
                      ++..+|++.+.++.|.++.+|...+......++++.... .....+.+.+|+.+++++ +||||+++++++..      .
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-CSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEec-CcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            567899999999999999988776654444444433222 234457899999999999 79999999999976      4


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      +.+++||||+++++|.+++.....  ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg  174 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE---VKLVDFG  174 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC---EEECCCT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC---EEEeeCc
Confidence            679999999999999999876532  23899999999999999999999999999999999999987666   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDR  231 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~  231 (249)
                      .+.......             .......+++.|+|||++.     +..++.++|+||||+++|+|++|..||.. ....
T Consensus       175 ~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  241 (326)
T 2x7f_A          175 VSAQLDRTV-------------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR  241 (326)
T ss_dssp             TTC--------------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH
T ss_pred             CceecCcCc-------------cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH
Confidence            876544321             0112234789999999986     45678999999999999999999999987 4444


Q ss_pred             HHHHHHcC
Q psy14626        232 LFQSITKG  239 (249)
Q Consensus       232 ~~~~i~~g  239 (249)
                      ....+..+
T Consensus       242 ~~~~~~~~  249 (326)
T 2x7f_A          242 ALFLIPRN  249 (326)
T ss_dssp             HHHHHHHS
T ss_pred             HHHHhhcC
Confidence            44444443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=252.81  Aligned_cols=200  Identities=25%  Similarity=0.391  Sum_probs=163.4

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc--------cchhHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--------HYTTEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      .++|++.+.++.|.++.+|...+......++++.....        .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            35888999999999999887765544433433322211        1124456788999999999999999999999999


Q ss_pred             eEEEEEeccCCC-chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         79 MLYMVFEYMDGS-DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        79 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      .+++|||++.++ +|.+++.....    +++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~---~kL~Dfg  175 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT---IKLIDFG  175 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCC----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCT
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc---EEEeecc
Confidence            999999999666 89888865433    899999999999999999999999999999999999987765   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .+........              .....+|+.|+|||++.+..+ +.++|+||||+++|+|++|..||..
T Consensus       176 ~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          176 SAAYLERGKL--------------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             TCEECCTTCC--------------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             cceECCCCCc--------------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            9977654321              112347999999999988776 7899999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-35  Score=242.35  Aligned_cols=229  Identities=17%  Similarity=0.224  Sum_probs=172.7

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhhee-ecCCeE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETY-SSEGML   80 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   80 (249)
                      ++.+.+++|++.+.++.|.++.+|...+......++++.....  ...+.+.+|+.+++.++|++++..+..+ ..++..
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 3uzp_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESC--SSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCC--cchhHHHHHHHHHHHhhcCCCCCccccccCCCCce
Confidence            3566788999999999999999987776544444444432222  2335689999999999988776666655 567788


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+ +++|.+++.....   .+++..+..++.|++.||.|||+++++|+||||+||+++.++....++|+|||.+.
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           81 VMVMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEEec-CCCHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            9999999 8899998874432   38999999999999999999999999999999999999632223349999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC----hHHHHHHH
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS----RDRLFQSI  236 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~----~~~~~~~i  236 (249)
                      ...........      .........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.    ..+....+
T Consensus       157 ~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 3uzp_A          157 KYRDARTHQHI------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             ECBCTTTCCBC------CCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             ccccccccccc------ccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence            77654321100      001123345899999999999988999999999999999999999999862    22344455


Q ss_pred             HcCccc
Q psy14626        237 TKGKLH  242 (249)
Q Consensus       237 ~~g~~~  242 (249)
                      ..+...
T Consensus       231 ~~~~~~  236 (296)
T 3uzp_A          231 SEKKMS  236 (296)
T ss_dssp             HHHHHH
T ss_pred             cccccC
Confidence            444433

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=247.01  Aligned_cols=200  Identities=23%  Similarity=0.378  Sum_probs=158.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCC--CChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKH--PHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~l   82 (249)
                      +++|++.+.++.|.++.+|...+.. ...++++...  .......+.+.+|+.+++.++|  |||+++++++..++.+++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTT-SCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCC-CCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            5789999999999999998776542 3334443222  2234456789999999999976  999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |||+ .+++|.+++.....    +++.++..++.|++.||.|||+++++|+||||+|||++. +.   ++|+|||++...
T Consensus        87 v~e~-~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~~---~kl~DFG~a~~~  157 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM---LKLIDFGIANQM  157 (343)
T ss_dssp             EECC-CSEEHHHHHHHSCC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE---EEECCCSSSCCC
T ss_pred             EEeC-CCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-Cc---EEEeeccccccc
Confidence            9995 57799999876543    899999999999999999999999999999999999963 33   999999998655


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----------QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....           ........+|+.|+|||++.+           ..++.++||||+||++|+|++|+.||..
T Consensus       158 ~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          158 QPDTT-----------SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             -----------------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             Ccccc-----------cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            43221           011122358999999999865           5678899999999999999999999987

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.8e-35  Score=251.11  Aligned_cols=212  Identities=22%  Similarity=0.342  Sum_probs=163.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcC--CCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLK--HPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++|++.+.|+.|.++.+|...+.. ...++++...  .......+.+.+|+.+++.++  ||||+++++++...+.+++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            469999999999999998766543 3334443222  223455678999999999996  59999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      || +.+++|.+++....    .+++.++..++.||+.||.|||+++++||||||+|||++. +.   ++|+|||++....
T Consensus       135 ~E-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~~---~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM---LKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-SC---EEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-Ce---EEEEecCcccccc
Confidence            99 55779999887654    3899999999999999999999999999999999999953 33   9999999986654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCCCCC--hH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----------QKYGKPVDIWAAGVLLHVLLTGTLPFVGS--RD  230 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~pf~~~--~~  230 (249)
                      .....           .......+|+.|+|||++.+           ..++.++|||||||++|+|++|+.||...  ..
T Consensus       206 ~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~  274 (390)
T 2zmd_A          206 PDTTS-----------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  274 (390)
T ss_dssp             -------------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred             CCCcc-----------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH
Confidence            32110           11123358999999999865           35788999999999999999999999873  33


Q ss_pred             HHHHHHHcCc
Q psy14626        231 RLFQSITKGK  240 (249)
Q Consensus       231 ~~~~~i~~g~  240 (249)
                      .....+..+.
T Consensus       275 ~~~~~~~~~~  284 (390)
T 2zmd_A          275 SKLHAIIDPN  284 (390)
T ss_dssp             HHHHHHHCTT
T ss_pred             HHHHHHhCcc
Confidence            4445555443

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.6e-35  Score=250.34  Aligned_cols=208  Identities=18%  Similarity=0.176  Sum_probs=156.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCC-----CcccCChhccccc-----------hhHHHHHHHHHHHHHcCCCChhhh
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEP-----ASFGLPDERLNHY-----------TTEADLKREATICHMLKHPHVVEL   70 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~~i~~~   70 (249)
                      .++|++.+.++.|.++.+|........     ..++++.......           .....+.+|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            458999999999999999877554321     2223322111110           011223445556667789999999


Q ss_pred             hheeecC----CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeee--e
Q psy14626         71 LETYSSE----GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLA--N  144 (249)
Q Consensus        71 ~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~--~  144 (249)
                      ++++...    ...++||||+ |++|.+++....   ..+++.+++.++.|++.||.|||+++++||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence            9998654    4589999999 899999887642   2389999999999999999999999999999999999998  4


Q ss_pred             cCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q psy14626        145 KENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLP  224 (249)
Q Consensus       145 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~p  224 (249)
                      ++.   ++|+|||++...........      ..........+|+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       190 ~~~---~kl~DFG~a~~~~~~~~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~P  260 (364)
T 3op5_A          190 PDQ---VYLVDYGLAYRYCPEGVHKA------YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP  260 (364)
T ss_dssp             TTC---EEECCCTTCEESSGGGCCCC------SSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             CCe---EEEEECCcceecccCCcccc------cccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            444   99999999977654321100      001112233489999999999999899999999999999999999999


Q ss_pred             CCC
Q psy14626        225 FVG  227 (249)
Q Consensus       225 f~~  227 (249)
                      |.+
T Consensus       261 f~~  263 (364)
T 3op5_A          261 WED  263 (364)
T ss_dssp             TGG
T ss_pred             ccc
Confidence            996

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.4e-35  Score=243.17  Aligned_cols=220  Identities=16%  Similarity=0.315  Sum_probs=164.3

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCC---CcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC---
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEG---   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---   78 (249)
                      .++|++.+.++.|.++.+|........   ..++++...  .......+.+.+|+.++++++||||+++++++.+.+   
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  112 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG  112 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence            458999999999999888865433211   122222221  223345678999999999999999999999997654   


Q ss_pred             --eEEEEEeccCCCchhHHHHHhh--hcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         79 --MLYMVFEYMDGSDICFEIVRRA--TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        79 --~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                        ..++||||+.+++|.+++....  .....+++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+
T Consensus       113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~---~kl~  189 (313)
T 3brb_A          113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT---VCVA  189 (313)
T ss_dssp             --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC---EEEC
T ss_pred             CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc---EEEe
Confidence              3599999999999999886543  22345899999999999999999999999999999999999987765   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRL  232 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~  232 (249)
                      |||.+.........           .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||.+ ....+
T Consensus       190 Dfg~~~~~~~~~~~-----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  258 (313)
T 3brb_A          190 DFGLSKKIYSGDYY-----------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM  258 (313)
T ss_dssp             SCSCC---------------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             ecCcceeccccccc-----------CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH
Confidence            99998765442211           11112236778999999999889999999999999999999 9999998 55566


Q ss_pred             HHHHHcCc
Q psy14626        233 FQSITKGK  240 (249)
Q Consensus       233 ~~~i~~g~  240 (249)
                      .+.+..+.
T Consensus       259 ~~~~~~~~  266 (313)
T 3brb_A          259 YDYLLHGH  266 (313)
T ss_dssp             HHHHHTTC
T ss_pred             HHHHHcCC
Confidence            66666653

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-36  Score=253.94  Aligned_cols=218  Identities=22%  Similarity=0.325  Sum_probs=160.5

Q ss_pred             cchHHHhhcccceeeEeeeccccCC---CcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheee-cCCeEEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYS-SEGMLYMV   83 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv   83 (249)
                      +|++.++++.|.++.+|........   ..++++.. ........+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            5778889999999998865532111   11222211 2333456788999999999999999999999864 45678999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++++|.+++.....   .++..++..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||++....
T Consensus       170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC-------
T ss_pred             EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCC---EEEeecccccccc
Confidence            999999999999865433   3789999999999999999999999999999999999987665   9999999997654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCcc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      ......         ........+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||.. +..++...+.++..
T Consensus       244 ~~~~~~---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~  314 (373)
T 3c1x_A          244 DKEFDS---------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR  314 (373)
T ss_dssp             -----------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCC
T ss_pred             cccccc---------ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCC
Confidence            322110         001112236778999999999999999999999999999999 8889987 44456666666653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-35  Score=241.05  Aligned_cols=220  Identities=20%  Similarity=0.269  Sum_probs=162.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .++|++.+.++.|.++.+|...+......++++....  ......+.+..+...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            4689999999999999998776654444444442222  22233344555666688889999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||+++ +|.+++.........+++..++.++.|++.||.+||++ |++|+||||+||+++.++.   ++|+|||.+....
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~---~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ---VKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC---EEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC---EEEeecCCccccc
Confidence            99975 88888776555556699999999999999999999998 9999999999999987665   9999999986654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCC--C-hHHHHHHH
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI----EDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--S-RDRLFQSI  236 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~-~~~~~~~i  236 (249)
                      ...              ......+++.|+|||.+    .+..++.++|+||+|+++++|++|+.||..  . ...+.+.+
T Consensus       162 ~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~  227 (290)
T 3fme_A          162 DDV--------------AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV  227 (290)
T ss_dssp             ----------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred             ccc--------------cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence            422              11122478999999996    456678999999999999999999999986  2 23445555


Q ss_pred             HcCccccc
Q psy14626        237 TKGKLHIL  244 (249)
Q Consensus       237 ~~g~~~~~  244 (249)
                      ....+..|
T Consensus       228 ~~~~~~~~  235 (290)
T 3fme_A          228 EEPSPQLP  235 (290)
T ss_dssp             HSCCCCCC
T ss_pred             ccCCCCcc
Confidence            55555444

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.9e-36  Score=250.72  Aligned_cols=215  Identities=23%  Similarity=0.394  Sum_probs=174.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccc--------------hhHHHHHHHHHHHHHcCCCChhhh
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHY--------------TTEADLKREATICHMLKHPHVVEL   70 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~--------------~~~~~~~~E~~~l~~l~h~~i~~~   70 (249)
                      ++|++.+.++.|.++.+|...+  ....++++   .......              ...+.+.+|+.+++.++||||+++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             CceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            5899999999999888887665  22233332   2221111              122889999999999999999999


Q ss_pred             hheeecCCeEEEEEeccCCCchhHH------HHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeee
Q psy14626         71 LETYSSEGMLYMVFEYMDGSDICFE------IVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLA  143 (249)
Q Consensus        71 ~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~  143 (249)
                      ++++.+.+..++||||+++++|.++      +...  ....+++..++.++.|++.||.+||+ +|++|+||+|+||+++
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEEC
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEc
Confidence            9999999999999999999999877      4331  12348999999999999999999999 9999999999999998


Q ss_pred             ecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCC-cchHHHHHHHHHHHHhC
Q psy14626        144 NKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGK-PVDIWAAGVLLHVLLTG  221 (249)
Q Consensus       144 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~~l~el~~g  221 (249)
                      .++.   ++|+|||.+.......               .....++..|+|||.+.+. .++. ++|+||+|+++++|++|
T Consensus       187 ~~~~---~kl~dfg~~~~~~~~~---------------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  248 (348)
T 2pml_X          187 KNGR---VKLSDFGESEYMVDKK---------------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN  248 (348)
T ss_dssp             TTSC---EEECCCTTCEECBTTE---------------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred             CCCc---EEEecccccccccccc---------------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence            7765   9999999997764421               1123478999999999877 5555 99999999999999999


Q ss_pred             CCCCCC-Ch-HHHHHHHHcCccccc
Q psy14626        222 TLPFVG-SR-DRLFQSITKGKLHIL  244 (249)
Q Consensus       222 ~~pf~~-~~-~~~~~~i~~g~~~~~  244 (249)
                      +.||.. +. .++.+.+..+.+.+|
T Consensus       249 ~~pf~~~~~~~~~~~~i~~~~~~~~  273 (348)
T 2pml_X          249 VVPFSLKISLVELFNNIRTKNIEYP  273 (348)
T ss_dssp             SCSSCCSSCSHHHHHHHTSCCCCCC
T ss_pred             CCCCCCCCcHHHHHHHHhccCcCCc
Confidence            999998 33 778889999888777

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.1e-35  Score=242.15  Aligned_cols=214  Identities=18%  Similarity=0.202  Sum_probs=160.8

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhhee-ecCCeE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETY-SSEGML   80 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   80 (249)
                      |+...+++|++.+.++.|.++.+|...+......++++...  .....+.+.+|+.+++.++|++++..+..+ ..+...
T Consensus         3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~--~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (296)
T 4hgt_A            3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   80 (296)
T ss_dssp             --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEE--C---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEE
T ss_pred             cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeec--ccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCce
Confidence            45677899999999999999999877755444444444222  122334688999999999988777776665 667788


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++|||++ +++|.+++.....   .+++.++..++.|++.||.|||+++++|+||||+||+++.++....++|+|||.+.
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEEcc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999999 8899998875433   38999999999999999999999999999999999999432223349999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...........      .........+++.|+|||.+.+..++.++|+||+||++|+|++|+.||.+
T Consensus       157 ~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  217 (296)
T 4hgt_A          157 KYRDARTHQHI------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             ECBCTTTCCBC------CCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             eccCcccCccC------CCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence            77654321100      00122234589999999999998899999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.1e-36  Score=249.97  Aligned_cols=198  Identities=21%  Similarity=0.277  Sum_probs=158.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----eEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG----MLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv   83 (249)
                      ++|++.++++.|.++.+|.....  ...++++.... .........+|+.++++++||||+++++++....    .+++|
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPI-QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECG-GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhchhhheecccCceEEEEEEEC--CCEEEEEEeec-CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            58999999999999999877654  22233332222 2344456677999999999999999999997643    47999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC----------CceeecCCCCCeeeeecCCCCCeEE
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN----------DIIHRDIKPHCVLLANKENSAPVKL  153 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~----------~~vH~dlkp~Nili~~~~~~~~~~l  153 (249)
                      |||+++++|.+++....     +++..+..++.|++.||.|||+.          +++|+||||+||+++.++.   ++|
T Consensus       101 ~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~---~kL  172 (322)
T 3soc_A          101 TAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT---ACI  172 (322)
T ss_dssp             EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC---EEE
T ss_pred             EecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe---EEE
Confidence            99999999999986532     89999999999999999999999          9999999999999987665   999


Q ss_pred             cCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        154 GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-----KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      +|||.+.........           .......+|+.|+|||++.+.     .++.++||||+||++|+|++|+.||.+
T Consensus       173 ~DFg~a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~  240 (322)
T 3soc_A          173 ADFGLALKFEAGKSA-----------GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG  240 (322)
T ss_dssp             CCCTTCEEECTTSCC-----------CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSS
T ss_pred             ccCCcccccccccCc-----------cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCC
Confidence            999999776543211           112223589999999999863     345678999999999999999999975

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-35  Score=240.77  Aligned_cols=217  Identities=22%  Similarity=0.312  Sum_probs=167.5

Q ss_pred             cchHHHhhcccceeeEeeeccccCC---CcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE-EEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML-YMV   83 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-~lv   83 (249)
                      +|...++++.|.++.+|........   ..++++.. ........+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            5667788999999998866532111   12333222 223345567899999999999999999999999766554 999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ||++.+++|.+++.....   .+++.++..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+....
T Consensus       102 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~---~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQR---NPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT---VKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc---EEeCcCCCccccc
Confidence            999999999998865332   3899999999999999999999999999999999999987765   9999999986554


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....         .........+++.|+|||.+.+..++.++|+||+|+++++|++ |.+||.. +...+.+.+..+.
T Consensus       176 ~~~~~---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~  245 (298)
T 3pls_A          176 DREYY---------SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR  245 (298)
T ss_dssp             TGGGG---------CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC
T ss_pred             CCccc---------ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC
Confidence            32211         1112223346789999999999889999999999999999999 5566666 4556666666655

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=7.5e-35  Score=242.73  Aligned_cols=199  Identities=22%  Similarity=0.394  Sum_probs=163.8

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheeec--CCe
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYSS--EGM   79 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~   79 (249)
                      ++....+|++.+.++.|.++.+|...+......++++...   ....+.+.+|+.+++.++ ||||+++++++..  ...
T Consensus        31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~---~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~  107 (330)
T 3nsz_A           31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRT  107 (330)
T ss_dssp             CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEC---SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred             cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEec---ccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence            3445678999999999999999977655444444443322   234578999999999996 9999999999987  667


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .++||||+.+++|.+++..       +++.+++.++.|++.||.+||++|++|+||||+||+++.++.  .++|+|||.+
T Consensus       108 ~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~~kl~Dfg~a  178 (330)
T 3nsz_A          108 PALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLA  178 (330)
T ss_dssp             EEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTC
T ss_pred             eEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC--EEEEEeCCCc
Confidence            9999999999999877632       899999999999999999999999999999999999986552  2899999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .......              ......++..|+|||.+.+ ..++.++|+||+||++++|++|+.||..
T Consensus       179 ~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~  233 (330)
T 3nsz_A          179 EFYHPGQ--------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  233 (330)
T ss_dssp             EECCTTC--------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             eEcCCCC--------------ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            7665422              1122357889999999877 6689999999999999999999999964

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-35  Score=243.89  Aligned_cols=218  Identities=23%  Similarity=0.373  Sum_probs=165.4

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheee-------
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYS-------   75 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-------   75 (249)
                      +++...+|++.+.++.|.++.+|...+......++++.....+....+.+.+|+.+++.++||||+++++++.       
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A            6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            4566789999999999999999877766555555555444555566788999999999999999999998873       


Q ss_pred             -------cCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC
Q psy14626         76 -------SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS  148 (249)
Q Consensus        76 -------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~  148 (249)
                             +....++||||+. ++|.+++..     ..+++..++.++.|++.||.+||++|++|+||||+||+++.++  
T Consensus        86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~--  157 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED--  157 (320)
T ss_dssp             C----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT--
T ss_pred             cccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC--
Confidence                   4467899999997 589888753     2389999999999999999999999999999999999997433  


Q ss_pred             CCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       149 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..++|+|||.+.........          ........++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.+
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  227 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSH----------KGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG  227 (320)
T ss_dssp             TEEEECCCTTCBCC------------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CeEEEccCccccccCCCccc----------ccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence            23899999998765432110          011122346889999998865 6678999999999999999999999998


Q ss_pred             -ChHHHHHHHHc
Q psy14626        228 -SRDRLFQSITK  238 (249)
Q Consensus       228 -~~~~~~~~i~~  238 (249)
                       +..+....+.+
T Consensus       228 ~~~~~~~~~~~~  239 (320)
T 2i6l_A          228 AHELEQMQLILE  239 (320)
T ss_dssp             SSHHHHHHHHHH
T ss_pred             CCHHHHHHHHHH
Confidence             44444444443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.6e-36  Score=263.82  Aligned_cols=214  Identities=18%  Similarity=0.307  Sum_probs=171.1

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.|+.|.++.+|....... ..++++..... ....+.+.+|+.+|++++||||+++++++.+ +.+++||||
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCC-CCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            45788899999999999987665422 12333222221 2345789999999999999999999999876 568999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +.+++|.+++......  .+++.++..++.||+.||.|||+++++|+||||+|||++.++.   ++|+|||++.......
T Consensus       343 ~~~gsL~~~l~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~---~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNE  417 (535)
T ss_dssp             CTTEEHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCTTSTTTCCCHH
T ss_pred             hcCCcHHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc---EEEcccccceecCCCc
Confidence            9999999999764332  3889999999999999999999999999999999999987765   9999999985543211


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .            +......++..|+|||++.+..++.++||||||+++|||++ |+.||.+ ...++.+.+.+|.
T Consensus       418 ~------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~  481 (535)
T 2h8h_A          418 Y------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY  481 (535)
T ss_dssp             H------------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             e------------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            0            11112235778999999998889999999999999999999 9999998 5667777877763

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=8.6e-35  Score=240.02  Aligned_cols=209  Identities=21%  Similarity=0.245  Sum_probs=166.5

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeecccc-CCCcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEI-EPASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML   80 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (249)
                      +++....|..++.++.|.++.+|.....- .++.+.+... ........+.+.+|+.+++.++||||+++++++...+..
T Consensus        26 ~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  105 (307)
T 2nru_A           26 NFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDL  105 (307)
T ss_dssp             TTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCce
Confidence            35666677778899999999988765431 1222222111 122344567899999999999999999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+++++|.+++..... ...+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~---~kl~Dfg~~~  181 (307)
T 2nru_A          106 CLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT---AKISDFGLAR  181 (307)
T ss_dssp             EEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCE
T ss_pred             EEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc---EEEeeccccc
Confidence            999999999999998875433 334899999999999999999999999999999999999987665   9999999987


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ........           .......+++.|+|||.+.+. ++.++|+||||+++|+|++|..||..
T Consensus       182 ~~~~~~~~-----------~~~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~  236 (307)
T 2nru_A          182 ASEKFAQT-----------VMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDE  236 (307)
T ss_dssp             ECCSCSSC-----------EECSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred             cccccccc-----------ccccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCccc
Confidence            76542211           111223578999999998764 68999999999999999999999987

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.9e-35  Score=244.72  Aligned_cols=221  Identities=21%  Similarity=0.344  Sum_probs=171.3

Q ss_pred             CCCcchHHHhhcccceeeEeeecc-----ccCCCcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSA-----EIEPASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSEG   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   78 (249)
                      +.++|++.+.++.|.++.+|....     ......++++.... ......+.+.+|+.+++++ +||||+++++++...+
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  104 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  104 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence            356899999999999998887642     11222233322211 2234456799999999999 7999999999987654


Q ss_pred             -eEEEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec
Q psy14626         79 -MLYMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK  145 (249)
Q Consensus        79 -~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~  145 (249)
                       .+++||||+++++|.+++......            ...+++..+..++.|++.||.+||++|++|+||||+||+++.+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence             589999999999999998765432            1227899999999999999999999999999999999999877


Q ss_pred             CCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCC
Q psy14626        146 ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLP  224 (249)
Q Consensus       146 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~p  224 (249)
                      +.   ++|+|||.+........           ........+++.|+|||.+.+..++.++|+||+|+++++|++ |..|
T Consensus       185 ~~---~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p  250 (316)
T 2xir_A          185 NV---VKICDFGLARDIYKDPD-----------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP  250 (316)
T ss_dssp             GC---EEECCCGGGSCTTTCTT-----------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CC---EEECCCccccccccCcc-----------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence            66   99999999865543221           011222346788999999998889999999999999999998 9999


Q ss_pred             CCC--ChHHHHHHHHcCc
Q psy14626        225 FVG--SRDRLFQSITKGK  240 (249)
Q Consensus       225 f~~--~~~~~~~~i~~g~  240 (249)
                      |.+  ..+.+...+..+.
T Consensus       251 ~~~~~~~~~~~~~~~~~~  268 (316)
T 2xir_A          251 YPGVKIDEEFCRRLKEGT  268 (316)
T ss_dssp             STTCCCSHHHHHHHHHTC
T ss_pred             CcccchhHHHHHHhccCc
Confidence            987  2455666666554

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-35  Score=264.43  Aligned_cols=207  Identities=23%  Similarity=0.357  Sum_probs=162.3

Q ss_pred             hhcccceeeEeeeccc-----cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         15 VINHKWLKMKLHTSAE-----IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      .|+.|.++.+|.....     ..++++.+...  ......+.+.+|+.+|++++||||+++++++.. +.+++||||+.+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCC--CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            6788888888765432     12333333222  233567889999999999999999999999976 459999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++....   ..+++.++..++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++......... 
T Consensus       420 g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~---vkL~DFGla~~~~~~~~~-  492 (613)
T 2ozo_A          420 GPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY---AKISDFGLSKALGADDSY-  492 (613)
T ss_dssp             CBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCSTTTTCC------
T ss_pred             CcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc---EEEeeccCcccccCCCce-
Confidence            99999886542   23899999999999999999999999999999999999998776   999999998654321110 


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                               .+......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+ +..++.+.+.+|.
T Consensus       493 ---------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~  556 (613)
T 2ozo_A          493 ---------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK  556 (613)
T ss_dssp             ------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTC
T ss_pred             ---------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence                     011112235688999999998899999999999999999998 9999998 6677888888775

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7e-35  Score=238.35  Aligned_cols=201  Identities=21%  Similarity=0.361  Sum_probs=160.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhcc---ccch----hHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL---NHYT----TEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      ..++|++.+.++.|.++.+|...+......++++....   ....    ..+.+.+|+.+++.++||||+++++++.+..
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            45789999999999999998776654444444332221   1111    1267999999999999999999999997765


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeeecCC--CCCeEEc
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKEN--SAPVKLG  154 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~~~~--~~~~~l~  154 (249)
                        ++||||+++++|.+.+.....   .+++..+..++.|++.||.+||+++  ++|+||||+||+++.++.  ...++|+
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~  171 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA  171 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred             --eEEEEecCCCCHHHHHhcccC---CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence              699999999999888765433   3899999999999999999999999  999999999999976543  2348999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE--DQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      |||.+.......                ....+++.|+|||.+.  ...++.++|+||+|+++|+|++|+.||..
T Consensus       172 Dfg~~~~~~~~~----------------~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  230 (287)
T 4f0f_A          172 DFGLSQQSVHSV----------------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE  230 (287)
T ss_dssp             CCTTCBCCSSCE----------------ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCccccccccc----------------cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            999986433311                1234789999999984  44568899999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.3e-35  Score=264.48  Aligned_cols=207  Identities=21%  Similarity=0.332  Sum_probs=162.8

Q ss_pred             hhcccceeeEeeeccc--c---CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCC
Q psy14626         15 VINHKWLKMKLHTSAE--I---EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG   89 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   89 (249)
                      .|+.|.++.+|.....  .   .++++.+.. ...+....+.+.+|+.++++++||||+++++++..+ ..++||||+.+
T Consensus       376 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~~~  453 (635)
T 4fl3_A          376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL  453 (635)
T ss_dssp             EEEECSSEEEEEEEEECSSCEEEEEEEEECG-GGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             EeccCCCEEEEEEEEcCCCcceEEEEEEecc-ccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEccCC
Confidence            6888889888865322  1   222332222 233345578899999999999999999999999754 58999999999


Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYC  169 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~  169 (249)
                      ++|.+++.....    +++..++.++.||+.||.|||+++++|+||||+|||++.++.   ++|+|||++......... 
T Consensus       454 g~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~---~kL~DFGla~~~~~~~~~-  525 (635)
T 4fl3_A          454 GPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADENY-  525 (635)
T ss_dssp             EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhCCC----CCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC---EEEEEcCCccccccCccc-
Confidence            999999975443    899999999999999999999999999999999999998776   999999998665432210 


Q ss_pred             cCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        170 SGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                               ........+++.|+|||++.+..++.++|||||||++|||++ |+.||.+ +..++.+.+.++.
T Consensus       526 ---------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~  589 (635)
T 4fl3_A          526 ---------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE  589 (635)
T ss_dssp             ------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             ---------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence                     011111235678999999999899999999999999999998 9999998 5667888888775

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=239.79  Aligned_cols=198  Identities=22%  Similarity=0.364  Sum_probs=156.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.++.|.++.+|...+......++++...  ............|+..+..+ +||||++++++|.+++.+++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            46888889999999999977665444444444222  22233444556666666555 8999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+ +++|.+.+.....   .+++..++.++.|++.||.|||+++++|+||||+|||++.++.   ++|+|||++.....
T Consensus       137 e~~-~~~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR---CKLGDFGLLVELGT  209 (311)
T ss_dssp             ECC-CCBHHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC---EEECCCTTCEECC-
T ss_pred             ecc-CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC---EEEccceeeeeccc
Confidence            999 5688888766533   3899999999999999999999999999999999999988776   99999999876654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ..              ......+|+.|+|||++.+ .++.++||||+||+++||++|..|+.+
T Consensus       210 ~~--------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          210 AG--------------AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             -------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             CC--------------CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            22              1122347999999999886 689999999999999999999766654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-34  Score=249.85  Aligned_cols=210  Identities=24%  Similarity=0.373  Sum_probs=168.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc------CCCChhhhhheeecCCeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML------KHPHVVELLETYSSEGML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~   80 (249)
                      ..||++.++|+.|.++.+|...+......++++... ........+.+|+.+++.+      +|+||+++++.+...+.+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEEC-SCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEEC-CccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            458999999999999999977655444444443322 2234456788899998888      467999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++|||++. ++|.+++......  .+++..++.++.|++.||.|||+++++||||||+|||++.++. ..++|+|||++.
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~-~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQ--GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTC--CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS-CCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC-cceEEeecccce
Confidence            99999996 5898888765433  3899999999999999999999999999999999999987543 238999999986


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      ......                ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+ +..+....+.
T Consensus       251 ~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~  312 (429)
T 3kvw_A          251 YEHQRV----------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMI  312 (429)
T ss_dssp             ETTCCC----------------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ecCCcc----------------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            654321                123578999999999999999999999999999999999999998 4444444433

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.7e-35  Score=251.05  Aligned_cols=199  Identities=28%  Similarity=0.354  Sum_probs=157.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec------CCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS------EGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~l   82 (249)
                      +|++.++|+.|.++.+|...+......++++.....    .....+|+.+++.++||||++++++|..      ...+++
T Consensus        55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l  130 (420)
T 1j1b_A           55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL  130 (420)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred             eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence            799999999999999998776544444444433221    1224579999999999999999999843      124679


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++ +|...+.........+++..++.++.||+.||.|||++|++||||||+|||++.++.  .++|+|||++...
T Consensus       131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~--~~kl~DFG~a~~~  207 (420)
T 1j1b_A          131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLCDFGSAKQL  207 (420)
T ss_dssp             EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT--EEEECCCTTCEEC
T ss_pred             ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC--eEEeccchhhhhc
Confidence            9999976 666666554444456999999999999999999999999999999999999986543  2799999999876


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .....              .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.
T Consensus       208 ~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~  260 (420)
T 1j1b_A          208 VRGEP--------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD  260 (420)
T ss_dssp             CTTCC--------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCC--------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            44221              1123578999999998764 6899999999999999999999999983

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-35  Score=243.21  Aligned_cols=210  Identities=26%  Similarity=0.416  Sum_probs=149.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .++|++.+.++.|.++.+|...+......++++..... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   93 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK   93 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence            46899999999999988887765433333333322211 12445678999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhh----cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         86 YMDGSDICFEIVRRAT----AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      |+++++|.+++.....    ....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.   ++|+|||.+..
T Consensus        94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~---~kl~dfg~~~~  170 (303)
T 2vwi_A           94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS---VQIADFGVSAF  170 (303)
T ss_dssp             CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC---EEECCCHHHHH
T ss_pred             hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC---EEEEeccchhe
Confidence            9999999998875322    1234899999999999999999999999999999999999987766   99999998755


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ........        .........+++.|+|||.+.+ ..++.++|+||||+++++|++|+.||..
T Consensus       171 ~~~~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  229 (303)
T 2vwi_A          171 LATGGDIT--------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK  229 (303)
T ss_dssp             CC-----------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             eccCCCcc--------chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence            43321000        0011122357899999999876 5678999999999999999999999998

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-35  Score=244.55  Aligned_cols=206  Identities=19%  Similarity=0.295  Sum_probs=165.8

Q ss_pred             CCcchHHHhhcccceeeEeeec----cccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC--eE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTS----AEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG--ML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~   80 (249)
                      .++|++.+.++.|.++.+|...    .......++++..........+.+.+|+.+++.++||||+++++++...+  .+
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            4578999999999999988665    22233334444433444566778999999999999999999999986543  68


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++|||++++++|.+++.....   .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~---~kL~Dfg~~~  193 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR---VKIGDFGLTK  193 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTCE
T ss_pred             EEEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc---EEEecCcchh
Confidence            999999999999999876533   3899999999999999999999999999999999999988776   9999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .........          .......++..|+|||.+.+..++.++|+||||+++++|++|..||...
T Consensus       194 ~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  251 (326)
T 2w1i_A          194 VLPQDKEYY----------KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP  251 (326)
T ss_dssp             ECCSSCSEE----------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred             hcccccccc----------ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence            765432110          0111223567899999999888899999999999999999999998753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.9e-35  Score=239.70  Aligned_cols=208  Identities=22%  Similarity=0.398  Sum_probs=161.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec-CCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS-EGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   85 (249)
                      .++|++.+.++.|.++.+|.....  ...++++.  .......+.+.+|+.+++.++||||+++++++.+ .+..++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEE--CCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEE--ecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            368999999999999888866543  12222221  1223456789999999999999999999998754 457899999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++++|.+++......  .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+......
T Consensus        96 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTKEASST  170 (278)
T ss_dssp             CCTTEEHHHHHHHHHHH--HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC---EEECCCCC-------
T ss_pred             cCCCCCHHHHHHhcccc--cCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc---EEEeecccccccccc
Confidence            99999999998765432  2789999999999999999999999999999999999987665   999999998654432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      .                ....+++.|+|||.+.+..++.++|+||||+++++|++ |+.||.. +..++...+.++
T Consensus       171 ~----------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~  230 (278)
T 1byg_A          171 Q----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG  230 (278)
T ss_dssp             ---------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred             c----------------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC
Confidence            1                11236788999999998889999999999999999998 9999998 556667777665

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-34  Score=243.74  Aligned_cols=209  Identities=22%  Similarity=0.349  Sum_probs=157.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc-----------cccchhHHHHHHHHHHHHHcCCCChhhhhhee
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-----------LNHYTTEADLKREATICHMLKHPHVVELLETY   74 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   74 (249)
                      ...+|++.+.++.|.++.+|...+.. ...++++...           ..+....+.+.+|+.++++++||||+++++++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            35789999999999999998765543 2223332211           12223357899999999999999999999998


Q ss_pred             e-----cCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC
Q psy14626         75 S-----SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus        75 ~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~  149 (249)
                      .     ....+++||||+. ++|.+.+....   ..+++..+..++.|++.||.+||++|++|+||||+||+++.++.  
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--  172 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--  172 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--
Confidence            4     3346899999997 57877776432   24899999999999999999999999999999999999987766  


Q ss_pred             CeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-
Q psy14626        150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-  227 (249)
Q Consensus       150 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-  227 (249)
                       ++|+|||.+.......              ......+++.|+|||.+.+ ..++.++|+||+||++++|++|+.||.+ 
T Consensus       173 -~kl~Dfg~~~~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          173 -ITICDFNLAREDTADA--------------NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             -EEECCTTC-----------------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             -EEEEecCccccccccc--------------ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence             9999999986543322              1112347888999999877 6689999999999999999999999998 


Q ss_pred             ChHHHHHHH
Q psy14626        228 SRDRLFQSI  236 (249)
Q Consensus       228 ~~~~~~~~i  236 (249)
                      +..+....+
T Consensus       238 ~~~~~~~~i  246 (362)
T 3pg1_A          238 TFYNQLNKI  246 (362)
T ss_dssp             SHHHHHHHH
T ss_pred             CHHHHHHHH
Confidence            433444443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-34  Score=243.33  Aligned_cols=210  Identities=21%  Similarity=0.334  Sum_probs=164.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCC-cccCChhccccchhHHHHHHHHHHHHHcCCCC------hhhhhheeecCCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPA-SFGLPDERLNHYTTEADLKREATICHMLKHPH------VVELLETYSSEGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~------i~~~~~~~~~~~~   79 (249)
                      .++|++.+.++.|.++.+|...+....+ .++++... ......+.+.+|+.+++.++|++      ++.+.+++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEC-SCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEc-ccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            4689999999999999998766543332 23332222 22345678899999999997655      8899999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec--------------
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK--------------  145 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~--------------  145 (249)
                      .++|||++ +++|.+.+.....  ..+++.+++.++.|++.||.+||++|++|+||||+||++..+              
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             EEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence            99999999 5577677665432  238999999999999999999999999999999999999432              


Q ss_pred             --CCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q psy14626        146 --ENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       146 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~  223 (249)
                        .....++|+|||.+.......                ....+|+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  237 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHEHH----------------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT  237 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTSCC----------------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCCcEEEeecCccccccccc----------------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence              122349999999987644321                12357899999999999889999999999999999999999


Q ss_pred             CCCC-ChHHHHHHH
Q psy14626        224 PFVG-SRDRLFQSI  236 (249)
Q Consensus       224 pf~~-~~~~~~~~i  236 (249)
                      ||.. +..+....+
T Consensus       238 pf~~~~~~~~~~~~  251 (355)
T 2eu9_A          238 LFQTHENREHLVMM  251 (355)
T ss_dssp             SCCCSSHHHHHHHH
T ss_pred             CCCCCCHHHHHHHH
Confidence            9998 343333333

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1e-34  Score=247.98  Aligned_cols=198  Identities=29%  Similarity=0.399  Sum_probs=153.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC------eEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG------MLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~   81 (249)
                      .+|++.++++.|.++.+|......... +++++....    .....+|+.+++.++||||++++++|...+      .++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD----KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC----TTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC----cchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            479999999999999998776543322 333322211    122347999999999999999999995433      388


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeee-ecCCCCCeEEcCcceeE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLA-NKENSAPVKLGGFGVAI  160 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~-~~~~~~~~~l~dfg~~~  160 (249)
                      +||||+++ ++...+.........+++..++.++.|++.||.|||++|++||||||+||+++ .++.   ++|+|||++.
T Consensus       115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~---~kL~DFG~a~  190 (394)
T 4e7w_A          115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV---LKLIDFGSAK  190 (394)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE---EEECCCTTCE
T ss_pred             EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc---EEEeeCCCcc
Confidence            99999986 44444443333344589999999999999999999999999999999999998 4444   9999999997


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .......              .....+++.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.
T Consensus       191 ~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  245 (394)
T 4e7w_A          191 ILIAGEP--------------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGE  245 (394)
T ss_dssp             ECCTTCC--------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCCC--------------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            7644221              1123478899999998764 4899999999999999999999999983

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1e-34  Score=246.06  Aligned_cols=205  Identities=23%  Similarity=0.357  Sum_probs=161.6

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeE---
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGML---   80 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~---   80 (249)
                      -.++|++.+.++.|.++.+|...+......++++...  .......+.+.+|+.+++.++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            3578999999999999999977655444444443222  22334567889999999999999999999999876654   


Q ss_pred             ---EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         81 ---YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        81 ---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                         ++||||+. ++|.+.+..      .+++..+..++.|++.||.|||++|++|+||||+||+++.++.   ++|+|||
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~---~kL~Dfg  189 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFG  189 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECSTT
T ss_pred             eeEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC---EEEEecC
Confidence               99999997 577666522      2899999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      .+.......                ....+|+.|+|||++.+ ..++.++|+|||||++++|++|+.||.+ +..+....
T Consensus       190 ~a~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  253 (371)
T 4exu_A          190 LARHADAEM----------------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  253 (371)
T ss_dssp             CC------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccccCc----------------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            986554321                12347899999999887 6789999999999999999999999998 43334433


Q ss_pred             H
Q psy14626        236 I  236 (249)
Q Consensus       236 i  236 (249)
                      +
T Consensus       254 i  254 (371)
T 4exu_A          254 I  254 (371)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=239.85  Aligned_cols=196  Identities=23%  Similarity=0.397  Sum_probs=154.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.++.|.++.+|......  ..++++.  .......+.+.+|+.++++++||||+++++++.+.  .++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~vavK~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWRA--KDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETT--EEEEEEE--CSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEECC--eeEEEEE--ecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEc
Confidence            4689999999999999888665431  1222221  22335567899999999999999999999998743  7899999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH---CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE---NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~---~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      +++++|.+++..... ...++...++.++.|++.||.+||+   +|++|+||||+||+++.++.  .++|+|||.+....
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~--~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT--VLKICDFGTACDIQ  157 (307)
T ss_dssp             CTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--EEEECCCCC-----
T ss_pred             CCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--EEEEcccccccccc
Confidence            999999998875432 1237889999999999999999999   89999999999999986553  26999999986543


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...                ....+++.|+|||.+.+..++.++|+||||+++++|++|+.||..
T Consensus       158 ~~~----------------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  205 (307)
T 2eva_A          158 THM----------------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE  205 (307)
T ss_dssp             -----------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred             ccc----------------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence            311                112478999999999998899999999999999999999999986

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-35  Score=245.65  Aligned_cols=206  Identities=15%  Similarity=0.237  Sum_probs=160.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC--------CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhh--------
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE--------PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVEL--------   70 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~--------   70 (249)
                      +++|++.+.++.|.++.+|...+...        ...++++....     .+.+.+|+.++++++||||+++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK-----DGRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEET-----TSTHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecc-----cchHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            57999999999999999987766542        22333332221     1568899999999999999985        


Q ss_pred             -------hheeec-CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeee
Q psy14626         71 -------LETYSS-EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLL  142 (249)
Q Consensus        71 -------~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili  142 (249)
                             ++++.. ++..++||||+ +++|.+++.....  ..+++.+++.++.|++.||.|||++|++|+||||+||++
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                   444443 67899999999 8999999986522  238999999999999999999999999999999999999


Q ss_pred             eecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCC
Q psy14626        143 ANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGT  222 (249)
Q Consensus       143 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~  222 (249)
                      +.++. ..++|+|||++..........      ...........+++.|+|||.+.+..++.++|+||||+++|+|++|+
T Consensus       193 ~~~~~-~~~kl~Dfg~a~~~~~~~~~~------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  265 (352)
T 2jii_A          193 DPEDQ-SQVTLAGYGFAFRYCPSGKHV------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF  265 (352)
T ss_dssp             ETTEE-EEEEECCGGGCBCSSGGGCCC------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             cCCCC-ceEEEecCcceeeccCCCccc------cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            87651 139999999997654322100      00011112335899999999999988999999999999999999999


Q ss_pred             CCCCC
Q psy14626        223 LPFVG  227 (249)
Q Consensus       223 ~pf~~  227 (249)
                      .||..
T Consensus       266 ~pf~~  270 (352)
T 2jii_A          266 LPWTN  270 (352)
T ss_dssp             CTTGG
T ss_pred             CCccc
Confidence            99987

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-34  Score=236.73  Aligned_cols=209  Identities=24%  Similarity=0.420  Sum_probs=167.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec----------
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS----------   76 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----------   76 (249)
                      ..+|++.+.++.|.++.+|...+......++++.....    .+.+.+|+.+++.++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            35788889999999888887766544444444433322    2457799999999999999999998854          


Q ss_pred             ------CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCC
Q psy14626         77 ------EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP  150 (249)
Q Consensus        77 ------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~  150 (249)
                            ...+++||||+++++|.+++.....  ..+++..++.++.|++.||.+||++|++|+||||+||+++.++.   
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---  160 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ---  160 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC---
Confidence                  4458999999999999999976543  23899999999999999999999999999999999999998776   


Q ss_pred             eEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCChH
Q psy14626        151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD  230 (249)
Q Consensus       151 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~~  230 (249)
                      ++|+|||.+........              .....+++.|+|||.+.+..++.++|+||||+++++|++|..|+... .
T Consensus       161 ~kl~Dfg~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~  225 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK--------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-S  225 (284)
T ss_dssp             EEECCCTTCEESSCCSC--------------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-H
T ss_pred             EEECcchhheecccccc--------------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-H
Confidence            99999999877654321              11234789999999999988999999999999999999999888542 2


Q ss_pred             HHHHHHHcC
Q psy14626        231 RLFQSITKG  239 (249)
Q Consensus       231 ~~~~~i~~g  239 (249)
                      .....+..+
T Consensus       226 ~~~~~~~~~  234 (284)
T 2a19_B          226 KFFTDLRDG  234 (284)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHhhcc
Confidence            234444443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=246.23  Aligned_cols=219  Identities=20%  Similarity=0.242  Sum_probs=168.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .++|++.+.++.|.++.+|.......++.+.+.... ......+.+.+|+.++++++||||+++++++...+.+++||||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  110 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL  110 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCS-CCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCC-CCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence            468999999999999998877665444444433322 2233446688999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      +++++|.+++....   ..+++..+..++.|++.||.+||++|++|+||||+||+++. +.   ++|+|||++.......
T Consensus       111 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~~-~~---~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          111 CKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GK---VVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---C---CEECCCSCCC------
T ss_pred             ccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEeC-CC---EEEeecCCcccccccc
Confidence            99999998886533   24899999999999999999999999999999999999973 33   8999999876543211


Q ss_pred             ccccCCccccccccccCCcccCCCCCCcccccc---------CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---------QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ...        .........+++.|+|||.+.+         ..++.++|+||||+++|+|++|+.||.. ..+.+...+
T Consensus       184 ~~~--------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          184 AGR--------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             ------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccc--------cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            100        0111222347889999999874         3468899999999999999999999998 556667677


Q ss_pred             HcCcc
Q psy14626        237 TKGKL  241 (249)
Q Consensus       237 ~~g~~  241 (249)
                      ..+..
T Consensus       256 ~~~~~  260 (319)
T 2y4i_B          256 GTGMK  260 (319)
T ss_dssp             HTTCC
T ss_pred             ccCCC
Confidence            66643

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=237.73  Aligned_cols=196  Identities=27%  Similarity=0.446  Sum_probs=157.8

Q ss_pred             hhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccCCCchhH
Q psy14626         15 VINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICF   94 (249)
Q Consensus        15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (249)
                      +++.|.++.+|...+......++++..........+.+.+|+.+++.++||||+++++++...+..++|||++++++|.+
T Consensus        29 ~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (295)
T 2clq_A           29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA  108 (295)
T ss_dssp             EEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHH
T ss_pred             EEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHH
Confidence            78888888888776554444444444333444556789999999999999999999999999999999999999999999


Q ss_pred             HHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeee-cCCCCCeEEcCcceeEEccCCCccccCCc
Q psy14626         95 EIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLAN-KENSAPVKLGGFGVAIQLQDGQLYCSGGE  173 (249)
Q Consensus        95 ~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~-~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  173 (249)
                      ++..... ...+++..+..++.|++.||.+||++|++|+||+|+||+++. ++.   ++|+|||.+........      
T Consensus       109 ~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~---~kl~Dfg~~~~~~~~~~------  178 (295)
T 2clq_A          109 LLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGV---LKISDFGTSKRLAGINP------  178 (295)
T ss_dssp             HHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCC---EEECCTTTCEESCC---------
T ss_pred             HHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCC---EEEeecccccccCCCCC------
Confidence            8876432 334678999999999999999999999999999999999986 444   99999999877654221      


Q ss_pred             cccccccccCCcccCCCCCCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        174 RLDHYTTKAGHRIGTPHYMAPEVIEDQK--YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                             ......+++.|+|||++.+..  ++.++|+||||+++|+|++|+.||..
T Consensus       179 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          179 -------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             ---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             -------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence                   112234789999999987643  78899999999999999999999976

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8e-35  Score=241.71  Aligned_cols=203  Identities=23%  Similarity=0.299  Sum_probs=160.3

Q ss_pred             Ccc-hHHHhhcccceeeEeee----ccccCCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeec--CCe
Q psy14626          8 KRI-TIHEVINHKWLKMKLHT----SAEIEPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSS--EGM   79 (249)
Q Consensus         8 ~~~-~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~   79 (249)
                      +|| ++.+.++.|.++.+|..    .+......++++.... ......+.+.+|+.+++.++||||+++++++.+  ...
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            455 89999999999988543    2222222233322221 223556789999999999999999999999976  467


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +++||||+++++|.+++....     +++..++.++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.+
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~---~kl~Dfg~a  181 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL---VKIGDFGLA  181 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCGGGC
T ss_pred             EEEEEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC---EEECCcccc
Confidence            899999999999998886432     899999999999999999999999999999999999987765   999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .........          ........++..|+|||.+.+..++.++|+||||+++++|++|..||...
T Consensus       182 ~~~~~~~~~----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~  240 (318)
T 3lxp_A          182 KAVPEGHEY----------YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP  240 (318)
T ss_dssp             EECCTTCSE----------EEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred             ccccccccc----------cccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence            876553211          01112234677899999999888899999999999999999999999863

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.4e-34  Score=251.08  Aligned_cols=214  Identities=16%  Similarity=0.193  Sum_probs=167.1

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCC-CChhhhhheeecCCeE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKH-PHVVELLETYSSEGML   80 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~   80 (249)
                      |+....++|++.+.|+.|.++.+|...+......++++.....  .....+.+|+.+++.++| +++..+..++...+..
T Consensus         1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETT--CSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccc--cccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            4566788999999999999999998776544444554432222  223458899999999976 5566666666778889


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+ +++|.+++.....   .+++.+++.++.||+.||.|||+++++|+||||+|||++.+.....++|+|||++.
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEECC-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            9999999 8899998875433   38999999999999999999999999999999999999532233349999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...........      .........++..|+|||.+.+..++.++|||||||++|+|++|+.||.+
T Consensus       155 ~~~~~~~~~~~------~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~  215 (483)
T 3sv0_A          155 KYRDTSTHQHI------PYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG  215 (483)
T ss_dssp             ECBCTTTCCBC------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             eccCCcccccc------ccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence            77653321100      00112234589999999999999999999999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.4e-34  Score=242.42  Aligned_cols=211  Identities=21%  Similarity=0.316  Sum_probs=153.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC-------eE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-------ML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-------~~   80 (249)
                      ++|++.+.++.|.++.+|...+......++++... .+........+|+..+..++||||+++++++...+       .+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI-QDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEE-CCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEe-cCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            48999999999999999877665444444444322 22333456778888899999999999999996533       28


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH--HCCceeecCCCCCeeeee-cCCCCCeEEcCcc
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH--ENDIIHRDIKPHCVLLAN-KENSAPVKLGGFG  157 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH--~~~~vH~dlkp~Nili~~-~~~~~~~~l~dfg  157 (249)
                      ++||||+.+ +|...+.........+++..+..++.|++.||.+||  ++|++|+||||+||+++. ++.   ++|+|||
T Consensus       102 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~---~kl~Dfg  177 (360)
T 3e3p_A          102 NVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT---LKLCDFG  177 (360)
T ss_dssp             EEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE---EEECCCT
T ss_pred             EEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc---EEEeeCC
Confidence            899999986 565555544444555899999999999999999999  999999999999999986 444   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      ++........              .....+|+.|+|||++.+.. ++.++|+||+||++|+|++|+.||.+ +.......
T Consensus       178 ~a~~~~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  243 (360)
T 3e3p_A          178 SAKKLSPSEP--------------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE  243 (360)
T ss_dssp             TCBCCCTTSC--------------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CceecCCCCC--------------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH
Confidence            9876554221              11234788999999987654 79999999999999999999999998 44444444


Q ss_pred             HH
Q psy14626        236 IT  237 (249)
Q Consensus       236 i~  237 (249)
                      +.
T Consensus       244 ~~  245 (360)
T 3e3p_A          244 IV  245 (360)
T ss_dssp             HH
T ss_pred             HH
Confidence            44

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.3e-34  Score=246.86  Aligned_cols=201  Identities=23%  Similarity=0.330  Sum_probs=162.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC--------CCChhhhhheee---
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK--------HPHVVELLETYS---   75 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~~i~~~~~~~~---   75 (249)
                      ..+|++.+.++.|.++.+|...+......++++... ......+.+.+|+.+++.++        |+||+++++.+.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~-~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVK-SAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-SCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEe-cCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            468999999999999999987665444444444332 22345678899999999995        788999999997   


Q ss_pred             -cCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecC-------
Q psy14626         76 -SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKE-------  146 (249)
Q Consensus        76 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~-------  146 (249)
                       .+..+++|||++ +++|.+.+.....  ..+++..++.++.||+.||.|||++ |++||||||+|||++.++       
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence             556799999999 4566666655432  2389999999999999999999998 999999999999998653       


Q ss_pred             ---------------------------------------CCCCeEEcCcceeEEccCCCccccCCccccccccccCCccc
Q psy14626        147 ---------------------------------------NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIG  187 (249)
Q Consensus       147 ---------------------------------------~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (249)
                                                             ....++|+|||.+.......                ....+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------------~~~~g  255 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------------TEDIQ  255 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------------CSCCS
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------------ccCCC
Confidence                                                   11249999999997764321                12257


Q ss_pred             CCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        188 TPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       188 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      |+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~  295 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEP  295 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence            9999999999998899999999999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-34  Score=247.73  Aligned_cols=206  Identities=21%  Similarity=0.354  Sum_probs=145.8

Q ss_pred             cchH-HHhhcccceeeEeeeccc--cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheee--cCCeEEEE
Q psy14626          9 RITI-HEVINHKWLKMKLHTSAE--IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYS--SEGMLYMV   83 (249)
Q Consensus         9 ~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv   83 (249)
                      +|.+ +.+|+.|.++.+|.....  .....++++...  .......+.+|+.+|+.++||||+++++++.  ....+++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECS--SSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEEC--CCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4554 447888999999877633  223333333222  2223357889999999999999999999994  46789999


Q ss_pred             EeccCCCchhHHHHHhhhc-----CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeec-CCCCCeEEcCcc
Q psy14626         84 FEYMDGSDICFEIVRRATA-----GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANK-ENSAPVKLGGFG  157 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~-~~~~~~~l~dfg  157 (249)
                      |||+.+ +|.+.+......     ...+++..++.++.||+.||.|||++|++||||||+|||+..+ .....++|+|||
T Consensus        99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  177 (405)
T 3rgf_A           99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG  177 (405)
T ss_dssp             EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTT
T ss_pred             EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECC
Confidence            999975 787777644321     2238999999999999999999999999999999999999543 223449999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++.........          ........+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.+
T Consensus       178 ~a~~~~~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  238 (405)
T 3rgf_A          178 FARLFNSPLKP----------LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  238 (405)
T ss_dssp             CCC--------------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             CceecCCCCcc----------cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCC
Confidence            98765432110          0111223579999999999874 489999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.9e-34  Score=260.39  Aligned_cols=215  Identities=23%  Similarity=0.368  Sum_probs=169.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccC---CCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIE---PASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      .++|++.+.++.|.++.+|.......   ...++++... .......+.+.+|+.++++++||||+++++++.+ +..++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence            35788889999999998886654321   1223332222 2233456789999999999999999999999854 45899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|.+++.....   .+++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++...
T Consensus       468 v~E~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~---vkL~DFG~a~~~  541 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKF---SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYM  541 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECCCCCCCSC
T ss_pred             EEEcCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC---EEEEecCCCeec
Confidence            9999999999999875432   3899999999999999999999999999999999999998776   999999998665


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      .....            .......+++.|+|||.+.+..++.++|+||+|+++|||++ |..||.+ +..++...+.++.
T Consensus       542 ~~~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~  609 (656)
T 2j0j_A          542 EDSTY------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE  609 (656)
T ss_dssp             CC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC
T ss_pred             CCCcc------------eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC
Confidence            43221            11112235678999999998889999999999999999997 9999998 5667777777764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.8e-34  Score=239.94  Aligned_cols=214  Identities=20%  Similarity=0.342  Sum_probs=164.8

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC----
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSE----   77 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----   77 (249)
                      .++..++|++.+.++.|.++.+|...+......++++... .........+.+|+.+++.++||||+++++++...    
T Consensus         6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            4567889999999999999999877665444444443322 22334566788999999999999999999987653    


Q ss_pred             -CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         78 -GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        78 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                       ...++|||++. ++|.+++...     .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+||
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~---~kl~Df  156 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD---LKVCDF  156 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCC
T ss_pred             cceEEEEEeccC-ccHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc---EEEEec
Confidence             67999999997 5888877652     2899999999999999999999999999999999999987766   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      |.+.............   ...........+++.|+|||++.+ ..++.++|+|||||++++|++|+.||.+.
T Consensus       157 g~a~~~~~~~~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  226 (353)
T 2b9h_A          157 GLARIIDESAADNSEP---TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR  226 (353)
T ss_dssp             TTCEECC-------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccccccccCc---cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9998765432111000   000011122357899999998764 66799999999999999999999999984

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=9.9e-35  Score=243.03  Aligned_cols=204  Identities=26%  Similarity=0.424  Sum_probs=144.3

Q ss_pred             CCCCCcchH-HHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec----CC
Q psy14626          4 VDPNKRITI-HEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS----EG   78 (249)
Q Consensus         4 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~~   78 (249)
                      +...++|++ .++++.|.++.+|...+......++++.....    ..........++.++||||+++++++..    +.
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            445678888 55799999999987776655445554433221    2222233344666799999999999965    45


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+++||||+++++|.+++.....  ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++....++|+|||+
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            58999999999999999876542  2489999999999999999999999999999999999998766556699999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      +.......               .....+++.|+|||++.+..++.++|+||+|+++|+|++|..||...
T Consensus       178 ~~~~~~~~---------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          178 AKETTQNA---------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             CEEC-------------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             ceeccccc---------------cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            87655422               11234789999999998888899999999999999999999999873

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=240.25  Aligned_cols=214  Identities=22%  Similarity=0.318  Sum_probs=152.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheee--------cCC
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYS--------SEG   78 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~--------~~~   78 (249)
                      .+|++.++++.|.++.+|...+......++++..........+.+.+|+.+++++. ||||+++++++.        ...
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            48999999999999999987765555555555444445566778999999999995 999999999983        344


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      .+++||||+. ++|.+++...... ..+++.+++.++.|++.||.|||+++  ++|+||||+||+++.++.   ++|+||
T Consensus       108 ~~~lv~e~~~-g~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~---~kl~Df  182 (337)
T 3ll6_A          108 EFLLLTELCK-GQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT---IKLCDF  182 (337)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHTT-CSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC---EEBCCC
T ss_pred             eEEEEEEecC-CCHHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC---EEEecC
Confidence            5899999996 6898888654332 24899999999999999999999999  999999999999987665   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI---EDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      |.+............... ...........+++.|+|||++   .+..++.++|+||||+++|+|++|+.||..
T Consensus       183 g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQR-RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             TTCBCCSSCC--------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             ccceeccccCcccccccc-cccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            998766543221100000 0000111233478999999998   566678999999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-34  Score=236.25  Aligned_cols=230  Identities=20%  Similarity=0.368  Sum_probs=168.0

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec---------
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS---------   76 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---------   76 (249)
                      ...+|++.+.++.|.++.+|...+......++++... ......+.+.+|+.+++.++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEE-EEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEe-ccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3457888999999999998877655444444443332 234556789999999999999999999998754         


Q ss_pred             ----CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         77 ----EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        77 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                          .+.+++||||+++++|.+++.....   .++...++.++.|++.||.+||++|++|+||||+||+++.++.   ++
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~---~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENL---NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN---VK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCG---GGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcccc---ccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC---EE
Confidence                4568999999999999999876432   3788999999999999999999999999999999999987665   99


Q ss_pred             EcCcceeEEccCCCcccc-CCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC--C
Q psy14626        153 LGGFGVAIQLQDGQLYCS-GGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG--S  228 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~--~  228 (249)
                      |+|||.+........... ................+++.|+|||.+.+. .++.++|+||+|+++|+|++   ||..  +
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            999999866543211000 000000001122234578999999999865 67999999999999999998   6664  3


Q ss_pred             hHHHHHHHHcCcccccc
Q psy14626        229 RDRLFQSITKGKLHILG  245 (249)
Q Consensus       229 ~~~~~~~i~~g~~~~~~  245 (249)
                      ...+.+.+..+...+|.
T Consensus       234 ~~~~~~~~~~~~~~~~~  250 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPP  250 (303)
T ss_dssp             HHHHHHHHHSTTCCCCT
T ss_pred             HHHHHHhccccccccCc
Confidence            44567777777766664

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-34  Score=238.24  Aligned_cols=203  Identities=20%  Similarity=0.307  Sum_probs=158.6

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHH--cCCCChhhhhheeec----
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHM--LKHPHVVELLETYSS----   76 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~----   76 (249)
                      +....++|++.+.++.|.++.+|.....  ...++++...   ......+.+|.+++..  ++||||+++++++..    
T Consensus         3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~---~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~   77 (301)
T 3q4u_A            3 QRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHS   77 (301)
T ss_dssp             -CCCGGGCEEEEEEEECSSEEEEEEEET--TEEEEEEEEC---GGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred             cccccCcEEEEEeeccCCCcEEEEEEEC--CEEEEEEEec---cccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence            3456789999999999999999876553  2223332221   2345566777777777  789999999998643    


Q ss_pred             CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH--------HCCceeecCCCCCeeeeecCCC
Q psy14626         77 EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH--------ENDIIHRDIKPHCVLLANKENS  148 (249)
Q Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH--------~~~~vH~dlkp~Nili~~~~~~  148 (249)
                      ...+++||||+++++|.+++...     .+++..+..++.|++.||.|||        +.+++|+||||+||+++.++. 
T Consensus        78 ~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~-  151 (301)
T 3q4u_A           78 STQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ-  151 (301)
T ss_dssp             EEEEEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC-
T ss_pred             CceeEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC-
Confidence            34689999999999999988432     3899999999999999999999        999999999999999987665 


Q ss_pred             CCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC------CCCCcchHHHHHHHHHHHHhC-
Q psy14626        149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ------KYGKPVDIWAAGVLLHVLLTG-  221 (249)
Q Consensus       149 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~~l~el~~g-  221 (249)
                        ++|+|||++..........         ........+|+.|+|||++.+.      .++.++|+||+|+++|+|++| 
T Consensus       152 --~kl~Dfg~a~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~  220 (301)
T 3q4u_A          152 --CCIADLGLAVMHSQSTNQL---------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM  220 (301)
T ss_dssp             --EEECCCTTCEEEETTTTEE---------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             --EEEeeCCCeeecccccccc---------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhh
Confidence              9999999997765533211         1112223589999999999876      345789999999999999999 


Q ss_pred             ---------CCCCCC
Q psy14626        222 ---------TLPFVG  227 (249)
Q Consensus       222 ---------~~pf~~  227 (249)
                               +.||..
T Consensus       221 ~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          221 VSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CBTTBCCCCCCTTTT
T ss_pred             cCccccccccccccc
Confidence                     889865

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-34  Score=245.76  Aligned_cols=198  Identities=11%  Similarity=0.123  Sum_probs=145.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHc--CCCChhhhhhe-------ee
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHML--KHPHVVELLET-------YS   75 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~-------~~   75 (249)
                      +.|++.+.++.|.++.+|...+......++++   ..........+.+.+|+.+++.+  +||||++++..       +.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45889999999999999877755443334433   33333445667788997666666  59998886533       32


Q ss_pred             cC-----------------CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHH------HHHHHHHHHHHHHHHHCCcee
Q psy14626         76 SE-----------------GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA------SHYMRQVLEALRYCHENDIIH  132 (249)
Q Consensus        76 ~~-----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~------~~~~~ql~~~l~~LH~~~~vH  132 (249)
                      ..                 ..+++||||++ ++|.+++......   ++...+      ..++.|++.||.|||++|++|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV---YVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc---cchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            22                 34899999998 7999999876442   444555      677799999999999999999


Q ss_pred             ecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHH
Q psy14626        133 RDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWA  210 (249)
Q Consensus       133 ~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Diws  210 (249)
                      |||||+|||++.++.   ++|+|||++........                ...+++.|+|||++.+  ..++.++|+||
T Consensus       218 rDikp~NIll~~~~~---~kL~DFG~a~~~~~~~~----------------~~~~t~~y~aPE~~~~~~~~~~~~~DiwS  278 (371)
T 3q60_A          218 GHFTPDNLFIMPDGR---LMLGDVSALWKVGTRGP----------------ASSVPVTYAPREFLNASTATFTHALNAWQ  278 (371)
T ss_dssp             TTCSGGGEEECTTSC---EEECCGGGEEETTCEEE----------------GGGSCGGGCCHHHHTCSEEECCHHHHHHH
T ss_pred             CcCCHHHEEECCCCC---EEEEecceeeecCCCcc----------------CccCCcCCcChhhccCCCCCcCccccHHH
Confidence            999999999987766   99999999987654210                1246799999999987  67899999999


Q ss_pred             HHHHHHHHHhCCCCCCCC
Q psy14626        211 AGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       211 lG~~l~el~~g~~pf~~~  228 (249)
                      +||++|+|++|+.||.+.
T Consensus       279 lG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          279 LGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             HHHHHHHHHHSSCSTTBC
T ss_pred             HHHHHHHHHhCCCCCCCc
Confidence            999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5e-34  Score=237.24  Aligned_cols=212  Identities=24%  Similarity=0.357  Sum_probs=164.2

Q ss_pred             CCCcchHHHhhcccceeeEeeeccc-cCCCcccCChhccc--cchhHHHHHHHHHHHHHc---CCCChhhhhheee----
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAE-IEPASFGLPDERLN--HYTTEADLKREATICHML---KHPHVVELLETYS----   75 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~----   75 (249)
                      ..++|++.+.++.|.++.+|...+. .....++++.....  .......+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            3578999999999999999877653 22222333222211  122234567788887777   8999999999986    


Q ss_pred             -cCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         76 -SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        76 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                       ....+++|||++. ++|.+++......  .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~---~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC---EEEe
Confidence             5567899999997 5998888765432  3899999999999999999999999999999999999987766   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLF  233 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~  233 (249)
                      |||.+.......              ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+ +.....
T Consensus       163 Dfg~~~~~~~~~--------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  228 (326)
T 1blx_A          163 DFGLARIYSFQM--------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL  228 (326)
T ss_dssp             SCCSCCCCCGGG--------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             cCcccccccCCC--------------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence            999986543211              11223578999999999988899999999999999999999999998 444444


Q ss_pred             HHHH
Q psy14626        234 QSIT  237 (249)
Q Consensus       234 ~~i~  237 (249)
                      ..+.
T Consensus       229 ~~i~  232 (326)
T 1blx_A          229 GKIL  232 (326)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            4443

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.6e-34  Score=241.58  Aligned_cols=210  Identities=22%  Similarity=0.337  Sum_probs=167.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-CC-----ChhhhhheeecCCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-HP-----HVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~~~   81 (249)
                      .+|++.+.++.|.++.+|...+......++++... ........+.+|+.+++.++ |+     +|+++++.+...+.++
T Consensus        54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~  132 (382)
T 2vx3_A           54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC  132 (382)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEC-SSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred             eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEe-ccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence            58999999999999999877665444444443332 22344567888999999885 55     4899999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH--HCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH--ENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH--~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +|||++.+ +|.+++......  .+++..++.++.|++.||.+||  +.|++||||||+|||++.+. ...++|+|||++
T Consensus       133 lv~e~~~~-~L~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~-~~~~kL~DFG~a  208 (382)
T 2vx3_A          133 LVFEMLSY-NLYDLLRNTNFR--GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK-RSAIKIVDFGSS  208 (382)
T ss_dssp             EEEECCCC-BHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT-SCCEEECCCTTC
T ss_pred             EEEecCCC-CHHHHHhhcCcC--CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC-CCcEEEEeccCc
Confidence            99999965 998888765432  3899999999999999999999  57999999999999996422 223999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      .......                ....+|+.|+|||++.+..++.++|+|||||++|+|++|+.||.+ +..+....+.+
T Consensus       209 ~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~  272 (382)
T 2vx3_A          209 CQLGQRI----------------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVE  272 (382)
T ss_dssp             EETTCCC----------------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             eeccccc----------------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            7764421                123478899999999998999999999999999999999999998 44455555544

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.8e-34  Score=246.68  Aligned_cols=227  Identities=18%  Similarity=0.310  Sum_probs=160.0

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~   81 (249)
                      +.+.+++|.+.++++.|.++.++..... ....++++....   ...+.+.+|+.+++.+ +||||+++++++.+++.++
T Consensus        10 ~~~l~~~~~~~~~LG~G~~g~V~~~~~~-~g~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   85 (434)
T 2rio_A           10 EQSLKNLVVSEKILGYGSSGTVVFQGSF-QGRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY   85 (434)
T ss_dssp             SCSCSSCEEEEEEEEECSTTCEEEEEES-SSSEEEEEEEEG---GGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             hhhhhheeeccCeEeeCCCeEEEEEEEE-CCeEEEEEEEcH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence            4566778888899999988877643322 233334332221   2345678999999987 8999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCc---cCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC----------CC
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFV---YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE----------NS  148 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~---~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~----------~~  148 (249)
                      +||||+. ++|.+++.........   .++..+..++.|++.||.|||++|++|+||||+||+++.++          ..
T Consensus        86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence            9999996 5999998765432111   12334578999999999999999999999999999997642          23


Q ss_pred             CCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-------CCCCCcchHHHHHHHHHHHHh-
Q psy14626        149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-------QKYGKPVDIWAAGVLLHVLLT-  220 (249)
Q Consensus       149 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~-  220 (249)
                      ..++|+|||++.........         ..+......+|+.|+|||++.+       ..++.++|+||+||++|+|++ 
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~  235 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSS---------FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK  235 (434)
T ss_dssp             CEEEECCCTTCEECCC-----------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             eEEEEcccccceecCCCCcc---------ceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhC
Confidence            35999999999876543210         0111223358999999999875       567899999999999999999 


Q ss_pred             CCCCCCCChHHHHHHHHcCccccc
Q psy14626        221 GTLPFVGSRDRLFQSITKGKLHIL  244 (249)
Q Consensus       221 g~~pf~~~~~~~~~~i~~g~~~~~  244 (249)
                      |..||....... ..+.++...++
T Consensus       236 g~~Pf~~~~~~~-~~i~~~~~~~~  258 (434)
T 2rio_A          236 GKHPFGDKYSRE-SNIIRGIFSLD  258 (434)
T ss_dssp             SCCTTCSTTTHH-HHHHHTCCCCC
T ss_pred             CCCCCCCchhhH-HHHhcCCCCcc
Confidence            999998743222 34455554443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.7e-34  Score=240.93  Aligned_cols=204  Identities=23%  Similarity=0.360  Sum_probs=160.3

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe-----
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM-----   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----   79 (249)
                      .++|.+.+.++.|.++.+|...+......++++...  .......+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            478999999999999999877655444344433222  2233456788999999999999999999999976653     


Q ss_pred             -EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         80 -LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        80 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                       +++|||++. ++|.+.+..      .+++..+..++.|++.||.+||++|++|+||||+||+++.++.   ++|+|||.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~---~kl~Dfg~  172 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE---LKILDFGL  172 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC---EEECSTTC
T ss_pred             eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc---EEEeeccc
Confidence             599999997 488665532      2899999999999999999999999999999999999987766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      +......                .....+++.|+|||.+.+ ..++.++|+||+|+++++|++|+.||.+ +..+....+
T Consensus       173 ~~~~~~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i  236 (353)
T 3coi_A          173 ARHADAE----------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI  236 (353)
T ss_dssp             TTC------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHH
T ss_pred             ccCCCCC----------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            8543321                112247899999999877 6679999999999999999999999998 433344443

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.5e-34  Score=254.25  Aligned_cols=207  Identities=26%  Similarity=0.368  Sum_probs=166.4

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeec------CCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSS------EGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~   79 (249)
                      ..+|++.+.++.|.++.+|...+......++++.... ......+.+.+|+.+++.++||||+++++++..      ++.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            4689999999999999988766554433344332221 234556789999999999999999999998765      667


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .++||||++|++|.+++..... ...+++..++.++.|++.||.|||++|++|+||||+||+++.++....++|+|||.+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            8999999999999998875432 224889999999999999999999999999999999999997766566899999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .......              ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...
T Consensus       172 ~~~~~~~--------------~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~  226 (676)
T 3qa8_A          172 KELDQGE--------------LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN  226 (676)
T ss_dssp             CBTTSCC--------------CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccc--------------ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence            7654422              112235789999999999999999999999999999999999999763

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8e-34  Score=240.21  Aligned_cols=201  Identities=23%  Similarity=0.374  Sum_probs=162.3

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-----------CCChhhhhheee
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-----------HPHVVELLETYS   75 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~   75 (249)
                      ..+|++.+.++.|.++.+|...+......++++... ......+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-SCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEec-CCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            468999999999999999877765444444443322 23345677899999999986           789999999997


Q ss_pred             cCC----eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecC---C
Q psy14626         76 SEG----MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKE---N  147 (249)
Q Consensus        76 ~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~---~  147 (249)
                      ..+    .+++|||++ +++|.+++......  .++...+..++.||+.||.+||++ |++|+||||+||+++.++   .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR--GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhcc--CCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence            543    789999999 78999988764432  389999999999999999999998 999999999999997543   1


Q ss_pred             CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        148 SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       148 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...++|+|||++.......                ....+|+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus       174 ~~~~kl~Dfg~a~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEHY----------------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             EEEEEECCCTTCEETTBCC----------------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             cceEEEcccccccccCCCC----------------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            2348999999987654321                122478999999999998899999999999999999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-33  Score=234.75  Aligned_cols=199  Identities=18%  Similarity=0.292  Sum_probs=153.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc--CCCChhhhhheeecC----CeE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML--KHPHVVELLETYSSE----GML   80 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~   80 (249)
                      .++|++.+.++.|.++.+|.....  ...++++...   ........+|..++..+  +||||+++++++...    ..+
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~---~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEE---GGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEe---ccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            458999999999999998876654  2223332221   22334555666666655  899999999999776    789


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC--------CceeecCCCCCeeeeecCCCCCeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN--------DIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~--------~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      ++||||+++++|.+++...     .+++..+..++.|++.||.|||++        +++|+||||+||+++.++.   ++
T Consensus       111 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~---~k  182 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT---CC  182 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC---EE
T ss_pred             EEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC---EE
Confidence            9999999999999998643     289999999999999999999998        9999999999999987665   99


Q ss_pred             EcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCc------chHHHHHHHHHHHHhC-----
Q psy14626        153 LGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKP------VDIWAAGVLLHVLLTG-----  221 (249)
Q Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~~l~el~~g-----  221 (249)
                      |+|||.+.........         .........+|+.|+|||++.+......      +|+|||||++|||++|     
T Consensus       183 l~Dfg~a~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~  253 (337)
T 3mdy_A          183 IADLGLAVKFISDTNE---------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG  253 (337)
T ss_dssp             ECCCTTCEECC------------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EEeCCCceeecccccc---------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence            9999998766543211         0111223458999999999987766555      9999999999999999     


Q ss_pred             -----CCCCCC
Q psy14626        222 -----TLPFVG  227 (249)
Q Consensus       222 -----~~pf~~  227 (249)
                           +.||..
T Consensus       254 ~~~~~~~p~~~  264 (337)
T 3mdy_A          254 IVEEYQLPYHD  264 (337)
T ss_dssp             BCCCCCCTTTT
T ss_pred             ccccccccHhh
Confidence                 778765

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-34  Score=237.15  Aligned_cols=201  Identities=23%  Similarity=0.407  Sum_probs=162.3

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhc---ccc---chhHHHHHHHHHHHHHcC--CCChhhhhheeecC
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LNH---YTTEADLKREATICHMLK--HPHVVELLETYSSE   77 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~   77 (249)
                      ...+|++.+.++.|.++.+|...+......++++...   ...   ....+.+.+|+.+++.++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3568999999999999999877654443333333222   111   123356788999999996  59999999999999


Q ss_pred             CeEEEEEeccCC-CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeee-ecCCCCCeEEcC
Q psy14626         78 GMLYMVFEYMDG-SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLA-NKENSAPVKLGG  155 (249)
Q Consensus        78 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~-~~~~~~~~~l~d  155 (249)
                      +..++|+|++.+ ++|.+++.....    +++..++.++.|++.||.+||+++++|+||||+||+++ .++.   ++|+|
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~---~kL~D  193 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE---LKLID  193 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTE---EEECC
T ss_pred             CcEEEEEEcCCCCccHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCC---EEEee
Confidence            999999999975 799998876543    89999999999999999999999999999999999998 4444   99999


Q ss_pred             cceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ||.+........               ....+++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...
T Consensus       194 fg~~~~~~~~~~---------------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          194 FGSGALLKDTVY---------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             CTTCEECCSSCB---------------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             Cccccccccccc---------------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            999877654221               12247899999999887665 68899999999999999999999763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-34  Score=236.09  Aligned_cols=200  Identities=22%  Similarity=0.394  Sum_probs=154.7

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccc------hhHHHHHHHHHHHHHc----CCCChhhhhheeec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHY------TTEADLKREATICHML----KHPHVVELLETYSS   76 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~E~~~l~~l----~h~~i~~~~~~~~~   76 (249)
                      .++|++.+.++.|.++.+|...+......++++.......      .....+.+|+.+++++    +||||+++++++..
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            4589999999999999998776554443344332221111      2334567899999999    89999999999999


Q ss_pred             CCeEEEEEec-cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeee-ecCCCCCeEEc
Q psy14626         77 EGMLYMVFEY-MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLA-NKENSAPVKLG  154 (249)
Q Consensus        77 ~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~-~~~~~~~~~l~  154 (249)
                      .+..++|+|+ +.+++|.+++.....    +++..++.++.|++.||.+||++|++|+||||+||+++ .++.   ++|+
T Consensus       110 ~~~~~~v~e~~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~---~kl~  182 (312)
T 2iwi_A          110 QEGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC---AKLI  182 (312)
T ss_dssp             ---CEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE---EEEC
T ss_pred             CCeEEEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe---EEEE
Confidence            8899999999 788999999877543    89999999999999999999999999999999999998 4444   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      |||.+........               ....++..|+|||++.+..+ +.++|+||+|+++++|++|+.||...
T Consensus       183 dfg~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  242 (312)
T 2iwi_A          183 DFGSGALLHDEPY---------------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD  242 (312)
T ss_dssp             CCSSCEECCSSCB---------------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             EcchhhhcccCcc---------------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence            9999877654221               12347899999999887665 45899999999999999999999763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.6e-33  Score=231.11  Aligned_cols=200  Identities=23%  Similarity=0.365  Sum_probs=156.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcC--CCChhhhhheeecCCeEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLK--HPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~l   82 (249)
                      +++|++.+.++.|.++.+|...+.. ...++++...  .......+.+.+|+.+++.++  ||||+++++++...+..++
T Consensus        27 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           27 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             cceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            4689999999999999998766543 3333333222  223455678999999999996  5999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||| +.+++|.+++....    .+++..++.++.|++.||.+||+++++|+||||+||+++. +.   ++|+|||.+...
T Consensus       106 v~e-~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~---~kL~Dfg~~~~~  176 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GM---LKLIDFGIANQM  176 (313)
T ss_dssp             EEC-CCSEEHHHHHHHCS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TE---EEECCCSSSCC-
T ss_pred             EEe-cCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-Ce---EEEeeccccccc
Confidence            999 45779999987654    3899999999999999999999999999999999999964 33   999999998655


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCcccccc-----------CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-----------QKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ......           .......+++.|+|||.+.+           ..++.++|+||||+++++|++|..||..
T Consensus       177 ~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          177 QPDTTS-----------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             ------------------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cCcccc-----------ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence            432210           11122357899999999875           4578899999999999999999999987

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.8e-33  Score=229.16  Aligned_cols=213  Identities=21%  Similarity=0.320  Sum_probs=148.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|...+......++++.....  .....+.+..+..+++.++||||+++++++.+++.+++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e  104 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAME  104 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEe
Confidence            4778888999999988887766544444444332221  12223344555567888899999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |+ ++.+........   ..+++..+..++.|++.||.+||++ |++|+||||+||+++.++.   ++|+|||.+.....
T Consensus       105 ~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~---~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          105 LM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVD  177 (318)
T ss_dssp             CC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC---EEECCCTTC-----
T ss_pred             cc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC---EEEEECCCchhccC
Confidence            99 545554443322   2389999999999999999999996 9999999999999987766   99999999865543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHH
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSIT  237 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i~  237 (249)
                      ...              .....+++.|+|||++.     +..++.++|+||+|+++++|++|+.||..  ...++...+.
T Consensus       178 ~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  243 (318)
T 2dyl_A          178 DKA--------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL  243 (318)
T ss_dssp             -----------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             Ccc--------------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHh
Confidence            221              11224789999999984     45678899999999999999999999987  3445555665


Q ss_pred             cCcc
Q psy14626        238 KGKL  241 (249)
Q Consensus       238 ~g~~  241 (249)
                      .+..
T Consensus       244 ~~~~  247 (318)
T 2dyl_A          244 QEEP  247 (318)
T ss_dssp             HSCC
T ss_pred             ccCC
Confidence            5543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.9e-33  Score=232.25  Aligned_cols=210  Identities=20%  Similarity=0.311  Sum_probs=162.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHH--cCCCChhhhhheeecCC----eEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHM--LKHPHVVELLETYSSEG----MLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~   81 (249)
                      ++|++.+.++.|.++.+|.....  ...++++..   .......+.+|+.+++.  ++||||+++++++....    .++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~---~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEE---CGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEe---CchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            57888899999998888876553  222333221   12345678889999988  68999999999998765    799


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH--------HCCceeecCCCCCeeeeecCCCCCeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH--------ENDIIHRDIKPHCVLLANKENSAPVKL  153 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH--------~~~~vH~dlkp~Nili~~~~~~~~~~l  153 (249)
                      +||||+++++|.+++...     .+++.++..++.|++.||.+||        +.+++|+||||+||+++.++.   ++|
T Consensus       117 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~---~kL  188 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCI  188 (342)
T ss_dssp             EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC---EEE
T ss_pred             EEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC---EEE
Confidence            999999999999998653     2899999999999999999999        899999999999999987765   999


Q ss_pred             cCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC------CCCcchHHHHHHHHHHHHhC------
Q psy14626        154 GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK------YGKPVDIWAAGVLLHVLLTG------  221 (249)
Q Consensus       154 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g------  221 (249)
                      +|||.+..........         ........+++.|+|||.+.+..      ++.++|+||||+++|+|++|      
T Consensus       189 ~Dfg~~~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTI---------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             CCCTTCEEEETTTTEE---------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             EECCCceecccccccc---------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            9999987765532110         01122335899999999987653      23689999999999999999      


Q ss_pred             ----CCCCCCC------hHHHHHHHHcC
Q psy14626        222 ----TLPFVGS------RDRLFQSITKG  239 (249)
Q Consensus       222 ----~~pf~~~------~~~~~~~i~~g  239 (249)
                          ..||...      .+.+.+.+..+
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~  287 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQ  287 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTS
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHH
Confidence                7899762      24455555443

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.7e-33  Score=230.78  Aligned_cols=203  Identities=25%  Similarity=0.307  Sum_probs=142.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHH-HHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREAT-ICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .++|++.+.++.|.++.+|..........++++..... .......+.+|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            35889999999999999987766544444444332221 2233445666665 677779999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhh-cCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         85 EYMDGSDICFEIVRRAT-AGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||+.+ +|.+++..... ....+++..+..++.|++.||.+||+. |++|+||||+||+++.++.   ++|+|||.+...
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~---~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE---EEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC---EEEccCCCceec
Confidence            99975 77777654222 133489999999999999999999998 9999999999999987766   999999998655


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCcccc----ccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI----EDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....              .....+++.|+|||++    .+..++.++|+||||+++++|++|+.||.+
T Consensus       177 ~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          177 VDSIA--------------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             -------------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             ccccc--------------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            43211              1112478999999998    456688999999999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.98  E-value=5e-33  Score=240.03  Aligned_cols=204  Identities=20%  Similarity=0.281  Sum_probs=149.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      .+|.+.++++.|.++.++..... ....++++.....   ....+.+|+.+++.+ +||||+++++++.+....++|||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~-~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEES-SSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEe-CCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            36888899999988875433222 2222333222111   112356899999999 799999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC--CCCeEEcCcceeEEccC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN--SAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~--~~~~~l~dfg~~~~~~~  164 (249)
                      +. ++|.+++......   +....+..++.|++.||.|||++|++||||||+||+++.++.  ..+++|+|||++.....
T Consensus       100 ~~-g~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 5998888755432   445566789999999999999999999999999999964332  23478999999976653


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccc---cCCCCCcchHHHHHHHHHHHHh-CCCCCCCCh
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLT-GTLPFVGSR  229 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~~l~el~~-g~~pf~~~~  229 (249)
                      ....          ........+|+.|+|||++.   +..++.++||||+||++++|++ |..||....
T Consensus       176 ~~~~----------~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~  234 (432)
T 3p23_A          176 GRHS----------FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL  234 (432)
T ss_dssp             --------------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT
T ss_pred             CCcc----------eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh
Confidence            2210          01112235899999999987   4556889999999999999999 999998743

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.98  E-value=2e-33  Score=234.67  Aligned_cols=202  Identities=20%  Similarity=0.327  Sum_probs=148.5

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHH--HHHcCCCChhhhhheee-----cCCe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATI--CHMLKHPHVVELLETYS-----SEGM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~~i~~~~~~~~-----~~~~   79 (249)
                      -++|++.+.++.|.++.+|.....  ...++++...   ......+..|..+  +..++||||+++++.+.     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~---~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFS---FANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET--TEEEEEEEEE---GGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC--CeEEEEEEee---ccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            358999999999999999876442  2223332222   1233444455554  44579999999997542     2346


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC---------CceeecCCCCCeeeeecCCCCC
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN---------DIIHRDIKPHCVLLANKENSAP  150 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---------~~vH~dlkp~Nili~~~~~~~~  150 (249)
                      +++||||+++++|.+++....     .++..+..++.|++.||.|||++         +++|+||||+|||++.++.   
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~---  158 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT---  158 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC---
T ss_pred             EEEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc---
Confidence            799999999999999986543     58899999999999999999999         9999999999999987665   


Q ss_pred             eEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-------CCCCCcchHHHHHHHHHHHHhCCC
Q psy14626        151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-------QKYGKPVDIWAAGVLLHVLLTGTL  223 (249)
Q Consensus       151 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~~l~el~~g~~  223 (249)
                      ++|+|||++............     ..........+|+.|+|||++.+       ..++.++|||||||++|||++|..
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~  233 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPG-----EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT  233 (336)
T ss_dssp             EEECCCTTCEECSSSSCC--------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred             EEEeeccceeecccccccCcc-----ccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence            999999999876543221110     00111223358999999999986       345678999999999999999866


Q ss_pred             CCC
Q psy14626        224 PFV  226 (249)
Q Consensus       224 pf~  226 (249)
                      ||.
T Consensus       234 p~~  236 (336)
T 3g2f_A          234 DLF  236 (336)
T ss_dssp             GGS
T ss_pred             cCC
Confidence            553

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.98  E-value=4.8e-33  Score=252.76  Aligned_cols=192  Identities=22%  Similarity=0.295  Sum_probs=155.6

Q ss_pred             CcchHHHhhcccceeeEeeecccc-CCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe-----E
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI-EPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM-----L   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~   80 (249)
                      .+|++.+.++.|.++.+|...+.. ....++++... .......+.+.+|+.+++.++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999998776543 22223333221 2233556788999999999999999999999976654     7


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      |+||||++|++|.+.+..      .+++.+++.++.|++.||.|||++|++|+||||+||+++.+ .   ++|+|||++.
T Consensus       160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~---~kl~DFG~a~  229 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-Q---LKLIDLGAVS  229 (681)
T ss_dssp             EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-C---EEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-c---EEEEecccch
Confidence            999999999999876643      38999999999999999999999999999999999999864 3   9999999997


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .....                 ....+|+.|+|||++.+.. +.++|||||||++++|++|..||.+
T Consensus       230 ~~~~~-----------------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          230 RINSF-----------------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             ETTCC-----------------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             hcccC-----------------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence            76542                 1234899999999987764 8899999999999999999998875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.98  E-value=8.3e-34  Score=237.26  Aligned_cols=195  Identities=17%  Similarity=0.178  Sum_probs=154.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc--------cchhHHHHHHHHHHHHHcC---------------
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--------HYTTEADLKREATICHMLK---------------   63 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~E~~~l~~l~---------------   63 (249)
                      .++|++.+.++.|.++.+|...+.  ...++++.....        .....+.+.+|+.+++.++               
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET--TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEeC--CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            357999999999999998877652  223333322211        2334578999999999997               


Q ss_pred             -----------CCChhhhhheeec-------------CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHH
Q psy14626         64 -----------HPHVVELLETYSS-------------EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVL  119 (249)
Q Consensus        64 -----------h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~  119 (249)
                                 ||||++++++|.+             .+.+++||||+++|++.+.+..     ..+++.+++.++.|++
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence                       7888888888875             7789999999998876555532     2389999999999999


Q ss_pred             HHHHHHH-HCCceeecCCCCCeeeeecCC-----------------CCCeEEcCcceeEEccCCCccccCCccccccccc
Q psy14626        120 EALRYCH-ENDIIHRDIKPHCVLLANKEN-----------------SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTK  181 (249)
Q Consensus       120 ~~l~~LH-~~~~vH~dlkp~Nili~~~~~-----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~  181 (249)
                      .||.||| +++++||||||+|||++.++.                 ...++|+|||+++......               
T Consensus       172 ~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~---------------  236 (336)
T 2vuw_A          172 ASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGI---------------  236 (336)
T ss_dssp             HHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTE---------------
T ss_pred             HHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCc---------------
Confidence            9999999 999999999999999998751                 1249999999997665421               


Q ss_pred             cCCcccCCCCCCccccccCCCCCcchHHHHHHH-HHHHHhCCCCCCC
Q psy14626        182 AGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVL-LHVLLTGTLPFVG  227 (249)
Q Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~-l~el~~g~~pf~~  227 (249)
                         ..+|+.|+|||++.+.. +.++||||++++ .++++.|..||.+
T Consensus       237 ---~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~  279 (336)
T 2vuw_A          237 ---VVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN  279 (336)
T ss_dssp             ---EECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred             ---EEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence               25899999999998776 889999998777 6678889999965

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=5.7e-32  Score=221.45  Aligned_cols=171  Identities=14%  Similarity=0.028  Sum_probs=141.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCC---cccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPA---SFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      .||++.+.++.|.++.+|...+.....   .+.+...........+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            589999999999999988776654333   33333333333455688999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++...      ....++..++.|++.||.|||++|++|+||||+||+++.++.   ++|++++.      
T Consensus       111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~---~kl~~~~~------  175 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD---VVLAYPAT------  175 (286)
T ss_dssp             ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC---EEECSCCC------
T ss_pred             EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC---EEEEeccc------
Confidence            999999999988431      356678899999999999999999999999999999987776   78774322      


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                                                 ++       .++.++|+|||||++|+|++|+.||.+
T Consensus       176 ---------------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~  204 (286)
T 3uqc_A          176 ---------------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPE  204 (286)
T ss_dssp             ---------------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred             ---------------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                                       22       257899999999999999999999987

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.97  E-value=4.1e-31  Score=217.46  Aligned_cols=178  Identities=29%  Similarity=0.500  Sum_probs=143.6

Q ss_pred             CcchHH-HhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHH-HHcCCCChhhhhheeec----CCeEE
Q psy14626          8 KRITIH-EVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATIC-HMLKHPHVVELLETYSS----EGMLY   81 (249)
Q Consensus         8 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~~i~~~~~~~~~----~~~~~   81 (249)
                      .+|.+. ++++.|.++.+|...+......++++...     ....+.+|+.++ +.++||||+++++++..    ...++
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-----~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE-----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEec-----ccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            356665 77898999888877665444444444332     235677899888 55589999999999976    66799


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++++|.+++.....  ..+++..++.++.|++.||.|||++|++|+||||+||+++.++....++|+|||++..
T Consensus        92 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            99999999999999876543  2489999999999999999999999999999999999998744344599999998754


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...                                   ..++.++|+||+||++|+|++|+.||.+
T Consensus       170 ~~~-----------------------------------~~~~~~~DiwslG~il~el~tg~~pf~~  200 (299)
T 3m2w_A          170 TTG-----------------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYS  200 (299)
T ss_dssp             CTT-----------------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccc-----------------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            322                                   2356889999999999999999999976

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=1.2e-31  Score=230.37  Aligned_cols=200  Identities=15%  Similarity=0.152  Sum_probs=147.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc---cccchhHHHHHHHHHHHHHcCC-CChhhhhhe----------
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER---LNHYTTEADLKREATICHMLKH-PHVVELLET----------   73 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~----------   73 (249)
                      +.++.+++|+.|.++.+|...+......++++...   .......+.+.+|+.+++.++| ++.......          
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            34778889999999999987755444444444322   2223346789999999999976 443333222          


Q ss_pred             -----------eec-----CCeEEEEEeccCCCchhHHHHHh---hhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeec
Q psy14626         74 -----------YSS-----EGMLYMVFEYMDGSDICFEIVRR---ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRD  134 (249)
Q Consensus        74 -----------~~~-----~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~d  134 (249)
                                 +..     ...++++|+++ +++|.+++...   ......+++..++.++.|++.||.|||++|++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence                       111     12467888877 56898887532   12233478889999999999999999999999999


Q ss_pred             CCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCcccc----------ccCCCCC
Q psy14626        135 IKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI----------EDQKYGK  204 (249)
Q Consensus       135 lkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~  204 (249)
                      |||+|||++.++.   ++|+|||++......                .....+ +.|+|||++          .+..++.
T Consensus       237 iKp~NILl~~~~~---~kL~DFG~a~~~~~~----------------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~  296 (413)
T 3dzo_A          237 LRPVDIVLDQRGG---VFLTGFEHLVRDGAS----------------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTF  296 (413)
T ss_dssp             CCGGGEEECTTCC---EEECCGGGCEETTEE----------------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECH
T ss_pred             cccceEEEecCCe---EEEEeccceeecCCc----------------cccCCC-CceeCchhhhccccccccccCcCCCc
Confidence            9999999988776   999999998765431                112246 899999998          5555788


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        205 PVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       205 ~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ++|+|||||++|+|++|+.||.+.
T Consensus       297 ~~DvwSlGvil~elltg~~Pf~~~  320 (413)
T 3dzo_A          297 AFDTWTLGLAIYWIWCADLPNTDD  320 (413)
T ss_dssp             HHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred             hhhHHHHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.6e-32  Score=240.48  Aligned_cols=152  Identities=13%  Similarity=0.122  Sum_probs=113.0

Q ss_pred             chhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHH
Q psy14626         46 YTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRY  124 (249)
Q Consensus        46 ~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~  124 (249)
                      ..+.++|.+|+++|+++ .|+||+++++++++++.+||||||++|++|.+++.....    ++..   .++.||+.||.|
T Consensus       282 ~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~----l~~~---~I~~QIl~AL~y  354 (569)
T 4azs_A          282 QRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE----IDRE---KILGSLLRSLAA  354 (569)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC----CCHH---HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC----CCHH---HHHHHHHHHHHH
Confidence            35567899999999999 799999999999999999999999999999999976543    6654   478999999999


Q ss_pred             HHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCC
Q psy14626        125 CHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGK  204 (249)
Q Consensus       125 LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  204 (249)
                      +|++|||||||||+|||++.++.   +||+|||+++......             +......||+.|+|||++.+. +..
T Consensus       355 lH~~GIIHRDIKPeNILL~~dg~---vKL~DFGlAr~~~~~~-------------~~~~t~vGTp~YmAPE~l~g~-~~~  417 (569)
T 4azs_A          355 LEKQGFWHDDVRPWNVMVDARQH---ARLIDFGSIVTTPQDC-------------SWPTNLVQSFFVFVNELFAEN-KSW  417 (569)
T ss_dssp             HHHTTCEESCCCGGGEEECTTSC---EEECCCTTEESCC----------------CCSHHHHHHHHHHHHHHC-------
T ss_pred             HHHCCceeccCchHhEEECCCCC---EEEeecccCeeCCCCC-------------ccccCceechhhccHHHhCCC-CCC
Confidence            99999999999999999988776   9999999997654322             122234689999999999865 467


Q ss_pred             cchHHHHHHHHHHHHhC
Q psy14626        205 PVDIWAAGVLLHVLLTG  221 (249)
Q Consensus       205 ~~DiwslG~~l~el~~g  221 (249)
                      ++|+||+|++++++.++
T Consensus       418 ~~d~~s~g~~~~~l~~~  434 (569)
T 4azs_A          418 NGFWRSAPVHPFNLPQP  434 (569)
T ss_dssp             -----------CCCCTT
T ss_pred             cccccccccchhhhccc
Confidence            89999999987765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=1.2e-25  Score=198.69  Aligned_cols=193  Identities=16%  Similarity=0.087  Sum_probs=134.6

Q ss_pred             hHHHhhcccceeeEeeecccc-CCCcccCCh-----hccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626         11 TIHEVINHKWLKMKLHTSAEI-EPASFGLPD-----ERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ...++++.|.++.+|.....- .++.+....     .........+.+.+|+.++++++||||+++..++...+..++||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            446688999999988553221 111111111     11122233567899999999999999997666666667789999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||++|++|.+++..            +..++.|++.+|.|||+++++||||||+|||++.     .++|+|||+++....
T Consensus       419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~-----~~kL~DFGla~~~~~  481 (540)
T 3en9_A          419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK-----DLYIIDFGLGKISNL  481 (540)
T ss_dssp             ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-----SEEECCCTTCEECCC
T ss_pred             ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-----eEEEEECccCEECCC
Confidence            99999999888754            4579999999999999999999999999999976     399999999987755


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED--QKYGKPVDIWAAGVLLHVLLTGTLPFV  226 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~pf~  226 (249)
                      ......      ..........+|+.|+|||++.+  ..++..+|+||..+-..+...++.+|.
T Consensus       482 ~~~~~~------~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAV------DLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHH------HHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cccccc------chhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            221000      00001122358999999999986  557778899999988888887777764

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.83  E-value=2.1e-21  Score=158.30  Aligned_cols=134  Identities=13%  Similarity=0.152  Sum_probs=99.4

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccc------------------hhHHHHHHHHHHHHHcCCCChhh
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHY------------------TTEADLKREATICHMLKHPHVVE   69 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~E~~~l~~l~h~~i~~   69 (249)
                      ..|.+.+.++.|.++.+|.... .....++++.......                  .....+.+|+.+++.++  | ++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~  165 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA  165 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence            3455568899999888887665 2222333332221110                  24677999999999999  5 77


Q ss_pred             hhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCC
Q psy14626         70 LLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus        70 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~  149 (249)
                      +.+.+.. +..++||||++|++|.+ +.        .  .....++.|++.||.+||++|++|+||||+|||++ ++.  
T Consensus       166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~--  230 (282)
T 1zar_A          166 VPKVYAW-EGNAVLMELIDAKELYR-VR--------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG--  230 (282)
T ss_dssp             SCCEEEE-ETTEEEEECCCCEEGGG-CC--------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE--
T ss_pred             cCeEEec-cceEEEEEecCCCcHHH-cc--------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc--
Confidence            7776654 44699999999999976 31        1  23456999999999999999999999999999998 555  


Q ss_pred             CeEEcCcceeEE
Q psy14626        150 PVKLGGFGVAIQ  161 (249)
Q Consensus       150 ~~~l~dfg~~~~  161 (249)
                       ++|+|||.+..
T Consensus       231 -vkl~DFG~a~~  241 (282)
T 1zar_A          231 -IWIIDFPQSVE  241 (282)
T ss_dssp             -EEECCCTTCEE
T ss_pred             -EEEEECCCCeE
Confidence             99999999843

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.64  E-value=4.9e-17  Score=130.76  Aligned_cols=138  Identities=13%  Similarity=0.052  Sum_probs=93.9

Q ss_pred             cchHHHhhcccceeeEeeeccc---cC--CCcccCChh--ccc-------------------cchhHHHHHHHHHHHHHc
Q psy14626          9 RITIHEVINHKWLKMKLHTSAE---IE--PASFGLPDE--RLN-------------------HYTTEADLKREATICHML   62 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~--~~~-------------------~~~~~~~~~~E~~~l~~l   62 (249)
                      .|.+...++.|.++.+|.....   ..  ++.+.....  ...                   .......+.+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            4566778888888888876552   12  222221111  110                   011234789999999999


Q ss_pred             CCCCh--hhhhheeecCCeEEEEEeccCC-C----chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH-HCCceeec
Q psy14626         63 KHPHV--VELLETYSSEGMLYMVFEYMDG-S----DICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH-ENDIIHRD  134 (249)
Q Consensus        63 ~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH-~~~~vH~d  134 (249)
                      .|+++  +.++..    ...++||||+.+ |    +|.+....       .++..+..++.|++.+|.+|| +.|++|+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~givHrD  196 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAELVHAD  196 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence            87754  333321    246899999942 3    56554321       234567789999999999999 99999999


Q ss_pred             CCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        135 IKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       135 lkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      |||+|||++.     .++|+|||.+...
T Consensus       197 lkp~NILl~~-----~~~liDFG~a~~~  219 (258)
T 1zth_A          197 LSEYNIMYID-----KVYFIDMGQAVTL  219 (258)
T ss_dssp             CSTTSEEESS-----SEEECCCTTCEET
T ss_pred             CCHHHEEEcC-----cEEEEECcccccC
Confidence            9999999976     3999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.42  E-value=7.6e-14  Score=117.42  Aligned_cols=145  Identities=9%  Similarity=0.042  Sum_probs=89.7

Q ss_pred             cchHHHhhcccceeeEeeecccc--CCCcccCChhccc-----------cchhHHHHHHHHHHHHHcCCCChhhhhheee
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEI--EPASFGLPDERLN-----------HYTTEADLKREATICHMLKHPHVVELLETYS   75 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   75 (249)
                      -|+++..|+.|.++.+|...+..  .++.+........           .........+++.++....|+|+.+++....
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            47888889999999998765542  2222221111100           0011222233333333344555555544332


Q ss_pred             cCC------eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCC-
Q psy14626         76 SEG------MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS-  148 (249)
Q Consensus        76 ~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~-  148 (249)
                      .-.      ..++||||++|.+|....          .......++.|++.++.+||..|+|||||||.|||++.++.. 
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~----------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVS----------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCC----------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhc----------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            111      136999999998875321          122345688999999999999999999999999999876531 


Q ss_pred             ------CCeEEcCcceeEEcc
Q psy14626        149 ------APVKLGGFGVAIQLQ  163 (249)
Q Consensus       149 ------~~~~l~dfg~~~~~~  163 (249)
                            ..+.|+||+-+....
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccceEEEEeCCcccCC
Confidence                  127899999776544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.19  E-value=1.2e-11  Score=99.15  Aligned_cols=100  Identities=17%  Similarity=0.186  Sum_probs=78.9

Q ss_pred             HHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH
Q psy14626         49 EADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE  127 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~  127 (249)
                      ...+.+|+.+++.+. +..++++++++...+..++|||+++|.+|.+...         +......++.++..++..||+
T Consensus        53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~  123 (263)
T 3tm0_A           53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHS  123 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhC
Confidence            346899999999994 6778899999988889999999999988865421         122234678899999999998


Q ss_pred             -----------------------------------------------------------CCceeecCCCCCeeeeecCCC
Q psy14626        128 -----------------------------------------------------------NDIIHRDIKPHCVLLANKENS  148 (249)
Q Consensus       128 -----------------------------------------------------------~~~vH~dlkp~Nili~~~~~~  148 (249)
                                                                                 ..++|+|++|.||+++.+.  
T Consensus       124 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~--  201 (263)
T 3tm0_A          124 IDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK--  201 (263)
T ss_dssp             SCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE--
T ss_pred             CCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc--
Confidence                                                                       3489999999999996532  


Q ss_pred             CCeEEcCcceeE
Q psy14626        149 APVKLGGFGVAI  160 (249)
Q Consensus       149 ~~~~l~dfg~~~  160 (249)
                       .+.|+||+.+.
T Consensus       202 -~~~lIDwe~a~  212 (263)
T 3tm0_A          202 -VSGFIDLGRSG  212 (263)
T ss_dssp             -EEEECCCTTCE
T ss_pred             -EEEEEEchhcc
Confidence             25799998763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.89  E-value=1.6e-09  Score=90.70  Aligned_cols=107  Identities=14%  Similarity=0.192  Sum_probs=82.4

Q ss_pred             HHHHHHHHHHHHHcC--CCChhhhhheeecC---CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHH
Q psy14626         49 EADLKREATICHMLK--HPHVVELLETYSSE---GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALR  123 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~  123 (249)
                      ...+.+|+.+++.+.  +..+++++..+.+.   +..++|||+++|..+.+..      ...++..+...++.++...|.
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La  153 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIA  153 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHH
Confidence            457889999999996  45678888888766   4589999999987764311      112678888889999999999


Q ss_pred             HHHH----------------------------------------------------------CCceeecCCCCCeeeeec
Q psy14626        124 YCHE----------------------------------------------------------NDIIHRDIKPHCVLLANK  145 (249)
Q Consensus       124 ~LH~----------------------------------------------------------~~~vH~dlkp~Nili~~~  145 (249)
                      .||.                                                          ..++|+|++|.||+++.+
T Consensus       154 ~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~  233 (359)
T 3dxp_A          154 AMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT  233 (359)
T ss_dssp             HHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS
T ss_pred             HHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC
Confidence            9997                                                          358999999999999865


Q ss_pred             CCCCCeEEcCcceeEEc
Q psy14626        146 ENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       146 ~~~~~~~l~dfg~~~~~  162 (249)
                      +. ..+.++||+.+...
T Consensus       234 ~~-~v~~viDwe~a~~g  249 (359)
T 3dxp_A          234 EP-RVLAVLDWELSTLG  249 (359)
T ss_dssp             SS-CEEEECCCTTCEEE
T ss_pred             CC-cEEEEECccccccC
Confidence            43 23589999987654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.80  E-value=2e-09  Score=85.65  Aligned_cols=97  Identities=16%  Similarity=0.202  Sum_probs=69.9

Q ss_pred             HHHHHHHHHHHHcCCCC--hhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH
Q psy14626         50 ADLKREATICHMLKHPH--VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE  127 (249)
Q Consensus        50 ~~~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~  127 (249)
                      ..+.+|+.+++.+.+.+  ++++++....++..++|||+++|.+|.  ..   .    .+.   ..++.+++..+..||.
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~----~~~---~~~~~~l~~~l~~lh~  125 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---H----LAP---AEKVSIMADAMRRLHT  125 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---C----CCH---HHHHHHHHHHHHHHTT
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---c----CCH---hHHHHHHHHHHHHHhC
Confidence            56789999999995433  667888888777899999999998773  11   0    121   2355666666666665


Q ss_pred             CC----------------------------------------------------------ceeecCCCCCeeeeecCCCC
Q psy14626        128 ND----------------------------------------------------------IIHRDIKPHCVLLANKENSA  149 (249)
Q Consensus       128 ~~----------------------------------------------------------~vH~dlkp~Nili~~~~~~~  149 (249)
                      ..                                                          ++|+|++|.||+++++.   
T Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~---  202 (264)
T 1nd4_A          126 LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR---  202 (264)
T ss_dssp             SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE---
T ss_pred             CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc---
Confidence            32                                                          99999999999996542   


Q ss_pred             CeEEcCcceeEE
Q psy14626        150 PVKLGGFGVAIQ  161 (249)
Q Consensus       150 ~~~l~dfg~~~~  161 (249)
                      .+.|+||+.+..
T Consensus       203 ~~~liD~~~a~~  214 (264)
T 1nd4_A          203 FSGFIDCGRLGV  214 (264)
T ss_dssp             EEEECCCTTCEE
T ss_pred             EEEEEcchhccc
Confidence            256999998643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.77  E-value=7.8e-09  Score=84.59  Aligned_cols=157  Identities=14%  Similarity=0.180  Sum_probs=100.5

Q ss_pred             hhHHHHHHHHHHHHHc-CCCC--hhhhhheeecCC---eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHML-KHPH--VVELLETYSSEG---MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLE  120 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~  120 (249)
                      .....+.+|+.+++.+ .+..  +++++.....++   ..|+||++++|.+|.+.....      ++..+...++.+++.
T Consensus        52 ~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~~------l~~~~~~~~~~~l~~  125 (304)
T 3sg8_A           52 RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNN------LPKQSQNQAAKDLAR  125 (304)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHHT------SCHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccccc------CCHHHHHHHHHHHHH
Confidence            3457899999999998 3332  344444433332   358899999998886543221      677777888888888


Q ss_pred             HHHHHHH----------------------------------------------------------CCceeecCCCCCeee
Q psy14626        121 ALRYCHE----------------------------------------------------------NDIIHRDIKPHCVLL  142 (249)
Q Consensus       121 ~l~~LH~----------------------------------------------------------~~~vH~dlkp~Nili  142 (249)
                      .+..||+                                                          ..++|+|++|.||++
T Consensus       126 ~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~  205 (304)
T 3sg8_A          126 FLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILF  205 (304)
T ss_dssp             HHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEE
T ss_pred             HHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEE
Confidence            8888885                                                          136999999999999


Q ss_pred             eecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCC---CCccccc----cCC----------CCCc
Q psy14626        143 ANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHY---MAPEVIE----DQK----------YGKP  205 (249)
Q Consensus       143 ~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y---~aPE~~~----~~~----------~~~~  205 (249)
                      +.+. ...+.++||+.+.......       ++   .       .....   .+|+...    .-.          ...-
T Consensus       206 ~~~~-~~~~~~iD~~~~~~~~~~~-------Dl---~-------~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~  267 (304)
T 3sg8_A          206 DTEK-NTICGIIDFGDAAISDPDN-------DF---I-------SLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMK  267 (304)
T ss_dssp             ETTT-TEEEEECCCTTCEEECTTH-------HH---H-------TTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHH
T ss_pred             eCCC-CCEEEEEeCCCCccCChHH-------HH---H-------HHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHH
Confidence            8641 2236899999876543311       00   0       00000   1222111    000          0112


Q ss_pred             chHHHHHHHHHHHHhCCCCCCC
Q psy14626        206 VDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       206 ~DiwslG~~l~el~~g~~pf~~  227 (249)
                      .+.|+++.+++.+.+|..+|..
T Consensus       268 ~~~~~l~~~~~~~~~g~~~~~~  289 (304)
T 3sg8_A          268 EKYWSFEKIIYGKEYGYMDWYE  289 (304)
T ss_dssp             HHHHHHHHHHHHHHTTCHHHHH
T ss_pred             HHHHHHHHHHHHHHcCCHHHHH
Confidence            6899999999999999887754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.37  E-value=2.3e-06  Score=69.99  Aligned_cols=110  Identities=15%  Similarity=0.178  Sum_probs=69.9

Q ss_pred             hhHHHHHHHHHHHHHcCCC---Chhhhhheee-cCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLKHP---HVVELLETYS-SEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEAL  122 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l  122 (249)
                      .....+.+|+.+|+.+.+.   .+++++.+.. ..+..++||++++|.++.......      ++..+...++.++...|
T Consensus        51 ~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~~------l~~~~~~~~~~~lg~~L  124 (306)
T 3tdw_A           51 QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMAV------LPDDAKDRLALQLAEFM  124 (306)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHTT------SCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhhh------CCHHHHHHHHHHHHHHH
Confidence            3457899999999999642   3566666653 445678999999998876521110      23333333444444444


Q ss_pred             HHHHH------------------------------------------------------------CCceeecCCCCCeee
Q psy14626        123 RYCHE------------------------------------------------------------NDIIHRDIKPHCVLL  142 (249)
Q Consensus       123 ~~LH~------------------------------------------------------------~~~vH~dlkp~Nili  142 (249)
                      ..||+                                                            ..++|+|++|.||++
T Consensus       125 a~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~  204 (306)
T 3tdw_A          125 NELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLT  204 (306)
T ss_dssp             HHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEE
T ss_pred             HHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEE
Confidence            44432                                                            146999999999999


Q ss_pred             eecCCC-CCeEEcCcceeEEc
Q psy14626        143 ANKENS-APVKLGGFGVAIQL  162 (249)
Q Consensus       143 ~~~~~~-~~~~l~dfg~~~~~  162 (249)
                      +.++.. ..+.|+||+.+...
T Consensus       205 ~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          205 NLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             CTTCSSCCEEEECCCTTCEEE
T ss_pred             ecCCCCCceEEEEehhhcCCC
Confidence            862111 22489999877554

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.27  E-value=2.4e-06  Score=68.26  Aligned_cols=104  Identities=10%  Similarity=0.066  Sum_probs=75.4

Q ss_pred             hhHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHH
Q psy14626         47 TTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYC  125 (249)
Q Consensus        47 ~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~L  125 (249)
                      .....+.+|..+|+.+. +--+++++.++.+.+..++||++++|.++.+.....        ......++.++...|..|
T Consensus        61 ~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~--------~~~~~~~~~~l~~~L~~L  132 (272)
T 4gkh_A           61 SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY--------PDSGENIVDALAVFLRRL  132 (272)
T ss_dssp             HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC--------GGGHHHHHHHHHHHHHHH
T ss_pred             CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC--------HHHHHHHHHHHHHHHHHh
Confidence            34567889999999984 334778888888889999999999998876654321        122234556666667777


Q ss_pred             HHC----------------------------------------------------------CceeecCCCCCeeeeecCC
Q psy14626        126 HEN----------------------------------------------------------DIIHRDIKPHCVLLANKEN  147 (249)
Q Consensus       126 H~~----------------------------------------------------------~~vH~dlkp~Nili~~~~~  147 (249)
                      |..                                                          .++|+|+++.||+++.++ 
T Consensus       133 h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-  211 (272)
T 4gkh_A          133 HSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-  211 (272)
T ss_dssp             HTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-
T ss_pred             cCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-
Confidence            741                                                          268999999999997543 


Q ss_pred             CCCeEEcCcceeEE
Q psy14626        148 SAPVKLGGFGVAIQ  161 (249)
Q Consensus       148 ~~~~~l~dfg~~~~  161 (249)
                        .+-|+||+.+..
T Consensus       212 --~~~viDwe~a~~  223 (272)
T 4gkh_A          212 --LIGCIDVGRVGI  223 (272)
T ss_dssp             --EEEECCCTTCEE
T ss_pred             --EEEEEECccccc
Confidence              257999987643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.53  E-value=5.1e-05  Score=63.06  Aligned_cols=43  Identities=12%  Similarity=0.220  Sum_probs=31.8

Q ss_pred             HHHHHHHHHHHHcC-C--CChhhhhheeecC---CeEEEEEeccCCCch
Q psy14626         50 ADLKREATICHMLK-H--PHVVELLETYSSE---GMLYMVFEYMDGSDI   92 (249)
Q Consensus        50 ~~~~~E~~~l~~l~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~~~L   92 (249)
                      ..+.+|+.+++.+. +  -.+++++.++..+   +..++|||+++|..+
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence            45788999998884 3  3577788777654   356899999988654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.46  E-value=0.00045  Score=56.68  Aligned_cols=32  Identities=16%  Similarity=0.165  Sum_probs=26.5

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ..++|+|+++.||+++.++.   +.++||+.+...
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~---~~lIDfe~a~~g  253 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQ---IWVIDLDTVSFD  253 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGC---EEECCCTTCEEC
T ss_pred             CceecCCCCcccEEEeCCCc---EEEEehhhcccC
Confidence            57999999999999976554   899999977443

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.90  E-value=0.0025  Score=53.63  Aligned_cols=31  Identities=19%  Similarity=0.250  Sum_probs=25.3

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ..++|||+.|.||+++.++    +.++||..+...
T Consensus       227 ~~L~HGDl~~~Nil~~~~~----~~lID~e~a~~G  257 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEHE----TKVIDPEFAFYG  257 (397)
T ss_dssp             CEEECSCCSGGGEEECSSC----EEECCCTTCEEE
T ss_pred             CceeeCCCCcCcEEEeCCC----eEEEeCcccccC
Confidence            5699999999999997543    899999776544

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.69  E-value=0.0037  Score=50.49  Aligned_cols=30  Identities=13%  Similarity=-0.039  Sum_probs=23.6

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      .++|+|+.+.||+ ..++.   +.++||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~---~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGER---MWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSC---EEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCC---EEEEecccccCC
Confidence            3899999999999 44444   899999876544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.45  E-value=0.0064  Score=51.02  Aligned_cols=111  Identities=14%  Similarity=0.144  Sum_probs=66.5

Q ss_pred             hHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCchh--------------HHHHHhhhc----CCcc--
Q psy14626         48 TEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDIC--------------FEIVRRATA----GFVY--  106 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~--------------~~l~~~~~~----~~~~--  106 (249)
                      ....+.+|..+++.+. +.-.+++++.+..+    +|||+++|..|.              ..+.+-..-    +...  
T Consensus        96 ~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~  171 (379)
T 3feg_A           96 GVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHW  171 (379)
T ss_dssp             CHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCccc
Confidence            3456779999999884 44456777666542    899999875442              111111111    1111  


Q ss_pred             CHHHHHHHHHHHHH-------------------HHHHHH----H----CCceeecCCCCCeeeeecC-CCCCeEEcCcce
Q psy14626        107 SEAVASHYMRQVLE-------------------ALRYCH----E----NDIIHRDIKPHCVLLANKE-NSAPVKLGGFGV  158 (249)
Q Consensus       107 ~~~~~~~~~~ql~~-------------------~l~~LH----~----~~~vH~dlkp~Nili~~~~-~~~~~~l~dfg~  158 (249)
                      -..++.+|..++..                   .+..|.    .    ..++|+|+.+.||+++.+. ....+.++||..
T Consensus       172 l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~  251 (379)
T 3feg_A          172 LFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEY  251 (379)
T ss_dssp             HHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTT
T ss_pred             HHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEeccc
Confidence            23566666655432                   123332    1    2589999999999998751 112389999987


Q ss_pred             eEEc
Q psy14626        159 AIQL  162 (249)
Q Consensus       159 ~~~~  162 (249)
                      +...
T Consensus       252 a~~~  255 (379)
T 3feg_A          252 SSYN  255 (379)
T ss_dssp             CEEE
T ss_pred             CCcC
Confidence            7554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.30  E-value=0.0082  Score=49.11  Aligned_cols=36  Identities=22%  Similarity=0.177  Sum_probs=26.8

Q ss_pred             CCceeecCCCCCeeeeecCC-CCCeEEcCcceeEEcc
Q psy14626        128 NDIIHRDIKPHCVLLANKEN-SAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~-~~~~~l~dfg~~~~~~  163 (249)
                      ..++|||+++.||+++.+.. ...+.++||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            46999999999999976311 1238999998875543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.05  E-value=0.06  Score=41.30  Aligned_cols=116  Identities=15%  Similarity=0.048  Sum_probs=68.2

Q ss_pred             CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626         90 SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus        90 ~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                      .+|.+.|.....   ++++++++.++.|.+.+|.-+-.+ .-...=+.|..|++..+|.   |.+.+ ..+.        
T Consensus        33 vSL~eIL~~~~~---PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~---V~f~~-~~s~--------   97 (229)
T 2yle_A           33 LSLEEILRLYNQ---PINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA---VTLAP-AADD--------   97 (229)
T ss_dssp             EEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC---EEECC-C-----------
T ss_pred             ccHHHHHHHcCC---CcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc---eeccc-cccc--------
Confidence            378888876543   499999999999999998776321 1112223457777777665   44432 1110        


Q ss_pred             ccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-----ChHHHHHHHHc
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-----SRDRLFQSITK  238 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-----~~~~~~~~i~~  238 (249)
                                       .....+.|||... ...+.+.=|+|||+++|..+. |-.+-..     ..+.++..+.+
T Consensus        98 -----------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~  155 (229)
T 2yle_A           98 -----------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMAN  155 (229)
T ss_dssp             --------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTT
T ss_pred             -----------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHh
Confidence                             1233456787764 334677899999999999997 4443322     23556655543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.46  E-value=0.023  Score=48.15  Aligned_cols=33  Identities=12%  Similarity=0.205  Sum_probs=26.8

Q ss_pred             HHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        126 HENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       126 H~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      +...++|||++|.||+++.++    +.++||+.+...
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~----~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS----TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC----EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC----CEEEeCcccccC
Confidence            346799999999999997643    899999877554

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=94.13  E-value=0.095  Score=41.77  Aligned_cols=24  Identities=21%  Similarity=0.094  Sum_probs=19.6

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      .++|+|+.+.|++++.++    ..++|-
T Consensus       189 ~LvHGDlw~gNvl~~~~g----~~~iDp  212 (288)
T 3f7w_A          189 ARIHGDLWNGNVLWQDDG----AVVIDP  212 (288)
T ss_dssp             EEECSCCSGGGEEEETTE----EEECSC
T ss_pred             eeeecCCCCCcEEEcCCC----eEEEec
Confidence            589999999999998765    456664

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=92.20  E-value=0.077  Score=43.01  Aligned_cols=29  Identities=14%  Similarity=0.011  Sum_probs=23.7

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      ..++|||+++.||+++ +    .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~----~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D----GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S----SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C----CCEEEECCCCCc
Confidence            3589999999999997 3    389999987644

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=91.64  E-value=0.042  Score=44.51  Aligned_cols=30  Identities=27%  Similarity=0.285  Sum_probs=24.0

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +++|+|++++||+++.+..   +.++||+.+..
T Consensus       188 ~liHgDl~~~Nil~~~~~~---~~lIDf~~a~~  217 (322)
T 2ppq_A          188 GVIHADLFQDNVFFLGDEL---SGLIDFYFACN  217 (322)
T ss_dssp             EEECSCCCGGGEEEETTEE---EEECCCTTCEE
T ss_pred             ccCCCCCCccCEEEeCCce---EEEecchhccC
Confidence            6899999999999976432   47999987644

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=91.33  E-value=0.41  Score=38.83  Aligned_cols=90  Identities=12%  Similarity=0.056  Sum_probs=59.0

Q ss_pred             hcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC---CCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         16 INHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK---HPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      +++|....+|.....  ...+.++..   .......+..|+..|+.+.   ...+++++......+..++|||+++|..+
T Consensus        44 l~gG~~n~~y~v~~~--~~~~vlK~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           44 LYSGEMNEIWLINDE--VQTVFVKIN---ERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             ECCSSSSEEEEEESS--SCEEEEEEE---EGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             eCCccceeeeEEEEC--CCeEEEEeC---CcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            455665555544432  222332211   1234677899999999983   35788888888877889999999998754


Q ss_pred             hHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC
Q psy14626         93 CFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN  128 (249)
Q Consensus        93 ~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~  128 (249)
                      ..                  ..+.++...|..||..
T Consensus       119 ~~------------------~~~~~lG~~LA~LH~~  136 (312)
T 3jr1_A          119 KQ------------------SSFTIFAEKIAQLHQI  136 (312)
T ss_dssp             CT------------------THHHHHHHHHHHHHHC
T ss_pred             Cc------------------hhHHHHHHHHHHHHcC
Confidence            10                  1345677888889975

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=91.09  E-value=0.14  Score=42.00  Aligned_cols=33  Identities=21%  Similarity=0.303  Sum_probs=26.6

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      ..++|+|+.+.||+++.++.   +.++||+.+....
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~---~~~iD~e~~~~~~  238 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEES---IYIIDWDEPMLAP  238 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGC---EEECCCSSCEEEC
T ss_pred             ceeEeCCCCcCCEEEeCCCe---EEEEECCCCeeCC
Confidence            36899999999999976554   8999998765543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.95  E-value=0.49  Score=36.06  Aligned_cols=82  Identities=9%  Similarity=0.094  Sum_probs=57.0

Q ss_pred             CCCChhhhhheeecCCeEEEEEeccC-CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCee
Q psy14626         63 KHPHVVELLETYSSEGMLYMVFEYMD-GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL  141 (249)
Q Consensus        63 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nil  141 (249)
                      .||+++.. .+-.+.+.+.+.++.-. +-++.. +..       ++....++++.+|+....+++  .-+|--++|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik~-------~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IKS-------FTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GGG-------SCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HHh-------cCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEE
Confidence            57888876 45566667777676654 223322 221       788899999999988664333  3488899999999


Q ss_pred             eeecCCCCCeEEcCcce
Q psy14626        142 LANKENSAPVKLGGFGV  158 (249)
Q Consensus       142 i~~~~~~~~~~l~dfg~  158 (249)
                      ++.++.   +++.-.|+
T Consensus       112 f~~~~~---p~i~~RGi  125 (215)
T 4ann_A          112 FTRDGL---PIAKTRGL  125 (215)
T ss_dssp             ECTTSC---EEESCCEE
T ss_pred             EcCCCC---EEEEEccC
Confidence            988776   78876665

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=89.70  E-value=0.28  Score=40.54  Aligned_cols=30  Identities=20%  Similarity=0.212  Sum_probs=23.7

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      .++|+|+++.||+++.+.    +.++||..+...
T Consensus       213 ~l~HgDl~~~Nil~~~~~----~~lID~e~a~~g  242 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC----LRLIDFEYSGFN  242 (369)
T ss_dssp             EEECSCCCGGGEEECC-C----EEECCCTTCEEE
T ss_pred             EEEeCCCCcccEEecCCc----EEEEEecCCCCC
Confidence            589999999999996432    899999866443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=86.94  E-value=0.23  Score=42.22  Aligned_cols=38  Identities=21%  Similarity=0.235  Sum_probs=26.4

Q ss_pred             HHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCc
Q psy14626         50 ADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSD   91 (249)
Q Consensus        50 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (249)
                      +.+.+|+.+++.+. +.-.+++++.+..    .+|++|++|.+
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~  158 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  158 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence            56668999999884 4334667766543    28999998644

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.43  E-value=1.5  Score=33.57  Aligned_cols=82  Identities=10%  Similarity=0.052  Sum_probs=56.8

Q ss_pred             CCCChhhhhheeecCCeEEEEEeccCCC-chhHHHHHhhhcCCccCHHHHHHHHHHHHHHHH-HHHHCCceeecCCCCCe
Q psy14626         63 KHPHVVELLETYSSEGMLYMVFEYMDGS-DICFEIVRRATAGFVYSEAVASHYMRQVLEALR-YCHENDIIHRDIKPHCV  140 (249)
Q Consensus        63 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~-~LH~~~~vH~dlkp~Ni  140 (249)
                      .||++  -..+-.+.+.+.+.++.-+++ ++. .+..       ++....++++.+|+.... ++  ..-+|--++|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~-------~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK-------TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT-------SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh-------cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceE
Confidence            57887  333446667777777765433 333 3321       788899998888887554 33  4458889999999


Q ss_pred             eeeecCCCCCeEEcCccee
Q psy14626        141 LLANKENSAPVKLGGFGVA  159 (249)
Q Consensus       141 li~~~~~~~~~~l~dfg~~  159 (249)
                      +++.++.   +++.-.|+-
T Consensus       116 ~f~~~~~---p~i~hRGi~  131 (219)
T 4ano_A          116 MFNRALE---PFFLHVGVK  131 (219)
T ss_dssp             EECTTCC---EEESCCEET
T ss_pred             EEeCCCc---EEEEEcCCc
Confidence            9987776   888877763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=85.01  E-value=0.37  Score=41.36  Aligned_cols=36  Identities=22%  Similarity=0.358  Sum_probs=24.9

Q ss_pred             HHHHHHHHHcCCC-ChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         53 KREATICHMLKHP-HVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        53 ~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      .+|..+++.+... -.+++++.+.  +  .+|++|++|.+|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL  188 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence            5899999999533 3467777663  2  259999987543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=80.14  E-value=0.73  Score=38.64  Aligned_cols=34  Identities=18%  Similarity=0.156  Sum_probs=25.6

Q ss_pred             ceeecCCCCCeeeeec---CCCCCeEEcCcceeEEcc
Q psy14626        130 IIHRDIKPHCVLLANK---ENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus       130 ~vH~dlkp~Nili~~~---~~~~~~~l~dfg~~~~~~  163 (249)
                      ++|+|+.+.||++..+   .....+.++||..|....
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~  282 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNY  282 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCC
Confidence            6799999999999542   223448999998876553

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	249
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-04
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	7e-04
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-44
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	0.001
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-44
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-04
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-04
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-42
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	0.002
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-04
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-41
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	0.002
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-41
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	0.004
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-40
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	0.001
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	0.002
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	0.001
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-04
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-36
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	0.002
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-35
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	7e-35
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	8e-04
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-34
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-33
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-33
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-33
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-32
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	0.003
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-04
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-31
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-04
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-30
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-30
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	0.001
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-30
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	0.002
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-29
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	0.001
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-29
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-29
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-29
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	0.003
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-29
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-28
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	0.002
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-28
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-27
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-26
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	0.001
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-26
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-24
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	0.002
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-23
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-05
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-22
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	5e-21
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	0.001
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-17
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	0.001
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-10

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  158 bits (400), Expect = 2e-47
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
              H + +  +++E     +L+HP +V L + +  +  + M++E+M G ++  ++     
Sbjct: 60  MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-- 117

Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
                SE  A  YMRQV + L + HEN+ +H D+KP  ++   K ++  +KL  FG+   
Sbjct: 118 -HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAH 175

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           L   Q                    GT  + APEV E +  G   D+W+ GVL ++LL+G
Sbjct: 176 LDPKQSVKV--------------TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221

Query: 222 TLPFVG-SRDRLFQSITKGKLHI 243
             PF G + D   +++     ++
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNM 244

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 38.9 bits (90), Expect = 3e-04
 Identities = 15/57 (26%), Positives = 23/57 (40%), Gaps = 5/57 (8%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREAT 57
           +L  DPN R+TIH+ + H WL        + +     +P  R          K +A 
Sbjct: 263 LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQ-----IPSSRYTKIRDSIKTKYDAW 314

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  156 bits (395), Expect = 1e-46
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
              +   +  +K E +I + L HP ++ L + +  +  + ++ E++ G ++   I     
Sbjct: 63  NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE-- 120

Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
             +  SEA   +YMRQ  E L++ HE+ I+H DIKP  ++   K+ S+ VK+  FG+A +
Sbjct: 121 -DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASS-VKIIDFGLATK 178

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           L   ++                    T  + APE+++ +  G   D+WA GVL +VLL+G
Sbjct: 179 LNPDEIVK--------------VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224

Query: 222 TLPFVG-SRDRLFQSITKGKLHI 243
             PF G       Q++ +     
Sbjct: 225 LSPFAGEDDLETLQNVKRCDWEF 247

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 38.1 bits (88), Expect = 7e-04
 Identities = 12/35 (34%), Positives = 19/35 (54%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPAS 35
           +L  +P KR+T+H+ + H WLK          P+S
Sbjct: 266 LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 4e-45
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 23/207 (11%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L   +L     E  L+RE  I   L+HP+++ L   +     +Y++ EY     +  E+ 
Sbjct: 39  LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ 98

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           + +     + E   + Y+ ++  AL YCH   +IHRDIKP  +LL +      +K+  FG
Sbjct: 99  KLSK----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFG 151

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
            ++     +                    GT  Y+ PE+IE + + + VD+W+ GVL + 
Sbjct: 152 WSVHAPSSRRT---------------TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE 196

Query: 218 LLTGTLPFVG-SRDRLFQSITKGKLHI 243
            L G  PF   +    ++ I++ +   
Sbjct: 197 FLVGKPPFEANTYQETYKRISRVEFTF 223

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 1e-44
 Identities = 46/194 (23%), Positives = 83/194 (42%), Gaps = 23/194 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
              + RE  + H    P++V     + S+G + +  E+MDG  +   + +         E
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPE 103

Query: 109 AVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
            +       V++ L Y  E + I+HRD+KP  +L+ ++     +KL  FGV+ QL D   
Sbjct: 104 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID--- 157

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                       + A   +GT  YM+PE ++   Y    DIW+ G+ L  +  G  P   
Sbjct: 158 ------------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205

Query: 228 SRDRLFQSITKGKL 241
              +  + +   ++
Sbjct: 206 PDAKELELMFGCQV 219

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.3 bits (86), Expect = 0.001
 Identities = 7/36 (19%), Positives = 19/36 (52%), Gaps = 2/36 (5%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASF 36
            L  +P +R  + +++ H ++K     + E++ A +
Sbjct: 281 CLIKNPAERADLKQLMVHAFIKR--SDAEEVDFAGW 314

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 4e-44
 Identities = 60/196 (30%), Positives = 103/196 (52%), Gaps = 19/196 (9%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           E  ++ E  + H +KHP++V L + Y S G LY++ + + G ++   IV +      Y+E
Sbjct: 51  EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF----YTE 106

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             AS  + QVL+A++Y H+  I+HRD+KP  +L  + +  + + +  FG++     G + 
Sbjct: 107 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL 166

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG- 227
            +                GTP Y+APEV+  + Y K VD W+ GV+ ++LL G  PF   
Sbjct: 167 ST--------------ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212

Query: 228 SRDRLFQSITKGKLHI 243
           +  +LF+ I K +   
Sbjct: 213 NDAKLFEQILKAEYEF 228

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 38.5 bits (89), Expect = 4e-04
 Identities = 11/64 (17%), Positives = 25/64 (39%), Gaps = 4/64 (6%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICH 60
           ++  DP KR T  + + H W+         I  +      E++     ++  K+      
Sbjct: 247 LMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVS----EQIKKNFAKSKWKQAFNATA 302

Query: 61  MLKH 64
           +++H
Sbjct: 303 VVRH 306

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-43
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 19/198 (9%)

Query: 47  TTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           T +  +K+E +I ++ +H +++ L E++ S   L M+FE++ G DI   I       F  
Sbjct: 43  TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS---AFEL 99

Query: 107 SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ 166
           +E     Y+ QV EAL++ H ++I H DI+P  ++   + + + +K+  FG A QL+ G 
Sbjct: 100 NEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRS-STIKIIEFGQARQLKPGD 158

Query: 167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFV 226
            +                    P Y APEV +        D+W+ G L++VLL+G  PF+
Sbjct: 159 NFRL--------------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204

Query: 227 G-SRDRLFQSITKGKLHI 243
             +  ++ ++I   +   
Sbjct: 205 AETNQQIIENIMNAEYTF 222

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.9 bits (90), Expect = 4e-04
 Identities = 9/25 (36%), Positives = 14/25 (56%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKL 25
           +L  +   R+T  E + H WLK K+
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKI 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 1e-42
 Identities = 52/200 (26%), Positives = 88/200 (44%), Gaps = 25/200 (12%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D   E  I     HP++V+LL+ +  E  L+++ E+  G  +   ++         +E+ 
Sbjct: 55  DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQ 111

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                +Q L+AL Y H+N IIHRD+K   +L     +   +KL  FGV+ +         
Sbjct: 112 IQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKNTRTI---- 164

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVI-----EDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                     +    IGTP++MAPEV+     +D+ Y    D+W+ G+ L  +     P 
Sbjct: 165 ---------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 215

Query: 226 VG-SRDRLFQSITKGKLHIL 244
              +  R+   I K +   L
Sbjct: 216 HELNPMRVLLKIAKSEPPTL 235

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (84), Expect = 0.002
 Identities = 4/23 (17%), Positives = 12/23 (52%)

Query: 1   MLSVDPNKRITIHEVINHKWLKM 23
            L  + + R T  +++ H ++ +
Sbjct: 252 CLEKNVDARWTTSQLLQHPFVTV 274

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (363), Expect = 2e-42
 Identities = 51/207 (24%), Positives = 88/207 (42%), Gaps = 19/207 (9%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L    +        + RE  +   L HP  V+L  T+  +  LY    Y    ++   I 
Sbjct: 41  LEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR 100

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           +  +    + E     Y  +++ AL Y H   IIHRD+KP  +LL    +   +++  FG
Sbjct: 101 KIGS----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFG 153

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
            A  L             +    +A   +GT  Y++PE++ ++   K  D+WA G +++ 
Sbjct: 154 TAKVLSP-----------ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQ 202

Query: 218 LLTGTLPFVG-SRDRLFQSITKGKLHI 243
           L+ G  PF   +   +FQ I K +   
Sbjct: 203 LVAGLPPFRAGNEYLIFQKIIKLEYDF 229

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 4e-42
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 23/204 (11%)

Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
            L     +  +  E  +    K+P++V  L++Y     L++V EY+ G  +   +     
Sbjct: 54  NLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC- 112

Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
                 E   +   R+ L+AL + H N +IHRDIK   +LL    +   VKL  FG   Q
Sbjct: 113 ----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQ 165

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           +                 +K    +GTP++MAPEV+  + YG  VDIW+ G++   ++ G
Sbjct: 166 I-------------TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Query: 222 TLPFVGSRDR--LFQSITKGKLHI 243
             P++       L+   T G   +
Sbjct: 213 EPPYLNENPLRALYLIATNGTPEL 236

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (88), Expect = 5e-04
 Identities = 8/23 (34%), Positives = 15/23 (65%)

Query: 1   MLSVDPNKRITIHEVINHKWLKM 23
            L +D  KR +  E++ H++LK+
Sbjct: 253 CLDMDVEKRGSAKELLQHQFLKI 275

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 3e-41
 Identities = 50/198 (25%), Positives = 78/198 (39%), Gaps = 28/198 (14%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           D+ +E      L+HP+ ++    Y  E   ++V EY  GS      V +        E  
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVE 116

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            +      L+ L Y H +++IHRD+K   +LL+       VKLG FG A  +     +  
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSASIMAPANSFV- 172

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIE---DQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                           GTP++MAPEVI    + +Y   VD+W+ G+    L     P   
Sbjct: 173 ----------------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216

Query: 228 SRDR-LFQSITKGKLHIL 244
                    I + +   L
Sbjct: 217 MNAMSALYHIAQNESPAL 234

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 36.5 bits (84), Expect = 0.002
 Identities = 5/32 (15%), Positives = 14/32 (43%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIE 32
            L   P  R T   ++ H+++  +   +  ++
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 9e-41
 Identities = 63/204 (30%), Positives = 91/204 (44%), Gaps = 24/204 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSE--GMLYMVFEYMDGSDICFEIVRRATAGFVY 106
           +  L  E  +   LKHP++V   +         LY+V EY +G D+   I +        
Sbjct: 47  KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 106

Query: 107 SEAVASHYMRQVLEALRYCHE-----NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
            E      M Q+  AL+ CH      + ++HRD+KP  V L  K+N   VKLG FG+A  
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGLARI 163

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG 221
           L                T+ A   +GTP+YM+PE +    Y +  DIW+ G LL+ L   
Sbjct: 164 LNHD-------------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210

Query: 222 TLPFVG-SRDRLFQSITKGKLHIL 244
             PF   S+  L   I +GK   +
Sbjct: 211 MPPFTAFSQKELAGKIREGKFRRI 234

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.4 bits (81), Expect = 0.004
 Identities = 4/21 (19%), Positives = 12/21 (57%)

Query: 1   MLSVDPNKRITIHEVINHKWL 21
           ML++    R ++ E++ +  +
Sbjct: 249 MLNLKDYHRPSVEEILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-40
 Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 19/183 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
             ++K+E  I  ML H +VV+         + Y+  EY  G    F+ +          E
Sbjct: 47  PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSG-GELFDRIEPDIG---MPE 102

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             A  +  Q++  + Y H   I HRDIKP  +LL  ++N   +K+  FG+A   +     
Sbjct: 103 PDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRY---- 155

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG 227
                  ++         GT  Y+APE+++ +++  +PVD+W+ G++L  +L G LP+  
Sbjct: 156 -------NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208

Query: 228 SRD 230
             D
Sbjct: 209 PSD 211

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 0.001
 Identities = 7/22 (31%), Positives = 13/22 (59%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L  +P+ RITI ++   +W  
Sbjct: 243 ILVENPSARITIPDIKKDRWYN 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-39
 Identities = 49/196 (25%), Positives = 86/196 (43%), Gaps = 23/196 (11%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
             K E  +    +H +++  +  YS+   L +V ++ +GS +   +    T    +    
Sbjct: 50  AFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETK---FEMIK 105

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                RQ  + + Y H   IIHRD+K + + L        VK+G FG+A           
Sbjct: 106 LIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT---VKIGDFGLATVKSRWS---- 158

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQK---YGKPVDIWAAGVLLHVLLTGTLPFVG 227
                   + +     G+  +MAPEVI  Q    Y    D++A G++L+ L+TG LP+  
Sbjct: 159 -------GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211

Query: 228 --SRDRLFQSITKGKL 241
             +RD++   + +G L
Sbjct: 212 INNRDQIIFMVGRGYL 227

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-38
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 26/203 (12%)

Query: 51  DLKREATI-CHMLKHPHVVELLETY----SSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
             +RE  +     + PH+V +++ Y    +    L +V E +DG ++   I  R    F 
Sbjct: 50  KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF- 108

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            +E  AS  M+ + EA++Y H  +I HRD+KP  +L  +K  +A +KL  FG A +    
Sbjct: 109 -TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                                 TP+Y+APEV+  +KY K  D+W+ GV++++LL G  PF
Sbjct: 168 NSLT--------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 213

Query: 226 VGSR-----DRLFQSITKGKLHI 243
             +        +   I  G+   
Sbjct: 214 YSNHGLAISPGMKTRIRMGQYEF 236

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.6 bits (84), Expect = 0.002
 Identities = 11/55 (20%), Positives = 23/55 (41%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKRE 55
           +L  +P +R+TI E +NH W+             S  L +++      + ++   
Sbjct: 255 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSA 309

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 2e-38
 Identities = 51/199 (25%), Positives = 91/199 (45%), Gaps = 30/199 (15%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSS----EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
              K EA +   L+HP++V   +++ S    +  + +V E M    +   + R      V
Sbjct: 53  QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----V 108

Query: 106 YSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ 163
               V   + RQ+L+ L++ H     IIHRD+K   + +     S  VK+G  G+A   +
Sbjct: 109 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS--VKIGDLGLATLKR 166

Query: 164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL 223
                           + A   IGTP +MAPE+ E +KY + VD++A G+ +  + T   
Sbjct: 167 A---------------SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEY 210

Query: 224 PFVGSRDR--LFQSITKGK 240
           P+   ++   +++ +T G 
Sbjct: 211 PYSECQNAAQIYRRVTSGV 229

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 0.001
 Identities = 4/22 (18%), Positives = 14/22 (63%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
            +  + ++R +I +++NH + +
Sbjct: 249 CIRQNKDERYSIKDLLNHAFFQ 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-37
 Identities = 47/196 (23%), Positives = 99/196 (50%), Gaps = 20/196 (10%)

Query: 50  ADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEA 109
            D++RE +I   ++HP+V+ L E Y ++  + ++ E + G ++   +  + +     +E 
Sbjct: 58  EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEE 113

Query: 110 VASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAP-VKLGGFGVAIQLQDGQLY 168
            A+ +++Q+L  + Y H   I H D+KP  ++L ++    P +K+  FG+A ++  G  +
Sbjct: 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS 228
                          +  GTP ++APE++  +  G   D+W+ GV+ ++LL+G  PF+G 
Sbjct: 174 K--------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 219

Query: 229 RD-RLFQSITKGKLHI 243
                  +++      
Sbjct: 220 TKQETLANVSAVNYEF 235

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (87), Expect = 6e-04
 Identities = 11/24 (45%), Positives = 16/24 (66%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMK 24
           +L  DP KR+TI + + H W+K K
Sbjct: 254 LLVKDPKKRMTIQDSLQHPWIKPK 277

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  129 bits (325), Expect = 1e-36
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  E +           E  +  ++ HP ++ +  T+     ++M+ +Y++G ++   + 
Sbjct: 37  LKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR 96

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           +       +   VA  Y  +V  AL Y H  DII+RD+KP  +LL    +   +K+  FG
Sbjct: 97  KS----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFG 149

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
            A  + D             YT       GTP Y+APEV+  + Y K +D W+ G+L++ 
Sbjct: 150 FAKYVPD-----------VTYT-----LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYE 193

Query: 218 LLTGTLPFVG-SRDRLFQSITKGKLHI 243
           +L G  PF   +  + ++ I   +L  
Sbjct: 194 MLAGYTPFYDSNTMKTYEKILNAELRF 220

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  127 bits (321), Expect = 2e-36
 Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 29/200 (14%)

Query: 52  LKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
             +E  I   +  HP++++L +TY +    ++VF+ M   ++   +  + T     SE  
Sbjct: 56  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKE 111

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
               MR +LE +   H+ +I+HRD+KP  +LL +  N   +KL  FG + QL  G+    
Sbjct: 112 TRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDFGFSCQLDPGE---- 164

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIE------DQKYGKPVDIWAAGVLLHVLLTGTLP 224
                     K     GTP Y+APE+IE         YGK VD+W+ GV+++ LL G+ P
Sbjct: 165 ----------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

Query: 225 FVG-SRDRLFQSITKGKLHI 243
           F    +  + + I  G    
Sbjct: 215 FWHRKQMLMLRMIMSGNYQF 234

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 36.6 bits (84), Expect = 0.002
 Identities = 8/22 (36%), Positives = 11/22 (50%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
            L V P KR T  E + H + +
Sbjct: 253 FLVVQPQKRYTAEEALAHPFFQ 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-36
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 21/206 (10%)

Query: 39  PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVR 98
            D  L     E  +  +  +    +HP +  +  T+ ++  L+ V EY++G D+ + I  
Sbjct: 37  KDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS 96

Query: 99  RATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV 158
                  +  + A+ Y  +++  L++ H   I++RD+K   +LL    +   +K+  FG+
Sbjct: 97  CHK----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGM 149

Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
             +   G               K     GTP Y+APE++  QKY   VD W+ GVLL+ +
Sbjct: 150 CKENMLGD-------------AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEM 196

Query: 219 LTGTLPFVG-SRDRLFQSITKGKLHI 243
           L G  PF G   + LF SI       
Sbjct: 197 LIGQSPFHGQDEEELFHSIRMDNPFY 222

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  128 bits (322), Expect = 8e-36
 Identities = 42/191 (21%), Positives = 81/191 (42%), Gaps = 23/191 (12%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           +   ++      P +V +   + +   L  + + M+G D+ + + +      V+SEA   
Sbjct: 55  RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMR 110

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
            Y  +++  L + H   +++RD+KP  +LL    +   V++   G+A      + + S  
Sbjct: 111 FYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACDFSKKKPHAS-- 165

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVGSRDR 231
                        +GT  YMAPEV++    Y    D ++ G +L  LL G  PF   + +
Sbjct: 166 -------------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212

Query: 232 LFQSITKGKLH 242
               I +  L 
Sbjct: 213 DKHEIDRMTLT 223

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 1e-35
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 21/207 (10%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  E +      A    E+ +    +HP +  L   + +   L  V EY +G ++ F + 
Sbjct: 38  LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           R      V++E  A  Y  +++ AL Y H  D+++RDIK   ++L    +   +K+  FG
Sbjct: 98  RE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFG 150

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +  +                         GTP Y+APEV+ED  YG+ VD W  GV+++ 
Sbjct: 151 LCKEGI-------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYE 197

Query: 218 LLTGTLPFVG-SRDRLFQSITKGKLHI 243
           ++ G LPF     +RLF+ I   ++  
Sbjct: 198 MMCGRLPFYNQDHERLFELILMEEIRF 224

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  123 bits (310), Expect = 7e-35
 Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 22/208 (10%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSE----GMLYMVFEYMDGSDIC 93
           L  +     +     +REA     L HP +V + +T  +E     + Y+V EY+DG  + 
Sbjct: 40  LRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR 99

Query: 94  FEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKL 153
             +          +   A   +    +AL + H+N IIHRD+KP  ++++       VK+
Sbjct: 100 DIVHTEGP----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKV 152

Query: 154 GGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGV 213
             FG+A  + D            +  T+    IGT  Y++PE           D+++ G 
Sbjct: 153 MDFGIARAIADS----------GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGC 202

Query: 214 LLHVLLTGTLPFVG-SRDRLFQSITKGK 240
           +L+ +LTG  PF G S   +     +  
Sbjct: 203 VLYEVLTGEPPFTGDSPVSVAYQHVRED 230

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  123 bits (309), Expect = 2e-34
 Identities = 35/194 (18%), Positives = 81/194 (41%), Gaps = 16/194 (8%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
             D   EA+I     HP+V+ L    +    + ++ E+M+   +   + +       ++ 
Sbjct: 71  RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG---QFTV 127

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 +R +   ++Y  + + +HRD+    +L+ +       K+  FG++  L+D    
Sbjct: 128 IQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLEDDTS- 183

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
                  D   T A        + APE I+ +K+    D+W+ G+++  +++ G  P+  
Sbjct: 184 -------DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236

Query: 228 -SRDRLFQSITKGK 240
            +   +  +I +  
Sbjct: 237 MTNQDVINAIEQDY 250

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-34
 Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 22/193 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
                RE  +   L HP+++ LL+ +  +  + +VF++M+                V + 
Sbjct: 44  NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTP 99

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           +    YM   L+ L Y H++ I+HRD+KP+ +LL        +KL  FG+A         
Sbjct: 100 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPNRA 156

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG 227
            +             H++ T  Y APE++   + YG  VD+WA G +L  LL       G
Sbjct: 157 YT-------------HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203

Query: 228 -SRDRLFQSITKG 239
            S       I + 
Sbjct: 204 DSDLDQLTRIFET 216

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (86), Expect = 8e-04
 Identities = 5/24 (20%), Positives = 11/24 (45%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMK 24
           +   +P  RIT  + +  K+   +
Sbjct: 263 LFLFNPCARITATQALKMKYFSNR 286

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 5e-34
 Identities = 40/194 (20%), Positives = 79/194 (40%), Gaps = 20/194 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
           + +L  EA +   L +P++V ++    +E    +V E  +   +   + +         +
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH----VKD 106

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 + QV   ++Y  E++ +HRD+    VLL  +      K+  FG++  L+  +  
Sbjct: 107 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALRADE-- 161

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
                   +Y     H      + APE I   K+    D+W+ GVL+    + G  P+ G
Sbjct: 162 --------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213

Query: 228 -SRDRLFQSITKGK 240
                +   + KG+
Sbjct: 214 MKGSEVTAMLEKGE 227

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 9e-34
 Identities = 43/202 (21%), Positives = 80/202 (39%), Gaps = 24/202 (11%)

Query: 42  RLNHYTTEADLKREATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRA 100
            + +  T      EA++   L+H ++V+LL      +G LY+V EYM    +   +  R 
Sbjct: 37  CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 96

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
            +           +   V EA+ Y   N+ +HRD+    VL++        K+  FG+  
Sbjct: 97  RSVL--GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTK 151

Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
           +    Q                        + APE + ++K+    D+W+ G+LL  + +
Sbjct: 152 EASSTQ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195

Query: 221 -GTLPFVG-SRDRLFQSITKGK 240
            G +P+       +   + KG 
Sbjct: 196 FGRVPYPRIPLKDVVPRVEKGY 217

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  120 bits (302), Expect = 2e-33
 Identities = 35/178 (19%), Positives = 66/178 (37%), Gaps = 11/178 (6%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEG-MLYMVFEYMDGSDICFEIVRRATAGFVYS 107
              L  E+ I  M++    +  +    +EG    MV E +  S               +S
Sbjct: 46  HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FS 101

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
                    Q++  + Y H  + IHRD+KP   L+   +    V +  FG+A + +D + 
Sbjct: 102 LKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
           +            +  +  GT  Y +       +  +  D+ + G +L     G+LP+
Sbjct: 162 HQ------HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 5e-33
 Identities = 41/195 (21%), Positives = 78/195 (40%), Gaps = 20/195 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E D   EA +   L HP +V+L      +  + +VFE+M+   +   +  +     +++
Sbjct: 43  SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFA 99

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
                     V E + Y  E  +IHRD+     L+   +    +K+  FG+   + D Q 
Sbjct: 100 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQY 156

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
             S G +                + +PEV    +Y    D+W+ GVL+  + +       
Sbjct: 157 TSSTGTK------------FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204

Query: 228 SRD--RLFQSITKGK 240
           +R    + + I+ G 
Sbjct: 205 NRSNSEVVEDISTGF 219

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 5e-33
 Identities = 37/192 (19%), Positives = 79/192 (41%), Gaps = 20/192 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
               EA +   L+H  +V L     ++  +Y++ EYM+   +   +   +  G   +   
Sbjct: 54  AFLAEANLMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPS--GIKLTINK 110

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                 Q+ E + +  E + IHRD++   +L+++  +    K+  FG+A  ++D +    
Sbjct: 111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDNEYTAR 167

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--S 228
            G +                + APE I    +    D+W+ G+LL  ++T         +
Sbjct: 168 EGAK------------FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT 215

Query: 229 RDRLFQSITKGK 240
              + Q++ +G 
Sbjct: 216 NPEVIQNLERGY 227

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 7e-33
 Identities = 40/195 (20%), Positives = 78/195 (40%), Gaps = 20/195 (10%)

Query: 48  TEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
           +E +   EA +   L H  +V+L    + +  ++++ EYM    +   +         + 
Sbjct: 42  SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQ 98

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
                   + V EA+ Y      +HRD+     L+ ++     VK+  FG++  + D + 
Sbjct: 99  TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLDDEY 155

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFV 226
             S G +                +  PEV+   K+    DIWA GVL+  + + G +P+ 
Sbjct: 156 TSSVGSK------------FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 203

Query: 227 G-SRDRLFQSITKGK 240
             +     + I +G 
Sbjct: 204 RFTNSETAEHIAQGL 218

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 9e-33
 Identities = 48/208 (23%), Positives = 78/208 (37%), Gaps = 19/208 (9%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  + L+      D  RE    H L H +++ L         + MV E      +   + 
Sbjct: 44  LKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLR 102

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           +       +     S Y  QV E + Y      IHRD+    +LLA ++    VK+G FG
Sbjct: 103 KHQGH---FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFG 156

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
           +   L             D +     HR     + APE ++ + +    D W  GV L  
Sbjct: 157 LMRALPQN----------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWE 206

Query: 218 LLT-GTLPFVG-SRDRLFQSITKGKLHI 243
           + T G  P++G +  ++   I K    +
Sbjct: 207 MFTYGQEPWIGLNGSQILHKIDKEGERL 234

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-32
 Identities = 47/203 (23%), Positives = 81/203 (39%), Gaps = 28/203 (13%)

Query: 44  NHYTTEADLKREATICHMLKHPH--VVELLETYSSEGMLYMVFEYMDGSDICFEIVRRAT 101
                   +  E  +   +      V+ LL+ +       ++ E  +     F+ +    
Sbjct: 46  GELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-- 103

Query: 102 AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ 161
                 E +A  +  QVLEA+R+CH   ++HRDIK   +L+    N   +KL  FG    
Sbjct: 104 -RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI--DLNRGELKLIDFGSGAL 160

Query: 162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLT 220
           L+D               T      GT  Y  PE I   +Y G+   +W+ G+LL+ ++ 
Sbjct: 161 LKD---------------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205

Query: 221 GTLPFVGSRDRLFQSITKGKLHI 243
           G +PF        + I +G++  
Sbjct: 206 GDIPFEHD-----EEIIRGQVFF 223

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 35.8 bits (82), Expect = 0.003
 Identities = 8/22 (36%), Positives = 14/22 (63%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
            L++ P+ R T  E+ NH W++
Sbjct: 238 CLALRPSDRPTFEEIQNHPWMQ 259

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 4e-32
 Identities = 56/198 (28%), Positives = 79/198 (39%), Gaps = 25/198 (12%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEG------MLYMVFEYMDGSDICFEIVRRATA 102
           +    RE  I   L H ++V L   + S G       L +V +Y+    +       + A
Sbjct: 57  KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA 115

Query: 103 GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
                      YM Q+  +L Y H   I HRDIKP  +LL    ++A +KL  FG A QL
Sbjct: 116 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL--DPDTAVLKLCDFGSAKQL 173

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAP-EVIEDQKYGKPVDIWAAGVLLHVLLTG 221
             G+   S               I + +Y AP  +     Y   +D+W+AG +L  LL G
Sbjct: 174 VRGEPNVS--------------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

Query: 222 TLPFVG-SRDRLFQSITK 238
              F G S       I K
Sbjct: 220 QPIFPGDSGVDQLVEIIK 237

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 3e-04
 Identities = 15/69 (21%), Positives = 24/69 (34%), Gaps = 10/69 (14%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYT---TEADLKREAT 57
           +L   P  R+T  E   H +         E+   +  LP+ R        T  +L     
Sbjct: 286 LLEYTPTARLTPLEACAHSFFD-------ELRDPNVKLPNGRDTPALFNFTTQELSSNPP 338

Query: 58  ICHMLKHPH 66
           +  +L  PH
Sbjct: 339 LATILIPPH 347

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  116 bits (290), Expect = 8e-32
 Identities = 32/193 (16%), Positives = 69/193 (35%), Gaps = 13/193 (6%)

Query: 42  RLNHYTTEADLKREATICHMLKH-PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRA 100
                +    L+ E     +L     +  +           +V + +  S      +   
Sbjct: 37  FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC-- 94

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN--SAPVKLGGFGV 158
             G  +S    +   +Q+L  ++  HE  +++RDIKP   L+    +  +  + +  FG+
Sbjct: 95  --GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 152

Query: 159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVL 218
               +D         +      +  +  GT  YM+      ++  +  D+ A G +    
Sbjct: 153 VKFYRDP------VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206

Query: 219 LTGTLPFVGSRDR 231
           L G+LP+ G +  
Sbjct: 207 LRGSLPWQGLKAA 219

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 2e-31
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 19/192 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           ++ REA I H L +P++V L+    +E  L +V E   G  +   +V +         + 
Sbjct: 55  EMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK---REEIPVSN 110

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
            +  + QV   ++Y  E + +HRD+    VLL N+      K+  FG++  L        
Sbjct: 111 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKALGAD----- 162

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-S 228
                D Y T          + APE I  +K+    D+W+ GV +   L+ G  P+    
Sbjct: 163 -----DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217

Query: 229 RDRLFQSITKGK 240
              +   I +GK
Sbjct: 218 GPEVMAFIEQGK 229

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-30
 Identities = 43/215 (20%), Positives = 78/215 (36%), Gaps = 36/215 (16%)

Query: 49  EADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR-------- 99
              L  E  +   L  H ++V LL   +  G +Y++FEY    D+   +  +        
Sbjct: 84  REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143

Query: 100 -----------ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS 148
                           V +      +  QV + + +      +HRD+    VL+ + +  
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV- 202

Query: 149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDI 208
             VK+  FG+A  +             D      G+      +MAPE + +  Y    D+
Sbjct: 203 --VKICDFGLARDIMS-----------DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249

Query: 209 WAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGKL 241
           W+ G+LL  + + G  P+ G   D  F  + +   
Sbjct: 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 284

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (282), Expect = 3e-30
 Identities = 40/183 (21%), Positives = 77/183 (42%), Gaps = 25/183 (13%)

Query: 51  DLKREATICHMLKHPHVVELLE-----TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV 105
              RE  I    +H +++ + +     T      +Y+V   M      +++++       
Sbjct: 52  RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGAD--LYKLLKTQH---- 105

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            S     +++ Q+L  L+Y H  +++HRD+KP  +LL    +   +K+  FG+A      
Sbjct: 106 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFGLARVADPD 162

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLP 224
             +                 + T  Y APE++ +   Y K +DIW+ G +L  +L+    
Sbjct: 163 HDHT----------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212

Query: 225 FVG 227
           F G
Sbjct: 213 FPG 215

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 8e-04
 Identities = 14/45 (31%), Positives = 23/45 (51%), Gaps = 1/45 (2%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAE-IEPASFGLPDERLN 44
           ML+ +P+KRI + + + H +L+     S E I  A F    E  +
Sbjct: 278 MLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDD 322

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 5e-30
 Identities = 38/194 (19%), Positives = 75/194 (38%), Gaps = 20/194 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
             ++  EA +   + +PHV  LL        + ++ + M    +   +            
Sbjct: 55  NKEILDEAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGS 110

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
               ++  Q+ + + Y  +  ++HRD+    VL+   ++   VK+  FG+A  L      
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGA---- 163

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG 227
                  +     A        +MA E I  + Y    D+W+ GV +  L+T G+ P+ G
Sbjct: 164 -------EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216

Query: 228 -SRDRLFQSITKGK 240
                +   + KG+
Sbjct: 217 IPASEISSILEKGE 230

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 5e-30
 Identities = 40/192 (20%), Positives = 73/192 (38%), Gaps = 20/192 (10%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
              +EA +   L+H  +V+L    S E  +Y+V EYM    +   +      G       
Sbjct: 58  AFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGET--GKYLRLPQ 114

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
                 Q+   + Y    + +HRD++   +L+         K+  FG+A  ++D +    
Sbjct: 115 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARLIEDNE---- 167

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-S 228
                    T          + APE     ++    D+W+ G+LL  L T G +P+ G  
Sbjct: 168 --------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 219

Query: 229 RDRLFQSITKGK 240
              +   + +G 
Sbjct: 220 NREVLDQVERGY 231

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  111 bits (277), Expect = 5e-30
 Identities = 48/183 (26%), Positives = 82/183 (44%), Gaps = 21/183 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
            +   RE +I   LKH ++V+L +   ++  L +VFE++D        V           
Sbjct: 44  PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LES 99

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
             A  ++ Q+L  + YCH+  ++HRD+KP  +L+  +     +K+  FG+A         
Sbjct: 100 VTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLA--------- 147

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIE-DQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                       K  H I T  Y AP+V+   +KY   +DIW+ G +   ++ GT  F G
Sbjct: 148 ----RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203

Query: 228 SRD 230
             +
Sbjct: 204 VSE 206

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 37.2 bits (85), Expect = 0.001
 Identities = 10/22 (45%), Positives = 15/22 (68%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML +DPN+RIT  + + H + K
Sbjct: 264 MLKLDPNQRITAKQALEHAYFK 285

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 6e-30
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 20/183 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
            +   RE ++   L HP++V+LL+   +E  LY+VFE++      F      T       
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPL 101

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
            +   Y+ Q+L+ L +CH + ++HRD+KP  +L+  +     +KL  FG+A         
Sbjct: 102 PLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVPVRT 158

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVG 227
            +             H + T  Y APE++   KY    VDIW+ G +   ++T    F G
Sbjct: 159 YT-------------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205

Query: 228 SRD 230
             +
Sbjct: 206 DSE 208

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.002
 Identities = 9/22 (40%), Positives = 13/22 (59%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML  DPNKRI+    + H + +
Sbjct: 266 MLHYDPNKRISAKAALAHPFFQ 287

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 1e-29
 Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 26/205 (12%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSS--------EGMLYMVFEYMDGSDICFEIVRRA 100
                RE  I  +LKH +VV L+E   +        +G +Y+VF++ +            
Sbjct: 53  PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV 112

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                ++ +     M+ +L  L Y H N I+HRD+K   VL+        +KL  FG+A 
Sbjct: 113 K----FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLADFGLAR 165

Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLL 219
                +         +    +  +R+ T  Y  PE++  ++ YG P+D+W AG ++  + 
Sbjct: 166 AFSLAK---------NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216

Query: 220 TGTLPFVGSRD-RLFQSITKGKLHI 243
           T +    G+ +      I++    I
Sbjct: 217 TRSPIMQGNTEQHQLALISQLCGSI 241

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.001
 Identities = 7/22 (31%), Positives = 13/22 (59%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L +DP +RI   + +NH +  
Sbjct: 288 LLVLDPAQRIDSDDALNHDFFW 309

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (279), Expect = 1e-29
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 24/207 (11%)

Query: 38  LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIV 97
           L  +++           E  I   +  P +V+L  ++     LYMV EY+ G ++   + 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133

Query: 98  RRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG 157
           R       +SE  A  Y  Q++    Y H  D+I+RD+KP  +L+  +     +++  FG
Sbjct: 134 RIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFG 186

Query: 158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHV 217
            A                     +     GTP  +APE+I  + Y K VD WA GVL++ 
Sbjct: 187 FA----------------KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYE 230

Query: 218 LLTGTLPFVG-SRDRLFQSITKGKLHI 243
           +  G  PF      ++++ I  GK+  
Sbjct: 231 MAAGYPPFFADQPIQIYEKIVSGKVRF 257

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (276), Expect = 1e-29
 Identities = 47/215 (21%), Positives = 81/215 (37%), Gaps = 36/215 (16%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDG------------------- 89
           +AD +REA +     +P++V+LL   +    + ++FEYM                     
Sbjct: 60  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 90  -SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENS 148
            SD+       +      S A      RQV   + Y  E   +HRD+     L+      
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV- 178

Query: 149 APVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDI 208
             VK+  FG++  +               Y    G+      +M PE I   +Y    D+
Sbjct: 179 --VKIADFGLSRNIYSAD-----------YYKADGNDAIPIRWMPPESIFYNRYTTESDV 225

Query: 209 WAAGVLLHVLLTGTL-PFVG-SRDRLFQSITKGKL 241
           WA GV+L  + +  L P+ G + + +   +  G +
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI 260

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-29
 Identities = 41/207 (19%), Positives = 74/207 (35%), Gaps = 32/207 (15%)

Query: 49  EADLKREATI-CHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR-------- 99
             D   E  + C +  HP+++ LL      G LY+  EY    ++   + +         
Sbjct: 54  HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113

Query: 100 ----ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
                +     S     H+   V   + Y  +   IHRD+    +L+         K+  
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---AKIAD 170

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
           FG++              R      K         +MA E +    Y    D+W+ GVLL
Sbjct: 171 FGLS--------------RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLL 216

Query: 216 HVLLT-GTLPFVG-SRDRLFQSITKGK 240
             +++ G  P+ G +   L++ + +G 
Sbjct: 217 WEIVSLGGTPYCGMTCAELYEKLPQGY 243

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (274), Expect = 2e-29
 Identities = 41/191 (21%), Positives = 78/191 (40%), Gaps = 19/191 (9%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
           +  +EA +   +KHP++V+LL   + E   Y++ E+M   ++   +          S  V
Sbjct: 59  EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV--SAVV 116

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
             +   Q+  A+ Y  + + IHRD+     L+        VK+  FG++  +        
Sbjct: 117 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTYTAH 173

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSRD 230
            G +                + APE +   K+    D+WA GVLL  + T  +      D
Sbjct: 174 AGAK------------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 221

Query: 231 --RLFQSITKG 239
             ++++ + K 
Sbjct: 222 LSQVYELLEKD 232

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (273), Expect = 5e-29
 Identities = 47/190 (24%), Positives = 89/190 (46%), Gaps = 27/190 (14%)

Query: 49  EADLKREATICHMLK-HPHVVELLETYSS--EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
           +  +KRE  I   L+  P+++ L +           +VFE+++ +D   ++ +       
Sbjct: 73  KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF-KQLYQT------ 125

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            ++     YM ++L+AL YCH   I+HRD+KPH V++ ++     ++L  +G+A     G
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPG 183

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLP 224
           Q Y                R+ + ++  PE++ D Q Y   +D+W+ G +L  ++    P
Sbjct: 184 QEYN--------------VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229

Query: 225 FVGSRDRLFQ 234
           F    D   Q
Sbjct: 230 FFHGHDNYDQ 239

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 36.0 bits (82), Expect = 0.003
 Identities = 6/22 (27%), Positives = 10/22 (45%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L  D   R+T  E + H +  
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFY 323

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 7e-29
 Identities = 36/194 (18%), Positives = 77/194 (39%), Gaps = 18/194 (9%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
             D   EA I     H +++ L    S    + ++ EYM+   +   +  +      +S 
Sbjct: 53  RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSV 109

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
                 +R +   ++Y    + +HRD+    +L+ +       K+  FG++  L+D    
Sbjct: 110 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFGLSRVLEDDP-- 164

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG- 227
                  +   T +G +     + APE I  +K+    D+W+ G+++  ++T        
Sbjct: 165 -------EATYTTSGGK-IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216

Query: 228 -SRDRLFQSITKGK 240
            S   + ++I  G 
Sbjct: 217 LSNHEVMKAINDGF 230

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-28
 Identities = 43/190 (22%), Positives = 69/190 (36%), Gaps = 28/190 (14%)

Query: 49  EADLKREATICHMLK---HPHVVELLETYSS-----EGMLYMVFEYMDGSDICFEIVRRA 100
                RE  +   L+   HP+VV L +  +      E  L +VFE++D     +      
Sbjct: 51  PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP- 109

Query: 101 TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                         M Q+L  L + H + ++HRD+KP  +L+ +                
Sbjct: 110 --EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA--------- 158

Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT 220
                     G  R+  +       + T  Y APEV+    Y  PVD+W+ G +   +  
Sbjct: 159 --------DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210

Query: 221 GTLPFVGSRD 230
               F GS D
Sbjct: 211 RKPLFRGSSD 220

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.4 bits (83), Expect = 0.002
 Identities = 6/22 (27%), Positives = 14/22 (63%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
            L+ +P KRI+ +  ++H + +
Sbjct: 276 CLTFNPAKRISAYSALSHPYFQ 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-28
 Identities = 47/194 (24%), Positives = 81/194 (41%), Gaps = 21/194 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
                +EA       HPH+V+L+   + E  ++++ E     ++   +  R  +      
Sbjct: 52  REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYS---LDL 107

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
           A    Y  Q+  AL Y      +HRDI    VL+++ +    VKLG FG++  ++D    
Sbjct: 108 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFGLSRYMEDST-- 162

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL-HVLLTGTLPFVG 227
                       KA        +MAPE I  +++    D+W  GV +  +L+ G  PF G
Sbjct: 163 ----------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

Query: 228 -SRDRLFQSITKGK 240
              + +   I  G+
Sbjct: 213 VKNNDVIGRIENGE 226

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-28
 Identities = 51/207 (24%), Positives = 83/207 (40%), Gaps = 29/207 (14%)

Query: 49  EADLKREATICHML-KHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVY- 106
            +DL  E  +  M+ KH +++ LL   + +G LY++ EY    ++   +  R   G  Y 
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 107 -----------SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGG 155
                      S         QV   + Y      IHRD+    VL+        +K+  
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIAD 178

Query: 156 FGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLL 215
           FG+A  +               Y  K  +      +MAPE + D+ Y    D+W+ GVLL
Sbjct: 179 FGLARDIHH-----------IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227

Query: 216 HVLLT-GTLPFVG-SRDRLFQSITKGK 240
             + T G  P+ G   + LF+ + +G 
Sbjct: 228 WEIFTLGGSPYPGVPVEELFKLLKEGH 254

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 5e-27
 Identities = 42/201 (20%), Positives = 80/201 (39%), Gaps = 22/201 (10%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFV--- 105
             +   EA++       HVV LL   S      ++ E M   D+   +     A      
Sbjct: 67  RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 126

Query: 106 ---YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL 162
               S +       ++ + + Y + N  +HRD+     ++A       VK+G FG+   +
Sbjct: 127 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDI 183

Query: 163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGT 222
            +             Y  K G  +    +M+PE ++D  +    D+W+ GV+L  + T  
Sbjct: 184 YETD-----------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232

Query: 223 -LPFVG-SRDRLFQSITKGKL 241
             P+ G S +++ + + +G L
Sbjct: 233 EQPYQGLSNEQVLRFVMEGGL 253

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 6e-27
 Identities = 43/217 (19%), Positives = 74/217 (34%), Gaps = 31/217 (14%)

Query: 45  HYTTEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRR---- 99
           H T    L  E  +   L  H ++V LL   +  G   ++ EY    D+   + R+    
Sbjct: 66  HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF 125

Query: 100 ----------ATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSA 149
                                   +  QV + + +    + IHRD+    +LL +     
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI-- 183

Query: 150 PVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIW 209
             K+  FG+A  +++           D      G+      +MAPE I +  Y    D+W
Sbjct: 184 -TKICDFGLARDIKN-----------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231

Query: 210 AAGVLLHVLLTGTLPFVGSR--DRLFQSITKGKLHIL 244
           + G+ L  L +           D  F  + K    +L
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML 268

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-26
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 23/195 (11%)

Query: 52  LKREATICHMLKH-PHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAV 110
            + E  +   ++  P +V L   + +E  L+++ +Y++G ++   + +R      ++E  
Sbjct: 75  TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR----ERFTEHE 130

Query: 111 ASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCS 170
              Y+ +++ AL + H+  II+RDIK   +LL +  +   V L  FG++ +         
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLSKEFV------- 180

Query: 171 GGERLDHYTTKAGHRIGTPHYMAPEVIE--DQKYGKPVDIWAAGVLLHVLLTGTLPFVG- 227
                   T +A    GT  YMAP+++   D  + K VD W+ GVL++ LLTG  PF   
Sbjct: 181 -----ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235

Query: 228 SRDRLFQSITKGKLH 242
                   I++  L 
Sbjct: 236 GEKNSQAEISRRILK 250

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 1e-26
 Identities = 44/185 (23%), Positives = 77/185 (41%), Gaps = 32/185 (17%)

Query: 51  DLKREATICHMLKHPHVVELLETYSSEGML------YMVFEYMDGSDICFEIVRRATAGF 104
              RE  +   ++H +V+ LL+ ++ +  L      Y+V  +M       ++++      
Sbjct: 63  RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEK--- 117

Query: 105 VYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD 164
              E      + Q+L+ LRY H   IIHRD+KP  + +                    +D
Sbjct: 118 -LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN-------------------ED 157

Query: 165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTL 223
            +L            ++    + T  Y APEVI    +Y + VDIW+ G ++  ++TG  
Sbjct: 158 CELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 217

Query: 224 PFVGS 228
            F GS
Sbjct: 218 LFKGS 222

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (85), Expect = 0.001
 Identities = 16/54 (29%), Positives = 25/54 (46%), Gaps = 2/54 (3%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKR 54
           ML +D  +R+T  E + H + +  LH + E EP      D   +   T  + KR
Sbjct: 284 MLVLDAEQRVTAGEALAHPYFE-SLHDT-EDEPQVQKYDDSFDDVDRTLDEWKR 335

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-26
 Identities = 44/195 (22%), Positives = 76/195 (38%), Gaps = 18/195 (9%)

Query: 49  EADLKREATICHMLKHPHVVELLET-YSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYS 107
            +    E  I     HP+V+ LL     SEG   +V  YM   D+    +R  T      
Sbjct: 72  VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL-RNFIRNETHNPTVK 130

Query: 108 EAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL 167
           + +   +  QV + +++      +HRD+     +L  K     VK+  FG+A  + D + 
Sbjct: 131 DLI--GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDMYDKEF 185

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                                  +MA E ++ QK+    D+W+ GVLL  L+T   P   
Sbjct: 186 DS---------VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

Query: 228 SRD--RLFQSITKGK 240
             +   +   + +G+
Sbjct: 237 DVNTFDITVYLLQGR 251

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 2e-25
 Identities = 39/196 (19%), Positives = 74/196 (37%), Gaps = 27/196 (13%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEG----MLYMVFEYMDGSDICFEIVRRAT--- 101
               + E     ML+H +++  +   + +      L++V +Y +   + F+ + R T   
Sbjct: 41  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYTVTV 99

Query: 102 -AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI 160
                 + + AS      +E +    +  I HRD+K   +L+          +   G+A+
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIADLGLAV 156

Query: 161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ------KYGKPVDIWAAGVL 214
           +              D       HR+GT  YMAPEV++D       +  K  DI+A G++
Sbjct: 157 RHDSAT---------DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207

Query: 215 LHVLLTGTLPFVGSRD 230
              +           D
Sbjct: 208 FWEIARRCSIGGIHED 223

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 1e-24
 Identities = 42/183 (22%), Positives = 72/183 (39%), Gaps = 21/183 (11%)

Query: 49  EADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSE 108
            +   RE  +   LKH ++V L +   S+  L +VFE+ D     +              
Sbjct: 45  PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD----LDP 100

Query: 109 AVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY 168
            +   ++ Q+L+ L +CH  +++HRD+KP  +L+        +KL  FG+A         
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLA--------- 148

Query: 169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG 227
                            + T  Y  P+V+   K Y   +D+W+AG +   L     P   
Sbjct: 149 ----RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

Query: 228 SRD 230
             D
Sbjct: 205 GND 207

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (83), Expect = 0.002
 Identities = 6/22 (27%), Positives = 12/22 (54%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           +L  +P +RI+  E + H +  
Sbjct: 266 LLKCNPVQRISAEEALQHPYFS 287

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 3e-23
 Identities = 41/196 (20%), Positives = 83/196 (42%), Gaps = 31/196 (15%)

Query: 52  LKREATICHMLKHPHVVELLETYSSEG------MLYMVFEYMDGSDICFEIVRRATAGFV 105
             RE  +   + H +++ LL  ++ +        +Y+V E MD +    ++++       
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQME----- 115

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
                 S+ + Q+L  +++ H   IIHRD+KP  +++ +      +K+  FG+A      
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGLA------ 166

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPF 225
                   R    +      + T +Y APEVI    Y + VDIW+ G ++  ++   + F
Sbjct: 167 --------RTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218

Query: 226 VG-SRDRLFQSITKGK 240
            G      +  + +  
Sbjct: 219 PGRDYIDQWNKVIEQL 234

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (95), Expect = 6e-05
 Identities = 11/54 (20%), Positives = 22/54 (40%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKR 54
           ML +DP KRI++ + + H ++ +    +    P       +      T  + K 
Sbjct: 294 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 2e-22
 Identities = 43/199 (21%), Positives = 72/199 (36%), Gaps = 27/199 (13%)

Query: 40  DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG-MLYMVFEYMDGSDICFEIVR 98
            E   H    A +     + H+  H +VV LL   +  G  L ++ E+    ++   +  
Sbjct: 52  KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 111

Query: 99  RATAGFVY------------SEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE 146
           +      Y            +      Y  QV + + +      IHRD+    +LL+ K 
Sbjct: 112 KRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171

Query: 147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPV 206
               VK+  FG+A  +             D    + G       +MAPE I D+ Y    
Sbjct: 172 V---VKICDFGLARDIYK-----------DPDYVRKGDARLPLKWMAPETIFDRVYTIQS 217

Query: 207 DIWAAGVLLHVLLTGTLPF 225
           D+W+ GVLL  + +     
Sbjct: 218 DVWSFGVLLWEIFSLGASP 236

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 5e-21
 Identities = 48/197 (24%), Positives = 80/197 (40%), Gaps = 31/197 (15%)

Query: 51  DLKREATICHMLKHPHVVELLETYSS-----EGMLYMVFEYMDGSDICFEIVRRATAGFV 105
              RE  +   +KH +V+ LL+ ++      E     +  ++ G+D    IV+       
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQK---- 117

Query: 106 YSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG 165
            ++      + Q+L  L+Y H  DIIHRD+KP  +          +K+  FG+A      
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKILDFGLA------ 168

Query: 166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVI-EDQKYGKPVDIWAAGVLLHVLLTGTLP 224
                      H   +    + T  Y APE++     Y + VDIW+ G ++  LLTG   
Sbjct: 169 ----------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

Query: 225 FVG-SRDRLFQSITKGK 240
           F G       + I +  
Sbjct: 219 FPGTDHIDQLKLILRLV 235

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.001
 Identities = 11/54 (20%), Positives = 21/54 (38%), Gaps = 2/54 (3%)

Query: 1   MLSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKR 54
           ML +D +KRIT  + + H +     +   + EP +        +      + K 
Sbjct: 284 MLVLDSDKRITAAQALAHAYFAQ--YHDPDDEPVADPYDQSFESRDLLIDEWKS 335

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 77.8 bits (190), Expect = 3e-17
 Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 23/180 (12%)

Query: 54  REATICHMLKHPHVVELLETYSS--EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVA 111
            + T    +   H+++LL+ ++      +++V  +    +    ++++            
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYV 127

Query: 112 SHYMRQVLEALRYCHEND-IIHRDIKPHCVLLA---NKENSAPVKLGGFGVAIQLQDGQL 167
               +Q+L  L Y H    IIH DIKP  VL+    + EN   +K+   G A    +   
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY- 186

Query: 168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG 227
                           + I T  Y +PEV+    +G   DIW+   L+  L+TG   F  
Sbjct: 187 ---------------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 37.3 bits (85), Expect = 0.001
 Identities = 11/22 (50%), Positives = 14/22 (63%)

Query: 1   MLSVDPNKRITIHEVINHKWLK 22
           ML +DP KR     ++NH WLK
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLK 332

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 55.9 bits (134), Expect = 2e-10
 Identities = 18/160 (11%), Positives = 45/160 (28%), Gaps = 35/160 (21%)

Query: 53  KREATICHMLKHPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVAS 112
           + E      L+   V ++         + M                              
Sbjct: 62  RNEFRALQKLQGLAVPKVYAWE--GNAVLMELIDAKELYRVRVENPD------------- 106

Query: 113 HYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLYCSGG 172
             +  +LE +   +   I+H D+  + VL++ +     + +  F  ++++ +        
Sbjct: 107 EVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IWIIDFPQSVEVGE-------- 154

Query: 173 ERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAG 212
           E       +    I   ++        + Y    DI +A 
Sbjct: 155 EGWREILERDVRNI-ITYFS-------RTYRTEKDINSAI 186

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	249
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.8
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.22
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.31
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	94.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.24

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=315.61  Aligned_cols=219  Identities=28%  Similarity=0.476  Sum_probs=184.2

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      -||.+||++.+.|+.|.++.+|...+......++++..........+.+.+|+.++++++||||++++++|.+++.+++|
T Consensus        16 ~dp~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             SCTTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCcccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            37889999999999999999998876655556666655555556678899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++...     .+++.+++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++....
T Consensus        96 mEy~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---vkl~DFG~a~~~~  167 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---VKLTDFGFCAQIT  167 (293)
T ss_dssp             EECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECC
T ss_pred             EEecCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc---Eeeccchhheeec
Confidence            9999999998876542     2899999999999999999999999999999999999987766   9999999998765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHH-HHHHHHcCcc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDR-LFQSITKGKL  241 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~-~~~~i~~g~~  241 (249)
                      ....             ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+ +..+ +...+..+.+
T Consensus       168 ~~~~-------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~  234 (293)
T d1yhwa1         168 PEQS-------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP  234 (293)
T ss_dssp             STTC-------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC
T ss_pred             cccc-------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC
Confidence            4321             12234589999999999999999999999999999999999999998 4334 4444445544


Q ss_pred             cc
Q psy14626        242 HI  243 (249)
Q Consensus       242 ~~  243 (249)
                      .+
T Consensus       235 ~~  236 (293)
T d1yhwa1         235 EL  236 (293)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=310.67  Aligned_cols=216  Identities=25%  Similarity=0.479  Sum_probs=186.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|++.+.|+.|.++.+|...+......++++   +....+....+.+.+|+.++++++||||+++++++.+++.+++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            36888889999999999877665444444433   344455566788999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+++|+|.+++.....    +++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++.....
T Consensus        86 Ey~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC---EeecccceeeecCC
Confidence            99999999999876554    899999999999999999999999999999999999987766   99999999865543


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..               .....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+ +..++.+.+.++++.+
T Consensus       159 ~~---------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~  223 (263)
T d2j4za1         159 SR---------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF  223 (263)
T ss_dssp             CC---------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC
T ss_pred             Cc---------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            22               1223589999999999999999999999999999999999999998 5678899999999988


Q ss_pred             cc
Q psy14626        244 LG  245 (249)
Q Consensus       244 ~~  245 (249)
                      |.
T Consensus       224 p~  225 (263)
T d2j4za1         224 PD  225 (263)
T ss_dssp             CT
T ss_pred             Cc
Confidence            85

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=314.66  Aligned_cols=222  Identities=24%  Similarity=0.363  Sum_probs=186.0

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      +.||.+.|++.+.|+.|.++.+|...+......++++..........+.+.+|+.+|++++||||+++++++.+++.+++
T Consensus         7 ~~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~l   86 (288)
T d2jfla1           7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWI   86 (288)
T ss_dssp             SSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEE
Confidence            57899999999999999999999887665555555554444455666789999999999999999999999999999999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++|+|.+++.....   .+++.+++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++...
T Consensus        87 vmEy~~~g~L~~~~~~~~~---~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~---~Kl~DFG~a~~~  160 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD---IKLADFGVSAKN  160 (288)
T ss_dssp             EEECCTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC---EEEEechhhhcc
Confidence            9999999999988765432   3899999999999999999999999999999999999987776   999999998665


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIE-----DQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ....             .......||+.|+|||++.     +..++.++||||+||++|+|++|+.||.+ +..++...+
T Consensus       161 ~~~~-------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i  227 (288)
T d2jfla1         161 TRTI-------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI  227 (288)
T ss_dssp             HHHH-------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH
T ss_pred             CCCc-------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence            4321             1122345899999999984     45578999999999999999999999998 666777788


Q ss_pred             HcCcccc
Q psy14626        237 TKGKLHI  243 (249)
Q Consensus       237 ~~g~~~~  243 (249)
                      .++.+..
T Consensus       228 ~~~~~~~  234 (288)
T d2jfla1         228 AKSEPPT  234 (288)
T ss_dssp             HHSCCCC
T ss_pred             HcCCCCC
Confidence            8876443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-48  Score=313.21  Aligned_cols=219  Identities=23%  Similarity=0.438  Sum_probs=185.2

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|++.++|+.|.++.+|...+......++++   +....+....+.+.+|+.++++++||||++++++|.+.+.+|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            4999999999999999977665444444443   3344445667889999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++||+|.+++.....    +++..++.++.|++.||.|||+++++||||||+||+++.++.   ++|+|||++......
T Consensus        89 y~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~---vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH---IQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECC--
T ss_pred             ccCCCCHHHhhhccCC----CCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce---EEecccccceecccC
Confidence            9999999998877654    899999999999999999999999999999999999987776   999999999876542


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      ..           ........||+.|+|||++.+..++.++||||+||++|+|++|+.||.+ +..++.+.|.++++.+|
T Consensus       162 ~~-----------~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p  230 (288)
T d1uu3a_         162 SK-----------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP  230 (288)
T ss_dssp             -------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             Cc-----------ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC
Confidence            21           1122234589999999999999999999999999999999999999998 66788999999999888


Q ss_pred             c
Q psy14626        245 G  245 (249)
Q Consensus       245 ~  245 (249)
                      .
T Consensus       231 ~  231 (288)
T d1uu3a_         231 E  231 (288)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-46  Score=309.45  Aligned_cols=222  Identities=28%  Similarity=0.505  Sum_probs=171.1

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhcccc-chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNH-YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      |..++|++.++|+.|.++.+|...+......++++...... ....+.+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            56678999999999999999877655444444443222111 23346788999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||++|++|.+++.....    +++.++..++.||+.||.|||++|++||||||+||++...+....++|+|||++....
T Consensus        86 mE~~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EeccCCCcHHHhhhcccC----CCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999999876433    9999999999999999999999999999999999999754444559999999997654


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ...              ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+ +..++...|.++.+.
T Consensus       162 ~~~--------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~  227 (307)
T d1a06a_         162 PGS--------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE  227 (307)
T ss_dssp             -------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC
T ss_pred             CCC--------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC
Confidence            422              11223589999999999999999999999999999999999999998 567788999999877


Q ss_pred             cc
Q psy14626        243 IL  244 (249)
Q Consensus       243 ~~  244 (249)
                      +|
T Consensus       228 ~~  229 (307)
T d1a06a_         228 FD  229 (307)
T ss_dssp             CC
T ss_pred             CC
Confidence            65

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-46  Score=308.54  Aligned_cols=218  Identities=25%  Similarity=0.481  Sum_probs=187.4

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      .|.+.++|+.|.++.++...+......++++   +.........+.+.+|+.+|++++||||++++++|.+.+.+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            4778889999999999877765544444443   4444445667889999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |++||+|.+++.....    +++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||++......
T Consensus        86 y~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~---vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          86 YANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH---IKITDFGLCKEGISD  158 (337)
T ss_dssp             CCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCSCCT
T ss_pred             ccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC---EEEeecccccccccC
Confidence            9999999998887654    899999999999999999999999999999999999988776   999999998765432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                      .             .......||+.|+|||++.+..++.++|+||+||++|||++|+.||.+ +..++.+.+..+++.+|
T Consensus       159 ~-------------~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p  225 (337)
T d1o6la_         159 G-------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP  225 (337)
T ss_dssp             T-------------CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred             C-------------cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC
Confidence            2             122234689999999999999999999999999999999999999999 67789999999999888


Q ss_pred             cc
Q psy14626        245 GC  246 (249)
Q Consensus       245 ~~  246 (249)
                      ..
T Consensus       226 ~~  227 (337)
T d1o6la_         226 RT  227 (337)
T ss_dssp             TT
T ss_pred             cc
Confidence            53

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=302.77  Aligned_cols=219  Identities=29%  Similarity=0.445  Sum_probs=172.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc--cchhHHHHHHHHHHHHHcCCCChhhhhheeec--CCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN--HYTTEADLKREATICHMLKHPHVVELLETYSS--EGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv   83 (249)
                      +.|.+.+.|+.|.++.+|...+......++++.....  +....+.+.+|+.++++++||||+++++++.+  ++.+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            4688889999999999998776655444554432221  23456779999999999999999999999854  4568999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC-----ceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND-----IIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~-----~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      |||+++|+|.+++.........+++..++.++.|++.||.|||+++     ++||||||+|||++.++.   ++|+|||+
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~---vkl~DFG~  160 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN---VKLGDFGL  160 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC---EEECCHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc---EEEeeccc
Confidence            9999999999999876655566999999999999999999999876     999999999999987766   99999999


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      +.......             .......+|+.|+|||++.+..++.++||||+||++|||++|+.||.+ +..++...|.
T Consensus       161 a~~~~~~~-------------~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~  227 (269)
T d2java1         161 ARILNHDT-------------SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR  227 (269)
T ss_dssp             HHHC------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             eeecccCC-------------CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence            86654322             111234589999999999999999999999999999999999999998 6678888998


Q ss_pred             cCccc
Q psy14626        238 KGKLH  242 (249)
Q Consensus       238 ~g~~~  242 (249)
                      ++.+.
T Consensus       228 ~~~~~  232 (269)
T d2java1         228 EGKFR  232 (269)
T ss_dssp             HTCCC
T ss_pred             cCCCC
Confidence            88764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.2e-46  Score=310.30  Aligned_cols=219  Identities=27%  Similarity=0.471  Sum_probs=185.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ++|++.+.|+.|.++.+|...+......++++..........+.+.+|+.+|++++||||+++++++.+++.+++||||+
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            37999999999999999987766555555555444444566788999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      +||+|.+++.....   .+++..++.++.||+.||.|||++|++||||||+|||++.+. ...++|+|||++........
T Consensus       106 ~gg~L~~~l~~~~~---~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~-~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         106 SGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKR-SNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             CSCBHHHHHTCTTS---CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-SCCEEECCCTTCEECCTTSC
T ss_pred             CCCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCC-CCeEEEeecchheecccccc
Confidence            99999988854432   389999999999999999999999999999999999996532 23499999999987655331


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccccc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHIL  244 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~  244 (249)
                                    .....+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+ +..++...|.++.+.+|
T Consensus       182 --------------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~  245 (350)
T d1koaa2         182 --------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD  245 (350)
T ss_dssp             --------------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSC
T ss_pred             --------------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence                          1223589999999999999999999999999999999999999998 67788899999887766

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.1e-46  Score=305.34  Aligned_cols=216  Identities=24%  Similarity=0.471  Sum_probs=185.8

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccC---ChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGL---PDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      +.|++.+.|+.|.++.+|...+......+++   .+.........+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            3588889999999999987766544444443   3334445566788999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.|++|..++.....    +++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++.....
T Consensus        84 E~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~---vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH---IKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC---EEECCCSSCEECSS
T ss_pred             eecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC---EEEecCccceEecc
Confidence            99999999888776554    789999999999999999999999999999999999987766   99999999987654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..                ....||+.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++...|.++++.+
T Consensus       157 ~~----------------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~  220 (316)
T d1fota_         157 VT----------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF  220 (316)
T ss_dssp             CB----------------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCC
T ss_pred             cc----------------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCC
Confidence            22                123589999999999999999999999999999999999999998 6678899999999888


Q ss_pred             ccc
Q psy14626        244 LGC  246 (249)
Q Consensus       244 ~~~  246 (249)
                      |+.
T Consensus       221 p~~  223 (316)
T d1fota_         221 PPF  223 (316)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-45  Score=299.42  Aligned_cols=222  Identities=22%  Similarity=0.467  Sum_probs=186.6

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhcc---ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERL---NHYTTEADLKREATICHMLKHPHVVELLETYSSEG   78 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   78 (249)
                      +.++||.+.+.|+.|.++.+|...+......++++   +...   ......+.+.+|+.+|++++||||++++++|.+.+
T Consensus         7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   86 (293)
T d1jksa_           7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT   86 (293)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            56679999999999999999987665444444433   2222   22235688999999999999999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC-CCCeEEcCcc
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN-SAPVKLGGFG  157 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~-~~~~~l~dfg  157 (249)
                      .+++||||++||+|.+++.....    +++..++.++.|++.||.|||+++++||||||+||+++.++. ...++++|||
T Consensus        87 ~~~iv~E~~~gg~L~~~i~~~~~----l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          87 DVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEEEcCCCccccchhccccc----cchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999999877643    899999999999999999999999999999999999987653 2358999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      ++.......              ......+++.|+|||++.+..++.++||||+||++|+|++|+.||.+ +..++...|
T Consensus       163 ~a~~~~~~~--------------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i  228 (293)
T d1jksa_         163 LAHKIDFGN--------------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV  228 (293)
T ss_dssp             TCEECTTSC--------------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             hhhhcCCCc--------------cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            998765432              11223578999999999998899999999999999999999999998 667788899


Q ss_pred             HcCccccc
Q psy14626        237 TKGKLHIL  244 (249)
Q Consensus       237 ~~g~~~~~  244 (249)
                      .++.+.+|
T Consensus       229 ~~~~~~~~  236 (293)
T d1jksa_         229 SAVNYEFE  236 (293)
T ss_dssp             HTTCCCCC
T ss_pred             HhcCCCCC
Confidence            99887765

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9e-46  Score=309.11  Aligned_cols=220  Identities=25%  Similarity=0.413  Sum_probs=185.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ++|++.+.|+.|.++.+|...+......++++..........+.+.+|+.+|++++||||++++++|.+++.+|+||||+
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            46899999999999999987766555556665444444455678999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      +|++|.+.+....   ..+++.+++.++.||+.||.|||++|++||||||+|||++.+. ...++|+|||++........
T Consensus       109 ~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~-~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         109 SGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTT-CCCEEECCCTTCEECCTTSC
T ss_pred             CCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccC-CCeEEEeecccceecCCCCc
Confidence            9999987765443   2389999999999999999999999999999999999997422 22399999999987765321


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                                    .....+++.|+|||++.+..++.++||||+||++|+|++|+.||.+ +..++.+.|.++.+.+|.
T Consensus       185 --------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~  249 (352)
T d1koba_         185 --------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE  249 (352)
T ss_dssp             --------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCS
T ss_pred             --------------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Confidence                          1123478999999999999999999999999999999999999998 667788999999887763

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-46  Score=300.38  Aligned_cols=215  Identities=23%  Similarity=0.434  Sum_probs=170.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccc-cchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN-HYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      +.|++.+.|+.|.++.+|...+......++++..... .....+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            4688999999999999987776554444554432222 123456789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      ++||+|.+++....    .+++.+++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++.......
T Consensus        85 ~~gg~L~~~l~~~~----~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~---~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          85 CSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN---LKISDFGLATVFRYNN  157 (271)
T ss_dssp             CTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC---EEECCCTTCEECEETT
T ss_pred             cCCCcHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC---EEEccchhheeeccCC
Confidence            99999998886543    3899999999999999999999999999999999999987766   9999999998765422


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCC--hHHHHHHHHcCc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVGS--RDRLFQSITKGK  240 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~~--~~~~~~~i~~g~  240 (249)
                      .           ........||+.|+|||++.+..+ +.++||||+||++|+|++|+.||...  .......+....
T Consensus       158 ~-----------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~  223 (271)
T d1nvra_         158 R-----------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK  223 (271)
T ss_dssp             E-----------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTC
T ss_pred             c-----------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC
Confidence            1           011223458999999999988775 67899999999999999999999873  233344444433

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-45  Score=294.96  Aligned_cols=214  Identities=24%  Similarity=0.408  Sum_probs=171.7

Q ss_pred             CCCCcc-hHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeec----C
Q psy14626          5 DPNKRI-TIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSS----E   77 (249)
Q Consensus         5 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----~   77 (249)
                      ..+.|| ++++.|+.|.++.+|...+......++++....  ......+.+.+|+++|++++||||++++++|.+    .
T Consensus         5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_           5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            445566 678889999999999776654433334332221  223456789999999999999999999999864    3


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCC--ceeecCCCCCeeeee-cCCCCCeEEc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEND--IIHRDIKPHCVLLAN-KENSAPVKLG  154 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~--~vH~dlkp~Nili~~-~~~~~~~~l~  154 (249)
                      ..+++||||+++++|.+++.....    +++.+++.++.||+.||.|||+++  ++||||||+|||++. ++.   ++|+
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~---~Kl~  157 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGS---VKIG  157 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSC---EEEC
T ss_pred             CEEEEEEeCCCCCcHHHHHhcccc----ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCC---EEEe
Confidence            468999999999999999976544    899999999999999999999998  999999999999964 344   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRL  232 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~  232 (249)
                      |||++.......               .....||+.|+|||++.+ +++.++||||+||++|||++|+.||.+  +...+
T Consensus       158 DFGla~~~~~~~---------------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~  221 (270)
T d1t4ha_         158 DLGLATLKRASF---------------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI  221 (270)
T ss_dssp             CTTGGGGCCTTS---------------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred             ecCcceeccCCc---------------cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH
Confidence            999985433211               122358999999999876 589999999999999999999999987  45667


Q ss_pred             HHHHHcCcc
Q psy14626        233 FQSITKGKL  241 (249)
Q Consensus       233 ~~~i~~g~~  241 (249)
                      .+.+.++..
T Consensus       222 ~~~i~~~~~  230 (270)
T d1t4ha_         222 YRRVTSGVK  230 (270)
T ss_dssp             HHHHTTTCC
T ss_pred             HHHHHcCCC
Confidence            888877754

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.1e-45  Score=305.00  Aligned_cols=216  Identities=24%  Similarity=0.441  Sum_probs=187.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      ++|.+.+.|+.|.++.+|...+......++++   +....+....+.+.+|+.+|+.++||||+++++++.+...+++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            47999999999999999987665444444443   344445566788999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.+++|..++.....    +++..++.++.||+.||.|||+++++||||||+|||++.++.   ++|+|||++.....
T Consensus       121 e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~---ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY---IQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC---EEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhcCC----CCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC---EEeeeceeeeeccc
Confidence            99999999998877654    899999999999999999999999999999999999987765   99999999987654


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHI  243 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~  243 (249)
                      ..                ....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+ +...+...|.++.+.+
T Consensus       194 ~~----------------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~  257 (350)
T d1rdqe_         194 RT----------------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF  257 (350)
T ss_dssp             CB----------------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             cc----------------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            22                123589999999999999999999999999999999999999998 5677899999999888


Q ss_pred             ccc
Q psy14626        244 LGC  246 (249)
Q Consensus       244 ~~~  246 (249)
                      |..
T Consensus       258 p~~  260 (350)
T d1rdqe_         258 PSH  260 (350)
T ss_dssp             CTT
T ss_pred             Ccc
Confidence            753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-45  Score=302.48  Aligned_cols=215  Identities=25%  Similarity=0.371  Sum_probs=176.9

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      +-||.++|+..+.|+.|.++.+|...+......++++   +.........+.+.+|+.+|++++||||+++++++.+++.
T Consensus        10 ~~dp~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   89 (309)
T d1u5ra_          10 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (309)
T ss_dssp             CSCHHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             ccCcHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE
Confidence            3478889999999999999999977655444444443   3333444556789999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +++||||+.+++|..++..+.    .+++.+++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++
T Consensus        90 ~~iv~E~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---~Kl~DFG~a  162 (309)
T d1u5ra_          90 AWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL---VKLGDFGSA  162 (309)
T ss_dssp             EEEEEECCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE---EEECCCTTC
T ss_pred             EEEEEEecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC---EEEeecccc
Confidence            999999999988876655443    3899999999999999999999999999999999999987766   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQS  235 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~  235 (249)
                      ......                 ....||+.|+|||++.+   ..++.++||||+||++|||++|+.||.+ +..+....
T Consensus       163 ~~~~~~-----------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~  225 (309)
T d1u5ra_         163 SIMAPA-----------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH  225 (309)
T ss_dssp             BSSSSB-----------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred             cccCCC-----------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            654321                 12358999999999864   3478899999999999999999999988 55556666


Q ss_pred             HHcCcc
Q psy14626        236 ITKGKL  241 (249)
Q Consensus       236 i~~g~~  241 (249)
                      +.++..
T Consensus       226 i~~~~~  231 (309)
T d1u5ra_         226 IAQNES  231 (309)
T ss_dssp             HHHSCC
T ss_pred             HHhCCC
Confidence            666554

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-45  Score=304.76  Aligned_cols=200  Identities=24%  Similarity=0.382  Sum_probs=169.3

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +++|++.+.|+.|.++.+|...+......++++.... .+....+.+.+|+.+|+.++||||++++++|.+.+.+++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4578999999999999999877654444455443322 234556789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHC-CceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHEN-DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~-~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      |++|++|.+++.+...    +++..++.++.|++.||.|||++ |++||||||+|||++.++.   ++|+|||+|....+
T Consensus        85 y~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~---vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC---EEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC---EEEeeCCCccccCC
Confidence            9999999999876544    89999999999999999999975 9999999999999987776   99999999865432


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      .               ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus       158 ~---------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         158 S---------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             H---------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             C---------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            1               122346899999999999999999999999999999999999999873

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-45  Score=294.36  Aligned_cols=219  Identities=23%  Similarity=0.331  Sum_probs=172.9

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      |+++ ..+|++.+.|+.|.++.+|.......++++.+.... .+....+.|.+|+.+|++++||||+++++++.. +.++
T Consensus         3 wei~-~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           3 WEIP-DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CBCC-TTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cccc-cccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            4554 356899999999999999988766555555544332 234567889999999999999999999998765 4589


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++|+|.+++.....   .+++.++..++.|++.||.|||+++++||||||+|||++.++.   +||+|||++..
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~---~Kl~DFGla~~  153 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT---VKIGDFGLATV  153 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS---EEECCCCCSCC
T ss_pred             EEEecCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC---EEEccccceee
Confidence            99999999999998865432   3899999999999999999999999999999999999987766   99999999866


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED---QKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSI  236 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i  236 (249)
                      ......           ........+|+.|+|||++.+   ..++.++||||+||++|||++|+.||.+  +...+...+
T Consensus       154 ~~~~~~-----------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~  222 (276)
T d1uwha_         154 KSRWSG-----------SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV  222 (276)
T ss_dssp             -----------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred             ccccCC-----------cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            543221           011223358999999999864   3478899999999999999999999998  345566677


Q ss_pred             HcCc
Q psy14626        237 TKGK  240 (249)
Q Consensus       237 ~~g~  240 (249)
                      .++.
T Consensus       223 ~~~~  226 (276)
T d1uwha_         223 GRGY  226 (276)
T ss_dssp             HHTS
T ss_pred             hcCC
Confidence            6664

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=296.75  Aligned_cols=218  Identities=25%  Similarity=0.464  Sum_probs=182.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHHHHHHH-HcCCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKREATICH-MLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      +.|.+.+.|+.|.++.+|...+......++++   +.........+.+.+|+.++. .++||||+++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            45888999999999999987766554444443   333333455566777777665 67999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++|+|.+++.....    +++.+++.++.||+.||.|||+++++||||||+|||++.++.   ++|+|||.+....
T Consensus        82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~---~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH---IKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC---EEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc---eeccccchhhhcc
Confidence            999999999999876654    899999999999999999999999999999999999987776   9999999987554


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCccc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLH  242 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~  242 (249)
                      ....             ......||+.|+|||++.+..++.++|+||+||++|+|++|+.||.+ +..++...|..+.+.
T Consensus       155 ~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~  221 (320)
T d1xjda_         155 LGDA-------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF  221 (320)
T ss_dssp             CTTC-------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             cccc-------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            3221             11223589999999999999999999999999999999999999998 677889999999998


Q ss_pred             ccc
Q psy14626        243 ILG  245 (249)
Q Consensus       243 ~~~  245 (249)
                      +|.
T Consensus       222 ~p~  224 (320)
T d1xjda_         222 YPR  224 (320)
T ss_dssp             CCT
T ss_pred             CCc
Confidence            884

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-44  Score=294.68  Aligned_cols=219  Identities=20%  Similarity=0.307  Sum_probs=175.9

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      ++|++.+.|+.|.++.+|..........++++... .+....+++.+|+.+|++++||||++++++|.+++.+++||||+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~   95 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   95 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECC-TTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEEC-CccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecc
Confidence            47888999999999999877665433333433222 22345678999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++|+|.+++.....  ..+++..++.++.|++.||.|||+++++||||||+|||++.++.   +||+|||+++.......
T Consensus        96 ~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~---~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          96 TYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL---VKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             TTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCCTTTCCSSSS
T ss_pred             cCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc---EEEccccceeecCCCCc
Confidence            99999998876433  24899999999999999999999999999999999999988776   99999999865543221


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCC-CCCC-ChHHHHHHHHcCc-cccc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTL-PFVG-SRDRLFQSITKGK-LHIL  244 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~-pf~~-~~~~~~~~i~~g~-~~~~  244 (249)
                                  .......+++.|+|||++.+..++.++||||+||++|||++|.. ||.+ +..++.+.+.++. +.+|
T Consensus       171 ------------~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~  238 (287)
T d1opja_         171 ------------TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP  238 (287)
T ss_dssp             ------------EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC
T ss_pred             ------------eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCC
Confidence                        11122347889999999999999999999999999999999554 5555 5666777777653 4444

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.9e-44  Score=295.15  Aligned_cols=219  Identities=17%  Similarity=0.285  Sum_probs=166.7

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCC---cccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPA---SFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      ++|++.++|+.|.++.+|.........   .++++... .......+.|.+|+.+|++++||||+++++++.+++.+++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            578889999999999998776543322   22332221 22334567899999999999999999999999999999999


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++|+|.+++.....   .+++.++..++.|++.||.|||+++++||||||+|||++.++.   +||+|||+++...
T Consensus       106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~---~Kl~DFGla~~~~  179 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV---CKVSDFGLSRFLE  179 (299)
T ss_dssp             EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCC-------
T ss_pred             EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc---EEECCcccceEcc
Confidence            999999999988765433   3899999999999999999999999999999999999987766   9999999997765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ......        ..+......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+ +..++...+.++.
T Consensus       180 ~~~~~~--------~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~  250 (299)
T d1jpaa_         180 DDTSDP--------TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY  250 (299)
T ss_dssp             ------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC
T ss_pred             CCCCcc--------eeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence            432110        0111112346889999999999999999999999999999998 8999998 6677888887764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=296.84  Aligned_cols=220  Identities=26%  Similarity=0.433  Sum_probs=184.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEY   86 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (249)
                      -+||++.+.|+.|.++.+|...+......++++..... ......+.+|+.+|+.++||||++++++|.+++.+|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            46899999999999999998776655445554433322 23456789999999999999999999999999999999999


Q ss_pred             cCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCC
Q psy14626         87 MDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQ  166 (249)
Q Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~  166 (249)
                      ++|++|.+++....   ..+++.+++.++.||+.||.|||++|++||||||+|||++.++ ...++|+|||++.......
T Consensus        83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~-~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-CCCEEECCCTTCEECCTTC
T ss_pred             CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCC-ceEEEEcccchhhccccCC
Confidence            99999999886543   2389999999999999999999999999999999999997643 2348999999997765432


Q ss_pred             ccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHcCcccccc
Q psy14626        167 LYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITKGKLHILG  245 (249)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~g~~~~~~  245 (249)
                      .              .....+++.|+|||...+..++.++||||+||++|+|++|+.||.+ +..++...|.++.+.+|.
T Consensus       159 ~--------------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~  224 (321)
T d1tkia_         159 N--------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE  224 (321)
T ss_dssp             E--------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCH
T ss_pred             c--------------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCh
Confidence            1              1123478999999999999999999999999999999999999998 667889999999987763

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-44  Score=291.58  Aligned_cols=218  Identities=23%  Similarity=0.370  Sum_probs=175.3

Q ss_pred             CcchHHHh-hcccceeeEeeecccc-----CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          8 KRITIHEV-INHKWLKMKLHTSAEI-----EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      ..+.+.++ |+.|.++.+|......     .++++.+..  .......+.|.+|+.+|++++||||+++++++..+ .++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQ--GTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECS--SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEECh--hcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence            45777776 9999999998764321     233333322  23345677899999999999999999999999754 589


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++|+|.+++.....   .+++.++..++.|++.||.|||+++++||||||+||+++.++.   ++|+|||+++.
T Consensus        85 lvmE~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~---~Kl~DFGla~~  158 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY---AKISDFGLSKA  158 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCTT---TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE---EEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc---eeeccchhhhc
Confidence            99999999999988754332   3899999999999999999999999999999999999998776   99999999987


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ........          .......+|+.|+|||++.+..++.++||||+||++|||++ |+.||.+ +..++.+.|.+|
T Consensus       159 ~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~  228 (285)
T d1u59a_         159 LGADDSYY----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG  228 (285)
T ss_dssp             CTTCSCEE----------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT
T ss_pred             cccccccc----------ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            76533211          11222347889999999998899999999999999999998 9999998 667788889887


Q ss_pred             c-cccc
Q psy14626        240 K-LHIL  244 (249)
Q Consensus       240 ~-~~~~  244 (249)
                      . +.+|
T Consensus       229 ~~~~~p  234 (285)
T d1u59a_         229 KRMECP  234 (285)
T ss_dssp             CCCCCC
T ss_pred             CCCCCC
Confidence            6 4444

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.3e-44  Score=289.28  Aligned_cols=221  Identities=24%  Similarity=0.363  Sum_probs=174.0

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCccc---CChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----e
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFG---LPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG----M   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~   79 (249)
                      +.||++.+.++.|.++.+|...+......++   +.+....+....+.+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            4689999999999999999876544433333   43444555566778999999999999999999999996543    4


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      +|+||||++|++|.+++.....    +++.+++.++.|++.||.|||++|++||||||+||+++.++.   .+++|||.+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~----l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~---~~l~d~~~~  158 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA---VKVMDFGIA  158 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC---EEECCCTTC
T ss_pred             EEEEEECCCCCEehhhhcccCC----CCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc---ceeehhhhh
Confidence            8999999999999988876654    899999999999999999999999999999999999988776   899999988


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      .........          ........||+.|+|||++.+..+++++||||+||++|+|++|+.||.+ +..++...+.+
T Consensus       159 ~~~~~~~~~----------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~  228 (277)
T d1o6ya_         159 RAIADSGNS----------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR  228 (277)
T ss_dssp             EECC--------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             hhhcccccc----------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh
Confidence            665442211          1122234589999999999999999999999999999999999999998 55566666666


Q ss_pred             Cccccc
Q psy14626        239 GKLHIL  244 (249)
Q Consensus       239 g~~~~~  244 (249)
                      +.+..|
T Consensus       229 ~~~~~~  234 (277)
T d1o6ya_         229 EDPIPP  234 (277)
T ss_dssp             CCCCCG
T ss_pred             cCCCCC
Confidence            655444

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.2e-43  Score=285.62  Aligned_cols=217  Identities=27%  Similarity=0.489  Sum_probs=180.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccc---c------chhHHHHHHHHHHHHHcC-CCChhhhhheeec
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLN---H------YTTEADLKREATICHMLK-HPHVVELLETYSS   76 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~------~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~   76 (249)
                      .++|.+.+.|+.|.++.+|...+......++++.....   .      ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            46899999999999999998776655545554432211   1      223457899999999996 9999999999999


Q ss_pred             CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         77 EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                      ++.+|+||||+++++|.+++..+..    +++.+++.++.||+.||.|||++|++||||||+||+++.++.   ++|+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~---~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN---IKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC---EEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC---eEEccc
Confidence            9999999999999999999976654    899999999999999999999999999999999999987666   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCCCC-Ch
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED------QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SR  229 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~~l~el~~g~~pf~~-~~  229 (249)
                      |++........              .....+|+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.+ +.
T Consensus       155 G~a~~~~~~~~--------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~  220 (277)
T d1phka_         155 GFSCQLDPGEK--------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ  220 (277)
T ss_dssp             TTCEECCTTCC--------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             hheeEccCCCc--------------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH
Confidence            99987765321              112358999999999863      3357899999999999999999999999 56


Q ss_pred             HHHHHHHHcCccccc
Q psy14626        230 DRLFQSITKGKLHIL  244 (249)
Q Consensus       230 ~~~~~~i~~g~~~~~  244 (249)
                      ..+.+.|.++..++|
T Consensus       221 ~~~~~~i~~~~~~~~  235 (277)
T d1phka_         221 MLMLRMIMSGNYQFG  235 (277)
T ss_dssp             HHHHHHHHHTCCCCC
T ss_pred             HHHHHHHHhCCCCCC
Confidence            678888999887655

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-43  Score=282.98  Aligned_cols=213  Identities=21%  Similarity=0.355  Sum_probs=166.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEecc
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYM   87 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (249)
                      +.|++.+.|+.|.++.+|...... ...++++... .+....+.+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECC-SSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEEC-CCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            368899999999999988765432 1122332222 23344578999999999999999999999999999999999999


Q ss_pred             CCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCc
Q psy14626         88 DGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQL  167 (249)
Q Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~  167 (249)
                      ++|+|.+++.....   .+++..++.++.|++.||.|||+++++||||||+|||++.++.   +||+|||+++.......
T Consensus        83 ~~g~L~~~l~~~~~---~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~---~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV---IKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TTCBHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC---EEECSCC----------
T ss_pred             CCCcHHHHhhcccc---CCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC---eEecccchheeccCCCc
Confidence            99999998865433   3889999999999999999999999999999999999988776   99999999976654321


Q ss_pred             cccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        168 YCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                                  .......+|+.|+|||++.+..++.++||||+||++|||++ |.+||.. +..++.+.+.+|.
T Consensus       157 ------------~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~  219 (263)
T d1sm2a_         157 ------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF  219 (263)
T ss_dssp             --------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC
T ss_pred             ------------eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC
Confidence                        11122357899999999999999999999999999999999 6777877 5667888888874

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=284.10  Aligned_cols=215  Identities=19%  Similarity=0.348  Sum_probs=173.1

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      |.++|++.+.|+.|.++.+|...... ...++++... ......+.|.+|+.++++++||||+++++++.++ .+++|||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~iv~E   87 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITE   87 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEEC-TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEECC-CCEEEEEEEc-cCcCCHHHHHHHHHHHHhCCCCCEeEEEeeeccC-CeEEEEE
Confidence            34689999999999999999776542 2223333222 2234567899999999999999999999988654 5799999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+++|+|.+++......  .+++.+++.++.|++.||.|||+++++||||||+|||++.++.   ++|+|||+++.....
T Consensus        88 y~~~g~L~~~~~~~~~~--~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~---~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          88 YMENGSLVDFLKTPSGI--KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS---CKIADFGLARLIEDN  162 (272)
T ss_dssp             CCTTCBHHHHTTSHHHH--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC---EEECCCTTCEECSSS
T ss_pred             eCCCCcHHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc---eeeccccceEEccCC
Confidence            99999998877654432  3899999999999999999999999999999999999987766   999999999877653


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ...            ......+++.|+|||++.+..++.++||||+||++|||++ |.+||.. +..++.+.+.+|.
T Consensus       163 ~~~------------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~  227 (272)
T d1qpca_         163 EYT------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY  227 (272)
T ss_dssp             CEE------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC
T ss_pred             ccc------------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence            321            1122357899999999998889999999999999999999 5666666 5667888888764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-43  Score=283.56  Aligned_cols=216  Identities=21%  Similarity=0.344  Sum_probs=170.5

Q ss_pred             chHHH-hhcccceeeEeeecccc-----CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEE
Q psy14626         10 ITIHE-VINHKWLKMKLHTSAEI-----EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus        10 ~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      +++++ .|+.|.++.+|......     .++++.+... ..+....+.+.+|+.+|++++||||++++++|..+ ..++|
T Consensus         8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lv   85 (277)
T d1xbba_           8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV   85 (277)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEE
T ss_pred             CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChh-hCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEE
Confidence            44444 58999999998764321     1233333222 23445567899999999999999999999999654 57899


Q ss_pred             EeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEcc
Q psy14626         84 FEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~  163 (249)
                      |||+++|+|.+++.....    +++.++..++.|++.||.|||+++++||||||+|||++.++.   ++++|||+++...
T Consensus        86 mE~~~~g~L~~~l~~~~~----l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~---~kl~DFGla~~~~  158 (277)
T d1xbba_          86 MEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY---AKISDFGLSKALR  158 (277)
T ss_dssp             EECCTTEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE---EEECCCTTCEECC
T ss_pred             EEcCCCCcHHHHHhhccC----CCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc---ccccchhhhhhcc
Confidence            999999999998876544    899999999999999999999999999999999999998776   9999999998765


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc-
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK-  240 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~-  240 (249)
                      .....          ........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+ +..++...|.+|. 
T Consensus       159 ~~~~~----------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~  228 (277)
T d1xbba_         159 ADENY----------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER  228 (277)
T ss_dssp             TTCSE----------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ccccc----------cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            43211          111222357899999999999889999999999999999998 9999998 6677888888875 


Q ss_pred             cccc
Q psy14626        241 LHIL  244 (249)
Q Consensus       241 ~~~~  244 (249)
                      +.+|
T Consensus       229 ~~~p  232 (277)
T d1xbba_         229 MGCP  232 (277)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            4554

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.4e-43  Score=293.57  Aligned_cols=216  Identities=20%  Similarity=0.380  Sum_probs=173.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccchhHHHHHHH---HHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHYTTEADLKRE---ATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~E---~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      +.|.+.++|+.|.++.+|...+......++++   +...........+.+|   +.+++.++||||++++++|.+.+.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            36889999999999999977765444444443   3333333444455555   56666678999999999999999999


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++|++|.+++.....    +++..++.++.||+.||.|||++|++||||||+|||++.++.   ++|+|||++..
T Consensus        84 ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~---iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH---VRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC---EEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhccc----ccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc---EEEeeeceeee
Confidence            99999999999999877654    899999999999999999999999999999999999987776   99999999987


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC----hHHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGS----RDRLFQSI  236 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~~----~~~~~~~i  236 (249)
                      .....               .....||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.    ...+...+
T Consensus       157 ~~~~~---------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~  221 (364)
T d1omwa3         157 FSKKK---------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT  221 (364)
T ss_dssp             CSSSC---------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS
T ss_pred             cCCCc---------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            65432               122358999999999864 56899999999999999999999999872    23455555


Q ss_pred             HcCcccccc
Q psy14626        237 TKGKLHILG  245 (249)
Q Consensus       237 ~~g~~~~~~  245 (249)
                      ....+.+|.
T Consensus       222 ~~~~~~~~~  230 (364)
T d1omwa3         222 LTMAVELPD  230 (364)
T ss_dssp             SSCCCCCCS
T ss_pred             ccCCCCCCC
Confidence            566666654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-43  Score=292.87  Aligned_cols=218  Identities=20%  Similarity=0.324  Sum_probs=168.3

Q ss_pred             CcchHHHhhcccceeeEeeeccccCC----C-cccCChh-ccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEP----A-SFGLPDE-RLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~-~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (249)
                      ++|.+.++|+.|.++.+|........    + .++++.. ..........+.+|+.+++++ +||||+++++++.+.+.+
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            57889999999999999876543211    1 1222211 112234456789999999998 899999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhhc-------------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCee
Q psy14626         81 YMVFEYMDGSDICFEIVRRATA-------------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVL  141 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~-------------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nil  141 (249)
                      ++||||+++|+|.+++..+...                   ...+++.+++.++.|++.||.|||+++++||||||+||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil  196 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL  196 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence            9999999999999999765321                   234889999999999999999999999999999999999


Q ss_pred             eeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-
Q psy14626        142 LANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-  220 (249)
Q Consensus       142 i~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-  220 (249)
                      ++.++.   ++|+|||+++.......           .+......+|+.|+|||++.+..++.++||||+||++|||++ 
T Consensus       197 l~~~~~---~Kl~DFGla~~~~~~~~-----------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         197 VTHGKV---VKICDFGLARDIMSDSN-----------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             EETTTE---EEECCCGGGSCGGGCTT-----------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             cccCCe---EEEeeccccccccCCCc-----------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhC
Confidence            987766   99999999866544221           111223347899999999999999999999999999999998 


Q ss_pred             CCCCCCC-Ch-HHHHHHHHcC
Q psy14626        221 GTLPFVG-SR-DRLFQSITKG  239 (249)
Q Consensus       221 g~~pf~~-~~-~~~~~~i~~g  239 (249)
                      |+.||.+ +. +.+.+.+.++
T Consensus       263 g~~Pf~~~~~~~~~~~~~~~~  283 (325)
T d1rjba_         263 GVNPYPGIPVDANFYKLIQNG  283 (325)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTT
T ss_pred             CCCCCCCCCHHHHHHHHHhcC
Confidence            9999998 44 4445444444

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-42  Score=278.61  Aligned_cols=215  Identities=20%  Similarity=0.333  Sum_probs=177.7

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEE
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVF   84 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (249)
                      || +.|++.+.|+.|.++.+|..... ....++++.... .....+.+.+|+.++++++||||++++++|.+.+.+++||
T Consensus         2 ~~-~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~-~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           2 DP-KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CC-CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEES-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             Ch-HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECc-CcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            55 57889999999999999877754 222233332222 2334578999999999999999999999999999999999


Q ss_pred             eccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccC
Q psy14626         85 EYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQD  164 (249)
Q Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~  164 (249)
                      ||+.+|+|..++......   +++..++.++.|++.||.|||++|++||||||+||+++.++.   ++|+|||+++....
T Consensus        79 Ey~~~g~l~~~~~~~~~~---~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~---~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV---VKVSDFGLSRYVLD  152 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGC---CCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC---EEECCCSSCCBCSS
T ss_pred             EccCCCcHHHhhhccccC---CcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc---EEECcchhheeccC
Confidence            999999998887665443   889999999999999999999999999999999999987665   99999999976554


Q ss_pred             CCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        165 GQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ...            .......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.+ +.+++.+.|.+|.
T Consensus       153 ~~~------------~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~  218 (258)
T d1k2pa_         153 DEY------------TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGL  218 (258)
T ss_dssp             SSC------------CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC
T ss_pred             CCc------------eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCC
Confidence            321            11122357889999999999999999999999999999998 8999998 6778888888874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-43  Score=292.14  Aligned_cols=216  Identities=28%  Similarity=0.464  Sum_probs=173.0

Q ss_pred             CcchHH-HhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHc-CCCChhhhhheeec----CCeEE
Q psy14626          8 KRITIH-EVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHML-KHPHVVELLETYSS----EGMLY   81 (249)
Q Consensus         8 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~   81 (249)
                      .+|.+. ++|+.|.++.+|...+......++++...     ....+.+|+.++.++ +||||++++++|++    +..+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~-----~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE-----CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC-----CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            467764 57999999999988776555566655432     235678999987655 89999999999865    45689


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++||+|.+++..+..  ..+++.+++.++.|++.||.|||++|++||||||+|||++.++....++|+|||++..
T Consensus        86 ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            99999999999999875432  3499999999999999999999999999999999999998766666799999999977


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCCh-----HHHHHHH
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGSR-----DRLFQSI  236 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~~-----~~~~~~i  236 (249)
                      .....              ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..     ..+...+
T Consensus       164 ~~~~~--------------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i  229 (335)
T d2ozaa1         164 TTSHN--------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI  229 (335)
T ss_dssp             CCCCC--------------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC
T ss_pred             ccCCC--------------ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH
Confidence            65532              1122358999999999999999999999999999999999999998732     2345566


Q ss_pred             HcCccccc
Q psy14626        237 TKGKLHIL  244 (249)
Q Consensus       237 ~~g~~~~~  244 (249)
                      ..+++.+|
T Consensus       230 ~~~~~~~~  237 (335)
T d2ozaa1         230 RMGQYEFP  237 (335)
T ss_dssp             CSCSSSCC
T ss_pred             hcCCCCCC
Confidence            66776666

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-42  Score=280.33  Aligned_cols=223  Identities=22%  Similarity=0.359  Sum_probs=168.8

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCC---CcccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEP---ASFGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSE   77 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (249)
                      |+++. ++|.+.+.|+.|.++.+|........   ..++++.. ........+.+.+|+.++++++||||+++++++.+ 
T Consensus         2 ~ei~~-~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-   79 (273)
T d1mp8a_           2 YEIQR-ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-   79 (273)
T ss_dssp             CBCCG-GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             CCcCH-HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            44543 47999999999999999876543221   12222222 22334556789999999999999999999999965 


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      +.+++||||+.+|+|.+++.....   .+++.+++.++.|++.||.|||+++++||||||+||+++.++.   +||+|||
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~---~Kl~DfG  153 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFG  153 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTT---TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE---EEECC--
T ss_pred             CeEEEEEEeccCCcHHhhhhccCC---CCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc---EEEccch
Confidence            568999999999999887765433   3899999999999999999999999999999999999998776   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~  235 (249)
                      ++........            .......+|+.|+|||.+.+..++.++||||+||++|||++ |.+||.+ +..++.+.
T Consensus       154 ~a~~~~~~~~------------~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~  221 (273)
T d1mp8a_         154 LSRYMEDSTY------------YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR  221 (273)
T ss_dssp             -----------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred             hheeccCCcc------------eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9976544221            11112347889999999999999999999999999999998 9999998 66778888


Q ss_pred             HHcCc-cccc
Q psy14626        236 ITKGK-LHIL  244 (249)
Q Consensus       236 i~~g~-~~~~  244 (249)
                      +.+|. +++|
T Consensus       222 i~~~~~~~~~  231 (273)
T d1mp8a_         222 IENGERLPMP  231 (273)
T ss_dssp             HHTTCCCCCC
T ss_pred             HHcCCCCCCC
Confidence            88876 4444

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-42  Score=278.40  Aligned_cols=221  Identities=18%  Similarity=0.288  Sum_probs=167.7

Q ss_pred             cCCCCCcchHHHhhcccceeeEeeeccccCC----CcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecC
Q psy14626          3 SVDPNKRITIHEVINHKWLKMKLHTSAEIEP----ASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSE   77 (249)
Q Consensus         3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (249)
                      +.+|.. |+...+|+.|.++.+|........    ..++++... .......+.|.+|+.++++++||||+++++++.+.
T Consensus         3 ei~~~~-~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSC-VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTT-EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHH-eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            456654 889999999999999876543221    112222211 12234456799999999999999999999999999


Q ss_pred             CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         78 GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      +..++||||+.++++.+.+.....   .+++.++..++.|++.||.|||+++++||||||+|||++.++.   +||+|||
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~---~Kl~DFG  155 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV---CKVSDFG  155 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCC
T ss_pred             CceEEEEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe---EEEcccc
Confidence            999999999999999887765433   3899999999999999999999999999999999999987766   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCC-ChHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG-TLPFVG-SRDRLFQS  235 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~pf~~-~~~~~~~~  235 (249)
                      +++........          ........+|+.|+|||++.+..++.++|||||||++|||++| .+|+.+ +..++.+.
T Consensus       156 la~~~~~~~~~----------~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~  225 (283)
T d1mqba_         156 LSRVLEDDPEA----------TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA  225 (283)
T ss_dssp             C---------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             hhhcccCCCcc----------ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH
Confidence            99776543211          0111122478899999999999999999999999999999995 555655 56778888


Q ss_pred             HHcCc
Q psy14626        236 ITKGK  240 (249)
Q Consensus       236 i~~g~  240 (249)
                      +.+|.
T Consensus       226 i~~~~  230 (283)
T d1mqba_         226 INDGF  230 (283)
T ss_dssp             HHTTC
T ss_pred             HhccC
Confidence            88764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-42  Score=276.78  Aligned_cols=219  Identities=23%  Similarity=0.344  Sum_probs=169.5

Q ss_pred             CcchHHHhhcccceeeEeeecccc------CCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI------EPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      +.|++.+.|+.|.++.+|......      .++++.+.+.........+.|.+|+.+|++++||||+++++++.++ .++
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            458999999999999998665322      2344555555555566678899999999999999999999999765 578


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||++++++.+++..+...   +++..++.++.|++.||.|||+++++||||||+||+++.++.   ++|+|||++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~---l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~---vkl~DfGl~~~  160 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGH---FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL---VKIGDFGLMRA  160 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGG---SCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE---EEECCCTTCEE
T ss_pred             eeeeeecCcchhhhhhcccCC---CCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc---eeeccchhhhh
Confidence            999999999998887765442   899999999999999999999999999999999999998776   99999999987


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g  239 (249)
                      ........          .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+ +..++.+.+.++
T Consensus       161 ~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~  230 (273)
T d1u46a_         161 LPQNDDHY----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE  230 (273)
T ss_dssp             CCC-CCEE----------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTS
T ss_pred             cccCCCcc----------eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhC
Confidence            75533211          11122236778999999999999999999999999999998 8999998 667788888776


Q ss_pred             cccc
Q psy14626        240 KLHI  243 (249)
Q Consensus       240 ~~~~  243 (249)
                      ...+
T Consensus       231 ~~~~  234 (273)
T d1u46a_         231 GERL  234 (273)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            5433

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-42  Score=278.13  Aligned_cols=222  Identities=17%  Similarity=0.289  Sum_probs=171.4

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLY   81 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (249)
                      |++|+ ++|++.+.|+.|.++.+|....... ..++++... ......+.|.+|+.++++++||||+++++++.++ .++
T Consensus        12 ~~i~~-~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~-~~~   87 (285)
T d1fmka3          12 WEIPR-ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIY   87 (285)
T ss_dssp             SBCCG-GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECC-TTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             eEcCH-HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEEC-cccCCHHHHHHHHHHHHhcccCCEeEEEEEEecC-CeE
Confidence            56654 5799999999999999987765432 223333222 2234457899999999999999999999999654 578


Q ss_pred             EEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626         82 MVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      +||||+++|+|..++......  .+++.+++.++.|++.||.|||+++++||||||+|||++.++.   ++|+|||+++.
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~--~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~---~kl~DfGla~~  162 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV---CKVADFGLARL  162 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC---EEECCCCTTC-
T ss_pred             EEEEecCCCchhhhhhhcccc--cchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc---EEEcccchhhh
Confidence            999999999998887765433  3899999999999999999999999999999999999988776   99999999876


Q ss_pred             ccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCC-ChHHHHHHHHcC
Q psy14626        162 LQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG-TLPFVG-SRDRLFQSITKG  239 (249)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~pf~~-~~~~~~~~i~~g  239 (249)
                      ......            .......+|+.|+|||++.+..++.++||||+||++|||++| ++|+.. ...++.+.+.++
T Consensus       163 ~~~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~  230 (285)
T d1fmka3         163 IEDNEY------------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG  230 (285)
T ss_dssp             -------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred             ccCCCc------------eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence            543221            111223478999999999999999999999999999999994 555665 566778888766


Q ss_pred             c-cccc
Q psy14626        240 K-LHIL  244 (249)
Q Consensus       240 ~-~~~~  244 (249)
                      . +.+|
T Consensus       231 ~~~~~~  236 (285)
T d1fmka3         231 YRMPCP  236 (285)
T ss_dssp             CCCCCC
T ss_pred             CCCCCC
Confidence            3 3444

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-42  Score=274.41  Aligned_cols=218  Identities=21%  Similarity=0.388  Sum_probs=169.9

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec-CCeE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS-EGML   80 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   80 (249)
                      |+.+.+ .|++.++|+.|.++.+|.....  ...++++.  +......+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus         2 w~i~~~-~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~--i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           2 WALNMK-ELKLLQTIGKGEFGDVMLGDYR--GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CBCCGG-GEEEEEEEEECSSCEEEEEEET--TEEEEEEE--CCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CccCHH-HeEEeEEEecCCCeEEEEEEEC--CeEEEEEE--ECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            566666 4888999999999998866543  11233322  2233456789999999999999999999999854 4568


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+++|+|.+++..+...  .+++..++.++.|++.||.|||+++++||||||+||+++.++.   ++++|||.+.
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~--~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~---~kl~dfg~s~  151 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRS--VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---AKVSDFGLTK  151 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHH--HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC---EEECCCCC--
T ss_pred             EEEEeccCCCCHHHHHHhcCCC--CCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC---Eeecccccce
Confidence            9999999999999998765432  3899999999999999999999999999999999999988776   9999999987


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHc
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~  238 (249)
                      ......                ....++..|+|||++.+..+++++|||||||++|||++ |++||.. +..++.+.|.+
T Consensus       152 ~~~~~~----------------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~  215 (262)
T d1byga_         152 EASSTQ----------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK  215 (262)
T ss_dssp             --------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT
T ss_pred             ecCCCC----------------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc
Confidence            654322                12246889999999999999999999999999999998 8999998 66778888877


Q ss_pred             C-cccccc
Q psy14626        239 G-KLHILG  245 (249)
Q Consensus       239 g-~~~~~~  245 (249)
                      | ++++|.
T Consensus       216 ~~~~~~~~  223 (262)
T d1byga_         216 GYKMDAPD  223 (262)
T ss_dssp             TCCCCCCT
T ss_pred             CCCCCCCc
Confidence            5 355553

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-41  Score=278.38  Aligned_cols=219  Identities=19%  Similarity=0.257  Sum_probs=171.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCC---Cc-ccCChh-ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEP---AS-FGLPDE-RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYM   82 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (249)
                      ..|++.++|+.|.++.+|........   +. ++++.. ...+....+.+.+|+.++++++||||++++++|.++. .++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence            45889999999999999876543221   11 122211 1233455778999999999999999999999998765 678


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      +++++.+++|.+.+.....   .+++..++.++.|++.||.|||+++++||||||+||+++.++.   ++|+|||++...
T Consensus        88 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~---~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH---VKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSS---SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE---EEECCCSHHHHT
T ss_pred             EEEeccCCccccccccccc---CCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC---eEeeccccceec
Confidence            8899989999887766533   3899999999999999999999999999999999999998776   999999998765


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCC-ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPFVG-SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf~~-~~~~~~~~i~~g~  240 (249)
                      ......           .......+|+.|+|||++.+..++.++|||||||++|||++ |++||.+ +..++...+.+|.
T Consensus       162 ~~~~~~-----------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~  230 (317)
T d1xkka_         162 GAEEKE-----------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE  230 (317)
T ss_dssp             TTTCC-------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTC
T ss_pred             cccccc-----------ccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence            442211           11122347899999999999999999999999999999998 8999998 6677888888876


Q ss_pred             -cccc
Q psy14626        241 -LHIL  244 (249)
Q Consensus       241 -~~~~  244 (249)
                       +..|
T Consensus       231 ~~~~p  235 (317)
T d1xkka_         231 RLPQP  235 (317)
T ss_dssp             CCCCC
T ss_pred             CCCCC
Confidence             4444

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-41  Score=278.87  Aligned_cols=205  Identities=25%  Similarity=0.409  Sum_probs=160.0

Q ss_pred             HhhcccceeeEeeeccccCCCcccCChhcccc-----chhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEeccC
Q psy14626         14 EVINHKWLKMKLHTSAEIEPASFGLPDERLNH-----YTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFEYMD   88 (249)
Q Consensus        14 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (249)
                      ++|+.|.++.+|...+......++++......     ....+.+.+|+.++++++||||+++++++..++.+++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            56888999999987765544444444322211     1123568999999999999999999999999999999999998


Q ss_pred             CCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCCCcc
Q psy14626         89 GSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDGQLY  168 (249)
Q Consensus        89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~~~~  168 (249)
                      ++++......    ...+++.+++.++.||+.||+|||++|++||||||+|||++.++.   ++|+|||.+.......  
T Consensus        84 ~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~---~KL~DFG~a~~~~~~~--  154 (299)
T d1ua2a_          84 TDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLADFGLAKSFGSPN--  154 (299)
T ss_dssp             EEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCCGGGSTTTSCC--
T ss_pred             chHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc---cccccCccccccCCCc--
Confidence            8766544322    234899999999999999999999999999999999999987766   9999999986544322  


Q ss_pred             ccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        169 CSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                                 .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+ +..+....|.+
T Consensus       155 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~  215 (299)
T d1ua2a_         155 -----------RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE  215 (299)
T ss_dssp             -----------CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             -----------ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHH
Confidence                       112223589999999998654 569999999999999999999999998 44455555554

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-41  Score=275.24  Aligned_cols=212  Identities=23%  Similarity=0.417  Sum_probs=167.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCC---hhccccc---hhHHHHHHHHHHHHHcC--CCChhhhhheeecCC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLP---DERLNHY---TTEADLKREATICHMLK--HPHVVELLETYSSEG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~   78 (249)
                      +.||++.++|+.|.++.+|...+......++++   +......   ....++.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            568999999999999999876655443334433   3322221   22345778999999996  899999999999999


Q ss_pred             eEEEEEeccCC-CchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         79 MLYMVFEYMDG-SDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        79 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                      .+++|||++.+ +++.+++.....    +++.+++.++.|++.||.|||++|++||||||+|||++.++.  .++|+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~----l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~--~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCC--eEEECccc
Confidence            99999999975 577777765543    899999999999999999999999999999999999985432  28999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCCChHHHHHHH
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKY-GKPVDIWAAGVLLHVLLTGTLPFVGSRDRLFQSI  236 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~pf~~~~~~~~~~i  236 (249)
                      ++.......               .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+..     .+
T Consensus       157 ~a~~~~~~~---------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i  216 (273)
T d1xwsa_         157 SGALLKDTV---------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI  216 (273)
T ss_dssp             TCEECCSSC---------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred             cceeccccc---------------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH
Confidence            997654422               122358999999999987665 677999999999999999999998732     34


Q ss_pred             HcCccccc
Q psy14626        237 TKGKLHIL  244 (249)
Q Consensus       237 ~~g~~~~~  244 (249)
                      .++...+|
T Consensus       217 ~~~~~~~~  224 (273)
T d1xwsa_         217 IRGQVFFR  224 (273)
T ss_dssp             HHCCCCCS
T ss_pred             hhcccCCC
Confidence            55555554

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-41  Score=274.73  Aligned_cols=211  Identities=27%  Similarity=0.432  Sum_probs=165.2

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++|++.+.++.|.++.+|...+......++++....  ......+.+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            368888999999999999887654444444433221  222345789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      |+.+ ++.+++.....  ..+++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||.+......
T Consensus        82 ~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~---~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA---IKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECSTTHHHHHCCC
T ss_pred             ecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc---ceeccCCcceeccCC
Confidence            9976 44444443322  23899999999999999999999999999999999999987665   999999998665432


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      .             .......+|+.|+|||.+.... .+.++|+||+||++|+|++|+.||.+ +.......+.
T Consensus       156 ~-------------~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~  216 (298)
T d1gz8a_         156 V-------------RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF  216 (298)
T ss_dssp             S-------------BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             c-------------ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHH
Confidence            2             1222335899999999977655 48899999999999999999999998 4444444443

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.7e-41  Score=274.06  Aligned_cols=222  Identities=22%  Similarity=0.331  Sum_probs=176.5

Q ss_pred             CCCcchHHHhhcccceeeEeeecccc-----CCCcccCChhcc-ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCe
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDERL-NHYTTEADLKREATICHMLKHPHVVELLETYSSEGM   79 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (249)
                      |..+|.+.+.|+.|.++.+|......     ....++++.... ......+.|.+|+.++++++||||+++++++.+.+.
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            56789999999999999998775431     111223322211 223456789999999999999999999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhh--------------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCC
Q psy14626         80 LYMVFEYMDGSDICFEIVRRAT--------------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHC  139 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~N  139 (249)
                      .+++||++++++|.+++.....                    ....+++..++.++.|++.||.|||+++++||||||+|
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N  170 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN  170 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence            9999999999999999865321                    12247889999999999999999999999999999999


Q ss_pred             eeeeecCCCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHH
Q psy14626        140 VLLANKENSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLL  219 (249)
Q Consensus       140 ili~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~  219 (249)
                      ||++.++.   +||+|||++....+...           ........+++.|+|||.+.+..++.++|||||||++|||+
T Consensus       171 ILld~~~~---~Kl~DFGls~~~~~~~~-----------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell  236 (301)
T d1lufa_         171 CLVGENMV---VKIADFGLSRNIYSADY-----------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF  236 (301)
T ss_dssp             EEECGGGC---EEECCCSCHHHHTGGGC-----------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred             eEECCCCc---EEEccchhheeccCCcc-----------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHH
Confidence            99988776   99999999865433221           11122234788999999999999999999999999999999


Q ss_pred             hC-CCCCCC-ChHHHHHHHHcCcc
Q psy14626        220 TG-TLPFVG-SRDRLFQSITKGKL  241 (249)
Q Consensus       220 ~g-~~pf~~-~~~~~~~~i~~g~~  241 (249)
                      +| .+||.+ +..++...+.+|..
T Consensus       237 ~~~~~p~~~~~~~e~~~~v~~~~~  260 (301)
T d1lufa_         237 SYGLQPYYGMAHEEVIYYVRDGNI  260 (301)
T ss_dssp             TTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCC
Confidence            97 478888 67788888988873

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-41  Score=275.09  Aligned_cols=220  Identities=20%  Similarity=0.351  Sum_probs=173.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCc--ccCCh-hccccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeEEEE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPAS--FGLPD-ERLNHYTTEADLKREATICHML-KHPHVVELLETYSSEGMLYMV   83 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv   83 (249)
                      +.|++.++|+.|.++.+|..........  .+++. .........+.+.+|+.+|+++ +||||+++++++.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            5788899999999999987665433221  22222 1222334566899999999999 799999999999999999999


Q ss_pred             EeccCCCchhHHHHHhh------------hcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCe
Q psy14626         84 FEYMDGSDICFEIVRRA------------TAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPV  151 (249)
Q Consensus        84 ~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~  151 (249)
                      |||+++|+|.+++..+.            .....+++..+..++.|++.||.|||+++++||||||+|||++.++.   +
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~---~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV---A  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC---E
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc---e
Confidence            99999999999987542            22345899999999999999999999999999999999999988776   9


Q ss_pred             EEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCC-Ch
Q psy14626        152 KLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG-TLPFVG-SR  229 (249)
Q Consensus       152 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~pf~~-~~  229 (249)
                      +|+|||+++......              ......+|..|+|||.+.+..++.++|||||||++|||++| .+||.+ +.
T Consensus       167 kl~DfG~a~~~~~~~--------------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~  232 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC  232 (309)
T ss_dssp             EECCTTCEESSCEEC--------------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEccccccccccccc--------------cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH
Confidence            999999986544321              11123478999999999999999999999999999999995 568887 67


Q ss_pred             HHHHHHHHcC-ccccc
Q psy14626        230 DRLFQSITKG-KLHIL  244 (249)
Q Consensus       230 ~~~~~~i~~g-~~~~~  244 (249)
                      .++.+.|.+| ++++|
T Consensus       233 ~~~~~~i~~~~~~~~~  248 (309)
T d1fvra_         233 AELYEKLPQGYRLEKP  248 (309)
T ss_dssp             HHHHHHGGGTCCCCCC
T ss_pred             HHHHHHHHhcCCCCCC
Confidence            7888888876 35444

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-40  Score=268.82  Aligned_cols=223  Identities=22%  Similarity=0.360  Sum_probs=173.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCC-------CcccCChhcc-ccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCC
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEP-------ASFGLPDERL-NHYTTEADLKREATICHML-KHPHVVELLETYSSEG   78 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~   78 (249)
                      ++|.+.+.|+.|.++.+|........       ..++++.... ........+.+|+..+.++ +||||++++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            68999999999999998875532111       1122222211 1224457789999999888 8999999999999999


Q ss_pred             eEEEEEeccCCCchhHHHHHhhh------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRAT------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                      .+++||||+.+|+|.+++..+..            ....+++.+++.++.|++.||.|||+++++||||||+|||++.++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~  172 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN  172 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCC
Confidence            99999999999999999976542            123589999999999999999999999999999999999998877


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF  225 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf  225 (249)
                      .   ++|+|||++........           ........+++.|+|||.+.+..++.++||||||+++|||++ |++||
T Consensus       173 ~---~kl~dfg~~~~~~~~~~-----------~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         173 V---MKIADFGLARDIHHIDY-----------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             C---EEECSTTCCCCGGGCCT-----------TCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             C---eEeccchhhcccccccc-----------ccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCC
Confidence            6   99999999876654321           112233457889999999999999999999999999999998 89999


Q ss_pred             CC-ChHHHHHHHHcCc-cccc
Q psy14626        226 VG-SRDRLFQSITKGK-LHIL  244 (249)
Q Consensus       226 ~~-~~~~~~~~i~~g~-~~~~  244 (249)
                      .+ +.+++.+.+.+|. +.+|
T Consensus       239 ~~~~~~~~~~~i~~~~~~~~p  259 (299)
T d1fgka_         239 PGVPVEELFKLLKEGHRMDKP  259 (299)
T ss_dssp             TTCCHHHHHHHHHTTCCCCCC
T ss_pred             CCCCHHHHHHHHHcCCCCCCC
Confidence            98 6677888887764 4444

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-40  Score=267.56  Aligned_cols=224  Identities=20%  Similarity=0.298  Sum_probs=165.9

Q ss_pred             CCcchHHHhhcccceeeEeeecccc-----CCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeec-CC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEI-----EPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSS-EG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-~~   78 (249)
                      .++|++.+.|+.|.++.+|......     ....++++... .......+.+.+|+.++.++ +|+||+.+++++.+ +.
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            3689999999999999988655321     11123332221 12234456788888888887 68999999998765 45


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhc------------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATA------------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~------------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                      .+++||||+++|+|.+++......            ...+++.+++.++.|++.||.|||+++++||||||+|||++.++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence            689999999999999999765431            22488999999999999999999999999999999999998877


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG-TLPF  225 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~pf  225 (249)
                      .   +||+|||+++.......           ........||+.|+|||.+.+..++.++||||+||++|||++| .+||
T Consensus       172 ~---~Kl~DFGla~~~~~~~~-----------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~  237 (299)
T d1ywna1         172 V---VKICDFGLARDIYKDPD-----------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  237 (299)
T ss_dssp             C---EEECC------CCSCTT-----------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             c---EEEccCcchhhcccccc-----------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence            6   99999999976554321           1122234589999999999999999999999999999999985 6789


Q ss_pred             CC--ChHHHHHHHHcCc-cccc
Q psy14626        226 VG--SRDRLFQSITKGK-LHIL  244 (249)
Q Consensus       226 ~~--~~~~~~~~i~~g~-~~~~  244 (249)
                      .+  ..+.+...+.+|. +.+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~  259 (299)
T d1ywna1         238 PGVKIDEEFCRRLKEGTRMRAP  259 (299)
T ss_dssp             TTCCCSHHHHHHHHHTCCCCCC
T ss_pred             CCCCHHHHHHHHHhcCCCCCCC
Confidence            87  3456667777664 4444

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-40  Score=269.06  Aligned_cols=213  Identities=23%  Similarity=0.328  Sum_probs=163.4

Q ss_pred             CCCcchHHHhhcccceeeEeeeccccC-CCcccCChhcc--ccchhHHHHHHHHHHHHHc---CCCChhhhhheeec---
Q psy14626          6 PNKRITIHEVINHKWLKMKLHTSAEIE-PASFGLPDERL--NHYTTEADLKREATICHML---KHPHVVELLETYSS---   76 (249)
Q Consensus         6 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l---~h~~i~~~~~~~~~---   76 (249)
                      .++||.+.+.|+.|.++.+|...+... ...++++....  ........+.+|+.+++.+   +||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            467999999999999999997765322 22233332221  1222234566788887776   79999999999853   


Q ss_pred             --CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         77 --EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        77 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                        ...++++||++.++++.......   ...+++..++.++.|++.||.|||+++++||||||+|||++.++.   ++|+
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~---~kl~  158 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ---IKLA  158 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEEC
T ss_pred             ccCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC---eeec
Confidence              34689999999887664433322   234899999999999999999999999999999999999987766   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLF  233 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~  233 (249)
                      |||.+......              .......||+.|+|||++.+.+++.++||||+||++|||++|+.||.+ +..+..
T Consensus       159 dfg~~~~~~~~--------------~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  224 (305)
T d1blxa_         159 DFGLARIYSFQ--------------MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL  224 (305)
T ss_dssp             SCCSCCCCCGG--------------GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             chhhhhhhccc--------------ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHH
Confidence            99997544321              122334589999999999999999999999999999999999999998 444555


Q ss_pred             HHHHc
Q psy14626        234 QSITK  238 (249)
Q Consensus       234 ~~i~~  238 (249)
                      ..|.+
T Consensus       225 ~~i~~  229 (305)
T d1blxa_         225 GKILD  229 (305)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            55543

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=267.63  Aligned_cols=214  Identities=23%  Similarity=0.306  Sum_probs=166.9

Q ss_pred             chHHHhhcccceeeEeeeccccC------CCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec-CCeEEE
Q psy14626         10 ITIHEVINHKWLKMKLHTSAEIE------PASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS-EGMLYM   82 (249)
Q Consensus        10 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l   82 (249)
                      +.++++|+.|.++.+|.......      ++++.+.  ...+....++|.+|+.+|++++||||+++++++.+ ++.+++
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~--~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEEC--CCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEEC--cccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            34478899999999987553221      2233222  23445667889999999999999999999999865 568999


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||+++++|.+++.....   .++...++.++.|++.||.|||+.+++||||||+|||++.++.   ++|+|||+++..
T Consensus       107 v~E~~~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~---~kL~DFG~~~~~  180 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT---VKVADFGLARDM  180 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC---EEECSSGGGCCT
T ss_pred             EEEEeecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC---EEEecccchhhc
Confidence            9999999999988765443   3778899999999999999999999999999999999987665   999999999776


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHcCc
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSITKGK  240 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i~~g~  240 (249)
                      ......         .........+|+.|+|||.+.+..++.++||||||+++|||++|..||..  +..++...+.+|.
T Consensus       181 ~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~  251 (311)
T d1r0pa_         181 YDKEFD---------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  251 (311)
T ss_dssp             TTTTCC---------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTC
T ss_pred             cccccc---------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC
Confidence            543211         11122223578999999999999999999999999999999997776665  4455677777775

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-39  Score=266.46  Aligned_cols=214  Identities=17%  Similarity=0.187  Sum_probs=168.0

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhh-hheeecCCeE
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVEL-LETYSSEGML   80 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~-~~~~~~~~~~   80 (249)
                      |+...++||++.+.|+.|.++.+|...+......++++.....  ...+.+.+|+.+++.++|++++.. ..++.+++..
T Consensus         1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~   78 (299)
T d1ckia_           1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN   78 (299)
T ss_dssp             CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred             CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence            6778899999999999999999997765544444544432222  333568899999999987765555 5555778889


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+. ++|.+.+.....   .+++.++..++.|++.||+|||++|++||||||+|||++..+....++++|||++.
T Consensus        79 ~ivme~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          79 VMVMELLG-PSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEEEECCC-CBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEEEEcC-CchhhhhhhccC---CCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence            99999995 566665544332   38999999999999999999999999999999999998765555669999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ...........      ..+......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~~~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~  215 (299)
T d1ckia_         155 KYRDARTHQHI------PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG  215 (299)
T ss_dssp             ECBCTTTCCBC------CCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eccccccccce------eccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccc
Confidence            87654321111      01122344689999999999999999999999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.5e-40  Score=267.15  Aligned_cols=210  Identities=27%  Similarity=0.428  Sum_probs=165.0

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhcc--ccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--NHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +||++.+.|+.|.++.+|...+. ....++++....  .+....+.+.+|+.+|++++||||++++++|...+..+++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            48999999999999999977654 223344433222  223346789999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++.++.+..+.....    .+++..++.++.|++.||+|||+.+++||||||+|||++.++.   ++++|||.+......
T Consensus        81 ~~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~---~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LKIADFGLARAFGIP  153 (286)
T ss_dssp             CCSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC---EEECCTTHHHHHCC-
T ss_pred             eehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC---EEecccccceecccC
Confidence            998766655544332    3999999999999999999999999999999999999988776   999999998665442


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHHc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSITK  238 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~~  238 (249)
                      ..             ......+++.|+|||.+.+. .++.++|+||+||+++||++|+.||.+ +..+...++.+
T Consensus       154 ~~-------------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~  215 (286)
T d1ob3a_         154 VR-------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR  215 (286)
T ss_dssp             ---------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             cc-------------ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            21             11223478899999998764 468999999999999999999999998 44445555443

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=267.83  Aligned_cols=219  Identities=21%  Similarity=0.351  Sum_probs=172.9

Q ss_pred             CcchHHHhhcccceeeEeeeccc-----cCCCcccCChhc-cccchhHHHHHHHHHHHHHc-CCCChhhhhheeecCCeE
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAE-----IEPASFGLPDER-LNHYTTEADLKREATICHML-KHPHVVELLETYSSEGML   80 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~   80 (249)
                      .+|.+.++|+.|.++.+|.....     .....++++... .........+.+|+.+++.+ +||||+++++++.++..+
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~  102 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT  102 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence            58889999999999999876432     121223333222 22345566899999999999 799999999999999999


Q ss_pred             EEEEeccCCCchhHHHHHhhh--------------cCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecC
Q psy14626         81 YMVFEYMDGSDICFEIVRRAT--------------AGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKE  146 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~  146 (249)
                      ++||||+++++|.+++.....              ....+++.++..++.||+.|++|||+++++||||||+||+++.++
T Consensus       103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~  182 (311)
T d1t46a_         103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR  182 (311)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT
T ss_pred             EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC
Confidence            999999999999999876542              123488999999999999999999999999999999999998766


Q ss_pred             CCCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy14626        147 NSAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLT-GTLPF  225 (249)
Q Consensus       147 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~-g~~pf  225 (249)
                      .   ++++|||.+.........           .......+|+.|+|||.+.+..++.++|||||||++|||++ |++||
T Consensus       183 ~---~ki~DfG~~~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         183 I---TKICDFGLARDIKNDSNY-----------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             E---EEECCCGGGSCTTSCTTS-----------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             c---ccccccchheeccCCCcc-----------eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence            5   999999998766543221           11223457899999999999999999999999999999998 77778


Q ss_pred             CC-C-hHHHHHHHHcCc
Q psy14626        226 VG-S-RDRLFQSITKGK  240 (249)
Q Consensus       226 ~~-~-~~~~~~~i~~g~  240 (249)
                      .+ + .+.+.+.+.+|.
T Consensus       249 ~~~~~~~~~~~~i~~~~  265 (311)
T d1t46a_         249 PGMPVDSKFYKMIKEGF  265 (311)
T ss_dssp             TTCCSSHHHHHHHHHTC
T ss_pred             CCCCHHHHHHHHHhcCC
Confidence            77 3 344555555554

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-39  Score=267.61  Aligned_cols=223  Identities=21%  Similarity=0.335  Sum_probs=178.5

Q ss_pred             CcCCCCCcchHHHhhcccceeeEeeeccc--------cCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhhe
Q psy14626          2 LSVDPNKRITIHEVINHKWLKMKLHTSAE--------IEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLET   73 (249)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   73 (249)
                      |++++ ++|++.+.|+.|.++.+|.....        ..++++.+...  ........+.+|+.++++++||||+++++.
T Consensus        15 ~ei~~-~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          15 WEVAR-EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             TBCCG-GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             eeecH-HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            45554 68899999999999998865432        22333333322  233455679999999999999999999999


Q ss_pred             eecCCeEEEEEeccCCCchhHHHHHhhhc------CCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC
Q psy14626         74 YSSEGMLYMVFEYMDGSDICFEIVRRATA------GFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN  147 (249)
Q Consensus        74 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~  147 (249)
                      +...+..++||||+.+|+|.+++......      ...++...+..++.|++.||.|||+++++||||||+|||++.+..
T Consensus        92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred             EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence            99999999999999999999988754321      123688999999999999999999999999999999999987766


Q ss_pred             CCCeEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCC
Q psy14626        148 SAPVKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTG-TLPFV  226 (249)
Q Consensus       148 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g-~~pf~  226 (249)
                         ++|+|||+++.......           ........+++.|+|||.+.+..++.++|+||+|+++|||++| .+||.
T Consensus       172 ---~Kl~DFGla~~~~~~~~-----------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~  237 (308)
T d1p4oa_         172 ---VKIGDFGMTRDIYETDY-----------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ  237 (308)
T ss_dssp             ---EEECCTTCCCGGGGGGC-----------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTT
T ss_pred             ---EEEeecccceeccCCcc-----------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCC
Confidence               99999999866544221           1112223578999999999999999999999999999999996 68898


Q ss_pred             C-ChHHHHHHHHcCcc
Q psy14626        227 G-SRDRLFQSITKGKL  241 (249)
Q Consensus       227 ~-~~~~~~~~i~~g~~  241 (249)
                      + +..++.+.+.+|..
T Consensus       238 ~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         238 GLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             TSCHHHHHHHHHTTCC
T ss_pred             CCCHHHHHHHHHhCCC
Confidence            8 67788888887663

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.5e-39  Score=262.51  Aligned_cols=209  Identities=16%  Similarity=0.190  Sum_probs=168.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCC-CChhhhhheeecCCeEEEEEe
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKH-PHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      ++||++.+.|+.|.++.+|...+......++++....  ......+.+|+..++.++| +|++.+++++.++...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~--~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEEC--CTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcc--ccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            5789999999999999999887655444455442221  2334567899999999964 899999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCC--CCCeEEcCcceeEEcc
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKEN--SAPVKLGGFGVAIQLQ  163 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~--~~~~~l~dfg~~~~~~  163 (249)
                      |+ +++|.+++.....   .++..++..++.|++.||.+||++|++||||||+||+++.+..  ...++|+|||++....
T Consensus        82 ~~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          82 LL-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             CC-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99 6799888765443   3899999999999999999999999999999999999975322  2449999999998876


Q ss_pred             CCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        164 DGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ........      .........||+.|+|||++.+..++.++|+||||+++|||++|+.||.+
T Consensus       158 ~~~~~~~~------~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~  215 (293)
T d1csna_         158 DPVTKQHI------PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  215 (293)
T ss_dssp             CTTTCCBC------CCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred             cCccccce------eecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCC
Confidence            54321110      11123344699999999999999999999999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=265.78  Aligned_cols=206  Identities=23%  Similarity=0.371  Sum_probs=161.8

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhc-cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER-LNHYTTEADLKREATICHMLKHPHVVELLETYSSEG----   78 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   78 (249)
                      ++.+.||++.+.|+.|.++.+|...+......++++... .......+.+.+|+.+|++++||||+++++++....    
T Consensus         4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence            566789999999999999999988765555555554332 223445678999999999999999999999986542    


Q ss_pred             -eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcc
Q psy14626         79 -MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFG  157 (249)
Q Consensus        79 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg  157 (249)
                       .+++++ ++.+++|.+++...     .+++..++.++.|++.||.|||++|++||||||+|||++.++.   ++|+|||
T Consensus        84 ~~~~l~~-~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~---~kl~DfG  154 (345)
T d1pmea_          84 KDVYLVT-HLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD---LKICDFG  154 (345)
T ss_dssp             CCEEEEE-ECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCCT
T ss_pred             ceEEEEE-eecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC---EEEcccC
Confidence             345554 55688999988643     2899999999999999999999999999999999999987765   9999999


Q ss_pred             eeEEccCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        158 VAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      ++.........          ........+++.|+|||.+.. ..++.++|+||+||++++|++|+.||.+.
T Consensus       155 ~a~~~~~~~~~----------~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~  216 (345)
T d1pmea_         155 LARVADPDHDH----------TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK  216 (345)
T ss_dssp             TCEECCGGGCB----------CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ceeeccCCCcc----------ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCC
Confidence            99776543211          112233458899999999854 55689999999999999999999999883

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-39  Score=267.47  Aligned_cols=207  Identities=24%  Similarity=0.376  Sum_probs=160.3

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG----   78 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----   78 (249)
                      +..+||++.+.|+.|.++.+|...+......++++..  ...+....+.+.+|+.+|+.++||||++++++|...+    
T Consensus        15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~   94 (346)
T d1cm8a_          15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD   94 (346)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence            4578999999999999999998766544444444322  2233455678999999999999999999999997654    


Q ss_pred             --eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCc
Q psy14626         79 --MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGF  156 (249)
Q Consensus        79 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~df  156 (249)
                        .+|+||||+ +.+|...... .    .+++..++.++.||+.||.|||++|++||||||+|||++.++.   ++++||
T Consensus        95 ~~~~~lv~e~~-~~~l~~~~~~-~----~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~---~kl~Df  165 (346)
T d1cm8a_          95 FTDFYLVMPFM-GTDLGKLMKH-E----KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE---LKILDF  165 (346)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH-C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC---EEECCC
T ss_pred             cceEEEEEecc-cccHHHHHHh-c----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc---cccccc
Confidence              479999999 5577665533 2    2899999999999999999999999999999999999988776   999999


Q ss_pred             ceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCCC-hHHHHH
Q psy14626        157 GVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVGS-RDRLFQ  234 (249)
Q Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~~-~~~~~~  234 (249)
                      |.+.......                ....+|+.|+|||.+.+. .++.++|+||+||++++|++|+.||.+. ......
T Consensus       166 g~a~~~~~~~----------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~  229 (346)
T d1cm8a_         166 GLARQADSEM----------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK  229 (346)
T ss_dssp             TTCEECCSSC----------------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cceeccCCcc----------------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHH
Confidence            9997765422                223588999999998764 4689999999999999999999999983 333333


Q ss_pred             HH
Q psy14626        235 SI  236 (249)
Q Consensus       235 ~i  236 (249)
                      .+
T Consensus       230 ~~  231 (346)
T d1cm8a_         230 EI  231 (346)
T ss_dssp             HH
T ss_pred             HH
Confidence            33

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-39  Score=264.93  Aligned_cols=220  Identities=23%  Similarity=0.351  Sum_probs=168.2

Q ss_pred             CCCCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeec------
Q psy14626          5 DPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSS------   76 (249)
Q Consensus         5 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------   76 (249)
                      |+-.||++.+.++.|.++.+|...+......++++..  ........+++.+|+.+|+.++||||+++++++..      
T Consensus         7 ~~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             CBGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             CccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            5668999999999999999998776544444444322  12223445678999999999999999999999854      


Q ss_pred             --CCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         77 --EGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        77 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                        ...+++|||++.++.+......    ...+++..++.++.|++.||.|||++|++||||||+|||++.++.   ++++
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~---~kl~  159 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV---LKLA  159 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC---EEEC
T ss_pred             ccCceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc---EEee
Confidence              3458999999987655433222    223899999999999999999999999999999999999987766   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHH
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ-KYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRL  232 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~  232 (249)
                      |||++..........         ........+|+.|+|||++.+. .+++++||||+||+++||++|+.||.+ +....
T Consensus       160 dfg~~~~~~~~~~~~---------~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~  230 (318)
T d3blha1         160 DFGLARAFSLAKNSQ---------PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ  230 (318)
T ss_dssp             CCTTCEECCC--------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ecceeeecccccccc---------cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHH
Confidence            999997765433211         1122234589999999998765 579999999999999999999999998 44455


Q ss_pred             HHHHHcCc
Q psy14626        233 FQSITKGK  240 (249)
Q Consensus       233 ~~~i~~g~  240 (249)
                      ...+.+..
T Consensus       231 ~~~i~~~~  238 (318)
T d3blha1         231 LALISQLC  238 (318)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHhc
Confidence            55555543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-39  Score=265.11  Aligned_cols=219  Identities=24%  Similarity=0.374  Sum_probs=173.1

Q ss_pred             CcchHHHhhcccceeeEeeecccc------CCCcccCChhcc-ccchhHHHHHHHHHHHHHcCC-CChhhhhheeecCCe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEI------EPASFGLPDERL-NHYTTEADLKREATICHMLKH-PHVVELLETYSSEGM   79 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~   79 (249)
                      ++|++.+.|+.|.++.+|...+..      .++.+.+.+... .+....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            468899999999999998765322      233333333332 223446778999999999966 899999999999999


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      ++++|||+.+++|.+++.....    +++..++.++.||+.||.|+|+++++||||||+||+++.++.   ++|+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~---vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH---VVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC---EEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC---EEEeeccch
Confidence            9999999999999999887665    789999999999999999999999999999999999988766   999999999


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCCC-----hHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQ--KYGKPVDIWAAGVLLHVLLTGTLPFVGS-----RDRL  232 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~pf~~~-----~~~~  232 (249)
                      ........            .......+++.|+|||.+.+.  .++.++||||+||+||+|++|+.||.+.     ...+
T Consensus       177 ~~~~~~~~------------~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i  244 (322)
T d1vzoa_         177 KEFVADET------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  244 (322)
T ss_dssp             EECCGGGG------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             hhhccccc------------ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            77644221            122334588999999998764  3678999999999999999999999872     2344


Q ss_pred             HHHHHcCcccccc
Q psy14626        233 FQSITKGKLHILG  245 (249)
Q Consensus       233 ~~~i~~g~~~~~~  245 (249)
                      ......+.+.+|.
T Consensus       245 ~~~~~~~~~~~~~  257 (322)
T d1vzoa_         245 SRRILKSEPPYPQ  257 (322)
T ss_dssp             HHHHHHCCCCCCT
T ss_pred             HHhcccCCCCCcc
Confidence            5555556666653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-38  Score=262.99  Aligned_cols=207  Identities=28%  Similarity=0.343  Sum_probs=161.5

Q ss_pred             cchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeec------CCeEEE
Q psy14626          9 RITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSS------EGMLYM   82 (249)
Q Consensus         9 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~l   82 (249)
                      +|+...+|+.|.++.+|...+......++++......    ..+.+|+.+|++++||||++++++|..      ...+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888899999999999987776555555554332221    234579999999999999999999843      335899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      ||||++++ +...+.........+++.+++.++.|++.||+|||++|++||||||+|||++.++.  .++|+|||++...
T Consensus        97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~--~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA--VLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC--CEEECCCTTCEEC
T ss_pred             EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC--ceeEecccchhhc
Confidence            99999765 44444443334445999999999999999999999999999999999999986642  2899999998776


Q ss_pred             cCCCccccCCccccccccccCCcccCCCCCCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHH
Q psy14626        163 QDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIED-QKYGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSI  236 (249)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i  236 (249)
                      .....              .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.. +....+..|
T Consensus       174 ~~~~~--------------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i  235 (350)
T d1q5ka_         174 VRGEP--------------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEI  235 (350)
T ss_dssp             CTTSC--------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred             cCCcc--------------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHH
Confidence            54321              122358999999998765 5679999999999999999999999998 444444444

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-38  Score=255.70  Aligned_cols=211  Identities=22%  Similarity=0.359  Sum_probs=170.5

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeecCCeEEEEEe
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSSEGMLYMVFE   85 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (249)
                      +||++.+.|+.|.++.+|...+......++++...  .......+++.+|+.+|+.++||||+++++++.+....++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            58999999999999999988776555445554322  2334567889999999999999999999999999999999999


Q ss_pred             ccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeEEccCC
Q psy14626         86 YMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQLQDG  165 (249)
Q Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~~~~  165 (249)
                      ++.+++|..++....    .+++..++.++.|++.||+|||+++++||||||+|||++.++.   ++++|||.+......
T Consensus        82 ~~~~~~l~~~~~~~~----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~---~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCNG----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---LKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---EEECCCTTCEECCSC
T ss_pred             ecccccccccccccc----ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc---eeeeecchhhcccCC
Confidence            999988877665443    3899999999999999999999999999999999999987665   999999999876543


Q ss_pred             CccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC--ChHHHHHHHHc
Q psy14626        166 QLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG--SRDRLFQSITK  238 (249)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~--~~~~~~~~i~~  238 (249)
                      ..             ......+++.|+|||.+.+.. ++.++||||+||+++||++|+.||..  +..+....+..
T Consensus       155 ~~-------------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~  217 (292)
T d1unla_         155 VR-------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR  217 (292)
T ss_dssp             CS-------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred             Cc-------------cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHh
Confidence            21             112224677899999987665 58999999999999999999988654  34444444433

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=9.6e-38  Score=258.53  Aligned_cols=198  Identities=22%  Similarity=0.392  Sum_probs=162.0

Q ss_pred             CCCCCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-CCChhhhhheeec--CCeE
Q psy14626          4 VDPNKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-HPHVVELLETYSS--EGML   80 (249)
Q Consensus         4 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~   80 (249)
                      +.-.++|++.+.|+.|.++.+|...+......++++...   ....+.+.+|+.+|+.++ ||||++++++|..  ...+
T Consensus        31 ~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~---~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~  107 (328)
T d3bqca1          31 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK---PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  107 (328)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---SSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred             CCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEC---HHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence            445568999999999999999987765554445544322   233567899999999995 9999999999974  4569


Q ss_pred             EEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626         81 YMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      ++||||+.+++|....       ..+++..++.++.||+.||.|||++|++||||||+|||++.++.  .++|+|||.+.
T Consensus       108 ~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~--~vkl~DFG~a~  178 (328)
T d3bqca1         108 ALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR--KLRLIDWGLAE  178 (328)
T ss_dssp             EEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCGGGCE
T ss_pred             eEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC--eeeecccccce
Confidence            9999999999986542       13899999999999999999999999999999999999986543  28999999998


Q ss_pred             EccCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        161 QLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ......              ......+|+.|+|||.+.+.. ++.++|+||+||++++|++|+.||..
T Consensus       179 ~~~~~~--------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~  232 (328)
T d3bqca1         179 FYHPGQ--------------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH  232 (328)
T ss_dssp             ECCTTC--------------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             eccCCC--------------cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence            765432              112235789999999987654 69999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-37  Score=260.38  Aligned_cols=198  Identities=23%  Similarity=0.323  Sum_probs=153.6

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhc--cccchhHHHHHHHHHHHHHcCCCChhhhhheeec------CC
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDER--LNHYTTEADLKREATICHMLKHPHVVELLETYSS------EG   78 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~   78 (249)
                      -+||++.++|+.|.++.+|...+......+|++...  ..+....+.+.+|+.++++++||||++++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            378999999999999999987765444444444322  2234556679999999999999999999999953      36


Q ss_pred             eEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCcce
Q psy14626         79 MLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGV  158 (249)
Q Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~  158 (249)
                      .+|+||||+.++.+ +.+.      ..+++..++.++.|++.||.|||++|++||||||+|||++.++.   ++++|||.
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~---~kl~df~~  165 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT---LKILDFGL  165 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC---EEECCCCC
T ss_pred             eeEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc---eeeechhh
Confidence            79999999976544 3332      13899999999999999999999999999999999999988776   89999998


Q ss_pred             eEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy14626        159 AIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVGS  228 (249)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~~  228 (249)
                      +.......              ......+|+.|+|||++.+..+++++|+||+||++++|++|+.||.+.
T Consensus       166 ~~~~~~~~--------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~  221 (355)
T d2b1pa1         166 ARTAGTSF--------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR  221 (355)
T ss_dssp             -----------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hhcccccc--------------ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence            76554422              122235789999999999999999999999999999999999999984

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-38  Score=256.35  Aligned_cols=200  Identities=19%  Similarity=0.227  Sum_probs=151.2

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcCCCChhhhhheeecCC----eEEE
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLKHPHVVELLETYSSEG----MLYM   82 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~l   82 (249)
                      +++|...+.|+.|.++.+|.....  ...++++..... .........|+..+.+++||||+++++++.+.+    .+++
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~-~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECcc-chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            467888899999999999876543  223333322111 122222334555556789999999999996543    5899


Q ss_pred             EEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH--------CCceeecCCCCCeeeeecCCCCCeEEc
Q psy14626         83 VFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE--------NDIIHRDIKPHCVLLANKENSAPVKLG  154 (249)
Q Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~--------~~~vH~dlkp~Nili~~~~~~~~~~l~  154 (249)
                      ||||+++|+|.+++.+..     +++.++..++.|++.||.++|+        ++++||||||+|||++.++.   +||+
T Consensus        79 v~Ey~~~g~L~~~l~~~~-----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~---~Kl~  150 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT---CCIA  150 (303)
T ss_dssp             EEECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC---EEEC
T ss_pred             EEecccCCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC---eEEE
Confidence            999999999999997542     8999999999999999999996        58999999999999987766   9999


Q ss_pred             CcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCC------CCCcchHHHHHHHHHHHHhCCCCCC
Q psy14626        155 GFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK------YGKPVDIWAAGVLLHVLLTGTLPFV  226 (249)
Q Consensus       155 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~~l~el~~g~~pf~  226 (249)
                      |||++..........         ........||+.|+|||++.+..      ++.++|||||||++|||++|..||.
T Consensus       151 DFGl~~~~~~~~~~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         151 DLGLAVRHDSATDTI---------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             CCTTCEEEETTTTEE---------CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred             ecCccccccCCCcce---------eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence            999998776533211         11223346899999999987643      4668999999999999999987764

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-37  Score=259.34  Aligned_cols=209  Identities=22%  Similarity=0.326  Sum_probs=161.9

Q ss_pred             CCcchHHHhhcccceeeEeeeccccCCCcccCChh--ccccchhHHHHHHHHHHHHHcCCCChhhhhheeecC-----Ce
Q psy14626          7 NKRITIHEVINHKWLKMKLHTSAEIEPASFGLPDE--RLNHYTTEADLKREATICHMLKHPHVVELLETYSSE-----GM   79 (249)
Q Consensus         7 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~   79 (249)
                      .+||++.+.|+.|.++.+|...+......++++..  ...+....+.+.+|+.+|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46899999999999999998765544444444322  223345567889999999999999999999998532     33


Q ss_pred             EEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeEEcCccee
Q psy14626         80 LYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVKLGGFGVA  159 (249)
Q Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~  159 (249)
                      .+++++++.+++|.+++..+     .+++.+++.++.||+.||.|||++|++||||||+|||++.++.   ++++|||.+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~---~kl~dfg~a  168 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE---LKILDFGLA  168 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC---EEECCC---
T ss_pred             eEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc---ccccccchh
Confidence            45666777789999887432     3899999999999999999999999999999999999988776   999999998


Q ss_pred             EEccCCCccccCCccccccccccCCcccCCCCCCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCC-ChHHHHHHHH
Q psy14626        160 IQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQK-YGKPVDIWAAGVLLHVLLTGTLPFVG-SRDRLFQSIT  237 (249)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~pf~~-~~~~~~~~i~  237 (249)
                      .....                ......+++.|+|||...+.. ++.++|+||+||++|+|++|+.||.+ +.......|.
T Consensus       169 ~~~~~----------------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~  232 (348)
T d2gfsa1         169 RHTDD----------------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  232 (348)
T ss_dssp             -CCTG----------------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             cccCc----------------ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            55433                122335788999999877654 58999999999999999999999998 4444555554


Q ss_pred             cC
Q psy14626        238 KG  239 (249)
Q Consensus       238 ~g  239 (249)
                      +.
T Consensus       233 ~~  234 (348)
T d2gfsa1         233 RL  234 (348)
T ss_dssp             HH
T ss_pred             Hh
Confidence            43

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=6e-31  Score=220.08  Aligned_cols=202  Identities=19%  Similarity=0.300  Sum_probs=153.1

Q ss_pred             CcchHHHhhcccceeeEeeeccccCCCcccCChhccccchhHHHHHHHHHHHHHcC-----------CCChhhhhheeec
Q psy14626          8 KRITIHEVINHKWLKMKLHTSAEIEPASFGLPDERLNHYTTEADLKREATICHMLK-----------HPHVVELLETYSS   76 (249)
Q Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~~i~~~~~~~~~   76 (249)
                      .||++.++|+.|.++.+|...+......++++.... +....+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~-~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec-cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            479999999999999999877654444444443222 2234567889999998885           4788889988854


Q ss_pred             C--CeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHH-CCceeecCCCCCeeeeecCCC---CC
Q psy14626         77 E--GMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHE-NDIIHRDIKPHCVLLANKENS---AP  150 (249)
Q Consensus        77 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~~vH~dlkp~Nili~~~~~~---~~  150 (249)
                      .  ...++++.+........... .......+++..++.++.|++.|+.+||+ .|++||||||+|||++.++..   ..
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALI-KKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHH-HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             ccccceeeeeeeccccccccccc-ccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence            3  45666777665444332222 22233458999999999999999999998 899999999999999866532   23


Q ss_pred             eEEcCcceeEEccCCCccccCCccccccccccCCcccCCCCCCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy14626        151 VKLGGFGVAIQLQDGQLYCSGGERLDHYTTKAGHRIGTPHYMAPEVIEDQKYGKPVDIWAAGVLLHVLLTGTLPFVG  227 (249)
Q Consensus       151 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~pf~~  227 (249)
                      ++++|||.+......                .....+|+.|+|||++.+..++.++|+||+||++++|++|+.||..
T Consensus       171 ~kl~dfg~s~~~~~~----------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         171 IKIADLGNACWYDEH----------------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             EEECCCTTCEETTBC----------------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             eeEeecccccccccc----------------cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence            799999998654432                2234589999999999998899999999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.80  E-value=1.3e-20  Score=143.06  Aligned_cols=134  Identities=11%  Similarity=0.124  Sum_probs=96.9

Q ss_pred             hHHHhhcccceeeEeeeccccCCCcccCChhcc--------c----------cchhHHHHHHHHHHHHHcCCCChhhhhh
Q psy14626         11 TIHEVINHKWLKMKLHTSAEIEPASFGLPDERL--------N----------HYTTEADLKREATICHMLKHPHVVELLE   72 (249)
Q Consensus        11 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~----------~~~~~~~~~~E~~~l~~l~h~~i~~~~~   72 (249)
                      .+++.|+.|.++.+|...+.. ...++++....        .          .........+|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~-g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETT-TEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECCC-CCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            467788999999999765442 22233321100        0          0122345667889999999999888765


Q ss_pred             eeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHHHCCceeecCCCCCeeeeecCCCCCeE
Q psy14626         73 TYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCHENDIIHRDIKPHCVLLANKENSAPVK  152 (249)
Q Consensus        73 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~~vH~dlkp~Nili~~~~~~~~~~  152 (249)
                      ...    .+++||++++..+..           ++...+..++.|++.++.+||++|++|+||||+|||++.++    ++
T Consensus        82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~----~~  142 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG----IW  142 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE----EE
T ss_pred             ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC----EE
Confidence            432    379999998765422           45556678999999999999999999999999999998543    89


Q ss_pred             EcCcceeEEccC
Q psy14626        153 LGGFGVAIQLQD  164 (249)
Q Consensus       153 l~dfg~~~~~~~  164 (249)
                      |+|||.+.....
T Consensus       143 liDFG~a~~~~~  154 (191)
T d1zara2         143 IIDFPQSVEVGE  154 (191)
T ss_dssp             ECCCTTCEETTS
T ss_pred             EEECCCcccCCC
Confidence            999999866543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.22  E-value=4.3e-07  Score=70.37  Aligned_cols=102  Identities=18%  Similarity=0.194  Sum_probs=68.2

Q ss_pred             hHHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCchhHHHHHhhhcCCccCHHHHHHHHHHHHHHHHHHH
Q psy14626         48 TEADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDICFEIVRRATAGFVYSEAVASHYMRQVLEALRYCH  126 (249)
Q Consensus        48 ~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH  126 (249)
                      ....+.+|+.++..+. +--+++++.+...++..++||++++|.++.+...         +......++.++...+..||
T Consensus        52 ~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~---------~~~~~~~~~~~l~~~l~~lH  122 (263)
T d1j7la_          52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFH  122 (263)
T ss_dssp             STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT---------TCSCHHHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc---------ccccHHHHHHHHHHHHHHHh
Confidence            3445788999888884 4346788888888888999999999877644321         11111223444444455555


Q ss_pred             H-----------------------------------------------------------CCceeecCCCCCeeeeecCC
Q psy14626        127 E-----------------------------------------------------------NDIIHRDIKPHCVLLANKEN  147 (249)
Q Consensus       127 ~-----------------------------------------------------------~~~vH~dlkp~Nili~~~~~  147 (249)
                      +                                                           ..++|+|+.|.||+++.++.
T Consensus       123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~  202 (263)
T d1j7la_         123 SIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKV  202 (263)
T ss_dssp             TSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEE
T ss_pred             ccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCce
Confidence            3                                                           12689999999999975432


Q ss_pred             CCCeEEcCcceeEE
Q psy14626        148 SAPVKLGGFGVAIQ  161 (249)
Q Consensus       148 ~~~~~l~dfg~~~~  161 (249)
                         +.|+||+.+..
T Consensus       203 ---~~lIDwe~a~~  213 (263)
T d1j7la_         203 ---SGFIDLGRSGR  213 (263)
T ss_dssp             ---EEECCCTTCEE
T ss_pred             ---EEEeechhccc
Confidence               46999987643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.57  E-value=2.6e-05  Score=59.60  Aligned_cols=44  Identities=18%  Similarity=0.290  Sum_probs=33.4

Q ss_pred             HHHHHHHHHHHHHcC--CCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         49 EADLKREATICHMLK--HPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      ...+..|+.+++.+.  .-.+++++....+++..++||++++|.++
T Consensus        48 ~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          48 LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            345788888888884  23367778777788889999999988654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.31  E-value=0.00023  Score=58.09  Aligned_cols=30  Identities=20%  Similarity=0.248  Sum_probs=25.0

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeEEc
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQL  162 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~~  162 (249)
                      .++|||++|.||+++.++    ++++||..+...
T Consensus       224 ~LiHGDl~~gNIlv~~~~----~~vID~E~a~~G  253 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE----TKVIDPEFAFYG  253 (392)
T ss_dssp             EEECSCCCGGGEEECSSC----EEECCCTTCEEE
T ss_pred             ceeccCCcCCceeEcCCc----eEEechhhcccC
Confidence            589999999999997653    899999877544

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.70  E-value=0.0078  Score=48.65  Aligned_cols=40  Identities=23%  Similarity=0.277  Sum_probs=28.4

Q ss_pred             HHHHHHHHHHHHHcC-CCChhhhhheeecCCeEEEEEeccCCCch
Q psy14626         49 EADLKREATICHMLK-HPHVVELLETYSSEGMLYMVFEYMDGSDI   92 (249)
Q Consensus        49 ~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   92 (249)
                      .....+|..+++.+. +.-.+++++++..    .+|++|++|..+
T Consensus        88 ~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          88 ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            345678999999884 5555677777653    578999987543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=94.86  E-value=0.042  Score=42.91  Aligned_cols=27  Identities=15%  Similarity=0.060  Sum_probs=22.1

Q ss_pred             CceeecCCCCCeeeeecCCCCCeEEcCcceeE
Q psy14626        129 DIIHRDIKPHCVLLANKENSAPVKLGGFGVAI  160 (249)
Q Consensus       129 ~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~  160 (249)
                      +++|+|+.+.|||+++ +    ..++||+-+.
T Consensus       193 ~liHgDlh~~NvL~~~-~----~~~IDFdd~~  219 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G----PMFVDLDDAR  219 (325)
T ss_dssp             EECCSSCSGGGEEESS-S----EEECCCTTCC
T ss_pred             eeecCCCCcccEEEeC-C----ceEEechhcc
Confidence            6899999999999963 2    4689998763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.24  E-value=0.0048  Score=48.17  Aligned_cols=31  Identities=26%  Similarity=0.273  Sum_probs=25.2

Q ss_pred             CCceeecCCCCCeeeeecCCCCCeEEcCcceeEE
Q psy14626        128 NDIIHRDIKPHCVLLANKENSAPVKLGGFGVAIQ  161 (249)
Q Consensus       128 ~~~vH~dlkp~Nili~~~~~~~~~~l~dfg~~~~  161 (249)
                      .|+||+|+.++|++++++.-   ..++||+.+..
T Consensus       183 ~giIHgDl~~dNvl~~~~~v---~gvIDF~~~~~  213 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDEL---SGLIDFYFACN  213 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEE---EEECCCTTCEE
T ss_pred             cccccCCcchhhhhcccccc---eeEeccccccc
Confidence            37999999999999986542   58999997743